PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Liu, JC; Ferreira, CG; Yusufzai, T				Liu, Jessica C.; Ferreira, Catarina G.; Yusufzai, Timur			Human CHD2 Is a Chromatin Assembly ATPase Regulated by Its Chromo- and DNA-binding Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; Chromatin Remodeling; DNA-binding Protein; Epilepsy; Nucleosome; CHD2; Chromodomains	REMODELING FACTOR; MOUSE DEVELOPMENT; SNF2 FAMILY; ISWI; ACF; NUCLEOSOMES; MUTATIONS; HELICASE; PROTEIN; IDENTIFICATION	Background: CHD2 is a conserved ATPase and deletions of CHD2 have been linked to developmental and neurological disorders. Results: The regions flanking the ATPase domain of CHD2 confer substrate specificity and couple ATP hydrolysis to remodeling. Conclusion: CHD2 possesses nucleosome assembly activity regulated by its accessory domains. Significance: Understanding the mechanisms of chromatin remodeling is crucial for delineating how remodeling defects contribute to human diseases. Chromodomain helicase DNA-binding protein 2 (CHD2) is an ATPase and a member of the SNF2-like family of helicase-related enzymes. Although deletions of CHD2 have been linked to developmental defects in mice and epileptic disorders in humans, little is known about its biochemical and cellular activities. In this study, we investigate the ATP-dependent activity of CHD2 and show that CHD2 catalyzes the assembly of chromatin into periodic arrays. We also show that the N-terminal region of CHD2, which contains tandem chromodomains, serves an auto-inhibitory role in both the DNA-binding and ATPase activities of CHD2. While loss of the N-terminal region leads to enhanced chromatin-stimulated ATPase activity, the N-terminal region is required for ATP-dependent chromatin remodeling by CHD2. In contrast, the C-terminal region, which contains a putative DNA-binding domain, selectively senses double-stranded DNA of at least 40 base pairs in length and enhances the ATPase and chromatin remodeling activities of CHD2. Our study shows that the accessory domains of CHD2 play central roles in both regulating the ATPase domain and conferring selectivity to chromatin substrates.	[Liu, Jessica C.; Ferreira, Catarina G.; Yusufzai, Timur] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Liu, Jessica C.; Ferreira, Catarina G.; Yusufzai, Timur] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02215 USA; [Liu, Jessica C.] Harvard Univ, Dept Mol & Cellular Biol, Grad Program Mol Cells & Organisms, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University	Yusufzai, T (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave,JF520, Boston, MA 02215 USA.	timur_yusufzai@dfci.harvard.edu	Ferreira, Carlos Gil/AAD-4104-2020; Ferreira, Carlos Gil/G-4957-2013	Ferreira, Carlos Gil/0000-0002-7228-7018; 				Alexiadis V, 2004, J BIOL CHEM, V279, P27824, DOI 10.1074/jbc.M402648200; Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Boyer LA, 2000, J BIOL CHEM, V275, P11545, DOI 10.1074/jbc.275.16.11545; Brehm A, 2004, BIOESSAYS, V26, P133, DOI 10.1002/bies.10392; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Chenier S, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-9; Clapier CR, 2012, NATURE, V492, P280, DOI 10.1038/nature11625; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Courage C, 2014, EUR J MED GENET, V57, P520, DOI 10.1016/j.ejmg.2014.06.003; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Gaffney DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003036; Gangaraju VK, 2007, MUTAT RES-FUND MOL M, V618, P3, DOI 10.1016/j.mrfmmm.2006.08.015; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Harada A, 2012, EMBO J, V31, P2994, DOI 10.1038/emboj.2012.136; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; HENIKOFF S, 1993, TRENDS BIOCHEM SCI, V18, P291, DOI 10.1016/0968-0004(93)90037-N; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kulkarni S, 2008, AM J MED GENET A, V146A, P1117, DOI 10.1002/ajmg.a.32178; Lake RJ, 2010, MOL CELL, V37, P235, DOI 10.1016/j.molcel.2009.10.027; Lund C, 2014, EPILEPSY BEHAV, V33, P18, DOI 10.1016/j.yebeh.2014.02.005; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Marfella CGA, 2006, J CELL PHYSIOL, V209, P162, DOI 10.1002/jcp.20718; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; Quan JH, 2014, J BIOL CHEM, V289, P20717, DOI 10.1074/jbc.M114.568568; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Robinson KM, 2003, MOL CELL BIOL, V23, P7937, DOI 10.1128/MCB.23.22.7937-7946.2003; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Suls A, 2013, AM J HUM GENET, V93, P967, DOI 10.1016/j.ajhg.2013.09.017; Torigoe SE, 2013, ELIFE, V2, DOI 10.7554/eLife.00863; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; WIDOM J, 1992, P NATL ACAD SCI USA, V89, P1095, DOI 10.1073/pnas.89.3.1095; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233	43	27	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					25	34		10.1074/jbc.M114.609156	http://dx.doi.org/10.1074/jbc.M114.609156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25384982	Green Published, hybrid			2022-12-26	WOS:000347231200003
J	Goelman, G; Gordon, N; Bonne, O				Goelman, Gadi; Gordon, Noam; Bonne, Omer			Maximizing Negative Correlations in Resting-State Functional Connectivity MRI by Time-Lag	PLOS ONE			English	Article							BOLD RESPONSES; DEFAULT-MODE; STRESS RESILIENCE; NEURONAL-ACTIVITY; NEURAL ORIGIN; GLOBAL SIGNAL; HUMAN BRAIN; BLOOD-FLOW; NETWORKS; FLUCTUATIONS	This paper aims to better understand the physiological meaning of negative correlations in resting state functional connectivity MRI (r-fcMRI). The correlations between anatomy-based brain regions of 18 healthy humans were calculated and analyzed with and without a correction for global signal and with and without spatial smoothing. In addition, correlations between anatomy-based brain regions of 18 naive anesthetized rats were calculated and compared to the human data. T-statistics were used to differentiate between positive and negative connections. The application of spatial smoothing and global signal correction increased the number of significant positive connections but their effect on negative connections was complex. Positive connections were mainly observed between cortical structures while most negative connections were observed between cortical and non-cortical structures with almost no negative connections between non-cortical structures. In both human and rats, negative connections were never observed between bilateral homologous regions. The main difference between positive and negative connections in both the human and rat data was that positive connections became less significant with time-lags, while negative connections became more significant with time-lag. This effect was evident in all four types of analyses (with and without global signal correction and spatial smoothing) but was most significant in the analysis with no correction for the global signal. We hypothesize that the valence of r-fcMRI connectivity reflects the relative contributions of cerebral blood volume (CBV) and flow (CBF) to the BOLD signal and that these relative contributions are location-specific. If cerebral circulation is primarily regulated by CBF in one region and by CBV in another, a functional connection between these regions can manifest as an r-fcMRI negative and time-delayed correlation. Similarly, negative correlations could result from spatially inhomogeneous responses of rCBV or rCBF alone. Consequently, neuronal regulation of brain circulation may be deduced from the valence of r-fcMRI connectivity.	[Goelman, Gadi; Gordon, Noam] Hadassah Hebrew Univ, Med Ctr, Human Biol Res Ctr, Dept Med Biophys,MRI MRS Lab, Jerusalem, Israel; [Bonne, Omer] Hadassah Hebrew Univ, Med Ctr, Dept Psychiat, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Goelman, G (corresponding author), Hadassah Hebrew Univ, Med Ctr, Human Biol Res Ctr, Dept Med Biophys,MRI MRS Lab, Jerusalem, Israel.	gadig@hadassah.org.il			Israel Ministry of Health under the Era-Net-Neuron program [8430]; Israeli Ministry of Science [3-9814]	Israel Ministry of Health under the Era-Net-Neuron program; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel)	Funding was provided by Israel Ministry of Health grant number 8430 under the Era-Net-Neuron program and the Israeli Ministry of Science grant number 3-9814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arichi T, 2012, NEUROIMAGE, V63, P663, DOI 10.1016/j.neuroimage.2012.06.054; Bianciardi M, 2011, J CEREBR BLOOD F MET, V31, P401, DOI 10.1038/jcbfm.2010.164; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; Carbonell F, 2011, BRAIN CONNECT, V1, P496, DOI 10.1089/brain.2011.0065; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chai XQJ, 2011, NEUROPSYCHOPHARMACOL, V36, P2009, DOI 10.1038/npp.2011.88; Chang C, 2010, FILM COMMENT, V46, P81; Chen YI, 2010, DEV NEUROSCI-BASEL, V32, P125, DOI 10.1159/000286215; Choi JK, 2010, PSYCHOPHARMACOLOGY, V212, P59, DOI 10.1007/s00213-010-1924-6; Choi JK, 2006, NEUROIMAGE, V30, P700, DOI 10.1016/j.neuroimage.2005.10.029; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Devor A, 2007, J NEUROSCI, V27, P4452, DOI 10.1523/JNEUROSCI.0134-07.2007; Easton N, 2009, NEUROPHARMACOLOGY, V57, P653, DOI 10.1016/j.neuropharm.2009.08.018; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Goelman G, 2014, EUR J NEUROSCI; Goense J, 2012, NEURON, V76, P629, DOI 10.1016/j.neuron.2012.09.019; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Kalthoff D, 2013, NMR BIOMED, V26, P638, DOI 10.1002/nbm.2908; Kastrup A, 2008, NEUROIMAGE, V41, P1364, DOI 10.1016/j.neuroimage.2008.03.049; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Kobayashi E, 2006, HUM BRAIN MAPP, V27, P488, DOI 10.1002/hbm.20193; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Lotan A, 2014, MOL PSYCHIATR, V19, P243, DOI 10.1038/mp.2013.123; Lotan A, 2014, MOL PSYCHIATR, V19, P144, DOI 10.1038/mp.2013.191; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mueggler T, 2011, EUR NEUROPSYCHOPHARM, V21, P344, DOI 10.1016/j.euroneuro.2010.06.010; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakata H, 2009, NEUROSCI LETT, V462, P101, DOI 10.1016/j.neulet.2009.06.088; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Pasley BN, 2007, NEUROIMAGE, V36, P269, DOI 10.1016/j.neuroimage.2006.09.015; Paxinos G., 2007, RAT BRAIN STEREOTACT; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schridde U, 2008, CEREB CORTEX, V18, P1814, DOI 10.1093/cercor/bhm208; Sforazzini F, 2014, NEUROIMAGE, V87, P403, DOI 10.1016/j.neuroimage.2013.09.050; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shih YYI, 2009, J NEUROSCI, V29, P3036, DOI 10.1523/JNEUROSCI.3447-08.2009; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Smith AT, 2004, HUM BRAIN MAPP, V21, P213, DOI 10.1002/hbm.20017; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wang K, 2011, NMR BIOMED, V24, P61, DOI 10.1002/nbm.1556; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zong XP, 2012, NEUROIMAGE, V60, P2238, DOI 10.1016/j.neuroimage.2012.02.052; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	58	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e111554	10.1371/journal.pone.0111554	http://dx.doi.org/10.1371/journal.pone.0111554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396416	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500019
J	Hormann, N; Brandao, I; Jackel, S; Ens, N; Lillich, M; Walter, U; Reinhardt, C				Hoermann, Nives; Brandao, Ines; Jaeckel, Sven; Ens, Nelli; Lillich, Maren; Walter, Ulrich; Reinhardt, Christoph			Gut Microbial Colonization Orchestrates TLR2 Expression, Signaling and Epithelial Proliferation in the Small Intestinal Mucosa	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNITY; GERM-FREE; CELLS; MICE; RECOGNITION; MICROFLORA; COMMENSAL; PATHWAY; TRIF	The gut microbiota is an environmental factor that determines renewal of the intestinal epithelium and remodeling of the intestinal mucosa. At present, it is not resolved if components of the gut microbiota can augment innate immune sensing in the intestinal epithelium via the up-regulation of Toll-like receptors (TLRs). Here, we report that colonization of germ-free (GF) Swiss Webster mice with a complex gut microbiota augments expression of TLR2. The microbiota-dependent upregulation of components of the TLR2 signaling complex could be reversed by a 7 day broad-spectrum antibiotic treatment. TLR2 downstream signaling via the mitogen-activated protein kinase (ERK1/2) and protein-kinase B (AKT) induced by bacterial TLR2 agonists resulted in increased proliferation of the small intestinal epithelial cell line MODE-K. Mice that were colonized from birth with a normal gut microbiota (conventionally-raised; CONV-R) showed signs of increased small intestinal renewal and apoptosis compared with GF controls as indicated by elevated mRNA levels of the proliferation markers Ki67 and Cyclin D1, elevated transcripts of the apoptosis marker Caspase-3 and increased numbers of TUNEL-positive cells per intestinal villus structure. In accordance, TLR2-deficient mice showed reduced proliferation and reduced apoptosis. Our findings suggest that a tuned proliferation response of epithelial cells following microbial colonization could aid to protect the host from its microbial colonizers and increase intestinal surface area.	[Hoermann, Nives; Brandao, Ines; Jaeckel, Sven; Ens, Nelli; Lillich, Maren; Walter, Ulrich; Reinhardt, Christoph] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Jr Grp Translat Res Thrombosis & Hemostasis, Mainz, Germany	Johannes Gutenberg University of Mainz	Reinhardt, C (corresponding author), Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Jr Grp Translat Res Thrombosis & Hemostasis, Mainz, Germany.	Christoph.Reinhardt@unimedizin-mainz.de	Walter, ulrich/W-2478-2017; Brandão, Inês/Y-4252-2019	Walter, ulrich/0000-0001-6784-2307; Brandão, Inês/0000-0003-3767-9515	EU Reintegration Grant [PERG05-GA-2009-249313]; Universitatsbund Wurzburg; Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich 688]; DFG Individual Grants [RE 3450/3-1, RE 3450/5-1]; Stiftung Pathobiochemie; Molekulare Diagnostik; German Federal Ministry for Education and Research (CTH, Junior Group, TRP A6) [BMBF 01EO1003]; Center for Thrombosis and Hemostasis (CTH) Doctoral Candidate Fellowship [BMBF 01EO1003]	EU Reintegration Grant; Universitatsbund Wurzburg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG Individual Grants; Stiftung Pathobiochemie; Molekulare Diagnostik; German Federal Ministry for Education and Research (CTH, Junior Group, TRP A6); Center for Thrombosis and Hemostasis (CTH) Doctoral Candidate Fellowship	This project was funded by an EU Reintegration Grant PERG05-GA-2009-249313 to Christoph Reinhardt, a project grant of the Universitatsbund Wurzburg to C.R., TP A2 of the Sonderforschungsbereich 688 of the Deutsche Forschungsgemeinschaft (DFG) to U.W., DFG Individual Grants to C.R. (RE 3450/3-1; RE 3450/5-1), a project grant from the Stiftung Pathobiochemie and Molekulare Diagnostik to C.R., and the German Federal Ministry for Education and Research (CTH, Junior Group, TRP A6, BMBF 01EO1003). N.H. was an associated member of GRK 1043 - DFG Graduate School of Immunotherapy and received a Center for Thrombosis and Hemostasis (CTH) Doctoral Candidate Fellowship (BMBF 01EO1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS GD, 1963, LAB INVEST, V12, P355; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caricilli AM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001212; Cario E, 2002, AM J PATHOL, V160, P165, DOI 10.1016/S0002-9440(10)64360-X; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Fuller Z, 2007, BRIT J NUTR, V98, P364, DOI 10.1017/S0007114507709091; Gao QX, 2012, MOL CELL BIOCHEM, V361, P31, DOI 10.1007/s11010-011-1084-y; Goke M, 1998, GASTROENTEROLOGY, V114, P697, DOI 10.1016/S0016-5085(98)70583-9; Hanson PJ, 2011, INNATE IMMUN-LONDON, V17, P269, DOI 10.1177/1753425910367813; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Ji YW, 2014, CELL REP, V8, P137, DOI 10.1016/j.celrep.2014.05.040; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Kaczmarek A, 2012, J PATHOL, V226, P598, DOI 10.1002/path.3009; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Petnicki-Ocwieja T, 2013, INFECT IMMUN, V81, P402, DOI 10.1128/IAI.00890-12; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Sheng H, 2003, GUT, V52, P1472, DOI 10.1136/gut.52.10.1472; Sommer F, 2015, MUCOSAL IMMUNOL, V8, P372, DOI 10.1038/mi.2014.74; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Tomas J, 2015, ISME J, V9, P46, DOI 10.1038/ismej.2014.111; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; VIDAL K, 1993, J IMMUNOL METHODS, V166, P63, DOI 10.1016/0022-1759(93)90329-6; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	37	71	72	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113080	10.1371/journal.pone.0113080	http://dx.doi.org/10.1371/journal.pone.0113080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396415	Green Published, Green Submitted, gold			2022-12-26	WOS:000345558500130
J	Zhang, Y; Kang, Y; Zhou, QJ; Zhou, JZ; Wang, HJ; Jin, H; Liu, XH; Ma, D; Li, XT				Zhang, Ying; Kang, Yuan; Zhou, Qiongjie; Zhou, Jizi; Wang, Huijun; Jin, Hong; Liu, Xiaohui; Ma, Duan; Li, Xiaotian			Quantitative Proteomic Analysis of Serum from Pregnant Women Carrying a Fetus with Conotruncal Heart Defect Using Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Labeling	PLOS ONE			English	Article							AMNIOTIC-FLUID; GELSOLIN EXPRESSION; PROTEIN MARKERS; DOWN-REGULATION; IDENTIFICATION; PEPTIDES; DISEASE; PREECLAMPSIA; ASSOCIATION; BIOMARKERS	Objective: To identify differentially expressed proteins from serum of pregnant women carrying a conotruncal heart defects (CTD) fetus, using proteomic analysis. Methods: The study was conducted using a nested case-control design. The 5473 maternal serum samples were collected at 14-18 weeks of gestation. The serum from 9 pregnant women carrying a CTD fetus, 10 with another CHD (ACHD) fetus, and 11 with a normal fetus were selected from the above samples, and analyzed by using isobaric tags for relative and absolute quantitation (iTRAQ) coupled with two-dimensional liquid chromatography-tandem mass spectrometry(2D LC-MS/MS). The differentially expressed proteins identified by iTRAQ were further validated with Western blot. Results: A total of 105 unique proteins present in the three groups were identified, and relative expression data were obtained for 92 of them with high confidence by employing the iTRAQ-based experiments. The downregulation of gelsolin in maternal serum of fetus with CTD was further verified by Western blot. Conclusions: The identification of differentially expressed protein gelsolin in the serum of the pregnant women carrying a CTD fetus by using proteomic technology may be able to serve as a foundation to further explore the biomarker for detection of CTD fetus from the maternal serum.	[Zhang, Ying; Kang, Yuan; Zhou, Qiongjie; Zhou, Jizi; Li, Xiaotian] Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Wang, Huijun] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Jin, Hong; Liu, Xiaohui] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Jin, Hong] Fudan Univ, Inst Biomed, Shanghai 200433, Peoples R China; [Ma, Duan; Li, Xiaotian] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Minist Educ,Key Lab Mol Med,Inst Biomed Sci, Shanghai 200433, Peoples R China; [Li, Xiaotian] Shanghai Key Lab Female Reprod Endocrine Related, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Li, XT (corresponding author), Fudan Univ, Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China.	duanma@fudan.edu.cn; xiaotianli555@163.com	wang, huimin/HDM-8421-2022; Ma, Duan/I-8330-2014; Li, Xiaotian/ABI-3309-2020; wang, hui/GRS-4730-2022	Li, Xiaotian/0000-0002-2051-4581; 	Shanghai Municipal Natural Science Foundation [10ZRI404900]; Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China [201002013]; National Science Fund of China [81270712]; Program of Shanghai Subject Chief Scientist [12XD1401300]; Program of Shanghai Leading Talent; Shanghai Municipal Health Bureau [12GWZX0301]; National Key Basic Research Plan of China (973 Plan) [2010CB529500]	Shanghai Municipal Natural Science Foundation; Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China; National Science Fund of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Program of Shanghai Leading Talent; Shanghai Municipal Health Bureau; National Key Basic Research Plan of China (973 Plan)(National Basic Research Program of China)	This project was supported by Shanghai Municipal Natural Science Foundation (10ZRI404900), Health industry special funds for Public Benefit Research Foundation from the Ministry of Health, People's Republic of China (201002013), the National Science Fund of China (81270712), Program of Shanghai Subject Chief Scientist (12XD1401300), Program of Shanghai Leading Talent (2012), Shanghai Municipal Health Bureau (12GWZX0301), and National Key Basic Research Plan of China (973 Plan) (2010CB529500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostopoulos AK, 2010, J PROTEOMICS, V73, P943, DOI 10.1016/j.jprot.2009.12.009; Auer J, 2010, J PROTEOMICS, V73, P1004, DOI 10.1016/j.jprot.2009.12.014; Benson D. Woodrow, 1996, Current Opinion in Pediatrics, V8, P505, DOI 10.1097/00008480-199610000-00015; Botto LD, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e32; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buskens E, 1996, OBSTET GYNECOL, V87, P423, DOI 10.1016/0029-7844(95)00439-4; Cantinotti M, 2011, CLIN CHEM LAB MED, V49, P567, DOI 10.1515/CCLM.2011.106; Cecconi D, 2011, ELECTROPHORESIS, V32, P3630, DOI 10.1002/elps.201100256; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P773; Clark EB, 1996, SEMIN PERINATOL, V20, P465, DOI 10.1016/S0146-0005(96)80062-0; Cohen TS, 2011, CYTOKINE, V54, P235, DOI 10.1016/j.cyto.2011.02.006; Datta A, 2014, J PROTEOMICS, V99, P54, DOI 10.1016/j.jprot.2014.01.011; Debrus S, 1996, HUM GENET, V97, P138, DOI 10.1007/BF02265254; Eindhoven JA, 2012, J AM COLL CARDIOL, V60, P2140, DOI 10.1016/j.jacc.2012.02.092; Galindo A, 2009, EUR J OBSTET GYN R B, V146, P55, DOI 10.1016/j.ejogrb.2009.04.032; Gardiner H.M., 2001, HEART, V86, P12; Gay F, 2008, HUM PATHOL, V39, P1420, DOI 10.1016/j.humpath.2008.02.020; Gercel-Taylor C, 2012, AM J OBSTET GYNECOL, V206, pE3, DOI 10.1016/j.ajog.2011.09.010; Graves SW, 2011, AM J OBSTET GYNECOL, V204, pS46, DOI 10.1016/j.ajog.2010.09.021; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Hu WS, 2014, MOL CELL BIOCHEM, V390, P263, DOI 10.1007/s11010-014-1977-7; Huang ZL, 2012, TOXICOLOGY, V291, P56, DOI 10.1016/j.tox.2011.10.023; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Jin Y, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.01.002; Kang Y, 2012, PRENATAL DIAG, V32, P284, DOI 10.1002/pd.3829; KIRBY ML, 1995, CIRC RES, V77, P211, DOI 10.1161/01.RES.77.2.211; Kolialexi A, 2008, PRENATAL DIAG, V28, P691, DOI 10.1002/pd.2040; Kolialexi A, 2010, J PROTEOME RES, V9, P5164, DOI 10.1021/pr100459q; Kolla V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/952047; Lee HK, 1999, PROSTATE, V40, P14, DOI 10.1002/(SICI)1097-0045(19990615)40:1<14::AID-PROS2>3.0.CO;2-6; Liao CJ, 2011, GYNECOL ONCOL, V120, P135, DOI 10.1016/j.ygyno.2010.10.005; Lisowski LA, 2010, HERZ, V35, P19, DOI 10.1007/s00059-010-3244-3; Long J, 2010, BIRTH DEFECTS RES A, V88, P971, DOI 10.1002/bdra.20724; Mani SK, 2008, AM J PHYSIOL-HEART C, V295, pH314, DOI 10.1152/ajpheart.00085.2008; Mavrou A, 2008, J PROTEOME RES, V7, P1862, DOI 10.1021/pr700588u; MERKATZ IR, 1984, AM J OBSTET GYNECOL, V148, P886, DOI 10.1016/0002-9378(84)90530-1; Nir A, 2012, BIOMARK MED, V6, P827, DOI [10.2217/BMM.12.73, 10.2217/bmm.12.73]; Noske A, 2005, EUR J CANCER, V41, P461, DOI 10.1016/j.ejca.2004.10.025; Park J, 2011, EXP MOL MED, V43, P427, DOI 10.3858/emm.2011.43.7.047; Park SJ, 2006, PROTEOMICS, V6, P349, DOI 10.1002/pmic.200500084; Pierpont ME, 2007, CIRCULATION, V115, P3015, DOI 10.1161/CIRCULATIONAHA.106.183056; Plageman TF, 2006, DEV DYNAM, V235, P2868, DOI 10.1002/dvdy.20923; Ratajska A, 2009, BIRTH DEFECTS RES A, V85, P599, DOI 10.1002/bdra.20578; Scholl PF, 2012, PLACENTA, V33, P424, DOI 10.1016/j.placenta.2012.02.009; Sezen D, 2009, AM J OBSTET GYNECOL, V200, pe191; Shaw GM, 2010, BIRTH DEFECTS RES A, V88, P144, DOI 10.1002/bdra.20648; van Beynum IM, 2006, EUR HEART J, V27, P981, DOI 10.1093/eurheartj/ehi815; Wald N J, 1997, J Med Screen, V4, P181; Wang TH, 2009, FERTIL STERIL, V92, P96, DOI 10.1016/j.fertnstert.2008.05.038; Winston JS, 2001, BREAST CANCER RES TR, V65, P11, DOI 10.1023/A:1006446108411; Xianhui L, 2014, BURNS, V40, P1552; Xu JF, 2012, J TRAUMA ACUTE CARE, V72, P491, DOI 10.1097/TA.0b013e318226ec39; Xuan C, 2014, ANN THORAC SURG, V97, P1414, DOI 10.1016/j.athoracsur.2013.11.069; Yang JC, 2000, CIRCULATION, V102, P3046; Zhang XP, 2012, ANALYST, V137, P490, DOI 10.1039/c1an15551b	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111645	10.1371/journal.pone.0111645	http://dx.doi.org/10.1371/journal.pone.0111645			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393621	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300017
J	Huang, YW; Liou, RS; Lin, YT; Huang, HH; Yang, TC				Huang, Yi-Wei; Liou, Rung-Shiuan; Lin, Yi-Tsung; Huang, Hsin-Hui; Yang, Tsuey-Ching			A Linkage between SmeIJK Efflux Pump, Cell Envelope Integrity, and sigma(E)-Mediated Envelope Stress Response in Stenotrophomonas maltophilia	PLOS ONE			English	Article							ESCHERICHIA-COLI; DRUG-RESISTANCE; SYSTEM; TRANSCRIPTION; INDUCTION; SIGMA(E)	Resistance nodulation division (RND) efflux pumps, such as the SmeIJK pump of Stenotrophomonas maltophilia, are known to contribute to the multidrug resistance in Gram-negative bacteria. However, some RND pumps are constitutively expressed even though no antimicrobial stresses occur, implying that there should be some physical implications for these RND pumps. In this study, the role of SmeIJK in antimicrobials resistance, envelope integrity, and sigma(E)-mediated envelope stress response (ESR) of S. maltophilia was assessed. SmeIJK was involved in the intrinsic resistance of S. maltophilia KJ to aminoglycosides and leucomycin. Compared with the wild-type KJ, the smeIJK deletion mutant exhibited growth retardation in the MH medium, an increased sensitivity to membrane-damaging agents (MDAs), as well as activation of an sigma(E)-mediated ESR. Moreover, the expression of smeIJK was further induced by sub-lethal concentrations of MDAs or surfactants in an sigma(E)-dependent manner. These data collectively suggested an alternative physiological role of smeIJK in cell envelope integrity maintenance and sigma(E)-mediated ESR beyond the efflux of antibiotics. Because of the necessity of the physiological role of SmeIJK in protecting S. maltophilia from the envelope stress, smeIJK is constitutively expressed, which, in turn, contributes the intrinsic resistance to aminoglycoside and leucomycin. This is the first demonstration of the linkage among RND-type efflux pump, cell envelope integrity, and sigma(E)-mediated ESR in S. maltophilia.	[Huang, Yi-Wei; Liou, Rung-Shiuan; Huang, Hsin-Hui; Yang, Tsuey-Ching] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Lin, Yi-Tsung] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Yang, TC (corresponding author), Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan.	tcyang@ym.edu.tw	Huang, Yi-Wei/K-9717-2019		Ministry of Science and Technology of Taiwan [NSC 101-2320-B-010-053-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	TCY: Ministry of Science and Technology of Taiwan, NSC 101-2320-B-010-053-MY3, http://www.most.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebusuyi AA, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-252; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Begic S, 2008, CAN J MICROBIOL, V54, P411, DOI [10.1139/W08-019, 10.1139/w08-019]; Bordes P, 2011, J BACTERIOL, V193, P246, DOI 10.1128/JB.00884-10; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Cheng CY, 2008, FEMS MICROBIOL LETT, V289, P250, DOI 10.1111/j.1574-6968.2008.01392.x; Clinical Laboratory Standards Institute (CLSI), M7S20 CLSI, P20; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Krulwich TA, 2005, NAT REV MICROBIOL, V3, P566, DOI 10.1038/nrmicro1181; Kumar A, 2005, ANTIMICROB AGENTS CH, V49, P1495, DOI 10.1128/AAC.49.4.1495-1501.2005; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Lin CW, 2009, RES MICROBIOL, V160, P152, DOI 10.1016/j.resmic.2008.11.001; Lin J, 2003, INFECT IMMUN, V71, P4250, DOI 10.1128/IAI.71.8.4250-4259.2003; Mima T, 2009, MICROBIOL-SGM, V155, P3509, DOI 10.1099/mic.0.031260-0; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Paulsen IT, 2001, J MOL MICROB BIOTECH, V3, P145; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Raivio TL, 2013, J BACTERIOL, V195, P2755, DOI 10.1128/JB.00105-13; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Staron A, 2009, MOL MICROBIOL, V74, P557, DOI 10.1111/j.1365-2958.2009.06870.x; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; Wood LF, 2012, MBIO, V3, DOI 10.1128/mBio.00094-12; Yang TC, 2009, ANTIMICROB AGENTS CH, V53, P2902, DOI 10.1128/AAC.01513-08	27	31	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111784	10.1371/journal.pone.0111784	http://dx.doi.org/10.1371/journal.pone.0111784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390933	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400033
J	Vleminckx, J; Morin-Rivat, J; Biwole, AB; Dainou, K; Gillet, JF; Doucet, JL; Drouet, T; Hardy, OJ				Vleminckx, Jason; Morin-Rivat, Julie; Biwole, Achille B.; Dainou, Kasso; Gillet, Jean-Francois; Doucet, Jean-Louis; Drouet, Thomas; Hardy, Olivier J.			Soil Charcoal to Assess the Impacts of Past Human Disturbances on Tropical Forests	PLOS ONE			English	Article							TREE SPECIES COMPOSITION; RAIN-FOREST; SOUTHERN NIGERIA; PLATEAU FOREST; HOLOCENE; OKOMU; WOOD; BP; HISTORY; AFRICA	The canopy of many central African forests is dominated by light-demanding tree species that do not regenerate well under themselves. The prevalence of these species might result from ancient slash-and-burn agricultural activities that created large openings, while a decline of these activities since the colonial period could explain their deficit of regeneration. To verify this hypothesis, we compared soil charcoal abundance, used as a proxy for past slash-and-burn agriculture, and tree species composition assessed on 208 rainforest 0.2 ha plots located in three areas from Southern Cameroon. Species were classified in regeneration guilds (pioneer, non-pioneer light-demanding, shade-bearer) and characterized by their wood-specific gravity, assumed to reflect light requirement. We tested the correlation between soil charcoal abundance and: (i) the relative abundance of each guild, (ii) each species and family abundance and (iii) mean wood-specific gravity. Charcoal was found in 83% of the plots, indicating frequent past forest fires. Radiocarbon dating revealed two periods of fires: "recent" charcoal were on average 300 years old (up to 860 BP, n = 16) and occurred in the uppermost 20 cm soil layer, while "ancient" charcoal were on average 1900 years old (range: 1500 to 2800 BP, n = 43, excluding one sample dated 9400 BP), and found in all soil layers. While we expected a positive correlation between the relative abundance of light-demanding species and charcoal abundance in the upper soil layer, overall there was no evidence that the current heterogeneity in tree species composition can be explained by charcoal abundance in any soil layer. The absence of signal supporting our hypothesis might result from (i) a relatively uniform impact of past slash-and-burn activities, (ii) pedoturbation processes bringing ancient charcoal to the upper soil layer, blurring the signal of centuries-old Human disturbances, or (iii) the prevalence of other environmental factors on species composition.	[Vleminckx, Jason; Hardy, Olivier J.] Univ Libre Bruxelles, Serv Evolut Biol & Ecol, Fac Sci, Brussels, Belgium; [Morin-Rivat, Julie; Biwole, Achille B.; Dainou, Kasso; Gillet, Jean-Francois; Doucet, Jean-Louis] Univ Liege, Unite Gest Ressources Forestieres & Milieux Nat, Lab Foresterie Reg Trop & Subtrop, Gembloux Agrobio Tech, Gembloux, Belgium; [Morin-Rivat, Julie] Royal Museum Cent Africa, Lab Wood Biol & Xylarium, Tervuren, Belgium; [Dainou, Kasso] Univ Abomey Calavi, Lab Appl Ecol, Cotonou, Benin; [Drouet, Thomas] Univ Libre Bruxelles, Fac Sci, Lab Ecol Vegetale & Biogeochim, Brussels, Belgium	Universite Libre de Bruxelles; Royal Museum for Central Africa; University of Abomey Calavi; Universite Libre de Bruxelles	Vleminckx, J (corresponding author), Univ Libre Bruxelles, Serv Evolut Biol & Ecol, Fac Sci, Brussels, Belgium.	jason.vleminckx@ulb.ac.be	Daïnou, Kasso/J-8920-2019	Daïnou, Kasso/0000-0003-2486-1895; Achille, Biwole/0000-0003-3964-771X; Drouet, Thomas/0000-0002-0023-0418	FRFC project (Fonds pour la Recherche Fondamentale et Collective) "Dynamics of tree and herbaceous communities of the tropical forests of Central Africa, in relation with past anthropogenic and climatic disturbance" [2.4577.10]; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA); CoForChange project - ERA-net BiodivERsA	FRFC project (Fonds pour la Recherche Fondamentale et Collective) "Dynamics of tree and herbaceous communities of the tropical forests of Central Africa, in relation with past anthropogenic and climatic disturbance"(Fonds de la Recherche Scientifique - FNRS); Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); CoForChange project - ERA-net BiodivERsA	This study is part of the FRFC project (<< Fonds pour la Recherche Fondamentale et Collective >>, convention n<SUP>o</SUP> 2.4577.10) entitled "Dynamics of tree and herbaceous communities of the tropical forests of Central Africa, in relation with past anthropogenic and climatic disturbance". J. Vleminckx and J. Morin-Rivat are funded by the "Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (FRIA)". The authors gratefully acknowledge the CoForChange project funded through the ERA-net BiodivERsA (http://www.coforchange.eu/fr/). The authors declare that the funders only provided financial support for the field inventories and had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo AGM, 2013, J ARCHAEOL SCI, V40, P2124, DOI 10.1016/j.jas.2012.12.035; Biwole AB, 2014, PLANT ECOLO IN PRESS, V148; Chabal L., 1997, DOCUMENTS ARCHEOLOGI; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Clist B., 2005, THESIS U LIBRE BRUXE; Dauby G, 2011, ECOGRAPHY, V34, P001; Denham TP, 2003, SCIENCE, V301, P189, DOI 10.1126/science.1085255; Elenga H, 1996, CR ACAD SCI II A, V323, P403; Fayolle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042381; Gillet J.-F., 2013, THESIS U LIEGE; Glaser B, 2012, GEOCHIM COSMOCHIM AC, V82, P39, DOI 10.1016/j.gca.2010.11.029; Gouveia SEM, 2000, CR ACAD SCI II A, V330, P133, DOI 10.1016/S1251-8050(00)00114-2; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Hawthorne W.D., 1995, ECOLOGICAL PROFILES; Hubau W, 2013, THESIS GHENT U; JM Fay, 1997, THESIS WASHINGTON U; JOHNSON DL, 1990, SOIL SCI, V149, P84, DOI 10.1097/00010694-199002000-00004; JONES EW, 1955, J ECOL, V43, P564, DOI 10.2307/2257012; JONES EW, 1956, J ECOL, V44, P83, DOI 10.2307/2257155; KEALHOFER L, 2003, ASIAN PERSPECT, V42, P72; Lavelle P, 1983, SOIL FAUNA TROPICAL; Lebrun J., 1954, PUBLICATION INEAC SE, V63; Lee K. E., 1971, TERMITES AND SOILS; MALEY J, 1992, B SOC GEOL FR, V163, P363; MANTEL N, 1967, CANCER RES, V27, P209; MCBREARTY S, 1990, J ARCHAEOL SCI, V17, P111, DOI 10.1016/0305-4403(90)90054-9; Miklos AAW, 1992, THESIS U PARIX 6 FRA; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Morin-Rivat J, 2014, RADIOCARBON, V56, P209, DOI 10.2458/56.16485; Neumann K, 2012, QUATERN INT, V249, P53, DOI 10.1016/j.quaint.2011.03.024; Ngomanda A, 2009, QUATERNARY RES, V71, P307, DOI 10.1016/j.yqres.2008.12.002; Oslisly R, 1996, GROWTH FARMING COMMU, VXXIX-XXX, P324; Oslisly R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0304; R Core Team, 2020, R LANG ENV STAT COMP; Ramsey CB, 2001, RADIOCARBON, V43, P355; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Ramsey CB, 2012, SCIENCE, V338, P370, DOI 10.1126/science.1226660; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Ross NJ, 2011, ECOL APPL, V21, P75, DOI 10.1890/09-0662.1; SCHWARTZ D, 1992, B SOC GEOL FR, V163, P353; Shanahan TM, 2012, PALAEOGEOGR PALAEOCL, V361, P49, DOI 10.1016/j.palaeo.2012.08.001; Slik JWF, 2006, J TROP ECOL, V22, P481, DOI 10.1017/S0266467406003324; Slik JWF, 2005, FOREST ECOL MANAG, V205, P241, DOI 10.1016/j.foreco.2004.10.011; SWAINE MD, 1988, J TROP ECOL, V4, P253, DOI 10.1017/S0266467400002819; Talon B, 2005, QUATERNARY RES, V64, P36, DOI 10.1016/j.yqres.2005.03.003; Talon B, 2010, HOLOCENE, V20, P35, DOI 10.1177/0959683609348842; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; Vincens A, 1998, QUATERNARY RES, V50, P34, DOI 10.1006/qres.1998.1979; White LJT, 1999, GLOBAL ECOL BIOGEOGR, V8, P355, DOI 10.1046/j.1365-2699.1999.00149.x; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991; Wotzka H.-P., 2006, GRUNDLEGUNGEN BEITRA, P271; WRB (World Reference Base for Soil Resources), 2006, WORLD SOIL RES REP, V103; Zanne AE, 2009, GLOBAL WOOD DENSITY	53	26	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e108121	10.1371/journal.pone.0108121	http://dx.doi.org/10.1371/journal.pone.0108121			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391134	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400004
J	Zahedi, K; Barone, S; Wang, Y; Murray-Stewart, T; Roy-Chaudhury, P; Smith, RD; Casero, RA; Soleimani, M				Zahedi, Kamyar; Barone, Sharon; Wang, Yang; Murray-Stewart, Tracy; Roy-Chaudhury, Prabir; Smith, Roger D.; Casero, Robert A., Jr.; Soleimani, Manoocher			Proximal Tubule Epithelial Cell Specific Ablation of the Spermidine/Spermine N-1-Acetyltransferase Gene Reduces the Severity of Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ACUTE KIDNEY INJURY; POLYAMINE CATABOLISM; CEREBRAL-ISCHEMIA; METABOLIC FLUX; DNA-DAMAGE; LIVER; OVEREXPRESSION; ACTIVATION; GROWTH	Background: Expression and activity of spermidine/spermine N-1-acetyltransferase (SSAT) increases in kidneys subjected to ischemia/reperfusion (I/R) injury, while its ablation reduces the severity of such injuries. These results suggest that increased SSAT levels contribute to organ injury; however, the role of SSAT specifically expressed in proximal tubule epithelial cells, which are the primary targets of I/R injury, in the mediation of renal damage remains unresolved. Methods: Severity of I/R injury in wt and renal proximal tubule specific SSAT-ko mice (PT-SSAT-Cko) subjected to bilateral renal I/R injury was assessed using cellular and molecular biological approaches. Results: Severity of the loss of kidney function and tubular damage are reduced in PT-SSAT-Cko-compared to wt-mice after I/R injury. In addition, animals treated with MDL72527, an inhibitor of polyamine oxidases, had less severe renal damage than their vehicle treated counter-parts. The renal expression of HMGB 1 and Toll like receptors (TLR) 2 and 4 were also reduced in PT-SSAT-Cko-compared to wt mice after I/R injury. Furthermore, infiltration of neutrophils, as well as expression of tumor necrosis factor-alpha (TNF-alpha), monocyte chemoattractant protein-1 (MCP-1) and interleukin-6 (IL-6) transcripts were lower in the kidneys of PT-SSAT-Cko compared to wt mice after I/R injury. Finally, the activation of caspase3 was more pronounced in the wt compared to PT-SSAT-Cko animals. Conclusions: Enhanced SSAT expression by proximal tubule epithelial cells leads to tubular damage, and its deficiency reduces the severity of renal I/R injury through reduction of cellular damage and modulation of the innate immune response.	[Zahedi, Kamyar; Barone, Sharon; Wang, Yang; Roy-Chaudhury, Prabir; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Dept Internal Med, Div Nephrol & Hypertens, Cincinnati, OH 45221 USA; [Murray-Stewart, Tracy; Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Smith, Roger D.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Vet Affair Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; Johns Hopkins University; Johns Hopkins Medicine; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Zahedi, K (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Div Nephrol & Hypertens, Cincinnati, OH 45221 USA.	zahedika@ucmail.uc.edu	Stewart, Tracy Murray/B-6137-2017; Zahedi, Kamyar/AAQ-3428-2021	Stewart, Tracy Murray/0000-0001-8679-6414; Casero, Robert/0000-0001-5653-3306	National Institutes of Health [CA051085, CA098454]; VA Merit Award; Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; DCI; US Renal Care Inc.; NATIONAL CANCER INSTITUTE [R01CA098454, R01CA051085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati; DCI; US Renal Care Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA051085 and CA098454 (RAC) from National Institutes of Health and VA Merit Award (MS). These studies were supported in part by funds from the Center on Genetics of Transport and Epithelial Biology at the University of Cincinnati, funds from DCI and US Renal Care Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhonen L, 2000, P NATL ACAD SCI USA, V97, P8290, DOI 10.1073/pnas.140122097; Barone S, 2005, AM J PHYSIOL-CELL PH, V289, pC826, DOI 10.1152/ajpcell.00629.2004; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chen Y, 2001, CANCER RES, V61, P6437; Gao J, 2011, RENAL FAILURE, V33, P805, DOI 10.3109/0886022X.2011.601829; Grenz A, 2012, J IMMUNOL, V189, P4566, DOI 10.4049/jimmunol.1201651; Ha HC, 1997, P NATL ACAD SCI USA, V94, P11557, DOI 10.1073/pnas.94.21.11557; HASAN R, 1995, FEBS LETT, V368, P27, DOI 10.1016/0014-5793(95)00591-V; Hegardt C, 2002, EUR J BIOCHEM, V269, P1033, DOI 10.1046/j.0014-2956.2001.02744.x; Hong SKS, 2010, INFLAMM BOWEL DIS, V16, P1557, DOI 10.1002/ibd.21224; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ivanova S, 2002, P NATL ACAD SCI USA, V99, P5579, DOI 10.1073/pnas.082609299; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; KRAMER D, 1995, BIOCHEM PHARMACOL, V50, P1433, DOI 10.1016/0006-2952(95)02037-3; Kramer DL, 2008, J BIOL CHEM, V283, P4241, DOI 10.1074/jbc.M706806200; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746; Pietila M, 2001, J INVEST DERMATOL, V116, P801, DOI 10.1046/j.1523-1747.2001.01330.x; Rusai K, 2010, PEDIATR NEPHROL, V25, P853, DOI 10.1007/s00467-009-1422-4; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Vujcic S, 2000, J BIOL CHEM, V275, P38319, DOI 10.1074/jbc.M003270200; Wang ZH, 2004, J AM SOC NEPHROL, V15, P1844, DOI 10.1097/01.ASN.0000131525.77636.D5; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Zahedi K, 2004, AM J PHYSIOL-CELL PH, V286, pC1203, DOI 10.1152/ajpcell.00432.2003; Zahedi K, 2003, AM J PHYSIOL-RENAL, V284, pF1046, DOI 10.1152/ajprenal.00318.2002; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zahedi K, 2012, AM J PHYSIOL-GASTR L, V303, pG546, DOI 10.1152/ajpgi.00431.2011; Zahedi K, 2010, AM J PHYSIOL-CELL PH, V299, pC164, DOI 10.1152/ajpcell.00512.2009; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zahedi K, 2009, AM J PHYSIOL-GASTR L, V296, pG899, DOI 10.1152/ajpgi.90507.2008; Zhang W, 2007, TRANSPL P, V39, P1332, DOI 10.1016/j.transproceed.2006.11.021	37	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110161	10.1371/journal.pone.0110161	http://dx.doi.org/10.1371/journal.pone.0110161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390069	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400012
J	van Dijk, JGB; Mateman, AC; Klaassen, M				van Dijk, Jacintha G. B.; Mateman, A. Christa; Klaassen, Marcel			Transfer of Maternal Antibodies against Avian Influenza Virus in Mallards (Anas platyrhynchos)	PLOS ONE			English	Article							EGG SIZE; HEMAGGLUTININ SUBTYPE; A VIRUS; YOLK; TRANSMISSION; PERSISTENCE; PATERNITY; IMMUNITY; PATTERNS; GROWTH	Maternal antibodies protect chicks from infection with pathogens early in life and may impact pathogen dynamics due to the alteration of the proportion of susceptible individuals in a population. We investigated the transfer of maternal antibodies against avian influenza virus (AIV) in a key AIV host species, the mallard (Anas platyrhynchos). Combining observations in both the field and in mallards kept in captivity, we connected maternal AIV antibody concentrations in eggs to (i) female body condition, (ii) female AIV antibody concentration, (iii) egg laying order, (iv) egg size and (v) embryo sex. We applied maternity analysis to the eggs collected in the field to account for intraspecific nest parasitism, which is reportedly high in Anseriformes, detecting parasitic eggs in one out of eight clutches. AIV antibody prevalence in free-living and captive females was respectively 48% and 56%, with 43% and 24% of the eggs receiving these antibodies maternally. In both field and captive study, maternal AIV antibody concentrations in egg yolk correlated positively with circulating AIV antibody concentrations in females. In the captive study, yolk AIV antibody concentrations correlated positively with egg laying order. Female body mass and egg size from the field and captive study, and embryos sex from the field study were not associated with maternal AIV antibody concentrations in eggs. Our study indicates that maternal AIV antibody transfer may potentially play an important role in shaping AIV infection dynamics in mallards.	[van Dijk, Jacintha G. B.; Mateman, A. Christa; Klaassen, Marcel] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Klaassen, Marcel] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic 3217, Australia	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	van Dijk, JGB (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	jacintha.vandijk@gmail.com	Mateman, Christa/C-9380-2012; Klaassen, Marcel/B-4325-2008; KNAW, NIOO-KNAW/A-4320-2012	Mateman, Christa/0000-0002-9832-5780; Klaassen, Marcel/0000-0003-3907-9599; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research (NWO) [820.01.018]; National Institutes of Health (NIH) [NIAID HHSN266200700010C]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Netherlands Organization for Scientific Research (NWO; grant 820.01.018) and the National Institutes of Health (NIH; contract NIAID HHSN266200700010C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Gomez JM, 2012, J AVIAN BIOL, V43, P491, DOI 10.1111/j.1600-048X.2012.05792.x; Al-Natour MQ, 2004, AVIAN DIS, V48, P177, DOI 10.1637/5319; Baker K, 1993, IDENTIFICATION GUIDE; Bates D., 2012, IME4 LINEAR MIXED EF; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Boutette JB, 2002, J AVIAN MED SURG, V16, P198, DOI 10.1647/1082-6742(2002)016[0198:AIPCRR]2.0.CO;2; Boyd H., 1975, DUCK WINGS STUDY DUC; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; BYERS SM, 1991, J WILDLIFE MANAGE, V55, P580, DOI 10.2307/3809502; Cramp S, 1977, HDB BIRDS EUROPE MID, P1; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Denk AG, 2004, MOL ECOL NOTES, V4, P506, DOI 10.1111/j.1471-8286.2004.00707.x; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Gasparini J, 2007, J EVOLUTION BIOL, V20, P874, DOI 10.1111/j.1420-9101.2007.01315.x; Gasparini J, 2002, ECOL LETT, V5, P519, DOI 10.1046/j.1461-0248.2002.00345.x; Geffen E, 2001, ANIM BEHAV, V62, P1027, DOI 10.1006/anbe.2001.1855; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Grindstaff JL, 2010, J ORNITHOL, V151, P423, DOI 10.1007/s10336-009-0472-5; Grindstaff JL, 2006, P ROY SOC B-BIOL SCI, V273, P2551, DOI 10.1098/rspb.2006.3608; Grindstaff JL, 2005, J ANIM ECOL, V74, P1051, DOI 10.1111/j.1365-2656.2005.01002.x; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Groothuis TGG, 2006, J EVOLUTION BIOL, V19, P1304, DOI 10.1111/j.1420-9101.2005.01072.x; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Gunnarsson G, 2008, ANN ZOOL FENN, V45, P483, DOI 10.5735/086.045.0603; Hammouda A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034966; Hammouda A, 2011, VECTOR-BORNE ZOONOT, V11, P1583, DOI 10.1089/vbz.2011.0639; Hargitai R, 2006, FUNCT ECOL, V20, P829, DOI 10.1111/j.1365-2435.2006.01171.x; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Holveck MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050389; Hoye BJ, 2012, METHODS ECOL EVOL, V3, P162, DOI 10.1111/j.2041-210X.2011.00135.x; HOYT DF, 1979, AUK, V96, P73; Ismail A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079942; Jacobson RH, 1998, REV SCI TECH OIE, V17, P469, DOI 10.20506/rst.17.2.1119; Jacquin L, 2013, BIOL J LINN SOC, V108, P647, DOI 10.1111/bij.12001; Jeong OM, 2010, VET MICROBIOL, V144, P287, DOI 10.1016/j.vetmic.2010.01.022; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karell P, 2008, FUNCT ECOL, V22, P682, DOI 10.1111/j.1365-2435.2008.01425.x; King MO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009639; KOWALCZYK K, 1985, IMMUNOLOGY, V54, P755; Kreisinger J, 2010, J AVIAN BIOL, V41, P551, DOI 10.1111/j.1600-048X.2010.05002.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; LIU SS, 1990, COMP BIOCHEM PHYS B, V97, P637, DOI 10.1016/0305-0491(90)90100-8; Maak S, 2003, MOL ECOL NOTES, V3, P224, DOI 10.1046/j.1471-8286.2003.00405.x; MacCluskie MC, 1997, CONDOR, V99, P224, DOI 10.2307/1370245; Martyka R, 2011, BIOL LETTERS, V7, P50, DOI 10.1098/rsbl.2010.0549; MOHAMMED HO, 1986, AVIAN DIS, V30, P398, DOI 10.2307/1590547; Morales J, 2006, BIOL LETTERS, V2, P334, DOI 10.1098/rsbl.2006.0471; Moreno J, 2008, OECOLOGIA, V156, P727, DOI 10.1007/s00442-008-1029-7; Muller W, 2004, FUNCT ECOL, V18, P719, DOI 10.1111/j.0269-8463.2004.00902.x; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; OTAKI Y, 1992, AVIAN PATHOL, V21, P147, DOI 10.1080/03079459208418828; Pearce-Duvet JMC, 2009, EMERG INFECT DIS, V15, P1147, DOI 10.3201/eid1507.090036; PEHRSSON O, 1991, CAN J ZOOL, V69, P156, DOI 10.1139/z91-024; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; R Development Core Team, 2012, R LANG ENV STAT COMP; RHYMER JM, 1988, OECOLOGIA, V75, P20, DOI 10.1007/BF00378809; Saino N, 2003, J EVOLUTION BIOL, V16, P516, DOI 10.1046/j.1420-9101.2003.00534.x; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1005, DOI 10.1098/rspb.2002.1992; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Staszewski V, 2007, J ANIM ECOL, V76, P1215, DOI 10.1111/j.1365-2656.2007.01293.x; Stearns S.C., 1992, pi; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1	65	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112595	10.1371/journal.pone.0112595	http://dx.doi.org/10.1371/journal.pone.0112595			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386907	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400069
J	Xiong, EH; Wu, XL; Yang, L; Gong, FP; Tai, FJ; Wang, W				Xiong, Erhui; Wu, Xiaolin; Yang, Le; Gong, Fangping; Tai, Fuju; Wang, Wei			Chloroform-Assisted Phenol Extraction Improving Proteome Profiling of Maize Embryos through Selective Depletion of High-Abundance Storage Proteins	PLOS ONE			English	Article							MEMBRANE-PROTEINS; GLOBULIN; PRECIPITATION; EXPRESSION; VICILINS; GENE	The presence of abundant storage proteins in plant embryos greatly impedes seed proteomics analysis. Vicilin (or globulin-1) is the most abundant storage protein in maize embryo. There is a need to deplete the vicilins from maize embryo extracts for enhanced proteomics analysis. We here reported a chloroform-assisted phenol extraction (CAPE) method for vicilin depletion. By CAPE, maize embryo proteins were first extracted in an aqueous buffer, denatured by chloroform and then subjected to phenol extraction. We found that CAPE can effectively deplete the vicilins from maize embryo extract, allowing the detection of low-abundance proteins that were masked by vicilins in 2-DE gel. The novelty of CAPE is that it selectively depletes abundant storage proteins from embryo extracts of both monocot (maize) and dicot (soybean and pea) seeds, whereas other embryo proteins were not depleted. CAPE can significantly improve proteome profiling of embryos and extends the application of chloroform and phenol extraction in plant proteomics. In addition, the rationale behind CAPE depletion of abundant storage proteins was explored.	[Xiong, Erhui; Wu, Xiaolin; Yang, Le; Gong, Fangping; Tai, Fuju; Wang, Wei] Henan Agr Univ, Coll Life Sci, Collaborat Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China	Henan Agricultural University	Wang, W (corresponding author), Henan Agr Univ, Coll Life Sci, Collaborat Innovat Ctr Henan Grain Crops, Zhengzhou 450002, Peoples R China.	wangwei@henau.edu.cn	Wang, Wei/R-7323-2016	Wang, Wei/0000-0002-3711-5181	National Natural Science Foundation of China [31371543]; Plan for Scientific Innovation Talent of Henan Province [144200510012]; State Key Laboratory of Crop Biology in Shandong Agricultural University [2012KF01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for Scientific Innovation Talent of Henan Province; State Key Laboratory of Crop Biology in Shandong Agricultural University	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/; grant no. 31371543, to WW), Plan for Scientific Innovation Talent of Henan Province (http://www.hnkjt.gov.cn/; grant no. 144200510012, to WW) and State Key Laboratory of Crop Biology in Shandong Agricultural University (http://klab.sdau.edu.cn/; grant no. 2012KF01, to WW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astwood JD, 2002, J ALLERGY CLIN IMMUN, V110, P26, DOI 10.1067/mai.2002.125690; BELANGER FC, 1991, GENETICS, V129, P863; BELANGER FC, 1989, PLANT PHYSIOL, V91, P636, DOI 10.1104/pp.91.2.636; Bellei E, 2011, AMINO ACIDS, V40, P145, DOI 10.1007/s00726-010-0628-x; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Colmsee C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-245; Di Girolamo F, 2010, ANTICANCER RES, V30, P1121; Fasoli E, 2009, J PROTEOMICS, V72, P501, DOI 10.1016/j.jprot.2009.01.013; Fukuda T, 2007, J AGR FOOD CHEM, V55, P3667, DOI 10.1021/jf063205l; Gerlach JQ, 2009, J BOT, DOI [DOI 10.1155/2009/560394, 10.1155/2009/560394]; GIBBS PEM, 1989, MOL BIOL EVOL, V6, P614; HIGGINS TJV, 1988, PLANT MOL BIOL, V11, P683, DOI 10.1007/BF00017468; Kim YJ, 2013, PROTEOMICS, V13, P2176, DOI 10.1002/pmic.201200555; Krishnan HB, 2009, PROTEOMICS, V9, P3174, DOI 10.1002/pmic.200800875; KRIZ AR, 1990, PLANT PHYSIOL, V92, P538, DOI 10.1104/pp.92.2.538; Liu B, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-24; Mirza SP, 2007, PHYSIOL GENOMICS, V30, P89, DOI 10.1152/physiolgenomics.00279.2006; Reigada R, 2014, BBA-BIOMEMBRANES, V1838, P814, DOI 10.1016/j.bbamem.2013.10.008; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI [10.1101/pdb.prot3966, 10.1101/pdb.prot4044, 10.1101/pdb.prot4085, 10.1101/pdb.prot4056, 10.1101/pdb.prot4027, 10.1101/pdb.prot4453, 10.1101/pdb.prot3825, 10.1101/pdb.prot4050, 10.1101/pdb.prot4022, 10.1101/pdb.prot3871, 10.1101/pdb.prot4455, 10.1101/pdb.prot3972, 10.1101/pdb.prot3723]; SHEWRY PR, 1995, PLANT CELL, V7, P945, DOI 10.1105/tpc.7.7.945; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Wu XL, 2014, PROTEOMICS, V14, P645, DOI 10.1002/pmic.201300239; Wu XL, 2014, NAT PROTOC, V9, P362, DOI 10.1038/nprot.2014.022; Wu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050497	24	13	13	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112724	10.1371/journal.pone.0112724	http://dx.doi.org/10.1371/journal.pone.0112724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386674	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400087
J	Duan, RY; Kong, XQ; Huang, MY; Fan, WY; Wang, ZG				Duan, Ren-Yan; Kong, Xiao-Quan; Huang, Min-Yi; Fan, Wei-Yi; Wang, Zhi-Gao			The Predictive Performance and Stability of Six Species Distribution Models	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; CLIMATE-CHANGE; UNCERTAINTY; NICHE; CLASSIFICATION; FORESTS; OAK; CONSERVATION; DISTURBANCE; VALIDATION	Background: Predicting species' potential geographical range by species distribution models (SDMs) is central to understand their ecological requirements. However, the effects of using different modeling techniques need further investigation. In order to improve the prediction effect, we need to assess the predictive performance and stability of different SDMs. Methodology: We collected the distribution data of five common tree species (Pinus massoniana, Betula platyphylla, Quercus wutaishanica, Quercus mongolica and Quercus variabilis) and simulated their potential distribution area using 13 environmental variables and six widely used SDMs: BIOCLIM, DOMAIN, MAHAL, RF, MAXENT, and SVM. Each model run was repeated 100 times (trials). We compared the predictive performance by testing the consistency between observations and simulated distributions and assessed the stability by the standard deviation, coefficient of variation, and the 99% confidence interval of Kappa and AUC values. Results: The mean values of AUC and Kappa from MAHAL, RF, MAXENT, and SVM trials were similar and significantly higher than those from BIOCLIM and DOMAIN trials (p<0.05), while the associated standard deviations and coefficients of variation were larger for BIOCLIM and DOMAIN trials (p<0.05), and the 99% confidence intervals for AUC and Kappa values were narrower for MAHAL, RF, MAXENT, and SVM. Compared to BIOCLIM and DOMAIN, other SDMs (MAHAL, RF, MAXENT, and SVM) had higher prediction accuracy, smaller confidence intervals, and were more stable and less affected by the random variable (randomly selected pseudo-absence points). Conclusions: According to the prediction performance and stability of SDMs, we can divide these six SDMs into two categories: a high performance and stability group including MAHAL, RF, MAXENT, and SVM, and a low performance and stability group consisting of BIOCLIM, and DOMAIN. We highlight that choosing appropriate SDMs to address a specific problem is an important part of the modeling process.	[Duan, Ren-Yan; Kong, Xiao-Quan; Huang, Min-Yi; Wang, Zhi-Gao] Anqing Normal Coll, Sch Life Sci, Anqing, Anhui, Peoples R China; [Fan, Wei-Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Shaanxi, Peoples R China	Anqing Normal University; Shaanxi Normal University	Huang, MY (corresponding author), Anqing Normal Coll, Sch Life Sci, Anqing, Anhui, Peoples R China.	huang.m.y@163.com	Kong, Xiaoquan/B-3571-2016	Kong, Xiaoquan/0000-0003-1039-494X	National Natural Science Foundation of China [NSFC 31100311]; excellent provincial young fund of Anhui [2012SQRL113ZD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); excellent provincial young fund of Anhui	This study was jointly funded by the National Natural Science Foundation of China (NSFC 31100311) and the excellent provincial young fund of Anhui (2012SQRL113ZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P885, DOI 10.1016/S0895-4356(99)00075-X; CARPENTER G, 1993, BIODIVERS CONSERV, V2, P667, DOI 10.1007/BF00051966; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Drake JM, 2006, J APPL ECOL, V43, P424, DOI 10.1111/j.1365-2664.2006.01141.x; Elith J, 2002, ECOL MODEL, V157, P313, DOI 10.1016/S0304-3800(02)00202-8; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Franklin J, 2006, J VEG SCI, V17, P233, DOI 10.1111/j.1654-1103.2006.tb02442.x; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Giovanelli JGR, 2010, ECOL MODEL, V221, P215, DOI 10.1016/j.ecolmodel.2009.10.009; Gomez-Mendoza L, 2007, CONSERV BIOL, V21, P1545, DOI 10.1111/j.1523-1739.2007.00814.x; Gritti ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068823; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo QH, 2005, ECOL MODEL, V182, P75, DOI 10.1016/j.ecolmodel.2004.07.012; Guyon I, 2010, J MACH LEARN RES, V11, P61; Hanberry BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044486; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hijmans R.J., SPECIES DISTRIBUTION; Hijmans R.J., 2013, DISMO SPECIES DISTRI, V0, P8; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Lawton J.L., 2000, ECOLOGICAL CONSEQUEN, P401; Li GQ, 2012, ECOL RES, V27, P427, DOI 10.1007/s11284-011-0914-4; Moisen GG, 2002, ECOL MODEL, V157, P209, DOI 10.1016/S0304-3800(02)00197-7; MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Nix H.A., 1986, ATLAS ELAPID SNAKES, P4; Olden JD, 2002, T AM FISH SOC, V131, P329, DOI 10.1577/1548-8659(2002)131<0329:PMOFSD>2.0.CO;2; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thuiller W, 2003, J VEG SCI, V14, P669, DOI 10.1111/j.1654-1103.2003.tb02199.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Wang R, 2006, DIVERS DISTRIB, V12, P397, DOI 10.1111/j.1366-9516.2006.00250.x; Wang XP, 2006, J INTEGR PLANT BIOL, V48, P778, DOI 10.1111/j.1744-7909.2006.00294.x; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Xu CG, 2004, ECOL MODEL, V180, P57, DOI 10.1016/j.ecolmodel.2004.01.018; Zhang MG, 2012, BIOL CONSERV, V153, P257, DOI 10.1016/j.biocon.2012.04.023; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4	58	89	96	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112764	10.1371/journal.pone.0112764	http://dx.doi.org/10.1371/journal.pone.0112764			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383906	gold, Green Submitted, Green Published			2022-12-26	WOS:000344816700092
J	Guo, YT; Niu, K; Momma, H; Kobayashi, Y; Chujo, M; Otomo, A; Fukudo, S; Nagatomi, R				Guo, Yinting; Niu, Kaijun; Momma, Haruki; Kobayashi, Yoritoshi; Chujo, Masahiko; Otomo, Atsushi; Fukudo, Shin; Nagatomi, Ryoichi			Irritable Bowel Syndrome Is Positively Related to Metabolic Syndrome: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							DIETARY PATTERN-ANALYSIS; GASTROINTESTINAL SYMPTOMS; PREVALENCE; FOOD; METAANALYSIS; ASSOCIATION; CONSUMPTION; DEPRESSION; MANAGEMENT; EXERCISE	Irritable bowel syndrome is a common gastrointestinal disorder that may affect dietary pattern, food digestion, and nutrient absorption. The nutrition-related factors are closely related to metabolic syndrome, implying that irritable bowel syndrome may be a potential risk factor for metabolic syndrome. However, few epidemiological studies are available which are related to this potential link. The purpose of this study is to determine whether irritable bowel syndrome is related to metabolic syndrome among middle-aged people. We designed a cross-sectional study of 1,096 subjects to evaluate the relationship between irritable bowel syndrome and metabolic syndrome and its components. Diagnosis of irritable bowel syndrome was based on the Japanese version of the Rome III Questionnaire. Metabolic syndrome was defined according to the criteria of the American Heart Association scientific statements of 2009. Dietary consumption was assessed via a validated food frequency questionnaire. Principal-components analysis was used to derive 3 major dietary patterns: "Japanese", "sweetsfruits", and "Izakaya (Japanese Pub) "from 39 food groups. The prevalence of irritable bowel syndrome and metabolic syndrome were 19.4% and 14.6%, respectively. No significant relationship was found between the dietary pattern factor score tertiles and irritable bowel syndrome. After adjustment for potential confounders (including dietary pattern), the odds ratio (95% confidence interval) of having metabolic syndrome and elevated triglycerides for subjects with irritable bowel syndrome as compared with non-irritable bowel syndrome are 2.01(1.13-3.55) and 1.50(1.03-2.18), respectively. Irritable bowel syndrome is significantly related to metabolic syndrome and it components. This study is the first to show that irritable bowel syndrome was significantly related to a higher prevalence of metabolic syndrome and elevated triglycerides among an adult population. The findings suggest that the treatment of irritable bowel syndrome may be a potentially beneficial factor for the prevention of metabolic syndrome. Further study is needed to clarify this association.	[Guo, Yinting; Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Guo, Yinting; Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China; [Guo, Yinting; Fukudo, Shin] Tohoku Univ, Dept Behav Med, Grad Sch Med, Sendai, Miyagi 980, Japan; [Momma, Haruki; Kobayashi, Yoritoshi; Chujo, Masahiko; Otomo, Atsushi; Nagatomi, Ryoichi] Tohoku Univ, Div Biomed Engn Hlth & Welf, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan	Tianjin Medical University; Tianjin Medical University; Tohoku University; Tohoku University	Niu, K (corresponding author), Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China.	nkj0809@163.com	Fukudo, Shin/J-4813-2014; Nagatomi, Ryoichi/T-5296-2019; Nagatomi, Ryoichi/Q-8792-2016	Nagatomi, Ryoichi/0000-0003-3038-7202; Momma, Haruki/0000-0003-1134-0898; Niu, Kaijun/0000-0002-8772-2481	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for "Knowledge Cluster Initiative" from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alkerwi A, 2009, ATHEROSCLEROSIS, V204, P624, DOI 10.1016/j.atherosclerosis.2008.10.036; Aller R, 2004, An Med Interna, V21, P577; BARRETT J, 1978, ARCH GEN PSYCHIAT, V35, P741; Bohn L, 2013, AM J GASTROENTEROL, V108, P634, DOI 10.1038/ajg.2013.105; Camilleri M, 2001, GASTROENTEROLOGY, V120, P652, DOI 10.1053/gast.2001.21908; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Leao LSCD, 2011, ARQ BRAS CARDIOL, V97, P260, DOI 10.1590/S0066-782X2011001200012; Cena H, 2011, NUTR REV, V69, P745, DOI 10.1111/j.1753-4887.2011.00446.x; Chang L, 2004, ALIMENT PHARM THER, V20, P31, DOI 10.1111/j.1365-2036.2004.02183.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; D'Aversa F, 2013, INTERN EMERG MED, V8, pS11, DOI 10.1007/s11739-013-0916-z; Feinle-Bisset C, 2013, AM J GASTROENTEROL, V108, P737, DOI 10.1038/ajg.2013.76; Fukuda K, 1973, Seishin Shinkeigaku Zasshi, V75, P673; Fukudo S, 2008, JAPANESE VERSION ROM; Ghoshal UC, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/151085; Gulcan E, 2009, AM J MED SCI, V338, P116, DOI 10.1097/MAJ.0b013e31819f7587; Guo H, 2012, NUTR METAB CARDIOVAS, V22, P277, DOI 10.1016/j.numecd.2010.06.006; Hayes P, 2014, J HUM NUTR DIET, V27, P36, DOI 10.1111/jhn.12114; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Ishikawa-Takata K, 2007, J EPIDEMIOL, V17, P177; Josse AR, 2008, J NUTRIGENET NUTRIGE, V1, P109, DOI 10.1159/000112458; Jung HJ, 2011, J NEUROGASTROENTEROL, V17, P294, DOI 10.5056/jnm.2011.17.3.294; Keller J, 2009, BEST PRACT RES CL GA, V23, P407, DOI 10.1016/j.bpg.2009.02.012; Kim J, 1978, FACTOR ANAL STAT MET; Li YQ, 2013, SAUDI MED J, V34, P929; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marciani L, 2010, GASTROENTEROLOGY, V138, P469, DOI 10.1053/j.gastro.2009.10.055; Morcos A, 2009, J DIGEST DIS, V10, P237, DOI 10.1111/j.1751-2980.2009.00392.x; Nestel P, 2004, ENDOCRIN METAB CLIN, V33, P483, DOI 10.1016/j.ecl.2004.03.010; Nikolopoulou A, 2012, EXPERT REV CARDIOVAS, V10, P933, DOI [10.1586/erc.12.74, 10.1586/ERC.12.74]; Niu K, 2013, INT J CARDIOL; Niu KJ, 2013, EUR J NUTR, V52, P771, DOI 10.1007/s00394-012-0383-8; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Park HJ, 2010, WESTERN J NURS RES, V32, P218, DOI 10.1177/0193945909349116; Saito YA, 2005, AM J GASTROENTEROL, V100, P2743, DOI 10.1111/j.1572-0241.2005.00288.x; SAKAI K, 1995, J LIPID NUTR, V4, P97; Sasaki S, 2005, SERUM BIOMARKER BASE, P10; Science and Technology Agency, 2000, STAND TABL FOOD COMP; Shimazu T, 2007, INT J EPIDEMIOL, V36, P600, DOI 10.1093/ije/dym005; Simren M, 2001, DIGESTION, V63, P108, DOI 10.1159/000051878; Simren M, 2007, CLIN GASTROENTEROL H, V5, P201, DOI 10.1016/j.cgh.2006.09.032; Willett WC, 2008, ASIA PAC J CLIN NUTR, V17, P75; Williams EA, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-9; Xiao SM, 2014, FEMS MICROBIOL ECOL, V87, P357, DOI 10.1111/1574-6941.12228; Yamaoka K, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-138; Yao CK, 2013, J HUM NUTR DIET	47	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112289	10.1371/journal.pone.0112289	http://dx.doi.org/10.1371/journal.pone.0112289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383869	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700045
J	Liao, YJ; Yang, JR; Chen, SE; Wu, SJ; Huang, SY; Lin, JJ; Chen, LR; Tang, PC				Liao, Yu-Jing; Yang, Jenn-Rong; Chen, Shuen-Ei; Wu, Sing-Jhou; Huang, San-Yuan; Lin, Jiang-Jen; Chen, Lih-Ren; Tang, Pin-Chi			Inhibition of Fumonisin B-1 Cytotoxicity by Nanosilicate Platelets during Mouse Embryo Development	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; SPHINGOLIPID METABOLISM; SILVER NANOPARTICLES; RISK-FACTOR; MYCOTOXINS; CLAY; EXFOLIATION; SYNTHASE; LASS5	Nanosilicate platelets (NSP), the form of natural silicate clay that was exfoliated from montmorillonite (MMT), is widely used as a feed additive for its high non-specific binding capacity with mycotoxins such as fumonisin B-1 (FB1), and has been evaluated its safety for biomedical use including cytotoxicity, genotoxicity, and lethal dosage (LD). In the study, we further examined its toxicity on the development of CD1 mouse embryos and its capacity to prevent teratogenesis-induced by FB1. In vitro cultures, NSP did not disturb the development and the quality of intact pre-implantation mouse embryos. Further, newborn mice from females consumed with NSP showed no abnormalities. NSP had an unexpected high adsorption capacity in vitro. In contrast to female mice consumed with FB1 only, a very low residual level of FB1 in the circulation, reduced incidence of neutral tube defects and significantly increased fetal weight were observed in the females consumed with FB1 and NSP, suggesting a high alleviation effect of NSP on FB1 in vivo. Furthermore, FB1 treatment disturbed the gene expression of sphingolipid metabolism enzymes (longevity assurance homolog 5, LASS 5; sphingosine kinase 1, Sphk1; sphingosine kinase 2, Sphk2; sphingosine 1-phosphate lyase, Sgpl1; sphingosine 1- phosphate phosphatase, Sgpp1) in the maternal liver, uterus, fetus, and placenta, but NSP administration reversed the perturbations. Based on these findings, we conclude that NSP is a feasible and effective agent for supplementary use in reducing the toxicity of FB1 to animals.	[Liao, Yu-Jing; Yang, Jenn-Rong; Chen, Lih-Ren] Council Agr Execut Yuan, Livestock Res Inst, Div Physiol, Tainan, Taiwan; [Liao, Yu-Jing; Chen, Shuen-Ei; Wu, Sing-Jhou; Huang, San-Yuan; Tang, Pin-Chi] Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan; [Chen, Shuen-Ei; Huang, San-Yuan; Tang, Pin-Chi] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan; [Chen, Shuen-Ei; Huang, San-Yuan; Tang, Pin-Chi] Natl Chung Hsing Univ, Ctr Integrat & Evolutionary Galliformes Genom, Taichung 40227, Taiwan; [Huang, San-Yuan] Natl Chung Hsing Univ, Ctr Nanosci & Nanotechnol, Taichung 40227, Taiwan; [Lin, Jiang-Jen] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan	Taiwan Livestock Research Institute; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Taiwan University	Tang, PC (corresponding author), Natl Chung Hsing Univ, Dept Anim Sci, Taichung 40227, Taiwan.	pctang@dragon.nchu.edu.tw	Chen, Shuen-Ei/AAE-3574-2019; Chen, Shuen-Ei/B-2341-2019	Chen, Shuen-Ei/0000-0003-1737-2591; LIN, JIANG-JEN/0000-0002-8704-9653; Liao, Yu Jing/0000-0003-0421-3268	National Science Council (NSC) [101-2313-B-005-006]; Ministry of Education, Taiwan, under the ATU (Aim for the Top University) plan; Ministry of Economic Affairs [101-EC-17-A-21-S1-229]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, under the ATU (Aim for the Top University) plan; Ministry of Economic Affairs	This study was supported, in part, by a grant from the National Science Council (NSC 101-2313-B-005-006), a grant from the Ministry of Education, Taiwan, under the ATU (Aim for the Top University) plan and also a grant from the Ministry of Economic Affairs (101-EC-17-A-21-S1-229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudergue C., 2009, EFSA SUPPORTING PUBL, V6; Cheng MC, 2008, THESIS NATL CHUNG H; Chiao SH, 2012, INT J NANOMED, V7, P2421, DOI 10.2147/IJN.S31594; Chu CC, 2005, MACROMOLECULES, V38, P6240, DOI 10.1021/ma0503716; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; GELDERBLOM WCA, 1988, APPL ENVIRON MICROB, V54, P1806, DOI 10.1128/AEM.54.7.1806-1811.1988; Gelineau-van Waes J, 2009, ADV FOOD NUTR RES, V56, P145, DOI 10.1016/S1043-4526(08)00605-0; Hansen DK, 2003, BIRTH DEFECTS RES A, V67, P475, DOI 10.1002/bdra.10072; Harrison L R, 1990, J Vet Diagn Invest, V2, P217; Hsu SH, 2009, ACS APPL MATER INTER, V1, P2556, DOI 10.1021/am900479q; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; Jones FT, 2007, UNDERSTANDING COPING, P1; KELLERMAN TS, 1990, ONDERSTEPOORT J VET, V57, P269; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Li PR, 2010, ACS APPL MATER INTER, V2, P1608, DOI 10.1021/am1001162; Lin JJ, 2006, J PHYS CHEM B, V110, P18115, DOI 10.1021/jp0636773; Lin JJ, 2013, ACS APPL MATER INTER, V5, P433, DOI 10.1021/am302534k; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Merrill AH, 2001, ENVIRON HEALTH PERSP, V109, P283, DOI 10.2307/3435020; NELSON PE, 1993, ANNU REV PHYTOPATHOL, V31, P233, DOI 10.1146/annurev.py.31.090193.001313; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Reddy RV, 1996, MYCOPATHOLOGIA, V134, P161, DOI 10.1007/BF00436724; Richard JL, 2007, INT J FOOD MICROBIOL, V119, P3, DOI 10.1016/j.ijfoodmicro.2007.07.019; Riley RT, 2001, ENVIRON HEALTH PERSP, V109, P301, DOI 10.2307/3435022; Rothenberg SP, 2004, OBSTET GYNECOL SURV, V59, P410; Saitsu H, 2003, DEV DYNAM, V226, P112, DOI 10.1002/dvdy.10203; Tao ZM, 2010, LANGMUIR, V26, P8914, DOI 10.1021/la904695a; Usuki A, 2001, NANO LETT, V1, P271, DOI 10.1021/nl010015a; Voss K A, 2006, Mycotoxin Res, V22, P61, DOI 10.1007/BF02954559; Voss KA, 2014, MOL NUTR FOOD RES, V58, P1190, DOI 10.1002/mnfr.201300720; Waes JG, 2005, BIRTH DEFECTS RES A, V73, P487, DOI 10.1002/bdra.20148; Wei JC, 2011, J PHYS CHEM C, V115, P18770, DOI 10.1021/jp2067233; Xu ZW, 2005, J LIPID RES, V46, P1229, DOI 10.1194/jlr.M500001-JLR200	33	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112290	10.1371/journal.pone.0112290	http://dx.doi.org/10.1371/journal.pone.0112290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383881	Green Submitted, gold, Green Published			2022-12-26	WOS:000344816700046
J	Chondrogianni, N; Georgila, K; Kourtis, N; Tavernarakis, N; Gonos, ES				Chondrogianni, Niki; Georgila, Konstantina; Kourtis, Nikos; Tavernarakis, Nektarios; Gonos, Efstathios S.			20S proteasome activation promotes life span extension and resistance to proteotoxicity in Caenorhabditis elegans	FASEB JOURNAL			English	Article						aging; daf-16; longevity; proteostasis	GENE-EXPRESSION ANALYSIS; OXIDATIVE-STRESS; TEMPORAL REQUIREMENTS; HUMAN FIBROBLASTS; UBIQUITIN LIGASE; FACTOR SKN-1; LONGEVITY; PROTEINS; SYSTEM; DAF-16	Protein homeostasis (proteostasis) is one of the nodal points that need to be preserved to retain physiologic cellular/organismal balance. The ubiquitinproteasome system(UPS) is responsible for the removal of both normal and damaged proteins, with the proteasome being the downstream effector. The proteasome is the major cellular protease with progressive impairment of function during aging and senescence. Despite the documented age-retarding properties of proteasome activation in various cellular models, simultaneous enhancement of the 20S core proteasome content, assembly, and function have never been reported in any multicellular organism. Consequently, the possible effects of the core proteasome modulation on organismal life span are elusive. In this study, we have achieved activation of the 20S proteasome at organismal level. We demonstrate enhancement of proteasome levels, assembly, and activity in the nematode Caenorhabditis elegans, resulting in life span extension and increased resistance to stress. We also provide evidence that the observed life span extension is dependent on the transcriptional activity of Dauer formation abnormal/ Forkhead box class O (DAF-16/FOXO), skinhead-1 (SKN1), and heat shock factor-1 (HSF-1) factors through regulation of downstream longevity genes. We further show that the reported beneficial effects are not ubiquitous but they are dependent on the genetic context. Finally, we provide evidence that proteasome core activation might be a potential strategy to minimize protein homeostasis deficiencies underlying aggregation-related diseases, such as Alzheimer's disease (AD) or Huntington's disease (HD). In summary, this is the first report demonstrating that 20S core proteasome up-regulation in terms of both content and activity is feasible in a multicellular eukaryotic organism and that in turn this modulation promotes extension of organismal health span and life span.-Chondrogianni, N., Georgila, K., Kourtis, N., Tavernarakis, N., Gonos, E. S. 20S proteasome activation promotes life span extension and resistance to proteotoxicity in Caenorhabditis elegans.	[Chondrogianni, Niki; Georgila, Konstantina; Gonos, Efstathios S.] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens 11635, Greece; [Kourtis, Nikos; Tavernarakis, Nektarios] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece	National Hellenic Research Foundation; Foundation for Research & Technology - Hellas (FORTH)	Gonos, ES (corresponding author), Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, 48 Vassileos Constantinou Ave, Athens 11635, Greece.	nikichon@eie.gr; sgonos@eie.gr	Tavernarakis, Nektarios/B-9684-2013	Tavernarakis, Nektarios/0000-0002-5253-1466	U.S.National Institutes of Health National Center for Research Resources; European Union ("Proteomage") [LSHM-CT-518230]; Thales "GenAge," cofinanced by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) [ThetaALambdaHSigma APi:10479/3.7.12 MIS380228]; IKYDA fellowship; John S.Latsis Public Benefit Foundation	U.S.National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Union ("Proteomage"); Thales "GenAge," cofinanced by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF); IKYDA fellowship; John S.Latsis Public Benefit Foundation	The authors are grateful to Prof.Osiewacz and Dr.Zhang for antibodies; to Dr.Ninios, K.Voutetakis, and A.Pasparaki for technical support; and to Drs.Bano and Troulinaki for discussions and reagents.Nematode strains used in this study were provided by the Caenorhabditis Genetics Center, supported by the U.S.National Institutes of Health National Center for Research Resources.This work was funded by a European Union ("Proteomage"; LSHM-CT-518230) grant (to E.S.G.), a Research Funding Program: Thales "GenAge," cofinanced by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) [Theta A Lambda H Sigma A Pi:10479/3.7.12 MIS380228] (to E.S.G.and N.C.), and an IKYDA 2012 fellowship and a Scientific Project funded by John S.Latsis Public Benefit Foundation (to N.C.).	Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Brignull HR, 2006, J NEUROSCI, V26, P7597, DOI 10.1523/JNEUROSCI.0990-06.2006; Carrano AC, 2009, NATURE, V460, P396, DOI 10.1038/nature08130; Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Chondrogianni N, 2000, EXP GERONTOL, V35, P721, DOI 10.1016/S0531-5565(00)00137-6; Chondrogianni N, 2008, IUBMB LIFE, V60, P651, DOI 10.1002/iub.99; Chondrogianni N, 2008, AGING CELL, V7, P717, DOI 10.1111/j.1474-9726.2008.00425.x; Chondrogianni N, 2014, MOL ASPECTS MED, V35, P1, DOI 10.1016/j.mam.2012.09.001; Coburn Cassandra, 2013, Frontiers in Genetics, V4, P151, DOI 10.3389/fgene.2013.00151; Cohen E, 2010, AGING CELL, V9, P126, DOI 10.1111/j.1474-9726.2009.00541.x; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gaczynska M, 1996, J BIOL CHEM, V271, P17275, DOI 10.1074/jbc.271.29.17275; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Ghazi A, 2007, P NATL ACAD SCI USA, V104, P5947, DOI 10.1073/pnas.0700638104; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Hassan WM, 2009, HUM MOL GENET, V18, P2739, DOI 10.1093/hmg/ddp209; Hines JK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001309; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huang QA, 2010, APOPTOSIS, V15, P1292, DOI 10.1007/s10495-010-0466-z; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kirkwood TBL, 2011, CURR BIOL, V21, pR701, DOI 10.1016/j.cub.2011.07.020; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Kwak MK, 2007, FREE RADICAL BIO MED, V43, P809, DOI 10.1016/j.freeradbiomed.2007.05.029; Layfield R, 2003, AGEING RES REV, V2, P343, DOI 10.1016/S1568-1637(03)00025-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Liu G, 2011, EMBO J, V30, P2990, DOI 10.1038/emboj.2011.195; Liu YZ, 2007, MOL VIS, V13, P31; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Matilainen O, 2013, CELL REP, V3, P1980, DOI 10.1016/j.celrep.2013.05.012; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Myeku N, 2011, METHODS MOL BIOL, V793, P273, DOI 10.1007/978-1-61779-328-8_18; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Paul S, 2008, BIOESSAYS, V30, P1172, DOI 10.1002/bies.20852; Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Sanchez-Blanco A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002047; Taylor RC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004440; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216; Vilchez D, 2012, NATURE, V489, P263, DOI 10.1038/nature11315; Volovik Y, 2012, AGING CELL, V11, P491, DOI 10.1111/j.1474-9726.2012.00811.x; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Wilkinson DS, 2012, METHOD CELL BIOL, V107, P353, DOI 10.1016/B978-0-12-394620-1.00012-6; Wojcik C, 2002, J BIOL CHEM, V277, P6188, DOI 10.1074/jbc.M109996200; Wolff S, 2006, CELL, V124, P1039, DOI 10.1016/j.cell.2005.12.042; Wu YJ, 2006, J NEUROSCI, V26, P13102, DOI 10.1523/JNEUROSCI.3448-06.2006; Yasuda K, 1999, J GERONTOL A-BIOL, V54, pB47, DOI 10.1093/gerona/54.2.B47; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105	67	93	96	1	29	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					611	622		10.1096/fj.14-252189	http://dx.doi.org/10.1096/fj.14-252189			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25395451	Green Published			2022-12-26	WOS:000349370400023
J	Eltit, JM; Franzini-Armstrong, C; Perez, CF				Eltit, Jose M.; Franzini-Armstrong, Clara; Perez, Claudio F.			Amino Acid Residues 489-503 of Dihydropyridine Receptor (DHPR) beta(1a) Subunit Are Critical for Structural Communication between the Skeletal Muscle DHPR Complex and Type 1 Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLOW CALCIUM CURRENT; C-TERMINAL TAIL; II-III-LOOP; BETA-1A SUBUNIT; CA2+ CHANNEL; CHARGE MOVEMENTS; MUSCULAR DYSGENESIS; CARBOXYL-TERMINUS; MYOTUBES; MUTATION	The beta(1a) subunit is a cytoplasmic component of the dihydropyridine receptor (DHPR) complex that plays an essential role in skeletal muscle excitation-contraction (EC) coupling. Here we investigate the role of the C-terminal end of this auxiliary subunit in the functional and structural communication between the DHPR and the Ca2+ release channel (RyR1). Progressive truncation of the beta(1a) C terminus showed that deletion of amino acid residues Gln(489) to Trp(503) resulted in a loss of depolarization-induced Ca2+ release, a severe reduction of L-type Ca2+ currents, and a lack of tetrad formation as evaluated by freeze-fracture analysis. However, deletion of this domain did not affect expression/targeting or density (Q(max)) of the DHPR-alpha(1S) subunit to the plasma membrane. Within this motif, triple alanine substitution of residues Leu(496), Leu(500), and Trp(503), which are thought to mediate direct beta(1a)-RyR1 interactions, weakened EC coupling but did not replicate the truncated phenotype. Therefore, these data demonstrate that an amino acid segment encompassing sequence (489)QVQVLTSLRRNLSFW(503) of beta(1a) contains critical determinant(s) for the physical link of DHPR and RyR1, further confirming a direct correspondence between DHPR positioning and DHPR/RyR functional interactions. In addition, our data strongly suggest that the motif Leu(496)-Leu(500)-Trp(503) within the beta(1a) C-terminal tail plays a nonessential role in the bidirectional DHPR/RyR1 signaling that supports skeletal-type EC coupling.	[Perez, Claudio F.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Eltit, Jose M.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Franzini-Armstrong, Clara] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Virginia Commonwealth University; University of Pennsylvania	Perez, CF (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 20 Shattuck St, Boston, MA 02115 USA.	cperez@zeus.bwh.harvard.edu			National Institutes of Health [R03AR066359, R01 HL48093, 2P01AR052354]; William S. Milton Fund/Harvard Medical School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR066359, P01AR052354] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William S. Milton Fund/Harvard Medical School; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R03AR066359 (to C. F. P.) and R01 HL48093 and 2P01AR052354 (to C. F. A.). This work was also supported by fund from the William S. Milton Fund/Harvard Medical School (to C. F. P.).	ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Ahern CA, 2001, P NATL ACAD SCI USA, V98, P6935, DOI 10.1073/pnas.111001898; Avila G, 2005, CELL CALCIUM, V38, P35, DOI 10.1016/j.ceca.2005.05.001; Avila G, 2001, J BIOL CHEM, V276, P17732, DOI 10.1074/jbc.M009685200; Bannister RA, 2010, J GEN PHYSIOL, V135, P629, DOI 10.1085/jgp.200910329; BEAM KG, 1986, NATURE, V320, P168, DOI 10.1038/320168a0; Beurg M, 1997, BIOPHYS J, V73, P807, DOI 10.1016/S0006-3495(97)78113-X; Beurg M, 1999, BIOPHYS J, V77, P2953, DOI 10.1016/S0006-3495(99)77128-6; CHAUDHARI N, 1989, DEV BIOL, V133, P456, DOI 10.1016/0012-1606(89)90049-3; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cheng WJ, 2005, P NATL ACAD SCI USA, V102, P19225, DOI 10.1073/pnas.0504334102; Coronado R, 2004, BIOL RES, V37, P565; Dayal A, 2013, P NATL ACAD SCI USA, V110, P7488, DOI 10.1073/pnas.1301087110; Dayal A, 2010, CELL CALCIUM, V47, P500, DOI 10.1016/j.ceca.2010.04.003; Eltit JM, 2011, P NATL ACAD SCI USA, V108, P7046, DOI 10.1073/pnas.1018380108; Flucher BE, 2005, J MUSCLE RES CELL M, V26, P1, DOI 10.1007/s10974-005-9000-2; Gach MP, 2008, BIOPHYS J, V94, P3023, DOI 10.1529/biophysj.107.118893; GARCIA J, 1994, J GEN PHYSIOL, V103, P125, DOI 10.1085/jgp.103.1.125; GARCIA J, 1994, J GEN PHYSIOL, V103, P107, DOI 10.1085/jgp.103.1.107; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Hernandez-Ochoa EO, 2014, BIOPHYS J, V106, P535, DOI 10.1016/j.bpj.2013.11.4503; Karunasekara Y, 2012, FASEB J, V26, P5049, DOI 10.1096/fj.12-211334; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; Lee DY, 2008, BLOOD, V111, P2280, DOI 10.1182/blood-2007-07-100032; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Nakai J, 1997, P NATL ACAD SCI USA, V94, P1019, DOI 10.1073/pnas.94.3.1019; Paolini C, 2004, J MOL BIOL, V342, P145, DOI 10.1016/j.jmb.2004.07.035; Protasi F, 1997, J CELL BIOL, V137, P859, DOI 10.1083/jcb.137.4.859; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Rebbeck RT, 2011, BIOPHYS J, V100, P922, DOI 10.1016/j.bpj.2011.01.022; Schredelseker J, 2005, P NATL ACAD SCI USA, V102, P17219, DOI 10.1073/pnas.0508710102; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Sheridan DC, 2006, P NATL ACAD SCI USA, V103, P19760, DOI 10.1073/pnas.0609473103; Sheridan DC, 2012, CHANNELS, V6, P26, DOI 10.4161/chan.18916; Sheridan DC, 2004, BIOPHYS J, V87, P929, DOI 10.1529/biophysj.104.043810; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; TAKEKURA H, 1994, BIOPHYS J, V67, P793, DOI 10.1016/S0006-3495(94)80539-9; Takekura H, 2004, MOL BIOL CELL, V15, P5408, DOI 10.1091/mbc.E04-05-0414; TAKEKURA H, 1995, P NATL ACAD SCI USA, V92, P3381, DOI 10.1073/pnas.92.8.3381; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Westerman KA, 2010, EXP CELL RES, V316, P1966, DOI 10.1016/j.yexcr.2010.03.022	44	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36116	36124		10.1074/jbc.M114.615526	http://dx.doi.org/10.1074/jbc.M114.615526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25384984	hybrid, Green Published			2022-12-26	WOS:000346897900038
J	Guseva, D; Loers, G; Schachner, M				Guseva, Daria; Loers, Gabriele; Schachner, Melitta			Function-Triggering Antibodies to the Adhesion Molecule L1 Enhance Recovery after Injury of the Adult Mouse Femoral Nerve	PLOS ONE			English	Article							SPINAL-CORD-INJURY; IMMUNOELECTRON MICROSCOPIC LOCALIZATION; RETINAL GANGLION-CELLS; GROWTH CONE MOTILITY; N-CAM; SCHWANN-CELLS; RECOGNITION MOLECULES; SCIATIC-NERVE; CARBOHYDRATE EPITOPE; CHOLINERGIC NEURONS	L1 is among the few adhesion molecules that favors repair after trauma in the adult central nervous system of vertebrates by promoting neuritogenesis and neuronal survival, among other beneficial features. In the peripheral nervous system, L1 is up-regulated in Schwann cells and regrowing axons after nerve damage, but the functional consequences of this expression remain unclear. Our previous study of L1-deficient mice in a femoral nerve injury model showed an unexpected improved functional recovery, attenuated motoneuronal cell death, and enhanced Schwann cell proliferation, being attributed to the persistent synthesis of neurotrophic factors. On the other hand, transgenic mice over-expressing L1 in neurons led to improved remyelination, but not improved functional recovery. The present study was undertaken to investigate whether the monoclonal L1 antibody 557 that triggers beneficial L1 functions in vitro would trigger these also in femoral nerve repair. We analyzed femoral nerve regeneration in C57BL/6J mice that received this antibody in a hydrogel filled conduit connecting the cut and sutured nerve before its bifurcation, leading to short-term release of antibody by diffusion. Video-based quantitative analysis of motor functions showed improved recovery when compared to mice treated with conduits containing PBS in the hydrogel scaffold, as a vehicle control. This improved recovery was associated with attenuated motoneuron loss, remyelination and improved precision of preferential motor reinnervation. We suggest that function-triggering L1 antibodies applied to the lesion site at the time of injury over a limited time period will not only be beneficial in peripheral, but also central nervous system regeneration.	[Guseva, Daria; Loers, Gabriele] Univ Klinikum Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Guseva, Daria] Hannover Med Sch, Hannover, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China; [Schachner, Melitta] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Shantou University; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Schachner, M (corresponding author), Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China.	schachner@stu.edu.cn	Guseva, Daria/AAW-2546-2021; Guseva, Daria/S-8582-2018	Guseva, PD, PhD, Daria/0000-0002-8844-572X	Hertie Stiftung [1.01.1/06/005]	Hertie Stiftung(Austrian Science Fund (FWF))	This work was supported by a grant from the Hertie Stiftung (1.01.1/06/005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock KH, 2004, EUR J NEUROSCI, V20, P1425, DOI 10.1111/j.1460-9568.2004.03573.x; Ahlborn P, 2007, EXP NEUROL, V208, P137, DOI 10.1016/j.expneurol.2007.08.005; Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Becker T, 2005, MOL CELL NEUROSCI, V30, P265, DOI 10.1016/j.mcn.2005.07.008; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Bernhardt RR, 1996, J COMP NEUROL, V376, P253, DOI 10.1002/(SICI)1096-9861(19961209)376:2<253::AID-CNE7>3.0.CO;2-2; Bernreuther C, 2006, J NEUROSCI, V26, P11532, DOI 10.1523/JNEUROSCI.2688-06.2006; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; Brannstrom T, 1999, EXP BRAIN RES, V125, P19, DOI 10.1007/s002210050653; BurdenGulley SM, 1997, CELL TISSUE RES, V290, P415, DOI 10.1007/s004410050948; Bushman J, 2014, NEUROPHARMACOLOGY, V79, P456, DOI 10.1016/j.neuropharm.2013.09.014; Chaisuksunt V, 2000, NEUROSCIENCE, V100, P87, DOI 10.1016/S0306-4522(00)00254-2; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Cui XZ, 2011, BRAIN BEHAV, V1, P73, DOI 10.1002/brb3.15; Cui YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017126; Cui YF, 2010, BRAIN, V133, P189, DOI 10.1093/brain/awp290; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; DANILOFF JK, 1986, J CELL BIOL, V103, P929, DOI 10.1083/jcb.103.3.929; DAVIS JQ, 1994, J BIOL CHEM, V269, P27163; Djogo N, 2013, NEUROBIOL DIS, V56, P104, DOI 10.1016/j.nbd.2013.04.014; Eberhardt KA, 2006, EXP NEUROL, V198, P500, DOI 10.1016/j.expneurol.2005.12.018; FAISSNER A, 1984, DEV BRAIN RES, V15, P69, DOI 10.1016/0165-3806(84)90141-X; GROTHE C, 1989, NEUROSCIENCE, V31, P649, DOI 10.1016/0306-4522(89)90430-2; Guan HJ, 2010, CEREB CORTEX, V20, P2684, DOI 10.1093/cercor/bhq016; Guseva D, 2011, EXP NEUROL, V229, P339, DOI 10.1016/j.expneurol.2011.02.018; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; HALL DE, 1987, J CELL BIOL, V104, P623, DOI 10.1083/jcb.104.3.623; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; Hortsch M, 2003, FRONT BIOSCI, V8, pD357, DOI 10.2741/1006; Hortsch M, 2009, CELL MOL BIOL LETT, V14, P57, DOI 10.2478/s11658-008-0035-4; Huang A, 2000, J NEUROPHYSIOL, V83, P3537, DOI 10.1152/jn.2000.83.6.3537; Irintchev A, 2005, EUR J NEUROSCI, V22, P802, DOI 10.1111/j.1460-9568.2005.04274.x; IRINTCHEV A, 1990, NEUROSCIENCE, V39, P231, DOI 10.1016/0306-4522(90)90236-W; Irintchev A, 2005, CEREB CORTEX, V15, P950, DOI 10.1093/cercor/bhh195; Irintchev A, 2011, J NEUROTRAUM, V28, P1295, DOI 10.1089/neu.2011.1775; Itoh K, 2005, MOL CELL NEUROSCI, V30, P131, DOI 10.1016/j.mcn.2005.06.006; Jung M, 1997, MOL CELL NEUROSCI, V9, P116, DOI 10.1006/mcne.1997.0611; KADMON G, 1990, J CELL BIOL, V110, P209, DOI 10.1083/jcb.110.1.209; Kamiguchi H, 1997, J NEUROSCI RES, V49, P1, DOI 10.1002/(SICI)1097-4547(19970701)49:1<1::AID-JNR1>3.0.CO;2-H; Khristy W, 2009, BRAIN RES, V1273, P9, DOI 10.1016/j.brainres.2009.03.060; KLEITMAN N, 1988, EXP NEUROL, V102, P298, DOI 10.1016/0014-4886(88)90223-3; Lavdas AA, 2010, J NEUROCHEM, V115, P1137, DOI 10.1111/j.1471-4159.2010.07003.x; LEIFER D, 1984, SCIENCE, V224, P303, DOI 10.1126/science.6143400; Loers G, 2014, BIOCH J; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Loers G, 2014, BIOCHEM J, V460, P437, DOI 10.1042/BJ20131677; Lutz D, 2014, J BIOL CHEM; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MARTINI R, 1986, J CELL BIOL, V103, P2439, DOI 10.1083/jcb.103.6.2439; MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813; MARTINI R, 1988, J CELL BIOL, V106, P1735, DOI 10.1083/jcb.106.5.1735; Mason MRJ, 2003, EUR J NEUROSCI, V18, P789, DOI 10.1046/j.1460-9568.2003.02809.x; McPhail LT, 2004, EXP NEUROL, V188, P331, DOI 10.1016/j.expneurol.2004.04.010; Mehanna A, 2009, BRAIN, V132, P1449, DOI 10.1093/brain/awp128; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; NIEKE J, 1985, DIFFERENTIATION, V30, P141, DOI 10.1111/j.1432-0436.1985.tb00525.x; Ramirez-Jarquin UN, 2014, NEUROPHARMACOLOGY, V82, P101, DOI 10.1016/j.neuropharm.2013.10.003; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Ourednik V, 2009, STEM CELLS, V27, P2846, DOI 10.1002/stem.227; PERSOHN E, 1987, J CELL BIOL, V105, P569, DOI 10.1083/jcb.105.1.569; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; Rudomin P, 2009, EXP BRAIN RES, V196, P139, DOI 10.1007/s00221-009-1758-9; Schuch U, 1989, NEURON, V3, P13; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SEILHEIMER B, 1989, J CELL BIOL, V109, P3095, DOI 10.1083/jcb.109.6.3095; SEILHEIMER B, 1987, EMBO J, V6, P1611, DOI 10.1002/j.1460-2075.1987.tb02408.x; Shelton DL, 2005, PAIN, V116, P8, DOI 10.1016/j.pain.2005.03.039; Simova O, 2006, ANN NEUROL, V60, P430, DOI 10.1002/ana.20948; Stallcup WB, 2000, J NEUROSCI RES, V61, P33, DOI 10.1002/1097-4547(20000701)61:1<33::AID-JNR4>3.0.CO;2-Y; STYREN SD, 1995, EXP NEUROL, V131, P165, DOI 10.1016/0014-4886(95)90038-1; Takeda Yasuo, 2001, Keio Journal of Medicine, V50, P240; WILLIAMS EJ, 1992, J CELL BIOL, V119, P883, DOI 10.1083/jcb.119.4.883; WOOD P, 1990, ANN NY ACAD SCI, V605, P1, DOI 10.1111/j.1749-6632.1990.tb42376.x; WOOD PM, 1990, J NEUROSCI, V10, P3635; Woolhead CL, 1998, J COMP NEUROL, V391, P259; Xu JC, 2011, J NEUROTRAUM, V28, P1921, DOI 10.1089/neu.2011.1783; ZHANG Y, 1995, J COMP NEUROL, V361, P193, DOI 10.1002/cne.903610202	80	8	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112984	10.1371/journal.pone.0112984	http://dx.doi.org/10.1371/journal.pone.0112984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393007	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300132
J	Liu, J; Wang, Q; Sun, MY; Zhu, LL; Yang, M; Zhao, Y				Liu, Jing; Wang, Qun; Sun, Minying; Zhu, Linlin; Yang, Michael; Zhao, Yu			Selection of Reference Genes for Quantitative Real-Time PCR Normalization in Panax ginseng at Different Stages of Growth and in Different Organs	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MESSENGER-RNA EXPRESSION; INTERNAL CONTROL; ANTLER-TIP; IDENTIFICATION; TRANSCRIPTOME; VALIDATION; BIOSYNTHESIS; CONSTITUENTS	Quantitative real-time reverse transcription PCR (qRT-PCR) has become a widely used method for gene expression analysis; however, its data interpretation largely depends on the stability of reference genes. The transcriptomics of Panax ginseng, one of the most popular and traditional ingredients used in Chinese medicines, is increasingly being studied. Furthermore, it is vital to establish a series of reliable reference genes when qRT-PCR is used to assess the gene expression profile of ginseng. In this study, we screened out candidate reference genes for ginseng using gene expression data generated by a high-throughput sequencing platform. Based on the statistical tests, 20 reference genes (10 traditional housekeeping genes and 10 novel genes) were selected. These genes were tested for the normalization of expression levels in five growth stages and three distinct plant organs of ginseng by qPCR. These genes were subsequently ranked and compared according to the stability of their expressions using geNorm, NormFinder, and BestKeeper computational programs. Although the best reference genes were found to vary across different samples, CYP and EF-1 alpha were the most stable genes amongst all samples. GAPDH/30S RPS20, CYP/60S RPL13 and CYP/QCR were the optimum pair of reference genes in the roots, stems, and leaves. CYP/60S RPL13, CYP/eIF-5A, aTUB/V-ATP, eIF-5A/SAR1, and aTUB/pol IIa were the most stably expressed combinations in each of the five developmental stages. Our study serves as a foundation for developing an accurate method of qRT-PCR and will benefit future studies on gene expression profiles of Panax Ginseng.	[Liu, Jing; Wang, Qun; Sun, Minying; Zhu, Linlin; Zhao, Yu] Changchun Univ Tradit Chinese Med, Tradit Chinese Med & Biotechnol Res & Dev Ctr, Changchun, Jilin, Peoples R China; [Yang, Michael] Columbia Univ, Coll Dent Med, New York, NY USA	Changchun University of Chinese Medicine; Columbia University	Zhao, Y (corresponding author), Changchun Univ Tradit Chinese Med, Tradit Chinese Med & Biotechnol Res & Dev Ctr, Changchun, Jilin, Peoples R China.	cnzhaoyu1972@126.com			National Natural Science Foundation of China [81373937]; National Key Technology R&D Program of China [2011BAI03B01-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (no. 81373937, URL: http://www.nsfc.gov.cn/Portal0/default152.htm) and the National Key Technology R&D Program of China (no. 2011BAI03B01-04, URL: http://www.863.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2009, ALTERN MED REV, V14, P172; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bemeur C, 2004, NEUROSCI LETT, V357, P211, DOI 10.1016/j.neulet.2003.12.081; Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Cankorur-Cetinkaya A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038351; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chen WY, 2010, GINSENG DEV PRACTICA; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Etschmann B, 2006, VET PATHOL, V43, P934, DOI 10.1354/vp.43-6-934; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Gamm M, 2011, MOL GENET GENOMICS, V285, P273, DOI 10.1007/s00438-011-0607-2; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han JY, 2011, PLANT CELL PHYSIOL, V52, P2062, DOI 10.1093/pcp/pcr150; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; HOU JP, 1977, COMP MED EAST WEST, V5, P123, DOI 10.1142/S0147291777000209; Jackson CJC, 2003, J GINSENG RES, V27, P135; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kim YK, 2012, J KOREAN SOC APPL BI, V55, P27, DOI 10.1007/s13765-012-0005-4; Kiselev KV, 2010, BIOL PLANTARUM, V54, P621, DOI 10.1007/s10535-010-0112-1; Lee OR, 2012, MOL BIOL REP, V39, P2365, DOI 10.1007/s11033-011-0987-8; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Liu DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046451; MacRae T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072884; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Pierzchala M, 2011, ANIM SCI PAP REP, V29, P53; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Sathiyaraj G, 2010, MOL BIOL REP, V37, P3445, DOI 10.1007/s11033-009-9936-1; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Volkov RA, 2003, J EXP BOT, V54, P2343, DOI 10.1093/jxb/erg244; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang Hongwei, 2009, Chin Med, V4, P20, DOI 10.1186/1749-8546-4-20; Wu Q, 2012, PLANT OMICS, V5, P414; Xie JT, 2011, GINSENG BENEFICIAL P; Yao BJ, 2012, BIOTECHNOL LETT, V34, P813, DOI 10.1007/s10529-011-0841-z; Yao BJ, 2012, MOL CELL BIOCHEM, V364, P93, DOI 10.1007/s11010-011-1209-3; YIP TT, 1985, AM J CHINESE MED, V13, P77, DOI 10.1142/S0192415X85000125; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	48	36	44	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112177	10.1371/journal.pone.0112177	http://dx.doi.org/10.1371/journal.pone.0112177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393243	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300039
J	Miles, KM; Seshadri, M; Ciamporcero, E; Adelaiye, R; Gillard, B; Sotomayor, P; Attwood, K; Shen, L; Conroy, D; Kuhnert, F; Lalani, AS; Thurston, G; Pili, R				Miles, Kiersten Marie; Seshadri, Mukund; Ciamporcero, Eric; Adelaiye, Remi; Gillard, Bryan; Sotomayor, Paula; Attwood, Kristopher; Shen, Li; Conroy, Dylan; Kuhnert, Frank; Lalani, Alshad S.; Thurston, Gavin; Pili, Roberto			Dll4 Blockade Potentiates the Anti-Tumor Effects of VEGF Inhibition in Renal Cell Carcinoma Patient-Derived Xenografts	PLOS ONE			English	Article							TUMOR-GROWTH; CANCER; ANGIOGENESIS; EXPRESSION; RESISTANCE; THERAPY	Background: The Notch ligand Delta-like 4 (Dll4) is highly expressed in vascular endothelium and has been shown to play a pivotal role in regulating tumor angiogenesis. Blockade of the Dll4-Notch pathway in preclinical cancer models has been associated with non-productive angiogenesis and reduced tumor growth. Given the cross-talk between the vascular endothelial growth factor (VEGF) and Delta-Notch pathways in tumor angiogenesis, we examined the activity of a function-blocking Dll4 antibody, REGN1035, alone and in combination with anti-VEGF therapy in renal cell carcinoma (RCC). Methods and Results: Severe combined immunodeficiency (SCID) mice bearing patient-derived clear cell RCC xenografts were treated with REGN1035 and in combination with the multi-targeted tyrosine kinase inhibitor sunitinib or the VEGF blocker ziv-aflibercept. Immunohistochemical and immunofluorescent analyses were carried out, as well as magnetic resonance imaging (MRI) examinations pre and 24 hours and 2 weeks post treatment. Single agent treatment with REGN1035 resulted in significant tumor growth inhibition (36-62%) that was equivalent to or exceeded the single agent anti-tumor activity of the VEGF pathway inhibitors sunitinib (38-54%) and ziv-aflibercept (46%). Importantly, combination treatments with REGN1035 plus VEGF inhibitors resulted in enhanced anti-tumor effects (72-80% growth inhibition), including some tumor regression. Magnetic resonance imaging showed a marked decrease in tumor perfusion in all treatment groups. Interestingly, anti-tumor efficacy of the combination of REGN1035 and ziv-aflibercept was also observed in a sunitinib resistant ccRCC model. Conclusions: Overall, these findings demonstrate the potent anti-tumor activity of Dll4 blockade in RCC patient-derived tumors and a combination benefit for the simultaneous targeting of the Dll4 and VEGF signaling pathways, highlighting the therapeutic potential of this treatment modality in RCC.	[Miles, Kiersten Marie; Shen, Li; Conroy, Dylan; Pili, Roberto] Roswell Pk Canc Inst, Genitourinary Program, Buffalo, NY 14263 USA; [Seshadri, Mukund; Gillard, Bryan] SUNY Buffalo, Roswell Pk Canc Inst Div, Dept Pharmacol & Therapeut, Buffalo, NY 14260 USA; [Adelaiye, Remi; Pili, Roberto] SUNY Buffalo, Roswell Pk Canc Inst Div, Dept Canc Pathol & Prevent, Buffalo, NY 14260 USA; [Sotomayor, Paula] SUNY Buffalo, Roswell Pk Canc Inst Div, Dept Mol & Cellular Biol, Buffalo, NY 14260 USA; [Attwood, Kristopher] SUNY Buffalo, Roswell Pk Canc Inst Div, Dept Biostat & Bioinformat, Buffalo, NY 14260 USA; [Ciamporcero, Eric] Univ Turin, Turin, Italy; [Kuhnert, Frank; Lalani, Alshad S.; Thurston, Gavin] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Turin; Regeneron	Pili, R (corresponding author), Roswell Pk Canc Inst, Genitourinary Program, Buffalo, NY 14263 USA.	Roberto.Pili@RoswellPark.org	Ciamporcero, Eric/M-6580-2017; Seshadri, Mukund/AAB-5011-2020	Ciamporcero, Eric/0000-0002-3856-6435; Thurston, Gavin/0000-0002-4105-5919; Adelaiye-Ogala, Remi/0000-0002-6581-7359	National Cancer Institute, National Institutes of Health [P30CA016056]; Regeneron Pharmaceuticals, Inc.; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Regeneron Pharmaceuticals, Inc.(Regeneron); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the National Cancer Institute, National Institutes of Health (P30CA016056) (RP), and by a research grant from Regeneron Pharmaceuticals, Inc. (RP). The funder provided support in the form of salaries for authors GT, ASL, FK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio LMA, 2011, CANCER GENOM PROTEOM, V8, P93; Bridges E, 2011, FUTURE ONCOL, V7, P569, DOI [10.2217/FON.11.20, 10.2217/fon.11.20]; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ellis L, 2012, MOL CANCER THER, V11, P383, DOI 10.1158/1535-7163.MCT-11-0748; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Gaya A, 2012, CANCER TREAT REV, V38, P484, DOI 10.1016/j.ctrv.2011.12.008; Gurney A, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-18; Hammers HJ, 2010, MOL CANCER THER, V9, P1525, DOI 10.1158/1535-7163.MCT-09-1106; Hassan KA, 2013, CLIN CANCER RES, V19, P1972, DOI 10.1158/1078-0432.CCR-12-0370; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Hu W, 2011, CANCER RES, V71, P6030, DOI 10.1158/0008-5472.CAN-10-2719; Ioffe E, 2012, P 103 ANN M AACR 201; Jubb AM, 2011, CLIN CANCER RES, V17, P372, DOI 10.1158/1078-0432.CCR-10-1791; Jubb AM, 2010, AM J PATHOL, V176, P2019, DOI 10.2353/ajpath.2010.090908; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Li JL, 2011, CANCER RES, V71, P6073, DOI 10.1158/0008-5472.CAN-11-1704; Li JL, 2010, FUTURE ONCOL, V6, P1099, DOI [10.2217/fon.10.62, 10.2217/FON.10.62]; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Seshadri M, 2006, NEOPLASIA, V8, P534, DOI 10.1593/neo.06295; Verheul HMW, 2007, CLIN CANCER RES, V13, P4201, DOI 10.1158/1078-0432.CCR-06-2553; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Yan MH, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-17; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Zhang JX, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0390-x	26	39	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112371	10.1371/journal.pone.0112371	http://dx.doi.org/10.1371/journal.pone.0112371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393540	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300054
J	Nostl, A; Marsh, JE; Sorqvist, P				Nostl, Anatole; Marsh, John E.; Sorqvist, Patrik			What We Expect Is Not Always What We Get: Evidence for Both the Direction-of-Change and the Specific-Stimulus Hypotheses of Auditory Attentional Capture	PLOS ONE			English	Article							BRAIN; ACTIVATION; MECHANISMS; NOVELTY; MEMORY	Participants were requested to respond to a sequence of visual targets while listening to a well-known lullaby. One of the notes in the lullaby was occasionally exchanged with a pattern deviant. Experiment 1 found that deviants capture attention as a function of the pitch difference between the deviant and the replaced/expected tone. However, when the pitch difference between the expected tone and the deviant tone is held constant, a violation to the direction-of-pitch change across tones can also capture attention (Experiment 2). Moreover, in more complex auditory environments, wherein it is difficult to build a coherent neural model of the sound environment from which expectations are formed, deviations can capture attention but it appears to matter less whether this is a violation from a specific stimulus or a violation of the current direction-of-change (Experiment 3). The results support the expectation violation account of auditory distraction and suggest that there are at least two different expectations that can be violated: One appears to be bound to a specific stimulus and the other would seem to be bound to a more global cross-stimulus rule such as the direction-of-change based on a sequence of preceding sound events. Factors like base-rate probability of tones within the sound environment might become the driving mechanism of attentional capture-rather than violated expectations-in complex sound environments.	[Nostl, Anatole; Marsh, John E.; Sorqvist, Patrik] Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden; [Marsh, John E.] Univ Cent Lancashire, Sch Psychol, Preston PR1 2HE, Lancs, England; [Sorqvist, Patrik] Linkoping Univ, Swedish Inst Disabil Res, Linnaeus Ctr HEAD, Linkoping, Sweden	University of Gavle; University of Central Lancashire; Linkoping University	Nostl, A (corresponding author), Univ Gavle, Dept Bldg Energy & Environm Engn, Gavle, Sweden.	anatole.nostl@hig.se		Marsh, John Everett/0000-0002-9494-1287; Sorqvist, Patrik/0000-0002-7584-2275	Swedish Research Council [2010-2042]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The research reported in this article was financially supported by a grant from the Swedish Research Council (2010-2042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Corral MJ, 2008, NEUROREPORT, V19, P1535, DOI 10.1097/WNR.0b013e3283110416; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Jaramillo M, 2000, NEUROSCI LETT, V290, P101, DOI 10.1016/S0304-3940(00)01344-6; Kimura M, 2010, J COGNITIVE NEUROSCI, V22, P1124, DOI 10.1162/jocn.2009.21299; Marsh JE, 2014, PSYCH J, V3, P58, DOI 10.1002/pchj.50; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Nostl A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048569; Parmentier FBR, 2011, COGNITION, V119, P374, DOI 10.1016/j.cognition.2011.02.001; Roer JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084166; Schroger E, 1997, PSYCHOPHYSIOLOGY, V34, P245, DOI 10.1111/j.1469-8986.1997.tb02395.x; Sorqvist P, 2012, PSYCHON B REV, V19, P245, DOI 10.3758/s13423-011-0203-9; Vachon F, 2012, J EXP PSYCHOL LEARN, V38, P164, DOI 10.1037/a0025054; Yago E, 2001, NEUROREPORT, V12, P4093, DOI 10.1097/00001756-200112210-00046	17	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111997	10.1371/journal.pone.0111997	http://dx.doi.org/10.1371/journal.pone.0111997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393298	gold, Green Submitted, Green Published			2022-12-26	WOS:000347709300027
J	Sarikonda, G; Fousteri, G; Sachithanantham, S; Miller, JF; Dave, A; Juntti, T; Coppieters, KT; von Herrath, M				Sarikonda, Ghanashyam; Fousteri, Georgia; Sachithanantham, Sowbarnika; Miller, Jacqueline F.; Dave, Amy; Juntti, Therese; Coppieters, Ken T.; von Herrath, Matthias			BDC12-4.1 T-Cell Receptor Transgenic Insulin-Specific CD4 T Cells Are Resistant to In Vitro Differentiation into Functional Foxp3(+) T Regulatory Cells	PLOS ONE			English	Article							NOD MICE; ANTIGEN; EPITOPE; ESCAPE; MHC; TOLERANCE; PEPTIDES; MOUSE	The infusion of ex vivo-expanded autologous T regulatory (Treg) cells is potentially an effective immunotherapeutic strategy against graft-versus-host disease (GvHD) and several autoimmune diseases, such as type 1 diabetes (T1D). However, in vitro differentiation of antigen-specific T cells into functional and stable Treg (iTreg) cells has proved challenging. As insulin is the major autoantigen leading to T1D, we tested the capacity of insulin-specific T-cell receptor (TCR) transgenic CD4(+) T cells of the BDC12-4.1 clone to convert into Foxp3(+) iTreg cells. We found that in vitro polarization toward Foxp3(+) iTreg was effective with a majority (>70%) of expanded cells expressing Foxp3. However, adoptive transfer of Foxp3(+) BDC12-4.1 cells did not prevent diabetes onset in immunocompetent NOD mice. Thus, in vitro polarization of insulin-specific BDC12-4.1 TCR transgenic CD4(+) T cells toward Foxp3(+) cells did not provide dominant tolerance in recipient mice. These results highlight the disconnect between an in vitro acquired Foxp3(+) cell phenotype and its associated in vivo regulatory potential.	[Sarikonda, Ghanashyam; Fousteri, Georgia; Sachithanantham, Sowbarnika; Miller, Jacqueline F.; Dave, Amy; Juntti, Therese; von Herrath, Matthias] La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA 92037 USA; [Coppieters, Ken T.; von Herrath, Matthias] Novo Nordisk Inc, Type Diabet R&D Ctr 1, Seattle, WA USA	La Jolla Institute for Immunology; Novo Nordisk	von Herrath, M (corresponding author), La Jolla Inst Allergy & Immunol, Ctr Diabet, La Jolla, CA 92037 USA.	matthias@liai.org	; Fousteri, Georgia/B-1226-2012	Jhatakia, Amy/0000-0001-6855-5342; Fousteri, Georgia/0000-0001-7745-7517	National Institute of Diabetes and Digestive and Kidney (NIDDK) [U01 (DK078013)]; University of Colorado, Denver (UCD); NIH [5U19AI050864-08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK078013] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Colorado, Denver (UCD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a U01 (DK078013) National Institute of Diabetes and Digestive and Kidney (NIDDK) grant to MvH and a subaward from the University of Colorado, Denver (UCD) to LIAI, issued under NIH award number 5U19AI050864-08 to UCD under the direction of Dr. George S. Eisenbarth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crawford F, 2011, P NATL ACAD SCI USA, V108, P16729, DOI 10.1073/pnas.1113954108; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Du W, 2006, J CLIN INVEST, V116, P1360, DOI 10.1172/JCI27030; FAIRCHILD PJ, 1993, INT IMMUNOL, V5, P1151, DOI 10.1093/intimm/5.9.1151; Fousteri G, 2012, DIABETES; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Jasinski JM, 2006, DIABETES, V55, P1978, DOI 10.2337/db06-0058; LIU GY, 1995, IMMUNITY, V3, P407, DOI 10.1016/1074-7613(95)90170-1; Marek-Trzonkowska N, 2013, PEDIATR DIABETES, V14, P322, DOI 10.1111/pedi.12029; Marek-Trzonkowska N, 2012, DIABETES CARE, V35, P1817, DOI 10.2337/dc12-0038; Mingueneau M, 2012, J EXP MED, V209, P623, DOI 10.1084/jem.20112593; Mohan JF, 2011, J EXP MED, V208, P2375, DOI 10.1084/jem.20111502; Mohan JF, 2010, NAT IMMUNOL, V11, P350, DOI 10.1038/ni.1850; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; WEGMANN DR, 1994, J AUTOIMMUN, V7, P833, DOI 10.1006/jaut.1994.1066; WEGMANN DR, 1994, EUR J IMMUNOL, V24, P1853, DOI 10.1002/eji.1830240820; Yu B, 2000, EUR J IMMUNOL, V30, P2497, DOI 10.1002/1521-4141(200009)30:9<2497::AID-IMMU2497>3.0.CO;2-J; Zekzer D, 1997, DIABETES, V46, P1124, DOI 10.2337/diabetes.46.7.1124; Zhang L, 2008, CURR OPIN IMMUNOL, V20, P111, DOI 10.1016/j.coi.2007.11.005	21	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112242	10.1371/journal.pone.0112242	http://dx.doi.org/10.1371/journal.pone.0112242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393309	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300041
J	Zhao, D; Cho, J; Kim, MH; Friedman, D; Guallar, E				Zhao, Di; Cho, Juhee; Kim, Myung Hun; Friedman, David; Guallar, Eliseo			Diabetes, Glucose Metabolism, and Glaucoma: The 2005-2008 National Health and Nutrition Examination Survey	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; RISK-FACTOR; INSULIN-RESISTANCE; EYE DISEASES; MELLITUS; POPULATION; PREVALENCE; ABNORMALITIES; HYPERTENSION	Background: Diabetes may affect vascular autoregulation of the retina and optic nerve and may be associated with an increased risk of glaucoma, but the association of prediabetes, insulin resistance, markers of glucose metabolismwith glaucoma has not beenevaluated in general population samples. Objective: To examine the relation between diabetes, pre-diabetes, metabolic syndrome and its components and the levels of fasting glucose, HbA1c and HOMA-IR with the prevalence of glaucoma in the general U.S. population. Methods: Cross-sectional study of 3,299 adult men and women from the 2005-2008 National Health and NutritionExamination Survey (NHANES). The presence of diabetes, prediabetes, the metabolic syndrome and its individual components and biomarkers of glucose metabolisms were based on standardized questionnaire and physical exam data and laboratory tests. The history of glaucoma was assessed through questionnaire during the home interview. Results: Diabetes was strongly associated with prevalent glaucoma. In fully adjusted models, the odds ratiofor glaucoma comparing participants with diabetes with participants in the reference group with neither pre-diabetes nor diabetes was 2.12 (95% CI: 1.23, 3.67). The corresponding odd ratio comparing participants with pre-diabetes to those in the reference group was 1.01 (95% CI: 0.57, 1.82). Patients with 5 or more years of diabetes duration hadan OR for glaucoma of 3.90 (95% CI: 1.63, 9.32) compared with patients with <5 years of diabetes duration. We also found a hockey-stick shaped associations between biomarkers of glucose metabolisms and the prevalence of glaucoma. Conclusions: Diabetes was associated with higher risk of glaucoma. Participants without diabetes but at the higher levels of fasting glucose, fasting insulin, HbA1c and HOMA-IR spectrum may also be at greater risk of glaucoma.	[Zhao, Di; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Zhao, Di; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Cho, Juhee] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Kim, Myung Hun] Saevit Eye Hosp, Goyang, Gyeonggi Do, South Korea; [Friedman, David] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University	Kim, MH (corresponding author), Saevit Eye Hosp, Goyang, Gyeonggi Do, South Korea.	philip.mhkim@gmail.com	Cho, Juhee/ABD-2280-2021	Friedman, David/0000-0002-2055-5797	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK079637] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Bonovas S, 2004, DIABETIC MED, V21, P609, DOI 10.1111/j.1464-5491.2004.01173.x; Centers for Disease Control and Prevention, 2005 2006 NAT HLTH N; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2007 2008 NAT HLTH N; Chang YC, 2010, EYE, V24, P1037, DOI 10.1038/eye.2009.247; Charliat G, 1994, Ophthalmic Epidemiol, V1, P131, DOI 10.3109/09286589409047221; Chen HY, 2005, SOUTH MED J, V98, P28, DOI 10.1097/01.SMJ.0000145389.15201.7F; Chopra V, 2008, OPHTHALMOLOGY, V115, P227, DOI 10.1016/j.ophtha.2007.04.049; de Voogd S, 2006, OPHTHALMOLOGY, V113, P1827, DOI 10.1016/j.ophtha.2006.03.063; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; Elisaf M, 2001, ACTA OPHTHALMOL SCAN, V79, P129, DOI 10.1034/j.1600-0420.2001.079002129.x; Ellis JD, 2000, BRIT J OPHTHALMOL, V84, P1218, DOI 10.1136/bjo.84.11.1218; Graw J, 2011, INVEST OPHTH VIS SCI, V52, P7778, DOI 10.1167/iovs.10-7113; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Howard DL, 2011, J NATL MED ASSOC, V103, P332, DOI 10.1016/S0027-9684(15)30314-X; Jonas JB, 1998, GRAEF ARCH CLIN EXP, V236, P202, DOI 10.1007/s004170050065; Kaimbo DKW, 2001, J CLIN EPIDEMIOL, V54, P166, DOI 10.1016/S0895-4356(00)00291-2; Kaimbo Wa Kaimbo D, 1997, Bull Soc Belge Ophtalmol, V267, P29; Kanamori A, 2004, CURR EYE RES, V28, P47, DOI 10.1076/ceyr.28.1.47.23487; King GL, 1996, ENDOCRIN METAB CLIN, V25, P255, DOI 10.1016/S0889-8529(05)70324-8; KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Lin CP, 2012, EUR J INTERN MED, V23, P76, DOI 10.1016/j.ejim.2011.06.002; MacLennan PA, 2013, CURR EYE RES, V38, P1, DOI 10.3109/02713683.2012.733054; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Nakamura M, 2005, OPHTHALMOLOGICA, V219, P1, DOI 10.1159/000081775; Nakamura M, 2001, J BIOL CHEM, V276, P43748, DOI 10.1074/jbc.M108594200; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Oh SW, 2005, DIABETES-METAB RES, V21, P434, DOI 10.1002/dmrr.529; Orzalesi N, 2007, GRAEF ARCH CLIN EXP, V245, P795, DOI 10.1007/s00417-006-0457-5; Park Sang-shin, 2010, J Prev Med Public Health, V43, P125, DOI 10.3961/jpmph.2010.43.2.125; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; Patty L, 2012, OPHTHALMOLOGY, V119, P1725, DOI 10.1016/j.ophtha.2012.02.029; Quigley HA, 2001, ARCH OPHTHALMOL-CHIC, V119, P1819, DOI 10.1001/archopht.119.12.1819; Sato T, 2002, INVEST OPHTH VIS SCI, V43, P170; Stanga P E, 1999, Curr Opin Ophthalmol, V10, P483, DOI 10.1097/00055735-199912000-00018; Szaflik JP, 2010, MUTAT RES-GEN TOX EN, V697, P19, DOI 10.1016/j.mrgentox.2010.02.003; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; TIELSCH JM, 1995, ARCH OPHTHALMOL-CHIC, V113, P216, DOI 10.1001/archopht.1995.01100020100038; Uhm K B, 1992, Korean J Ophthalmol, V6, P91; van Dam PS, 2002, DIABETES-METAB RES, V18, P176, DOI 10.1002/dmrr.287; Welinder Lotte G, 2009, Clin Epidemiol, V1, P125; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wise LA, 2011, ANN EPIDEMIOL, V21, P430, DOI 10.1016/j.annepidem.2011.03.006; World Health Organization, GLOB REC PHYS ACT HL; Xu L, 2009, EYE, V23, P676, DOI 10.1038/sj.eye.6703104	48	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112460	10.1371/journal.pone.0112460	http://dx.doi.org/10.1371/journal.pone.0112460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393836	Green Submitted, gold, Green Published			2022-12-26	WOS:000347709300057
J	Al-Henhena, N; Ying, RPY; Ismail, S; Najm, W; Khalifa, SAM; El-Seedi, H; Abdulla, MA				Al-Henhena, Nawal; Ying, Rozaida Poh Yuen; Ismail, Salmah; Najm, Wala; Khalifa, Shaden A. M.; El-Seedi, Hesham; Abdulla, Mahmood Ameen			Chemopreventive Efficacy of Andrographis paniculata on Azoxymethane-Induced Aberrant Colon Crypt Foci In Vivo	PLOS ONE			English	Article							TOTAL PHENOLIC CONTENT; COLORECTAL-CANCER; OXIDATIVE STRESS; ANTIOXIDANT; PLANTS; EXTRACT; 5-FLUOROURACIL; CARCINOGENESIS; ABSORPTION; PREVENTION	Andrographis paniculata is a grass-shaped medicinal herb, traditionally used in Southeast Asia. The aim of this study was to evaluate the chemoprotective effects of A. paniculata on colorectal cancer. A. paniculata ethanol extract was tested on azoxymethane (AOM)-induced aberrant crypt foci (ACF) in vivo and in vitro. A. paniculata treated groups showed a significant reduction in the number of ACF of the treated rats. Microscopically, ACF showed remarkably elongated and stratified cells, and depletion of the submucosal glands of AOM group compared to the treated groups. Histologically, staining showed slightly elevated masses above the surrounding mucosa with oval or slit-like orifices. Immunohistochemically, expression of proliferating cell nuclear antigen (PCNA) and beta-catenin protein were down-regulated in the A. paniculata treated groups compared to the AOM group. When colon tissue was homogenized, malondialdehyde (MDA) and nitric oxide (NO) levels were significantly decreased, whereas superoxide dismutase (SOD) activity was increased in the treated groups compared to the AOM group. A. paniculata ethanol extract showed antioxidant and free radical scavenging activity, as elucidated by the measure of oxidative stress markers. Further, the active fractions were assessed against cell lines of CCD841 and HT29 colon cancer cells.	[Al-Henhena, Nawal; Ying, Rozaida Poh Yuen; Najm, Wala; Abdulla, Mahmood Ameen] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur 50603, Malaysia; [Khalifa, Shaden A. M.] Karolinska Univ Hosp, Dept Expt Hematol, SE-14186 Huddinge, Sweden; [El-Seedi, Hesham] Uppsala Univ, Dept Med Chem, Div Pharmacognosy, SE-75123 Uppsala, Sweden; [Ismail, Salmah] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Karolinska Institutet; Karolinska University Hospital; Uppsala University; Universiti Malaya	Abdulla, MA (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur 50603, Malaysia.	ammeen@um.edu.my	ISMAIL, SALMAH/B-9680-2010; Ismail, Salmah/A-6504-2016; El-Seedi, Hesham R./C-8627-2018; POH, ROZAIDA Yuen Ying/B-9625-2010	ISMAIL, SALMAH/0000-0001-5595-8222; POH, ROZAIDA Yuen Ying/0000-0002-7893-9929	University of Malaya [PS246-2010B]; Ministry of Higher Education Malaysia [UM-MOHE UM.C/625/1/HIR/MOHE/SC/09]	University of Malaya(Universiti Malaya); Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	Funding provided by University of Malaya, Grant No. (PS246-2010B) and High Impact Research Grant UM-MOHE UM.C/625/1/HIR/MOHE/SC/09 from the Ministry of Higher Education Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek Niranjan, 2010, Indian Journal of Natural Products and Resources, V1, P125; Akowuah GA, 2009, FOOD CHEM TOXICOL, V47, P2321, DOI 10.1016/j.fct.2009.06.022; Al Batran R, 2013, BIOMED RES INT 2013, V2013; Al-Bayaty FH, 2012, NAT PROD RES, V26, P423, DOI 10.1080/14786419.2010.496114; Amaryan G, 2003, PHYTOMEDICINE, V10, P271, DOI 10.1078/094471103322004767; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Calabrese C, 2000, PHYTOTHER RES, V14, P333, DOI 10.1002/1099-1573(200008)14:5&lt;333::AID-PTR584&gt;3.0.CO;2-D; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Cheah PL, 2014, ASIAN PAC J CANCER P, V15, P3287, DOI 10.7314/APJCP.2014.15.7.3287; El-Seedi HR, 2013, J ETHNOPHARMACOL, V145, P746, DOI 10.1016/j.jep.2012.12.007; FRAGA CG, 1987, BIOCHEM PHARMACOL, V36, P717, DOI 10.1016/0006-2952(87)90724-6; Gan RY, 2010, J MED PLANTS RES, V4, P2438; Hosono K, 2010, MOL CARCINOGEN, V49, P662, DOI 10.1002/mc.20637; Ikram EHK, 2009, J FOOD COMPOS ANAL, V22, P388, DOI 10.1016/j.jfca.2009.04.001; Jarukamjorn K, 2008, J HEALTH SCI, V54, P370, DOI 10.1248/jhs.54.370; Jubeh TT, 2006, J DRUG TARGET, V14, P155, DOI 10.1080/10611860600648429; Khalifa SAM, 2014, BIOCHEM BIOPH RES CO, V446, P681, DOI 10.1016/j.bbrc.2013.12.134; Ko HC, 2006, J ETHNOPHARMACOL, V107, P205, DOI 10.1016/j.jep.2006.03.004; Koukourakis M, 2009, COLORECTAL CANC; Lin FL, 2009, PHYTOTHER RES, V23, P958, DOI 10.1002/ptr.2701; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marotta F, 2003, HEPATO-GASTROENTEROL, V50, P1914; Murthy NS, 2009, J POSTGRAD MED, V55, P45, DOI 10.4103/0022-3859.43549; Neelwarne B., 2012, RED BEET BIOTECHNOLO, DOI [10.1007/978-1-4614-3458-0, DOI 10.1007/978-1-4614-3458-0]; Norwati D, 2014, ASIAN PAC J CANCER P, V15, P2901, DOI 10.7314/APJCP.2014.15.6.2901; OECD, 2005, DOFO OECD GUID TEST; Ohishi T, 2002, CANCER LETT, V177, P49, DOI 10.1016/S0304-3835(01)00767-4; PINEDO HM, 1988, J CLIN ONCOL, V6, P1653, DOI 10.1200/JCO.1988.6.10.1653; Qader SW, 2011, MOLECULES, V16, P3433, DOI 10.3390/molecules16043433; RADERER M, 1995, EUR J CANCER, V31A, P1002, DOI 10.1016/0959-8049(95)00078-X; Rajagopal Sriram, 2003, J Exp Ther Oncol, V3, P147, DOI 10.1046/j.1359-4117.2003.01090.x; Rao NK., 2006, IRAN J PHARM THERAP, V5, P47; Roy S, 2010, WORLD J MICROB BIOT, V26, P85, DOI 10.1007/s11274-009-0146-8; Saha K, 2004, J ETHNOPHARMACOL, V92, P263, DOI [10.1016/j.jep.2004.03.007, 10.1016/j/jep.2004.03.007]; Samy RP, 2008, J ETHNOPHARMACOL, V115, P302, DOI 10.1016/j.jep.2007.10.006; Sathuvan Malairaj, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS741; Segui J, 2005, INFLAMM BOWEL DIS, V11, P872, DOI 10.1097/01.MIB.0000183420.25186.7a; Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353; Shafie NH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/681027; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; Sheeja K, 2007, IMMUNOPHARM IMMUNOT, V29, P81, DOI 10.1080/08923970701282726; Sheeja K, 2006, IMMUNOPHARM IMMUNOT, V28, P129, DOI 10.1080/08923970600626007; Singha PK, 2003, FITOTERAPIA, V74, P692, DOI [10.1016/S0367-326X(03)00159-X, 10.1016/s0367-326X(03)00159-X]; Skrovankova S, 2012, ADV FOOD NUTR RES; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tomimatsu T, 2005, CHEM-BIOL INTERACT, V155, P129, DOI 10.1016/j.cbi.2005.04.001; Traverso G, 2002, LANCET, V359, P403, DOI 10.1016/S0140-6736(02)07591-8; Violette S, 2002, INT J CANCER, V98, P498, DOI 10.1002/ijc.10146; Wasman SQ, 2011, INDIAN J EXP BIOL, V49, P767; Yamaguchi H, 2003, CANCER RES, V63, P1483; Yen GC, 2001, FOOD CHEM, V74, P471, DOI 10.1016/S0308-8146(01)00165-0; Yoopan N, 2007, PLANTA MED, V73, P503, DOI 10.1055/s-2007-967181; Yu CC, 2005, J PLANT PHYSIOL, V162, P1319, DOI 10.1016/j.jplph.2005.02.003; Zhao F, 2008, J ASIAN NAT PROD RES, V10, P473, DOI [10.1080/10286020801948334, 10.1080/10286020801948599]	56	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111118	10.1371/journal.pone.0111118	http://dx.doi.org/10.1371/journal.pone.0111118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390042	Green Published, gold			2022-12-26	WOS:000349144400018
J	Partha, R; Raman, K				Partha, Raghavendran; Raman, Karthik			Revisiting Robustness and Evolvability: Evolution in Weighted Genotype Spaces	PLOS ONE			English	Article							AU-RICH ELEMENTS; SECONDARY STRUCTURES; RNA; SEQUENCES; PLASTICITY	Robustness and evolvability are highly intertwined properties of biological systems. The relationship between these properties determines how biological systems are able to withstand mutations and show variation in response to them. Computational studies have explored the relationship between these two properties using neutral networks of RNA sequences (genotype) and their secondary structures (phenotype) as a model system. However, these studies have assumed every mutation to a sequence to be equally likely; the differences in the likelihood of the occurrence of various mutations, and the consequence of probabilistic nature of the mutations in such a system have previously been ignored. Associating probabilities to mutations essentially results in the weighting of genotype space. We here perform a comparative analysis of weighted and unweighted neutral networks of RNA sequences, and subsequently explore the relationship between robustness and evolvability. We show that assuming an equal likelihood for all mutations (as in an unweighted network), underestimates robustness and overestimates evolvability of a system. In spite of discarding this assumption, we observe that a negative correlation between sequence (genotype) robustness and sequence evolvability persists, and also that structure (phenotype) robustness promotes structure evolvability, as observed in earlier studies using unweighted networks. We also study the effects of base composition bias on robustness and evolvability. Particularly, we explore the association between robustness and evolvability in a sequence space that is AU-rich -sequences with an AU content of 80% or higher, compared to a normal (unbiased) sequence space. We find that evolvability of both sequences and structures in an AU-rich space is lesser compared to the normal space, and robustness higher. We also observe that AU-rich populations evolving on neutral networks of phenotypes, can access less phenotypic variation compared to normal populations evolving on neutral networks.	[Partha, Raghavendran; Raman, Karthik] Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Raman, K (corresponding author), Indian Inst Technol, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	kraman@iitm.ac.in	Raman, Karthik/Q-5278-2019; Partha, Raghavendran/L-1273-2019; Raman, Karthik/A-6459-2011	Partha, Raghavendran/0000-0002-7900-4375; Raman, Karthik/0000-0002-9311-7093	Indian Institute of Technology Madras; Centre for Industrial Consultancy and Sponsored Research, IITM [BIO/12-13/579/NFSC/KARH]	Indian Institute of Technology Madras; Centre for Industrial Consultancy and Sponsored Research, IITM	This work was supported from the Indian Institute of Technology Madras (IITM; http://www.iitm.ac.in/) and the seed grant BIO/12-13/579/NFSC/KARH from the Centre for Industrial Consultancy and Sponsored Research, IITM (https://icandsr.iitm.ac.in/) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gruner W, 1996, MONATSH CHEM, V127, P355, DOI 10.1007/BF00810881; Hershberg R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001115; Hurst LD, 2001, P ROY SOC B-BIOL SCI, V268, P493, DOI 10.1098/rspb.2000.1397; Huynen MA, 1996, J MOL EVOL, V43, P165; KIMURA M, 1989, GENOME, V31, P24, DOI 10.1139/g89-009; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Schuster P, 2005, EVOLUTIONARY DYNAMIC, P1; Stich M, 2008, J THEOR BIOL, V252, P750, DOI 10.1016/j.jtbi.2008.02.018; Stich M, 2011, J THEOR BIOL, V280, P117, DOI 10.1016/j.jtbi.2011.03.010; Sumedha, 2007, BIOSYSTEMS, V90, P475, DOI 10.1016/j.biosystems.2006.11.007; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wagner A, 2014, BIOPHYS J, V106, P955, DOI [10.1016/j.bpj.2014.01.003, 10.1016/j.bpj.2013.01.003]; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7	24	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112792	10.1371/journal.pone.0112792	http://dx.doi.org/10.1371/journal.pone.0112792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390641	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400128
J	Schutkowski, A; Wege, N; Stangl, GI; Konig, B				Schutkowski, Alexandra; Wege, Nicole; Stangl, Gabriele I.; Koenig, Bettina			Tissue-Specific Expression of Monocarboxylate Transporters during Fasting in Mice	PLOS ONE			English	Article							THYROID-HORMONE TRANSPORTER; AMINO-ACID TRANSPORTER; ALPHA PPAR-ALPHA; XENOPUS-LAEVIS OOCYTES; PSYCHOMOTOR RETARDATION; TRANSLATIONAL ACTIVATION; ANCILLARY PROTEIN; SKELETAL-MUSCLES; TAT1 SLC16A10; NULL MOUSE	Monocarboxylates such as pyruvate, lactate and ketone bodies are crucial for energy supply of all tissues, especially during energy restriction. The transport of monocarboxylates across the plasma membrane of cells is mediated by monocarboxylate transporters (MCTs). Out of 14 known mammalian MCTs, six isoforms have been functionally characterized to transport monocarboxylates and short chain fatty acids (MCT1-4), thyroid hormones (MCT8, -10) and aromatic amino acids (MCT10). Knowledge on the regulation of the different MCT isoforms is rare. In an attempt to get more insights in regulation of MCT expression upon energy deprivation, we carried out a comprehensive analysis of tissue specific expression of five MCT isoforms upon 48 h of fasting in mice. Due to the crucial role of peroxisome proliferator-activated receptor (PPAR)-alpha as a central regulator of energy metabolism and as known regulator of MCT1 expression, we included both wildtype (WT) and PPAR alpha knockout (KO) mice in our study. Liver, kidney, heart, small intestine, hypothalamus, pituitary gland and thyroid gland of the mice were analyzed. Here we show that the expression of all examined MCT isoforms was markedly altered by fasting compared to feeding. Expression of MCT1, MCT2 and MCT10 was either increased or decreased by fasting dependent on the analyzed tissue. MCT4 and MCT8 were down-regulated by fasting in all examined tissues. However, PPARa appeared to have a minor impact on MCT isoform regulation. Due to the fundamental role of MCTs in transport of energy providing metabolites and hormones involved in the regulation of energy homeostasis, we assumed that the observed fasting-induced adaptations of MCT expression seem to ensure an adequate energy supply of tissues during the fasting state. Since, MCT isoforms 1-4 are also necessary for the cellular uptake of drugs, the fasting-induced modifications of MCT expression have to be considered in future clinical care algorithms.	[Schutkowski, Alexandra; Wege, Nicole; Stangl, Gabriele I.; Koenig, Bettina] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany	Martin Luther University Halle Wittenberg	Konig, B (corresponding author), Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany.	bettina.koenig@landw.uni-halle.de		Schutkowski, Alexandra/0000-0002-9387-7869				Abe S, 2012, ENDOCRINOLOGY, V153, P4049, DOI 10.1210/en.2011-1713; Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P4322, DOI 10.1210/jc.2004-2567; Becker HM, 2010, AM J PHYSIOL-RENAL, V299, pF141, DOI 10.1152/ajprenal.00488.2009; Bettzieche A, 2009, MOL NUTR FOOD RES, V53, P1134, DOI 10.1002/mnfr.200800393; Borthakur A, 2008, J CELL BIOCHEM, V103, P1452, DOI 10.1002/jcb.21532; Borthakur A, 2012, AM J PHYSIOL-GASTR L, V303, pG1126, DOI 10.1152/ajpgi.00308.2012; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Campbell FM, 2002, J BIOL CHEM, V277, P4098, DOI 10.1074/jbc.M106054200; Chenal J, 2008, EUR J NEUROSCI, V27, P53, DOI 10.1111/j.1460-9568.2007.05981.x; Chenal J, 2007, J NEUROCHEM, V102, P389, DOI 10.1111/j.1471-4159.2007.04495.x; Cortes-Campos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062532; DEHOFF JL, 1978, CLIN CHEM, V24, P433; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Enoki T, 2003, J APPL PHYSIOL, V94, P2433, DOI 10.1152/japplphysiol.01155.2002; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Friesema ECH, 2006, NAT CLIN PRACT ENDOC, V2, P512, DOI 10.1038/ncpendmet0262; Gelinas R, 2008, AM J PHYSIOL-HEART C, V294, pH1571, DOI 10.1152/ajpheart.01340.2007; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Heuer H, 2005, ENDOCRINOLOGY, V146, P1701, DOI 10.1210/en.2004-1179; Iwanaga T, 2006, BIOMED RES-TOKYO, V27, P243, DOI 10.2220/biomedres.27.243; Kekuda R, 2013, DIGEST DIS SCI, V58, P660, DOI 10.1007/s10620-012-2407-x; Kersten S, 2001, FASEB J, V15, P1971, DOI 10.1096/fj.01-0147com; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim DK, 2001, J BIOL CHEM, V276, P17221, DOI 10.1074/jbc.M009462200; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Konig B, 2008, BBA-GEN SUBJECTS, V1780, P899, DOI 10.1016/j.bbagen.2008.03.002; Konig B, 2010, MOL NUTR FOOD RES, V54, P1248, DOI 10.1002/mnfr.200900432; Lee SST, 2004, J LIPID RES, V45, P2025, DOI 10.1194/jlr.M400078-JLR200; Leino RL, 2001, NEUROCHEM INT, V38, P519, DOI 10.1016/S0197-0186(00)00102-9; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liepinsh E, 2014, METABOLISM, V63, P127, DOI 10.1016/j.metabol.2013.09.014; Mariotta L, 2012, J PHYSIOL-LONDON, V590, P6413, DOI 10.1113/jphysiol.2012.239574; Matsuyama S, 2009, J REPROD DEVELOP, V55, P256, DOI 10.1262/jrd.20214; Morris ME, 2008, AAPS J, V10, P311, DOI 10.1208/s12248-008-9035-6; Moschen I, 2012, NEUROCHEM RES, V37, P2562, DOI 10.1007/s11064-012-0857-3; Murray CM, 2005, NAT CHEM BIOL, V1, P371, DOI 10.1038/nchembio744; Ovens MJ, 2010, BIOCHEM J, V431, P217, DOI 10.1042/BJ20100890; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Ramadan T, 2006, J CELL PHYSIOL, V206, P771, DOI 10.1002/jcp.20531; Rinholm JE, 2012, NATURE, V487, P435, DOI 10.1038/487435a; Ritzhaupt A, 1998, J PHYSIOL-LONDON, V513, P719, DOI 10.1111/j.1469-7793.1998.719ba.x; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Thomas C, 2012, AM J PHYSIOL-REG I, V302, pR1, DOI 10.1152/ajpregu.00250.2011; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Vijay N, 2014, CURR PHARM DESIGN, V20, P1487, DOI 10.2174/13816128113199990462; Visser W, 2007, BEST PRACT RES CL EN, V21, P223, DOI 10.1016/j.beem.2007.03.008; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Wege N, 2013, MOL NUTR FOOD RES, V57, P376, DOI 10.1002/mnfr.201200409; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Xu J, 2002, J BIOL CHEM, V277, P50237, DOI 10.1074/jbc.M201208200	60	31	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112118	10.1371/journal.pone.0112118	http://dx.doi.org/10.1371/journal.pone.0112118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390336	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400055
J	Shimamoto, A; Kagawa, H; Zensho, K; Sera, Y; Kazuki, Y; Osaki, M; Oshimura, M; Ishigaki, Y; Hamasaki, K; Kodama, Y; Yuasa, S; Fukuda, K; Hirashima, K; Seimiya, H; Koyama, H; Shimizu, T; Takemoto, M; Yokote, K; Goto, M; Tahara, H				Shimamoto, Akira; Kagawa, Harunobu; Zensho, Kazumasa; Sera, Yukihiro; Kazuki, Yasuhiro; Osaki, Mitsuhiko; Oshimura, Mitsuo; Ishigaki, Yasuhito; Hamasaki, Kanya; Kodama, Yoshiaki; Yuasa, Shinsuke; Fukuda, Keiichi; Hirashima, Kyotaro; Seimiya, Hiroyuki; Koyama, Hirofumi; Shimizu, Takahiko; Takemoto, Minoru; Yokote, Koutaro; Goto, Makoto; Tahara, Hidetoshi			Reprogramming Suppresses Premature Senescence Phenotypes of Werner Syndrome Cells and Maintains Chromosomal Stability over Long-Term Culture	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; INFLAMMATION; INDUCTION; GENE; ABNORMALITIES; OPPORTUNITIES; FIBROBLASTS; EXPRESSION; MUTATIONS; PREVENTS	Werner syndrome (WS) is a premature aging disorder characterized by chromosomal instability and cancer predisposition. Mutations in WRN are responsible for the disease and cause telomere dysfunction, resulting in accelerated aging. Recent studies have revealed that cells from WS patients can be successfully reprogrammed into induced pluripotent stem cells (iPSCs). In the present study, we describe the effects of long-term culture on WS iPSCs, which acquired and maintained infinite proliferative potential for self-renewal over 2 years. After long-term cultures, WS iPSCs exhibited stable undifferentiated states and differentiation capacity, and premature upregulation of senescence-associated genes in WS cells was completely suppressed in WS iPSCs despite WRN deficiency. WS iPSCs also showed recapitulation of the phenotypes during differentiation. Furthermore, karyotype analysis indicated that WS iPSCs were stable, and half of the descendant clones had chromosomal profiles that were similar to those of parental cells. These unexpected properties might be achieved by induced expression of endogenous telomerase gene during reprogramming, which trigger telomerase reactivation leading to suppression of both replicative senescence and telomere dysfunction in WS cells. These findings demonstrated that reprogramming suppressed premature senescence phenotypes in WS cells and WS iPSCs could lead to chromosomal stability over the long term. WS iPSCs will provide opportunities to identify affected lineages in WS and to develop a new strategy for the treatment of WS.	[Shimamoto, Akira; Kagawa, Harunobu; Zensho, Kazumasa; Sera, Yukihiro; Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cellular & Mol Biol, Hiroshima, Japan; [Kazuki, Yasuhiro; Osaki, Mitsuhiko; Oshimura, Mitsuo] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Dept Biomed Sci, Yonago, Tottori, Japan; [Osaki, Mitsuhiko] Tottori Univ, Fac Med, Div Pathol Biochem, Yonago, Tottori 683, Japan; [Ishigaki, Yasuhito] Kanazawa Med Univ, Med Res Inst, Kahoku, Ishikawa 92002, Japan; [Hamasaki, Kanya; Kodama, Yoshiaki] Radiat Effects Res Fdn, Dept Genet, Hiroshima, Japan; [Yuasa, Shinsuke; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Hirashima, Kyotaro; Seimiya, Hiroyuki] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Biotherapy, Tokyo 170, Japan; [Koyama, Hirofumi; Shimizu, Takahiko] Chiba Univ, Grad Sch Med, Dept Adv Aging Med, Chiba, Japan; [Takemoto, Minoru; Yokote, Koutaro] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol & Med, Chiba, Japan; [Goto, Makoto] Tokyo Womens Med Univ, Med Ctr East, Div Orthoped Surg & Rheumatol, Tokyo, Japan	Hiroshima University; Tottori University; Tottori University; Kanazawa Medical University; Radiation Effects Research Foundation - Japan; Keio University; Japanese Foundation for Cancer Research; Chiba University; Chiba University	Shimamoto, A (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cellular & Mol Biol, Hiroshima, Japan.	shim@hiroshima-u.ac.jp; toshi@hiroshima-u.ac.jp	Tahara, Hidetoshi/G-7697-2019; Fukuda, Keiichi/L-3777-2013	Seimiya, Hiroyuki/0000-0003-3314-9736; Kagawa, Harunobu/0000-0003-0436-3805; Yuasa, Shinsuke/0000-0001-5593-7552	Ministry of Education, Culture, Sports, Science and Technology of Japan [25670030, 20014015, 24590902]; Ministry of Health Labor and Welfare of Japan; Grants-in-Aid for Scientific Research [24590902, 221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Challenging Exploratory Research No. 25670030 (to A.S) and for Scientific Research No. 20014015 (to H.T) and No. 24590902 (to M.G) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by a Health and Labor Sciences Research Grant from the Ministry of Health Labor and Welfare of Japan (to A.S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Batista LFZ, 2011, NATURE, V474, P399, DOI 10.1038/nature10084; Cheung HH, 2014, STEM CELL REP, V2, P534, DOI 10.1016/j.stemcr.2014.02.006; Choi DH, 2001, FASEB J, V15, P1014, DOI 10.1096/fj.00-0104com; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Crabbe L, 2007, P NATL ACAD SCI USA, V104, P2205, DOI 10.1073/pnas.0609410104; Davis T, 2006, REJUV RES, V9, P402, DOI 10.1089/rej.2006.9.402; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Goto M, 1997, HUM GENET, V99, P191, DOI 10.1007/s004390050336; Goto M, 2000, CLIN EXP RHEUMATOL, V18, P760; Goto M, 1996, CANCER EPIDEM BIOMAR, V5, P239; Goto M, 2013, BIOSCI TRENDS; Goto M, 2012, EXP GERONTOL, V47, P936, DOI 10.1016/j.exger.2012.08.010; Goto M, 2008, BIOSCI TRENDS, V2, P218; Kojima H, 2012, CELL CYCLE, V11, P730, DOI 10.4161/cc.11.4.19172; KUMAR S, 1993, EXP GERONTOL, V28, P505, DOI 10.1016/0531-5565(93)90039-G; Martins-Taylor K, 2011, NAT BIOTECHNOL, V29, P488, DOI 10.1038/nbt.1890; Mathew R, 2010, FASEB J, V24, P2702, DOI 10.1096/fj.09-148973; Matsumoto T, 1997, HUM GENET, V100, P123, DOI 10.1007/s004390050477; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murano S, 1997, GERONTOLOGY, V43, P43; OHTAKI K, 1994, MUTAT RES, V316, P49, DOI 10.1016/0921-8734(94)90007-8; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Oshima J, 1996, HUM MOL GENET, V5, P1909, DOI 10.1093/hmg/5.12.1909; Rossi ML, 2010, DNA REPAIR, V9, P331, DOI 10.1016/j.dnarep.2009.12.011; RUBIN CD, 1992, J AM GERIATR SOC, V40, P1161, DOI 10.1111/j.1532-5415.1992.tb01808.x; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; SALK D, 1981, CYTOGENET CELL GENET, V30, P108, DOI 10.1159/000131597; SALK D, 1981, HUM GENET, V57, P269; Shimamoto Akira, 2004, Int J Clin Oncol, V9, P288, DOI 10.1007/s10147-004-0426-0; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaziri H, 2010, REGEN MED, V5, P345, DOI 10.2217/RME.10.21; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Yokote K, 2004, DIABETES CARE, V27, P2562, DOI 10.2337/diacare.27.10.2562; Yu CE, 1996, SCIENCE, V272, P258, DOI 10.1126/science.272.5259.258; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	41	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112900	10.1371/journal.pone.0112900	http://dx.doi.org/10.1371/journal.pone.0112900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390333	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400139
J	Wada, Y; Iyoda, M; Matsumoto, K; Shindo-Hirai, Y; Kuno, Y; Yamamoto, Y; Suzuki, T; Saito, T; Iseri, K; Shibata, T				Wada, Yukihiro; Iyoda, Masayuki; Matsumoto, Kei; Shindo-Hirai, Yuki; Kuno, Yoshihiro; Yamamoto, Yasutaka; Suzuki, Taihei; Saito, Tomohiro; Iseri, Ken; Shibata, Takanori			Epidermal Growth Factor Receptor Inhibition with Erlotinib Partially Prevents Cisplatin-Induced Nephrotoxicity in Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; TUBULAR EPITHELIAL-CELLS; PHASE-II TRIAL; RENAL INJURY; INDUCED APOPTOSIS; ERK ACTIVATION; CANCER; DEDIFFERENTIATION; PROLIFERATION; CHEMOTHERAPY	The effects of blocking the epidermal growth factor receptor (EGFR) in acute kidney injury (AKI) are controversial. Here we investigated the renoprotective effect of erlotinib, a selective tyrosine kinase inhibitor that can block EGFR activity, on cisplatin (CP)-induced AKI. Groups of animals were given either erlotinib or vehicle from one day before up to Day 3 following induction of CP-nephrotoxicity (CP-N). In addition, we analyzed the effects of erlotinib on signaling pathways involved in CP-N by using human renal proximal tubular cells (HK-2). Compared to controls, rats treated with erlotinib exhibited significant improvement of renal function and attenuation of tubulointerstitial injury, and reduced the number of apoptotic and proliferating cells. Erlotinib-treated rats had a significant reduction of renal cortical mRNA for profibrogenic genes. The Bax/Bcl-2 mRNA and protein ratios were significantly reduced by erlotinib treatment. In vitro, we observed that erlotinib significantly reduced the phosphorylation of MEK1 and Akt, processes that were induced by CP in HK-2. Taken together, these data indicate that erlotinib has renoprotective properties that are likely mediated through decreases in the apoptosis and proliferation of tubular cells, effects that reflect inhibition of downstream signaling pathways of EGFR. These results suggest that erlotinib may be useful for preventing AKI in patients receiving CP chemotherapy.	[Wada, Yukihiro; Iyoda, Masayuki; Matsumoto, Kei; Shindo-Hirai, Yuki; Kuno, Yoshihiro; Yamamoto, Yasutaka; Suzuki, Taihei; Saito, Tomohiro; Iseri, Ken; Shibata, Takanori] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan	Showa University	Iyoda, M (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan.	iyoda@med.showa-u.ac.jp	Saito, Tomohiro/AAD-6724-2021; Iseri, Ken/K-6376-2019	Iseri, Ken/0000-0002-6610-2451	Showa University; Showa University Medical Foundation	Showa University; Showa University Medical Foundation	YW and YK were supported by a Showa University Research Grant for Young Researchers. MI was supported by the Showa University Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ali BH, 2006, FOOD CHEM TOXICOL, V44, P1173, DOI 10.1016/j.fct.2006.01.013; Ali BH, 2011, BASIC CLIN PHARMACOL, V109, P300, DOI 10.1111/j.1742-7843.2011.00724.x; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Benhar M, 2002, ONCOGENE, V21, P8723, DOI 10.1038/sj.onc.1205980; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; BREYER MD, 1990, AM J PHYSIOL, V259, pF553, DOI 10.1152/ajprenal.1990.259.4.F553; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Coaxum SD, 2009, BIOCHIM BIOPHYS ACTA, V1973, P1174; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; de Jonge MJA, 2006, SEMIN ONCOL, V33, P68, DOI 10.1053/j.seminoncol.2005.11.011; Flamant M, 2012, NEPHROL DIAL TRANSPL, V27, P1297, DOI 10.1093/ndt/gfs030; Gao S, 2013, CANCER LETT, V333, P36, DOI 10.1016/j.canlet.2012.12.029; Hanigan Marie H, 2003, Cancer Ther, V1, P47; He S, 2013, AM J PHYSIOL-RENAL, V304, pF356, DOI 10.1152/ajprenal.00553.2012; Hirai Y, 2012, AM J PHYSIOL-RENAL, V302, pF244, DOI 10.1152/ajprenal.00113.2011; Hise MK, 2001, NEPHRON, V88, P71, DOI 10.1159/000045962; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Humanes B, 2012, KIDNEY INT, V82, P652, DOI 10.1038/ki.2012.199; Hwang IG, 2012, INVEST NEW DRUG, V30, P2371, DOI 10.1007/s10637-012-9792-z; Iyoda M, 2011, J AM SOC NEPHROL, V22, P1486, DOI 10.1681/ASN.2010111158; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jo SK, 2005, KIDNEY INT, V67, P458, DOI 10.1111/j.1523-1755.2005.67102.x; Kaushal GP, 2001, KIDNEY INT, V60, P1726, DOI 10.1046/j.1523-1755.2001.00026.x; Kim YK, 2005, J APPL TOXICOL, V25, P374, DOI 10.1002/jat.1081; Kuwana H, 2008, KIDNEY INT, V73, P430, DOI 10.1038/sj.ki.5002702; Lee JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048532; Maeda Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058775; Martins RG, 2013, J CLIN ONCOL, V31, P1415, DOI 10.1200/JCO.2012.46.3299; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Nakagawa T, 1997, KIDNEY INT, V51, P1774, DOI 10.1038/ki.1997.244; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Perol M, 2012, J CLIN ONCOL, V30, P3516, DOI 10.1200/JCO.2011.39.9782; Sakai M, 1997, J CLIN INVEST, V99, P2128, DOI 10.1172/JCI119386; Santarpia L, 2012, EXPERT OPIN THER TAR, V16, P103, DOI 10.1517/14728222.2011.645805; Schrier RW, 2002, J CLIN INVEST, V110, P743, DOI 10.1172/JCI200216568; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; Sorensen OE, 2006, J CLIN INVEST, V116, P1878, DOI 10.1172/JCI28422; Tang JH, 2013, AM J PATHOL, V183, P160, DOI 10.1016/j.ajpath.2013.04.005; Tang JH, 2013, KIDNEY INT, V83, P804, DOI 10.1038/ki.2012.435; Terada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080850; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Zhuang SG, 2004, AM J PHYSIOL-RENAL, V287, pF365, DOI 10.1152/ajprenal.00035.2004; Zhuang SG, 2012, J CELL PHYSIOL, V227, P2138, DOI 10.1002/jcp.22946	46	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111728	10.1371/journal.pone.0111728	http://dx.doi.org/10.1371/journal.pone.0111728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390346	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400031
J	Bennmann, D; Horstkorte, R; Hofmann, B; Jacobs, K; Navarrete-Santos, A; Simm, A; Bork, K; Gnanapragassam, VS				Bennmann, Dorit; Horstkorte, Ruediger; Hofmann, Britt; Jacobs, Kathleen; Navarrete-Santos, Alexander; Simm, Andreas; Bork, Kaya; Gnanapragassam, Vinayaga S.			Advanced Glycation Endproducts Interfere with Adhesion and Neurite Outgrowth	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; END-PRODUCTS; PC12 CELLS; MAILLARD REACTION; PHOSPHORYLATION; IDENTIFICATION; GERONTOTOXINS; ACTIVATION; BIOMARKERS	Advanced glycation endproducts (AGEs) represent a non-enzymatic posttranslational protein modification. AGEs are generated by a series of chemical reactions of free reducing monosaccharides, such as glucose, fructose or metabolites of the monosaccharide metabolism with amino groups of proteins. After oxidation, dehydration and condensation, stable AGE-modifications are formed. AGE-modified proteins accumulate in all cells and tissues as a normal feature of ageing and correlate with the glucose concentration in the blood. AGEs are increased in diabetic patients and play a significant role in the pathogenesis of most age-related neural disorders, such as Alzheimer's disease. We examined the role of AGEs on neurite outgrowth of PC12 cells. We induced the formation of AGEs using the reactive carbonyl compound methylglyoxal (MGO) as a physiological metabolite of glucose. We found that AGE-modification of laminin or collagen interfered with adhesion but not with neurite outgrowth of PC12 cells. Furthermore, the AGE-modification of PC12 cell proteins reduced NGF-induced neurite outgrowth. In conclusion, our data show that AGEs negatively influence neural plasticity.	[Bennmann, Dorit; Horstkorte, Ruediger; Bork, Kaya; Gnanapragassam, Vinayaga S.] Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Saale, Germany; [Hofmann, Britt; Jacobs, Kathleen; Navarrete-Santos, Alexander; Simm, Andreas] Univ Hosp, Dept Cardiothorac Surg, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Gnanapragassam, VS (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, D-06108 Halle, Saale, Germany.	vinayaga.gnanapragassam@medizin.uni-halle.de			Medical Faculty of the Martin-Luther-University (Roux-TIF)	Medical Faculty of the Martin-Luther-University (Roux-TIF)	The authors received funding by the Medical Faculty of the Martin-Luther-University (Roux-TIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2011, DIS MARKERS, V30, P317, DOI [10.3233/DMA-2011-0791, 10.1155/2011/718694]; Colaco CALS, 1996, NEPHROL DIAL TRANSPL, V11, P7; Gasser A, 2008, PROTEIN PEPTIDE LETT, V15, P385, DOI 10.2174/092986608784246515; Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Heidland A, 1998, Przegl Lek, V55 Suppl 1, P29; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; KIM UH, 1991, J BIOL CHEM, V266, P1359; Kontou M, 2008, NEUROREPORT, V19, P1239, DOI 10.1097/WNR.0b013e32830b368a; Kovacic U, 2009, INT REV NEUROBIOL, V87, P465, DOI 10.1016/S0074-7742(09)87026-8; Krautwald M, 2010, EXP GERONTOL, V45, P744, DOI 10.1016/j.exger.2010.03.001; LABATROBERT J, 1988, EXP GERONTOL, V23, P5, DOI 10.1016/0531-5565(88)90015-0; Loske C, 1998, J NEURAL TRANSM, V105, P1005, DOI 10.1007/s007020050108; Monnier V.M., 1989, Progress in Clinical and Biological Research, V304, P1; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; Munch G, 2012, AMINO ACIDS, V42, P1221, DOI 10.1007/s00726-010-0777-y; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Plantman S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/981695; Pollscheit J, 2012, J NEUROSCI RES, V90, P1577, DOI 10.1002/jnr.23038; Rahmadi A, 2011, CLIN CHEM LAB MED, V49, P385, DOI 10.1515/CCLM.2011.079; Requena V, 1996, MECH AGEING DEV, V89, P185, DOI 10.1016/0047-6374(96)01752-6; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; SMITH MA, 1995, NATURE, V374, P316, DOI 10.1038/374316b0; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Tan J, 2007, AM J CLIN NUTR, V86, P1502; Thorpe SR, 1996, DRUG AGING, V9, P69, DOI 10.2165/00002512-199609020-00001; TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347; Yamagishi S, 2002, BIOCHEM BIOPH RES CO, V290, P973, DOI 10.1006/bbrc.2001.6312	29	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112115	10.1371/journal.pone.0112115	http://dx.doi.org/10.1371/journal.pone.0112115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386903	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400041
J	Malik, P; Zuleger, N; de las Heras, JI; Saiz-Ros, N; Makarov, AA; Lazou, V; Meinke, P; Waterfall, M; Kelly, DA; Schirmer, EC				Malik, Poonam; Zuleger, Nikolaj; de las Heras, Jose I.; Saiz-Ros, Natalia; Makarov, Alexandr A.; Lazou, Vassiliki; Meinke, Peter; Waterfall, Martin; Kelly, David A.; Schirmer, Eric C.			NET23/STING Promotes Chromatin Compaction from the Nuclear Envelope	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; HUTCHINSON-GILFORD-PROGERIA; LAMIN-B RECEPTOR; DEACETYLASE 3 HDAC3; TRANSCRIPTIONAL REPRESSOR; TAIL DOMAIN; PROTEIN; MEMBRANE; BINDING; EMERIN	Changes in the peripheral distribution and amount of condensed chromatin are observed in a number of diseases linked to mutations in the lamin A protein of the nuclear envelope. We postulated that lamin A interactions with nuclear envelope transmembrane proteins (NETs) that affect chromatin structure might be altered in these diseases and so screened thirty-one NETs for those that promote chromatin compaction as determined by an increase in the number of chromatin clusters of high pixel intensity. One of these, NET23 (also called STING, MITA, MPYS, ERIS, Tmem173), strongly promoted chromatin compaction. A correlation between chromatin compaction and endogenous levels of NET23/STING was observed for a number of human cell lines, suggesting that NET23/STING may contribute generally to chromatin condensation. NET23/STING has separately been found to be involved in innate immune response signaling. Upon infection cells make a choice to either apoptose or to alter chromatin architecture to support focused expression of interferon genes and other response factors. We postulate that the chromatin compaction induced by NET23/STING may contribute to this choice because the cells expressing NET23/STING eventually apoptose, but the chromatin compaction effect is separate from this as the condensation was still observed when cells were treated with Z-VAD to block apoptosis. NET23/STING-induced compacted chromatin revealed changes in epigenetic marks including changes in histone methylation and acetylation. This indicates a previously uncharacterized nuclear role for NET23/STING potentially in both innate immune signaling and general chromatin architecture.	[Malik, Poonam; Zuleger, Nikolaj; de las Heras, Jose I.; Saiz-Ros, Natalia; Makarov, Alexandr A.; Lazou, Vassiliki; Meinke, Peter; Kelly, David A.; Schirmer, Eric C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Malik, Poonam; Zuleger, Nikolaj; de las Heras, Jose I.; Saiz-Ros, Natalia; Makarov, Alexandr A.; Lazou, Vassiliki; Meinke, Peter; Kelly, David A.; Schirmer, Eric C.] Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland; [Waterfall, Martin] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Schirmer, EC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	e.schirmer@ed.ac.uk	Meinke, Peter/AAS-9231-2021; Malik, Poonam/A-1756-2008	Meinke, Peter/0000-0003-3359-3837; Malik, Poonam/0000-0002-1733-722X; Schirmer, Eric/0000-0003-2635-1338	Wellcome Trust Senior Research Fellowship [076616, 095209, 077707]; Royal Society Research Fellowship [DH051766]; Royal Society Research Grant [RG090330]	Wellcome Trust Senior Research Fellowship(Wellcome Trust); Royal Society Research Fellowship(Royal Society of London); Royal Society Research Grant(Royal Society of London)	This work was supported by Wellcome Trust Senior Research Fellowship (076616 and 095209) to E.C.S., core funding to the Wellcome Trust Centre for Cell Biology (077707), and a Royal Society Research Fellowship (DH051766) and a Royal Society Research Grant (RG090330) to P.M. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abe T, 2013, MOL CELL, V50, P5, DOI 10.1016/j.molcel.2013.01.039; Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002; Berghe W.V., 2006, BIOCHEM PHARMACOL, V72, P1114, DOI DOI 10.1016/j.bcp.2006.07.012; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; BURKE B, 1990, EXP CELL RES, V186, P169, DOI 10.1016/0014-4827(90)90223-W; Clements L, 2000, BIOCHEM BIOPH RES CO, V267, P709, DOI 10.1006/bbrc.1999.2023; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; de las Heras JI, 2013, NUCLEUS-PHILA, V4, P460, DOI 10.4161/nucl.26872; De Sandre-Giovannoli A, 2003, SCIENCE, DOI DOI 10.1126; Demmerle J, 2013, CHROMOSOME RES, V21, P765, DOI 10.1007/s10577-013-9381-9; Demmerle J, 2012, J BIOL CHEM, V287, P22080, DOI 10.1074/jbc.M111.325308; Ding B, 2012, PLANT CELL, V24, P3783, DOI 10.1105/tpc.112.101972; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fang TC, 2012, J EXP MED, V209, P661, DOI 10.1084/jem.20112343; Fidzianska A, 1998, J NEUROL SCI, V159, P88, DOI 10.1016/S0022-510X(98)00130-0; Filesi I, 2005, PHYSIOL GENOMICS, V23, P150, DOI 10.1152/physiolgenomics.00060.2005; Furukawa K, 1997, BIOCHEM BIOPH RES CO, V238, P240, DOI 10.1006/bbrc.1997.7235; Goldberg M, 1999, P NATL ACAD SCI USA, V96, P2852, DOI 10.1073/pnas.96.6.2852; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Haraguchi T, 2004, EUR J BIOCHEM, V271, P1035, DOI 10.1111/j.1432-1033.2004.04007.x; Hartel S, 2003, CYTOM PART A, V55A, P15, DOI 10.1002/cyto.a.10068; HIRSCHHORN R, 1971, CELL IMMUNOL, V2, P696, DOI 10.1016/0008-8749(71)90016-5; HOGER TH, 1991, EXP CELL RES, V197, P280, DOI 10.1016/0014-4827(91)90434-V; Holaska JM, 2003, J BIOL CHEM, V278, P6969, DOI 10.1074/jbc.M208811200; Huang L, 2013, J IMMUNOL, V191, P3509, DOI 10.4049/jimmunol.1301419; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Lattanzi G, 2007, J CELL BIOCHEM, V102, P1149, DOI 10.1002/jcb.21467; Lemos H, 2014, J IMMUNOL; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Malik P, 2012, J BIOL CHEM, V287, P12277, DOI 10.1074/jbc.M111.331777; Malik P, 2010, CELL MOL LIFE SCI, V67, P1353, DOI 10.1007/s00018-010-0257-2; Maraldi NM, 2006, ADV ENZYME REGUL, V46, P33, DOI 10.1016/j.advenzreg.2006.01.001; Maraldi NM, 2011, J CELL BIOCHEM, V112, P979, DOI 10.1002/jcb.22992; Maraldi NM, 2002, ADV ENZYME REGUL, V42, P1, DOI 10.1016/S0065-2571(01)00022-X; Melcon G, 2006, HUM MOL GENET, V15, P637, DOI 10.1093/hmg/ddi479; MIRSKY AE, 1960, DIS NERV SYST, V21, P23; Ognibene A, 1999, MUSCLE NERVE, V22, P864, DOI 10.1002/(SICI)1097-4598(199907)22:7<864::AID-MUS8>3.3.CO;2-7; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Ohzeki J, 2012, EMBO J, V31, P2391, DOI 10.1038/emboj.2012.82; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Sabbattini P, 2014, MOL BIOL CELL, V25, P904, DOI 10.1091/mbc.E13-10-0628; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Schirmer EC, 2001, J CELL BIOL, V153, P479, DOI 10.1083/jcb.153.3.479; Sewry CA, 2001, NEUROPATH APPL NEURO, V27, P281, DOI 10.1046/j.0305-1846.2001.00323.x; Shimizu N, 1998, J CELL BIOL, V140, P1307, DOI 10.1083/jcb.140.6.1307; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Stender JD, 2013, CURR OPIN PHARMACOL, V13, P582, DOI 10.1016/j.coph.2013.06.002; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; Toth KF, 2004, J CELL SCI, V117, P4277, DOI 10.1242/jcs.01293; Tsukahara T, 2002, MUSCLE NERVE, V25, P898, DOI 10.1002/mus.10085; Verga L, 2003, VIRCHOWS ARCH, V443, P664, DOI 10.1007/s00428-003-0865-4; Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; Zuleger N, 2011, J CELL BIOL, V193, P109, DOI 10.1083/jcb.201009068; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	75	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111851	10.1371/journal.pone.0111851	http://dx.doi.org/10.1371/journal.pone.0111851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386906	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000345250400027
J	Park, JI; Frantz, MG; Kast, RJ; Chapman, KS; Dorton, HM; Stephany, CE; Arnett, MT; Herman, DH; McGee, AW				Park, Jennifer I.; Frantz, Michael G.; Kast, Ryan J.; Chapman, Katherine S.; Dorton, Hilary M.; Stephany, Celeste-Elise; Arnett, Megan T.; Herman, David H.; McGee, Aaron W.			Nogo Receptor 1 Limits Tactile Task Performance Independent of Basal Anatomical Plasticity	PLOS ONE			English	Article							LONG-TERM; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; NEURONAL CIRCUITS; REGENERATION; RECOVERY; CORTEX; MYELIN; NEOCORTEX; PROTEINS	The genes that govern how experience refines neural circuitry and alters synaptic structural plasticity are poorly understood. The nogo-66 receptor 1 gene (ngr1) is one candidate that may restrict the rate of learning as well as basal anatomical plasticity in adult cerebral cortex. To investigate if ngr1 limits the rate of learning we tested adult ngr1 null mice on a tactile learning task. Ngr1 mutants display greater overall performance despite a normal rate of improvement on the gap-cross assay, a whisker-dependent learning paradigm. To determine if ngr1 restricts basal anatomical plasticity in the associated sensory cortex, we repeatedly imaged dendritic spines and axonal varicosities of both constitutive and conditional adult ngr1 mutant mice in somatosensory barrel cortex for two weeks through cranial windows with two-photon chronic in vivo imaging. Neither constant nor acute deletion of ngr1 affected turnover or stability of dendritic spines or axonal boutons. The improved performance on the gap-cross task is not attributable to greater motor coordination, as ngr1 mutant mice possess a mild deficit in overall performance and a normal learning rate on the rotarod, a motor task. Mice lacking ngr1 also exhibit normal induction of tone-associated fear conditioning yet accelerated fear extinction and impaired consolidation. Thus, ngr1 alters tactile and motor task performance but does not appear to limit the rate of tactile or motor learning, nor determine the low set point for synaptic turnover in sensory cortex.	[Park, Jennifer I.; Frantz, Michael G.; Kast, Ryan J.; Chapman, Katherine S.; Dorton, Hilary M.; Stephany, Celeste-Elise; Arnett, Megan T.; McGee, Aaron W.] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dev Neurosci Program,Saban Res Inst,Dept Pediat, Los Angeles, CA 90027 USA; [Herman, David H.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California	McGee, AW (corresponding author), Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Dev Neurosci Program,Saban Res Inst,Dept Pediat, Los Angeles, CA 90027 USA.	amcgee@usc.edu		Stephany, Celeste-Elise/0000-0001-9997-5745	National Eye Institute [1R01EY021580]; National Institute of Neurological Disorder and Stroke [5R21NS077288]; Research Development Career Award from Children's Hospital Los Angeles; Biological Sciences (CABS) from the Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R01EY021580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS077288] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurological Disorder and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Research Development Career Award from Children's Hospital Los Angeles; Biological Sciences (CABS) from the Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research is supported by the National Eye Institute (1R01EY021580), the National Institute of Neurological Disorder and Stroke (5R21NS077288) and a Research Development Career Award from Children's Hospital Los Angeles. AWM is the recipient of a Career Award in the Biological Sciences (CABS) from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Akbik FV, 2013, NEURON, V77, P859, DOI 10.1016/j.neuron.2012.12.027; Barrette B, 2007, MOL CELL NEUROSCI, V34, P519, DOI 10.1016/j.mcn.2006.12.004; Bridge KE, 2009, NEUROBIOL AGING, V30, P309, DOI 10.1016/j.neurobiolaging.2007.06.002; Celikel T, 2007, P NATL ACAD SCI USA, V104, P1395, DOI 10.1073/pnas.0610267104; Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Kuhlman SJ, 2014, J NEUROSCI, V34, P6078, DOI 10.1523/JNEUROSCI.4919-12.2014; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lebron-Milad K, 2012, BIOL MOOD ANXIETY DI, V2, DOI [10.1186/2045-5380-2-7, 10.1186/2045-5380-2-3]; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Milad MR, 2009, NEUROSCIENCE, V164, P887, DOI 10.1016/j.neuroscience.2009.09.011; Mostany R, 2013, J NEUROSCI, V33, P4094, DOI 10.1523/JNEUROSCI.4825-12.2013; Padmashri R, 2013, J NEUROSCI, V33, P19715, DOI 10.1523/JNEUROSCI.2514-13.2013; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Sato M, 2008, J NEUROSCI, V28, P10278, DOI 10.1523/JNEUROSCI.2451-08.2008; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; Stephany CE, 2014, J NEUROSCI, V34, P11631, DOI 10.1523/JNEUROSCI.0545-14.2014; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voigts J, 2008, J NEUROPHYSIOL, V100, P504, DOI 10.1152/jn.00012.2008; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Wang XX, 2011, ANN NEUROL, V70, P805, DOI 10.1002/ana.22527; Wang XX, 2002, J NEUROSCI, V22, P5505; Wilbrecht L, 2010, J NEUROSCI, V30, P4927, DOI 10.1523/JNEUROSCI.6403-09.2010; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Xu HT, 2007, NAT NEUROSCI, V10, P549, DOI 10.1038/nn1883; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112678	10.1371/journal.pone.0112678	http://dx.doi.org/10.1371/journal.pone.0112678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386856	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400082
J	Zhao, W; Shi, XZ; Li, JN; Guo, W; Liu, CB; Chen, X				Zhao, Wei; Shi, Xiaozheng; Li, Jiangnan; Guo, Wei; Liu, Chengbai; Chen, Xia			Genetic, Epigenetic, and HPLC Fingerprint Differentiation between Natural and Ex Situ Populations of Rhodiola sachalinensis from Changbai Mountain, China	PLOS ONE			English	Article							DNA METHYLATION; PLANT; ADAPTATION; DIVERSITY; FLOW; CHROMATOGRAPHY; CONSERVATION; EXTINCTION; PATTERNS; RISK	Rhodiola sachalinensis is an endangered species with important medicinal value. We used inter-simple sequence repeat (ISSR) and methylation-sensitive amplified polymorphism (MSAP) markers to analyze genetic and epigenetic differentiation in different populations of R. sachalinensis, including three natural populations and an ex situ population. Chromatographic fingerprint was used to reveal HPLC fingerprint differentiation. According to our results, the ex situ population of R. sachalinensis has higher level genetic diversity and greater HPLC fingerprint variation than natural populations, but shows lower epigenetic diversity. Most genetic variation (54.88%) was found to be distributed within populations, and epigenetic variation was primarily distributed among populations (63.87%). UPGMA cluster analysis of ISSR and MSAP data showed identical results, with individuals from each given population grouping together. The results of UPGMA cluster analysis of HPLC fingerprint patterns was significantly different from results obtained from ISSR and MSAP data. Correlation analysis revealed close relationships among altitude, genetic structure, epigenetic structure, and HPLC fingerprint patterns (R-2 = 0.98 for genetic and epigenetic distance; R-2 = 0.90 for DNA methylation level and altitude; R-2 = -0.95 for HPLC fingerprint and altitude). Taken together, our results indicate that ex situ population of R. sachalinensis show significantly different genetic and epigenetic population structures and HPLC fingerprint patterns. Along with other potential explanations, these findings suggest that the ex situ environmental factors caused by different altitude play an important role in keeping hereditary characteristic of R. sachalinensis.	[Zhao, Wei; Li, Jiangnan; Guo, Wei; Liu, Chengbai; Chen, Xia] Jilin Univ, Sch Life Sci, Natl & Local United Engn Lab Chinese Herbal Med B, Changchun 130023, Jilin, Peoples R China; [Shi, Xiaozheng] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Jilin, Peoples R China; [Zhao, Wei; Shi, Xiaozheng; Li, Jiangnan; Guo, Wei; Liu, Chengbai; Chen, Xia] Jilin Univ, Sch Life Sci, Changchun 130023, Jilin, Peoples R China; [Zhao, Wei; Guo, Wei] Changbai Mt Acad Sci, Inst Bot, Erdao, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Chen, X (corresponding author), Jilin Univ, Sch Life Sci, Natl & Local United Engn Lab Chinese Herbal Med B, Changchun 130023, Jilin, Peoples R China.	chenxiajlu@163.com	chen, xia/GXM-5435-2022		Project for Wildlife Conservation and Management of the National Forestry Bureau of China; Program for Science and Technology Support of Jilin; National Special Research Foundation for the Earthquake Industry of China [201208005]	Project for Wildlife Conservation and Management of the National Forestry Bureau of China; Program for Science and Technology Support of Jilin; National Special Research Foundation for the Earthquake Industry of China	This study was supported by the Project for Wildlife Conservation and Management of the National Forestry Bureau of China (No relevent grant number was provided when we applied for this fund.), the Program for Science and Technology Support of Jilin, and the National Special Research Foundation for the Earthquake Industry of China (Grant number: 201208005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bijlsma R, 2000, J EVOLUTION BIOL, V13, P502, DOI 10.1046/j.1420-9101.2000.00177.x; Bossdorf O, 2008, ECOL LETT, V11, P106, DOI 10.1111/j.1461-0248.2007.01130.x; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Cervera MT, 2002, MOL GENET GENOMICS, V268, P543, DOI 10.1007/s00438-002-0772-4; [段传人 Duan Chuanren], 2003, [重庆大学学报. 自然科学版, Journal of Chongqing University(Natural Science Edition)], V26, P67; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; EXCOFFIER L, 1992, GENETICS, V131, P479; Falconer D. S., 1996, INTRO QUANTITATIVE G; Falk DA, 1991, GENETICS CONSERVATIO; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; FU LG, 1992, RED BOOK CHINESE PLA; Gao LX, 2010, PLANT CELL ENVIRON, V33, P1820, DOI 10.1111/j.1365-3040.2010.02186.x; Gu M, 2004, J CHROMATOGR A, V1022, P139, DOI 10.1016/j.chroma.2003.09.038; Hamrick J.L., 1989, PLANT POPULATION GEN; Herrera CM, 2011, MOL ECOL, V20, P1675, DOI 10.1111/j.1365-294X.2011.05026.x; Hou Y, 2014, J HERED, V105, P101, DOI 10.1093/jhered/est072; Huang S, 2000, CHINESE BIODIVERSITY, V4, P359; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li QM, 2002, BIOL CONSERV, V106, P151, DOI 10.1016/S0006-3207(01)00240-3; Li TL, 2007, PHYTOMEDICINE, V14, P601, DOI 10.1016/j.phymed.2006.12.016; Liang YZ, 2004, J CHROMATOGR B, V812, P53, DOI 10.1016/j.jchromb.2004.08.041; Lin MJ, 2005, J BIOL CHEM, V280, P861, DOI 10.1074/jbc.C400477200; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Ma XC, 2014, PHARM CROPS, V5, P1, DOI DOI 10.2174/2210290601405010001; Maxted N., 1997, PLANT GENETIC CONSER; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Nakamura S, 2007, CHEM PHARM BULL, V55, P1505, DOI 10.1248/cpb.55.1505; Navascues M, 2007, FOREST ECOL MANAG, V244, P122, DOI 10.1016/j.foreco.2007.04.009; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; NEI M, 1978, GENETICS, V89, P583; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; Paun O, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-113; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Pichersky E, 2000, TRENDS PLANT SCI, V5, P439, DOI 10.1016/S1360-1385(00)01741-6; Rafii ZA, 1998, BIOCHEM SYST ECOL, V26, P441, DOI 10.1016/S0305-1978(97)00125-7; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rohlf FJ, 1997, NTSYS PC VERSION 2 0; Sakthivel K, 2010, EUPHYTICA, V175, P303, DOI 10.1007/s10681-010-0167-2; Schellenbaum P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-78; SFDA. State Drug Administration of China, 2000, CHIN TRADIT PAT MED, V22, P671; Shepherdson D., 1994, P167; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; van Beek TA, 2002, J CHROMATOGR A, V967, P21, DOI 10.1016/S0021-9673(02)00172-3; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang Yang, 2003, Journal of Plant Physiology and Molecular Biology, V29, P357; Wolf DE, 2001, CONSERV BIOL, V15, P1039, DOI 10.1046/j.1523-1739.2001.0150041039.x; Wu WC, 1987, CHANGBAI MOUNTAIN RA; Yan TF, 2003, CONSERV GENET, V4, P213, DOI 10.1023/A:1023342723814; [阎秀峰 Yan Xiufeng], 2004, [生态学报, Acta Ecologica Sinica], V24, P674; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang ZQ, 2011, FLORA, V206, P567, DOI 10.1016/j.flora.2011.01.008; Zhou GB, 2007, J CHROMATOGR A, V1142, P236, DOI 10.1016/j.chroma.2006.12.093; Zhu XF, 2010, BIOL LETTERS, V6, P785, DOI 10.1098/rsbl.2010.0345	60	15	15	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112869	10.1371/journal.pone.0112869	http://dx.doi.org/10.1371/journal.pone.0112869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386983	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400098
J	Englert, NA; Luo, G; Goldstein, JA; Surapureddi, S				Englert, Neal A.; Luo, George; Goldstein, Joyce A.; Surapureddi, Sailesh			Epigenetic Modification of Histone 3 Lysine 27 MEDIATOR SUBUNIT MED25 IS REQUIRED FOR THE DISSOCIATION OF POLYCOMB REPRESSIVE COMPLEX 2 FROM THE PROMOTER OF CYTOCHROME P450 2C9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ANDROSTANE RECEPTOR; RNA-POLYMERASE-II; HEPATIC NUCLEAR FACTOR-4-ALPHA; REPRESSIVE COMPLEX 2; GENOME-WIDE ANALYSIS; PREGNANE-X-RECEPTOR; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; HUMAN HEPATOCYTES; MEDIATOR COMPLEX	The Mediator complex is vital for the transcriptional regulation of eukaryotic genes. Mediator binds to nuclear receptors at target response elements and recruits chromatin-modifying enzymes and RNA polymerase II. Here, we examine the involvement of Mediator subunit MED25 in the epigenetic regulation of human cytochrome P450 2C9 (CYP2C9). MED25 is recruited to the CYP2C9 promoter through association with liver-enriched HNF4 alpha, and we show that MED25 influences the H3K27 status of the HNF4 alpha binding region. This region was enriched for the activating marker H3K27ac and histone acetyltransferase CREBBP after MED25 overexpression but was trimethylated when MED25 expression was silenced. The epigenetic regulator Polycomb repressive complex (PRC2), which represses expression by methylating H3K27, plays an important role in target gene regulation. Silencing MED25 correlated with increased association of PRC2 not only with the promoter region chromatin but with HNF4 alpha itself. We confirmed the involvement of MED25 for fully functional preinitiation complex recruitment and transcriptional output in vitro. Formaldehyde-assisted isolation of regulatory elements (FAIRE) revealed chromatin conformation changes that were reliant on MED25, indicating that MED25 induced a permissive chromatin state that reflected increases in CYP2C9 mRNA. For the first time, we showed evidence that a functionally relevant human gene is transcriptionally regulated by HNF4 alpha via MED25 and PRC2. CYP2C9 is important for the metabolism of many exogenous chemicals including pharmaceutical drugs as well as endogenous substrates. Thus, MED25 is important for regulating the epigenetic landscape resulting in transcriptional activation of a highly inducible gene, CYP2C9.	[Englert, Neal A.; Luo, George; Goldstein, Joyce A.; Surapureddi, Sailesh] NIEHS, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Goldstein, JA (corresponding author), NIEHS, Lab Toxicol & Pharmacol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	goldste1@niehs.nih.gov			National Institutes of Health Intramural Research Program, NIEHS [ES021024-32]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES021024] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program, NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIEHS Project ES021024-32.	Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Beck DB, 2010, COLD SH Q B, V75, P11, DOI 10.1101/sqb.2010.75.052; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Caron S, 2013, MOL CELL BIOL, V33, P2202, DOI 10.1128/MCB.01004-12; Chen YP, 2005, J PHARMACOL EXP THER, V314, P1125, DOI 10.1124/jpet.105.087072; Chu CS, 2014, P NATL ACAD SCI USA, V111, P1355, DOI 10.1073/pnas.1323226111; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Corvetta D, 2013, J BIOL CHEM, V288, P8332, DOI 10.1074/jbc.M113.454280; Danielson PB, 2002, CURR DRUG METAB, V3, P561, DOI 10.2174/1389200023337054; Dannenberg LO, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-181; Delest A, 2012, CURR OPIN CELL BIOL, V24, P405, DOI 10.1016/j.ceb.2012.01.008; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ferguson SS, 2005, MOL PHARMACOL, V68, P747, DOI 10.1124/mol.105.013169; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gomez A, 2009, PHARMACOGENOMICS, V10, P1067, DOI [10.2217/pgs.09.56, 10.2217/PGS.09.56]; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Holmqvist PH, 2013, TRANSCR-AUSTIN, V4, P18, DOI 10.4161/trns.22601; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kurzawski M, 2012, PHARMACOL REP, V64, P927, DOI 10.1016/S1734-1140(12)70888-5; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Lee JY, 2012, BBA-PROTEINS PROTEOM, V1824, P974, DOI 10.1016/j.bbapap.2012.05.006; Lehmann L, 2012, J BIOL CHEM, V287, P35784, DOI 10.1074/jbc.M112.397430; Li TG, 2010, J LIPID RES, V51, P832, DOI 10.1194/jlr.M002782; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Miura H, 2009, NUCLEIC ACIDS RES, V37, P778, DOI 10.1093/nar/gkn978; Neri F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r91; Pascussi JM, 2000, MOL PHARMACOL, V58, P1441, DOI 10.1124/mol.58.6.1441; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Paul DS, 2013, GENOME RES, V23, P1130, DOI 10.1101/gr.155127.113; Poss ZC, 2013, CRIT REV BIOCHEM MOL, V48, P575, DOI 10.3109/10409238.2013.840259; Rana R, 2011, MOL CELL BIOL, V31, P466, DOI 10.1128/MCB.00847-10; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sela D, 2013, J BIOL CHEM, V288, P26179, DOI 10.1074/jbc.M113.496968; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Sugathan A, 2013, MOL CELL BIOL, V33, P3594, DOI 10.1128/MCB.00280-13; Surapureddi S, 2002, P NATL ACAD SCI USA, V99, P11836, DOI 10.1073/pnas.182426699; Surapureddi S, 2008, MOL PHARMACOL, V74, P913, DOI 10.1124/mol.108.048983; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Thomas M, 2013, MOL PHARMACOL, V83, P709, DOI 10.1124/mol.112.082503; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Viswakarma N, 2013, J BIOL CHEM, V288, P27898, DOI 10.1074/jbc.M113.486696; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Weng Y, 2005, J BIOL CHEM, V280, P31686, DOI 10.1074/jbc.M504447200; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Wu SY, 2003, MOL CELL BIOL, V23, P6229, DOI 10.1128/MCB.23.17.6229-6242.2003; Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333; Yang H, 2010, EXP BIOL MED, V235, P32, DOI 10.1258/ebm.2009.009252; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	62	19	21	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2264	2278		10.1074/jbc.M114.579474	http://dx.doi.org/10.1074/jbc.M114.579474			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25391650	Green Published, hybrid			2022-12-26	WOS:000348588000030
J	Yoshida, A; Tomita, T; Fujimura, T; Nishiyama, C; Kuzuyama, T; Nishiyama, M				Yoshida, Ayako; Tomita, Takeo; Fujimura, Tsutomu; Nishiyama, Chiharu; Kuzuyama, Tomohisa; Nishiyama, Makoto			Structural Insight into Amino Group-carrier Protein-mediated Lysine Biosynthesis CRYSTAL STRUCTURE OF THE LYSZ.LYSW COMPLEX FROM THERMUS THERMOPHILUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosynthesis; Crystal Structure; Evolution; Isothermal Titration Calorimetry (ITC); Thermophile; Carrier Protein; Lysine Biosynthesis	FATTY-ACID SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; ARGININE-BIOSYNTHESIS; ALPHA-AMINOADIPATE; CYSTEINE SYNTHASE; GLUTAMATE KINASE; BACTERIUM; ASPARTOKINASE; PURIFICATION; PATHWAY	Background: The amino group-carrier protein TtLysW is required for the biosynthesis of lysine by T. thermophilus. Results: The crystal structure of the lysine biosynthetic enzyme TtLysZ was determined in a complex with TtLysW. Conclusion: The two proteins interacted with each other through electrostatic interactions. Significance: Elucidating the mechanisms by which TtLysW is recognized by enzymes is crucial for understanding the evolution of lysine biosynthesis. In the biosynthesis of lysine by Thermus thermophilus, the metabolite -ketoglutarate is converted to the intermediate -aminoadipate (AAA), which is protected by the 54-amino acid acidic protein LysW. In this study, we determined the crystal structure of LysZ from T. thermophilus (TtLysZ), an amino acid kinase that catalyzes the second step in the AAA to lysine conversion, which was in a complex with LysW at a resolution of 1.85 . A crystal analysis coupled with isothermal titration calorimetry of the TtLysZ mutants for TtLysW revealed tight interactions between LysZ and the globular and C-terminal extension domains of the LysW protein, which were mainly attributed to electrostatic forces. These results provided structural evidence for LysW acting as a protecting molecule for the -amino group of AAA and also as a carrier protein to guarantee better recognition by biosynthetic enzymes for the efficient biosynthesis of lysine.	[Yoshida, Ayako; Tomita, Takeo; Kuzuyama, Tomohisa; Nishiyama, Makoto] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; [Fujimura, Tsutomu] Juntendo Univ, Sch Med, Cent Lab Med Sci, Div Biochem Anal,Bunkyo Ku, Tokyo 1138421, Japan; [Nishiyama, Chiharu] Tokyo Univ Sci, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan	University of Tokyo; Juntendo University; Tokyo University of Science	Nishiyama, M (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	umanis@mail.ecc.u-tokyo.ac.jp	Nishiyama, Chiharu/GPW-9372-2022	Yoshida, Ayako/0000-0002-3668-9001; Kuzuyama, Tomohisa/0000-0002-7221-5858; Fujimura, Tsutomu/0000-0003-1744-7725; Nishiyama, Makoto/0000-0001-8143-8052				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLACK S, 1955, J BIOL CHEM, V213, P27; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gil-Ortiz F, 2003, J MOL BIOL, V331, P231, DOI 10.1016/S0022-2836(03)00716-2; Gill DJ, 2007, EMBO J, V26, P600, DOI 10.1038/sj.emboj.7601501; GILSON MK, 1988, PROTEINS, V4, P7, DOI 10.1002/prot.340040104; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HAAS D, 1975, EUR J BIOCHEM, V52, P365, DOI 10.1111/j.1432-1033.1975.tb04004.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Jia YH, 2006, BIOCHEM J, V396, P479, DOI 10.1042/BJ20051711; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Kobashi N, 1999, J BACTERIOL, V181, P1713, DOI 10.1128/JB.181.6.1713-1718.1999; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Kumaran S, 2009, J BIOL CHEM, V284, P10268, DOI 10.1074/jbc.M900154200; Liu XY, 2008, J BIOL CHEM, V283, P16216, DOI 10.1074/jbc.M800760200; Lomakin IB, 2007, CELL, V129, P319, DOI 10.1016/j.cell.2007.03.013; MAJERUS PW, 1964, P NATL ACAD SCI USA, V51, P1231, DOI 10.1073/pnas.51.6.1231; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyazaki J, 2003, J BIOL CHEM, V278, P1864, DOI 10.1074/jbc.M205133200; Miyazaki J, 2002, FEBS LETT, V512, P269, DOI 10.1016/S0014-5793(02)02290-1; Miyazaki J, 2001, J BACTERIOL, V183, P5067, DOI 10.1128/JB.183.17.5067-5073.2001; Miyazaki T, 2004, MICROBIOL-SGM, V150, P2327, DOI 10.1099/mic.0.27037-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida H, 1999, GENOME RES, V9, P1175, DOI 10.1101/gr.9.12.1175; O'Leary SE, 2008, BIOCHEMISTRY-US, V47, P11606, DOI 10.1021/bi8013664; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouchi T, 2013, NAT CHEM BIOL, V9, P277, DOI [10.1038/NCHEMBIO.1200, 10.1038/nchembio.1200]; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Stachelhaus T, 1996, CHEM BIOL, V3, P913, DOI 10.1016/S1074-5521(96)90180-5; STRASSMAN M, 1953, J AM CHEM SOC, V75, P1680, DOI 10.1021/ja01103a049; Sundaresan R, 2012, BIOCHEM BIOPH RES CO, V420, P692, DOI 10.1016/j.bbrc.2012.03.072; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VOGEL HJ, 1964, AM NAT, V98, P435, DOI 10.1086/282338; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Yi H, 2013, J BIOL CHEM, V288, P36463, DOI 10.1074/jbc.M113.527143	45	9	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					435	447		10.1074/jbc.M114.595983	http://dx.doi.org/10.1074/jbc.M114.595983			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25392000	hybrid, Green Published			2022-12-26	WOS:000347231200038
J	Li, L; Guo, YF; Zhai, HX; Yin, YX; Zhang, JJ; Chen, HW; Wang, L; Li, N; Liu, RM; Xia, YF				Li, Liang; Guo, Yingfei; Zhai, Hongxia; Yin, Yaxin; Zhang, Jinjin; Chen, Haiwei; Wang, Lei; Li, Na; Liu, Runmei; Xia, Yunfeng			Aging Increases the Susceptivity of MSCs to Reactive Oxygen Species and Impairs Their Therapeutic Potency for Myocardial Infarction	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; BONE-MARROW; ISCHEMIC-HEART; TRANSPLANTATION; RATS; PROGENITOR; ADIPOSE; ISCHEMIA/REPERFUSION; CARDIOMYOCYTES	Myocardial infarction (MI) is one of the leading causes of death worldwide and Mesenchymal Stem Cells (MSCs) transplantation has been considered a promising therapy. Recently, it was reported that the therapeutic effectiveness of MSCs is dependent on the age of the donor, yet the underlying mechanism has not been thoroughly investigated. This study was designed to investigate whether this impaired therapeutic potency is caused by an increased susceptivity of MSCs from old donors to reactive oxygen species (ROS). The MSCs were isolated from the subcutaneous inguinal region of young (8-10 weeks) and old (18 months) Sprague-Dawley (SD) rats. By exposing these MSCs to H2O2, we found that the adhesion of MSCs from old donors was damaged more severely. Specifically, decreased expression of integrin and reduced phosphorylation of focal adhesion kinase Src and FAK were observed. Furthemore, H2O2 triggered an increased apoptosis of MSCs from old donors. To study the viability and therapeutic potency of MSCs from young and old donors in vivo, these MSCs were transplanted into acute MI model rats. We observed a more rapidly decreased survival rate of the old MSCs in the infarct region, which may be caused by their increased susceptivity to the micro-environmental ROS, as transplantation of the old MSCs with N-acetyl-L-cysteine (NAC), a ROS scavenger, protected them. The low viability of engrafted old MSCs consequently impaired their therapeutic effectiveness, judging by the histology and function of heart. Our study may help to understand the mechanism of MSCs-host interaction during MI, as well as shed light on the design of therapeutic strategy in clinic.	[Li, Liang; Zhai, Hongxia; Yin, Yaxin; Zhang, Jinjin; Chen, Haiwei; Wang, Lei; Li, Na; Liu, Runmei; Xia, Yunfeng] Gen Hosp Peoples Liberat Army, Hosp 1, Dept Cadres 1, Beijing, Peoples R China; [Guo, Yingfei] Gen Hosp Peoples Liberat Army, Hosp 1, Dept Emergency, Beijing, Peoples R China		Xia, YF (corresponding author), Gen Hosp Peoples Liberat Army, Hosp 1, Dept Cadres 1, Beijing, Peoples R China.	xiayf3691@sina.com	zhang, jin/GXV-9154-2022					Angelos MG, 2006, AM J PHYSIOL-HEART C, V290, pH341, DOI 10.1152/ajpheart.00223.2005; Ayala-Lugo A, 2011, CELL TRANSPLANT, V20, P407, DOI 10.3727/096368909X519283; Bajek A, 2012, AGING CLIN EXP RES, V24, P404, DOI 10.3275/8424; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Carvalho PH, 2013, ARQ BRAS CARDIOL, V100, P82, DOI 10.1590/S0066-782X2012005000114; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Fan Q, 2013, AGE, V35, P1017, DOI 10.1007/s11357-012-9421-y; Fan QA, 2011, CLIN SCI, V120, P251, DOI 10.1042/CS20100369; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040; Jain M, 2005, CORONARY ARTERY DIS, V16, P93, DOI 10.1097/00019501-200503000-00003; Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406; Khan M, 2011, J CELL MOL MED, V15, P1515, DOI 10.1111/j.1582-4934.2009.00998.x; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Liu MB, 2012, AGE, V34, P621, DOI 10.1007/s11357-011-9259-8; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Mantovani C, 2012, EXP CELL RES, V318, P2034, DOI 10.1016/j.yexcr.2012.05.008; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Piccirillo G, 2013, HEART RHYTHM; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Ruan W, 2005, CHINESE MED J-PEKING, V118, P1175; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Shi RZ, 2008, BIOCHEM BIOPH RES CO, V376, P247, DOI 10.1016/j.bbrc.2008.09.004; Song H, 2010, STEM CELLS, V28, P555, DOI 10.1002/stem.302; Stolzing A, 2006, AGING CELL, V5, P213, DOI 10.1111/j.1474-9726.2006.00213.x; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Wu LW, 2014, TRANSPL IMMUNOL, V30, P122, DOI 10.1016/j.trim.2014.03.001; Xaymardan M, 2012, J MOL CELL CARDIOL, V52, P1265, DOI 10.1016/j.yjmcc.2012.03.002; Xu GW, 2007, CELL RES, V17, P240, DOI 10.1038/cr.2007.4; Yao EH, 2006, CURR PHARM BIOTECHNO, V7, P101, DOI 10.2174/138920106776597685	37	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111850	10.1371/journal.pone.0111850	http://dx.doi.org/10.1371/journal.pone.0111850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393016	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300024
J	Li, XF; Xu, L; Li, JF; Li, BQ; Bai, XH; Strauss, JF; Zhang, ZB; Wang, HB				Li, Xiaofei; Xu, Lei; Li, Jianfeng; Li, Boqin; Bai, Xiaohui; Strauss, Jerome F., III; Zhang, Zhibing; Wang, Haibo			Otitis Media in Sperm-Associated Antigen 6 (Spag6)-Deficient Mice	PLOS ONE			English	Article							PRIMARY CILIARY DYSKINESIA; CENTRAL APPARATUS; POLARITY; HYDROCEPHALUS; MICROTUBULE; EPITHELIUM; EXPRESSION; EFFUSION; CHILDREN; PROTEIN	Mammalian SPAG6 protein is localized to the axoneme central apparatus, and it is required for normal flagella and cilia motility. Recent studies demonstrated that the protein also regulates ciliogenesis and cilia polarity in the epithelial cells of brain ventricles and trachea. Motile cilia are also present in the epithelial cells of the middle ear and Eustachian tubes, where the ciliary system participates in the movement of serous fluid and mucus in the middle ear. Cilia defects are associated with otitis media (OM), presumably due to an inability to efficiently transport fluid, mucus and particles including microorganisms. We investigated the potential role of SPAG6 in the middle ear and Eustachian tubes by studying mice with a targeted mutation in the Spag6 gene. SPAG6 is expressed in the ciliated cells of middle ear epithelial cells. The orientation of the ciliary basal feet was random in the middle ear epithelial cells of Spag6-deficient mice, and there was an associated disrupted localization of the planar cell polarity (PCP) protein, FZD6. These features are associated with disordered cilia orientation, confirmed by scanning electron microscopy, which leads to uncoordinated cilia beating. The Spag6 mutant mice were also prone to develop OM. However, there were no significant differences in bacterial populations, epithelial goblet cell density, mucin expression and Eustachian tube angle between the mutant and wild-type mice, suggesting that OM was due to accumulation of fluid and mucus secondary to the ciliary dysfunction. Our studies demonstrate a role for Spag6 in the pathogenesis of OM in mice, possibly through its role in the regulation of cilia/basal body polarity through the PCP-dependent mechanisms in the middle ear and Eustachian tubes.	[Li, Xiaofei; Xu, Lei; Wang, Haibo] Shandong Univ, Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Li, Xiaofei; Li, Jianfeng; Li, Boqin; Bai, Xiaohui; Wang, Haibo] Shandong Prov Key Lab Otol, Jinan, Shandong, Peoples R China; [Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA; [Strauss, Jerome F., III; Zhang, Zhibing] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA USA	Shandong University; Virginia Commonwealth University; Virginia Commonwealth University	Zhang, ZB (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23284 USA.	zzhang4@vcu.edu; wang.hb7585@hotmail.com	Li, xiaofei/GXF-7187-2022	Bai, Xiaohui/0000-0002-4027-7798; Li, Xiaofei/0000-0001-6968-6256	National Basic Research Program of China (973 Program) [2014CB541703]; 12th Five-Year National key technologies R D program [2012BAI12B01]; National Institutes of Health [HD076257]; VCU Massey Cancer Center Award; National Natural Science Foundation of China [81000407, 81470704]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076257] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); 12th Five-Year National key technologies R D program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VCU Massey Cancer Center Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Basic Research Program of China (973 Program 2014CB541703 to HBW), The 12th Five-Year National key technologies R & D program (No. 2012BAI12B01 to HBW), National Institutes of Health grant (HD076257 to ZBZ), VCU Massey Cancer Center Award (to ZBZ), and National Natural Science Foundation of China (81000407, 81470704 to XHB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO OP, 1995, ARCH OTOLARYNGOL, V121, P432; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; Campbell RG, 2009, INT J PEDIATR OTORHI, V73, P1630, DOI 10.1016/j.ijporl.2009.08.024; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; GREEN MARGARET C., 1952, OHIO JOUR SCI, V52, P31; Hendolin PH, 1997, J CLIN MICROBIOL, V35, P2854, DOI 10.1128/JCM.35.11.2854-2858.1997; Juhn S K, 1985, Auris Nasus Larynx, V12 Suppl 1, pS63; Kerschner JE, 2013, INT J PEDIATR OTORHI, V77, P1, DOI 10.1016/j.ijporl.2012.11.038; Kerschner JE, 2010, ARCH OTOLARYNGOL, V136, P819, DOI 10.1001/archoto.2010.123; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Lin JZ, 2003, JARO-J ASSOC RES OTO, V4, P384, DOI 10.1007/s10162-002-3023-9; Majithia A, 2005, INT J PEDIATR OTORHI, V69, P1061, DOI 10.1016/j.ijporl.2005.02.013; Mata M, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0420-1; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Riley B, 2011, PLOS ONE, V6; Rosenfeld RM, 2004, OTOLARYNG HEAD NECK, V130, pS95, DOI 10.1016/j.otohns.2004.02.002; Rousseau K, 2007, AM J PHYSIOL-LUNG C, V292, pL1396, DOI 10.1152/ajplung.00444.2006; SADE J, 1975, ACTA OTO-LARYNGOL, V79, P277, DOI 10.3109/00016487509124685; Sapiro R, 2002, MOL CELL BIOL, V22, P6298, DOI 10.1128/MCB.22.17.6298-6305.2002; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Smith EF, 1996, J CELL BIOL, V132, P359, DOI 10.1083/jcb.132.3.359; Teves ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107271; Thompson H, 2013, SCIENCE, V339, P1453, DOI 10.1126/science.1232862; Trune DR, 2009, BRAIN RES, V1277, P90, DOI 10.1016/j.brainres.2009.02.047; Vladar EK, 2012, CURR BIOL, V22, P2203, DOI 10.1016/j.cub.2012.09.046; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wansleeben C, 2011, DEV DYNAM, V240, P616, DOI 10.1002/dvdy.22564; Zhang X, 2012, PLOS ONE, V7; Zhang ZB, 2007, CELL MOTIL CYTOSKEL, V64, P360, DOI 10.1002/cm.20189	32	18	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112879	10.1371/journal.pone.0112879	http://dx.doi.org/10.1371/journal.pone.0112879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393619	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300116
J	Torre, S; Tattini, M; Brunetti, C; Fineschi, S; Fini, A; Ferrini, F; Sebastiani, F				Torre, Sara; Tattini, Massimiliano; Brunetti, Cecilia; Fineschi, Silvia; Fini, Alessio; Ferrini, Francesco; Sebastiani, Federico			RNA-Seq Analysis of Quercus pubescens Leaves: De Novo Transcriptome Assembly, Annotation and Functional Markers Development	PLOS ONE			English	Article							CLIMATE-CHANGE; TRICHOMES; DROUGHT; L.; BIOSYNTHESIS; PYRIMIDINE; RESPONSES; PURINE; END; OAK	Quercus pubescens Willd., a species distributed from Spain to southwest Asia, ranks high for drought tolerance among European oaks. Q. pubescens performs a role of outstanding significance in most Mediterranean forest ecosystems, but few mechanistic studies have been conducted to explore its response to environmental constrains, due to the lack of genomic resources. In our study, we performed a deep transcriptomic sequencing in Q. pubescens leaves, including de novo assembly, functional annotation and the identification of new molecular markers. Our results are a pre-requisite for undertaking molecular functional studies, and may give support in population and association genetic studies. 254,265,700 clean reads were generated by the Illumina HiSeq 2000 platform, with an average length of 98 bp. De novo assembly, using CLC Genomics, produced 96,006 contigs, having a mean length of 618 bp. Sequence similarity analyses against seven public databases (Uniprot, NR, RefSeq and KOGs at NCBI, Pfam, InterPro and KEGG) resulted in 83,065 transcripts annotated with gene descriptions, conserved protein domains, or gene ontology terms. These annotations and local BLAST allowed identify genes specifically associated with mechanisms of drought avoidance. Finally, 14,202 microsatellite markers and 18,425 single nucleotide polymorphisms (SNPs) were, in silico, discovered in assembled and annotated sequences. We completed a successful global analysis of the Q. pubescens leaf transcriptome using RNA-seq. The assembled and annotated sequences together with newly discovered molecular markers provide genomic information for functional genomic studies in Q. pubescens, with special emphasis to response mechanisms to severe constrain of the Mediterranean climate. Our tools enable comparative genomics studies on other Quercus species taking advantage of large intra-specific ecophysiological differences.	[Torre, Sara; Tattini, Massimiliano; Brunetti, Cecilia; Fineschi, Silvia] Natl Res Council Italy CNR, Dept Biol Agr & Food Sci, Inst Plant Protect, Sesto Fiorentino, Italy; [Brunetti, Cecilia; Fini, Alessio; Ferrini, Francesco] Univ Florence, Dept Agri Food & Environm Sci, Sesto Fiorentino, Italy; [Sebastiani, Federico] Natl Res Council Italy CNR, Dept Biol Agr & Food Sci, Inst Biosci & BioResources, Sesto Fiorentino, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Sebastiani, F (corresponding author), Natl Res Council Italy CNR, Dept Biol Agr & Food Sci, Inst Biosci & BioResources, Sesto Fiorentino, Italy.	federico.sebastiani@ibbr.cnr.it	Cecilia, Brunetti/Q-4724-2018; Fineschi, Silvia/ABF-9775-2020; Tattini, Massimiliano/K-1238-2019; Brunetti, Cecilia/D-3439-2016	Tattini, Massimiliano/0000-0001-5434-8860; FINI, ALESSIO/0000-0002-9713-689X; TORRE, SARA/0000-0002-3496-4057; Brunetti, Cecilia/0000-0002-8531-6076; SEBASTIANI, FEDERICO/0000-0003-4676-7381; FINESCHI, SILVIA/0000-0002-3583-6073; ferrini, Francesco/0000-0003-2222-0437	Italian Ministry of University and Research (MIUR/PRIN TreeCity)	Italian Ministry of University and Research (MIUR/PRIN TreeCity)(Ministry of Education, Universities and Research (MIUR))	This work was supported by the following Research Grants: Italian Ministry of University and Research (MIUR/PRIN-2012 TreeCity). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1990, TREE PHYSIOL, V7, P227, DOI 10.1093/treephys/7.1-2-3-4.227; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Ashrafi H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-571; Avise J, 2004, MOL MARKERS NATURAL; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Boldt R, 2003, PHYSIOL PLANTARUM, V117, P297, DOI 10.1034/j.1399-3054.2003.00030.x; Bouck A, 2007, MOL ECOL, V16, P907, DOI 10.1111/j.1365-294X.2006.03195.x; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Bruschi P, 2003, ANN BOT-LONDON, V91, P707, DOI 10.1093/aob/mcg075; Bussotti F, 1998, NEW PHYTOL, V138, P469, DOI 10.1046/j.1469-8137.1998.00121.x; Bussotti F, 2014, ENVIRON EXP BOT, V103, P80, DOI 10.1016/j.envexpbot.2013.09.013; Christensen JH, 2007, CLIMATIC CHANGE, V81, P1, DOI 10.1007/s10584-006-9211-6; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DAMESIN C, 1995, NEW PHYTOL, V131, P159, DOI 10.1111/j.1469-8137.1995.tb05717.x; Dickson RE, 1996, ANN SCI FOREST, V53, P181, DOI 10.1051/forest:19960202; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; EHLERINGER JR, 1984, OECOLOGIA, V63, P153, DOI 10.1007/BF00379871; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Grivet D, 2011, MOL BIOL EVOL, V28, P101, DOI 10.1093/molbev/msq190; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Hanewinkel M, 2013, NAT CLIM CHANGE, V3, P203, DOI [10.1038/nclimate1687, 10.1038/NCLIMATE1687]; Hu B, 2013, TREE PHYSIOL, V33, P489, DOI 10.1093/treephys/tpt025; Ishida T, 2008, ANNU REV PLANT BIOL, V59, P365, DOI 10.1146/annurev.arplant.59.032607.092949; JOHNSON PS, 2002, ECOLOGY SILVICULTURE; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KUBISKE ME, 1993, PLANT CELL ENVIRON, V16, P1123, DOI 10.1111/j.1365-3040.1996.tb02070.x; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Morales F, 2002, TREES-STRUCT FUNCT, V16, P504, DOI 10.1007/s00468-002-0195-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ohlemuller R, 2006, GLOBAL CHANGE BIOL, V12, P1788, DOI 10.1111/j.1365-2486.2006.01231.x; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Petit RJ, 2005, TAXON, V54, P877, DOI 10.2307/25065474; Petritan AM, 2009, EUR J FOREST RES, V128, P61, DOI 10.1007/s10342-008-0239-1; Rozen S, 2000, Methods Mol Biol, V132, P365; Schellmann S, 2005, INT J DEV BIOL, V49, P579, DOI 10.1387/ijdb.051983ss; Sebastiani F, 2012, CONSERV GENET RESOUR, V4, P231, DOI 10.1007/s12686-011-9513-5; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063993; Stasolla C, 2003, J PLANT PHYSIOL, V160, P1271, DOI 10.1078/0176-1617-01169; Struve D, 2010, HORTSCIENCE, V45, P1729, DOI 10.21273/HORTSCI.45.11.1729; Tattini M, 2007, PLANT BIOLOGY, V9, P411, DOI 10.1055/s-2006-924662; Tattini M, 2005, NEW PHYTOL, V167, P457, DOI 10.1111/j.1469-8137.2005.01442.x; Torales SL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-705; Torales SL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-291; Ueno S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-650; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093; Wang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-836; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Xia ZH, 2011, PLANT MOL BIOL, V77, P299, DOI 10.1007/s11103-011-9811-z; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421	63	38	39	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112487	10.1371/journal.pone.0112487	http://dx.doi.org/10.1371/journal.pone.0112487			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393112	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300059
J	Gierman, HJ; Fortney, K; Roach, JC; Coles, NS; Li, H; Glusman, G; Markov, GJ; Smith, JD; Hood, L; Coles, LS; Kim, SK				Gierman, Hinco J.; Fortney, Kristen; Roach, Jared C.; Coles, Natalie S.; Li, Hong; Glusman, Gustavo; Markov, Glenn J.; Smith, Justin D.; Hood, Leroy; Coles, L. Stephen; Kim, Stuart K.			Whole-Genome Sequencing of the World's Oldest People	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; GENETIC-VARIATION; ACMG RECOMMENDATIONS; WIDE ASSOCIATION; HUMAN LONGEVITY; TWIN PAIRS; LIFE-SPAN; SUPERCENTENARIANS; VARIANTS; CENTENARIANS	Supercentenarians (110 years or older) are the world's oldest people. Seventy four are alive worldwide, with twenty two in the United States. We performed whole-genome sequencing on 17 supercentenarians to explore the genetic basis underlying extreme human longevity. We found no significant evidence of enrichment for a single rare protein-altering variant or for a gene harboring different rare protein altering variants in supercentenarian compared to control genomes. We followed up on the gene most enriched for rare protein-altering variants in our cohort of supercentenarians, TSHZ3, by sequencing it in a second cohort of 99 long-lived individuals but did not find a significant enrichment. The genome of one supercentenarian had a pathogenic mutation in DSC2, known to predispose to arrhythmogenic right ventricular cardiomyopathy, which is recommended to be reported to this individual as an incidental finding according to a recent position statement by the American College of Medical Genetics and Genomics. Even with this pathogenic mutation, the proband lived to over 110 years. The entire list of rare protein-altering variants and DNA sequence of all 17 supercentenarian genomes is available as a resource to assist the discovery of the genetic basis of extreme longevity in future studies.	[Gierman, Hinco J.; Fortney, Kristen; Markov, Glenn J.; Smith, Justin D.; Kim, Stuart K.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Gierman, Hinco J.; Fortney, Kristen; Markov, Glenn J.; Smith, Justin D.; Kim, Stuart K.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Roach, Jared C.; Li, Hong; Glusman, Gustavo; Hood, Leroy] Inst Syst Biol, Seattle, WA USA; [Coles, Natalie S.; Coles, L. Stephen] Gerontol Res Grp, Los Angeles, CA USA; [Coles, Natalie S.; Coles, L. Stephen] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Stanford University; Stanford University; Institute for Systems Biology (ISB); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kim, SK (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	stuartkm@stanford.edu		Glusman, Gustavo/0000-0001-8060-5955; Smith, Justin/0000-0003-3079-3534	Ellison Medical Foundation/American Federation for Aging Research Fellowship; Stanford Dean's Fellowship; Paul Glenn Foundation Biology of Aging Seed Grant; National Institute of General Medical Sciences Center for Systems Biology [P50 GM076547]; University of Luxembourg - Institute for Systems Biology Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025941] Funding Source: NIH RePORTER	Ellison Medical Foundation/American Federation for Aging Research Fellowship; Stanford Dean's Fellowship; Paul Glenn Foundation Biology of Aging Seed Grant; National Institute of General Medical Sciences Center for Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Luxembourg - Institute for Systems Biology Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Ellison Medical Foundation/American Federation for Aging Research Fellowship, Stanford Dean's Fellowship, The Paul Glenn Foundation Biology of Aging Seed Grant, National Institute of General Medical Sciences Center for Systems Biology (P50 GM076547) and the University of Luxembourg - Institute for Systems Biology Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Baskin B, 2013, HUM GENET, V132, P1245, DOI 10.1007/s00439-013-1323-2; Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Blake JA, 2013, NUCLEIC ACIDS RES, V41, pD530, DOI 10.1093/nar/gks1050; Carvalho MA, 2007, CANCER RES, V67, P1494, DOI 10.1158/0008-5472.CAN-06-3297; Coles LS, 2014, REJUV RES, V17, P80, DOI 10.1089/rej.2014.1553; Cooper DN, 1996, HUM GENET, V98, P629, DOI 10.1007/s004390050272; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gerontology Research Group, 2014, TABL A VER SUP; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Han J, 2013, MECH AGEING DEV, V134, P478, DOI 10.1016/j.mad.2013.01.005; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Heuser A, 2006, AM J HUM GENET, V79, P1081, DOI 10.1086/509044; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004144; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Panguluri RCK, 1999, HUM GENET, V105, P28, DOI 10.1007/s004390051059; Pavlidis N, 2012, CRIT REV ONCOL HEMAT, V83, P145, DOI 10.1016/j.critrevonc.2011.09.007; Perl Development Team, 2013, PERL PROGR LANG; Perls T, 2007, J GERONTOL A-BIOL, V62, P1028, DOI 10.1093/gerona/62.9.1028; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; R Core Team, 2013, INT J AGING HUM DEV, DOI DOI 10.2190/8M7H-CJL7-6K5T-UMFV; Rajpathak SN, 2011, J AM GERIATR SOC, V59, P1509, DOI 10.1111/j.1532-5415.2011.03498.x; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Schoenhofen EA, 2006, J AM GERIATR SOC, V54, P1237, DOI 10.1111/j.1532-5415.2006.00826.x; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Sebastiani Paola, 2012, Frontiers in Genetics, V2, P90, DOI 10.3389/fgene.2011.00090; Sebastiani Paola, 2012, Frontiers in Genetics, V3, P277, DOI 10.3389/fgene.2012.00277; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Zwaag PA, 2009, HUM MUTAT, V30, P1278, DOI 10.1002/humu.21064; van Tintelen JP, 2007, CURR OPIN CARDIOL, V22, P185, DOI 10.1097/HCO.0b013e3280d942c4; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Willcox DC, 2008, J GERONTOL A-BIOL, V63, P1201, DOI 10.1093/gerona/63.11.1201; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Ye K, 2013, TWIN RES HUM GENET, V16, P1026, DOI 10.1017/thg.2013.73	54	41	43	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112430	10.1371/journal.pone.0112430	http://dx.doi.org/10.1371/journal.pone.0112430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390934	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400081
J	Izzo, NJ; Xu, J; Zeng, C; Kirk, MJ; Mozzoni, K; Silky, C; Rehak, C; Yurko, R; Look, G; Rishton, G; Safferstein, H; Cruchaga, C; Goate, A; Cahill, MA; Arancio, O; Mach, RH; Craven, R; Head, E; LeVine, H; Spires-Jones, TL; Catalano, SM				Izzo, Nicholas J.; Xu, Jinbin; Zeng, Chenbo; Kirk, Molly J.; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Cruchaga, Carlos; Goate, Alison; Cahill, Michael A.; Arancio, Ottavio; Mach, Robert H.; Craven, Rolf; Head, Elizabeth; LeVine, Harry, III; Spires-Jones, Tara L.; Catalano, Susan M.			Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity	PLOS ONE			English	Article							MEMBRANE COMPONENT 1; SOLUBLE A-BETA; SYNAPTIC PLASTICITY; MOLECULAR-BASIS; CELL-DEATH; DISEASE; PROTEIN; ACTIVATION; LIGANDS; BRAIN	Amyloid beta (Abeta) 1-42 oligomers accumulate in brains of patients with Mild Cognitive Impairment (MCI) and disrupt synaptic plasticity processes that underlie memory formation. Synaptic binding of Abeta oligomers to several putative receptor proteins is reported to inhibit long-term potentiation, affect membrane trafficking and induce reversible spine loss in neurons, leading to impaired cognitive performance and ultimately to anterograde amnesia in the early stages of Alzheimer's disease (AD). We have identified a receptor not previously associated with AD that mediates the binding of Abeta oligomers to neurons, and describe novel therapeutic antagonists of this receptor capable of blocking Abeta toxic effects on synapses in vitro and cognitive deficits in vivo. Knockdown of sigma-2/PGRMC1 (progesterone receptor membrane component 1) protein expression in vitro using siRNA results in a highly correlated reduction in binding of exogenous Abeta oligomers to neurons of more than 90%. Expression of sigma-2/PGRMC1 is upregulated in vitro by treatment with Abeta oligomers, and is dysregulated in Alzheimer's disease patients' brain compared to age-matched, normal individuals. Specific, high affinity small molecule receptor antagonists and antibodies raised against specific regions on this receptor can displace synthetic Abeta oligomer binding to synaptic puncta in vitro and displace endogenous human AD patient oligomers from brain tissue sections in a dose-dependent manner. These receptor antagonists prevent and reverse the effects of Abeta oligomers on membrane trafficking and synapse loss in vitro and cognitive deficits in AD mouse models. These findings suggest sigma-2/PGRMC1 receptors mediate saturable oligomer binding to synaptic puncta on neurons and that brain penetrant, small molecules can displace endogenous and synthetic oligomers and improve cognitive deficits in AD models. We propose that sigma-2/PGRMC1 is a key mediator of the pathological effects of Abeta oligomers in AD and is a tractable target for small molecule disease-modifying therapeutics.	[Izzo, Nicholas J.; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Catalano, Susan M.] Cognit Therapeut Inc, Pittsburgh, PA 15203 USA; [Xu, Jinbin; Zeng, Chenbo; Mach, Robert H.] Washington Univ, Med Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [LeVine, Harry, III] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Craven, Rolf; Head, Elizabeth] Univ Kentucky, Dept Mol & Biol Pharmacol, Lexington, KY USA; [Kirk, Molly J.; Spires-Jones, Tara L.] Harvard Univ, Sch Med, Dept Neurol & Neurosci, Boston, MA USA; [Cruchaga, Carlos; Goate, Alison] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Spires-Jones, Tara L.] Univ Edinburgh, Ctr Cognit & Neural Syst & Euan MacDonald, Ctr Motorneurone Dis, Edinburgh, Midlothian, Scotland; [Kirk, Molly J.] Charles Sturt Univ, Northeastern Univ, Sch Biomed Sci 10, Dept Neurol, Wagga Wagga, NSW, Australia	Washington University (WUSTL); University of Kentucky; Harvard University; Harvard Medical School; Washington University (WUSTL); Columbia University; Columbia University; Charles Sturt University	Catalano, SM (corresponding author), Cognit Therapeut Inc, Pittsburgh, PA 15203 USA.	scatalano@cogrx.com	Cruchaga, Carlos/ABF-4065-2020; Xu, Jinbin/ABG-1280-2020; CAHILL, Michael/J-8035-2012; Spires-Jones, Tara/AAR-7697-2020; Kirk, Molly/AAW-5286-2021; arancio, ottavio/AAB-7959-2019	Cruchaga, Carlos/0000-0002-0276-2899; Xu, Jinbin/0000-0002-2120-8287; CAHILL, Michael/0000-0002-8593-8844; Spires-Jones, Tara/0000-0003-2530-0598; Mach, Robert/0000-0002-7645-2869; arancio, ottavio/0000-0001-6335-164X; Goate, Alison/0000-0002-0576-2472; Catalano, Susan/0000-0001-7278-3233; Izzo, Nicholas/0000-0002-0196-2055; Kirk, Molly/0000-0003-2265-6169	National Institute on Aging [SC AG-037337, TS AG033670]; National Institute on Neurological Diseases and Stroke The Alzheimer's Drug Discovery Foundation [SC NS-083175, OA NS-49442]; Alzheimer's Research, UK; Charles and Joanne Knight Alzheimer's Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS090214, R43NS083175, R01NS049442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG033670, K99AG033670, R43AG037337] Funding Source: NIH RePORTER; Alzheimers Research UK [ARUK-SPG2013-1] Funding Source: researchfish	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Neurological Diseases and Stroke The Alzheimer's Drug Discovery Foundation; Alzheimer's Research, UK(Alzheimer's Research UK (ARUK)); Charles and Joanne Knight Alzheimer's Research Initiative; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	National Institute on Aging http://www.nia.nih.gov/(SC AG-037337), TS AG033670) National Institute on Neurological Diseases and Stroke http://www.ninds.nih.gov/(SC NS-083175, OA NS-49442) The Alzheimer's Drug Discovery Foundation http://www.alzdiscovery.org/(SC) Alzheimer's Research, UK http://www.alzheimersresearchuk.org/(TS) Charles and Joanne Knight Alzheimer's Research Initiative http://alzheimer.wustl.edu/(RM) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed IS, 2010, J BIOL CHEM, V285, P24775, DOI 10.1074/jbc.M110.134585; Bao FX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.003; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Herskovits AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067898; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hyman BT, 2011, NAT NEUROSCI, V14, P5, DOI 10.1038/nn0111-5; Izzo NJ, 2014, PLOS ONE, V10; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kessels HW, 2013, P NATL ACAD SCI USA, V110, P4033, DOI 10.1073/pnas.1219605110; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2011, NEUROBIOL AGING, V32, P614, DOI 10.1016/j.neurobiolaging.2009.04.005; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Leonard BE, 2004, PHARMACOPSYCHIATRY, V37, pS166, DOI 10.1055/s-2004-832674; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Marcello E, 2008, EUR J PHARMACOL, V585, P109, DOI 10.1016/j.ejphar.2007.11.083; McDonald JM, 2012, BRAIN RES, V1450, P138, DOI 10.1016/j.brainres.2012.02.041; Mir SUR, 2012, INT J CANCER, V131, pE1, DOI 10.1002/ijc.26432; Mir SU, 2013, SIGMA 2 RECEPTOR ASS; Mishina M, 2008, ANN NUCL MED, V22, P151, DOI 10.1007/s12149-007-0094-z; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nolte I, 2000, BBA-PROTEIN STRUCT M, V1543, P123, DOI 10.1016/S0167-4838(00)00188-6; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; Savage MJ, 2014, J NEUROSCI, V34, P2884, DOI 10.1523/JNEUROSCI.1675-13.2014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selkoe DJ, 2013, CELL, V154, P468, DOI 10.1016/j.cell.2013.07.003; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Sun J, 2013, NEUROSCIENCE, V248, P112, DOI 10.1016/j.neuroscience.2013.05.048; Szczesna-Skorupa E, 2011, MOL PHARMACOL, V79, P340, DOI 10.1124/mol.110.068478; Thomas P, 2014, ENDOCRINOLOGY; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Troy CM, 2000, J NEUROSCI, V20, P1386; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; VILNER BJ, 1995, CANCER RES, V55, P408; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zempel H, 2012, NEURODEGENER DIS, V10, P64, DOI 10.1159/000332816; Zeng C, 2012, BRIT J CANCER, V106, P693, DOI 10.1038/bjc.2011.602; Zeng CB, 2014, ANAL BIOCHEM, V448, P68, DOI 10.1016/j.ab.2013.12.008	60	124	127	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111899	10.1371/journal.pone.0111899	http://dx.doi.org/10.1371/journal.pone.0111899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390692	Green Published, gold			2022-12-26	WOS:000349144400038
J	Li, M; Liang, Z; Sun, X; Gong, T; Zhang, ZR				Li, Man; Liang, Zhen; Sun, Xun; Gong, Tao; Zhang, Zhirong			A Polymeric Prodrug of 5-Fluorouracil-1-Acetic Acid Using a Multi-Hydroxyl Polyethylene Glycol Derivative as the Drug Carrier	PLOS ONE			English	Article							DELIVERY SYSTEMS; IN-VIVO; CLINICAL PHARMACOKINETICS; MACROMOLECULAR PRODRUGS; VASCULAR-PERMEABILITY; CANCER-CHEMOTHERAPY; ANTITUMOR-ACTIVITY; LIVER-MICROSOMES; PHASE-I; TUMOR	Purpose: Macromolecular prodrugs obtained by covalently conjugating small molecular drugs with polymeric carriers were proven to accomplish controlled and sustained release of the therapeutic agents in vitro and in vivo. Polyethylene glycol (PEG) has been extensively used due to its low toxicity, low immunogenicity and high biocompatibility. However, for linear PEG macromolecules, the number of available hydroxyl groups for drug coupling does not change with the length of polymeric chain, which limits the application of PEG for drug conjugation purposes. To increase the drug loading and prolong the retention time of 5-fluorouracil (5-Fu), a macromolecular prodrug of 5-Fu, 5-fluorouracil-1 acid-PAE derivative (5-FA-PAE) was synthesized and tested for the antitumor activity in vivo. Methods: PEG with a molecular weight of 38 kDa was selected to synthesize the multi-hydroxyl polyethylene glycol derivative (PAE) through an addition reaction. 5-fluorouracil-1 acetic acid (5-FA), a 5-Fu derivative was coupled with PEG derivatives via ester bond to form a macromolecular prodrug, 5-FA-PAE. The in vitro drug release, pharmacokinetics, in vivo distribution and antitumor effect of the prodrug were investigated, respectively. Results: The PEG-based prodrug obtained in this study possessed an exceedingly high 5-FA loading efficiency of 10.58%, much higher than the maximum drug loading efficiency of unmodified PEG with the same molecular weight, which was 0.98% theoretically. Furthermore, 5-FA-PAE exhibited suitable sustained release in tumors. Conclusion: This study provides a new approach for the development of the delivery to tumors of anticancer agents with PEG derivatives.	[Li, Man; Liang, Zhen; Sun, Xun; Gong, Tao; Zhang, Zhirong] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Gong, T (corresponding author), Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Minist Educ, Chengdu 610064, Sichuan, Peoples R China.	gongtaoy@126.com; zrzzl@vip.sina.com		Gong, Tao/0000-0002-9866-9911	National Natural Science Foundation of China [30873167]; National Basic Research Program of China (973 program) [2013CB932504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China)	The authors acknowledge the financial support from the National Natural Science Foundation of China (no. 30873167) and the National Basic Research Program of China (973 program, No: 2013CB932504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias JL, 2008, MOLECULES, V13, P2340, DOI 10.3390/molecules13102340; AZORI M, 1987, CRIT REV THER DRUG, V4, P39; Burton SC, 1998, J CHROMATOGR A, V796, P273, DOI 10.1016/S0021-9673(97)01020-0; CHUNG SM, 1991, INT J PHARM, V68, P61; D'Souza AJM, 2004, J PHARM SCI-US, V93, P1962, DOI 10.1002/jps.20096; Dang CT, 2006, EXPERT REV ANTICANC, V6, P427, DOI 10.1586/14737140.6.3.427; Deeken JF, 2007, ANTI-CANCER DRUG, V18, P111, DOI 10.1097/CAD.0b013e3280109411; DUSCHINSKY R, 1957, J AM CHEM SOC, V79, P4559, DOI 10.1021/ja01573a087; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; Greenwald RB, 1996, J MED CHEM, V39, P424, DOI 10.1021/jm950475e; Guo Z, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.2556; Gupta Y, 2007, J DRUG TARGET, V15, P231, DOI 10.1080/10611860701289719; Hao AJ, 2006, DRUG DEV IND PHARM, V32, P757, DOI 10.1080/03639040600683436; Hoste K, 2004, INT J PHARMACEUT, V277, P119, DOI 10.1016/j.ijpharm.2003.07.016; Huang YZ, 2010, CURR PHARM DESIGN, V16, P2369, DOI 10.2174/138161210791920441; Hwu WJ, 2006, CANCER-AM CANCER SOC, V106, P2445, DOI 10.1002/cncr.21909; Iyer L, 1999, CANCER INVEST, V17, P494; Kang NI, 2002, POLYM INT, V51, P443, DOI 10.1002/pi.786; KELLOFF GJ, 1993, BASIC LIFE SCI, V61, P373; KINTZEL PE, 1995, CANCER TREAT REV, V21, P33, DOI 10.1016/0305-7372(95)90010-1; Koyama Y, 1996, BIOCONJUGATE CHEM, V7, P298, DOI 10.1021/bc9600123; Macdonald JS, 1999, ONCOLOGY-NY, V13, P33; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Maeda H, 2009, EUR J PHARM BIOPHARM, V71, P409, DOI 10.1016/j.ejpb.2008.11.010; Malet-Martino M, 2002, ONCOLOGIST, V7, P288, DOI 10.1634/theoncologist.7-4-288; Meada H, 2001, ADV DRUG DELIV REV, V46, P169; Menei P, 1999, CANCER, V86, P325, DOI 10.1002/(SICI)1097-0142(19990715)86:2<325::AID-CNCR17>3.0.CO;2-S; Milano G, 2002, CHRONOBIOL INT, V19, P177, DOI 10.1081/CBI-120002597; Na Y, 2009, J PHARM PHARMACOL, V61, P707, DOI [10.1211/jpp/61.06.0002, 10.1211/jpp.61.06.0002]; OGISO T, 1976, JPN J PHARMACOL, V26, P445, DOI 10.1254/jjp.26.445; OGISO T, 1978, JPN J PHARMACOL, V28, P175, DOI 10.1254/jjp.28.175; Onishi H, 2008, MOLECULES, V13, P2136, DOI 10.3390/molecules13092136; PARKER WB, 1990, PHARMACOL THERAPEUT, V48, P381, DOI 10.1016/0163-7258(90)90056-8; Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008; Pasut G, 2009, ADV DRUG DELIVER REV, V61, P1177, DOI 10.1016/j.addr.2009.02.010; Pazdur R, 1998, ONCOLOGY-NY, V12, P48; RICHTER AW, 1983, INT ARCH ALLER A IMM, V70, P124, DOI 10.1159/000233309; Riebeseel K, 2002, BIOCONJUGATE CHEM, V13, P773, DOI 10.1021/bc010098m; Rowinsky EK, 2003, J CLIN ONCOL, V21, P148, DOI 10.1200/JCO.2003.03.143; Sarkar FH, 2010, MINI-REV MED CHEM, V10, P357; Sartor O, 2010, CLIN GENITOURIN CANC, V8, P23, DOI 10.3816/CGC.2010.n.004; Sawa T, 2000, CANCER RES, V60, P666; SCHALHORN A, 1992, SEMIN ONCOL, V19, P82; Sheridan W, 1998, Stem Cells, V16 Suppl 2, P193; SHUEY DL, 1995, TOXICOLOGY, V102, P207, DOI 10.1016/0300-483X(95)03049-L; SMYTH HF, 1950, J AM PHARM ASSOC SCI, V39, P349, DOI 10.1002/jps.3030390615; TAKAKURA Y, 1995, CRIT REV ONCOL HEMAT, V18, P207, DOI 10.1016/1040-8428(94)00131-C; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Ton NC, 2007, CLIN CANCER RES, V13, P7113, DOI 10.1158/1078-0432.CCR-07-1550; Udo K, 2010, INT J PHARMACEUT, V388, P95, DOI 10.1016/j.ijpharm.2009.12.039; van Kuilenburg ABP, 2004, NUCLEOS NUCLEOT NUCL, V23, P1371, DOI 10.1081/NCN-200027624; Veronese FM, 2002, ADV DRUG DELIVER REV, V54, P453; Wang JX, 2002, EUR J PHARM BIOPHARM, V54, P285, DOI 10.1016/S0939-6411(02)00083-8; Yang ZY, 2000, J RARE EARTH, V18, P140; ZALIPSKY S, 1983, EUR POLYM J, V19, P1177, DOI 10.1016/0014-3057(83)90016-2; Zhao H, 2008, BIOCONJUGATE CHEM, V19, P849, DOI 10.1021/bc700333s; Zuo DS, 2001, MOLECULES, V6, P647, DOI 10.3390/60800647	58	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112888	10.1371/journal.pone.0112888	http://dx.doi.org/10.1371/journal.pone.0112888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389968	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400138
J	Alvarez, GG; Van Dyk, DD; Davies, N; Aaron, SD; Cameron, DW; Desjardins, M; Mallick, R; Obed, N; Baikie, M				Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Davies, Naomi; Aaron, Shawn D.; Cameron, D. William; Desjardins, Marc; Mallick, Ranjeeta; Obed, Natan; Baikie, Maureen			The Feasibility of the Interferon Gamma Release Assay and Predictors of Discordance with the Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in a Remote Aboriginal Community	PLOS ONE			English	Article							HEALTH-CARE WORKERS; BCG VACCINATION; CHILDREN; COST	Background: The tuberculin skin test (TST) is the standard test used to screen for latent TB infection (LTBI) in the northern Canadian territory of Nunavut. Interferon gamma release assays (IGRA) are T cell blood-based assays to diagnose LTBI. The Bacillus Calmette-Guerin (BCG) vaccine is part of the routine immunization schedule in Nunavut. The objective of this study was to test the feasibility, and predictors of discordance between the Tuberculin Skin Test (TST) and the IGRA assay in a medically under-serviced remote arctic Aboriginal population. Methods: Both the TST and QuantiFERON-TB Gold (Qiagen group) IGRA tests were offered to people in their homes as part of a public health campaign aimed at high TB risk residential areas in Iqaluit, Nunavut, Canada. Feasibility was measured by the capacity of the staff to do the test successfully as measured by the proportion of results obtained. Results: In this population of predominantly young Inuit who were mostly BCG vaccinated, the use of IGRA for the diagnosis of LTBI was feasible. IGRA testing resulted in more available test results reaching patients (95.6% vs 90.9% p = 0.02) but took longer (median 8 days (IGRA) vs 2 days (TST), p value <0.0001). 44/256 participants (17.2%) had discordant results. Multivariable regression analysis suggested that discordant results were most likely to have received multiple BCG vaccinations (RR 20.03, 95% CI, 3.94-101.82)), followed by BCG given post infancy (RR 8.13, 95% CI, 2.54-26.03)) and then to a lesser degree when BCG was given in infancy (RR 6.43, 95% CI, 1.72-24.85). Interpretation: IGRA is feasible in Iqaluit, Nunavut, a remote Arctic community. IGRA testing results in more test results available to patients compared to TST. This test could result in fewer patients requiring latent TB treatment among those previously vaccinated with BCG in a region with limited public health human resources.	[Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Desjardins, Marc; Mallick, Ranjeeta] Univ Ottawa, Ottawa Hosp Res Inst, Div Respirol, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Desjardins, Marc; Mallick, Ranjeeta] Ottawa Hosp, Dept Med, Div Infect Dis, Ottawa, ON, Canada; [Alvarez, Gonzalo G.; Van Dyk, Deborah D.; Aaron, Shawn D.; Cameron, D. William; Desjardins, Marc; Mallick, Ranjeeta] Ottawa Hosp, Dept Microbiol, Ottawa, ON, Canada; [Van Dyk, Deborah D.; Davies, Naomi; Baikie, Maureen] Govt Nunavut, Iqaluit, NU, Canada; [Obed, Natan] Nunavut Tunngavik Inc, Iqaluit, NU, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Alvarez, GG (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Div Respirol, Ottawa, ON, Canada.	galvarez@ohri.ca	Cameron, Bill/E-9180-2010	Cameron, Bill/0000-0002-0090-3539; Alvarez, Gonzalo G/0000-0003-1562-5305; Aaron, Shawn/0000-0002-4762-3542	Public Health Agency of Canada; National Lung Health Framework	Public Health Agency of Canada; National Lung Health Framework	The Public Health Agency of Canada, The National Lung Health Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nunavut Tunngavik Inc. did not provide support in the form of salaries and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this authors is articulated in the 'author contributions' section.	Alvarez GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100975; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Dewan PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-47; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; FRIEDLAND IR, 1990, S AFR MED J, V77, P387; Government of Nunavut Nunavut TB, CONTR EL MAN; GRINDULIS H, 1984, ARCH DIS CHILD, V59, P614, DOI 10.1136/adc.59.7.614; GRZYBOWSKI S, 1976, TUBERCLE, V57, pS1, DOI 10.1016/0041-3879(76)90059-3; Jacobs S, 2011, PEDIATR INFECT DIS J, V30, P754, DOI 10.1097/INF.0b013e31821b8f54; Machado A, 2009, INT J TUBERC LUNG D, V13, P446; Machingaidze S, 2012, AM J RESP CRIT CARE, V186, P1051, DOI 10.1164/rccm.201206-1134OC; Mancuso JD, 2012, AM J RESP CRIT CARE, V185, P427, DOI 10.1164/rccm.201107-1244OC; Menzies D, 2013, CANADIAN RESP J, V20; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pai M, 2012, CAN RESPIR J, V19, P81, DOI 10.1155/2012/420392; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Rangaka MX, 2012, LANCET INFECT DIS, V12, P45, DOI 10.1016/S1473-3099(11)70210-9; Shah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036551; Soborg B, 2010, EUR RESPIR J, V36, P878, DOI 10.1183/09031936.00015510; Zwerling A, 2012, THORAX, V67, P62, DOI 10.1136/thx.2010.143180	23	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111986	10.1371/journal.pone.0111986	http://dx.doi.org/10.1371/journal.pone.0111986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386908	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400034
J	Campisano, A; Antonielli, L; Pancher, M; Yousaf, S; Pindo, M; Pertot, I				Campisano, Andrea; Antonielli, Livio; Pancher, Michael; Yousaf, Sohail; Pindo, Massimo; Pertot, Ilaria			Bacterial Endophytic Communities in the Grapevine Depend on Pest Management	PLOS ONE			English	Article							VITIS-VINIFERA L.; DIVERSITY; ROOTS; SOIL; SEQUENCE; BIOCONTROL; INFECTION; RHIZOBIA; NUMBER; LEAVES	Microbial plant endophytes are receiving ever-increasing attention as a result of compelling evidence regarding functional interaction with the host plant. Microbial communities in plants were recently reported to be influenced by numerous environmental and anthropogenic factors, including soil and pest management. In this study we used automated ribosomal intergenic spacer analysis (ARISA) fingerprinting and pyrosequencing of 16S rDNA to assess the effect of organic production and integrated pest management (IPM) on bacterial endophytic communities in two widespread grapevines cultivars (Merlot and Chardonnay). High levels of the dominant Ralstonia, Burkholderia and Pseudomonas genera were detected in all the samples We found differences in the composition of endophytic communities in grapevines cultivated using organic production and IPM. Operational taxonomic units (OTUs) assigned to the Mesorhizobium, Caulobacter and Staphylococcus genera were relatively more abundant in plants from organic vineyards, while Ralstonia, Burkholderia and Stenotrophomonas were more abundant in grapevines from IPM vineyards. Minor differences in bacterial endophytic communities were also found in the grapevines of the two cultivars.	[Campisano, Andrea; Antonielli, Livio; Pancher, Michael; Yousaf, Sohail; Pindo, Massimo; Pertot, Ilaria] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, TN, Italy; [Antonielli, Livio] Austrian Inst Technol GmbH, Dept Hlth & Environm, Bioresources Unit, Tulln, Austria; [Yousaf, Sohail] Quaid I Azam Univ, Dept Environm Sci, Islamabad, Pakistan	Fondazione Edmund Mach; Quaid I Azam University	Campisano, A (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, TN, Italy.	andrea.campisano@fmach.it	Campisano, Andrea/F-2077-2010	Campisano, Andrea/0000-0003-4865-5105	Provincia Autonoma di Trento; progetto PAT - Call 2 Team - Incoming - Mecagrafic; COST Action [FA1103]; Austrian Institute of Technology GmbH	Provincia Autonoma di Trento(Autonomous Province of Trento); progetto PAT - Call 2 Team - Incoming - Mecagrafic; COST Action(European Cooperation in Science and Technology (COST)); Austrian Institute of Technology GmbH	This work was supported by Provincia Autonoma di Trento, progetto PAT - Call 2 Team 2009 - Incoming - Mecagrafic and COST Action FA1103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Livio Antonielli is currently employed by Austrian Institute of Technology GmbH. Austrian Institute of Technology GmbH provided support in the form of salary for author Livio Antonielli, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bienhold C, 2012, ISME J, V6, P724, DOI 10.1038/ismej.2011.140; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bulgari D, 2011, APPL ENVIRON MICROB, V77, P5018, DOI 10.1128/AEM.00051-11; Bulgari D, 2009, J MICROBIOL, V47, P393, DOI 10.1007/s12275-009-0082-1; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Caffarra A, 2011, AUST J GRAPE WINE R, V17, P52, DOI 10.1111/j.1755-0238.2010.00118.x; Calbrix R, 2003, ABSTR PAP AM CHEM S, V225, pU911; Campisano A, 2014, MOL BIOL EV IN PRESS; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CHAO A, 1984, SCAND J STAT, V11, P265; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chi F, 2005, APPL ENVIRON MICROB, V71, P7271, DOI 10.1128/AEM.71.11.7271-7278.2005; Compant S, 2005, APPL ENVIRON MICROB, V71, P1685, DOI 10.1128/AEM.71.4.1685-1693.2005; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Corneo PE, 2013, FEMS MICROBIOL ECOL, V84, P588, DOI 10.1111/1574-6941.12087; Corneo PE, 2013, PLANT SOIL, P1; De Caceres M, 2009, ECOLOGY, V90, P3566, DOI 10.1890/08-1823.1; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Estrada-de los Santos P, 2013, CURR MICROBIOL, V67, P51, DOI 10.1007/s00284-013-0330-9; Fernandez O, 2012, MOL PLANT MICROBE IN, V25, P496, DOI 10.1094/MPMI-09-11-0245; Gage DJ, 2004, MICROBIOL MOL BIOL R, V68, P280, DOI 10.1128/MMBR.68.2.280-300.2004; Ghyselinck J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071360; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; Gowen JC, 2005, QUAL QUANT, V39, P359, DOI 10.1007/s11135-005-3005-1; Granado J, 2008, MICROB ECOL, V56, P720, DOI 10.1007/s00248-008-9391-x; Halary S, 2010, P NATL ACAD SCI USA, V107, P127, DOI 10.1073/pnas.0908978107; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Hartmann M, 2014, ISME J, V8, P226, DOI 10.1038/ismej.2013.141; Hartmann M, 2012, ISME J, V6, P2199, DOI 10.1038/ismej.2012.84; Heungens K, 2000, APPL ENVIRON MICROB, V66, P5192, DOI 10.1128/AEM.66.12.5192-5200.2000; Hilton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059859; Ikeda S, 2010, PLANT CELL PHYSIOL, V51, P1398, DOI 10.1093/pcp/pcq119; Jabbour R, 2009, BIOL CONTROL, V51, P435, DOI 10.1016/j.biocontrol.2009.08.004; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Legendre P., 2012, NUMERICAL ECOLOGY; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moy M, 2002, PLANT PHYSIOL, V130, P1298, DOI 10.1104/pp.010108; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pinamonti F, 1997, RESOUR CONSERV RECY, V21, P129, DOI 10.1016/S0921-3449(97)00032-3; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmid F, 2011, APPL ENVIRON MICROB, V77, P2188, DOI 10.1128/AEM.02187-10; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sessitsch A, 2012, MOL PLANT MICROBE IN, V25, P28, DOI 10.1094/MPMI-08-11-0204; Setati ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052609; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Theocharis A, 2012, MOL PLANT MICROBE IN, V25, P241, DOI 10.1094/MPMI-05-11-0124; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Ulrich K, 2008, FEMS MICROBIOL ECOL, V63, P169, DOI 10.1111/j.1574-6941.2007.00419.x; van Elsas JD, 2008, TRENDS BIOTECHNOL, V26, P591, DOI 10.1016/j.tibtech.2008.07.004; van Overbeek LS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00104; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; West ER, 2010, CAN J MICROBIOL, V56, P209, DOI [10.1139/w10-004, 10.1139/W10-004]; Wright KM, 2013, PHYTOPATHOLOGY, V103, P333, DOI 10.1094/PHYTO-08-12-0209-FI; Yousaf S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00327; Zabalgogeazcoa I, 2008, SPAN J AGRIC RES, V6, P138, DOI 10.5424/sjar/200806S1-382	76	68	70	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112763	10.1371/journal.pone.0112763	http://dx.doi.org/10.1371/journal.pone.0112763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387008	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400091
J	Fastner, C; Mairbaurl, H; Weber, NC; van der Sluijs, K; Hackl, F; Hotz, L; Dahan, A; Hollmann, MW; Berger, MM				Fastner, Christian; Mairbaeurl, Heimo; Weber, Nina C.; van der Sluijs, Koen; Hackl, Florian; Hotz, Lorenz; Dahan, Albert; Hollmann, Markus W.; Berger, Marc M.			Intravenous S-Ketamine Does Not Inhibit Alveolar Fluid Clearance in a Septic Rat Model	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; EPITHELIAL SODIUM-CHANNELS; EDEMA-CLEARANCE; TRANSPORT; HYPOXIA; INFUSION; ANESTHESIA; CHILDREN; SEDATION	We previously demonstrated that intratracheally administered S-ketamine inhibits alveolar fluid clearance (AFC), whereas an intravenous (IV) bolus injection had no effect. The aim of the present study was to characterize whether continuous IV infusion of S-ketamine, yielding clinically relevant plasma concentrations, inhibits AFC and whether its effect is enhanced in acute lung injury (ALI) which might favor the appearance of IV S-ketamine at the alveolar surface. AFC was measured in fluid-instilled rat lungs. S-ketamine was administered IV over 6 h (loading dose: 20 mg/kg, followed by 20 mg/kg/h), or intratracheally by addition to the instillate (75 mu g/ml). ALI was induced by IV lipopolysaccharide (LPS; 7 mg/kg). Interleukin (IL)-6 and cytokine-induced neutrophil chemoattractant (CINC)-3 were measured by ELISA in plasma and bronchoalveolar lavage fluid. Isolated rat alveolar type-II cells were exposed to S-ketamine (75 mu g/ml) and/or LPS (1 mg/ml) for 6 h, and transepithelial ion transport was measured as short circuit current (ISC). AFC was 27 +/- 5% (mean +/- SD) over 60 min in control rats and was unaffected by IV S-ketamine. Tracheal S-ketamine reduced AFC to 18 +/- 9%. In LPS-treated rats, AFC decreased to 16 +/- 6%. This effect was not enhanced by IV S-ketamine. LPS increased IL-6 and CINC-3 in plasma and bronchoalveolar lavage fluid. In alveolar type-II cells, S-ketamine reduced ISC by 37% via a decrease in amiloride-inhibitable sodium transport. Continuous administration of IV S-ketamine does not affect rat AFC even in endotoxin-induced ALI. Tracheal application with direct exposure of alveolar epithelial cells to S-ketamine decreases AFC by inhibition of amiloride-inhibitable sodium transport.	[Fastner, Christian; Hotz, Lorenz; Berger, Marc M.] Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany; [Fastner, Christian; Mairbaeurl, Heimo] Univ Heidelberg Hosp, Med Clin 7, Heidelberg, Germany; [Weber, Nina C.; van der Sluijs, Koen] Univ Amsterdam AMC, Lab Expt Intens Care & Anesthesiol, Amsterdam, Netherlands; [Dahan, Albert] Univ Med Ctr, Dept Anesthesiol, Leiden, Netherlands; [Hollmann, Markus W.] Univ Amsterdam AMC, Dept Anesthesiol, Amsterdam, Netherlands; [Hackl, Florian; Hotz, Lorenz; Berger, Marc M.] Paracelsus Med Univ, Salzburg Gen Hosp, Dept Anesthesiol Crit Care & Pain Med, Salzburg, Austria	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Paracelsus Private Medical University	Berger, MM (corresponding author), Univ Heidelberg Hosp, Dept Anesthesiol, Heidelberg, Germany.	ma.berger@salk.at	Berger, Marc/AAN-2887-2020; Dahan, Albert/B-8845-2008; Weber, Nina/CAH-0231-2022	Dahan, Albert/0000-0003-3161-3945; Weber, Nina/0000-0003-1111-9042; Berger, Marc Moritz/0000-0001-6771-3193	Pfizer; Eurocept	Pfizer(Pfizer); Eurocept	The authors of this manuscript have the following competing interests: Markus Hollmann has received speaker fees and research support from Pfizer and Eurocept. For the remaining authors, none were declared. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Berger MM, 2010, ANESTH ANALG, V111, P164, DOI 10.1213/ANE.0b013e3181e21cc9; Berger MM, 2009, ANESTH ANALG, V108, P225, DOI 10.1213/ane.0b013e31818881a8; Berthiaume Y, 2002, J APPL PHYSIOL, V93, P2207, DOI 10.1152/japplphysiol.01201.2001; Bourgoin A, 2005, CRIT CARE MED, V33, P1109, DOI 10.1097/01.CCM.0000162491.26292.98; Craven R, 2007, ANAESTHESIA, V62, P48, DOI 10.1111/j.1365-2044.2007.05298.x; Cui Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/460596; Dallimore D, 2008, PEDIATR ANESTH, V18, P708, DOI 10.1111/j.1460-9592.2008.02665.x; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Durmus M, 2003, ANESTH ANALG, V97, P1377, DOI 10.1213/01.ANE.0000080611.29106.9E; Haitsma JJ, 2009, ACTA ANAESTH SCAND, V53, P176, DOI 10.1111/j.1399-6576.2008.01844.x; Herd DW, 2008, PEDIATR ANESTH, V18, P36, DOI 10.1111/j.1460-9592.2007.02384.x; Laffon M, 2002, ANESTHESIOLOGY, V96, P392, DOI 10.1097/00000542-200202000-00026; LASH JM, 1992, J APPL PHYSIOL, V72, P1247, DOI 10.1152/jappl.1992.72.4.1247; Mairbaurl H, 2002, AM J PHYSIOL-LUNG C, V282, pL659, DOI 10.1152/ajplung.00355; MATALON S, 1991, AM J PHYSIOL, V261, pC727, DOI 10.1152/ajpcell.1991.261.5.C727; Matthay MA, 2002, J APPL PHYSIOL, V93, P1533, DOI 10.1152/japplphysiol.01210.2001; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; Miller AC, 2011, MINERVA ANESTESIOL, V77, P812; Molina R, 2011, BBA-BIOMEMBRANES, V1808, P1818, DOI 10.1016/j.bbamem.2011.03.004; Ostermann ME, 2000, JAMA-J AM MED ASSOC, V283, P1451, DOI 10.1001/jama.283.11.1451; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Perkins GD, 2008, THORAX, V63, P215, DOI 10.1136/thx.2007.080382; Perkins GD, 2006, AM J RESP CRIT CARE, V173, P281, DOI 10.1164/rccm.200508-1302OC; Planes C, 1997, AM J RESP CELL MOL, V17, P508, DOI 10.1165/ajrcmb.17.4.2680; Sakuma T, 2006, CRIT CARE MED, V34, P676, DOI 10.1097/01.CCM.0000201403.70636.0F; Sakuma T, 2002, J THORAC CARDIOV SUR, V124, P668, DOI 10.1067/mtc.2002.122549; Sakuma T, 2001, J APPL PHYSIOL, V91, P1766, DOI 10.1152/jappl.2001.91.4.1766; SAKUMA T, 1993, J APPL PHYSIOL, V74, P176, DOI 10.1152/jappl.1993.74.1.176; Sartori C, 2002, EUR RESPIR J, V20, P1299, DOI 10.1183/09031936.02.00401602; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; Welters ID, 2011, BRIT J ANAESTH, V106, P172, DOI 10.1093/bja/aeq341; Yamasawa H, 1999, INFLAMMATION, V23, P263; Zeyed YF, 2012, AM J PHYSIOL-LUNG C, V303, pL550, DOI 10.1152/ajplung.00190.2012	36	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112622	10.1371/journal.pone.0112622	http://dx.doi.org/10.1371/journal.pone.0112622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386677	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400073
J	Khosravi, Y; Dieye, Y; Loke, MF; Goh, KL; Vadivelu, J				Khosravi, Yalda; Dieye, Yakhya; Loke, Mun Fai; Goh, Khean Lee; Vadivelu, Jamuna			Streptococcus mitis Induces Conversion of Helicobacter pylori to Coccoid Cells during Co-Culture In Vitro	PLOS ONE			English	Article							GUT MICROBIOTA; MONGOLIAN GERBILS; INFECTION; STOMACH; FORMS; FLORA	Helicobacter pylori (H. pylori) is a major gastric pathogen that has been associated with humans for more than 60,000 years. H. pylori causes different gastric diseases including dyspepsia, ulcers and gastric cancers. Disease development depends on several factors including the infecting H. pylori strain, environmental and host factors. Another factor that might influence H. pylori colonization and diseases is the gastric microbiota that was overlooked for long because of the belief that human stomach was a hostile environment that cannot support microbial life. Once established, H. pylori mainly resides in the gastric mucosa and interacts with the resident bacteria. How these interactions impact on H. pylori-caused diseases has been poorly studied in human. In this study, we analyzed the interactions between H. pylori and two bacteria, Streptocccus mitis and Lactobacillus fermentum that are present in the stomach of both healthy and gastric disease human patients. We have found that S. mitis produced and released one or more diffusible factors that induce growth inhibition and coccoid conversion of H. pylori cells. In contrast, both H. pylori and L. fermentum secreted factors that promote survival of S. mitis during the stationary phase of growth. Using a metabolomics approach, we identified compounds that might be responsible for the conversion of H. pylori from spiral to coccoid cells. This study provide evidences that gastric bacteria influences H. pylori physiology and therefore possibly the diseases this bacterium causes.	[Khosravi, Yalda; Loke, Mun Fai; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Dieye, Yakhya] Univ Malaya, Vice Chancellors Off, Kuala Lumpur, Malaysia; [Goh, Khean Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Dieye, Yakhya/P-9086-2019; VADIVELU, JAMUNARANI S/B-8696-2010; Loke, Mun Fai/B-1060-2011; Goh, Khean-Lee/B-6404-2009; Dieye, Yakhya/A-5175-2012	VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Loke, Mun Fai/0000-0002-3554-5313; Goh, Khean-Lee/0000-0002-9965-1561; Dieye, Yakhya/0000-0003-2461-6558	University of Malaya-Ministry of Higher Education, UM-MOHE; High Impact Research (HIR) [UM.C/625/1/HIR/MOHE/CHAN-02, A000002-50001]	University of Malaya-Ministry of Higher Education, UM-MOHE; High Impact Research (HIR)	This work was supported by University of Malaya-Ministry of Higher Education, UM-MOHE, High Impact Research (HIR) grant UM.C/625/1/HIR/MOHE/CHAN-02; account no. A000002-50001, "Molecular Genetics''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2006, FEMS IMMUNOL MED MIC, V46, P221, DOI 10.1111/rp10.1016-j.femsim.2004.05.008; CATRENICH CE, 1991, SCAND J GASTROENTERO, V26, P58, DOI 10.3109/00365529109093209; CELLINI L, 1994, MICROBIOL IMMUNOL, V38, P25, DOI 10.1111/j.1348-0421.1994.tb01740.x; CHAN WY, 1994, AM J CLIN PATHOL, V102, P503, DOI 10.1093/ajcp/102.4.503; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Cox AJ, 2010, BRIT J SPORT MED, V44, P222, DOI 10.1136/bjsm.2007.044628; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; Donelli G, 1998, FEMS MICROBIOL LETT, V168, P9, DOI 10.1016/S0378-1097(98)00405-4; Engstrand L, 2013, BEST PRACT RES CL GA, V27, P39, DOI 10.1016/j.bpg.2013.03.016; Figura N, 2012, NEW MICROBIOL, V35, P335; Hu Y, 2012, WORLD J GASTROENTERO, V18, P1257, DOI 10.3748/wjg.v18.i11.1257; Khalifa MM, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-2; Khosravi Y, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-25; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lee CW, 2009, CANCER RES, V69, P8166, DOI 10.1158/0008-5472.CAN-08-3856; Li N, 2013, J BASIC MICROB, V53, P147, DOI 10.1002/jobm.201100370; Li XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007985; Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048; Maldonado J, 2012, J PEDIATR GASTR NUTR, V54, P55, DOI 10.1097/MPG.0b013e3182333f18; McCarthy AR, 2012, BIOORGAN MED CHEM, V20, P1779, DOI 10.1016/j.bmc.2012.01.001; Mikelsaar Marika, 2009, Microbial Ecology in Health and Disease, V21, P1, DOI 10.1080/08910600902815561; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505; NILIUS M, 1993, ZBL BAKT-INT J MED M, V280, P259; Nilsson HO, 2002, APPL ENVIRON MICROB, V68, P11, DOI 10.1128/AEM.68.1.11-19.2002; Osaki T, 2012, MICROB PATHOGENESIS, V53, P12, DOI 10.1016/j.micpath.2012.03.008; Pacifico L, 2014, WORLD J GASTROENTERO, V20, P673, DOI 10.3748/wjg.v20.i3.673; Ricci V, 2011, WORLD J GASTROENTERO, V17, P1383, DOI 10.3748/wjg.v17.i11.1383; Rolig AS, 2013, INFECT IMMUN, V81, P1382, DOI 10.1128/IAI.00044-13; Ruiz-Moyano S, 2011, FOOD MICROBIOL, V28, P839, DOI 10.1016/j.fm.2011.01.006; Saito Nagahito, 2008, Hokkaido Igaku Zasshi, V83, P291; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sheh A, 2013, GUT MICROBES, V4, P505, DOI 10.4161/gmic.26205; Sun YQ, 2003, HELICOBACTER, V8, P149, DOI 10.1046/j.1523-5378.2003.00136.x; Ueno T, 2013, ONCOL RES, V21, P155, DOI 10.3727/096504013X13854886566598; van Leeuwen IMM, 2012, CELL CYCLE, V11, P1851, DOI 10.4161/cc.20254; Wang ZK, 2013, WORLD J GASTROENTERO, V19, P1541, DOI 10.3748/wjg.v19.i10.1541; Yin YN, 2011, HELICOBACTER, V16, P389, DOI 10.1111/j.1523-5378.2011.00862.x; Zaman C, 2014, J MED MICROBIOL, V63, P129, DOI 10.1099/jmm.0.061135-0	41	25	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112214	10.1371/journal.pone.0112214	http://dx.doi.org/10.1371/journal.pone.0112214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386948	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400050
J	Ramirez-Perez, FI; Schenewerk, AL; Coffman, KL; Foote, C; Ji, TM; Rivera, RM; Martinez-Lemus, LA				Ramirez-Perez, Francisco I.; Schenewerk, Angela L.; Coffman, Katy L.; Foote, Christopher; Ji, Tieming; Rivera, Rocio M.; Martinez-Lemus, Luis A.			Effects of the Use of Assisted Reproductive Technologies and an Obesogenic Environment on Resistance Artery Function and Diabetes Biomarkers in Mice Offspring	PLOS ONE			English	Article							DIET-INDUCED OBESITY; PLASMINOGEN-ACTIVATOR INHIBITOR-1; PREIMPLANTATION MOUSE EMBRYOS; IN-VITRO FERTILIZATION; INSULIN-RESISTANCE; OXIDATIVE STRESS; WEIGHT-GAIN; BIRTH-DEFECTS; GHRELIN; EXPRESSION	Maternal obesity affects the incidence of cardiovascular disease and diabetes in offspring. Also the use of assisted reproductive technologies (ART) has been associated with cardiovascular deficiencies in offspring. Obese women often suffer from infertility and use ART to achieve a pregnancy, but the combined effects of maternal obesity and ART on cardiovascular health and incidence of diabetes in the offspring is not known. Here, we report the effects of the use of ART within an obesogenic environment, consisting of feeding a western diet (WD) to dams and offspring, on resistance artery function and presence of diabetes biomarkers in juvenile mice offspring. Our results indicate that WD and ART interacted to induce endothelial dysfunction in mesenteric resistance arteries isolated from 7-week-old mice offspring. This was determined by presence of a reduced acetylcholine-induced dilation compared to controls. The arteries from these WD-ART mice also had greater wall cross-sectional areas and wall to lumen ratios indicative of vascular hypertrophic remodeling. Of the diabetes biomarkers measured, only resistin was affected by a WD x ART interaction. Serum resistin was significantly greater in WD-ART offspring compared to controls. Diet and sex effects were observed in other diabetes biomarkers. Our conclusion is that in mice the use of ART within an obesogenic environment interacts to favor the development of endothelial dysfunction in the resistance arteries of juvenile offspring, while having marginal effects on diabetes biomarkers.	[Ramirez-Perez, Francisco I.; Foote, Christopher; Martinez-Lemus, Luis A.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Ramirez-Perez, Francisco I.; Martinez-Lemus, Luis A.] Univ Missouri, Dept Biol Engn, Columbia, MO 65211 USA; [Schenewerk, Angela L.; Rivera, Rocio M.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Coffman, Katy L.; Ji, Tieming] Univ Missouri, Dept Stat, Columbia, MO 65211 USA; [Martinez-Lemus, Luis A.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Rivera, RM (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	riverarm@missouri.edu; martinezlemusl@missouri.edu	Ramirez-Perez, Francisco I./ABC-8674-2020	Ramirez-Perez, Francisco/0000-0003-4920-383X; Rivera, Rocio Melissa/0000-0002-9832-9618	National Institutes of Health [RO1 HL088105]; Animal Reproductive Biology Cluster [F21C]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Animal Reproductive Biology Cluster; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (RO1 HL088105 to LAM), and Animal Reproductive Biology Cluster (F21C to RMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El Gawad SS, 2012, ENDOCR PRACT, V18, P376, DOI 10.4158/EP11130.OR; Barbero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078424; Birk RZ, 2014, BRIT J NUTR, V112, P154, DOI 10.1017/S0007114514000816; Briggs DI, 2010, ENDOCRINOLOGY, V151, P4745, DOI 10.1210/en.2010-0556; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Calvert JW, 2009, EXP PHYSIOL, V94, P805, DOI 10.1113/expphysiol.2009.047183; Chrissobolis S, 2011, FRONT BIOSCI-LANDMRK, V16, P1733, DOI 10.2741/3816; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Dahlhoff M, 2014, BBA-MOL BASIS DIS, V1842, P304, DOI 10.1016/j.bbadis.2013.11.021; del Mar Bibiloni M., 2013, ISRN OBES, V2013, DOI DOI 10.1155/2013/392747; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Gillman MW, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e221; Jayaram B, 2013, J APPL PHYSIOL, V114, P734, DOI 10.1152/japplphysiol.01499.2012; Jungheim ES, 2013, NUTR REV, V71, pS3, DOI 10.1111/nure.12056; Kallen B, 2010, BIRTH DEFECTS RES A, V88, P137, DOI 10.1002/bdra.20645; Katan MB, 2010, JAMA-J AM MED ASSOC, V303, P65, DOI 10.1001/jama.2009.1912; Katz P, 2011, FERTIL STERIL, V95, P915, DOI 10.1016/j.fertnstert.2010.11.026; Kelsall CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034492; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Lacerda-Miranda G, 2012, PEPTIDES, V35, P65, DOI 10.1016/j.peptides.2012.02.025; LANDIN K, 1990, METABOLISM, V39, P1044, DOI 10.1016/0026-0495(90)90164-8; Lobo TF, 2013, J REPROD IMMUNOL, V97, P120, DOI 10.1016/j.jri.2012.10.004; Lodefalk M, 2010, HORM RES PAEDIAT, V73, P355, DOI 10.1159/000308168; Lopez-Ruiz A, 2008, AM J PHYSIOL-HEART C, V295, pH466, DOI 10.1152/ajpheart.01232.2007; Martinez-Lemus LA, 2008, J VASC RES, V45, P211, DOI 10.1159/000112513; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; McGillicuddy FC, 2013, AM J PHYSIOL-ENDOC M, V305, pE834, DOI 10.1152/ajpendo.00297.2013; McTernan PG, 2006, CURR OPIN LIPIDOL, V17, P170, DOI 10.1097/01.mol.0000217899.59820.9a; Olson CK, 2005, FERTIL STERIL, V84, P1308, DOI 10.1016/j.fertnstert.2005.03.086; Palik E, 2007, DIABETES RES CLIN PR, V76, P351, DOI 10.1016/j.diabres.2006.09.005; Petitt D J, 1985, Diabetes, V34 Suppl 2, P119; Reefhuis J, 2009, HUM REPROD, V24, P360, DOI 10.1093/humrep/den387; Reynolds RM, 2010, J CLIN ENDOCR METAB, V95, P5365, DOI 10.1210/jc.2010-0697; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Rindler PM, 2013, AM J PHYSIOL-HEART C, V305, pH634, DOI 10.1152/ajpheart.00799.2012; Rochette L, 2014, BBA-GEN SUBJECTS, V1840, P2709, DOI 10.1016/j.bbagen.2014.05.017; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Samuelsson AM, 2010, HYPERTENSION, V55, P76, DOI 10.1161/HYPERTENSIONAHA.109.139402; Schenewerk AL, 2014, REPRODUCTION, V147, P111, DOI 10.1530/REP-13-0354; Sommovilla J, 2005, REPRODUCTION, V130, P599, DOI 10.1530/rep.1.00872; Souza-Smith FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023337; Sturm R, 2007, PUBLIC HEALTH, V121, P492, DOI 10.1016/j.puhe.2007.01.006; Suzuki K, 2013, J BIOL CHEM, V288, P1929, DOI 10.1074/jbc.M112.423137; Torrens C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050671; Tran M, 2014, AM J PHYSIOL-REG I, V306, pR607, DOI 10.1152/ajpregu.00523.2013; Verschuur M, 2005, ATHEROSCLEROSIS, V181, P275, DOI 10.1016/j.atherosclerosis.2005.01.036; Wang Jeff, 2006, Ther Clin Risk Manag, V2, P355, DOI 10.2147/tcrm.2006.2.4.355; Zhang SY, 2013, MOL MED REP, V7, P223, DOI 10.3892/mmr.2012.1154	52	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112651	10.1371/journal.pone.0112651	http://dx.doi.org/10.1371/journal.pone.0112651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386661	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400079
J	Boddicker, RL; Seibert, JT; Johnson, JS; Pearce, SC; Selsby, JT; Gabler, NK; Lucy, MC; Safranski, TJ; Rhoads, RP; Baumgard, LH; Ross, JW				Boddicker, Rebecca L.; Seibert, Jacob T.; Johnson, Jay S.; Pearce, Sarah C.; Selsby, Joshua T.; Gabler, Nicholas K.; Lucy, Matthew C.; Safranski, Timothy J.; Rhoads, Robert P.; Baumgard, Lance H.; Ross, Jason W.			Gestational Heat Stress Alters Postnatal Offspring Body Composition Indices and Metabolic Parameters in Pigs	PLOS ONE			English	Article							MUSCLE-FIBER DEVELOPMENT; MATERNAL UNDERNUTRITION; REARING-TEMPERATURE; SKELETAL-MUSCLE; PRENATAL STRESS; BIRTH-WEIGHT; FEED-INTAKE; GROWTH; FETAL; EXPRESSION	The study objectives were to test the hypothesis that heat stress (HS) during gestational development alters postnatal growth, body composition, and biological response to HS conditions in pigs. To investigate this, 14 first parity crossbred gilts were exposed to one of four environmental treatments (TNTN, TNHS, HSTN, or HSHS) during gestation. TNTN and HSHS dams were exposed to thermal neutral (TN, cyclical 18-22 degrees C) or HS conditions (cyclical 28-34 degrees C) during the entire gestation, respectively. Dams assigned to HSTN and TNHS treatments were heat-stressed for the first or second half of gestation, respectively. Postnatal offspring were exposed to one of two thermal environments for an acute (24 h) or chronic (five weeks) duration in either constant TN (21 degrees C) or HS (35 degrees C)environment. Exposure to chronic HS during their growth phase resulted in decreased longissimus dorsi cross-sectional area (LDA) in offspring from HSHS and HSTN treated dams whereas LDA was larger in offspring from dams in TNTN and TNHS conditions. Irrespective of HS during prepubertal postnatal growth, pigs from dams that experienced HS during the first half of gestation (HSHS and HSTN) had increased (13.9%) subcutaneous fat thickness compared to pigs from dams exposed to TN conditions during the first half of gestation. This metabolic repartitioning towards increased fat deposition in pigs from dams heat-stressed during the first half of gestation was accompanied by elevated blood insulin concentrations (33%; P = 0.01). Together, these results demonstrate HS during the first half of gestation altered metabolic and body composition parameters during future development and in biological responses to a subsequent HS challenge.	[Boddicker, Rebecca L.; Seibert, Jacob T.; Johnson, Jay S.; Pearce, Sarah C.; Selsby, Joshua T.; Gabler, Nicholas K.; Baumgard, Lance H.; Ross, Jason W.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Lucy, Matthew C.; Safranski, Timothy J.] Univ Missouri, Div Anim Sci, Columbia, MO USA; [Rhoads, Robert P.] Virginia Tech Univ, Dept Anim & Poultry Sci, Blacksburg, VA USA	Iowa State University; University of Missouri System; University of Missouri Columbia; Virginia Polytechnic Institute & State University	Ross, JW (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	jwross@iastate.edu	Rhoads, Robert P/F-2861-2016; Baumgard, Lance Hall/AAZ-7090-2021	Rhoads, Robert P/0000-0002-5205-5834; Luchtel, Rebecca/0000-0002-7523-5010	National Research Initiative Competitive Grant from 440 the USDA National Institute of Food and Agriculture [2011-67003-30007]	National Research Initiative Competitive Grant from 440 the USDA National Institute of Food and Agriculture	This work was supported by the National Research Initiative Competitive Grant no. 2011-67003-30007 from 440 the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgard LH, 2012, J ANIM SCI, V90, P1855, DOI 10.2527/jas.2011-4675; Baumgard L. H., 2012, ENV STRESS AMELIORAT, P413, DOI [DOI 10.1007/978-3-642-29205-7_15, 10.1007/978-3-642-29205-7_15]; Bee G, 2004, J ANIM SCI, V82, P826; Boddicker N, 2011, J ANIM SCI, V89, P40, DOI 10.2527/jas.2010-3106; Cerisuelo A, 2009, J ANIM SCI, V87, P729, DOI 10.2527/jas.2007-0677; Chen XC, 2010, J PHYSIOL-LONDON, V588, P3539, DOI 10.1113/jphysiol.2010.192310; Close WH, 1971, ANIM PROD, V13; Crosier AE, 2002, BIOL REPROD, V67, P401, DOI 10.1095/biolreprod67.2.401; CSABA G, 1984, ACTA PHYSIOL HUNG, V63, P93; DREILING CE, 1991, J DAIRY SCI, V74, P312, DOI 10.3168/jds.S0022-0302(91)78175-7; DWYER CM, 1994, BRIT J NUTR, V72, P173, DOI 10.1079/BJN19940022; EARLY RJ, 1991, J ANIM SCI, V69, P3610, DOI 10.2527/1991.6993610x; Fahey AJ, 2005, J ANIM SCI, V83, P2564; Foxcroft G R, 2006, J Anim Sci, V84 Suppl, pE105; Foxcroft G R, 2009, Soc Reprod Fertil Suppl, V66, P213; Galan HL, 1999, AM J OBSTET GYNECOL, V180, P1278, DOI 10.1016/S0002-9378(99)70629-0; Garofano A, 1998, DIABETOLOGIA, V41, P1114, DOI 10.1007/s001250051038; Graham JM, 1998, TERATOLOGY, V58, P209, DOI 10.1002/(SICI)1096-9926(199811)58:5<209::AID-TERA8>3.0.CO;2-Q; Halevy O, 2001, AM J PHYSIOL-REG I, V281, pR302, DOI 10.1152/ajpregu.2001.281.1.R302; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; HEATH ME, 1983, COMP BIOCHEM PHYS A, V76, P363, DOI 10.1016/0300-9629(83)90338-9; HEATH ME, 1989, CAN J PHYSIOL PHARM, V67, P526, DOI 10.1139/y89-084; Johnson JS, 2013, INT J HYPERTHER, V29, P696, DOI 10.3109/02656736.2013.843723; JONSON KM, 1976, BRAIN RES BULL, V1, P133, DOI 10.1016/0361-9230(76)90056-3; Kisliouk T, 2010, DEV NEUROBIOL, V70, P100, DOI 10.1002/dneu.20763; Li GF, 2006, AM J PHYSIOL-HEART C, V291, pH1709, DOI 10.1152/ajpheart.00201.2006; Lucy MC, 2012, J ANIM SCI, V90, P574; McCoard SA, 1997, REPROD FERT DEVELOP, V9, P675, DOI 10.1071/R97061; Mueller BR, 2006, PHYSIOL BEHAV, V88, P605, DOI 10.1016/j.physbeh.2006.05.019; OMTVEDT IT, 1971, J ANIM SCI, V32, P312; Pearce SC, 2013, J ANIMAL SCI; Poston L, 2011, PROG BIOPHYS MOL BIO, V106, P315, DOI 10.1016/j.pbiomolbio.2010.11.011; Quigley SP, 2005, ANIM REPROD SCI, V87, P241, DOI 10.1016/j.anireprosci.2004.11.005; Renaudeau D, 2011, J ANIM SCI; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; SHIOTA K, 1989, BIOL NEONATE, V56, P6; Tamashiro KLK, 2009, DIABETES, V58, P1116, DOI 10.2337/db08-1129; Tetievsky A, 2010, J APPL PHYSIOL, V109, P1552, DOI 10.1152/japplphysiol.00469.2010; Town SC, 2004, REPRODUCTION, V128, P443, DOI 10.1530/rep.1.00069; Tse WY, 2008, REPROD FERT DEVELOP, V20, P497, DOI 10.1071/RD07200; Tygesen MP, 2008, ARCH ANIM NUTR, V62, P44, DOI 10.1080/17450390701780276; VERSTEGEN MWA, 1978, CAN J ANIM SCI, V58, P1, DOI 10.4141/cjas78-001; Wang XQ, 2010, J PROTEOME RES, V9, P924, DOI 10.1021/pr900747d; WIGMORE PMC, 1983, J ANAT, V137, P235; Woodall SM, 1996, J ENDOCRINOL, V150, P231, DOI 10.1677/joe.0.1500231; Yahav S, 2001, POULTRY SCI, V80, P1662, DOI 10.1093/ps/80.12.1662; Yates DT, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/631038; Yoshihara T, 2012, ACTA PHYSL OXF, V207, P416	49	48	52	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110859	10.1371/journal.pone.0110859	http://dx.doi.org/10.1371/journal.pone.0110859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383953	Green Published, gold			2022-12-26	WOS:000344816700012
J	Costa, SS; Druzian, JI; Machado, BAS; de Souza, CO; Guimaraes, AG				Costa, Samantha Serra; Druzian, Janice Izabel; Souza Machado, Bruna Aparecida; de Souza, Carolina Oliveira; Guimaraes, Alaise Gil			Bi-Functional Biobased Packing of the Cassava Starch, Glycerol, Licuri Nanocellulose and Red Propolis	PLOS ONE			English	Article							BARRIER PROPERTIES; FILMS; WATER	The aim of this study was to characterize and determine the bi-functional efficacy of active packaging films produced with starch (4%) and glycerol (1.0%), reinforced with cellulose nanocrystals (0-1%) and activated with alcoholic extracts of red propolis (0.4 to 1.0%). The cellulose nanocrystals used in this study were extracted from licuri leaves. The films were characterized using moisture, water-activity analyses and water vapor-permeability tests and were tested regarding their total phenolic compounds and mechanical properties. The antimicrobial and antioxidant efficacy of the films were evaluated by monitoring the use of the active films for packaging cheese curds and butter, respectively. The cellulose nanocrystals increased the mechanical strength of the films and reduced the water permeability and water activity. The active film had an antimicrobial effect on coagulase-positive staphylococci in cheese curds and reduced the oxidation of butter during storage.	[Costa, Samantha Serra] Univ Fed Bahia, Fac Pharm, BR-40171970 Salvador, BA, Brazil; [Druzian, Janice Izabel; de Souza, Carolina Oliveira; Guimaraes, Alaise Gil] Univ Fed Bahia, Fac Pharm, Dept Bromatol Anal, BR-40171970 Salvador, BA, Brazil; [Souza Machado, Bruna Aparecida] Serv Nacl Aprendizagem Ind SENAI, SENAI CIMATEC, Fac Technol, BR-41650010 Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Faculdade de Tecnologia Senai Cimatec	Costa, SS (corresponding author), Univ Fed Bahia, Fac Pharm, Rua Barao de Geremoabo S-N, BR-40171970 Salvador, BA, Brazil.	manthasc@yahoo.com.br	Druzian, Janice Izabel/G-6884-2015; Souza, Carolina O/G-8869-2015; Machado, Bruna Aparecida Souza/C-3130-2016; Machado, Bruna/AAP-6877-2021	Machado, Bruna Aparecida Souza/0000-0003-1655-0325; Oliveira de Souza, Carolina/0000-0002-8028-5418; Druzian, Janice Izabel/0000-0001-8940-6098	CAPES (Coordination of Improvement of Higher Education Personnel)	CAPES (Coordination of Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The research was funded by CAPES (Coordination of Improvement of Higher Education Personnel), through design nanobiotec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amal AM, 2013, PLOS ONE, V8, P1; American Oil Chemists Society (AOCS), 1997, CD8B90; American Society for Testing and Materials (ASTM), 2005, E96E96M ASTM; ASTM, 2001, D88200 ASTM; Azeredo HMC, 2009, J FOOD SCI, V74, pN31, DOI 10.1111/j.1750-3841.2009.01186.x; Reis LCB, 2015, FOOD BIOPROD PROCESS, V94, P382, DOI 10.1016/j.fbp.2014.05.004; Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p; Cagri A, 2001, J FOOD SCI, V66, P865, DOI 10.1111/j.1365-2621.2001.tb15188.x; Coutinho Fernanda M. B., 2003, Polímeros, V13, P01, DOI 10.1590/S0104-14282003000100005; de Mesquita JP, 2011, SOFT MATTER, V7, P4405, DOI 10.1039/c0sm01168a; Gill AO, 2002, INT J FOOD MICROBIOL, V73, P83, DOI 10.1016/S0168-1605(01)00712-7; GONTARD N, 1992, J FOOD SCI, V57, P190, DOI 10.1111/j.1365-2621.1992.tb05453.x; Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w; Holt BL, 2010, J MATER CHEM, V20, P10058, DOI 10.1039/c0jm01022g; Kechichian V, 2010, LWT-FOOD SCI TECHNOL, V43, P1088, DOI 10.1016/j.lwt.2010.02.014; Luz JMR, 2013, PLOS ONE, V8, P8, DOI DOI 10.1371/J0URNAL.P0NE.0069386.G003; Massaro FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081297; Mathlouthi M, 2001, FOOD CONTROL, V12, P409, DOI 10.1016/S0956-7135(01)00032-9; Mohamed AA, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/annotation/f9aef9a9-5488-4492-8b8c-1cdded2e3d79; Park YK, 1998, BIOSCI BIOTECH BIOCH, V62, P2230, DOI 10.1271/bbb.62.2230; Pelissari FM, 2009, J AGR FOOD CHEM, V57, P7499, DOI 10.1021/jf9002363; Cavalcante DRR, 2011, BRAZ J OTORHINOLAR, V77, P278, DOI 10.1590/S1808-86942011000300002; Rohn S, 2004, J AGR FOOD CHEM, V52, P4725, DOI 10.1021/jf0496797; Rosa MF, 2010, CARBOHYD POLYM, V81, P83, DOI 10.1016/j.carbpol.2010.01.059; Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685; Santos FA, 2002, J ETHNOPHARMACOL, V80, P1, DOI 10.1016/S0378-8741(02)00003-X; Silva JBA, 2012, J FOOD SCI, V77, P14; Siripatrawan U, 2010, FOOD HYDROCOLLOID, V24, P770, DOI 10.1016/j.foodhyd.2010.04.003; Souza CO, 2011, J AGR FOOD CHEM, V1, P1; Taketoshi H, 2012, PLOS ONE, V7, P11; Tanja P, 2013, PLOS ONE, V8, P2; Veiga-Santos P, 2007, FOOD CHEM, V103, P255, DOI 10.1016/j.foodchem.2006.07.048; Wenbin G, 2012, PLOS ONE, V7, P5; Zinoviadou KG, 2009, MEAT SCI, V82, P338, DOI 10.1016/j.meatsci.2009.02.004	34	40	41	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112554	10.1371/journal.pone.0112554	http://dx.doi.org/10.1371/journal.pone.0112554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383783	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700081
J	Yeom, SK; Fazli, S; Muller, KR; Lee, SW				Yeom, Seul-Ki; Fazli, Siamac; Mueller, Klaus-Robert; Lee, Seong-Whan			An Efficient ERP-Based Brain-Computer Interface Using Random Set Presentation and Face Familiarity	PLOS ONE			English	Article							P300 SPELLER; BCI; COMMUNICATION; CLASSIFICATION; RECOGNITION; PERFORMANCE; INTERVAL; PEOPLE	Event-related potential (ERP)-based P300 spellers are commonly used in the field of brain-computer interfaces as an alternative channel of communication for people with severe neuro-muscular diseases. This study introduces a novel P300 based brain-computer interface (BCI) stimulus paradigm using a random set presentation pattern and exploiting the effects of face familiarity. The effect of face familiarity is widely studied in the cognitive neurosciences and has recently been addressed for the purpose of BCI. In this study we compare P300-based BCI performances of a conventional row-column (RC)-based paradigm with our approach that combines a random set presentation paradigm with (non-) self-face stimuli. Our experimental results indicate stronger deflections of the ERPs in response to face stimuli, which are further enhanced when using the self-face images, and thereby improving P300-based spelling performance. This lead to a significant reduction of stimulus sequences required for correct character classification. These findings demonstrate a promising new approach for improving the speed and thus fluency of BCI-enhanced communication with the widely used P300-based BCI setup.	[Yeom, Seul-Ki; Fazli, Siamac; Mueller, Klaus-Robert; Lee, Seong-Whan] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Berlin Inst Technol, Machine Learning Grp, Berlin, Germany	Korea University; Technical University of Berlin	Lee, SW (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.	sw.lee@korea.ac.kr	Fazli, Siamac/GYQ-9627-2022; Mueller, Klaus-Robert/Y-3547-2019	Fazli, Siamac/0000-0003-3397-0647; Mueller, Klaus-Robert/0000-0002-3861-7685	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2012005741]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (No. 2012005741). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2006, INT J PSYCHOPHYSIOL, V59, P127, DOI 10.1016/j.ijpsycho.2005.02.007; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bishop C. M, 2006, PATTERN RECOGNITION; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazel-Rezai R, 2009, CAN J ELECT COMPUT E, V34, P81, DOI 10.1109/CJECE.2009.5443854; Gao SK, 2014, IEEE T BIO-MED ENG, V61, P1436, DOI 10.1109/TBME.2014.2300164; Gibert G, 2008, 4 BCI WORKSH TRAIN C; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Jin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049688; Jin J, 2012, MED BIOL ENG COMPUT, V50, P289, DOI 10.1007/s11517-012-0868-x; Jin J, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036006; Jin J, 2011, MED BIOL ENG COMPUT, V49, P181, DOI 10.1007/s11517-010-0689-8; KANWISHER NG, 1987, COGNITION, V27, P117, DOI 10.1016/0010-0277(87)90016-3; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00129; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Keyes H, 2010, BRAIN COGNITION, V72, P244, DOI 10.1016/j.bandc.2009.09.006; Kindermans P., 2012, ADV NEURAL INFORM PR, V25; Kindermans PJ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035005; Kohlmorgen J., 2007, BRAIN COMPUTER INTER, P409; Krusienski DJ, 2008, J NEUROSCI METH, V167, P15, DOI 10.1016/j.jneumeth.2007.07.017; Krusienski DJ, 2006, J NEURAL ENG, V3, P299, DOI 10.1088/1741-2560/3/4/007; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Kubler A, 2008, CLIN NEUROPHYSIOL, V119, P2658, DOI 10.1016/j.clinph.2008.06.019; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Liu T, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036003; Mak Joseph N, 2009, IEEE Rev Biomed Eng, V2, P187, DOI 10.1109/RBME.2009.2035356; Martens SMM, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/2/026003; McFarland DJ, 2011, CLIN NEUROPHYSIOL, V122, P731, DOI 10.1016/j.clinph.2010.10.029; Miyakoshi M, 2010, NEUROIMAGE, V50, P1666, DOI 10.1016/j.neuroimage.2010.01.030; Muller KR, 2003, IEEE T NEUR SYS REH, V11, P165, DOI 10.1109/TNSRE.2003.814484; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Ninomiya H, 1998, PSYCHIAT CLIN NEUROS, V52, P519, DOI 10.1046/j.1440-1819.1998.00445.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polprasert C, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036012; PRITCHARD WS, 1981, PSYCHOL BULL, V89, P506, DOI 10.1037/0033-2909.89.3.506; Rakotomarnonjy A, 2008, IEEE T BIO-MED ENG, V55, P1147, DOI 10.1109/TBME.2008.915728; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; Rivet B, 2009, IEEE T BIO-MED ENG, V56, P2035, DOI 10.1109/TBME.2009.2012869; Salvaris M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046011; Sanders AF, 2002, ACTA PSYCHOL, V109, P41, DOI 10.1016/S0001-6918(01)00048-8; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; SIEGEL S., 1956, NONPARAMETRIC STAT B; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; Takano K, 2009, CLIN NEUROPHYSIOL, V120, P1562, DOI 10.1016/j.clinph.2009.06.002; Townsend G, 2010, CLIN NEUROPHYSIOL, V121, P1109, DOI 10.1016/j.clinph.2010.01.030; Townsend G, 2012, NEUROSCI LETT, V531, P63, DOI 10.1016/j.neulet.2012.08.041; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wintink AJ, 2001, BRAIN COGNITION, V46, P307, DOI 10.1016/S0278-2626(01)80090-7; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, V3, P123, DOI [DOI 10.1093/ACPROF:OSO/9780195388855.001.0001, 10.1093/acprof:oso/9780195388855.003.0001]; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu N, 2004, IEEE T BIO-MED ENG, V51, P1067, DOI 10.1109/TBME.2004.826699; Yeom SK, 2013, PATTERN RECOGN, V46, P1159, DOI 10.1016/j.patcog.2012.10.023; Zhang Y, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026018	63	63	65	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111157	10.1371/journal.pone.0111157	http://dx.doi.org/10.1371/journal.pone.0111157			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384045	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700014
J	Deng, GJ; Shen, JQ; Yin, M; McManus, J; Mathieu, M; Gee, P; He, T; Shi, CM; Bedel, O; McLean, LR; Le-Strat, F; Zhang, Y; Marquette, JP; Gao, Q; Zhang, BL; Rak, A; Hoffmann, D; Rooney, E; Vassort, A; Englaro, W; Li, Y; Patel, V; Adrian, F; Gross, S; Wiederschain, D; Cheng, H; Licht, S				Deng, Gejing; Shen, Junqing; Yin, Ming; McManus, Jessica; Mathieu, Magali; Gee, Patricia; He, Timothy; Shi, Chaomei; Bedel, Olivier; McLean, Larry R.; Le-Strat, Frank; Zhang, Ying; Marquette, Jean-Pierre; Gao, Qiang; Zhang, Bailin; Rak, Alexey; Hoffmann, Dietmar; Rooney, Eamonn; Vassort, Aurelie; Englaro, Walter; Li, Yi; Patel, Vinod; Adrian, Francisco; Gross, Stefan; Wiederschain, Dmitri; Cheng, Hong; Licht, Stuart			Selective Inhibition of Mutant Isocitrate Dehydrogenase 1 (IDH1) via Disruption of a Metal Binding Network by an Allosteric Small Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; ONCOMETABOLITE 2-HYDROXYGLUTARATE; MUTATIONS; DIFFERENTIATION; MECHANISM; GLIOMA; TRANSFORMATION; SWITCH; R132H; CELLS	Cancer-associated point mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) confer a neomorphic enzymatic activity: the reduction of alpha-ketoglutarate to D-2-hydroxyglutaric acid, which is proposed to act as an oncogenic metabolite by inducing hypermethylation of histones and DNA. Although selective inhibitors of mutant IDH1 and IDH2 have been identified and are currently under investigation as potential cancer therapeutics, the mechanistic basis for their selectivity is not yet well understood. A high throughput screen for selective inhibitors of IDH1 bearing the oncogenic mutation R132H identified compound 1, a bis-imidazole phenol that inhibits D-2-hydroxyglutaric acid production in cells. We investigated the mode of inhibition of compound 1 and a previously published IDH1 mutant inhibitor with a different chemical scaffold. Steady-state kinetics and biophysical studies show that both of these compounds selectively inhibit mutant IDH1 by binding to an allosteric site and that inhibition is competitive with respect to Mg2+. A crystal structure of compound 1 complexed with R132H IDH1 indicates that the inhibitor binds at the dimer interface and makes direct contact with a residue involved in binding of the catalytically essential divalent cation. These results show that targeting a divalent cation binding residue can enable selective inhibition of mutant IDH1 and suggest that differences in magnesium binding between wild-type and mutant enzymes may contribute to the inhibitors' selectivity for the mutant enzyme.	[Deng, Gejing; Shen, Junqing; Yin, Ming; McManus, Jessica; Gee, Patricia; He, Timothy; Shi, Chaomei; Bedel, Olivier; Gao, Qiang; Zhang, Bailin; Hoffmann, Dietmar; Adrian, Francisco; Gross, Stefan; Wiederschain, Dmitri; Cheng, Hong; Licht, Stuart] Sanofi, Div Oncol Drug Discovery & Preclin Dev, Cambridge, MA 02139 USA; [Mathieu, Magali; Marquette, Jean-Pierre; Rak, Alexey; Rooney, Eamonn; Vassort, Aurelie; Englaro, Walter] Sanofi, Div Lead Generat & Compound Realizat, F-94403 Vitry Sur Seine, France; [McLean, Larry R.; Zhang, Ying; Li, Yi; Patel, Vinod] Sanofi, Div Lead Generat & Compound Realizat, Waltham, MA 02452 USA; [Le-Strat, Frank] Sanofi, Dept Disposit Safety & Anim Res, F-91385 Chilly Mazarin, France	Sanofi-Aventis; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi-Aventis; Sanofi France	Deng, GJ (corresponding author), Sanofi Oncol, 640 Mem Dr, Cambridge, MA 02139 USA.	gejing.deng@sanofi.com						ALBERT R, 1987, SYNTHESIS-STUTTGART, P635; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis MI, 2014, J BIOL CHEM, V289, P13717, DOI 10.1074/jbc.M113.511030; Deechongkit S, 2004, ORG LETT, V6, P497, DOI 10.1021/ol036102m; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Geisbrecht BV, 1999, J BIOL CHEM, V274, P30527, DOI 10.1074/jbc.274.43.30527; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Jin GL, 2013, CANCER RES, V73, P496, DOI 10.1158/0008-5472.CAN-12-2852; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Liu RC, 2009, TETRAHEDRON LETT, V50, P4046, DOI 10.1016/j.tetlet.2009.04.097; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Paschka P, 2010, J CLIN ONCOL, V28, P3636, DOI 10.1200/JCO.2010.28.3762; Pietrak B, 2011, BIOCHEMISTRY-US, V50, P4804, DOI 10.1021/bi200499m; Popovici-Muller J., 2012, Preparation of Cycloalkylheteroarylacetylphenylaminopheny-lacetamide Derivatives and Analogs for Use as Antitumor Agents, Patent No. [WO 2012009678A1, 2012009678]; Popovici-Muller J, 2012, ACS MED CHEM LETT, V3, P850, DOI 10.1021/ml300225h; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Rendina AR, 2013, BIOCHEMISTRY-US, V52, P4563, DOI 10.1021/bi400514k; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Segel IH, 1975, ENZYME KINETICS BEHA; Soundar S, 1996, PROTEIN EXPRES PURIF, V8, P305, DOI 10.1006/prep.1996.0105; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Thol F, 2010, BLOOD, V116, P614, DOI 10.1182/blood-2010-03-272146; Wagner K, 2010, J CLIN ONCOL, V28, P2356, DOI 10.1200/JCO.2009.27.6899; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; YAN JM, 1994, SYNTHETIC COMMUN, V24, P47, DOI 10.1080/00397919408012624; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zheng BS, 2013, ACS MED CHEM LETT, V4, P542, DOI 10.1021/ml400036z	37	96	103	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					762	774		10.1074/jbc.M114.608497	http://dx.doi.org/10.1074/jbc.M114.608497			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25391653	hybrid, Green Published			2022-12-26	WOS:000347778200007
J	Ermolova, N; Kramerova, I; Spencer, MJ				Ermolova, Natalia; Kramerova, Irina; Spencer, Melissa J.			Autolytic Activation of Calpain 3 Proteinase Is Facilitated by Calmodulin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; MUSCLE-SPECIFIC CALPAIN; CRYSTAL-STRUCTURE; IN-VIVO; P94; MUTATIONS; EXPRESSION; DOMAIN; 2A	Calpains are broadly distributed, calcium-dependent enzymes that induce limited proteolysis in a wide range of substrates. Mutations in the gene encoding the muscle-specific family member calpain 3 (CAPN3) underlie limb-girdle muscular dystrophy 2A. We have shown previously that CAPN3 knockout muscles exhibit attenuated calcium release, reduced calmodulin kinase (CaMKII) signaling, and impaired muscle adaptation to exercise. However, neither the precise role of CAPN3 in these processes nor the mechanisms of CAPN3 activation in vivo have been fully elucidated. In this study, we identify calmodulin (CaM), a known transducer of the calcium signal, as the first positive regulator of CAPN3 autolytic activity. CaM was shown to bind CAPN3 at two sites located in the C2L domain. Biochemical studies using muscle extracts from transgenic mice overexpressing CAPN3 or its inactive mutant revealed that CaM binding enhanced CAPN3 autolytic activation. Furthermore, CaM facilitated CAPN3-mediated cleavage of its in vivo substrate titin in tissue extracts. Therefore, these studies reveal a novel interaction between CAPN3 and CaM and identify CaM as the first positive regulator of CAPN3 activity.	Univ Calif Los Angeles, Dept Neurol, Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Ctr Duchenne Muscular Dystrophy, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Spencer, MJ (corresponding author), Univ Calif Los Angeles, Dept Neurol, Neurosci Res Bldg,635 Charles Young Dr S, Los Angeles, CA 90095 USA.	mspencer@mednet.ucla.edu			NIAMS/National Institutes of Health [U54AR052646, 2RO1AR048177, 2 P30 AR057230-06]; Muscular Dystrophy Association of America [MDA241489]; Coalition to Cure Calpain 3; Crystal Ball Fund; My Directives; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048177, P30AR057230, U54AR052646] Funding Source: NIH RePORTER	NIAMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association of America(Muscular Dystrophy Association); Coalition to Cure Calpain 3; Crystal Ball Fund; My Directives; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported, in whole or in part, by NIAMS/National Institutes of Health GrantsU54AR052646, 2RO1AR048177, and 2 P30 AR057230-06 (to M. S.). This work was also supported by Muscular Dystrophy Association of America Grant MDA241489 (to M. S.), by the Coalition to Cure Calpain 3, by the Crystal Ball Fund, and by My Directives.	Anderson LVB, 1998, AM J PATHOL, V153, P1169, DOI 10.1016/S0002-9440(10)65661-1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Bossuyt J, 2013, J MOL MED, V91, P907, DOI 10.1007/s00109-013-1060-y; Campbell RL, 2012, BIOCHEM J, V447, P335, DOI 10.1042/BJ20120921; Diaz BEG, 2006, BIOCHEMISTRY-US, V45, P3714, DOI 10.1021/bi051917j; Ermolova N, 2011, HUM MOL GENET, V20, P3331, DOI 10.1093/hmg/ddr239; Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1; Garnham CP, 2009, BIOCHEMISTRY-US, V48, P3457, DOI 10.1021/bi900130u; Garvey SM, 2002, GENOMICS, V79, P146, DOI 10.1006/geno.2002.6685; Gautel M, 2011, PFLUG ARCH EUR J PHY, V462, P119, DOI 10.1007/s00424-011-0946-1; Hanna RA, 2007, FEBS LETT, V581, P2894, DOI 10.1016/j.febslet.2007.05.035; Haravuori H, 2001, NEUROLOGY, V56, P869, DOI 10.1212/WNL.56.7.869; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Jia ZC, 2001, BIOPHYS J, V80, P2590, DOI 10.1016/S0006-3495(01)76229-7; Jia Zongchao, 2002, Methods Mol Biol, V172, P51; Kichard I., 1999, AM J HUM GENET, V64, P1524; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kinbara K, 1998, BIOCHEM J, V335, P589, DOI 10.1042/bj3350589; Kramerova I, 2007, HUM MOL GENET, V16, P1006, DOI 10.1093/hmg/ddm044; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2012, HUM MOL GENET, V21, P3193, DOI 10.1093/hmg/dds144; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2013, J MOL BIOL, V425, P2955, DOI 10.1016/j.jmb.2013.05.009; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Partha SK, 2014, FEBS J, V281, P3138, DOI 10.1111/febs.12849; PEITSCH MC, 1995, TRENDS BIOCHEM SCI, V20, P82, DOI 10.1016/S0968-0004(00)88963-X; Persechini A, 2002, TRENDS CARDIOVAS MED, V12, P32, DOI 10.1016/S1050-1738(01)00144-X; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Ravulapalli R, 2005, BIOCHEM J, V388, P585, DOI 10.1042/BJ20041821; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299	36	12	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					996	1004		10.1074/jbc.M114.588780	http://dx.doi.org/10.1074/jbc.M114.588780			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25389288	Green Published, hybrid			2022-12-26	WOS:000347778200033
J	Bradley, EW; Carpio, LR; Olson, EN; Westendorf, JJ				Bradley, Elizabeth W.; Carpio, Lomeli R.; Olson, Eric N.; Westendorf, Jennifer J.			Histone Deacetylase 7 (Hdac7) Suppresses Chondrocyte Proliferation and beta-Catenin Activity during Endochondral Ossification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin (-catenin); Cartilage; Growth Plate; Histone Deacetylase (HDAC); Insulin; ATDC5 Cells; Histone Deacetylase 7 (Hdac7)	PROTEIN-KINASE-D; GROWTH-PLATE; ARTICULAR-CARTILAGE; NUCLEAR EXPORT; IN-VIVO; DIFFERENTIATION; HYPERTROPHY; EXPRESSION; OSTEOBLAST; MICE	Background: Hdac7 is a transcriptional co-repressor in skeletal tissues, but its role in chondrocytes is undefined. Results: Proteasomal degradation reduced Hdac7 levels during chondrogenic maturation and conditional deletion of Hdac7 in chondrocytes increased proliferation and -catenin levels. Conclusion: Hdac7 degradation enhances -catenin transcriptional activity in growth plate chondrocytes. Significance: Suppressing Hdac7 levels increases chondrocyte proliferation and promotes cartilage formation and regeneration. Histone deacetylases (Hdacs) regulate endochondral ossification by suppressing gene transcription and modulating cellular responses to growth factors and cytokines. We previously showed that Hdac7 suppresses Runx2 activity and osteoblast differentiation. In this study, we examined the role of Hdac7 in postnatal chondrocytes. Hdac7 was highly expressed in proliferating cells within the growth plate. Postnatal tissue-specific ablation of Hdac7 with a tamoxifen-inducible collagen type 2a1-driven Cre recombinase increased proliferation and -catenin levels in growth plate chondrocytes and expanded the proliferative zone. Similar results were obtained in primary chondrocyte cultures where Hdac7 was deleted with adenoviral-Cre. Hdac7 bound -catenin in proliferating chondrocytes, but stimulation of chondrocyte maturation promoted the translocation of Hdac7 to the cytoplasm where it was degraded by the proteasome. As a result, -catenin levels and transcription activity increased in the nucleus. These data demonstrate that Hdac7 suppresses proliferation and -catenin activity in chondrocytes. Reducing Hdac7 levels in early chondrocytes may promote the expansion and regeneration of cartilage tissues.	[Bradley, Elizabeth W.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Carpio, Lomeli R.] Mayo Clin, Mayo Grad Sch, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas	Westendorf, JJ (corresponding author), Mayo Clin, 200 First St SW, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu		Bradley, Elizabeth/0000-0002-8814-5524; Shull, Lomeli/0000-0001-7537-8516	National Institutes of Health [AR056950, AR61873, AR65397, GM055252]; MayoClinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950, K01AR065397, F32AR061873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MayoClinic; Mayo Graduate School; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR056950, AR61873, AR65397, and GM055252, MayoClinic, and the Mayo Graduate School.	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Bradley EW, 2013, J BIOL CHEM, V288, P9572, DOI 10.1074/jbc.M112.423723; Bradley EW, 2010, MOL ENDOCRINOL, V24, P1581, DOI 10.1210/me.2010-0037; Chagin AS, 2007, BONE, V40, P1415, DOI 10.1016/j.bone.2006.12.066; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chen M, 2008, J CELL SCI, V121, P1455, DOI 10.1242/jcs.020362; Dao DY, 2012, J BONE MINER RES, V27, P1680, DOI 10.1002/jbmr.1639; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jensen ED, 2009, J BIOL CHEM, V284, P2225, DOI 10.1074/jbc.M800586200; Kolettas E, 2001, RHEUMATOLOGY, V40, P1146, DOI 10.1093/rheumatology/40.10.1146; Kozhemyakina E, 2009, MOL CELL BIOL, V29, P5751, DOI 10.1128/MCB.00415-09; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Pham L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.216853; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; McGee-Lawrence ME, 2013, BONE, V52, P296, DOI 10.1016/j.bone.2012.10.015; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Schmidt MB, 2006, OSTEOARTHR CARTILAGE, V14, P403, DOI 10.1016/j.joca.2005.10.011; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Staines KA, 2013, J ENDOCRINOL, V219, pR1, DOI 10.1530/JOE-13-0276; Talwar RM, 2006, J ORAL MAXIL SURG, V64, P600, DOI 10.1016/j.joms.2005.12.006; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Wang BL, 2014, ARTHRITIS RHEUMATOL, V66, P107, DOI 10.1002/art.38195; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Wang YM, 2011, J BONE MINER RES, V26, P1437, DOI 10.1002/jbmr.359; Yuasa T, 2009, AM J PATHOL, V175, P1993, DOI 10.2353/ajpath.2009.081173; Zhu M, 2008, ARTHRITIS RHEUM-US, V58, P2053, DOI 10.1002/art.23614; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	40	37	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					118	126		10.1074/jbc.M114.596247	http://dx.doi.org/10.1074/jbc.M114.596247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389289	Green Published, hybrid			2022-12-26	WOS:000347231200011
J	Ma, F; Ding, XY; Fan, Y; Ying, JM; Zheng, S; Lu, N; Xu, BH				Ma, Fei; Ding, Xiaoyan; Fan, Ying; Ying, Jianming; Zheng, Shan; Lu, Ning; Xu, Binghe			A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer	PLOS ONE			English	Article							INVASIVE DUCTAL CARCINOMA; LOW INTRINSIC SUBTYPE; CLAUDIN EXPRESSION; FEATURES; MARKERS; GRADE	Introduction: Triple-negative breast cancer (TNBC) is a heterogeneous disease with no definitive prognostic markers. As a major component of tight junctions, claudins (CLDNs) presumably play an important role in carcinogenesis and progression of breast cancer. This study was aimed at determining the relationship between the expression of CLDNs and the clinical outcomes of TNBCs. Materials and Methods: The surgical specimens of primary breast tumors from a consecutive cohort of 173 TNBC patients were retrospectively collected. The membranous expression of CLDN1, CLDN2, CLDN4, and CLDN7 was measured by immunohistochemistry. Then, the associations between CLDN expression, clinicopathological features, and clinical outcomes were assessed. Results: Positive CLDN1, CLDN2, CLDN4, and CLDN7 membrane expression was detected in 44.5%, 54.9%, 76.9%, and 73.4% of the cohort specimens, respectively. A lack of CLDN1 expression was related to only lymph node metastasis (P = 0.014). The rate of CLDN4-positive tumors was significantly increased in tumors of a higher grade (P = 0.003). Importantly, negative CLDN1 expression was associated with worse relapse-free survival (RFS) in both lymph node positive (LN+) and negative (LN2) cases (both P<0.001). Similarly it was also associated with shorter overall survival (OS)(P = 0.003 in LN+ cases; P = 0.018 in LN- cases). In the LN+ subgroup, CLDN2-negative cases had a significantly higher risk of recurrence (P = 0.008). Multivariate analysis revealed that negative CLDN1 expression was an independent prognostic factor for high risk of both recurrence and death (HR 5.529, 95% CI 2.664-11.475, P<0.001; HR 3.459, 95% CI 1.555-7.696, P = 0.002). However, neither CLDN4 nor CLDN7 expression was associated with survival. Conclusion: In TNBC, the CLDN1-negative phenotype predicts a high risk of recurrence and death. The absence of CLDN1 expression is strongly suggested to be an independent adverse prognostic factor in this heterogeneous subtype of breast cancer.	[Ma, Fei; Fan, Ying; Xu, Binghe] Chinese Acad Med Sci, Canc Hosp, Dept Med Oncol, Beijing 100730, Peoples R China; [Ma, Fei; Fan, Ying; Ying, Jianming; Zheng, Shan; Lu, Ning; Xu, Binghe] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ding, Xiaoyan] Capital Med Univ, Beijing DiTan Hosp, Dept Med Oncol, Beijing, Peoples R China; [Ying, Jianming; Zheng, Shan; Lu, Ning] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Lu, N (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China.	nlu03@126.com; binghxu@126.com		Ma, Fei/0000-0001-9432-1902	Beijing Medicine Research and Development Fund [2011-4002-02]; Beijing Hope Run Special Fund [LC2012A51]	Beijing Medicine Research and Development Fund; Beijing Hope Run Special Fund	The present study was supported by Beijing Medicine Research and Development Fund (2011-4002-02) and Beijing Hope Run Special Fund (LC2012A51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, Am J Clin Pathol, V78, P806; Bevers TB, 2009, J NATL COMPR CANC NE, V7, P1060, DOI 10.6004/jnccn.2009.0070; Blanchard AA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-268; Blanchard AA, 2009, VIRCHOWS ARCH, V454, P647, DOI 10.1007/s00428-009-0770-6; Charpin C, 2012, INT J CANCER, V131, pE236, DOI 10.1002/ijc.27371; De Brot M, 2009, REV ASSOC MED BRAS, V55, P529, DOI 10.1590/S0104-42302009000500014; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Eichhorn JH, 2004, SEMIN DIAGN PATHOL, V21, P65, DOI 10.1053/j.semdp.2003.10.005; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; Fountzilas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037946; Gerhard R, 2012, BREAST, V21, P354, DOI 10.1016/j.breast.2012.03.001; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Hammond MEH, 2010, J ONCOL PRACT, V6, P195, DOI 10.1200/JOP.777003; Hernandez-Aya LF, 2011, J CLIN ONCOL, V29, P2628, DOI 10.1200/JCO.2010.32.1877; Hewitt KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-186; Hoevel T, 2004, INT J CANCER, V108, P374, DOI 10.1002/ijc.11571; Kashiwagi S, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3068; Kennecke H, 2010, J CLIN ONCOL, V28, P3271, DOI 10.1200/JCO.2009.25.9820; Kim TH, 2008, HISTOPATHOLOGY, V53, P48, DOI 10.1111/j.1365-2559.2008.03052.x; Kolokytha P, 2014, APPL IMMUNOHISTO M M, V22, P125, DOI 10.1097/PAI.0b013e31828d9d62; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Kulka J, 2009, PATHOL ONCOL RES, V15, P59, DOI 10.1007/s12253-008-9089-x; Lu SL, 2013, MODERN PATHOL, V26, P485, DOI 10.1038/modpathol.2012.187; Mahler-Araujo B, 2008, J CLIN PATHOL, V61, P615, DOI 10.1136/jcp.2007.053991; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morohashi S, 2007, INT J MOL MED, V20, P139; Myal Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/956897; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Sauer T, 2005, CYTOPATHOLOGY, V16, P193, DOI 10.1111/j.1365-2303.2005.00257.x; Singletary SE, 2003, SURG CLIN N AM, V83, P803, DOI 10.1016/S0039-6109(03)00034-3; Szasz AM, 2011, CLIN EXP METASTAS, V28, P55, DOI 10.1007/s10585-010-9357-5; Tokes AM, 2005, BREAST CANCER RES, V7, pR296, DOI 10.1186/bcr983; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775	36	28	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112765	10.1371/journal.pone.0112765	http://dx.doi.org/10.1371/journal.pone.0112765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393310	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300099
J	Padhi, S; Burri, RR; Jameel, S; Priyakumar, UD				Padhi, Siladitya; Burri, Raghunadha Reddy; Jameel, Shahid; Priyakumar, U. Deva			Atomistic Detailed Mechanism and Weak Cation-Conducting Activity of HIV-1 Vpu Revealed by Free Energy Calculations	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; VIRUS PROTEIN-U; INTEGRAL MEMBRANE-PROTEIN; CHANNEL-FORMING PROTEINS; GATED ION-CHANNEL; TRANSMEMBRANE DOMAIN; MEAN FORCE; 3-DIMENSIONAL STRUCTURE; COMPUTER-SIMULATIONS; FUNCTIONAL MOTIONS	The viral protein U (Vpu) encoded by HIV-1 has been shown to assist in the detachment of virion particles from infected cells. Vpu forms cation-specific ion channels in host cells, and has been proposed as a potential drug target. An understanding of the mechanism of ion transport through Vpu is desirable, but remains limited because of the unavailability of an experimental structure of the channel. Using a structure of the pentameric form of Vpu - modeled and validated based on available experimental data - umbrella sampling molecular dynamics simulations (cumulative simulation time of more than 0.4 mu s) were employed to elucidate the energetics and the molecular mechanism of ion transport in Vpu. Free energy profiles corresponding to the permeation of Na+ and K+ were found to be similar to each other indicating lack of ion selection, consistent with previous experimental studies. The Ser23 residue is shown to enhance ion transport via two mechanisms: creating a weak binding site, and increasing the effective hydrophilic length of the channel, both of which have previously been hypothesized in experiments. A two-dimensional free energy landscape has been computed to model multiple ion permeation, based on which a mechanism for ion conduction is proposed. It is shown that only one ion can pass through the channel at a time. This, along with a stretch of hydrophobic residues in the transmembrane domain of Vpu, explains the slow kinetics of ion conduction. The results are consistent with previous conductance studies that showed Vpu to be a weakly conducting ion channel.	[Padhi, Siladitya; Burri, Raghunadha Reddy; Priyakumar, U. Deva] Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India; [Jameel, Shahid] Int Ctr Genet Engn & Biotechnol, New Delhi, India	International Institute of Information Technology Hyderabad; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Priyakumar, UD (corresponding author), Int Inst Informat Technol, Ctr Computat Nat Sci & Bioinformat, Hyderabad, Andhra Pradesh, India.	deva@iiit.ac.in	Priyakumar, Deva/F-6793-2010	Padhi, Siladitya/0000-0002-4272-6040	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR12729/BID/07/297/2009]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India (http://dbtindia.nic.in/index.asp, grant no. BT/PR12729/BID/07/297/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2014, CHEM PHYS LETT, V599, P116, DOI 10.1016/j.cplett.2014.03.033; Allen TW, 2006, BIOPHYS J, V90, P3447, DOI 10.1529/biophysj.105.077073; Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2007, BIOPHYS J, V92, P854, DOI 10.1529/biophysj.106.095216; Chipot C, 2014, WIRES COMPUT MOL SCI, V4, P71, DOI 10.1002/wcms.1157; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P851, DOI 10.1016/j.bbamem.2012.09.012; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Egwolf B, 2010, J MOL BIOL, V401, P831, DOI 10.1016/j.jmb.2010.07.006; Ewart GD, 1996, J VIROL, V70, P7108, DOI 10.1128/JVI.70.10.7108-7115.1996; Federau T, 1996, INT J PEPT PROT RES, V47, P297; Fischer WB, 2014, BBA-BIOMEMBRANES, V1838, P1113, DOI 10.1016/j.bbamem.2013.08.017; Fischer WB, 2011, BBA-BIOMEMBRANES, V1808, P561, DOI 10.1016/j.bbamem.2010.05.014; Fowler PW, 2013, J CHEM THEORY COMPUT, V9, P5176, DOI 10.1021/ct4005933; Fritsch S, 2011, BIOPHYS J, V100, P390, DOI 10.1016/j.bpj.2010.11.077; Grossfield A., WHAM WEIGHTED HISTOG; Hsu HJ, 2012, J MOL MODEL, V18, P501, DOI 10.1007/s00894-011-1092-6; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussain A, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-81; Johnston JM, 2011, CURR OPIN STRUC BIOL, V21, P552, DOI 10.1016/j.sbi.2011.06.008; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Khalili-Araghi F, 2009, CURR OPIN STRUC BIOL, V19, P128, DOI 10.1016/j.sbi.2009.02.011; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kukol A, 1999, BIOPHYS J, V77, P1594, DOI 10.1016/S0006-3495(99)77007-4; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lai CL, 2013, J MOL BIOL, V425, P3073, DOI 10.1016/j.jmb.2013.05.026; Li LH, 2013, BIOPOLYMERS, V99, P517, DOI 10.1002/bip.22210; Lopez CF, 2002, BIOPHYS J, V83, P1259, DOI 10.1016/S0006-3495(02)73898-8; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Marassi FM, 1999, P NATL ACAD SCI USA, V96, P14336, DOI 10.1073/pnas.96.25.14336; Mehnert T, 2008, PROTEINS, V70, P1488, DOI 10.1002/prot.21642; Mehnert T, 2007, J BIOMOL STRUCT DYN, V24, P589, DOI 10.1080/07391102.2007.10507148; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Padhi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079779; Park SH, 2006, BIOPHYS J, V91, P3032, DOI 10.1529/biophysj.106.087106; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; Patargias G, 2009, J BIOMOL STRUCT DYN, V27, P1; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Priyakumar UD, 2006, CHEM REV, V106, P489, DOI 10.1021/cr040475z; Priyakumar UD, 2006, J AM CHEM SOC, V128, P678, DOI 10.1021/ja056445a; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; Roux B, 2011, J GEN PHYSIOL, V137, P415, DOI 10.1085/jgp.201010577; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Shaikh SA, 2013, BIOCHEMISTRY-US, V52, P569, DOI 10.1021/bi301086x; Shaikh SA, 2010, J COMPUT THEOR NANOS, V7, P2481, DOI 10.1166/jctn.2010.1636; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Strebel K, 2014, BBA-BIOMEMBRANES, V1838, P1074, DOI 10.1016/j.bbamem.2013.06.029; Tokarev Andrey, 2011, Cell Logist, V1, P90; Wang K, 2011, BBA-BIOMEMBRANES, V1808, P510, DOI 10.1016/j.bbamem.2010.05.006; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; WRAY V, 1995, INT J PEPT PROT RES, V45, P35; Wray V, 1999, BIOCHEMISTRY-US, V38, P5272, DOI 10.1021/bi982755c; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107	66	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112983	10.1371/journal.pone.0112983	http://dx.doi.org/10.1371/journal.pone.0112983			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392993	gold, Green Submitted, Green Published			2022-12-26	WOS:000347709300131
J	Wei, FH; Zhang, YY; Zhao, WM; Yu, XP; Liu, CJ				Wei, Fanhua; Zhang, Yuying; Zhao, Weiming; Yu, Xiuping; Liu, Chuan-ju			Progranulin Facilitates Conversion and Function of Regulatory T Cells under Inflammatory Conditions	PLOS ONE			English	Article							GROWTH-FACTOR PROGRANULIN; GRANULIN-EPITHELIN PRECURSOR; INTRAVENOUS IMMUNOGLOBULIN; TNF-ALPHA; RHEUMATOID-ARTHRITIS; HOST-DEFENSE; AUTOIMMUNE; PROLIFERATION; DEFICIENCY; MECHANISMS	The progranulin (PGRN) is known to protect regulatory T cells (Tregs) from a negative regulation by TNF-alpha, and its levels are elevated in various kinds of autoimmune diseases. Whether PGRN directly regulates the conversion of CD4+CD25-T cells into Foxp3-expressing regulatory T cells (iTreg), and whether PGRN affects the immunosuppressive function of Tregs, however, remain unknown. In this study we provide evidences demonstrating that PGRN is able to stimulate the conversion of CD4+CD25-T cells into iTreg in a dose-dependent manner in vitro. In addition, PGRN showed synergistic effects with TGF-beta 1 on the induction of iTreg. PGRN was required for the immunosuppressive function of Tregs, since PGRN-deficient Tregs have a significant decreased ability to suppress the proliferation of effector T cells (Teff). In addition, PGRN deficiency caused a marked reduction in Tregs number in the course of inflammatory arthritis, although no significant difference was observed in the numbers of Tregs between wild type and PGRN deficient mice during development. Furthermore, PGRN deficiency led to significant upregulation of the Wnt receptor gene Fzd2. Collectively, this study reveals that PGRN directly regulates the numbers and function of Tregs under inflammatory conditions, and provides new insight into the immune regulatory mechanism of PGRN in the pathogenesis of inflammatory and immune-related diseases.	[Wei, Fanhua; Zhang, Yuying; Liu, Chuan-ju] NYU, Med Ctr, Dept Orthopaed Surg, New York, NY 10016 USA; [Wei, Fanhua; Zhao, Weiming; Yu, Xiuping] Shandong Univ, Sch Med, Inst Pathogen Biol, Jinan 250100, Peoples R China; [Liu, Chuan-ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	New York University; Shandong University; New York University	Liu, CJ (corresponding author), NYU, Med Ctr, Dept Orthopaed Surg, New York, NY 10016 USA.	chuanju.liu@nyumc.org	Liu, Chuan-ju/AAT-8165-2021	liu, chuanju/0000-0002-7181-8032; Wei, Fanhua/0000-0002-2997-922X	NIH [R01AR062207, R01AR061484, R56AI100901]; Disease Targeted Research Grant from Rheumatology Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI100901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061484, R01AR062207] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Disease Targeted Research Grant from Rheumatology Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported partly by NIH research grants R01AR062207, R01AR061484, R56AI100901, and a Disease Targeted Research Grant from Rheumatology Research Foundation. The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAKWE OO, 1990, BIOL REPROD, V42, P317, DOI 10.1095/biolreprod42.2.317; Bayry J, 2007, DRUG DISCOV TODAY, V12, P548, DOI 10.1016/j.drudis.2007.05.002; Bayry J, 2012, J RHEUMATOL, V39, P450, DOI 10.3899/jrheum.111123; Bluestone JA, 2008, NAT MED, V14, P118, DOI 10.1038/nm0208-118; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; De Riz M, 2010, NEUROSCI LETT, V469, P234, DOI 10.1016/j.neulet.2009.12.002; Ding Y, 2008, NAT MED, V14, P162, DOI 10.1038/nm1707; Dons EM, 2012, HUM IMMUNOL, V73, P328, DOI 10.1016/j.humimm.2011.12.011; Egashira Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-105; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Ephrem A, 2008, BLOOD, V111, P715, DOI 10.1182/blood-2007-03-079947; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Guo ZL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/540794; He ZH, 2002, CANCER RES, V62, P5590; Hu Y, 2014, IMMUNOLOGY, V142, P193, DOI 10.1111/imm.12241; Jian JL, 2013, FEBS LETT, V587, P3428, DOI 10.1016/j.febslet.2013.09.024; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Kawase R, 2013, CARDIOVASC RES, V100, P125, DOI 10.1093/cvr/cvt178; Kessel A, 2007, J IMMUNOL, V179, P5571, DOI 10.4049/jimmunol.179.8.5571; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Lan Q, 2012, J MOL CELL BIOL, V4, P22, DOI 10.1093/jmcb/mjr039; Li ML, 2014, CELL SIGNAL, V26, P1539, DOI 10.1016/j.cellsig.2014.03.026; Maddur MS, 2010, J CLIN IMMUNOL, V30, pS4, DOI 10.1007/s10875-010-9394-5; Miller ZA, 2013, J NEUROL NEUROSUR PS, V84, P956, DOI 10.1136/jnnp-2012-304644; Miyara M, 2014, NAT REV RHEUMATOL; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Ong CHP, 2003, HISTOL HISTOPATHOL, V18, P1275, DOI 10.14670/HH-18.1275; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Qiu F, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-88; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Schmitt EG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00152; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Takahashi T, 2003, INT REV CYTOL, V225, P1, DOI 10.1016/S0074-7696(05)25001-5; Takahashi T, 2003, CURR MOL MED, V3, P693, DOI 10.2174/1566524033479429; Tanaka A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4087; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Thurner L, 2014, DIGESTIVE DIS SCI; Thurner L, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4406; Thurner L, 2013, J AUTOIMMUN, V42, P29, DOI 10.1016/j.jaut.2012.10.003; Tian QY, 2014, FRONT BIOSCI-LANDMRK, V19, P1176, DOI 10.2741/4274; Trinath J, 2013, BLOOD, V122, P1419, DOI 10.1182/blood-2012-11-468264; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; Vezina A, 2014, CANCER LETT, V345, P100, DOI 10.1016/j.canlet.2013.11.021; Wexler EM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002282; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Xu L, 2010, MUCOSAL IMMUNOL, V3, P230, DOI 10.1038/mi.2010.7; Yamamoto Y, 2014, INCREASED SERUM GP88; Yamano Y, 2005, J CLIN INVEST, V115, P1361, DOI [10.1172/JCI200523913, 10.1172/JCI23913]; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068; Zhao YP, 2013, FEBS LETT, V587, P1805, DOI 10.1016/j.febslet.2013.04.037; Zhou XH, 2011, AUTOIMMUNITY, V44, P43, DOI 10.3109/08916931003782163; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	57	33	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112110	10.1371/journal.pone.0112110	http://dx.doi.org/10.1371/journal.pone.0112110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393765	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300032
J	Xie, P; Hu, ZZ; Zhang, XJ; Li, XH; Gao, ZS; Yuan, DQ; Liu, QH				Xie, Ping; Hu, Zizhong; Zhang, Xiaojun; Li, Xinhua; Gao, Zhishan; Yuan, Dongqing; Liu, Qinghuai			Application of 3-Dimensional Printing Technology to Construct an Eye Model for Fundus Viewing Study	PLOS ONE			English	Article							CONTACT-LENS; OPTICAL-PERFORMANCE; SYSTEM; ABERRATIONS	Objective: To construct a life-sized eye model using the three-dimensional (3D) printing technology for fundus viewing study of the viewing system. Methods: We devised our schematic model eye based on Navarro's eye and redesigned some parameters because of the change of the corneal material and the implantation of intraocular lenses (IOLs). Optical performance of our schematic model eye was compared with Navarro's schematic eye and other two reported physical model eyes using the ZEMAX optical design software. With computer aided design (CAD) software, we designed the 3D digital model of the main structure of the physical model eye, which was used for three-dimensional (3D) printing. Together with the main printed structure, polymethyl methacrylate(PMMA) aspherical cornea, variable iris, and IOLs were assembled to a physical eye model. Angle scale bars were glued from posterior to periphery of the retina. Then we fabricated other three physical models with different states of ammetropia. Optical parameters of these physical eye models were measured to verify the 3D printing accuracy. Results: In on-axis calculations, our schematic model eye possessed similar size of spot diagram compared with Navarro's and Bakaraju's model eye, much smaller than Arianpour's model eye. Moreover, the spherical aberration of our schematic eye was much less than other three model eyes. While in off-axis simulation, it possessed a bit higher coma and similar astigmatism, field curvature and distortion. The MTF curves showed that all the model eyes diminished in resolution with increasing field of view, and the diminished tendency of resolution of our physical eye model was similar to the Navarro's eye. The measured parameters of our eye models with different status of ametropia were in line with the theoretical value. Conclusions: The schematic eye model we designed can well simulate the optical performance of the human eye, and the fabricated physical one can be used as a tool in fundus range viewing research.	[Xie, Ping; Hu, Zizhong; Yuan, Dongqing; Liu, Qinghuai] Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Xiaojun] Nanjing Med Univ, Affiliated Hosp 2, Dept Ophthalmol, Nanjing 210000, Jiangsu, Peoples R China; [Li, Xinhua; Gao, Zhishan] Nanjing Univ Sci & Technol, Sch Opt Engn, Nanjing 210094, Jiangsu, Peoples R China; [Li, Xinhua] Jinling Inst Technol, Ophthalm Technol Coll, Nanjing 210001, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University of Science & Technology; Jinling Institute of Technology	Liu, QH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanjing 210029, Jiangsu, Peoples R China.	liuqh@njmu.edu.cn	zhang, jin/GXV-9154-2022	Liu, Qinghuai/0000-0003-1605-1964; Xie, Ping/0000-0003-4257-8970; hu, zizhong/0000-0001-6289-1804	National Basic Research Program of China (973 Program) [2011CB510200, 2013CB967500]; National Natural Science Foundation of China [81170855, 60977008]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Basic Research Program of China (973 Program): No. 2011CB510200 (http://www.973.gov.cn/English/Index.aspx) to Qinghuai Liu; National Basic Research Program of China (973 Program): No. 2013CB967500 (http://www.973.gov.cn/English/Index.aspx) to Qinghuai Liu; National Natural Science Foundation of China: No. 81170855 (http://www.nsfc.gov.cn) to Qinghuai Liu; National Natural Science Foundation of China: No. 60977008 (http://www.nsfc.gov.cn) to Zhishan Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann R, 2013, BIOMED OPT EXPRESS, V4, P220, DOI 10.1364/BOE.4.000220; Arianpour A, 2013, J REFRACT SURG, V29, P126, DOI 10.3928/1081597X-20130117-08; Bakaraju RC, 2010, OPT EXPRESS, V18, P16868, DOI 10.1364/OE.18.016868; Chalam KV, 2004, SURV OPHTHALMOL, V49, P437, DOI 10.1016/j.survophthal.2004.04.010; Choi J, 2008, J REFRACT SURG, V24, P218, DOI 10.3928/1081597X-20080301-02; Eppig T, 2008, OPHTHAL PHYSL OPT, V28, P467, DOI 10.1111/j.1475-1313.2008.00582.x; Escudero-Sanz I, 1999, J OPT SOC AM A, V16, P1881, DOI 10.1364/JOSAA.16.001881; Gobbi PG, 2006, J CATARACT REFR SURG, V32, P643, DOI 10.1016/j.jcrs.2006.01.026; Gullstrand A., 1909, PHYSIOLOGISCHE OPTIK, V1, P350; Hitani K, 2011, OPHTHAL SURG LAS IM, V42, P523, DOI 10.3928/15428877-20111017-02; Holladay JT, 2002, J REFRACT SURG, V18, P683; Huang TQ, 2014, BIOMED MICRODEVICES, V16, P127, DOI 10.1007/s10544-013-9812-6; Hull CW, 1986, US Patent, Patent No. [4575330A, 4575330, 4,575,330]; Inoue M, 2013, AM J OPHTHALMOL, V155, P243, DOI 10.1016/j.ajo.2012.07.017; Inoue M, 2011, AM J OPHTHALMOL, V151, P644, DOI 10.1016/j.ajo.2010.09.029; International Organization for Standardization, 119792 ISO; Kamei M, 2012, CLIN OPHTHALMOL, V6, P1321, DOI [10.2147/Opth.S33595, 10.2147/OPTH.S33595]; Kasparova M, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-49; Kiyokawa Masatoshi, 2009, International Ophthalmology, V29, P169, DOI 10.1007/s10792-007-9181-3; KOOIJMAN AC, 1983, J OPT SOC AM, V73, P1544, DOI 10.1364/JOSA.73.001544; Mashiko T, 2013, WORLD NEURO IN PRESS; Murthy RK, 2010, RETINA-J RET VIT DIS, V30, P1551, DOI 10.1097/IAE.0b013e3181f442f7; NAVARRO R, 1985, J OPT SOC AM A, V2, P1273, DOI 10.1364/JOSAA.2.001273; Norrby S, 2007, APPL OPTICS, V46, P6597, DOI 10.1364/AO.46.006597; Ohji M, 2011, RETINA-J RET VIT DIS, V31, P1958, DOI 10.1097/IAE.0b013e31822a900b; Ohtsuki M, 2012, RETINA-J RET VIT DIS, V32, P1983, DOI 10.1097/IAE.0b013e31826711be; RETZLAFF JA, 1990, J CATARACT REFR SURG, V16, P333, DOI 10.1016/S0886-3350(13)80705-5; Xue Shi-hua, 2013, Beijing Da Xue Xue Bao Yi Xue Ban, V45, P105; Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004	29	20	24	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e109373	10.1371/journal.pone.0109373	http://dx.doi.org/10.1371/journal.pone.0109373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393277	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300003
J	Chen, SC; Su, YC; Lu, YT; Ko, PCI; Chang, PY; Lin, HJ; Ho, HN; Lai, YP				Chen, Shu-Ching; Su, Yu-Chia; Lu, Ya-Ting; Ko, Patrick Chow-In; Chang, Pei-Yu; Lin, Hung-Ju; Ho, Hong-Nerng; Lai, Yo-Ping			Defects in the Acquisition of Tumor-Killing Capability of CD8(+) Cytotoxic T Cells in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							CYTOLYTIC ACTIVITY; COLORECTAL-CANCER; IMMUNE-RESPONSE; B-CELL; LYMPHOCYTES; MELLITUS; ACTIVATION; CTL; DIFFERENTIATION; IMMUNOTHERAPY	Emerging evidences have shown that diabetes mellitus not only raises risk but also heightens mortality rate of cancer. It is not clear, however, whether antitumor CD8(+) cytotoxic T lymphocyte (CTL) response is down-modulated in diabetic hosts. We investigated the impact of hyperglycemia on CTLs' acquisition of tumor-killing capability by utilizing streptozotocin-induced diabetic (STZ-diabetic) mice. Murine diabetes was induced by intraperitoneal injection of STZ (200 mg/kg) in C57BL/6 mice, 2C-T cell receptor (TCR) transgenic and P14-TCR transgenic mice. The study found that, despite harboring intact proliferative capacity measured with CFSE labeling and MTT assay, STZ-diabetic CD8(+) CTLs displayed impaired effector functions. After stimulation, STZ-diabetic CD8(+) CTLs produced less perforin and TNF alpha assessed by intracellular staining, as well as expressed less CD103 protein. Furthermore, adoptive transfer of STZ-diabetic P14 CD8(+) effector cells showed an insufficient recruitment to the B16.gp33 melanoma and inadequate production of perforin, granzyme B and TNF alpha determined by immunohistochemistry in the tumor milieu. As a result, STZ-diabetic CD8(+) effector cells were neither able to eliminate tumor nor to improve survival of tumor-bearing mice. Taken together, our data suggest that CD8(+) CTLs are crippled to infiltrate into tumors and thus fail to acquire tumor-killing capability in STZ-diabetic hosts.	[Chen, Shu-Ching; Chang, Pei-Yu] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Su, Yu-Chia] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan; [Lu, Ya-Ting; Lin, Hung-Ju; Lai, Yo-Ping] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Ko, Patrick Chow-In] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Ho, Hong-Nerng] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Applied Research Laboratories - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lai, YP (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	yopinglai@ntu.edu.tw	NTU, Ref07/AAX-7890-2021	Chen, Shu-Ching/0000-0001-9112-1526	National Science Council (NSC) [99-2314-B-002-081-MY3]; National Taiwan University Hospital (NTUH) [98P22]; Liver Disease Prevention and Treatment Research Foundation	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital (NTUH); Liver Disease Prevention and Treatment Research Foundation	The study was supported by grants from National Science Council (NSC 99-2314-B-002-081-MY3), National Taiwan University Hospital (NTUH. 98P22) and Liver Disease Prevention and Treatment Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; BENTAL M, 1993, MAGN RESON MED, V29, P317, DOI 10.1002/mrm.1910290307; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067420; Connolly GC, 2012, CANCER INVEST, V30, P698, DOI 10.3109/07357907.2012.732162; DELESPESSE G, 1974, CLIN EXP IMMUNOL, V18, P461; DEMARIA R, 1994, EUR J IMMUNOL, V24, P999; DIEPERSLOOT RJA, 1987, DIABETOLOGIA, V30, P397, DOI 10.1007/BF00292541; Eibl N, 2002, CLIN IMMUNOL, V103, P249, DOI 10.1006/clim.2002.5220; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Franciszkiewicz K, 2013, CANCER RES, V73, P617, DOI 10.1158/0008-5472.CAN-12-2569; Franciszkiewicz K, 2009, CANCER RES, V69, P6249, DOI 10.1158/0008-5472.CAN-08-3571; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Ganss R, 2002, CANCER RES, V62, P1462; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; JANEWAY CA, 1987, J IMMUNOL, V138, P1051; Johansson A, 2012, ONCOIMMUNOLOGY, V1, P1395, DOI 10.4161/onci.20981; Johansson A, 2012, P NATL ACAD SCI USA, V109, P7841, DOI 10.1073/pnas.1118296109; JUNOD A, 1969, J CLIN INVEST, V48, P2129, DOI 10.1172/JCI106180; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; KAKIUCHI T, 1983, J IMMUNOL, V131, P109; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; LAVECCHIA C, 1991, EUR J CANCER, V27, P582, DOI 10.1016/0277-5379(91)90223-Z; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Lyman MA, 2004, J IMMUNOL, V172, P6558, DOI 10.4049/jimmunol.172.11.6558; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; MAHMOUD AAF, 1976, J CLIN INVEST, V57, P362, DOI 10.1172/JCI108287; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Milstein O, 2011, BLOOD, V117, P1042, DOI 10.1182/blood-2010-05-283770; Naito Y, 1998, CANCER RES, V58, P3491; Prevost-Blondel A, 1998, J IMMUNOL, V161, P2187; RAKIETEN N, 1963, CANCER CHEMOTH REP, P91; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Stentz FB, 2003, CURR DRUG TARGETS, V4, P493, DOI 10.2174/1389450033490966; WILLIAMS JC, 1984, CANCER, V54, P3070, DOI 10.1002/1097-0142(19841215)54:12<3070::AID-CNCR2820541243>3.0.CO;2-N	39	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e109961	10.1371/journal.pone.0109961	http://dx.doi.org/10.1371/journal.pone.0109961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390652	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400008
J	Costa, A; Hortal, E; Ianez, E; Azorin, JM				Costa, Alvaro; Hortal, Enrique; Ianez, Eduardo; Azorin, Jose M.			A Supplementary System for a Brain-Machine Interface Based on Jaw Artifacts for the Bidimensional Control of a Robotic Arm	PLOS ONE			English	Article							COMPUTER-INTERFACE; POTENTIALS; BCI	Non-invasive Brain-Machine Interfaces (BMIs) are being used more and more these days to design systems focused on helping people with motor disabilities. Spontaneous BMIs translate user's brain signals into commands to control devices. On these systems, by and large, 2 different mental tasks can be detected with enough accuracy. However, a large training time is required and the system needs to be adjusted on each session. This paper presents a supplementary system that employs BMI sensors, allowing the use of 2 systems (the BMI system and the supplementary system) with the same data acquisition device. This supplementary system is designed to control a robotic arm in two dimensions using electromyographical (EMG) signals extracted from the electroencephalographical (EEG) recordings. These signals are voluntarily produced by users clenching their jaws. EEG signals (with EMG contributions) were registered and analyzed to obtain the electrodes and the range of frequencies which provide the best classification results for 5 different clenching tasks. A training stage, based on the 2-dimensional control of a cursor, was designed and used by the volunteers to get used to this control. Afterwards, the control was extrapolated to a robotic arm in a 2-dimensional workspace. Although the training performed by volunteers requires 70 minutes, the final results suggest that in a shorter period of time (45 min), users should be able to control the robotic arm in 2 dimensions with their jaws. The designed system is compared with a similar 2-dimensional system based on spontaneous BMIs, and our system shows faster and more accurate performance. This is due to the nature of the control signals. Brain potentials are much more difficult to control than the electromyographical signals produced by jaw clenches. Additionally, the presented system also shows an improvement in the results compared with an electrooculographic system in a similar environment.	[Costa, Alvaro; Hortal, Enrique; Ianez, Eduardo; Azorin, Jose M.] Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Elche, Spain		Costa, A (corresponding author), Miguel Hernandez Univ, Brain Machine Interface Syst Lab, Elche, Spain.	acosta@umh.es	Azorin, Jose M/G-2157-2011; Iáñez, Eduardo/J-9765-2014; Hortal, Enrique/R-9176-2018; Azorin, Jose M./M-8956-2019	Azorin, Jose M/0000-0001-5548-9657; Iáñez, Eduardo/0000-0001-8057-5952; Hortal, Enrique/0000-0003-2119-4169; Azorin, Jose M./0000-0001-5548-9657	Commission of the European Union [IFP7-ICT- 2013-10-611695]	Commission of the European Union(European Commission)	This research has been funded by the Commission of the European Union under the BioMot project - Smart Wearable Robots with Bioinspired Sensory-Motor Skills (Grant Agreement number IFP7-ICT- 2013-10-611695). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi LZ, 2014, IEEE T INTELL TRANSP, V15, P959, DOI 10.1109/TITS.2013.2291402; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Daly I, 2013, IEEE T NEUR SYS REH, V21, P427, DOI 10.1109/TNSRE.2013.2254724; Dasey TJ, 2000, IEEE T INF TECHNOL B, V4, P216, DOI 10.1109/4233.870032; Duvinage M, 2012, IEEE ENG MED BIO, P3845, DOI 10.1109/EMBC.2012.6346806; Fatourechi M, 2007, CLIN NEUROPHYSIOL, V118, P480, DOI 10.1016/j.clinph.2006.10.019; Frisoli A, 2012, IEEE T SYST MAN CY C, V42, P1169, DOI 10.1109/TSMCC.2012.2226444; Fujita T, 2011, RES AUTISM SPECT DIS, V5, P277, DOI 10.1016/j.rasd.2010.04.009; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Hamadicharef Brahim, 2010, 2010 10th International Conference on Information Sciences, Signal Processing and their Applications (ISSPA 2010), P626, DOI 10.1109/ISSPA.2010.5605421; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Hortal E, 2014, COMPUTER METHODS PRO; Huang DD, 2012, IEEE T NEUR SYS REH, V20, P379, DOI 10.1109/TNSRE.2012.2190299; Ianez Eduardo, 2013, Natural and Artificial Models in Computation and Biology. 5th International Work-Conference on the Interplay Between Natural and Artificial Computation, IWINAC 2013. Proceedings, Part I: LNCS 7930, P151, DOI 10.1007/978-3-642-38637-4_16; Marshall D, 2013, IEEE T COMP INTEL AI, V5, P82, DOI 10.1109/TCIAIG.2013.2263555; Nakamae T, 2010, EUR SPINE J, V19, P685, DOI 10.1007/s00586-009-1246-8; Postelnicu CC, 2013, IEEE T BIO-MED ENG, V60, P534, DOI 10.1109/TBME.2012.2228645; Roy RN, 2013, IEEE ENG MED BIO, P6607, DOI 10.1109/EMBC.2013.6611070; Ruth R, 1991, OTOLARYNGOLOGIC CLIN, V24; Savelainen A., 2010, INDEPENDENT RES PROJ; Blasco JLS, 2012, EXPERT SYST APPL, V39, P7908, DOI 10.1016/j.eswa.2012.01.110; SOKOL S, 1976, Survey of Ophthalmology, V21, P18, DOI 10.1016/0039-6257(76)90046-1; Takahashi K, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATIONS, VOLS 1-4, CONFERENCE PROCEEDINGS, P999; Trejo LJ, 2006, IEEE T NEUR SYS REH, V14, P225, DOI 10.1109/TNSRE.2006.875578; Ubeda A, 2011, IEEE-ASME T MECH, V16, P870, DOI 10.1109/TMECH.2011.2160354; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Volosyak I, 2010, IEEE ENG MED BIO, P4201, DOI 10.1109/IEMBS.2010.5627390; YONG XY, 2008, COMM CONTR SIGN PROC, P729, DOI DOI 10.1109/ISCCSP.2008.4537319	28	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112352	10.1371/journal.pone.0112352	http://dx.doi.org/10.1371/journal.pone.0112352			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390372	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400073
J	Feyissa, TR; Melka, AS				Feyissa, Tesfaye Regassa; Melka, Alemu Sufa			Demand for Modern Family Planning among Married Women Living with HIV in Western Ethiopia	PLOS ONE			English	Article							UNMET NEED; INFECTION	Introduction: People living with HIV (PLHIV) have diverse family planning (FP) needs. Little is reported on FP needs among women living with HIV in Ethiopia. Thus, the objective of the study was to assess the demand for modern FP among married women living with HIV in western Ethiopia. Methods: A facility-based cross-sectional survey was conducted on 401 married women living with HIV selected from Nekemte Referral Hospital and Health Center, Nekemte, Oromia, Ethiopia. Convenience sampling of every other eligible patient was used to recruit respondents. Data were collected using a pretested, structured questionnaire. We first calculated frequency and percentage of unmet need, met need and total demand by each explanatory variable, and performed chi-squared testing to assess for differences in groups. We then fitted logistic regression models to identify correlates of unmet need for modern FP at 95% CL. Results: The proportion of respondents with met need for modern FP among married women living with HIV was 61.6% (30.7% for spacing and 30.9% for limiting). Demand for family planning was reported in 77.0% (38.2% for spacing and 38.8% for limiting), making unmet need for modern FP prevalent in 15.4% (7.5% for spacing and 7.9% for limiting). Whereas age 25-34 years [adjusted odds ratio (AOR) (95% confidence interval (CI)) = .397 (.204-.771)] was protective against unmet need for modern FP, not having knowledge of MTCT [AOR (95% CI) = 2.531 (1.689-9.290)] and not discussing FP with a partner [AOR (95% CI) = 3.616(1.869-6.996)] were associated with increased odds of unmet need for modern FP. Conclusions: There is high unmet need for modern FP in HIV-positive married women in western Ethiopia. Health care providers and program managers at a local and international level should work to satisfy the unmet need for modern family planning.	[Feyissa, Tesfaye Regassa; Melka, Alemu Sufa] Wollega Univ, Coll Med & Hlth Sci, Nekemte, Oromia, Ethiopia	University of Gondar	Feyissa, TR (corresponding author), Wollega Univ, Coll Med & Hlth Sci, Nekemte, Oromia, Ethiopia.	regassatesfaye@gmail.com	Feyissa, Tesfaye R/K-1003-2017	Feyissa, Tesfaye Regassa/0000-0002-6883-7312	Wollega University	Wollega University	This study was supported by Wollega University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2012, SCI TECHNOLOGY ARTS, V1, P38; Adir T, 2007, DESIRE CHILDREN UNME; Agboghoroma Chris O, 2011, Afr J Reprod Health, V15, P15; Akelo V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066593; Ali AAA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-102; Baroncelli S, 2011, AIDS PATIENT CARE ST, V25, P639, DOI 10.1089/apc.2011.0172; Bizuneh G, 2008, UNMET NEED EVALUATIO, P9; Bradley SEK, 2012, REVISING UNMET NEED, P3; Cooper D, 2009, AIDS BEHAV, V13, pS38, DOI 10.1007/s10461-009-9550-1; Delvaux T, 2007, REPROD HEALTH MATTER, V15, P46, DOI 10.1016/S0968-8080(07)29031-7; FHAPCO, 2011, HIV AIDS EST PROJ ET, P1; Finocchario-Kessler S, 2010, AIDS PATIENT CARE ST, V24, P317, DOI 10.1089/apc.2009.0293; Halperin DT, 2009, AIDS, V23, pS123, DOI 10.1097/01.aids.0000363785.73450.5a; Hladik W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007691; Jhangri GS, 2012, J FAM PLAN REPROD H, V38, P23, DOI 10.1136/jfprhc-2011-0108; Mccoy SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105320; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; MOH, 2011, GUID PREV MOTH CHILD, P3; MOH, 2007, GUID PREV MOTH TO CH; Oliveras E, 2013, ADDRESSING UNMET NEE, P6; Yeatman S, 2009, STUD FAMILY PLANN, V40, P261, DOI 10.1111/j.1728-4465.2009.00210.x; Yeatman SE, 2009, AIDS BEHAV, V13, pS12, DOI 10.1007/s10461-009-9534-1	22	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e113008	10.1371/journal.pone.0113008	http://dx.doi.org/10.1371/journal.pone.0113008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390620	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400146
J	Mastrogiacomo, R; D'Ambrosio, C; Niccolini, A; Serra, A; Gazzano, A; Scaloni, A; Pelosi, P				Mastrogiacomo, Rosa; D'Ambrosio, Chiara; Niccolini, Alberto; Serra, Andrea; Gazzano, Angelo; Scaloni, Andrea; Pelosi, Paolo			An Odorant-Binding Protein Is Abundantly Expressed in the Nose and in the Seminal Fluid of the Rabbit	PLOS ONE			English	Article							MAJOR URINARY PROTEIN; BOAR SALIVARY LIPOCALIN; LIGAND-BINDING; NASAL-MUCOSA; POSTTRANSLATIONAL MODIFICATIONS; DIFFERENTIAL EXPRESSION; PERIRECEPTOR EVENTS; OLFACTORY RECEPTOR; PHEROMONE BINDING; MASS-SPECTROMETRY	We have purified an abundant lipocalin from the seminal fluid of the rabbit, which shows significant similarity with the subclass of pheromone carriers "urinary" and "salivary" and presents an N-terminal sequence identical with that of an odorant-binding protein (rabOBP3) expressed in the nasal tissue of the same species. This protein is synthesised in the prostate and found in the seminal fluid, but not in sperm cells. The same protein is also expressed in the nasal epithelium of both sexes, but is completely absent in female reproductive organs. It presents four cysteines, among which two are arranged to form a disulphide bridge, and is glycosylated. This is the first report of an OBP identified at the protein level in the seminal fluid of a vertebrate species. The protein purified from seminal fluid is bound to some organic chemicals whose structure is currently under investigation. We reasonably speculate that, like urinary and salivary proteins reported in other species of mammals, this lipocalin performs a dual role, as carrier of semiochemicals in the seminal fluid and as detector of chemical signals in the nose.	[Mastrogiacomo, Rosa; Serra, Andrea; Pelosi, Paolo] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [D'Ambrosio, Chiara; Scaloni, Andrea] CNR, ISPAAM, Prote & Mass Spectrometry Lab, I-80125 Naples, Italy; [Niccolini, Alberto; Gazzano, Angelo] Univ Pisa, Dept Vet Sci, Pisa, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Sistema Produzione Animale In Ambiente Mediterraneo (ISPAAM-CNR); University of Pisa	Scaloni, A (corresponding author), CNR, ISPAAM, Prote & Mass Spectrometry Lab, I-80125 Naples, Italy.	andrea.scaloni@ispaam.cnr.it; ppelosi@agr.unipi.it	Gazzano, Angelo/AAH-1640-2020; Rocco, Patricia/I-7460-2012; D'Ambrosio, Chiara/C-2753-2012; Serra, Andrea/AFO-7144-2022	Gazzano, Angelo/0000-0001-9649-2027; Rocco, Patricia/0000-0003-1412-7136; D'Ambrosio, Chiara/0000-0003-2810-9270; Serra, Andrea/0000-0001-7728-3430; Scaloni, Andrea/0000-0001-9362-8515; NICCOLINI MARMONT DU HAUT CHAMP, CARLO ALBERTO/0000-0003-4726-9747				AVANZINI F, 1987, CELL TISSUE RES, V247, P461, DOI 10.1007/BF00218329; BACCHINI A, 1992, EXPERIENTIA, V48, P419, DOI 10.1007/BF01923448; BIGNETTI E, 1985, EUR J BIOCHEM, V149, P227, DOI 10.1111/j.1432-1033.1985.tb08916.x; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Briand L, 2002, BIOCHEMISTRY-US, V41, P7241, DOI 10.1021/bi015916c; CAVAGGIONI A, 1990, COMP BIOCHEM PHYS B, V96, P513, DOI 10.1016/0305-0491(90)90049-Y; CAVAGGIONI A, 1987, FEBS LETT, V212, P225, DOI 10.1016/0014-5793(87)81349-2; Charra R, 2012, BEHAV BRAIN RES, V226, P179, DOI 10.1016/j.bbr.2011.09.008; D'Innocenzo B, 2006, BIOCHEMISTRY-US, V45, P13418, DOI 10.1021/bi061409p; Dal Monte M, 1993, CHEM SENSES, V18, P713; Dal Monte M, 1991, COMP BIOCHEM PHYS B, V99, P445, DOI 10.1016/0305-0491(91)90068-O; DINH BAO-LMH, 1965, J IMMUNOL, V95, P574; FINLAYSON JS, 1965, SCIENCE, V149, P981, DOI 10.1126/science.149.3687.981; Flower DR, 1996, BIOCHEM J, V318, P1; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P46, DOI 10.1016/S0167-4838(00)00147-3; Ganni M, 1997, COMP BIOCHEM PHYS B, V117, P287, DOI 10.1016/S0305-0491(97)00089-8; Garibotti M, 1997, CHEM SENSES, V22, P383, DOI 10.1093/chemse/22.4.383; Herent MF, 1995, CHEM SENSES, V20, P601, DOI 10.1093/chemse/20.6.601; Hilger C, 2012, CURR ALLERGY ASTHM R, V12, P438, DOI 10.1007/s11882-012-0283-2; Hilvo M, 2008, J BIOL CHEM, V283, P27799, DOI 10.1074/jbc.M800938200; Hurst JL, 2001, NATURE, V414, P631, DOI 10.1038/414631a; Lacazette E, 2000, HUM MOL GENET, V9, P289, DOI 10.1093/hmg/9.2.289; Lobel D, 1998, EUR J BIOCHEM, V254, P318, DOI 10.1046/j.1432-1327.1998.2540318.x; Loebel D, 2000, BIOCHEM J, V350, P369, DOI 10.1042/0264-6021:3500369; Marchese S, 1998, EUR J BIOCHEM, V252, P563, DOI 10.1046/j.1432-1327.1998.2520563.x; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Mechref Y, 2000, GLYCOBIOLOGY, V10, P231, DOI 10.1093/glycob/10.3.231; Millery J, 2005, EUR J NEUROSCI, V22, P1389, DOI 10.1111/j.1460-9568.2005.04337.x; MIYAWAKI A, 1994, EMBO J, V13, P5835, DOI 10.1002/j.1460-2075.1994.tb06927.x; MONACO HL, 1995, SCIENCE, V268, P1039, DOI 10.1126/science.7754382; Ohno K, 1996, NEUROSCIENCE, V71, P355, DOI 10.1016/0306-4522(95)00454-8; Paolini S, 1998, CHEM SENSES, V23, P689, DOI 10.1093/chemse/23.6.689; PELOSI P, 1982, BIOCHEM J, V201, P245, DOI 10.1042/bj2010245; Pelosi P, 2001, CELL MOL LIFE SCI, V58, P503, DOI 10.1007/PL00000875; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Pelosi P, 1996, J NEUROBIOL, V30, P3; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; Pelosi P, 1998, ANN NY ACAD SCI, V855, P281, DOI 10.1111/j.1749-6632.1998.tb10584.x; PELOSI P, 1981, CHEM SENSES, V6, P77, DOI 10.1093/chemse/6.2.77; Perez-Miller S, 2010, PROTEIN SCI, V19, P1469, DOI 10.1002/pro.426; PES D, 1995, COMP BIOCHEM PHYS B, V112, P471, DOI 10.1016/0305-0491(95)00063-1; Pes D, 1998, GENE, V212, P49, DOI 10.1016/S0378-1119(98)00131-0; PEVSNER J, 1990, J BIOL CHEM, V265, P6118; PEVSNER J, 1985, P NATL ACAD SCI USA, V82, P3050, DOI 10.1073/pnas.82.9.3050; PEVSNER J, 1988, P NATL ACAD SCI USA, V85, P2383, DOI 10.1073/pnas.85.7.2383; Picariello G, 2008, PROTEOMICS, V8, P3833, DOI 10.1002/pmic.200701057; ROBERTSON DHL, 1993, J CHEM ECOL, V19, P1405, DOI 10.1007/BF00984885; Rouvinen J, 1999, J BIOL CHEM, V274, P2337, DOI 10.1074/jbc.274.4.2337; Salzano AM, 2013, J PROTEOMICS, V94, P240, DOI 10.1016/j.jprot.2013.09.007; Sawyer L, 2000, BBA-PROTEIN STRUCT M, V1482, P136, DOI 10.1016/S0167-4838(00)00160-6; Scaloni A, 1999, BIOCHEM BIOPH RES CO, V266, P386, DOI 10.1006/bbrc.1999.1791; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; SINGER AG, 1986, J BIOL CHEM, V261, P3323; Spinelli S, 2002, EUR J BIOCHEM, V269, P2449, DOI 10.1046/j.1432-1033.2002.02901.x; Spinelli S, 1998, BIOCHEMISTRY-US, V37, P7913, DOI 10.1021/bi980179e; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Sun YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032759; Swarup S, 2011, GENES BRAIN BEHAV, V10, P648, DOI 10.1111/j.1601-183X.2011.00704.x; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; Tegoni M, 1996, NAT STRUCT BIOL, V3, P863, DOI 10.1038/nsb1096-863; Vincent F, 2004, EUR J BIOCHEM, V271, P3832, DOI 10.1111/j.1432-1033.2004.04315.x; Vincent F, 2001, J MOL BIOL, V305, P459, DOI 10.1006/jmbi.2000.4241; Vincent F, 2000, J MOL BIOL, V300, P127, DOI 10.1006/jmbi.2000.3820; Virtanen T, 2012, CLIN EXP ALLERGY, V42, P494, DOI 10.1111/j.1365-2222.2011.03903.x; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	66	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111932	10.1371/journal.pone.0111932	http://dx.doi.org/10.1371/journal.pone.0111932			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391153	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400040
J	Paladini, F; Porciello, N; Camilli, G; Tuncer, S; Cocco, E; Fiorillo, MT; Sorrentino, R				Paladini, Fabiana; Porciello, Nicla; Camilli, Giorgio; Tuncer, Sinem; Cocco, Elisa; Fiorillo, Maria Teresa; Sorrentino, Rosa			Single Nucleotide Polymorphisms in the 3 ' UTR of VPAC-1 Cooperate in Modulating Gene Expression and Impact Differently on the Interaction with miR525-5p	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CYCLASE-ACTIVATING PROTEIN; 3' UNTRANSLATED REGIONS; RECEPTOR 1 GENE; DEPENDENT ASSOCIATION; EMERGING ROLES; DISEASE; NEUROPEPTIDE; AUTOIMMUNE; CELLS	Complex immune and neurodegenerative disorders are the result of multiple interactions between common genetic variations having, individually, a weak effect on the disease susceptibility or resistance. Interestingly, some genes have been found to be associated with more than one disease although not necessarily the same SNPs are involved. In this context, single nucleotide polymorphisms in the 3'UTR region of type 1 receptor (VPAC-1) for vasoactive intestinal peptide (VIP) have been reported to be associated with some immune-mediated as well as with neurodegenerative diseases such as Alzheimer's Disease (AD). Here, we demonstrate that variations at the 3'UTR of the VPAC-1 gene act synergistically to affect the expression of the luciferase as well as of the GFP reporter genes expressed in HEK293T cells. Moreover, the miRNA 525-5p, previously shown by us to target the 3'UTR of VPAC-1, is more efficient in decreasing GFP expression when co-expressed with constructs carrying the allele C at rs896 (p<10(-3)) suggesting that this miRNA regulates VPAC-1 expression at different levels depending on rs896 polymorphism and thus adding complexity to the network of disease susceptibility.	[Paladini, Fabiana; Porciello, Nicla; Camilli, Giorgio; Tuncer, Sinem; Cocco, Elisa; Fiorillo, Maria Teresa; Sorrentino, Rosa] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy	Sapienza University Rome	Paladini, F (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	fabiana.paladini@uniroma1.it	Porciello, Nicla/AHH-2927-2022; Tunçer, Sinem/AAF-5871-2021; Sorrentino, Rosa/G-5472-2012	Tunçer, Sinem/0000-0002-8947-8646; Sorrentino, Rosa/0000-0002-9632-2383; Camilli, Giorgio/0000-0002-6662-0072; FIORILLO, Maria Teresa/0000-0002-6859-5851; Porciello, Nicla/0000-0002-5603-4408; Paladini, Fabiana/0000-0003-1040-452X	Istituto Pasteur-Fondazione Cenci- Bolognetti; Sapienza University of Rome through "Progetti di Ateneo" [C26A13RJ5WC26A13RJ5W]	Istituto Pasteur-Fondazione Cenci- Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Sapienza University of Rome through "Progetti di Ateneo"	This work was supported by Istituto Pasteur-Fondazione Cenci- Bolognetti and by Sapienza University of Rome through "Progetti di Ateneo" (C26A13RJ5WC26A13RJ5W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Chorny A, 2008, AM J PATHOL, V172, P1297, DOI 10.2353/ajpath.2008.070969; Cocco E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012067; Couvineau A, 2012, FRONT ENDOCRINOL LAU, V16, P139; Delgado M, 1999, J BIOL CHEM, V274, P31930, DOI 10.1074/jbc.274.45.31930; Delgado M, 2003, FASEB J, V17, P944, DOI 10.1096/fj.02-0799fje; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Delgado M, 2008, ARTHRITIS RHEUM-US, V58, P1010, DOI 10.1002/art.23482; Delgado M, 2013, AMINO ACIDS, V45, P25, DOI 10.1007/s00726-011-1184-8; Dorsam G, 2000, ANN NY ACAD SCI, V921, P79; El Zein N, 2007, CELL SIGNAL, V19, P152, DOI 10.1016/j.cellsig.2006.05.031; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Gonzalez-Rey E, 2006, AM J PATHOL, V168, P1179, DOI 10.2353/ajpath.2006.051081; Gonzalez-Rey E, 2006, GASTROENTEROLOGY, V131, P1799, DOI 10.1053/j.gastro.2006.10.023; Gonzalez-Rey E, 2007, ANN RHEUM DIS, V66, P70, DOI 10.1136/ard.2007.078519; Harfi I, 2005, J IMMUNOL, V175, P4091, DOI 10.4049/jimmunol.175.6.4091; Herrera JL, 2006, ANN NY ACAD SCI, V1070, P337, DOI 10.1196/annals.1317.041; Lara-Marquez ML, 2001, J IMMUNOL, V166, P2522, DOI 10.4049/jimmunol.166.4.2522; Li J, 2013, CANCER LETT, V337, P22, DOI 10.1016/j.canlet.2013.05.034; Lodde BM, 2006, ANN RHEUM DIS, V65, P195, DOI 10.1136/ard.2005.038232; Martin B, 2005, NEUROMOL MED, V7, P3, DOI 10.1385/NMM:7:1-2:003; Michalova E, 2013, INT J MOL SCI, V14, P15681, DOI 10.3390/ijms140815681; Nunan R, 2014, GLIA, V62, P1313, DOI 10.1002/glia.22682; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Paladini F, 2009, NEUROGASTROENT MOTIL, V21, P597, DOI 10.1111/j.1365-2982.2009.01284.x; Paladini F, 2008, GENES IMMUN, V9, P659, DOI 10.1038/gene.2008.60; Paladini F, 2012, GENE, V493, P278, DOI 10.1016/j.gene.2011.11.055; Prasse A, 2010, AM J RESP CRIT CARE, V182, P540, DOI 10.1164/rccm.200909-1451OC; Ramirez-Bello J, 2013, GAC MED MEX, V149, P220; Sorrentino R, 2014, IMMUNOL LETT, V158, P116, DOI 10.1016/j.imlet.2013.12.005; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031429	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112646	10.1371/journal.pone.0112646	http://dx.doi.org/10.1371/journal.pone.0112646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390694	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400116
J	Kopecky, J; Nesvorna, M; Mareckova-Sagova, M; Hubert, J				Kopecky, Jan; Nesvorna, Marta; Mareckova-Sagova, Marketa; Hubert, Jan			The Effect of Antibiotics on Associated Bacterial Community of Stored Product Mites	PLOS ONE			English	Article							HOUSE-DUST MITE; DERMATOPHAGOIDES-PTERONYSSINUS; GUT MICROBIOTA; IN-VITRO; ACARI; IDENTIFICATION; ENDOSYMBIONTS; INFECTION; LYSOZYME; BACILLUS	Background: Bacteria are associated with the gut, fat bodies and reproductive organs of stored product mites (Acari: Astigmata). The mites are pests due to the production of allergens. Addition of antibiotics to diets can help to characterize the association between mites and bacteria. Methodology and Principal Findings: Ampicillin, neomycin and streptomycin were added to the diets of mites and the effects on mite population growth (Acarus siro, Lepidoglyphus destructor and Tyrophagus putrescentiae) and associated bacterial community structure were assessed. Mites were treated by antibiotic supplementation (1 mgg(-1) of diet) for 21 days and numbers of mites and bacterial communities were analyzed and compared to the untreated control. Bacterial quantities, determined by real-time PCR, significantly decreased in antibiotic treated specimens from 5 to 30 times in A. siro and T. putrescentiae, while no decline was observed in L. destructor. Streptomycin treatment eliminated Bartonella-like bacteria in the both A. siro and T. putrescentiae and Cardinium in T. putrescentiae. Solitalea-like bacteria proportion increased in the communities of neomycin and streptomycin treated A. siro specimens. Kocuria proportion increased in the bacterial communities of ampicillin and streptomycin treated A. siro and neomycin and streptomycin treated L. destructor. Conclusions/Significance: The work demonstrated the changes of mite associated bacterial community under antibiotic pressure in pests of medical importance. Pre-treatment of mites by 1 mgg(-1) antibiotic diets improved mite fitness as indicated accelerated population growth of A. siro pretreated streptomycin and neomycin and L. destructor pretreated by neomycin. All tested antibiotics supplemented to diets caused the decrease of mite growth rate in comparison to the control diet.	[Kopecky, Jan; Mareckova-Sagova, Marketa] Crop Res Inst, Prague, Czech Republic; [Nesvorna, Marta; Hubert, Jan] Crop Res Inst, Biol Act Subst Crop Protect, Prague, Czech Republic	Czech Crop Research Institute (CRI); Czech Crop Research Institute (CRI)	Hubert, J (corresponding author), Crop Res Inst, Biol Act Subst Crop Protect, Prague, Czech Republic.	hubert@vurv.cz	Nesvorná, Marta/ABA-4351-2020; Hubert, Jan/K-5489-2012; Kopecky, Jan/C-7400-2013; Mareckova, Marketa/D-9898-2017; Mareckova, Marketa/AAD-7361-2021	Nesvorná, Marta/0000-0003-0572-4131; Hubert, Jan/0000-0003-0740-166X; Kopecky, Jan/0000-0002-3437-257X; Mareckova, Marketa/0000-0002-0331-8570; Mareckova, Marketa/0000-0002-0331-8570	Czech Science Foundation [GA525/09/1872]; Ministrz of education youth and sport of the Czech Republic [LD13052/COST FA1105]; Ministry of Agriculture of the Czech Republic [RO0414]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministrz of education youth and sport of the Czech Republic; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work was supported by the Czech Science Foundation (http://www.gacr.cz/en/) grant No. GA525/09/1872 to JK, Ministrz of education youth and sport of the Czech Republic (www.msmt.cz/index.php? lang = 2) grant No. LD13052/COST FA1105 action to JH and Ministry of Agriculture of the Czech Republic (http://eagri.cz/public/web/en/mze/) grant NO. RO0414 to MMS and MN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian LG, 2011, INT ARCH ALLERGY IMM, V156, P171, DOI 10.1159/000323351; Barbieri E, 2001, ENVIRON MICROBIOL, V3, P151, DOI 10.1046/j.1462-2920.2001.00172.x; Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x; Boczek J., 1965, Bollettino di Zoologia Agraria e Bachicoltura (2), V7, P299; Boczek J, 1968, ROCZ NAUK ROLN, V93, P579; BREZNAK JA, 1982, ANNU REV MICROBIOL, V36, P323, DOI 10.1146/annurev.mi.36.100182.001543; Castagnoli Marisa, 2006, Redia, V89, P55; Chigira A, 2005, EXP APPL ACAROL, V37, P107, DOI 10.1007/s10493-005-0592-4; CHILDS M, 1981, COMP BIOCHEM PHYS B, V70, P615, DOI 10.1016/0305-0491(81)90305-9; Diaz A, 2000, EXP APPL ACAROL, V24, P85, DOI 10.1023/A:1006304300657; Douglas A.E., 2009, FUNCT ECOL, V23, P38; Edlund A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033107; Erban T, 2008, EXP APPL ACAROL, V44, P199, DOI 10.1007/s10493-008-9138-x; Erban T, 2009, EXP APPL ACAROL, V49, P339, DOI 10.1007/s10493-009-9265-z; Fernandez-Caldas E, 2006, CURR ALLERGY ASTHM R, V6, P413, DOI 10.1007/s11882-996-0015-6; Genta FA, 2006, J INSECT PHYSIOL, V52, P593, DOI 10.1016/j.jinsphys.2006.02.007; Gotoh T, 2007, HEREDITY, V98, P13, DOI 10.1038/sj.hdy.6800881; Greewood D, 2003, ANTIBIOTIC CHEMOTHER; HAY DB, 1993, MED VET ENTOMOL, V7, P271, DOI 10.1111/j.1365-2915.1993.tb00687.x; Hubert J, 2005, EXP APPL ACAROL, V35, P281, DOI 10.1007/s10493-004-7834-8; Hubert J, 2008, EXP APPL ACAROL, V44, P315, DOI 10.1007/s10493-008-9146-x; Hubert J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048429; Hubert J, 2012, MICROB ECOL, V63, P919, DOI 10.1007/s00248-011-9969-6; Hughes AM, 1976, TECHNICAL B UK MINIS; Kafil M, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.9901; Koga R, 2007, FEMS MICROBIOL ECOL, V60, P229, DOI 10.1111/j.1574-6941.2007.00284.x; Kopecky J, 2014, EXP APPL ACAROL, V64, P21, DOI 10.1007/s10493-014-9811-1; Kopecky J, 2013, J INVERTEBR PATHOL, V112, P20, DOI 10.1016/j.jip.2012.11.001; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; Morag N, 2013, APPL ENVIRON MICROB, V79, P6260, DOI 10.1128/AEM.01793-13; Morales-Jimenez J, 2012, MICROB ECOL, V64, P268, DOI 10.1007/s00248-011-9999-0; Moran NA, 2007, P NATL ACAD SCI USA, V104, P8627, DOI 10.1073/pnas.0611659104; Morimoto S, 2006, CURR MICROBIOL, V52, P324, DOI 10.1007/s00284-005-0349-7; Oliwa-Stasiak K, 2010, J APPL MICROBIOL, V108, P266, DOI 10.1111/j.1365-2672.2009.04419.x; Palyvos NE, 2011, EXP APPL ACAROL, V54, P139, DOI 10.1007/s10493-011-9427-7; Robinson CJ, 2010, MICROB ECOL, V59, P199, DOI 10.1007/s00248-009-9595-8; Rosengaus RB, 2011, APPL ENVIRON MICROB, V77, P4303, DOI 10.1128/AEM.01886-10; Sagova-Mareckova M, 2011, APPL ENVIRON MICROB, V77, P7560, DOI 10.1128/AEM.00527-11; SALEH SM, 1991, ACAROLOGIA, V32, P257; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smrz J, 2003, EXP APPL ACAROL, V31, P105, DOI 10.1023/B:APPA.0000005111.05959.d6; Smrz J, 2010, SYMBIOSIS, V52, P33, DOI 10.1007/s13199-010-0099-6; Tang VH, 2013, EXP APPL ACAROL, V61, P431, DOI 10.1007/s10493-013-9712-8; Van Asselt L, 1999, INDOOR BUILT ENVIRON, V8, P216, DOI 10.1177/1420326X9900800402; Van der Geest LPS, 2000, EXP APPL ACAROL, V24, P497, DOI 10.1023/A:1026518418163; Wang JJ, 2008, J ECON ENTOMOL, V101, P1711, DOI 10.1603/0022-0493(2008)101[1711:EOROCI]2.0.CO;2; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wenzel M, 2002, J APPL MICROBIOL, V92, P32, DOI 10.1046/j.1365-2672.2002.01502.x; Xia B, 2012, EXP APPL ACAROL, V56, P33, DOI 10.1007/s10493-011-9481-1; Zdarkova E., 1998, Integrated Pest Management Reviews, V3, P111, DOI 10.1023/A:1009647814477; Zindel R, 2013, FASEB J, V27, P1488, DOI 10.1096/fj.12-216242	51	26	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112919	10.1371/journal.pone.0112919	http://dx.doi.org/10.1371/journal.pone.0112919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387104	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400105
J	Bustamante, P; Tello, M; Orellana, O				Bustamante, Paula; Tello, Mario; Orellana, Omar			Toxin-Antitoxin Systems in the Mobile Genome of Acidithiobacillus ferrooxidans	PLOS ONE			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; CRYSTAL-STRUCTURE; SEQUENCE; PROTEIN; LOCI; BACTERIA; WEB; RIBONUCLEASES; EVOLUTION	Toxin-antitoxin (TA) systems are genetic modules composed of a pair of genes encoding a stable toxin and an unstable antitoxin that inhibits toxin activity. They are widespread among plasmids and chromosomes of bacteria and archaea. TA systems are known to be involved in the stabilization of plasmids but there is no consensus about the function of chromosomal TA systems. To shed light on the role of chromosomally encoded TA systems we analyzed the distribution and functionality of type II TA systems in the chromosome of two strains from Acidithiobacillus ferrooxidans (ATCC 23270 and 53993), a Gram-negative, acidophilic, environmental bacterium that participates in the bioleaching of minerals. As in other environmental microorganisms, A. ferrooxidans has a high content of TA systems (28-29) and in twenty of them the toxin is a putative ribonuclease. According to the genetic context, some of these systems are encoded near or within mobile genetic elements. Although most TA systems are shared by both strains, four of them, which are encoded in the active mobile element ICEAfe1, are exclusive to the type strain ATCC 23270. We demostrated that two TA systems from ICEAfe1 are functional in E. coli cells, since the toxins inhibit growth and the antitoxins counteract the effect of their cognate toxins. All the toxins from ICEAfe1, including a novel toxin, are RNases with different ion requirements. The data indicate that some of the chromosomally encoded TA systems are actually part of the A. ferrooxidans mobile genome and we propose that could be involved in the maintenance of these integrated mobile genetic elements.	[Bustamante, Paula; Orellana, Omar] Univ Chile, Fac Med, ICBM, Programa Biol Celular & Mol, Santiago 7, Chile; [Tello, Mario] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Ctr Biotecnol Acuicola, Santiago, Chile	Universidad de Chile; Universidad de Santiago de Chile	Orellana, O (corresponding author), Univ Chile, Fac Med, ICBM, Programa Biol Celular & Mol, Santiago 7, Chile.	oorellan@med.uchile.cl	Tello, Mario/N-4198-2019	Tello, Mario/0000-0003-4573-6460; Bustamante, Paula/0000-0001-7200-4439	Fondecyt Chile [1110203]; Proyecto Bicentenario [PDA20]; Proyecto FIA [PYT20120056]; Conicyt, Chile [AT-24100112]	Fondecyt Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Proyecto Bicentenario; Proyecto FIA; Conicyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by grants from Fondecyt Chile 1110203 to OO (http://www.conicyt.cl/fondecyt/) and Proyecto Bicentenario PDA20 (www.conicyt.cl) and Proyecto FIA PYT20120056 to MT (www.fia.cl). PB was the recipient of a graduate studies fellowship and supporting fellowship AT-24100112 from Conicyt (www.conicyt.cl), Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078237; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Blower TR, 2012, NUCLEIC ACIDS RES, V40, P6158, DOI 10.1093/nar/gks231; Blower TR, 2011, CURR OPIN STRUC BIOL, V21, P109, DOI 10.1016/j.sbi.2010.10.009; Bonnefoy V, 2012, ENVIRON MICROBIOL, V14, P1597, DOI 10.1111/j.1462-2920.2011.02626.x; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Bukowski M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3012; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Bustamante P, 2012, J MOL MICROB BIOTECH, V22, P399, DOI 10.1159/000346669; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cook GM, 2013, BBA-GENE REGUL MECH, V1829, P523, DOI 10.1016/j.bbagrm.2013.02.007; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; Dy RL, 2014, NUCLEIC ACIDS RES, V42, P4590, DOI 10.1093/nar/gkt1419; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fozo EM, 2010, NUCLEIC ACIDS RES, V38, P3743, DOI 10.1093/nar/gkq054; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GERDES K, 1986, EMBO J, V5, P2023, DOI 10.1002/j.1460-2075.1986.tb04459.x; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Guerout AM, 2013, J BACTERIOL, V195, P2270, DOI 10.1128/JB.01389-12; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; Holmes DS, 2001, J BACTERIOL, V183, P4323, DOI 10.1128/JB.183.14.4323-4329.2001; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Masuda H, 2012, MOL MICROBIOL, V84, P979, DOI 10.1111/j.1365-2958.2012.08068.x; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; Oppon JC, 1998, J BACTERIOL, V180, P3007, DOI 10.1128/JB.180.11.3007-3012.1998; Orellana LH, 2011, APPL MICROBIOL BIOT, V92, P761, DOI 10.1007/s00253-011-3494-x; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sala A, 2014, TOXINS, V6, P1002, DOI 10.3390/toxins6031002; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Sevin EW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r155; Shao YC, 2011, NUCLEIC ACIDS RES, V39, pD606, DOI 10.1093/nar/gkq908; Szekeres S, 2007, MOL MICROBIOL, V63, P1588, DOI 10.1111/j.1365-2958.2007.05613.x; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Tsilibaris V, 2007, J BACTERIOL, V189, P6101, DOI 10.1128/JB.00527-07; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; Wang XX, 2012, NAT CHEM BIOL, V8, P855, DOI 10.1038/NCHEMBIO.1062; Wilbaux M, 2007, J BACTERIOL, V189, P2712, DOI 10.1128/JB.01679-06; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000786; Wozniak RAF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000439; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	62	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112226	10.1371/journal.pone.0112226	http://dx.doi.org/10.1371/journal.pone.0112226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384039	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700041
J	Kott, M; Elke, G; Reinicke, M; Winoto-Morbach, S; Schadler, D; Zick, G; Frerichs, I; Weiler, N; Schutze, S				Kott, Matthias; Elke, Gunnar; Reinicke, Maike; Winoto-Morbach, Supandi; Schaedler, Dirk; Zick, Guenther; Frerichs, Inez; Weiler, Norbert; Schuetze, Stefan			Acid Sphingomyelinase Serum Activity Predicts Mortality in Intensive Care Unit Patients after Systemic Inflammation: A Prospective Cohort Study	PLOS ONE			English	Article							ORGAN FAILURE; SEVERE SEPSIS; PROCALCITONIN; CERAMIDE; APOPTOSIS; ALPHA; SCORE	Introduction: Acid sphingomyelinase is involved in lipid signalling pathways and regulation of apoptosis by the generation of ceramide and plays an important role during the host response to infectious stimuli. It thus has the potential to be used as a novel diagnostic marker in the management of critically ill patients. The objective of our study was to evaluate acid sphingomyelinase serum activity (ASM) as a diagnostic and prognostic marker in a mixed intensive care unit population before, during, and after systemic inflammation. Methods: 40 patients admitted to the intensive care unit at risk for developing systemic inflammation (defined as systemic inflammatory response syndrome plus a significant procalcitonin [PCT] increase) were included. ASM was analysed on ICU admission, before (PCTbefore), during (PCTpeak) and after (PCTlow) onset of SIRS. Patients undergoing elective surgery served as control (N=8). Receiver-operating characteristics curves were computed. Results: ASM significantly increased after surgery in the eight control patients. Patients from the intensive care unit had significantly higher ASM on admission than control patients after surgery. 19 out of 40 patients admitted to the intensive care unit developed systemic inflammation and 21 did not, with no differences in ASM between these two groups on admission. In patients with SIRS and PCTpeak, ASM between admission and PCTbefore was not different, but further increased at PCTpeak in non-survivors and was significantly higher at PCTlow compared to survivors. Survivors exhibited decreased ASM at PCTpeak and PCTlow. Receiver operating curve analysis on discrimination of ICU mortality showed an area under the curve of 0.79 for ASM at PCTlow. Conclusions: In summary, ASM was generally higher in patients admitted to the intensive care unit compared to patients undergoing uncomplicated surgery. ASM did not indicate onset of systemic inflammation. In contrast to PCT however, it remained high in non-surviving ICU patients after systemic inflammation.	[Kott, Matthias; Elke, Gunnar; Reinicke, Maike; Schaedler, Dirk; Zick, Guenther; Frerichs, Inez; Weiler, Norbert] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Kiel, Germany; [Reinicke, Maike; Winoto-Morbach, Supandi; Schuetze, Stefan] Univ Med Ctr Schleswig Holstein, Inst Immunol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Kott, M (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel, Kiel, Germany.	matthias.kott@uksh.de	Frerichs, I./AAT-3685-2021; Lindner, Matthias/O-1961-2018; Elke, Gunnar/S-8579-2016; Schädler, Dirk/A-7253-2012	Frerichs, I./0000-0002-7712-6539; Lindner, Matthias/0000-0003-2647-7790; Elke, Gunnar/0000-0002-4948-1605; Schädler, Dirk/0000-0002-5745-4797	Christian-Albrechts University Kiel, Germany; Deutsche Forschungsgemeinschaft [SCHU 733/9-2]	Christian-Albrechts University Kiel, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by a restricted grant of the Christian-Albrechts University Kiel, Germany and in part supported by a grant of the Deutsche Forschungsgemeinschaft (SCHU 733/9-2) given to S. Schutze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; Castillo SS, 2007, EXP CELL RES, V313, P816, DOI 10.1016/j.yexcr.2006.12.001; Claus RA, 2005, FASEB J, V19, P1719, DOI 10.1096/fj.04-2842fje; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; Cullen D J, 1974, Crit Care Med, V2, P57, DOI 10.1097/00003246-197403000-00001; Drobnik W, 2003, J LIPID RES, V44, P754, DOI 10.1194/jlr.M200401-JLR200; Edelmann B, 2011, EMBO J, V30, P379, DOI 10.1038/emboj.2010.326; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Herrmann W, 2000, CLIN CHEM LAB MED, V38, P41, DOI 10.1515/CCLM.2000.007; Jbeily N, 2013, J LIPID RES, V54, P410, DOI 10.1194/jlr.M031625; Jenkins RW, 2009, CELL SIGNAL, V21, P836, DOI 10.1016/j.cellsig.2009.01.026; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Prkno A, 2013, CRIT CARE, V17, DOI 10.1186/cc13157; Reinhart K, 2010, ANAESTHESIST, V59, P347, DOI 10.1007/s00101-010-1719-5; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Tokuda H, 1999, J CELL BIOCHEM, V72, P262, DOI 10.1002/(SICI)1097-4644(19990201)72:2<262::AID-JCB10>3.0.CO;2-N; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7	27	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112323	10.1371/journal.pone.0112323	http://dx.doi.org/10.1371/journal.pone.0112323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384060	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700050
J	Hulleman, JD; Kelly, JW				Hulleman, John D.; Kelly, Jeffery W.			Genetic ablation of N-linked glycosylation reveals two key folding pathways for R345W fibulin-3, a secreted protein associated with retinal degeneration	FASEB JOURNAL			English	Article						EFEMP1; endoplasmic reticulum; malattia leventinese; unfolded protein response	RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; MACULAR DEGENERATION; ABERRANT ACCUMULATION; MALATTIA LEVENTINESE; EFEMP1; MUTATION; OLIGOSACCHARIDES; GLYCOPROTEINS; STABILITY	An R345W mutation in the N- glycoprotein, fibulin- 3 ( F3), results in inefficient F3 folding/ secretion and higher intracellular F3 levels. Inheritance of this mutation causes the retinal dystrophy malattia leventinese. N- Linked glycosylation is a common cotranslational protein modification that can regulate protein folding efficiency and energetics. Therefore, we explored how N- glycosylation alters the protein homeostasis or proteostasis of wild- type ( WT) and R345W F3 in ARPE- 19 cells. Enzymatic and lectin binding assays confirmed that WT and R345W F3 are both primarily N- glycosylated at Asn249. Tunicamycin treatment selectively reduced R345W F3 secretion by 87% ( vs. WTF3). Genetic elimination of F3 N- glycosylation ( via an N249Q mutation) caused R345W F3 to aggregate intracellularly and adopt an altered secreted conformation. The endoplasmic reticulum ( ER) chaperones GRP78 ( glucose- regulated protein 78) and GRP94 ( glucose- regulated protein 94), and the ER lectins calnexin and calreticulin were identified as F3 binding partners by immunoprecipitation. Significantly more N249Q and N249Q/ R345W F3 interacted with GRP94, while substantially lessN249Q andN249Q/ R345W interacted with the ER lectins than their N- glycosylated counterparts. Inhibition of GRP94 ATPase activity reduced only N249Q/ R345W F3 secretion ( by 62%), demonstrating this variant's unique reliance on GRP94 for secretion. These observations suggest that R345W F3, but not WT F3, requires N- glycosylation to acquire a stable, native- like structure.-	[Hulleman, John D.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Hulleman, John D.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol & Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Hulleman, JD (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	john.hulleman@utsouthwestern.edu; jkelly@scripps.edu	Hulleman, John D./AAV-8242-2020	Hulleman, John/0000-0001-8149-656X	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY020799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018917] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025774, RR025774] Funding Source: Medline; NEI NIH HHS [EY020799, P30 EY020799] Funding Source: Medline; NIA NIH HHS [R01 AG018917, AG018917] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Appenzeller-Herzog C, 2010, EMBO J, V29, P3318, DOI 10.1038/emboj.2010.203; Attebo K, 1996, OPHTHALMOLOGY, V103, P357; Baetens M, 2011, HUM MUTAT, V32, P1053, DOI 10.1002/humu.21525; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; Culyba EK, 2011, SCIENCE, V331, P571, DOI 10.1126/science.1198461; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Djokic J, 2013, J BIOL CHEM, V288, P22821, DOI 10.1074/jbc.M112.439158; Fu L, 2007, HUM MOL GENET, V16, P2411, DOI 10.1093/hmg/ddm198; Garland DL, 2014, HUM MOL GENET, V23, P52, DOI 10.1093/hmg/ddt395; Gould DB, 2007, HUM MOL GENET, V16, P798, DOI 10.1093/hmg/ddm024; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; HEIFETZ A, 1979, BIOCHEMISTRY-US, V18, P2186, DOI 10.1021/bi00578a008; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hulleman JD, 2013, J BIOMOL SCREEN, V18, P647, DOI 10.1177/1087057112469405; Hulleman JD, 2012, FASEB J, V26, P4548, DOI 10.1096/fj.11-202861; Hulleman JD, 2011, MOL BIOL CELL, V22, P4765, DOI 10.1091/mbc.E11-08-0695; Ireland BS, 2008, MOL BIOL CELL, V19, P2413, DOI 10.1091/mbc.E07-10-1055; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Klenotic PA, 2004, J BIOL CHEM, V279, P30469, DOI 10.1074/jbc.M403026200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kroeger H, 2012, INVEST OPHTH VIS SCI, V53, P7590, DOI 10.1167/iovs.12-10221; Kroeger H, 2012, ADV EXP MED BIOL, V723, P559, DOI 10.1007/978-1-4614-0631-0_71; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Marmorstein LHY, 2002, P NATL ACAD SCI USA, V99, P13067, DOI 10.1073/pnas.202491599; Marmorstein LY, 2007, HUM MOL GENET, V16, P2423, DOI 10.1093/hmg/ddm199; MAY LT, 1991, CYTOKINE, V3, P204, DOI 10.1016/1043-4666(91)90018-9; Merulla J, 2013, TRAFFIC, V14, P767, DOI 10.1111/tra.12068; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; NARHI LO, 1991, J BIOL CHEM, V266, P23022; O'Connor SE, 2001, J AM CHEM SOC, V123, P6187, DOI 10.1021/ja010094s; Oka OBV, 2013, MOL CELL, V50, P793, DOI 10.1016/j.molcel.2013.05.014; PIGUET B, 1995, EYE, V9, P34, DOI 10.1038/eye.1995.5; Putnam EA, 1996, AM J MED GENET, V62, P233, DOI 10.1002/(SICI)1096-8628(19960329)62:3<233::AID-AJMG7>3.0.CO;2-U; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roybal CN, 2005, INVEST OPHTH VIS SCI, V46, P3973, DOI 10.1167/iovs.05-0070; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Sercu S, 2009, MATRIX BIOL, V28, P160, DOI 10.1016/j.matbio.2009.02.003; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2001, HUM MOL GENET, V10, P2285, DOI 10.1093/hmg/10.20.2285; TIELSCH JM, 1995, NEW ENGL J MED, V332, P1205, DOI 10.1056/NEJM199505043321806; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wallis DD, 2003, J CELL BIOCHEM, V90, P641, DOI 10.1002/jcb.10657; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wyatt MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068088; Zhang YW, 2010, EXP EYE RES, V90, P374, DOI 10.1016/j.exer.2009.09.018	48	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					565	575		10.1096/fj.14-255414	http://dx.doi.org/10.1096/fj.14-255414			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25389134	Green Published			2022-12-26	WOS:000349370400019
J	Homer-Bouthiette, C; Doetschman, T; Xiao, LP; Hurley, MM				Homer-Bouthiette, Collin; Doetschman, Thomas; Xiao, Liping; Hurley, Marja M.			Knockout of Nuclear High Molecular Weight FGF2 Isoforms in Mice Modulates Bone and Phosphate Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; MATRIX PROTEIN; EXPRESSION; RECEPTOR; GENE; MINERALIZATION; MASS; HYPOPHOSPHATEMIA; DIVERSITY	We previously reported that targeted overexpression of the fibroblast growth factor 2 (FGF2) high molecular weight (HMW) isoforms in osteoblastic lineage cells in mice resulted in phenotypic changes, including dwarfism, rickets, osteomalacia, hypophosphatemia, increased serum parathyroid hormone, and increased levels of the phosphatonin FGF23 in serum and bone. This study examined the effects of genetically knocking out the FGF2HMW isoforms (HMWKO) on bone and phosphate homeostasis. HMWKO mice were not dwarfed and had significantly increased bone mineral density and bone mineral content in femurs and lumbar vertebrae when compared with the wild-type (WT) littermates. Micro-computed tomography analysis of femurs revealed increased trabecular bone volume, thickness, number, and connective tissue density with decreased trabecular spacing compared with WT. In addition, there was significantly decreased cortical porosity and increased cortical thickness and sub-periosteal area in femurs of HMWKO. Histomorphometric analysis demonstrated increased osteoblast activity and diminished osteoclast activity in the HMWKO. In vitro bone marrow stromal cell cultures showed there was a significant increase in alkaline phosphatase-positive colony number at 1 week in HMWKO. At 3 weeks of culture, the mineralized area was also significantly increased. There was increased expression of osteoblast differentiation marker genes and reduced expression of genes associated with impaired mineralization, including a significant reduction in Fgf23 and Sost mRNA. Normal serum phosphate and parathyroid hormone were observed in HMWKO mice. This study demonstrates a significant negative impact of HMWFGF2 on biological functions in bone and phosphate homeostasis in mice.	[Homer-Bouthiette, Collin; Xiao, Liping; Hurley, Marja M.] Univ Connecticut, Ctr Hlth, Dept Med, Inst Syst Genom, Farmington, CT 06030 USA; [Doetschman, Thomas] Univ Arizona, Inst B105, Tucson, AZ 85724 USA; [Doetschman, Thomas] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA	University of Connecticut; University of Arizona; University of Arizona	Xiao, LP (corresponding author), Univ Connecticut, Ctr Hlth, Dept Med, 263 Farmington Ave, Farmington, CT 06030 USA.	xiao@uchc.edu; hurley@nso1.uchc.edu			National Institutes of Health [DK098566-01-A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK098566-01-A1 (to M. M. H. and L. X.).	Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Arnaud E, 1999, MOL CELL BIOL, V19, P505; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Azhar M, 2009, DEV DYNAM, V238, P351, DOI 10.1002/dvdy.21835; Beck L, 1997, J CLIN INVEST, V99, P1200, DOI 10.1172/JCI119276; Butler JS, 2011, J ORTHOP RES, V29, P414, DOI 10.1002/jor.21260; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; GOSPODAROWICZ D, 1990, CLIN ORTHOP RELAT R, P231; He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945; Hurley MM, 1999, J BONE MINER RES, V14, P776, DOI 10.1359/jbmr.1999.14.5.776; Juppner H, 2011, KIDNEY INT, V79, pS24, DOI 10.1038/ki.2011.27; Kardami E, 2004, CARDIOVASC RES, V63, P458, DOI 10.1016/j.cardiores.2004.04.024; Kumar J, 2011, BONE, V49, P343, DOI 10.1016/j.bone.2011.05.018; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Liao SY, 2010, J MOL CELL CARDIOL, V48, P1245, DOI 10.1016/j.yjmcc.2010.01.014; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Lu Yongbo, 2011, Curr Osteoporos Rep, V9, P103, DOI 10.1007/s11914-011-0053-4; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Masuda M, 2010, BIOCHEM J, V429, P583, DOI 10.1042/BJ20100484; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Okada-Ban M, 2000, INT J BIOCHEM CELL B, V32, P263, DOI 10.1016/S1357-2725(99)00133-8; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Sapir-Koren R, 2011, IBMS BONEKEY, V8, P286, DOI [10.1138/20110516, DOI 10.1138/20110516]; Sims NA, 2000, J CLIN INVEST, V106, P1095, DOI 10.1172/JCI10753; Sobue T, 2005, J CELL BIOCHEM, V95, P83, DOI 10.1002/jcb.20389; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wang H, 2008, J BONE MINER RES, V23, P939, DOI 10.1359/JBMR.080220; Xiao LP, 2013, J BONE MINER RES, V28, P35, DOI 10.1002/jbmr.1721; Xiao LP, 2010, BONE, V47, P360, DOI 10.1016/j.bone.2010.05.021; Xiao LP, 2010, J BIOL CHEM, V285, P2834, DOI 10.1074/jbc.M109.030577; Xiao LP, 2009, J BIOL CHEM, V284, P3170, DOI 10.1074/jbc.M804900200; Yu XJ, 2005, CYTOKINE GROWTH F R, V16, P221, DOI 10.1016/j.cytogfr.2005.01.002; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200	44	22	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36303	36314		10.1074/jbc.M114.619569	http://dx.doi.org/10.1074/jbc.M114.619569			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25389287	hybrid, Green Published			2022-12-26	WOS:000346897900053
J	Borrayo, E; Mendizabal-Ruiz, EG; Velez-Perez, H; Romo-Vazquez, R; Mendizabal, AP; Morales, JA				Borrayo, Ernesto; Gerardo Mendizabal-Ruiz, E.; Velez-Perez, Hugo; Romo-Vazquez, Rebeca; Mendizabal, Adriana P.; Alejandro Morales, J.			Genomic Signal Processing Methods for Computation of Alignment-Free Distances from DNA Sequences	PLOS ONE			English	Article							SIMILARITY; IDENTIFICATION; PREDICTION; SEARCH	Genomic signal processing (GSP) refers to the use of digital signal processing (DSP) tools for analyzing genomic data such as DNA sequences. A possible application of GSP that has not been fully explored is the computation of the distance between a pair of sequences. In this work we present GAFD, a novel GSP alignment-free distance computation method. We introduce a DNA sequence-to-signal mapping function based on the employment of doublet values, which increases the number of possible amplitude values for the generated signal. Additionally, we explore the use of three DSP distance metrics as descriptors for categorizing DNA signal fragments. Our results indicate the feasibility of employing GAFD for computing sequence distances and the use of descriptors for characterizing DNA fragments.	[Borrayo, Ernesto; Gerardo Mendizabal-Ruiz, E.; Velez-Perez, Hugo; Romo-Vazquez, Rebeca; Alejandro Morales, J.] Univ Guadalajara, CUCEI, Dept Comp Sci, Guadalajara 44430, Jalisco, Mexico; [Mendizabal, Adriana P.] Univ Guadalajara, CUCEI, Mol Biol Lab, Farmacobiol Dept, Guadalajara 44430, Jalisco, Mexico; [Alejandro Morales, J.] Univ Guadalajara, Ctr Theoret Res & High Performance Comp, CUCEI, Guadalajara 44430, Jalisco, Mexico	Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara	Morales, JA (corresponding author), Univ Guadalajara, CUCEI, Dept Comp Sci, Guadalajara 44430, Jalisco, Mexico.	alejandro.morales@cucei.udg.mx	Mendizabal, Adriana P/A-9689-2015; Romo-Vazquez, Rebeca/AAS-2119-2021; Morales, J. Alejandro/G-1938-2018	Mendizabal, Adriana P/0000-0001-7553-6350; Morales, J. Alejandro/0000-0001-8088-9724; romo-vazquez, rebeca/0000-0001-6459-8070; Borrayo, Ernesto/0000-0002-0752-6721	National Council for Science and Technology (CONACyT); FOMIXJal project [2010-10-149481]	National Council for Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); FOMIXJal project	The authors wish to thank the National Council for Science and Technology (CONACyT) for PhD scholarship support to EB, and FOMIXJal project no. 2010-10-149481 that supported the infrastructure for experimentation.	Akhtar M, 2007, IEEE INT WORK GENOM, P54; Akhtar M, 2008, IEEE J-STSP, V2, P310, DOI 10.1109/JSTSP.2008.923854; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anastassiou D, 2001, IEEE SIGNAL PROC MAG, V18, P8, DOI 10.1109/79.939833; Anastassiou D, 2000, BIOINFORMATICS, V16, P1073, DOI 10.1093/bioinformatics/16.12.1073; [Anonymous], [No title captured]; Antoniadis A., 2001, J STAT SOFTW, V6, P1, DOI [10.18637/jss.v006.i06, DOI 10.18637/JSS.V006.I06]; Antoniadis A, 2007, STAT SURV, V1, P16, DOI 10.1214/07-SS014; Bernaola-Galvan P, 2002, GENE, V300, P105, DOI 10.1016/S0378-1119(02)01037-5; Chakravarthy N, 2004, EURASIP J APPL SIG P, V2004, P13, DOI 10.1155/S111086570430925X; Cristea PD, 2002, J CELL MOL MED, V6, P279, DOI 10.1111/j.1582-4934.2002.tb00196.x; DEMELER B, 1991, NUCLEIC ACIDS RES, V19, P1593, DOI 10.1093/nar/19.7.1593; Donoho DL, 1995, J AM STAT ASSOC, V90, P1200, DOI 10.1080/01621459.1995.10476626; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Gabrielian A, 1996, FEBS LETT, V393, P65, DOI 10.1016/0014-5793(96)00855-1; Holden T, 2007, PROC SPIE, V6694, DOI 10.1117/12.732283; Hon Keung Kwan, 2009, 2009 IEEE International Conference on Electro/Information Technology (EIT '09), P307, DOI 10.1109/EIT.2009.5189632; Inbamalar TM, 2012, INT P COMP SCI INF T, V28, P1; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kotlar D, 2003, GENOME RES, V13, P1930, DOI 10.1101/gr.1261703; Liao B, 2004, CHEM PHYS LETT, V388, P195, DOI 10.1016/j.cplett.2004.02.089; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lorenzo-Ginori JV, 2009, CURR BIOINFORM, V4, P28, DOI 10.2174/157489309787158134; Marhon SA, 2011, J COMPUT BIOL, V18, P639, DOI 10.1089/cmb.2010.0184; Nair AS, 2006, BIOINFORMATION, V1, P197; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Panjkovich A, 2005, BIOINFORMATICS, V21, P711, DOI 10.1093/bioinformatics/bti066; Qi XQ, 2012, SCI WORLD J, DOI 10.1100/2012/104269; Qi XQ, 2011, EVOL BIOINFORM, V7, P149, DOI 10.4137/EBO.S7364; Ranawana R, 2005, NEURAL COMPUT APPL, V14, P122, DOI 10.1007/s00521-004-0447-7; Reese E, 2010, BIOINFORMATION, V4, P463, DOI 10.6026/97320630004463; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Vazquez RR, 2012, BIOMED SIGNAL PROCES, V7, P389, DOI 10.1016/j.bspc.2011.06.005; Rosen GL, 2009, CURR GENOMICS, V10, P493, DOI 10.2174/138920209789208255; Rushdi A., 2006, 2006 IEEE INT C AC S, P1024; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103; SILVERMAN BD, 1986, J THEOR BIOL, V118, P295, DOI 10.1016/S0022-5193(86)80060-1; Sims GE, 2009, P NATL ACAD SCI USA, V106, P2677, DOI 10.1073/pnas.0813249106; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STUDIER JA, 1988, MOL BIOL EVOL, V5, P729; Tang YY, 2001, LECT NOTES COMPUTER, V2251, DOI [10.1007/3-540-45333-4, DOI 10.1007/3-540-45333-4]; Tiwari S, 1997, COMPUT APPL BIOSCI, V13, P263; VELEZPEREZ H, 2008, C P INT C IEEE ENG M, P2606; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; VOSS RF, 1992, PHYS REV LETT, V68, P3805, DOI 10.1103/PhysRevLett.68.3805; Yan M, 1998, BIOINFORMATICS, V14, P685, DOI 10.1093/bioinformatics/14.8.685; Yin CC, 2005, J COMPUT BIOL, V12, P1153, DOI 10.1089/cmb.2005.12.1153; Yu JF, 2009, J THEOR BIOL, V261, P459, DOI 10.1016/j.jtbi.2009.08.005; Yu ZG, 2007, WMSCI 2007: 11TH WORLD MULTI-CONFERENCE ON SYSTEMICS, CYBERNETICS AND INFORMATICS, VOL I, PROCEEDINGS, P171; Zhang YS, 2011, J BIOMOL STRUCT DYN, V28, P557, DOI 10.1080/07391102.2011.10508595	53	20	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110954	10.1371/journal.pone.0110954	http://dx.doi.org/10.1371/journal.pone.0110954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393409	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300006
J	Fajs, L; Humolli, I; Saksida, A; Knap, N; Jelovsek, M; Korva, MA; Dedushaj, I; Avsic-Zupanc, T				Fajs, Luka; Humolli, Isme; Saksida, Ana; Knap, Natasa; Jelovsek, Mateja; Korva, Misa A.; Dedushaj, Isuf; Avsic-Zupanc, Tatjana			Prevalence of Crimean-Congo Hemorrhagic Fever Virus in Healthy Population, Livestock and Ticks in Kosovo	PLOS ONE			English	Article							VIRAL LOAD; SEROPREVALENCE; EPIDEMIOLOGY; PATHOGENESIS	Crimean-Congo hemorrhagic fever (CCHF) is an acute, tick borne disease often associated with hemorrhagic presentations and high case fatality rate. Kosovo is a highly endemic area for CCHF, with a significant case fatality rate. The aim of our study was to determine the prevalence of CCHF in Kosovo. We tested 1105 serum samples from healthy population in both endemic and non-endemic areas in the country. Our results revealed a seroprevalence of 4.0% (range 0-9.3%) which is comparable to the seroprevalence in other countries. We show that seroprevalence is correlated to the disease incidence in each studied municipality. We also tested 401 animal sera (353 cow, 30 sheep, 10 goat and 8 chicken) in four endemic municipalities in Kosovo. We detected specific antibodies in all animals except in chicken. Seroprevalence in cows is comparable to other endemic areas and correlates to the seroprevalence in humans. No CCHF RNA could be detected in 105 tick samples obtained in 2012 and 2013. Sequencing of CCHFV positive ticks from 2001 revealed that the virus is most closely related to viral strains that were detected in CCHF patients from Kosovo. Results suggest that mild CCHF cases are most probably underdiagnosed and consequently that the burden of disease is higher than reported. Our study provides key information for CCHF surveillance and raises awareness for possible imported cases in CCHF non-endemic countries.	[Fajs, Luka; Saksida, Ana; Knap, Natasa; Jelovsek, Mateja; Korva, Misa A.; Avsic-Zupanc, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia; [Humolli, Isme; Dedushaj, Isuf] Natl Inst Publ Hlth Kosovo, Pristina, Kosovo, Uruguay	University of Ljubljana	Avsic-Zupanc, T (corresponding author), Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.	tatjana.avsic@mf.uni-lj.si		Korva, Misa/0000-0003-1501-1004; AVSIC ZUPANC, TATJANA/0000-0001-6243-0688; Knap, Natasa/0000-0002-8068-7302	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme [260427]; European Virus Archive, FP7 CAPACITIES project, GA [228292]	European Commission under the Health Cooperation Work Programme of the 7th Framework Programme; European Virus Archive, FP7 CAPACITIES project, GA	This work is a part of the CCH Fever network (Collaborative Project) supported by the European Commission under the Health Cooperation Work Programme of the 7th Framework Programme (grant agreement no. 260427) and by European Virus Archive, FP7 CAPACITIES project, GA no. 228292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam IA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-178; Avsic-Zupanc T, 2007, CRIMEAN CONGO HEMORR, P328; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Bodur H, 2012, EMERG INFECT DIS, V18, P640, DOI 10.3201/eid1804.111374; Christova I, 2013, EMERG INFECT DIS, V19, P177, DOI 10.3201/eid1901.120299; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dokuzoguz B, 2013, CLIN INFECT DIS, V57, P1270, DOI 10.1093/cid/cit527; Duh D, 2006, J VIROL METHODS, V133, P175, DOI 10.1016/j.jviromet.2005.11.006; Duh D, 2007, EMERG INFECT DIS, V13, P1769, DOI 10.3201/eid1311.070222; Duh D, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-7; Durmisi E, 2011, VECTOR-BORNE ZOONOT, V11, P659, DOI 10.1089/vbz.2010.0054; Ertugrul B, 2012, SCAND J INFECT DIS, V44, P276, DOI 10.3109/00365548.2011.621445; Estrada-Pena A, 2012, VECTOR-BORNE ZOONOT, V12, P743, DOI 10.1089/vbz.2011.0767; Fajs L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002647; Gergova I, 2013, J VECTOR DIS, V50, P265; HOOGSTRAAL H, 1979, J MED ENTOMOL, V15, P307, DOI 10.1093/jmedent/15.4.307; Humolli Isme, 2010, Med Arh, V64, P91; Koksal I, 2013, EPIDEMIOL INFECT, V21, P1; Mostafavi E, 2013, AM J TROP MED HYG, V89, P1135, DOI 10.4269/ajtmh.12-0509; Mourya DT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001653; Rodriguez LL, 1997, AM J TROP MED HYG, V57, P512, DOI 10.4269/ajtmh.1997.57.512; Saksida A, 2010, CLIN VACCINE IMMUNOL, V17, P1086, DOI 10.1128/CVI.00530-09; Sidira P, 2012, CLIN MICROBIOL INFEC, V18, pE16, DOI 10.1111/j.1469-0691.2011.03718.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vanhomwegen J, 2012, EMERG INFECT DIS, V18, P1958, DOI 10.3201/eid1812.120710; Yagci-Caglayik D, 2014, J MED VIROL, V86, P306, DOI 10.1002/jmv.23699	26	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110982	10.1371/journal.pone.0110982	http://dx.doi.org/10.1371/journal.pone.0110982			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393542	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300007
J	Cheng, JQ; Gonzalez-Vallejo, C				Cheng, Jiuqing; Gonzalez-Vallejo, Claudia			Hyperbolic Discounting: Value and Time Processes of Substance Abusers and Non-Clinical Individuals in Intertemporal Choice	PLOS ONE			English	Article							DELAY; PERCEPTION; REWARDS	The single parameter hyperbolic model has been frequently used to describe value discounting as a function of time and to differentiate substance abusers and non-clinical participants with the model's parameter k. However, k says little about the mechanisms underlying the observed differences. The present study evaluates several alternative models with the purpose of identifying whether group differences stem from differences in subjective valuation, and/ or time perceptions. Using three two-parameter models, plus secondary data analyses of 14 studies with 471 indifference point curves, results demonstrated that adding a valuation, or a time perception function led to better model fits. However, the gain in fit due to the flexibility granted by a second parameter did not always lead to a better understanding of the data patterns and corresponding psychological processes. The k parameter consistently indexed group and context ( magnitude) differences; it is thus a mixed measure of person and task level effects. This was similar for a parameter meant to index payoff devaluation. A time perception parameter, on the other hand, fluctuated with contexts in a non-predicted fashion and the interpretation of its values was inconsistent with prior findings that supported enlarged perceived delays for substance abusers compared to controls. Overall, the results provide mixed support for hyperbolic models of intertemporal choice in terms of the psychological meaning afforded by their parameters.	[Cheng, Jiuqing; Gonzalez-Vallejo, Claudia] Ohio Univ, Dept Psychol, Athens, OH 45701 USA	Ohio University	Cheng, JQ (corresponding author), Ohio Univ, Dept Psychol, Athens, OH 45701 USA.	jc311609@ohio.edu	Gonzalez-Vallejo, Claudia/H-7681-2016					Aaberge R, 2001, REV INCOME WEALTH, P181; Andersen S, 2008, ECONOMETRICA, V76, P583, DOI 10.1111/j.1468-0262.2008.00848.x; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; Bickel WK, 2011, BIOL PSYCHIAT, V69, P260, DOI 10.1016/j.biopsych.2010.08.017; Burks SV, 2009, P NATL ACAD SCI USA, V106, P7745, DOI 10.1073/pnas.0812360106; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; Cheng JQ, 2012, EXP CLIN PSYCHOPHARM, V20, P400, DOI 10.1037/a0029657; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Espin AM, 2012, P ROY SOC B-BIOL SCI, V279, P4923, DOI 10.1098/rspb.2012.2043; ESTES WK, 1956, PSYCHOL BULL, V53, P134, DOI 10.1037/h0045156; Estle SJ, 2006, MEM COGNITION, V34, P914, DOI 10.3758/BF03193437; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; French S., 1986, DECISION THEORY INTR; Gonzalez-Vallejo C, 2001, ORGAN BEHAV HUM DEC, V86, P216, DOI 10.1006/obhd.2001.2953; GONZALEZVALLEJO C, 1992, J EXP PSYCHOL LEARN, V18, P855, DOI 10.1037/0278-7393.18.4.855; GONZALEZVALLEJO CC, 1994, AM J PSYCHOL, V107, P157, DOI 10.2307/1423035; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hadiati W, 2011, LONG QUEUES ZIMBABWE; Hunter J.E., 2004, METHODS META ANAL CO; Johnson MW, 2002, J EXP ANAL BEHAV, V77, P129, DOI 10.1901/jeab.2002.77-129; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; LOEWENSTEIN G, 1992, Q J ECON, V107, P573, DOI 10.2307/2118482; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McKerchar TL, 2009, BEHAV PROCESS, V81, P256, DOI 10.1016/j.beproc.2008.12.017; Meier S, 2012, PSYCHOL SCI, V23, P56, DOI 10.1177/0956797611425931; Mercer DE, 1999, INDIVIDUAL DRUG COUN; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Odum AL, 2000, DRUG ALCOHOL DEPEN, V60, P259, DOI 10.1016/S0376-8716(00)00111-3; Rachlin H, 2006, J EXP ANAL BEHAV, V85, P425, DOI 10.1901/jeab.2006.85-05; RODRIGUEZ ML, 1988, J EXP PSYCHOL ANIM B, V14, P105, DOI 10.1037/0097-7403.14.1.105; Roelofsma PHMP, 2000, J BEHAV DECIS MAKING, V13, P161, DOI 10.1002/(SICI)1099-0771(200004/06)13:2<161::AID-BDM348>3.0.CO;2-P; Scholten M, 2006, MANAGE SCI, V52, P1424, DOI 10.1287/mnsc.1060.0534; Scholten M, 2010, PSYCHOL REV, V117, P925, DOI 10.1037/a0019619; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SIDMAN M, 1952, PSYCHOL BULL, V49, P263, DOI 10.1037/h0063643; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Takahashi T, 2011, NEUROENDOCRINOL LETT, V32, P221; Wittmann M, 2007, DRUG ALCOHOL DEPEN, V90, P183, DOI 10.1016/j.drugalcdep.2007.03.005; Zauberman G, 2009, J MARKETING RES, V46, P543, DOI 10.1509/jmkr.46.4.543	42	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111378	10.1371/journal.pone.0111378	http://dx.doi.org/10.1371/journal.pone.0111378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390941	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400021
J	Goyal, U; Renvoise, B; Chang, J; Blackstone, C				Goyal, Uma; Renvoise, Benoit; Chang, Jaerak; Blackstone, Craig			Spastin-Interacting Protein NA14/SSNA1 Functions in Cytokinesis and Axon Development	PLOS ONE			English	Article							MICROTUBULE-SEVERING PROTEINS; AUTOSOMAL-DOMINANT; ESCRT-III; SUBCELLULAR-LOCALIZATION; NEURONAL DEVELOPMENT; SJOGRENS-SYNDROME; GENE DOSAGE; IN-VITRO; PARAPLEGIA; NA14	Hereditary spastic paraplegias (HSPs) are a genetically diverse group of inherited neurological disorders (SPG1-72) with the cardinal feature of prominent lower-extremity spasticity due to a length-dependent axonopathy of corticospinal motor neurons. The most frequent form of autosomal dominant HSP results from mutations of the SPG4 gene product spastin. This is an ATPase associated with diverse cellular activities (AAA) protein that binds to and severs microtubules. While spastin participates in crucial cellular processes such as cytokinesis, endosomal tubulation, and axon development, its role in HSP pathogenesis remains unclear. Spastin interacts in cells with the NA14 protein, a major target for auto-antibodies in Sjogren's syndrome (nuclear autoantigen 1; SSNA1). Our analysis of endogenous spastin and NA14 proteins in HeLa cells and rat cortical neurons in primary culture revealed a clear distribution of both proteins to centrosomes, with NA14 localizing specifically to centrioles. Stable NA14 knockdown in cell lines dramatically affected cell division, in particular cytokinesis. Furthermore, overexpression of NA14 in neurons significantly increased axon outgrowth and branching, while also enhancing neuronal differentiation. We postulate that NA14 may act as an adaptor protein regulating spastin localization to centrosomes, temporally and spatially regulating the microtubule-severing activity of spastin that is particularly critical during the cell cycle and neuronal development.	[Goyal, Uma; Renvoise, Benoit; Chang, Jaerak; Blackstone, Craig] NINDS, Cell Biol Sect, Neurogenet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Blackstone, C (corresponding author), NINDS, Cell Biol Sect, Neurogenet Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	blackstc@ninds.nih.gov		Chang, Jaerak/0000-0003-1732-2076	Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH); Howard Hughes Medical Institute-NIH Research Scholars Program; NIH Clinical Research Training Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002992] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH); Howard Hughes Medical Institute-NIH Research Scholars Program(Howard Hughes Medical Institute); NIH Clinical Research Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health (NIH). U.G. was supported by the Howard Hughes Medical Institute-NIH Research Scholars Program, and A.T. was supported by the NIH Clinical Research Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; Aki T, 2008, J CELL PHYSIOL, V217, P194, DOI 10.1002/jcp.21492; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016; Baas PW, 1996, MOL NEUROBIOL, V12, P145, DOI 10.1007/BF02740651; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; Charron F, 2007, ADV EXP MED BIOL, V621, P116, DOI 10.1007/978-0-387-76715-4_9; Claudiani P, 2005, EXP CELL RES, V309, P358, DOI 10.1016/j.yexcr.2005.06.009; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Denton KR, 2014, STEM CELLS, V32, P414, DOI 10.1002/stem.1569; Dogterom M, 2013, CURR OPIN CELL BIOL, V25, P23, DOI 10.1016/j.ceb.2012.12.002; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Gress TM, 1996, ONCOGENE, V13, P1819; HARDING AE, 1983, LANCET, V1, P1151; Havlicek S, 2014, HUM MOL GENET, V23, P2527, DOI 10.1093/hmg/ddt644; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Lee S, 2012, MOL BIOL CELL, V23, P4347, DOI 10.1091/mbc.E12-04-0292; McDermott CJ, 2003, ANN NEUROL, V54, P748, DOI 10.1002/ana.10757; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; Nozawa K, 2009, FRONT BIOSCI-LANDMRK, V14, P3733, DOI [10.2741/4084, 10.2741/3484]; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pfannenschmid F, 2003, J CELL SCI, V116, P1449, DOI 10.1242/jcs.00337; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Price HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031842; Ramos-Morales F, 1998, J BIOL CHEM, V273, P1634, DOI 10.1074/jbc.273.3.1634; Reid E, 2003, J MED GENET, V40, P81, DOI 10.1136/jmg.40.2.81; Renvoise B, 2012, HUM MOL GENET, V21, P3604, DOI 10.1093/hmg/dds191; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Riano E, 2009, J NEUROCHEM, V108, P1277, DOI 10.1111/j.1471-4159.2009.05875.x; Rodriguez-Rodriguez M, 2011, PROTEIN ENG DES SEL, V24, P883, DOI 10.1093/protein/gzr050; Schoppmeier J, 2005, CELL MOTIL CYTOSKEL, V61, P189, DOI 10.1002/cm.20074; Soderblom C, 2006, PHARMACOL THERAPEUT, V109, P42, DOI 10.1016/j.pharmthera.2005.06.001; Solowska JM, 2008, J NEUROSCI, V28, P2147, DOI 10.1523/JNEUROSCI.3159-07.2008; Stone MC, 2012, CELL REP, V2, P1340, DOI 10.1016/j.celrep.2012.09.032; Svenson IK, 2005, NEUROGENETICS, V6, P135, DOI 10.1007/s10048-005-0219-2; van Vlierberghe P, 2006, LEUKEMIA, V20, P1245, DOI 10.1038/sj.leu.2404247; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B	50	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112428	10.1371/journal.pone.0112428	http://dx.doi.org/10.1371/journal.pone.0112428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390646	Green Submitted, gold, Green Published			2022-12-26	WOS:000349144400080
J	Kohsaka, A; Das, P; Hashimoto, I; Nakao, T; Deguchi, Y; Gouraud, SS; Waki, H; Muragaki, Y; Maeda, M				Kohsaka, Akira; Das, Partha; Hashimoto, Izumi; Nakao, Tomomi; Deguchi, Yoko; Gouraud, Sabine S.; Waki, Hidefumi; Muragaki, Yasuteru; Maeda, Masanobu			The Circadian Clock Maintains Cardiac Function by Regulating Mitochondrial Metabolism in Mice	PLOS ONE			English	Article							ARNT-LIKE PROTEIN-1; CONTRACTILE FUNCTION; REDOX STATE; PPAR-ALPHA; CARDIOMYOCYTE; PRESSURE; HEART; RESPONSIVENESS; INTEGRATION; BIOGENESIS	Cardiac function is highly dependent on oxidative energy, which is produced by mitochondrial respiration. Defects in mitochondrial function are associated with both structural and functional abnormalities in the heart. Here, we show that heart-specific ablation of the circadian clock gene Bmal1 results in cardiac mitochondrial defects that include morphological changes and functional abnormalities, such as reduced enzymatic activities within the respiratory complex. Mice without cardiac Bmal1 function show a significant decrease in the expression of genes associated with the fatty acid oxidative pathway, the tricarboxylic acid cycle, and the mitochondrial respiratory chain in the heart and develop severe progressive heart failure with age. Importantly, similar changes in gene expression related to mitochondrial oxidative metabolism are also observed in C57BL/6J mice subjected to chronic reversal of the light-dark cycle; thus, they show disrupted circadian rhythmicity. These findings indicate that the circadian clock system plays an important role in regulating mitochondrial metabolism and thereby maintains cardiac function.	[Kohsaka, Akira; Das, Partha; Hashimoto, Izumi; Nakao, Tomomi; Deguchi, Yoko; Gouraud, Sabine S.; Waki, Hidefumi; Maeda, Masanobu] Wakayama Med Univ, Sch Med, Dept Physiol, Wakayama, Japan; [Muragaki, Yasuteru] Wakayama Med Univ, Sch Med, Dept Pathol 1, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Kohsaka, A (corresponding author), Wakayama Med Univ, Sch Med, Dept Physiol, Wakayama, Japan.	kohsaka@wakayama-med.ac.jp	Gouraud, Sabine S. S/N-3395-2018	Gouraud, Sabine S. S/0000-0002-4917-0647; Waki, Hidefumi/0000-0002-4278-2077	JSPS KAKENHI [25460316]; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by JSPS KAKENHI Grant Number 25460316 (to A. K.) and the Takeda Science Foundation (to A. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arjona A, 2012, TRENDS IMMUNOL, V33, P607, DOI 10.1016/j.it.2012.08.007; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Durgan DJ, 2011, CHRONOBIOL INT, V28, P187, DOI 10.3109/07420528.2010.550406; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Firsov D, 2010, KIDNEY INT, V78, P640, DOI 10.1038/ki.2010.227; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Hussain MM, 2009, TRENDS ENDOCRIN MET, V20, P177, DOI 10.1016/j.tem.2009.01.001; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lefta M, 2012, AM J PHYSIOL-HEART C, V303, pH475, DOI 10.1152/ajpheart.00238.2012; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Marin-Garcia J, 2005, DEV CARDIOVASC MED, P1; Marin-Garcia J, 2013, HEART FAIL REV, V18, P439, DOI 10.1007/s10741-012-9330-2; Mavroudis PD, 2013, J INNATE IMMUN, V5, P153, DOI 10.1159/000342427; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Pacha J, 2013, ACTA PHYSIOL, V208, P11, DOI 10.1111/apha.12090; Peek CB, 2012, TRENDS ENDOCRIN MET, V23, P312, DOI 10.1016/j.tem.2012.02.003; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Stow LR, 2011, J AM SOC NEPHROL, V22, P598, DOI 10.1681/ASN.2010080803; Tsai JY, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.077800; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213	50	69	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112811	10.1371/journal.pone.0112811	http://dx.doi.org/10.1371/journal.pone.0112811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389966	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400132
J	Schnyder, HA; Vanderelst, D; Bartenstein, S; Firzlaff, U; Luksch, H				Schnyder, Hans A.; Vanderelst, Dieter; Bartenstein, Sophia; Firzlaff, Uwe; Luksch, Harald			The Avian Head Induces Cues for Sound Localization in Elevation	PLOS ONE			English	Article							BARN OWL; LOCATION; PREY	Accurate sound source localization in three-dimensional space is essential for an animal's orientation and survival. While the horizontal position can be determined by interaural time and intensity differences, localization in elevation was thought to require external structures that modify sound before it reaches the tympanum. Here we show that in birds even without external structures like pinnae or feather ruffs, the simple shape of their head induces sound modifications that depend on the elevation of the source. Based on a model of localization errors, we show that these cues are sufficient to locate sounds in the vertical plane. These results suggest that the head of all birds induces acoustic cues for sound localization in the vertical plane, even in the absence of external ears.	[Schnyder, Hans A.; Bartenstein, Sophia; Firzlaff, Uwe; Luksch, Harald] Tech Univ Munich, Chair Zool, D-80290 Munich, Germany; [Vanderelst, Dieter] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Vanderelst, Dieter] Univ Antwerp, Act Percept Lab, B-2020 Antwerp, Belgium	Technical University of Munich; University of Bristol; University of Antwerp	Schnyder, HA (corresponding author), Tech Univ Munich, Chair Zool, D-80290 Munich, Germany.	hansa.schnyder@gmail.com		Firzlaff, Uwe/0000-0003-2803-3587; Luksch, Harald/0000-0002-9835-7715	Bernstein Center for Computational Neuroscience Munich (BMBF) fund [FKZ01GQ1004B]; Research Foundation - Flanders (FWO); Marie Curie Intra-European Fellowship	Bernstein Center for Computational Neuroscience Munich (BMBF) fund(Federal Ministry of Education & Research (BMBF)); Research Foundation - Flanders (FWO)(FWO); Marie Curie Intra-European Fellowship(European Commission)	The project was supported by a Bernstein Center for Computational Neuroscience Munich (BMBF) fund to HL (FKZ01GQ1004B), http://www.bccn-munich.de; a postdoctoral fellowship from the Research Foundation - Flanders (FWO); and a Marie Curie Intra-European Fellowship to DV, http://ec.europa.eu/research/mariecurieactions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blauert J., 1997, SPATIAL HEARING PSYC; Christensen-Dalsgaard J, 2005, SPR HDB AUD, V25, P67, DOI 10.1007/0-387-28863-5_4; Dooling RJ, 2000, SPR HDB AUD, V13, P308; Fay R. R., 1988, HEARING VERTEBRATES; Firzlaff U, 2003, HEARING RES, V185, P109, DOI 10.1016/S0378-5955(03)00278-8; GARDNER MB, 1973, J ACOUST SOC AM, V53, P400, DOI 10.1121/1.1913336; Harmening WM, 2011, J COMP PHYSIOL A, V197, P1031, DOI 10.1007/s00359-011-0664-3; Hausmann L, 2010, J COMP PHYSIOL A, V196, P601, DOI 10.1007/s00359-010-0546-0; Hausmann L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007721; Hill EM, 2014, J COMP PHYSL A; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Keller CH, 1998, HEARING RES, V118, P13, DOI 10.1016/S0378-5955(98)00014-8; Klump GM, 2000, SPR HDB AUD, V13, P249; Koka K, 2011, HEARING RES, V272, P135, DOI 10.1016/j.heares.2010.10.007; Larsen ON, 2004, AN ACAD BRAS CIENC, V76, P267, DOI 10.1590/S0001-37652004000200013; McAlpine D, 2003, TRENDS NEUROSCI, V26, P347, DOI 10.1016/S0166-2236(03)00140-1; Middlebrooks J, 1991, ANN REV PSYCHOL; Mills AW., 1972, FOUNDATIONS MODERN A, P303; MOISEFF A, 1989, J COMP PHYSIOL A, V164, P629, DOI 10.1007/BF00614505; MOORE BCJ, 1989, J ACOUST SOC AM, V85, P820, DOI 10.1121/1.397554; PAYNE RS, 1971, J EXP BIOL, V54, P535; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Reijniers J, 2014, BIOL CYBERN, V108, P169, DOI 10.1007/s00422-014-0588-4; Reijniers J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.148701; RICE WR, 1982, AUK, V99, P403; Vanderelst D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002268; Viete S, 1997, J NEUROSCI, V17, P1815; Welch TE, 2011, J ACOUST SOC AM, V130, P2293, DOI 10.1121/1.3628335; WIENER FM, 1947, J ACOUST SOC AM, V19, P444, DOI 10.1121/1.1916501; Witten IB, 2005, NEURON, V48, P489, DOI 10.1016/j.neuron.2005.10.020; WRIGHT D, 1974, J ACOUST SOC AM, V56, P957, DOI 10.1121/1.1903355; Young ED, 1996, J ACOUST SOC AM, V99, P3064, DOI 10.1121/1.414883	33	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112178	10.1371/journal.pone.0112178	http://dx.doi.org/10.1371/journal.pone.0112178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390036	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400060
J	Vieira, S; Martins, S; Hawkes, LA; Marco, A; Teodosio, MA				Vieira, Sara; Martins, Samir; Hawkes, Lucy A.; Marco, Adolfo; Alexandra Teodosio, M.			Biochemical Indices and Life Traits of Loggerhead Turtles (Caretta caretta) from Cape Verde Islands	PLOS ONE			English	Article							SEA-TURTLE; INCUBATION-TEMPERATURE; RNA/DNA RATIOS; SATELLITE TRACKING; MARINE TURTLES; ADULT FEMALE; BODY-SIZE; CONSERVATION; HATCHLINGS; DICHOTOMY	The loggerhead turtle (Caretta caretta) is an endangered marine reptile for whom assessing population health requires knowledge of demographic parameters such as individual growth rate. In Cape Verde, as within several populations, adult female loggerhead sea turtles show a size-related behavioral and trophic dichotomy. While smaller females are associated with oceanic habitats, larger females tend to feed in neritic habitats, which is reflected in their physiological condition and in their offspring. The ratio of RNA/DNA provides a measure of cellular protein synthesis capacity, which varies depending on changes in environmental conditions such as temperature and food availability. The purpose of this study was to evaluate the combined use of morphometric data and biochemical indices as predictors of the physiological condition of the females of distinct sizes and hatchlings during their nesting season and how temperature may influence the physiological condition on the offspring. Here we employed biochemical indices based on nucleic acid derived indices (standardized RNA/DNA ratio-sRD, RNA concentration and DNA concentration) in skin tissue as a potential predictor of recent growth rate in nesting females and hatchling loggerhead turtles. Our major findings were that the physiological condition of all nesting females (sRD) decreased during the nesting season, but that females associated with neritic habitats had a higher physiological condition than females associated with oceanic habitats. In addition, the amount of time required for a hatchling to right itself was negatively correlated with its physiological condition (sRD) and shaded nests produced hatchlings with lower sRD. Overall, our results showed that nucleic acid concentrations and ratios of RNA to DNA are an important tool as potential biomarkers of recent growth in marine turtles. Hence, as biochemical indices of instantaneous growth are likely temperature-, size- and age-dependent, the utility and validation of these indices on marine turtles stocks deserves further study.	[Vieira, Sara; Martins, Samir; Alexandra Teodosio, M.] Univ Algarve, Ctr Ciencias Mar, Faro, Portugal; [Hawkes, Lucy A.] Univ Exeter, Coll Life & Environm Sci, Penryn, Cornwall, England; [Marco, Adolfo] CSIC, Estn Biol Donana, E-41080 Seville, Spain	Universidade do Algarve; University of Exeter; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Teodosio, MA (corresponding author), Univ Algarve, Ctr Ciencias Mar, Campus Gambelas, Faro, Portugal.	mchichar@ualg.pt	Teodosio, M A/B-5077-2013; Marco, Adolfo/B-7118-2009; Hawkes, Lucy/L-7407-2014	Teodosio, M A/0000-0002-0939-9885; Marco, Adolfo/0000-0002-6523-9704; Hawkes, Lucy/0000-0002-6696-1862; Martins, Samir/0000-0003-3156-9630; Vieira, Sara/0000-0001-6113-1862	Cape Verde Ministry of Environment (General Direction for the Environment); INDP (National Fisheries Institution); Canary Islands Government (D.G. Africa); ICCM (Canarian Institution for Marine Sciences); Andalusian Government (Andalusian Environmental Office); AEGINA PROJECT (INTERREG IIIB); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; national funds through FCT [PEst-C/MAR/LA0015/2011]; Canary Islands Government (D.G. Research and Universities)	Cape Verde Ministry of Environment (General Direction for the Environment); INDP (National Fisheries Institution); Canary Islands Government (D.G. Africa); ICCM (Canarian Institution for Marine Sciences); Andalusian Government (Andalusian Environmental Office); AEGINA PROJECT (INTERREG IIIB); European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme; national funds through FCT(Portuguese Foundation for Science and Technology); Canary Islands Government (D.G. Research and Universities)	The authors thank the Cape Verde Ministry of Environment (General Direction for the Environment), INDP (National Fisheries Institution), the Canary Islands Government (D.G. Africa and D.G. Research and Universities), ICCM (Canarian Institution for Marine Sciences), the Andalusian Government (Andalusian Environmental Office) and AEGINA PROJECT (INTERREG IIIB) for funding and hosting them during this study. The authors also thank the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Programme, and national funds through FCT - PEst-C/MAR/LA0015/2011 for supporting the biochemical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral V, 2008, MAR FRESHWATER RES, V59, P726, DOI 10.1071/MF08006; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; BJORNDAL KA, 1995, COPEIA, P71; Booth DT, 2004, INT CONGR SER, V1275, P226, DOI 10.1016/j.ics.2004.08.057; Broad S, 2003, TRADE IN WILDLIFE: REGULATION FOR CONSERVATION, P3; Buckley LJ, 2008, MAR ECOL PROG SER, V371, P221, DOI 10.3354/meps07648; Caldarone EM, 2006, LIMNOL OCEANOGR-METH, V4, P153, DOI 10.4319/lom.2006.4.153; Caldarone EM, 2001, PROTOCOL GUIDE ESTIM; CHEREL Y, 1988, AM J PHYSIOL, V254, pR170, DOI 10.1152/ajpregu.1988.254.2.R170; Chicharo MA, 2003, FISH RES, V1525, P1; Chicharo MA, 2008, INT J MOL SCI, V9, P1453, DOI 10.3390/ijms9081453; Davenport J, 1997, J THERM BIOL, V22, P479, DOI 10.1016/S0306-4565(97)00066-1; Delmas V, 2007, BIOL J LINN SOC, V91, P99, DOI 10.1111/j.1095-8312.2007.00780.x; Dutton P.H., 1996, P INT S SEA TURTL CO, V396, P17, DOI [10.1051/parasite/2014024, DOI 10.1051/PARASITE/2014024]; Eder E, 2012, MAR ECOL PROG SER, V470, P113, DOI 10.3354/meps10018; Esteves E, 2000, J EXP MAR BIOL ECOL, V245, P43, DOI 10.1016/S0022-0981(99)00150-1; Frommel A, 2009, SCI MAR, V73, P159, DOI 10.3989/scimar.2009.73s1159; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Goldberg DW, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot016; Gyuris Emma, 2000, P143; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hamann M, 2002, J COMP PHYSIOL B, V172, P485, DOI [10.1002/s00360-002-0271-2, 10.1007/s00360-002-0271-2]; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hatase H, 2007, J ZOOL, V273, P46, DOI 10.1111/j.1469-7998.2007.00298.x; Hatase H, 2014, J EXP MAR BIOL ECOL, V455, P56, DOI 10.1016/j.jembe.2014.03.002; Hatase H, 2010, MAR BIOL, V157, P1337, DOI 10.1007/s00227-010-1413-9; Hawkes LA, 2006, CURR BIOL, V16, P990, DOI 10.1016/j.cub.2006.03.063; Hawkes LA, 2013, AQUAT BIOL, V18, P9, DOI 10.3354/ab00475; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Ikeda T, 2007, AQUAT BIOL, V1, P99, DOI 10.3354/ab00011; JANZEN FJ, 1993, ECOLOGY, V74, P332, DOI 10.2307/1939296; Ji X, 2002, J EXP ZOOL, V292, P649, DOI 10.1002/jez.10101; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; LIMPUS CJ, 1979, HERPETOLOGICA, V35, P335; LIMPUS CJ, 1992, WILDLIFE RES, V19, P457, DOI 10.1071/WR9920457; Limpus CJ, 1993, FAUNA OF AUSTR, V2, P113; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Marco A, 2012, ANIM CONSERV, V15, P351, DOI 10.1111/j.1469-1795.2012.00547.x; Meyer S, 2012, J MARINE SYST, V93, P11, DOI 10.1016/j.jmarsys.2011.09.010; Miller Jeffrey D., 1997, P51; Monzon-Arguello C, 2010, CONSERV GENET, V11, P1871, DOI 10.1007/s10592-010-0079-7; Mortimer Jeanne A., 1999, P175; Ozdemir A, 2007, ZOOL SCI, V24, P376, DOI 10.2108/zsj.24.376; Packard G.C., 1988, Biology of Reptilia, V16, P523; Pendoley KL, 2014, MAR BIOL, V161, P1455, DOI 10.1007/s00227-014-2433-7; Perrault JR, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou002; Olivar MP, 2009, SCI MAR, V73, P171, DOI 10.3989/scimar.2009.73s1171; PINCKNEY J, 1990, B MAR SCI, V47, P670; Plot V, 2013, PHYSIOL BIOCHEM ZOOL, V86, P385, DOI 10.1086/671127; Rafferty AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021038; Roark AM, 2009, J EXP MAR BIOL ECOL, V376, P59, DOI 10.1016/j.jembe.2009.06.004; Seminoff JA, 2008, J EXP MAR BIOL ECOL, V356, P52, DOI 10.1016/j.jembe.2007.12.007; Steyermark AC, 2001, COPEIA, P129; VANBUSKIRK J, 1994, COPEIA, P66; Varo Cruz Nuria, 2007, P127; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wood A, 2014, J EXP MAR BIOL ECOL, V451, P105, DOI 10.1016/j.jembe.2013.11.005; Zbinden JA, 2011, MAR ECOL PROG SER, V421, P291, DOI 10.3354/meps08871	59	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112181	10.1371/journal.pone.0112181	http://dx.doi.org/10.1371/journal.pone.0112181			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390348	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400061
J	Hussain, S; Nasare, V; Kumari, M; Sharma, S; Khan, MA; Das, BC; Bharadwaj, M				Hussain, Showket; Nasare, Vilas; Kumari, Malasha; Sharma, Shashi; Khan, Mohammad Aijaz; Das, Bhudev C.; Bharadwaj, Mausumi			Perception of Human Papillomavirus Infection, Cervical Cancer and HPV Vaccination in North Indian Population	PLOS ONE			English	Article							COLLEGE-STUDENTS; PARENTAL ACCEPTANCE; FEMALE STUDENTS; SOUTHERN WOMEN; RISK-FACTORS; YOUNG-WOMEN; RURAL INDIA; KNOWLEDGE; AWARENESS; ATTITUDES	Background: Human Papillomavirus (HPV) -associated cervical cancer is the second-most common cancer in women worldwide but it is the most frequent gynaecological cancer and cancer associated death in India women. The objective of this study was to assess knowledge about cervical cancer, HPV, HPV vaccine, HPV vaccine acceptance among school and undergraduates students and their parent's perception about acceptance of HPV vaccine in Northern part of India (Delhi and NCR regions). Materials and Methods: A qualitative questionnaire based survey among 2500 urban/rural students aged 12-22 years was conducted. Results: Overall, a low frequency (15%) of HPV and cervical cancer awareness was observed in students and their parents. However, the awareness was much higher in females belonging to urban setup compared to boys with a perception that HPV causes cervical cancer in women only. Additionally, only (13%) participants who were aware of cervical cancer and HPV) were willing to accept HPV vaccination. Apparently, parents of female students were two times more willing to accept HPV vaccination for their ward than male students (p<0.001; OR 95%CI = 2.09 (1.58-2.76). Conclusion: Cervical cancer and HPV awareness among school, undergraduate students and also to their parents was found to be very low in this part of India. The level of awareness and education appears to be insignificant determinants in rural compared to urban setup. Better health education will be needed to maximize public awareness for cervical cancer prevention.	[Hussain, Showket; Nasare, Vilas; Bharadwaj, Mausumi] Inst Cytol & Prevent Oncol ICMR, Div Mol Genet & Biochem, Noida, Uttar Pradesh, India; [Kumari, Malasha] Inst Cytol & Prevent Oncol ICMR, Div Clin Oncol, Noida, Uttar Pradesh, India; [Sharma, Shashi] Inst Cytol & Prevent Oncol ICMR, Div Biostat & Epidemiol, Noida, Uttar Pradesh, India; [Khan, Mohammad Aijaz] Inst Cytol & Prevent Oncol ICMR, Div Behav Oncol, Noida, Uttar Pradesh, India; [Das, Bhudev C.] Inst Cytol & Prevent Oncol ICMR, Div Mol Oncol, Noida, Uttar Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cancer Prevention & Research (NICPR)	Khan, MA (corresponding author), Inst Cytol & Prevent Oncol ICMR, Div Behav Oncol, Noida, Uttar Pradesh, India.	madrkhan@gmail.com; bharadwajm@icmr.org.in		Nasare, Vilas/0000-0002-0016-9610				Abotchie PN, 2009, INT J GYNECOL CANCER, V19, P412, DOI 10.1111/IGC.0b013e3181a1d6de; Bair RM, 2008, J PEDIATR ADOL GYNEC, V21, P329, DOI 10.1016/j.jpag.2008.02.007; Bharadwaj M, 2009, INDIAN J MED RES, V130, P327; Bingham A, 2009, ARCH PEDIAT ADOL MED, V163, P455, DOI 10.1001/archpediatrics.2009.50; Brabin L, 2006, VACCINE, V24, P3087, DOI 10.1016/j.vaccine.2006.01.048; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Brinton L A, 1992, IARC Sci Publ, P3; BRINTON LA, 1989, AM J EPIDEMIOL, V130, P486, DOI 10.1093/oxfordjournals.aje.a115362; Caskey R, 2009, J ADOLESCENT HEALTH, V45, P453, DOI 10.1016/j.jadohealth.2009.04.021; Cates JR, 2012, PERSPECT SEX REPRO H, V44, P39, DOI 10.1363/4403912; Cates JR, 2009, J RURAL HEALTH, V25, P93, DOI 10.1111/j.1748-0361.2009.00204.x; Chelimo C, 2010, SEX HEALTH, V7, P394, DOI 10.1071/SH10005; Conroy K, 2009, J WOMENS HEALTH, V18, P1679, DOI 10.1089/jwh.2008.1329; Constantine NA, 2007, J ADOLESCENT HEALTH, V40, P108, DOI 10.1016/j.jadohealth.2006.10.007; Crosby R, 2007, SEX HEALTH, V4, P71, DOI 10.1071/SH06046; Das BC, 2008, VACCINE, V26, P2669, DOI 10.1016/j.vaccine.2008.03.056; Dell DL, 2000, OBSTET GYNECOL, V96, P653, DOI 10.1016/S0029-7844(00)01009-7; Dempsey AF, 2006, PEDIATRICS, V117, P1486, DOI 10.1542/peds.2005-1381; Di Giuseppe G, 2008, BRIT J CANCER, V99, P225, DOI 10.1038/sj.bjc.6604454; Dinh TA, 2007, J ADOLESCENT HEALTH, V40, P559, DOI 10.1016/j.jadohealth.2007.02.003; Donadiki EM, 2012, HUM VACCIN IMMUNOTHE, V9; DUrso J, 2007, J AM COLL HEALTH, V56, P159, DOI 10.3200/JACH.56.2.159-164; Fazekas KI, 2008, J WOMENS HEALTH, V17, P539, DOI 10.1089/jwh.2007.0489; Gerend MA, 2008, J ADOLESCENT HEALTH, V42, P237, DOI 10.1016/j.jadohealth.2007.08.022; Gerend MA, 2007, SEX TRANSM DIS, V34, P468, DOI 10.1097/01.olq.0000245915.38315.bd; Gottvall M, 2009, EUR J CONTRACEP REPR, V14, P399, DOI 10.3109/13625180903229605; Hilton S, 2011, VACCINE, V29, P4409, DOI 10.1016/j.vaccine.2011.03.101; Holly EA, 1996, ANNU REV PUBL HEALTH, V17, P69; Hoover D R, 2000, Health Care Women Int, V21, P375; Hoque ME, 2013, J CANCER RES THER, V9, P25, DOI 10.4103/0973-1482.110350; Hsu Yu-Yun, 2011, Oncol Nurs Forum, V38, pE297, DOI 10.1188/11.ONF.E297-E304; Hussain S, 2012, J MED VIROL, V84, P298, DOI 10.1002/jmv.22261; Joy T, 2011, ASIAN PAC J CANCER P, V12, P1707; Kahn JA, 2008, OBSTET GYNECOL, V111, P1103, DOI 10.1097/AOG.0b013e31817051fa; Kamzol W, 2013, EUR J OBSTET GYN R B, V166, P196, DOI 10.1016/j.ejogrb.2012.10.019; Kim JJ, 2009, ANN INTERN MED, V151, P538, DOI 10.7326/0003-4819-151-8-200910200-00007; 한유정, 2007, Obstetrics & Gynecology Science, V50, P1090; Klug SJ, 2008, PREV MED, V46, P87, DOI 10.1016/j.ypmed.2007.09.003; Kohaar I, 2007, CELL ONCOL, V29, P249; Kohaar I, 2009, HUM IMMUNOL, V70, P222, DOI 10.1016/j.humimm.2009.01.003; Lambert E C, 2001, J Am Board Fam Pract, V14, P178; Lee PWH, 2007, PREV MED, V45, P130, DOI 10.1016/j.ypmed.2007.07.013; Lenselink CH, 2008, EUR J OBSTET GYN R B, V137, P103, DOI 10.1016/j.ejogrb.2007.02.012; Li J, 2009, VACCINE, V27, P1210, DOI 10.1016/j.vaccine.2008.12.020; Lopez R., 2007, CALIFORNIAN J HLTH P, V5, P12, DOI [10.32398/cjhp.v5i3.1246, DOI 10.32398/CJHP.V5I3.1246]; Marlow LAV, 2007, VACCINE, V25, P1945, DOI 10.1016/j.vaccine.2007.01.059; Mehta Sumita, 2013, Indian J Community Med, V38, P92, DOI 10.4103/0970-0218.112438; Morison LA, 2010, BRIT J HEALTH PSYCH, V15, P151, DOI 10.1348/135910709X437092; Nnodu Obiageli, 2010, Afr J Reprod Health, V14, P95; Ogilvie GS, 2007, CAN MED ASSOC J, V177, P1506, DOI 10.1503/cmaj.071022; Oh JK, 2010, VACCINE, V28, P1854, DOI 10.1016/j.vaccine.2009.11.079; Pandey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040619; PARAZZINI F, 1989, BRIT J CANCER, V59, P805, DOI 10.1038/bjc.1989.168; Pelucchi C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-378; Pitts MK, 2007, SEX HEALTH, V4, P177, DOI 10.1071/SH07023; Pitts MK, 2010, SEX HEALTH, V7, P299, DOI 10.1071/SH09150; Ralston JD, 2003, J COMMUN HEALTH, V28, P41, DOI 10.1023/A:1021381105325; Saha A, 2010, ASIAN PAC J CANCER P, V11, P1085; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sehgal A, 2009, INDIAN J MED RES, V130, P234; Singh E, 2012, J GYNECOL ONCOL, V23, P141, DOI 10.3802/jgo.2012.23.3.141; Sperber NR, 2008, CANCER CAUSE CONTROL, V19, P115, DOI 10.1007/s10552-007-9074-9; Tiro JA, 2008, CANCER-AM CANCER SOC, V113, P3013, DOI 10.1002/cncr.23760; Uzunlar O, 2013, VACCINE, V31, P2191, DOI 10.1016/j.vaccine.2013.01.033; Vogtmann E, 2011, HEALTH SOC CARE COMM, V19, P148, DOI 10.1111/j.1365-2524.2010.00954.x; Walsh CD, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-368; Wheeler CM, 2007, NAT CLIN PRACT ONCOL, V4, P224, DOI 10.1038/ncponc0770; Wong LP, 2009, SINGAP MED J, V50, P49; Woodhall SC, 2007, J ADOLESCENT HEALTH, V40, P466, DOI 10.1016/j.jadohealth.2007.01.005; Zimet GD, 2006, VACCINE, V24, P201, DOI 10.1016/j.vaccine.2006.06.017	70	33	34	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112861	10.1371/journal.pone.0112861	http://dx.doi.org/10.1371/journal.pone.0112861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386964	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400097
J	Li, YX; Zhang, GP; Galvin, JJ; Fu, QJ				Li, Yongxin; Zhang, Guoping; Galvin, John J., III; Fu, Qian-Jie			Mandarin Speech Perception in Combined Electric and Acoustic Stimulation	PLOS ONE			English	Article							COCHLEAR IMPLANT USERS; USE HEARING-AIDS; FUNDAMENTAL-FREQUENCY; BIMODAL HEARING; TONE RECOGNITION; OPPOSITE EARS; CHILDREN; BENEFITS; INFORMATION; CONJUNCTION	For deaf individuals with residual low-frequency acoustic hearing, combined use of a cochlear implant (CI) and hearing aid (HA) typically provides better speech understanding than with either device alone. Because of coarse spectral resolution, CIs do not provide fundamental frequency (F0) information that contributes to understanding of tonal languages such as Mandarin Chinese. The HA can provide good representation of F0 and, depending on the range of aided acoustic hearing, first and second formant (F1 and F2) information. In this study, Mandarin tone, vowel, and consonant recognition in quiet and noise was measured in 12 adult Mandarin-speaking bimodal listeners with the CI-only and with the CI+HA. Tone recognition was significantly better with the CI+HA in noise, but not in quiet. Vowel recognition was significantly better with the CI+HA in quiet, but not in noise. There was no significant difference in consonant recognition between the CI-only and the CI+HA in quiet or in noise. There was a wide range in bimodal benefit, with improvements often greater than 20 percentage points in some tests and conditions. The bimodal benefit was compared to CI subjects' HA-aided pure-tone average (PTA) thresholds between 250 and 2000 Hz; subjects were divided into two groups: "better'' PTA (<50 dB HL) or "poorer'' PTA (>50 dB HL). The bimodal benefit differed significantly between groups only for consonant recognition. The bimodal benefit for tone recognition in quiet was significantly correlated with CI experience, suggesting that bimodal CI users learn to better combine low-frequency spectro-temporal information from acoustic hearing with temporal envelope information from electric hearing. Given the small number of subjects in this study (n = 12), further research with Chinese bimodal listeners may provide more information regarding the contribution of acoustic and electric hearing to tonal language perception.	[Li, Yongxin; Zhang, Guoping] Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China; [Galvin, John J., III; Fu, Qian-Jie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA	Capital Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fu, QJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	qfu@mednet.ucla.edu			National Institute of Health [R01-DC004792, R01-DC004993]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004993, R01DC004792] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	QF and JG were supported by the National Institute of Health, grants R01-DC004792 and R01-DC004993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown CA, 2009, EAR HEARING, V30, P489, DOI 10.1097/AUD.0b013e3181ab2b87; Chen ZN, 2009, ORL-J OTO-RHIN-LARYN, V71, P187, DOI 10.1159/000229296; Ching TYC, 2004, EAR HEARING, V25, P9, DOI 10.1097/01.AUD.0000111261.84611.C8; Dillon MT, 2014, J AM ACAD AUDIOL, V25, P133, DOI 10.3766/jaaa.25.2.2; Dorman MF, 2008, AUDIOL NEURO-OTOL, V13, P105, DOI 10.1159/000111782; Fu Q-J, 2000, ASIA PAC J SPEECH LA, V5, P45, DOI DOI 10.1179/136132800807547582; Fu QJ, 1998, J ACOUST SOC AM, V104, P505, DOI 10.1121/1.423251; Fu QJ, 2004, EAR HEARING, V25, P501, DOI 10.1097/01.aud.0000145125.50433.19; Geurts L, 2004, J ACOUST SOC AM, V115, P844, DOI 10.1121/1.1642623; Geurts L, 2001, J ACOUST SOC AM, V109, P713, DOI 10.1121/1.1340650; Gifford RH, 2007, J SPEECH LANG HEAR R, V50, P835, DOI 10.1044/1092-4388(2007/058); Green T, 2005, J ACOUST SOC AM, V118, P375, DOI 10.1121/1.1925827; Gstoettner W, 2004, ACTA OTO-LARYNGOL, V124, P348, DOI 10.1080/00016480410016432; Hamzavi J, 2004, INT J AUDIOL, V43, P61, DOI 10.1080/14992020400050010; Huang T S, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P294; Jang JH, 2014, OTOL NEUROTOL; Kiefer J, 2005, AUDIOL NEURO-OTOL, V10, P134, DOI 10.1159/000084023; Kong YY, 2011, J SPEECH LANG HEAR R, V54, P959, DOI 10.1044/1092-4388(2010/10-0197); Kong YY, 2005, J ACOUST SOC AM, V117, P1351, DOI 10.1121/1.1857526; Lee KYS, 2002, INT J PEDIATR OTORHI, V63, P137, DOI 10.1016/S0165-5876(02)00005-8; Li B, 2014, INT J PEDIATR OTORHI, V78, P1000, DOI 10.1016/j.ijporl.2014.03.020; Lin M., 1988, J CHINESE LINGUIST, V204, P182; Luo X, 2008, EAR HEARING, V29, P957, DOI 10.1097/AUD.0b013e3181888f61; Luo X, 2006, J ACOUST SOC AM, V120, P2260, DOI 10.1121/1.2336990; Luo X, 2009, HEARING RES, V256, P75, DOI 10.1016/j.heares.2009.07.001; Mok M, 2006, J SPEECH LANG HEAR R, V49, P338, DOI 10.1044/1092-4388(2006/027); Morera C, 2012, ACTA OTO-LARYNGOL, V132, P1084, DOI 10.3109/00016489.2012.677546; Neuman AC, 2013, EAR HEARING, V34, P553, DOI 10.1097/AUD.0b013e31828e86e8; Shannon RV, 2004, ACTA OTO-LARYNGOL, V124, P50, DOI 10.1080/03655230410017562; Sheffield BM, 2012, J ACOUST SOC AM, V131, P518, DOI 10.1121/1.3662074; Sheffield SW, 2014, AUDIOL NEURO-OTOL, V19, P151, DOI 10.1159/000357588; Tao D, 2014, EAR HEAR; Turner CW, 2004, J ACOUST SOC AM, V115, P1729, DOI 10.1121/1.1687425; Wang RH, 1993, STANDARD CHINESE DAT; Wang WQ, 2011, INT J AUDIOL, V50, P270, DOI 10.3109/14992027.2010.542490; Wei WI, 2000, ACTA OTO-LARYNGOL, V120, P218; WHALEN DH, 1992, PHONETICA, V49, P25, DOI 10.1159/000261901; Wu JL, 2006, INT J PEDIATR OTORHI, V70, P207, DOI 10.1016/j.ijporl.2005.06.013; Wu JL, 2003, INT J PEDIATR OTORHI, V67, P247, DOI 10.1016/S0165-5876(02)00378-6; Xin L, 2004, J ACOUST SOC AM, V116, P3659, DOI 10.1121/1.1783352; Yoon YS, 2012, J SPEECH LANG HEAR R, V55, P105, DOI 10.1044/1092-4388(2011/10-0325); Zhang T, 2013, EAR HEARING, V34, P133, DOI 10.1097/AUD.0b013e31826709af; Zhang T, 2012, EAR HEARING, V33, pE70, DOI 10.1097/AUD.0b013e318259e5dd; Zhang T, 2010, EAR HEARING, V31, P63, DOI 10.1097/AUD.0b013e3181b7190c; Zhou N, 2013, OTOL NEUROTOL, V34, P499, DOI 10.1097/MAO.0b013e318287ca86	45	9	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112471	10.1371/journal.pone.0112471	http://dx.doi.org/10.1371/journal.pone.0112471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386962	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400064
J	Rajasundaram, D; Runavot, JL; Guo, XY; Willats, WGT; Meulewaeter, F; Selbig, J				Rajasundaram, Dhivyaa; Runavot, Jean-Luc; Guo, Xiaoyuan; Willats, William G. T.; Meulewaeter, Frank; Selbig, Joachim			Understanding the Relationship between Cotton Fiber Properties and Non-Cellulosic Cell Wall Polysaccharides	PLOS ONE			English	Article							PARTIAL LEAST-SQUARES; CARBOHYDRATE MICROARRAYS; MONOCLONAL-ANTIBODIES; ARABINOGALACTAN-PROTEIN; GENE-EXPRESSION; ELONGATION; PECTIN; BIOINFORMATICS; BINDING; ARRAY	A detailed knowledge of cell wall heterogeneity and complexity is crucial for understanding plant growth and development. One key challenge is to establish links between polysaccharide-rich cell walls and their phenotypic characteristics. It is of particular interest for some plant material, like cotton fibers, which are of both biological and industrial importance. To this end, we attempted to study cotton fiber characteristics together with glycan arrays using regression based approaches. Taking advantage of the comprehensive microarray polymer profiling technique (CoMPP), 32 cotton lines from different cotton species were studied. The glycan array was generated by sequential extraction of cell wall polysaccharides from mature cotton fibers and screening samples against eleven extensively characterized cell wall probes. Also, phenotypic characteristics of cotton fibers such as length, strength, elongation and micronaire were measured. The relationship between the two datasets was established in an integrative manner using linear regression methods. In the conducted analysis, we demonstrated the usefulness of regression based approaches in establishing a relationship between glycan measurements and phenotypic traits. In addition, the analysis also identified specific polysaccharides which may play a major role during fiber development for the final fiber characteristics. Three different regression methods identified a negative correlation between micronaire and the xyloglucan and homogalacturonan probes. Moreover, homogalacturonan and callose were shown to be significant predictors for fiber length. The role of these polysaccharides was already pointed out in previous cell wall elongation studies. Additional relationships were predicted for fiber strength and elongation which will need further experimental validation.	[Rajasundaram, Dhivyaa; Selbig, Joachim] Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany; [Rajasundaram, Dhivyaa; Selbig, Joachim] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Runavot, Jean-Luc; Meulewaeter, Frank] Bayer CropSci NV, Innovat Ctr, B-9052 Ghent, Belgium; [Guo, Xiaoyuan; Willats, William G. T.] Univ Copenhagen, Fac Sci, Dept Plant & Environm Sci, DK-1871 Frederiksberg C, Denmark	University of Potsdam; Max Planck Society; Bayer AG; Bayer CropScience; University of Copenhagen	Selbig, J (corresponding author), Univ Potsdam, Inst Biochem & Biol, D-14476 Potsdam, Germany.	jselbig@uni-potsdam.de	; Runavot, Jean-Luc/F-6930-2012	Meulewaeter, Frank/0000-0002-3589-6471; Runavot, Jean-Luc/0000-0001-5451-2616	European Union Seventh Framework Programme (FP7) under the WallTraC project [263916]	European Union Seventh Framework Programme (FP7) under the WallTraC project	This work was supported by the European Union Seventh Framework Programme (FP7 2007-2013) under the WallTraC project (grant agreement No. 263916). This paper reflects the authors' views only. The European Community is not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Aoki-Kinoshita KF, 2006, CURR OPIN MOL THER, V8, P514; Avci U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056315; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; Bowling AJ, 2011, PROTOPLASMA, V248, P579, DOI 10.1007/s00709-010-0212-y; Bowman MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082634; Bryan MC, 2004, TETRAHEDRON LETT, V45, P3639, DOI 10.1016/j.tetlet.2004.03.035; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chapple C, 1998, CURR OPIN PLANT BIOL, V1, P179, DOI 10.1016/S1369-5266(98)80022-8; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; de Paz JL, 2006, J AM CHEM SOC, V128, P2766, DOI 10.1021/ja057584v; Dejean S., 2013, MIXOMICS OMICS DATA; Disney MD, 2007, BIOCHEMISTRY-US, V46, P11223, DOI 10.1021/bi701071h; Ekins R, 1999, TRENDS BIOTECHNOL, V17, P217, DOI 10.1016/S0167-7799(99)01329-3; Ellis M, 2010, PLANT PHYSIOL, V153, P403, DOI 10.1104/pp.110.156000; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Gilbert MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-403; Goldberg R, 1996, PROGR BIOTECHNOL, V14, P151, DOI 10.1016/S0921-0423(96)80253-X; Gonzalez I, 2009, J BIOL SYST, V17, P173, DOI 10.1142/S0218339009002831; Gonzalez I, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-19; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Gupta G, 2010, OMICS, V14, P419, DOI 10.1089/omi.2009.0150; Haigler CH, 2012, FRONT PLANT SCI, P3; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hanson SR, 2007, J AM CHEM SOC, V129, P7266, DOI 10.1021/ja0724083; Hao ZY, 2014, CRIT REV BIOCHEM MOL, V49, P212, DOI 10.3109/10409238.2014.889651; HEREDIA A, 1995, Z LEBENSM UNTERS FOR, V200, P24, DOI 10.1007/BF01192903; Hsu TL, 2007, P NATL ACAD SCI USA, V104, P2614, DOI 10.1073/pnas.0611307104; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; Huang GQ, 2013, PLANT PHYSIOL, V161, P1278, DOI 10.1104/pp.112.203760; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Lacape JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048855; Lawrie CH, 2006, INT J CANCER, V118, P3161, DOI 10.1002/ijc.21762; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Liang PH, 2007, J AM CHEM SOC, V129, P11177, DOI 10.1021/ja072931h; LUTZ JG, 1994, EDUC PSYCHOL MEAS, V54, P666, DOI 10.1177/0013164494054003009; Marchal I, 2003, BIOCHIMIE, V85, P75, DOI 10.1016/S0300-9084(03)00068-3; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCann M, 2010, PLANT PHYSIOL, V153, P365, DOI 10.1104/pp.110.900324; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; Minorsky Peter V., 2002, Plant Physiology (Rockville), V128, P345, DOI 10.1104/pp.900022; Moller I, 2008, GLYCOCONJUGATE J, V25, P37, DOI 10.1007/s10719-007-9059-7; Morris GA, 2010, BIOTECHNOL GENET ENG, V27, P257, DOI 10.1080/02648725.2010.10648153; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Park S, 2008, CHEM COMMUN, P4389, DOI 10.1039/b806699j; Pedersen HL, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.396598; Pettolino FA, 2001, PLANTA, V214, P235, DOI 10.1007/s004250100606; Pilling E, 2003, CURR OPIN PLANT BIOL, V6, P611, DOI 10.1016/j.pbi.2003.09.004; Qin LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059115; R Core Team, 2013, LANG ENV STAT COMP; Rambani A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-3; Ratner DM, 2007, CURR PHARM DESIGN, V13, P173, DOI 10.2174/138161207779313650; Rencher A.C., 2003, METHODS MULTIVARIATE, P361, DOI [DOI 10.1002/0471271357.CH11, 10.1002/0471271357.ch11]; Roberts K, 2001, PLANT PHYSIOL, V125, P127, DOI 10.1104/pp.125.1.127; Ruan YL, 2004, PLANT PHYSIOL, V136, P4104, DOI 10.1104/pp.104.051540; SADAVA D, 1973, DEV BIOL, V30, P49, DOI 10.1016/0012-1606(73)90047-X; Salnikov VV, 2003, PROTOPLASMA, V221, P175, DOI 10.1007/s00709-002-0079-7; Schena M, 1996, BIOESSAYS, V18, P427, DOI 10.1002/bies.950180513; Schneider A, 2010, DTSCH ARZTEBL INT, V107, P776, DOI [10.3238/arztebl.2010.0799, 10.3238/arztebl.2010.0776]; Shin I, 2005, CHEM-EUR J, V11, P2894, DOI 10.1002/chem.200401030; Singh B, 2009, PLANT PHYSIOL, V150, P684, DOI 10.1104/pp.109.135459; SMALLWOOD M, 1994, PLANT J, V5, P237, DOI 10.1046/j.1365-313X.1994.05020237.x; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Tabachnick B. G.., 2012, USING MULTIVARIATE S; Tenenhaus A, 2014, BIOSTATISTICS, V15, P569, DOI 10.1093/biostatistics/kxu001; Thakur BR, 1997, CRIT REV FOOD SCI, V37, P47, DOI 10.1080/10408399709527767; Thompson B., 1984, CANONICAL CORRELATIO; Tokumoto H, 2002, PLANT CELL PHYSIOL, V43, P411, DOI 10.1093/pcp/pcf048; Uchiyama N, 2006, METHOD ENZYMOL, V415, P341, DOI 10.1016/S0076-6879(06)15021-1; Vaughn KC, 1999, PROTOPLASMA, V209, P226, DOI 10.1007/BF01453451; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; von der Lieth CW, 2004, BRIEF BIOINFORM, V5, P164, DOI 10.1093/bib/5.2.164; Wang DN, 2003, PROTEOMICS, V3, P2167, DOI 10.1002/pmic.200300601; Wang HH, 2010, PLANT MOL BIOL, V72, P397, DOI 10.1007/s11103-009-9578-7; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang RB, 2005, METH MOL B, V310, P241; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; Willats WGT, 2000, CARBOHYD RES, V327, P309, DOI 10.1016/S0008-6215(00)00039-2; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131	87	10	11	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112168	10.1371/journal.pone.0112168	http://dx.doi.org/10.1371/journal.pone.0112168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383868	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700037
J	Van Campenhout, J; Derycke, S; Moens, T; Vanreusel, A				Van Campenhout, Jelle; Derycke, Sofie; Moens, Tom; Vanreusel, Ann			Differences in Life-Histories Refute Ecological Equivalence of Cryptic Species and Provide Clues to the Origin of Bathyal Halomonhystera (Nematoda)	PLOS ONE			English	Article							FREE-LIVING MARINE; BRACKISH-WATER NEMATODES; MOSBY-MUD-VOLCANO; MONHYSTERA-DISJUNCTA; GENETIC-STRUCTURE; TEMPERATURE; COEXISTENCE; SALINITY; NICHE; SPECIATION	The discovery of morphologically very similar but genetically distinct species complicates a proper understanding of the link between biodiversity and ecosystem functioning. Cryptic species have been frequently observed to co-occur and are thus expected to be ecological equivalent. The marine nematode Halomonhystera disjuncta contains five cryptic species (GD1-5) that co-occur in the Westerschelde estuary. In this study, we investigated the effect of three abiotic factors (salinity, temperature and sulphide) on life-history traits of three cryptic H. disjuncta species (GD1-3). Our results show that temperature had the most profound influence on all life-cycle parameters compared to a smaller effect of salinity. Life-history traits of closely related cryptic species were differentially affected by temperature, salinity and presence of sulphides which shows that cryptic H. disjuncta species are not ecologically equivalent. Our results further revealed that GD1 had the highest tolerance to a combination of sulphides, high salinities and low temperatures. The close phylogenetic position of GD1 to Halomonhystera hermesi, the dominant species in sulphidic sediments of the Hakon Mosby mud volcano (Barent Sea, 1280 m depth), indicates that both species share a recent common ancestor. Differential life-history responses to environmental changes among cryptic species may have crucial consequences for our perception on ecosystem functioning and coexistence of cryptic species.	[Van Campenhout, Jelle; Derycke, Sofie; Moens, Tom; Vanreusel, Ann] Univ Ghent, Dept Biol, Res Grp Marine Biol, B-9000 Ghent, Belgium; [Van Campenhout, Jelle; Derycke, Sofie; Moens, Tom] Univ Ghent, Ctr Mol Phylogenet & Evolut CeMoFe, B-9000 Ghent, Belgium	Ghent University; Ghent University	Van Campenhout, J (corresponding author), Univ Ghent, Dept Biol, Res Grp Marine Biol, B-9000 Ghent, Belgium.	Jelle.Vancampenhout@ugent.be	Moens, Tom/AAB-8701-2019		GOA funds from Ghent University; 7th FP MIDAS [603418]	GOA funds from Ghent University; 7th FP MIDAS	This work was supported by GOA funds from Ghent University and by the 7th FP MIDAS (Grant agreement No. 603418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2003, INT J PLANT SCI, V164, pS1, DOI 10.1086/374729; Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Anderson M. J., 2008, PLYMOUTH; [Anonymous], 2004, PERMDISP FORTRAN COM; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bik HM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-389; Boffe A, 1985, VERGELIJKEND TOXICOL, P70; Bottcher ME, 2000, CONT SHELF RES, V20, P1749, DOI 10.1016/S0278-4343(00)00046-7; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Cothran RD, 2013, OIKOS, V122, P1429, DOI 10.1111/j.1600-0706.2013.00294.x; Cunning R, 2013, CORAL REEFS, V32, P795, DOI 10.1007/s00338-013-1036-y; De Meester N, 2011, MAR BIOL, V158, P2717, DOI 10.1007/s00227-011-1769-5; De Meester N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042674; De Oliveira DAS, 2012, ZOOL J LINN SOC-LOND, V164, P18, DOI 10.1111/j.1096-3642.2011.00758.x; Derycke S, 2008, MOL ECOL, V17, P3306, DOI 10.1111/j.1365-294X.2008.03846.x; Derycke S, 2007, LIMNOL OCEANOGR, V52, P992, DOI 10.4319/lo.2007.52.3.0992; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; FERRIS H, 1995, SOIL BIOL BIOCHEM, V27, P319, DOI 10.1016/0038-0717(94)00186-5; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Gabaldon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057087; GERLACH SA, 1971, MAR BIOL, V9, P274, DOI 10.1007/BF00351390; Gomez A, 2002, EVOLUTION, V56, P1431; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Jelle V, 2014, J ZOOL SYST EVOL RES, V52, P203, DOI 10.1111/jzs.12054; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Lambshead PJD, 2003, J BIOGEOGR, V30, P475, DOI 10.1046/j.1365-2699.2003.00843.x; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levins R., 1968, EVOLUTION CHANGING E; LEVINTON JS, 1970, LETHAIA, V3, P69, DOI 10.1111/j.1502-3931.1970.tb01264.x; Lonsdale DJ, 1998, J MARINE SYST, V15, P1, DOI 10.1016/S0924-7963(97)00044-4; Lowe CD, 2007, MAR BIOL, V150, P377, DOI 10.1007/s00227-006-0366-5; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P137, DOI 10.1016/S0022-0981(99)00114-8; Moens T, 1998, HELGOLANDER MEERESUN, V52, P115, DOI 10.1007/BF02908742; Moens T, 2000, J EXP MAR BIOL ECOL, V243, P115, DOI 10.1016/S0022-0981(99)00113-6; Moens T, 1999, FEEDING ECOLOGY FREE; Mokievsky VO, 2005, OCEANOLOGY+, V45, P689; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021530; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020314; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; Ott J, 2004, SYMBIOSIS, V36, P103; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Portnova D, 2010, 14 INT MEIOF C FOURT, P174; Sauter EJ, 2006, EARTH PLANET SC LETT, V243, P354, DOI 10.1016/j.epsl.2006.01.041; Schmidt AL, 2012, LIMNOL OCEANOGR, V57, P1389, DOI 10.4319/lo.2012.57.5.1389; Smith KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051219; STANHOPE MJ, 1992, J CHEM ECOL, V18, P1871, DOI 10.1007/BF02751110; Tahseen Qudsia, 2012, Biodiversity Journal, V3, P13; Tchesunov AV, 2015, HELGOLAND MAR RES, V69, P57, DOI 10.1007/s10152-014-0416-1; Thiermann F, 2000, MAR ECOL PROG SER, V193, P251, DOI 10.3354/meps193251; TROTTER D, 1983, MAR BIOL, V78, P39, DOI 10.1007/BF00392969; Van Gaever S, 2006, MAR ECOL PROG SER, V321, P143, DOI 10.3354/meps321143; Van Gaever S, 2009, MAR BIOL, V156, P1289, DOI 10.1007/s00227-009-1170-9; VRANKEN G, 1988, MAR ENVIRON RES, V26, P161, DOI 10.1016/0141-1136(88)90025-6; VRANKEN G, 1989, MAR ENVIRON RES, V27, P127, DOI 10.1016/0141-1136(89)90004-4; Vranken G., 1984, Ecotoxiciological testing for the marine environmental. Volume 2., P271; Vranken G., 1987, Mededelingen van de Koninklijke Academie voor Wetenschappen Letteren en Schone Kunsten van Belgie Klasse der Wetenschappen, V49, P73; VRANKEN G, 1988, OECOLOGIA, V77, P296, DOI 10.1007/BF00378033; VRANKEN G, 1985, DIS AQUAT ORGAN, V1, P49, DOI 10.3354/dao001049; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; Westram AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069576; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Zhang DY, 1998, J THEOR BIOL, V193, P465, DOI 10.1006/jtbi.1998.0712; Zhao YL, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/564093	71	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111889	10.1371/journal.pone.0111889	http://dx.doi.org/10.1371/journal.pone.0111889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384013	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700022
J	Zipkin, AM; Wagner, M; McGrath, K; Brooks, AS; Lucas, PW				Zipkin, Andrew M.; Wagner, Mark; McGrath, Kate; Brooks, Alison S.; Lucas, Peter W.			An Experimental Study of Hafting Adhesives and the Implications for Compound Tool Technology	PLOS ONE			English	Article							MIDDLE STONE-AGE; RESIDUE ANALYSIS; HOWIESONS POORT; COMPLEX COGNITION; OCHRE; CAVE; IDENTIFICATION; AFRICA	Experimental studies of hafting adhesives and modifications to compound tool components can demonstrate the extent to which human ancestors understood and exploited material properties only formally defined by science within the last century. Discoveries of Stone Age hafting adhesives at archaeological sites in Europe, the Middle East, and Africa have spurred experiments that sought to replicate or create models of such adhesives. Most of these studies, however, have been actualistic in design, focusing on replicating ancient applications of adhesive technology. In contrast, this study tested several glues based on Acacia resin within a materials science framework to better understand the effect of each adhesive ingredient on compound tool durability. Using an overlap joint as a model for a compound tool, adhesives formulated with loading agents from a range of particle sizes and mineral compositions were tested for toughness on smooth and rough substrates. Our results indicated that overlap joint toughness is significantly increased by using a roughened joint surface. Contrary to some previous studies, there was no evidence that particle size diversity in a loading agent improved adhesive effectiveness. Generally, glues containing quartz or ochre loading agents in the silt and clay-sized particle class yielded the toughest overlap joints, with the effect of particle size found to be more significant for rough rather than smooth substrate joints. Additionally, no particular ochre mineral or mineral mixture was found to be a clearly superior loading agent. These two points taken together suggest that Paleolithic use of ochre-loaded adhesives and the criteria used to select ochres for this purpose may have been mediated by visual and symbolic considerations rather than purely functional concerns.	[Zipkin, Andrew M.; McGrath, Kate; Brooks, Alison S.; Lucas, Peter W.] George Washington Univ, Ctr Adv Study Hominid Paleobiol, Dept Anthropol, Washington, DC 20052 USA; [Wagner, Mark] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC USA; [Brooks, Alison S.] US Natl Museum Nat Hist, Smithsonian Inst, Human Origins Program, Washington, DC USA; [Lucas, Peter W.] Kuwait Univ, Dept Bioclin Sci, Kuwait, Kuwait	George Washington University; George Washington University; Smithsonian Institution; Smithsonian National Museum of Natural History; Kuwait University	Zipkin, AM (corresponding author), George Washington Univ, Ctr Adv Study Hominid Paleobiol, Dept Anthropol, Washington, DC 20052 USA.	amzipkin@gwmail.gwu.edu	Zipkin, Andrew M/AAI-9285-2020	Zipkin, Andrew M/0000-0002-3813-8051; McGrath, Kate/0000-0003-1533-4313	National Science Foundation [DGE-0801634, 2011116368, BCS-1240694]; Wenner-Gren Foundation [8623]; Direct For Social, Behav & Economic Scie [1240694] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This study was made possible by funding from National Science Foundation (http://www.nsf.gov/) grants IGERT #DGE-0801634, GRF #2011116368, and DDIG #BCS-1240694 and Wenner-Gren Foundation (http://www.wennergren.org/) grant DFG #8623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN J, 1986, ANTHROPOLOGIE, V90, P713; Allen KW, 1996, INT J ADHES ADHES, V16, P47, DOI 10.1016/0143-7496(96)88486-7; Ambrose SH, 2010, CURR ANTHROPOL, V51, pS135, DOI 10.1086/650296; [Anonymous], 1999, JOINT FAO WHO EXP CO; Barham LS, 2013, HAND HANDLE 1 IND RE, P177; Boeda E, 1999, ANTIQUITY, V73, P394, DOI 10.1017/S0003598X00088335; Boeda E, 2008, ANTIQUITY, V82, P853, DOI 10.1017/S0003598X00097623; Brandt SA, 2002, ARCHAEOLOGY, V55, P50; Carciumaru M, 2012, J ARCHAEOL SCI, V39, P1942, DOI 10.1016/j.jas.2012.02.016; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40, P3506, DOI 10.1016/j.jas.2012.12.026; Delagnes A., 2006, SO AFRICAN HUMANITIE, V18, P43; EVANS AG, 1990, MAT SCI ENG A-STRUCT, V126, P53, DOI 10.1016/0921-5093(90)90113-H; Fauvelle M, 2012, J ARCHAEOL SCI, V39, P2802, DOI 10.1016/j.jas.2012.04.014; Frey SH, 2007, CORTEX, V43, P368, DOI 10.1016/S0010-9452(08)70462-3; Frison GC, 1991, PREHISTORIC HUNTERS, P39; Gibson N. E., 2004, SOUTH AFR HUMANIT, V16, P1; Groom P, 2015, ARCHAEOL ANTHROP SCI, V7, P47, DOI 10.1007/s12520-013-0144-5; Grunberg JM, 2002, ANTIQUITY, V76, P15, DOI 10.1017/S0003598X00089638; Helwig K, 2014, J ARCHAEOL SCI, V41, P655, DOI 10.1016/j.jas.2013.09.010; Hodgskiss T, 2005, MIX REPLICATION STUD, P15; Islam AM, 1997, FOOD HYDROCOLLOID, V11, P493, DOI 10.1016/S0268-005X(97)80048-3; KENDALL K, 1975, J PHYS D APPL PHYS, V8, P512, DOI 10.1088/0022-3727/8/5/010; Kendall K, 2001, MOL ADHESION ITS APP, P353; LAHREN L, 1974, SCIENCE, V186, P147, DOI 10.1126/science.186.4159.147; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Mazza PPA, 2006, J ARCHAEOL SCI, V33, P1310, DOI 10.1016/j.jas.2006.01.006; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Monnier GF, 2013, J ARCHAEOL SCI, V40, P3722, DOI 10.1016/j.jas.2013.03.018; Palgrave KC, 1984, TREES SO AFRICA, P463; Pawlik AF, 2011, J ARCHAEOL SCI, V38, P1699, DOI 10.1016/j.jas.2011.03.001; Powell O, 2013, ECON BOT, V67, P210, DOI 10.1007/s12231-013-9238-3; Rots V, 2014, PROJECTILES ABUSE US; TANKERSLEY KB, 1994, J ARCHAEOL SCI, V21, P117, DOI 10.1006/jasc.1994.1012; Wadley L, 2005, J HUM EVOL, V49, P587, DOI 10.1016/j.jhevol.2005.06.007; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L, 2010, CURR ANTHROPOL, V51, pS111, DOI 10.1086/649836; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Weniger G. C., 2000, CHASSE PREHISTOIRE, P79; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910; Wilkins J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104514; Wilkins J, 2012, SCIENCE, V338, P942, DOI 10.1126/science.1227608; Williamson BS, 2004, S AFR J SCI, V100, P174; Wynn T, 2009, P NATL ACAD SCI USA, V106, P9544, DOI 10.1073/pnas.0904369106	46	33	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112560	10.1371/journal.pone.0112560	http://dx.doi.org/10.1371/journal.pone.0112560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AT3DP	25383871	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700082
J	Singh, S; Simpson, RL; Bennett, RG				Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.			Relaxin Activates Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) through a Pathway Involving PPAR gamma Coactivator 1 alpha ( PGC1 alpha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY PEPTIDE RECEPTORS; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); PARENCHYMAL ARTERIOLES; INTERNATIONAL-UNION; SIGNALING PATHWAYS; HORMONE; LIGANDS; CELLS; GLUCONEOGENESIS; ROSIGLITAZONE	Relaxin activation of its receptor RXFP1 triggers multiple signaling pathways. Previously, we have shown that relaxin activates PPAR gamma transcriptional activity in a ligand-independent manner, but the mechanism for this effect was unknown. In this study, we examined the signaling pathways of downstream of RXFP1 leading to PPAR gamma activation. Using cells stably expressing RXFP1, we found that relaxin regulation of PPAR gamma activity requires accumulation of cAMP and subsequent activation of cAMP-dependent protein kinase (PKA). The activated PKA subsequently phosphorylated cAMP response element-binding protein (CREB) at Ser-133 to activate it directly, as well as indirectly through mitogen activated protein kinase p38 MAPK. Activated CREB was required for relaxin stimulation of PPAR gamma activity, while there was no evidence for a role of the nitric oxide or ERK MAPK pathways. Relaxin increased the mRNA and protein levels of the coactivator protein PGC1 alpha, and this effect was dependent on PKA, and was completely abrogated by a dominant-negative form of CREB. This mechanism was confirmed in a hepatic stellate cell line stably that endogenously expresses RXFP1. Reduction of PGC1 alpha levels using siRNA diminished the regulation of PPAR gamma by relaxin. These results suggest that relaxin activates the cAMP/PKA and p38 MAPK pathways to phosphorylate CREB, resulting in increased PGC1 alpha levels. This provides a mechanism for the ligand-independent activation of PPAR gamma in response to relaxin.	[Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.] Nebraska Western Iowa Hlth Care Syst, Dept Vet Affairs, Med Res Serv, Omaha, NE 68105 USA; [Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA; [Singh, Sudhir; Simpson, Ronda L.; Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Bennett, RG (corresponding author), Dept Med Res 151, 4101 Woolworth Ave, Omaha, NE 68105 USA.	rgbennet@unmc.edu			Dept. of Veterans Affairs Biomedical Laboratory Research & Development Program [BX000849]; National Institutes of Health NIAAA [R01 AA015509]; Bly Memorial Research Fund; University of Nebraska Medical Center Graduate College Fellowship; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015509] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000849] Funding Source: NIH RePORTER	Dept. of Veterans Affairs Biomedical Laboratory Research & Development Program; National Institutes of Health NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Bly Memorial Research Fund; University of Nebraska Medical Center Graduate College Fellowship; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by funding through the Dept. of Veterans Affairs Biomedical Laboratory Research & Development Program (BX000849), National Institutes of Health NIAAA (R01 AA015509), the Bly Memorial Research Fund (to R. G. B.), and by a University of Nebraska Medical Center Graduate College Fellowship (to S. S.).	Baccari MC, 2008, CURR PROTEIN PEPT SC, V9, P638, DOI 10.2174/138920308786733921; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bennett RG, 2003, BIOCHEM PHARMACOL, V66, P867, DOI 10.1016/S0006-2952(03)00403-9; Bennett RG, 2007, BIOCHEM PHARMACOL, V73, P1033, DOI 10.1016/j.bcp.2006.12.007; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Chan SL, 2013, FASEB J, V27, P3917, DOI 10.1096/fj.13-230797; Chan SL, 2011, FASEB J, V25, P3229, DOI 10.1096/fj.10-175471; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; DAY RN, 1989, J BIOL CHEM, V264, P431; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Dschietzig T, 2003, CIRC RES, V92, P32, DOI 10.1161/01.RES.0000051884.27117.7E; Fallowfield JA, 2014, HEPATOLOGY, V59, P1492, DOI 10.1002/hep.26627; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Genovese T, 2005, EUR RESPIR J, V25, P225, DOI 10.1183/09031936.05.00049704; Halls ML, 2007, BRIT J PHARMACOL, V150, P677, DOI 10.1038/sj.bjp.0707140; Halls ML, 2009, ANN NY ACAD SCI, V1160, P108, DOI 10.1111/j.1749-6632.2008.03814.x; Halls ML, 2006, MOL PHARMACOL, V70, P214, DOI 10.1124/mol.105.021691; Halls ML, 2007, J PHARMACOL EXP THER, V320, P281, DOI 10.1124/jpet.106.113225; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hirate Y, 2012, CONNECT TISSUE RES, V53, P207, DOI 10.3109/03008207.2011.628060; Hong T, 2011, AM J PHYSIOL-ENDOC M, V300, pE500, DOI 10.1152/ajpendo.00225.2010; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Iglarz M, 2003, HYPERTENSION, V42, P737, DOI 10.1161/01.HYP.0000083511.91817.B1; Ivell R, 2005, ANN NY ACAD SCI, V1041, P280, DOI 10.1196/annals.1282.041; Ivell R, 2007, ADV EXP MED BIOL, V612, P26; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Moon JS, 2014, J BONE MINER RES, V29, P1586, DOI 10.1002/jbmr.2197; Nguyen BT, 2005, ANN NY ACAD SCI, V1041, P296, DOI 10.1196/annals.1282.044; Nguyen BT, 2003, MOL ENDOCRINOL, V17, P1075, DOI 10.1210/me.2002-0284; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Sasser JM, 2013, AM J PHYSIOL-REG I, V305, pR559, DOI 10.1152/ajpregu.00528.2012; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Singh S, 2010, MOL CELL ENDOCRINOL, V315, P239, DOI 10.1016/j.mce.2009.08.014; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsukamoto H, 2006, J GASTROEN HEPATOL, V21, pS102, DOI 10.1111/j.1440-1746.2006.04573.x; Wright DC, 2007, J BIOL CHEM, V282, P18793, DOI 10.1074/jbc.M611252200; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zhang Q, 2002, J CELL BIOCHEM, V85, P536, DOI 10.1002/jcb.10150	52	44	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					950	959		10.1074/jbc.M114.589325	http://dx.doi.org/10.1074/jbc.M114.589325			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25389293	hybrid, Green Published			2022-12-26	WOS:000347778200029
J	Kim, E; Lin, Y; Kerney, R; Blumenberg, L; Bishop, C				Kim, Eunsoo; Lin, Yuan; Kerney, Ryan; Blumenberg, Lili; Bishop, Cory			Phylogenetic Analysis of Algal Symbionts Associated with Four North American Amphibian Egg Masses	PLOS ONE			English	Article							AMBYSTOMATID SALAMANDERS CAUDATA; GREEN-ALGAE; EMBRYONIC-DEVELOPMENT; SEQUENCE COMPARISONS; MOLECULAR PHYLOGENY; SPOTTED SALAMANDER; HATCHING SUCCESS; SSU RDNA; MACULATUM; CHLOROPHYCEAE	Egg masses of the yellow-spotted salamander Ambystoma maculatum form an association with the green alga "Oophila amblystomatis'' (Lambert ex Wille), which, in addition to growing within individual egg capsules, has recently been reported to invade embryonic tissues and cells. The binomial O. amblystomatis refers to the algae that occur in A. maculatum egg capsules, but it is unknown whether this population of symbionts constitutes one or several different algal taxa. Moreover, it is unknown whether egg masses across the geographic range of A. maculatum, or other amphibians, associate with one or multiple algal taxa. To address these questions, we conducted a phylogeographic study of algae sampled from egg capsules of A. maculatum, its allopatric congener A. gracile, and two frogs: Lithobates sylvatica and L. aurora. All of these North American amphibians form associations with algae in their egg capsules. We sampled algae from egg capsules of these four amphibians from localities across North America, established representative algal cultures, and amplified and sequenced a region of 18S rDNA for phylogenetic analysis. Our combined analysis shows that symbiotic algae found in egg masses of four North American amphibians are closely related to each other, and form a well-supported clade that also contains three strains of free-living chlamydomonads. We designate this group as the 'Oophila' clade, within which the symbiotic algae are further divided into four distinct subclades. Phylogenies of the host amphibians and their algal symbionts are only partially congruent, suggesting that host-switching and co-speciation both play roles in their associations. We also established conditions for isolating and rearing algal symbionts from amphibian egg capsules, which should facilitate further study of these egg mass specialist algae.	[Kim, Eunsoo; Blumenberg, Lili] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Kim, Eunsoo; Blumenberg, Lili] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Lin, Yuan; Bishop, Cory] St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada; [Kerney, Ryan] Gettysburg Coll, Dept Biol, Gettysburg, PA 17325 USA	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Saint Francis Xavier University - Canada; Gettysburg College	Kim, E (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	ekim1@amnh.org; cbishop@stfx.ca		Blumenberg, Lili/0000-0002-4886-8752	Natural Sciences and Engineering Research Council of Canada; Direct For Biological Sciences [1428065, 1428062] Funding Source: National Science Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the Natural Sciences and Engineering Research Council of Canada - Discovery Grant to CB (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp). EK and RK were funded by startup grants by their respective institutions, which are intramural by definition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN MD, 1986, CAN J ZOOL, V64, P1586, DOI 10.1139/z86-239; Bianchini K, 2012, PHYSIOL BIOCHEM ZOOL, V85, P470, DOI 10.1086/667407; Collins FS, 1905, PHYCOTHECA BOREALI A, P1267; Gatz J, 1973, J HERPETOL, V7, P137; Gilbert PW, 1944, ECOLOGY, V25, P366, DOI 10.2307/1931284; Gilbert PW, 1942, ECOLOGY, V23, P215, DOI 10.2307/1931088; Gilbert S. F., 2008, ECOLOGICAL DEV BIOL; GOFF LJ, 1978, LIFE SCI, V22, P1463, DOI 10.1016/0024-3205(78)90641-0; Gontcharov AA, 2004, MOL BIOL EVOL, V21, P612, DOI 10.1093/molbev.msh052; Gontcharov AA, 2003, J MOL EVOL, V56, P89, DOI 10.1007/s00239-002-2383-4; Graham ER, 2013, J EXP BIOL, V216, P452, DOI 10.1242/jeb.076711; HARDY LM, 1991, COMP BIOCHEM PHYS A, V100, P653, DOI 10.1016/0300-9629(91)90385-P; Harrison R.G, 1969, ORG DEV EMBRYO, V1, P44; Hoham RW, 2002, J PHYCOL, V38, P1051, DOI 10.1046/j.1529-8817.2002.t01-1-01227.x; Hoshina R, 2008, PROTIST, V159, P53, DOI 10.1016/j.protis.2007.08.002; JONES TR, 1993, SYST BIOL, V42, P92, DOI 10.2307/2992560; Kawaida H, 2013, MOL PHYLOGENET EVOL, V66, P906, DOI 10.1016/j.ympev.2012.11.018; Kerney R, 2011, SYMBIOSIS, V54, P107, DOI 10.1007/s13199-011-0134-2; Kerney R, 2011, P NATL ACAD SCI USA, V108, P6497, DOI 10.1073/pnas.1018259108; Kim E, 2006, MOL BIOL EVOL, V23, P2455, DOI 10.1093/molbev/msl120; Kim E, 2013, PROTIST, V164, P160, DOI 10.1016/j.protis.2012.10.002; Lee R., 2008, PHYCOLOGY, VFourth, DOI DOI 10.1016/j.energy.2014.06.023; Maddison WP, 2011, MESQUITE MODULAR SYS; Nakada T, 2008, MOL PHYLOGENET EVOL, V48, P281, DOI 10.1016/j.ympev.2008.03.016; NatureServe and IUCN (International Union for Conservation of Nature), 2007, IUCN 2012 IUCN RED L; ORR H, 1888, Q J MICRO SCI N S, V115, P483; PINDER AW, 1994, J EXP BIOL, V197, P17; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2018, R LANG ENV STAT COMP; RUTH BC, 1993, J HERPETOL, V27, P306, DOI 10.2307/1565152; Sacerdote AB, 2009, WETLANDS, V29, P1202, DOI 10.1672/08-235.1; SAGER R, 1954, J GEN PHYSIOL, V37, P729, DOI 10.1085/jgp.37.6.729; SHAFFER HB, 1991, SYST ZOOL, V40, P284, DOI 10.2307/2992323; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tattersall GJ, 2008, CAN J ZOOL, V86, P1289, DOI 10.1139/Z08-115; Valls JH, 2007, J EXP BIOL, V210, P2430, DOI 10.1242/jeb.003541; Wantanabe MM, 2000, MICROALGAE PROTOZOA; Wille N, 1909, 7 ABTEILUNG CHLOROPH, V6; Yumoto K, 2013, J MICROBIOL CULT COL, V29, P1; Zamudio KR, 2003, EVOLUTION, V57, P1631	42	14	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e108915	10.1371/journal.pone.0108915	http://dx.doi.org/10.1371/journal.pone.0108915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393119	gold, Green Published			2022-12-26	WOS:000347709300002
J	Verstrepen, BE; Oostermeijer, H; Fagrouch, Z; van Heteren, M; Niphuis, H; Haaksma, T; Kondova, I; Bogers, WM; de Filette, M; Sanders, N; Stertman, L; Magnusson, S; Lorincz, O; Lisziewicz, J; Barzon, L; Palu, G; Diamond, MS; Chabierski, S; Ulbert, S; Verschoor, EJ				Verstrepen, Babs E.; Oostermeijer, Herman; Fagrouch, Zahra; van Heteren, Melanie; Niphuis, Henk; Haaksma, Tom; Kondova, Ivanela; Bogers, Willy M.; de Filette, Marina; Sanders, Niek; Stertman, Linda; Magnusson, Sofia; Lorincz, Orsolya; Lisziewicz, Julianna; Barzon, Luisa; Palu, Giorgio; Diamond, Michael S.; Chabierski, Stefan; Ulbert, Sebastian; Verschoor, Ernst J.			Vaccine-Induced Protection of Rhesus Macaques against Plasma Viremia after Intradermal Infection with a European Lineage 1 Strain of West Nile Virus	PLOS ONE			English	Article							CYCLE FLAVIVIRUS VACCINE; CD8(+) T-CELLS; IMMUNE-RESPONSES; PRECLINICAL EVALUATION; ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; UNITED-STATES; REPLIVAX WN; MICE; IMMUNOGENICITY	The mosquito-borne West Nile virus (WNV) causes human and animal disease with outbreaks in several parts of the world including North America, the Mediterranean countries, Central and East Europe, the Middle East, and Africa. Particularly in elderly people and individuals with an impaired immune system, infection with WNV can progress into a serious neuroinvasive disease. Currently, no treatment or vaccine is available to protect humans against infection or disease. The goal of this study was to develop a WNV-vaccine that is safe to use in these high-risk human target populations. We performed a vaccine efficacy study in non-human primates using the contemporary, pathogenic European WNV genotype 1a challenge strain, WNV-Ita09. Two vaccine strategies were evaluated in rhesus macaques (Macaca mulatta) using recombinant soluble WNV envelope (E) ectodomain adjuvanted with Matrix-M, either with or without DNA priming. The DNA priming immunization was performed with WNV-DermaVir nanoparticles. Both vaccination strategies successfully induced humoral and cellular immune responses that completely protected the macaques against the development of viremia. In addition, the vaccine was well tolerated by all animals. Overall, The WNV E protein adjuvanted with Matrix-M is a promising vaccine candidate for a non-infectious WNV vaccine for use in humans, including at-risk populations.	[Verstrepen, Babs E.; Oostermeijer, Herman; Fagrouch, Zahra; Niphuis, Henk; Bogers, Willy M.; Verschoor, Ernst J.] BPRC, Dept Virol, Rijswijk, Netherlands; [Haaksma, Tom; Kondova, Ivanela] BPRC, Dept Anim Sci, Div Pathol & Microbiol, Rijswijk, Netherlands; [de Filette, Marina; Sanders, Niek] Univ Ghent, Fac Vet Sci, Lab Gene Therapy, Merelbeke, Belgium; [Stertman, Linda; Magnusson, Sofia] Novavax AB, Uppsala, Sweden; [Lorincz, Orsolya; Lisziewicz, Julianna] eMMUNITY Inc, Budapest, Hungary; [Barzon, Luisa; Palu, Giorgio] Univ Padua, Dept Mol Med, Padua, Italy; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Med Mol Microbiol & Pathol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Immunol, St Louis, MO USA; [Chabierski, Stefan; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany	Ghent University; University of Padua; Washington University (WUSTL); Washington University (WUSTL); Fraunhofer Gesellschaft	Verschoor, EJ (corresponding author), BPRC, Dept Virol, Rijswijk, Netherlands.	verschoor@bprc.nl	Barzon, Luisa/K-7961-2016; Diamond, Michael/AAH-1733-2019	Barzon, Luisa/0000-0003-0720-8456; Diamond, Michael/0000-0002-8791-3165; Lorincz, Orsolya/0000-0003-4847-526X; Verstrepen, Babs E/0000-0002-4666-0798; Ulbert, Sebastian/0000-0001-5910-3643; Lisziewicz, Julianna/0000-0002-3349-4495; Sanders, Niek/0000-0003-4585-0343	European Community FP7 project WINGS [261426]	European Community FP7 project WINGS	The project was funded by the European Community FP7 project WINGS (grant no. 261426). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2012, NAT MED, V18, P974, DOI 10.1038/nm.2763; Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Barzon L, 2009, EURO SURVEILL, V14, P19384; Barzon L, 2012, EURO SURVEILL, V17, P20260; Barzon L, 2013, EURO SURVEILL, V18; Bengtsson KL, 2013, EXPERT REV VACCINES, V12, P821, DOI 10.1586/14760584.2013.814822; Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467; Chung WM, 2013, JAMA-J AM MED ASSOC, V310, P297, DOI 10.1001/jama.2013.8267; Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525; De Filette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087837; De Filette M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-16; Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Diebold SS, 1999, J BIOL CHEM, V274, P19087, DOI 10.1074/jbc.274.27.19087; Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011; ECDC, 2012, EP SIT W NIL VIR INF; Hughes HR, 2012, VIROLOGY, V424, P129, DOI 10.1016/j.virol.2011.12.012; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Larsen MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012697; Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09; Lorincz O, 2012, NANOMED-NANOTECHNOL, V8, P497, DOI 10.1016/j.nano.2011.07.013; Magnusson SE, 2014, VACCINE, V32, P800, DOI 10.1016/j.vaccine.2013.12.030; Magnusson SE, 2013, VACCINE, V31, P1725, DOI 10.1016/j.vaccine.2013.01.039; Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103; Mooij P, 2004, J VIROL, V78, P3333, DOI 10.1128/JVI.78.7.3333-3342.2004; Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573; Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2007, J VIROL, V81, P11828, DOI 10.1128/JVI.00643-07; Papa A, 2012, EXPERT REV ANTI-INFE, V10, P743, DOI [10.1586/ERI.12.59, 10.1586/eri.12.59]; Pervanidou D, 2014, EURO SURVEILL, V19, P20758; Pesko KN, 2012, INFECT GENET EVOL, V12, P181, DOI 10.1016/j.meegid.2011.11.014; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12; Pletnev AG, 2006, VACCINE, V24, P6392, DOI 10.1016/j.vaccine.2006.06.008; Popovic N, 2013, EUROSURVEILLANCE, V18, P18, DOI 10.2807/1560-7917.ES2013.18.43.20613; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Rollier C, 2005, J INFECT DIS, V192, P920, DOI 10.1086/432517; Sambri V, 2013, CLIN MICROBIOL INFEC, V19, P699, DOI 10.1111/1469-0691.12211; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Throsby M, 2007, EXPERT REV VACCINES, V6, P183, DOI 10.1586/14760584.6.2.183; Toke ER, 2010, INT J PHARMACEUT, V392, P261, DOI 10.1016/j.ijpharm.2010.03.048; Vazquez A, 2010, EMERG INFECT DIS, V16, P549, DOI 10.3201/eid1603.091033; Verstrepen BE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002797; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112; Widman DG, 2010, AM J TROP MED HYG, V82, P1160, DOI 10.4269/ajtmh.2010.09-0310; Widman DG, 2009, VACCINE, V27, P5550, DOI 10.1016/j.vaccine.2009.07.016	60	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112568	10.1371/journal.pone.0112568	http://dx.doi.org/10.1371/journal.pone.0112568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392925	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300070
J	Robert, J; Grayfer, L; Edholm, ES; Ward, B; Andino, FD				Robert, Jacques; Grayfer, Leon; Edholm, Eva-Stina; Ward, Brian; Andino, Francisco De Jesus			Inflammation-Induced Reactivation of the Ranavirus Frog Virus 3 in Asymptomatic Xenopus laevis	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; T-CELL RESPONSES; PERITONEAL LEUKOCYTES; FAMILY-IRIDOVIRIDAE; AMPHIBIAN XENOPUS; IN-VITRO; INFECTION; ANTIGEN; ADULT; FROG-VIRUS-3	Natural infections of ectothermic vertebrates by ranaviruses (RV, family Iridoviridae) are rapidly increasing, with an alarming expansion of RV tropism and resulting die-offs of numerous animal populations. Notably, infection studies of the amphibian Xenopus laevis with the ranavirus Frog Virus 3 (FV3) have revealed that although the adult frog immune system is efficient at controlling RV infections, residual quiescent virus can be detected in mononuclear phagocytes of otherwise asymptomatic animals following the resolution of RV infections. It is noteworthy that macrophage-lineage cells are now believed to be a critical element in the RV infection strategy. In the present work, we report that inflammation induced by peritoneal injection of heat-killed bacteria in asymptomatic frogs one month after infection with FV3 resulted in viral reactivation including detectable viral DNA and viral gene expression in otherwise asymptomatic frogs. FV3 reactivation was most prominently detected in kidneys and in peritoneal HAM56+ mononuclear phagocytes. Notably, unlike adult frogs that typically clear primary FV3 infections, a proportion of the animals succumbed to the reactivated FV3 infection, indicating that previous exposure does not provide protection against subsequent reactivation in these animals.	[Robert, Jacques; Grayfer, Leon; Edholm, Eva-Stina; Ward, Brian; Andino, Francisco De Jesus] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14627 USA	University of Rochester	Robert, J (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14627 USA.	Jacques_Robert@urmc.rochester.edu	Ward, Brian/AAQ-4895-2020; Robert, Jacques/B-2179-2008	Robert, Jacques/0000-0003-4380-1476	National Institutes of Health [R24-AI-059830]; Life Sciences Research Fellowship from the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI059830] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Research Fellowship from the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health Grant (R24-AI-059830); LG was supported by a Life Sciences Research Fellowship from the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams AJ, 2013, J GEN VIROL, V94, P2082, DOI 10.1099/vir.0.052837-0; Allender MC, 2006, J WILDLIFE DIS, V42, P677, DOI 10.7589/0090-3558-42.3.677; Andino FD, 2012, VIROLOGY, V432, P435, DOI 10.1016/j.virol.2012.07.001; BLEICHER PA, 1983, DEV COMP IMMUNOL, V7, P483, DOI 10.1016/0145-305X(83)90033-2; Chen GC, 2011, J VIROL, V85, P11131, DOI 10.1128/JVI.05589-11; Cunningham AA, 2008, J COMP PATHOL, V138, P3, DOI 10.1016/j.jcpa.2007.08.003; de Vries RD, 2012, CURR OPIN VIROL, V2, P248, DOI 10.1016/j.coviro.2012.03.005; Duncan CJA, 2011, VIRUSES-BASEL, V3, P2255, DOI 10.3390/v3112255; Gantress J, 2003, VIROLOGY, V311, P254, DOI 10.1016/S0042-6822(03)00151-X; GENDRAULT JL, 1981, VIROLOGY, V112, P375, DOI 10.1016/0042-6822(81)90284-1; Gray MJ, 2009, DIS AQUAT ORGAN, V87, P243, DOI 10.3354/dao02138; Grayfer L, 2014, J LEUK BIOL IN PRESS; Grayfer L, 2012, VIRUSES-BASEL, V4, P1075, DOI 10.3390/v4071075; GUT JP, 1981, LAB INVEST, V45, P218; HADJIAZIMI I, 1987, DEV COMP IMMUNOL, V11, P807, DOI 10.1016/0145-305X(87)90068-1; Hyatt AD, 2002, J WILDLIFE DIS, V38, P239, DOI 10.7589/0090-3558-38.2.239; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jancovich JK, 2010, J VIROL, V84, P2636, DOI 10.1128/JVI.01991-09; Lei XY, 2012, ARCH VIROL, V157, P1559, DOI 10.1007/s00705-012-1316-9; Marr S, 2005, IMMUNOGENETICS, V56, P735, DOI 10.1007/s00251-004-0736-4; Marr S, 2007, J IMMUNOL, V179, P6783, DOI 10.4049/jimmunol.179.10.6783; Miller DL, 2007, EMERG INFECT DIS, V13, P342, DOI 10.3201/eid1302.061073; Morales H, 2008, BIOL PROCED ONLINE, V10, P1, DOI 10.1251/bpo137; Morales HD, 2007, J VIROL, V81, P2240, DOI 10.1128/JVI.01104-06; Morales HD, 2010, J VIROL, V84, P4912, DOI 10.1128/JVI.02486-09; Robert J, 2005, VIROLOGY, V332, P667, DOI 10.1016/j.virol.2004.12.012; Robert J, 2008, J IMMUNOL, V180, P3176, DOI 10.4049/jimmunol.180.5.3176; Robert J, 2007, J WILDLIFE DIS, V43, P645, DOI 10.7589/0090-3558-43.4.645; Robert J, 2012, DEV COMP IMMUNOL, V36, P259, DOI 10.1016/j.dci.2011.08.008; Robert J, 2011, VIROLOGY, V417, P410, DOI 10.1016/j.virol.2011.06.026; Robert J, 2009, DEV DYNAM, V238, P1249, DOI 10.1002/dvdy.21891; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Tan WGH, 2004, VIROLOGY, V323, P70, DOI 10.1016/j.virol.2004.02.019; Weck KE, 1996, J VIROL, V70, P6775, DOI 10.1128/JVI.70.10.6775-6780.1996; Whitley DS, 2010, VIROLOGY, V405, P448, DOI 10.1016/j.virol.2010.06.034	35	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112904	10.1371/journal.pone.0112904	http://dx.doi.org/10.1371/journal.pone.0112904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390636	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400140
J	Schneiderova, I; Zouhar, J				Schneiderova, Irena; Zouhar, Jan			Resting-Associated Vocalization Emitted by Captive Asian House Shrews (Suncus murinus): Acoustic Structure and Variability in an Unusual Mammalian Vocalization	PLOS ONE			English	Article							VOCAL REPERTOIRE; CROCIDURA-RUSSULA; GROUND-SQUIRRELS; NEOMYS-FODIENS; CONTACT CALLS; WATER-SHREW; COMMUNICATION; BEHAVIOR; SORICIDAE; GUAM	Shrews have rich vocal repertoires that include vocalizations within the human audible frequency range and ultrasonic vocalizations. Here, we recorded and analyzed in detail the acoustic structure of a vocalization with unclear functional significance that was spontaneously produced by 15 adult, captive Asian house shrews (Suncus murinus) while they were lying motionless and resting in their nests. This vocalization was usually emitted repeatedly in a long series with regular intervals. It showed some structural variability; however, the shrews most frequently emitted a tonal, low-frequency vocalization with minimal frequency modulation and a low, non-vocal click that was clearly noticeable at its beginning. There was no effect of sex, but the acoustic structure of the analyzed vocalizations differed significantly between individual shrews. The encoded individuality was low, but it cannot be excluded that this individuality would allow discrimination of family members, i.e., a male and female with their young, collectively resting in a common nest. The question remains whether the Asian house shrews indeed perceive the presence of their mates, parents or young resting in a common nest via the resting-associated vocalization and whether they use it to discriminate among their family members. Additional studies are needed to explain the possible functional significance of resting-associated vocalizations emitted by captive Asian house shrews. Our study highlights that the acoustic communication of shrews is a relatively understudied topic, particularly considering that they are highly vocal mammals.	[Schneiderova, Irena] Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic; [Zouhar, Jan] Univ Econ, Fac Informat & Stat, Dept Econometr, Prague, Czech Republic	Czech University of Life Sciences Prague; Prague University of Economics & Business	Schneiderova, I (corresponding author), Czech Univ Life Sci, Fac Forestry & Wood Sci, Dept Game Management & Wildlife Biol, Prague, Czech Republic.	schneiderova@fld.czu.cz	Zouhar, Jan/E-9659-2013	Zouhar, Jan/0000-0002-1164-7948; Schneiderova, Irena/0000-0001-5485-7630	Internal Grant Agency of the Czech University of Life Sciences in Prague (CIGA) [20134311]	Internal Grant Agency of the Czech University of Life Sciences in Prague (CIGA)	IS was supported by Internal Grant Agency of the Czech University of Life Sciences in Prague (CIGA), project no. 20134311. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, WALKERS MAMMALS WORL; Arnold BD, 2011, BEHAV ECOL SOCIOBIOL, V65, P1581, DOI 10.1007/s00265-011-1168-4; BEECHER MD, 1989, ANIM BEHAV, V38, P248, DOI 10.1016/S0003-3472(89)80087-9; Bezerra BM, 2008, INT J PRIMATOL, V29, P671, DOI 10.1007/s10764-008-9250-0; Blumstein DT, 2005, ANIM BEHAV, V69, P353, DOI 10.1016/j.anbehav.2004.10.001; CANTONI D, 1989, ANIM BEHAV, V38, P205, DOI 10.1016/S0003-3472(89)80083-1; Cap H, 2008, CLADISTICS, V24, P917, DOI 10.1111/j.1096-0031.2008.00223.x; Carter GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038791; Clay Z, 2012, ANIM BEHAV, V83, P323, DOI 10.1016/j.anbehav.2011.12.008; Credner S, 1997, J COMP PHYSIOL A, V180, P245, DOI 10.1007/s003590050045; DRYDEN GL, 1968, J MAMMAL, V49, P51, DOI 10.2307/1377727; Ehrlich C, 2006, KLEINSAUGER TERRARIU; Fitch W.T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Fons R, 1974, TERRE VIE, V1, P131; Fritts TH, 1998, ANNU REV ECOL SYST, V29, P113, DOI 10.1146/annurev.ecolsys.29.1.113; Gillam EH, 2012, ANIM BEHAV, V83, P269, DOI 10.1016/j.anbehav.2011.11.002; Gould E., 1969, Communications in Behavioral Biology (Ser A), V3, P11; Hashimoto H, 2004, EXP ANIM TOKYO, V53, P53, DOI 10.1538/expanim.53.53; HASKELL D, 1994, P ROY SOC B-BIOL SCI, V257, P161, DOI 10.1098/rspb.1994.0110; HASLER MJ, 1977, J MAMMAL, V58, P285, DOI 10.2307/1379327; HUTTERER R, 1977, Bonner Zoologische Beitraege, V28, P218; HUTTERER R, 1978, Z SAUGETIERKD, V43, P330; Hutterer R, 2008, IUCN 2013 IUCN RED L; Jones C.G, 1993, P ROYAL SOC ARTS SCI, V5, P71; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Klump GM, 1984, J COMP ETHOL, V66, P189; Knornschild M, 2010, ACTA CHIROPTEROL, V12, P205, DOI 10.3161/150811010X504707; KOHLER D, 1987, ZOOL JAHRB ALLG ZOOL, V91, P89; Kohler D, 1998, BUB, V3, P91; Long CV, 2007, BIOACOUSTICS, V16, P223, DOI 10.1080/09524622.2007.9753579; Long JL, 2003, INTRO MAMMALS WORLD; LOUCH CD, 1966, J MAMMAL, V47, P73, DOI 10.2307/1378070; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Matrosova VA, 2007, BEHAV ECOL SOCIOBIOL, V62, P181, DOI 10.1007/s00265-007-0452-9; Maurello MA, 2000, J MAMMAL, V81, P415, DOI 10.1644/1545-1542(2000)081<0415:SCICCO>2.0.CO;2; Messeri P, 1987, ITAL J ZOOL, V19, P341; MOVCHAN VN, 1982, ZOOL ZH, V61, P1695; Mumm CAS, 2014, ANIM BEHAV, V88, P243, DOI 10.1016/j.anbehav.2013.12.005; PEPPER JW, 1991, BIOL NAKED MOLE RAT, P241; Peters Gustav, 1999, Journal of Mammalian Evolution, V6, P129, DOI 10.1023/A:1020620121416; Romanow P, 1996, CONTRIB ZOOL, V66, P43; Rutovskaya MV, 2011, BIOL BULL+, V38, P927, DOI 10.1134/S1062359011090068; Schneiderova I, 2014, ACTA THERIOL, V59, P149, DOI 10.1007/s13364-013-0141-1; Shapiro A. D., 2009, HDB MAMMALIAN VOCALI, P495; Siemers BM, 2009, BIOL LETTERS, V5, P593, DOI 10.1098/rsbl.2009.0378; Simeonovska-Nikolova DM, 2004, ACTA THERIOL, V49, P157, DOI 10.1007/BF03192517; SOLOW AR, 1990, ECOLOGY, V71, P2379, DOI 10.2307/1938650; Temple JL, 2004, ILAR J, V45, P25, DOI 10.1093/ilar.45.1.25; TSUJI K, 1984, BEHAVIOUR, V90, P167, DOI 10.1163/156853984X00605; Tsuji Keiichiro, 1999, Japanese Journal of Animal Psychology, V49, P1; VOGEL P, 1981, J ZOOL, V195, P549; Volodina EV, 2010, BIOACOUSTICS, V20, P87; ZIMMERMANN E, 1985, BEHAVIOUR, V94, P212, DOI 10.1163/156853985X00190	54	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111571	10.1371/journal.pone.0111571	http://dx.doi.org/10.1371/journal.pone.0111571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390304	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400025
J	Zhang, L; Ma, HJ; Chen, TT; Pen, J; Yu, SX; Zhao, XH				Zhang, Lei; Ma, Huijuan; Chen, Tingting; Pen, Jun; Yu, Shuxun; Zhao, Xinhua			Morphological and Physiological Responses of Cotton (Gossypium hirsutum L.) Plants to Salinity	PLOS ONE			English	Article							ANTIOXIDANT ENZYME-ACTIVITY; INDUCED OXIDATIVE STRESS; SALT-TOLERANCE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; ION ACCUMULATION; RICE SEEDLINGS; GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; PERENNIAL HALOPHYTE	Salinization usually plays a primary role in soil degradation, which consequently reduces agricultural productivity. In this study, the effects of salinity on growth parameters, ion, chlorophyll, and proline content, photosynthesis, antioxidant enzyme activities, and lipid peroxidation of two cotton cultivars, [ CCRI-79 (salt tolerant) and Simian 3 (salt sensitive)], were evaluated. Salinity was investigated at 0 mM, 80 mM, 160 mM, and 240 mM NaCl for 7 days. Salinity induced morphological and physiological changes, including a reduction in the dry weight of leaves and roots, root length, root volume, average root diameter, chlorophyll and proline contents, net photosynthesis and stomatal conductance. In addition, salinity caused ion imbalance in plants as shown by higher Na+ and Cl- contents and lower K+, Ca2+, and Mg2+ concentrations. Ion imbalance was more pronounced in CCRI-79 than in Simian 3. In the leaves and roots of the salt-tolerant cultivar CCRI-79, increasing levels of salinity increased the activities of superoxide dismutase (SOD), ascorbate peroxidase (APX), and glutathione reductase (GR), but reduced catalase (CAT) activity. The activities of SOD, CAT, APX, and GR in the leaves and roots of CCRI-79 were higher than those in Simian 3. CAT and APX showed the greatest H2O2 scavenging activity in both leaves and roots. Moreover, CAT and APX activities in conjunction with SOD seem to play an essential protective role in the scavenging process. These results indicate that CCRI-79 has a more effective protection mechanism and mitigated oxidative stress and lipid peroxidation by maintaining higher antioxidant activities than those in Simian 3. Overall, the chlorophyll a, chlorophyll b, and Chl (a+b) contents, net photosynthetic rate and stomatal conductance, SOD, CAT, APX, and GR activities showed the most significant variation between the two cotton cultivars.	[Zhang, Lei; Ma, Huijuan; Chen, Tingting; Pen, Jun; Yu, Shuxun; Zhao, Xinhua] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Yu, SX (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	yu@cricaas.com.cn; zhaoxinhua1968@126.com			National Natural Science Foundation of China [31301262]; China Postdoctoral Science Foundation [2013M540169]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (31301262) and China Postdoctoral Science Foundation (Grant no. 2013M540169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; Amor NB, 2007, J INTEGR PLANT BIOL, V126, P446; Arzani A, 2008, IN VITRO CELL DEV-PL, V44, P373, DOI 10.1007/s11627-008-9157-7; Asgari HR, 2012, INT J PLANT PROD, V6, P195; Asharf M, 2005, ADV AGRON, V88, P223; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Ashraf M, 2006, J ARID ENVIRON, V64, P209, DOI 10.1016/j.jaridenv.2005.04.015; Aziz I, 2001, AQUAT BOT, V70, P259, DOI 10.1016/S0304-3770(01)00160-7; BEERS RF, 1952, J BIOL CHEM, V195, P133; Ben Amor N, 2005, PLANT SCI, V168, P889, DOI 10.1016/j.plantsci.2004.11.002; Berkelaar E, 2000, CAN J BOT, V78, P381, DOI 10.1139/cjb-78-3-381; Bernt E., 1974, METHOD ENZYMAT AN, V4, P2246, DOI DOI 10.1016/B978-0-12-091304-6.50090-2; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Boo YC, 1999, J PLANT PHYSIOL, V155, P255, DOI 10.1016/S0176-1617(99)80016-9; Borsani O, 2003, PLANT CELL TISS ORG, V73, P101, DOI 10.1023/A:1022849200433; Bower C, 1992, ANNU REV PLANT PHYS, V43, P81; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; Cuartero J, 1999, SCI HORTIC-AMSTERDAM, V78, P83, DOI 10.1016/S0304-4238(98)00191-5; CURTIS PS, 1986, AUST J PLANT PHYSIOL, V13, P553, DOI 10.1071/PP9860553; de Lacerda CF, 2003, ENVIRON EXP BOT, V49, P107, DOI 10.1016/S0098-8472(02)00064-3; Delfine S, 1999, PLANT PHYSIOL, V119, P1101, DOI 10.1104/pp.119.3.1101; Demiral T, 2005, ENVIRON EXP BOT, V53, P247, DOI 10.1016/j.envexpbot.2004.03.017; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; Dubey RS, 1997, BOOKS SOIL PLANT ENV, P859; FEDINA IS, 1993, PHOTOSYNTHETICA, V29, P521; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Garratt LC, 2002, FREE RADICAL BIO MED, V33, P502, DOI 10.1016/S0891-5849(02)00838-9; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GOSSETT DR, 1994, CROP SCI, V34, P706, DOI 10.2135/cropsci1994.0011183X003400030020x; GRAIFENBERG A, 1995, SCI HORTIC-AMSTERDAM, V63, P1, DOI 10.1016/0304-4238(95)00797-W; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Guo WX, 2012, PRECIS AGRIC, V13, P678, DOI 10.1007/s11119-012-9277-2; Hassan, 2002, ASIAN J PLANT SCI, DOI [10.3923/ajps.2002.715.719, DOI 10.3923/AJPS.2002.715.719]; Henandez JA, 2000, PLANT CELL ENVIRON, V23, P853; Hernandez JA, 2000, PLANT CELL ENVIRON, V23, P853, DOI 10.1046/j.1365-3040.2000.00602.x; Hernandez JA, 2002, PLANT CELL ENVIRON, V23, P853; Kaya C, 2007, ENVIRON EXP BOT, V60, P397, DOI 10.1016/j.envexpbot.2006.12.008; Khan MA, 2000, ANN BOT-LONDON, V85, P225, DOI 10.1006/anbo.1999.1022; Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007; Lee DH, 2001, J PLANT PHYSIOL, V158, P737, DOI 10.1078/0176-1617-00174; Lee MH, 2013, PLANT PHYSIOL BIOCH, V70, P325, DOI 10.1016/j.plaphy.2013.05.047; Liang YC, 2003, J PLANT PHYSIOL, V160, P1157, DOI 10.1078/0176-1617-01065; Liu J, 2010, PHOTOSYNTHETICA, V48, P278, DOI 10.1007/s11099-010-0034-3; Locato V, 2008, PLANT CELL ENVIRON, V31, P1606, DOI 10.1111/j.1365-3040.2008.01867.x; Locy RD, 1996, PLANT PHYSIOL, V110, P321, DOI 10.1104/pp.110.1.321; Meloni DA, 2003, ENVIRON EXP BOT, V49, P69, DOI 10.1016/S0098-8472(02)00058-8; Meloni DA, 2001, J PLANT NUTR, V24, P599, DOI 10.1081/PLN-100104983; Meneguzzo S, 1999, J PLANT PHYSIOL, V155, P274, DOI 10.1016/S0176-1617(99)80019-4; Meng HB, 2011, AGR SCI CHINA, V10, P363, DOI 10.1016/S1671-2927(11)60015-1; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mittova V, 2003, PLANT CELL ENVIRON, V26, P845, DOI 10.1046/j.1365-3040.2003.01016.x; Morita S, 1999, PLANT CELL PHYSIOL, V40, P417, DOI 10.1093/oxfordjournals.pcp.a029557; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; MUNNS R, 1995, AUST J PLANT PHYSIOL, V22, P561, DOI 10.1071/PP9950561; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parida AK, 2004, TREES-STRUCT FUNCT, V18, P167, DOI 10.1007/s00468-003-0293-8; Qidar M, 1997, J AGRON CROP SCI, V179, P101; Queval G, 2008, J EXP BOT, V59, P135, DOI 10.1093/jxb/erm193; Rabie GH, 2005, AFR J BIOTECHNOL, V4, P210; Rout NP, 2001, PLANT SCI, V160, P415, DOI 10.1016/S0168-9452(00)00406-4; RuizLozano JM, 1997, SYMBIOSIS, V23, P9; Seckin B, 2010, ENVIRON EXP BOT, V69, P76, DOI 10.1016/j.envexpbot.2010.02.013; Sekmen AH, 2007, PHYSIOL PLANTARUM, V131, P399, DOI 10.1111/j.1399-3054.2007.00970.x; Senadheera P, 2012, RICE SCI, V19, P36, DOI 10.1016/S1672-6308(12)60018-3; Sestak K., 1971, PLANT PHOTOSYNTHETIC; Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073; Sigaud-Kutner TCS, 2002, PHYSIOL PLANTARUM, V114, P566, DOI 10.1034/j.1399-3054.2002.1140409.x; SINGH AK, 1995, PHOTOSYNTHETICA, V31, P489; Siroka B, 2004, BIOLOGIA, V59, P513; Steduto P, 2000, ENVIRON EXP BOT, V44, P243, DOI 10.1016/S0098-8472(00)00071-X; Sudhakar C, 2001, PLANT SCI, V161, P613, DOI 10.1016/S0168-9452(01)00450-2; Takemura T, 2000, AQUAT BOT, V68, P15, DOI 10.1016/S0304-3770(00)00106-6; TALEISNIK E, 1994, PHYSIOL PLANTARUM, V92, P528, DOI 10.1111/j.1399-3054.1994.tb08847.x; Tan W, 2008, PHOTOSYNTHETICA, V46, P21, DOI 10.1007/s11099-008-0005-0; THIEL G, 1988, J PLANT PHYSIOL, V132, P38, DOI 10.1016/S0176-1617(88)80180-9; Xiong L, 2002, PLANT CELL ENVIRON, V25, P131, DOI 10.1046/j.1365-3040.2002.00782.x; Xu R, 2013, PEDOSPHERE, V23, P213, DOI 10.1016/S1002-0160(13)60009-0; Zhang L, 2013, J PLANT RES, V126, P293, DOI 10.1007/s10265-012-0533-3; Zhang Q, 2011, PHOTOSYNTHETICA, V49, P201, DOI 10.1007/s11099-011-0012-4; Zhang Q, 2005, ENVIRON SCI TECHNOL, V39, P4938, DOI 10.1021/es048568l; Zheng CF, 2009, PLANT SCI, V176, P575, DOI 10.1016/j.plantsci.2009.01.015; Zheng YH, 2008, ENVIRON EXP BOT, V62, P129, DOI 10.1016/j.envexpbot.2007.07.011	89	107	113	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112807	10.1371/journal.pone.0112807	http://dx.doi.org/10.1371/journal.pone.0112807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391141	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400130
J	Lendvai, AZ; Ouyang, JQ; Schoenle, LA; Fasanello, V; Haussmann, MF; Bonier, F; Moore, IT				Lendvai, Adam Z.; Ouyang, Jenny Q.; Schoenle, Laura A.; Fasanello, Vincent; Haussmann, Mark F.; Bonier, Frances; Moore, Ignacio T.			Experimental Food Restriction Reveals Individual Differences in Corticosterone Reaction Norms with No Oxidative Costs	PLOS ONE			English	Article							STRESS-INDUCED CORTICOSTERONE; LIFE-HISTORY; BASE-LINE; PHENOTYPIC PLASTICITY; PLASMA-CORTICOSTERONE; REPRODUCTIVE SUCCESS; ANIMAL PERSONALITY; NATURAL-SELECTION; HOUSE SPARROWS; RESPONSES	Highly plastic endocrine traits are thought to play a central role in allowing organisms to respond rapidly to environmental change. Yet, not all individuals display the same degree of plasticity in these traits, and the costs of this individual variation in plasticity are unknown. We studied individual differences in corticosterone levels under varying conditions to test whether there are consistent individual differences in (1) baseline corticosterone levels; (2) plasticity in the hormonal response to an ecologically relevant stressor (food restriction); and (3) whether individual differences in plasticity are related to fitness costs, as estimated by oxidative stress levels. We took 25 wild-caught house sparrows into captivity and assigned them to repeated food restricted and control treatments (60% and 110% of their daily food intake), such that each individual experienced both food restricted and control diets twice. We found significant individual variation in baseline corticosterone levels and stress responsiveness, even after controlling for changes in body mass. However, these individual differences in hormonal responsiveness were not related to measures of oxidative stress. These results have implications for how corticosterone levels may evolve in natural populations and raise questions about what we can conclude from phenotypic correlations between hormone levels and fitness measures.	[Lendvai, Adam Z.; Ouyang, Jenny Q.; Schoenle, Laura A.; Moore, Ignacio T.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Ouyang, Jenny Q.] Netherlands Inst Ecol NIOO KNAW, Wageningen, Netherlands; [Fasanello, Vincent; Haussmann, Mark F.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA; [Bonier, Frances] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Virginia Polytechnic Institute & State University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Bucknell University; Queens University - Canada	Lendvai, AZ (corresponding author), Univ Debrecen, Dept Evolutionary Zool, H-4012 Debrecen, Hungary.	lendvai@vt.edu	Schoenle, Laura/J-7978-2016; Schoenle, Laura A/M-9614-2017; Lendvai, Adam Z/B-8546-2008; Fasanello, Vincent/ABC-8322-2020; KNAW, NIOO-KNAW/A-4320-2012	Schoenle, Laura/0000-0002-9591-1194; Lendvai, Adam Z/0000-0002-8953-920X; KNAW, NIOO-KNAW/0000-0002-3835-159X	U.S. National Science Foundation (NSF) [IOS-1145625]; Natural Sciences and Engineering Research Council of Canada; Eotvos State Grant from the Hungarian Scholarship Board (Balassi Institute); NSF [DBI-1306025]	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Eotvos State Grant from the Hungarian Scholarship Board (Balassi Institute); NSF(National Science Foundation (NSF))	Funding was provided by a U.S. National Science Foundation (NSF) grant (FB, ITM, and MFH; IOS-1145625), and by the Natural Sciences and Engineering Research Council of Canada Banting Postdoctoral Fellowship (FB). AZL was supported by an Eotvos State Grant from the Hungarian Scholarship Board (Balassi Institute), LS by the Virginia Tech Institute for Critical Technology and Applied Science. During the preparation of the manuscript, JQO was supported by a NSF postdoctoral grant (DBI-1306025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 2008, PHILOS T R SOC B, V363, P1599, DOI 10.1098/rstb.2007.0005; Angelier F, 2009, P ROY SOC B-BIOL SCI, V276, P3545, DOI 10.1098/rspb.2009.0868; Baugh AT, 2012, GEN COMP ENDOCR, V175, P488, DOI 10.1016/j.ygcen.2011.12.012; Bennett AJ, 2008, DEV PSYCHOBIOL, V50, P48, DOI 10.1002/dev.20263; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Bokony V, 2009, AM NAT, V173, P589, DOI 10.1086/597610; Bonier F, 2010, TRENDS ECOL EVOL, V25, P262, DOI 10.1016/j.tree.2010.01.009; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Breuner CW, 1999, J EXP ZOOL, V284, P334, DOI 10.1002/(SICI)1097-010X(19990801)284:3<334::AID-JEZ11>3.3.CO;2-R; Brommer JE, 2013, CURR ZOOL, V59, P485, DOI 10.1093/czoolo/59.4.485; Brommer JE, 2013, BEHAV ECOL SOCIOBIOL, V67, P1027, DOI 10.1007/s00265-013-1527-4; Buck CL, 2007, GEN COMP ENDOCR, V150, P430, DOI 10.1016/j.ygcen.2006.10.011; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chevin LM, 2013, AM NAT, V182, P13, DOI 10.1086/670613; Cockrem JF, 2010, BRIT POULTRY SCI, V51, P453, DOI 10.1080/00071668.2010.503637; Cockrem JF, 2013, GEN COMP ENDOCR, V181, P45, DOI 10.1016/j.ygcen.2012.11.025; Cockrem JF, 2009, GEN COMP ENDOCR, V163, P158, DOI 10.1016/j.ygcen.2009.03.029; Conti G, 2012, P NATL ACAD SCI USA, V109, P8866, DOI 10.1073/pnas.1205340109; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Costantini D, 2008, J COMP PHYSIOL B, V178, P829, DOI 10.1007/s00360-008-0270-z; Costantini D, 2011, J COMP PHYSIOL B, V181, P447, DOI 10.1007/s00360-011-0566-2; Crespi EJ, 2013, FUNCT ECOL, V27, P93, DOI 10.1111/1365-2435.12009; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P261, DOI 10.1016/j.tree.2010.01.008; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Dingemanse NJ, 2013, ANIM BEHAV; Dochtermann NA, 2013, BEHAV ECOL, V24, P806, DOI 10.1093/beheco/art002; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Evans MR, 2006, J EVOLUTION BIOL, V19, P343, DOI 10.1111/j.1420-9101.2005.01034.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Fokidis HB, 2012, J EXP BIOL, V215, P2920, DOI 10.1242/jeb.071043; Fokidis HB, 2011, PHYSIOL BIOCHEM ZOOL, V84, P595, DOI 10.1086/662068; Fokidis HB, 2009, GEN COMP ENDOCR, V160, P259, DOI 10.1016/j.ygcen.2008.12.005; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gomez-Mestre I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1869; Goutte A, 2011, HORM BEHAV, V59, P167, DOI 10.1016/j.yhbeh.2010.11.004; Groscolas R, 2008, HORM BEHAV, V53, P51, DOI 10.1016/j.yhbeh.2007.08.010; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Haussmann MF, 2012, P ROY SOC B-BIOL SCI, V279, P1447, DOI 10.1098/rspb.2011.1913; Haussmann MF, 2010, CURR ZOOL, V56, P714, DOI 10.1093/czoolo/56.6.714; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Jenkins BR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1302; Kitaysky AS, 2001, BEHAV ECOL, V12, P619, DOI 10.1093/beheco/12.5.619; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Lendvai AZ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1734; Lendvai AZ, 2008, HORM BEHAV, V53, P395, DOI 10.1016/j.yhbeh.2007.11.011; Lendvai AZ, 2007, P ROY SOC B-BIOL SCI, V274, P391, DOI 10.1098/rspb.2006.3735; Lessells CM, 2008, PHILOS T R SOC B, V363, P1589, DOI 10.1098/rstb.2007.0008; Love OP, 2008, HORM BEHAV, V54, P496, DOI 10.1016/j.yhbeh.2008.01.006; Love OP, 2014, GEN COMP ENDOCR, V199, P65, DOI 10.1016/j.ygcen.2014.01.001; Love OP, 2013, FUNCT ECOL, V27, P81, DOI 10.1111/j.1365-2435.2012.02040.x; MacDougall-Shackleton SA, 2009, BIOL LETTERS, V5, P746, DOI 10.1098/rsbl.2009.0382; MacDougall-Shackleton SA, 2013, GEN COMP ENDOCR, V190, P188, DOI 10.1016/j.ygcen.2013.05.026; Malueg AL, 2009, BEHAV ECOL SOCIOBIOL, V63, P687, DOI 10.1007/s00265-008-0702-5; Martin LB, 2012, J EXP BIOL, V215, P4097, DOI 10.1242/jeb.073049; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McGlothlin JW, 2010, AM NAT, V175, P687, DOI 10.1086/652469; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Narayan EJ, 2013, COMP BIOCHEM PHYS A, V164, P21, DOI 10.1016/j.cbpa.2012.10.001; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Ottinger MA, 2005, MECH AGEING DEV, V126, P967, DOI 10.1016/j.mad.2005.03.017; Ouyang JQ, 2013, J EVOLUTION BIOL, V26, P1988, DOI 10.1111/jeb.12202; Ouyang JQ, 2011, P ROY SOC B-BIOL SCI, V278, P2537, DOI 10.1098/rspb.2010.2490; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Patterson SH, 2014, J EVOLUTION BIOL, V27, P259, DOI 10.1111/jeb.12286; Pigliucci M., 2001, SYN ECO EVO; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; R Core Team, 2021, R LANGUAGE ENV STAT; Rensel MA, 2011, HORM BEHAV, V59, P497, DOI 10.1016/j.yhbeh.2011.01.010; Romero LM, 2008, GEN COMP ENDOCR, V156, P27, DOI 10.1016/j.ygcen.2007.10.001; Romero LM, 2006, GEN COMP ENDOCR, V149, P58, DOI 10.1016/j.ygcen.2006.05.004; Romero LM, 2010, P ROY SOC B-BIOL SCI, V277, P3157, DOI 10.1098/rspb.2010.0678; Schmidt KL, 2014, GEN COMP ENDOCR, V196, P72, DOI 10.1016/j.ygcen.2013.11.014; Schoech SJ, 2013, FUNCT ECOL, V27, P1100, DOI 10.1111/1365-2435.12142; Selman C, 2012, TRENDS ECOL EVOL, V27, P570, DOI 10.1016/j.tree.2012.06.006; Speakman JR, 2014, BIOESSAYS, V36, P93, DOI 10.1002/bies.201300108; Spencer KA, 2009, ENDOCRINOLOGY, V150, P1931, DOI 10.1210/en.2008-1471; Strochlic DE, 2008, COMP BIOCHEM PHYS A, V149, P68, DOI 10.1016/j.cbpa.2007.10.011; Treidel LA, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0684; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Wilcoxen TE, 2011, GEN COMP ENDOCR, V173, P461, DOI 10.1016/j.ygcen.2011.07.007; Williams TD, 2008, PHILOS T R SOC B, V363, P1687, DOI 10.1098/rstb.2007.0003; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; WINGFIELD JC, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P520; WINGFIELD JC, 1992, HORM BEHAV, V26, P145, DOI 10.1016/0018-506X(92)90038-W; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105	91	50	50	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e110564	10.1371/journal.pone.0110564	http://dx.doi.org/10.1371/journal.pone.0110564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386675	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400010
J	Muscarella, R; Uriarte, M; Erickson, DL; Swenson, NG; Zimmerman, JK; Kress, WJ				Muscarella, Robert; Uriarte, Maria; Erickson, David L.; Swenson, Nathan G.; Zimmerman, Jess K.; Kress, W. John			A Well-Resolved Phylogeny of the Trees of Puerto Rico Based on DNA Barcode Sequence Data	PLOS ONE			English	Article							MISSING DATA; COMMUNITY STRUCTURE; PLANT-COMMUNITIES; DIVERSITY; TRAIT; ACCURACY; ECOLOGY; COEXISTENCE; PATTERNS; HISTORY	Background: The use of phylogenetic information in community ecology and conservation has grown in recent years. Two key issues for community phylogenetics studies, however, are (i) low terminal phylogenetic resolution and (ii) arbitrarily defined species pools. Methodology/principal findings: We used three DNA barcodes (plastid DNA regions rbcL, matK, and trnH-psbA) to infer a phylogeny for 527 native and naturalized trees of Puerto Rico, representing the vast majority of the entire tree flora of the island (89%). We used a maximum likelihood (ML) approach with and without a constraint tree that enforced monophyly of recognized plant orders. Based on 50% consensus trees, the ML analyses improved phylogenetic resolution relative to a comparable phylogeny generated with PHYLOMATIC (proportion of internal nodes resolved: constrained ML = 74%, unconstrained ML = 68%, PHYLOMATIC = 52%). We quantified the phylogenetic composition of 15 protected forests in Puerto Rico using the constrained ML and PHYLOMATIC phylogenies. We found some evidence that tree communities in areas of high water stress were relatively phylogenetically clustered. Reducing the scale at which the species pool was defined (from island to soil types) changed some of our results depending on which phylogeny (ML vs. PHYLOMATIC) was used. Overall, the increased terminal resolution provided by the ML phylogeny revealed additional patterns that were not observed with a less-resolved phylogeny. Conclusions/significance: With the DNA barcode phylogeny presented here (based on an island-wide species pool), we show that a more fully resolved phylogeny increases power to detect nonrandom patterns of community composition in several Puerto Rican tree communities. Especially if combined with additional information on species functional traits and geographic distributions, this phylogeny will (i) facilitate stronger inferences about the role of historical processes in governing the assembly and composition of Puerto Rican forests, (ii) provide insight into Caribbean biogeography, and (iii) aid in incorporating evolutionary history into conservation planning.	[Muscarella, Robert; Uriarte, Maria] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Erickson, David L.; Kress, W. John] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, MRC 166, Washington, DC 20013 USA; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Zimmerman, Jess K.] Univ Puerto Rico, Dept Environm Sci, San Juan, PR 00925 USA	Columbia University; Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University; University of Puerto Rico; University of Puerto Rico Rio Piedras	Muscarella, R (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	bob.muscarella@gmail.com			NSF DEB [1050957, 1311367]; Smithsonian Institution; Division Of Environmental Biology [1239764, 1311367] Funding Source: National Science Foundation	NSF DEB(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Smithsonian Institution(Smithsonian Institution); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF DEB 1050957 to MU, NSF DEB 1311367 to MU and RM, and the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Rodriguez P., 2011, FLORA W INDIES CATAL; Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Axelrod F.S., 2011, SYSTEMATIC VADEMECUM; Bawiec W. J., 1998, 9838 GEOL SURV US; Beaulieu JM, 2012, ECOLOGY, V93, pS4, DOI 10.1890/11-0638.1; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brunbjerg AK, 2014, J PLANT ECOL, V7, P101, DOI 10.1093/jpe/rtt069; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2006, ECOLOGY, V87, pS109, DOI 10.1890/0012-9658(2006)87[109:PSOFPC]2.0.CO;2; Cavender-Bares J, 2012, ECOLOGY, V93, pS1, DOI 10.1890/12-0092.1; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; Daly C, 2003, INT J CLIMATOL, V23, P1359, DOI 10.1002/joc.937; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davies TJ, 2012, ECOLOGY, V93, P242, DOI 10.1890/11-1360.1; de Bello F, 2012, ECOLOGY, V93, P2263, DOI 10.1890/11-1394.1; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards EJ, 2010, P NATL ACAD SCI USA, V107, P2532, DOI 10.1073/pnas.0909672107; Eiserhardt WL, 2013, BOT J LINN SOC, V171, P244, DOI 10.1111/j.1095-8339.2012.01276.x; Ewel J.J., 1973, ECOLOGICAL LIFE ZONE; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Felsenstein J., 2004, INFERRING PHYLOGENIE; Gesch D. B., 2007, DIGITAL ELEVATION MO, P99; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gould W., 2008, IITFGTR39 USDA FOR S, V165, DOI DOI 10.2737/IITF-GTR-39; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kivlin SN, 2011, SOIL BIOL BIOCHEM, V43, P2294, DOI 10.1016/j.soilbio.2011.07.012; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lessard JP, 2012, TRENDS ECOL EVOL, V27, P600, DOI 10.1016/j.tree.2012.07.006; Lessard JP, 2012, P ROY SOC B-BIOL SCI, V279, P266, DOI 10.1098/rspb.2011.0552; Letcher SG, 2012, PERSPECT PLANT ECOL, V14, P79, DOI 10.1016/j.ppees.2011.09.005; Letcher SG, 2010, P ROY SOC B-BIOL SCI, V277, P97, DOI 10.1098/rspb.2009.0865; Little E.L., 1964, COMMON TREES PUERTO; Little E. L., 1974, TREES PUERTO RICO VI; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Losos JB, 1996, ECOLOGY, V77, P1344, DOI 10.2307/2265532; Magallon S, 2009, AM J BOT, V96, P349, DOI 10.3732/ajb.0800060; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Mi XC, 2012, AM NAT, V180, pE17, DOI 10.1086/665999; Miller GL, 2009, IITFGTR35 USDA FOR S, P437; Miller M.A., 2010, P GAT COMP ENV WORKS; Munkemuller T, 2014, GLOBAL ECOL BIOGEOGR, V23, P620, DOI 10.1111/geb.12137; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; Parmentier I, 2014, J ECOL, V102, P1008, DOI 10.1111/1365-2745.12254; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; PICKETT STA, 1978, ECOLOGY, V59, P1248, DOI 10.2307/1938238; Poe S, 1999, NATURE, V398, P299, DOI 10.1038/18592; Poe S, 2003, SYST BIOL, V52, P423, DOI 10.1080/10635150390197046; R Development Core Team, 2012, R LANG ENV STAT COMP; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2011, PHILOS T R SOC B, V366, P2438, DOI 10.1098/rstb.2011.0066; Schoch CL, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.64.01; Sedio BE, 2012, J ECOL, V100, P1183, DOI 10.1111/j.1365-2745.2012.01993.x; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Smith SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-37; Stefanovic S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-35; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Swenson NG, 2007, ECOLOGY, V88, P1770, DOI 10.1890/06-1499.1; Swenson NG, 2014, J PLANT ECOL, V7, P166, DOI 10.1093/jpe/rtt074; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Swenson NG, 2012, PHYLOGENETIC FUNCTIO; Uriarte M, 2010, ECOL LETT, V13, P1503, DOI 10.1111/j.1461-0248.2010.01541.x; USFS, 2006, FOR INV AN NAT COR F; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Vellend Mark, 2011, P194; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 1998, SYST BIOL, V47, P625, DOI 10.1080/106351598260635; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; WILLIAMS P H, 1991, Australian Systematic Botany, V4, P665, DOI 10.1071/SB9910665; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105	91	19	20	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112843	10.1371/journal.pone.0112843	http://dx.doi.org/10.1371/journal.pone.0112843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386879	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400096
J	Renner, SC; Gossner, MM; Kahl, T; Kalko, EKV; Weisser, WW; Fischer, M; Allan, E				Renner, Swen C.; Gossner, Martin M.; Kahl, Tiemo; Kalko, Elisabeth K. V.; Weisser, Wolfgang W.; Fischer, Markus; Allan, Eric			Temporal Changes in Randomness of Bird Communities across Central Europe	PLOS ONE			English	Article							LAND-USE INTENSIFICATION; FOREST FRAGMENTATION; HABITAT; DIVERSITY; QUALITY	Many studies have examined whether communities are structured by random or deterministic processes, and both are likely to play a role, but relatively few studies have attempted to quantify the degree of randomness in species composition. We quantified, for the first time, the degree of randomness in forest bird communities based on an analysis of spatial autocorrelation in three regions of Germany. The compositional dissimilarity between pairs of forest patches was regressed against the distance between them. We then calculated the y-intercept of the curve, i.e. the 'nugget', which represents the compositional dissimilarity at zero spatial distance. We therefore assume, following similar work on plant communities, that this represents the degree of randomness in species composition. We then analysed how the degree of randomness in community composition varied over time and with forest management intensity, which we expected to reduce the importance of random processes by increasing the strength of environmental drivers. We found that a high portion of the bird community composition could be explained by chance (overall mean of 0.63), implying that most of the variation in local bird community composition is driven by stochastic processes. Forest management intensity did not consistently affect the mean degree of randomness in community composition, perhaps because the bird communities were relatively insensitive to management intensity. We found a high temporal variation in the degree of randomness, which may indicate temporal variation in assembly processes and in the importance of key environmental drivers. We conclude that the degree of randomness in community composition should be considered in bird community studies, and the high values we find may indicate that bird community composition is relatively hard to predict at the regional scale.	[Renner, Swen C.; Kalko, Elisabeth K. V.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Renner, Swen C.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Gossner, Martin M.; Weisser, Wolfgang W.] Tech Univ Munich, Ctr Food & Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, Freising Weihenstephan, Germany; [Kahl, Tiemo] Univ Freiburg, Chair Silviculture, D-79106 Freiburg, Germany; [Fischer, Markus] Univ Bern, Inst Plant Sci & Bot Garden, Bern, Switzerland; [Allan, Eric] Univ Bern, Inst Plant Sci, Bern, Switzerland	Ulm University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Technical University of Munich; University of Freiburg; University of Bern; University of Bern	Renner, SC (corresponding author), Univ Nat Resources & Life Sci, Inst Zool, Vienna, Austria.	swen.renner@boku.ac.at	Gossner, Martin M./J-2730-2015; Fischer, Markus/C-6411-2008; Weisser, Wolfgang W/B-9718-2014; Allan, Eric/AAR-9566-2020	Gossner, Martin M./0000-0003-1516-6364; Fischer, Markus/0000-0002-5589-5900; Weisser, Wolfgang W/0000-0002-2757-8959; Allan, Eric/0000-0001-9641-9436; /0000-0002-6893-4219	German Science Foundation Priority Program 1374 Infrastructure Biodiversity-Exploratories [Ka 1241/19-1, Re 1733/6-1]	German Science Foundation Priority Program 1374 Infrastructure Biodiversity-Exploratories	The work has been funded by the German Science Foundation(www.dfg.de) Priority Program 1374 Infrastructure Biodiversity-Exploratories (Ka 1241/19-1, Re 1733/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge MW, 2008, J APPL ECOL, V45, P1349, DOI 10.1111/j.1365-2664.2008.01517.x; Boulinier T, 2001, ECOLOGY, V82, P1159, DOI 10.1890/0012-9658(2001)082[1159:FFABCD]2.0.CO;2; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Brownstein G, 2012, J ECOL, V100, P987, DOI 10.1111/j.1365-2745.2012.01973.x; Chalcraft DR, 2004, ECOLOGY, V85, P2701, DOI 10.1890/03-0561; Colwell R.K., 2006, ESTIMATES STAT ESTIM; DRAKE JA, 1999, NATURE ASSEMBLY TRAJ, P233; Eglington SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030407; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Farmer RG, 2012, AUK, V129, P76, DOI 10.1525/auk.2012.11129; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Glutz von Blotzheim UN, 1988, HDB VOGEL MITTELEURO; Goetz SJ, 2010, ECOLOGY, V91, P1569, DOI 10.1890/09-1670.1; Gossner MM, 2013, BIOL CONSERV, V166, P212, DOI 10.1016/j.biocon.2013.06.033; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Grothendieck G, 2013, NLS2 NONLINEAR REGRE; Hanski I., 1999, METAPOPULATION ECOLO; Haskell JP, 2002, NATURE, V418, P527, DOI 10.1038/nature00840; Hines J, 2013, PROGRAM PRESENCE 61; Honnay O, 2001, ECOLOGY, V82, P1691, DOI 10.1890/0012-9658(2001)082[1691:PCAADN]2.0.CO;2; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Kahl T, 2014, NAT CONSERV-BULGARIA, P15, DOI 10.3897/natureconservation.7.7281; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; Kubiczek K, 2014, PEERJ, V2, DOI 10.7717/peerj.368; Laliberte E, 2010, ECOL LETT, V13, P76, DOI 10.1111/j.1461-0248.2009.01403.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McLoughlin PD, 2000, EVOL ECOL, V14, P39, DOI 10.1023/A:1011019031766; Mistral M, 2000, J VEG SCI, V11, P911, DOI 10.2307/3236561; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Renner SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053121; Sauer JR, 2012, N AM BREEDING BIRD S; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stouffer PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020543; Suarez-Rubio M, 2011, J ORNITHOL, V152, P461, DOI 10.1007/s10336-010-0605-x	41	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112347	10.1371/journal.pone.0112347	http://dx.doi.org/10.1371/journal.pone.0112347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386924	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400056
J	Soong, C; Kurabi, B; Wells, D; Caines, L; Morgan, MW; Ramsden, R; Bell, CM				Soong, Christine; Kurabi, Bochra; Wells, David; Caines, Lesley; Morgan, Matthew W.; Ramsden, Rebecca; Bell, Chaim M.			Do Post Discharge Phone Calls Improve Care Transitions? A Cluster-Randomized Trial	PLOS ONE			English	Article							HOSPITAL DISCHARGE; QUALITY; REHOSPITALIZATION; INTERVENTION; HOME	Importance: The transition from hospital to home can expose patients to adverse events during the post discharge period. Post discharge care including phone calls may provide support for patients returning home but the impact on care transitions is unknown. Objective: To examine the effect of a 72-hour post discharge phone call on the patient's transition of care experience. Design: Cluster-randomized control trial. Setting: Urban, academic medical center. Participants: General medical patients age 18 and older discharged home after hospitalization. Main Outcomes and Measures: Primary outcome measure was the Care Transition Measure (CTM-3) score, a validated measure of the quality of care transitions. Secondary measures included self-reported adherence to medication and follow up plans, and 30-day composite of emergency department (ED) visits and hospital readmission. Results: 328 patients were included in the study over an 6-month period. 114 (69%) received a post discharge phone call, and 214 of all patients in the study completed the follow outcome survey (65% response rate). A small difference in CTM-3 scores was observed between the intervention and control groups (1.87 points, 95% CI 0.47-3.27, p = 0.01). Self-reported adherence to treatment plans, ED visits, and emergency readmission rates were similar between the two groups (odds ratio 0.57, 95% CI 0.13-2.45, 1.20, 95% CI 0.61-2.37, and 1.18, 95% CI 0.53-2.61, respectively). Conclusions and Relevance: A single post discharge phone call had a small impact on the quality of care transitions and no effect on hospital utilization. Higher intensity post discharge support may be required to improve the patient experience upon returning home.	[Soong, Christine; Kurabi, Bochra; Morgan, Matthew W.; Bell, Chaim M.] Univ Toronto, Div Gen Internal Med, Toronto, ON, Canada; [Soong, Christine; Wells, David; Caines, Lesley; Morgan, Matthew W.; Ramsden, Rebecca; Bell, Chaim M.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Soong, C (corresponding author), Univ Toronto, Div Gen Internal Med, Toronto, ON, Canada.	christine.soong@utoronto.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469	Mount Sinai Hospital Department of Medicine Physician Fund Campaign	Mount Sinai Hospital Department of Medicine Physician Fund Campaign	This study was funded by a grant from the Mount Sinai Hospital Department of Medicine Physician Fund Campaign. The funding agency had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	Arbaje AI, 2010, J AM GERIATR SOC, V58, P364, DOI 10.1111/j.1532-5415.2009.02682.x; Braun E, 2009, EUR J INTERN MED, V20, P221, DOI 10.1016/j.ejim.2008.07.021; Burke RE, 2013, JAMA INTERN MED, DOI [10.1001/jamain-ternmed.2013.171., DOI 10.1001/JAMAIN-TERNMED.2013.171]; Cain CH, 2012, J HOSP MED, V7, P382, DOI 10.1002/jhm.1918; Callen J, 2011, BMJ QUAL SAF, V20, P194, DOI 10.1136/bmjqs.2010.044339; Coleman E, 2012, COMMUNICATION; Coleman EA, 2005, MED CARE, V43, P246, DOI 10.1097/00005650-200503000-00007; Dedhia P, 2009, J AM GERIATR SOC, V57, P1540, DOI 10.1111/j.1532-5415.2009.02430.x; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Hansen LO, 2011, ANN INTERN MED, V155, P520, DOI 10.7326/0003-4819-155-8-201110180-00008; Hardin J.W., 2013, GEN ESTIMATING EQUAT, V2nd ed., DOI [https://doi.org/10.1201/b13880, DOI 10.1201/B13880]; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Kangovi S, 2012, J HOSP MED, V7, P709, DOI 10.1002/jhm.1966; Kripalani S, 2012, ANN INTERN MED, V157, P1, DOI 10.7326/0003-4819-157-1-201207030-00003; Maslove DM, 2009, J GEN INTERN MED, V24, P995, DOI 10.1007/s11606-009-1053-2; Mistiaen P, 2006, COCHRANE DB SYST REV, V2006; National Research Corporation Canada, 2014, PAT FAM EXP; Parry C, 2008, MED CARE, V46, P317, DOI 10.1097/MLR.0b013e3181589bdc; Poon EG, 2004, ARCH INTERN MED, V164, P2223, DOI 10.1001/archinte.164.20.2223; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Society of Hospital Medicine, 2014, PROJ BOOST BETT OUTC; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x	25	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112230	10.1371/journal.pone.0112230	http://dx.doi.org/10.1371/journal.pone.0112230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386678	Green Submitted, gold, Green Published			2022-12-26	WOS:000345250400052
J	Wang, XG; Yang, L; Wang, HJ; Shao, F; Yu, JF; Jiang, HL; Han, YP; Gong, DQ; Gu, ZL				Wang, Xingguo; Yang, Lei; Wang, Huijuan; Shao, Fang; Yu, JianFeng; Jiang, Honglin; Han, Yaoping; Gong, Daoqing; Gu, Zhiliang			Growth Hormone-Regulated mRNAs and miRNAs in Chicken Hepatocytes	PLOS ONE			English	Article							FOWL GALLUS-DOMESTICUS; LIPID-METABOLISM; IN-VIVO; GENE-EXPRESSION; ADIPOSE-TISSUE; ULTRADIAN RHYTHM; SECRETION; LIVER; GH; ACTIVATION	Growth hormone (GH) is a key regulatory factor in animal growth, development and metabolism. Based on the expression level of the GH receptor, the chicken liver is a major target organ of GH, but the biological effects of GH on the chicken liver are not fully understood. In this work we identified mRNAs and miRNAs that are regulated by GH in primary hepatocytes from female chickens through RNA-seq, and analyzed the functional relevance of these mRNAs and miRNAs through GO enrichment analysis and miRNA target prediction. A total of 164 mRNAs were found to be differentially expressed between GH-treated and control chicken hepatocytes, of which 112 were up-regulated and 52 were down-regulated by GH. A total of 225 chicken miRNAs were identified by the RNA-Seq analysis. Among these miRNAs 16 were up-regulated and 1 miRNA was down-regulated by GH. The GH-regulated mRNAs were mainly involved in growth and metabolism. Most of the GH-upregulated or GH-downregulated miRNAs were predicted to target the GH-downregulated or GH-upregulated mRNAs, respectively, involved in lipid metabolism. This study reveals that GH regulates the expression of many mRNAs involved in metabolism in female chicken hepatocytes, which suggests that GH plays an important role in regulating liver metabolism in female chickens. The results of this study also support the hypothesis that GH regulates lipid metabolism in chicken liver in part by regulating the expression of miRNAs that target the mRNAs involved in lipid metabolism.	[Wang, Xingguo; Yang, Lei; Wang, Huijuan; Shao, Fang; Yu, JianFeng; Han, Yaoping; Gu, Zhiliang] Changshu Inst Technol, Dept Life Sci & Technol, Changshu, Peoples R China; [Wang, Xingguo; Gong, Daoqing] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Peoples R China; [Jiang, Honglin] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Changshu Institute of Technology; Yangzhou University; Virginia Polytechnic Institute & State University	Gu, ZL (corresponding author), Changshu Inst Technol, Dept Life Sci & Technol, Changshu, Peoples R China.	zhilianggu88@hotmail.com	wang, hui/GRS-4730-2022; wang, xingguo/AAF-3020-2020; wang, huimin/HDM-8421-2022	, Honglin/0000-0001-9540-5788	National Natural Science Foundation of China [31072025, 31272438]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (31072025, 31272438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartke A, 2000, J ANDROL, V21, P181; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; Brooks AJ, 2010, NAT REV ENDOCRINOL, V6, P515, DOI 10.1038/nrendo.2010.123; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Bu SY, 2009, J BIOL CHEM, V284, P30474, DOI 10.1074/jbc.M109.036665; BUONOMO FC, 1984, COMP BIOCHEM PHYS C, V78, P409, DOI 10.1016/0742-8413(84)90107-5; CAMPBELL RM, 1988, P SOC EXP BIOL MED, V188, P177; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen YL, 2009, ENDOCRINOLOGY, V150, P3645, DOI 10.1210/en.2009-0212; Cheung L, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-13; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; CUPO MA, 1989, COMP BIOCHEM PHYS B, V94, P355, DOI 10.1016/0305-0491(89)90355-6; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Estabrook RW, 1996, P NATL ACAD SCI USA, V93, P13552, DOI 10.1073/pnas.93.24.13552; Gent J, 2002, P NATL ACAD SCI USA, V99, P9858, DOI 10.1073/pnas.152294299; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Harvey S, 2013, GEN COMP ENDOCR, V190, P3, DOI 10.1016/j.ygcen.2013.01.008; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hull KL, 2001, J ENDOCRINOL, V168, P1, DOI 10.1677/joe.0.1680001; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; JOHNSON RJ, 1988, J ENDOCRINOL, V119, P101, DOI 10.1677/joe.0.1190101; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; LEVEILLE GA, 1968, P SOC EXP BIOL MED, V128, P398; Li RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038716; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Moller N, 2009, ENDOCR REV, V30, P152, DOI 10.1210/er.2008-0027; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; OHEA EK, 1968, COMP BIOCHEM PHYSIOL, V26, P111, DOI 10.1016/0010-406X(68)90317-4; Ono M, 2007, MOL ENDOCRINOL, V21, P1443, DOI 10.1210/me.2006-0543; PRESS M, 1988, DIABETES METAB REV, V4, P391, DOI 10.1002/dmr.5610040406; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Ren H, 2013, BBA-MOL CELL BIOL L, V1831, P126, DOI 10.1016/j.bbalip.2012.07.012; Sidhu RS, 2005, J BIOL CHEM, V280, P21933, DOI 10.1074/jbc.M412966200; Stroh T, 2009, J NEUROSCI, V29, P8198, DOI 10.1523/JNEUROSCI.0336-09.2009; SUGAWARA T, 1995, BIOCHEMISTRY-US, V34, P12506, DOI 10.1021/bi00039a004; TANNENBAUM GS, 1976, ENDOCRINOLOGY, V98, P562, DOI 10.1210/endo-98-3-562; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; Wang X, 2007, CYTOGENET GENOME RES, V117, P174, DOI 10.1159/000103178; Wang XG, 2013, POULTRY SCI, V92, P1888, DOI 10.3382/ps.2012-02919; Waters MJ, 2012, ENDOCR DEV, V23, P86, DOI 10.1159/000341761; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1; Winston LA, 1995, J BIOL CHEM, V270, P30837, DOI 10.1074/jbc.270.52.30837; Wu MH, 2011, INT J MOL MED, V27, P655, DOI 10.3892/ijmm.2011.624; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhang YH, 2013, DIABETES RES CLIN PR, V99, P327, DOI 10.1016/j.diabres.2012.11.025; Zhao JT, 2011, J CLIN ENDOCR METAB, V96, pE1188, DOI 10.1210/jc.2010-2679	57	19	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112896	10.1371/journal.pone.0112896	http://dx.doi.org/10.1371/journal.pone.0112896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386791	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400102
J	Reichenbacher, B; Reichard, M				Reichenbacher, Bettina; Reichard, Martin			Otoliths of Five Extant Species of the Annual Killifish Nothobranchius from the East African Savannah	PLOS ONE			English	Article							APHANIUS-DISPAR TELEOSTEI; CYPRINODONTIFORMES NOTHOBRANCHIIDAE; SHAPE-ANALYSIS; ANNUAL FISH; INNER-EAR; KORTHAUSAE CYPRINODONTIFORMES; EVOLUTIONARY HISTORY; UTRICULAR OTOLITHS; SOUTHERN IRAN; MORPHOLOGY	This study presents, for the first time, a comprehensive dataset that documents the range of inter-and intraspecific otolith variation in aplocheiloid killifish, based on a total of 86 individuals representing five extant species of Nothobranchius PETERS, 1868, from East Africa: the sympatric pairs N. rubripinnis SEEGERS, 1986 and N. ruudwildekampi COSTA, 2009 (Eastern Tanzania), and N. orthonotus (PETERS, 1844) and N. furzeri JUBB, 1971 (Southern Mozambique), and two isolated populations of N. korthausae MEINKEN, 1973 (Eastern Tanzania). Otolith characters were analysed based on SEM images, and otolith morphometry was conducted using uni- and multivariate statistics. Two ancient clades of probably Early to Middle Miocene age in eastern Tanzania and southern Mozambique can be recognized based on otolith morphologies, which is consistent with previous work based on molecular data. The distinctive sulcus morphologies in the otoliths of sympatric species may be linked to species-specific hearing capabilities, perhaps constituting a case of character displacement in an area of secondary sympatry. The otoliths of the studied species of Nothobranchius are diagnostic at the species level, even in the case of closely related species diagnosable otherwise only by minor differences in coloration. The two populations of N. korthausae also displayed some differences in their otolith characters. The new data may facilitate future recognition of fossil species of Nothobranchius. As no fossil remains of extant aplocheiloid killifishes have yet been described, the discovery of fossil otoliths of Nothobranchius would significantly advance understanding of the evolutionary history of this interesting group of fishes.	[Reichenbacher, Bettina] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Reichard, Martin] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic	University of Munich; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Reichenbacher, B (corresponding author), Univ Munich, Dept Earth & Environm Sci, Munich, Germany.	b.reichenbacher@lrz.uni-muenchen.de	Reichenbacher, Bettina/AAM-9684-2020; Reichard, Martin/C-6563-2009	Reichard, Martin/0000-0002-9306-0074; Reichenbacher, Bettina/0000-0001-6678-5080	CSF (Czech Science Foundation) [P505/12/G112]	CSF (Czech Science Foundation)	This work was supported by CSF (Czech Science Foundation) project P505/12/G112. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre H, 1999, J FISH BIOL, V55, P105, DOI 10.1006/jfbi.1999.0974; Altner M, 2014, PLOS ONE REV; Annabi A, 2013, SCI MAR, V77, P269, DOI 10.3989/scimar.03763.02A; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Assis CA, 2005, SCI MAR, V69, P259, DOI 10.3989/scimar.2005.69n2259; Assis CA, 2003, J FISH BIOL, V62, P1268, DOI 10.1046/j.1095-8649.2003.00106.x; Avigliano E, 2014, FISH RES, V149, P55, DOI 10.1016/j.fishres.2013.09.013; Bartakova V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-196; Blazek R, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-24; Brzobohaty R., 1969, FOLIA FACULTATIS SCI, V10, P1; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; Campana SE, 2004, PHOTOGRAPHIC ATLAS F; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Costa WJEM, 2013, VERTEBR ZOOL, V63, P139; Costa WJEM, 2009, ICHTHYOL EXPLOR FRES, V20, P111; Costa Wilson J.E.M., 1998, P537; Doadrio I, 1996, ENVIRON BIOL FISH, V45, P259, DOI 10.1007/BF00003094; Dorn A, 2011, MOL PHYLOGENET EVOL, V61, P739, DOI 10.1016/j.ympev.2011.06.010; Dorn A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0210-3; Esmaeili HR, 2012, ZOOTAXA, P58; Esmaeili HR, 2014, ZOOTAXA, V3786, P246, DOI 10.11646/zootaxa.3786.3.2; Fekete DM, 2003, SCIENCE, V302, P241, DOI 10.1126/science.1091171; Ferrito V, 2013, MAR BIOL, V160, P3193, DOI 10.1007/s00227-013-2307-4; Froese R., 2014, FISHBASE WORLD WIDE; Gauldie RW, 2002, J FISH BIOL, V60, P1204, DOI 10.1006/jfbi.2002.1938; Gholami Z, 2014, J ZOOL SYST EVOL RES, V52, P130, DOI 10.1111/jzs.12052; Gierl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064117; HAAS R, 1976, EVOLUTION, V30, P614, DOI 10.1111/j.1558-5646.1976.tb00938.x; Horstkotte J, 2005, BIOL J LINN SOC, V85, P125, DOI 10.1111/j.1095-8312.2005.00476.x; Hrbek T, 2003, J EVOLUTION BIOL, V16, P17, DOI 10.1046/j.1420-9101.2003.00475.x; LEVELS PJ, 1986, COMP BIOCHEM PHYS A, V84, P767, DOI 10.1016/0300-9629(86)90403-2; LOMBARTE A, 1993, ENVIRON BIOL FISH, V37, P297, DOI 10.1007/BF00004637; Lombarte A, 2010, ENVIRON BIOL FISH, V89, P607, DOI 10.1007/s10641-010-9673-2; MALZ H, 1978, Senckenbergiana Lethaea, V59, P441; Tuset VM, 2012, SCI MAR, V76, P289, DOI 10.3989/scimar.03420.18E; Martin CH, 2011, EVOLUTION, V65, P2197, DOI 10.1111/j.1558-5646.2011.01294.x; Nolf D, 1995, BEL BAR LIB, P513; Nolf D., 2013, DIVERSITY FISH OTOLI; Nolf Dirk, 2006, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V76, P147; Oliva-Paterna FJ, 2006, ENVIRON BIOL FISH, V75, P415, DOI 10.1007/s10641-005-0001-1; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; PARKER A, 1995, COPEIA, P8; Plath M, 2008, BEHAV ECOL SOCIOBIOL, V62, P1727, DOI 10.1007/s00265-008-0601-9; Polacik M, 2014, HYDROBIOLOGIA, V721, P99, DOI 10.1007/s10750-013-1652-0; Polacik M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022684; Polacik M, 2009, BEHAV ECOL SOCIOBIOL, V63, P1427, DOI 10.1007/s00265-009-0798-2; Popper AN, 2005, MAR FRESHWATER RES, V56, P497, DOI 10.1071/MF04267; POPPER AN, 1976, SCIENCE, V192, P1020, DOI 10.1126/science.1273585; Ramcharitar JU, 2004, J COMP NEUROL, V475, P531, DOI 10.1002/cne.20192; Reichard M, 2009, J FISH BIOL, V74, P198, DOI 10.1111/j.1095-8649.2008.02129.x; Reichard M, 2010, ZOOTAXA, P49; Reichard M, 2010, BIOL J LINN SOC, V100, P62, DOI 10.1111/j.1095-8312.2010.01406.x; Reichenbacher B, 2003, ECLOGAE GEOL HELV, V96, P509, DOI 10.1007/s00015-003-1098-x; Reichenbacher B, 2001, GEOBIOS-LYON, V34, P69, DOI 10.1016/S0016-6995(01)80047-4; Reichenbacher B, 2007, J MORPHOL, V268, P898, DOI 10.1002/jmor.10561; Reichenbacher B, 2009, ENVIRON BIOL FISH, V86, P507, DOI 10.1007/s10641-009-9549-5; Reichenbacher B, 2009, PALAEOGEOGR PALAEOCL, V281, P43, DOI 10.1016/j.palaeo.2009.07.008; Reichenbacher B, 2009, J MORPHOL, V270, P469, DOI 10.1002/jmor.10702; Ruckert-Ulkumen N, 2002, MITTEILUNGEN BAYERIS, V42, P51; Sadighzadeh Z, 2014, SCI MAR, V78, P353, DOI 10.3989/scimar.03982.16C; Schulz-Mirbach T, 2008, GEODIVERSITAS, V30, P577; Schulz-Mirbach T, 2008, NEUES JAHRB GEOL P-A, V249, P223, DOI 10.1127/0077-7749/2008/0249-0223; Schulz-Mirbach T, 2008, EVOL ECOL RES, V10, P537; Schulz-Mirbach T, 2006, ACTA PALAEONTOL POL, V51, P283; Schulz-Mirbach T, 2012, MAR FRESHWATER RES, V63, P934, DOI 10.1071/MF12132; Schulz-Mirbach T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027734; Schwarzhans W., 1993, PISCIUM CATALOGUS PA, VI; Schwarzhans W, 2012, ACTA PALAEONTOL POL, V57, P319, DOI 10.4202/app.2010.0127; Seegers L., 1997, KILLIFISHES WORLD OL; Shidlovskiy KM, 2010, ZOOTAXA, P37; Skelton P.H., 2001, COMPLETE GUTIDE FRES, V2nd ed.; Smale M J, 1995, OTOLITH ATLAS SO AFR, P253; Stransky C, 2008, FISH RES, V89, P159, DOI 10.1016/j.fishres.2007.09.017; Teimori A, 2014, ZOOL ANZ, V253, P327, DOI 10.1016/j.jcz.2013.12.001; Teimori A, 2012, SCI MAR, V76, P637, DOI 10.3989/scimar.03635.26C; Teimori A, 2012, J ZOOL SYST EVOL RES, V50, P289, DOI 10.1111/j.1439-0469.2012.00667.x; Teimori A, 2012, ZOOKEYS, P55, DOI 10.3897/zookeys.215.1731; Terzibasi E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003866; Torres GJ, 2000, FISH RES, V46, P5, DOI 10.1016/S0165-7836(00)00128-4; Tozzini ET, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-77; Tuset VM, 2008, SCI MAR, V72, P7, DOI 10.3989/scimar.2008.72s1199; VALDESALICI S, 2008, INT J ICHTHYOLOGY, V14, P187; Valdesalici S, 2007, ZOOTAXA, P61, DOI 10.11646/zootaxa.1587.1.5; Valdesalici S, 2012, ICHTHYOL EXPLOR FRES, V23, P19; Valdesalici Stefano, 2011, Bonn Zoological Bulletin, V60, P89; Valdesalicil S, 2003, P ROY SOC B-BIOL SCI, V270, pS189, DOI 10.1098/rsbl.2003.0048; Vignon M, 2008, J FISH BIOL, V73, P2305, DOI 10.1111/j.1095-8649.2008.02070.x; Vignon M, 2010, MAR ECOL PROG SER, V411, P231, DOI 10.3354/meps08651; Volpedo A, 2003, FISH RES, V60, P551, DOI 10.1016/S0165-7836(02)00170-4; Volpedo A., 2000, CATALOGO CLAVES OTOL, V1; Watters B.R., 2009, J AM KILLFISH ASSOC, V42, P37; Watters B.R., 2007, J AM KILLIFISH ASS, V40, P129; Wildekamp R. H., 1993, WORLD KILLIES ATLAS, VI; Wildekamp RH, 2004, WORLD KILLIES ATLAS, VIV; Wildekamp RH, 2009, ICHTHYOL EXPLOR FRES, V20, P237	95	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112459	10.1371/journal.pone.0112459	http://dx.doi.org/10.1371/journal.pone.0112459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383789	Green Published, gold			2022-12-26	WOS:000344816700063
J	Spencer, NJ; Kyloh, M; Duffield, M				Spencer, Nick J.; Kyloh, Melinda; Duffield, Michael			Identification of Different Types of Spinal Afferent Nerve Endings That Encode Noxious and Innocuous Stimuli in the Large Intestine Using a Novel Anterograde Tracing Technique	PLOS ONE			English	Article							INTRAGANGLIONIC LAMINAR; RECTAL MECHANORECEPTORS; COLORECTAL DISTENSION; SMOOTH-MUSCLE; MOUSE; NEURONS; INNERVATION; GUT	In mammals, sensory stimuli in visceral organs, including those that underlie pain perception, are detected by spinal afferent neurons, whose cell bodies lie in dorsal root ganglia (DRG). One of the major challenges in visceral organs has been how to identify the different types of nerve endings of spinal afferents that transduce sensory stimuli into action potentials. The reason why spinal afferent nerve endings have been so challenging to identify is because no techniques have been available, until now, that can selectively label only spinal afferents, in high resolution. We have utilized an anterograde tracing technique, recently developed in our laboratory, which facilitates selective labeling of only spinal afferent axons and their nerve endings in visceral organs. Mice were anesthetized, lumbosacral DRGs surgically exposed, then injected with dextran-amine. Seven days post-surgery, the large intestine was removed. The characteristics of thirteen types of spinal afferent nerve endings were identified in detail. The greatest proportion of nerve endings was in submucosa (32%), circular muscle (25%) and myenteric ganglia (22%). Two morphologically distinct classes innervated myenteric ganglia. These were most commonly a novel class of intraganglionic varicose endings (IGVEs) and occasionally rectal intraganglionic laminar endings (rIGLEs). Three distinct classes of varicose nerve endings were found to innervate the submucosa and circular muscle, while one class innervated internodal strands, blood vessels, crypts of lieberkuhn, the mucosa and the longitudinal muscle. Distinct populations of sensory endings were CGRP-positive. We present the first complete characterization of the different types of spinal afferent nerve endings in a mammalian visceral organ. The findings reveal an unexpectedly complex array of different types of primary afferent endings that innervate specific layers of the large intestine. Some of the novel classes of nerve endings identified must underlie the transduction of noxious and/or innocuous stimuli from the large intestine.	[Spencer, Nick J.] Flinders Univ South Australia, Sch Med, Discipline Human Physiol, Adelaide, SA, Australia; Flinders Univ South Australia, Sch Med, Ctr Neurosci, Adelaide, SA, Australia	Flinders University South Australia; Flinders University South Australia	Spencer, NJ (corresponding author), Flinders Univ South Australia, Sch Med, Discipline Human Physiol, Adelaide, SA, Australia.	nicholas.spencer@flinders.edu.au		Spencer, Nicholas/0000-0003-2190-5303	National Health & Medical Research Council (NH& MRC) of Australia [10257566]	National Health & Medical Research Council (NH& MRC) of Australia	The authors would like to acknowledge the financial support provided by the National Health & Medical Research Council (NH& MRC) of Australia, grant #10257566, to NS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud HR, 1997, ANAT EMBRYOL, V195, P183, DOI 10.1007/s004290050037; BERTHOUD HR, 1992, ANAT EMBRYOL, V186, P431; BERTHOUD HR, 1992, J COMP NEUROL, V319, P261, DOI 10.1002/cne.903190206; Bornstein JC, 2006, J NEUROPHYSIOL, V96, P973, DOI 10.1152/jn.00511.2006; Brierley SM, 2004, GASTROENTEROLOGY, V127, P166, DOI 10.1053/j.gastro.2004.04.008; Brookes SJH, 2013, NAT REV GASTRO HEPAT, V10, P286, DOI 10.1038/nrgastro.2013.29; COSTA M, 1982, CIBA F SYMP, V91, P129; Costa M, 1996, NEUROSCIENCE, V75, P949, DOI 10.1016/0306-4522(96)00275-8; Furness J.B., 2006, ENTERIC NERVOUS SYST; Furness JB, 2004, CELL TISSUE RES, V317, P1, DOI 10.1007/s00441-004-0895-5; Furness JB, 2006, AUTON NEUROSCI-BASIC, V125, P81, DOI 10.1016/j.autneu.2006.01.007; Hibberd TJ, 2012, NEUROSCIENCE, V225, P118, DOI 10.1016/j.neuroscience.2012.08.040; Ivanusic JJ, 2013, J COMP NEUROL, V521, P877, DOI 10.1002/cne.23207; Kyloh M, 2014, NEUROGASTROENT MOTIL, V26, P440, DOI 10.1111/nmo.12266; Kyloh M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00016; Lynn PA, 2011, NEUROGASTROENT MOTIL, V23, P88, DOI 10.1111/j.1365-2982.2010.01593.x; Lynn PA, 2003, GASTROENTEROLOGY, V125, P786, DOI 10.1016/S0016-5085(03)01050-3; Powley TL, 2011, NEUROSCIENCE, V186, P188, DOI 10.1016/j.neuroscience.2011.04.036; Powley TL, 2011, J COMP NEUROL, V519, P644, DOI 10.1002/cne.22541; POWLEY TL, 1991, J NEUROSCI METH, V36, P9, DOI 10.1016/0165-0270(91)90132-J; Robinson DR, 2004, NEUROGASTROENT MOTIL, V16, P113, DOI 10.1046/j.1365-2982.2003.00456.x; Song XY, 2009, GASTROENTEROLOGY, V137, P274, DOI 10.1053/j.gastro.2009.02.061; Spencer NJ, 2008, NEUROSCIENCE, V153, P518, DOI 10.1016/j.neuroscience.2008.02.054; Spencer NJ, 2008, AM J PHYSIOL-GASTR L, V294, pG855, DOI 10.1152/ajpgi.00502.2007; Tan LL, 2008, NEUROSCIENCE, V156, P334, DOI 10.1016/j.neuroscience.2008.06.071; Tan LL, 2010, NEUROSCIENCE, V166, P564, DOI 10.1016/j.neuroscience.2009.12.034; Tassicker BC, 1999, CELL TISSUE RES, V295, P437, DOI 10.1007/s004410051250; Traub RJ, 2000, NEUROREPORT, V11, P2113, DOI 10.1097/00001756-200007140-00011; Yu SY, 2005, J PHYSIOL-LONDON, V563, P831, DOI 10.1113/jphysiol.2004.079574; Zagorodnyuk VP, 2011, J PHYSIOL-LONDON, V589, P1691, DOI 10.1113/jphysiol.2010.202820	30	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112466	10.1371/journal.pone.0112466	http://dx.doi.org/10.1371/journal.pone.0112466			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383884	Green Published, gold			2022-12-26	WOS:000344816700065
J	Al-Nedawi, K; Mian, MF; Hossain, N; Karimi, K; Mao, YK; Forsythe, P; Min, KK; Stanisz, AM; Kunze, WA; Bienenstock, J				Al-Nedawi, Khalid; Mian, M. Firoz; Hossain, Nazia; Karimi, Khalil; Mao, Yu-Kang; Forsythe, Paul; Min, Kevin K.; Stanisz, Andrew M.; Kunze, Wolfgang A.; Bienenstock, John			Gut commensal microvesicles reproduce parent bacterial signals to host immune and enteric nervous systems	FASEB JOURNAL			English	Article						bacterial microvesicles; immunoregulation	OUTER-MEMBRANE VESICLES; LACTOBACILLUS-REUTERI; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; INTERCELLULAR TRANSFER; DENDRITIC CELLS; MOTILITY; EXPRESSION; INDUCTION; VIRULENCE	Ingestion of a commensal bacteria, Lactobacillus rhamnosus JB-1, has potent immunoregulatory effects, and changes nerve-dependent colon migrating motor complexes (MMCs), enteric nerve function, and behavior. How these alterations occur is unknown. JB-1 microvesicles (MVs) are enriched for heat shock protein components such as chaperonin 60 heat-shock protein isolated from Escherichia coli (GroEL) and reproduce regulatory and neuronal effects in vitro and in vivo. Ingested labeled MVs were detected in murine Peyer's patch (PP) dendritic cells (DCs) within 18 h. After 3 d, PP and mesenteric lymph node DCs assumed a regulatory phenotype and increased functional regulatory CD4(+)25(+)Foxp3(+) T cells. JB-1, MVs, and GroEL similarly induced phenotypic change in cocultured DCs via multiple pathways including C-type lectin receptors specific intercellular adhesion molecule-3 grabbing non-integrin-related 1 and Dectin-1, as well as TLR-2 and -9. JB-1 and MVs also decreased the amplitude of neuronally dependent MMCs in an ex vivo model of peristalsis. Gut epithelial, but not direct neuronal application of, MVs, replicated functional effects of JB-1 on in situ patch-clamped enteric neurons. GroEL and anti-TLR-2 were without effect in this system, suggesting the importance of epithelium neuron signaling and discrimination between pathways for bacteria-neuron and -immune communication. Together these results offer a mechanistic explanation of howGram-positive commensals and probiotics may influence the host's immune and nervous systems.-Al-Nedawi, K., Mian, M. F., Hossain, N., Karimi, K., Mao, Y.-K., Forsythe, P., Min, K. K., Stanisz, A. M., Kunze, W. A., Bienenstock, J. Gut commensal microvesicles reproduce parent bacterial signals to host immune and enteric nervous systems.	[Al-Nedawi, Khalid] McMaster Univ, Div Nephrol, Hamilton, ON, Canada; [Karimi, Khalil; Forsythe, Paul] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Kunze, Wolfgang A.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Bienenstock, John] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Mian, M. Firoz; Hossain, Nazia; Karimi, Khalil; Mao, Yu-Kang; Forsythe, Paul; Min, Kevin K.; Stanisz, Andrew M.; Kunze, Wolfgang A.; Bienenstock, John] St Josephs Healthcare Hamilton, McMaster Brain Body Inst, Hamilton, ON L8N 4A6, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Bienenstock, J (corresponding author), St Josephs Healthcare Hamilton, McMaster Brain Body Inst, Juravinski Tower Room T3303-1, Hamilton, ON L8N 4A6, Canada.	bienens@mcmaster.ca	Karimi, Khalil/ABA-4735-2020	Karimi, Khalil/0000-0002-7245-5851; , Khalid/0000-0001-5140-3799	Giovanni and Concetta Guglietti Family Foundation; National Science Engineering Council [371513-2009]; McMaster Brain-Body Institute	Giovanni and Concetta Guglietti Family Foundation; National Science Engineering Council; McMaster Brain-Body Institute	The authors acknowledge the invaluable help from Dr. Eric Bonneil (IRIC-Universite de Montreal, Quebec, Canada), who performed the proteomic analysis. The authors thank Dr. Liam O'Mahony (Swiss Institute of Allergy and Asthma Research) and Ray Grant (Alimentary Health Pharma Davos, Davos, Switzerland) for invaluable discussion and advice. This work was supported by the Giovanni and Concetta Guglietti Family Foundation, National Science Engineering Council Grant 371513-2009 (to P.F.), and the McMaster Brain-Body Institute.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; Blaiotta G, 2008, APPL ENVIRON MICROB, V74, P208, DOI 10.1128/AEM.01711-07; Bravo JA, 2012, CURR OPIN PHARMACOL, V12, P667, DOI 10.1016/j.coph.2012.09.010; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cummings R.D., 2009, ANTIBODIES LECTINS G; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Dinan TG, 2013, BIOL PSYCHIAT, V74, P720, DOI 10.1016/j.biopsych.2013.05.001; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; Forsythe P, 2013, CELL MOL LIFE SCI, V70, P55, DOI 10.1007/s00018-012-1028-z; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Kadurugamuwa JL, 1999, MICROBIOL-SGM, V145, P2051, DOI 10.1099/13500872-145-8-2051; Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996; Kang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076520; Karimi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047556; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Klieve AV, 2005, APPL ENVIRON MICROB, V71, P4248, DOI 10.1128/AEM.71.8.4248-4253.2005; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936; Kuehn MJ, 2012, CELL HOST MICROBE, V12, P392, DOI 10.1016/j.chom.2012.10.005; Kunze WA, 2009, J CELL MOL MED, V13, P2261, DOI 10.1111/j.1582-4934.2009.00686.x; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; MacDonald IA, 2012, RES MICROBIOL, V163, P607, DOI 10.1016/j.resmic.2012.10.020; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Mao YK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2478; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Rivera J, 2010, P NATL ACAD SCI USA, V107, P19002, DOI 10.1073/pnas.1008843107; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sanchez B, 2010, MICROBIOL-SGM, V156, P3232, DOI 10.1099/mic.0.044057-0; Saygili T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049252; Schwechheimer C, 2013, BIOCHEMISTRY-US, V52, P3031, DOI 10.1021/bi400164t; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; van Bergenhenegouwen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089121; Wang B, 2010, NEUROGASTROENT MOTIL, V22, P98, DOI 10.1111/j.1365-2982.2009.01384.x; Wang BX, 2010, FASEB J, V24, P4078, DOI 10.1096/fj.09-153841; Wang XF, 2009, EUR J IMMUNOL, V39, P3052, DOI 10.1002/eji.200939335; Wu RY, 2013, NEUROGASTROENT MOTIL, V25, pE205, DOI 10.1111/nmo.12072; Zhu HY, 2013, MICROBES INFECT, V15, P172, DOI 10.1016/j.micinf.2012.10.001	54	85	88	1	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					684	695		10.1096/fj.14-259721	http://dx.doi.org/10.1096/fj.14-259721			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25392266				2022-12-26	WOS:000349370400029
J	Dkhar, HK; Gopalsamy, A; Loharch, S; Kaur, A; Bhutani, I; Saminathan, K; Bhagyaraj, E; Chandra, V; Swaminathan, K; Agrawal, P; Parkesh, R; Gupta, P				Dkhar, Hedwin Kitdorlang; Gopalsamy, Anupriya; Loharch, Saurabh; Kaur, Amandeep; Bhutani, Isha; Saminathan, Kanmani; Bhagyaraj, Ella; Chandra, Vemika; Swaminathan, Kunchithapadam; Agrawal, Pushpa; Parkesh, Raman; Gupta, Pawan			Discovery of Mycobacterium tuberculosis alpha-1,4-Glucan Branching Enzyme (GlgB) Inhibitors by Structure- and Ligand-based Virtual Screening	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Docking; Molecular Docking; Mycobacterium tuberculosis; Pathogenesis; Small Molecule	MOLECULAR-FORCE FIELD; ALPHA-GLUCAN PATHWAY; ALAMAR BLUE ASSAY; IN-VIVO; ENRICHMENT FACTORS; ACCURATE DOCKING; PROTEIN; EXPRESSION; GLYCOGEN; H37RV	Background:M. tuberculosis GlgB is essential for the biosynthesis of branched glucan and modulates pathogenesis and survival. Results: Two novel small molecules demonstrated significant inhibition of M. tuberculosis GlgB enzyme activity, growth and survival. Conclusion: Small molecules with diverse scaffolds but similar three-dimensional-structures show a similar biological effect. Significance: Deriving scaffolds from docking and similarity search is a successful design strategy for difficult targets. GlgB (-1,4-glucan branching enzyme) is the key enzyme involved in the biosynthesis of -glucan, which plays a significant role in the virulence and pathogenesis of Mycobacterium tuberculosis. Because -glucans are implicated in the survival of both replicating and non-replicating bacteria, there exists an exigent need for the identification and development of novel inhibitors for targeting enzymes, such as GlgB, involved in this pathway. We have used the existing structural information of M. tuberculosis GlgB for high throughput virtual screening and molecular docking. A diverse database of 330,000 molecules was used for identifying novel and efficacious therapeutic agents for targeting GlgB. We also used three-dimensional shape as well as two-dimensional similarity matrix methods to identify diverse molecular scaffolds that inhibit M. tuberculosis GlgB activity. Virtual hits were generated after structure and ligand-based screening followed by filters based on interaction with human GlgB and in silico pharmacokinetic parameters. These hits were experimentally evaluated and resulted in the discovery of a number of structurally diverse chemical scaffolds that target M. tuberculosis GlgB. Although a number of inhibitors demonstrated in vitro enzyme inhibition, two compounds in particular showed excellent inhibition of in vivo M. tuberculosis survival and its ability to get phagocytosed. This work shows that in silico docking and three-dimensional chemical similarity could be an important therapeutic approach for developing inhibitors to specifically target the M. tuberculosis GlgB enzyme.	[Dkhar, Hedwin Kitdorlang; Loharch, Saurabh; Kaur, Amandeep; Bhutani, Isha; Bhagyaraj, Ella; Chandra, Vemika; Agrawal, Pushpa; Parkesh, Raman; Gupta, Pawan] Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India; [Gopalsamy, Anupriya; Saminathan, Kanmani; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); National University of Singapore	Parkesh, R (corresponding author), Inst Microbial Technol, Council Sci & Ind Res, Chandigarh 160036, India.	rparkesh@imtech.res.in; pawan@imtech.res.in	Agrawal, Pushpa/P-2282-2016; Chandra, Vemika/AAK-6997-2020	Agrawal, Pushpa/0000-0003-3568-8119; Chandra, Vemika/0000-0001-5360-7875; Loharch, Saurabh/0000-0002-5496-8784; Ella, Bhagyaraj/0000-0002-5887-9228; Gopalsamy, Anupriya/0000-0002-2774-5454	Council of Scientific and Industrial Research (CSIR) 12th Plan project Infectious Disease [BSC0210]; Genesis [BSC0121]; OLP projects; CSIR-UGC junior research fellowship; Institute of Microbial Technology research internship	Council of Scientific and Industrial Research (CSIR) 12th Plan project Infectious Disease; Genesis; OLP projects; CSIR-UGC junior research fellowship; Institute of Microbial Technology research internship(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Council of Scientific and Industrial Research (CSIR) 12th Plan project Infectious Disease (BSC0210), Genesis (BSC0121), and OLP projects (to P. G., R. P., and P. A.).; Supported by a CSIR-UGC junior research fellowship.; Recipient of an Institute of Microbial Technology research internship.	Agrawal P, 2014, CURR MED CHEM, V21, P4074, DOI 10.2174/0929867321666140826120449; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bittencourt VCB, 2006, J BIOL CHEM, V281, P22614, DOI 10.1074/jbc.M511417200; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Cowley SC, 2001, GENE, V264, P225, DOI 10.1016/S0378-1119(01)00336-5; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Duffy EM, 2000, J AM CHEM SOC, V122, P2878, DOI 10.1021/ja993663t; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gagliardi MC, 2007, CELL MICROBIOL, V9, P2081, DOI 10.1111/j.1462-5822.2007.00940.x; Garg S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-1; Garg SK, 2007, PROTEIN EXPRES PURIF, V51, P198, DOI 10.1016/j.pep.2006.08.005; Geurtsen J, 2009, J IMMUNOL, V183, P5221, DOI 10.4049/jimmunol.0900768; Haigh JA, 2005, J CHEM INF MODEL, V45, P673, DOI 10.1021/ci049651v; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Halgren TA, 1996, J COMPUT CHEM, V17, P616, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hammes GG, 2002, BIOCHEMISTRY-US, V41, P8221, DOI 10.1021/bi0260839; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Hevener KE, 2012, J MED CHEM, V55, P268, DOI 10.1021/jm201168g; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Jones SA, 2008, INFECT IMMUN, V76, P2531, DOI 10.1128/IAI.00096-08; Jorgensen WL, 2000, BIOORG MED CHEM LETT, V10, P1155, DOI 10.1016/S0960-894X(00)00172-4; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kalscheuer R, 2010, DRUG NEWS PERSPECT, V23, P619, DOI 10.1358/dnp.2010.23.10.1534855; Kalscheuer R, 2010, NAT CHEM BIOL, V6, P376, DOI 10.1038/nchembio.340; Krieger IV, 2012, CHEM BIOL, V19, P1556, DOI 10.1016/j.chembiol.2012.09.018; Kruger DM, 2010, CHEMMEDCHEM, V5, P148, DOI 10.1002/cmdc.200900314; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lombardo MJ, 2007, P NATL ACAD SCI USA, V104, P18229, DOI 10.1073/pnas.0705636104; Martin A, 2003, ANTIMICROB AGENTS CH, V47, P3616, DOI 10.1128/AAC.47.11.3616-3619.2003; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Mitchison DA, 2005, AM J RESP CRIT CARE, V171, P699, DOI 10.1164/rccm.200411-1603OE; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Pal K, 2010, J BIOL CHEM, V285, P20897, DOI 10.1074/jbc.M110.121707; Petsko G. A., 2004, PROTEIN STRUCTURE FU, P50; Sambou T, 2008, MOL MICROBIOL, V70, P762, DOI 10.1111/j.1365-2958.2008.06445.x; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Schwebach JR, 2001, INFECT IMMUN, V69, P5671, DOI 10.1128/IAI.69.9.5671-5678.2001; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	47	15	16	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					76	89		10.1074/jbc.M114.589200	http://dx.doi.org/10.1074/jbc.M114.589200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25384979	Green Published, hybrid			2022-12-26	WOS:000347231200008
J	Gadalla, KKE; Ross, PD; Riddell, JS; Bailey, MES; Cobb, SR				Gadalla, Kamal K. E.; Ross, Paul D.; Riddell, John S.; Bailey, Mark E. S.; Cobb, Stuart R.			Gait Analysis in a Mecp2 Knockout Mouse Model of Rett Syndrome Reveals Early-Onset and Progressive Motor Deficits	PLOS ONE			English	Article							CPG-BINDING PROTEIN-2; PARKINSONS-DISEASE; MICE; SYMPTOMS; REVERSAL; MUTATION; NEURONS	Rett syndrome (RTT) is a genetic disorder characterized by a range of features including cognitive impairment, gait abnormalities and a reduction in purposeful hand skills. Mice harbouring knockout mutations in the Mecp2 gene display many RTT-like characteristics and are central to efforts to find novel therapies for the disorder. As hand stereotypies and gait abnormalities constitute major diagnostic criteria in RTT, it is clear that motor and gaitrelated phenotypes will be of importance in assessing preclinical therapeutic outcomes. We therefore aimed to assess gait properties over the prodromal phase in a functional knockout mouse model of RTT. In male Mecp2 knockout mice, we observed alterations in stride, coordination and balance parameters at 4 weeks of age, before the onset of other overt phenotypic changes as revealed by observational scoring. These data suggest that gait measures may be used as a robust and early marker of MeCP2-dysfunction in future preclinical therapeutic studies.	[Gadalla, Kamal K. E.; Ross, Paul D.; Riddell, John S.; Cobb, Stuart R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Bailey, Mark E. S.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland; [Gadalla, Kamal K. E.] Tanta Univ, Fac Med, Dept Pharmacol, Tanta, Egypt	University of Glasgow; University of Glasgow; Egyptian Knowledge Bank (EKB); Tanta University	Cobb, SR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	stuart.cobb@glasgow.ac.uk		Gadalla, Kamal/0000-0002-1657-8953; , Paul/0000-0002-4093-5703; Riddell, John/0000-0001-6366-6545; Bailey, Mark E. S./0000-0002-9788-2278	Rett Syndrome Research Trust; Rett Syndrome Association Scotland; Chief Scientist Office; Chief Scientist Office [ETM/334] Funding Source: researchfish	Rett Syndrome Research Trust; Rett Syndrome Association Scotland; Chief Scientist Office; Chief Scientist Office	The work was supported by the following: Rett Syndrome Research Trust (www.rsrt.org/) SC/MB; Rett Syndrome Association Scotland (http://rettsyndromescotland.co.uk/) SC/MB; and Chief Scientist Office (http://www.cso.scot.nhs.uk/) SC/MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amende Ivo, 2005, J Neuroeng Rehabil, V2, P20, DOI 10.1186/1743-0003-2-20; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Basso DM, 2002, RESTOR NEUROL NEUROS, V20, P189; Carter RJ, 1999, J NEUROSCI, V19, P3248; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheval H, 2012, HUM MOL GENET, V21, P3806, DOI 10.1093/hmg/dds208; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Domanskyi A, 2011, FASEB J, V25, P2898, DOI 10.1096/fj.11-181958; Fernagut PO, 2002, J NEUROSCI METH, V113, P123, DOI 10.1016/S0165-0270(01)00485-X; Gadalla KKE, 2013, MOL THER, V21, P18, DOI 10.1038/mt.2012.200; Gadalla KKE, 2011, BIOCHEM J, V439, P1, DOI 10.1042/BJ20110648; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Glajch KE, 2012, BEHAV BRAIN RES, V230, P309, DOI 10.1016/j.bbr.2011.12.007; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1986, AM J MED GENET S, V1, P47; Johnson EM, 2007, J PHYSIOL-LONDON, V582, P629, DOI 10.1113/jphysiol.2007.133561; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kerr B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011534; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; McGraw CM, 2011, SCIENCE, V333, P186, DOI 10.1126/science.1206593; NAIDU S, 1986, American Journal of Medical Genetics, P61; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; NOMURA Y, 1992, BRAIN DEV-JPN, V14, pS21; NOMURA Y, 1990, BRAIN DEV-JPN, V12, P27, DOI 10.1016/S0387-7604(12)80170-7; Robinson L, 2012, BRAIN, V135, P2699, DOI 10.1093/brain/aws096; Santos M, 2010, NEUROSCIENCE, V170, P453, DOI 10.1016/j.neuroscience.2010.07.010; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Weng SM, 2011, NEUROSCIENCE, V180, P314, DOI 10.1016/j.neuroscience.2011.01.061; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228	33	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112889	10.1371/journal.pone.0112889	http://dx.doi.org/10.1371/journal.pone.0112889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392929	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300118
J	Xing, J; Wang, C; Kimura, H; Takasaki, Y; Kunimoto, S; Yoshimi, A; Nakamura, Y; Koide, T; Banno, M; Kushima, I; Uno, Y; Okada, T; Aleksic, B; Ikeda, M; Iwata, N; Ozaki, N				Xing, Jingrui; Wang, Chenyao; Kimura, Hiroki; Takasaki, Yuto; Kunimoto, Shohko; Yoshimi, Akira; Nakamura, Yukako; Koide, Takayoshi; Banno, Masahiro; Kushima, Itaru; Uno, Yota; Okada, Takashi; Aleksic, Branko; Ikeda, Masashi; Iwata, Nakao; Ozaki, Norio			Resequencing and Association Analysis of PTPRA, a Possible Susceptibility Gene for Schizophrenia and Autism Spectrum Disorders	PLOS ONE			English	Article							GENOME-WIDE; PREFRONTAL CORTEX; RPTP-ALPHA; ERBB4; VARIANTS; MATTER; WHITE; NEUREGULIN-1; METAANALYSIS; EXPRESSION	Background: The PTPRA gene, which encodes the protein RPTP-alpha, is critical to neurodevelopment. Previous linkage studies, genome-wide association studies, controlled expression analyses and animal models support an association with both schizophrenia and autism spectrum disorders, both of which share a substantial portion of genetic risks. Methods: We sequenced the protein-encoding areas of the PTPRA gene for single nucleotide polymorphisms or small insertions/deletions (InDel) in 382 schizophrenia patients. To validate their association with the disorders, rare (minor allele frequency, <1%), missense mutations as well as one InDel in the 39UTR region were then genotyped in another independent sample set comprising 944 schizophrenia patients, 336 autism spectrum disorders patients, and 912 healthy controls. Results: Eight rare mutations, including 3 novel variants, were identified during the mutation-screening phase. In the following association analysis, L59P, one of the two missense mutations, was only observed among patients of schizophrenia. Additionally, a novel duplication in the 3'UTR region, 174620_174623dupTGAT, was predicted to be located within a Musashi Binding Element. Major Conclusions: No evidence was seen for the association of rare, missense mutations in the PTPRA gene with schizophrenia or autism spectrum disorders; however, we did find some rare variants with possibly damaging effects that may increase the susceptibility of carriers to the disorders.	[Xing, Jingrui; Wang, Chenyao; Kimura, Hiroki; Takasaki, Yuto; Kunimoto, Shohko; Yoshimi, Akira; Nakamura, Yukako; Koide, Takayoshi; Banno, Masahiro; Kushima, Itaru; Uno, Yota; Okada, Takashi; Aleksic, Branko; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Ikeda, Masashi; Iwata, Nakao] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan	Nagoya University; Fujita Health University	Aleksic, B (corresponding author), Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan.	branko@med.nagoya-u.ac.jp	KUSHIMA, Itaru/M-8872-2014; YOSHIMI, Akira/M-8934-2014; Aleksic, Branko/G-1540-2011; Ozaki, Norio/M-8908-2014; Aleksic, Branko/L-7851-2019; nakamura, yukako/M-8889-2014; Banno, Masahiro/E-5341-2010; UNO, Yota/M-8928-2014; OKADA, Takashi/M-8902-2014	Aleksic, Branko/0000-0001-8982-4580; Ozaki, Norio/0000-0002-7360-4898; Aleksic, Branko/0000-0001-8982-4580; nakamura, yukako/0000-0002-3306-7127; Banno, Masahiro/0000-0002-2539-1031; Yoshimi, Akira/0000-0001-6636-7970; Kushima, Itaru/0000-0002-0018-5178; IWATA, Nakao/0000-0003-3189-6076; OKADA, Takashi/0000-0001-5580-9913	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Science, Sports and Culture of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding for this study was provided by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Ministry of Health, Labor and Welfare of Japan; Grant-in-Aid for "Integrated research on neuropsychiatric disorders'' carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant-in-Aid for Scientific Research on Innovative Areas, "Glial assembly: a new regulatory machinery of brain function and disorders''; and Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bartlett CW, 2012, BIOL PSYCHIAT, V72, P692, DOI 10.1016/j.biopsych.2012.05.019; Bodrikov V, 2005, J CELL BIOL, V168, P127, DOI 10.1083/jcb.200405073; Bodrikov V, 2008, J CELL BIOL, V182, P1185, DOI 10.1083/jcb.200803045; Buonanno A, 2010, BRAIN RES BULL, V83, P122, DOI 10.1016/j.brainresbull.2010.07.012; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; Carmody DP, 2010, DEV PSYCHOBIOL, V52, P755, DOI 10.1002/dev.20471; Crespi BJ, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-15; Fanous AH, 2008, BIOL PSYCHIAT, V64, P121, DOI 10.1016/j.biopsych.2007.11.023; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Firth HVea, 2009, AM J HUM GENET; Fischbach GD, 2007, NEURON, V54, P495, DOI 10.1016/j.neuron.2007.05.009; Ginsberg MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044736; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Hoistad M, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.009.2009; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Ikeda M, 2011, BIOL PSYCHIAT, V69, P472, DOI 10.1016/j.biopsych.2010.07.010; Johnson NL, 2013, J NURS SCHOLARSHIP, V45, P69, DOI 10.1111/j.1547-5069.2012.01483.x; Kleinhans NM, 2012, BRAIN RES, V1479, P1, DOI 10.1016/j.brainres.2012.07.056; Ku CS, 2013, MOL PSYCHIATR, V18, P141, DOI 10.1038/mp.2012.58; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Lin Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074264; Liu L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003443; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martins-de-Souza D, 2010, J PSYCHIATR RES, V44, P149, DOI 10.1016/j.jpsychires.2009.07.007; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mistry M, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-105; Okano H, 2002, J CELL SCI, V115, P1355; Owen MJ, 2010, ARCH GEN PSYCHIAT, V67, P667, DOI 10.1001/archgenpsychiatry.2010.69; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Silberberg G, 2006, AM J MED GENET B, V141B, P142, DOI 10.1002/ajmg.b.30275; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Takahashi N, 2011, BIOL PSYCHIAT, V70, P626, DOI 10.1016/j.biopsych.2011.06.016; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Teltsh O, 2008, AM J MED GENET B, V147B, P209, DOI 10.1002/ajmg.b.30591; Vawter MP, 2011, BRIEF FUNCT GENOMICS, V10, P387, DOI 10.1093/bfgp/elr036; Wang PS, 2009, J BIOL CHEM, V284, P33692, DOI 10.1074/jbc.M109.061770; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Ye H, 2008, EMBO J, V27, P188, DOI 10.1038/sj.emboj.7601939	44	2	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112531	10.1371/journal.pone.0112531	http://dx.doi.org/10.1371/journal.pone.0112531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393624	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300065
J	Doyle, JR; Harwood, BN; Krishnaji, ST; Krishnamurthy, VM; Lin, WE; Fortin, JP; Kumar, K; Kopin, AS				Doyle, Jamie R.; Harwood, Benjamin N.; Krishnaji, Subrahmanian Tarakkad; Krishnamurthy, Vijay M.; Lin, Wei-En; Fortin, Jean-Philippe; Kumar, Krishna; Kopin, Alan S.			A Two-Step Strategy to Enhance Activity of Low Potency Peptides	PLOS ONE			English	Article							CHOLECYSTOKININ-B RECEPTOR; MEMBRANE-TETHERED LIGANDS; PROTEIN-COUPLED RECEPTORS; HUMAN SERUM-ALBUMIN; FATTY-ACIDS; IN-VITRO; REVERSIBLE LIPIDIZATION; PHARMACOLOGICAL PROFILE; NEUROKININ-1 RECEPTOR; ALPHA-AMIDATION	Novel strategies are needed to expedite the generation and optimization of peptide probes targeting G protein-coupled receptors (GPCRs). We have previously shown that membrane tethered ligands (MTLs), recombinant proteins comprised of a membrane anchor, an extracellular linker, and a peptide ligand can be used to identify targeted receptor modulators. Although MTLs provide a useful tool to identify and/or modify functionally active peptides, a major limitation of this strategy is the reliance on recombinant protein expression. We now report the generation and pharmacological characterization of prototype peptide-linker-lipid conjugates, synthetic membrane anchored ligands (SMALs), which are designed as mimics of corresponding MTLs. In this study, we systematically compare the activity of selected peptides as MTLs versus SMALs. As prototypes, we focused on the precursor proteins of mature Substance P (SubP) and Cholecystokinin 4 (CCK4), specifically non-amidated SubP (SubP-COOH) and glycine extended CCK4 (CCK4-Gly-COOH). As low affinity soluble peptides these ligands each presented a challenging test case for assessment of MTL/SMAL technology. For each ligand, MTLs and corresponding SMALs showed agonist activity and comparable subtype selectivity. In addition, our results illustrate that membrane anchoring increases ligand potency. Furthermore, both MTL and SMAL induced signaling can be blocked by specific non-peptide antagonists suggesting that the anchored constructs may be orthosteric agonists. In conclusion, MTLs offer a streamlined approach for identifying low activity peptides which can be readily converted to higher potency SMALs. The ability to recapitulate MTL activity with SMALs extends the utility of anchored peptides as probes of GPCR function.	[Doyle, Jamie R.; Harwood, Benjamin N.; Fortin, Jean-Philippe; Kopin, Alan S.] Tufts Med Ctr, Mol Pharmacol Res Ctr, Mol Cardiol Res Inst, Boston, MA USA; [Harwood, Benjamin N.; Kopin, Alan S.] Tufts Univ, Sackler Sch Grad Biomed Sci, Genet Program, Boston, MA 02111 USA; [Krishnaji, Subrahmanian Tarakkad; Krishnamurthy, Vijay M.; Lin, Wei-En; Kumar, Krishna] Tufts Univ, Dept Chem, Medford, MA USA	Tufts Medical Center; Tufts University; Tufts University	Kumar, K (corresponding author), Tufts Univ, Dept Chem, Medford, MA 02155 USA.	krishna.kumar@tufts.edu; akopin@tuftsmedicalcenter.org	Kumar, Krishna/B-3151-2009	Kumar, Krishna/0000-0002-0548-5014; Tarakkad Krishnaji, Subrahmanian/0000-0001-8950-6072	National Institutes of Health Heart, Lung, and Blood Institute [T32-HL069770]; National Institutes of Health Neurological Disorders and Stroke [T32-NS061764]; National Institutes of Health General Medical Sciences [R01-GM65500]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS061764] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Heart, Lung, and Blood Institute [Grant T32-HL069770] (www.nhlbi.nih.gov); The National Institutes of Health Neurological Disorders and Stroke [Grant T32-NS061764] (www.drugabuse.gov); The National Institutes of Health General Medical Sciences [Grant R01-GM65500](www.nigms.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beinborn M, 1998, YALE J BIOL MED, V71, P337; Bellmann-Sickert K, 2011, J MED CHEM, V54, P2658, DOI 10.1021/jm101357e; Bellucci F, 2002, BRIT J PHARMACOL, V135, P266, DOI 10.1038/sj.bjp.0704443; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328; CUTTITTA F, 1993, ANAT REC, V236, P87, DOI 10.1002/ar.1092360112; Dasgupta P, 2000, BRIT J PHARMACOL, V129, P101, DOI 10.1038/sj.bjp.0702990; Doyle JR, 2012, J PHARMACOL EXP THER, V342, P318, DOI 10.1124/jpet.112.194548; EIPPER BA, 1988, ANNU REV PHYSIOL, V50, P333, DOI 10.1146/annurev.ph.50.030188.002001; EIPPER BA, 1992, ANNU REV NEUROSCI, V15, P57, DOI 10.1146/annurev.ne.15.030192.000421; EIPPER BA, 1993, PROTEIN SCI, V2, P489; Fortin JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024693; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Fujita T, 1998, PHARMACEUT RES, V15, P1387, DOI 10.1023/A:1011997404306; Fujiwara SI, 2008, BIOPHYS J, V94, P95, DOI 10.1529/biophysj.107.111377; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Harwood BN, 2013, MOL PHARMACOL, V83, P814, DOI 10.1124/mol.112.081570; HUGHES J, 1990, P NATL ACAD SCI USA, V87, P6728, DOI 10.1073/pnas.87.17.6728; ITO M, 1993, J BIOL CHEM, V268, P18300; Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011; LEE YM, 1993, J BIOL CHEM, V268, P8164; Leeman SE, 2000, NEUROPEPTIDES, V34, P249, DOI 10.1054/npep.2000.0826; Lindstrom E, 2007, J PHARMACOL EXP THER, V322, P1286, DOI 10.1124/jpet.107.124958; MATSUEDA GR, 1982, INT J PEPT PROT RES, V20, P26; MCLEAN S, 1993, J PHARMACOL EXP THER, V267, P472; Myers SR, 1997, DIABETES, V46, P637, DOI 10.2337/diabetes.46.4.637; NISHIDA A, 1994, J PHARMACOL EXP THER, V269, P725; Pennington M W, 1994, Methods Mol Biol, V35, P41; PISEGNA JR, 1994, ANN NY ACAD SCI, V713, P338, DOI 10.1111/j.1749-6632.1994.tb44086.x; Rask-Andersen M, 2014, ANNU REV PHARMACOL, V54, P9, DOI 10.1146/annurev-pharmtox-011613-135943; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Seong B. L., 2001, BIOTECHNOL BIOPROC E, V6, P244; SETOH K, 1995, J PHARM PHARMACOL, V47, P808, DOI 10.1111/j.2042-7158.1995.tb05745.x; Tanaka K, 1996, BBA-BIOMEMBRANES, V1283, P119, DOI 10.1016/0005-2736(96)00087-9; TENMA T, 1993, PHARMACEUT RES, V10, P1488, DOI 10.1023/A:1018983511247; Wang J, 2006, J DRUG TARGET, V14, P127, DOI 10.1080/10611860600648221; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; YODOYA E, 1994, J PHARMACOL EXP THER, V271, P1509; Yuan LY, 2005, PHARM RES-DORDR, V22, P220, DOI 10.1007/s11095-004-1189-z; Zarandi M, 2006, P NATL ACAD SCI USA, V103, P4610, DOI 10.1073/pnas.0511348103; Zhang L, 2012, CURR MED CHEM, V19, P1602	43	7	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110502	10.1371/journal.pone.0110502	http://dx.doi.org/10.1371/journal.pone.0110502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391026	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400015
J	Hocking, DP; Salverson, M; Fitzgerald, EMG; Evans, AR				Hocking, David P.; Salverson, Marcia; Fitzgerald, Erich M. G.; Evans, Alistair R.			Australian Fur Seals (Arctocephalus pusillus doriferus) Use Raptorial Biting and Suction Feeding When Targeting Prey in Different Foraging Scenarios	PLOS ONE			English	Article							DIET; BEHAVIOR; KINEMATICS	Foraging behaviours used by two female Australian fur seals (Arctocephalus pusillus doriferus) were documented during controlled feeding trials. During these trials the seals were presented with prey either free-floating in open water or concealed within a mobile ball or a static box feeding device. When targeting free-floating prey both subjects primarily used raptorial biting in combination with suction, which was used to draw prey to within range of the teeth. When targeting prey concealed within either the mobile or static feeding device, the seals were able to use suction to draw out prey items that could not be reached by biting. Suction was followed by lateral water expulsion, where water drawn into the mouth along with the prey item was purged via the sides of the mouth. Vibrissae were used to explore the surface of the feeding devices, especially when locating the openings in which the prey items had been hidden. The mobile ball device was also manipulated by pushing it with the muzzle to knock out concealed prey, which was not possible when using the static feeding device. To knock prey out of this static device one seal used targeted bubble blowing, where a focused stream of bubbles was blown out of the nose into the openings in the device. Once captured in the jaws, prey items were manipulated and re-oriented using further mouth movements or chews so that they could be swallowed head first. While most items were swallowed whole underwater, some were instead taken to the surface and held in the teeth, while being vigorously shaken to break them into smaller pieces before swallowing. The behavioural flexibility displayed by Australian fur seals likely assists in capturing and consuming the extremely wide range of prey types that are targeted in the wild, during both benthic and epipelagic foraging.	[Hocking, David P.; Evans, Alistair R.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Hocking, David P.; Fitzgerald, Erich M. G.; Evans, Alistair R.] Museum Victoria, Melbourne, Vic, Australia; [Hocking, David P.; Salverson, Marcia] Zoos Victoria, Wild Sea Precinct, Melbourne, Vic, Australia	Monash University; Museum Victoria	Hocking, DP (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	email@david-hocking.com	Evans, Alistair R/D-4239-2011; Hocking, David Philip/A-2666-2017	Evans, Alistair R/0000-0002-4078-4693; Hocking, David Philip/0000-0001-6848-1208	Holsworth Wildlife Research Endowment and Monash University; Australian Research Council	Holsworth Wildlife Research Endowment and Monash University; Australian Research Council(Australian Research Council)	This study was supported by the Holsworth Wildlife Research Endowment and Monash University. ARE acknowledges the support of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Peter J., 2002, Oryctos, V4, P83; Arnould JPY, 2006, LOW WAKE FI, P309; Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Arnould JPY, 2001, CAN J ZOOL, V79, P35, DOI 10.1139/cjz-79-1-35; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Deagle BE, 2009, MOL ECOL, V18, P2022, DOI 10.1111/j.1365-294X.2009.04158.x; GALES R, 1993, AUST J MAR FRESH RES, V44, P657; GALES R, 1994, AUST J MAR FRESH RES, V45, P653; Hocking DP, 2013, POLAR BIOL, V36, P211, DOI 10.1007/s00300-012-1253-9; Hume F, 2004, MAR BIOL, V144, P407, DOI 10.1007/s00227-003-1219-0; Jones KE, 2013, ANAT REC, V296, P1049, DOI 10.1002/ar.22710; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; KASTELEIN R A, 1991, Aquatic Mammals, V17, P156; Kastelein R.A., 1989, Aquatic Mammals, V15, P3; Kirkwood R, 2013, AUSTRAL NAT HIST SER, P1; Kirkwood R, 2008, MAR ECOL PROG SER, V369, P297, DOI 10.3354/meps07633; KLAGES NTW, 1990, POLAR BIOL, V10, P403; Marshall CD, 2008, J EXP BIOL, V211, P699, DOI 10.1242/jeb.009852; Marshall CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086710; R Core Team, 2021, R LANGUAGE ENV STAT; Werth A, 2000, MAR MAMMAL SCI, V16, P299, DOI 10.1111/j.1748-7692.2000.tb00926.x; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Werth AJ, 2006, J MORPHOL, V267, P1415, DOI 10.1002/jmor.10486; Ydesen KS, 2014, J EXP BIOL, V217, P2239, DOI 10.1242/jeb.100016	26	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112521	10.1371/journal.pone.0112521	http://dx.doi.org/10.1371/journal.pone.0112521			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390347	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400091
J	Turchiano, G; Latella, MC; Gogol-Doring, A; Cattoglio, C; Mavilio, F; Izsvak, Z; Ivics, Z; Recchia, A				Turchiano, Giandomenico; Latella, Maria Carmela; Gogol-Doering, Andreas; Cattoglio, Claudia; Mavilio, Fulvio; Izsvak, Zsuzsanna; Ivics, Zoltan; Recchia, Alessandra			Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells	PLOS ONE			English	Article							STABLE GENE-TRANSFER; GERMLINE TRANSGENESIS; PRONUCLEAR MICROINJECTION; RETROVIRAL INTEGRATION; SITE SELECTION; T-CELLS; VECTOR; EXPRESSION; DNA; EVOLUTION	The Sleeping Beauty (SB) transposon is a non-viral integrating vector system with proven efficacy for gene transfer and functional genomics. However, integration efficiency is negatively affected by the length of the transposon. To optimize the SB transposon machinery, the inverted repeats and the transposase gene underwent several modifications, resulting in the generation of the hyperactive SB100X transposase and of the high-capacity "sandwich'' (SA) transposon. In this study, we report a side-by-side comparison of the SA and the widely used T2 arrangement of transposon vectors carrying increasing DNA cargoes, up to 18 kb. Clonal analysis of SA integrants in human epithelial cells and in immortalized keratinocytes demonstrates stability and integrity of the transposon independently from the cargo size and copy number-dependent expression of the cargo cassette. A genome-wide analysis of unambiguously mapped SA integrations in keratinocytes showed an almost random distribution, with an overrepresentation in repetitive elements (satellite, LINE and small RNAs) compared to a library representing insertions of the first-generation transposon vector and to gammaretroviral and lentiviral libraries. The SA transposon/SB100X integrating system therefore shows important features as a system for delivering large gene constructs for gene therapy applications.	[Turchiano, Giandomenico; Latella, Maria Carmela; Mavilio, Fulvio; Recchia, Alessandra] Univ Modena & Reggio Emilia, Ctr Regenerat Med, Dept Life Sci, Modena, Italy; [Gogol-Doering, Andreas] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Gogol-Doering, Andreas] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Germany; [Cattoglio, Claudia] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Mavilio, Fulvio] Genethon, Evry, France; [Izsvak, Zsuzsanna] Max Delbruck Ctr Mol Med, Berlin, Germany; [Ivics, Zoltan] Paul Ehrlich Inst, Div Med Biotechnol, Langen, Germany	Universita di Modena e Reggio Emilia; Martin Luther University Halle Wittenberg; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Paul Ehrlich Institute	Recchia, A (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med, Dept Life Sci, Modena, Italy.	alessandra.recchia@unimore.it		Izsvak, Zsuzsanna/0000-0002-2053-2384; Mavilio, Fulvio/0000-0003-0459-4320; Turchiano, Giandomenico/0000-0001-9980-6810	Italian Ministry of University and Research-FIRB; DEBRA international; European Research Council (GT-SKIN)	Italian Ministry of University and Research-FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); DEBRA international; European Research Council (GT-SKIN)	Funding was received for this study from Italian Ministry of University and Research-FIRB 2008 (AR), DEBRA international (AR) and the European Research Council (GT-SKIN) (FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti A, 2007, J CLIN INVEST, V117, P2233, DOI 10.1172/JCI31666; Ammar I, 2012, NUCLEIC ACIDS RES, V40, P6693, DOI 10.1093/nar/gks317; Belur LR, 2003, MOL THER, V8, P501, DOI 10.1016/S1525-0016(03)00211-9; Biffi A, 2011, BLOOD, V117, P5332, DOI 10.1182/blood-2010-09-306761; Borradori L, 1998, EXP CELL RES, V239, P463, DOI 10.1006/excr.1997.3923; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Bushman FD, 2007, J CLIN INVEST, V117, P2083, DOI 10.1172/JCI32949; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Cattoglio C, 2007, BLOOD, V110, P1770, DOI 10.1182/blood-2007-01-068759; Cavazza A, 2013, GENE THER, V20, P949, DOI 10.1038/gt.2013.18; Cesana D, 2012, J CLIN INVEST, V122, P1667, DOI 10.1172/JCI62189; Cui ZB, 2002, J MOL BIOL, V318, P1221, DOI 10.1016/S0022-2836(02)00237-1; de Jong J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004250; De Luca M, 2009, BRIT J DERMATOL, V161, P19, DOI 10.1111/j.1365-2133.2009.09243.x; Field AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068201; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Galla M, 2011, NUCLEIC ACIDS RES, V39, P7147, DOI 10.1093/nar/gkr384; Garrels W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096673; Garrels W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023573; Grabundzija I, 2013, NUCLEIC ACIDS RES, V41, P1829, DOI 10.1093/nar/gks1305; Hackett P, 2013, TRANSLATIONAL RES; Hackett PB, 2010, MOL THER, V18, P674, DOI 10.1038/mt.2010.2; Holkers M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1446; Huang X, 2006, BLOOD, V107, P483, DOI 10.1182/blood-2005-05-2133; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2004, CURR ISSUES MOL BIOL, V6, P43; Ivics Z, 1996, P NATL ACAD SCI USA, V93, P5008, DOI 10.1073/pnas.93.10.5008; Ivics Z, 2014, NAT PROTOC, V9, P810, DOI 10.1038/nprot.2014.010; Ivics Z, 2014, NAT PROTOC, V9, P794, DOI 10.1038/nprot.2014.009; Ivics Z, 2014, NAT PROTOC, V9, P773, DOI 10.1038/nprot.2014.008; Izsvak Z, 2000, J MOL BIOL, V302, P93, DOI 10.1006/jmbi.2000.4047; Jin Z, 2011, GENE THER, V18, P849, DOI 10.1038/gt.2011.40; Katter K, 2013, FASEB J, V27, P930, DOI 10.1096/fj.12-205526; Liu GY, 2005, J MOL BIOL, V346, P161, DOI 10.1016/j.jmb.2004.09.086; Liu L, 2004, MOL THER, V10, P97, DOI 10.1016/j.ymthe.2004.04.006; Masumoto H, 2004, CHROMOSOME RES, V12, P543, DOI 10.1023/B:CHRO.0000036593.72788.99; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; McCormack WM, 2006, J THROMB HAEMOST, V4, P1218, DOI 10.1111/j.1538-7836.2006.01901.x; Moiani A, 2012, J CLIN INVEST, V122, P1653, DOI 10.1172/JCI61852; Moldt B, 2011, MOL THER, V19, P1499, DOI 10.1038/mt.2011.47; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Olson WK, 2011, CURR OPIN STRUC BIOL, V21, P348, DOI 10.1016/j.sbi.2011.03.006; Sambrook J., 2001, MOL CLONING LAB MANU; Schmidt M, 2001, HUM GENE THER, V12, P743, DOI 10.1089/104303401750148649; Smit A, 1996, REPEATMASKER OPEN 30; Titeux M, 2010, MOL THER, V18, P1509, DOI 10.1038/mt.2010.91; Vigdal TJ, 2002, J MOL BIOL, V323, P441, DOI 10.1016/S0022-2836(02)00991-9; Voigt K, 2012, MOL THER, V20, P1852, DOI 10.1038/mt.2012.126; Wang YM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004103; Wilber A, 2007, STEM CELLS, V25, P2919, DOI 10.1634/stemcells.2007-0026; Yant SR, 2002, NAT BIOTECHNOL, V20, P999, DOI 10.1038/nbt738; Yant SR, 2005, MOL CELL BIOL, V25, P2085, DOI 10.1128/MCB.25.6.2085-2094.2005; Zayed H, 2004, MOL THER, V9, P292, DOI 10.1016/j.ymthe.2003.11.024; Zhang WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075344; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064601, 10.1371/journal.pone.0071243, 10.1371/journal.pone.0067564]; Zhu JH, 2007, BIOCHEMISTRY-US, V46, P6844, DOI 10.1021/bi6024484	57	27	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112712	10.1371/journal.pone.0112712	http://dx.doi.org/10.1371/journal.pone.0112712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390293	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000349144400121
J	Wangpraseurt, D; Tamburic, B; Szabo, M; Suggett, D; Ralph, PJ; Kuhl, M				Wangpraseurt, Daniel; Tamburic, Bojan; Szabo, Milan; Suggett, David; Ralph, Peter J.; Kuhl, Michael			Spectral Effects on Symbiodinium Photobiology Studied with a Programmable Light Engine	PLOS ONE			English	Article							SCLERACTINIAN CORALS; PHOTOCHEMICAL EFFICIENCY; DIURNAL CHANGES; PHOTOSYNTHESIS; ZOOXANTHELLAE; PHOTOPROTECTION; ACCLIMATION; RESPIRATION; IRRADIANCE; PHOTON	The spectral light field of Symbiodinium within the tissue of the coral animal host can deviate strongly from the ambient light field on a coral reef and that of artificial light sources used in lab studies on coral photobiology. Here, we used a novel approach involving light microsensor measurements and a programmable light engine to reconstruct the spectral light field that Symbiodinium is exposed to inside the coral host and the light field of a conventional halogen lamp in a comparative study of Symbiodinium photobiology. We found that extracellular gross photosynthetic O-2 evolution was unchanged under different spectral illumination, while the more red-weighted halogen lamp spectrum decreased PSII electron transport rates and there was a trend towards increased light-enhanced dark respiration rates under excess irradiance. The approach provided here allows for reconstructing and comparing intra-tissue coral light fields and other complex spectral compositions of incident irradiance. This novel combination of sensor technologies provides a framework to studying the influence of macro- and microscale optics on Symbiodinium photobiology with unprecedented spectral resolution.	[Wangpraseurt, Daniel; Tamburic, Bojan; Szabo, Milan; Suggett, David; Ralph, Peter J.; Kuhl, Michael] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia; [Kuhl, Michael] Univ Copenhagen, Dept Biol, Marine Biol Sect, Helsingor, Denmark; [Kuhl, Michael] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Sch Biol Sci, Singapore 639798, Singapore	University of Technology Sydney; University of Copenhagen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kuhl, M (corresponding author), Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Sydney, NSW 2007, Australia.	mkuhl@bio.ku.dk	Ralph, Peter J/C-5029-2009; Suggett, David J/G-9212-2017; Ralph, Peter/L-1527-2019; Szabo, Milan/L-9942-2014; Tamburic, Bojan/G-8484-2013; Kühl, Michael/A-1977-2009	Ralph, Peter J/0000-0002-3103-7346; Suggett, David J/0000-0001-5326-2520; Ralph, Peter/0000-0002-3103-7346; Szabo, Milan/0000-0001-6235-2894; Tamburic, Bojan/0000-0001-5720-9380; Kühl, Michael/0000-0002-1792-4790; Wangpraseurt, Daniel/0000-0003-4834-8981	Australian Research Council (Future Fellowship); Danish Council for Independent Research|Natural Sciences; Carlsberg Foundation; Plant Functional Biology and Climate Change Cluster; University of Technology Sydney president's scholarship	Australian Research Council (Future Fellowship)(Australian Research Council); Danish Council for Independent Research|Natural Sciences(Det Frie Forskningsrad (DFF)); Carlsberg Foundation(Carlsberg Foundation); Plant Functional Biology and Climate Change Cluster; University of Technology Sydney president's scholarship	This research was funded by grants from the Australian Research Council (PJR; DS, Future Fellowship), the Danish Council for Independent Research|Natural Sciences (MK), the Carlsberg Foundation (MK), the Plant Functional Biology and Climate Change Cluster (DW, MK, PJR, MS, BT) and the University of Technology Sydney president's scholarship (DW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2005, CORAL REEFS, V24, P173, DOI 10.1007/s00338-004-0461-3; Asada K, 2000, PHILOS T ROY SOC B, V355, P1419, DOI 10.1098/rstb.2000.0703; Bader MR, 2000, PHILOS T R SOC B, V355, P1433, DOI 10.1098/rstb.2000.0704; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Brown BE, 1999, CORAL REEFS, V18, P99; Buxton L, 2012, J PHYCOL, V48, P117, DOI 10.1111/j.1529-8817.2011.01099.x; Cooper TF, 2011, P ROY SOC B-BIOL SCI, V278, P1840, DOI 10.1098/rspb.2010.2321; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P107, DOI 10.1007/978-94-007-0114-4_8; DUSTAN P, 1982, MAR BIOL, V68, P253, DOI 10.1007/BF00409592; EDMUNDS PJ, 1988, CORAL REEFS, V7, P7, DOI 10.1007/BF00301975; GARCIA HE, 1992, LIMNOL OCEANOGR, V37, P1307, DOI 10.4319/lo.1992.37.6.1307; Gorbunov MY, 2001, LIMNOL OCEANOGR, V46, P75, DOI 10.4319/lo.2001.46.1.0075; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HALLDAL P, 1968, BIOL BULL, V134, P411, DOI 10.2307/1539860; Hennige SJ, 2009, CORAL REEFS, V28, P179, DOI 10.1007/s00338-008-0444-x; Hennige SJ, 2008, MAR ECOL PROG SER, V369, P77, DOI 10.3354/meps07612; Hill R, 2012, CORAL REEFS, V31, P963, DOI 10.1007/s00338-012-0914-z; Hill R, 2008, SYMBIOSIS, V46, P45; Hochberg EJ, 2003, REMOTE SENS ENVIRON, V85, P159, DOI 10.1016/S0034-4257(02)00201-8; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; IGLESIASPRIETO R, 1994, MAR ECOL PROG SER, V113, P163, DOI 10.3354/meps113163; Jerlov N. G., 1976, MARINE OPTICS; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; Kanazawa A, 2014, BBA-BIOENERGETICS, V1837, P1227, DOI 10.1016/j.bbabio.2014.03.019; KINZIE RA, 1987, MAR BIOL, V94, P95, DOI 10.1007/BF00392902; KINZIE RA, 1984, MAR BIOL, V78, P239, DOI 10.1007/BF00393009; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kramer WE, 2012, PHOTOCHEM PHOTOBIOL, V88, P398, DOI 10.1111/j.1751-1097.2011.01048.x; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; LASSEN C, 1992, FEMS MICROBIOL ECOL, V86, P247, DOI 10.1111/j.1574-6968.1992.tb04816.x; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Mass T, 2010, J EXP BIOL, V213, P4084, DOI 10.1242/jeb.039891; MOREL A, 1987, LIMNOL OCEANOGR, V32, P1066, DOI 10.4319/lo.1987.32.5.1066; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Platt T, 1981, J MAR RES, V38, P222; Ragni M, 2010, MAR ECOL PROG SER, V406, P57, DOI 10.3354/meps08571; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Reynolds JM, 2008, P NATL ACAD SCI USA, V105, P13674, DOI 10.1073/pnas.0805187105; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Saragosti E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012508; Schreiber U., 2011, PAM APPL NOTES, V1, P1; Schreiber U, 2012, PHOTOSYNTH RES, V113, P127, DOI 10.1007/s11120-012-9758-1; Smith ER, 2013, CLIN CHEM LAB MED, P1; Sorek M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00536; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; Szabo M, 2014, PLANT PHYSIOL BIOCH, V83, P159, DOI 10.1016/j.plaphy.2014.07.015; Ulstrup KE, 2007, MAR BIOL, V153, P225, DOI 10.1007/s00227-007-0806-x; Ulstrup KE, 2006, MAR BIOL, V149, P1325, DOI 10.1007/s00227-006-0286-4; Ulstrup KE, 2011, AQUAT BIOL, V12, P241, DOI 10.3354/ab00338; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wang DL, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00427, 10.3389/fmicb.2012.00316]; Wangpraseurt D, 2014, LIMNOL OCEANOGR, V59, P917, DOI 10.4319/lo.2014.59.3.0917; Wangpraseurt D, 2014, PROC SPIE, V8941, DOI 10.1117/12.2038339; Wangpraseurt D, 2014, J EXP BIOL, V217, P489, DOI 10.1242/jeb.091116; Wangpraseurt D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031192; Xue XP, 1996, PLANT PHYSIOL, V112, P1005, DOI 10.1104/pp.112.3.1005	60	22	22	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112809	10.1371/journal.pone.0112809	http://dx.doi.org/10.1371/journal.pone.0112809			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389753	Green Published, gold			2022-12-26	WOS:000349144400131
J	Christian, JR				Christian, James R.			Timing of the Departure of Ocean Biogeochemical Cycles from the Preindustrial State	PLOS ONE			English	Article							ANTHROPOGENIC CLIMATE-CHANGE; ECOSYSTEM MODEL; ACIDIFICATION; VARIABILITY; LIMITATION; SYSTEM; TRENDS	Changes in ocean chemistry and climate induced by anthropogenic CO2 affect a broad range of ocean biological and biogeochemical processes; these changes are already well underway. Direct effects of CO2 (e.g. on pH) are prominent among these, but climate model simulations with historical greenhouse gas forcing suggest that physical and biological processes only indirectly forced by CO2 (via the effect of atmospheric CO2 on climate) begin to show anthropogenically-induced trends as early as the 1920s. Dates of emergence of a number of representative ocean fields from the envelope of natural variability are calculated for global means and for spatial 'fingerprints' over a number of geographic regions. Emergence dates are consistent among these methods and insensitive to the exact choice of regions, but are generally earlier with more spatial information included. Emergence dates calculated for individual sampling stations are more variable and generally later, but means across stations are generally consistent with global emergence dates. The last sign reversal of linear trends calculated for periods of 20 or 30 years also functions as a diagnostic of emergence, and is generally consistent with other measures. The last sign reversal among 20 year trends is found to be a conservative measure (biased towards later emergence), while for 30 year trends it is found to have an early emergence bias, relative to emergence dates calculated by departure from the preindustrial mean. These results are largely independent of emission scenario, but the latest-emerging fields show a response to mitigation. A significant anthropogenic component of ocean variability has been present throughout the modern era of ocean observation.	[Christian, James R.] Canadian Ctr Climate Modelling & Anal, Victoria, BC, Canada; [Christian, James R.] Inst Ocean Sci, Fisheries & Oceans Canada, Sidney, BC V8L 4B2, Canada	Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); Fisheries & Oceans Canada	Christian, JR (corresponding author), Canadian Ctr Climate Modelling & Anal, Victoria, BC, Canada.	jim.christian@ec.gc.ca						Andrews OD, 2013, BIOGEOSCIENCES, V10, P1799, DOI 10.5194/bg-10-1799-2013; ARMSTRONG RA, 1994, LIMNOL OCEANOGR, V39, P597, DOI 10.4319/lo.1994.39.3.0597; Arora VK, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046270; Arora VK, 2009, J CLIMATE, V22, P6066, DOI 10.1175/2009JCLI3037.1; Barnett T, 2005, J CLIMATE, V18, P1291, DOI 10.1175/JCLI3329.1; Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; Bates NR, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003759; Beaulieu C, 2013, BIOGEOSCIENCES, V10, P2711, DOI 10.5194/bg-10-2711-2013; Bindoff NL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P867; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Chou SH, 2003, J CLIMATE, V16, P3256, DOI 10.1175/1520-0442(2003)016<3256:STHAMF>2.0.CO;2; Christian JR, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2008JG000920; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Easterling DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037810; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Friedrich T, 2012, NAT CLIM CHANGE, V2, P167, DOI [10.1038/NCLIMATE1372, 10.1038/nclimate1372]; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; HASSELMANN K, 1993, J CLIMATE, V6, P1957, DOI 10.1175/1520-0442(1993)006<1957:OFFTDO>2.0.CO;2; Hegerl G, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044025; Hegerl GC, 1997, CLIM DYNAM, V13, P613, DOI 10.1007/s003820050186; Helm KP, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044222; Henson SA, 2010, BIOGEOSCIENCES, V7, P621, DOI 10.5194/bg-7-621-2010; Huybers P, 2006, NATURE, V441, P329, DOI 10.1038/nature04745; KARL DM, 1995, NATURE, V373, P230, DOI 10.1038/373230a0; Mahlstein I, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034009; Moore JK, 2001, DEEP-SEA RES PT II, V49, P403, DOI 10.1016/S0967-0645(01)00108-4; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muir L, 2013, CAWCR RES LETT, V10, P8; Najjar R., 1998, DESIGN OCMIP 2 SIMUL; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Santer BD, 1995, CLIMATE CHANGE 1995: THE SCIENCE OF CLIMATE CHANGE, P407; SANTER BD, 1995, J GEOPHYS RES-OCEANS, V100, P10693, DOI 10.1029/95JC00683; Sarmiento JL, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001919; Taucher J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045934; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Wang MY, 2010, J MARINE SYST, V79, P258, DOI 10.1016/j.jmarsys.2008.11.028; Zahariev K, 2008, PROG OCEANOGR, V77, P56, DOI 10.1016/j.pocean.2008.01.007	41	13	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109820	10.1371/journal.pone.0109820	http://dx.doi.org/10.1371/journal.pone.0109820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386910	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400006
J	Gower, DJ; Hancox, PJ; Botha-Brink, J; Sennikov, AG; Butler, RJ				Gower, David J.; Hancox, P. John; Botha-Brink, Jennifer; Sennikov, Andrey G.; Butler, Richard J.			A New Species of Garjainia Ochev, 1958 (Diapsida: Archosauriformes: Erythrosuchidae) from the Early Triassic of South Africa	PLOS ONE			English	Article							BONE-GROWTH RATE; SEXUAL SELECTION; BEAUFORT-GROUP; LIFE-STYLE; PHYLOGENETIC SIGNAL; BIZARRE STRUCTURES; EARLY EVOLUTION; AMPRINOS RULE; EARLY HISTORY; KAROO BASIN	A new species of the erythrosuchid archosauriform reptile Garjainia Ochev, 1958 is described on the basis of disarticulated but abundant and well-preserved cranial and postcranial material from the late Early Triassic (late Olenekian) Subzone A of the Cynognathus Assemblage Zone of the Burgersdorp Formation (Beaufort Group) of the Karoo Basin of South Africa. The new species, G. madiba, differs from its unique congener, G. prima from the late Olenekian of European Russia, most notably in having large bony bosses on the lateral surfaces of the jugals and postorbitals. The new species also has more teeth and a proportionately longer postacetabular process of the ilium than G. prima. Analysis of G. madiba bone histology reveals thick compact cortices comprised of highly vascularized, rapidly forming fibro-lamellar bone tissue, similar to Erythrosuchus africanus from Subzone B of the Cynognathus Assemblage Zone. The most notable differences between the two taxa are the predominance of a radiating vascular network and presence of annuli in the limb bones of G. madiba. These features indicate rapid growth rates, consistent with data for many other Triassic archosauriforms, but also a high degree of developmental plasticity as growth remained flexible. The diagnoses of Garjainia and of Erythrosuchidae are addressed and revised. Garjainia madiba is the geologically oldest erythrosuchid known from the Southern Hemisphere, and demonstrates that erythrosuchids achieved a cosmopolitan biogeographical distribution by the end of the Early Triassic, within five million years of the end-Permian mass extinction event. It provides new insights into the diversity of the Subzone A vertebrate assemblage, which partially fills a major gap between classic 'faunal' assemblages from the older Lystrosaurus Assemblage Zone (earliest Triassic) and the younger Subzone B of the Cynognathus Assemblage Zone (early Middle Triassic).	[Gower, David J.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Hancox, P. John; Butler, Richard J.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Botha-Brink, Jennifer] Natl Museum, Bloemfontein, South Africa; [Botha-Brink, Jennifer] Univ Orange Free State, Dept Zool & Entomol, Bloemfontein, South Africa; [Sennikov, Andrey G.] Russian Acad Sci, Borissiak Paleontol Inst, Moscow, Russia; [Sennikov, Andrey G.] Kazan Fed Univ, Kazan, Russia; [Butler, Richard J.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Butler, Richard J.] Univ Munich, GeoBioctr, Munich, Germany	Natural History Museum London; University of Witwatersrand; University of the Free State; Russian Academy of Sciences; Paleontological Institute of the Russian Academy of Sciences; Kazan Federal University; University of Birmingham; University of Munich	Gower, DJ (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	d.gower@nhm.ac.uk	Botha, Jennifer/N-1893-2013; Butler, Richard J./A-5239-2011; Сенников, Андрей Г/I-9907-2017	Botha, Jennifer/0000-0001-8824-9334; Butler, Richard J./0000-0003-2136-7541; Sennikov, Andrey/0000-0002-1932-0907	National Research Foundation [UID 80587]; Palaeontological Scientific Trust; Russian Foundation for Basic Research [13-05-00274, 14-04-00185, 14-05-93964]; Program of Basic Research of the Presidium of the Russian Academy of Sciences [28]; Russian Government; Marie Curie Career Integration Grant [PCIG-GA-2013-630123 ARCHOSAUR RISE]; DFG [BU 2587/3-1]; NERC at the University of Bristol	National Research Foundation; Palaeontological Scientific Trust; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of Basic Research of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Government; Marie Curie Career Integration Grant; DFG(German Research Foundation (DFG)); NERC at the University of Bristol	DJG carried out much of the comparative work for this project during tenure of a NERC PhD studentship at the University of Bristol (1990-1994), supervised by Mike Benton. PJH was supported by the NRF African Origins Platform and the DST/NRF Centre of Excellence for Palaeosciences. JBB is supported by the National Research Foundation (UID 80587) and the Palaeontological Scientific Trust. AGS was supported by the Russian Foundation for Basic Research (projects 13-05-00274, 14-04-00185 and 14-05-93964), the Program of Basic Research of the Presidium of the Russian Academy of Sciences no. 28, and the Russian Government funded Program of Competitive Growth of Kazan Federal University. RJB is supported by a Marie Curie Career Integration Grant (PCIG-GA-2013-630123 ARCHOSAUR RISE) and an Emmy Noether Programme Award from the DFG (BU 2587/3-1), which also supported visits to Munich and Moscow by DJG as part of the completion of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala F, 2006, ZOOL J LINN SOC-LOND, V147, P383, DOI 10.1111/j.1096-3642.2006.00224.x; Amprino R., 1947, ARCH BIOL SCI, V58, P315; [Anonymous], 1990, SKELETAL BIOMINERALI, DOI DOI 10.1029/SC005P0175; Azzie BA, 1994, THESIS U WITWATERSRA; BENTON MJ, 1983, Q REV BIOL, V58, P29, DOI 10.1086/413056; Benton MJ, 1993, PHILOS T R SOC B, V302, P605; Botha-Brink J, 2011, J VERTEBR PALEONTOL, V31, P1238, DOI 10.1080/02724634.2011.621797; Broom R., 1905, RECORDS ALBANY MUSEU, V1, P331, DOI DOI 10.1111/J.1096-3642.1948.TB00384.X; Broom R., 1903, ANN S AFR MUS, V4, P159; Broom R, 1906, ANN S AFR MUS, V5, P187; Butler RJ, 2013, J VERTEBRATE PALEO S, P97; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; Charig A. J, 1970, Biol. J., V2, P125, DOI 10.1111/j.1095-8312.1970.tb01708.x; Charig AJ, 1976, HDB PALAOHERPETOLOGI, V13, P11; Cheng Z.W., 1980, MESOZOIC STRATIGRAPH, P114; CHINSAMY A, 1995, J VERTEBR PALEONTOL, V15, P96, DOI 10.1080/02724634.1995.10011209; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Chinsamy A, 1991, THESIS U WITWATERSRA; Cisneros JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013425; CORMACK DH, 1987, HAMS HISTOLOGY; Cox, 1976, MORPHOLOGY BIOL REPT, P123; Cruickshank A.R.I., 1972, P89; Cubo J, 2005, SYST BIOL, V54, P562, DOI 10.1080/10635150591003461; Cubo J, 2012, PALEOBIOLOGY, V38, P335, DOI 10.1666/08093.1; CURREY JD, 1985, J ZOOL, V206, P453; Damiani RJ, 2001, ZOOL J LINN SOC-LOND, V133, P379, DOI 10.1006/zjls.2001.0304; de Buffrenil V., 1990, Journal of Vertebrate Paleontology, V10, P455; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; Evans S.E., 1986, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V173, P181; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; Ezcurra MD, 2013, GEOL SOC SPEC PUBL, V379, P9, DOI 10.1144/SP379.11; Ezcurra MD, 2010, J VERTEBR PALEONTOL, V30, P1433, DOI 10.1080/02724634.2010.501446; Fraser NC, 1994, SHADOW DINOSAURS EAR; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Germain D, 2005, ZOOL SCR, V34, P335, DOI 10.1111/j.1463-6409.2005.00198.x; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; Gow C.E., 1999, Palaeontologia Africana, V35, P21; Gower David J., 2000, P140; Gower David J., 1999, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V280, P1; Gower David John, 2003, Annals of the South African Museum, V110, P1; Gower DJ, 2006, J VERTEBR PALEONTOL, V26, P79, DOI 10.1671/0272-4634(2006)26[79:TBOABE]2.0.CO;2; Gower DJ, 1997, J ZOOL, V242, P557; Gower DJ, 1997, J VERTEBR PALEONTOL, V17, P60, DOI 10.1080/02724634.1997.10010954; Gower DJ, 1998, BIOL REV, V73, P367, DOI 10.1017/S0006323198005222; Gower DJ, 1996, ZOOL J LINN SOC-LOND, V116, P347, DOI 10.1006/zjls.1996.0024; Gower DJ, 1996, PALAEONTOLOGY, V39, P883; Groenewald GH, 2001, PALAIOS, V16, P148, DOI 10.2307/3515526; GROSS WALTER, 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P731, DOI 10.1007/BF02118752; Hancox P. J., 2000, ZENTRALBLATT GEOLOGI, V1998, P1285; Hancox P.J, 1998, THESIS U WITWATERSRA; Hancox PJ, 2001, J AFR EARTH SCI, V33, P563, DOI 10.1016/S0899-5362(01)00081-1; HANCOX PJ, 1995, S AFR J SCI, V91, P143; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Hua S, 1996, J VERTEBR PALEONTOL, V16, P703, DOI 10.1080/02724634.1996.10011359; Huene F. F. von, 1960, Palaeontographica A, V114, P105; HUTTON JM, 1986, COPEIA, P332, DOI 10.2307/1444994; King Gillian M., 1996, Annals of the South African Museum, V104, P379; Knell RJ, 2011, J ZOOL, V283, P18, DOI 10.1111/j.1469-7998.2010.00758.x; Laurin M, 2004, PALEOBIOLOGY, V30, P589, DOI 10.1666/0094-8373(2004)030<0589:TEOLBM>2.0.CO;2; Lee AH, 2013, BONE HISTOLOGY OF FOSSIL TETRAPODS: ADVANCING METHODS, ANALYSIS, AND INTERPRETATION, P217; Miall A.D., 1996, GEOLOGY FLUVIAL DEPO; Modesto SP, 2008, J VERTEBR PALEONTOL, V28, P914, DOI 10.1671/0272-4634(2008)28[914:EOASLA]2.0.CO;2; Montes L, 2010, ANIM BIOL, V60, P25, DOI 10.1163/157075610X12610595764093; Nesbitt Sterling J., 2005, Historical Biology, V17, P19, DOI 10.1080/08912960500476499; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2008, J VERTEBR PALEONTOL, V28, P1063, DOI 10.1671/0272-4634-28.4.1063; Ochev V, 1975, PALEONTOL J, V1980, P98; Ochev V.G., 1980, Paleontologicheskii Zhurnal, V1980, P101; OCHEV VG, 1958, DOKL AKAD NAUK SSSR+, V123, P749; Ochev VG, 1981, VOPROSY GEOLOGII YUZ, V22, P3; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Osborn HF, 1903, MEM AM MUS NAT HIST, V1, P449; Padian K, 2011, J ZOOL, V283, P23, DOI 10.1111/j.1469-7998.2010.00761.x; Padian K, 2011, J ZOOL, V283, P3, DOI 10.1111/j.1469-7998.2010.00719.x; Parrish J.M., 1992, Journal of Vertebrate Paleontology, V12, P93; Peng Jianghua, 1991, Vertebrata Palasiatica, V29, P95; Reid REH., 1996, GEOLOGY STUDIES, V41, P25; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Rutherford AB, 2009, THESIS U WITWATERSRA; Sennikov AG, 2011, PALEONTOL J+, V45, P90, DOI 10.1134/S0031030111010151; Sennikov A.G., 1995, Trudy Paleontologicheskogo Instituta, V263, P1; Sennikov AG, 1996, PALAEOGEOGR PALAEOCL, V120, P331, DOI 10.1016/0031-0182(95)00041-0; Shishkin MA, 2006, PALEONTOL J+, V40, P1, DOI 10.1134/S0031030106010011; Shishkin MA, 1995, 6 S MES TERR EC BIOT, P39; Shishkin Mikhail A., 2000, P120; Smith R, 2005, CR PALEVOL, V4, P623, DOI 10.1016/j.crpv.2005.07.005; Smith R, 2012, FORERUNNERS MAMMALS, P31; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Starck JM, 2002, J MORPHOL, V254, P232, DOI 10.1002/jmor.10029; von Huene F, 1911, GEOLOGISCHE PALAONTO, V10, P67, DOI DOI 10.1086/621900; von Huene FRF, 1946, BIOL ZBL, V65, P268; WALL WP, 1983, J PALEONTOL, V57, P197; Watson DMS, 1917, P ZOOL SOC LOND, V1917, P167; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; Welman J., 1991, South African Journal of Geology, V94, P245; Werning S, 2011, 4 C LAT PAL VERT, P73; Werning S, 2011, J VERTEBR PALEONTOL, V31, P213; Wilkinson Mark, 1995, Historical Biology, V10, P137; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson J, 2011, TLS-TIMES LIT SUPPL, P6; Young C. C., 1964, Palaeontologia Sinica No 151 NS G, VNo. 19, P1; Young C-C, 1973, MEMOIRS I VERTEBRATE, V10, P38	106	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111154	10.1371/journal.pone.0111154	http://dx.doi.org/10.1371/journal.pone.0111154			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386937	gold, Green Published			2022-12-26	WOS:000345250400014
J	Gunnelius, L; Kurkela, J; Hakkila, K; Koskinen, S; Parikainen, M; Tyystjarvi, T				Gunnelius, Liisa; Kurkela, Juha; Hakkila, Kaisa; Koskinen, Satu; Parikainen, Marjaana; Tyystjarvi, Taina			The omega Subunit of RNA Polymerase Is Essential for Thermal Acclimation of the Cyanobacterium Synechocystis Sp PCC 6803	PLOS ONE			English	Article							HEAT-SHOCK RESPONSE; INORGANIC CARBON LIMITATION; GENE-EXPRESSION; PHOTOSYSTEM-II; SIGMA FACTORS; MORPHOLOGICAL-DIFFERENTIATION; PHYCOBILISOME DEGRADATION; ELECTRON-TRANSPORT; GROWTH TEMPERATURE; MEMBRANE-LIPIDS	The rpoZ gene encodes the small omega subunit of RNA polymerase. A Delta rpoZ strain of the cyanobacterium Synechocystis sp. PCC 6803 grew well in standard conditions (constant illumination at 40 mu mol photons m(-2) s(-1); 32 degrees C; ambient CO2) but was heat sensitive and died at 40 degrees C. In the control strain, 71 genes were at least two-fold up-regulated and 91 genes down-regulated after a 24-h treatment at 40 degrees C, while in Delta rpoZ 394 genes responded to heat. Only 62 of these heat-responsive genes were similarly regulated in both strains, and 80% of heat-responsive genes were unique for Delta rpoZ. The RNA polymerase core and the primary sigma factor SigA were down-regulated in the control strain at 40 degrees C but not in Delta rpoZ. In accordance with reduced RNA polymerase content, the total RNA content of mild-heat-stress-treated cells was lower in the control strain than in Delta rpoZ. Light-saturated photosynthetic activity decreased more in Delta rpoZ than in the control strain upon mild heat stress. The amounts of photosystem II and rubisco decreased at 40 degrees C in both strains while PSI and the phycobilisome antenna protein allophycocyanin remained at the same level as in standard conditions. The phycobilisome rod proteins, phycocyanins, diminished during the heat treatment in Delta rpoZ but not in the control strain, and the nblA1 and nblA2 genes (encode NblA proteins required for phycobilisome degradation) were up-regulated only in Delta rpoZ. Our results show that the omega subunit of RNAP is essential in heat stress because it is required for heat acclimation of diverse cellular processes.	[Gunnelius, Liisa; Kurkela, Juha; Hakkila, Kaisa; Koskinen, Satu; Parikainen, Marjaana; Tyystjarvi, Taina] Univ Turku, Dept Biochem, SF-20500 Turku, Finland	Finland National Institute for Health & Welfare; University of Turku	Tyystjarvi, T (corresponding author), Univ Turku, Dept Biochem, SF-20500 Turku, Finland.	taityy@utu.fi	Hakkila, Kaisa/K-2172-2015	Hakkila, Kaisa/0000-0003-3529-6895; Koskinen, Satu/0000-0003-0149-2070; Tyystjarvi, Taina/0000-0003-0591-8630	Academy of Finland; Finnish Cultural Foundation;  [265807]	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); 	This work was supported by the Academy of Finland, grant 265807, and the Finnish Cultural Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Refaii A, 2009, MOL MICROBIOL, V71, P748, DOI 10.1111/j.1365-2958.2008.06561.x; Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Azuma M, 2011, PLANT CELL PHYSIOL, V52, P404, DOI 10.1093/pcp/pcq204; Baier A, 2014, J BIOL CHEM, V289, P11755, DOI 10.1074/jbc.M113.520601; Baier K, 2001, FEMS MICROBIOL LETT, V195, P35, DOI 10.1111/j.1574-6968.2001.tb10494.x; Cameron JC, 2013, CELL, V155, P1131, DOI 10.1016/j.cell.2013.10.044; Decker KB, 2013, ANNU REV MICROBIOL, V67, P113, DOI 10.1146/annurev-micro-092412-155756; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Fang F, 2003, CURR MICROBIOL, V47, P341, DOI 10.1007/s00284-002-4015-z; Garcia-Dominguez M, 1997, PLANT MOL BIOL, V35, P723, DOI 10.1023/A:1005846626187; GENTRY DR, 1989, J BACTERIOL, V171, P1271, DOI 10.1128/jb.171.3.1271-1277.1989; Ghosh P, 2001, EUR J BIOCHEM, V268, P4621, DOI 10.1046/j.1432-1327.2001.02381.x; Gunnelius L, 2014, NUCLEIC ACIDS RES, V42, P4606, DOI 10.1093/nar/gku084; Gunnelius L, 2010, MICROBIOL-SGM, V156, P220, DOI 10.1099/mic.0.032565-0; Hakkila K, 2013, PLANT CELL PHYSIOL, V54, P1780, DOI 10.1093/pcp/pct123; Imamura S, 2003, J MOL BIOL, V325, P857, DOI 10.1016/S0022-2836(02)01242-1; Inoue N, 2001, PLANT CELL PHYSIOL, V42, P1140, DOI 10.1093/pcp/pce147; Karradt A, 2008, J BIOL CHEM, V283, P32394, DOI 10.1074/jbc.M805823200; Kojima I, 2002, J BACTERIOL, V184, P6417, DOI 10.1128/JB.184.23.6417-6423.2002; Lee S, 2000, CURR MICROBIOL, V40, P283, DOI 10.1007/s002849910056; LEHEL C, 1993, PLANT PHYSIOL BIOCH, V31, P81; Lehmann R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-133; MAMEDOV M, 1993, BIOCHIM BIOPHYS ACTA, V1142, P1, DOI 10.1016/0005-2728(93)90077-S; Mathew R, 2006, MICROBIOL-SGM, V152, P1741, DOI 10.1099/mic.0.28879-0; Minakhin L, 2001, P NATL ACAD SCI USA, V98, P892, DOI 10.1073/pnas.98.3.892; Mironov KS, 2012, MOL BIOL+, V46, P134, DOI 10.1134/S002689331201013X; Nakamoto H, 2003, FEBS LETT, V549, P57, DOI 10.1016/S0014-5793(03)00768-3; Nishiyama Y, 1997, PLANT PHYSIOL, V115, P1473, DOI 10.1104/pp.115.4.1473; Pollari M, 2011, J BACTERIOL, V193, P265, DOI 10.1128/JB.01045-10; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Rowland JG, 2010, PROTEOMICS, V10, P1917, DOI 10.1002/pmic.200900337; Rowland JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010511; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Santos-Beneit F, 2011, APPL ENVIRON MICROB, V77, P7586, DOI 10.1128/AEM.00465-11; SCHNEIDER GJ, 1988, J BACTERIOL, V170, P4136, DOI 10.1128/jb.170.9.4136-4140.1988; Singh AK, 2006, ARCH MICROBIOL, V186, P273, DOI 10.1007/s00203-006-0138-0; Suzuki I, 2006, J EXP BOT, V57, P1573, DOI 10.1093/jxb/erj148; Suzuki I, 2005, PLANT PHYSIOL, V138, P1409, DOI 10.1104/pp.104.059097; Tasaka Y, 1996, EMBO J, V15, P6416, DOI 10.1002/j.1460-2075.1996.tb01033.x; Tuominen I, 2006, FEBS LETT, V580, P319, DOI 10.1016/j.febslet.2005.11.082; Tuominen I, 2003, J BACTERIOL, V185, P1116, DOI 10.1128/JB.185.3.1116-1119.2003; Tuominen I, 2008, FEBS LETT, V582, P346, DOI 10.1016/j.febslet.2007.12.030; Tyystjarvi T, 1998, FEBS LETT, V436, P483, DOI 10.1016/S0014-5793(98)01181-8; Tyystjarvi T, 2001, MOL MICROBIOL, V40, P476, DOI 10.1046/j.1365-2958.2001.02402.x; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Wosten MMSM, 1998, FEMS MICROBIOL REV, V22, P127, DOI 10.1016/S0168-6445(98)00011-4; Yoshida H, 2014, WIRES RNA, V5, P723, DOI 10.1002/wrna.1242; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526	51	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112599	10.1371/journal.pone.0112599	http://dx.doi.org/10.1371/journal.pone.0112599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386944	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400071
J	Lin, CM; Yen, TH; Juang, YY; Lin, JL; Lee, SH				Lin, Chemin; Yen, Tzung-Hai; Juang, Yeong-Yuh; Lin, Ja-Liang; Lee, Shwu-Hua			Psychiatric Comorbidity and Its Impact on Mortality in Patients Who Attempted Suicide by Paraquat Poisoning during 2000-2010	PLOS ONE			English	Article							PULSE THERAPY; DEXAMETHASONE THERAPY; MENTAL-DISORDERS; SUBSTANCE USE; DEPRESSION; METHYLPREDNISOLONE; CYCLOPHOSPHAMIDE; RISK; PREVALENCE; PREVENTION	Background: Paraquat poisoning is a lethal method of suicide used around the world. Although restricting its accessibility had been widely discussed, the underlying psychopathological mechanism of paraquat self-poisoning and its association with mortality have not yet been explicitly evaluated. Methods: We included all patients admitted to a tertiary general hospital in Taiwan between 2000 and 2010 following a suicide attempt by paraquat self-administration. Diagnoses were made upon psychiatric consultation based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria. The risk of mortality was calculated by logistic regression with various psychiatric or medical covariates. Results: The consultation-liaison psychiatry team assessed 157 patients who attempted suicide by paraquat poisoning. Mood disorders (54.0%), including dysthymic (26.7%) and major depressive disorders (24.7%), were the most common psychiatric diagnoses among the self-poisoning patients. Among those who attempted suicide, 87 patients (58.0%) died and dysthymic disorder (OR = 5.58, 95% CI: 1.13-27.69; p<0.05) significantly increased the mortality risk after adjustment for relevant medical variables, including age, gender, severity index of paraquat poisoning (SIPP), and risk for respiratory failure. Conclusions: Awareness of comorbid psychiatric illnesses, especially dysthymic disorder, is vital in the prevention and treatment of suicide by paraquat poisoning.	[Lin, Chemin] Chang Gung Mem Hosp, Keelung Branch, Dept Psychiat, Keelung, Taiwan; [Lin, Chemin; Juang, Yeong-Yuh; Lee, Shwu-Hua] Chang Gung Mem Hosp, Linkou Branch, Dept Psychiat, Taoyuan, Taiwan; [Yen, Tzung-Hai; Lin, Ja-Liang] Chang Gung Mem Hosp, Dept Nephrol, Taipei 10591, Taiwan; [Yen, Tzung-Hai; Lin, Ja-Liang] Chang Gung Mem Hosp, Div Clin Toxicol, Taipei 10591, Taiwan; [Yen, Tzung-Hai; Juang, Yeong-Yuh; Lin, Ja-Liang; Lee, Shwu-Hua] Chang Gung Univ, Sch Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lee, SH (corresponding author), Chang Gung Mem Hosp, Linkou Branch, Dept Psychiat, Taoyuan, Taiwan.	shlee@adm.cgmh.org.tw	Yen, Tzung-Hai/AAQ-4525-2020; Lin, Chemin/AAG-9983-2019	Yen, Tzung-Hai/0000-0002-0907-1505; Lee, Shwu-Hua/0000-0001-5606-1118; Lin, Chemin/0000-0001-6889-4686				Association AP, 2013, DIAGN STAT MAN MENT, V5; Baltazar T, 2013, BRIT J PHARMACOL, V168, P44, DOI 10.1111/j.1476-5381.2012.02017.x; Bertolote JM, 2006, BRIT J PSYCHIAT, V189, P201, DOI 10.1192/bjp.bp.105.020834; Bertolote JM, 2006, B WORLD HEALTH ORGAN, V84, P260; Borges G, 2000, AM J EPIDEMIOL, V151, P781; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Chang SS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-260; Chen GH, 2002, CRIT CARE MED, V30, P2584, DOI 10.1097/00003246-200211000-00030; Cristancho MA, 2012, FOCUS J LIFELONG LEA, V10, P422, DOI DOI 10.1176/APPI.F0CUS.10.4.422; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Cuijpers Pim, 2004, Curr Psychiatry Rep, V6, P430, DOI 10.1007/s11920-004-0007-y; Dawson AH, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000357; Desapriya EBR, 2004, INJURY PREV, V10, P125, DOI 10.1136/ip.2003.004283; Fu TST, 2013, LANCET, V381, P235, DOI 10.1016/S0140-6736(12)61264-1; Gawarammana IB, 2011, BRIT J CLIN PHARMACO, V72, P745, DOI 10.1111/j.1365-2125.2011.04026.x; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; HENRIKSSON MM, 1993, AM J PSYCHIAT, V150, P935; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hsu Hsiang-Hao, 2003, Journal of Toxicology Clinical Toxicology, V41, P87, DOI 10.1081/CLT-120018278; Hutchinson G, 1999, SUICIDE LIFE-THREAT, V29, P186; Ji JL, 2001, HARVARD REV PSYCHIAT, V9, P1; Keller MB, 1982, AM J PSYCHIAT; Kiecolt-Glaser JK, 2002, J PSYCHOSOM RES, V53, P873, DOI 10.1016/S0022-3999(02)00309-4; Klein DN, 2008, J ABNORM PSYCHOL, V117, P552, DOI 10.1037/0021-843X.117.3.552; Klein DN, 2006, AM J PSYCHIAT, V163, P872, DOI 10.1176/appi.ajp.163.5.872; Koenig HG, 1997, AM J PSYCHIAT, V154, P1376; Lee W.J., 2009, J RURAL MED, V4, P53, DOI [10.2185/jrm.4.53, DOI 10.2185/JRM.4.53]; Lin CM, 2012, GEN HOSP PSYCHIAT, V34, P552, DOI 10.1016/j.genhosppsych.2012.03.015; Lin JJ, 2010, BMC PUBLIC HEALTH, V10, P1471; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 2006, CRIT CARE MED, V34, P368, DOI 10.1097/01.CCM.0000195013.47004.A8; Lin JL, 1996, THORAX, V51, P661, DOI 10.1136/thx.51.7.661; Lin NC, 2003, J TOXICOL-CLIN TOXIC, V41, P877, DOI 10.1081/CLT-120025356; London L, 2005, AM J IND MED, V47, P308, DOI 10.1002/ajim.20147; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mishara BL, 2007, CRISIS, V28, P10, DOI 10.1027/0227-5910.28.S1.10; Nagami H, 2005, INT J OCCUP ENV HEAL, V11, P180, DOI 10.1179/oeh.2005.11.2.180; Nagami H, 2007, J RURAL MED, V2, P85; O'Keeffe N, 2007, CLIN MED, V7, P478, DOI 10.7861/clinmedicine.7-5-478; Pai L, 1987, CHINESE J MENTAL HLT, V3, P195; Phillips MR, 2009, RESTRICTIONS ACCESS; Rhebergen D, 2009, J AFFECT DISORDERS, V115, P450, DOI 10.1016/j.jad.2008.10.018; SAWADA Y, 1988, LANCET, V1, P1333; Schneider B, 2009, ARCH SUICIDE RES, V13, P303, DOI 10.1080/13811110903263191; Schulz R, 2002, BIOL PSYCHIAT, V52, P205, DOI 10.1016/S0006-3223(02)01423-3; Senarathna L, 2009, QJM-INT J MED, V102, P251, DOI 10.1093/qjmed/hcp006; Seok Su-Jin, 2009, Korean Journal of Internal Medicine, V24, P247, DOI 10.3904/kjim.2009.24.3.247; von Elm E, 2008, GAC SANIT, V22, P144, DOI 10.1157/13119325; Wananukul W, 2007, CLIN TOXICOL, V45, P582, DOI 10.1080/15563650701382789; Weng CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082695; Weng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051743; Wesseling C, 2001, Int J Occup Environ Health, V7, P275; Wilks MF, 2008, PLOS MED, V5, P250, DOI 10.1371/journal.pmed.0050049; Wulsin LR, 1999, PSYCHOSOM MED, V61, P6, DOI 10.1097/00006842-199901000-00003; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x; Yip PSF, 2006, BRIT J PSYCHIAT, V189, P465, DOI 10.1192/bjp.bp.106.021816	56	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112160	10.1371/journal.pone.0112160	http://dx.doi.org/10.1371/journal.pone.0112160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386676	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400045
J	da Costa, DCS; Palmeiro, MR; Moreira, JS; Martins, ACD; da Silva, AF; Madeira, MD; Quintella, LP; Confort, EM; Schubach, AD; Silva, FD; Valete-Rosalino, CM				Silva da Costa, Daniel Cesar; Palmeiro, Mariana Reuter; Moreira, Joao Soares; da Costa Martins, Ana Cristina; da Silva, Aline Fagundes; Madeira, Maria de Fatima; Quintella, Leonardo Pereira; Confort, Eliame Mouta; Schubach, Armando de Oliveira; Silva, Fatima da Conceicao; Valete-Rosalino, Claudia Maria			Oral Manifestations in the American Tegumentary Leishmaniasis	PLOS ONE			English	Article							MUCOSAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; SODIUM STIBOGLUCONATE; RISK-FACTORS; EFFICACY	Introduction: American tegumentary leishmaniasis (ATL) can affect the skin or mucosa (mucocutaneous leishmaniasis MCL) including the oral cavity. MCL oral lesions are often confused with other oral diseases, delaying diagnosis and specific treatment, and increasing the likelihood of sequelae. Thus, increasing the knowledge of the evolution of ATL oral lesions can facilitate its early diagnosis improving the prognosis of healing. Objectives: Evaluate the frequency of ATL oral lesion and describe its clinical, laboratory and therapeutic peculiarities. Methods: A descriptive transversal study was carried out, using data from medical records of 206 patients with MCL examined at the outpatient clinics-IPEC-Fiocruz between 1989 and 2013. Proportions were calculated for the categorical variables and the association among them was assessed by the Pearson's chi-square test. Measures of central tendency and dispersion were used for the continuous variables and their differences were assessed by both parametric (t test) and non parametric (Mann-Whitney) tests. P-values, <0.05 were considered as significant. Results: The most affected site was the nose, followed by the mouth, pharynx and larynx. Seventy eight (37.9%) have oral lesions and the disease presented a lower median of the evolution time than in other mucous sites as well as an increased time to heal. The presence of oral lesion was associated with: the presence of lesions in the other three mucosal sites; a smaller median of the leishmanin skin test values; a longer healing time of the mucosal lesions; a higher recurrence frequency; and a smaller frequency of treatment finishing and healing. When the oral lesion was isolated, it was associated with an age 20 years lower than when the oral lesion was associated with other mucosal sites. Conclusion: Considering the worst therapy results associated with the presence of oral lesions, we suggest that lesions in this location represent a factor of worse prognosis for MCL.	[Silva da Costa, Daniel Cesar; Palmeiro, Mariana Reuter; Moreira, Joao Soares; da Costa Martins, Ana Cristina; da Silva, Aline Fagundes; Madeira, Maria de Fatima; Quintella, Leonardo Pereira; Confort, Eliame Mouta; Schubach, Armando de Oliveira; Valete-Rosalino, Claudia Maria] Fundacao Oswaldo Cruz, Evandro Chagas Natl Inst Infect Dis, Rio De Janeiro, RJ, Brazil; [Silva, Fatima da Conceicao] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil; [Valete-Rosalino, Claudia Maria] Univ Fed Rio de Janeiro, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Silva, FD (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil.	fconcei@ioc.fiocruz.br; claudia.valete@ini.fiocruz.br	Silva, Aline/AAP-4691-2021; Fagundes, Aline/E-1471-2015; Valete-Rosalino, Cláudia Maria/AAR-4293-2021	Silva, Aline/0000-0001-7345-0350; Fagundes, Aline/0000-0001-7345-0350; 	IPEC [(PA2010-2013)-FIOCRUZ]; Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPQ) [407758/2012-7]; CNPq [470886/2003-0]; PROEP-CNPq [402557/2011-5]; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil [E-26/102.183/2013, E26.111.717/2012]; CNPq, Brazil; FAPERJ, Brazil	IPEC; Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROEP-CNPq; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by IPEC (PA2010-2013)-FIOCRUZ, Papes VI/FIOCRUZ/Brazilian National Council for Scientific and Technological Development (CNPQ) (407758/2012-7), CNPq (470886/2003-0) PROEP-CNPq 402557/2011-5 and Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) (E-26/102.183/2013; E26.111.717/2012), Brazil. AOS is the recipient of fellowships from CNPq and FAPERJ, Brazil. CMVR is the recipient of fellowships from FAPERJ. The funders had no role in study design data collection and analysis, decision to publish, or preparing the manuscript.	Aliaga L, 2003, MEDICINE, V82, P147, DOI 10.1097/00005792-200305000-00001; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Amato VS, 2009, J EUR ACAD DERMATOL, V23, P1026, DOI 10.1111/j.1468-3083.2009.03238.x; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Amato VS, 2003, ACTA TROP, V85, P39, DOI 10.1016/S0001-706X(02)00260-7; Antonio LF, 2014, I MED TROP IN PRESS; Boaventura VS, 2006, AM J TROP MED HYG, V75, P267, DOI 10.4269/ajtmh.2006.75.267; Brasil DATASUS, 2013, LEISHM TEG AM CAS CO; CARVALHO EM, 1985, J IMMUNOL, V135, P4144; Daneshbod Y, 2011, ARCH PATHOL LAB MED, V135, P478, DOI 10.1043/2010-0069-OA.1; Guerra JAD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000980; FRANKE ED, 1994, AM J TROP MED HYG, V51, P77, DOI 10.4269/ajtmh.1994.51.77; FRANKE ED, 1990, ANN INTERN MED, V113, P934, DOI 10.7326/0003-4819-113-12-934; Genaro O, 2002, LEISHMANIOSE TEGUMEN, P36; Gontijo Bernardo, 2003, Rev. Soc. Bras. Med. Trop., V36, P71, DOI 10.1590/S0037-86822003000100011; KANAN MW, 1975, BRIT J DERMATOL, V92, P663, DOI 10.1111/j.1365-2133.1975.tb03147.x; Lawn SD, 2004, QJM-INT J MED, V97, P781, DOI 10.1093/qjmed/hch127; LLANOSCUENTAS EA, 1984, LANCET, V2, P295, DOI 10.1016/S0140-6736(84)90346-5; MARSDEN PD, 1986, T ROY SOC TROP MED H, V80, P859, DOI 10.1016/0035-9203(86)90243-9; Ministerio da Saude, 2010, MAN CONTR LEISHM TEG; Lessa Marcus Miranda, 2007, Rev. Bras. Otorrinolaringol., V73, P843, DOI [10.1590/S0034-72992007000600016, 10.1016/S1808-8694(15)31181-2]; Motta ACF, 2007, ORAL DIS, V13, P335, DOI 10.1111/j.1601-0825.2006.01296.x; Oliveira AGL, 2013, ACTA TROP, V128, P36, DOI 10.1016/j.actatropica.2013.06.005; Oliveira-Neto Manoel Paes de, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P321, DOI 10.1590/S0036-46652000000600004; Palmeiro MR, 2012, PARASITE IMMUNOL, V34, P23, DOI 10.1111/j.1365-3024.2011.01343.x; Palmeiro MR, 2007, ORAL SURG ORAL MED O, V104, pE12, DOI 10.1016/j.tripleo.2007.07.008; Schubach A, 1998, J INFECT DIS, V178, P911, DOI 10.1086/515355; Tuon FF, 2008, CLIN IMMUNOL, V128, P442, DOI 10.1016/j.clim.2008.05.007; WHO, 2010, WHO TECH REP SER, V949, P1	29	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109790	10.1371/journal.pone.0109790	http://dx.doi.org/10.1371/journal.pone.0109790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386857	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400005
J	Carstensen, DW; Sabatino, M; Trojelsgaard, K; Morellato, LPC				Carstensen, Daniel W.; Sabatino, Malena; Trojelsgaard, Kristian; Morellato, Leonor Patricia C.			Beta Diversity of Plant-Pollinator Networks and the Spatial Turnover of Pairwise Interactions	PLOS ONE			English	Article							SPECIALIZATION	Interactions between species form complex networks that vary across space and time. Even without spatial or temporal constraints mutualistic pairwise interactions may vary, or rewire, across space but this variability is not well understood. Here, we quantify the beta diversity of species and interactions and test factors influencing the probability of turnover of pairwise interactions across space. We ask: 1) whether beta diversity of plants, pollinators, and interactions follow a similar trend across space, and 2) which interaction properties and site characteristics are related to the probability of turnover of pairwise interactions. Geographical distance was positively correlated with plant and interaction beta diversity. We find that locally frequent interactions are more consistent across space and that local flower abundance is important for the realization of pairwise interactions. While the identity of pairwise interactions is highly variable across space, some species-pairs form interactions that are locally frequent and spatially consistent. Such interactions represent cornerstones of interacting communities and deserve special attention from ecologists and conservation planners alike.	[Carstensen, Daniel W.; Morellato, Leonor Patricia C.] Univ Estadual Paulista, Dept Bot, UNESP, Plant Phenol & Seed Dispersal Grp,Lab Fenol, Sao Paulo, Brazil; [Sabatino, Malena] Univ Nacl Comahue, Lab Ecotono CRUB, San Carlos De Bariloche, Rio Negro, Argentina; [Sabatino, Malena] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Trojelsgaard, Kristian] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Trojelsgaard, Kristian] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Aalborg, Denmark	Universidade Estadual Paulista; Universidad Nacional del Comahue; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Aarhus University; Aalborg University	Carstensen, DW (corresponding author), Univ Estadual Paulista, Dept Bot, UNESP, Plant Phenol & Seed Dispersal Grp,Lab Fenol, Sao Paulo, Brazil.	daniel.carstensen@gmail.com	Trøjelsgaard, Kristian/U-4442-2018; Morellato, Patricia/B-6026-2013	Trøjelsgaard, Kristian/0000-0001-6807-8363; Morellato, Patricia/0000-0001-5265-8988	Sao Paulo Research Foundation [2010/51307-0, 2011/22635-2, 2013/05920-0]; UNESP; CNPq	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); UNESP; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Sao Paulo Research Foundation grant # 2010/51307-0 (FAPESP-VALE), grant # 2011/22635-2 and # 2013/05920-0 to DWC. UNESP grant to MS. Research Productivity fellowship CNPq to LPCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; ALVES RJV, 1994, VEGETATIO, V113, P125; Bascompte J., 2013, MUTUALISTIC NETWORKS; Basilio AM, 2006, AUSTRAL ECOL, V31, P975, DOI 10.1111/j.1442-9993.2006.01666.x; Benites Vinicius M., 2007, Braz. J. Bot., V30, P569, DOI 10.1590/S0100-84042007000400003; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Brosi BJ, 2013, P NATL ACAD SCI USA, V110, P13044, DOI 10.1073/pnas.1307438110; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Canard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038295; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Dattilo W, 2013, OIKOS, V122, P1643, DOI 10.1111/j.1600-0706.2013.00562.x; Dunne JA, 2006, SFI S SCI C, P27; Dupont YL, 2003, ECOGRAPHY, V26, P301, DOI 10.1034/j.1600-0587.2003.03443.x; Dupont YL, 2009, OIKOS, V118, P1261, DOI 10.1111/j.1600-0706.2009.17594.x; Echternacht L, 2011, FLORA, V206, P782, DOI 10.1016/j.flora.2011.04.003; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FARIA GM, 1994, THESIS U ESTADUAL PA; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Giulietti AM, 1987, B BOT U SAO PAULO, V9, P1, DOI DOI 10.11606/ISSN.2316-9052.V9I0P1-151; Giulietti AM., 1997, CTR PLANT DIVERSITY; Gravel D, 2013, METHODS ECOL EVOL, V4, P1083, DOI 10.1111/2041-210X.12103; Hagen M, 2012, ADV ECOL RES, V46, P89, DOI 10.1016/B978-0-12-396992-7.00002-2; Hubbell Stephen P., 2001, V32, pi; Johnson SD, 2000, TRENDS ECOL EVOL, V15, P140, DOI 10.1016/S0169-5347(99)01811-X; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Lazaro A, 2010, OIKOS, V119, P825, DOI 10.1111/j.1600-0706.2009.18017.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Novotny V, 2009, INSECT CONSERV DIVER, V2, P5, DOI 10.1111/j.1752-4598.2008.00035.x; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026455; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; PIMM SL, 1992, SCIENCE, V255, P940, DOI 10.1126/science.1546290; Poisot T, 2015, OIKOS, V124, P243, DOI 10.1111/oik.01719; Poisot T, 2013, PARASITOLOGY, V140, P1340, DOI 10.1017/S0031182013000851; Poisot T, 2012, ECOL LETT, V15, P1353, DOI 10.1111/ele.12002; R Core Team, 2018, R LANG ENV STAT COMP; Rasmussen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081694; Sabatino M, 2010, ECOL APPL, V20, P1491, DOI 10.1890/09-1626.1; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Stang M, 2006, OIKOS, V112, P111, DOI 10.1111/j.0030-1299.2006.14199.x; ter Steege H, 2013, SCIENCE, V342, P325, DOI 10.1126/science.1243092; Thompson JD., 1994, COEVOLUTIONARY PROCE; Vazquez DP, 2007, OIKOS, V116, P1120, DOI 10.1111/j.0030-1299.2007.15828.x; Vazquez DP, 2009, ANN BOT-LONDON, V103, P1445, DOI 10.1093/aob/mcp057; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, ECOL LETT, V8, P1088, DOI 10.1111/j.1461-0248.2005.00810.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiersma YF, 2005, CONSERV BIOL, V19, P1262, DOI 10.1111/j.1523-1739.2005.00099.x	53	84	85	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112903	10.1371/journal.pone.0112903	http://dx.doi.org/10.1371/journal.pone.0112903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384058	Green Submitted, gold, Green Published			2022-12-26	WOS:000344816700103
J	Kwon, HN; Lee, YJ; Kang, JH; Choi, JH; An, YJ; Kang, S; Lee, DH; Suh, YJ; Heo, Y; Park, S				Kwon, Hyuk Nam; Lee, Yeon Ji; Kang, Ju-Hee; Choi, Ji-Ho; An, Yong Jin; Kang, Sunmi; Lee, Dae Hyun; Suh, Young Ju; Heo, Yoonseok; Park, Sunghyouk			Prediction of Glycated Hemoglobin Levels at 3 Months after Metabolic Surgery Based on the 7-Day Plasma Metabolic Profile	PLOS ONE			English	Article							HYPOTHALAMIC LEPTIN; INSULIN SENSITIVITY; BARIATRIC SURGERY; TYPE-2; RISK; WEIGHT; REDUCTION; THERAPY; OBESITY; DIET	Metabolic surgery has been shown to provide better glycemic control for type 2 diabetes than conventional therapies. Still, the outcomes of the surgery are variable, and prognostic markers reflecting the metabolic changes by the surgery are yet to be established. NMR-based plasma metabolomics followed by multivariate regression was used to test the correlation between the metabolomic profile at 7-days after surgery and glycated hemoglobin (HbA1c) levels at 3-months (and up to 12 months with less patients), and to identify the relevant markers. Metabolomic profiles at 7-days could differentiate the patients according to the HbA1c improvement status at 3-months. The HbA1c values were predicted based on the metabolomics profile with partial least square regression, and found to be correlated with the observed values. Metabolite analysis suggested that 3-Hydroxybutyrate (3-HB) and glucose contributes to this prediction, and the [3-HB]/[glucose] exhibited a modest to good correlation with the HbA1c level at 3-months. The prediction of 3-month HbA1c using 7-day metabolomic profile and the suggested new criterion [3-HB]/[glucose] could augment current prognostic modalities and help clinicians decide if drug therapy is necessary.	[Kwon, Hyuk Nam; An, Yong Jin; Kang, Sunmi; Park, Sunghyouk] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul 151742, South Korea; [Lee, Yeon Ji; Choi, Ji-Ho] Inha Univ, Sch Med, Inha Univ Hosp, Dept Family Med,Obes Ctr, Inchon 400712, South Korea; [Kang, Ju-Hee] Inha Univ, Sch Med, Inha Univ Hosp, Dept Pharmacol & Hypoxia Related Dis Res, Inchon 400712, South Korea; [Lee, Dae Hyun] Inha Univ, Sch Med, Inha Univ Hosp, Dept Med, Inchon 400712, South Korea; [Suh, Young Ju] Inha Univ, Sch Med, Inha Univ Hosp, Dept Biostat, Inchon 400712, South Korea; [Heo, Yoonseok] Inha Univ, Sch Med, Inha Univ Hosp, Dept Gen Surg, Inchon 400712, South Korea	Seoul National University (SNU); Inha University; Inha University Hospital; Inha University; Inha University Hospital; Inha University; Inha University Hospital; Inha University; Inha University Hospital; Inha University; Inha University Hospital	Heo, Y (corresponding author), Inha Univ, Sch Med, Inha Univ Hosp, Dept Gen Surg, Inchon 400712, South Korea.	gshur@inha.ac.kr; psh@snu.ac.kr	Kwon, Hyuk Nam/V-2301-2018; Lee, Dae Hyun/AAZ-6007-2021; Suh, Young Ju/AAD-5737-2021; Lee, Dae Hyun/T-9838-2019	Kwon, Hyuk Nam/0000-0003-4096-4712; An, Yong Jin/0000-0001-8010-8035; Lee, Dae Hyun/0000-0001-8141-0404	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012011362, 2014009392, 2009-93144]; National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1420290]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012011362, 2014009392, and 2009-93144), and by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1420290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle J, 2012, EXP CLIN ENDOCR DIAB, V120, P152, DOI 10.1055/s-0031-1285911; [Anonymous], 2009, DIABETES CARE, V32, pS6, DOI 10.2337/dc09-S006; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H., 1978, METABOLIC SURG; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; DePaula AL, 2008, SURG ENDOSC, V22, P2670, DOI 10.1007/s00464-008-9808-0; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Geloneze B, 2012, ANN SURG, V256, P72, DOI 10.1097/SLA.0b013e3182592c62; HALVERSON JD, 1982, SURGERY, V92, P235; Hosokawa YA, 1996, J CLIN INVEST, V97, P180, DOI 10.1172/JCI118387; de Moura EGH, 2011, OBES SURG, V21, P941, DOI 10.1007/s11695-011-0387-0; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; International Diabetes Federation, 2011, MODULE 2 2B NUTR THE; Kang J, 2008, J AGR FOOD CHEM, V56, P11589, DOI 10.1021/jf802088a; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; Mingrone G, 2012, N ENGL J MED; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Park S, 2011, BRAIN RES, V1401, P95, DOI 10.1016/j.brainres.2011.05.040; Park S, 2011, EXP BIOL MED, V236, P194, DOI 10.1258/ebm.2010.010186; Pirsch JD, 1996, AM J KIDNEY DIS, V27, P444, DOI 10.1016/S0272-6386(96)90372-8; PORIES WJ, 1995, ANN SURG, V222, P339, DOI 10.1097/00000658-199509000-00011; Schauer PR, 2012, N ENGL J MED; Umpierrez Guillermo E, 2003, Treat Endocrinol, V2, P95, DOI 10.2165/00024677-200302020-00003; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	30	9	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e109609	10.1371/journal.pone.0109609	http://dx.doi.org/10.1371/journal.pone.0109609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384027	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700005
J	Liu, CY; Zhao, LN; Liu, CC				Liu, Chengyu; Zhao, Lina; Liu, Changchun			Effects of Blood Pressure and Sex on the Change of Wave Reflection: Evidence from Gaussian Fitting Method for Radial Artery Pressure Waveform	PLOS ONE			English	Article							CENTRAL PULSE PRESSURE; STIFFNESS; AORTA; AGE	An early return of the reflected component in the arterial pulse has been recognized as an important indicator of cardiovascular risk. This study aimed to determine the effects of blood pressure and sex factor on the change of wave reflection using Gaussian fitting method. One hundred and ninety subjects were enrolled. They were classified into four blood pressure categories based on the systolic blood pressures (i.e., <= 110, 111-120, 121-130 and >= 131 mmHg). Each blood pressure category was also stratified for sex factor. Electrocardiogram (ECG) and radial artery pressure waveforms (RAPW) signals were recorded for each subject. Ten consecutive pulse episodes from the RAPW signal were extracted and normalized. Each normalized pulse episode was fitted by three Gaussian functions. Both the peak position and peak height of the first and second Gaussian functions, as well as the peak position interval and peak height ratio, were used as the evaluation indices of wave reflection. Two-way ANOVA results showed that with the increased blood pressure, the peak position of the second Gaussian significantly shorten (P<0.01), the peak height of the first Gaussian significantly decreased (P<0.01) and the peak height of the second Gaussian significantly increased (P<0.01), inducing the significantly decreased peak position interval and significantly increased peak height ratio (both P<0.01). Sex factor had no significant effect on all evaluation indices (all P>0.05). Moreover, the interaction between sex and blood pressure factors also had no significant effect on all evaluation indices (all P>0.05). These results showed that blood pressure has significant effect on the change of wave reflection when using the recently developed Gaussian fitting method, whereas sex has no significant effect. The results also suggested that the Gaussian fitting method could be used as a new approach for assessing the arterial wave reflection.	[Liu, Chengyu; Zhao, Lina; Liu, Changchun] Shandong Univ, Sch Control Sci & Engn, Jinan 250100, Shandong, Peoples R China; [Liu, Chengyu] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Shandong University; Newcastle University - UK	Liu, CY (corresponding author), Shandong Univ, Sch Control Sci & Engn, Jinan 250100, Shandong, Peoples R China.	bestlcy@sdu.edu.cn	Liu, Chengyu/I-6411-2012	Liu, Chengyu/0000-0003-1965-3020	National Natural Science Foundation of China [61201049]; Hi-Tech Research and Development Program of China [2009AA02Z408]; Excellent Young Scientist Awarded Foundation of Shandong Province in China [BS2013DX029]; China Postdoctoral Science Foundation [2013M530323]; Postdoctoral Innovation Foundation of Shandong Province in China [201303102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Excellent Young Scientist Awarded Foundation of Shandong Province in China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Innovation Foundation of Shandong Province in China	This work was supported by the National Natural Science Foundation of China (61201049), the Hi-Tech Research and Development Program of China (2009AA02Z408), the Excellent Young Scientist Awarded Foundation of Shandong Province in China (BS2013DX029), the China Postdoctoral Science Foundation (2013M530323), and the Postdoctoral Innovation Foundation of Shandong Province in China (201303102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruch Martin C, 2011, Nonlinear Biomed Phys, V5, P1, DOI 10.1186/1753-4631-5-1; Beevers G, 2001, BMJ-BRIT MED J, V322, P1043, DOI 10.1136/bmj.322.7293.1043; Carlson RV, 2004, BRIT J CLIN PHARMACO, V57, P695, DOI 10.1111/j.1365-2125.2004.02103.x; Chirinos JA, 2005, AM J CARDIOL, V96, P645, DOI 10.1016/j.amjcard.2005.04.036; CHIU YC, 1991, AM HEART J, V121, P1460, DOI 10.1016/0002-8703(91)90153-9; Frimodt-Moller M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041757; Hermeling E, 2010, HYPERTENSION, V55, P124, DOI 10.1161/HYPERTENSIONAHA.109.143867; Hughes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059371; Huotari M., 2011, J STRUCT MECH, V44, P345; Huotari M., 2012, P WORLD C MED PHYS B, V39, P526; Khalil A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006134; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lisheng Xu, 2011, Proceedings 2011 International Conference on Information and Automation (ICIA 2011), P544, DOI 10.1109/ICINFA.2011.5949053; Liu CY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/923260; Liu CY, 2014, BIO-MED MATER ENG, V24, P271, DOI 10.3233/BME-130808; Liu CY, 2013, BIOMED SIGNAL PROCES, V8, P449, DOI 10.1016/j.bspc.2013.01.003; Liu CY, 2012, J MED BIOL ENG, V32, P245, DOI 10.5405/jmbe.1006; Martinez JP, 2004, IEEE T BIO-MED ENG, V51, P570, DOI 10.1109/TBME.2003.821031; Millasseau SC, 2005, HYPERTENSION, V45, P222, DOI 10.1161/01.HYP.0000154229.97341.d2; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Munir S, 2008, HYPERTENSION, V51, P112, DOI 10.1161/HYPERTENSIONAHA.107.096016; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; O'Rourke MF, 2004, HYPERTENSION, V44, pE10, DOI 10.1161/01.HYP.0000146403.99648.c6; Pickering TG, 2005, CIRCULATION, V111, P697, DOI 10.1161/01.CIR.0000154900.76284.F6; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Roman MJ, 2009, J AM COLL CARDIOL, V54, P1730, DOI 10.1016/j.jacc.2009.05.070; Rubins U, 2008, MED BIOL ENG COMPUT, V46, P1271, DOI 10.1007/s11517-008-0406-z; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Segers P, 2007, PHYSIOL MEAS, V28, P1045, DOI 10.1088/0967-3334/28/9/006; Sugawara J, 2010, HYPERTENSION, V56, P920, DOI 10.1161/HYPERTENSIONAHA.110.160549; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; Wang L, 2013, COMPUT BIOL MED, V43, P1661, DOI 10.1016/j.compbiomed.2013.08.004; Westerhof BE, 2006, HYPERTENSION, V48, P595, DOI 10.1161/01.HYP.0000238330.08894.17	34	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112895	10.1371/journal.pone.0112895	http://dx.doi.org/10.1371/journal.pone.0112895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384042	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700102
J	Cho, YL; Hur, SM; Kim, JY; Kim, JH; Lee, DK; Choe, J; Won, MH; Ha, KS; Jeoung, D; Han, S; Ryoo, S; Lee, H; Min, JK; Kwon, YG; Kim, DH; Kim, YM				Cho, Young-Lai; Hur, Sung-Mo; Kim, Ji-Yoon; Kim, Ji-Hee; Lee, Dong-Keon; Choe, Jongeon; Won, Moo-Ho; Ha, Kwon-Soo; Jeoung, Dooil; Han, Sanghwa; Ryoo, Sungwoo; Lee, Hansoo; Min, Jeong-Ki; Kwon, Young-Guen; Kim, Dong-Hyun; Kim, Young-Myeong			Specific Activation of Insulin-like Growth Factor-1 Receptor by Ginsenoside Rg5 Promotes Angiogenesis and Vasorelaxation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Endothelial Cell; Insulin-like Growth Factor (IGF); Nitric Oxide; Vascular Biology; Insulin-like Growth Factor-1 Receptor; Vascular Function	NITRIC-OXIDE SYNTHASE; VASCULAR-PERMEABILITY; SIGNAL PATHWAYS; PROTEIN-KINASE; MICE; DIMERIZATION; CELLS; PHOSPHORYLATION; INFLAMMATION; CONTRIBUTES	Background: The mechanism by which ginsenoside Rg5 regulates vascular function remains unclear. Results: Rg5 increases angiogenesis and vasorelxation by activating multiple signal transduction pathways downstream of insulin-like growth fastor-1 receptor (IGF-1R). Conclusion: Rg5 promotes endothelial cell function through activation of IGF-1R. Significance: These findings reveal a mechanism for the positive regulation of vascular function by Rg5-mediated IGF-1R activation. Ginsenoside Rg5 is a compound newly synthesized during the steaming process of ginseng; however, its biological activity has not been elucidated with regard to endothelial function. We found that Rg5 stimulated in vitro angiogenesis of human endothelial cells, consistent with increased neovascularization and blood perfusion in a mouse hind limb ischemia model. Rg5 also evoked vasorelaxation in aortic rings isolated from wild type and high cholesterol-fed ApoE(-/-) mice but not from endothelial nitric-oxide synthase (eNOS) knock-out mice. Angiogenic activity of Rg5 was highly associated with a specific increase in insulin-like growth factor-1 receptor (IGF-1R) phosphorylation and subsequent activation of multiple angiogenic signals, including ERK, FAK, Akt/eNOS/NO, and G(i)-mediated phospholipase C/Ca2+/eNOS dimerization pathways. The vasodilative activity of Rg5 was mediated by the eNOS/NO/cGMP axis. IGF-1R knockdown suppressed Rg5-induced angiogenesis and vasorelaxation by inhibiting key angiogenic signaling and NO/cGMP pathways. In silico docking analysis showed that Rg5 bound with high affinity to IGF-1R at the same binding site of IGF. Rg5 blocked binding of IGF-1 to its receptor with an IC50 of approximate to 90 nmol/liter. However, Rg5 did not induce vascular inflammation and permeability. These data suggest that Rg5 plays a novel role as an IGF-1R agonist, promoting therapeutic angiogenesis and improving hypertension without adverse effects in the vasculature.	[Cho, Young-Lai; Hur, Sung-Mo; Kim, Ji-Yoon; Kim, Ji-Hee; Lee, Dong-Keon; Ha, Kwon-Soo; Kim, Young-Myeong] Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Gangwon Do, South Korea; [Choe, Jongeon] Kangwon Natl Univ, Dept Immunol, Sch Med, Chunchon 200701, Gangwon Do, South Korea; [Won, Moo-Ho] Kangwon Natl Univ, Dept Neurobiol, Sch Med, Chunchon 200701, Gangwon Do, South Korea; [Jeoung, Dooil; Han, Sanghwa] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, Gangwon Do, South Korea; [Ryoo, Sungwoo; Lee, Hansoo] Kangwon Natl Univ, Coll Nat Sci, Dept Life Sci, Chunchon 200701, Gangwon Do, South Korea; [Min, Jeong-Ki; Kwon, Young-Guen] Yonsei Univ, Dept Biochem, Coll Sci & Biotechnol, Seoul 120749, South Korea; [Kim, Dong-Hyun] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Coll Pharm, Seoul 130701, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Yonsei University; Kyung Hee University	Kim, YM (corresponding author), Kangwon Natl Univ, Dept Mol & Cellular Biochem, Sch Med, Chunchon 200701, Gangwon Do, South Korea.	ymkim@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787; Min, Jeong-Ki/0000-0003-4924-8739	National Research Foundation of Korea - Korean government (Ministry of Science, ICT and Future Planning) [NRF-2011-0028790, NRF-2013M3A9B6046563]; Kangwon National University	National Research Foundation of Korea - Korean government (Ministry of Science, ICT and Future Planning); Kangwon National University	This work was supported by Grants NRF-2011-0028790 and NRF-2013M3A9B6046563 from the National Research Foundation of Korea, funded by the Korean government (Ministry of Science, ICT and Future Planning), and a research grant from Kangwon National University.	Aghdam SY, 2012, BIOCHEM BIOPH RES CO, V421, P197, DOI 10.1016/j.bbrc.2012.03.134; Baek YY, 2012, EUR J PHARMACOL, V674, P188, DOI 10.1016/j.ejphar.2011.11.022; Cheung LWT, 2011, CARDIOVASC RES, V89, P419, DOI 10.1093/cvr/cvq300; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Chung BH, 2012, EXP MOL MED, V44, P191, DOI 10.3858/emm.2012.44.3.014; Chung BH, 2010, BIOCHEM BIOPH RES CO, V391, P254, DOI 10.1016/j.bbrc.2009.11.045; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Conti E, 2004, CIRCULATION, V110, P2260, DOI 10.1161/01.CIR.0000144309.87183.FB; Fan RS, 2005, J BIOL CHEM, V280, P24212, DOI 10.1074/jbc.M500716200; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; GRANT MB, 1993, ANN NY ACAD SCI, V692, P230; Han RNN, 2003, AM J RESP CELL MOL, V28, P159, DOI 10.1165/rcmb.4764; Handa P, 2011, ARTERIOSCL THROM VAS, V31, P2827, DOI 10.1161/ATVBAHA.111.236554; Hartnett L, 2010, INT J DEV BIOL, V54, P573, DOI 10.1387/ijdb.092922lh; Hellermann GR, 1997, J BIOL CHEM, V272, P12030, DOI 10.1074/jbc.272.18.12030; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Hwang YP, 2010, TOXICOL APPL PHARM, V242, P18, DOI 10.1016/j.taap.2009.09.009; Imrie H, 2012, DIABETES, V61, P2359, DOI 10.2337/db11-1494; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; Kim CK, 2010, MOL PHARMACOL, V78, P142, DOI 10.1124/mol.110.063586; Kim TW, 2012, INT IMMUNOPHARMACOL, V12, P110, DOI 10.1016/j.intimp.2011.10.023; Lee KS, 2012, BIOCHEM BIOPH RES CO, V418, P49, DOI 10.1016/j.bbrc.2011.12.123; Lee ZW, 2000, CELL SIGNAL, V12, P91, DOI 10.1016/S0898-6568(99)00069-8; Lyons-Darden T, 2004, J MOL ENDOCRINOL, V33, P165, DOI 10.1677/jme.0.0330165; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moser C, 2008, EUR J CANCER, V44, P1577, DOI 10.1016/j.ejca.2008.04.003; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Perrault R, 2013, BIOCHEM J, V450, P209, DOI 10.1042/BJ20112158; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piecewicz SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032191; Poiraudeau S, 1997, J CELL BIOCHEM, V64, P414; Pyun BJ, 2008, CANCER RES, V68, P227, DOI 10.1158/0008-5472.CAN-07-2799; Sengupta S, 2004, CIRCULATION, V110, P1219, DOI 10.1161/01.CIR.0000140676.88412.CF; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257	37	36	38	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					467	477		10.1074/jbc.M114.603142	http://dx.doi.org/10.1074/jbc.M114.603142			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391655	Green Published, hybrid			2022-12-26	WOS:000347231200041
J	Dahl, JU; Koldewey, P; Salmon, L; Horowitz, S; Bardwell, JCA; Jakob, U				Dahl, Jan-Ulrik; Koldewey, Philipp; Salmon, Loic; Horowitz, Scott; Bardwell, James C. A.; Jakob, Ursula			HdeB Functions as an Acid-protective Chaperone in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Chaperone; Protein Aggregation; Protein Folding; Stress Response	ESCHERICHIA-COLI; PERIPLASMIC PROTEIN; SHIGELLA-FLEXNERI; ENTERIC BACTERIA; INTERNAL PH; RESISTANCE; DISORDER; NMR; SPECTROSCOPY; EXPRESSION	Background: Periplasmic chaperones HdeA and HdeB are involved in the acid stress response in Escherichia coli. Results: HdeB requires its folded and dimeric state to protect E. coli from protein aggregation at pH 4. Conclusion: HdeA and HdeB use different mechanisms to prevent periplasmic protein aggregation, allowing them to function over a broad pH range. Significance: This study furthers the understanding of how enteric bacteria counteract acid stress. Enteric bacteria such as Escherichia coli utilize various acid response systems to counteract the acidic environment of the mammalian stomach. To protect their periplasmic proteome against rapid acid-mediated damage, bacteria contain the acid-activated periplasmic chaperones HdeA and HdeB. Activation of HdeA at pH 2 was shown to correlate with its acid-induced dissociation into partially unfolded monomers. In contrast, HdeB, which has high structural similarities to HdeA, shows negligible chaperone activity at pH 2 and only modest chaperone activity at pH 3. These results raised intriguing questions concerning the physiological role of HdeB in bacteria, its activation mechanism, and the structural requirements for its function as a molecular chaperone. In this study, we conducted structural and biochemical studies that revealed that HdeB indeed works as an effective molecular chaperone. However, in contrast to HdeA, whose chaperone function is optimal at pH 2, the chaperone function of HdeB is optimal at pH 4, at which HdeB is still fully dimeric and largely folded. NMR, analytical ultracentrifugation, and fluorescence studies suggest that the highly dynamic nature of HdeB at pH 4 alleviates the need for monomerization and partial unfolding. Once activated, HdeB binds various unfolding client proteins, prevents their aggregation, and supports their refolding upon subsequent neutralization. Overexpression of HdeA promotes bacterial survival at pH 2 and 3, whereas overexpression of HdeB positively affects bacterial growth at pH 4. These studies demonstrate how two structurally homologous proteins with seemingly identical in vivo functions have evolved to provide bacteria with the means for surviving a range of acidic protein-unfolding conditions.	[Dahl, Jan-Ulrik; Koldewey, Philipp; Salmon, Loic; Horowitz, Scott; Bardwell, James C. A.; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Koldewey, Philipp; Salmon, Loic; Horowitz, Scott; Bardwell, James C. A.; Jakob, Ursula] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Bardwell, JCA (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	jbardwel@umich.edu; ujakob@umich.edu	Dahl, Jan-Ulrik/J-1893-2019; Dahl, Jan-Ulrik/J-4970-2017; Salmon, Loic/C-9162-2018	Dahl, Jan-Ulrik/0000-0001-8597-7416; Dahl, Jan-Ulrik/0000-0002-4164-6129; Salmon, Loic/0000-0002-0249-6279; Horowitz, Scott/0000-0002-1148-0105	National Institutes of Health [GM102829]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM102829 (to J. C. A. B. and U. J.). This work was also supported by the Howard Hughes Medical Institute (to J. C. A. B.).	Bardwell JCA, 2012, TRENDS BIOCHEM SCI, V37, P517, DOI 10.1016/j.tibs.2012.08.006; Baryshnikova OK, 2008, J BIOMOL NMR, V41, P5, DOI 10.1007/s10858-008-9234-6; CHUANG SE, 1993, J BACTERIOL, V175, P5242, DOI 10.1128/JB.175.16.5242-5252.1993; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fan Yao, 2010, Journal of Structural and Functional Genomics, V11, P101, DOI 10.1007/s10969-010-9079-6; Foit L, 2013, P NATL ACAD SCI USA, V110, pE1254, DOI 10.1073/pnas.1222458110; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gajiwala KS, 2000, J MOL BIOL, V295, P605, DOI 10.1006/jmbi.1999.3347; Goddard T. D., 2008, SPARKY3; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hong WZ, 2012, TRENDS MICROBIOL, V20, P328, DOI 10.1016/j.tim.2012.03.001; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Jakob U, 2014, CHEM REV, V114, P6779, DOI 10.1021/cr400459c; Kern R, 2007, J BACTERIOL, V189, P603, DOI 10.1128/JB.01522-06; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; LIN JS, 1995, J BACTERIOL, V177, P4097, DOI 10.1128/jb.177.14.4097-4104.1995; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Parker BW, 2013, J BIOL CHEM, V288, P32574, DOI 10.1074/jbc.M113.503516; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Smith JL, 2003, J FOOD PROTECT, V66, P1292, DOI 10.4315/0362-028X-66.7.1292; Szakacs Z, 2004, ANAL CHIM ACTA, V522, P247, DOI 10.1016/j.aca.2004.07.005; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Tucker DL, 2002, J BACTERIOL, V184, P6551, DOI 10.1128/JB.184.23.6551-6558.2002; Valderas MW, 2005, VET MICROBIOL, V107, P307, DOI 10.1016/j.vetmic.2005.01.018; Wang WJ, 2012, J MOL BIOL, V415, P538, DOI 10.1016/j.jmb.2011.11.026; WARD FW, 1987, LAB ANIM, V21, P216, DOI 10.1258/002367787781268693; Waterman SR, 1996, MOL MICROBIOL, V21, P925, DOI 10.1046/j.1365-2958.1996.00058.x; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zhang BW, 2011, J AM CHEM SOC, V133, P19393, DOI 10.1021/ja2060066; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	36	38	40	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					65	75		10.1074/jbc.M114.612986	http://dx.doi.org/10.1074/jbc.M114.612986			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391835	Green Published, hybrid			2022-12-26	WOS:000347231200007
J	Ham, H; Woolery, AR; Tracy, C; Stenesen, D; Kramer, H; Orth, K				Ham, Hyeilin; Woolery, Andrew R.; Tracy, Charles; Stenesen, Drew; Kraemer, Helmut; Orth, Kim			Unfolded Protein Response-regulated Drosophila Fic (dFic) Protein Reversibly AMPylates BiP Chaperone during Endoplasmic Reticulum Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; ADP-RIBOSYLATION; MOLECULAR CHAPERONES; BINDING-PROTEIN; ATPASE ACTIVITY; NEUROLOGICAL DISORDERS; GLUTAMINE-SYNTHETASE; STRESS INDUCTION; QUALITY CONTROL; DNAJ HOMOLOG	Drosophila Fic (dFic) mediates AMPylation, a covalent attachment of adenosine monophosphate (AMP) from ATP to hydroxyl side chains of protein substrates. Here, we identified the endoplasmic reticulum (ER) chaperone BiP as a substrate for dFic and mapped the modification site to Thr-366 within the ATPase domain. The level of AMPylated BiP in Drosophila S2 cells is high during homeostasis, whereas the level of AMPylated BiP decreases upon the accumulation of misfolded proteins in the ER. Both dFic and BiP are transcriptionally activated upon ER stress, supporting the role of dFic in the unfolded protein response pathway. The inactive conformation of BiP is the preferred substrate for dFic, thus endorsing a model whereby AMPylation regulates the function of BiP as a chaperone, allowing acute activation of BiP by deAMPylation during an ER stress response. These findings not only present the first substrate of eukaryotic AMPylator but also provide a target for regulating the unfolded protein response, an emerging avenue for cancer therapy.	[Ham, Hyeilin; Woolery, Andrew R.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Tracy, Charles; Stenesen, Drew; Kraemer, Helmut] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Kramer, Helmut/0000-0002-1167-2676	Cancer Prevention and Research Institute of Texas Grant [RP120613]; NATIONAL EYE INSTITUTE [R01EY021922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Orth laboratory and Lawrence Lum for helpful discussion and assistance. We acknowledge the services of the UT Southwestern Proteomics Core, supported by Cancer Prevention and Research Institute of Texas Grant RP120613 (to Drs. David Trudgian and Hamid Mirzaei).	Andreasson C, 2010, J BIOL CHEM, V285, P12445, DOI 10.1074/jbc.M109.096735; Brodsky JL, 1997, TRENDS CELL BIOL, V7, P151, DOI 10.1016/S0962-8924(97)01020-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CARLSSON L, 1983, P NATL ACAD SCI-BIOL, V80, P4664, DOI 10.1073/pnas.80.15.4664; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Ceriani M Fernanda, 2007, Methods Mol Biol, V362, P415; Chambers JE, 2012, J CELL BIOL, V198, P371, DOI 10.1083/jcb.201202005; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Cruz JW, 2014, J BIOL CHEM, V289, P7788, DOI 10.1074/jbc.M113.544429; DORNER AJ, 1992, EMBO J, V11, P1563, DOI 10.1002/j.1460-2075.1992.tb05201.x; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gaut JR, 1997, CELL STRESS CHAPERON, V2, P252, DOI 10.1379/1466-1268(1997)002<0252:IVTPOI>2.3.CO;2; GAUT JR, 1993, J BIOL CHEM, V268, P12691; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Hao YH, 2011, J BIOTECHNOL, V151, P251, DOI 10.1016/j.jbiotec.2010.12.013; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; KOCH GLE, 1990, BIOESSAYS, V12, P527, DOI 10.1002/bies.950121105; LEDFORD BE, 1994, MOL CELL BIOCHEM, V138, P141, DOI 10.1007/BF00928456; LENO GH, 1990, FEBS LETT, V276, P29, DOI 10.1016/0014-5793(90)80499-9; LEUSTEK T, 1991, ARCH BIOCHEM BIOPHYS, V289, P256, DOI 10.1016/0003-9861(91)90469-Y; Li JZ, 2006, CURR MOL MED, V6, P45, DOI 10.2174/156652406775574523; McClellan AJ, 1998, MOL BIOL CELL, V9, P3533, DOI 10.1091/mbc.9.12.3533; Mei Y., 2013, J PHARMACEUT BIOMED, V1; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rahman M, 2012, NAT NEUROSCI, V15, P871, DOI 10.1038/nn.3102; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; SHAPIRO BM, 1967, P NATL ACAD SCI USA, V58, P642, DOI 10.1073/pnas.58.2.642; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Vandewynckel YP, 2013, ANTICANCER RES, V33, P4683; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Weng WC, 2011, J FORMOS MED ASSOC, V110, P428, DOI 10.1016/S0929-6646(11)60064-8; Woolery AR, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.601310; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	60	73	74	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36059	36069		10.1074/jbc.M114.612515	http://dx.doi.org/10.1074/jbc.M114.612515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25395623	hybrid, Green Published			2022-12-26	WOS:000346897900034
J	Chen, C; Sun, P; Dai, QS; Weng, HW; Li, HP; Ye, S				Chen, Cui; Sun, Peng; Dai, Qiang-sheng; Weng, Hui-wen; Li, He-ping; Ye, Sheng			The Glasgow Prognostic Score Predicts Poor Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma	PLOS ONE			English	Article							PLATELET-LYMPHOCYTE RATIO; IV COLORECTAL-CANCER; NEUTROPHIL-LYMPHOCYTE; SYSTEMIC INFLAMMATION; LUNG-CANCER; EPIDEMIOLOGY; CACHEXIA; THERAPY; EBV	Background: Several inflammation-based prognostic scoring systems, including Glasgow Prognostic Score (GPS), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) have been reported to predict survival in many malignancies, whereas their role in metastatic nasopharyngeal carcinoma (NPC) remains unclear. The aim of this study is to evaluate the clinical value of these prognostic scoring systems in a cohort of cisplatin-based treated patients with metastatic NPC. Methods: Two hundred and eleven patients with histologically proven metastatic NPC treated with first-line cisplatin-based chemotherapy were retrospectively evaluated. Demographics, disease-related characteristics and relevant laboratory data before treatment were recorded. GPS, NLR and PLR were calculated as described previously. Response to first-line therapy and survival data were also collected. Survival was analyzed in Cox regressions and stability of the models was examined by bootstrap resampling. The area under the receiver operating characteristics curve (AUC) was calculated to compare the discriminatory ability of each scoring system. Results: Among the above three inflammation-based prognostic scoring systems, GPS (P<0.001) and NLR (P = 0.019) were independently associated with overall survival, which showed to be stable in a bootstrap resampling study. The GPS consistently showed a higher AUC value at 6-month (0.805), 12-month (0.705), and 24-month (0.705) in comparison with NLR and PLR. Further analysis of the association of GPS with progression-free survival showed GPS was also associated independently with progression-free survival (P<0.001). Conclusions: Our study demonstrated that the GPS may be of prognostic value in metastatic NPC patients treated with cisplatin-based palliative chemotherapy and facilitate individualized treatment. However a prospective study to validate this prognostic model is still needed.	[Chen, Cui; Dai, Qiang-sheng; Weng, Hui-wen; Li, He-ping; Ye, Sheng] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Peng] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Peng] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China	Ye, S (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou 510275, Guangdong, Peoples R China.	yes20111212@163.com						An X, 2011, CANCER-AM CANCER SOC, V117, P3750, DOI 10.1002/cncr.25932; An X, 2011, TUMOR BIOL, V32, P317, DOI 10.1007/s13277-010-0124-7; Bensouda Y, 2011, EUR ANN OTORHINOLARY, V128, P79, DOI 10.1016/j.anorl.2010.10.003; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Chiesa F, 2001, ORL J OTO-RHINO-LARY, V63, P214, DOI 10.1159/000055743; Donohoe CL, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/601434; Eliopoulos AG, 1997, ONCOGENE, V14, P2899, DOI 10.1038/sj.onc.1201258; Fearon KC, 2006, AM J CLIN NUTR, V83, P1345, DOI 10.1093/ajcn/83.6.1345; Feng JF, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-58; Fuchs CS, 2013, J CLIN ONCOL, V31, P4358, DOI 10.1200/JCO.2013.52.0080; Gioulbasanis I, 2012, LUNG CANCER, V77, P383, DOI 10.1016/j.lungcan.2012.04.008; Gridelli C, 2007, LANCET ONCOL, V8, P500, DOI 10.1016/S1470-2045(07)70146-8; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Ishizuka M, 2013, AM J SURG, V205, P22, DOI 10.1016/j.amjsurg.2012.04.012; Kinoshita A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-52; Kwon HC, 2012, BIOMARKERS, V17, P216, DOI 10.3109/1354750X.2012.656705; Laviano A, 2005, NAT CLIN PRACT ONCOL, V2, P158, DOI 10.1038/ncponc0112; Liaw CC, 1997, ACTA ONCOL, V36, P159, DOI 10.3109/02841869709109224; Liu MT, 2003, JPN J CLIN ONCOL, V33, P501, DOI 10.1093/jjco/hyg092; Maeda K, 2013, ANTICANCER RES, V33, P5567; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; SENBA M, 1994, LANCET, V343, P1104, DOI 10.1016/S0140-6736(94)90217-8; Szumilo Justyna, 2009, Pol Merkur Lekarski, V27, P408; Twu CW, 2007, INT J RADIAT ONCOL, V67, P130, DOI 10.1016/j.ijrobp.2006.07.012; Vashist YK, 2011, ANN SURG ONCOL, V18, P1130, DOI 10.1245/s10434-010-1383-7; Wang DS, 2012, MED ONCOL, V29, P3092, DOI 10.1007/s12032-012-0226-8; Wang DS, 2012, TUMOR BIOL, V33, P749, DOI 10.1007/s13277-011-0285-z; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	32	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112581	10.1371/journal.pone.0112581	http://dx.doi.org/10.1371/journal.pone.0112581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393117	Green Submitted, gold, Green Published			2022-12-26	WOS:000347709300074
J	Kumar, NP; Banurekha, VV; Nair, D; Sridhar, R; Kornfeld, H; Nutman, TB; Babu, S				Kumar, Nathella Pavan; Banurekha, Vaithilingam V.; Nair, Dina; Sridhar, Rathinam; Kornfeld, Hardy; Nutman, Thomas B.; Babu, Subash			Coincident Pre-Diabetes Is Associated with Dysregulated Cytokine Responses in Pulmonary Tuberculosis	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; TYPE-2; IMMUNITY; INNATE	Background: Cytokines play an important role in the pathogenesis of pulmonary tuberculosis (PTB) - Type 2 diabetes mellitus co-morbidity. However, the cytokine interactions that characterize PTB coincident with pre-diabetes (PDM) are not known. Methods: To identify the influence of coincident PDM on cytokine levels in PTB, we examined circulating levels of a panel of cytokines in the plasma of individuals with TB-PDM and compared them with those without PDM (TB-NDM). Results: TB-PDM is characterized by elevated circulating levels of Type 1 (IFN gamma, TNF alpha and IL-2), Type 17 (IL-17A and IL-17F) and other pro-inflammatory (IL-1 beta, IFN beta and GM-CSF) cytokines. TB-PDM is also characterized by increased systemic levels of Type 2 (IL-5) and regulatory (IL-10 and TGF beta) cytokines. Moreover, TB antigen stimulated whole blood also showed increased levels of pro-inflammatory (IFN gamma, TNF alpha and IL-1 beta) cytokines as well. However, the cytokines did not exhibit any significant correlation with HbA1C levels or with bacterial burdens. Conclusion: Our data reveal that pre-diabetes in PTB individuals is characterized by heightened cytokine responsiveness, indicating that a balanced pro and anti - inflammatory cytokine milieu is a feature of pre-diabetes -TB co-morbidity.	[Kumar, Nathella Pavan; Babu, Subash] Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India; [Kumar, Nathella Pavan; Banurekha, Vaithilingam V.; Nair, Dina] Natl Inst Res TB, Madras, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Madras, Tamil Nadu, India; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Nutman, Thomas B.; Babu, Subash] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Babu, S (corresponding author), Int Ctr Excellence Res, Natl Inst Hlth, Madras, Tamil Nadu, India.	sbabu@mail.nih.gov	Kornfeld, Hardy/AAS-2903-2021; Kumar, Nathella Pavan/AAU-2328-2021; Babu, Subash/GXG-4746-2022		Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001065] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Cooper AM, 2011, MUCOSAL IMMUNOL, V4, P252, DOI 10.1038/mi.2011.13; Deepa M, 2003, J Assoc Physicians India, V51, P863; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Ellner JJ, 2010, CTS-CLIN TRANSL SCI, V3, P23, DOI 10.1111/j.1752-8062.2010.00180.x; Forouhi NG, 2007, DIABETIC MED, V24, P200, DOI 10.1111/j.1464-5491.2007.02068.x; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Kapur A, 2013, DIABETES RES CLIN PR; Kumar Nathella Pavan, 2013, Ann Am Thorac Soc, V10, P441, DOI 10.1513/AnnalsATS.201305-112OC; Kumar NP, 2013, J INFECT DIS, V208, P739, DOI 10.1093/infdis/jit241; Kumar NP, 2014, J INFECT DIS; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Mayer-Barber KD, 2011, IMMUNITY, V35, P1023, DOI 10.1016/j.immuni.2011.12.002; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Restrepo BI, 2014, DIABETES RES CLIN PR; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2013, TUBERCULOSIS, V93, pS10, DOI 10.1016/S1472-9792(13)70004-0; Rook GAW, 2007, CURR MOL MED, V7, P327; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Torrado E, 2013, ADV EXP MED BIOL, V783, P121, DOI 10.1007/978-1-4614-6111-1_7; Torrado E, 2011, TRENDS IMMUNOL, V32, P66, DOI 10.1016/j.it.2010.12.001; Velloso LA, 2013, NAT REV ENDOCRINOL, V9, P750, DOI 10.1038/nrendo.2013.131; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang QZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082660; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029	33	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112108	10.1371/journal.pone.0112108	http://dx.doi.org/10.1371/journal.pone.0112108			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393696	Green Accepted, gold, Green Published			2022-12-26	WOS:000347709300031
J	Redlarski, G; Gradolewski, D; Palkowski, A				Redlarski, Grzegorz; Gradolewski, Dawid; Palkowski, Aleksander			A System for Heart Sounds Classification	PLOS ONE			English	Article							NEURAL-NETWORK CLASSIFICATION; SUPPORT VECTOR MACHINES; DIAGNOSIS; IDENTIFICATION; SIGNALS	The future of quick and efficient disease diagnosis lays in the development of reliable non-invasive methods. As for the cardiac diseases - one of the major causes of death around the globe - a concept of an electronic stethoscope equipped with an automatic heart tone identification system appears to be the best solution. Thanks to the advancement in technology, the quality of phonocardiography signals is no longer an issue. However, appropriate algorithms for auto-diagnosis systems of heart diseases that could be capable of distinguishing most of known pathological states have not been yet developed. The main issue is non-stationary character of phonocardiography signals as well as a wide range of distinguishable pathological heart sounds. In this paper a new heart sound classification technique, which might find use in medical diagnostic systems, is presented. It is shown that by combining Linear Predictive Coding coefficients, used for future extraction, with a classifier built upon combining Support Vector Machine and Modified Cuckoo Search algorithm, an improvement in performance of the diagnostic system, in terms of accuracy, complexity and range of distinguishable heart sounds, can be made. The developed system achieved accuracy above 93% for all considered cases including simultaneous identification of twelve different heart sound classes. The respective system is compared with four different major classification methods, proving its reliability.	[Redlarski, Grzegorz; Gradolewski, Dawid; Palkowski, Aleksander] Gdansk Univ Technol, Dept Mechatron & High Voltage Engn, Gdansk, Poland	Fahrenheit Universities; Gdansk University of Technology	Palkowski, A (corresponding author), Gdansk Univ Technol, Dept Mechatron & High Voltage Engn, Gdansk, Poland.	a.palkowski@eia.pg.gda.pl	Palkowski, Aleksander/J-7272-2012	Palkowski, Aleksander/0000-0002-3140-8469; /0000-0003-1597-5145				ABDELMOTALEB I, 2012, EL INF TECHN EIT 201, P1; Agostinho M, 1997, P 19 ANN INT C IEEE, V1, P201, DOI [DOI 10.1109/IEMBS.1997.754540, 10.1109/IEMBS.1997.754540]; Avci E, 2009, EXPERT SYST APPL, V36, P10618, DOI 10.1016/j.eswa.2009.02.053; Avci E, 2009, EXPERT SYST APPL, V36, P2873, DOI 10.1016/j.eswa.2008.01.030; Babaei S, 2009, COMPUT BIOL MED, V39, P8, DOI 10.1016/j.compbiomed.2008.10.004; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boutana D, 2011, IET SIGNAL PROCESS, V5, P527, DOI 10.1049/iet-spr.2010.0013; Chauhan S, 2008, COMPUT BIOL MED, V38, P221, DOI 10.1016/j.compbiomed.2007.10.006; Civicioglu P, 2013, ARTIF INTELL REV, V39, P315, DOI 10.1007/s10462-011-9276-0; Comak E, 2007, COMPUT BIOL MED, V37, P21, DOI 10.1016/j.compbiomed.2005.11.002; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; GIVEKI D, 2012, CORR; Goel S., 2011, Proceedings of the 2011 World Congress on Information and Communication Technologies (WICT), P916, DOI 10.1109/WICT.2011.6141370; Gupta CN, 2007, APPL SOFT COMPUT, V7, P286, DOI 10.1016/j.asoc.2005.06.006; Jabbari S, 2011, COMPUT BIOL MED, V41, P802, DOI 10.1016/j.compbiomed.2011.06.016; Jian-bo Wu, 2012, 2012 International Conference on Systems and Informatics (ICSAI 2012), P1732, DOI 10.1109/ICSAI.2012.6223377; Jiang ZW, 2006, EXPERT SYST APPL, V31, P286, DOI 10.1016/j.eswa.2005.09.025; Kapp MN, 2012, APPL SOFT COMPUT, V12, P2550, DOI 10.1016/j.asoc.2012.04.001; Maglogiannis I, 2009, COMPUT METH PROG BIO, V95, P47, DOI 10.1016/j.cmpb.2009.01.003; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Melgani F, 2008, IEEE T INF TECHNOL B, V12, P667, DOI 10.1109/TITB.2008.923147; Redlarski Grzegorz, 2013, Przeglad Elektrotechniczny, V89, P40; Syed Z, 2007, IEEE T BIO-MED ENG, V54, P651, DOI 10.1109/TBME.2006.889189; Turkoglu I, 2002, EXPERT SYST APPL, V23, P229, DOI 10.1016/S0957-4174(02)00042-8; Valian E., 2011, INT J ARTIFICIAL INT, V2, P36, DOI DOI 10.5121/IJAIA.2011.2304; Vazquez RA, 2011, IEEE C EVOL COMPUTAT, P679; Walton S, 2011, CHAOS SOLITON FRACT, V44, P710, DOI 10.1016/j.chaos.2011.06.004; WEI J, 2011, EXPERT SYSTEMS APPL, V38, P4390; Yang XS, 2009, WOR CONG NAT BIOL, P210, DOI 10.1109/nabic.2009.5393690; Yang XS, 2014, NEURAL COMPUT APPL, V24, P169, DOI 10.1007/s00521-013-1367-1; Zahiri SH, 2007, J FRANKLIN I, V344, P362, DOI 10.1016/j.jfranklin.2005.12.006	31	39	42	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112673	10.1371/journal.pone.0112673	http://dx.doi.org/10.1371/journal.pone.0112673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393113	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300083
J	Zhou, ZX; Zhang, BC; Sun, L				Zhou, Zhi-xia; Zhang, Bao-cun; Sun, Li			Poly(I:C) Induces Antiviral Immune Responses in Japanese Flounder (Paralichthys olivaceus) That Require TLR3 and MDA5 and Is Negatively Regulated by Myd88	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; I-LIKE RECEPTORS; RAINBOW-TROUT; FUNCTIONAL-CHARACTERIZATION; ADAPTER MOLECULE; DNA VACCINES; VIRUS; GENE; EXPRESSION	Polyinosinic:polycytidylic acid (poly(I:C)) is a ligand of toll-like receptor (TLR) 3 that has been used as an immunostimulant in humans and mice against viral diseases based on its ability to enhance innate and adapt immunity. Antiviral effect of poly(I:C) has also been observed in teleost, however, the underling mechanism is not clear. In this study, we investigated the potential and signaling mechanism of poly(I:C) as an antiviral agent in a model of Japanese flounder (Paralichthys olivaceus) infected with megalocytivirus. We found that poly(I:C) exhibited strong antiviral activity and enhanced activation of head kidney macrophages and peripheral blood leukocytes. In vivo studies showed that (i) TLR3 as well as MDA5 knockdown reduced poly(I:C)-mediated immune response and antiviral activity to significant extents; (ii) when Myd88 was overexpressed in flounder, poly(I:C)-mediated antiviral activity was significantly decreased; (iii) when Myd88 was inactivated, the antiviral effect of poly(I:C) was significantly increased. Cellular study showed that (i) the NF-kappa B activity induced by poly(I:C) was upregulated in Myd88-overexpressing cells and unaffected in Myd88-inactivated cells; (ii) Myd88 overexpression inhibited and upregulated the expression of poly(I:C)-induced antiviral genes and inflammatory genes respectively; (iii) Myd88 inactivation enhanced the expression of the antiviral genes induced by poly(I:C). Taken together, these results indicate that poly(I:C) is an immunostimulant with antiviral potential, and that the immune response of poly(I:C) requires TLR3 and MDA5 and is negatively regulated by Myd88 in a manner not involving NK-kappa B. These results provide insights to the working mechanism of poly(I:C), TLR3, and Myd88 in fish.	[Zhou, Zhi-xia; Zhang, Bao-cun; Sun, Li] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Zhang, Bao-cun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Sun, Li] Zhejiang Univ, Collaborat Innovat Ctr Deep Sea Biol, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University	Sun, L (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	lsun@qdio.ac.cn		Zhang, Bao-cun/0000-0001-6104-0848; Zhou, Zhixia/0000-0002-4080-5749	China Postdoctoral Science Foundation [Y22121102H]; National Basic Research Program of China [2012CB114406]; Taishan Scholar Program of Shandong Province	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Basic Research Program of China(National Basic Research Program of China); Taishan Scholar Program of Shandong Province	This work was supported by grants from China Postdoctoral Science Foundation (Y22121102H), the National Basic Research Program of China (2012CB114406), and the Taishan Scholar Program of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2012, J VIROL, V86, P185, DOI 10.1128/JVI.05245-11; Abston ED, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/129486; Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baoprasertkul P, 2006, IMMUNOGENETICS, V58, P817, DOI 10.1007/s00251-006-0144-z; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Chen LJ, 2013, FISH SHELLFISH IMMUN, V34, P909, DOI 10.1016/j.fsi.2013.01.003; Chi H, 2014, DEV COMP IMMUNOL, V42, P125, DOI 10.1016/j.dci.2013.09.001; Esposito S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-270; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Guo YQ, 2011, J EXP MED, V208, P2083, DOI 10.1084/jem.20101568; Hafner AM, 2013, ADV DRUG DELIVER REV, V65, P1386, DOI 10.1016/j.addr.2013.05.013; Han KJ, 2010, J BIOL CHEM, V285, P12543, DOI 10.1074/jbc.M109.072231; Hardarson HS, 2007, AM J PHYSIOL-HEART C, V292, pH251, DOI 10.1152/ajpheart.00398.2006; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Hutchens M, 2008, J IMMUNOL, V180, P483, DOI 10.4049/jimmunol.180.1.483; Hwang SD, 2012, DEV COMP IMMUNOL, V37, P87, DOI 10.1016/j.dci.2011.12.004; Jensen I, 2002, FISH SHELLFISH IMMUN, V13, P311, DOI 10.1006/fsim.2001.0406; Jiao XD, 2009, VACCINE, V27, P5195, DOI 10.1016/j.vaccine.2009.06.071; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Kim HJ, 2009, DIS AQUAT ORGAN, V83, P105, DOI 10.3354/dao02000; Kindberg E, 2011, J INFECT DIS, V203, P523, DOI 10.1093/infdis/jiq082; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Li GG, 2013, TUMOR BIOL, V34, P1589, DOI 10.1007/s13277-013-0689-z; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Lockhart K, 2004, FISH SHELLFISH IMMUN, V17, P347, DOI 10.1016/j.fsi.2004.04.011; Matsumoto M, 2011, REV MED VIROL, V21, P67, DOI 10.1002/rmv.680; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mikami T, 2012, GENE, V503, P235, DOI 10.1016/j.gene.2012.04.007; Negishi H, 2008, P NATL ACAD SCI USA, V105, P20446, DOI 10.1073/pnas.0810372105; Oh MJ, 2012, J FISH DIS, V35, P187, DOI 10.1111/j.1365-2761.2011.01334.x; Ohtani M, 2011, DEV COMP IMMUNOL, V35, P554, DOI 10.1016/j.dci.2010.12.013; Oshiumi H, 2003, IMMUNOGENETICS, V54, P791, DOI 10.1007/s00251-002-0519-8; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Perales-Linares R, 2013, IMMUNOLOGY, V140, P153, DOI 10.1111/imm.12143; Phelan PE, 2005, MOL IMMUNOL, V42, P1057, DOI 10.1016/j.molimm.2004.11.005; Plant KP, 2005, DEV COMP IMMUNOL, V29, P627, DOI 10.1016/j.dci.2004.09.008; Pott J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002670; Pulko V, 2009, J IMMUNOL, V183, P3634, DOI 10.4049/jimmunol.0900974; Purcell MK, 2004, FISH SHELLFISH IMMUN, V17, P447, DOI 10.1016/j.fsi.2004.04.017; Reimer T, 2008, J LEUKOCYTE BIOL, V83, P1249, DOI 10.1189/jlb.0607412; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Rodriguez MF, 2005, IMMUNOGENETICS, V57, P510, DOI 10.1007/s00251-005-0013-1; Rong YH, 2013, INFLAMMATION, V36, P413, DOI 10.1007/s10753-012-9560-4; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Shojaei H, 2009, CANCER RES, V69, P8710, DOI 10.1158/0008-5472.CAN-09-1602; Siednienko J, 2011, J IMMUNOL, V186, P2514, DOI 10.4049/jimmunol.1003093; Siednienko J, 2010, EUR J IMMUNOL, V40, P3150, DOI 10.1002/eji.201040547; Strandskog G, 2011, DEV COMP IMMUNOL, V35, P1116, DOI 10.1016/j.dci.2011.03.016; Su JG, 2010, FISH SHELLFISH IMMUN, V28, P712, DOI 10.1016/j.fsi.2010.01.009; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Svingerud T, 2012, J IMMUNOL, V189, P5912, DOI 10.4049/jimmunol.1201188; Swaminathan G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002937; Takami I, 2010, DIS AQUAT ORGAN, V89, P109, DOI 10.3354/dao02185; Thim HL, 2012, VACCINE, V30, P4828, DOI 10.1016/j.vaccine.2012.05.010; Tong SL, 1997, AQUACULTURE, V156, P327, DOI 10.1016/S0044-8486(97)00070-7; Wang HR, 2009, VACCINE, V27, P4047, DOI 10.1016/j.vaccine.2009.04.023; Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070; Wornle M, 2006, AM J PATHOL, V168, P370, DOI 10.2353/ajpath.2006.050491; Yu LP, 2013, FISH SHELLFISH IMMUN, V35, P1293, DOI 10.1016/j.fsi.2013.07.043; Yu M, 2011, CYTOKINE GROWTH F R, V22, P63, DOI 10.1016/j.cytogfr.2011.02.001; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang J, 2013, VET IMMUNOL IMMUNOP, V152, P303, DOI 10.1016/j.vetimm.2012.12.018; Zhang M, 2012, FISH SHELLFISH IMMUN, V33, P1192, DOI 10.1016/j.fsi.2012.09.010; Zheng WJ, 2011, FISH SHELLFISH IMMUN, V30, P638, DOI 10.1016/j.fsi.2010.12.014; Zhou ZX, 2014, DEV COMP IMMUNOL, V44, P124, DOI 10.1016/j.dci.2013.12.002; Zou PF, 2014, IMMUNOLOGY, V141, P192, DOI 10.1111/imm.12179	73	168	170	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112918	10.1371/journal.pone.0112918	http://dx.doi.org/10.1371/journal.pone.0112918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393122	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300122
J	Banerjee, S; Ghosh, T; Barik, S; Das, A; Ghosh, S; Bhuniya, A; Bose, A; Baral, R				Banerjee, Saptak; Ghosh, Tithi; Barik, Subhasis; Das, Arnab; Ghosh, Sarbari; Bhuniya, Avishek; Bose, Anamika; Baral, Rathindranath			Neem Leaf Glycoprotein Prophylaxis Transduces Immune Dependent Stop Signal for Tumor Angiogenic Switch within Tumor Microenvironment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MURINE EHRLICH CARCINOMA; BLOOD MONONUCLEAR-CELLS; T-CELLS; ANTIANGIOGENIC THERAPY; B16 MELANOMA; BONE-MARROW; NK CELLS; INHIBITION; VACCINE	We have reported that prophylactic as well as therapeutic administration of neem leaf glycoprotein (NLGP) induces significant restriction of solid tumor growth in mice. Here, we investigate whether the effect of such pretreatment (25 mu g/mice; weekly, 4 times) benefits regulation of tumor angiogenesis, an obligate factor for tumor progression. We show that NLGP pretreatment results in vascular normalization in melanoma and carcinoma bearing mice along with downregulation of CD31, VEGF and VEGFR2. NLGP pretreatment facilitates profound infiltration of CD8(+) T cells within tumor parenchyma, which subsequently regulates VEGF-VEGFR2 signaling in CD31(+) vascular endothelial cells to prevent aberrant neovascularization. Pericyte stabilization, VEGF dependent inhibition of VEC proliferation and subsequent vascular normalization are also experienced. Studies in immune compromised mice confirmed that these vascular and intratumoral changes in angiogenic profile are dependent upon active adoptive immunity particularly those mediated by CD8+ T cells. Accumulated evidences suggest that NLGP regulated immunomodulation is active in tumor growth restriction and normalization of tumor angiogenesis as well, thereby, signifying its clinical translation.	[Banerjee, Saptak; Ghosh, Tithi; Barik, Subhasis; Das, Arnab; Ghosh, Sarbari; Bhuniya, Avishek; Bose, Anamika; Baral, Rathindranath] CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India		Baral, R (corresponding author), CNCI, Dept Immunoregulat & Immunodiagnost, Kolkata, India.	baralrathin@hotmail.com	Banerjee, Dr Saptak/HDO-6987-2022	Banerjee, Dr Saptak/0000-0001-9211-2074; Bhuniya, Avishek/0000-0001-6253-0400; GHOSH HALDER, TITHI/0000-0002-4292-1153; Barik, Subhasis/0000-0002-0488-0434	Council of Scientific and Industrial Research, New Delhi [09/030(0050)/2008-EMR-I, 09/030(0063)/2011-EMRI]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The work was partially supported by Council of Scientific and Industrial Research, New Delhi (grant no. 09/030(0050)/2008-EMR-I to S. Banerjee, grant no. 09/030(0063)/2011-EMRI to S. Barik and grant SRA, Scientists' Pool Scheme No: 8463A to A. Bose). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2010, DRUG RESIST UPDATE, V13, P16, DOI 10.1016/j.drup.2009.12.001; Bailey J.L., 1967, TECHNIQUES PROTEIN C; Baral R, 2005, INT IMMUNOPHARMACOL, V5, P1343, DOI 10.1016/j.intimp.2005.03.008; Baral R, 2004, INT IMMUNOPHARMACOL, V4, P355, DOI 10.1016/j.intimp.2003.09.006; Barik S, 2013, TRIALS VACCINOLOGY; Barik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066501; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bose A, 2009, HUM IMMUNOL, V70, P6, DOI 10.1016/j.humimm.2008.09.004; Bose A, 2007, HUM IMMUNOL, V68, P823, DOI 10.1016/j.humimm.2007.08.002; Bose A, 2007, PHYTOTHER RES, V21, P914, DOI 10.1002/ptr.2185; Bose A, 2009, J IMMUNOTHER, V32, P42, DOI 10.1097/CJI.0b013e31818e997d; Breier G, 2000, PLACENTA, V21, pS11, DOI 10.1053/plac.1999.0525; Chakraborty K, 2008, INT IMMUNOPHARMACOL, V8, P330, DOI 10.1016/j.intimp.2007.10.015; Chakraborty K, 2010, CELL MOL IMMUNOL, V7, P396, DOI 10.1038/cmi.2010.29; Chakraborty T, 2011, IMMUNOTHERAPY-UK, V3, P949, DOI [10.2217/IMT.11.81, 10.2217/imt.11.81]; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Cirone P, 2004, HUM GENE THER, V15, P945, DOI 10.1089/hum.2004.15.945; Daniel WM, AM J PATHOL, V167, P1389; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Goswami KK, 2014, MOL IMMUNOL, V59, P119, DOI 10.1016/j.molimm.2014.01.015; Goswami S, 2010, VACCINE, V28, P1241, DOI 10.1016/j.vaccine.2009.11.018; Guillem EB, 2002, CANCER RES, V62, P7042; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haque E, 2006, IMMUNOPHARM IMMUNOT, V28, P33, DOI 10.1080/08923970600623632; Haque E, 2006, IMMUNOBIOLOGY, V211, P721, DOI 10.1016/j.imbio.2006.02.005; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Itasaka S, 2007, INT J RADIAT ONCOL, V67, P870, DOI 10.1016/j.ijrobp.2006.10.030; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kaigler D, 2003, TISSUE ENG, V9, P95, DOI 10.1089/107632703762687573; Khan M, 2012, CLIN CANCER INVESTIG, V1, P127, DOI 10.4103/2278-0513.102880; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Mallick A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047434; Niethammer AG, 2002, NAT MED, V8, P1369, DOI 10.1038/nm794; Qin ZH, 2003, CANCER RES, V63, P4095; Rafiee Parvaneh, 2004, Cell Commun Signal, V2, P3, DOI 10.1186/1478-811X-2-3; Ribatti D, 2009, J CELL MOL MED, V13, P2822, DOI 10.1111/j.1582-4934.2009.00810.x; Roy S, 2011, CLIN VACCINE IMMUNOL, V18, P571, DOI 10.1128/CVI.00499-10; Shi SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065757; Shiao SL, 2011, GENE DEV, V25, P2559, DOI 10.1101/gad.169029.111; Sihvo EIT, 2003, J THORAC CARDIOV SUR, V126, P1952, DOI 10.1016/j.jtcvs.2003.08.014; Sonnenschein C, 2013, J BIOSCIENCES, V38, P651, DOI 10.1007/s12038-013-9335-6; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; Terme M, 2012, ANTIANGIOGENIC MOL C, V2012, P1, DOI DOI 10.1155/2012/492920; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Vosseler S, 2005, CANCER RES, V65, P1294, DOI 10.1158/0008-5472.CAN-03-3986; Wang D, 2008, BIOTECH HISTOCHEM, V83, P179, DOI 10.1080/10520290802451085; Zhou H, 2005, BLOOD, V106, P2026, DOI 10.1182/blood-2005-03-0969; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	53	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110040	10.1371/journal.pone.0110040	http://dx.doi.org/10.1371/journal.pone.0110040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391149	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400010
J	Burke, DF; Smith, DJ				Burke, David F.; Smith, Derek J.			A Recommended Numbering Scheme for Influenza A HA Subtypes	PLOS ONE			English	Article							HUMAN-TYPE RECEPTOR; AMINO-ACID; HEMAGGLUTININ PROTEIN; VIRUS HEMAGGLUTININ; BINDING; TRANSMISSION; SPECIFICITY; EVOLUTION; CLEAVAGE; FERRETS	Comparisons of residues between sub-types of influenza virus is increasingly used to assess the zoonotic potential of a circulating strain and for comparative studies across subtypes. An analysis of N-terminal cleavage sites for thirteen subtypes of influenza A hemagglutinin (HA) sequences, has previously been described by Nobusawa and colleagues. We have expanded this analysis for the eighteen known subtypes of influenza. Due to differences in the length of HA, we have included strains from multiple clades of H1 and H5, as well as strains of H5 and H7 subtypes with both high and low pathogenicity. Analysis of known structures of influenza A HA enables us to define amino acids which are structurally and functionally equivalent across all HA subtypes using a numbering system based on the mature HA sequence. We provide a list of equivalences for amino acids which are known to affect the phenotype of the virus.	[Burke, David F.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Burke, DF (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	dfb21@cam.ac.uk	Smith, Derek/Z-3075-2019; Burke, David F/C-2091-2013	Smith, Derek/0000-0002-2393-1890; Burke, David F/0000-0001-8830-3951	Bill & Melinda Gates Foundation Global Health [OPPGH5383]; European Union FP7 program ANTIGONE [278976]; National Institute of Allergy and Infectious disease [HHSN266200700010C]	Bill & Melinda Gates Foundation Global Health; European Union FP7 program ANTIGONE; National Institute of Allergy and Infectious disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by (DJS) Bill & Melinda Gates Foundation Global Health (http://www.gatesfoundation.org/) Grant # OPPGH5383, (DJS) European Union FP7 program ANTIGONE (http://cordis.europa.eu/programme/rcn/852_en.html) (278976) and (DJS) National Institute of Allergy and Infectious disease (http://www.niaid.nih.gov) Contract HHSN266200700010C. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	Auewarakul P, 2007, J VIROL, V81, P9950, DOI 10.1128/JVI.00468-07; BOSCH FX, 1981, VIROLOGY, V113, P725, DOI 10.1016/0042-6822(81)90201-4; Chen LM, 2012, VIROLOGY, V422, P105, DOI 10.1016/j.virol.2011.10.006; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; DeLano WL, 2002, J VIROL; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Gambaryan A, 2006, VIROLOGY, V344, P432, DOI 10.1016/j.virol.2005.08.035; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Murakami S, 2012, J VIROL, V86, P1405, DOI 10.1128/JVI.06009-11; Naughtin M, 2011, ANTIMICROB AGENTS CH, V55, P2004, DOI 10.1128/AAC.01773-10; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Suarez DL, 1999, J VIROL, V73, P3567, DOI 10.1128/JVI.73.5.3567-3573.1999; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Zaraket H, 2013, J VIROL, V87, P9911, DOI 10.1128/JVI.01175-13	26	94	96	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112302	10.1371/journal.pone.0112302	http://dx.doi.org/10.1371/journal.pone.0112302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391151	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400070
J	De Maio, F; Maulucci, G; Minerva, M; Anoosheh, S; Palucci, I; Iantomasi, R; Palmieri, V; Camassa, S; Sali, M; Sanguinetti, M; Bitter, W; Manganelli, R; De Spirito, M; Delogu, G				De Maio, Flavio; Maulucci, Giuseppe; Minerva, Mariachiara; Anoosheh, Saber; Palucci, Ivana; Iantomasi, Raffaella; Palmieri, Valentina; Camassa, Serena; Sali, Michela; Sanguinetti, Maurizio; Bitter, Wilbert; Manganelli, Riccardo; De Spirito, Marco; Delogu, Giovanni			Impact of Protein Domains on PE_PGRS30 Polar Localization in Mycobacteria	PLOS ONE			English	Article							PE-PGRS PROTEINS; VII SECRETION; CELL-WALL; OUTER-MEMBRANE; TUBERCULOSIS; EXPRESSION; COMPLEX; VACCINE; SYSTEM; ESX-5	PE_PGRS proteins are unique to the Mycobacterium tuberculosis complex and a number of other pathogenic mycobacteria. PE_PGRS30, which is required for the full virulence of M. tuberculosis (Mtb), has three main domains, i.e. an N-terminal PE domain, repetitive PGRS domain and the unique C-terminal domain. To investigate the role of these domains, we expressed a GFP-tagged PE_PGRS30 protein and a series of its functional deletion mutants in different mycobacterial species ( Mtb, Mycobacterium bovis BCG and Mycobacterium smegmatis) and analysed protein localization by confocal microscopy. We show that PE_PGRS30 localizes at the mycobacterial cell poles in Mtb and M. bovis BCG but not in M. smegmatis and that the PGRS domain of the protein strongly contributes to protein cellular localization in Mtb. Immunofluorescence studies further showed that the unique C-terminal domain of PE_PGRS30 is not available on the surface, except when the PGRS domain is missing. Immunoblot demonstrated that the PGRS domain is required to maintain the protein strongly associated with the non-soluble cellular fraction. These results suggest that the repetitive GGA-GGN repeats of the PGRS domain contain specific sequences that contribute to protein cellular localization and that polar localization might be a key step in the PE_PGRS30-dependent virulence mechanism.	[De Maio, Flavio; Minerva, Mariachiara; Palucci, Ivana; Iantomasi, Raffaella; Camassa, Serena; Sali, Michela; Sanguinetti, Maurizio; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Maulucci, Giuseppe; Palmieri, Valentina; De Spirito, Marco] Univ Cattolica Sacro Cuore, Inst Phys, Rome, Italy; [Bitter, Wilbert] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Manganelli, Riccardo] Univ Padua, Dept Mol Med, Padua, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Vrije Universiteit Amsterdam; University of Padua	Delogu, G (corresponding author), Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy.	gdelogu@rm.unicatt.it	anoosheh, saber/D-1891-2011; Bitter, W/CAJ-5778-2022; Bitter, Wilbert/AAA-6872-2019; De Spirito, Marco/C-5386-2008; Bitter, Wilbert/ABG-3726-2020; Sanguinetti, Maurizio/A-1453-2019; Palmieri, Valentina/AAB-3564-2021; De Maio, Flavio/J-9452-2018; Anoosheh, Saber/AAK-3400-2021; Manganelli, Riccardo/A-7361-2009; De Spirito, Marco/U-3817-2019; Palmieri, Valentina/H-7836-2012; De Maio, Flavio/AAL-7355-2021; Maulucci, Giuseppe/C-7400-2009; De Maio, Flavio/AAD-1076-2022; palucci, ivana/J-8542-2018	anoosheh, saber/0000-0003-4614-0757; De Spirito, Marco/0000-0003-4260-5107; Bitter, Wilbert/0000-0001-8347-6511; Sanguinetti, Maurizio/0000-0002-9780-7059; Palmieri, Valentina/0000-0002-6358-9647; De Maio, Flavio/0000-0002-4744-9820; Manganelli, Riccardo/0000-0003-0940-7336; De Spirito, Marco/0000-0003-4260-5107; Palmieri, Valentina/0000-0002-6358-9647; De Maio, Flavio/0000-0002-4744-9820; Maulucci, Giuseppe/0000-0002-2154-319X; Minerva, Mariachiara/0000-0003-1518-7050; palucci, ivana/0000-0003-2106-1761	EU (FP7) [201762]; MIUR (Ministero dell'istruzione, Universita e Ricerca of the Italian Governement) [Y8RZTF]	EU (FP7); MIUR (Ministero dell'istruzione, Universita e Ricerca of the Italian Governement)	This work was funded by the EU (FP7/2007-2013) under grant agreement no201762 awarded to GD and RM and by MIUR (Ministero dell'istruzione, Universita e Ricerca of the Italian Governement) (project number PRIN 2008 Y8RZTF) awarded to GD and RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah AM, 2009, MOL MICROBIOL, V73, P329, DOI 10.1111/j.1365-2958.2009.06783.x; Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773; Balaji KN, 2007, MICROBES INFECT, V9, P271, DOI 10.1016/j.micinf.2006.11.013; Balogh G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021182; Banu S, 2002, MOL MICROBIOL, V44, P9, DOI 10.1046/j.1365-2958.2002.02813.x; Bitter W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000507; Bottai D, 2012, MOL MICROBIOL; Bottai D, 2012, MOL MICROBIOL, V83, P1195, DOI 10.1111/j.1365-2958.2012.08001.x; Brennan MJ, 2002, TRENDS MICROBIOL, V10, P246, DOI 10.1016/S0966-842X(02)02335-1; Brennan MJ, 2001, INFECT IMMUN, V69, P7326, DOI 10.1128/IAI.69.12.7326-7333.2001; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cadieux N, 2011, MICROBIOL-SGM, V157, P793, DOI 10.1099/mic.0.041996-0; Campuzano J, 2007, VACCINE, V25, P3722, DOI 10.1016/j.vaccine.2006.12.042; Carlsson F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000285; Cascioferro A, 2007, MOL MICROBIOL, V66, P1536, DOI 10.1111/j.1365-2958.2007.06023.x; Cascioferro A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027713; Chatrath S, 2014, FEBS LETT, V588, P990, DOI 10.1016/j.febslet.2014.01.059; Chatrath S, 2011, FEMS MICROBIOL LETT, V322, P194, DOI 10.1111/j.1574-6968.2011.02354.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Copin R, 2014, MBIO, V5, DOI 10.1128/mBio.00960-13; Daleke MH, 2012, J BIOL CHEM, V287, P31939, DOI 10.1074/jbc.M112.397596; Daleke MH, 2012, P NATL ACAD SCI USA, V109, P11342, DOI 10.1073/pnas.1119453109; Daleke MH, 2011, J BIOL CHEM; Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000; Delogu G, 2014, CLIN MICROBIOL INFEC, V20, P59, DOI 10.1111/1469-0691.12460; Delogu G, 2004, MOL MICROBIOL, V52, P725, DOI 10.1111/j.1365-2958.2004.04007.x; Delogu G, 2008, HDB TUBERCULOSIS, P131; Delogu G, 2006, MICROBES INFECT, V8, P2061, DOI 10.1016/j.micinf.2006.03.015; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hett EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001020; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Houben ENG, 2012, MOL MICROBIOL, V86, P472, DOI 10.1111/j.1365-2958.2012.08206.x; Huang Y, 2010, MOL CELL BIOCHEM, V340, P223, DOI 10.1007/s11010-010-0421-x; Iantomasi R, 2012, CELL MICROBIOL, V14, P356, DOI 10.1111/j.1462-5822.2011.01721.x; Maulucci G, 2009, BIOSENS BIOELECTRON, V25, P682, DOI 10.1016/j.bios.2009.07.038; McEvoy CRE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030593; Morandi M, 2013, J INFECT DEV COUNTR, V7, P169, DOI 10.3855/jidc.3114; Moreno-Altamirano Maria Maximina Bertha, 2012, Microb Inform Exp, V2, P9, DOI 10.1186/2042-5783-2-9; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Riley R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000174; Sali M, 2010, INFECT IMMUN, V78, P5202, DOI 10.1128/IAI.00267-10; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sayes F, 2012, CELL HOST MICROBE, V11, P352, DOI 10.1016/j.chom.2012.03.003; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Singh PP, 2008, MICROBIOL-SGM, V154, P3469, DOI 10.1099/mic.0.2008/019968-0; Soldini S, 2011, TUBERCULOSIS EDINB; Stoop EJM, 2012, TRENDS MICROBIOL, V20, P477, DOI 10.1016/j.tim.2012.07.001; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Thi EP, 2013, CELL MICROBIOL, V15, P795, DOI 10.1111/cmi.12073; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wirth SE, 2012, MOL MICROBIOL, V83, P654, DOI 10.1111/j.1365-2958.2011.07958.x; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07; Zumbo A, 2013, PATHOG DIS, V69, P232, DOI 10.1111/2049-632X.12096	56	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112482	10.1371/journal.pone.0112482	http://dx.doi.org/10.1371/journal.pone.0112482			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390359	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400085
J	Duan, GC; Yang, HY; Shi, LB; Sun, WM; Sui, ML; Zhang, RG; Wang, XH; Wang, F; Zhang, WD; Xi, YL; Fan, QT				Duan, Guangcai; Yang, Haiyan; Shi, Lubin; Sun, Wumei; Sui, Meili; Zhang, Rongguang; Wang, Xinhong; Wang, Fang; Zhang, Weidong; Xi, Yuanlin; Fan, Qingtang			Serum Inflammatory Cytokine Levels Correlate with Hand-Foot-Mouth Disease Severity: A Nested Serial Case-Control Study	PLOS ONE			English	Article							ENTEROVIRUS 71 INFECTION; BRAIN-STEM ENCEPHALITIS; CENTRAL-NERVOUS-SYSTEM; CHILDREN; TAIWAN; COMPLICATIONS; SINGAPORE; EPIDEMIC; MALAYSIA; CHINA	Background: Hand-food-mouth disease (HFMD) cases can be fatal. These cases develop rapidly, and it is important to predict the severity of HFMD from mild to fatal and to identify risk factors for mild HFMD. The objective of this study was to correlate the levels of serum inflammatory cytokines with HFMD severity. Methods: This study was designed as a nested serial case-control study. The data collected included general information, clinical symptoms and signs, laboratory findings and serum cytokine levels. Results: The levels of IL-4, IL-6, IL-10, TNF-alpha and IFN-gamma in patients with severe HFMD were significantly higher than in mild patients during the 2nd to 5th day after disease onset. The levels of IL-4, IL-6, IL-10 and IFN-gamma increased from the 2nd day to the 4th day and later decreased. The levels of TNF-alpha were high on the first two days and subsequently decreased. The changes of IL-10, TNF-alpha and IFN-gamma in the controls were similar for all cases. The levels of IL-4, IL-6 and IL-17 in the controls were not significantly different with the progression of HFMD. Conclusions: Our findings indicate that the IL-4, IL-6, IL-10, TNF-alpha and IFN-gamma levels correlate with HFMD severity.	[Duan, Guangcai; Yang, Haiyan; Shi, Lubin; Sun, Wumei; Sui, Meili; Zhang, Rongguang; Zhang, Weidong; Xi, Yuanlin; Fan, Qingtang] Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol, Zhengzhou 450052, Henan, Peoples R China; [Duan, Guangcai] Xinxiang Med Univ, Henan Innovat Ctr Mol Diag & Lab Med, Xinxiang, Henan, Peoples R China; [Shi, Lubin] Henan Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Wang, Xinhong; Wang, Fang] Childrens Hosp Zhengzhou City, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Xinxiang Medical University	Duan, GC (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Dept Epidemiol, Zhengzhou 450052, Henan, Peoples R China.	gcduan@zzu.edu.cn			National Natural Science Foundation of China [81172740]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from National Natural Science Foundation of China (81172740) (http://isisn.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P629; Chang LY, 2006, PEDIATR RES, V60, P466, DOI 10.1203/01.pdr.0000238247.86041.19; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Chen JG, 2012, J MED VIROL, V84, P763, DOI 10.1002/jmv.23254; Chong CY, 2003, ACTA PAEDIATR, V92, P1163, DOI 10.1080/08035250310005242; Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8; Chung YC, 2008, VACCINE, V26, P1855, DOI 10.1016/j.vaccine.2008.01.058; DUFF MF, 1968, BMJ-BRIT MED J, V2, P661, DOI 10.1136/bmj.2.5606.661; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Lin MT, 2006, J CRIT CARE, V21, P280, DOI 10.1016/j.jcrc.2006.02.005; Lin TY, 2003, CLIN INFECT DIS, V36, P269, DOI 10.1086/345905; Lin TY, 2002, ACTA PAEDIATR, V91, P632, DOI 10.1080/080352502760069016; Liu CC, 2000, J CLIN VIROL, V17, P23, DOI 10.1016/S1386-6532(00)00068-8; Ma E, 2010, INT J INFECT DIS, V14, pE775, DOI 10.1016/j.ijid.2010.02.2265; Momoki TS, 2009, JPN J INFECT DIS, V62, P471; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; RICHARDSON HB, 1965, J PEDIATR-US, V67, P6, DOI 10.1016/S0022-3476(65)80297-9; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Wan J, 2008, ANHUI MED J, V29, P344, DOI DOI 10.3969/J.ISSN.1000-0399.2008.04.003; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang SM, 2003, J INFECT DIS, V188, P564, DOI 10.1086/376998; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wei RC, 2013, VIRUS RES, V177, P62, DOI 10.1016/j.virusres.2013.07.009; Yang TC, 2012, EUR J PEDIATR, V171, P1359, DOI 10.1007/s00431-012-1731-7; Zeng M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002599; Zhang J, 2011, BIOMED ENVIRON SCI, V24, P214, DOI 10.3967/0895-3988.2011.03.002; Zheng X, 2013, CLIN EXP MED, DOI [10.1007/s10238-10013-10237-10236, DOI 10.1007/S10238-10013-10237-10236]; Zhu D, 2013, DIAGN MICR INFEC DIS, V76, P162, DOI 10.1016/j.diagmicrobio.2013.02.011	30	28	35	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112676	10.1371/journal.pone.0112676	http://dx.doi.org/10.1371/journal.pone.0112676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391156	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400118
J	Lopez-Antonanzas, R; Pelaez-Campomanes, P; Alvarez-Sierra, A				Lopez-Antonanzas, Raquel; Pelaez-Campomanes, Pablo; Alvarez-Sierra, Angeles			New Species of Rotundomys (Cricetinae) from the Late Miocene of Spain and Its Bearing on the Phylogeny of Cricetulodon and Rotundomys	PLOS ONE			English	Article							SUCCESSION; RODENTIA; HISTORY; BASIN	The material of Rotundomys (Rodentia, Cricetinae) from the Late Miocene fossiliferous complex of Cerro de los Batallones (Madrid, Spain) is described and compared with all species currently placed in the genera Rotundomys and Cricetulodon. Both the morphology and size variation encompassed in the collection of specimens from Batallones suggest they belong to a single taxon different from the other known species of these genera. A new species Rotundomys intimus sp. nov. is, therefore, named for it. A cladistic analysis, which is the first ever published concernig these taxa, has been conducted to clear up the phylogenetic position of the new species. Our results suggest that Rotundomys intimus sp. nov. inserts between R. mundi and R. sabatieri as a relatively primitive taxon inside the clade Rotundomys. The new taxon is more derived than R. mundi in having a transversal connection between the metalophulid and the anterolophulid on some m1 but more primitive than R. sabatieri and the most evolved species of Rotundomys (R. montisrotuni + R. bressanus) in its less developed lophodonty showing distinct cusps, shallower valleys, and the presence of a subdivided anteroloph on the M1. The species of Cricetulodon do not form a monophyletic group. As a member of Rotundomys, Rotundomys intimus sp. nov. is more derived than all of these taxa in its greater lophodonty and the complete loss of the anterior protolophule, mesolophs, and mesolophids.	[Lopez-Antonanzas, Raquel; Pelaez-Campomanes, Pablo] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Lopez-Antonanzas, Raquel] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, E-28006 Madrid, Spain; [Alvarez-Sierra, Angeles] Univ Complutense, Fac Ciencias Geol, Inst Geociencias IGEO,Dept Paleontol, CSIC,Dept Geol Sedimentaria & Cambio Medioambient, E-28040 Madrid, Spain	University of Bristol; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UCM - Instituto de Geociencias (IGEO)	Lopez-Antonanzas, R (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	r.lopez-antonanzas@bristol.ac.uk	Peláez-Campomanes, Pablo/G-4561-2010	Peláez-Campomanes, Pablo/0000-0002-6551-1026; Lopez-Antonanzas, Raquel/0000-0003-3025-0476; ALVAREZ SIERRA, MARIA DE LOS ANGELES/0000-0002-2649-5887	Ministerio de EconomA-a y Competitividad, Madrid [CGL2008-05813-CO2-01, CGL2011-25754, CGL2011-24829, CGL2011-28877]; Research Group UCM [910607]; RamA3n y Cajal Program; Marie Curie Actions	Ministerio de EconomA-a y Competitividad, Madrid; Research Group UCM; RamA3n y Cajal Program; Marie Curie Actions(European Commission)	This is a contribution to the research projects CGL2008-05813-CO2-01, CGL2011-25754, CGL2011-24829, and CGL2011-28877 (Ministerio de EconomA-a y Competitividad, Madrid) and the Research Group UCM 910607. RLA has been supported by the RamA3n y Cajal Program from 2009 until 2014 and by the Marie Curie Actions since then. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar J.-P., 1982, Palaeovertebrata (Montpellier), V12, P75; Aguilar Jean-Pierre, 2007, Geologie de la France, V1, P63; Aguilar JP, 1999, PALAEOGEOGR PALAEOCL, V145, P215, DOI 10.1016/S0031-0182(98)00103-5; AGUSTI J, 1986, Geobios (Villeurbanne), V19, P5, DOI 10.1016/S0016-6995(86)80032-8; Agusti J, 1997, PALAEOGEOGR PALAEOCL, V133, P149, DOI 10.1016/S0031-0182(97)00084-9; Agusti J., 1982, Paleontologia i Evolucio, V17, P29; Agusti J, 2003, J HUM EVOL, V45, P145, DOI 10.1016/S0047-2484(03)00091-5; Agusti J., 1979, Paleontologia i Evolucio, V14, P17; Agusti J., 1981, THESIS U BARCELONA B; Alvarez-Sierra MA, 1983, THESIS U COMPLUTENSE; [Anonymous], 1821, ANAL NATURAL CLASSIF; [Anonymous], 1984, VOLUME HOMMAGE GEOLO, P257; ANTUNES M T, 1979, Geobios (Villeurbanne), V12, P913, DOI 10.1016/S0016-6995(79)80009-1; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Calvo J., 1978, BOL GEOL MIN, V89, P407; Calvo JP, 2013, SEDIMENTOLOGY, V60, P1681, DOI 10.1111/sed.12048; Casanovas Vilar I, 2007, THESIS U BARCELONA B; Chaline J, 1999, ANN ZOOL FENN, V36, P239; Checa L, 1998, TRIB ARQUEOL, V1999-2000, P19; De Bruijn H., 1971, P KONINKLIJKE NEDE B, V74, P1; Farjanel G, 1984, GEOL FR, V12, P131; Fejfar O, 2011, PALAEONTOL ELECTRON, V14; Fischer de Waldheim G., 1817, MEMOIRES SOC IMPERIA, V5, P357; FREUDENTHAL M, 1967, PROC K NED AKAD B-PH, V70, P298; Freudenthal M., 1994, Scripta Geologica, V104, P57; Freudenthal M., 1991, Scripta Geologica, V96, P9; Freudenthal Matthijs, 1998, Treballs del Museu de Geologia de Barcelona, V7, P11; Garcia Moreno E., 1988, PALEONTOLOGIA EVOLUC, V22, P103; Goloboff PA, 2001, CLADISTICS, V17, pS26, DOI 10.1111/j.1096-0031.2001.tb00102.x; Goloboff P, 2008, CLADISTICS, V24, P91; Guerin C, 1971, DOCUMENTS LAB GEOLOG, P131; Guerra-Merchan A, 2001, GEOBIOS-LYON, V34, P85, DOI 10.1016/S0016-6995(01)80049-8; Hartenberger J. L., 1965, Bulletin de la Societe Geologique de France Ser 7, V7, P487; Kalin Daniel, 1999, P373; Lopez-Antonanzas R, 2010, ZOOL J LINN SOC-LOND, V160, P725, DOI 10.1111/j.1096-3642.2010.00618.x; Lopez-Martinez N, 1986, STUD GEOL SALMANTICE, V22, P191; Mein P., 1975, COLLOQ INT CNRS, V218, P759; Mein P., 1999, HOMINOID EVOLUTION C, V1, P140; Mein P, 1965, B SOC GEOLOGIQUE FRA, V7, P421; Morales J., 2008, Publicaciones del Seminario de Paleontologia de Zaragoza, V8, P41; MORENO EG, 1987, THESIS U COMPLUTENSE; Pineda-Munoz S, 2011, VIAJANDO MUNDOS PRET, P289; Schaub S., 1944, ECLOGAE GEOL HELV, V37, P453; Van Dam Jan A., 1997, Geologica Ultraiectina, V156, P1	44	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112704	10.1371/journal.pone.0112704	http://dx.doi.org/10.1371/journal.pone.0112704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389967	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400120
J	Soto-Hermida, A; Fernandez-Moreno, M; Oreiro, N; Fernandez-Lopez, C; Pertega, S; Cortes-Pereira, E; Rego-Perez, I; Blanco, FJ				Soto-Hermida, Angel; Fernandez-Moreno, Mercedes; Oreiro, Natividad; Fernandez-Lopez, Carlos; Pertega, Sonia; Cortes-Pereira, Estefania; Rego-Perez, Ignacio; Blanco, Francisco J.			Mitochondrial DNA (mtDNA) Haplogroups Influence the Progression of Knee Osteoarthritis. Data from the Osteoarthritis Initiative (OAI)	PLOS ONE			English	Article							NORMAL HUMAN CHONDROCYTES; RECEPTOR ANTAGONIST GENE; DEGENERATIVE DISEASES; DYSFUNCTION; ASSOCIATION; CARTILAGE; POPULATION; SUSCEPTIBILITY; SENSITIVITY; PREVALENCE	Objective: To evaluate the influence of the mtDNA haplogroups on knee osteoarthritis progression in Osteoarthritis Initiative ( OAI) participants through longitudinal data from radiographs and magnetic resonance imaging (MRI). Methods: Four-year knee osteoarthritis progression was analyzed as increase in Kellgren and Lawrence (KL) grade, in addition to increase in OARSI atlas grade for joint space narrowing (JSN), osteophytes and subchondral sclerosis in the tibia medial compartment of 891 Caucasian individuals from the progression subcohort. The influence of the haplogroups on the rate of structural progression was also assessed as the four-year change in minimum joint space width (mJSW in millimetres) in both knees of (n = 216) patients with baseline unilateral medial-tibiofemoral JSN. Quantitative cartilage measures from longitudinal MRI data were those related to cartilage thickness and volume with a 24 month follow-up period (n = 381). Results: During the four-year follow-up period, knee OA patients with the haplogroup T showed the lowest increase in KL grade (Hazard Risk [HR] = 0.499; 95% Confidence Interval [CI]: 0.261-0.819; p<0.05) as well as the lowest cumulative probability of progression for JSN (HR = 0.547; 95% CI: 0.280-0.900; p<0.05), osteophytes (HR = 0.573; 95% CI: 0.304-0.893; p, 0.05) and subchondral sclerosis (HR = 0.549; 95% CI: 0.295-0.884; p<0.05). They also showed the lowest decline in mJSW (standardized response means (SRM) = 20.39; p = 0.037) in those knees without baseline medial JSN (no-JSN knees). Normalized cartilage volume loss was significantly lower in patients carrying the haplogroup T at medial tibia femoral (SRM = 20.33; p = 0.023) and central medial femoral (SRM = 20.27; p = 0.031) compartments. Cartilage thickness loss was significantly lower in carriers of haplogroup T at central medial tibia-femoral (SRM = 20.42; p = 0.011), medial tibia femoral (SRM = 20.32; p = 0.018), medial tibia anterior (SRM = + 0.31; p = 0.013) and central medial femoral (SRM = 20.19; p = 0.013) compartments. Conclusions: Mitochondrial genome seems to play a role in the progression of knee osteoarthritis. mtDNA variation could improve identification of patients predisposed to faster or severe progression of the disease.	[Soto-Hermida, Angel; Fernandez-Moreno, Mercedes; Oreiro, Natividad; Fernandez-Lopez, Carlos; Cortes-Pereira, Estefania; Rego-Perez, Ignacio; Blanco, Francisco J.] UDC, Complexo Hosp Univ A Coruna CHUAC, Inst Invest Biomed A Coruna INIBIC, Grp Genom,Serv Reumatol, La Coruna, Spain; [Pertega, Sonia] UDC, Complexo Hosp Univ A Coruna CHUAC, Inst Invest Biomed A Coruna INIBIC, Unidad Epidemiol, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Rego-Perez, I (corresponding author), UDC, Complexo Hosp Univ A Coruna CHUAC, Inst Invest Biomed A Coruna INIBIC, Grp Genom,Serv Reumatol, La Coruna, Spain.	Igancio.rego.perez@sergas.es; fblagar@sergas.es	Pértega-Díaz, Sonia/E-4353-2013; Soto-Hermida, Angel/ABE-1924-2020; fernandez-moreno, mercedes MFM/I-3219-2017; Blanco, Francisco J./C-3192-2014; Rego-Pérez, Ignacio/B-1665-2012	Pértega-Díaz, Sonia/0000-0003-3891-3203; Soto-Hermida, Angel/0000-0003-2475-9305; fernandez-moreno, mercedes MFM/0000-0001-5077-1274; Blanco, Francisco J./0000-0001-9821-7635; Rego-Pérez, Ignacio/0000-0003-1754-1164	Fundacion Espanola de Reumatologia (programa GEN-SER); Fondo Investigacion Sanitaria-Spain [CIBERCB06/01/0040]; Fondo Investigacion Sanitaria-PI [08/2028]; Ministerio Ciencia e Innovacion [PLE2009-0144]; FEDER (European Community); Contrato Miguel Servet-Fondo Investigacion Sanitaria [CP12/03192]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022262, N01AR022260, N01AR022258, N01AR022261, N01AR022259] Funding Source: NIH RePORTER	Fundacion Espanola de Reumatologia (programa GEN-SER); Fondo Investigacion Sanitaria-Spain(Instituto de Salud Carlos III); Fondo Investigacion Sanitaria-PI; Ministerio Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER (European Community)(European Commission); Contrato Miguel Servet-Fondo Investigacion Sanitaria; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from Fundacion Espanola de Reumatologia (programa GEN-SER) and from Fondo Investigacion Sanitaria (CIBERCB06/01/0040)-Spain, Fondo Investigacion Sanitaria-PI 08/2028, Ministerio Ciencia e Innovacion PLE2009-0144, with a contribution of funds from FEDER (European Community). IRP was supported by Contrato Miguel Servet-Fondo Investigacion Sanitaria (CP12/03192). The authors would like to thank the participants, principal investigators, coinvestigators and staff of the OAI. The Osteoarthritis Initiative (OAI) is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; and GlaxoSmithKline. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. This manuscript has received the approval of the OAI Publications Committee based on a review of its scientific content and data interpretation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Attur M, 2010, ANN RHEUM DIS, V69, P856, DOI 10.1136/ard.2009.113043; Benichou OD, 2010, ARTHRIT CARE RES, V62, P924, DOI 10.1002/acr.20149; Blanco FJ, 2004, MITOCHONDRION, V4, P715, DOI 10.1016/j.mito.2004.07.022; Blanco FJ, 2011, NAT REV RHEUMATOL, V7, P161, DOI 10.1038/nrrheum.2010.213; Brown, 2006, APPL MIXED MODELS ME; Cillero-Pastor B, 2008, ARTHRITIS RHEUM-US, V58, P2409, DOI 10.1002/art.23644; Cillero-Pastor B, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-235; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; Eckstein F, 2009, ANN RHEUM DIS, V68, P674, DOI 10.1136/ard.2008.089904; Eckstein F, 2013, ANN RHEUM DIS, V72, P707, DOI 10.1136/annrheumdis-2011-201164; Eckstein F, 2012, NAT REV RHEUMATOL, V8, P622, DOI 10.1038/nrrheum.2012.113; Eckstein F, 2011, ARTHRIT CARE RES, V63, P311, DOI 10.1002/acr.20370; Fang HZ, 2014, INT J MOL SCI, V15, P2646, DOI 10.3390/ijms15022646; Fernandez-Moreno M, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-283; Fernandez-Moreno M, 2008, CURR GENOMICS, V9, P542, DOI 10.2174/138920208786847953; Garnero P, 2003, CURR OPIN RHEUMATOL, V15, P641, DOI 10.1097/00002281-200309000-00020; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; Gomez-Duran A, 2010, HUM MOL GENET, V19, P3343, DOI 10.1093/hmg/ddq246; Grishko VI, 2009, OSTEOARTHR CARTILAGE, V17, P107, DOI 10.1016/j.joca.2008.05.009; Henrotin Y, 2007, CURR DRUG TARGETS, V8, P347, DOI 10.2174/138945007779940151; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Hudson G, 2013, ANN RHEUM DIS, V72, P136, DOI 10.1136/annrheumdis-2012-201932; Kamarainen OP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2374; Kenney MC, 2014, BBA-MOL BASIS DIS, V1842, P208, DOI 10.1016/j.bbadis.2013.10.016; Kenney MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054339; Kerkhof HJM, 2011, OSTEOARTHR CARTILAGE, V19, P265, DOI 10.1016/j.joca.2010.12.003; Kim HA, 2007, CURR DRUG TARGETS, V8, P333, DOI 10.2174/138945007779940025; Le Graverand MPH, 2008, ANN RHEUM DIS, V67, P1562, DOI 10.1136/ard.2007.077834; LEDINGHAM J, 1993, ANN RHEUM DIS, V52, P520, DOI 10.1136/ard.52.7.520; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; Mazzuca SA, 2006, ANN RHEUM DIS, V65, P515, DOI 10.1136/ard.2005.039115; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Mueller EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052367; Nardelli C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/631082; Pan W, 1999, J COMPUT GRAPH STAT, V8, P109, DOI 10.2307/1390923; Rego I, 2010, ANN RHEUM DIS, V69, P210, DOI 10.1136/ard.2008.105254; Rego-Perez I, 2011, ANN RHEUM DIS, V70, P646, DOI 10.1136/ard.2010.133637; Rego-Perez I, 2010, ANN RHEUM DIS, V69, P910, DOI 10.1136/ard.2009.117416; Rego-Perez I, 2008, ARTHRITIS RHEUM-US, V58, P2387, DOI 10.1002/art.23659; Rego-Perez Ignacio, 2013, Front Biosci (Schol Ed), V5, P360; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Soto-Hermida A, 2014, MITOCHONDRION, V15, P18, DOI 10.1016/j.mito.2014.03.001; Soto-Hermida A, 2014, RHEUMATOL INT; Suantawee T, 2013, J CLIN DIAGN RES, V7, P1855, DOI 10.7860/JCDR/2013/5802.3333; Sun J., 2006, STAT ANAL INTERVAL C; Takahashi H, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3157; Torroni A, 1996, GENETICS, V144, P1835; TURNBULL BW, 1976, J R STAT SOC B, V38, P290; Vaamonde-Garcia C, 2012, ARTHRITIS RHEUM-US, V64, P2927, DOI 10.1002/art.34508; Valdes AM, 2004, ARTHRITIS RHEUM-US, V50, P2497, DOI 10.1002/art.20443; Valdes AM, 2011, NAT REV RHEUMATOL, V7, P23, DOI 10.1038/nrrheum.2010.191; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479; Wallace DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0267; Wirth W, 2010, OSTEOARTHR CARTILAGE, V18, P547, DOI 10.1016/j.joca.2009.12.003; Wirth W, 2009, OSTEOARTHR CARTILAGE, V17, P291, DOI 10.1016/j.joca.2008.07.008; Wu LH, 2014, CURR DRUG TARGETS, V15, P710, DOI 10.2174/1389450115666140417120305; Wu X, 2013, OSTEOARTHR CARTILAGE, V21, P930, DOI 10.1016/j.joca.2013.04.003; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zhai G, 2007, OSTEOARTHR CARTILAGE, V15, P222, DOI 10.1016/j.joca.2006.09.004; Zhao D, 2007, J ORTHOP RES, V25, P593, DOI 10.1002/jor.20362	63	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112735	10.1371/journal.pone.0112735	http://dx.doi.org/10.1371/journal.pone.0112735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390621	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400122
J	Brotons, L				Brotons, Lluis			Species Distribution Models and Impact Factor Growth in Environmental Journals: Methodological Fashion or the Attraction of Global Change Science	PLOS ONE			English	Article							CITED PAPERS; ECOLOGY; QUALITY; BIOLOGY; TIME	In this work, I evaluate the impact of species distribution models (SDMs) on the current status of environmental and ecological journals by asking the question to which degree development of SDMs in the literature is related to recent changes in the impact factors of ecological journals. The hypothesis evaluated states that research fronts are likely to attract research attention and potentially drive citation patterns, with journals concentrating papers related to the research front receiving more attention and benefiting from faster increases in their impact on the ecological literature. My results indicate a positive relationship between the number of SDM related articles published in a journal and its impact factor (IF) growth during the period 2000-09. However, the percentage of SDM related papers in a journal was strongly and positively associated with the percentage of papers on climate change and statistical issues. The results support the hypothesis that global change science has been critical in the development of SDMs and that interest in climate change research in particular, rather than the usage of SDM per se, appears as an important factor behind journal IF increases in ecology and environmental sciences. Finally, our results on SDM application in global change science support the view that scientific interest rather than methodological fashion appears to be the major driver of research attraction in the scientific literature.	[Brotons, Lluis] Forest Sci Ctr Catalonia, CEMFOR CTFC, Solsona, Catalonia, Spain; [Brotons, Lluis] Ctr Ecol Res & Forestry Applicat, CREAF, Cerdanyola Del Valles, Catalonia, Spain	Centre Tecnologic Forestal de Catalunya (CTFC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF)	Brotons, L (corresponding author), Forest Sci Ctr Catalonia, CEMFOR CTFC, Solsona, Catalonia, Spain.	lluis.brotons@ctfc.cat	Brotons, Lluís/D-1570-2009	Brotons, Lluís/0000-0002-4826-4457	Spanish Ministry of Education and Science (MEC) [CGL2011-29539/BOS, Consolider Montes CSD2008-00040]; Catalan government [2010 BE 272]; SCALES [FP7-226852]	Spanish Ministry of Education and Science (MEC)(Spanish Government); Catalan government; SCALES	This study has received financial support from the projects CGL2011-29539/BOS and Consolider Montes CSD2008-00040 granted by the Spanish Ministry of Education and Science (MEC) and it is also a contribution to the FP7-226852 project SCALES. Additional funding to LB was received from the Catalan government through project 2010 BE 272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althouse BM, 2009, J AM SOC INF SCI TEC, V60, P27, DOI 10.1002/asi.20936; Barbosa FG, 2012, BRAZ J BIOL, V72, P821, DOI 10.1590/S1519-69842012000500007; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Groesser SN, 2012, SYST RES BEHAV SCI, V29, P624, DOI 10.1002/sres.2142; Institute for Scientific Information&REG, 2005, THOMS ISI ESS SCI IN; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Leimu R, 2005, TRENDS ECOL EVOL, V20, P28, DOI 10.1016/j.tree.2004.10.010; Lortie CJ, 2013, SCIENTOMETRICS, V94, P675, DOI 10.1007/s11192-012-0822-6; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Neff BD, 2010, BIOSCIENCE, V60, P455, DOI 10.1525/bio.2010.60.6.9; Neff MW, 2009, SCIENTOMETRICS, V80, P657, DOI 10.1007/s11192-008-2099-3; Olden JD, 2007, ECOSCIENCE, V14, P370, DOI 10.2980/1195-6860(2007)14[370:HDEJSR]2.0.CO;2; Pysek P, 2006, PRESLIA, V78, P437; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Venables WN., 2002, MODERN APPL STAT S 4; Walsh C., 2005, HIER PART PACKAGE VE; Wilson AE, 2007, BIOSCIENCE, V57, P550, DOI 10.1641/B570702	19	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111996	10.1371/journal.pone.0111996	http://dx.doi.org/10.1371/journal.pone.0111996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386926	Green Submitted, gold, Green Published			2022-12-26	WOS:000345250400035
J	Martin-Sanchez, E; Odqvist, L; Rodriguez-Pinilla, SM; Sanchez-Beato, M; Roncador, G; Dominguez-Gonzalez, B; Blanco-Aparicio, C; Collazo, AMG; Cantalapiedra, EG; Fernandez, JP; del Olmo, SC; Pisonero, H; Madureira, R; Almaraz, C; Mollejo, M; Alves, FJ; Menarguez, J; Gonzalez-Palacios, F; Rodriguez-Peralto, JL; Ortiz-Romero, PL; Real, FX; Garcia, JF; Bischoff, JR; Piris, MA				Martin-Sanchez, Esperanza; Odqvist, Lina; Rodriguez-Pinilla, Socorro M.; Sanchez-Beato, Margarita; Roncador, Giovanna; Dominguez-Gonzalez, Beatriz; Blanco-Aparicio, Carmen; Garcia Collazo, Ana M.; Gonzalez Cantalapiedra, Esther; Pastor Fernandez, Joaquin; Curiel del Olmo, Soraya; Pisonero, Helena; Madureira, Rebeca; Almaraz, Carmen; Mollejo, Manuela; Javier Alves, F.; Menarguez, Javier; Gonzalez-Palacios, Fernando; Luis Rodriguez-Peralto, Jose; Ortiz-Romero, Pablo L.; Real, Francisco X.; Garcia, Juan F.; Bischoff, James R.; Piris, Miguel A.			PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DOUBLE-STRAND BREAKS; GENE-EXPRESSION; DNA-DAMAGE; INHIBITOR; CANCER; GAMMA-H2AX; SURVIVAL; SGI-1776; SPECTRUM	Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL). The Proviral Integration site of Moloney murine leukemia virus (PIM) kinases are important mediators of cell survival. We aimed to determine the therapeutic value of PIM kinases because they are overexpressed in PTCL patients, T cell lines and primary tumoral T cells. PIM kinases were inhibited genetically (using small interfering and short hairpin RNAs) and pharmacologically (mainly with the pan-PIM inhibitor (PIMi) ETP-39010) in a panel of 8 PTCL cell lines. Effects on cell viability, apoptosis, cell cycle, key proteins and gene expression were evaluated. Individual inhibition of each of the PIM genes did not affect PTCL cell survival, partially because of a compensatory mechanism among the three PIM genes. In contrast, pharmacological inhibition of all PIM kinases strongly induced apoptosis in all PTCL cell lines, without cell cycle arrest, in part through the induction of DNA damage. Therefore, pan-PIMi synergized with Cisplatin. Importantly, pharmacological inhibition of PIM reduced primary tumoral T cell viability without affecting normal T cells ex vivo. Since anaplastic large cell lymphoma (ALK+ ALCL) cell lines were the most sensitive to the pan-PIMi, we tested the simultaneous inhibition of ALK and PIM kinases and found a strong synergistic effect in ALK+ ALCL cell lines. Our findings suggest that PIM kinase inhibition could be of therapeutic value in a subset of PTCL, especially when combined with ALK inhibitors, and might be clinically beneficial in ALK+ ALCL.	[Martin-Sanchez, Esperanza; Odqvist, Lina; Dominguez-Gonzalez, Beatriz; Real, Francisco X.; Piris, Miguel A.] Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain; [Martin-Sanchez, Esperanza; Curiel del Olmo, Soraya; Pisonero, Helena; Madureira, Rebeca; Almaraz, Carmen; Piris, Miguel A.] Hosp Univ Marques de Valdecilla, Marques de Valdecilla Res Inst IDIVAL, Canc Genom Grp, Santander, Spain; [Martin-Sanchez, Esperanza; Curiel del Olmo, Soraya; Pisonero, Helena; Madureira, Rebeca; Almaraz, Carmen; Piris, Miguel A.] Hosp Univ Marques de Valdecilla, Dept Pathol, Santander, Spain; [Rodriguez-Pinilla, Socorro M.] Fdn Jimenez Diaz, Dept Pathol, E-28040 Madrid, Spain; [Sanchez-Beato, Margarita] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria, Oncohematol Area, Madrid, Spain; [Roncador, Giovanna] Spanish Natl Canc Res Ctr CNIO, Monoclonal Antibodies Core Unit, Madrid, Spain; [Blanco-Aparicio, Carmen; Garcia Collazo, Ana M.; Gonzalez Cantalapiedra, Esther; Pastor Fernandez, Joaquin] Spanish Natl Canc Res Ctr CNIO, Expt Therapeut Programme, Madrid, Spain; [Mollejo, Manuela] Hosp Virgen de la Salud, Dept Pathol, Toledo, Spain; [Javier Alves, F.] Hosp La Paz, Dept Pathol, Madrid, Spain; [Menarguez, Javier] Hosp Gregorio Maranon, Dept Pathol, Madrid, Spain; [Gonzalez-Palacios, Fernando] Hosp Ramon & Cajal, Dept Pathol, E-28034 Madrid, Spain; [Luis Rodriguez-Peralto, Jose] Univ Complutense Madrid, Sch Med, Octubre Univ Hosp 12, Pathol Dept,Inst I 12, Madrid, Spain; [Ortiz-Romero, Pablo L.] Univ Complutense Madrid, Sch Med, Octubre Univ Hosp 12, Dermatol Dept,Inst I 12, Madrid, Spain; [Garcia, Juan F.] MD Anderson Canc Ctr Madrid, Translat Res Lab, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario Marques de Valdecilla (HUMV); Hospital Puerta de Hierro-Majadahonda; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Complejo Hospitalario de Toledo; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; Hospital Universitario Ramon y Cajal; Complutense University of Madrid; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Hospital Universitario 12 de Octubre; University of Texas System; UTMD Anderson Cancer Center	Piris, MA (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Pathol Programme, Madrid, Spain.	mapiris@humv.es	Arribas, Francisco X Real/H-5275-2015; MENARGUEZ, JAVIER/ABC-7303-2020; Piris, Miguel A/B-7067-2008; Cantalapiedra, Esther González/N-2079-2015; Piris, Miguel A/AAP-1445-2020; Fernandez, Joaquin Pastor/I-4567-2015; Blanco-Aparicio, Carmen/I-3162-2015; Sanchez-Beato, Margarita/G-8753-2012; GARCIA, JUAN/L-2118-2016; Martín-Sánchez, Esperanza/M-7578-2015; Roncador, Giovanna/L-1764-2014	Arribas, Francisco X Real/0000-0001-9501-498X; MENARGUEZ, JAVIER/0000-0001-5318-9976; Piris, Miguel A/0000-0001-5839-3634; Cantalapiedra, Esther González/0000-0002-4883-9492; Piris, Miguel A/0000-0001-5839-3634; Fernandez, Joaquin Pastor/0000-0003-0553-8021; Blanco-Aparicio, Carmen/0000-0002-3249-6595; Sanchez-Beato, Margarita/0000-0002-0058-7599; Martín-Sánchez, Esperanza/0000-0002-8155-9185; Almaraz Pro, Maria del Carmen/0000-0002-6714-4450; Rodriguez-Peralto, Jose Luis/0000-0002-6578-7153; Roncador, Giovanna/0000-0002-9807-2875; Mollejo, Manuela/0000-0001-5658-0532	Asociacion Espanola Contra el Cancer; Fondo de Investigaciones Sanitarias [PI051623, PI052800, FIS 11/1759, CP11/00018]; RTICC [RD06/0020/0107]; Ministerio de Ciencia e Innovacion [SAF2008-0387-1]; Department of Education, Universities and Research of the Basque Government [BFI08.207]	Asociacion Espanola Contra el Cancer; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); RTICC(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Department of Education, Universities and Research of the Basque Government	This work was supported by grants from the Asociacion Espanola Contra el Cancer, Fondo de Investigaciones Sanitarias (PI051623, PI052800 and FIS 11/1759), RTICC (RD06/0020/0107) and Ministerio de Ciencia e Innovacion (SAF2008-0387-1). EMS was supported by a grant from the Department of Education, Universities and Research of the Basque Government (BFI08.207). MSB was supported by a Contract Miguel Servet from Fondo de Investigaciones Sanitarias (CP11/00018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado Y, 2012, EXPERT REV HEMATOL, V5, P81, DOI [10.1586/EHM.11.69, 10.1586/ehm.11.69]; An NF, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-12; Armitage JO, 2012, AM J HEMATOL, V87, P512, DOI 10.1002/ajh.23144; Barreca A, 2011, J MOL ENDOCRINOL, V47, pR11, DOI 10.1530/JME-11-0004; Bednarski JJ, 2012, J EXP MED, V209, P11, DOI 10.1084/jem.20112078; Blanco-Aparicio C, 2013, BIOCHEM PHARMACOL, V85, P629, DOI 10.1016/j.bcp.2012.09.018; Blanco-Aparicio C, 2011, CANCER LETT, V300, P145, DOI 10.1016/j.canlet.2010.09.016; Brault L, 2010, HAEMATOL-HEMATOL J, V95, P1004, DOI 10.3324/haematol.2009.017079; Chen LS, 2011, BLOOD, V118, P693, DOI 10.1182/blood-2010-12-323022; Chen LS, 2009, BLOOD, V114, P4150, DOI 10.1182/blood-2009-03-212852; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; de Leval L, 2007, BLOOD, V109, P4952, DOI 10.1182/blood-2006-10-055145; de Leval L, 2009, CRIT REV ONCOL HEMAT, V72, P125, DOI 10.1016/j.critrevonc.2009.01.002; Drygin D, 2012, J MED CHEM, V55, P8199, DOI 10.1021/jm3009234; Dunleavy K, 2010, CLIN CANCER RES, V16, P5608, DOI 10.1158/1078-0432.CCR-09-1995; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Foss FM, 2011, BLOOD, V117, P6756, DOI 10.1182/blood-2010-05-231548; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; Garcia PD, 2014, CLIN CANC RES; Horwitz SM, 2014, OBJECTIVE RESPONSES; Hsu JL, 2012, CANCER LETT, V319, P214, DOI 10.1016/j.canlet.2012.01.004; Intlekofer AM, 2014, INT J HEMATOL, V99, P249, DOI 10.1007/s12185-014-1521-2; Jackson LJ, 2012, CELL IMMUNOL, V272, P200, DOI 10.1016/j.cellimm.2011.10.011; Keeton EK, 2014, BLOOD, V123, P905, DOI 10.1182/blood-2013-04-495366; Laimer D, 2012, NAT MED, V18, P1699, DOI 10.1038/nm.2966; Lin YW, 2010, BLOOD, V115, P824, DOI 10.1182/blood-2009-07-233445; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Mahalingam D, 2011, BRIT J CANCER, V105, P1563, DOI 10.1038/bjc.2011.426; Mak V, 2013, J CLIN ONCOL, V31, P1970, DOI 10.1200/JCO.2012.44.7524; Martin-Sanchez E, 2013, HAEMATOL-HEMATOL J, V98, P57, DOI 10.3324/haematol.2012.068510; Martin-Sanchez E, 2011, BRIT J HAEMATOL, V152, P352, DOI 10.1111/j.1365-2141.2010.08401.x; Min XW, 2012, J HUAZHONG U SCI-MED, V32, P17, DOI 10.1007/s11596-012-0003-0; Mologni L, 2012, EXPERT OPIN INV DRUG, V21, P985, DOI 10.1517/13543784.2012.690031; Moskowitz AJ, 2014, BLOOD; Mumenthaler SM, 2009, MOL CANCER THER, V8, P2882, DOI 10.1158/1535-7163.MCT-09-0293; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; O'Leary H, 2009, CURR OPIN HEMATOL, V16, P292, DOI 10.1097/MOH.0b013e32832b89a9; Pastor Fernandez J, 2011, TRICYCLIC COMPOUNDS; Pearson JD, 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/123253.EPUB; Sak A, 2010, SEMIN RADIAT ONCOL, V20, P223, DOI 10.1016/j.semradonc.2010.05.004; Scarisbrick JJ, 2014, BR J DERMATOL; Siu A, 2011, ONCOTARGET, V2, P1134; Song JH, 2012, CANCER RES, V72, P294, DOI 10.1158/0008-5472.CAN-11-3240; Yang Qingshan, 2013, Clin Lymphoma Myeloma Leuk, V13 Suppl 2, pS355, DOI 10.1016/j.clml.2013.05.024; Yang QS, 2012, BLOOD, V120, P3491, DOI 10.1182/blood-2012-02-412643; Zhang Y, 2010, J NEUROCHEM, V112, P497, DOI 10.1111/j.1471-4159.2009.06476.x	46	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112148	10.1371/journal.pone.0112148	http://dx.doi.org/10.1371/journal.pone.0112148			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386922	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400042
J	Dai, ZZ; Ji, J; Xiao, G; Yan, G; Li, SK; Zhang, GS; Lin, Y; Shen, ZW; Wu, RH				Dai, Zhuozhi; Ji, Jim; Xiao, Gang; Yan, Gen; Li, Shengkai; Zhang, Guishan; Lin, Yan; Shen, Zhiwei; Wu, Renhua			Magnetization Transfer Prepared Gradient Echo MRI for CEST Imaging	PLOS ONE			English	Article							EXCHANGE SATURATION-TRANSFER; IN-VIVO; CONTRAST AGENT; PH; RELAXATION; ACIDOSIS; RATIO	Chemical exchange saturation transfer (CEST) is an emerging MRI contrast mechanism that is capable of noninvasively imaging dilute CEST agents and local properties such as pH and temperature, augmenting the routine MRI methods. However, the routine CEST MRI includes a long RF saturation pulse followed by fast image readout, which is associated with high specific absorption rate and limited spatial resolution. In addition, echo planar imaging (EPI)-based fast image readout is prone to image distortion, particularly severe at high field. To address these limitations, we evaluated magnetization (MT) prepared gradient echo (GRE) MRI for CEST imaging. We proved the feasibility using numerical simulations and experiments in vitro and in vivo. Then we optimized the sequence by serially evaluating the effects of the number of saturation steps, MT saturation power (B1), GRE readout flip angle (FA), and repetition time (TR) upon the CEST MRI, and further demonstrated the endogenous amide proton CEST imaging in rats brains (n = 5) that underwent permanent middle cerebral artery occlusion. The CEST images can identify ischemic lesions in the first 3 hours after occlusion. In summary, our study demonstrated that the readily available MT-prepared GRE MRI, if optimized, is CEST-sensitive and remains promising for translational CEST imaging.	[Dai, Zhuozhi; Yan, Gen; Li, Shengkai; Zhang, Guishan; Lin, Yan; Wu, Renhua] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Med Imaging, Shantou 515000, Guangdong, Peoples R China; [Dai, Zhuozhi] Univ Alberta, Fac Med, Dept Biomed Engn, Edmonton, AB T6G 2V2, Canada; [Ji, Jim] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA; [Xiao, Gang] Hanshan Normal Univ, Dept Math & Informat Technol, Chaozhou 521000, Guangdong, Peoples R China; [Shen, Zhiwei; Wu, Renhua] Prov Key Lab Med Mol Imaging, Shantou 515000, Guangdong, Peoples R China	Shantou University; University of Alberta; Texas A&M University System; Texas A&M University College Station; Hanshan Normal University	Wu, RH (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Med Imaging, Shantou 515000, Guangdong, Peoples R China.	rhwu@stu.edu.cn		Ji, Jim/0000-0001-7147-7920	NSF [S2011010004973, B2013281];  [NSFC-30930027];  [NSFC-81101102]	NSF(National Science Foundation (NSF)); ; 	This study was funded in part by NSFC-30930027 (Wu RH), NSFC-81101102 (Lin Y), NSF of Guangdong Province-S2011010004973 (Lin Y), MSF of Guangdong Province-B2013281 (Dai ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai KJ, 2012, NAT MED, V18, P302, DOI 10.1038/nm.2615; Dixon WT, 2010, MAGN RESON MED, V63, P253, DOI 10.1002/mrm.22193; Dula AN, 2011, MAGN RESON MED, V66, P831, DOI 10.1002/mrm.22862; Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277; Jokivarsi KT, 2007, MAGN RESON MED, V57, P647, DOI 10.1002/mrm.21181; Jones CK, 2012, MAGN RESON MED, V67, P1579, DOI 10.1002/mrm.23141; Li YG, 2011, CONTRAST MEDIA MOL I, V6, P219, DOI 10.1002/cmmi.421; Ling W, 2008, P NATL ACAD SCI USA, V105, P2266, DOI 10.1073/pnas.0707666105; Longo DL, 2011, MAGN RESON MED, V65, P202, DOI 10.1002/mrm.22608; Opina ACL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027370; Shah T, 2011, MAGN RESON MED, V65, P432, DOI 10.1002/mrm.22637; Singh A, 2012, MAGN RESON MED, V68, P588, DOI 10.1002/mrm.23250; Sun PZ, 2008, MAGN RESON MED, V59, P1175, DOI 10.1002/mrm.21591; Sun PZ, 2007, MAGN RESON MED, V57, P405, DOI 10.1002/mrm.21151; Sun PZ, 2013, PHYS MED BIOL, V58, pN229, DOI 10.1088/0031-9155/58/17/N229; Sun PZ, 2013, CONTRAST MEDIA MOL I, V8, P246, DOI 10.1002/cmmi.1524; Sun PZ, 2012, NEUROIMAGE, V60, P1, DOI 10.1016/j.neuroimage.2011.11.091; Sun PZ, 2011, MAGN RESON MED, V66, P1042, DOI 10.1002/mrm.22894; Sun PZ, 2011, J CEREBR BLOOD F MET, V31, P1743, DOI 10.1038/jcbfm.2011.23; Sun PZ, 2010, STROKE, V41, pS147, DOI 10.1161/STROKEAHA.110.595777; Terreno E, 2010, CHEM REV, V110, P3019, DOI 10.1021/cr100025t; Terreno E, 2009, CONTRAST MEDIA MOL I, V4, P237, DOI 10.1002/cmmi.290; Togao O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077019; van Zijl PCM, 2007, P NATL ACAD SCI USA, V104, P4359, DOI 10.1073/pnas.0700281104; van Zijl PCM, 2011, MAGN RESON MED, V65, P927, DOI 10.1002/mrm.22761; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wei M, 2011, IMAGING PH PHANTOMS, P329; Wu RH, 2012, CONTRAST MEDIA MOL I, V7, P384, DOI 10.1002/cmmi.505; Zhang SR, 2003, J AM CHEM SOC, V125, P15288, DOI 10.1021/ja038345f; Zhou JY, 2008, MAGN RESON MED, V60, P842, DOI 10.1002/mrm.21712; Zhou JY, 2003, NAT MED, V9, P1085, DOI 10.1038/nm907; Zu ZL, 2011, MAGN RESON MED, V66, P1100, DOI 10.1002/mrm.22884	32	17	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112219	10.1371/journal.pone.0112219	http://dx.doi.org/10.1371/journal.pone.0112219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384020	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700040
J	Nguyen, Y; Sugiman-Marangos, S; Harvey, H; Bell, SD; Charlton, CL; Junop, MS; Burrows, LL				Ylan Nguyen; Sugiman-Marangos, Seiji; Harvey, Hanjeong; Bell, Stephanie D.; Charlton, Carmen L.; Junop, Murray S.; Burrows, Lori L.			Pseudomonas aeruginosa Minor Pilins Prime Type IVa Pilus Assembly and Promote Surface Display of the PilY1 Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adhesin; Bacterial Adhesion; Crystal Structure; Pseudomonas aeruginosa (P; aeruginosa); Type II Secretion System (T2SS); Type IV Pili; Pilin; Pseudopilin; Twitching Motility	II SECRETION SYSTEM; NEISSERIA-MENINGITIDIS; PROTEIN-SECRETION; FIMBRIAL BIOGENESIS; AMINO-ACID; TWITCHING MOTILITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PSEUDOPILIN EPSH; ANALYSIS REVEALS	Background: Type IV pili (T4P) are virulence factors composed of major and minor pilins. Results: Minor pilins prime pilus assembly and traffic anti-retraction protein PilY1 to the surface; FimU and GspH are structurally similar. Conclusion: Minor pilins are essential for pilus assembly and function. Significance: This work expands the structural and functional similarities between the T4P and T2S systems. Type IV pili (T4P) contain hundreds of major subunits, but minor subunits are also required for assembly and function. Here we show that Pseudomonas aeruginosa minor pilins prime pilus assembly and traffic the pilus-associated adhesin and anti-retraction protein, PilY1, to the cell surface. PilV, PilW, and PilX require PilY1 for inclusion in surface pili and vice versa, suggestive of complex formation. PilE requires PilVWXY1 for inclusion, suggesting that it binds a novel interface created by two or more components. FimU is incorporated independently of the others and is proposed to couple the putative minor pilin-PilY1 complex to the major subunit. The production of small amounts of T4P by a mutant lacking the minor pilin operon was traced to expression of minor pseudopilins from the P. aeruginosa type II secretion (T2S) system, showing that under retraction-deficient conditions, T2S minor subunits can prime T4P assembly. Deletion of all minor subunits abrogated pilus assembly. In a strain lacking the minor pseudopilins, PilVWXY1 and either FimU or PilE comprised the minimal set of components required for pilus assembly. Supporting functional conservation of T2S and T4P minor components, our 1.4 crystal structure of FimU revealed striking architectural similarity to its T2S ortholog GspH, despite minimal sequence identity. We propose that PilVWXY1 form a priming complex for assembly and that PilE and FimU together stably couple the complex to the major subunit. Trafficking of the anti-retraction factor PilY1 to the cell surface allows for production of pili of sufficient length to support adherence and motility.	[Ylan Nguyen; Sugiman-Marangos, Seiji; Harvey, Hanjeong; Bell, Stephanie D.; Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Ylan Nguyen; Sugiman-Marangos, Seiji; Harvey, Hanjeong; Bell, Stephanie D.; Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Charlton, Carmen L.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2R3, Canada; [Charlton, Carmen L.] Prov Lab Publ Hlth, Edmonton, AB T6G 2J2, Canada; [Junop, Murray S.] Univ Western Ontario, Dept Biochem, London, ON N6A 3K7, Canada	McMaster University; McMaster University; University of Alberta; Western University (University of Western Ontario)	Burrows, LL (corresponding author), 4H18 Hlth Sci Ctr, 1200 Main St West, Hamilton, ON L8N 3Z5, Canada.	burrowl@mcmaster.ca	Junop, Murray S/E-4160-2015	Junop, Murray S/0000-0001-6676-5717; Sugiman-Marangos, Seiji/0000-0002-8475-5456; Charlton, Carmen/0000-0002-9129-5136	Canadian Institutes of Health Research [MOP 93585, MOP 89903]; Cystic Fibrosis Canada; Banting Scholarship from the Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada; Banting Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research Grants MOP 93585 (to L. L. B.) and MOP 89903 (to M. S. J.).; Recipient of a graduate studentship from Cystic Fibrosis Canada and a Banting Scholarship from the Canadian Institutes of Health Research.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALM RA, 1995, MOL MICROBIOL, V16, P485, DOI 10.1111/j.1365-2958.1995.tb02413.x; Alm RA, 1996, J BACTERIOL, V178, P3809, DOI 10.1128/jb.178.13.3809-3817.1996; Alm RA, 1996, MOL MICROBIOL, V22, P161; Arts J, 2007, J BACTERIOL, V189, P2069, DOI 10.1128/JB.01236-06; Ball G, 2002, MOL MICROBIOL, V43, P475, DOI 10.1046/j.1365-2958.2002.02759.x; Belete B, 2008, J BACTERIOL, V190, P2023, DOI 10.1128/JB.01623-07; Bleves S, 1998, MOL MICROBIOL, V27, P31, DOI 10.1046/j.1365-2958.1998.00653.x; Bohn YST, 2009, MOL MICROBIOL, V71, P730, DOI 10.1111/j.1365-2958.2008.06559.x; Brissac T, 2012, INFECT IMMUN, V80, P3297, DOI 10.1128/IAI.00369-12; Brown DR, 2010, INFECT IMMUN, V78, P3053, DOI 10.1128/IAI.00099-10; Burrows LL, 2012, MOL MICROBIOL, V86, P765, DOI 10.1111/mmi.12034; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Cisneros DA, 2012, MOL MICROBIOL, V86, P805, DOI 10.1111/mmi.12033; Cisneros DA, 2012, EMBO J, V31, P1041, DOI 10.1038/emboj.2011.454; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; de Bentzmann S, 2006, J BACTERIOL, V188, P4851, DOI 10.1128/JB.00345-06; DeLano WL, 2002, PYMOL USERS MANUAL; Douzi B, 2009, J BIOL CHEM, V284, P34580, DOI 10.1074/jbc.M109.042366; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forest KT, 2008, NAT STRUCT MOL BIOL, V15, P428, DOI 10.1038/nsmb0508-428; Francetic O, 2007, J BACTERIOL, V189, P1783, DOI 10.1128/JB.01230-06; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2011, ENVIRON MICROBIOL, V13, P250, DOI 10.1111/j.1462-2920.2010.02327.x; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; Imhaus AF, 2014, EMBO J, V33, P1767, DOI 10.15252/embj.201488031; Johnson MDL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029629; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Kuchma SL, 2012, J BACTERIOL, V194, P5388, DOI 10.1128/JB.00899-12; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; Kuo WW, 2005, J BIOMED SCI, V12, P587, DOI 10.1007/s11373-005-7372-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Lu HM, 1997, MOL MICROBIOL, V25, P247, DOI 10.1046/j.1365-2958.1997.4561818.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mattick JS, 1996, GENE, V179, P147, DOI 10.1016/S0378-1119(96)00441-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NUNN DN, 1991, P NATL ACAD SCI USA, V88, P3281, DOI 10.1073/pnas.88.8.3281; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Raghunathan K, 2014, BBA-PROTEINS PROTEOM, V1844, P406, DOI 10.1016/j.bbapap.2013.11.013; RUDEL T, 1995, P NATL ACAD SCI USA, V92, P7986, DOI 10.1073/pnas.92.17.7986; RUSSELL MA, 1994, MOL MICROBIOL, V13, P973, DOI 10.1111/j.1365-2958.1994.tb00489.x; SASTRY PA, 1985, J BACTERIOL, V164, P571, DOI 10.1128/JB.164.2.571-577.1985; Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; STROM MS, 1991, J BIOL CHEM, V266, P1656; STROM MS, 1993, P NATL ACAD SCI USA, V90, P2404, DOI 10.1073/pnas.90.6.2404; Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Winther-Larsen HC, 2005, MOL MICROBIOL, V56, P903, DOI 10.1111/j.1365-2958.2005.04591.x; Winther-Larsen HC, 2001, P NATL ACAD SCI USA, V98, P15276, DOI 10.1073/pnas.261574998; Yanez ME, 2008, J MOL BIOL, V377, P91, DOI 10.1016/j.jmb.2007.08.041; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035	68	67	71	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					601	611		10.1074/jbc.M114.616904	http://dx.doi.org/10.1074/jbc.M114.616904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389296	Green Published, hybrid			2022-12-26	WOS:000347231200052
J	Lee, CW; Wang, HJ; Hwang, JK; Tseng, CP				Lee, Chi-Wen; Wang, Hsiu-Jung; Hwang, Jenn-Kang; Tseng, Ching-Ping			Protein Thermal Stability Enhancement by Designing Salt Bridges: A Combined Computational and Experimental Study	PLOS ONE			English	Article							CHARGE-CHARGE INTERACTIONS; MOLECULAR-DYNAMICS SIMULATIONS; BETA-GLUCOSIDASE; ELECTROSTATIC CONTRIBUTIONS; BACILLUS-POLYMYXA; HYPERTHERMOPHILIC PROTEINS; SOLVENT ACCESSIBILITY; SECONDARY STRUCTURE; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURE	Protein thermal stability is an important factor considered in medical and industrial applications. Many structural characteristics related to protein thermal stability have been elucidated, and increasing salt bridges is considered as one of the most efficient strategies to increase protein thermal stability. However, the accurate simulation of salt bridges remains difficult. In this study, a novel method for salt-bridge design was proposed based on the statistical analysis of 10,556 surface salt bridges on 6,493 X-ray protein structures. These salt bridges were first categorized based on pairing residues, secondary structure locations, and C alpha-C alpha distances. Pairing preferences generalized from statistical analysis were used to construct a salt-bridge pair index and utilized in a weighted electrostatic attraction model to find the effective pairings for designing salt bridges. The model was also coupled with B-factor, weighted contact number, relative solvent accessibility, and conservation prescreening to determine the residues appropriate for the thermal adaptive design of salt bridges. According to our method, eight putative salt-bridges were designed on a mesophilic beta-glucosidase and 24 variants were constructed to verify the predictions. Six putative salt-bridges leaded to the increase of the enzyme thermal stability. A significant increase in melting temperature of 8.8, 4.8, 3.7, 1.3, 1.2, and 0.7 degrees C of the putative salt-bridges N437K-D49, E96R-D28, E96K-D28, S440K-E70, T231K-D388, and Q277E-D282 was detected, respectively. Reversing the polarity of T231K-D388 to T231D-D388K resulted in a further increase in melting temperatures by 3.6 degrees C, which may be caused by the transformation of an intra-subunit electrostatic interaction into an inter-subunit one depending on the local environment. The combination of the thermostable variants (N437K, E96R, T231D and D388K) generated a melting temperature increase of 15.7 degrees C. Thus, this study demonstrated a novel method for the thermal adaptive design of salt bridges through inference of suitable positions and substitutions.	[Lee, Chi-Wen; Hwang, Jenn-Kang] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Wang, Hsiu-Jung; Tseng, Ching-Ping] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Dept Biol Sci & Technol, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hwang, JK (corresponding author), Natl Chiao Tung Univ, Coll Biol Sci & Technol, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	jkhwang@cc.nctu.edu.tw; cpts@cc.nctu.edu.tw			National Science Council, Taiwan [NSC-98-2321-B-009-002]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council, Taiwan (NSC-98-2321-B-009-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop E, 2003, PROTEIN ENG, V16, P871, DOI 10.1093/protein/gzg131; Anbar M, 2012, APPL ENVIRON MICROB, V78, P3458, DOI 10.1128/AEM.07985-11; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Binter A, 2009, FEBS J, V276, P5263, DOI 10.1111/j.1742-4658.2009.07222.x; Bleicher L, 2011, J PHYS CHEM B, V115, P7940, DOI 10.1021/jp200330z; Bogin O, 2002, PROTEIN SCI, V11, P2561, DOI 10.1110/ps.0222102; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; Brian N., 2004, PROTEIN-STRUCT FUNCT, V57, P128; Cavagnero S, 1998, BIOCHEMISTRY-US, V37, P3369, DOI 10.1021/bi9721795; Chan CH, 2004, PROTEINS, V57, P684, DOI 10.1002/prot.20263; Chang CS, 1999, J MOL BIOL, V288, P623, DOI 10.1006/jmbi.1999.2696; Charbonneau DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076675; DAGGETT V, 1992, P NATL ACAD SCI USA, V89, P5142, DOI 10.1073/pnas.89.11.5142; DELBONI LF, 1995, PROTEIN SCI, V4, P2594, DOI 10.1002/pro.5560041217; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; El-Bondkly AMA, 2012, ANTON LEEUW INT J G, V101, P331, DOI 10.1007/s10482-011-9639-1; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Fukuchi S, 2001, J MOL BIOL, V309, P835, DOI 10.1006/jmbi.2001.4718; Gonzalez-Blasco G, 2000, J BIOL CHEM, V275, P13708, DOI 10.1074/jbc.275.18.13708; GONZALEZCANDELAS L, 1989, APPL ENVIRON MICROB, V55, P3173; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jelesarov Ilian, 2009, V490, P227, DOI 10.1007/978-1-59745-367-7_10; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kumar S, 2000, PROTEINS, V41, P485, DOI 10.1002/1097-0134(20001201)41:4<485::AID-PROT60>3.3.CO;2-5; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Lam SY, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001027; Lazaridis T, 1997, PROTEIN SCI, V6, P2589; Liang HK, 2005, PROTEINS, V59, P58, DOI 10.1002/prot.20386; Lin CP, 2008, PROTEINS, V72, P929, DOI 10.1002/prot.21983; Loladze VV, 1999, BIOCHEMISTRY-US, V38, P16419, DOI 10.1021/bi992271w; Lu CH, 2008, PROTEINS, V72, P625, DOI 10.1002/prot.21954; Luke KA, 2007, FEBS J, V274, P4023, DOI 10.1111/j.1742-4658.2007.05955.x; Olson CA, 2001, PROTEINS, V44, P123, DOI 10.1002/prot.1079; Parthasarathy S, 2000, PROTEIN ENG, V13, P9, DOI 10.1093/protein/13.1.9; Qin SB, 2005, PROTEINS, V61, P473, DOI 10.1002/prot.20645; Rader AJ, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016002; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Rosato V, 2002, TRENDS GENET, V18, P278, DOI 10.1016/S0168-9525(02)02691-4; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Rovo P, 2011, J PEPT SCI, V17, P610, DOI 10.1002/psc.1377; Sandgren M, 2003, PROTEIN SCI, V12, P848, DOI 10.1110/ps.0237703; Sanz-Aparicio J, 1998, PROTEINS, V33, P567, DOI 10.1002/(SICI)1097-0134(19981201)33:4<567::AID-PROT9>3.0.CO;2-U; Sanz-Aparicio J, 1998, J MOL BIOL, V275, P491, DOI 10.1006/jmbi.1997.1467; Schweiker KL, 2007, PROTEIN SCI, V16, P2694, DOI 10.1110/ps.073091607; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Vetriani C, 1998, P NATL ACAD SCI USA, V95, P12300, DOI 10.1073/pnas.95.21.12300; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; ZAMOST BL, 1991, J IND MICROBIOL, V8, P71, DOI 10.1007/BF01578757; Zhou HX, 2003, BIOPHYS J, V84, P2216, DOI 10.1016/S0006-3495(03)75027-9	55	34	35	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112751	10.1371/journal.pone.0112751	http://dx.doi.org/10.1371/journal.pone.0112751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393107	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300096
J	Puig-Barbera, J; Garcia-de-Lomas, J; Diez-Domingo, J; Arnedo-Pena, A; Ruiz-Garcia, M; Limon-Ramirez, R; Perez-Vilar, S; Mico-Esparza, JL; Tortajada-Girbes, M; Carratala-Munuera, C; Larrea-Gonzalez, R; Beltran-Garrido, JM; Otero-Reigada, MD; Mollar-Maseres, J; Correcher-Medina, P; Schwarz-Chavarri, G; Gil-Guillen, V				Puig-Barbera, Joan; Garcia-de-Lomas, Juan; Diez-Domingo, Javier; Arnedo-Pena, Alberto; Ruiz-Garcia, Montserrat; Limon-Ramirez, Ramon; Perez-Vilar, Silvia; Luis Mico-Esparza, Jose; Tortajada-Girbes, Miguel; Carratala-Munuera, Concha; Larrea-Gonzalez, Rosa; Manuel Beltran-Garrido, Juan; del Carmen Otero-Reigada, Maria; Mollar-Maseres, Joan; Correcher-Medina, Patricia; Schwarz-Chavarri, German; Gil-Guillen, Vicente		Valencia Hosp Network Study Influe	Influenza Vaccine Effectiveness in Preventing Influenza A(H3N2)-Related Hospitalizations in Adults Targeted for Vaccination by Type of Vaccine: A Hospital-Based Test-Negative Study, 2011-2012 A(H3N2) Predominant Influenza Season, Valencia, Spain	PLOS ONE			English	Article							LABORATORY-CONFIRMED INFLUENZA; RESPIRATORY SYNCYTIAL VIRUS; DESIGN; PROTECTION; MORTALITY; EFFICACY; ANTIBODY	Background: Most evidence of the effectiveness of influenza vaccines comes from studies conducted in primary care, but less is known about their effectiveness in preventing serious complications. Here, we examined the influenza vaccine effectiveness (IVE) against hospitalization with PCR-confirmed influenza in the predominant A(H3N2) 2011-2012 influenza season. Methods: A hospital-based, test-negative study was conducted in nine hospitals in Valencia, Spain. All emergency admissions with a predefined subset of symptoms were eligible. We enrolled consenting adults age 18 and over, targeted for influenza vaccination because of comorbidity, with symptoms of influenza-like-illness within seven days of admission. We estimated IVE as (1-adjusted vaccination odds ratio)* 100 after accounting for major confounders, calendar time and recruitment hospital. Results: The subjects included 544 positive for influenza A(H3N2) and 1,370 negative for influenza admissions. Age was an IVE modifying factor. Regardless of vaccine administration, IVE was 72% (38 to 88%) in subjects aged under 65 and 21% (-5% to 40%) in subjects aged 65 and over. By type of vaccine, the IVE of classical intramuscular split-influenza vaccine, used in subjects 18 to 64, was 68% (12% to 88%). The IVE for intradermal and virosomal influenza vaccines, used in subjects aged 65 and over, was 39% (11% to 58%) and 16% (-39% to 49%), respectively. Conclusions: The split-influenza vaccine was effective in preventing influenza-associated hospitalizations in adults aged under 65. The intradermal vaccine was moderately effective in those aged 65 and over.	[Puig-Barbera, Joan; Diez-Domingo, Javier] Fdn Fomento Invest Sanitaria & Biomed Comunitat V, Valencia, Spain; [Puig-Barbera, Joan; Arnedo-Pena, Alberto; Ruiz-Garcia, Montserrat] Ctr Salud Publ Castellon, Castellon de La Plana, Spain; [Garcia-de-Lomas, Juan] Inst Valenciano Microbiol, Valencia, Spain; [Limon-Ramirez, Ramon; Perez-Vilar, Silvia] Hosp Plana, Vila Real, Spain; [Luis Mico-Esparza, Jose] Hosp Aranau de Vilanova, Valencia, Spain; [Tortajada-Girbes, Miguel] Hosp Doctor Peset, Valencia, Spain; [Carratala-Munuera, Concha] Hosp San Juan, Alicante, Spain; [Carratala-Munuera, Concha; Gil-Guillen, Vicente] Univ Miguel Hernandez, Dept Clin Med, Catedra Med Familia, Alicante, Spain; [Larrea-Gonzalez, Rosa; Manuel Beltran-Garrido, Juan] Hosp Gen Castellon, Castellon de La Plana, Spain; [del Carmen Otero-Reigada, Maria; Mollar-Maseres, Joan] Hosp Univ & Politecn La Fe, Valencia, Spain; [Correcher-Medina, Patricia] Hosp Lluis Alcanyis, Xativa, Spain; [Schwarz-Chavarri, German] Ctr Salud San Blas, Alicante, Spain; [Gil-Guillen, Vicente] Hosp Elda, Elda, Spain	Universidad Miguel Hernandez de Elche; Hospital Universitari i Politecnic La Fe	Puig-Barbera, J (corresponding author), Fdn Fomento Invest Sanitaria & Biomed Comunitat V, Valencia, Spain.	puig_joa@gva.es	Medina, Patricia Correcher/AAL-9598-2020; Puig-Barberà, Joan/F-1563-2015; Domingo, Javier Diez/B-7293-2015; Guillén, Vicente Francisco Gil/AAE-8201-2019; Perez-Vilar, Silvia/H-4372-2016; Carratala-Munuera, Concepcion/ABH-1205-2020	Medina, Patricia Correcher/0000-0002-9704-9534; Puig-Barberà, Joan/0000-0001-5783-0409; Domingo, Javier Diez/0000-0003-1008-3922; Perez-Vilar, Silvia/0000-0003-1272-1502; Carratala-Munuera, Concepcion/0000-0002-1303-6294; Gil-Guillen, Vicente F/0000-0003-3793-9786	FISABIO-Salud Publica; Sanofi-Pasteur; Sanofi-Pasteur MSD	FISABIO-Salud Publica; Sanofi-Pasteur; Sanofi-Pasteur MSD	The study was funded by contracts between FISABIO-Salud Publica (former CSISP) and Sanofi-Pasteur and FISABIO-Salud Publica (former CSISP) and Sanofi-Pasteur MSD. Sanofi-Pasteur and Sanofi-Pasteur MSD did not participate in the design or conduct of the study, collection, management, analysis, or interpretation of the data, writing of the manuscript, and the decision to submit the manuscript for publication.	[Anonymous], 2013, Weekly Epidemiological Record, V88, P225; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P101; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P83; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Benach Joan, 2004, Gac Sanit, V18, P16, DOI 10.1157/13062246; Bloom-Feshbach K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054445; Bonmarin I, 2012, EUROSURVEILLANCE, V17; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Castilla J, 2013, EURO SURVEILL, V18; Cheng AC, 2013, COMMUN DIS INTELL, V37, pE246; De Serres G, 2013, EUROSURVEILLANCE, V18; Delgado-Sanz C, 2013, B EPIDEMIOLOGICO SEM, V20, P153; European Influenza Surveillance Network (EISN) website, INFL CAS DEF CLIN CR; Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026; GREENLAND S, 1985, AM J EPIDEMIOL, V122, P495, DOI 10.1093/oxfordjournals.aje.a114131; Jackson LA, 2006, INT J EPIDEMIOL, V35, P337, DOI 10.1093/ije/dyi274; Jackson LA, 2006, INT J EPIDEMIOL, V35, P345, DOI 10.1093/ije/dyi275; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Jimenez-Jorge S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-441; KATZ JM, 1989, J INFECT DIS, V160, P191, DOI 10.1093/infdis/160.2.191; Kissling E, 2013, EURO SURVEILL, V18; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Legrand J, 2006, VACCINE, V24, P6605, DOI 10.1016/j.vaccine.2006.05.063; Maciosek MV, 2006, AM J PREV MED, V31, P90, DOI 10.1016/j.amepre.2006.03.011; McElhaney JE, 2013, LANCET INFECT DIS, V13, P485, DOI 10.1016/S1473-3099(13)70046-X; Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106; Nelson JC, 2009, J CLIN EPIDEMIOL, V62, P687, DOI 10.1016/j.jclinepi.2008.06.014; Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pebody R., 2013, EURO SURVEILL, V18; Portero-Alonso A, 2012, INFORME DIRECCION GE; Puig-Barbera J, 2004, VACCINE, V23, P283, DOI 10.1016/j.vaccine.2004.07.017; Puig-Barbera J, 2012, VACCINE, V30, P5714, DOI 10.1016/j.vaccine.2012.07.006; Puig-Barbera J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100497; Puig-Barbera J, 2010, VACCINE, V28, P7460, DOI 10.1016/j.vaccine.2010.09.042; Regidor E, 2001, Rev Esp Salud Publica, V75, P13; ROCHA EP, 1993, J GEN VIROL, V74, P2513, DOI 10.1099/0022-1317-74-11-2513; Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P111; Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Skowronski DM, 2012, J INFECT DIS, V206, P1852, DOI 10.1093/infdis/jis500; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Talbot HK, 2013, CLIN INFECT DIS, V56, P1774, DOI 10.1093/cid/cit124; Thomas HL, 2014, EPIDEMIOL INFECT, V142, P126, DOI 10.1017/S0950268813000824; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Turner N, 2014, VACCINE; Zhou H, 2012, CLIN INFECT DIS, V54, P1427, DOI 10.1093/cid/cis211	50	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112294	10.1371/journal.pone.0112294	http://dx.doi.org/10.1371/journal.pone.0112294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392931	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300046
J	Tsukumo, Y; Tsukahara, S; Furuno, A; Iemura, S; Natsume, T; Tomida, A				Tsukumo, Yoshinori; Tsukahara, Satomi; Furuno, Aki; Iemura, Shun-ichiro; Natsume, Toru; Tomida, Akihiro			TBL2 Is a Novel PERK-Binding Protein that Modulates Stress-Signaling and Cell Survival during Endoplasmic Reticulum Stress	PLOS ONE			English	Article							MESSENGER-RNA; ER STRESS; TRANSCRIPTIONAL INDUCTION; TRANSLATION; ATF6; IDENTIFICATION; EXPRESSION; DELETION; PATHWAY; REPEAT	Under ER stress, PKR-like ER-resident kinase (PERK) phosphorylates translation initiation factor eIF2a, resulting in repression of global protein synthesis and concomitant upregulation of the translation of specific mRNAs such as activating transcription factor 4 (ATF4). This PERK function is important for cell survival under ER stress and poor nutrient conditions. However, mechanisms of the PERK signaling pathway are not thoroughly understood. Here we identify transducin (beta)like 2 (TBL2) as a novel PERK-binding protein. We found that TBL2 is an ER-localized type-I transmembrane protein and preferentially binds to the phosphorylated form of PERK, but not another eIF2a kinase GCN2 or ER-resident kinase IRE1, under ER stress. Immunoprecipitation analysis using various deletion mutants revealed that TBL2 interacts with PERK via the N-terminus proximal region and also associates with eIF2a via the WD40 domain. In addition, TBL2 knockdown can lead to impaired ATF4 induction under ER stress or poor nutrient conditions such as glucose and oxygen deprivation. Consistently, TBL2 knockdown rendered cells vulnerable to stresses similarly to PERK knockdown. Thus, TBL2 serves as a potential regulator of the PERK pathway.	[Tsukumo, Yoshinori; Tsukahara, Satomi; Furuno, Aki; Tomida, Akihiro] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 170, Japan; [Iemura, Shun-ichiro; Natsume, Toru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo, Japan	Japanese Foundation for Cancer Research; National Institute of Advanced Industrial Science & Technology (AIST)	Tomida, A (corresponding author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Koto Ku, Tokyo 170, Japan.	akihiro.tomida@jfcr.or.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	Ministry of Education, Culture, Sports, Science and Technology of Japan [22700892, 22300342, 25290061, 24650626]; National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare [21-3-1]; Kobayashi Foundation for Cancer Research; Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research [24650626] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Cancer Center Research and Development Fund from the Ministry of Health, Labour and Welfare; Kobayashi Foundation for Cancer Research(Kobayashi Foundation for Cancer Research); Vehicle Racing Commemorative Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Young Scientists (B) (22700892 YT), a Grant-in-Aid for scientific research (B) (22300342, 25290061 AT), a Grant-in-Aid for challenging Exploratory Research (24650626 AT), from the Ministry of Education, Culture, Sports, Science and Technology of Japan, National Cancer Center Research and Development Fund (21-3-1) from the Ministry of Health, Labour and Welfare, a Grant from Kobayashi Foundation for Cancer Research, and from the Vehicle Racing Commemorative Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jurado LAP, 1999, CYTOGENET CELL GENET, V86, P277, DOI 10.1159/000015319; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Marciniak SJ, 2006, J CELL BIOL, V172, P201, DOI 10.1083/jcb.200508099; Meng X, 1998, HUM GENET, V103, P590, DOI 10.1007/s004390050874; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Pober Barbara R, 2010, N Engl J Med, V362, P239, DOI 10.1056/NEJMra0903074; Roberts LO, 2009, PROG MOL BIOL TRANSL, V90, P313, DOI 10.1016/S1877-1173(09)90009-6; Saito S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045845; Shan JX, 2009, J BIOL CHEM, V284, P21241, DOI 10.1074/jbc.M109.011338; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Singleton DC, 2012, EXPERT OPIN THER TAR, V16, P1189, DOI 10.1517/14728222.2012.728207; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Tang T, 2010, NAT BIOTECHNOL, V28, P749, DOI 10.1038/nbt.1644; Tsukumo Y, 2007, J BIOL CHEM, V282, P29264, DOI 10.1074/jbc.M705038200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	35	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112761	10.1371/journal.pone.0112761	http://dx.doi.org/10.1371/journal.pone.0112761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393282	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300098
J	Zerillo, MM; Caballero, JI; Woeste, K; Graves, AD; Hartel, C; Pscheidt, JW; Tonos, J; Broders, K; Cranshaw, W; Seybold, SJ; Tisserat, N				Zerillo, Marcelo M.; Caballero, Jorge Ibarra; Woeste, Keith; Graves, Andrew D.; Hartel, Colleen; Pscheidt, Jay W.; Tonos, Jadelys; Broders, Kirk; Cranshaw, Whitney; Seybold, Steven J.; Tisserat, Ned			Population Structure of Geosmithia morbida, the Causal Agent of Thousand Cankers Disease of Walnut Trees in the United States	PLOS ONE			English	Article							BEETLE PITYOPHTHORUS-JUGLANDIS; TWIG BEETLE; BAYESIAN-INFERENCE; FUNGUS; NIGRA; DIFFERENTIATION; INTRODUCTIONS; DIVERSITY; GENETICS; FUSARIUM	The ascomycete Geosmithia morbida and the walnut twig beetle Pityophthorus juglandis are associated with thousand cankers disease of Juglans (walnut) and Pterocarya (wingnut). The disease was first reported in the western United States (USA) on several Juglans species, but has been found more recently in the eastern USA in the native range of the highly susceptible Juglans nigra. We performed a comprehensive population genetic study of 209 G. morbida isolates collected from Juglans and Pterocarya from 17 geographic regions distributed across 12 U.S. states. The study was based on sequence typing of 27 single nucleotide polymorphisms from three genomic regions and genotyping with ten microsatellite primer pairs. Using multilocus sequence-typing data, 197 G. morbida isolates were placed into one of 57 haplotypes. In some instances, multiple haplotypes were recovered from isolates collected on the same tree. Twenty-four of the haplotypes (42%) were recovered from more than one isolate; the two most frequently occurring haplotypes (H02 and H03) represented 36% of all isolates. These two haplotypes were abundant in California, but were not recovered from Arizona or New Mexico. G. morbida population structure was best explained by four genetically distinct groups that clustered into three geographic regions. Most of the haplotypes isolated from the native range of J. major (Arizona and New Mexico) were found in those states only or present in distinct genetic clusters. There was no evidence of sexual reproduction or genetic recombination in any population. The scattered distribution of the genetic clusters indicated that G. morbida was likely disseminated to different regions at several times and from several sources. The large number of haplotypes observed and the genetic complexity of G. morbida indicate that it evolved in association with at least one Juglans spp. and the walnut twig beetle long before the first reports of the disease.	[Zerillo, Marcelo M.; Caballero, Jorge Ibarra; Cranshaw, Whitney; Tisserat, Ned] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Woeste, Keith] Purdue Univ, Dept Forestry & Nat Resources, USDA, US Forest Service,Hardwood Tree Improvement & Reg, W Lafayette, IN 47907 USA; [Graves, Andrew D.] US Forest Serv, USDA, Forest Hlth Protect, Albuquerque, NM USA; [Hartel, Colleen; Tonos, Jadelys] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; [Pscheidt, Jay W.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Broders, Kirk] Univ New Hampshire, Dept Biol Sci, Durham, NC USA; [Seybold, Steven J.] US Forest Serv, USDA, Pacific Southwest Res Stn, Davis, CA USA	Colorado State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Oregon State University; University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA); United States Forest Service	Zerillo, MM (corresponding author), Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA.	mzerillo@colostate.edu	zerillo, marcelo M/AAE-1735-2022	Broders, Kirk/0000-0002-8569-6005	USDA NIFA Western Region IPM Center; Critical Issues-Emerging and New Plant and Animal Pests and Diseases grant programs; USDA Forest Service Forest Health Monitoring Program [INT-DM-09-01, INT-EM-B-11-03]; USDA Forest Service Special Technology Development [R4-2011-01]	USDA NIFA Western Region IPM Center; Critical Issues-Emerging and New Plant and Animal Pests and Diseases grant programs; USDA Forest Service Forest Health Monitoring Program(United States Department of Agriculture (USDA)United States Forest Service); USDA Forest Service Special Technology Development	This research was supported by funds provided by the USDA NIFA Western Region IPM Center and Critical Issues-Emerging and New Plant and Animal Pests and Diseases grant programs, the USDA Forest Service Forest Health Monitoring Program (Detection Monitoring Grant No. INT-DM-09-01 and Evaluation Monitoring Grant No. INT-EM-B-11-03), and USDA Forest Service Special Technology Development Grant R4-2011-01 (administered by A. S. Munson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Blackman MW, 1928, B NEW YORK STATE COL, V1, P183; Bright D. E., 2014, Insecta Mundi, P1; BRIGHT DE, 1981, MEM ENTOMOL SOC CAN, P1; Broders KD, 2012, ECOL EVOL, V2, P2114, DOI 10.1002/ece3.332; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Cranshaw W, 2011, COLEOPTS BULL, V65, P48, DOI 10.1649/0010-065X-65.1.48; Debourgogne A, 2010, J MICROBIOL METH, V82, P319, DOI 10.1016/j.mimet.2010.07.008; Delmotte F, 2008, INFECT GENET EVOL, V8, P534, DOI 10.1016/j.meegid.2008.02.012; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Excoffier L, 1995, AMOVA ANAL MOL VARIA; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher J. R., 2013, PLANT HLTH PROG, DOI [10.1094/ PHP-2013-1201-01-BR, DOI 10.1094/PHP-2013-1201-01-BR, 10.1094/PHP-2013-1201-01-BR]; Force PFPT, 2012, COMM PENNS 1000 CANK; Fournier E, 2008, J EVOLUTION BIOL, V21, P122, DOI 10.1111/j.1420-9101.2007.01462.x; Freeland E, 2012, PLANT HLTH PROGR, DOI [10.1094/PHP-2012-0618-01-RS, DOI 10.1094/PHP-2012-0618-01-RS]; Freeland E., 2012, INTRASPECIFIC VARIAB; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Goss EM, 2011, PHYTOPATHOLOGY, V101, P166, DOI 10.1094/PHYTO-05-10-0133; Grant JF, 2011, FORESTS, V2, P741, DOI 10.3390/f2030741; Graves AD, 2011, MONITORING WALNUT HL; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Griffin JR, 1972, PSW82 USDA FOR SERV; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hadziabdic D, 2014, PLANT DIS, V98, P992, DOI 10.1094/PDIS-06-13-0630-PDN; Hadziabdic D, 2014, CURR GENET, V60, P75, DOI 10.1007/s00294-013-0414-x; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanson MA, 2011, WALNUT 1000 CANKERS; Hardin JW, 2000, HARLOW HARRARS TXB D; Haun WG, 2010, STATE TENNESSEE 1000; Huang WC, 2008, GENOME RES, V18, P1538, DOI 10.1101/gr.076067.108; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Keller SR, 2012, MOL ECOL, V21, P4721, DOI 10.1111/j.1365-294X.2012.05751.x; Kolarik M, 2013, MICROB ECOL, V66, P682, DOI 10.1007/s00248-013-0228-x; Kolarik M, 2011, MYCOLOGIA, V103, P325, DOI 10.3852/10-124; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Little EL, 1979, CHECKLIST US TREES N; Montecchio L, 2014, PLANT DIS, V98, P696, DOI 10.1094/PDIS-10-13-1027-PDN; Newton L, 2009, PATHWAY ASSESSMENT G, V1; Nicodemus MA, 2008, TREES-STRUCT FUNCT, V22, P685, DOI 10.1007/s00468-008-0226-7; ODonnell K, 1997, MOL PHYLOGENET EVOL, V7, P103, DOI 10.1006/mpev.1996.0376; Pritchard JK, 2000, GENETICS, V155, P945; Pscheidt JW, 2014, PACIFIC NW PLANT DIS; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Serdani M., 2013, PLANT HLTH PROGR, DOI [10.1094/PHP-2013-1018-01-BR, DOI 10.1094/PHP-2013-1018-01-BR]; Services. VDoAaC, 2011, VDACS PLANT PEST SER; Seybold SJ, 2013, NAPR0210 USDA FOR SE; Seybold SJ, 2012, PAN-PAC ENTOMOL, V88, P277, DOI 10.3956/2012-32.1; Sitz R, 2013, MANAGEMENT OPTIONS W; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tisserat N., 2011, PLANT HLTH PROGR, V10, P1094, DOI DOI 10.1094/PHP-2011-0630-01-BR; Tisserat N., 2009, PLANT HLTH PROGR, V11; USDA-FS, 2001, USDA FS SW REG FOR F; Utley C, 2013, PLANT DIS, V97, P601, DOI 10.1094/PDIS-07-12-0636-RE; Williams R.D., 1990, SILVICS N AM, V2, P391	64	33	34	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112847	10.1371/journal.pone.0112847	http://dx.doi.org/10.1371/journal.pone.0112847			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393300	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300113
J	Chen, MP; Cabantchik, ZI; Chan, S; Chan, GCF; Cheung, YF				Chen, Mei-pian; Cabantchik, Z. Ioav; Chan, Shing; Chan, Godfrey Chi-fung; Cheung, Yiu-fai			Iron Overload and Apoptosis of HL-1 Cardiomyocytes: Effects of Calcium Channel Blockade	PLOS ONE			English	Article							TRANSFERRIN-BOUND-IRON; CA2+ CHANNELS; CARDIOVASCULAR FUNCTION; BETA-THALASSEMIA; HEART-FAILURE; EXPRESSION; DEATH; CARDIOMYOPATHY; MITOCHONDRIA; DEFERIPRONE	Background: Iron overload cardiomyopathy that prevails in some forms of hemosiderosis is caused by excessive deposition of iron into the heart tissue and ensuing damage caused by a raise in labile cell iron. The underlying mechanisms of iron uptake into cardiomyocytes in iron overload condition are still under investigation. Both L-type calcium channels (LTCC) and T-type calcium channels (TTCC) have been proposed to be the main portals of non-transferrinic iron into heart cells, but controversies remain. Here, we investigated the roles of LTCC and TTCC as mediators of cardiac iron overload and cellular damage by using specific Calcium channel blockers as potential suppressors of labile Fe(II) and Fe(III) ingress in cultured cardiomyocytes and ensuing apoptosis. Methods: Fe(II) and Fe(III) uptake was assessed by exposing HL-1 cardiomyocytes to iron sources and quantitative real-time fluorescence imaging of cytosolic labile iron with the fluorescent iron sensor calcein while iron-induced apoptosis was quantitatively measured by flow cytometry analysis with Annexin V. The role of calcium channels as routes of iron uptake was assessed by cell pretreatment with specific blockers of LTCC and TTCC. Results: Iron entered HL-1 cardiomyocytes in a time-and dose-dependent manner and induced cardiac apoptosis via mitochondria-mediated caspase-3 dependent pathways. Blockade of LTCC but not of TTCC demonstrably inhibited the uptake of ferric but not of ferrous iron. However, neither channel blocker conferred cardiomyocytes with protection from iron-induced apoptosis. Conclusion: Our study implicates LTCC as major mediators of Fe(III) uptake into cardiomyocytes exposed to ferric salts but not necessarily as contributors to ensuing apoptosis. Thus, to the extent that apoptosis can be considered a biological indicator of damage, the etiopathology of cardiosiderotic damage that accompanies some forms of hemosiderosis would seem to be unrelated to LTCC or TTCC, but rather to other routes of iron ingress present in heart cells.	[Chen, Mei-pian; Chan, Shing; Chan, Godfrey Chi-fung; Cheung, Yiu-fai] Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Cabantchik, Z. Ioav] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	University of Hong Kong; Hebrew University of Jerusalem	Chan, GCF (corresponding author), Univ Hong Kong, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China.	gcfchan@hku.hk; xfcheung@hku.hk	Cheung, Yiu Fai/C-4240-2009; Chan, Godfrey Chi Fung/C-4205-2009	Cheung, Yiu Fai/0000-0002-7279-4992; Chan, Godfrey Chi Fung/0000-0001-5032-8985	Children's Thalassemia Foundation; Edward Sai Kim Hotung Pediatric Education and Research Fund	Children's Thalassemia Foundation; Edward Sai Kim Hotung Pediatric Education and Research Fund	This work was supported by Children's Thalassemia Foundation and Edward Sai Kim Hotung Pediatric Education and Research Fund (http://www.thalassaemia.org.hk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; CATTERALL WA, 1992, TRENDS PHARMACOL SCI, V13, P256, DOI 10.1016/0165-6147(92)90079-L; Chattipakorn N, 2011, WORLD J CARDIOL, V3, P215, DOI 10.4330/wjc.v3.i7.215; Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Dai JS, 2004, TOXICOLOGY, V203, P199, DOI 10.1016/j.tox.2004.06.009; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Foo RSY, 2005, J CLIN INVEST, V115, P565, DOI 10.1172/JCI200524569; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Grandi E, 2011, CIRC RES, V109, P1055, DOI 10.1161/CIRCRESAHA.111.253955; Gujja P, 2010, J AM COLL CARDIOL, V56, P1001, DOI 10.1016/j.jacc.2010.03.083; HAMANN SR, 1984, CLIN PHARMACOKINET, V9, P26, DOI 10.2165/00003088-198409010-00002; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hershko Chaim M, 2005, Curr Hematol Rep, V4, P110; Horwitz LD, 1999, VASC MED, V4, P93, DOI 10.1191/135886399676588477; Huang BY, 2000, CARDIOVASC RES, V46, P442, DOI 10.1016/S0008-6363(00)00017-1; Jonsson MKB, 2011, ASSAY DRUG DEV TECHN, V9, P589, DOI 10.1089/adt.2011.0396; Kang PM, 2000, CIRC RES, V86, P1107; Kolnagou A, 2011, HEMOGLOBIN, V35, P186, DOI 10.3109/03630269.2011.576153; Kontoghiorghes GJ, 2006, HEMOGLOBIN, V30, P183, DOI 10.1080/03630260600642450; KREMASTINOS DT, 1995, CIRCULATION, V91, P66, DOI 10.1161/01.CIR.91.1.66; Kremastinos DT, 1999, CIRCULATION, V100, P2074, DOI 10.1161/01.CIR.100.20.2074; Kumfu S, 2012, EUR J HAEMATOL, V88, P535, DOI 10.1111/j.1600-0609.2012.01779.x; Kumfu S, 2011, EUR J HAEMATOL, V86, P156, DOI 10.1111/j.1600-0609.2010.01549.x; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; Lecoeur H, 2008, METHOD ENZYMOL, V442, P51, DOI 10.1016/S0076-6879(08)01403-1; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Li W, 2008, HAEMATOLOGICA, V93, P311, DOI 10.3324/haematol.11958; Lieu Pauline T., 2001, Molecular Aspects of Medicine, V22, P1, DOI 10.1016/S0098-2997(00)00006-6; Lu Wen-yi, 2013, Zhonghua Yi Xue Za Zhi, V93, P930; Lu Wen-yi, 2013, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V35, P6, DOI 10.3881/j.issn.1000-503X.2013.01.002; MAK IT, 1990, CIRC RES, V66, P1449, DOI 10.1161/01.RES.66.5.1449; Martinez ML, 1999, J MOL CELL CARDIOL, V31, P1617, DOI 10.1006/jmcc.1999.0998; Muhlestein JB, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P297; Munoz JP, 2010, FREE RADICAL BIO MED, V48, P526, DOI 10.1016/j.freeradbiomed.2009.11.017; Murphy CJ, 2010, J CARD FAIL, V16, P888, DOI 10.1016/j.cardfail.2010.05.009; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Nday CM, 2012, J INORG BIOCHEM, V117, P342, DOI 10.1016/j.jinorgbio.2012.08.009; Oancea Marcela, 2006, V129, P279; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Oteiza PI, 2011, NEUROTOXICOLOGY, V32, P75; Oudit GY, 2006, J MOL MED, V84, P349, DOI 10.1007/s00109-005-0029-x; Oudit GY, 2004, CIRCULATION, V109, P1877, DOI 10.1161/01.CIR.0000124229.40424.80; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Parkes JG, 1997, TOXICOLOGY, V117, P141, DOI 10.1016/S0300-483X(96)03566-4; RANDELL EW, 1994, J BIOL CHEM, V269, P16046; Rao F, 2013, EXP PHYSIOL, V98, P172, DOI 10.1113/expphysiol.2012.066761; Rosa JM, 2012, J MOL NEUROSCI; Rousan RM, 2009, AM J HEMATOL, V84, P565; Shvartsman M, 2007, AM J PHYSIOL-CELL PH, V293, pC1383, DOI 10.1152/ajpcell.00054.2007; Shvartsman M, 2012, BIOMETALS, V25, P711, DOI 10.1007/s10534-012-9529-7; Shvartsman M, 2010, BIOCHEM J, V429, P185, DOI 10.1042/BJ20100213; Sohn YS, 2012, HAEMATOL-HEMATOL J, V97, P670, DOI 10.3324/haematol.2011.054858; Tsushima RG, 1999, CIRC RES, V84, P1302, DOI 10.1161/01.RES.84.11.1302; Wang TX, 2013, BIOSENS BIOELECTRON, V49, P9, DOI 10.1016/j.bios.2013.04.039; Wang YL, 2011, J PHARMACOL EXP THER, V336, P56, DOI 10.1124/jpet.110.172668; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; WINEGAR BD, 1991, J GEN PHYSIOL, V97, P351, DOI 10.1085/jgp.97.2.351; Xia M, 2004, J MOL CELL CARDIOL, V36, P111, DOI 10.1016/j.yjmcc.2003.10.007; Yasui K, 2005, J PHARM SCI, V99, P205	63	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112915	10.1371/journal.pone.0112915	http://dx.doi.org/10.1371/journal.pone.0112915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390893	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400141
J	Haeler, E; Fiedler, K; Grill, A				Haeler, Elena; Fiedler, Konrad; Grill, Andrea			What Prolongs a Butterfly's Life?: Trade-Offs between Dormancy, Fecundity and Body Size	PLOS ONE			English	Article							MANIOLA-JURTINA LEPIDOPTERA; PHENOTYPIC PLASTICITY; REPRODUCTIVE DIAPAUSE; STRESS RESISTANCE; SPAN; HISTORY; DIFFERENTIATION; EVOLUTION; TEMPERATURE; MATURATION	In butterflies, life span often increases only at the expense of fecundity. Prolonged life span, on the other hand, provides more opportunities for oviposition. Here, we studied the association between life span and summer dormancy in two closely related species of Palearctic Meadow Brown butterflies, the endemic Maniola nurag and the widespread M. jurtina, from two climatic provenances, a Mediterranean and a Central European site, and tested the relationships between longevity, body size and fecundity. We experimentally induced summer dormancy and hence prolonged the butterflies' life in order to study the effects of such a prolonged life. We were able to modulate longevity only in Mediterranean females by rearing them under summer photoperiodic conditions (light 16 h : dark 8 h), thereby more than doubling their natural life span, to up to 246 days. Central European individuals kept their natural average live span under all treatments, as did Mediterranean individuals under autumn treatment (light 11: dark 13). Body size only had a significant effect in the smaller species, M. nurag, where it affected the duration of dormancy and lifetime fecundity. In the larger species, M. jurtina, a prolonged adult life span did, surprisingly, not convey any fecundity loss. In M. nurag, which generally deposited fewer eggs, extended life had a fecundity cost. We conclude that Mediterranen M. jurtina butterflies have an extraordinary plasticity in aging which allows them to extend life span in response to adverse environmental conditions and relieve the time limitation on egg-laying while maintaining egg production at equal levels.	[Haeler, Elena; Fiedler, Konrad; Grill, Andrea] Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria	University of Vienna	Grill, A (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Vienna, Austria.	a.grill@univie.ac.at	Fiedler, Konrad/H-8788-2019	Fiedler, Konrad/0000-0002-4789-3753; Haeler, Elena/0000-0002-3732-4565	Austrian Science Foundation [V169-B17]; University of Vienna; Austrian Science Fund (FWF) [V 169] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by an Elise Richter grant number V169-B17 from the Austrian Science Foundation (Fonds zur Forderung von Wissenschaft und Forschung) to Andrea Grill and a scholarship by the University of Vienna to E. Haeler. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2008, EVOL ECOL, V22, P507, DOI 10.1007/s10682-007-9179-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger D, 2012, J ANIM ECOL, V81, P1244, DOI 10.1111/j.1365-2656.2012.02010.x; Berger D, 2012, AM NAT, V180, P464, DOI 10.1086/667594; Braby MF, 2002, EVOL ECOL, V16, P399, DOI 10.1023/A:1020226426031; Bradshaw WE, 2010, ANNU REV PHYSIOL, V72, P147, DOI 10.1146/annurev-physiol-021909-135837; BRAKEFIELD P, 1979, HEREDITY, V42, P259, DOI 10.1038/hdy.1979.27; Brakefield PM, 2007, J BIOSCIENCES, V32, P465, DOI 10.1007/s12038-007-0046-8; BRAKEFIELD PM, 1991, ECOL ENTOMOL, V16, P291, DOI 10.1111/j.1365-2311.1991.tb00220.x; BRAKEFIELD PM, 1982, J ANIM ECOL, V51, P713, DOI 10.2307/4000; BRAKEFIELD PM, 1982, J ANIM ECOL, V51, P727, DOI 10.2307/4001; Brakefield PM, 1997, ENV STRESS ADAPTATIO, P66; Bubli OA, 2005, J EVOLUTIONARY BIOL, V14, P148; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; DANKS HV, 1987, BIOL SURVEY CANADA M, V1; Dapporto L, 2011, BIOL J LINN SOC, V103, P571, DOI 10.1111/j.1095-8312.2011.01639.x; DUNLAPPIANKA H, 1977, SCIENCE, V197, P487, DOI 10.1126/science.197.4302.487; Fischer K, 2007, ECOLOGICAL ENTOMOLOG, V32, P212; Fischer K, 2012, EVOL ECOL, V26, P1067, DOI 10.1007/s10682-011-9547-x; Flatt T, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P1; Flatt T, 2013, Q REV BIOL, V88, P185, DOI 10.1086/671484; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; GOULSON D, 1993, BIOL J LINN SOC, V49, P127, DOI 10.1111/j.1095-8312.1993.tb00894.x; Grill A, 2006, BIOL J LINN SOC, V89, P561, DOI 10.1111/j.1095-8312.2006.00683.x; Grill A, 2006, EUR J ENTOMOL, V103, P613, DOI 10.14411/eje.2006.082; Grill A, 2013, CONTRIB ZOOL, V82, P27, DOI 10.1163/18759866-08201002; Hamilton WJ, 1937, AM NAT, V71, P500, DOI 10.1086/280735; Heinze J, 2013, BEHAV ECOL SOCIOBIOL, V67, P1555, DOI 10.1007/s00265-013-1567-9; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hulbert AJ, 2007, PHYSIOL REV, V87, P1175, DOI 10.1152/physrev.00047.2006; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jervis MA, 2005, ECOL ENTOMOL, V30, P359, DOI 10.1111/j.0307-6946.2005.00712.x; Karl I, 2009, FUNCT ECOL, V23, P1132, DOI 10.1111/j.1365-2435.2009.01607.x; Karlsson B, 2008, FUNCT ECOL, V22, P121, DOI 10.1111/j.1365-2435.2007.01334.x; Kengeri SS, 2013, AGE, V35, P2503, DOI 10.1007/s11357-013-9529-8; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P439, DOI 10.1016/j.mad.2004.09.008; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kirkwood TBL, 2002, MECH AGEING DEV, V123, P737, DOI 10.1016/S0047-6374(01)00419-5; Kirkwood TBL, 2011, CURR BIOL, V21, pR701, DOI 10.1016/j.cub.2011.07.020; Kraus C, 2013, AM NAT, V181, P492, DOI 10.1086/669665; Le Bourg E, 2007, AGEING RES REV, V6, P141, DOI 10.1016/j.arr.2007.04.002; Lefranc A, 2000, HEREDITAS, V132, P243, DOI 10.1111/j.1601-5223.2000.00243.x; Lehtovaara A, 2013, AM NAT, V182, P653, DOI 10.1086/673296; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Loewy KJ, 2013, J LEPID SOC, V67, P196; Molleman F, 2007, EXP GERONTOL, V42, P472, DOI 10.1016/j.exger.2007.01.008; Moraiti CA, 2012, J INSECT PHYSIOL, V58, P1128, DOI 10.1016/j.jinsphys.2012.05.012; Pijpe J, 2008, AM NAT, V171, P81, DOI 10.1086/524200; Pijpe J, 2007, EVOL ECOL, V21, P589, DOI 10.1007/s10682-006-9137-5; R Core Team, 2021, R LANGUAGE ENV STAT; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SCALI V, 1971, J ANIM ECOL, V40, P467, DOI 10.2307/3255; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; Spieth HR, 2011, EUR J ENTOMOL, V108, P377, DOI 10.14411/eje.2011.047; Stearns S.C., 1992, pi; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Trager MD, 2011, J INSECT BEHAV, V24, P34, DOI 10.1007/s10905-010-9234-8; Xiao HJ, 2012, B ENTOMOL RES, V102, P267, DOI 10.1017/S0007485311000587; Ziehm M, 2013, AGING CELL, V12, P917, DOI 10.1111/acel.12123	62	15	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111955	10.1371/journal.pone.0111955	http://dx.doi.org/10.1371/journal.pone.0111955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390334	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400043
J	MacNulty, DR; Tallian, A; Stahler, DR; Smith, DW				MacNulty, Daniel R.; Tallian, Aimee; Stahler, Daniel R.; Smith, Douglas W.			Influence of Group Size on the Success of Wolves Hunting Bison	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; BEHAVIOR; LIONS; PREY; PREDATION; WOLF; SYSTEM; RATES	An intriguing aspect of social foraging behaviour is that large groups are often no better at capturing prey than are small groups, a pattern that has been attributed to diminished cooperation (i.e., free riding) in large groups. Although this suggests the formation of large groups is unrelated to prey capture, little is known about cooperation in large groups that hunt hard-to-catch prey. Here, we used direct observations of Yellowstone wolves (Canis lupus) hunting their most formidable prey, bison (Bison bison), to test the hypothesis that large groups are more cooperative when hunting difficult prey. We quantified the relationship between capture success and wolf group size, and compared it to previously reported results for Yellowstone wolves hunting elk (Cervus elaphus), a prey that was, on average, 3 times easier to capture than bison. Whereas improvement in elk capture success levelled off at 2-6 wolves, bison capture success levelled off at 9-13 wolves with evidence that it continued to increase beyond 13 wolves. These results are consistent with the hypothesis that hunters in large groups are more cooperative when hunting more formidable prey. Improved ability to capture formidable prey could therefore promote the formation and maintenance of large predator groups, particularly among predators that specialize on such prey.	[MacNulty, Daniel R.; Tallian, Aimee] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Tallian, Aimee] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Stahler, Daniel R.; Smith, Douglas W.] Yellowstone Ctr Resources, Yellowstone Wolf Project, Mammoth, WY USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	MacNulty, DR (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	dan.macnulty@usu.edu	MacNulty, Dan/L-3965-2016		National Science Foundation [DEB-0613730, DEB-1245373]; Yellowstone National Park; Yellowstone Park Foundation; Canon USA; National Science Foundation Graduate Research Fellowship [DGE-1147384]; Direct For Biological Sciences [1245373] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Yellowstone National Park; Yellowstone Park Foundation; Canon USA; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation (DEB-0613730, DEB-1245373), Yellowstone National Park, and many donors through the Yellowstone Park Foundation, including an anonymous donor, Canon USA, Annie and Bob Graham, and Frank and Kay Yeager. Aimee Tallian was also supported by a National Science Foundation Graduate Research Fellowship (DGE-1147384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Bangs EE, 1996, WILDLIFE SOC B, V24, P402; Becker MS, 2009, TERR ECOL SER, V3, P305, DOI 10.1016/S1936-7961(08)00216-9; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carbyn L.N., 1993, WOLVES BISON DYNAMIC; CARBYN LN, 1987, CAN J ZOOL, V65, P2072, DOI 10.1139/z87-317; Caro T., 1994, CHEETAHS SERENGETI P; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Creel S, 2002, AFRICAN WILD DOG; Cubaynes S, 2014, J ANIMAL ECOLOGY; EATON R L, 1970, Journal of Wildlife Management, V34, P56, DOI 10.2307/3799492; Escobedo R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0204; EUBANK RL, 1984, COMMUN STAT-THEOR M, V13, P433, DOI 10.1080/03610928408828695; FANSHAWE JH, 1993, ANIM BEHAV, V45, P479, DOI 10.1006/anbe.1993.1059; FULLER W. A., 1959, JOUR WILDLIFE MANAGEMENT, V23, P342, DOI 10.2307/3796894; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Garrott RA, 2009, TERR ECOL SER, V3, P191, DOI 10.1016/S1936-7961(08)00211-X; Gittleman J.L., 1989, P183; Holekamp KE, 1997, J ZOOL, V242, P1, DOI 10.1111/j.1469-7998.1997.tb02925.x; Houston D.B., 1982, NO YELLOWSTONE ELK E; Kim K, 2005, BEHAV ECOL SOCIOBIOL, V59, P92, DOI 10.1007/s00265-005-0013-z; Kruuk H, 1975, FUNCTION EVOLUTION B, P521; KRUUK H, 1972, SPOTTED HYENA; MacNulty DR, 2008, J WILDLIFE MANAGE, V72, P1834, DOI 10.2193/2008-069; MacNulty DR, 2007, J MAMMAL, V88, P595, DOI 10.1644/06-MAMM-A-119R1.1; MacNulty DR, 2012, BEHAV ECOL, V23, P75, DOI 10.1093/beheco/arr159; MacNulty DR, 2009, ECOL LETT, V12, P1347, DOI 10.1111/j.1461-0248.2009.01385.x; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; MacNulty DR, 2001, CAN FIELD NAT, V115, P495; MacNulty DR, 2002, PREDATORY SEQUENCE I; Mech L. David, 2003, P131; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; MILLS MGL, 1985, NATURE, V316, P61, DOI 10.1038/316061a0; Mukherjee S, 2013, BIOL REV, V88, P550, DOI 10.1111/brv.12014; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Pulliam HR, 1984, BEHAV ECOLOGY EVOLUT, P122; Rose LM, 1997, INT J PRIMATOL, V18, P727, DOI 10.1023/A:1026343812980; Schaller G. B., 1972, SERENGETI LION; SCHEEL D, 1991, ANIM BEHAV, V41, P697, DOI 10.1016/S0003-3472(05)80907-8; Seber G. A. F., 2003, NONLINEAR REGRESSION; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Smith DW, 2000, J MAMMAL, V81, P1128, DOI 10.1644/1545-1542(2000)081<1128:WBIIYN>2.0.CO;2; Stahler DR, 2013, J ANIM ECOL, V82, P222, DOI 10.1111/j.1365-2656.2012.02039.x; STANDER PE, 1992, CAN J ZOOL, V70, P8, DOI 10.1139/z92-002; VANORSDOL KG, 1984, AFR J ECOL, V22, P79; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; White PJ, 2011, BIOL CONSERV, V144, P1322, DOI 10.1016/j.biocon.2011.01.003; WOLD S, 1974, TECHNOMETRICS, V16, P1, DOI 10.2307/1267485	52	83	85	3	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112884	10.1371/journal.pone.0112884	http://dx.doi.org/10.1371/journal.pone.0112884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389760	gold, Green Published			2022-12-26	WOS:000349144400137
J	Searle, KR; Barber, J; Stubbins, F; Labuschagne, K; Carpenter, S; Butler, A; Denison, E; Sanders, C; Mellor, PS; Wilson, A; Nelson, N; Gubbins, S; Purse, BV				Searle, Kate R.; Barber, James; Stubbins, Francesca; Labuschagne, Karien; Carpenter, Simon; Butler, Adam; Denison, Eric; Sanders, Christopher; Mellor, Philip S.; Wilson, Anthony; Nelson, Noel; Gubbins, Simon; Purse, Bethan V.			Environmental Drivers of Culicoides Phenology: How Important Is Species-Specific Variation When Determining Disease Policy?	PLOS ONE			English	Article							MIDGES DIPTERA-CERATOPOGONIDAE; BLUETONGUE VIRUS SEROTYPE-8; BITING MIDGES; SCHMALLENBERG-VIRUS; NORTHERN EUROPE; VECTORS; NETHERLANDS; SPP.; IDENTIFICATION; CLIMATE	Since 2006, arboviruses transmitted by Culicoides biting midges (Diptera: Ceratopogonidae) have caused significant disruption to ruminant production in northern Europe. The most serious incursions involved strains of bluetongue virus (BTV), which cause bluetongue (BT) disease. To control spread of BTV, movement of susceptible livestock is restricted with economic and animal welfare impacts. The timing of BTV transmission in temperate regions is partly determined by the seasonal presence of adult Culicoides females. Legislative measures therefore allow for the relaxation of ruminant movement restrictions during winter, when nightly light-suction trap catches of Culicoides fall below a threshold (the 'seasonally vector free period': SVFP). We analysed five years of time-series surveillance data from light-suction trapping in the UK to investigate whether significant inter-specific and yearly variation in adult phenology exists, and whether the SVFP is predictable from environmental factors. Because female vector Culicoides are not easily morphologically separated, interspecific comparisons in phenology were drawn from male populations. We demonstrate significant inter-specific differences in Culicoides adult phenology with the season of Culicoides scoticus approximately eight weeks shorter than Culicoides obsoletus. Species-specific differences in the length of the SVFP were related to host density and local variation in landscape habitat. When the Avaritia Culicoides females were modelled as a group (as utilised in the SFVP), we were unable to detect links between environmental drivers and phenological metrics. We conclude that the current treatment of Avaritia Culicoides as a single group inhibits understanding of environmentally-driven spatial variation in species phenology and hinders the development of models for predicting the SVFP from environmental factors. Culicoides surveillance methods should be adapted to focus on concentrated assessments of species-specific abundance during the start and end of seasonal activity in temperate regions to facilitate refinement of ruminant movement restrictions thereby reducing the impact of Culicoides-borne arboviruses.	[Searle, Kate R.; Purse, Bethan V.] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Barber, James; Stubbins, Francesca; Carpenter, Simon; Denison, Eric; Sanders, Christopher; Mellor, Philip S.; Wilson, Anthony; Gubbins, Simon] Pirbright Inst, Woking, Surrey, England; [Labuschagne, Karien] ARC Onderstepoort Vet Inst, PVVD, Onderstepoort, South Africa; [Butler, Adam] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Nelson, Noel] Pirbright Inst, Met Off, Woking, Surrey, England	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; James Hutton Institute; Met Office - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Searle, KR (corresponding author), Ctr Ecol & Hydrol, Bush Estate, Penicuik, Midlothian, Scotland.	katrle@ceh.ac.uk	Labuschagne, Karien/J-9084-2019; Carpenter, Simon T/C-2718-2013; Searle, Kate R/F-4922-2011; Purse, Bethan V/I-6640-2012	Carpenter, Simon T/0000-0001-5775-045X; Searle, Kate R/0000-0003-4624-9023; Purse, Bethan V/0000-0001-5140-2710; Gubbins, Simon/0000-0003-0538-4173; Labuschagne, Karien/0000-0002-8352-0313; Wilson, Anthony/0000-0002-2000-2914	EU grant EDENext [FP7-261504]; EDENext Steering Committee [EDENext268]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001701] Funding Source: researchfish; Natural Environment Research Council [ceh010010] Funding Source: researchfish; BBSRC [BBS/E/I/00001701] Funding Source: UKRI	EU grant EDENext; EDENext Steering Committee; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext268 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch S, 2009, PARASITOL RES, V105, P373, DOI 10.1007/s00436-009-1408-y; Bessell PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01178; Blackwell A, 1997, MED VET ENTOMOL, V11, P361, DOI 10.1111/j.1365-2915.1997.tb00423.x; Campbell J. A., 1960, Proceedings of the Royal Society of Edinburgh (Sect B), V67, P181; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; Carpenter S, 2009, OUTLOOKS PEST MANAGE, V20, P161; Carpenter S, 2008, J APPL ECOL, V45, P1237, DOI 10.1111/j.1365-2664.2008.01511.x; Carpenter S, 2009, TRENDS MICROBIOL, V17, P172, DOI 10.1016/j.tim.2009.01.001; Davies I, 2012, IN PRACTICE, V34, P598, DOI 10.1136/inp.e7372; De Regge N, 2012, TRANSBOUND EMERG DIS, V59, P471, DOI 10.1111/tbed.12000; DYCE A L, 1969, Journal of the Australian Entomological Society, V8, P11; EFSA, 2008, ANN REPORT, P108; Elbers ARW, 2013, EMERG INFECT DIS, V19, P106, DOI 10.3201/eid1901.121054; Fisher NI, 1995, STAT ANAL CIRCULAR D; Garcia-Saenz A, 2011, MED VET ENTOMOL, V25, P113, DOI 10.1111/j.1365-2915.2010.00904.x; Gariglinany MM, 2012, EMERG INFECT DIS; Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002; Gelman A., 2007, DATA ANAL USING REGR; Gubbins S, 2008, J R SOC INTERFACE, V5, P363, DOI 10.1098/rsif.2007.1110; Harrup LE, 2013, MED VET ENTOMOLOGY; Hartemink NA, 2009, EPIDEMICS-NETH, V1, P153, DOI 10.1016/j.epidem.2009.05.004; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; KETTLE DS, 1952, B ENTOMOL RES, V43, P421, DOI 10.1017/S000748530002945X; Kluiters G, 2013, J APPL ECOL, V50, P232, DOI 10.1111/1365-2664.12030; Lassen SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-143; Lassen SB, 2011, PARASITOL RES, V108, P823, DOI 10.1007/s00436-010-2123-4; Lievaart-Peterson K, 2012, SMALL RUMINANT RES, V106, P71, DOI 10.1016/j.smallrumres.2012.03.006; Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Martinez-de la Puente J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-147; Mathieu B, 2011, VET PARASITOL, V182, P297, DOI 10.1016/j.vetpar.2011.05.052; Meiswinkel R, 2008, PREV VET MED, V87, P182, DOI 10.1016/j.prevetmed.2008.06.008; Mellor P. S., 2004, VET ITAL, V40, P715; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mintiens K, 2008, PREV VET MED, V87, P131, DOI 10.1016/j.prevetmed.2008.06.011; Modlin D, 2012, ENVIRONMETRICS, V23, P46, DOI 10.1002/env.1133; Morton D., 2011, 1107NERC CTR EC HYDR; Ninio C, 2001, PARASITOL RES, V108, P657; Purse BV, 2012, MED VET ENTOMOL, V26, P168, DOI 10.1111/j.1365-2915.2011.00991.x; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Sanders CJ, 2011, J APPL ECOL, V48, P1355, DOI 10.1111/j.1365-2664.2011.02051.x; Schley D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005481; Searle KR, 2013, B ENTOMOL RES, V103, P155, DOI 10.1017/S0007485312000466; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Takken W, 2008, PREV VET MED, V87, P41, DOI 10.1016/j.prevetmed.2008.06.015; van Rijn PA, 2012, VET MICROBIOL, V158, P23, DOI 10.1016/j.vetmic.2012.01.022; Vandenbussche F, 2009, TRANSBOUND EMERG DIS, V56, P346, DOI 10.1111/j.1865-1682.2009.01093.x; Viennet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048120; Viennet E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-119; Wilson A, 2007, VET REC, V161, P487, DOI 10.1136/vr.161.14.487	51	30	30	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111876	10.1371/journal.pone.0111876	http://dx.doi.org/10.1371/journal.pone.0111876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386940	gold, Green Accepted, Green Published			2022-12-26	WOS:000345250400029
J	Song, ZM; Liu, Y; Hao, BS; Yu, SJ; Zhang, H; Liu, DH; Zhou, B; Wu, L; Wang, M; Xiong, ZJ; Wu, CD; Zhu, JM; Qian, XX				Song, Zhiming; Liu, Yong; Hao, Baoshun; Yu, Shujie; Zhang, Hui; Liu, Dinghui; Zhou, Bin; Wu, Lin; Wang, Min; Xiong, Zhaojun; Wu, Chaodong; Zhu, Jieming; Qian, Xiaoxian			Ginsenoside Rb1 Prevents H2O2-Induced HUVEC Senescence by Stimulating Sirtuin-1 Pathway	PLOS ONE			English	Article							INDUCED PREMATURE SENESCENCE; HUMAN ENDOTHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; PEROXIDE-INDUCED APOPTOSIS; HUMAN-DIPLOID FIBROBLASTS; OXIDATIVE STRESS; CELLULAR SENESCENCE; SIRT1; ATHEROSCLEROSIS; DYSFUNCTION	Purposes: We have previously reported that Ginsenoside Rb1 may effectively prevent HUVECs from senescence, however, the detailed mechanism has not demonstrated up to now. Recent studies have shown that sirtuin-1 (Sirt1) plays an important role in the development of endothelial senescence. The purpose of this study was to explore whether Sirt1 is involved in the action of Ginsenoside Rb1 regarding protection against H2O2-induced HUVEC Senescence. Methods and Results: Senescence induced by hydrogen peroxide (H2O2) in human umbilical vein endothelial cells (HUVECs) was examined by analyzing plasminogen activator inhibitor-1 (PAI-1) expression, cell morphology, and senescence-associated beta-galactosidase (SA-beta-gal) activity. The results revealed that 42% of control-treated HUVECs were SA-b-gal positive after treatment by 60 mmol/L H2O2, however, this particular effect of H2O2 was decreased more than 2-fold (19%) in the HUVECs when pretreated with Rb1 (20 mu mol/L) for 30 min. Additionally, Rb1 decreased eNOS acetylation, as well as promoted more NO production that was accompanied by an increase in Sirt1 expression. Furthermore, upon knocking down Sirt1, the effect of Rb1 on HUVEC senescence was blunted. Conclusions: The present study indicated that Ginsenoside Rb1 acts through stimulating Sirt1 in order to protect against endothelial senescence and dysfunction. As such, Sirt1 appears to be of particular importance in maintaining endothelial functions and delaying vascular aging.	[Song, Zhiming; Liu, Yong; Hao, Baoshun; Yu, Shujie; Liu, Dinghui; Zhou, Bin; Wu, Lin; Wang, Min; Xiong, Zhaojun; Zhu, Jieming; Qian, Xiaoxian] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Hui] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Ultrasonog, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Chaodong] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Qian, Xiaoxian] Sun Yat Sen Univ, Inst Integrated Tradit Chinese & Western Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Texas A&M University System; Texas A&M University College Station; Sun Yat Sen University	Zhu, JM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China.	zhujieming2011@126.com; xiaoxianq@qq.com		song, zhiming/0000-0002-4004-7052	National Natural Science Foundation of China [81370447]; Natural Science Foundation of Guangdong Province [8151008901000209, S2012020010924]; Science and Technology Planning Project of Guangdong Province [2007B060401024, 2011B031800024, 2011B031800155]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095828] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the grants from the National Natural Science Foundation of China (grant number: 81370447, to XQ); Natural Science Foundation of Guangdong Province (grant number: 8151008901000209 and S2012020010924, to XQ); Science and Technology Planning Project of Guangdong Province (grant number: 2007B060401024, 2011B031800024 and 2011B031800155 to XQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shaer MH, 2006, INT J CARDIOL, V109, P201, DOI 10.1016/j.ijcard.2005.06.002; Albrecht EWJA, 2003, J PATHOL, V199, P8, DOI 10.1002/path.1250; Arunachalam G, 2010, BIOCHEM BIOPH RES CO, V393, P66, DOI 10.1016/j.bbrc.2010.01.080; Bai B, 2012, CIRCULATION, V126, P729, DOI 10.1161/CIRCULATIONAHA.112.118778; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Coleman PR, 2010, BLOOD, V116, P4016, DOI 10.1182/blood-2009-11-252700; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fabian D., 2011, NATURE ED KNOWLEDGE; Finegold JA, 2013, INT J CARDIOL, V168, P934, DOI 10.1016/j.ijcard.2012.10.046; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Gomes P, 2009, OXID MED CELL LONGEV, V2, P138, DOI 10.4161/oxim.2.3.8819; Gong GH, 2010, EUR J PHARMACOL, V628, P27, DOI 10.1016/j.ejphar.2009.11.028; Gorenne I, 2013, CIRCULATION, V127, P386, DOI 10.1161/CIRCULATIONAHA.112.124404; Haines DD, 2013, J CELL MOL MED, V17, P936, DOI 10.1111/jcmm.12074; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Ido Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035092; Zarzuelo MJ, 2013, BIOCHEM PHARMACOL, V85, P1288, DOI 10.1016/j.bcp.2013.02.015; Kao CL, 2010, J ATHEROSCLER THROMB, V17, P970, DOI 10.5551/jat.4333; Lan TH, 2011, BIOCHEM PHARMACOL, V82, P148, DOI 10.1016/j.bcp.2011.04.001; Li LX, 2010, ANN NY ACAD SCI, V1203, P151, DOI 10.1111/j.1749-6632.2010.05555.x; Lin YJ, 2011, ACTA PHARMACOL SIN, V32, P1246, DOI 10.1038/aps.2011.101; Liu DH, 2011, BIOL PHARM BULL, V34, P1072, DOI 10.1248/bpb.34.1072; Liu L, 2013, EUR REV MED PHARMACO, V17, P88; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Matsushita H, 2001, CIRC RES, V89, P793, DOI 10.1161/hh2101.098443; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Oeseburg H, 2009, HYPERTENSION, V53, P417, DOI 10.1161/HYPERTENSIONAHA.108.123729; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Ota H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029598; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Ota H, 2010, J ATHEROSCLER THROMB, V17, P431, DOI 10.5551/jat.3525; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Rippe C, 2012, EXP GERONTOL, V47, P45, DOI 10.1016/j.exger.2011.10.004; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043186; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080859; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; Xia N, 2013, NITRIC OXIDE-BIOL CH, V32, P29, DOI 10.1016/j.niox.2013.04.001; Zdanov S, 2006, ANN NY ACAD SCI, V1067, P210, DOI 10.1196/annals.1354.025; Zhou W, 2005, J VASC SURG, V41, P861, DOI 10.1016/j.jvs.2005.01.054; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	49	53	63	6	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112699	10.1371/journal.pone.0112699	http://dx.doi.org/10.1371/journal.pone.0112699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386949	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400084
J	Valentini, E; Koch, K; Aglioti, SM				Valentini, Elia; Koch, Katharina; Aglioti, Salvatore Maria			Thoughts of Death Modulate Psychophysical and Cortical Responses to Threatening Stimuli	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; EVOKED EEG RESPONSES; NEED SELF-ESTEEM; MORTALITY SALIENCE; PAIN PERCEPTION; POTENTIALS; ACCESSIBILITY; SUPPRESSION; NEUROTICISM; COVARIANCE	Existential social psychology studies show that awareness of one's eventual death profoundly influences human cognition and behaviour by inducing defensive reactions against end-of-life related anxiety. Much less is known about the impact of reminders of mortality on brain activity. Therefore we explored whether reminders of mortality influence subjective ratings of intensity and threat of auditory and painful thermal stimuli and the associated electroencephalographic activity. Moreover, we explored whether personality and demographics modulate psychophysical and neural changes related to mortality salience (MS). Following MS induction, a specific increase in ratings of intensity and threat was found for both nociceptive and auditory stimuli. While MS did not have any specific effect on nociceptive and auditory evoked potentials, larger amplitude of theta oscillatory activity related to thermal nociceptive activity was found after thoughts of death were induced. MS thus exerted a top-down modulation on theta electroencephalographic oscillatory amplitude, specifically for brain activity triggered by painful thermal stimuli. This effect was higher in participants reporting higher threat perception, suggesting that inducing a death-related mind-set may have an influence on body-defence related somatosensory representations.	[Valentini, Elia; Koch, Katharina; Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Valentini, Elia; Koch, Katharina; Aglioti, Salvatore Maria] Fdn Santa Lucia, Ist Ricovero & Cura Carattere Sci, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Valentini, E (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy.	elia.valentini@uniroma1.it	Aglioti, Salvatore M/E-9829-2012; Valentini, Elia/H-3188-2019	Valentini, Elia/0000-0003-0259-6824; Aglioti, Salvatore Maria/0000-0001-8175-7563	Avvio alla Ricerca Sapienza grant scheme; European Union Information and Communication Technologies Grant (VERE project, FP7-ICT-5) [257695]; Italian Ministry of Health [RC11.G, RF-2010-2312912]	Avvio alla Ricerca Sapienza grant scheme; European Union Information and Communication Technologies Grant (VERE project, FP7-ICT-5); Italian Ministry of Health(Ministry of Health, Italy)	E. Valentini is supported by the Avvio alla Ricerca Sapienza grant scheme. S. M. Aglioti was funded by the European Union Information and Communication Technologies Grant (VERE project, FP7-ICT-2009-5, Prot. Num. 257695) and the Italian Ministry of Health (grant RC11.G and RF-2010-2312912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt J, 1997, J PERS SOC PSYCHOL, V73, P5, DOI 10.1037/0022-3514.73.1.5; Arndt J, 1998, PERS SOC PSYCHOL B, V24, P1216, DOI 10.1177/01461672982411008; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Cruccu G, 2003, BRAIN, V126, P2246, DOI 10.1093/brain/awg227; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dimitrov Dimiter M, 2003, Work, V20, P159; FRUHSTOR.H, 1970, ELECTROEN CLIN NEURO, V28, P153, DOI 10.1016/0013-4694(70)90183-5; Goldenberg JL, 2006, PERS SOC PSYCHOL B, V32, P1264, DOI 10.1177/0146167206289505; Gontkovsky ST, 2004, APPL NEUROPSYCHOL, V11, P75, DOI 10.1207/s15324826an1102_2; GREENBERG J, 1992, J PERS SOC PSYCHOL, V63, P212, DOI 10.1037/0022-3514.63.2.212; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1992, J PERS SOC PSYCHOL, V63, P913, DOI 10.1037/0022-3514.63.6.913; Han SH, 2010, NEUROPSYCHOLOGIA, V48, P3436, DOI 10.1016/j.neuropsychologia.2010.07.026; Harmon-Jones E, 1997, J PERS SOC PSYCHOL, V72, P24, DOI 10.1037/0022-3514.72.1.24; Hayes J, 2010, PSYCHOL BULL, V136, P699, DOI 10.1037/a0020524; Henry EA, 2010, SOC COGN AFFECT NEUR, V5, P77, DOI 10.1093/scan/nsp041; Hirsh JB, 2008, PSYCHOL SCI, V19, P962, DOI 10.1111/j.1467-9280.2008.02183.x; Hu L, 2010, NEUROIMAGE, V50, P99, DOI 10.1016/j.neuroimage.2009.12.010; Hu L, 2013, J PAIN, V14, P89, DOI 10.1016/j.jpain.2012.10.008; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2005, NEUROIMAGE, V28, P708, DOI 10.1016/j.neuroimage.2005.06.060; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; KASTENBAUM R, 1977, ANNU REV PSYCHOL, V28, P225, DOI 10.1146/annurev.ps.28.020177.001301; Klackl J, 2013, SOC COGN AFFECT NEUR, V8, P333, DOI 10.1093/scan/nss003; Legrain V, 2012, NEUROPHYSIOL CLIN, V42, P325, DOI 10.1016/j.neucli.2012.06.003; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Luck S.J., 2005, INTRO EVENT RELATED; Luo S, 2013, SOC COGN AFFECT NEUR; Maxfield M, 2007, PSYCHOL AGING, V22, P341, DOI 10.1037/0882-7974.22.2.341; Mitsis GD, 2008, NEUROIMAGE, V40, P121, DOI 10.1016/j.neuroimage.2007.11.026; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Mouraux A, 2003, CLIN NEUROPHYSIOL, V114, P710, DOI 10.1016/S1388-2457(03)00027-0; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; Ploner M, 2006, CEREB CORTEX, V16, P537, DOI 10.1093/cercor/bhj001; PORTER AC, 1987, J COUNS PSYCHOL, V34, P383; Pyszczynski T, 1999, PSYCHOL REV, V106, P835, DOI 10.1037/0033-295X.106.4.835; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Quirin M, 2012, SOC COGN AFFECT NEUR, V7, P193, DOI 10.1093/scan/nsq106; Rausch JR, 2003, J CLIN CHILD ADOLESC, V32, P467, DOI 10.1207/S15374424JCCP3203_15; Rengachary J, 2011, FRONT HUM NEUROSCI, V5, DOI [10.3389/fnhum.2011.00029, 10.3389/fnhum.2011.00069]; Ronga I, 2013, J NEUROPHYSIOL, V109, P692, DOI 10.1152/jn.00464.2012; ROSENBLATT A, 1989, J PERS SOC PSYCHOL, V57, P681, DOI 10.1037/0022-3514.57.4.681; Schlereth T, 2001, PAIN, V92, P187, DOI 10.1016/S0304-3959(00)00484-X; Schulz E, 2012, CEREB CORTEX, V22, P1118, DOI 10.1093/cercor/bhr186; Schulz E, 2011, CEREB CORTEX, V21, P2408, DOI 10.1093/cercor/bhr027; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Spielberger C. D., 1973, MANUAL STATE TRAIT I; TARKKA IM, 1993, J CLIN NEUROPHYSIOL, V10, P513, DOI 10.1097/00004691-199310000-00009; Todorovic A, 2012, J NEUROSCI, V32, P13389, DOI 10.1523/JNEUROSCI.2227-12.2012; Torta DM, 2012, EXP BRAIN RES, V218, P361, DOI 10.1007/s00221-012-3019-6; Tritt SM, 2012, SOC COGNITION, V30, P715, DOI 10.1521/soco.2012.30.6.715; Valentini E, 2013, CORTEX, V49, P446, DOI 10.1016/j.cortex.2012.02.005; Valentini E, 2012, HUM BRAIN MAPP, V33, P2873, DOI 10.1002/hbm.21408; Valentini E, 2011, J COGNITIVE NEUROSCI, V23, P2822, DOI 10.1162/jocn.2011.21609; Walton KD, 2010, PAIN, V150, P41, DOI 10.1016/j.pain.2010.02.023; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zhang ZG, 2012, J NEUROSCI, V32, P7429, DOI 10.1523/JNEUROSCI.5877-11.2012	60	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112324	10.1371/journal.pone.0112324	http://dx.doi.org/10.1371/journal.pone.0112324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386905	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000345250400055
J	Szule, J; Kondor, D; Dobos, L; Csabai, I; Vattay, G				Szuele, Janos; Kondor, Daniel; Dobos, Laszlo; Csabai, Istvan; Vattay, Gabor			Lost in the City: Revisiting Milgram's Experiment in the Age of Social Networks	PLOS ONE			English	Article							SMALL WORLD; DIMENSION; SEARCH	As more and more users access social network services from smart devices with GPS receivers, the available amount of geo-tagged information makes repeating classical experiments possible on global scales and with unprecedented precision. Inspired by the original experiments of Milgram, we simulated message routing within a representative sub-graph of the network of Twitter users with about 6 million geo-located nodes and 122 million edges. We picked pairs of users from two distant metropolitan areas and tried to find a route between them using local geographic information only; our method was to forward messages to a friend living closest to the target. We found that the examined network is navigable on large scales, but navigability breaks down at the city scale and the network becomes unnavigable on intra-city distances. This means that messages usually arrived to the close proximity of the target in only 3-6 steps, but only in about 20% of the cases was it possible to find a route all the way to the recipient, in spite of the network being connected. This phenomenon is supported by the distribution of link lengths; on larger scales the distribution behaves approximately as P(d) similar to 1/d, which was found earlier by Kleinberg to allow efficient navigation, while on smaller scales, a fractal structure becomes apparent. The intra-city correlation dimension of the network was found to be D-2 = 1.25, less than the dimension D-2 = 1.78 of the distribution of the population.	[Szuele, Janos; Kondor, Daniel; Dobos, Laszlo; Csabai, Istvan; Vattay, Gabor] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary	Eotvos Lorand University	Szule, J (corresponding author), Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary.	szule@complex.elte.hu	Vattay, Gabor/Q-4266-2019; Csabai, Istvan/F-6045-2011; Vattay, Gabor/G-9638-2017; Kondor, Daniel/AAD-9871-2019; Dobos, Laszlo/E-6071-2012	Csabai, Istvan/0000-0001-9232-9898; Vattay, Gabor/0000-0002-0919-9429; Kondor, Daniel/0000-0003-3720-7462; Dobos, Laszlo/0000-0001-7679-9478	European Union; European Social Fund [TAMOP-4.2.2.C-11/1/KONV-2012-0013]; Hungarian Government [EITKIC_12-1-2012-0001]; Research and Technology Innovation Fund; MAKOG Foundation	European Union(European Commission); European Social Fund(European Social Fund (ESF)); Hungarian Government; Research and Technology Innovation Fund; MAKOG Foundation	The authors are thankful for the partial support of the European Union and the European Social Fund through project FuturICT.hu (grant no. TAMOP-4.2.2.C-11/1/KONV-2012-0013). EITKIC_12-1-2012-0001 project was partially supported by the Hungarian Government, managed by the National Development Agency, and financed by the Research and Technology Innovation Fund and the MAKOG Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby S, 1996, GEOGR ANAL, V28, P147; Bakhshandeh R, 2011, P S COMB SEARCH; Bliss CA, 2012, J COMPUT SCI-NETH, V3, P388, DOI 10.1016/j.jocs.2012.05.001; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Boillot A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052708, 10.1371/journal.pone.0064417]; Cartozo CC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.238703; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Chung F, 2002, P NATL ACAD SCI USA, V99, P15879, DOI 10.1073/pnas.252631999; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Goldenberg J, 2009, DISTANCE IS NOT DEAD; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Hu YQ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.108701; Klein J.T., 2000, P 19 ACM SIGACT SIGM, P1; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Kondor D, 2013, PHYSICA A, V392, P4160, DOI 10.1016/j.physa.2013.04.046; Lambiotte R, 2008, PHYSICA A, V387, P5317, DOI 10.1016/j.physa.2008.05.014; Dobos L, 2013, INT CONF COGN INFO, P289, DOI 10.1109/CogInfoCom.2013.6719259; Li DQ, 2011, NAT PHYS, V7, P481, DOI [10.1038/NPHYS1932, 10.1038/nphys1932]; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Matray P, 2012, COMPUT NETW, V56, P2237, DOI 10.1016/j.comnet.2012.03.005; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roberson MR, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.017101; Sakaki T., 2010, P 19 INT C WORLD WID, P851, DOI [10.1145/1772690.1772777, DOI 10.1145/1772690.1772777, 10.1145/1772690.1772777.]; Shen GQ, 2002, INT J GEOGR INF SCI, V16, P419, DOI 10.1080/13658810210137013; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Ugander J., 2011, ARXIV11114503; Watts DJ, 2002, SCIENCE, V296, P1302, DOI 10.1126/science.1070120; Westerman D, 2012, COMPUT HUM BEHAV, V28, P199, DOI 10.1016/j.chb.2011.09.001; Yook SH, 2002, P NATL ACAD SCI USA, V99, P13382, DOI 10.1073/pnas.172501399; Zhang X, 2011, PROCD SOC BEHV, V26, DOI 10.1016/j.sbspro.2011.10.562	33	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111973	10.1371/journal.pone.0111973	http://dx.doi.org/10.1371/journal.pone.0111973			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3DP	25383796	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700027
J	Zanier, K; Stutz, C; Kintscher, S; Reinz, E; Sehr, P; Bulkescher, J; Hoppe-Seyler, K; Trave, G; Hoppe-Seyler, F				Zanier, Katia; Stutz, Christina; Kintscher, Susanne; Reinz, Eileen; Sehr, Peter; Bulkescher, Julia; Hoppe-Seyler, Karin; Trave, Gilles; Hoppe-Seyler, Felix			The E6AP Binding Pocket of the HPV16 E6 Oncoprotein Provides a Docking Site for a Small Inhibitory Peptide Unrelated to E6AP, Indicating Druggability of E6	PLOS ONE			English	Article							POSITIVE CANCER-CELLS; PATHWAYS; PROTEINS; P53; PAPILLOMAVIRUSES; ASSOCIATION; DEGRADATION; INDUCTION; APOPTOSIS; DESIGN	The HPV E6 oncoprotein maintains the malignant phenotype of HPV-positive cancer cells and represents an attractive therapeutic target. E6 forms a complex with the cellular E6AP ubiquitin ligase, ultimately leading to p53 degradation. The recently elucidated x-ray structure of a HPV16 E6/E6AP complex showed that HPV16 E6 forms a distinct binding pocket for E6AP. This discovery raises the question whether the E6AP binding pocket is druggable, i.e. whether it provides a docking site for functional E6 inhibitors. To address these issues, we performed a detailed analysis of the HPV16 E6 interactions with two small peptides: (i) E6APpep, corresponding to the E6 binding domain of E6AP, and (ii) pep11**, a peptide that binds to HPV16 E6 and, in contrast to E6APpep, induces apoptosis, specifically in HPV16-positive cancer cells. Surface plasmon resonance, NMR chemical shift perturbation, and mammalian two-hybrid analyses coupled to mutagenesis indicate that E6APpep contacts HPV16 E6 amino acid residues within the E6AP pocket, both in vitro and intracellularly. Many of these amino acids were also important for binding to pep11**, suggesting that the binding sites for the two peptides on HPV16 E6 overlap. Yet, few E6 amino acids were differentially involved which may contribute to the higher binding affinity of pep11**. Data from the HPV16 E6/pep11** interaction allowed the rational design of single amino acid exchanges in HPV18 and HPV31 E6 that enabled their binding to pep11**. Taken together, these results suggest that E6 molecular surfaces mediating E6APpep binding can also accommodate pro-apoptotic peptides that belong to different sequence families. As proof of concept, this study provides the first experimental evidence that the E6AP binding pocket is druggable, opening new possibilities for rational, structure-based drug design.	[Zanier, Katia; Trave, Gilles] Ecole Biotechnol Strasbourg IREBS, Inst Rech, F-67412 Illkirch Graffenstaden, France; [Stutz, Christina; Kintscher, Susanne; Reinz, Eileen; Bulkescher, Julia; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix] German Canc Res Ctr, Program Infect & Canc, D-69120 Heidelberg, Germany; [Sehr, Peter] European Mol Biol Lab, EMBL DKFZ Chem Biol Core Facil, D-69117 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); European Molecular Biology Laboratory (EMBL)	Zanier, K (corresponding author), Ecole Biotechnol Strasbourg IREBS, Inst Rech, F-67412 Illkirch Graffenstaden, France.	zanier@unistra.fr; hoppe-seyler@dkfz.de	TRAVE, Gilles/P-8577-2016	Sehr, Peter/0000-0002-4348-5066; Hoppe-Seyler, Felix/0000-0002-1864-300X	Deutsche Krebshilfe [109392]; National Institutes of Health [R01CA134737]; NATIONAL CANCER INSTITUTE [R01CA134737] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant (# 109392) of the Deutsche Krebshilfe (http://www.krebshilfe.de/metanavigation/english.html) to F. H. S. and a National Institutes of Health (http://www.nih.gov/)grant (# R01CA134737) to G.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butz K, 2000, P NATL ACAD SCI USA, V97, P6693, DOI 10.1073/pnas.110538897; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Butz K, 2001, ONCOGENE, V20, P6579, DOI 10.1038/sj.onc.1204805; Cherry JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084506; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dymalla S, 2009, J MOL MED, V87, P321, DOI 10.1007/s00109-008-0432-1; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Goodwin EC, 2000, P NATL ACAD SCI USA, V97, P12513, DOI 10.1073/pnas.97.23.12513; Griffin H, 2006, J MOL BIOL, V355, P360, DOI 10.1016/j.jmb.2005.10.077; Hoppe-Seyler F, 2011, INT J CANCER, V129, P1289, DOI 10.1002/ijc.26087; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; Keller RLJ., 2004, OPTIMIZING PROCESS N; Lagrange M, 2007, BIOCHEM BIOPH RES CO, V361, P487, DOI 10.1016/j.bbrc.2007.07.040; Mason JM, 2010, FUTURE MED CHEM, V2, P1813, DOI [10.4155/fmc.10.259, 10.4155/FMC.10.259]; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Tomaic V, 2009, VIROLOGY, V393, P7, DOI 10.1016/j.virol.2009.07.029; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yamato K, 2006, CANCER GENE THER, V13, P234, DOI 10.1038/sj.cgt.7700891; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zanier K, 2007, PROTEIN EXPRES PURIF, V51, P59, DOI 10.1016/j.pep.2006.07.029; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zheng XL, 2013, AAPS J, V15, P228, DOI 10.1208/s12248-012-9426-6; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	32	26	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112514	10.1371/journal.pone.0112514	http://dx.doi.org/10.1371/journal.pone.0112514			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383876	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700073
J	Kadare, G; Gervasi, N; Brami-Cherrier, K; Blockus, H; El Messari, S; Arold, ST; Girault, JA				Kadare, Gress; Gervasi, Nicolas; Brami-Cherrier, Karen; Blockus, Heike; El Messari, Said; Arold, Stefan T.; Girault, Jean-Antoine			Conformational Dynamics of the Focal Adhesion Targeting Domain Control Specific Functions of Focal Adhesion Kinase in Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Conformational Change; Focal Adhesions; Protein Kinase; Protein Structure; Tyrosine-Protein Kinase (Tyrosine Kinase)	SRC FAMILY KINASES; FAK PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; DEPENDENT FUNCTIONS; STRUCTURAL BASIS; ERK ACTIVATION; LD MOTIFS; PAXILLIN; BINDING; LOCALIZATION	Background: Focal adhesion kinase (FAK) is enriched at focal adhesions through its focal adhesion targeting (FAT) domain, a four-helix bundle. Results: Mutations that facilitate or prevent opening of the first helix have profound consequences on the biochemical properties of FAK and its function in cells. Conclusion: The ability of FAT to open and close is essential for FAK function. Significance: This provides evidence for the functional importance of the conformational dynamics of FAT. Focal adhesion (FA) kinase (FAK) regulates cell survival and motility by transducing signals from membrane receptors. The C-terminal FA targeting (FAT) domain of FAK fulfils multiple functions, including recruitment to FAs through paxillin binding. Phosphorylation of FAT on Tyr(925) facilitates FA disassembly and connects to the MAPK pathway through Grb2 association, but requires dissociation of the first helix (H1) of the four-helix bundle of FAT. We investigated the importance of H1 opening in cells by comparing the properties of FAK molecules containing wild-type or mutated FAT with impaired or facilitated H1 openings. These mutations did not alter the activation of FAK, but selectively affected its cellular functions, including self-association, Tyr(925) phosphorylation, paxillin binding, and FA targeting and turnover. Phosphorylation of Tyr(861), located between the kinase and FAT domains, was also enhanced by the mutation that opened the FAT bundle. Similarly phosphorylation of Ser(910) by ERK in response to bombesin was increased by FAT opening. Although FAK molecules with the mutation favoring FAT opening were poorly recruited at FAs, they efficiently restored FA turnover and cell shape in FAK-deficient cells. In contrast, the mutation preventing H1 opening markedly impaired FAK function. Our data support the biological importance of conformational dynamics of the FAT domain and its functional interactions with other parts of the molecule.	[Kadare, Gress; Gervasi, Nicolas; Brami-Cherrier, Karen; Blockus, Heike; El Messari, Said; Girault, Jean-Antoine] INSERM, UMR S 839, F-75005 Paris, France; [Kadare, Gress; Gervasi, Nicolas; Brami-Cherrier, Karen; Blockus, Heike; El Messari, Said; Girault, Jean-Antoine] Univ Paris 06, Sorbonne Univ, F-75005 Paris, France; [Kadare, Gress; Gervasi, Nicolas; Brami-Cherrier, Karen; Blockus, Heike; El Messari, Said; Girault, Jean-Antoine] Inst Fer Moulin, F-75005 Paris, France; [Arold, Stefan T.] King Abdullah Univ Sci & Technol KAUST, Div Biol & Environm Sci & Engn, Computat Biosci Res Ctr CBRC, Thuwal, Saudi Arabia; [Arold, Stefan T.] Univ Montpellier I & II, CNRS, Ctr Biochim Struct, INSERM,U1054,UMR5048, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; King Abdullah University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Girault, JA (corresponding author), UPMC, INSERM, UMR S 839, Inst Fer Moulin, 17 Rue Fer Moulin, F-75005 Paris, France.	jean-antoine.girault@inserm.fr	Gervasi, Nicolas/P-6047-2017; Girault, Jean-Antoine/F-7518-2013; brami-cherrier, karen/I-9263-2014; Arold, Stefan/T-2612-2019	Gervasi, Nicolas/0000-0002-1924-2443; Girault, Jean-Antoine/0000-0002-7900-1705; brami-cherrier, karen/0000-0002-3009-3821; Blockus, Heike/0000-0001-5274-2805; Arold, Stefan T/0000-0001-5278-0668; Kadare, Gress/0000-0002-8865-5743	Agence Nationale de la Recherche [ANR-05-2_42589]; Association pour la Recherche sur le Cancer (ARC) [A05/3/3138]; Fondation pour la Recherche Medicale; European Research Council; Inserm; UPMC; King Abdullah University of Science and Technology (KAUST); Paris School of Neuroscience (ENP)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Paris School of Neuroscience (ENP)	This work was supported in part by Agence Nationale de la Recherche Grant ANR-05-2_42589, Association pour la Recherche sur le Cancer (ARC) Grant A05/3/3138, Fondation pour la Recherche Medicale, European Research Council, Inserm, UPMC, and King Abdullah University of Science and Technology (KAUST).; Undergraduate funded by the Paris School of Neuroscience (ENP). Present address: Institut de la Vision, UMR-S 968 Inserm/UPMC/CNRS 7210, 75012 Paris, France.	Alam T, 2014, BIOCHEM J, V460, P317, DOI 10.1042/BJ20140298; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Bergdoll M, 1997, STRUCTURE, V5, P391, DOI 10.1016/S0969-2126(97)00196-2; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; BOURNE Y, 1995, P NATL ACAD SCI USA, V92, P10232, DOI 10.1073/pnas.92.22.10232; Brami-Cherrier K, 2014, EMBO J, V33, P356, DOI 10.1002/embj.201386399; Burgaya F, 1996, MOL BRAIN RES, V37, P63, DOI 10.1016/0169-328X(95)00273-U; Cable J, 2012, BIOCHEMISTRY-US, V51, P2213, DOI 10.1021/bi300123a; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Corsi JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-198; Corsi JM, 2009, J BIOL CHEM, V284, P34769, DOI 10.1074/jbc.M109.067280; Deramaudt TB, 2011, MOL BIOL CELL, V22, P964, DOI 10.1091/mbc.E10-08-0725; Dixon RDS, 2004, STRUCTURE, V12, P2161, DOI 10.1016/j.str.2004.09.011; Dunty JM, 2004, MOL CELL BIOL, V24, P5353, DOI 10.1128/MCB.24.12.5353-5368.2004; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Garron ML, 2008, J MOL BIOL, V375, P1320, DOI 10.1016/j.jmb.2007.11.040; Girault JA, 1999, TRENDS BIOCHEM SCI, V24, P54, DOI 10.1016/S0968-0004(98)01331-0; Grigera PR, 2005, J CELL SCI, V118, P4931, DOI 10.1242/jcs.02696; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hamadi A, 2010, J ONCOL, V2010, DOI 10.1155/2010/932803; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Hayashi I, 2002, NAT STRUCT BIOL, V9, P101, DOI 10.1038/nsb755; HILDEBRAND JD, 1993, J CELL BIOL, V123, P993, DOI 10.1083/jcb.123.4.993; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Hunger-Glaser I, 2004, J CELL PHYSIOL, V200, P213, DOI 10.1002/jcp.20018; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Jiang XH, 2007, CELL SIGNAL, V19, P1000, DOI 10.1016/j.cellsig.2006.11.004; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Katz BZ, 2003, J BIOL CHEM, V278, P29115, DOI 10.1074/jbc.M212396200; Ladbury JE, 2012, TRENDS BIOCHEM SCI, V37, P173, DOI 10.1016/j.tibs.2012.01.001; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lim YM, 2004, J BIOL CHEM, V279, P29060, DOI 10.1074/jbc.M401183200; Liu GH, 2002, MOL CELL BIOL, V22, P2751, DOI 10.1128/MCB.22.8.2751-2760.2002; Ma A, 2001, MOL BIOL CELL, V12, P1; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; OWENS LV, 1995, CANCER RES, V55, P2752; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Prutzman KC, 2004, STRUCTURE, V12, P881, DOI 10.1016/S0969-2126(04)00097-8; Rousseau F, 2001, P NATL ACAD SCI USA, V98, P5596, DOI 10.1073/pnas.101542098; Schaller MD, 2001, BBA-MOL CELL RES, V1540, P1, DOI 10.1016/S0167-4889(01)00123-9; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; SCHLAEPFER DD, 1994, NATURE, V372, P786; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; TACHIBANA K, 1995, J EXP MED, V182, P1089, DOI 10.1084/jem.182.4.1089; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P; Zhou Z, 2006, PROTEINS, V65, P259, DOI 10.1002/prot.21107	56	23	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					478	491		10.1074/jbc.M114.593632	http://dx.doi.org/10.1074/jbc.M114.593632			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391654	Green Published, hybrid			2022-12-26	WOS:000347231200042
J	Engstrom, M; Warntjes, JBM; Tisell, A; Landtblom, AM; Lundberg, P				Engstrom, Maria; Warntjes, Jan B. M.; Tisell, Anders; Landtblom, Anne-Marie; Lundberg, Peter			Multi-Parametric Representation of Voxel-Based Quantitative Magnetic Resonance Imaging	PLOS ONE			English	Article							APPEARING WHITE-MATTER; HIGH-RESOLUTION T-1; GRAY-MATTER; BRAIN; SCLEROSIS; T2; QUANTIFICATION; RELAXOMETRY; DISABILITY; INJURY	The aim of the study was to explore the possibilities of multi-parametric representations of voxel-wise quantitative MRI data to objectively discriminate pathological cerebral tissue in patients with brain disorders. For this purpose, we recruited 19 patients with Multiple Sclerosis (MS) as benchmark samples and 19 age and gender matched healthy subjects as a reference group. The subjects were examined using quantitative Magnetic Resonance Imaging (MRI) measuring the tissue structure parameters: relaxation rates, R-1 and R-2, and proton density. The resulting parameter images were normalized to a standard template. Tissue structure in MS patients was assessed by voxel-wise comparisons with the reference group and with correlation to a clinical measure, the Expanded Disability Status Scale (EDSS). The results were visualized by conventional geometric representations and also by multi-parametric representations. Data showed that MS patients had lower R-1 and R-2, and higher proton density in periventricular white matter and in wide-spread areas encompassing central and sub-cortical white matter structures. MS-related tissue abnormality was highlighted in posterior white matter whereas EDSS correlation appeared especially in the frontal cortex. The multi-parameter representation highlighted disease-specific features. In conclusion, the proposed method has the potential to visualize both high-probability focal anomalies and diffuse tissue changes. Results from voxel-based statistical analysis, as exemplified in the present work, may guide radiologists where in the image to inspect for signs of disease. Future clinical studies must validate the usability of the method in clinical practice.	[Engstrom, Maria] Linkoping Univ, Dept Med & Hlth Sci, Div Radiol, Linkoping, Sweden; [Engstrom, Maria; Warntjes, Jan B. M.; Tisell, Anders; Landtblom, Anne-Marie; Lundberg, Peter] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden; [Warntjes, Jan B. M.] Linkoping Univ, Dept Med & Hlth Sci, Div Cardiovasc Med, Linkoping, Sweden; [Warntjes, Jan B. M.] SyntheticMR AB, Linkoping, Sweden; [Tisell, Anders; Lundberg, Peter] Linkoping Univ, Dept Med & Hlth Sci, Div Radiat Phys, Linkoping, Sweden; [Landtblom, Anne-Marie] Linkoping Univ, Dept Clin & Expt Med, Div Neurol, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Engstrom, M (corresponding author), Linkoping Univ, Dept Med & Hlth Sci, Div Radiol, Linkoping, Sweden.	maria.engstrom@liu.se	Lundberg, Peter/AGD-9679-2022	Landtblom, Anne-Marie/0000-0001-9567-470X; Engstrom, Maria/0000-0002-2167-2450	National Research Council [VR/NT 2008-3368]; Linkoping University; County Council of Ostergotland	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Linkoping University; County Council of Ostergotland	The National Research Council (grant number VR/NT 2008-3368), Linkoping University, and the County Council of Ostergotland are acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SyntheticMR AB provided support in the form of salary for author JBMW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alfano B, 1997, MAGNET RESON MED, V37, P84, DOI 10.1002/mrm.1910370113; Ambarki K, 2012, AM J NEURORADIOL, V33, P1951, DOI 10.3174/ajnr.A3067; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Audoin B, 2004, J MAGN RESON IMAGING, V20, P765, DOI 10.1002/jmri.20178; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Bates D., 2013, LME4 LINEAR MIXED EF; BOBMAN SA, 1985, AM J NEURORADIOL, V6, P265; Bodini B, 2009, HUM BRAIN MAPP, V30, P2852, DOI 10.1002/hbm.20713; Ceccarelli A, 2008, NEUROIMAGE, V39, P1499, DOI 10.1016/j.neuroimage.2007.11.002; Deichmann R, 2005, MAGNET RESON MED, V54, P20, DOI 10.1002/mrm.20552; Deoni SCL, 2005, MAGN RESON MED, V53, P237, DOI 10.1002/mrm.20314; Draganski B, 2011, NEUROIMAGE, V55, P1423, DOI 10.1016/j.neuroimage.2011.01.052; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; Filippi M, 2000, J NEUROVIROL, V6, pS115; Hasan KM, 2012, J MAGN RESON IMAGING, V35, P1300, DOI 10.1002/jmri.23539; Hasan KM, 2012, J NEUROL SCI, V313, P99, DOI 10.1016/j.jns.2011.09.015; Jure L, 2010, J MAGN RESON IMAGING, V32, P424, DOI 10.1002/jmri.22265; Kincses ZT, 2011, MULT SCLER J, V17, P681, DOI 10.1177/1352458510391342; Kumar R, 2012, J MAGN RESON IMAGING, V35, P300, DOI 10.1002/jmri.22831; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LARSSON HBW, 1989, MAGNET RESON MED, V11, P337, DOI 10.1002/mrm.1910110308; Levesque IR, 2009, MAGN RESON MED, V62, P1487, DOI 10.1002/mrm.22131; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Neeb H, 2006, NEUROIMAGE, V31, P1156, DOI 10.1016/j.neuroimage.2005.12.063; Neema M, 2007, J NEUROIMAGING, V17, p16S, DOI 10.1111/j.1552-6569.2007.00131.x; Neema M, 2009, NEUROIMAGE, V46, P633, DOI 10.1016/j.neuroimage.2009.03.001; Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335; RCore Team, 2020, R LANG ENV STAT COMP; Riederer S J, 1986, Acta Radiol Suppl, V369, P466; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, pXV; Vagberg M, 2013, AM J NEURORADIOL, V34, P498, DOI 10.3174/ajnr.A3262; Warnties JBM, 2008, MAGN RESON MED, V60, P320, DOI 10.1002/mrm.21635; Warntjes J, 2012, PLOS ONE, V8; Warntjes JBM, 2007, MAGN RESON MED, V57, P528, DOI 10.1002/mrm.21165; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Whittall KP, 2002, MAGNET RESON MED, V47, P403, DOI 10.1002/mrm.10076	39	14	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111688	10.1371/journal.pone.0111688	http://dx.doi.org/10.1371/journal.pone.0111688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393722	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300018
J	Lewinska, M; Juvan, P; Perse, M; Jeruc, J; Kos, S; Lorbek, G; Urlep, Z; Keber, R; Horvat, S; Rozman, D				Lewinska, Monika; Juvan, Peter; Perse, Martina; Jeruc, Jera; Kos, Spela; Lorbek, Gregor; Urlep, Ziga; Keber, Rok; Horvat, Simon; Rozman, Damjana			Hidden Disease Susceptibility and Sexual Dimorphism in the Heterozygous Knockout of Cyp51 from Cholesterol Synthesis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LANOSTEROL 14-ALPHA-DEMETHYLASE CYP51; FATTY LIVER-DISEASE; BILE-ACID SYNTHESIS; STEROL 27-HYDROXYLASE; EMBRYONIC LETHALITY; MICE REVEALS; MOUSE-MODEL; GENE; METABOLISM	We examined the genotype-phenotype interactions of Cyp51(+/-) mice carrying one functional allele of lanosterol 14 alpha-demethylase from cholesterol biosynthesis. No distinct developmental or morphological abnormalities were observed by routine visual inspection of Cyp51(+/-) and Cyp51(+/+) mice and fertility was similar. We further collected a large data-set from female and male Cyp51(+/-) mice and controls fed for 16 weeks with three diets and applied linear regression modeling. We used 3 predictor variables (genotype, sex, diet), and 39 response variables corresponding to the organ characteristics (7), plasma parameters (7), and hepatic gene expression (25). We observed significant differences between Cyp51(+/-) and wildtype mice in organ characteristics and blood lipid profile. Hepatomegaly was observed in Cyp51(+/-) males, together with elevated total and low-density lipoprotein cholesterol. Cyp51(+/-) females fed high-fat, high-cholesterol diet were leaner and had elevated plasma corticosterone compared to controls. We observed elevated hepatocyte apoptosis, mitosis and lipid infiltration in heterozygous knockouts of both sexes. The Cyp51(+/-) females had a modified lipid storage homeostasis protecting them from weight-gain when fed high-fat high-cholesterol diet. Malfunction of one Cyp51 allele therefore initiates disease pathways towards cholesterol-linked liver pathologies and sex-dependent response to dietary challenge.	[Lewinska, Monika; Juvan, Peter; Kos, Spela; Lorbek, Gregor; Urlep, Ziga; Rozman, Damjana] Univ Ljubljana, Ctr Funct Genom & Biochips, Fac Med, SI-1000 Ljubljana, Slovenia; [Perse, Martina; Jeruc, Jera] Univ Ljubljana, Inst Pathol, Ctr Med Expt, Fac Med, SI-1000 Ljubljana, Slovenia; [Kos, Spela] Inst Oncol Ljubljana, SI-1000 Ljubljana, Slovenia; [Keber, Rok; Horvat, Simon] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale 1230, Slovenia; [Horvat, Simon] Natl Inst Chem, Ljubljana 1000, Slovenia	University of Ljubljana; University of Ljubljana; Institute of Oncology - Slovenia; University of Ljubljana; National Institute of Chemistry - Slovenia	Rozman, D (corresponding author), Univ Ljubljana, Ctr Funct Genom & Biochips, Fac Med, SI-1000 Ljubljana, Slovenia.	damjana.rozman@mf.uni-lj.si	Lewinska, Monika/N-9919-2017; Perse, Martina/AAS-2898-2020; Jeruc, Jera/AAL-5258-2021	Lewinska, Monika/0000-0002-5275-992X; Juvan, Peter/0000-0003-2873-5247	FP7 FightingDrugFailure ITN Marie Curie grant [238132]; Slovenian Research Agency [P1-0104, P1-0010, J7-4053]	FP7 FightingDrugFailure ITN Marie Curie grant; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported by FP7 FightingDrugFailure ITN Marie Curie grant #238132 and Slovenian Research Agency program grant P1-0104, grant P1-0010 and project J7-4053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acimovic J, 2013, MOLECULES, V18, P4002, DOI 10.3390/molecules18044002; Aldahmesh MA, 2012, GENET MED, V14, P955, DOI 10.1038/gim.2012.86; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BJORKHEM I, 1994, P NATL ACAD SCI USA, V91, P8592, DOI 10.1073/pnas.91.18.8592; Bream ENA, 2013, PEDIATR RES, V73, P135, DOI 10.1038/pr.2012.166; Caldas H, 2005, MOL GENET METAB, V84, P48, DOI 10.1016/j.ymgme.2004.08.007; Caldas H, 2003, HUM MOL GENET, V12, P2981, DOI 10.1093/hmg/ddg321; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cunningham D, 2009, MOL GENETICS METABOL, V98, P356; D'souza AM, 2012, AM J PHYSIOL-GASTR L, V302, pG850, DOI 10.1152/ajpgi.00378.2011; De Marinis E, 2008, J ENDOCRINOL, V198, P635, DOI 10.1677/JOE-08-0242; Debeljak N, 2000, ARCH BIOCHEM BIOPHYS, V379, P37, DOI 10.1006/abbi.2000.1859; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; DIETSCHY JM, 1984, KLIN WOCHENSCHR, V62, P338, DOI 10.1007/BF01716251; Dietschy JM, 2002, J BIOL CHEM, V277, P3801, DOI 10.1074/jbc.R100057200; Erickson SK, 2003, J LIPID RES, V44, P1001, DOI 10.1194/jlr.M200489-JLR200; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Febbraio M, 2002, MOL CELL BIOCHEM, V239, P193, DOI 10.1023/A:1020515210972; Fernandez C, 2005, J LIPID RES, V46, P920, DOI 10.1194/jlr.M400407-JLR200; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; Fox J., 2019, R COMPANION APPL REG, V.; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gatti DM, 2010, PHYSIOL GENOMICS, V42, P456, DOI 10.1152/physiolgenomics.00110.2009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geske FJ, 2001, HUM PATHOL, V32, P1029, DOI 10.1053/hupa.2001.28250; Goedeke L, 2012, CELL MOL LIFE SCI, V69, P915, DOI 10.1007/s00018-011-0857-5; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Hager EJ, 2007, J INHERIT METAB DIS, V30, P888, DOI 10.1007/s10545-007-0776-7; Henkel AS, 2011, J LIPID RES, V52, P289, DOI 10.1194/jlr.M012781; Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580; Ikonen E, 2006, PHYSIOL REV, V86, P1237, DOI 10.1152/physrev.00022.2005; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Itabe H, 2007, J ATHEROSCLER THROMB, V14, P1, DOI 10.5551/jat.14.1; Jokela H, 2010, ENDOCRINOLOGY, V151, P1884, DOI 10.1210/en.2009-0928; Kavanagh IC, 2003, ATHEROSCLEROSIS, V168, P271, DOI 10.1016/S0021-9150(03)00148-5; Keber R, 2013, J LIPID RES, V54, P1653, DOI 10.1194/jlr.M035717; Keber R, 2013, J LIPID RES, V54, P20, DOI 10.1194/jlr.R032326; Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172; Lewinska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082554; Lewinska M, 2013, ACTA CHIM SLOV, V60, P875; Li-Hawkins J, 2002, J CLIN INVEST, V110, P1191, DOI 10.1172/JCI200216309; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lorbek G, 2013, MOLECULES, V18, P11067, DOI 10.3390/molecules180911067; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Mirza R, 2006, J INVEST DERMATOL, V126, P638, DOI 10.1038/sj.jid.5700111; Muscarella LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/854737; Ohashi K, 2003, J BIOL CHEM, V278, P42936, DOI 10.1074/jbc.M307228200; Pellegrini M, 2014, CURRENT MED CHEM; Pikuleva I, 2003, ARCH BIOCHEM BIOPHYS, V420, P35, DOI 10.1016/j.abb.2003.09.028; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Ricart-Jane D, 2002, METABOLISM, V51, P925, DOI 10.1053/meta.2002.33353; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Romero-Aleshire MJ, 2009, AM J PHYSIOL-REG I, V297, pR587, DOI 10.1152/ajpregu.90762.2008; Shea HC, 2007, P NATL ACAD SCI USA, V104, P11526, DOI 10.1073/pnas.0705089104; Singh P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058833; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steffen KM, 2007, J PERINATOL, V27, P672, DOI 10.1038/sj.jp.7211806; Team RDC, 2013, R LANG ENV STAT COMP; Tozawa R, 1999, J BIOL CHEM, V274, P30843, DOI 10.1074/jbc.274.43.30843; Trapani L, 2010, EXP GERONTOL, V45, P119, DOI 10.1016/j.exger.2009.10.014; TURLEY SD, 1995, J LIPID RES, V36, P67; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wang XW, 2011, J CLIN ENDOCR METAB, V96, P885, DOI 10.1210/jc.2010-2061; Wechsler A, 2003, SCIENCE, V302, P2087, DOI 10.1126/science.1090776; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Younossi ZM, 2012, MEDICINE, V91, P319, DOI 10.1097/MD.0b013e3182779d49; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399	75	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112787	10.1371/journal.pone.0112787	http://dx.doi.org/10.1371/journal.pone.0112787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393872	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300104
J	Li, LH; Chen, X; Lv, S; Dong, MM; Zhang, L; Tu, JH; Yang, J; Zhang, LL; Song, YA; Xu, LT; Zou, J				Li, Lihui; Chen, Xi; Lv, Shuang; Dong, Miaomiao; Zhang, Li; Tu, Jiaheng; Yang, Jie; Zhang, Lingli; Song, Yinan; Xu, Leiting; Zou, Jun			Influence of Exercise on Bone Remodeling-Related Hormones and Cytokines in Ovariectomized Rats: A Model of Postmenopausal Osteoporosis	PLOS ONE			English	Article							MINERAL DENSITY; MECHANICAL-PROPERTIES; REPLACEMENT THERAPY; ENDURANCE EXERCISE; OLDER WOMEN; ESTROGEN; MASS; METABOLISM; RESORPTION; RECEPTOR	This study aims to explore the effects of exercise on postmenopausal osteoporosis and the mechanisms by which exercise affects bone remodeling. Sixty-three Wistar female rats were randomly divided into five groups: (1) control group, (2) shamoperated group, (3) OVX (Ovariectomy) group, (4) DES-OVX (Diethylstilbestrol-OVX) group, and (5) Ex-OVX (Exercise-OVX) group. The rat osteoporosis model was established through ovariectomy. The Ex-OVX rats were made to run 251.2 meters every day, 6 d/wk for 3 months in a running wheel. Trabecular bone volume (TBV%), total resorption surface (TRS%), trabecular formation surface (TFS%), mineralization rate (MAR), bone cortex mineralization rate (mAR), and osteoid seam width (OSW) were determined by bone histomorphometry. The mRNA and protein levels of interleukin-1 beta (IL-1 beta(2)), interleukin-6 (IL-6), and cyclooxygenase-2 (Cox-2) were determined by in situ hybridization and immunohistochemistry, respectively. Serum levels of estrogen estradiol (E-2), calcitonin (CT), osteocalcin (BGP), and parathyroid hormone (PTH) were determined by ELISA assays. The investigation revealed that compared to the control and the sham-operated groups, the OVX group showed significantly lower levels of TBV%, E-2, and CT, but much higher levels of TRS%, TFS%, MAR, OSW, BGP, and PTH. The Ex-OVX group showed increased TBV% and serum levels of E-2 and CT compared to the OVX group. Ovariectomy also led to a significant increase in IL-1 beta mRNA and protein levels in the bone marrow and IL-6 and Cox-2 protein levels in tibias. In addition, the Ex-OVX group showed lower levels of IL-beta mRNA and protein, IL-6 mRNA, and Cox-2 mRNA and protein than those in the OVX group. The upshot of the study suggests that exercise can significantly increase bone mass in postmenopausal osteoporosis rat models by inhibiting bone resorption and increasing bone formation, especially in trabecular bones.	[Li, Lihui; Chen, Xi; Lv, Shuang; Dong, Miaomiao; Zhang, Li; Tu, Jiaheng; Yang, Jie; Zhang, Lingli; Song, Yinan; Xu, Leiting] Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China; [Zou, Jun] Shanghai Univ Sport, Sci Res Dept, Shanghai, Peoples R China; [Xu, Leiting] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China; [Chen, Xi] Wenzhou Med Univ, Sch Sports Sci, Wenzhou, Peoples R China	Shanghai University of Sport; Shanghai University of Sport; Ningbo University; Wenzhou Medical University	Xu, LT (corresponding author), Shanghai Univ Sport, Sch Kinesiol, Shanghai, Peoples R China.	xuleiting@nbu.edu.cn; zoujun777@126.com	Chen, Xi/AGS-6702-2022		Shanghai Key Lab of Human Sport Competence Development and Maintenance (Shanghai University of sport) [11DZ2261100]; National Natural Science Foundation of China [81170323]	Shanghai Key Lab of Human Sport Competence Development and Maintenance (Shanghai University of sport); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Shanghai Key Lab of Human Sport Competence Development and Maintenance (Shanghai University of sport) (NO. 11DZ2261100), The National Natural Science Foundation of China (Grant No. 81170323). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARENGOLTS EI, 1994, BONE MINER, V26, P133, DOI 10.1016/S0169-6009(08)80058-X; BARENGOLTS EI, 1993, J BONE MINER RES, V8, P937; Campbell KL, 2007, CANCER EPIDEM BIOMAR, V16, P731, DOI 10.1158/1055-9965.EPI-06-0784; Carrillo-Lopez N, 2009, J AM SOC NEPHROL, V20, P2009, DOI 10.1681/ASN.2008121258; Chachra D, 2000, BIOMED SCI INSTRUM, V395, P123; Charatcharoenwitthaya N, 2007, J BONE MINER RES, V22, P724, DOI 10.1359/JBMR.070207; Chen YJ, 2011, EUR J APPL PHYSIOL, V111, P1759, DOI 10.1007/s00421-010-1820-0; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; de Araujo RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066391; Denkert C, 2004, CLIN CANCER RES, V10, P5580, DOI 10.1158/1078-0432.CCR-04-0070; Doggrell SA, 2004, EXPERT OPIN PHARMACO, V5, P1635, DOI 10.1517/14656566.5.7.1635; Edwards CJ, 2010, OSTEOPOROSIS INT, V21, P1287, DOI 10.1007/s00198-010-1192-7; Evans EM, 2007, MENOPAUSE, V14, P481, DOI 10.1097/01.gme.0000243570.78570.f7; Gesty-Palmer D, 2011, BRIT J PHARMACOL, V164, P59, DOI 10.1111/j.1476-5381.2011.01450.x; Going S, 2003, OSTEOPOROSIS INT, V14, P637, DOI 10.1007/s00198-003-1436-x; Gong YS, 2006, J ASIAN NAT PROD RES, V8, P649, DOI 10.1080/10286020500246063; Inada Masaki, 2011, Clin Calcium, V21, P164, DOI CliCa1102164170; Iwamoto Jun, 1998, Keio Journal of Medicine, V47, P162; Joo YI, 2003, BONE, V33, P485, DOI 10.1016/S8756-3282(03)00212-6; Karsdal MA, 2008, BIODRUGS, V22, P137, DOI 10.2165/00063030-200822030-00001; Kemmler W, 2010, ARCH INTERN MED, V170, P179, DOI 10.1001/archinternmed.2009.499; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; LeBlanc A, 2013, OSTEOPOROSIS INT, V24, P2105, DOI 10.1007/s00198-012-2243-z; Liu M, 2012, CHINESE MED J-PEKING, V125, P1784, DOI 10.3760/cma.j.issn.0366-6999.2012.10.018; Liu SQ, 1996, CHINESE J PATHOL, V25, P49; Nakamura M, 2003, ENDOCRINOLOGY, V144, P5441, DOI 10.1210/en.2003-0717; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872; Prestwood KM, 2003, JAMA-J AM MED ASSOC, V290, P1042, DOI 10.1001/jama.290.8.1042; PRICE PA, 1980, J CLIN INVEST, V66, P878, DOI 10.1172/JCI109954; Sakakura Y, 2001, J BONE MINER METAB, V19, P159, DOI 10.1007/s007740170036; SAVILLE PD, 1969, J AM GERIATR SOC, V17, P155, DOI 10.1111/j.1532-5415.1969.tb03169.x; Scott JPR, 2014, J CLIN ENDOCR METAB, V99, P1774, DOI 10.1210/jc.2013-3027; Steeve KT, 2004, CYTOKINE GROWTH F R, V15, P49, DOI 10.1016/j.cytogfr.2003.10.005; Subbaramaiah K, 2003, J BIOL CHEM, V278, P37637, DOI 10.1074/jbc.M301481200; Tromp AM, 2006, CALCIFIED TISSUE INT, V79, P404, DOI 10.1007/s00223-006-0045-z; Wallace BA, 2000, CALCIFIED TISSUE INT, V67, P10, DOI 10.1007/s00223001089; Winters-Stone KM, 2013, OSTEOPOROSIS INT, V24, P1637, DOI 10.1007/s00198-012-2143-2; Wood CE, 2012, TOXICOL PATHOL, V40, P55, DOI 10.1177/0192623311425509; Yuk TH, 2002, AM J CHINESE MED, V30, P95, DOI 10.1142/S0192415X02000119; Zhao X, 2011, J ETHNOPHARMACOL, V137, P1083, DOI 10.1016/j.jep.2011.07.017	42	45	49	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112845	10.1371/journal.pone.0112845	http://dx.doi.org/10.1371/journal.pone.0112845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393283	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300112
J	Ma, XT; Tan, JJ; Su, M; Li, CH; Zhang, XY; Wang, CX				Ma, Xueting; Tan, Jianjun; Su, Min; Li, Chunhua; Zhang, Xiaoyi; Wang, Cunxin			Molecular Dynamics Studies of the Inhibitor C34 Binding to the Wild-Type and Mutant HIV-1 gp41: Inhibitory and Drug Resistant Mechanism	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL MEMBRANE-FUSION; ENVELOPE GLYCOPROTEIN; TRANSMEMBRANE GLYCOPROTEIN; INTERHELICAL INTERACTIONS; ATOMIC-STRUCTURE; 6-HELIX BUNDLE; BASE-LINE; ENFUVIRTIDE; PEPTIDE	Mutations on NHR (N-terminal heptad repeat) associated with resistance to fusion inhibitor were observed. In addition, mutations on CHR (C-terminal heptad repeat) accompanied NHR mutations of gp41 are noted in many cases, like N43D/S138A double mutation. In this work, we explored the drug resistant mechanism of N43D mutation and the role of S138A second mutation in drug resistance. The binding modes of the wild type gp41 and the two mutants, N43D and N43D/S138A, with the HIV-1 fusion inhibitor C34, a 34-residue peptide mimicking CHR of gp41, were carried out by using molecular dynamics simulations. Based on the MD simulations, N43D mutation affects not only the stability of C34 binding, but also the binding energy of the inhibitor C34. Because N43D mutation may also affect the stable conformation of 6-HB, we introduced S138A second mutation into CHR of gp41 and determined the impact of this mutation. Through the comparative analysis of MD results of the N43D mutant and the N43D/S138A mutant, we found that CHR with S138A mutation shown more favorable affinity to NHR. Compelling differences in structures have been observed for these two mutants, particularly in the binding modes and in the hydrophobic interactions of the CHR (C34) located near the hydrophobic groove of the NHR. Because the conformational stability of 6-HB is important to HIV-1 infection, we suggested a hypothetical mechanism for the drug resistance: N43D single mutation not only impact the binding of inhibitor, but also affect the affinity between NHR and CHR of gp41, thus may reduce the rate of membrane fusion; compensatory mutation S138A would induce greater hydrophobic interactions between NHR and CHR, and render the CHR more compatible to NHR than inhibitors.	[Ma, Xueting; Tan, Jianjun; Su, Min; Li, Chunhua; Zhang, Xiaoyi; Wang, Cunxin] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China	Beijing University of Technology	Tan, JJ (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China.	tanjianjun@bjut.edu.cn	Tan, Jianjun/E-5867-2011	Tan, Jianjun/0000-0003-3573-0807	Chinese Natural Science Foundation [21173014, 31100523, 31171267]	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The authors thank Chinese Natural Science Foundation project (No. 21173014, 31100523, and 31171267). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Ugon M, 2005, VIROLOGY, V343, P141, DOI 10.1016/j.virol.2005.08.007; Armand-Ugon M, 2003, ANTIVIR RES, V59, P137, DOI 10.1016/S0166-3542(03)00071-8; Bai XF, 2008, BIOCHEMISTRY-US, V47, P6662, DOI 10.1021/bi702509d; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chong HH, 2012, J BIOL CHEM, V287, P34558, DOI 10.1074/jbc.M112.390393; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Follis KE, 2002, J VIROL, V76, P7356, DOI 10.1128/JVI.76.14.7356-7362.2002; Greenberg ML, 2004, J ANTIMICROB CHEMOTH, V54, P333, DOI 10.1093/jac/dkh330; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; He YX, 2008, J BIOL CHEM, V283, P11126, DOI 10.1074/jbc.M800200200; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Leung MYK, 2011, BIOPHYS J, V100, P1960, DOI 10.1016/j.bpj.2011.02.053; Li CY, 2003, COMPOS SCI TECHNOL, V63, P1517, DOI 10.1016/S0266-3538(03)00072-1; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lu J, 2004, J VIROL, V78, P4628, DOI 10.1128/JVI.78.9.4628-4637.2004; Lu M, 1997, J BIOMOL STRUCT DYN, V15, P465, DOI 10.1080/07391102.1997.10508958; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu M, 1999, J VIROL, V73, P4433, DOI 10.1128/JVI.73.5.4433-4438.1999; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; Melby T, 2006, AIDS RES HUM RETROV, V22, P375, DOI 10.1089/aid.2006.22.375; Melikyan GB, 2000, J CELL BIOL, V151, P413, DOI 10.1083/jcb.151.2.413; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Mink M, 2005, J VIROL, V79, P12447, DOI 10.1128/JVI.79.19.12447-12454.2005; Nameki D, 2005, J VIROL, V79, P764, DOI 10.1128/JVI.79.2.764-770.2005; Ray N, 2009, J VIROL, V83, P2989, DOI 10.1128/JVI.02496-08; Reeves JD, 2005, J VIROL, V79, P4991, DOI 10.1128/JVI.79.8.4991-4999.2005; Rimsky LT, 1998, J VIROL, V72, P986, DOI 10.1128/JVI.72.2.986-993.1998; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sabin C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001195; Suntoke TR, 2005, J BIOL CHEM, V280, P19852, DOI 10.1074/jbc.M502196200; Tan JJ, 2010, DRUG DISCOV TODAY, V15, P186, DOI 10.1016/j.drudis.2010.01.004; Tan JJ, 2005, MOL SIMULAT, V31, P1051, DOI 10.1080/08927020500447132; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wang RR, 2009, BIOCHEM BIOPH RES CO, V382, P540, DOI 10.1016/j.bbrc.2009.03.057; Watabe T, 2009, J MOL BIOL, V392, P657, DOI 10.1016/j.jmb.2009.07.027; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; Xu L, 2005, ANTIMICROB AGENTS CH, V49, P1113, DOI 10.1128/AAC.49.3.1113-1119.2005	41	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111923	10.1371/journal.pone.0111923	http://dx.doi.org/10.1371/journal.pone.0111923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393106	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300025
J	Susser, S; Herrmann, E; Lange, C; Hamdi, N; Muller, T; Berg, T; Perner, D; Zeuzem, S; Sarrazin, C				Susser, Simone; Herrmann, Eva; Lange, Christian; Hamdi, Nabila; Mueller, Tobias; Berg, Thomas; Perner, Dany; Zeuzem, Stefan; Sarrazin, Christoph			Predictive Value of Interferon-Lambda Gene Polymorphisms for Treatment Response in Chronic Hepatitis C	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE 1 INFECTION; VIRUS-INFECTION; VIROLOGICAL RESPONSE; TREATMENT FAILURE; STIMULATED GENES; INTERLEUKIN 28B; VIRAL CLEARANCE; IL28B GENOTYPE; HCV INFECTION	Background: IL28B gene polymorphism is the best baseline predictor of response to interferon alfa-based antiviral therapies in chronic hepatitis C. Recently, a new IFN-L4 polymorphism was identified as first potential functional variant for induction of IL28B expression. Individualization of interferon alfa-based therapies based on a combination of IL28B/IFN-L4 polymorphisms may help to optimize virologic outcome and economic resources. Methods: Optimization of treatment outcome prediction was assessed by combination of different IL28B and IFN-L4 polymorphisms in patients with chronic HCV genotype 1 (n = 385), 2/3 (n = 267), and 4 (n = 220) infection treated with pegylated interferon alfa (PEG-IFN) and ribavirin with (n = 79) or without telaprevir. Healthy people from Germany (n = 283) and Egypt (n = 96) served as controls. Results: Frequencies of beneficial IL28B rs12979860 C/C genotypes were lower in HCV genotype 1/4 infected patients in comparison to controls (20-35% vs. 46-47%) this was also true for ss469415590 TT/TT (20-35% vs. 45-47%). Single interferon-lambda SNPs (rs12979860, rs8099917, ss469415590) correlated with sustained virologic response (SVR) in genotype 1, 3, and 4 infected patients while no association was observed for genotype 2. Interestingly, in genotype 3 infected patients, best SVR prediction was based on IFN-L4 genotype. Prediction of SVR with high accuracy (71-96%) was possible in genotype 1, 2, 3 and 4 infected patients who received PEG-IFN/ribavirin combination therapy by selection of beneficial IL28B rs12979860 C/C and/or ss469415590 TT/TT genotypes (p<0.001). For triple therapy with first generation protease inhibitors (PIs) (boceprevir, telaprevir) prediction of high SVR (90%) rates was based on the presence of at least one beneficial genotype of the 3 IFN-lambda SNPs. Conclusion: IFN-L4 seems to be the best single predictor of SVR in genotype 3 infected patients. For optimized prediction of SVR by treatment with dual combination or first generation PI triple therapies, grouping of interferon-lambda haplotypes may be helpful with positive predictive values of 71-96%.	[Susser, Simone; Lange, Christian; Perner, Dany; Zeuzem, Stefan; Sarrazin, Christoph] Goethe Univ Hosp Frankfurt Main, Med Dept 1, Frankfurt, Germany; [Herrmann, Eva] Goethe Univ Hosp Frankfurt Main, Inst Biostat & Math Modeling, Frankfurt, Germany; [Hamdi, Nabila] German Univ Cairo, Dept Pharmacol & Toxicol, Cairo, Egypt; [Mueller, Tobias; Berg, Thomas] Univ Hosp Leipzig, Sect Hepatol, Gastroenterol Clin, Leipzig, Germany	Egyptian Knowledge Bank (EKB); German University in Cairo; Leipzig University	Sarrazin, C (corresponding author), Goethe Univ Hosp Frankfurt Main, Med Dept 1, Frankfurt, Germany.	sarrazin@em.uni-frankfurt.de	Hamdi, Nabila/AAF-2049-2020; Zeuzem, Stefan/AAE-7435-2019	Mueller, Tobias/0000-0003-3426-5421; Berg, Thomas/0000-0003-0003-6241				Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Duong FHT, 2014, J EXP MED, V211, P857, DOI 10.1084/jem.20131557; Fischer J, 2012, HEPATOLOGY, V55, P1700, DOI 10.1002/hep.25582; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jimenez-Sousa MA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-6; Lagging M, 2012, PHARMACOGENOMICS, V13, P847, DOI [10.2217/PGS.12.57, 10.2217/pgs.12.57]; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Mangia A, 2013, WORLD J GASTROENTERO, V19, P8924, DOI 10.3748/wjg.v19.i47.8924; Meissner EG, 2014, J INFECT DIS, V209, P1700, DOI 10.1093/infdis/jit827; Metz P, 2013, J HEPATOL, V59, P1331, DOI 10.1016/j.jhep.2013.07.033; Nelson DR, 2013, J HEPATOL, V58, pS362, DOI 10.1016/S0168-8278(13)60883-1; Pearlman BL, 2014, HEPATOLOGY, V59, P71, DOI 10.1002/hep.26624; Pol S, 2013, J HEPATOL, V58, P883, DOI 10.1016/j.jhep.2012.12.023; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Sarrazin C, 2011, GASTROENTEROLOGY, V141, P1656, DOI 10.1053/j.gastro.2011.07.019; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Schreiber J, 2012, ALIMENT PHARM THER, V36, P353, DOI 10.1111/j.1365-2036.2012.05197.x; Shemis MA, 2012, HEPAT MON, V12, P265, DOI 10.5812/hepatmon.830; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P104, DOI 10.1111/apt.12547; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; World Health Organization, 2013, HEP C FACT SHEET 164; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	38	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112592	10.1371/journal.pone.0112592	http://dx.doi.org/10.1371/journal.pone.0112592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393304	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300077
J	Cardini, B; Watschinger, K; Hermann, M; Obrist, P; Oberhuber, R; Brandacher, G; Chuaiphichai, S; Channon, KM; Pratschke, J; Maglione, M; Werner, ER				Cardini, Benno; Watschinger, Katrin; Hermann, Martin; Obrist, Peter; Oberhuber, Rupert; Brandacher, Gerald; Chuaiphichai, Surawee; Channon, Keith M.; Pratschke, Johann; Maglione, Manuel; Werner, Ernst R.			Crucial Role for Neuronal Nitric Oxide Synthase in Early Microcirculatory Derangement and Recipient Survival following Murine Pancreas Transplantation	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ENDOTHELIAL FUNCTION; IN-VIVO; HUMAN ATHEROSCLEROSIS; OXIDATIVE STRESS; ANGIOTENSIN-II; TETRAHYDROBIOPTERIN; MICE; RATS; KIDNEY	Objective: Aim of this study was to identify the nitric oxide synthase (NOS) isoform involved in early microcirculatory derangements following solid organ transplantation. Background: Tetrahydrobiopterin donor treatment has been shown to specifically attenuate these derangements following pancreas transplantation, and tetrahydrobiopterin-mediated protective effects to rely on its NOS-cofactor activity, rather than on its antioxidant capacity. However, the NOS-isoform mainly involved in this process has still to be defined. Methods: Using a murine pancreas transplantation model, grafts lacking one of the three NOS-isoforms were compared to grafts from wild-type controls. Donors were treated with either tetrahydrobiopterin or remained untreated. All grafts were subjected to 16 h cold ischemia time and transplanted into wild-type recipients. Following 4 h graft reperfusion, microcirculation was analysed by confocal intravital fluorescence microscopy. Recipient survival was monitored for 50 days. Results: Transplantation of the pancreas from untreated wild-type donor mice resulted in microcirculatory damage of the transplanted graft and no recipient survived more than 72 h. Transplanting grafts from untreated donor mice lacking either endothelial or inducible NOS led to similar outcomes. In contrast, donor treatment with tetrahydrobiopterin prevented microcirculatory breakdown enabling long-term survival. Sole exception was transplantation of grafts from untreated donor mice lacking neuronal NOS. It resulted in intact microvascular structure and long-term recipient survival, either if donor mice were untreated or treated with tetrahydrobiopterin. Conclusion: We demonstrate for the first time the crucial involvement of neuronal NOS in early microcirculatory derangements following solid organ transplantation. In this model, protective effects of tetrahydrobiopterin are mediated by targeting this isoform.	[Cardini, Benno; Oberhuber, Rupert; Brandacher, Gerald; Pratschke, Johann; Maglione, Manuel] Med Univ Innsbruck, Ctr Operat Med, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria; [Cardini, Benno; Watschinger, Katrin; Werner, Ernst R.] Med Univ Innsbruck, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria; [Hermann, Martin] Med Univ Innsbruck, Dept Anaesthesiol & Crit Care Med, A-6020 Innsbruck, Austria; [Obrist, Peter] St Vinzenz Krankenhaus, Inst Pathol, Zams, Austria; [Brandacher, Gerald] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA; [Chuaiphichai, Surawee; Channon, Keith M.] Univ Oxford, Radcliffe Dept Med, Wellcome Trust Ctr Human Genet, Div Cardiovasc Med, Oxford, England	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Johns Hopkins University; University of Oxford; Wellcome Centre for Human Genetics	Maglione, M (corresponding author), Med Univ Innsbruck, Ctr Operat Med, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria.	manuel.maglione@i-med.ac.at; ernst.r.werner@i-med.ac.at	Maglione, Manuel/AAK-8599-2020; Brandacher, Gerald/L-7540-2016; Watschinger, Katrin/AHC-9948-2022	Maglione, Manuel/0000-0003-1479-6129; Watschinger, Katrin/0000-0002-1122-8444; Chuaiphichai, Surawee/0000-0002-7512-6252; Werner, Ernst R./0000-0003-1948-3391; channon, keith/0000-0002-1043-4342; Hermann, Martin/0000-0003-2213-3448	Austrian Science Funds (FWF) [P22289]; Tiroler Wissenschaftsfonds (TWF) [2008-1-596]; MRC [G0200482] Funding Source: UKRI; Austrian Science Fund (FWF) [P 22289] Funding Source: researchfish; British Heart Foundation [RG/12/5/29576] Funding Source: researchfish; Medical Research Council [G0200482] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10247] Funding Source: researchfish	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); Tiroler Wissenschaftsfonds (TWF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Austrian Science Funds (FWF) Project P22289 (http://www.fwf.ac.at/en/index.asp) and by grant 2008-1-596 of the Tiroler Wissenschaftsfonds (TWF) (https://www.tirol.gv.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine EH, 2006, J VASC RES, V43, P309, DOI 10.1159/000093196; Antoniades C, 2007, CIRCULATION, V116, P2851, DOI 10.1161/CIRCULATIONAHA.107.704155; Antoniades C, 2011, CIRCULATION, V124, P335, DOI 10.1161/CIRCULATIONAHA.110.985150; Arciszewski MB, 2007, ANAT HISTOL EMBRYOL, V36, P375, DOI 10.1111/j.1439-0264.2007.00777.x; Bachetti T, 2004, J MOL CELL CARDIOL, V37, P939, DOI 10.1016/j.yjmcc.2004.07.006; Bendall JK, 2005, CIRC RES, V97, P864, DOI 10.1161/01.RES.0000187447.03525.72; Boer R, 2000, MOL PHARMACOL, V58, P1026, DOI 10.1124/mol.58.5.1026; Boulanger CM, 1998, CIRC RES, V83, P1271, DOI 10.1161/01.RES.83.12.1271; Cunnington C, 2010, HEART, V96, P1872, DOI 10.1136/hrt.2009.180430; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; DiMagno MJ, 2004, AM J PHYSIOL-GASTR L, V286, pG428, DOI 10.1152/ajpgi.00368.2003; Drognitz O, 2009, PANCREAS, V38, P226, DOI 10.1097/MPA.0b013e3181788e2b; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Gruessner AC, 2012, CURR OPIN ORGAN TRAN, V17, P100, DOI 10.1097/MOT.0b013e32834ee700; Gruessner Angelika C, 2011, Rev Diabet Stud, V8, P6, DOI 10.1900/RDS.2011.8.6; HADDAD IY, 1994, J CLIN INVEST, V94, P2407, DOI 10.1172/JCI117607; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Kang KT, 2011, AM J PHYSIOL-HEART C, V300, pH718, DOI 10.1152/ajpheart.00393.2010; Katusic ZS, 2009, TRENDS PHARMACOL SCI, V30, P48, DOI 10.1016/j.tips.2008.10.003; Leindler L, 2004, PANCREAS, V29, P157, DOI 10.1097/00006676-200408000-00011; Long J, 2005, WORLD J GASTROENTERO, V11, P4277; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Maglione M, 2006, AM J TRANSPLANT, V6, P1551, DOI 10.1111/j.1600-6143.2006.01345.x; Maglione M, 2010, AM J TRANSPLANT, V10, P2231, DOI 10.1111/j.1600-6143.2010.03262.x; Maglione M, 2012, TRANSPL INT; Maglione M, 2007, SURGERY, V141, P682, DOI 10.1016/j.surg.2006.07.037; Maglione M, 2012, TRANSPL INT, V25, P1084, DOI 10.1111/j.1432-2277.2012.01530.x; Maier W, 2000, J CARDIOVASC PHARM, V35, P173, DOI 10.1097/00005344-200002000-00001; Mayahi L, 2007, ARTERIOSCL THROM VAS, V27, P1334, DOI 10.1161/ATVBAHA.107.142257; Melikian N, 2009, TRENDS CARDIOVAS MED, V19, P256, DOI 10.1016/j.tcm.2010.02.007; MULSCH A, 1990, N-S ARCH PHARMACOL, V341, P143; Nowak EC, 2012, J EXP MED, V209, P2127, DOI 10.1084/jem.20120408; Obermaier R, 2002, PANCREAS, V25, P142, DOI 10.1097/00006676-200208000-00005; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Schaser KD, 2005, AM J TRANSPLANT, V5, P341, DOI 10.1111/j.1600-6143.2004.00663.x; Schmid RA, 1999, J THORAC CARDIOV SUR, V118, P726, DOI 10.1016/S0022-5223(99)70019-X; SCHMIDT J, 1992, ANN SURG, V215, P44, DOI 10.1097/00000658-199201000-00007; Schneeberger S, 2009, TRANSPL INT, V22, P217, DOI 10.1111/j.1432-2277.2008.00773.x; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Seddon M, 2009, CIRCULATION, V119, P2656, DOI 10.1161/CIRCULATIONAHA.108.822205; Sollinger HW, 2009, ANN SURG, V250, P618, DOI [10.1097/SLA.0b013e3181b7d2b, 10.1097/SLA.0b013e3181b76d2b]; Sucher R, 2010, KIDNEY INT, V77, P681, DOI 10.1038/ki.2010.7; Sugiyama Y, 2006, DIGEST DIS SCI, V51, P1396, DOI 10.1007/s10620-006-9125-1; Tiefenbacher CP, 1996, CIRCULATION, V94, P1423, DOI 10.1161/01.CIR.94.6.1423; Um SH, 2003, J KOREAN MED SCI, V18, P520, DOI 10.3346/jkms.2003.18.4.520; Watschinger K, 2010, P NATL ACAD SCI USA, V107, P13672, DOI 10.1073/pnas.1002404107; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Yamaleyeva LM, 2012, J CARDIOVASC PHARM, V59, P529, DOI 10.1097/FJC.0b013e31824dd15b	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112570	10.1371/journal.pone.0112570	http://dx.doi.org/10.1371/journal.pone.0112570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389974	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400102
J	Casellato, C; Antonietti, A; Garrido, JA; Carrillo, RR; Luque, NR; Ros, E; Pedrocchi, A; D'Angelo, E				Casellato, Claudia; Antonietti, Alberto; Garrido, Jesus A.; Carrillo, Richard R.; Luque, Niceto R.; Ros, Eduardo; Pedrocchi, Alessandra; D'Angelo, Egidio			Adaptive Robotic Control Driven by a Versatile Spiking Cerebellar Network	PLOS ONE			English	Article							VESTIBULO-OCULAR-REFLEX; NEURAL-NETWORKS; INFERIOR OLIVE; PURKINJE-CELLS; MODEL; NEURONS; SIMULATION; OSCILLATIONS; STIMULATION; ADAPTATION	The cerebellum is involved in a large number of different neural processes, especially in associative learning and in fine motor control. To develop a comprehensive theory of sensorimotor learning and control, it is crucial to determine the neural basis of coding and plasticity embedded into the cerebellar neural circuit and how they are translated into behavioral outcomes in learning paradigms. Learning has to be inferred from the interaction of an embodied system with its real environment, and the same cerebellar principles derived from cell physiology have to be able to drive a variety of tasks of different nature, calling for complex timing and movement patterns. We have coupled a realistic cerebellar spiking neural network (SNN) with a real robot and challenged it in multiple diverse sensorimotor tasks. Encoding and decoding strategies based on neuronal firing rates were applied. Adaptive motor control protocols with acquisition and extinction phases have been designed and tested, including an associative Pavlovian task (Eye blinking classical conditioning), a vestibulo-ocular task and a perturbed arm reaching task operating in closed-loop. The SNN processed in real-time mossy fiber inputs as arbitrary contextual signals, irrespective of whether they conveyed a tone, a vestibular stimulus or the position of a limb. A bidirectional long-term plasticity rule implemented at parallel fibers-Purkinje cell synapses modulated the output activity in the deep cerebellar nuclei. In all tasks, the neurorobot learned to adjust timing and gain of the motor responses by tuning its output discharge. It succeeded in reproducing how human biological systems acquire, extinguish and express knowledge of a noisy and changing world. By varying stimuli and perturbations patterns, real-time control robustness and generalizability were validated. The implicit spiking dynamics of the cerebellar model fulfill timing, prediction and learning functions.	[Casellato, Claudia; Antonietti, Alberto; Pedrocchi, Alessandra] Politecn Milan, Dept Elect Informat & Bioengn, NeuroEngn & Med Robot Lab, I-20133 Milan, Italy; [Antonietti, Alberto; Garrido, Jesus A.; D'Angelo, Egidio] Brain Connect Ctr, Ist Ricovero & Cura Carattere Sci, Ist Neurol Nazl Casimiro Mondino, Pavia, Italy; [Garrido, Jesus A.; D'Angelo, Egidio] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy; [Carrillo, Richard R.; Luque, Niceto R.; Ros, Eduardo] Univ Granada, Escuela Tecn Super Ingn Informat & Telecomunca, Granada, Spain	Polytechnic University of Milan; IRCCS Fondazione Casimiro Mondino; University of Pavia; University of Granada	Casellato, C (corresponding author), Politecn Milan, Dept Elect Informat & Bioengn, NeuroEngn & Med Robot Lab, I-20133 Milan, Italy.	claudia.casellato@polimi.it; dangelo@unipv.it	Ros, Eduardo/B-1107-2012; Garrido, Jesus A/J-3892-2014; Pedrocchi, Alessandra/A-6634-2012; D'Angelo, Egidio/AAC-3846-2022; Antonietti, Alberto/M-8981-2014; Pedrocchi, Alessandra/AAF-2655-2019; Luque, Niceto Rafael/AAK-7407-2020	Ros, Eduardo/0000-0001-6613-5256; Garrido, Jesus A/0000-0001-6648-7075; Pedrocchi, Alessandra/0000-0001-9957-2786; D'Angelo, Egidio/0000-0002-6007-7187; Antonietti, Alberto/0000-0003-0388-6321; Pedrocchi, Alessandra/0000-0001-9957-2786; Luque, Niceto Rafael/0000-0002-0626-5048; Carrillo, Richard R./0000-0003-3359-4565; casellato, claudia/0000-0002-8729-0391	European Union (Human Brain Project) [REALNET FP7-ICT270434, CEREBNET FP7-ITN238686, HBP-604102]	European Union (Human Brain Project)	The study design, data collection and analysis were supported by European Union grants [REALNET FP7-ICT270434, CEREBNET FP7-ITN238686, Human Brain Project HBP-604102] to ED, AP and ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bahro M, 1995, PSYCHOPHARMACOLOGY, V122, P395, DOI 10.1007/BF02246273; Batllori R, 2011, PROCEDIA COMPUT SCI, V6, DOI 10.1016/j.procs.2011.08.060; Bouganis A., 2010, 2010 INT JOINT C NEU, P1, DOI DOI 10.1109/IJCNN.2010.5596525; Boyden ES, 2004, NEUROSCIENCE, V27; Bracha V, 2000, BRAIN RES, V860, P87, DOI 10.1016/S0006-8993(00)01995-8; Bruderle D, 2011, BIOL CYBERN, V104, P263, DOI 10.1007/s00422-011-0435-9; Carrillo RR, 2008, BIOSYSTEMS, V94, P18, DOI 10.1016/j.biosystems.2008.05.008; Casellato Claudia, 2013, IJCCI 2013. 5th International Joint Conference on Computational Intelligence. Proceedings, P568; Cheron G, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/853654; Chettih SN, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00072; Clopath C, 2014, J NEUROSCI, V34, P7203, DOI 10.1523/JNEUROSCI.2791-13.2014; D'Angelo E, 2005, LECT NOTES COMPUT SC, V3512, P107; D'Angelo E, 2009, NEUROSCIENCE, V162, P805, DOI 10.1016/j.neuroscience.2009.01.048; D'Angelo E, 2013, FUNCT NEUROL, V28, P153, DOI 10.11138/FNeur/2013.28.3.153; Day JJ, 2006, EUR J NEUROSCI, V23, P1341, DOI 10.1111/j.1460-9568.2006.04654.x; de Gruijl JR, 2009, NEUROSCIENCE, V162, P777, DOI 10.1016/j.neuroscience.2009.02.041; Gamez D, 2010, CONSCIOUS COGN, V19, P294, DOI 10.1016/j.concog.2009.11.001; Gao ZY, 2012, NAT REV NEUROSCI, V13, P619, DOI 10.1038/nrn3312; Garrido JA, 2013, BMC NEUROSCI, V14, pP81, DOI DOI 10.1186/1471-2202-14-S1-P81; Garrido JA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00159; Gerstner W, 2002, SPIKING NEURON MODEL; Gerwig M, 2005, J NEUROSCI, V25, P3919, DOI 10.1523/JNEUROSCI.0266-05.2005; Hagras H, 2004, IEEE INT CONF ROBOT, P4620, DOI 10.1109/ROBOT.2004.1302446; Herreros I, 2013, NEURAL NETWORKS, V47, P64, DOI 10.1016/j.neunet.2013.01.026; Hoffland BS, 2012, J PHYSIOL-LONDON, V590, P887, DOI 10.1113/jphysiol.2011.218537; Hofstotter C, 2002, EUR J NEUROSCI, V16, P1361, DOI 10.1046/j.1460-9568.2002.02182.x; Indiveri GC, 1999, IEEE T CIRCUITS-II, V46, P1337, DOI 10.1109/82.803473; ITO M, 1978, EXP BRAIN RES, V33, P143; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 1997, INT REV NEUROBIOL, V41, P475, DOI 10.1016/S0074-7742(08)60366-9; Ito M, 2011, UNDERSTANDING STRETC, V44, P435; Ivry R B, 1992, Curr Opin Neurobiol, V2, P212, DOI 10.1016/0959-4388(92)90015-D; Jaeger D, 2003, J COMPUT NEUROSCI, V14, P311, DOI 10.1023/A:1023217111784; Kimpo RR, 2005, J NEUROPHYSIOL, V94, P3092, DOI 10.1152/jn.00048.2005; Lang EJ, 1999, J NEUROSCI, V19, P2728; Lazdins E., 2011, P INT WORKSH BIOINSP; Lenz A, 2009, IEEE T SYST MAN CY B, V39, P1420, DOI 10.1109/TSMCB.2009.2018138; Lepora NF, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00140; Lu J, 2011, J NEUROSCI, V31, P15065, DOI 10.1523/JNEUROSCI.2364-11.2011; Luque NR, 2011, INT J NEURAL SYST, V21, P385, DOI 10.1142/S0129065711002900; Luque NR, 2012, INT J NEURAL SYST, V22, DOI 10.1142/S012906571250013X; Luque NR, 2011, IEEE T NEURAL NETWOR, V22, P1321, DOI 10.1109/TNN.2011.2156809; Maass W, 1997, NEURAL NETWORKS, V10, P1659, DOI 10.1016/S0893-6080(97)00011-7; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Masuda N, 2008, J COMPUT NEUROSCI, V24, P137, DOI 10.1007/s10827-007-0045-7; Mathy A, 2009, NEURON, V62, P388, DOI 10.1016/j.neuron.2009.03.023; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; McKinstry JL, 2006, P NATL ACAD SCI USA, V103, P3387, DOI 10.1073/pnas.0511281103; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Naveros F, 2013, BMC NEUROSCI, V14, pP328; Nolfi S, 2002, TRENDS COGN SCI, V6, P31, DOI 10.1016/S1364-6613(00)01812-X; Porrill J, 2007, PLOS COMPUT BIOL, V3, P1935, DOI 10.1371/journal.pcbi.0030197; Luque NR, 2011, IEEE T SYST MAN CY B, V41, P1299, DOI 10.1109/TSMCB.2011.2138693; Rasmussen A, 2013, J NEUROSCI, V33, P13436, DOI 10.1523/JNEUROSCI.1527-13.2013; Ros E, 2006, NEURAL COMPUT, V18, P2959, DOI 10.1162/neco.2006.18.12.2959; Sarlegna FR, 2010, NEUROPSYCHOLOGIA, V48, P60, DOI 10.1016/j.neuropsychologia.2009.08.011; Scheidt RA, 2000, J NEUROPHYSIOL, V84, P853, DOI 10.1152/jn.2000.84.2.853; Schemmel J, 2007, IEEE INT SYMP CIRC S, P3367, DOI 10.1109/ISCAS.2007.378289; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sharp T, 2011, LECT NOTES COMPUT SC, V7064, P424, DOI 10.1007/978-3-642-24965-5_48; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Simpson JI, 1996, BEHAV BRAIN SCI, V19, P384, DOI 10.1017/S0140525X00081486; Solinas S, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00012; Spoelstra J, 2000, BIOL CYBERN, V82, P321, DOI 10.1007/s004220050586; Spoelstra J, 2001, AUTON ROBOT, V11, P273, DOI 10.1023/A:1012447225242; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; Thompson RF, 2009, NEUROSCIENCE, V162, P732, DOI 10.1016/j.neuroscience.2009.01.041; Trhan P, 2010, COMPUTING INFORM, V29; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; van der Smagt P, 2000, ROBOT AUTON SYST, V32, P237, DOI 10.1016/S0921-8890(00)00090-7; Verschure P, 1999, BILDUNG ERZIEHUNG, V52, P317; Vijayakumar S, 2005, NEURAL COMPUT, V17, P2602, DOI 10.1162/089976605774320557; Voegtlin T, 1999, REV NEUROSCIENCE, V10, P291; WELSH JP, 1991, J PHYSIOL-LONDON, V444, P459, DOI 10.1113/jphysiol.1991.sp018888; Yamamoto K, 2007, J NEUROPHYSIOL, V97, P1588, DOI 10.1152/jn.00206.2006; Yamazaki T, 2007, NEURAL NETWORKS, V20, P290, DOI 10.1016/j.neunet.2007.04.004; Yamazaki T, 2013, NEURAL NETWORKS, V47, P103, DOI 10.1016/j.neunet.2013.01.019; Yamazaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033319	81	47	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112265	10.1371/journal.pone.0112265	http://dx.doi.org/10.1371/journal.pone.0112265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390365	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400067
J	Estevez, S; Marrero, MT; Quintana, J; Estevez, F				Estevez, Sara; Teresa Marrero, Maria; Quintana, Jose; Estevez, Francisco			Eupatorin-Induced Cell Death in Human Leukemia Cells Is Dependent on Caspases and Activates the Mitogen-Activated Protein Kinase Pathway	PLOS ONE			English	Article							MAPK PATHWAY; APOPTOSIS; CANCER; FLAVONOIDS; CONSTITUENTS; METABOLISM; CLEAVAGE; THERAPY	Eupatorin is a naturally occurring flavone that inhibits cell proliferation in human tumor cells. Here we demonstrate that eupatorin arrests cells at the G(2)-M phase of the cell cycle and induces apoptotic cell death involving activation of multiple caspases, mitochondrial release of cytochrome c and poly(ADP-ribose) polymerase cleavage in human leukemia cells. This flavonoid induced the phosphorylation of members of the mitogen-activated protein kinases and cell death was attenuated by inhibition of c-jun N-terminal kinases/stress activated protein kinases. Eupatorin-induced cell death is mediated by both the extrinsic and the intrinsic apoptotic pathways and through a mechanism dependent on reactive oxygen species generation.	[Estevez, Sara; Teresa Marrero, Maria; Quintana, Jose; Estevez, Francisco] Univ Las Palmas Gran Canaria, Dept Biochem & Mol Biol, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria	Estevez, F (corresponding author), Univ Las Palmas Gran Canaria, Dept Biochem & Mol Biol, Las Palmas Gran Canaria, Spain.	francisco.estevez@ulpgc.es	Quintana, José/K-5709-2014; Estévez, Francisco/K-5125-2014	Quintana, José/0000-0001-8225-4538; Estévez, Francisco/0000-0002-9728-2774	Spanish Ministry of Science and Innovation [SAF2010-21380]; European Regional Development Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission)	This work was supported by a grant (number: SAF2010-21380) from the Spanish Ministry of Science and Innovation and European Regional Development Fund (URL: www.micinn.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, CANCER RES, V60, P6101; Androutsopoulos V, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2090; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Bellows DS, 2000, J VIROL, V74, P5024, DOI 10.1128/JVI.74.11.5024-5031.2000; Benov L, 1998, FREE RADICAL BIO MED, V25, P826, DOI 10.1016/S0891-5849(98)00163-4; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; DIVE C, 1991, BRIT J CANCER, V64, P192, DOI 10.1038/bjc.1991.269; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Nagao T, 2002, BIOL PHARM BULL, V25, P875, DOI 10.1248/bpb.25.875; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ramos S, 2007, J NUTR BIOCHEM, V18, P427, DOI 10.1016/j.jnutbio.2006.11.004; Ravishankar D, 2013, INT J BIOCHEM CELL B, V45, P2821, DOI 10.1016/j.biocel.2013.10.004; Rubio S, 2007, CARCINOGENESIS, V28, P2105, DOI 10.1093/carcin/bgm131; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Schinella GR, 1998, J PHARM PHARMACOL, V50, P1069, DOI 10.1111/j.2042-7158.1998.tb06924.x; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tezuka Y, 2000, CHEM PHARM BULL, V48, P1711, DOI 10.1248/cpb.48.1711; Torres F, 2008, APOPTOSIS, V13, P716, DOI 10.1007/s10495-008-0202-0; Torres F, 2010, MOL CARCINOGEN, V49, P464, DOI 10.1002/mc.20619; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wood DE, 2000, EXP CELL RES, V256, P375, DOI 10.1006/excr.2000.4859	30	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112536	10.1371/journal.pone.0112536	http://dx.doi.org/10.1371/journal.pone.0112536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390937	Green Submitted, gold, Green Published			2022-12-26	WOS:000349144400093
J	Khan, S; Greco, D; Michailidou, K; Milne, RL; Muranen, TA; Heikkinen, T; Aaltonen, K; Dennis, J; Bolla, MK; Liu, J; Hall, P; Irwanto, A; Humphreys, K; Li, J; Czene, K; Chang-Claude, J; Hein, R; Rudolph, A; Seibold, P; Flesch-Janys, D; Fletcher, O; Peto, J; Silva, ID; Johnson, N; Gibson, L; Aitken, Z; Hopper, JL; Tsimiklis, H; Bui, M; Makalic, E; Schmidt, DF; Southey, MC; Apicella, C; Stone, J; Waisfisz, Q; Meijers-Heijboer, H; Adank, MA; van der Luijt, RB; Meindl, A; Schmutzler, RK; Muller-Myhsok, B; Lichtner, P; Turnbull, C; Rahman, N; Chanock, SJ; Hunter, DJ; Cox, A; Cross, SS; Reed, MWR; Schmidt, MK; Broeks, A; Van't Veer, LJ; Hogervorst, FB; Fasching, PA; Schrauder, MG; Ekici, AB; Beckmann, MW; Bojesen, SE; Nordestgaard, BG; Nielsen, SF; Flyger, H; Benitez, J; Zamora, PM; Perez, JIA; Haiman, CA; Henderson, BE; Schumacher, F; Le Marchand, L; Pharoah, PDP; Dunning, AM; Shah, M; Luben, R; Brown, J; Couch, FJ; Wang, X; Vachon, C; Olson, JE; Lambrechts, D; Moisse, M; Paridaens, R; Christiaens, MR; Guenel, P; Truong, T; Laurent-Puig, P; Mulot, C; Marme, F; Burwinkel, B; Schneeweiss, A; Sohn, C; Sawyer, EJ; Tomlinson, I; Kerin, MJ; Miller, N; Andrulis, IL; Knight, JA; Tchatchou, S; Mulligan, AM; Dork, T; Bogdanova, NV; Antonenkova, NN; Anton-Culver, H; Darabi, H; Eriksson, M; Garcia-Closas, M; Figueroa, J; Lissowska, J; Brinton, L; Devilee, P; Tollenaar, RAEM; Seynaeve, C; van Asperen, CJ; Kristensen, VN; Slager, S; Toland, AE; Ambrosone, CB; Yannoukakos, D; Lindblom, A; Margolin, S; Radice, P; Peterlongo, P; Barile, M; Mariani, P; Hooning, MJ; Martens, JWM; Collee, JM; Jager, A; Jakubowska, A; Lubinski, J; Jaworska-Bieniek, K; Durda, K; Giles, GG; McLean, C; Brauch, H; Bruning, T; Ko, YD; Brenner, H; Dieffenbach, AK; Arndt, V; Stegmaier, C; Swerdlow, A; Ashworth, A; Orr, N; Jones, M; Simard, J; Goldberg, MS; Labreche, F; Dumont, M; Winqvist, R; Pylkas, K; Jukkola-Vuorinen, A; Grip, M; Kataja, V; Kosma, VM; Hartikainen, JM; Mannermaa, A; Hamann, U; Chenevix-Trench, G; Blomqvist, C; Aittomaki, K; Easton, DF; Nevanlinna, H				Khan, Sofia; Greco, Dario; Michailidou, Kyriaki; Milne, Roger L.; Muranen, Taru A.; Heikkinen, Tuomas; Aaltonen, Kirsimari; Dennis, Joe; Bolla, Manjeet K.; Liu, Jianjun; Hall, Per; Irwanto, Astrid; Humphreys, Keith; Li, Jingmei; Czene, Kamila; Chang-Claude, Jenny; Hein, Rebecca; Rudolph, Anja; Seibold, Petra; Flesch-Janys, Dieter; Fletcher, Olivia; Peto, Julian; Silva, Isabel dos Santos; Johnson, Nichola; Gibson, Lorna; Aitken, Zoe; Hopper, John L.; Tsimiklis, Helen; Bui, Minh; Makalic, Enes; Schmidt, Daniel F.; Southey, Melissa C.; Apicella, Carmel; Stone, Jennifer; Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.; van der Luijt, Rob B.; Meindl, Alfons; Schmutzler, Rita K.; Muller-Myhsok, Bertram; Lichtner, Peter; Turnbull, Clare; Rahman, Nazneen; Chanock, Stephen J.; Hunter, David J.; Cox, Angela; Cross, Simon S.; Reed, Malcolm W. R.; Schmidt, Marjanka K.; Broeks, Annegien; Van't Veer, Laura J.; Hogervorst, Frans B.; Fasching, Peter A.; Schrauder, Michael G.; Ekici, Arif B.; Beckmann, Matthias W.; Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.; Flyger, Henrik; Benitez, Javier; Zamora, Pilar M.; Perez, Jose I. A.; Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick; Le Marchand, Loic; Pharoah, Paul D. P.; Dunning, Alison M.; Shah, Mitul; Luben, Robert; Brown, Judith; Couch, Fergus J.; Wang, Xianshu; Vachon, Celine; Olson, Janet E.; Lambrechts, Diether; Moisse, Matthieu; Paridaens, Robert; Christiaens, Marie-Rose; Guenel, Pascal; Truong, Therese; Laurent-Puig, Pierre; Mulot, Claire; Marme, Frederick; Burwinkel, Barbara; Schneeweiss, Andreas; Sohn, Christof; Sawyer, Elinor J.; Tomlinson, Ian; Kerin, Michael J.; Miller, Nicola; Andrulis, Irene L.; Knight, Julia A.; Tchatchou, Sandrine; Mulligan, Anna Marie; Dork, Thilo; Bogdanova, Natalia V.; Antonenkova, Natalia N.; Anton-Culver, Hoda; Darabi, Hatef; Eriksson, Mikael; Garcia-Closas, Montserrat; Figueroa, Jonine; Lissowska, Jolanta; Brinton, Louise; Devilee, Peter; Tollenaar, Robert A. E. M.; Seynaeve, Caroline; van Asperen, Christi J.; Kristensen, Vessela N.; Slager, Susan; Toland, Amanda E.; Ambrosone, Christine B.; Yannoukakos, Drakoulis; Lindblom, Annika; Margolin, Sara; Radice, Paolo; Peterlongo, Paolo; Barile, Monica; Mariani, Paolo; Hooning, Maartje J.; Martens, John W. M.; Collee, J. Margriet; Jager, Agnes; Jakubowska, Anna; Lubinski, Jan; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna; Giles, Graham G.; McLean, Catriona; Brauch, Hiltrud; Bruning, Thomas; Ko, Yon-Dschun; Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker; Stegmaier, Christa; Swerdlow, Anthony; Ashworth, Alan; Orr, Nick; Jones, Michael; Simard, Jacques; Goldberg, Mark S.; Labreche, France; Dumont, Martine; Winqvist, Robert; Pylkas, Katri; Jukkola-Vuorinen, Arja; Grip, Mervi; Kataja, Vesa; Kosma, Veli-Matti; Hartikainen, Jaana M.; Mannermaa, Arto; Hamann, Ute; Chenevix-Trench, Georgia; Blomqvist, Carl; Aittomaki, Kristiina; Easton, Douglas F.; Nevanlinna, Heli		KConFab Investigators; Australian Ovarian Canc Study Grp; GENICA Network	MicroRNA Related Polymorphisms and Breast Cancer Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; BINDING-SITES; COMMON VARIANT; REDUCED RISK; IDENTIFIES 3; HUMAN GENES; CASP8 GENE; SUSCEPTIBILITY; EXPRESSION	Genetic variations, such as single nucleotide polymorphisms (SNPs) in microRNAs (miRNA) or in the miRNA binding sites may affect the miRNA dependent gene expression regulation, which has been implicated in various cancers, including breast cancer, and may alter individual susceptibility to cancer. We investigated associations between miRNA related SNPs and breast cancer risk. First we evaluated 2,196 SNPs in a case-control study combining nine genome wide association studies (GWAS). Second, we further investigated 42 SNPs with suggestive evidence for association using 41,785 cases and 41,880 controls from 41 studies included in the Breast Cancer Association Consortium (BCAC). Combining the GWAS and BCAC data within a meta-analysis, we estimated main effects on breast cancer risk as well as risks for estrogen receptor (ER) and age defined subgroups. Five miRNA binding site SNPs associated significantly with breast cancer risk: rs1045494 (odds ratio (OR) 0.92; 95% confidence interval (CI): 0.88-0.96), rs1052532 (OR 0.97; 95% CI: 0.95-0.99), rs10719 (OR 0.97; 95% CI: 0.94-0.99), rs4687554 (OR 0.97; 95% CI: 0.95-0.99, and rs3134615 (OR 1.03; 95% CI: 1.01-1.05) located in the 3' UTR of CASP8, HDDC3, DROSHA, MUSTN1, and MYCL1, respectively. DROSHA belongs to miRNA machinery genes and has a central role in initial miRNA processing. The remaining genes are involved in different molecular functions, including apoptosis and gene expression regulation. Further studies are warranted to elucidate whether the miRNA binding site SNPs are the causative variants for the observed risk effects.	[Khan, Sofia; Greco, Dario; Muranen, Taru A.; Heikkinen, Tuomas; Aaltonen, Kirsimari; Nevanlinna, Heli] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Khan, Sofia; Greco, Dario; Muranen, Taru A.; Heikkinen, Tuomas; Aaltonen, Kirsimari; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Greco, Dario] Finnish Inst Occupat Hlth, Helsinki, Finland; [Michailidou, Kyriaki; Dennis, Joe; Bolla, Manjeet K.; Pharoah, Paul D. P.; Brown, Judith; Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Milne, Roger L.; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Australia; [Milne, Roger L.; Giles, Graham G.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Australia; [Aaltonen, Kirsimari; Aittomaki, Kristiina] Univ Helsinki, Dept Clin Genet, Helsinki, Finland; [Aaltonen, Kirsimari; Blomqvist, Carl; Aittomaki, Kristiina] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Aaltonen, Kirsimari; Blomqvist, Carl] Univ Helsinki, Dept Oncol, Helsinki, Finland; [Liu, Jianjun; Irwanto, Astrid; Li, Jingmei] Genome Inst Singapore, Div Human Genet, Singapore, Singapore; [Hall, Per; Humphreys, Keith; Czene, Kamila; Darabi, Hatef; Eriksson, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chang-Claude, Jenny; Hein, Rebecca; Rudolph, Anja; Seibold, Petra] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Hein, Rebecca] Univ Cologne, Dept Child & Adolescent Psychiat & Psychotherapy, PMV Res Grp, D-50931 Cologne, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Dept Canc Epidemiol, Clin Canc Registry, Hamburg, Germany; [Flesch-Janys, Dieter] Univ Clin Hamburg Eppendorf, Inst Med Biometr & Epidemiol, Hamburg, Germany; [Fletcher, Olivia; Johnson, Nichola; Ashworth, Alan; Orr, Nick] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Peto, Julian; Silva, Isabel dos Santos; Gibson, Lorna; Aitken, Zoe] London Sch Hyg & Trop Med, Dept Non Communicable Dis Epidemiol Dept, London WC1, England; [Hopper, John L.; Bui, Minh; Makalic, Enes; Schmidt, Daniel F.; Apicella, Carmel; Stone, Jennifer] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Australia; [Tsimiklis, Helen; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Australia; [Waisfisz, Quinten; Meijers-Heijboer, Hanne; Adank, Muriel A.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [van der Luijt, Rob B.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Meindl, Alfons] Tech Univ Munich, Div Gynaecol & Obstet, D-80290 Munich, Germany; [Schmutzler, Rita K.] Univ Hosp, Dept Obstet & Gynaecol, Div Mol Gynecooncol, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Hosp, CIO, Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Muller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Lichtner, Peter] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Human Genet, Neuherberg, Germany; [Turnbull, Clare; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; [Chanock, Stephen J.; Figueroa, Jonine; Brinton, Louise] Natl Canc Inst, Div Canc Epidemiol & Genet, Rockville, MD USA; [Hunter, David J.] Harvard Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA USA; [Hunter, David J.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Cox, Angela; Reed, Malcolm W. R.] Univ Sheffield, Dept Oncol, CRUK YCR Sheffield Canc Res Ctr, Sheffield, S Yorkshire, England; [Cross, Simon S.] Univ Sheffield, Dept Neurosci, Acad Unit Pathol, Sheffield, S Yorkshire, England; [Schmidt, Marjanka K.; Broeks, Annegien; Van't Veer, Laura J.; Hogervorst, Frans B.] Antoni Leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands; [Fasching, Peter A.; Schrauder, Michael G.; Beckmann, Matthias W.] Univ Erlangen Nurnberg, Univ Breast Ctr Franconia, Dept Gynecol & Obstet, Univ Hosp Erlangen,Comprehens Canc Canc Erlangen, D-91054 Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Ekici, Arif B.] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, Comprehens Canc Ctr Erlangen EMN, D-91054 Erlangen, Germany; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Herlev Hosp, Copenhagen Univ Hosp, Copenhagen, Denmark; [Bojesen, Stig E.; Nordestgaard, Borge G.; Nielsen, Sune F.] Herlev Hosp, Copenhagen Univ Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Flyger, Henrik] Copenhagen Univ Hosp, Herlev Hosp, Dept Breast Surg, Copenhagen, Denmark; [Benitez, Javier] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genet Grp, Madrid, Spain; [Benitez, Javier] Centro Invest Red Enfermedades Raras CIBERER, Valencia, Spain; [Zamora, Pilar M.] Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain; [Perez, Jose I. A.] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo, Spain; [Haiman, Christopher A.; Henderson, Brian E.; Schumacher, Fredrick] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96822 USA; [Pharoah, Paul D. P.; Dunning, Alison M.; Shah, Mitul; Easton, Douglas F.] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge, England; [Luben, Robert] Univ Cambridge, Dept Publ Hlth & Primary Care, Clin Gerontol, Cambridge, England; [Couch, Fergus J.; Wang, Xianshu] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Vachon, Celine; Olson, Janet E.; Slager, Susan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Lambrechts, Diether; Moisse, Matthieu] VIB, VRC, Leuven, Belgium; [Lambrechts, Diether; Moisse, Matthieu] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Paridaens, Robert; Christiaens, Marie-Rose] Univ Hosp Gasthuisberg, Dept Oncol, Leuven, Belgium; [Guenel, Pascal; Truong, Therese] INSERM, Ctr Res Epidemiol & Populat Health, Natl Inst Hlth & Med Res, CESP,U1018, Villejuif, France; [Guenel, Pascal; Truong, Therese] Univ Paris Sud, UMRS 1018, Villejuif, France; [Laurent-Puig, Pierre; Mulot, Claire] Univ Paris Sorbonne Cite, INSERM, UMR S775, Paris, France; [Marme, Frederick; Burwinkel, Barbara; Schneeweiss, Andreas; Sohn, Christof] Heidelberg Univ, Dept Obstet & Gynecol, Heidelberg, Germany; [Marme, Frederick; Schneeweiss, Andreas] Heidelberg Univ, Natl Ctr Tumor Dis, Heidelberg, Germany; [Burwinkel, Barbara] German Canc Res Ctr, Mol Epidemiol Grp, Heidelberg, Germany; [Sawyer, Elinor J.] Guys Hosp, Kings Coll London, Div Canc Studies, London SE1 9RT, England; [Tomlinson, Ian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Tomlinson, Ian] Univ Oxford, Oxford Biomed Res Ctr, Oxford, England; [Kerin, Michael J.; Miller, Nicola] Univ Hosp, Inst Clin Sci, Galway, Ireland; [Andrulis, Irene L.; Tchatchou, Sandrine] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Andrulis, Irene L.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Knight, Julia A.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Knight, Julia A.] Univ Toronto, Div Epidemiol, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mulligan, Anna Marie] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mulligan, Anna Marie] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Mulligan, Anna Marie] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Dork, Thilo] Hannover Med Sch, Dept Obstet & Gynaecol, Hannover, Germany; [Bogdanova, Natalia V.] Hannover Med Sch, Dept Radiat Oncol, Hannover, Germany; [Antonenkova, Natalia N.] NN Alexandrov Res Inst Oncol & Med Radiol, Minsk, BELARUS; [Anton-Culver, Hoda] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Garcia-Closas, Montserrat; Jones, Michael] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Garcia-Closas, Montserrat] Inst Canc Res, Div Breast Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet & Dept Pathol, Leiden, Netherlands; [Tollenaar, Robert A. E. M.] Leiden Univ, Med Ctr, Dept Surg Oncol, Leiden, Netherlands; [Seynaeve, Caroline] Erasmus MC Daniel Hoed Canc Ctr, Dept Med Oncol, Family Canc Clin, Rotterdam, Netherlands; [van Asperen, Christi J.] Leiden Univ, Med Ctr, Dept Clin Genet, Leiden, Netherlands; [Kristensen, Vessela N.] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Dept Clin Mol Biol EpiGen, Oslo, Norway; [Kristensen, Vessela N.] Oslo Univ Hosp, Dept Genet, Inst Canc Res, Radiumhosp, Oslo, Norway; [KConFab Investigators] Peter MacCallum Canc Ctr, Melbourne, Australia; [Australian Ovarian Canc Study Grp] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Toland, Amanda E.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Ambrosone, Christine B.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Yannoukakos, Drakoulis] IRRP, Mol Diagnost Lab, Natl Ctr Sci Res Demokritos Aghia Paraskevi Attik, Athens, Greece; [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Margolin, Sara] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Radice, Paolo] Fdn IRCCS, INT, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, Milan, Italy; [Peterlongo, Paolo; Mariani, Paolo] IFOM, Fdn Ist FIRC Oncol Mol, Milan, Italy; [Barile, Monica] IEO, Div Canc Prevent & Genet, Milan, Italy; [Mariani, Paolo] Cogentech Canc Genet Test Lab, Milan, Italy; [Hooning, Maartje J.; Martens, John W. M.; Jager, Agnes] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands; [Collee, J. Margriet] Erasmus Univ, Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Jakubowska, Anna; Lubinski, Jan; Jaworska-Bieniek, Katarzyna; Durda, Katarzyna] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland; [Jaworska-Bieniek, Katarzyna] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [McLean, Catriona] Alfred Hosp, Melbourne, Australia; [Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Clin Pharmacol, Stuttgart, Germany; [Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Bruning, Thomas] Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Inst Ruhr, Bochum, Germany; [Ko, Yon-Dschun] Evangel Kliniken Bonn gGmbH, Dept Internal Med, Bonn, Germany; [Hamann, Ute] German Canc Res Ctr, Heidelberg, Germany; Univ Med Ctr Hamburg Eppendorf, Inst Occupat Med & Maritime Med, Hamburg, Germany; [GENICA Network] Univ Bonn, Inst Pathol, Fac Med, Bonn, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina; Arndt, Volker] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann; Dieffenbach, Aida Karina] German Canc Consortium DKTK, Heidelberg, Germany; [Stegmaier, Christa] Saarland Canc Registry, Saarbrucken, Germany; [Swerdlow, Anthony] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England; [Swerdlow, Anthony] Inst Canc Res, Div Breast Canc Res, Sutton, Surrey, England; [Simard, Jacques; Dumont, Martine] Univ Quebec, Res Ctr, Ctr Hosp, Ste Foy, PQ G1V 2M3, Canada; [Simard, Jacques; Dumont, Martine] Univ Laval, Canc Genom Lab, Quebec City, PQ G1K 7P4, Canada; [Goldberg, Mark S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goldberg, Mark S.] McGill Univ Hlth Ctr, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Dept Sante Environm, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Dept Sante Travail, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Dept Sociale Med, Montreal, PQ, Canada; [Labreche, France] Univ Montreal, Dept Prevent, Montreal, PQ, Canada; [Winqvist, Robert; Pylkas, Katri] Univ Oulu, Lab Canc Genet & Tumor Biol, Dept Clin Chem & Biocenter Oulu, NordLab Oulu,Oulu Univ Hosp, Oulu, Finland; [Jukkola-Vuorinen, Arja] Univ Oulu, Dept Oncol, Oulu Univ Hosp, Oulu, Finland; [Grip, Mervi] Univ Oulu, Oulu Univ Hosp, Dept Surg, Oulu, Finland; [Kataja, Vesa] Univ Eastern Finland, Inst Clin Med Oncol, Sch Med, Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland; [Kosma, Veli-Matti; Hartikainen, Jaana M.; Mannermaa, Arto] Univ Eastern Finland, Inst Clin Med Pathol & Forens Med, Sch Med, Kuopio, Finland; [Kosma, Veli-Matti; Hartikainen, Jaana M.; Mannermaa, Arto] Kuopio Univ Hosp, Imaging Ctr, Dept Clin Pathol, SF-70210 Kuopio, Finland; [Kosma, Veli-Matti; Hartikainen, Jaana M.; Mannermaa, Arto] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld, Australia	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finnish Institute of Occupational Health; University of Cambridge; Cancer Council Victoria; University of Melbourne; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Karolinska Institutet; Helmholtz Association; German Cancer Research Center (DKFZ); University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Melbourne; University of Melbourne; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; Technical University of Munich; University of Cologne; University of Cologne; University of Cologne; University of Cologne; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; Institute of Cancer Research - UK; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Sheffield; University of Sheffield; Netherlands Cancer Institute; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Erlangen Nuremberg; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; University of Cambridge; Mayo Clinic; Mayo Clinic; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Ollscoil na Gaillimhe-University of Galway; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Hannover Medical School; Hannover Medical School; University of California System; University of California Irvine; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oslo; University of Oslo; University of Oslo; Peter Maccallum Cancer Center; QIMR Berghofer Medical Research Institute; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Roswell Park Cancer Institute; National Centre of Scientific Research "Demokritos"; Karolinska Institutet; Karolinska Institutet; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Pomeranian Medical University; Medical University of Warsaw; Florey Institute of Neuroscience & Mental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Ruhr University Bochum; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; Laval University; University of Quebec; Laval University; McGill University; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Oulu; University of Oulu; University of Oulu; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; QIMR Berghofer Medical Research Institute	Nevanlinna, H (corresponding author), Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland.	mkh39@medschl.cam.ac.uk; dfe20@medschl.cam.ac.uk	/AAM-5330-2020; Hartikainen, Jaana M/E-6256-2015; Figueroa, Jonine/AAG-1065-2022; Dörk, Thilo/J-8620-2012; Devilee, Peter/GXV-8005-2022; Reed, Malcolm Walter/AAG-9219-2020; Garcia-Closas, Montserrat/F-3871-2015; Flyger, Henrik/AAM-6494-2021; Chenevix-Trench, Georgia/AAV-2014-2020; Lambrechts, Diether/AAJ-3167-2020; Muranen, Taru/AAC-8418-2019; Bowtell, David/H-1007-2016; Knight, Julia/A-6843-2012; Arndt, Volker/B-4999-2014; truong, therese/A-2837-2013; Laurent-Puig, Pierre/K-3641-2019; Guenel, Pascal/AAS-7688-2021; Zamora, Pilar/AAM-9336-2021; Jakubowska, Anna/O-8050-2014; Radice, Paolo/O-3119-2013; jager, agnes/V-6381-2017; DEVILEE, PETER/ABR-2140-2022; Figueroa, Jonine/AFK-2752-2022; Arndt, Volker/AAI-7282-2020; Guenel, Pascal/H-3728-2018; Schmidt, Marjanka K/G-9058-2011; Nordestgaard, Borge Gronne/ABF-1310-2020; Lissowska, Jolanta/AAH-3252-2020; Peterlongo, Paolo/Q-4717-2018; laurent-puig, pierre/B-2226-2013; Brinton, Louise A/G-7486-2015; Brüning, Thomas/G-8120-2015; Miller, Nicola/F-4009-2018; Haviv, Izhak/E-3782-2015; Bogdanova, Natalia V./Y-2205-2019; Margolin, Sara/AAX-9034-2020; Schneeweiss, Andreas/HHS-4098-2022; van Asperen, Christi J/D-3970-2012; Figueroa, Jonine/GWD-1322-2022; Garcia-Closas, Montserrat/AAZ-6930-2021; Michailidou, Kyriaki/ABD-5122-2020; Li, Jingmei/I-2904-2012; Schumacher, Fredrick/R-6043-2019; Knight, Julia/R-5617-2019; Liu, Jianjun/AAK-4989-2020; Brenner, Hermann/ABE-6383-2020; Turnbull, Clare/AAA-6596-2019; Greco, Dario/T-7113-2019; Ekici, Arif B/C-3971-2013; Pharoah, Paul/V-6658-2019; Fasching, Peter A/ABH-9912-2020; Brenner, Hermann/B-4627-2017; Luben, Robert N/H-5519-2015; Rahman, Nazneen/D-2802-2013; Wyld, David/B-8893-2015	Hartikainen, Jaana M/0000-0001-8267-1905; Figueroa, Jonine/0000-0002-5100-623X; Dörk, Thilo/0000-0002-9458-0282; Reed, Malcolm Walter/0000-0001-7442-2132; Garcia-Closas, Montserrat/0000-0003-1033-2650; Chenevix-Trench, Georgia/0000-0002-1878-2587; Lambrechts, Diether/0000-0002-3429-302X; Muranen, Taru/0000-0002-5895-1808; Bowtell, David/0000-0001-9089-7525; Arndt, Volker/0000-0001-9320-8684; truong, therese/0000-0002-2943-6786; Laurent-Puig, Pierre/0000-0001-8475-5459; Guenel, Pascal/0000-0002-8359-518X; Jakubowska, Anna/0000-0002-5650-0501; Radice, Paolo/0000-0001-6298-4111; jager, agnes/0000-0002-7713-1450; Figueroa, Jonine/0000-0002-5100-623X; Arndt, Volker/0000-0001-9320-8684; Guenel, Pascal/0000-0002-8359-518X; Schmidt, Marjanka K/0000-0002-2228-429X; Lissowska, Jolanta/0000-0003-2695-5799; Peterlongo, Paolo/0000-0001-6951-6855; laurent-puig, pierre/0000-0001-8475-5459; Brinton, Louise A/0000-0003-3853-8562; Brüning, Thomas/0000-0001-9560-5464; Miller, Nicola/0000-0002-5416-7047; Haviv, Izhak/0000-0002-0837-5005; van Asperen, Christi J/0000-0002-1436-7650; Figueroa, Jonine/0000-0002-5100-623X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Michailidou, Kyriaki/0000-0001-7065-1237; Li, Jingmei/0000-0001-8587-7511; Schumacher, Fredrick/0000-0002-3073-7463; Knight, Julia/0000-0002-7610-7635; Liu, Jianjun/0000-0002-3255-3019; Brenner, Hermann/0000-0002-6129-1572; Greco, Dario/0000-0001-9195-9003; Ekici, Arif B/0000-0001-6099-7066; Pharoah, Paul/0000-0001-8494-732X; Fasching, Peter A/0000-0003-4885-8471; Brenner, Hermann/0000-0002-6129-1572; Luben, Robert N/0000-0002-5088-6343; eriksson, mikael/0000-0001-8135-4270; Makalic, Enes/0000-0003-3017-0871; Turnbull, Clare/0000-0002-1734-5772; Bui, Minh/0000-0002-9099-6870; Swerdlow, Anthony/0000-0001-5550-4159; van der Luijt, Rob/0000-0002-0018-1089; Giles, Graham/0000-0003-4946-9099; Stone, Jennifer/0000-0001-5077-0124; Yannoukakos, Drakoulis/0000-0001-7509-3510; Kataja, Vesa/0000-0003-4846-4843; Nordestgaard, Borge/0000-0002-1954-7220; Pylkas, Katri/0000-0002-2449-0521; Moisse, Matthieu/0000-0001-8880-9311; Khan, Sofia/0000-0003-4185-8882; Winqvist, Robert/0000-0003-0932-9104; dos Santos Silva, Isabel/0000-0002-6596-8798; Bojesen, Stig/0000-0002-4061-4133; Brauch, Hiltrud/0000-0001-7531-2736; Blomqvist, Carl/0000-0003-3041-1938; Southey, Melissa/0000-0002-6313-9005; Aitken, Zoe/0000-0002-5413-2450; Kerin, Michael/0000-0003-4164-5561; Simard, Jacques/0000-0001-6906-3390; Czene, Kamila/0000-0002-3233-5695; Margolin, Sara/0000-0002-5526-5570; Durocher, Francine/0000-0001-8012-4641; Mulligan, Anna Marie/0000-0002-7239-5297; Fletcher, Olivia/0000-0001-9387-7116; Roth, Rebecca/0000-0002-2841-4921; Devilee, Peter/0000-0002-8023-2009; Labreche, France/0000-0001-8722-0433; Cox, Angela/0000-0002-5138-1099; Lotz, Anne/0000-0002-8715-0743; Dunning, Alison Margaret/0000-0001-6651-7166; Rahman, Nazneen/0000-0003-4376-0440; Lubinski, Jan/0000-0003-2931-3003; Wyld, David/0000-0001-9523-4333; McLean, Catriona/0000-0002-0302-5727; Jones, Michael/0000-0001-7479-3451; Heikkinen, Tuomas/0000-0003-1154-6204; Waisfisz, Quinten/0000-0002-7384-9182; Cross, Simon/0000-0003-2044-1754	European Community's Seventh Framework Programme (COGS) [223175 (HEALTH-F2-2009-223175)]; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program; Ministry of Economic Development, Innovation and Export Trade of Quebec [PSR-SIIRI-701]; Helsinki University Central Hospital Research Fund; Academy of Finland [266528]; Finnish Cancer Society; Nordic Cancer Union; Sigrid Juselius Foundation; Nordic Center of Excellence in Disease Genetics; Wellcome Trust; Cancer Research UK [C8620/A8372]; United States National Cancer Institute, National Institutes of Health (NIH) [RFA-CA-06-503]; Cancer Care Ontario [U01 CA69467]; Northern California Cancer Center [U01 CA69417]; University of Melbourne [U01 CA69638]; Canadian Institutes of Health Research for "CIHR Team in Familial Risks of Breast Cancer" program; National Cancer Institute [UM1 CA164920]; National Health and Medical Research Council of Australia; New South Wales Cancer Council; Victorian Health Promotion Foundation (Australia); Victorian Breast Cancer Research Consortium; Dutch Cancer Society [NKI 2007-3839, 2009 4363, DDHK 2004-3124, DDHK 2009-4318, RUL 1997-1505]; Dutch government (NWO) [184.021.007]; Dutch National Genomics Initiative; Breakthrough Breast Cancer; NHS; National Cancer Research Network (NCRN); Institut National de Cancer; ELAN-Fond of the University Hospital of Erlangen; NIHR Comprehensive Biomedical Research Centre; Guy's & St. Thomas' NHS Foundation Trust; King's College London, United Kingdom; Oxford Biomedical Research Centre; Dietmar-Hopp Foundation; Helmholtz Society; German Cancer Research Center; Fondation de France [2004012618, 2007005156]; Institut National du Cancer (INCa) [2007-1/SPC2, 2008-1-CP-4, 2009-1-SHS/SP-04]; Ligue Nationale contre le Cancer; Association pour la Recherche contre le Cancer (ARC) [2008-1-CP-4]; Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET - ANSES) [ST-2005-003, EST2008/1/26, VS-2009-21]; Ligue contre le Cancer Grand Ouest; Chief Physician Johan Boserup and Lise Boserup Fund; Danish Medical Research Council; Herlev Hospital; Genome Spain Foundation; Red Tematica de Investigacion Cooperativa en Cancer; Asociacion Espanola Contra el Cancer; Fondo de Investigacion Sanitario [PI11/00923, PI081120]; Human Genotyping-CEGEN Unit (CNIO); Instituto de Salud Carlos III; California Breast Cancer Act of 1993; National Institutes of Health [R01 CA77398]; Lon V Smith Foundation [LVS39420]; California Breast Cancer Research Fund [97-10500]; California Department of Public Health, statewide cancer reporting program [103885]; Hellenic Cooperative Oncology Group research grant [HR R_BG/04]; Greek General Secretary for Research and Technology (GSRT) Program, Research Excellence II; European Union; Netherlands Organisation for Scientific Research (NWO), ZonMw/VIDI [91756341]; Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Baden Wurttemberg Ministry of Science, Research and Arts; German Cancer Aid (Deutsche Krebshilfe); Friends of Hannover Medical School; Rudolf Bartling Foundation; Stockholm County Council; Karolinska Institutet; Swedish Cancer Society; Bert von Kantzow foundation; Deutsche Krebshilfe [107054]; German Cancer Research Centre (DKFZ); German Cancer Aid [107352]; Federal Ministry of Education and Research (BMBF) Germany [01KW9975/5, 01KW9976/8, 01KW9977/0, 01KW0114, 01KH0402]; Robert Bosch Foundation; Stuttgart; Deutsches Krebsforschungszentrum (DKFZ); Heidelberg; German Social Accident Insurance; Institute of the Ruhr University Bochum (IPA), Germany; Department of Internal Medicine; Evangelische Kliniken Bonn gGmbH; Johanniter Krankenhaus, Bonn, Germany; Government Funding (EVO) of Kuopio University Hospital grants; Cancer Fund of North Savo; Finnish Cancer Organizations; University of Eastern Finland; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC); Queensland Cancer Fund; Cancer Council of New South Wales; Cancer Council of Victoria; Cancer Council of Tasmania; Cancer Council of South Australia; Cancer Foundation of Western Australia; NHMRC [145684, 288704, 454508, 199600]; United States Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Stichting tegen Kanker [232-2008, 196-2010]; FWO; Deutsche Krebshilfe e.V. [70-2892-BR I]; Hamburg Cancer Society; Italian Association for Cancer Research (AIRC); INT-Institutional strategic projects "5x1000"; Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201]; Breast Cancer Research Foundation; VicHealth and Cancer Council Victoria; Australian NHMRC [209057, 251553, 504711]; NIH [CA122340, CA63464, CA54281, CA098758, CA132839, CA128978, CA 65725, CA87969, CA49449, CA67262, CA50385, 5UO1CA098233]; Canadian Breast Cancer Research Initiative; Quebec Breast Cancer Foundation; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program [CRN-87521]; Ministry of Economic Development, Innovation and Export Trade [PSR-SIIRI-701]; Norwegian Research council [155218/V40, 175240/S10, FUGE-NFR 181600/V11]; Swizz Bridge Award; Finnish Cancer Foundation; Academy of Finland; University of Oulu; Oulu University Hospital; Biobanking and Biomolecular Resources Research Infrastructure [BBMRI-NL CP16]; Stefanie Spielman fund; OSU Comprehensive Cancer Center; Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA; Marit and Hans Rausings Initiative Against Breast Cancer; Cancer Risk Prediction Center, Linneus Centre - Swedish Research Council [70867902]; Swedish Research Council; RPCI DataBank and BioRepository (DBBR), Cancer Center Support Grant Shared Resource [P30 CA016056-32]; Agency for Science, Technology and Research of Singapore (A*STAR); US National Institute of Health (NIH); Susan G. Komen Breast Cancer Foundation; Yorkshire Cancer Research [S295, S299, S305PA]; programme grant from Cancer Research UK [C490/A10124]; UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge; Joseph Mitchell Fund; DKFZ; Polish Foundation of Science; Komen Foundation for the Cure; Ohio State University Comprehensive Cancer Center; Stefanie Spielman fund for Breast Cancer Research; European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program of the General Secretariat for Research & Technology: ARISTEIA; Institute of Cancer Research (ICR);  [KULPFV/10/016-SymBioSysII];  [PBZ_KBN_122/P05/2004]; MRC [G0700491] Funding Source: UKRI; Cancer Research UK [15106, 16565, 16561, 16563] Funding Source: researchfish; Medical Research Council [G0700491] Funding Source: researchfish; National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish; Cancer Foundation Finland sr [130168] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; The Francis Crick Institute [10124] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R37CA054281, R01CA063464, U01CA069638, UM1CA164920, R01CA132839, U01CA049449, P30CA016056, U01CA069417, P01CA087969, R01CA122340, U01CA063464, P50CA116201, U01CA098758, R01CA065725, R01CA067262, R01CA050385, ZIACP010126, R01CA128978, R01CA049449, R01CA077398, U01CA067262, U01CA098233, U01CA069467, R01CA054281] Funding Source: NIH RePORTER	European Community's Seventh Framework Programme (COGS); Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade of Quebec; Helsinki University Central Hospital Research Fund; Academy of Finland(Academy of Finland); Finnish Cancer Society; Nordic Cancer Union; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Nordic Center of Excellence in Disease Genetics; Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); United States National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Care Ontario; Northern California Cancer Center; University of Melbourne(University of Melbourne); Canadian Institutes of Health Research for "CIHR Team in Familial Risks of Breast Cancer" program(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales Cancer Council(Cancer Council New South Wales); Victorian Health Promotion Foundation (Australia); Victorian Breast Cancer Research Consortium; Dutch Cancer Society(KWF Kankerbestrijding); Dutch government (NWO); Dutch National Genomics Initiative; Breakthrough Breast Cancer; NHS; National Cancer Research Network (NCRN); Institut National de Cancer; ELAN-Fond of the University Hospital of Erlangen; NIHR Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Guy's & St. Thomas' NHS Foundation Trust; King's College London, United Kingdom; Oxford Biomedical Research Centre; Dietmar-Hopp Foundation; Helmholtz Society(Helmholtz Association); German Cancer Research Center; Fondation de France(Fondation de France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET - ANSES); Ligue contre le Cancer Grand Ouest(Ligue nationale contre le cancer); Chief Physician Johan Boserup and Lise Boserup Fund; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Herlev Hospital; Genome Spain Foundation; Red Tematica de Investigacion Cooperativa en Cancer; Asociacion Espanola Contra el Cancer; Fondo de Investigacion Sanitario; Human Genotyping-CEGEN Unit (CNIO); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); California Breast Cancer Act of 1993; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lon V Smith Foundation; California Breast Cancer Research Fund; California Department of Public Health, statewide cancer reporting program; Hellenic Cooperative Oncology Group research grant; Greek General Secretary for Research and Technology (GSRT) Program, Research Excellence II; European Union(European Commission); Netherlands Organisation for Scientific Research (NWO), ZonMw/VIDI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Baden Wurttemberg Ministry of Science, Research and Arts; German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Friends of Hannover Medical School; Rudolf Bartling Foundation; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Cancer Society(Swedish Cancer Society); Bert von Kantzow foundation; Deutsche Krebshilfe(Deutsche Krebshilfe); German Cancer Research Centre (DKFZ)(Helmholtz Association); German Cancer Aid(Deutsche Krebshilfe); Federal Ministry of Education and Research (BMBF) Germany(Federal Ministry of Education & Research (BMBF)); Robert Bosch Foundation; Stuttgart; Deutsches Krebsforschungszentrum (DKFZ)(Helmholtz Association); Heidelberg; German Social Accident Insurance; Institute of the Ruhr University Bochum (IPA), Germany; Department of Internal Medicine; Evangelische Kliniken Bonn gGmbH; Johanniter Krankenhaus, Bonn, Germany; Government Funding (EVO) of Kuopio University Hospital grants; Cancer Fund of North Savo; Finnish Cancer Organizations; University of Eastern Finland; National Breast Cancer Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Cancer Fund; Cancer Council of New South Wales(Cancer Council New South Wales); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council of Tasmania(Cancer Council Tasmania); Cancer Council of South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Stichting tegen Kanker; FWO(FWO); Deutsche Krebshilfe e.V.(Deutsche Krebshilfe); Hamburg Cancer Society; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); INT-Institutional strategic projects "5x1000"; Specialized Program of Research Excellence (SPORE) in Breast Cancer; Breast Cancer Research Foundation; VicHealth and Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Breast Cancer Research Initiative; Quebec Breast Cancer Foundation; Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program(Canadian Institutes of Health Research (CIHR)); Ministry of Economic Development, Innovation and Export Trade; Norwegian Research council(Research Council of NorwayEuropean Commission); Swizz Bridge Award; Finnish Cancer Foundation; Academy of Finland(Academy of Finland); University of Oulu; Oulu University Hospital; Biobanking and Biomolecular Resources Research Infrastructure; Stefanie Spielman fund; OSU Comprehensive Cancer Center; Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA; Marit and Hans Rausings Initiative Against Breast Cancer; Cancer Risk Prediction Center, Linneus Centre - Swedish Research Council; Swedish Research Council(Swedish Research CouncilEuropean Commission); RPCI DataBank and BioRepository (DBBR), Cancer Center Support Grant Shared Resource; Agency for Science, Technology and Research of Singapore (A*STAR)(Agency for Science Technology & Research (A*STAR)); US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Yorkshire Cancer Research; programme grant from Cancer Research UK; UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge; Joseph Mitchell Fund; DKFZ(Helmholtz Association); Polish Foundation of Science; Komen Foundation for the Cure(Susan G. Komen Breast Cancer Foundation); Ohio State University Comprehensive Cancer Center; Stefanie Spielman fund for Breast Cancer Research; European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program of the General Secretariat for Research & Technology: ARISTEIA; Institute of Cancer Research (ICR); ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Foundation Finland sr; National Breast Cancer Foundation; The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the iCOGS infrastructure came from the European Community's Seventh Framework Programme under grant agreement number 223175 (HEALTH-F2-2009-223175) (COGS). iCOGS was also partly supported by the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program (JS & DFE), and the Ministry of Economic Development, Innovation and Export Trade of Quebec - grant # PSR-SIIRI-701 (JS & DFE, P. Hall). HEBCS was financially supported by the Helsinki University Central Hospital Research Fund, Academy of Finland (266528), the Finnish Cancer Society, The Nordic Cancer Union and the Sigrid Juselius Foundation. The population allele and genotype frequencies were obtained from the data source funded by the Nordic Center of Excellence in Disease Genetics based on samples regionally selected from Finland, Sweden and Denmark. The UK2 GWAS was funded by Wellcome Trust and Cancer Research UK. It included samples collected through the FBCS study which is funded by Cancer Research UK [C8620/A8372]. The WTCCC was funded by the Wellcome Trust. The ABCFS and OFBCR studies were supported by the United States National Cancer Institute, National Institutes of Health (NIH) under RFA-CA-06-503 and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR) and Principal Investigators, including Cancer Care Ontario (U01 CA69467), Northern California Cancer Center (U01 CA69417), University of Melbourne (U01 CA69638). Samples from the NC-BCFR were processed and distributed by the Coriell Institute for Medical Research. OFBCR was supported by the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program and grant UM1 CA164920 from the National Cancer Institute. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the Breast Cancer Family Registry (BCFR), nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the BCFR. The ABCFS was also supported by the National Health and Medical Research Council of Australia, the New South Wales Cancer Council, the Victorian Health Promotion Foundation (Australia) and the Victorian Breast Cancer Research Consortium. JLH is a National Health and Medical Research Council (NHMRC) Australia Fellow and a Victorian Breast Cancer Research Consortium Group Leader. MCS is a NHMRC Senior Research Fellow and a Victorian Breast Cancer Research Consortium Group Leader. JLH and MCS are both group leaders of the Victoria Breast Cancer Research Consortium. The ABCS study was supported by the Dutch Cancer Society [grants NKI 2007-3839; 2009 4363]; BBMRI-NL, which is a Research Infrastructure financed by the Dutch government (NWO 184.021.007); and the Dutch National Genomics Initiative. The BBCS is funded by Cancer Research UK and Breakthrough Breast Cancer and acknowledges NHS funding to the NIHR Biomedical Research Centre, and the National Cancer Research Network (NCRN). The BBCS GWAS received funding from The Institut National de Cancer. The work of the BBCC was partly funded by ELAN-Fond of the University Hospital of Erlangen. ES (BIGGS) is supported by NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, United Kingdom. IT is supported by the Oxford Biomedical Research Centre.; The BSUCH study was supported by the Dietmar-Hopp Foundation, the Helmholtz Society and the German Cancer Research Center (DKFZ). The CECILE study was funded by Fondation de France [contract grant number 2004012618 and 2007005156], Institut National du Cancer (INCa) [2007-1/SPC2, 2008-1-CP-4 and 2009-1-SHS/SP-04], Ligue Nationale contre le Cancer, Association pour la Recherche contre le Cancer (ARC) [2008-1-CP-4]; Agence Francaise de Securite Sanitaire de l'Environnement et du Travail (AFSSET - ANSES) [ST-2005-003, EST2008/1/26, and VS-2009-21], Ligue contre le Cancer Grand Ouest. The CGPS was supported by the Chief Physician Johan Boserup and Lise Boserup Fund, the Danish Medical Research Council and Herlev Hospital. The CNIO-BCS was supported by the Genome Spain Foundation, the Red Tematica de Investigacion Cooperativa en Cancer and grants from the Asociacion Espanola Contra el Cancer and the Fondo de Investigacion Sanitario (PI11/00923 and PI081120). We acknowledge the support of Alvarez lvarez, Daniel Herrero, Primitiva Menendez and the Human Genotyping-CEGEN Unit (CNIO). The Human Genotyping-CEGEN Unit is supported by the Instituto de Salud Carlos III. The CTS was supported by the California Breast Cancer Act of 1993; National Institutes of Health (grants R01 CA77398 and the Lon V Smith Foundation [LVS39420].); and the California Breast Cancer Research Fund (contract 97-10500). Collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885. DEMOKRITOS is supported by a Hellenic Cooperative Oncology Group research grant (HR R_BG/04) and the Greek General Secretary for Research and Technology (GSRT) Program, Research Excellence II, funded at 75% by the European Union. The DFBBCS GWAS was funded by The Netherlands Organisation for Scientific Research (NWO) as part of a ZonMw/VIDI grant number 91756341. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The ESTHER study was supportd by a grant from the Baden Wurttemberg Ministry of Science, Research and Arts. Additional cases were recruited in the context of the VERDI study, which was supported by a grant from the German Cancer Aid (Deutsche Krebshilfe). The HMBCS was supported by a grant from the Friends of Hannover Medical School and by the Rudolf Bartling Foundation. The Financial support for KARBAC was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet, The Swedish Cancer Society and Bert von Kantzow foundation. The GC-HBOC was supported by Deutsche Krebshilfe [107054], the Dietmar-Hopp Foundation, the Helmholtz society and the German Cancer Research Centre (DKFZ).; The GC-HBOC GWAS was supported by the German Cancer Aid (grant no. 107352). The GENICA was funded by the Federal Ministry of Education and Research (BMBF) Germany grants 01KW9975/5, 01KW9976/8, 01KW9977/0 and 01KW0114, the Robert Bosch Foundation, Stuttgart, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Germany, as well as the Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany. The KBCP was financially supported by the special Government Funding (EVO) of Kuopio University Hospital grants, Cancer Fund of North Savo, the Finnish Cancer Organizations, and by the strategic funding of the University of Eastern Finland. kConFab is supported by a grant from the National Breast Cancer Foundation, and previously by the National Health and Medical Research Council (NHMRC), the Queensland Cancer Fund, the Cancer Councils of New South Wales, Victoria, Tasmania and South Australia, and the Cancer Foundation of Western Australia. The kConFab Clinical Follow Up Study was funded by the NHMRC [145684, 288704, 454508]. Financial support for the AOCS was provided by the United States Army Medical Research and Materiel Command [DAMD17-01-1-0729], the Cancer Council of Tasmania and Cancer Foundation of Western Australia and the NHMRC [199600]. GCT is supported by the NHMRC. LMBC is supported by the 'Stichting tegen Kanker' (232-2008 and 196-2010). Diether Lambrechts is supported by the FWO and the KULPFV/10/016-SymBioSysII. The MARIE study was supported by the Deutsche Krebshilfe e.V. [70-2892-BR I], the Hamburg Cancer Society, the German Cancer Research Center and the genotype work in part by the Federal Ministry of Education and Research (BMBF) Germany [01KH0402]. MBCSG is supported by grants from the Italian Association for Cancer Research (AIRC) and by funds from the Italian citizens who allocated the 5/1000 share of their tax payment in support of the Fondazione IRCCS Istituto Nazionale Tumori, according to Italian laws (INT-Institutional strategic projects "5x1000"). The MCBCS was supported by the NIH grants [CA122340, CA128978] and a Specialized Program of Research Excellence (SPORE) in Breast Cancer [CA116201], the Breast Cancer Research Foundation and a generous gift from the David F. and Margaret T. Grohne Family Foundation and the Ting Tsung and Wei Fong Chao Foundation. MCCS cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further supported by Australian NHMRC grants 209057, 251553 and 504711 and by infrastructure provided by Cancer Council Victoria. The MEC was supported by NIH grants CA63464, CA54281, CA098758 and CA132839. For the MTLGEBCS study, the initial case-control study was supported by the Canadian Breast Cancer Research Initiative. Work was also supported by the Quebec Breast Cancer Foundation, the Canadian Institutes of Health Research for the "CIHR Team in Familial Risks of Breast Cancer" program - grant # CRN-87521 and the Ministry of Economic Development, Innovation and Export Trade - grant # PSR-SIIRI-701. The NBCS was supported by grants from the Norwegian Research council, 155218/V40, 175240/S10 to ALBD, FUGE-NFR 181600/V11 to VNK and a Swizz Bridge Award to ALBD. The OBCS was supported by research grants from the Finnish Cancer Foundation, the Academy of Finland, the University of Oulu, and the Oulu University Hospital.; The ORIGO study was supported by the Dutch Cancer Society (RUL 1997-1505) and the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL CP16). The OSU study was funded by the Stefanie Spielman fund and the OSU Comprehensive Cancer Center. The PBCS was funded by Intramural Research Funds of the National Cancer Institute, Department of Health and Human Services, USA. The pKARMA study was supported by Marit and Hans Rausings Initiative Against Breast Cancer and Cancer Risk Prediction Center, a Linneus Centre (contract 70867902) financed by the Swedish Research Council. The RBCS was funded by the Dutch Cancer Society (DDHK 2004-3124, DDHK 2009-4318). The RPCI study was supported by RPCI DataBank and BioRepository (DBBR), a Cancer Center Support Grant Shared Resource (P30 CA016056-32). The SASBAC study was supported by funding from the Agency for Science, Technology and Research of Singapore (A*STAR), the US National Institute of Health (NIH) and the Susan G. Komen Breast Cancer Foundation. The SBCS was supported by Yorkshire Cancer Research S295, S299, S305PA. SEARCH is funded by a programme grant from Cancer Research UK [C490/A10124] and supported by the the UK National Institute for Health Research Biomedical Research Centre at the University of Cambridge. AMD has been supported by Cancer Research UK grant [C8197/A10865] and by the Joseph Mitchell Fund. SKKDKFZS is supported by the DKFZ. The SZBCS was supported by Grant PBZ_KBN_122/P05/2004; Katarzyna Jaworska is a fellow of International PhD program, Postgraduate School of Molecular Medicine, Warsaw Medical University, supported by the Polish Foundation of Science. The TNBCC was supported by the NIH grant [CA128978], the Breast Cancer Research Foundation, Komen Foundation for the Cure, the Ohio State University Comprehensive Cancer Center, the Stefanie Spielman fund for Breast Cancer Research and a generous gift from the David F. and Margaret T. Grohne Family Foundation and the Ting Tsung and Wei Fong Chao Foundation. Part of the TNBCC (DEMOKRITOS) has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program of the General Secretariat for Research & Technology: ARISTEIA. The UKBGS is funded by Breakthrough Breast Cancer and the Institute of Cancer Research (ICR). ICR acknowledges NHS funding to the NIHR Biomedical Research Centre. CGEMS, The Nurses' Health Studies are supported by NIH grants CA 65725, CA87969, CA49449, CA67262, CA50385 and 5UO1CA098233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; BIRRER MJ, 1988, MOL CELL BIOL, V8, P2668, DOI 10.1128/MCB.8.6.2668; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; de Martino M, 2013, J UROL; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dite GS, 2003, J NATL CANCER I, V95, P448, DOI 10.1093/jnci/95.6.448; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Fiesch-Janys D, 2008, INT J CANCER, V123, P933, DOI 10.1002/ijc.23655; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fletcher O, 2006, J NATL CANCER I, V98, P1014, DOI 10.1093/jnci/djj268; Frank B, 2006, CARCINOGENESIS, V27, P606, DOI 10.1093/carcin/bgi248; Frank B, 2005, J NATL CANCER I, V97, P1012, DOI 10.1093/jnci/dji178; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ghoussaini M, 2012, NAT GENET, V44, P312, DOI 10.1038/ng.1049; Guo L, 2012, MOL BIOL REP; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kapushesky M, 2012, NUCLEIC ACIDS RES, V40, pD1077, DOI 10.1093/nar/gkr913; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kontorovich T, 2010, INT J CANCER, V127, P589, DOI 10.1002/ijc.25065; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Leu M, 2010, EUR J HUM GENET, V18, P1322, DOI 10.1038/ejhg.2010.112; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JM, 2011, BREAST CANCER RES TR, V126, P717, DOI 10.1007/s10549-010-1172-9; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Liang Zhongxing, 2010, Biochem Pharmacol, V79, P817, DOI 10.1016/j.bcp.2009.10.017; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin WY, 2014, HUM MOL GENET; Lombardo F, 2004, FASEB J, V18, P52, DOI 10.1096/fj.03-0521com; MacPherson G, 2004, JNCI-J NATL CANCER I, V96, P1866, DOI 10.1093/jnci/dji001; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Ruiz-Ruiz C, 2000, CANCER RES, V60, P5673; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Sosio M, 2004, MICROBIOL-SGM, V150, P95, DOI 10.1099/mic.0.26507-0; Sun D, 2010, NAT STRUCT MOL BIOL, V17, P1188, DOI 10.1038/nsmb.1906; Sung H, 2011, BREAST CANCER RES TR, V130, P939, DOI 10.1007/s10549-011-1656-2; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Volinia S, 2013, P NATL ACAD SCI USA, V110, P7413, DOI 10.1073/pnas.1304977110; Wang XG, 2013, ONCOL REP, V30, P643, DOI 10.3892/or.2013.2530; Witkos TM, 2011, CURR MOL MED, V11, P93; Wu R, 2003, AM J PATHOL, V162, P1603, DOI 10.1016/S0002-9440(10)64294-0; Xiong F, 2011, CANCER RES, V71, P5175, DOI 10.1158/0008-5472.CAN-10-4407; Zhong Xiaomin, 2012, Methods Mol Biol, V822, P295, DOI 10.1007/978-1-61779-427-8_21	53	30	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e109973	10.1371/journal.pone.0109973	http://dx.doi.org/10.1371/journal.pone.0109973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390939	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000349144400009
J	Zheng, MG; Liao, YS; He, JJ				Zheng, Mingguo; Liao, Yishan; He, Jijun			Sediment Delivery Ratio of Single Flood Events and the Influencing Factors in a Headwater Basin of the Chinese Loess Plateau	PLOS ONE			English	Article							SOIL-EROSION; HYPERCONCENTRATED FLOW; HILLY AREAS; LAND-USE; YIELD; TRANSPORT; IMPACTS; RUNOFF; RIVER	Little is known about the sediment delivery of single flood events although it has been well known that the sediment delivery ratio at the inter-annual time scale is close to 1 in the Chinese Loess Plateau. This study examined the sediment delivery of single flood events and the influencing factors in a headwater basin of the Loess Plateau, where hyperconcentrated flows are dominant. Data observed from plot to subwatershed over the period from 1959 to 1969 were presented. Sediment delivery ratio of a single event (SDRe) was calculated as the ratio of sediment output from the subwatershed to sediment input into the channel. It was found that SDRe varies greatly for small events (runoff depth < 5 mm or rainfall depth <30 mm) and remains fairly constant (approximately between 1.1 and 1.3) for large events (runoff depth >5 mm or rainfall depth >30 mm). We examined 11 factors of rainfall (rainfall amount, rainfall intensity, rainfall kinetic energy, rainfall erosivity and rainfall duration), flood (area-specific sediment yield, runoff depth, peak flow discharge, peak sediment concentration and flood duration) and antecedent land surface (antecedent precipitation) in relation to SDRe. Only the peak sediment concentration significantly correlates with SDRe. Contrary to popular belief, channel scour tends to occur in cases of higher peak sediment concentrations. Because small events also have chances to attain a high sediment concentration, many small events (rainfall depth <20 mm) are characterized by channel scour with an SDRe larger than 1. Such observations can be related to hyperconcentrated flows, which behave quite differently from normal stream flows. Our finding that large events have a nearly constant SDRe is useful for sediment yield predictions in the Loess Plateau and other regions where hyperconcentrated flows are well developed.	[Zheng, Mingguo] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proces, Beijing, Peoples R China; [Liao, Yishan] Guangdong Inst Ecoenvironm & Soil Sci, Guangzhou, Guangdong, Peoples R China; [He, Jijun] Capital Normal Univ, Base State Lab Urban Environm Processes & Digital, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Guangdong Academy of Sciences; Institute of Eco-environmental & Soil Sciences, Guangdong Academy of Sciences	He, JJ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proces, Beijing, Peoples R China.	hejiun_200018@163.com			Non-profit Industry Financial Program of MWR [201201083]; National Natural Science Foundation of China [41401302, 41271306]	Non-profit Industry Financial Program of MWR; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this research was provided by Non-profit Industry Financial Program of MWR (201201083; www.cws.net.cn) and National Natural Science Foundation of China (41401302 and 41271306; www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatorre LC, 2010, J HYDROL, V391, P111, DOI 10.1016/j.jhydrol.2010.07.010; Anctil F, 2004, J HYDROL, V286, P155, DOI 10.1016/j.jhydrol.2003.09.006; Cai QG, 1998, PROCESSES SOIL EROSI; Chen Y., 1988, MODERN EROSION CONTR; Cheng X.A., 2010, THESIS HUAZHONG AGR, P54; Chien N., 1999, MECH SEDIMENT TRANSP, DOI 10.1061/9780784404003; de Vente J, 2007, PROG PHYS GEOG, V31, P155, DOI 10.1177/0309133307076485; ENGELUND F, 1984, J HYDRAUL ENG-ASCE, V110, P219, DOI 10.1061/(ASCE)0733-9429(1984)110:3(219); FERRO V, 1995, HYDROLOG SCI J, V40, P703, DOI 10.1080/02626669509491460; FOSTER GR, 1982, T ASAE, V25, P124, DOI 10.13031/2013.33490; Gong SY, 1979, YELLOW RIVER, P7; Goudie A, 2004, ENCY GEOMORPHOLOGY, V2, P932; [韩鹏 Han Peng], 2003, [水利学报, Journal of Hydraulic Engineering], V0, P51; Heggen RJ, 2001, J HYDROL ENG, V6, P377, DOI 10.1061/(ASCE)1084-0699(2001)6:5(377); Hessel R, 2006, EARTH SURF PROC LAND, V31, P1100, DOI 10.1002/esp.1307; Jiang ZS, 1983, SOIL WATER CONSERVAT, P32; Jing K, 1993, SEDIMENT ENV HUANSHE; Kinnell PIA, 2010, J HYDROL, V385, P384, DOI 10.1016/j.jhydrol.2010.01.024; Lane LJ, 1997, ENVIRON MODELL SOFTW, V12, P355, DOI 10.1016/S1364-8152(97)00027-3; Li Q., 1989, YELLOW RIVER, V3, P18; Liu QJ, 2013, GEOMORPHOLOGY, V186, P181, DOI 10.1016/j.geomorph.2013.01.012; Lu H, 2006, ENVIRON MODELL SOFTW, V21, P1297, DOI 10.1016/j.envsoft.2005.04.021; Ma TH, 2014, GEOMORPHOLOGY, V216, P187, DOI 10.1016/j.geomorph.2014.03.033; Mou J.Z., 1982, J SEDIMENT RES, V2, P223; Pierson TC, 2005, S-P BKS GEOPHYS SCI, P159; PIERSON TC, 1985, WATER RESOUR RES, V21, P1511, DOI 10.1029/WR021i010p01511; Rovira A, 2006, GEOMORPHOLOGY, V79, P58, DOI 10.1016/j.geomorph.2005.09.016; Schiettecatte W, 2008, EARTH SURF PROC LAND, V33, P1302, DOI 10.1002/esp.1642; Shi ZH, 2013, J HYDROL, V498, P165, DOI 10.1016/j.jhydrol.2013.06.031; Shi ZH, 2012, J HYDROL, V438, P156, DOI 10.1016/j.jhydrol.2012.03.016; Walling DE, 1999, HYDROBIOLOGIA, V410, P223, DOI 10.1023/A:1003825813091; WALLING DE, 1988, J HYDROL, V100, P113, DOI 10.1016/0022-1694(88)90183-7; WALLING DE, 1983, J HYDROL, V65, P209, DOI 10.1016/0022-1694(83)90217-2; Wan Z., 1994, IAHR MONOGRAPH SERIE; Wang L, 2014, J HYDROL, V512, P168, DOI 10.1016/j.jhydrol.2014.02.066; Wirtz S, 2012, CATENA, V91, P21, DOI 10.1016/j.catena.2010.12.002; Wischmeier WH, 1978, USDA HDB; Xu JX, 1999, CATENA, V36, P1, DOI 10.1016/S0341-8162(99)00009-0; Yan B, 2013, J HYDROL, V484, P26, DOI 10.1016/j.jhydrol.2013.01.008; Zhang KL, 1999, J SEDIMENT RES, P55; Zheng MG, 2013, CATENA, V109, P164, DOI 10.1016/j.catena.2013.03.017; Zheng MG, 2012, CATENA, V98, P29, DOI 10.1016/j.catena.2012.05.013; [郑明国 ZHENG MingGuo], 2007, [生态学报, Acta Ecologica Sinica], V27, P3572; Zhou P.H., 1992, J SOIL WATER CONSERV, V6, P1, DOI DOI 10.13870/J.CNID.STBC.XB.1992.03.001	44	10	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112594	10.1371/journal.pone.0112594	http://dx.doi.org/10.1371/journal.pone.0112594			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389752	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400107
J	Chen, ML; Wu, RM; Tai, CH; Lin, CH				Chen, Meng-Ling; Wu, Ruey-Meei; Tai, Chun-Hwei; Lin, Chin-Hsien			Mutational Analysis of Angiogenin Gene in Parkinson's Disease	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; VARIANTS; ALS	Mutations in the angiogenic factor, angiogenin (ANG), have been identified in patients with both familial and sporadic amyotrophic lateral sclerosis (ALS) and are thought to have a neuroprotective function. Parkinsonism has been noted in kindreds with ANG mutations and variants in the ANG gene have been found to associate with PD in two Caucasian populations. We therefore hypothesized that mutations in ANG may also contribute to idiopathic Parkinson's disease (PD). We sequenced ANG gene in a total of 1498 participants comprising 750 PD patients and 748 age/gender matched controls from Taiwan. We identified one novel synonymous substitution, c.C100T (p.L10L), in a single heterozygous state in one PD patient, which was not observed in controls. The clinical phenotypes and [Tc-99m]-TORDAT-SPECT images of the p.L10L carrier were similar to that seen in idiopathic PD. In addition, we also identified one common variant, c.T330G (p.G110G, rs11701), which was previously reported to associate with PD risk in Caucasians. However, the frequency of TG/GG genotype was comparable between PD cases and controls (odds ratio: 0.85, 95% confidence interval: 0.29-2.55, P = 0.78). Our results did not support that ANG rs11701 variant is a genetic risk factor for PD in our population. We conclude that mutations in ANG are not a common cause for idiopathic PD.	[Chen, Meng-Ling; Wu, Ruey-Meei; Tai, Chun-Hwei; Lin, Chin-Hsien] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei 10764, Taiwan; [Chen, Meng-Ling] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, CH (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Dept Neurol, Taipei 10764, Taiwan.	chlin@ntu.edu.tw		Lin, Chin-Hsien/0000-0001-8566-7573; Tai, Chun-Hwei/0000-0002-3493-8879; Wu, Ruey-Meei/0000-0002-4947-5467; Chen, Meng-Ling/0000-0003-3980-5546	National Taiwan University Hospital [NTUH.102-S2072]	National Taiwan University Hospital(National Taiwan University)	This study is funded by the National Taiwan University Hospital (NTUH.102-S2072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen RC, 2001, NEUROLOGY, V57, P1679, DOI 10.1212/WNL.57.9.1679; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Lee MJ, 2009, MOVEMENT DISORD, V24, P104, DOI 10.1002/mds.22093; Lin CB, 2011, J APPL PHYS, V110, DOI 10.1063/1.3606513; Lin CH, 2008, NEUROLOGY, V71, P1727, DOI 10.1212/01.wnl.0000335167.72412.68; Lin CH, 2007, AM J MED GENET B, V144B, P434, DOI 10.1002/ajmg.b.30427; Lin CH, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00059; Liu B, 2013, PARKINSONISM RELAT D, V19, P446, DOI 10.1016/j.parkreldis.2012.11.016; MAJOORKRAKAUER D, 1994, NEUROLOGY, V44, P1872, DOI 10.1212/WNL.44.10.1872; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rayaprolu S, 2012, ANN NEUROL, V71, P725, DOI 10.1002/ana.23586; Steidinger TU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056092; Steidinger TU, 2011, J NEUROCHEM, V116, P334, DOI 10.1111/j.1471-4159.2010.07112.x; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Thiyagarajan N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2126; van Es MA, 2009, NEUROLOGY, V72, P287, DOI 10.1212/01.wnl.0000339487.84908.00; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; Wu RM, 2005, ARCH NEUROL-CHICAGO, V62, P82, DOI 10.1001/archneur.62.1.82	20	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112661	10.1371/journal.pone.0112661	http://dx.doi.org/10.1371/journal.pone.0112661			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386690	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400080
J	Golenia, L; Schoemaker, MM; Mouton, LJ; Bongers, RM				Golenia, Laura; Schoemaker, Marina M.; Mouton, Leonora J.; Bongers, Raoul M.			Individual Differences in Learning a Novel Discrete Motor Task	PLOS ONE			English	Article							TOOL USE; COORDINATION; PREHENSION; MOVEMENTS; DYNAMICS; POLYMORPHISM; LEVEL; SKILL; THUMB; HAND	Many motor learning studies focus on average performance while it is known from everyday life experience that humans differ in their way of learning new motor tasks. This study emphasises the importance of recognizing individual differences in motor learning. We studied individual tool grasping profiles of individuals who learned to pick up objects with a novel tool, a pair of pliers. The pair of pliers was attached to the thumb and the index finger so that the tip of the thumb and the tip of the index finger were displaced to the beaks of the pair of pliers. The grasp component was manipulated by varying the location of the hinge of the pair of pliers, which resulted in different relations between beak opening and closing and finger opening and closing. The Wider Beak group had the hinge at 7 cm, the Same Beak group had the hinge at 10 cm (i.e., in the middle), and the Smaller Beak group had the hinge at 13 cm from the digits. Each group consisted of ten right-handed participants who picked up an object with one of the pairs of pliers 200 times on two subsequent days. Hand opening, plateau phase, hand closing, grasping time and maximum aperture were analyzed. To characterize individual changes over practice time, a log function was fitted on these dependent variables and the ratio of improvement was determined. Results showed that at the beginning stage of tool use learning the characteristic grasping profile consisted of three phases; hand opening, plateau phase and hand closing. Over practicing individual participants differed in the number of phases that changed, the amount of change in a phase and/or the direction of change. Moreover, with different pliers different learning paths were found. The importance of recognizing individual differences in motor learning is discussed.	[Golenia, Laura; Schoemaker, Marina M.; Mouton, Leonora J.; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	Bongers, RM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	r.m.bongers@umcg.nl	Bongers, Raoul/C-1094-2012	Bongers, Raoul/0000-0002-3518-7464; Mouton, Leonora/0000-0001-8389-2013				Atun-Einy O, 2012, DEV PSYCHOBIOL, V54, P187, DOI 10.1002/dev.20593; BEEK PJ, 1995, HUM MOVEMENT SCI, V14, P573, DOI 10.1016/0167-9457(95)00028-5; Beisert M, 2010, J EXP PSYCHOL HUMAN, V36, P359, DOI 10.1037/a0016801; Berger SE, 2003, DEV PSYCHOL, V39, P594, DOI 10.1037/0012-1649.39.3.594; Biryukova EV, 2008, MOTOR CONTROL, V12, P181, DOI 10.1123/mcj.12.3.181; Bongers RM, 2012, HUM MOVEMENT SCI, V31, P487, DOI 10.1016/j.humov.2011.07.014; Bongers RM, 2010, LECT NOTES COMPUT SC, V6192, P271, DOI 10.1007/978-3-642-14075-4_39; Bouwsema H, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-16; Bouwsema H, 2012, J REHABIL RES DEV, V49, P1331, DOI 10.1682/JRRD.2011.09.0179; Bouwsema H, 2010, ARCH PHYS MED REHAB, V91, P1442, DOI 10.1016/j.apmr.2010.06.025; Campolo D, 2012, PLOS ONE, V9; Cesqui B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031770; Cheeran BJ, 2009, NEUROSCIENCE, V164, P156, DOI 10.1016/j.neuroscience.2009.01.054; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Cluff T, 2012, J NEUROPHYSIOL, V108, P1167, DOI 10.1152/jn.00691.2011; Cuijpers RH, 2004, J NEUROPHYSIOL, V91, P2598, DOI 10.1152/jn.00644.2003; Davare M, 2011, CURR OPIN NEUROBIOL, V21, P565, DOI 10.1016/j.conb.2011.05.021; Gentilucci M, 2004, EXP BRAIN RES, V157, P496, DOI 10.1007/s00221-004-1863-8; Hesse C, 2009, HUM MOVEMENT SCI, V28, P415, DOI 10.1016/j.humov.2009.03.001; Jacobs DM, 2007, ECOL PSYCHOL, V19, P321, DOI 10.1080/10407410701432337; Jacobs DM, 2012, J EXP PSYCHOL HUMAN, V38, P1215, DOI 10.1037/a0027632; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Kelso S., 1995, DYNAMIC PATTERNS SEL; King AC, 2012, NEUROSCI LETT, V529, P144, DOI 10.1016/j.neulet.2012.08.014; Kostrubiec V, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00222; Kruger M, 2012, HUM MOVEMENT SCI, V31, P1071, DOI 10.1016/j.humov.2011.12.002; Massen C, 2010, ACTA PSYCHOL, V135, P201, DOI 10.1016/j.actpsy.2010.06.007; Michaels C, 1995, ECOL PSYCHOL, V7, P259, DOI 10.1207/s15326969eco0704_2; Michaels CF, 2012, PERCEPTION, V41, P93, DOI 10.1068/p6994; Mon-Williams M, 2001, CURR BIOL, V11, P1058, DOI 10.1016/S0960-9822(01)00293-7; Newell A., 1981, COGNITIVE SKILLS THE, P1; Newell K.M., 1986, MOTOR DEV CHILDREN A, VVolume 34, P341, DOI DOI 10.1007/978-94-009-4460-2_19; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Snapp-Childs W, 2013, J CHILD NEUROL, V28, P204, DOI 10.1177/0883073812461945; Snoddy GS, 1926, J APPL PSYCHOL, V10, P1, DOI 10.1037/h0075814; Sulzenbruck S, 2009, EXP BRAIN RES, V195, P153, DOI 10.1007/s00221-009-1764-y; THELEN E, 1993, CHILD DEV, V64, P1058, DOI 10.2307/1131327; Thelen E, 1996, J EXP PSYCHOL HUMAN, V22, P1059, DOI 10.1037/0096-1523.22.5.1059; TURVEY MT, 1990, AM PSYCHOL, V45, P938, DOI 10.1037/0003-066X.45.8.938; Vegter RJK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089729; WING AM, 1983, Q J EXP PSYCHOL-A, V35, P297, DOI 10.1080/14640748308402135; Zaal FTJM, 1998, EXP BRAIN RES, V119, P427, DOI 10.1007/s002210050358; ZANONE PG, 1992, J EXP PSYCHOL HUMAN, V18, P403, DOI 10.1037/0096-1523.18.2.403; Zanone PG, 1997, J EXP PSYCHOL HUMAN, V23, P1454, DOI 10.1037/0096-1523.23.5.1454; Zheng C. L., 2007, HUM FACTORS ERGONOM, V51, P1353, DOI DOI 10.1177/154193120705101917	45	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112806	10.1371/journal.pone.0112806	http://dx.doi.org/10.1371/journal.pone.0112806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386708	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400094
J	Hou, YJ; Wang, Y; Zhao, J; Li, XH; Cui, J; Ding, JQ; Wang, Y; Zeng, XL; Ling, Y; Shen, XH; Chen, SD; Huang, CG; Pei, G				Hou, Yujun; Wang, Ying; Zhao, Jian; Li, Xiaohang; Cui, Jin; Ding, Jianqing; Wang, Ying; Zeng, Xianglu; Ling, Yun; Shen, Xiaoheng; Chen, Shengdi; Huang, Chenggang; Pei, Gang			Smart Soup, a Traditional Chinese Medicine Formula, Ameliorates Amyloid Pathology and Related Cognitive Deficits	PLOS ONE			English	Article							MOUSE MODEL; ALZHEIMERS-DISEASE; MEMORY DEFICITS; BETA; DROSOPHILA; EXPRESSION; OLIGOMERS; EXTRACT; BT-11; BRAIN	Alzheimer's disease (AD) is a progressive neurodegenerative disease that causes substantial public health care burdens. Intensive efforts have been made to find effective and safe disease-modifying treatment and symptomatic intervention alternatives against AD. Smart Soup (SS), a Chinese medicine formula composed of Rhizoma Acori Tatarinowii (AT), Poria cum Radix Pini (PRP) and Radix Polygalae (RP), is a typical prescription against memory deficits. Here, we assessed the efficacy of SS against AD. Oral administration of SS ameliorated the cognitive impairment of AD transgenic mice, with reduced A beta levels, retarded A beta amyloidosis and reduced A beta-induced gliosis and neuronal loss in the brains of AD mice. Consistently, SS treatment reduced amyloid-related locomotor dysfunctions and premature death of AD transgenic Drosophila. Mechanistic studies showed that RP reduced A beta generation, whereas AT and PRP exerted neuroprotective effects against A beta. Taken together, our study indicates that SS could be effective against AD, providing a practical therapeutic strategy against the disease.	[Hou, Yujun; Zhao, Jian; Li, Xiaohang; Cui, Jin; Zeng, Xianglu; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Wang, Ying; Ding, Jianqing; Chen, Shengdi] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Inst Neurol, Shanghai 200030, Peoples R China; [Wang, Ying] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China; [Ling, Yun; Huang, Chenggang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Shen, Xiaoheng] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Tradit Chinese Med, Shanghai 200030, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University; Tongji University	Zhao, J (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Grad Sch, State Key Lab Cell Biol,Inst Biochem & Cell Biol, Shanghai, Peoples R China.	jzhao@sibs.ac.cn; gpei@sibs.ac.cn	Hou, Yujun/AFX-2626-2022; Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591; Hou, Yujun/0000-0003-1778-1176; Li, Xiaohang/0000-0002-7316-2196	National Natural Science Foundation of China [31371419]; Chinese Academy of Sciences [KSCX2-EW-Q-1-01, KSCX2-YW-R-252]; National Science and Technology [2012BAI10B03]; Ministry of Science and Technology [2011CB910202]; Shanghai Municipal Commission for Science and Technology [13401900600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Shanghai Municipal Commission for Science and Technology	This work was supported by National Natural Science Foundation of China (31371419), Chinese Academy of Sciences (KSCX2-EW-Q-1-01, KSCX2-YW-R-252), National Science and Technology Support Program (2012BAI10B03), the Ministry of Science and Technology (2011CB910202) and Shanghai Municipal Commission for Science and Technology (13401900600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cao DF, 2007, J BIOL CHEM, V282, P36275, DOI 10.1074/jbc.M703561200; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Chakraborty R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020799; Chen YL, 2004, J ETHNOPHARMACOL, V95, P47, DOI 10.1016/j.jep.2004.06.015; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Hamilton A, 2012, BRAIN RES, V1449, P83, DOI 10.1016/j.brainres.2012.02.015; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Howes MJR, 2003, PHARMACOL BIOCHEM BE, V75, P513, DOI 10.1016/S0091-3057(03)00128-X; Iijima K, 2008, J ALZHEIMERS DIS, V15, P523; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kraft AW, 2012, FASEB J OFFICIAL PUB; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lee BB, 2003, LIFE SCI, V74, P435, DOI 10.1016/j.lfs.2003.06.034; Lee JY, 2009, NEUROSCI LETT, V454, P111, DOI 10.1016/j.neulet.2009.03.024; Lesne S, 2008, NEUROSCIENCE, V151, P745, DOI 10.1016/j.neuroscience.2007.10.054; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lin ZH, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/692621; Ling Y, 2013, PHYTOCHEM ANALYSIS, V24, P677, DOI 10.1002/pca.2454; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Lu JH, 2011, CHEMBIOCHEM, V12, P615, DOI 10.1002/cbic.201000604; McGeer EG, 2003, PROG NEURO-PSYCHOPH, V27, P741, DOI 10.1016/S0278-5846(03)00124-6; Mhatre SD, 2014, DIS MODEL MECH, V7, P373, DOI 10.1242/dmm.012104; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muqit MMK, 2002, NAT REV NEUROSCI, V3, P237, DOI 10.1038/nrn751; Park CH, 2002, J NEUROSCI RES, V70, P484, DOI 10.1002/jnr.10429; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Selkoe DJ, 2002, J CLIN INVEST, V110, P1375, DOI 10.1172/JCI200216783; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shin KY, 2009, NEUROSCI LETT, V465, P157, DOI 10.1016/j.neulet.2009.08.033; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Tian XY, 2012, CHIN J INTEGR MED, V18, P539, DOI 10.1007/s11655-011-0900-2; Tong XG, 2010, J ASIAN NAT PROD RES, V12, P419, DOI 10.1080/10286021003762010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Winslow BT, 2011, AM FAM PHYSICIAN, V83, P1403; Zhao XL, 2010, J NEUROSCI, V30, P1512, DOI 10.1523/JNEUROSCI.3699-09.2010	47	33	37	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111215	10.1371/journal.pone.0111215	http://dx.doi.org/10.1371/journal.pone.0111215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386946	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400015
J	Jaber, L; Zhao, FL; Kolli, T; Herness, S				Jaber, Luc; Zhao, Fang-li; Kolli, Tamara; Herness, Scott			A Physiologic Role for Serotonergic Transmission in Adult Rat Taste Buds	PLOS ONE			English	Article							REUPTAKE INHIBITOR PAROXETINE; RECEPTOR-CELLS; FUNCTIONAL EXPRESSION; 5-HT1A RECEPTORS; GAP-JUNCTION; ATP RELEASE; III CELLS; G-PROTEIN; LOCALIZATION; COMMUNICATION	Of the multiple neurotransmitters and neuropeptides expressed in the mammalian taste bud, serotonin remains both the most studied and least understood. Serotonin is expressed in a subset of taste receptor cells that form synapses with afferent nerve fibers (type III cells) and was once thought to be essential to neurotransmission (now understood as purinergic). However, the discovery of the 5-HT1A serotonin receptor in a subset of taste receptor cells paracrine to type III cell suggested a role in cell-to-cell communication during the processing of taste information. Functional data describing this role are lacking. Using anatomical and neurophysiological techniques, this study proposes a modulatory role for serotonin during the processing of taste information. Double labeling immunocytochemical and single cell RT-PCR technique experiments documented that 5-HT1A-expressing cells co-expressed markers for type II cells, cells which express T1R or T2R receptors and release ATP. These cells did not co-express type III cells markers. Neurophysiological recordings from the chorda tympani nerve, which innervates anterior taste buds, were performed prior to and during intravenous injection of a 5-HT1A receptor antagonist. These experiments revealed that serotonin facilitates processing of taste information for tastants representing sweet, sour, salty, and bitter taste qualities. On the other hand, injection of ondansetron, a 5-HT3 receptor antagonist, was without effect. Collectively, these data support the hypothesis that serotonin is a crucial element in a finely-tuned feedback loop involving the 5-HT1A receptor, ATP, and purinoceptors. It is hypothesized that serotonin facilitates gustatory signals by regulating the release of ATP through ATP-release channels possibly through phosphatidylinositol 4,5-bisphosphate resynthesis. By doing so, 5-HT1A activation prevents desensitization of post-synaptic purinergic receptors expressed on afferent nerve fibers and enhances the afferent signal. Serotonin may thus play a major modulatory role within peripheral taste in shaping the afferent taste signals prior to their transmission across gustatory nerves.	[Jaber, Luc; Zhao, Fang-li; Kolli, Tamara; Herness, Scott] Ohio State Univ, Coll Dent, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Herness, S (corresponding author), Ohio State Univ, Coll Dent, Columbus, OH 43210 USA.	herness.1@osu.edu	Jaber-Luc, Fadi/AAD-9932-2020		National Institute on Deafness and Other Communication Disorders, National Institutes of Health [5R01DC00401]; Ohio State University Open Access Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000401] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Ohio State University Open Access Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders, National Institutes of Health (www.nidcd.nih.gov; 5R01DC00401). Partial funding for Open Access provided by The Ohio State University Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Antunes VR, 2005, CLIN EXP PHARMACOL P, V32, P467, DOI 10.1111/j.1440-1681.2005.04213.x; Baryshnikov SG, 2003, J NEUROPHYSIOL, V90, P3283, DOI 10.1152/jn.00312.2003; Beider L. M., 1971, HDB SENSORY PHYSL, V4, P200; Bo XN, 1999, NEUROREPORT, V10, P1107, DOI 10.1097/00001756-199904060-00037; Borroto-Escuela DO, 2012, J NEUROSCI, V32, P6295, DOI 10.1523/JNEUROSCI.4203-11.2012; Bystrova MF, 2006, CELL TISSUE RES, V323, P377, DOI 10.1007/s00441-005-0098-8; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Chen K, 2010, BRAIN RES, V1325, P53, DOI 10.1016/j.brainres.2010.02.026; Cook SP, 1997, NEUROPHARMACOLOGY, V36, P1303, DOI 10.1016/S0028-3908(97)00132-9; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Delay RJ, 1997, J NEUROPHYSIOL, V77, P2515, DOI 10.1152/jn.1997.77.5.2515; EWALD DA, 1994, J NEUROSCI, V14, P3791; Fedorov IV, 2007, BBA-BIOMEMBRANES, V1768, P1727, DOI 10.1016/j.bbamem.2007.04.002; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Florea L, 2005, GENOME RES, V15, P54, DOI 10.1101/gr.2889405; FUJIMOTO S, 1987, ACTA ANAT, V128, P80; Getchell TV, 1997, NEUROREPORT, V8, pR3; Hayato R, 2007, J PHYSIOL-LONDON, V584, P473, DOI 10.1113/jphysiol.2007.138370; He ML, 2002, MOL PHARMACOL, V62, P1187, DOI 10.1124/mol.62.5.1187; Heath TP, 2006, J NEUROSCI, V26, P12664, DOI 10.1523/JNEUROSCI.3459-06.2006; HERNESS MS, 1985, J GEN PHYSIOL, V86, P59, DOI 10.1085/jgp.86.1.59; Herness MS, 2000, J MEMBRANE BIOL, V173, P127, DOI 10.1007/s002320001014; Herness S, 1997, NEUROREPORT, V8, P3257, DOI 10.1097/00001756-199710200-00014; Herness S, 2012, PHYSL GASTROINTESTIN, V1, P741; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; HOON MA, 1995, BIOCHEM J, V309, P629, DOI 10.1042/bj3090629; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Imendra KG, 2000, NEUROSCI LETT, V294, P151, DOI 10.1016/S0304-3940(00)01567-6; Imendra KG, 2002, EUR J NEUROSCI, V16, P629, DOI 10.1046/j.1460-9568.2002.02107.x; Ishikawa M, 2011, J CELL BIOL, V193, P1257, DOI 10.1083/jcb.201101050; Kakinohana O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030561; Kataoka S, 2004, HISTOCHEM CELL BIOL, V121, P419, DOI 10.1007/s00418-004-0647-3; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; KIM DJ, 1995, J COMP NEUROL, V353, P364, DOI 10.1002/cne.903530304; Kinnamon SC, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00264; Kishi M, 2001, NEUROSCIENCE, V106, P217, DOI 10.1016/S0306-4522(01)00184-1; Kokrashvili Z, 2009, ANN NY ACAD SCI, V1170, P91, DOI 10.1111/j.1749-6632.2009.04485.x; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Ma HZ, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-5; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Mathes CM, 2013, CHEM SENSES, V38, P211, DOI 10.1093/chemse/bjs096; Mathes CM, 2011, CHEM SENSES, V36, P515, DOI 10.1093/chemse/bjr011; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MINISCLOU C, 1995, NEUROCHEM RES, V20, P977, DOI 10.1007/BF00995549; Montmayeur JP, 2002, CURR OPIN NEUROBIOL, V12, P366, DOI 10.1016/S0959-4388(02)00345-8; Murata Y, 2010, J NEUROPHYSIOL, V104, P896, DOI 10.1152/jn.00414.2010; NADA O, 1975, HISTOCHEMISTRY, V43, P237, DOI 10.1007/BF00499704; Ni YG, 1997, MOL BRAIN RES, V51, P115, DOI 10.1016/S0169-328X(97)00225-8; Obata H, 1997, MOL BRAIN RES, V49, P29, DOI 10.1016/S0169-328X(97)00118-6; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Ohmoto M, 2011, J COMP NEUROL, V519, P1616, DOI 10.1002/cne.22589; Raymond JR, 1999, BRIT J PHARMACOL, V127, P1751, DOI 10.1038/sj.bjp.0702723; Ren Y, 1999, MOL BRAIN RES, V74, P221, DOI 10.1016/S0169-328X(99)00253-3; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Romanov RA, 2008, J GEN PHYSIOL, V132, P731, DOI 10.1085/jgp.200810108; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; SATO T, 1983, COMP BIOCHEM PHYS A, V75, P131, DOI 10.1016/0300-9629(83)90058-0; Shindler KS, 1996, J HISTOCHEM CYTOCHEM, V44, P1331, DOI 10.1177/44.11.8918908; SHINGAI T, 1985, BRAIN RES, V335, P245, DOI 10.1016/0006-8993(85)90476-7; Simon SA, 2003, AM J PHYSIOL-REG I, V284, pR1494, DOI 10.1152/ajpregu.00544.2002; SMITH DV, 1993, J COMP NEUROL, V336, P493, DOI 10.1002/cne.903360403; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; THOMAS T, 1993, EXP PHYSIOL, V78, P541, DOI 10.1113/expphysiol.1993.sp003705; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Uchida T., 1985, JPN J ORAL BIOL, V27, P509; Ueda K, 2006, ARCH HISTOL CYTOL, V69, P289, DOI 10.1679/aohc.69.289; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao FL, 2009, J PHYSIOL-LONDON, V587, P363, DOI 10.1113/jphysiol.2008.165167; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	81	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112152	10.1371/journal.pone.0112152	http://dx.doi.org/10.1371/journal.pone.0112152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386961	Green Published, gold			2022-12-26	WOS:000345250400043
J	Rakotosamimanana, S; Mandrosovololona, V; Rakotonirina, J; Ramamonjisoa, J; Ranjalahy, JR; Randremanana, RV; Rakotomanana, F				Rakotosamimanana, Sitraka; Mandrosovololona, Vatsiharizandry; Rakotonirina, Julio; Ramamonjisoa, Joselyne; Ranjalahy, Justin Rasolofomanana; Randremanana, Rindra Vatosoa; Rakotomanana, Fanjasoa			Spatial Analysis of Pulmonary Tuberculosis in Antananarivo Madagascar: Tuberculosis-Related Knowledge, Attitude and Practice	PLOS ONE			English	Article							COMMUNITIES; PATTERNS; MIDDLE; AREA	Introduction: Tuberculosis infection may remain latent, but the disease is nevertheless a serious public health issue. Various epidemiological studies on pulmonary tuberculosis have considered the spatial component and taken it into account, revealing the tendency of this disease to cluster in particular locations. The aim was to assess the contribution of Knowledge Attitude and Practice (KAP) to the distribution of tuberculosis and to provide information for the improvement of the National Tuberculosis Program. Methods: We investigated the role of KAP to distribution patterns of pulmonary tuberculosis in Antananarivo. First, we performed spatial scanning of tuberculosis aggregation among permanent cases resident in Antananarivo Urban Township using the Kulldorff method, and then we carried out a quantitative study on KAP, involving TB patients. The KAP study in the population was based on qualitative methods with focus groups. Results: The disease still clusters in the same districts identified in the previous study. The principal cluster covered 22 neighborhoods. Most of them are part of the first district. A secondary cluster was found, involving 18 neighborhoods in the sixth district and two neighborhoods in the fifth. The relative risk was respectively 1.7 (p<10(-6)) in the principal cluster and 1.6 (p<10(-3)) in the secondary cluster. Our study showed that more was known about TB symptoms than about the duration of the disease or free treatment. Knowledge about TB was limited to that acquired at school or from relatives with TB. The attitude and practices of patients and the population in general indicated that there is still a stigma attached to tuberculosis. Conclusion: This type of survey can be conducted in remote zones where the tuberculosis-related KAP of the TB patients and the general population is less known or not documented; the findings could be used to adapt control measures to the local particularities.	[Rakotosamimanana, Sitraka; Ramamonjisoa, Joselyne] Univ Antananarivo, Fac Lettres & Sci Humaines, Dept Geog, Antananarivo, Madagascar; [Mandrosovololona, Vatsiharizandry; Rakotonirina, Julio; Ranjalahy, Justin Rasolofomanana] Inst Natl Sante Publ & Communautaire, Antananarivo, Madagascar; [Rakotonirina, Julio] Etab Univ Soins Sante Publ Analakely, Antananarivo, Madagascar; [Randremanana, Rindra Vatosoa; Rakotomanana, Fanjasoa] Inst Pasteur Madagascar, Antananarivo, Madagascar	University Antananarivo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Rakotomanana, F (corresponding author), Inst Pasteur Madagascar, Antananarivo, Madagascar.	fanja@pasteur.mg	Rakotosamimanana, Sitraka/AAD-8165-2022	RAKOTOSAMIMANANA, Sitraka/0000-0002-1028-0427; RAKOTOMANANA, Fanjasoa/0000-0002-3373-1075	Institut Pasteur de Madagascar	Institut Pasteur de Madagascar	This work was supported by Institut Pasteur de Madagascar. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Cadot, 1998, Sante, V8, P447; Dangendorf F, 2002, INT J HYG ENVIR HEAL, V205, P183, DOI 10.1078/1438-4639-00151; Deribew A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-400; Gelaw M, 2001, East Afr Med J, V78, P382; Gonzalez-Ochoa E, 2009, TROP MED INT HEALTH, V14, P131, DOI 10.1111/j.1365-3156.2008.02201.x; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2014, SATSCAN TM USER GUID; Legesse M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-187; Maciel EL, INT J TUBERC LUNG DI, V14, P1403; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Munch Z, 2003, INT J TUBERC LUNG D, V7, P271; Mushtaq MU, 2010, INT J TUBERC LUNG D, V14, P303; Onozuka D, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-26; Rahalison L, 2003, ADV EXP MED BIOL, V529, P439; Raharimanga V., 2001, Archives de l'Institut Pasteur de Madagascar, V67, P19; Randremanana R. V., 2001, Archives de l'Institut Pasteur de Madagascar, V67, P74; Randremanana RV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-21; Randremanana RV, 2009, TROP MED INT HEALTH, V14, P429, DOI 10.1111/j.1365-3156.2009.02239.x; Singh M. Meghachandra, 2002, Journal of Communicable Diseases, V34, P203; Tadesse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065022; Tiwari Neeraj, 2006, Int J Health Geogr, V5, P33, DOI 10.1186/1476-072X-5-33; Touray K, 2010, TROP MED INT HEALTH, V15, P664, DOI 10.1111/j.1365-3156.2010.02533.x; Vukovic DS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-284; Wandwalo ER, 2000, INT J TUBERC LUNG D, V4, P1041; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; Zaffar Sadiq MGSM, GIS PUBLIC HLTH MANA; Bastida AZ, 2012, SCI WORLD J, DOI 10.1100/2012/570278	29	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e110471	10.1371/journal.pone.0110471	http://dx.doi.org/10.1371/journal.pone.0110471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386655	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400009
J	Pomari, E; Valle, LD; Pertile, P; Colombo, L; Thornton, MJ				Pomari, Elena; Valle, Luisa Dalla; Pertile, Paolo; Colombo, Lorenzo; Thornton, M. Julie			Intracrine sex steroid synthesis and signaling in human epidermal keratinocytes and dermal fibroblasts	FASEB JOURNAL			English	Article						DHEA; testosterone; estradiol; aromatase; wound healing	ESTROGEN-RECEPTOR-BETA; TRANSCRIPTIONAL CONTROL; BIOLOGICAL ACTIONS; GENE-EXPRESSION; HUMAN SKIN; IN-VITRO; DEHYDROEPIANDROSTERONE; ANDROGEN; DHEA; PROLIFERATION	Peripheral intracrine sex steroid synthesis from adrenal precursors dehydroepiandrosterone (DHEA) and DHEA-sulfate has evolved in humans. We sought to establish if there are differences in intracrine, paracrine, and endocrine regulation of sex steroids by primary cultures of human skin epidermal keratinocytes and dermal fibroblasts. Microarray analysis identified multifunctional genes modulated by steroids, quantitative RT-PCR (qRT-PCR) mRNA expression, enzymatic assay aromatase activity, scratch assay cell migration, immunocytochemistry alpha-smooth muscle actin (alpha-SMA), and collagen gel fibroblast contraction. All steroidogenic components were present, although only keratinocytes expressed the organic anion organic anion transporter protein (OATP) 2B1 transporter. Both expressed the G-protein-coupled estrogen receptor (GPER1). Steroids modulated multifunctional genes, up-regulating genes important in repair andaging [angiopoietin-like 4 (ANGPTL4), chemokine (C-X-C motif) ligand 1 (CXCL1), lamin B1 (LMNB1), and thioredoxin interacting protein (TXNIP)]. DHEA-sulfate (DHEA-S), DHEA, and 17 beta-estradiol stimulated keratinocyte andfibroblastmigration at early (4 h) and late (24-48 h) time points, suggesting involvement of genomic and nongenomic signaling. Migration was blocked by aromatase and steroid sulfatase (STS) inhibitors confirming intracrine synthesis to estrogen. Testosterone had little effect, implying it is not an intermediate. Steroids stimulated fibroblast contraction but not a-SMA expression. Mechanical wounding reduced fibroblast aromatase activity but increased keratinocyte activity, amplifying the bioavailability of intracellular estrogen. Cultured fibroblasts and keratinocytes provide a biologically relevant model system to investigate the complex pathways of sex steroid intracrinology in human skin.	[Pomari, Elena; Thornton, M. Julie] Univ Bradford, Ctr Skin Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Pomari, Elena; Valle, Luisa Dalla; Colombo, Lorenzo] Univ Padua, Dept Biol, Comparat Endocrinol Lab, Padua, Italy; [Pertile, Paolo] Cutech, Padua, Italy	University of Bradford; University of Padua	Thornton, MJ (corresponding author), Univ Bradford, Ctr Skin Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England.	m.j.thornton@bradford.ac.uk	Dalla Valle, Luisa/G-6721-2011; Pomari, Elena/J-8184-2018; Pomari, Elena/ABG-7666-2020	Dalla Valle, Luisa/0000-0001-8097-6369; Pomari, Elena/0000-0002-5182-0231; Pomari, Elena/0000-0002-5182-0231; Thornton, M Julie/0000-0002-3395-7066	Regione Veneto [DGR 3794]	Regione Veneto(Regione Veneto)	The authors thank Ola Kamala, Susan Stevenson, Nanda Kandamany, and the Plastic Surgery and Burns Unit, University of Bradford, United Kingdom. This study was supported by Regione Veneto (DGR 3794, Azione Biotech 3 bis), Italy (HAIR ATI project no. 4), and the Centre for Skin Sciences, University of Bradford, United Kingdom.	Alexaki VI, 2009, EXP CELL RES, V315, P2275, DOI 10.1016/j.yexcr.2009.04.006; Ashcroft GS, 1999, AM J PATHOL, V155, P1137, DOI 10.1016/S0002-9440(10)65217-0; Bader RA, 2009, J BIOMAT SCI-POLYM E, V20, P1005, DOI 10.1163/156856209X444402; Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell L, 2010, J EXP MED, V207, P1825, DOI 10.1084/jem.20100500; Celec P, 2003, PHYSIOL RES, V52, P397; Champliaud MF, 2003, J INVEST DERMATOL, V121, P781, DOI 10.1046/j.1523-1747.2003.12539.x; Chen F, 2005, ENDOCRINOLOGY, V146, P4568, DOI 10.1210/en.2005-0368; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Emmerson E, 2012, BIOGERONTOLOGY, V13, P3, DOI 10.1007/s10522-011-9322-y; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gilliver SC, 2009, J PATHOL, V217, P73, DOI 10.1002/path.2444; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Gopaul R, 2012, BIOFACTORS, V38, P44, DOI 10.1002/biof.191; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y; Kandamany N, 2010, BRIT J DERMATOL, V162, P931; KILLINGER DW, 1995, J STEROID BIOCHEM, V52, P195, DOI 10.1016/0960-0760(94)00164-H; Koenen A, 2012, EUR J PHARM SCI, V47, P774, DOI 10.1016/j.ejps.2012.08.017; Kroeze KL, 2012, J INVEST DERMATOL, V132, P216, DOI 10.1038/jid.2011.245; Labrie F, 2003, ENDOCR REV, V24, P152, DOI 10.1210/er.2001-0031; Labrie F, 2013, CLIMACTERIC, V16, P205, DOI 10.3109/13697137.2012.733983; Labrie F, 1995, ANN NY ACAD SCI, V774, P16, DOI 10.1111/j.1749-6632.1995.tb17369.x; Labrie F, 2000, HORM RES, V54, P218, DOI 10.1159/000053264; Labrie F, 2000, J MOL ENDOCRINOL, V25, P1, DOI 10.1677/jme.0.0250001; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makrantonaki E, 2010, EXP GERONTOL, V45, P801, DOI 10.1016/j.exger.2010.08.005; Miller KKM, 2013, STEROIDS, V78, P15, DOI 10.1016/j.steroids.2012.10.002; Nardi A, 2009, J STEROID BIOCHEM, V115, P68, DOI 10.1016/j.jsbmb.2009.02.017; O'Kane D, 2014, EXP DERMATOL, V23, P497, DOI 10.1111/exd.12452; Olde B, 2009, TRENDS ENDOCRIN MET, V20, P409, DOI 10.1016/j.tem.2009.04.006; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; Pelletier G, 2004, HISTOL HISTOPATHOL, V19, P629, DOI 10.14670/HH-19.629; Pomari E, 2014, J INFLAMM RES, V7, P103, DOI 10.2147/JIR.S61471; Pomari E, 2013, VET IMMUNOL IMMUNOP, V156, P159, DOI 10.1016/j.vetimm.2013.10.008; Pomari E, 2009, J STEROID BIOCHEM, V115, P146, DOI 10.1016/j.jsbmb.2009.04.003; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Rasmussen Cathy, 2013, Methods Mol Biol, V945, P161, DOI 10.1007/978-1-62703-125-7_11; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roth M, 2012, BRIT J PHARMACOL, V165, P1260, DOI 10.1111/j.1476-5381.2011.01724.x; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Samson M, 2005, J STEROID BIOCHEM, V94, P253, DOI 10.1016/j.jsbmb.2005.01.011; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Sbai O, 2010, J CELL SCI, V123, P4332, DOI 10.1242/jcs.074674; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Stanway SJ, 2007, ONCOLOGIST, V12, P370, DOI 10.1634/theoncologist.12-4-370; Stevenson S, 2008, J BIOMAT SCI-POLYM E, V19, P1097, DOI 10.1163/156856208784909354; Stevenson S, 2007, CLIN INTERV AGING, V2, P283; Stevenson S, 2008, WOUND REPAIR REGEN, V16, P243, DOI 10.1111/j.1524-475X.2008.00365.x; Stevenson S, 2009, EXP DERMATOL, V18, P988, DOI 10.1111/j.1600-0625.2009.00864.x; Thornton MJ, 2006, J INVEST DERMATOL, V126, P2010, DOI 10.1038/sj.jid.5700344; Thornton MJ, 2013, DERM-ENDOCRINOL, V5, P264, DOI 10.4161/derm.23872; Thornton MJ, 2005, EXPERT OPIN THER TAR, V9, P617, DOI 10.1517/14728222.9.3.617; Thornton MJ, 2003, J INVEST DERM SYMP P, V8, P100, DOI 10.1046/j.1523-1747.2003.12181.x; Thornton MJ, 2002, EXP DERMATOL, V11, P487, DOI 10.1034/j.1600-0625.2002.110601.x; Toraldo G, 2012, WOUND REPAIR REGEN, V20, P61, DOI 10.1111/j.1524-475X.2011.00757.x; Van LT, 2010, PROG BRAIN RES, V181, P177, DOI 10.1016/S0079-6123(08)81010-2; Verdier-Sevrain S, 2006, EXP DERMATOL, V15, P83, DOI 10.1111/j.1600-0625.2005.00377.x; Webb SJ, 2006, DRUG METAB REV, V38, P89, DOI 10.1080/03602530600569877; Williams MRI, 2004, J CLIN ENDOCR METAB, V89, P4708, DOI 10.1210/jc.2003-031560; Williams MRI, 2002, J CLIN ENDOCR METAB, V87, P176, DOI 10.1210/jc.87.1.176; Wong V, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/969618; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807; Zouboulis CC, 2012, REJUV RES, V15, P302, DOI 10.1089/rej.2011.1249; Zouboulis Christos C, 2004, Hormones (Athens), V3, P9	67	29	31	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					508	524		10.1096/fj.14-251363	http://dx.doi.org/10.1096/fj.14-251363			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25392269	Green Submitted			2022-12-26	WOS:000349370400015
J	Goncalves, RLS; Quinlan, CL; Perevoshchikova, IV; Hey-Mogensen, M; Brand, MD				Goncalves, Renata L. S.; Quinlan, Casey L.; Perevoshchikova, Irina V.; Hey-Mogensen, Martin; Brand, Martin D.			Sites of Superoxide and Hydrogen Peroxide Production by Muscle Mitochondria Assessed ex Vivo under Conditions Mimicking Rest and Exercise	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exercise; Hydrogen Peroxide; Mitochondria; Mitochondrial Respiratory Chain Complex; Reactive Oxygen Species (ROS); Rat Skeletal Muscle; Superoxide	RAT SKELETAL-MUSCLE; AMINO-ACID-METABOLISM; OXYGEN SPECIES PRODUCTION; OXIDOREDUCTASE COMPLEX-I; BRANCHED-CHAIN AMINO; EXPERIMENTAL CHRONIC UREMIA; NUCLEAR-MAGNETIC-RESONANCE; DIGITORUM LONGUS MUSCLES; ELECTRON-TRANSPORT CHAIN; PURINE-NUCLEOTIDE CYCLE	Background: Ten mitochondrial sites of superoxide/H2O2 generation are known, but their contributions in vivo are undefined. Results: We assessed their rates ex vivo in conditions mimicking rest and exercise. Conclusion: Sites I-Q and IIF generated half the signal at rest. During exercise, rates were lower, and site I-F dominated. Significance: Contributing sites ex vivo probably reflect those in vivo. The sites and rates of mitochondrial production of superoxide and H(2)O(2)in vivo are not yet defined. At least 10 different mitochondrial sites can generate these species. Each site has a different maximum capacity (e.g. the outer quinol site in complex III (site IIIQo) has a very high capacity in rat skeletal muscle mitochondria, whereas the flavin site in complex I (site I-F) has a very low capacity). The maximum capacities can greatly exceed the actual rates observed in the absence of electron transport chain inhibitors, so maximum capacities are a poor guide to actual rates. Here, we use new approaches to measure the rates at which different mitochondrial sites produce superoxide/H2O2 using isolated muscle mitochondria incubated in media mimicking the cytoplasmic substrate and effector mix of skeletal muscle during rest and exercise. We find that four or five sites dominate during rest in this ex vivo system. Remarkably, the quinol site in complex I (site I-Q) and the flavin site in complex II (site IIF) each account for about a quarter of the total measured rate of H2O2 production. Site I-F, site IIIQo, and perhaps site E-F in the -oxidation pathway account for most of the remainder. Under conditions mimicking mild and intense aerobic exercise, total production is much less, and the low capacity site I-F dominates. These results give novel insights into which mitochondrial sites may produce superoxide/H(2)O(2)in vivo.	[Goncalves, Renata L. S.; Quinlan, Casey L.; Perevoshchikova, Irina V.; Hey-Mogensen, Martin; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA	Buck Institute for Research on Aging	Goncalves, RLS (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	rgoncalves@buckinstitute.org	Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153; Quinlan, Casey/0000-0002-7808-8271	National Institutes of Health [TL1 AG032116]; Brazilian Government through the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e ao Conselho de Nacional de Desenvolvimento Cientifico e Tecnologico programa Ciencias Sem Fronteiras (CNPq-CSF); Glenn Foundation; Carlsberg Foundation; NATIONAL INSTITUTE ON AGING [TL1AG032116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brazilian Government through the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e ao Conselho de Nacional de Desenvolvimento Cientifico e Tecnologico programa Ciencias Sem Fronteiras (CNPq-CSF)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Glenn Foundation; Carlsberg Foundation(Carlsberg Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant TL1 AG032116 (to C. L. Q.). This work was also supported by the Brazilian Government through the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e ao Conselho de Nacional de Desenvolvimento Cientifico e Tecnologico programa Ciencias Sem Fronteiras (CNPq-CSF) (to R. L. S. G.), the Glenn Foundation (to R. L. S. G. and I. V. P.), and the Carlsberg Foundation (to M. H.-M.).	ADIBI SA, 1971, AM J PHYSIOL, V221, P829; Affourtit C, 2012, METHODS MOL BIOL, V810, P165, DOI 10.1007/978-1-61779-382-0_11; AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; ARAGON JJ, 1980, EUR J BIOCHEM, V110, P371, DOI 10.1111/j.1432-1033.1980.tb04877.x; ARDAWI MSM, 1990, CLIN SCI, V79, P139, DOI 10.1042/cs0790139; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; ARNOLD H, 1970, EUR J BIOCHEM, V15, P360, DOI 10.1111/j.1432-1033.1970.tb01016.x; AWAPARA J, 1956, J BIOL CHEM, V218, P571; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Baraban SC, 1997, J PHYSIOL-LONDON, V498, P679, DOI 10.1113/jphysiol.1997.sp021892; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BERGER M, 1976, BIOCHEM J, V158, P191, DOI 10.1042/bj1580191; Bertocci LA, 1999, J APPL PHYSIOL, V86, P2077, DOI 10.1152/jappl.1999.86.6.2077; BHUIYAN AKMJ, 1988, BIOCHEM J, V253, P337, DOI 10.1042/bj2530337; Borsheim E, 2006, AM J PHYSIOL-ENDOC M, V290, pE643, DOI 10.1152/ajpendo.00267.2005; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; BRASS EP, 1978, J BIOL CHEM, V253, P2688; BROCKS DG, 1980, BIOCHEM J, V188, P207, DOI 10.1042/bj1880207; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Bruton J, 2003, J PHYSIOL-LONDON, V551, P179, DOI 10.1113/jphysiol.2003.043927; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Callahan LA, 2001, J APPL PHYSIOL, V90, P45, DOI 10.1152/jappl.2001.90.1.45; CHALLISS RAJ, 1989, AM J PHYSIOL, V256, pE129, DOI 10.1152/ajpendo.1989.256.1.E129; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; CHEN V, 1984, DIABETES, V33, P1078, DOI 10.2337/diabetes.33.11.1078; Chung YR, 1998, AM J PHYSIOL-CELL PH, V274, pC846, DOI 10.1152/ajpcell.1998.274.3.C846; Cieslar J, 1998, AM J PHYSIOL-REG I, V275, pR1530, DOI 10.1152/ajpregu.1998.275.5.R1530; Cieslar JH, 2000, J BIOL CHEM, V275, P6129, DOI 10.1074/jbc.275.9.6129; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V723, P202, DOI 10.1016/0005-2728(83)90120-2; DALE RA, 1965, J PHYSIOL-LONDON, V181, P701, DOI 10.1113/jphysiol.1965.sp007792; Damink SWMO, 1999, CLIN SCI, V96, P639, DOI 10.1042/CS19980389; Dawson KD, 2005, J PHYSIOL-LONDON, V565, P637, DOI 10.1113/jphysiol.2004.079939; DESPLANCHES D, 1990, J APPL PHYSIOL, V69, P504, DOI 10.1152/jappl.1990.69.2.504; DOHM GL, 1981, J APPL PHYSIOL, V50, P41, DOI 10.1152/jappl.1981.50.1.41; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Dumas JF, 2005, DIABETOLOGIA, V48, P328, DOI 10.1007/s00125-004-1631-0; ELSE PL, 1985, AM J PHYSIOL, V248, pR415, DOI 10.1152/ajpregu.1985.248.4.R415; Essen-Gustavsson B, 2002, ACTA PHYSIOL SCAND, V174, P275, DOI 10.1046/j.1365-201x.2002.00942.x; FELLENIU.E, 1973, ACTA CHEM SCAND, V27, P2361, DOI 10.3891/acta.chem.scand.27-2361; GARBER AJ, 1976, J BIOL CHEM, V251, P826; GARBER AJ, 1978, J CLIN INVEST, V62, P633, DOI 10.1172/JCI109170; GARBER AJ, 1978, J CLIN INVEST, V62, P623, DOI 10.1172/JCI109169; GEERS C, 1990, J PHYSIOL-LONDON, V423, P279, DOI 10.1113/jphysiol.1990.sp018022; GILLIN AG, 1992, AM J PHYSIOL, V262, pF1061; GOLDSTEIN L, 1983, BIOCHEM J, V214, P757, DOI 10.1042/bj2140757; GOODMAN MN, 1974, DIABETES, V23, P881, DOI 10.2337/diab.23.11.881; GOODMAN MN, 1977, J BIOL CHEM, V252, P5054; GOODMAN MN, 1978, DIABETES, V27, P1065, DOI 10.2337/diab.27.11.1065; HAGG SA, 1976, BIOCHEM J, V158, P203, DOI 10.1042/bj1580203; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HENSGENS HESJ, 1978, BIOCHEM J, V170, P699, DOI 10.1042/bj1700699; Hey-Mogensen M, 2014, FREE RADICAL BIO MED, V72, P149, DOI 10.1016/j.freeradbiomed.2014.04.007; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P131, DOI 10.1093/ajcn/36.1.131; HINKLE PC, 1967, J BIOL CHEM, V242, P5169; HINTZ CS, 1982, AM J PHYSIOL, V242, pC218, DOI 10.1152/ajpcell.1982.242.3.C218; Hitchins S, 2001, AM J PHYSIOL-HEART C, V281, pH882, DOI 10.1152/ajpheart.2001.281.2.H882; Horska A, 1999, AM J PHYSIOL-ENDOC M, V276, pE766, DOI 10.1152/ajpendo.1999.276.4.E766; Howarth KR, 2004, J APPL PHYSIOL, V97, P579, DOI 10.1152/japplphysiol.01344.2003; HOWARTH RE, 1971, J NUTR, V101, P485, DOI 10.1093/jn/101.4.485; HULTMAN E, 1986, J PHYSIOL-LONDON, V374, P493, DOI 10.1113/jphysiol.1986.sp016093; HUTSON SM, 1981, AM J CLIN NUTR, V34, P173, DOI 10.1093/ajcn/34.2.173; HUTSON SM, 1980, J BIOL CHEM, V255, P2418; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; Ingalls CP, 1999, J APPL PHYSIOL, V87, P386, DOI 10.1152/jappl.1999.87.1.386; KARL IE, 1976, J BIOL CHEM, V251, P844; KASPEREK GJ, 1989, AM J PHYSIOL, V256, pE186, DOI 10.1152/ajpendo.1989.256.1.E186; KAUPPINEN RA, 1982, BIOCHIM BIOPHYS ACTA, V681, P286, DOI 10.1016/0005-2728(82)90033-0; KIRKWOOD SP, 1986, AM J PHYSIOL, V251, pC395, DOI 10.1152/ajpcell.1986.251.3.C395; KLINGENBERG M, 1960, ANNU REV BIOCHEM, V29, P669, DOI 10.1146/annurev.bi.29.070160.003321; KONDOH Y, 1992, RES EXP MED, V192, P407, DOI 10.1007/BF02576298; KONIJN AM, 1976, J NUTR, V106, P1507, DOI 10.1093/jn/106.10.1507; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; KUSHMERICK MJ, 1985, AM J PHYSIOL, V248, pC542, DOI 10.1152/ajpcell.1985.248.5.C542; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lee S, 2011, CELL RES, V21, P817, DOI 10.1038/cr.2011.55; LEE SH, 1979, J BIOL CHEM, V254, P420; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Loffler M, 1996, HISTOCHEM CELL BIOL, V105, P119, DOI 10.1007/BF01696151; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; MACDERMOTT M, 1990, EXP PHYSIOL, V75, P763, DOI 10.1113/expphysiol.1990.sp003458; MAIZELS EZ, 1977, BIOCHEM J, V162, P557, DOI 10.1042/bj1620557; Makara JK, 2000, ENDOCRINOLOGY, V141, P1705, DOI 10.1210/en.141.5.1705; MANCHESTER KL, 1963, BIOCHEM J, V89, P202, DOI 10.1042/bj0890202; MARQUIS NR, 1964, J LIPID RES, V5, P184; Mathieu-Costello O, 2005, J APPL PHYSIOL, V99, P281, DOI 10.1152/japplphysiol.00750.2004; MAY RC, 1987, AM J PHYSIOL, V252, pE712, DOI 10.1152/ajpendo.1987.252.6.E712; MILLWARD DJ, 1974, BRIT J NUTR, V32, P127, DOI 10.1079/BJN19740063; MINATOGAWA Y, 1984, BIOCHEM J, V223, P73, DOI 10.1042/bj2230073; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; Munkvik M, 2009, AM J PHYSIOL-REG I, V297, pR900, DOI 10.1152/ajpregu.91043.2008; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nakamura K, 2001, J BIOL CHEM, V276, P34402, DOI 10.1074/jbc.M103766200; Nicholls D. G., 2002, BIOENERGETICS, V3, P105; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; OWEN OE, 1973, BIOCHEM J, V134, P499, DOI 10.1042/bj1340499; PARRILLA R, 1978, PFLUG ARCH EUR J PHY, V374, P9, DOI 10.1007/BF00585691; PASTORIS O, 1995, NEUROCHEM RES, V20, P143, DOI 10.1007/BF00970538; PAUL HS, 1978, METABOLISM, V27, P185, DOI 10.1016/0026-0495(78)90164-6; PEARSON DJ, 1967, BIOCHEM J, V105, P953, DOI 10.1042/bj1050953; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; PETERSON RD, 1964, AM J PHYSIOL, V206, P599, DOI 10.1152/ajplegacy.1964.206.3.599; PICHARD C, 1988, J CLIN INVEST, V82, P895, DOI 10.1172/JCI113695; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Quinlan CL, 2013, METHOD ENZYMOL, V526, P189, DOI 10.1016/B978-0-12-405883-5.00012-0; Quinlan CL, 2012, FREE RADICAL BIO MED, V53, P1807, DOI 10.1016/j.freeradbiomed.2012.08.015; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; RENNIE MJ, 1976, BIOCHEM J, V156, P647, DOI 10.1042/bj1560647; RUDERMAN NB, 1977, AM J PHYSIOL, V233, pE109, DOI 10.1152/ajpendo.1977.233.2.E109; SACKTOR B, 1965, J BIOL CHEM, V240, P2678; Saha AK, 1999, AM J PHYSIOL-ENDOC M, V276, pE1030, DOI 10.1152/ajpendo.1999.276.6.E1030; Sakellariou GK, 2014, FREE RADICAL RES, V48, P12, DOI 10.3109/10715762.2013.830718; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; SCHARFF R, 1966, BIOCHEM J, V99, P173, DOI 10.1042/bj0990173; SCHIAFFINO S, 1970, J CELL BIOL, V47, P107, DOI 10.1083/jcb.47.1.107; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; SOBOLL S, 1992, BIOCHEM J, V281, P171, DOI 10.1042/bj2810171; SPYDEVOLD O, 1976, EUR J BIOCHEM, V71, P155, DOI 10.1111/j.1432-1033.1976.tb11101.x; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; SUNDQVIST KE, 1987, BIOCHEM J, V243, P853, DOI 10.1042/bj2430853; Thyfault JP, 2010, AM J PHYSIOL-REG I, V299, pR926, DOI 10.1152/ajpregu.00093.2010; TISCHLER ME, 1988, MUSCLE NERVE, V11, P752, DOI 10.1002/mus.880110711; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; TURINSKY J, 1990, AM J PHYSIOL, V258, pE485, DOI 10.1152/ajpendo.1990.258.3.E485; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; VANEKEREN GJ, 1992, INT J EXP PATHOL, V73, P51; VEECH RL, 1969, BIOCHEM J, V115, P837, DOI 10.1042/bj1150837; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Vinnakota KC, 2004, AM J PHYSIOL-HEART C, V286, pH1742, DOI 10.1152/ajpheart.00478.2003; WALSER M, 1973, J CLIN INVEST, V52, P2865, DOI 10.1172/JCI107483; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; WESTERBLAD H, 1993, J PHYSIOL-LONDON, V468, P729, DOI 10.1113/jphysiol.1993.sp019797; WIESNER RJ, 1988, BIOCHIM BIOPHYS ACTA, V936, P114, DOI 10.1016/0005-2728(88)90258-7; Wijekoon EP, 2004, CAN J PHYSIOL PHARM, V82, P506, DOI [10.1139/y04-067, 10.1139/Y04-067]; WILLIAMS JA, 1971, J PHYSIOL-LONDON, V212, P101, DOI 10.1113/jphysiol.1971.sp009312; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; ZORZANO A, 1985, BIOCHEM J, V232, P585, DOI 10.1042/bj2320585	159	203	205	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					209	227		10.1074/jbc.M114.619072	http://dx.doi.org/10.1074/jbc.M114.619072			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389297	hybrid, Green Published			2022-12-26	WOS:000347231200018
J	Ohno, M; Deguchi, F; Izumi, K; Ishigaki, H; Sarui, H; Sasaki, A; Segawa, T; Yamaki, T; Kojima, T; Ohashi, H				Ohno, Michiya; Deguchi, Fumiko; Izumi, Kumiko; Ishigaki, Hirotoshi; Sarui, Hiroshi; Sasaki, Akihiko; Segawa, Tomonori; Yamaki, Takahiko; Kojima, Takao; Ohashi, Hiroshige			Correlation between Renal Function and Common Risk Factors for Chronic Kidney Disease in a Healthy Middle-Aged Population: A Prospective Observational 2-Year Study	PLOS ONE			English	Article							SERUM URIC-ACID; GENERAL JAPANESE POPULATION; COMMUNITY-BASED POPULATION; METABOLIC SYNDROME; BLOOD-PRESSURE; INDEPENDENT MECHANISM; SCREENED COHORT; HYPERURICEMIA; HYPERTENSION; PROGRESSION	Background/Aims: Age, proteinuria, metabolic syndrome, and hyperuricemia are the reported risk factors for chronic kidney disease (CKD) and cardiovascular disease (CVD). However, the best predictor of changes in renal function in the early stages of renal disease in a healthy middle-aged population is still unknown. Our study evaluated the correlation between changes in renal function and common risk factors to determine such a predictor. Methods: In total, 2,853 healthy persons aged <= 50 years participated in the study. They had no proteinuria and were not on medications for hypertension, diabetes mellitus, hyperlipidemia, or hyperuricemia. Over 2 years, participants underwent annual health screening. The relationship between changes in estimated glomerular filtration rate (eGFR) and changes in risk factors for CKD was evaluated using univariate and multivariate linear regression analyses. Results: Over 2 years, eGFR showed a significant decrease. Univariate regression analysis revealed that changes in fasting plasma glucose (FPG), total cholesterol, LDL-cholesterol, serum uric acid levels, and hemoglobin showed a significant negative correlation with changes in eGFR. Multiple regression analysis confirmed that changes in FPG, serum uric acid levels, in particular, and hemoglobin had a significant negative correlation with changes in eGFR. Conclusion: The changes in eGFR and other variables over 2 years were small and could be within expected biologic variation. A longer observational study is needed to elucidate whether FPG, serum uric acid and hemoglobin represent the earliest markers of eGFR decline.	[Ohno, Michiya; Izumi, Kumiko; Ishigaki, Hirotoshi; Ohashi, Hiroshige] Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Nephrol, Gifu, Japan; [Deguchi, Fumiko; Kojima, Takao] Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Hlth Ctr, Gifu, Japan; [Sarui, Hiroshi; Sasaki, Akihiko] Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Diabet & Endocrinol, Gifu, Japan; [Segawa, Tomonori; Yamaki, Takahiko] Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Cardiol, Gifu, Japan	Asahi University; Asahi University; Asahi University; Asahi University	Ohno, M (corresponding author), Asahi Univ, Sch Dent, Murakami Mem Hosp, Div Nephrol, Gifu, Japan.	mohno@murakami.asahi-u.ac.jp						Badve SV, 2011, NAT REV NEPHROL, V7, P295, DOI 10.1038/nrneph.2010.186; Bellomo G, 2010, AM J KIDNEY DIS, V56, P264, DOI 10.1053/j.ajkd.2010.01.019; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Culleton BF, 1999, ARCH INTERN MED, V159, P1785, DOI 10.1001/archinte.159.15.1785; Feig DI, 2009, CURR OPIN NEPHROL HY, V18, P526, DOI 10.1097/MNH.0b013e328330d9d0; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Forman JP, 2007, J AM SOC NEPHROL, V18, P287, DOI 10.1681/ASN.2006080865; Girillo P, 2006, J AM SOC NEPHROL, V17, pS165, DOI 10.1681/ASN.2006080909; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Iseki K, 2013, HYPERTENS RES, V36, P650, DOI 10.1038/hr.2013.11; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Kanbay M, 2011, AM J NEPHROL, V33, P325, DOI 10.1159/000324916; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kimiyoshi I, 2012, NAT COMMUN, V3, P1; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Nagahama K, 2004, HYPERTENS RES, V27, P835, DOI 10.1291/hypres.27.835; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; Nakanishi N, 1999, INT J EPIDEMIOL, V28, P888, DOI 10.1093/ije/28.5.888; Nashar K, 2012, ADV CHRONIC KIDNEY D, V19, P386, DOI 10.1053/j.ackd.2012.05.004; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Ninomiya T, 2006, AM J KIDNEY DIS, V48, P383, DOI 10.1053/j.ajkd.2006.06.003; Ryan TP, 2009, AM J NEPHROL, V29, P620, DOI 10.1159/000194455; Sanchez-Lozada LG, 2002, AM J PHYSIOL-RENAL, V283, pF1105, DOI 10.1152/ajprenal.00170.2002; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Sonoda H, 2011, AM J NEPHROL, V33, P352, DOI 10.1159/000326848; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Suzuki K, 2013, CLIN EXP NEPHROL, V17, P541, DOI 10.1007/s10157-012-0743-y; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Yamada T, 2011, AM J MED SCI, V342, P461, DOI 10.1097/MAJ.0b013e318218bd89; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d	39	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e113263	10.1371/journal.pone.0113263	http://dx.doi.org/10.1371/journal.pone.0113263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396414	Green Published, gold, Green Submitted			2022-12-26	WOS:000345558500144
J	Eli, K; Howell, K; Fisher, PA; Nowicka, P				Eli, Karin; Howell, Kyndal; Fisher, Philip A.; Nowicka, Paulina			"Those Comments Last Forever'': Parents and Grandparents of Preschoolers Recount How They Became Aware of Their Own Body Weights as Children	PLOS ONE			English	Article							PREVENTION; OBESITY; DISSATISFACTION; IMAGE; MEDIA; ASSOCIATIONS; OVERWEIGHT; STIGMA; GIRLS; FAT	Background: Parents' and grandparents' willingness to talk about children's body weights may be influenced by their own childhood experiences of body weight awareness and 'weight talk' in the family; however, little is known about how adults describe their recollected weight-related childhood experiences. Aims: This paper examines how parents and grandparents of preschoolers describe the emergence of their own body weight awareness in childhood or adolescence. The analysis highlights the sources that participants identify as having instigated their body weight awareness, the feelings and experiences participants associate with the experience of becoming aware of their body weights, and their framings of potential links between childhood experiences and attitudes and practices in adulthood. Methods: 49 participants (22 parents, 27 grandparents, 70% women, 60% with overweight/obesity) from sixteen low-income families of children aged 3-5 years (50% girls, 56% with overweight/obesity) in the Pacific Northwest were interviewed. The interviews were videotaped, transcribed, and analyzed qualitatively. Results: Twenty-five participants (51%) said they became aware of their body weights in childhood or adolescence. Fourteen participants said their body weight awareness emerged through comments made by others, with the majority citing parents or peers. No participant described the emergence of body weight awareness in positive terms. Four participants directly linked their own negative experiences to the decision not to discuss body weight with their preschoolers. All four cited critical comments from their parents as instigating their own body weight awareness in childhood. Conclusions: In most cases, participants associated their emergent awareness of body weight with overtly negative feelings or consequences; some participants said these negative experiences continued to affect them as adults. Since family-based childhood obesity interventions involve open discussion of children's body sizes, the results suggest that clinicians should reframe the discussion to deconstruct obesity stigma and emphasize inclusive, affirmative, and health-focused messages.	[Eli, Karin; Nowicka, Paulina] Univ Oxford, Inst Social & Cultural Anthropol, Unit Biocultural Variat & Obes, Oxford, England; [Howell, Kyndal; Fisher, Philip A.] Univ Oregon, Dept Psychol, Eugene, OR 97403 USA; [Nowicka, Paulina] Karolinska Inst, Dept Clin Sci Intervent & Technol, Pediat Unit, Stockholm, Sweden	University of Oxford; University of Oregon; Karolinska Institutet	Eli, K (corresponding author), Univ Oxford, Inst Social & Cultural Anthropol, Unit Biocultural Variat & Obes, Oxford, England.	karin.eli@anthro.ox.ac.uk		Fisher, Philip/0000-0002-5399-7233; Nowicka, Paulina/0000-0001-9707-8768; Eli, Karin/0000-0001-9132-8404	Sweden-America Foundation; Oregon Social Learning Center; Marie Curie VINNMER International Qualification [2011-03443]	Sweden-America Foundation; Oregon Social Learning Center; Marie Curie VINNMER International Qualification	PN received funding for this study from the Sweden-America Foundation, the Oregon Social Learning Center and the Marie Curie VINNMER International Qualification (grant number 2011-03443). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ata RN, 2010, OBESITY FACTS, V3, P41, DOI 10.1159/000276547; Becker A, 2004, CULT MED PSYCHIAT, V28, P533, DOI 10.1007/s11013-004-1067-5; Borra ST, 2003, J AM DIET ASSOC, V103, P721, DOI 10.1053/jada.2003.50140; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brewis AA, 2011, CURR ANTHROPOL, V52, P269, DOI 10.1086/659309; Bronfenbrenner U., 1992, 6 THEORIES CHILD DEV, P187, DOI DOI 10.1037/10518-046; Clark L, 2006, SOC DEV, V15, P628, DOI 10.1111/j.1467-9507.2006.00361.x; Davison KK, 2001, PEDIATRICS, V107, P46, DOI 10.1542/peds.107.1.46; Eisenberg ME, 2003, ARCH PEDIAT ADOL MED, V157, P733, DOI 10.1001/archpedi.157.8.733; Hargreaves Duane A, 2004, Body Image, V1, P351, DOI 10.1016/j.bodyim.2004.10.002; Hart LM, 2014, BODY IMAGE, V11, P418, DOI 10.1016/j.bodyim.2014.06.010; Hayes S, 2010, BRIT J DEV PSYCHOL, V28, P413, DOI 10.1348/026151009X424240; Hoelscher DM, 2013, J ACAD NUTR DIET, V113, P1375, DOI 10.1016/j.jand.2013.08.004; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Kuczmarski RJ., 2000, ADV DATA, P1; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Latner JD, 2003, OBES RES, V11, P452, DOI 10.1038/oby.2003.61; McCabe MP, 2004, J PSYCHOSOM RES, V56, P675, DOI 10.1016/S0022-3999(03)00129-6; Neumark-Sztainer D, 2005, INT J EAT DISORDER, V38, P220, DOI 10.1002/eat.20181; Neumark-Sztainer D, 2002, INT J OBESITY, V26, P123, DOI 10.1038/sj.ijo.0801853; Neumark-Sztainer D, 2010, J ADOLESCENT HEALTH, V47, P270, DOI 10.1016/j.jadohealth.2010.02.001; O'Dea JA, 2005, HEALTH EDUC RES, V20, P259, DOI 10.1093/her/cyg116; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Pagnini D, 2009, INT J PEDIATR OBES, V4, P233, DOI 10.3109/17477160902763333; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Schwartz DJ, 1999, INT J EAT DISORDER, V25, P339, DOI 10.1002/(SICI)1098-108X(199904)25:3<339::AID-EAT13>3.0.CO;2-V; Sleddens EFC, 2012, OBES REV, V13, P1015, DOI 10.1111/j.1467-789X.2012.01018.x; Smolak L, 1999, INT J EAT DISORDER, V25, P263, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;263::AID-EAT3&gt;3.0.CO;2-V; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; VAN IJZENDOORN MH, 1992, DEV REV, V12, P76, DOI 10.1016/0273-2297(92)90004-L; Ventura AK, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-15; World Health Organization, 2000, WHO TECHN REP SER, P894	34	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111974	10.1371/journal.pone.0111974	http://dx.doi.org/10.1371/journal.pone.0111974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393236	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300026
J	Morelli, A; Haugner, J; Seelig, B				Morelli, Aleardo; Haugner, John; Seelig, Burckhard			Thermostable Artificial Enzyme Isolated by In Vitro Selection	PLOS ONE			English	Article							DIRECTED EVOLUTION; MESSENGER-RNA; PROTEIN STABILITY; STRATEGIES; LESSONS; DESIGN	Artificial enzymes hold the potential to catalyze valuable reactions not observed in nature. One approach to build artificial enzymes introduces mutations into an existing protein scaffold to enable a new catalytic activity. This process commonly results in a simultaneous reduction of protein stability as an undesired side effect. While protein stability can be increased through techniques like directed evolution, care needs to be taken that added stability, conversely, does not sacrifice the desired activity of the enzyme. Ideally, enzymatic activity and protein stability are engineered simultaneously to ensure that stable enzymes with the desired catalytic properties are isolated. Here, we present the use of the in vitro selection technique mRNA display to isolate enzymes with improved stability and activity in a single step. Starting with a library of artificial RNA ligase enzymes that were previously isolated at ambient temperature and were therefore mostly mesophilic, we selected for thermostable active enzyme variants by performing the selection step at 65 degrees C. The most efficient enzyme, ligase 10C, was not only active at 65 degrees C, but was also an order of magnitude more active at room temperature compared to related enzymes previously isolated at ambient temperature. Concurrently, the melting temperature of ligase 10C increased by 35 degrees compared to these related enzymes. While low stability and solubility of the previously selected enzymes prevented a structural characterization, the improved properties of the heat-stable ligase 10C finally allowed us to solve the three-dimensional structure by NMR. This artificial enzyme adopted an entirely novel fold that has not been seen in nature, which was published elsewhere. These results highlight the versatility of the in vitro selection technique mRNA display as a powerful method for the isolation of thermostable novel enzymes.	[Seelig, Burckhard] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Seelig, B (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	seelig@umn.edu	Seelig, Burckhard/D-1042-2013	Seelig, Burckhard/0000-0001-8598-0586	US National Aeronautics and Space Administration (NASA) through the NASA Astrobiology Institute-Ames Research Center [NNX09AH70A]; US National Institutes of Health (NIH) [T32 GM08347]; Biocatalysis Initiative of the BioTechnology Institute at the University of Minnesota; Minnesota Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008347] Funding Source: NIH RePORTER	US National Aeronautics and Space Administration (NASA) through the NASA Astrobiology Institute-Ames Research Center; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biocatalysis Initiative of the BioTechnology Institute at the University of Minnesota; Minnesota Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the US National Aeronautics and Space Administration (NASA) Agreement no. NNX09AH70A through the NASA Astrobiology Institute-Ames Research Center (to A.M. and B.S.), the US National Institutes of Health (NIH) (T32 GM08347 to J.C.H.) and by a grant from the Biocatalysis Initiative of the BioTechnology Institute at the University of Minnesota and the Minnesota Medical Foundation (to B.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Auerbach G, 1998, STRUCTURE, V6, P769, DOI 10.1016/S0969-2126(98)00078-1; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bommarius AS, 2013, CHEM SOC REV, V42, P6534, DOI 10.1039/c3cs60137d; Bornscheuer UT, 2012, NATURE, V485, P185, DOI 10.1038/nature11117; Chao FA, 2013, NAT CHEM BIOL, V9, P81, DOI [10.1038/NCHEMBIO.1138, 10.1038/nchembio.1138]; Chaput JC, 2004, CHEM BIOL, V11, P865, DOI 10.1016/j.chembiol.2004.04.006; Cho GS, 2006, CHEM BIOL, V13, P139, DOI 10.1016/j.chembiol.2005.10.015; Diaz JE, 2011, PROTEIN SCI, V20, P1597, DOI 10.1002/pro.691; Eijsink VGH, 2005, BIOMOL ENG, V22, P21, DOI 10.1016/j.bioeng.2004.12.003; Elias M, 2014, TRENDS BIOCHEM SCI, V39, P1, DOI 10.1016/j.tibs.2013.11.001; Golynskiy MV, 2013, CHEMBIOCHEM, V14, P1553, DOI 10.1002/cbic.201300326; Golynskiy Misha V, 2013, Methods Mol Biol, V978, P73, DOI 10.1007/978-1-62703-293-3_6; Golynskiy MV, 2010, TRENDS BIOTECHNOL, V28, P340, DOI 10.1016/j.tibtech.2010.04.003; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haugner JC, 2013, CHEM COMMUN, V49, P7322, DOI 10.1039/c3cc44454f; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Jackel C, 2010, J MOL BIOL, V399, P541, DOI 10.1016/j.jmb.2010.04.039; Lane MD, 2014, CURR OPIN CHEM BIOL, V22, P129, DOI 10.1016/j.cbpa.2014.09.013; MacedoRibeiro S, 1996, STRUCTURE, V4, P1291, DOI 10.1016/S0969-2126(96)00137-2; Martin A, 2001, J MOL BIOL, V309, P717, DOI 10.1006/jmbi.2001.4698; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Nemoto N, 1997, FEBS LETT, V414, P405, DOI 10.1016/S0014-5793(97)01026-0; Palackal N, 2004, PROTEIN SCI, V13, P494, DOI 10.1110/ps.03333504; Ramanathan A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001193; Reetz MT, 2009, ANGEW CHEM INT EDIT, V48, P8268, DOI 10.1002/anie.200904209; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; Schmid FX, 2011, CHEMBIOCHEM, V12, P1501, DOI 10.1002/cbic.201100018; Seelig B, 2007, NATURE, V448, P828, DOI 10.1038/nature06032; Seelig B, 2011, NAT PROTOC, V6, P540, DOI 10.1038/nprot.2011.312; Sieber V, 1998, NAT BIOTECHNOL, V16, P955, DOI 10.1038/nbt1098-955; Smith MD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000467; Socha RD, 2013, FEBS J, V280, P5582, DOI 10.1111/febs.12354; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Wijma HJ, 2013, CURR OPIN STRUC BIOL, V23, P588, DOI 10.1016/j.sbi.2013.04.008	43	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112028	10.1371/journal.pone.0112028	http://dx.doi.org/10.1371/journal.pone.0112028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393375	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300028
J	Cho, JS; Kang, JH; Um, JY; Han, IH; Park, IH; Lee, HM				Cho, Jung-Sun; Kang, Ju-Hyung; Um, Ji-Young; Han, In-Hye; Park, Il-Ho; Lee, Heung-Man			Lipopolysaccharide Induces Pro-Inflammatory Cytokines and MMP Production via TLR4 in Nasal Polyp-Derived Fibroblast and Organ Culture	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; EXPRESSION; EOTAXIN; CELLS; LPS	Nasal polyposis is characterized by persistent inflammation and remodeling in sinonasal mucosa. Toll-like receptors (TLRs) play a role in the innate immune response to microbes in the sinonasal cavity. The aim of this study was to evaluate whether nasal polyp-derived fibroblasts (NPDFs) and organ-cultured nasal polyps can synthesize pro-inflammatory cytokines and matrix metalloproteinases (MMPs) after exposure to lipopolysaccharide (LPS), a TLR4 agonist. NPDFs and organ-cultured nasal polyps were isolated from nasal polyps of 8 patients and exposed to LPS. The mRNA and protein expression levels of TLRs, cytokines, and MMPs were determined using a gene expression microarray, real-time RT-PCR, western blot analysis, enzyme-linked immunosorbent assay, and immunofluorescence staining. The enzymatic activities of MMPs were analyzed using collagen or gelatin zymography. The protein expression level of MMP-1 increased in nasal polyp tissues compared to inferior turbinate tissues. LPS induced mRNA expression of TLR4, IL-6, IL-8, and MMP-1 and activated MAPK signaling in NPDFs. LPS promoted the release of interleukin (IL)-6 through extracellular signal-related kinase (ERK) and IL-8 through ERK and c-Jun N-terminal kinases (JNK). Production of IL-6 and IL-8 was induced by PI3K/Akt signaling in LPS-stimulated NPDFs. LPS increased the transcript and protein expression levels of MMP-1 and induced collagenase activity of MMP-1 via ERK and p38, but did not induce gelatinase activity of MMP-2 and MMP-9. LPS from Rhodobacter sphaeroides (LPS-RS) inhibited the stimulatory effects of LPS in NPDFs as well as in organ culture of nasal polyp. LPS triggers immune response via TLR 4 and activates MAPK and PI3K/Akt signaling pathway, which is involved in remodeling of nasal polyps.	[Cho, Jung-Sun; Kang, Ju-Hyung; Um, Ji-Young; Han, In-Hye; Lee, Heung-Man] Korea Univ, Coll Med, Seoul 136705, South Korea; [Cho, Jung-Sun; Park, Il-Ho; Lee, Heung-Man] Korea Univ, Guro Hosp, Clin Trial Ctr, Inst Med Devices, Seoul, South Korea; [Park, Il-Ho; Lee, Heung-Man] Korea Univ, Dept Otorhinolaryngol Head & Neck Surg, Guro Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Lee, HM (corresponding author), Korea Univ, Coll Med, Seoul 136705, South Korea.	lhman@korea.ac.kr	Park, Il-Ho/AAI-1394-2019	Park, Il-Ho/0000-0002-7011-6071	National Research Foundation of Korea (NRF) grant - Korea Government (MEST) [2012-0005455]; Korea University Grant	National Research Foundation of Korea (NRF) grant - Korea Government (MEST); Korea University Grant	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MEST; no. 2012-0005455) and a Korea University Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein Joel M, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P39, DOI 10.1097/00020840-200502000-00010; Bromfield JJ, 2011, ENDOCRINOLOGY, V152, P5029, DOI 10.1210/en.2011-1124; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Cho JS, 2013, AM J RHINOL ALLERGY, V27, P18, DOI 10.2500/ajra.2013.27.3827; Chung K.F., 2001, EUR RESPIR J, V34, P50, DOI DOI 10.1183/09031936.01.00229701; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Eyibilen A, 2011, HISTOL HISTOPATHOL, V26, P615, DOI 10.14670/HH-26.615; Gibbs DF, 1999, AM J RESP CELL MOL, V20, P1145, DOI 10.1165/ajrcmb.20.6.3482; Harris JF, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-24; Hyc A, 2011, INT J MOL MED, V27, P127, DOI 10.3892/ijmm.2010.550; Lechapt-Zalcman E, 2001, J PATHOL, V193, P233, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH771>3.0.CO;2-W; Liu CM, 2001, ANN OTO RHINOL LARYN, V110, P1129, DOI 10.1177/000348940111001209; Ngkelo A, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-1; Nonaka M, 2004, CLIN EXP ALLERGY, V34, P804, DOI 10.1111/j.1365-2222.2004.1954.x; Norlander T, 1996, LARYNGOSCOPE, V106, P196, DOI 10.1097/00005537-199602000-00017; Park SK, 2009, BIOCHEM BIOPH RES CO, V379, P255, DOI 10.1016/j.bbrc.2008.12.034; Pawankar R, 2003, CURR OPIN ALLERGY CL, V3, P1, DOI 10.1097/01.all.0000053260.61007.d6; Rostkowska-Nadolska Beata, 2006, Otolaryngol Pol, V60, P143; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Shin SH, 2010, INT ARCH ALLERGY IMM, V153, P46, DOI 10.1159/000301578; Shin SH, 2004, J ALLERGY CLIN IMMUN, V114, P1369, DOI 10.1016/j.jaci.2004.08.012; Smith RS, 1997, AM J PATHOL, V151, P317; Sorsa T, 2004, ORAL DIS, V10, P311, DOI 10.1111/j.1601-0825.2004.01038.x; Takashiba S, 2003, J PERIODONTOL, V74, P103, DOI 10.1902/jop.2003.74.1.103; Teran LM, 1999, J ALLERGY CLIN IMMUN, V103, pS206; VanderMeer, 2005, ARCH OTOLARYNGOL, V131, P406; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wang LF, 2012, AM J RHINOL ALLERGY, V26, pE1, DOI 10.2500/ajra.2012.26.3724; Wong Y, 2011, INVEST OPHTH VIS SCI, V52, P2796, DOI 10.1167/iovs.10-5459	31	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e90683	10.1371/journal.pone.0090683	http://dx.doi.org/10.1371/journal.pone.0090683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390332	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400001
J	Dusane, DH; Hosseinidoust, Z; Asadishad, B; Tufenkji, N				Dusane, Devendra H.; Hosseinidoust, Zeinab; Asadishad, Bahareh; Tufenkji, Nathalie			Alkaloids Modulate Motility, Biofilm Formation and Antibiotic Susceptibility of Uropathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; GENE-EXPRESSION; BLACK PEPPER; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; BACTERIAL BIOFILMS; SWARMING MOTILITY; MECHANISMS; PIPERINE; CIPROFLOXACIN	Alkaloid-containing natural compounds have shown promise in the treatment of microbial infections. However, practical application of many of these compounds is pending a mechanistic understanding of their mode of action. We investigated the effect of two alkaloids, piperine (found in black pepper) and reserpine (found in Indian snakeroot), on the ability of the uropathogenic bacterium Escherichia coli CFT073 to colonize abiotic surfaces. Sub-inhibitory concentrations of both compounds (0.5 to 10 mu g/mL) decreased bacterial swarming and swimming motilities and increased biofilm formation. qRT-PCR revealed a decrease in the expression of the flagellar gene (fliC) and motility genes (motA and motB) along with an increased expression of adhesin genes (fimA, papA, uvrY). Interestingly, piperine increased penetration of the antibiotics ciprofloxacin and azithromycin into E. coli CFT073 biofilms and consequently enhanced the ability of these antibiotics to disperse pre-established biofilms. The findings suggest that these alkaloids can potentially affect bacterial colonization by hampering bacterial motility and may aid in the treatment of infection by increasing antibiotic penetration in biofilms.	[Dusane, Devendra H.; Hosseinidoust, Zeinab; Asadishad, Bahareh; Tufenkji, Nathalie] McGill Univ, Dept Chem Engn, Montreal, PQ, Canada	McGill University	Tufenkji, N (corresponding author), McGill Univ, Dept Chem Engn, Montreal, PQ, Canada.	nathalie.tufenkji@mcgill.ca	Dusane, PhD, Devendra/AAZ-9820-2021; Dusane, Devendra/P-9829-2018; Hosseinidoust, zeinab/G-7617-2012	Dusane, Devendra/0000-0003-4340-6214; Hosseinidoust, zeinab/0000-0001-9261-7611	Natural Sciences and Engineering Research Council of Canada [311566]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (Grant #311566, www.nserc.ca) awarded to NT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubacker M.N., 2011, DRUG INVENT TODAY, V3, P16; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Asadishad B, 2012, FEMS MICROBIOL LETT, V334, P87, DOI 10.1111/j.1574-6968.2012.02622.x; ATAL CK, 1985, J PHARMACOL EXP THER, V232, P258; Badmaev V, 1999, NUTR RES, V19, P381, DOI 10.1016/S0271-5317(99)00007-X; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Boll EJ, 2013, INFECT IMMUN, V81, P1164, DOI 10.1128/IAI.01376-12; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Corona F, 2013, ANTIBIOTICS-BASEL, V2, P237, DOI 10.3390/antibiotics2020237; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Desai MG, 2012, INDIAN J CLIN PRACTI, V22, P11; Dhakal BK, 2008, EUR J CLIN INVEST, V38, P2, DOI 10.1111/j.1365-2362.2008.01986.x; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUNNE WM, 1990, ANTIMICROB AGENTS CH, V34, P390, DOI 10.1128/AAC.34.3.390; Ferrieres L, 2003, MOL MICROBIOL, V50, P1665, DOI 10.1046/j.1365-2958.2003.03815.x; Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Han HK, 2011, EXPERT OPIN DRUG MET, V7, P721, DOI 10.1517/17425255.2011.570332; Hancock V, 2007, FEMS MICROBIOL LETT, V267, P30, DOI 10.1111/j.1574-6968.2006.00507.x; Hidalgo G, 2011, APPL ENVIRON MICROB, V77, P6852, DOI 10.1128/AEM.05561-11; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hosseinidoust Z, 2013, BIOFOULING, V29, P457, DOI 10.1080/08927014.2013.779370; Jones BV, 2004, INFECT IMMUN, V72, P3941, DOI 10.1128/IAI.72.7.3941-3950.2004; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Khan IA, 2006, ANTIMICROB AGENTS CH, V50, P810, DOI 10.1128/AAC.50.2.810-812.2006; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lane MC, 2007, J BACTERIOL, V189, P5523, DOI 10.1128/JB.00434-07; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACNAB RM, 1992, ANNU REV GENET, V26, P131, DOI 10.1146/annurev.ge.26.120192.001023; Mitra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055492; O'May C, 2012, BIOFOULING, V28, P1063, DOI 10.1080/08927014.2012.725130; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x; Serra DO, 2013, MBIO, V4, DOI 10.1128/mBio.00103-13; Sharma A, 2009, INDIAN J PHARM SCI, V71, P136, DOI 10.4103/0250-474X.54279; Singh M, 2005, J Vet Sci, V6, P197; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Srinivasan K, 2007, CRIT REV FOOD SCI, V47, P735, DOI 10.1080/10408390601062054; Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196; STOCK J, 1994, CURR BIOL, V4, P143, DOI 10.1016/S0960-9822(94)00033-3; Trautner BW, 2004, AM J INFECT CONTROL, V32, P177, DOI 10.1016/j.ajic.2003.08.005; Walters MC, 2003, ANTIMICROB AGENTS CH, V47, P317, DOI 10.1128/AAC.47.1.317-323.2003; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Williams D H, 2004, Minerva Urol Nefrol, V56, P15; Wink M, 2008, MODERN ALKALOIDS STR, P3, DOI [10.1002/9783527621071.ch1, DOI 10.1002/9783527621071.CHL]; WOLFE AJ, 1989, P NATL ACAD SCI USA, V86, P6973, DOI 10.1073/pnas.86.18.6973	51	31	31	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112093	10.1371/journal.pone.0112093	http://dx.doi.org/10.1371/journal.pone.0112093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391152	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400052
J	Heier, CR; Guerron, AD; Korotcov, A; Lin, S; Gordish-Dressman, H; Fricke, S; Sze, RW; Hoffman, EP; Wang, P; Nagaraju, K				Heier, Christopher R.; Guerron, Alfredo D.; Korotcov, Alexandru; Lin, Stephen; Gordish-Dressman, Heather; Fricke, Stanley; Sze, Raymond W.; Hoffman, Eric P.; Wang, Paul; Nagaraju, Kanneboyina			Non-Invasive MRI and Spectroscopy of mdx Mice Reveal Temporal Changes in Dystrophic Muscle Imaging and in Energy Deficits	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; MAGNETIC-RESONANCE; CLINICAL-ASSESSMENTS; MURINE MODEL; MOUSE MODEL; DISEASE; PATHOLOGY; INVOLVEMENT; MYOPATHY	In Duchenne muscular dystrophy (DMD), a genetic disruption of dystrophin protein expression results in repeated muscle injury and chronic inflammation. Magnetic resonance imaging shows promise as a surrogate outcome measure in both DMD and rehabilitation medicine that is capable of predicting clinical benefit years in advance of functional outcome measures. The mdx mouse reproduces the dystrophin deficiency that causes DMD and is routinely used for preclinical drug testing. There is a need to develop sensitive, non-invasive outcome measures in the mdx model that can be readily translatable to human clinical trials. Here we report the use of magnetic resonance imaging and spectroscopy techniques for the non-invasive monitoring of muscle damage in mdx mice. Using these techniques, we studied dystrophic mdx muscle in mice from 6 to 12 weeks of age, examining both the peak disease phase and natural recovery phase of the mdx disease course. T2 and fat-suppressed imaging revealed significant levels of tissue with elevated signal intensity in mdx hindlimb muscles at all ages; spectroscopy revealed a significant deficiency of energy metabolites in 6-week-old mdx mice. As the mdx mice progressed from the peak disease stage to the recovery stage of disease, each of these phenotypes was either eliminated or reduced, and the cross-sectional area of the mdx muscle was significantly increased when compared to that of wild-type mice. Histology indicates that hyper-intense MRI foci correspond to areas of dystrophic lesions containing inflammation as well as regenerating, degenerating and hypertrophied myofibers. Statistical sample size calculations provide several robust measures with the ability to detect intervention effects using small numbers of animals. These data establish a framework for further imaging or preclinical studies, and they support the development of MRI as a sensitive, non-invasive outcome measure for muscular dystrophy.	[Heier, Christopher R.; Guerron, Alfredo D.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Korotcov, Alexandru; Lin, Stephen; Wang, Paul] Howard Univ, Coll Med, Dept Radiol, Washington, DC USA; [Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA; [Fricke, Stanley] Childrens Natl Med Ctr, Dept Diagnost Imaging & Radiol, Washington, DC 20010 USA; [Sze, Raymond W.] Childrens Natl Med Ctr, Dept Radiol, Washington, DC 20010 USA; [Wang, Paul] Fu Jen Catholic Univ, Dept Elect Engn, Taipei, Taiwan	Children's National Health System; Howard University; George Washington University; Children's National Health System; Children's National Health System; Fu Jen Catholic University	Nagaraju, K (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	KNagaraju@childrensnational.org	Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021; Cruz, Alfredo Daniel Guerron/V-5188-2019	Cruz, Alfredo Daniel Guerron/0000-0002-4632-1681; Heier, Christopher/0000-0001-7914-2068; Hoffman, Eric/0000-0001-6470-5139	National Institutes of Health's [5T32AR056993, 5R24HD050846-02, G12MD007597, K26OD011171, P50AR060836]; United States Army Medical Research and Materiel Command [W81XWH 10-1-0767]; Muscular Dystrophy Association [30000783/4736]; United States Department of Defense [W81XWH-05-1-0659, W81XWH-11-1-0782, W81XWH-11-1-0330]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR060836, T32AR056993] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007597] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	National Institutes of Health's(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Muscular Dystrophy Association(Muscular Dystrophy Association); United States Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CRH is supported by the National Institutes of Health's (http://www.nih.gov/) 5T32AR056993 and 5R24HD050846-02 grants. PW and this work were supported in part by the National Institutes of Health's G12MD007597 and United States Army Medical Research and Materiel Command (http://mrmc.amedd.army.mil/) W81XWH 10-1-0767 grants. KN is supported by National Institutes of Health's K26OD011171 and P50AR060836 grants, a Muscular Dystrophy Association (http://mda.org/) translational grant 30000783/4736, and the United States Department of Defense (http://www.defense.gov/) grants W81XWH-05-1-0659, W81XWH-11-1-0782, W81XWH-11-1-0330, and W81XWH-11-1-0782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Amthor H, 2004, NEUROMUSCULAR DISORD, V14, P791, DOI 10.1016/j.nmd.2004.08.004; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Arpan I, 2013, NMR BIOMED, V26, P320, DOI 10.1002/nbm.2851; Bach JR, 2007, AM J PHYS MED REHAB, V86, P349, DOI 10.1097/PHM.0b013e31804b1d66; Banerjee B, 2010, MAGN RESON IMAGING, V28, P698, DOI 10.1016/j.mri.2010.03.008; Cahill KS, 2004, TRANSPLANTATION, V78, P1626, DOI 10.1097/01.TP.0000145528.51525.8B; Chamberlain JS, 2007, FASEB J, V21, P2195, DOI 10.1096/fj.06-7353com; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P299, DOI 10.1111/j.1365-2990.1988.tb00890.x; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Dellorusso C, 2001, J MUSCLE RES CELL M, V22, P467, DOI 10.1023/A:1014587918367; Dunn JF, 1999, MUSCLE NERVE, V22, P1367, DOI 10.1002/(SICI)1097-4598(199910)22:10<1367::AID-MUS5>3.3.CO;2-8; Forbes SC, 2013, RADIOLOGY, V269, P198, DOI 10.1148/radiol.13121948; Heier CR, 2013, EMBO MOL MED, V5, P1569, DOI 10.1002/emmm.201302621; Hoffman EP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008873; HUANG YM, 1994, JMRI-J MAGN RESON IM, V4, P59, DOI 10.1002/jmri.1880040113; Huynh T, 2013, J PATHOL, V231, P223, DOI 10.1002/path.4231; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Kim HK, 2013, PEDIATR RADIOL, V43, P1327, DOI 10.1007/s00247-013-2696-z; Kim HK, 2010, RADIOLOGY, V255, P899, DOI 10.1148/radiol.10091547; Kinali M, 2011, NEUROLOGY, V76, P346, DOI 10.1212/WNL.0b013e318208811f; Kumar A, 2010, AM J PATHOL, V177, P248, DOI 10.2353/ajpath.2010.091176; KUSHMERICK MJ, 1987, BASIC RES CARDIOL, V82, P17; KUSHMERICK MJ, 1985, J EXP BIOL, V115, P165; Kushmerick MJ, 1995, J BIOENERG BIOMEMBR, V27, P555, DOI 10.1007/BF02111654; LAMMINEN AE, 1990, BRIT J RADIOL, V63, P946, DOI 10.1259/0007-1285-63-756-946; Lu QL, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.6; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Martins-Bach AB, 2012, MAGN RESON IMAGING, V30, P1167, DOI 10.1016/j.mri.2012.04.003; Mathur S, 2011, MUSCLE NERVE, V43, P878, DOI 10.1002/mus.21986; McIntosh LM, 1998, BIOCHEM CELL BIOL, V76, P532; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; MUNTONI F, 1993, J NEUROL SCI, V120, P71, DOI 10.1016/0022-510X(93)90027-V; NEWMAN RJ, 1982, BRIT MED J, V284, P1072, DOI 10.1136/bmj.284.6322.1072; Odintsov B, 2011, MAGN RESON MED, V66, P1704, DOI 10.1002/mrm.22942; Pacak CA, 2007, MOL THER, V15, P1775, DOI 10.1038/sj.mt.6300246; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Phoenix J, 1996, MUSCLE NERVE, V19, P302, DOI 10.1002/(SICI)1097-4598(199603)19:3<302::AID-MUS4>3.0.CO;2-H; Pratt Stephen J P, 2013, BMC Res Notes, V6, P262, DOI 10.1186/1756-0500-6-262; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Roos M, 2009, J CARDIOVASC ELECTR, V20, P342, DOI 10.1111/j.1540-8167.2008.01327.x; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sharma U, 2007, MAGN RESON IMAGING, V25, P244, DOI 10.1016/j.mri.2006.09.016; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Straub V, 2000, MAGNET RESON MED, V44, P655, DOI 10.1002/1522-2594(200010)44:4<655::AID-MRM22>3.0.CO;2-T; Stuckey DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028569; TANABE Y, 1986, ACTA NEUROPATHOL, V69, P91, DOI 10.1007/BF00687043; TAYLOR DJ, 1994, J NEUROL SCI, V127, P198, DOI 10.1016/0022-510X(94)90073-6; Walter G, 2005, MAGN RESON MED, V54, P1369, DOI 10.1002/mrm.20721; Walter GA, 2004, MAGN RESON MED, V51, P273, DOI 10.1002/mrm.10684; Willcocks RJ, 2014, NEUROMUSCULAR DISORD, V24, P393, DOI 10.1016/j.nmd.2013.12.012; Xu S, 2012, J APPL PHYSIOL, V113, P808, DOI 10.1152/japplphysiol.00530.2012; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627; Zhang W, 2008, J MOL CELL CARDIOL, V45, P754, DOI 10.1016/j.yjmcc.2008.09.125	58	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112477	10.1371/journal.pone.0112477	http://dx.doi.org/10.1371/journal.pone.0112477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390038	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400084
J	Wilson, EA; Sullivan, PJ; Dickinson, JL				Wilson, Ethan A.; Sullivan, Patrick J.; Dickinson, Janis L.			Spatial Distribution of Oak Mistletoe as It Relates to Habits of Oak Woodland Frugivores	PLOS ONE			English	Article							PHORADENDRON-VILLOSUM; FORAGING BEHAVIOR; DISPERSAL; EVOLUTION; PATTERNS; RESOURCE; HOST	This study addresses the underlying spatial distribution of oak mistletoe, Phoradendron villosum, a hemi-parasitic plant that provides a continuous supply of berries for frugivorous birds overwintering the oak savanna habitat of California's outer coast range. As the winter community of birds consuming oak mistletoe varies from group-living territorial species to birds that roam in flocks, we asked if mistletoe volume was spatially autocorrelated at the scale of persistent territories or whether the patterns predicted by long-term territory use by western bluebirds are overcome by seed dispersal by more mobile bird species. The abundance of mistletoe was mapped on trees within a 700 ha study site in Carmel Valley, California. Spatial autocorrelation of mistletoe volume was analyzed using the variogram method and spatial distribution of oak mistletoe trees was analyzed using Ripley's K and O-ring statistics. On a separate set of 45 trees, mistletoe volume was highly correlated with the volume of female, fruit-bearing plants, indicating that overall mistletoe volume is a good predictor of fruit availability. Variogram analysis showed that mistletoe volume was spatially autocorrelated up to approximately 250 m, a distance consistent with persistent territoriality of western bluebirds and philopatry of sons, which often breed next door to their parents and are more likely to remain home when their parents have abundant mistletoe. Using Ripley's K and O-ring analyses, we showed that mistletoe trees were aggregated for distances up to 558 m, but for distances between 558 to 724 m the O-ring analysis deviated from Ripley's K in showing repulsion rather than aggregation. While trees with mistletoe were aggregated at larger distances, mistletoe was spatially correlated at a smaller distance, consistent with what is expected based on persistent group territoriality of western bluebirds in winter and the extreme philopatry of their sons.	[Wilson, Ethan A.; Sullivan, Patrick J.; Dickinson, Janis L.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14850 USA; [Dickinson, Janis L.] Cornell Lab Ornithol, Ithaca, NY 14850 USA	Cornell University; Cornell University	Wilson, EA (corresponding author), Cornell Univ, Dept Nat Resources, Ithaca, NY 14850 USA.	ethanw31@uw.edu			National Science Foundation-IOS [0097027, 0718416]; NSF REU [0718416]	National Science Foundation-IOS(National Science Foundation (NSF)); NSF REU(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by grants from National Science Foundation-IOS (0097027 and 0718416 to J.L.D.). Ethan Wilson was supported on a NSF REU Supplement to NSF grant 0718416. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukema JE, 2004, ECOGRAPHY, V27, P137, DOI 10.1111/j.0906-7590.2004.03640.x; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bivand RS, 2008, USE R, P191; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; CHAVEZRAMIREZ F, 1994, OIKOS, V71, P40, DOI 10.2307/3546170; Dickinson JL, 2005, P ROY SOC B-BIOL SCI, V272, P2423, DOI 10.1098/rspb.2005.3269; Dickinson JL, 2014, BEHAV ECOLOGY, DOI 10.1093/beheco/aru042; eBird, 2012, EBRID ONL DAT BIRD D; EMLEN ST, 1982, AM NAT, V119, P29, DOI 10.1086/283888; EMLEN ST, 1982, AM NAT, V119, P40, DOI 10.1086/283889; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; ESRI, 2011, ARCGIS DESKT REL 10; Hirth DH, 1969, J FIELD ORNITHOL, V40, P208; HOLLINGER DY, 1983, OECOLOGIA, V60, P396, DOI 10.1007/BF00376858; Jolles AE, 2002, ECOLOGY, V83, P2373, DOI 10.1890/0012-9658(2002)083[2373:DTOAIS]2.0.CO;2; Keppie D.M., 2000, BIRDS N AM, DOI [10.2173/bna.530., DOI 10.2173/BNA.530]; Kraaijeveld K, 2001, ANIM BEHAV, V61, P109, DOI 10.1006/anbe.2000.1591; Kraft CE, 2002, ECOL APPL, V12, P749; Laland KN, 1996, J EVOLUTION BIOL, V9, P293, DOI 10.1046/j.1420-9101.1996.9030293.x; Lewontin R.C., 1982, LEARNING DEV CULTURE, P151; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Putnam L. S., 1949, Wilson Bulletin Baltimore, V61, P141; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SALLABANKS R, 1993, J FIELD ORNITHOL, V64, P42; THOMSON VE, 1983, BOT GAZ, V144, P124, DOI 10.1086/337353; Vanderhoff N, 2016, BIRDS N AM, DOI [10.2173/bna.462, DOI 10.2173/BNA.462]; Watson DM, 2013, OECOLOGIA, V172, P925, DOI 10.1007/s00442-013-2693-9; Watson DM, 2001, ANNU REV ECOL SYST, V32, P219, DOI 10.1146/annurev.ecolsys.32.081501.114024; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Witmer M. C, 2014, BIRDS N AM ONLINE DA, DOI [10.2173/bna.309, DOI 10.2173/BNA.309]	30	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111947	10.1371/journal.pone.0111947	http://dx.doi.org/10.1371/journal.pone.0111947			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389971	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400042
J	Gannavarpu, R; Bhaduri, B; Tangella, K; Popescu, G				Gannavarpu, Rajshekhar; Bhaduri, Basanta; Tangella, Krishnarao; Popescu, Gabriel			Spatiotemporal Characterization of a Fibrin Clot Using Quantitative Phase Imaging	PLOS ONE			English	Article							CONFOCAL MICROSCOPY; GEL STRUCTURE; NETWORKS; GROWTH; CELL; GENERATION; SCATTERING; THROMBIN; RHEOLOGY; SYSTEM	Studying the dynamics of fibrin clot formation and its morphology is an important problem in biology and has significant impact for several scientific and clinical applications. We present a label-free technique based on quantitative phase imaging to address this problem. Using quantitative phase information, we characterized fibrin polymerization in real-time and present a mathematical model describing the transition from liquid to gel state. By exploiting the inherent optical sectioning capability of our instrument, we measured the three-dimensional structure of the fibrin clot. From this data, we evaluated the fractal nature of the fibrin network and extracted the fractal dimension. Our non-invasive and speckle-free approach analyzes the clotting process without the need for external contrast agents.	[Gannavarpu, Rajshekhar; Bhaduri, Basanta; Popescu, Gabriel] Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61820 USA; [Tangella, Krishnarao] Christie Clin, Dept Pathol, Urbana, IL USA; [Tangella, Krishnarao] Univ Illinois, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Popescu, G (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Dept Elect & Comp Engn, Quantitat Light Imaging Lab, Urbana, IL 61820 USA.	gpopescu@illinois.edu	Gannavarpu, Rajshekhar/GSE-6148-2022	Gannavarpu, Rajshekhar/0000-0002-4277-590X; Bhaduri, Basanta/0000-0001-9737-0996	National Science Foundation [CBET-1040462 MRI]; Swiss National Science Foundation [146495]	National Science Foundation(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	National Science Foundation (grant CBET-1040462 MRI) (http://www.nsf.gov) and Swiss National Science Foundation (grant 146495) (http://www.snf.ch/en/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SM, 2012, CELL MOL BIOENG, V5, P488, DOI 10.1007/s12195-012-0249-4; Baker-Groberg SM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.016014; Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110; BAUMANN P, 1989, HAEMOSTASIS, V19, P309; Bhaduri B., 2013, PLOS ONE, V8; Blinc A, 2000, FIBRINOLYSIS PROTEOL, V14, P288, DOI 10.1054/fipr.2000.0085; BLOMBACK B, 1982, THROMB RES, V25, P51, DOI 10.1016/0049-3848(82)90214-6; Chernysh IN, 2008, BLOOD, V111, P4854, DOI 10.1182/blood-2007-08-105247; Chernysh IN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00879; Colace TV, 2013, ANNU REV BIOMED ENG, V15, P283, DOI 10.1146/annurev-bioeng-071812-152406; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Doolittle RF, 2003, BLOOD REV, V17, P33, DOI 10.1016/S0268-960X(02)00060-7; Evans PA, 2010, BLOOD, V116, P3341, DOI 10.1182/blood-2010-02-269324; Ferri F, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.011913; Ferri F, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031401; Hategan A, 2013, BLOOD, V121, P1455, DOI 10.1182/blood-2012-08-451518; Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327; Jorneskog G, 1996, DIABETOLOGIA, V39, P1519, DOI 10.1007/s001250050607; Kim T, 2014, NAT PHOTONICS, V8, P256, DOI [10.1038/NPHOTON.2013.350, 10.1038/nphoton.2013.350]; Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x; Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317; Magatti D, 2013, BIOPHYS J, V104, P1151, DOI 10.1016/j.bpj.2013.01.024; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211; Mills JD, 2002, CIRCULATION, V106, P1938, DOI 10.1161/01.CIR.0000033221.73082.06; Mir M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04434; Mir M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089000; Mir M, 2011, BIOMED OPT EXPRESS, V2, P3259, DOI 10.1364/BOE.2.003259; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x; Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110; Neeves KB, 2014, J THROMB HAEMOST, V12, P418, DOI 10.1111/jth.12482; Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030; Persson BNJ, 2005, J PHYS-CONDENS MAT, V17, pR1, DOI 10.1088/0953-8984/17/1/R01; Popescu G., 2011, QUANTITATIVE PHASE I; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025; Tripathi MM, 2014, BIOMED OPT EXPRESS, V5, P817, DOI 10.1364/BOE.5.000817; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Undas A, 2009, BLOOD, V114, P4272, DOI 10.1182/blood-2009-05-222380; Undas A, 2009, STROKE, V40, P1499, DOI 10.1161/STROKEAHA.108.532812; VanCott E. M., 2001, LAB TEST HDB, P327; Vikinge TP, 2000, J BIOMED OPT, V5, P51, DOI 10.1117/1.429968; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Weigandt KM, 2011, SOFT MATTER, V7, P9992, DOI 10.1039/c1sm06176c; Weigandt KM, 2009, SOFT MATTER, V5, P4321, DOI 10.1039/b906256d; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Woodruff RS, 2011, J THROMB THROMBOLYS, V32, P9, DOI 10.1007/s11239-011-0578-5; Yeromonahos C, 2010, BIOPHYS J, V99, P2018, DOI 10.1016/j.bpj.2010.04.059	50	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111381	10.1371/journal.pone.0111381	http://dx.doi.org/10.1371/journal.pone.0111381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386701	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400017
J	Kurai, J; Watanabe, M; Tomita, K; Yamasaki, HSA; Shimizu, E				Kurai, Jun; Watanabe, Masanari; Tomita, Katsuyuki; Yamasaki, Hiroyuki Sano Akira; Shimizu, Eiji			Influence of Asian Dust Particles on Immune Adjuvant Effects and Airway Inflammation in Asthma Model Mice	PLOS ONE			English	Article							SAND DUST; AMORPHOUS SILICA; DESERT DUST; HOSPITALIZATION; SYMPTOMS; EXPOSURE	Objective: An Asian dust storm (ADS) contains airborne particles that affect conditions such as asthma, but the mechanism of exacerbation is unclear. The objective of this study was to compare immune adjuvant effects and airway inflammation induced by airborne particles collected on ADS days and the original ADS soil (CJ-1 soil) in asthma model mice. Methods: Airborne particles were collected on ADS days in western Japan. NC/Nga mice were co-sensitized by intranasal instillation with ADS airborne particles and/or Dermatophagoides farinae (Df), and with CJ-1 soil and/or Df for 5 consecutive days. Df-sensitized mice were stimulated with Df challenge intranasally at 7 days after the last Df sensitization. At 24 hours after challenge, serum allergen specific antibody, differential leukocyte count and inflammatory cytokines in bronchoalveolar lavage fluid (BALF) were measured, and airway inflammation was examined histopathologically. Results: Co-sensitization with ADS airborne particles and Df increased the neutrophil and eosinophil counts in BALF. Augmentation of airway inflammation was also observed in peribronchiolar and perivascular lung areas. Df-specific serum IgE was significantly elevated by ADS airborne particles, but not by CJ-1 soil. Levels of interleukin (IL)-5, IL-13, IL-6, and macrophage inflammatory protein-2 were higher in BALF in mice treated with ADS airborne particles. Conclusion: These results suggest that substances attached to ADS airborne particles that are not in the original ADS soil may play important roles in immune adjuvant effects and airway inflammation.	[Kurai, Jun; Watanabe, Masanari; Shimizu, Eiji] Tottori Univ, Fac Med, Dept Resp Med & Rheumatol, Yonago, Tottori 683, Japan; [Tomita, Katsuyuki] Yonago Med Ctr, Dept Resp Med, Yonago, Tottori, Japan; [Yamasaki, Hiroyuki Sano Akira] Kinki Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama, Osaka, Japan	Tottori University; Kindai University (Kinki University)	Kurai, J (corresponding author), Tottori Univ, Fac Med, Dept Resp Med & Rheumatol, Yonago, Tottori 683, Japan.	kurajun@med.tottori-u.ac.jp			Environment Research and Technology Development Fund of the Japanese Ministry of the Environment [5C-1154]	Environment Research and Technology Development Fund of the Japanese Ministry of the Environment	This research was supported by the Environment Research and Technology Development Fund (5C-1154) of the Japanese Ministry of the Environment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis N, 2001, J ALLERGY CLIN IMMUN, V107, P31, DOI 10.1067/mai.2001.111594; Alexis NE, 2006, J ALLERGY CLIN IMMUN, V117, P1185, DOI 10.1016/j.jaci.2005.12.1305; Bellido-Casado J, 2010, ARCH BRONCONEUMOL, V46, P587, DOI 10.1016/j.arbres.2010.07.002; Chen PS, 2010, ENVIRON HEALTH PERSP, V118, P1211, DOI 10.1289/ehp.0901782; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; DUCE RA, 1980, SCIENCE, V209, P1522, DOI 10.1126/science.209.4464.1522; Fukuyama T, 2011, TOXICOLOGY, V289, P132, DOI 10.1016/j.tox.2011.08.003; He M, 2013, TOXICOL APPL PHARM, V272, P647, DOI 10.1016/j.taap.2013.07.010; He M, 2010, INHAL TOXICOL, V22, P1012, DOI 10.3109/08958378.2010.510151; Honda A, 2013, J APPL TOXICOL; Ichinose T, 2008, ARCH ENVIRON CON TOX, V55, P348, DOI 10.1007/s00244-007-9128-8; Ichinose T, 2008, INHAL TOXICOL, V20, P685, DOI [10.1080/08958370801935133, 10.1080/08958370801935133 ]; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Maki T, 2010, SCI TOTAL ENVIRON, V408, P4556, DOI 10.1016/j.scitotenv.2010.04.002; MANCINO D, 1980, INT ARCH ALLER A IMM, V61, P253, DOI 10.1159/000232443; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Shannon J, 2008, CHEST, V133, P420, DOI 10.1378/chest.07-1881; Shibamori M, 2006, LIFE SCI, V78, P987, DOI 10.1016/j.lfs.2005.06.020; Taylor DA, 2002, ENVIRON HEALTH PERSP, V110, pA80, DOI 10.1289/ehp.110-a80; Ueda Kayo, 2010, Environmental Health and Preventive Medicine, V15, P350, DOI 10.1007/s12199-010-0150-5; WARE JH, 1981, ENVIRON HEALTH PERSP, V41, P255, DOI 10.2307/3429322; Watanabe M, 2014, J ASTHMA; Watanabe Masanari, 2011, Allergology International, V60, P517, DOI 10.2332/allergolint.10-OA-0298; Watanabe Masanari, 2011, Allergology International, V60, P267, DOI 10.2332/allergolint.10-OA-0239; Wittkopp S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064444; Wood LG, 2012, CHEST, V142, P86, DOI 10.1378/chest.11-1838; Yoo Y, 2008, J KOREAN MED SCI, V23, P66, DOI 10.3346/jkms.2008.23.1.66	27	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111831	10.1371/journal.pone.0111831	http://dx.doi.org/10.1371/journal.pone.0111831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386753	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400025
J	Vingtdeux, V; Tanis, JE; Chandakkar, P; Zhao, HT; Dreses-Werringloer, U; Campagne, F; Foskett, JK; Marambaud, P				Vingtdeux, Valerie; Tanis, Jessica E.; Chandakkar, Pallavi; Zhao, Haitian; Dreses-Werringloer, Ute; Campagne, Fabien; Foskett, J. Kevin; Marambaud, Philippe			Effect of the CALHM1 G330D and R154H Human Variants on the Control of Cytosolic Ca2+ and A beta Levels	PLOS ONE			English	Article							MODULATOR 1 CALHM1; ALZHEIMERS-DISEASE; ION-CHANNEL; POLYMORPHISM; HOMEOSTASIS; EXPRESSION; CSF; IDENTIFICATION; TISSUEINFO; BACE1	CALHM1 is a plasma membrane voltage-gated Ca2+-permeable ion channel that controls amyloid-beta (A beta) metabolism and is potentially involved in the onset of Alzheimer's disease (AD). Recently, Rubio-Moscardo et al. (PLoS One (2013) 8: e74203) reported the identification of two CALHM1 variants, G330D and R154H, in early-onset AD (EOAD) patients. The authors provided evidence that these two human variants were rare and resulted in a complete loss of CALHM1 function. Recent publicly available large-scale exome sequencing data confirmed that R154H is a rare CALHM1 variant (minor allele frequency (MAF) = 0.015%), but that G330D is not (MAF = 3.5% in an African American cohort). Here, we show that both CALHM1 variants exhibited gating and permeation properties indistinguishable from wild-type CALHM1 when expressed in Xenopus oocytes. While there was also no effect of the G330D mutation on Ca2+ uptake by CALHM1 in transfected mammalian cells, the R154H mutation was associated with defects in the control by CALHM1 of both Ca2+ uptake and A beta levels in this cell system. Together, our data show that the frequent CALHM1 G330D variant has no obvious functional consequences and is therefore unlikely to contribute to EOAD. Our data also demonstrate that the rare R154H variant interferes with CALHM1 control of cytosolic Ca2+ and A beta accumulation. While these results strengthen the notion that CALHM1 influences Ab metabolism, further investigation will be required to determine whether CALHM1 R154H, or other natural variants in CALHM1, is/are associated with EOAD.	[Vingtdeux, Valerie; Chandakkar, Pallavi; Zhao, Haitian; Dreses-Werringloer, Ute; Marambaud, Philippe] Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY 11030 USA; [Tanis, Jessica E.; Foskett, J. Kevin] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Campagne, Fabien] Weill Cornell Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY USA; [Foskett, J. Kevin] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Northwell Health; University of Pennsylvania; Pennsylvania Medicine; Cornell University; University of Pennsylvania; Pennsylvania Medicine	Marambaud, P (corresponding author), Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY 11030 USA.	PMaramba@nshs.edu	Vingtdeux, Valerie/C-2463-2012	Vingtdeux, Valerie/0000-0003-4550-503X; Campagne, Fabien/0000-0001-6237-3564; Foskett, J. Kevin/0000-0002-8854-0268	National Institutes of Health [R01AG042508, R01DC012538]; American Heart Association postdoctoral fellowship [12POST11940054]; NATIONAL INSTITUTE ON AGING [R01AG042508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health grants R01AG042508 (to P.M.) and R01DC012538 (to J.K.F.), and an American Heart Association postdoctoral fellowship 12POST11940054 (to J.E.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2008, NUCLEIC ACIDS RES, V36, P3728, DOI 10.1093/nar/gkn233; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chapuis J, 2011, HUM MOL GENET, V20, P2026, DOI 10.1093/hmg/ddr085; Cho HJ, 2008, AGING CELL, V7, P137, DOI 10.1111/j.1474-9726.2007.00360.x; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Dreses-Werringloer U, 2013, J CELL SCI, V126, P1199, DOI 10.1242/jcs.117135; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Ertekin-Taner N, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt26; Gallego-Sandin S, 2011, BIOCHEM J, V437, P469, DOI 10.1042/BJ20110479; Giedraitis V, 2010, NEUROSCI LETT, V469, P265, DOI 10.1016/j.neulet.2009.12.011; Goate A, 2012, J NEUROCHEM, V120, P3, DOI 10.1111/j.1471-4159.2011.07575.x; Kauwe JSK, 2010, J ALZHEIMERS DIS, V21, P833, DOI 10.3233/JAD-2010-091711; Koppel J, 2011, MOL MED, V17, P974, DOI 10.2119/molmed.2011.00154; Lambert JC, 2007, PSYCHONEUROENDOCRINO, V32, pS62, DOI 10.1016/j.psyneuen.2007.05.015; Lambert JC, 2010, J ALZHEIMERS DIS, V22, P247, DOI 10.3233/JAD-2010-100933; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Moreno-Ortega AJ, 2010, BIOCHEM BIOPH RES CO, V391, P722, DOI 10.1016/j.bbrc.2009.11.127; Rubio-Moscardo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074203; Selkoe D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011460; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Skrabanek L, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.21.e102; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Tanis JE, 2013, J NEUROSCI, V33, P12275, DOI 10.1523/JNEUROSCI.5919-12.2013; Vingtdeux V, 2012, J NEUROCHEM, V120, P34, DOI 10.1111/j.1471-4159.2011.07477.x; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wen Y, 2008, NEURON, V57, P680, DOI 10.1016/j.neuron.2008.02.024	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112484	10.1371/journal.pone.0112484	http://dx.doi.org/10.1371/journal.pone.0112484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386646	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400065
J	Sato, K; Takaishi, M; Tokuoka, S; Sano, S				Sato, Kenji; Takaishi, Mikiro; Tokuoka, Shota; Sano, Shigetoshi			Involvement of TNF-alpha Converting Enzyme in the Development of Psoriasis-Like Lesions in a Mouse Model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; STAT3 ACTIVATION; SKIN; INHIBITION; KERATINOCYTES; INFLAMMATION; EXPRESSION; THERAPY; METALLOPROTEINASE	TNF-alpha plays a crucial role in psoriasis; therefore, TNF inhibition has become a gold standard for the treatment of psoriasis. TNF-alpha is processed from a membrane-bound form by TNF-alpha converting enzyme (TACE) to soluble form, which exerts a number of biological activities. EGF receptor (EGFR) ligands, including heparin-binding EGF-like growth factor (HB-EGF), amphiregulin and transforming growth factor (TGF)-alpha are also TACE substrates and are psoriasis-associated growth factors. Vascular endothelial growth factor (VEGF), one of the downstream molecules of EGFR and TNF signaling, plays a key role in angiogenesis for developing psoriasis. In the present study, to assess the possible role of TACE in the pathogenesis of psoriasis, we investigated the involvement of TACE in TPA-induced psoriasis-like lesions in K5.Stat3C mice, which represent a mouse model of psoriasis. In this mouse model, TNF-alpha, amphiregulin, HB-EGF and TGF-alpha were significantly up-regulated in the skin lesions, similar to human psoriasis. Treatment of K5.Stat3C mice with TNF-alpha or EGFR inhibitors attenuated the skin lesions, suggesting the roles of TACE substrates in psoriasis. Furthermore, the skin lesions of K5.Stat3C mice showed down-regulation of tissue inhibitor of metalloproteinase-3, an endogenous inhibitor of TACE, and an increase in soluble TNF-alpha. A TACE inhibitor abrogated EGFR ligand-dependent keratinocyte proliferation and VEGF production in vitro, suggesting that TACE was involved in both epidermal hyperplasia and angiogenesis during psoriasis development. These results strongly suggest that TACE contributes to the development of psoriatic lesions through releasing two kinds of psoriasis mediators, TNF-alpha and EGFR ligands. Therefore, TACE could be a potential therapeutic target for the treatment of psoriasis.	[Sato, Kenji; Takaishi, Mikiro; Sano, Shigetoshi] Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi, Japan; [Sato, Kenji; Tokuoka, Shota] Kaken Pharmaceut Co Ltd, Dept Pharmacol, Drug Res Ctr, Kyoto, Japan	Kochi University; Kaken Pharmaceutical Co Ltd	Sano, S (corresponding author), Kochi Univ, Kochi Med Sch, Dept Dermatol, Nankoku, Kochi, Japan.	sano.derma@kochi-u.ac.jp			Kaken Pharmaceuticals Co. Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour, and Welfare of Japan	Kaken Pharmaceuticals Co. Ltd.; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was funded in part by Kaken Pharmaceuticals Co. Ltd. KS, ST, SS received the funding. This study was additionally funded by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by a grant for Research on Intractable Diseases from the Ministry of Health, Labour, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman A, 2009, CLIN EXP DERMATOL, V34, pE202, DOI 10.1111/j.1365-2230.2008.02991.x; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blaydon DC, 2011, NEW ENGL J MED, V365, P1502, DOI 10.1056/NEJMoa1100721; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Cook PW, 1997, J CLIN INVEST, V100, P2286, DOI 10.1172/JCI119766; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Gais P, 2010, J IMMUNOL, V184, P5842, DOI 10.4049/jimmunol.0902456; Gaspari AA, 2006, J AM ACAD DERMATOL, V54, pS67, DOI 10.1016/j.jaad.2005.10.057; Gordon K, 2012, J AM ACAD DERMATOL, V66, P241, DOI 10.1016/j.jaad.2010.12.005; Gottlieb AB, 2005, J IMMUNOL, V175, P2721, DOI 10.4049/jimmunol.175.4.2721; Guinea-Viniegra J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008089; Guinea-Viniegra J, 2009, GENE DEV, V23, P2663, DOI 10.1101/gad.543109; Hirai T, 2013, J IMMUNOL, V190, P4805, DOI 10.4049/jimmunol.1200901; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Johnston A, 2011, J INVEST DERMATOL, V131, P329, DOI 10.1038/jid.2010.313; Kawaguchi M, 2005, BRIT J DERMATOL, V152, P915, DOI 10.1111/j.1365-2133.2005.06440.x; Kawaguchi M, 2004, CLIN EXP DERMATOL, V29, P185, DOI 10.1111/j.1365-2230.2004.01455.x; Kim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072981; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 2002, FEBS LETT, V520, P102, DOI 10.1016/S0014-5793(02)02776-X; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Maretzky T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1232; Menter A, 2007, J AM ACAD DERMATOL, V56, P31, DOI 10.1016/j.jaad.2006.07.017; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murakawa M, 2006, BIOCHEM PHARMACOL, V71, P1331, DOI 10.1016/j.bcp.2006.01.005; Nakai K, 2009, J DERMATOL SCI, V55, P170, DOI 10.1016/j.jdermsci.2009.06.002; Nakajima K, 2011, J IMMUNOL, V186, P4481, DOI 10.4049/jimmunol.1000148; Neyns B, 2008, CURR ONCOL, V15, P196; Oyama N, 2012, J AM ACAD DERMATOL, V66, pE251, DOI 10.1016/j.jaad.2011.08.009; Peus D, 1997, J INVEST DERMATOL, V109, P751, DOI 10.1111/1523-1747.ep12340759; Piepkorn M, 1998, J INVEST DERMATOL, V111, P715, DOI 10.1046/j.1523-1747.1998.00390.x; Sano S, 2005, CANCER RES, V65, P5720, DOI 10.1158/0008-5472.CAN-04-4359; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Sano S, 2008, J DERMATOL SCI, V50, P1, DOI 10.1016/j.jdermsci.2007.05.016; Stoll SW, 2010, J INVEST DERMATOL, V130, P2031, DOI 10.1038/jid.2010.98; Stoll SW, 2010, J INVEST DERMATOL, V130, P295, DOI 10.1038/jid.2009.211; Sugita S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3824; Terajima S, 1998, ARCH DERMATOL RES, V290, P246, DOI 10.1007/s004030050299; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; Weidemann AK, 2013, CLIN COSMET INV DERM, V6, P233, DOI 10.2147/CCID.S35312; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J ALLERGY CLIN IMMUN, V124, P1022, DOI 10.1016/j.jaci.2009.08.046; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004	52	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112408	10.1371/journal.pone.0112408	http://dx.doi.org/10.1371/journal.pone.0112408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384035	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700058
J	Carr, R; Du, Y; Quoyer, J; Panettieri, RA; Janz, JM; Bouvier, M; Kobilka, BK; Benovic, JL				Carr, Richard, III; Du, Yang; Quoyer, Julie; Panettieri, Reynold A., Jr.; Janz, Jay M.; Bouvier, Michel; Kobilka, Brian K.; Benovic, Jeffrey L.			Development and Characterization of Pepducins as G(s)-biased Allosteric Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-ADRENERGIC RECEPTOR; BETA-ARRESTIN; CRYSTAL-STRUCTURE; INTRACELLULAR LOOP; LIGAND BIAS; PROTEIN; ACTIVATION; PHOSPHORYLATION; DESENSITIZATION; INTERNALIZATION	The beta(2)-adrenergic receptor (beta(2)AR) is a prototypical G protein-coupled receptor that mediates many hormonal responses, including cardiovascular and pulmonary function. beta-Agonists used to combat hypercontractility in airway smooth muscle stimulate beta(2)AR-dependent cAMP production that ultimately promotes airway relaxation. Chronic stimulation of the beta(2)ARby long acting beta-agonists used in the treatment of asthma can promote attenuated responsiveness to agonists and an increased frequency of fatal asthmatic attacks. beta(2)AR desensitization to beta-agonists is primarily mediated by G protein-coupled receptor kinases and beta-arrestins that attenuate receptor-G(s) coupling and promote beta(2)AR internalization and degradation. A biased agonist that can selectively stimulate G(s) signaling without promoting receptor interaction with G protein-coupled receptor kinases and beta-arrestins should serve as an advantageous asthma therapeutic. To identify such molecules, we screened similar to 50 lipidated peptides derived from the intracellular loops of the beta(2)AR, known as pepducins. This screen revealed two classes of G(s)-biased pepducins, receptor-independent and receptor-dependent, as well as several beta-arrestin-biased pepducins. The receptor-independent G(s)-biased pepducins operate by directly stimulating G protein activation. In contrast, receptor-dependent G(s)-biased pepducins appear to stabilize a G(s)-biased conformation of the beta(2)AR that couples to G(s) but does not undergo G protein-coupled receptor kinase-mediated phosphorylation or beta-arrestin-mediated internalization. Functional studies in primary human airway smooth muscle cells demonstrate that G(s)-biased pepducins are not subject to conventional desensitization and thus may be good candidates for the development of next generation asthma therapeutics. Our study reports the first G(s)-biased activator of the beta(2)AR and provides valuable tools for the study of beta(2)AR function.	[Carr, Richard, III; Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Du, Yang; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Quoyer, Julie; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Quoyer, Julie; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Panettieri, Reynold A., Jr.] Univ Penn, Perelman Sch Med, Airways Biol Initiat, Dept Med,Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Janz, Jay M.] Anchor Therapeut, Cambridge, MA 02139 USA	Jefferson University; Stanford University; Universite de Montreal; Universite de Montreal; University of Pennsylvania; Pennsylvania Medicine	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St,926 BLSB, Philadelphia, PA 19107 USA.	jeffrey.benovic@jefferson.edu	panettieri, reynold/AAG-9485-2019; Bouvier, Michel/H-2758-2014	Bouvier, Michel/0000-0003-1128-0100; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [R37 GM047417, R01 GM044944, P01 HL114471, P30 ES013508, T32 GM100836]; Canadian Institute for Health Research Grant [CIHR-11215]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM100836, R01GM044944, R37GM047417, R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Health Research Grant(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 GM047417 and R01 GM044944 (to J. L. B.), P01 HL114471 (to J. L. B. and R. A. P.), P30 ES013508 (to R. A. P.), and T32 GM100836 (to R. C.). This work was also supported by Canadian Institute for Health Research Grant CIHR-11215 (to M. B.).	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2011, TRENDS PHARMACOL SCI, V32, P227, DOI 10.1016/j.tips.2011.02.010; Baltoumas FA, 2013, J STRUCT BIOL, V182, P209, DOI 10.1016/j.jsb.2013.03.004; BRIL A, 1992, CARDIOVASC RES, V26, P518, DOI 10.1093/cvr/26.5.518; Cazzola M, 2011, BRIT J PHARMACOL, V163, P4, DOI 10.1111/j.1476-5381.2011.01216.x; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHEUNG AH, 1991, FEBS LETT, V279, P277, DOI 10.1016/0014-5793(91)80167-2; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Deshpande DA, 2008, FASEB J, V22, P2134, DOI 10.1096/fj.07-102459; Deshpande DA, 2006, CELL SIGNAL, V18, P2105, DOI 10.1016/j.cellsig.2006.04.008; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Erickson CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071980; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hollingsworth JW, 2010, AM J RESP CELL MOL, V43, P269, DOI 10.1165/rcmb.2009-0198OC; January B, 1998, BRIT J PHARMACOL, V123, P701, DOI 10.1038/sj.bjp.0701658; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Kang DS, 2014, CURR OPIN CELL BIOL, V27, P63, DOI 10.1016/j.ceb.2013.11.005; Lee HY, 2010, FEBS LETT, V584, P4102, DOI 10.1016/j.febslet.2010.08.036; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Licht T, 2003, BLOOD, V102, P2099, DOI 10.1182/blood-2002-12-3634; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2014, MOL ENDOCRINOL, V28, P281, DOI 10.1210/me.2013-1314; McMahon AW, 2011, PEDIATRICS, V128, pE1147, DOI 10.1542/peds.2010-1720; Nelson HS, 2006, CHEST, V129, P15, DOI 10.1378/chest.129.1.15; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Penn RB, 1998, AM J RESP CELL MOL, V19, P338, DOI 10.1165/ajrcmb.19.2.3025; Poirier L, 2014, CAN J CARDIOL, V30, pS9, DOI 10.1016/j.cjca.2013.12.001; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Remsberg JR, 2007, J MED CHEM, V50, P4534, DOI 10.1021/jm0705657; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; RUFFOLO RR, 1993, CARDIOLOGY, V82, P24; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; SAMAMA P, 1994, MOL PHARMACOL, V45, P390; Schellenberg R, 2008, HEADACHE, V48, P118, DOI 10.1111/j.1526-4610.2007.00785.x; Staus DP, 2014, MOL PHARMACOL, V85, P472, DOI 10.1124/mol.113.089516; Tchernychev B, 2010, P NATL ACAD SCI USA, V107, P22255, DOI 10.1073/pnas.1009633108; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zocher M, 2012, STRUCTURE, V20, P1391, DOI 10.1016/j.str.2012.05.010	59	55	56	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35668	35684		10.1074/jbc.M114.618819	http://dx.doi.org/10.1074/jbc.M114.618819			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25395624	Green Published, hybrid			2022-12-26	WOS:000346897900001
J	Kawaguchi, Y; Sugawara, Y; Akamatsu, N; Kaneko, J; Hamada, T; Tanaka, T; Ishizawa, T; Tamura, S; Aoki, T; Sakamoto, Y; Hasegawa, K; Kokudo, N				Kawaguchi, Yoshikuni; Sugawara, Yasuhiko; Akamatsu, Nobuhisa; Kaneko, Junichi; Hamada, Tsuyoshi; Tanaka, Tomohiro; Ishizawa, Takeaki; Tamura, Sumihito; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro			Impact of Early Reoperation following Living-Donor Liver Transplantation on Graft Survival	PLOS ONE			English	Article							SINGLE-CENTER; RISK-FACTORS; COMPLICATIONS; MORTALITY; OUTCOMES; HEPATECTOMY; HEMORRHAGE; EXPERIENCE; THROMBOSIS; MORBIDITY	Background: The reoperation rate remains high after liver transplantation and the impact of reoperation on graft and recipient outcome is unclear. The aim of our study is to evaluate the impact of early reoperation following living-donor liver transplantation (LDLT) on graft and recipient survival. Methods: Recipients that underwent LDLT (n = 111) at the University of Tokyo Hospital between January 2007 and December 2012 were divided into two groups, a reoperation group (n = 27) and a non-reoperation group (n = 84), and case-control study was conducted. Results: Early reoperation was performed in 27 recipients (24.3%). Mean time [standard deviation] from LDLT to reoperation was 10 [9.4] days. Female sex, Child-Pugh class C, Non-HCV etiology, fulminant hepatitis, and the amount of intraoperative fresh frozen plasma administered were identified as possibly predictive variables, among which females and the amount of FFP were identified as independent risk factors for early reoperation by multivariable analysis. The 3-, and 6-month graft survival rates were 88.9% (95% confidential intervals [CI], 70.7-96.4), and 85.2% (95% CI, 66.5-94.3), respectively, in the reoperation group (n = 27), and 95.2% (95% CI, 88.0-98.2), and 92.9% (95% CI, 85.0-96.8), respectively, in the non-reoperation group (n = 84) (the log-rank test, p = 0.31). The 12- and 36-month overall survival rates were 96.3% (95% CI, 77.9-99.5), and 88.3% (95% CI, 69.3-96.2), respectively, in the reoperation group, and 89.3% (95% CI, 80.7-94.3) and 88.0% (95% CI, 79.2-93.4), respectively, in the non-reoperation group (the log-rank test, p = 0.59). Conclusions: Observed graft survival for the recipients who underwent reoperation was lower compared to those who did not undergo reoperation, though the result was not significantly different. Recipient overall survival with reoperation was comparable to that without reoperation. The present findings enhance the importance of vigilant surveillance for postoperative complication and surgical rescue at an early postoperative stage in the LDLT setting.	[Kawaguchi, Yoshikuni; Sugawara, Yasuhiko; Akamatsu, Nobuhisa; Kaneko, Junichi; Ishizawa, Takeaki; Tamura, Sumihito; Aoki, Taku; Sakamoto, Yoshihiro; Hasegawa, Kiyoshi; Kokudo, Norihiro] Univ Tokyo, Dept Surg, Artificial Organ & Transplantat Surg Div, Grad Sch Med, Tokyo, Japan; [Tanaka, Tomohiro] Univ Tokyo, Organ Transplantat Serv, Tokyo, Japan; [Hamada, Tsuyoshi] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Sugawara, Y (corresponding author), Univ Tokyo, Dept Surg, Artificial Organ & Transplantat Surg Div, Grad Sch Med, Tokyo, Japan.	yasusugatky@yahoo.co.jp	Kawaguchi, Yoshikuni/AAB-1718-2022	Kawaguchi, Yoshikuni/0000-0003-2986-3224	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan (AIDS Research)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan (AIDS Research)(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and from the Ministry of Health, Labor and Welfare of Japan (AIDS Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2003, LIVER TRANSPLANT, V9, P1231, DOI 10.1016/j.lts.2003.09.018; Anderson ML, 2012, CIRCULATION, V126, P2190, DOI 10.1161/CIRCULATIONAHA.112.111369; [Anonymous], 2010, JPN J TRANSPL, V46, P524; Arshad F, 2013, LIVER INT, V33, P820, DOI 10.1111/liv.12140; Barbas AS, 2013, J AM COLL SURGEONS, V216, P915, DOI 10.1016/j.jamcollsurg.2013.01.008; Duailibi DF, 2010, TRANSPL P, V42, P517, DOI 10.1016/j.transproceed.2010.01.017; Freise CE, 2008, AM J TRANSPLANT, V8, P2569, DOI 10.1111/j.1600-6143.2008.02440.x; Hendriks HGD, 2004, TRANSPL INT, V17, P673, DOI 10.1111/j.1432-2277.2004.tb00493.x; Imamura H, 2003, ARCH SURG-CHICAGO, V138, P1198, DOI 10.1001/archsurg.138.11.1198; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kappa SF, 2010, AM SURGEON, V76, P969; Khalaf H, 2010, TRANSPL P, V42, P865, DOI 10.1016/j.transproceed.2010.02.037; Kokudo N, 2005, AM J TRANSPLANT, V5, P1694, DOI 10.1111/j.1600-6143.2005.00917.x; Lisman T, 2010, J HEPATOL, V53, P362, DOI 10.1016/j.jhep.2010.01.042; Lisman T, 2009, TRANSPL INT, V22, P162, DOI 10.1111/j.1432-2277.2008.00762.x; Onaca NN, 2003, LIVER TRANSPLANT, V9, P117, DOI 10.1053/jlts.2003.50027; Peterson ED, 2001, AM J CARDIOL, V88, P359, DOI 10.1016/S0002-9149(01)01679-4; Pomposelli JJ, 2006, AM J TRANSPLANT, V6, P589, DOI 10.1111/j.1600-6143.2005.01220.x; Rahbari NN, 2011, HPB, V13, P528, DOI 10.1111/j.1477-2574.2011.00319.x; Sanada Y, 2013, J HEPATOBILIARY PANC; Schroeder RA, 2006, ANN SURG, V243, P373, DOI 10.1097/01.sla.0000201483.95911.08; Soong RS, 2012, TRANSPL P, V44, P784, DOI 10.1016/j.transproceed.2012.03.028; STARZL TE, 1981, NEW ENGL J MED, V305, P266, DOI 10.1056/NEJM198107303050507; Sugawara Y, 2004, LIVER TRANSPLANT, V10, P541, DOI 10.1002/lt.20129; Sugawara Y, 2002, CLIN TRANSPLANT, V16, P102, DOI 10.1034/j.1399-0012.2002.1o106.x; Sugawara Yasuhiko, 2003, J Hepatobiliary Pancreat Surg, V10, P1; Tripodi A, 2009, GASTROENTEROLOGY, V137, P2105, DOI 10.1053/j.gastro.2009.08.045; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Yoshiya S, 2012, TRANSPLANTATION, V94, P947, DOI 10.1097/TP.0b013e31826969e6	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e109731	10.1371/journal.pone.0109731	http://dx.doi.org/10.1371/journal.pone.0109731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396413	gold, Green Published, Green Submitted			2022-12-26	WOS:000345558500005
J	Azouaoui, H; Montigny, C; Ash, MR; Fijalkowski, F; Jacquot, A; Gronberg, C; Lopez-Marques, RL; Palmgren, MG; Garrigos, M; le Maire, M; Decottignies, P; Gourdon, P; Nissen, P; Champeil, P; Lenoir, G				Azouaoui, Hassina; Montigny, Cedric; Ash, Miriam-Rose; Fijalkowski, Frank; Jacquot, Aurore; Gronberg, Christina; Lopez-Marques, Rosa L.; Palmgren, Michael G.; Garrigos, Manuel; le Maire, Marc; Decottignies, Paulette; Gourdon, Pontus; Nissen, Poul; Champeil, Philippe; Lenoir, Guillaume			A High-Yield Co-Expression System for the Purification of an Intact Drs2p-Cdc50p Lipid Flippase Complex, Critically Dependent on and Stabilized by Phosphatidylinositol-4-Phosphate	PLOS ONE			English	Article							P-TYPE ATPASE; SARCOPLASMIC-RETICULUM CA2+-ATPASE; MEMBRANE-SURFACE CHARGE; PLASMA-MEMBRANE; PHOSPHOLIPID FLIPPASE; CRYSTAL-STRUCTURE; AMINOPHOSPHOLIPID TRANSLOCASE; SUBCELLULAR-LOCALIZATION; PROTEIN-TRANSPORT; CDC50 PROTEINS	P-type ATPases from the P4 subfamily (P4-ATPases) are energy-dependent transporters, which are thought to establish lipid asymmetry in eukaryotic cell membranes. Together with their Cdc50 accessory subunits, P4-ATPases couple ATP hydrolysis to lipid transport from the exoplasmic to the cytoplasmic leaflet of plasma membranes, late Golgi membranes, and endosomes. To gain insights into the structure and function of these important membrane pumps, robust protocols for expression and purification are required. In this report, we present a procedure for high-yield co-expression of a yeast flippase, the Drs2p-Cdc50p complex. After recovery of yeast membranes expressing both proteins, efficient purification was achieved in a single step by affinity chromatography on streptavidin beads, yielding, similar to 1-2 mg purified Drs2p-Cdc50p complex per liter of culture. Importantly, the procedure enabled us to recover a fraction that mainly contained a 1: 1 complex, which was assessed by size-exclusion chromatography and mass spectrometry. The functional properties of the purified complex were examined, including the dependence of its catalytic cycle on specific lipids. The dephosphorylation rate was stimulated in the simultaneous presence of the transported substrate, phosphatidylserine (PS), and the regulatory lipid phosphatidylinositol-4-phosphate (PI4P), a phosphoinositide that plays critical roles in membrane trafficking events from the trans-Golgi network (TGN). Likewise, overall ATP hydrolysis by the complex was critically dependent on the simultaneous presence of PI4P and PS. We also identified a prominent role for PI4P in stabilization of the Drs2p-Cdc50p complex towards temperature-or C12E8-induced irreversible inactivation. These results indicate that the Drs2p-Cdc50p complex remains functional after affinity purification and that PI4P as a cofactor tightly controls its stability and catalytic activity. This work offers appealing perspectives for detailed structural and functional characterization of the Drs2p-Cdc50p lipid transport mechanism.	[Azouaoui, Hassina; Montigny, Cedric; Jacquot, Aurore; Garrigos, Manuel; le Maire, Marc; Champeil, Philippe; Lenoir, Guillaume] Univ Paris 11, UMR 8221, Orsay, France; [Azouaoui, Hassina; Montigny, Cedric; Jacquot, Aurore; Garrigos, Manuel; le Maire, Marc; Champeil, Philippe; Lenoir, Guillaume] CEA, iBiTec S Inst Biol & Technol Saclay, SB2 SM Serv Bioenerget Biol Struct & Mecanismes, Lab Prot Membranaires, Gif Sur Yvette, France; [Azouaoui, Hassina; Montigny, Cedric; Jacquot, Aurore; Garrigos, Manuel; le Maire, Marc; Champeil, Philippe; Lenoir, Guillaume] CNRS, UMR 8221, Gif Sur Yvette, France; [Ash, Miriam-Rose; Fijalkowski, Frank; Gronberg, Christina; Lopez-Marques, Rosa L.; Palmgren, Michael G.; Gourdon, Pontus; Nissen, Poul] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Aarhus, Denmark; [Ash, Miriam-Rose; Fijalkowski, Frank; Gronberg, Christina; Gourdon, Pontus; Nissen, Poul] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Lopez-Marques, Rosa L.; Palmgren, Michael G.] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Decottignies, Paulette] CNRS, Inst Biochim & Biophys Mol & Cellulair, UMR 8619, F-91405 Orsay, France; [Decottignies, Paulette] Univ Paris 11, Orsay, France	UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Danmarks Grundforskningsfond; Aarhus University; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lenoir, G (corresponding author), Univ Paris 11, UMR 8221, Orsay, France.	guillaume.lenoir@cea.fr	Palmgren, Michael/A-9808-2013; Marques, Rosa Laura Lopez/AAI-8071-2020; Lenoir, Guillaume/I-4002-2019; Gourdon, Pontus/E-1076-2014; Gourdon, Pontus/HCI-8898-2022; Lopez-Marques, Rosa L/F-8536-2014; MONTIGNY, Cédric/AAH-4216-2021	Palmgren, Michael/0000-0002-9982-6114; Marques, Rosa Laura Lopez/0000-0002-5663-7903; Lenoir, Guillaume/0000-0002-8759-5179; Gourdon, Pontus/0000-0002-8631-3539; Lopez-Marques, Rosa L/0000-0002-5663-7903; Ash, Miriam-Rose/0000-0002-0573-9854; Nissen, Poul/0000-0003-0948-6628; Gronberg, Christina/0000-0002-2231-8816	Agence Nationale pour la Recherche (ANR Blanc program) [MIT-2M]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; Lundbeck Foundation [R139-2012-12689] Funding Source: researchfish	Agence Nationale pour la Recherche (ANR Blanc program)(French National Research Agency (ANR)); French Infrastructure for Integrated Structural Biology (FRISBI); Lundbeck Foundation(Lundbeckfonden)	This work was supported by a grant from the Agence Nationale pour la Recherche (ANR Blanc program MIT-2M to MlM and CM) and by the French Infrastructure for Integrated Structural Biology (FRISBI, ANR-10-INSB-05-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Alexander RT, 2011, EMBO J, V30, P679, DOI 10.1038/emboj.2010.356; Angelaccio S, 2002, ANAL BIOCHEM, V306, P346, DOI 10.1006/abio.2002.5689; Baekgaard L, 2005, J BIOENERG BIOMEMBR, V37, P369, DOI 10.1007/s10863-005-9473-0; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bohdanowicz M, 2013, PHYSIOL REV, V93, P69, DOI 10.1152/physrev.00002.2012; Bryde S, 2010, J BIOL CHEM, V285, P40562, DOI 10.1074/jbc.M110.139543; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896; Chen CY, 1999, J CELL BIOL, V147, P1223, DOI 10.1083/jcb.147.6.1223; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Coleman JA, 2012, P NATL ACAD SCI USA, V109, P1449, DOI 10.1073/pnas.1108862109; Coleman JA, 2011, J BIOL CHEM, V286, P17205, DOI 10.1074/jbc.M111.229419; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; DRUECKES P, 1995, ANAL BIOCHEM, V230, P173, DOI 10.1006/abio.1995.1453; Ekberg K, 2010, J BIOL CHEM, V285, P7344, DOI 10.1074/jbc.M109.096123; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Furuta N, 2007, MOL BIOL CELL, V18, P295, DOI 10.1091/mbc.E06-05-0461; GARRIGOS M, 1991, ANAL BIOCHEM, V194, P82, DOI 10.1016/0003-2697(91)90154-L; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hatori Y, 2008, J BIOL CHEM, V283, P22541, DOI 10.1074/jbc.M802735200; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lenoir G, 2004, J BIOL CHEM, V279, P32125, DOI 10.1074/jbc.M402934200; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lenoir G, 2007, CURR OPIN CHEM BIOL, V11, P654, DOI 10.1016/j.cbpa.2007.09.008; Lenoir G, 2009, J BIOL CHEM, V284, P17956, DOI 10.1074/jbc.M109.013722; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025; Lopez-Marques RL, 2014, PFLUG ARCH EUR J PHY, V466, P1227, DOI 10.1007/s00424-013-1363-4; LUND S, 1988, J BIOL CHEM, V263, P1654; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Montigny C, 2014, OVEREXPRESSION MEMBR; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; ONEAL SG, 1979, BIOCHEM BIOPH RES CO, V89, P845, DOI 10.1016/0006-291X(79)91855-2; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Picard M, 2006, J BIOL CHEM, V281, P3360, DOI 10.1074/jbc.M511385200; PICK U, 1982, J BIOL CHEM, V257, P6111; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; ROSING J, 1980, J BIOL CHEM, V255, P274; Saito K, 2004, MOL BIOL CELL, V15, P3418, DOI 10.1091/mbc.E03-11-0829; Sebastian TT, 2012, BIOCH BIOPHYS ACTA; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Takeda M, 2014, EUKARYOT CELL, V13, P363, DOI 10.1128/EC.00279-13; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; van der Velden LM, 2010, J BIOL CHEM, V285, P40088, DOI 10.1074/jbc.M110.139006; Vestergaard AL, 2014, P NATL ACAD SCI USA, V111, pE1334, DOI 10.1073/pnas.1321165111; Yeung T, 2009, J CELL BIOL, V185, P917, DOI 10.1083/jcb.200903020; Zhang BL, 2001, J BIOL CHEM, V276, P8958, DOI 10.1074/jbc.M008720200; Zhou XM, 2013, J BIOL CHEM, V288, P31807, DOI 10.1074/jbc.M113.481986; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106	67	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112176	10.1371/journal.pone.0112176	http://dx.doi.org/10.1371/journal.pone.0112176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393116	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300038
J	Cai, CW; Shen, J; Zhao, D; Qiao, YQ; Xu, AT; Jin, S; Ran, ZH; Zheng, Q				Cai, Chenwen; Shen, Jun; Zhao, Di; Qiao, Yuqi; Xu, Antao; Jin, Shuang; Ran, Zhihua; Zheng, Qing			Serological Investigation of Food Specific Immunoglobulin G Antibodies in Patients with Inflammatory Bowel Diseases	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CROHNS-DISEASE; IGG ANTIBODIES; CLINICAL-COURSE; DIETARY FACTORS; ALLERGY; ANTIGENS; INTOLERANCE; IMMUNITY; RISK	Objective: Dietary factors have been indicated to influence the pathogenesis and nature course of inflammatory bowel diseases (IBD) with their wide variances. The aim of the study was to assess the prevalence and clinical significance of 14 serum food specific immunoglobulin G (sIgG) antibodies in patients with IBD. Methods: This retrospective study comprised a total of 112 patients with IBD, including 79 with Crohn's disease (CD) and 33 with ulcerative colitis (UC). Medical records, clinical data and laboratory results were collected for analysis. Serum IgG antibodies against 14 unique food allergens were detected by semi-quantitative enzyme linked immunosorbent assay (ELISA). Results: Food sIgG antibodies were detected in 75.9% (60/79) of CD patients, 63.6% (21/33) of UC patients and 33.1% (88/266) of healthy controls (HC). IBD patients showed the significantly higher antibodies prevalence than healthy controls (CD vs. HC, P = 0.000; UC vs. HC, P = 0.001). However no marked difference was observed between CD and UC groups (P = 0.184). More subjects were found with sensitivity to multiple antigens (>= 3) in IBD than in HC group (33.9% vs. 0.8%, P = 0.000). Egg was the most prevalent food allergen. There was a remarkable difference in the levels of general serum IgM (P = 0.045) and IgG (P = 0.041) between patients with positive and negative sIgG antibodies. Patients with multiple positive allergens (>= 3) were especially found with significant higher total IgG levels compared with sIgG-negative patients (P = 0.003). Age was suggested as a protective factor against the occurrence of sIgG antibodies (P = 0.002). Conclusions: The study demonstrates a high prevalence of serum IgG antibodies to specific food allergens in patients with IBD. sIgG antibodies may potentially indicate disease status in clinical and be utilized to guide diets for patients.	[Cai, Chenwen; Shen, Jun; Zhao, Di; Qiao, Yuqi; Xu, Antao; Jin, Shuang; Ran, Zhihua; Zheng, Qing] Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Key Lab Gastroenterol & Hepatol,Sch Med, Minist Hlth,Div Gastroenterol & Hepatol,Ren Ji Ho, Shanghai 200001, Peoples R China	Shanghai Jiao Tong University	Zheng, Q (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Dis, Key Lab Gastroenterol & Hepatol,Sch Med, Minist Hlth,Div Gastroenterol & Hepatol,Ren Ji Ho, 145 Middle Shandong Rd, Shanghai 200001, Peoples R China.	qingzheng101@163.com			National Key Technology R&D Program of China [2012BAI06B03]; National Natural Science Foundations of China [81170362, 81200280, 81370508]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	The work was supported by grants from the National Key Technology R&D Program of China (No. 2012BAI06B03), http://kjzc.jhgl.org/and National Natural Science Foundations of China (No. 81170362, 81200280 and 81370508), http://isisn.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson W, 2004, GUT, V53, P1459, DOI 10.1136/gut.2003.037697; Banai Janos, 2009, Orvosi Hetilap, V150, P839, DOI 10.1556/OH.2009.28599; Bentz S, 2010, DIGESTION, V81, P252, DOI 10.1159/000264649; Bernstein C N, 2001, Curr Gastroenterol Rep, V3, P477; BINDER HJ, 1966, AM J DIG DIS, V11, P858, DOI 10.1007/BF02233942; Brunner B, 2007, DIS COLON RECTUM, V50, P83, DOI 10.1007/s10350-006-0749-1; Cashman KD, 2003, EUR J GASTROEN HEPAT, V15, P607, DOI 10.1097/00042737-200306000-00005; Chahine BG, 2010, CURR OPIN ALLERGY CL, V10, P220, DOI 10.1097/ACI.0b013e32833982ab; CROWE SE, 1992, GASTROENTEROLOGY, V103, P1075, DOI 10.1016/0016-5085(92)90047-3; David TJ, 2000, BRIT MED BULL, V56, P34, DOI 10.1258/0007142001902950; Foster AP, 2003, VET IMMUNOL IMMUNOP, V92, P113, DOI 10.1016/S0165-2427(03)00033-3; GLASSMAN MS, 1990, AM J GASTROENTEROL, V85, P838; Goh KL, 2009, J DIGEST DIS, V10, P1, DOI 10.1111/j.1751-2980.2008.00355.x; Haboubi NY, 2005, GUT, V54, P567; HARVEY RF, 1980, LANCET, V1, P514; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; HUSBY S, 1985, INT ARCH ALLER A IMM, V77, P416, DOI 10.1159/000233819; Isolauri E, 2004, GUT, V53, P1391, DOI 10.1136/gut.2004.044990; Jowett SL, 2004, GUT, V53, P1479, DOI 10.1136/gut.2003.024828; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Magee EA, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-7; Malbec O, 2007, IMMUNOL REV, V217, P206, DOI 10.1111/j.1600-065X.2007.00510.x; Mekkel Gabriella, 2005, Orvosi Hetilap, V146, P797; Meulenbroek LAPM, 2013, J IMMUNOL, V191, P3526, DOI 10.4049/jimmunol.1202398; Mishkin B, 1997, AM J GASTROENTEROL, V92, P1148; Ortolani C, 2006, BEST PRACT RES CL GA, V20, P467, DOI 10.1016/j.bpg.2005.11.010; Palmieri B, 2011, Minerva Gastroenterol Dietol, V57, P1; Sai Xiao-yong, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P302; Sakamoto N, 2005, INFLAMM BOWEL DIS, V11, P154, DOI 10.1097/00054725-200502000-00009; Sampson HA, 2004, J ALLERGY CLIN IMMUN, V113, P805, DOI 10.1016/j.jaci.2004.03.014; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Stange EF, 2008, J CROHNS COLITIS, V2, P1, DOI 10.1016/j.crohns.2007.11.001; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; TRUELOVE SC, 1961, BMJ-BRIT MED J, V1, P154, DOI 10.1136/bmj.1.5220.154; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Van Den Bogaerde J, 2002, ALIMENT PHARM THER, V16, P1903, DOI 10.1046/j.1365-2036.2002.01360.x; Vidal A, 2008, INFLAMM BOWEL DIS, V14, P977, DOI 10.1002/ibd.20388; Wang J, 2009, CLIN EXP ALLERGY, V39, P1381, DOI 10.1111/j.1365-2222.2009.03225.x; Wuthrich B, 2009, Praxis (Bern 1994), V98, P375, DOI 10.1024/1661-8157.98.7.375; Zallot C, 2013, INFLAMM BOWEL DIS, V19, P66, DOI 10.1002/ibd.22965; Zar S, 2001, ALIMENT PHARM THER, V15, P439, DOI 10.1046/j.1365-2036.2001.00951.x	41	27	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112154	10.1371/journal.pone.0112154	http://dx.doi.org/10.1371/journal.pone.0112154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393003	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300036
J	Chen, YY; Tseng, FC; Chang, JR; Kuo, SC; Lee, JJ; Yeh, JJ; Chiueh, TS; Sun, JR; Su, IJ; Dou, HY				Chen, Yih-Yuan; Tseng, Fan-Chen; Chang, Jia-Ru; Kuo, Shu-Chen; Lee, Jen-Jyh; Yeh, Jun-Jun; Chiueh, Tzong-Shi; Sun, Jun-Ren; Su, Ih-Jen; Dou, Horng-Yunn			Distinct Modes of Transmission of Tuberculosis in Aboriginal and Non-Aboriginal Populations in Taiwan	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; ASSOCIATION; DATABASE; STRAINS; CHINA	Tuberculosis incidence among aborigines is significantly higher than for Han Chinese in Taiwan, but the extent to which Mycobacterium tuberculosis (MTB) strain characteristics contribute to this difference is not well understood. MTB isolates from aborigines and Han Chinese living in eastern and southern Taiwan, the major regions of aborigines, were analyzed by spoligotyping and 24-loci MIRU-VNTR. In eastern Taiwan, 60% of aboriginal patients were <= 20 years old, significantly younger than the non-aboriginal patients there; aborigines were more likely to have clustered MTB isolates than Han Chinese (odds ratio (OR) = 5.98, p<0.0001). MTB lineages with high clustering were EAI (54.9%) among southern people, and Beijing (62.5%) and Haarlem (52.9%) among eastern aborigines. Resistance to first-line drugs and multidrug resistance (MDR) were significantly higher among eastern aborigines (>= 15%) than in any other geographic and ethnic group (p<0.05); MDR was detected in 5 of 28 eastern aboriginal patients <= 20 years old. Among patients from the eastern region, clustered strains (p = 0.01) and aboriginal ethnicity (p = 0.04) were independent risk factors for MDR. The lifestyles of aborigines in eastern Taiwan may explain why the percentage of infected aborigines is much higher than for their Han Chinese counterparts. The significantly higher percentage of the MDR-MTB strains in the aboriginal population warrants close attention to control policy and vaccination strategy.	[Chen, Yih-Yuan; Tseng, Fan-Chen; Chang, Jia-Ru; Kuo, Shu-Chen; Su, Ih-Jen; Dou, Horng-Yunn] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan; [Tseng, Fan-Chen] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Lee, Jen-Jyh] Hualien Tzu Chi Med Ctr, Dept Microbiol, Hualien, Taiwan; [Yeh, Jun-Jun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan; [Yeh, Jun-Jun] China Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Yeh, Jun-Jun] Pingtung Christian Hosp, Dept Med Res, Pingtung, Taiwan; [Yeh, Jun-Jun] Chung Shan Med Univ, Taichung, Taiwan; [Chiueh, Tzong-Shi; Sun, Jun-Ren] Triserv Gen Hosp, Dept Pathol, Div Clin Pathol, Taipei, Taiwan; [Chiueh, Tzong-Shi; Sun, Jun-Ren] Natl Def Med Ctr, Taipei, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; Buddhist Tzu Chi General Hospital; Chung Shan Medical University; Tri-Service General Hospital; National Defense Medical Center	Dou, HY (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Miaoli, Taiwan.	hydou@nhri.org.tw	Dou, Horng-Yunn/B-2652-2010; Su, Ih-Jen/B-2655-2010; Tseng, Fan-Chen/D-2097-2010; Kuo, Shu-Chen/G-9108-2011	Sun, jun-ren/0000-0002-8769-9170	National Health Research Institutes; National Science Council, Taiwan [NSC 102-2320-B-400-006]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This project was supported by grants from National Health Research Institutes and National Science Council (NSC 102-2320-B-400-006), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; CDC, 2012, TUB CONTR REP 2012; Chakraborty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062966; Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018; Chen YY, 2014, J INFECTION, V68, P332, DOI 10.1016/j.jinf.2013.12.004; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dou HY, 2011, INT J EVOL BIOL, V2011; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; Hsu AH, 2010, INT J TUBERC LUNG D, V14, P924; Hsu YH, 2006, J FORMOS MED ASSOC, V105, P363, DOI 10.1016/S0929-6646(09)60131-5; Huang SF, 2012, INFECT GENET EVOL, V12, P28, DOI 10.1016/j.meegid.2011.10.001; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Jeon BY, 2008, INFECT IMMUN, V76, P5173, DOI 10.1128/IAI.00019-08; KOLK AHJ, 1992, J CLIN MICROBIOL, V30, P2567, DOI 10.1128/JCM.30.10.2567-2575.1992; Lai CC, 2011, INT J ANTIMICROB AG, V38, P125, DOI 10.1016/j.ijantimicag.2011.03.016; Li WM, 2005, INT J TUBERC LUNG D, V9, P1314; PA W, 2000, SUSCEPTIBILITY TESTI; Shamputa IC, 2010, J CLIN MICROBIOL, V48, P387, DOI 10.1128/JCM.02167-09; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; WHO Global Tuberculosis Control Report, 2010, CENT EUR J PUBL HEAL, V18, P237; Yung-Ming Chang, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P161	23	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112633	10.1371/journal.pone.0112633	http://dx.doi.org/10.1371/journal.pone.0112633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393403	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300078
J	Poissonnier, LA; Simpson, SJ; Dussutour, A				Poissonnier, Laure-Anne; Simpson, Stephen J.; Dussutour, Audrey			Observations of the "Egg White Injury'' in Ants	PLOS ONE			English	Article							IMPORTED FIRE ANT; BIOTIN-BINDING PROTEIN; WORKERS; HEALTH; GROWTH; AVIDIN; ADULT	A key determinant of the relationship between diet and longevity is the balance of protein to carbohydrate in the diet. Eating excess protein relative to carbohydrate shortens lifespan in solitary and social insects. Here we explored how lifespan and behavior in ants was affected by the quality of protein ingested and the presence of associated antinutrients (i.e. compounds that interfere with the absorption of nutrients). We tested diets prepared with either egg white protein only or a protein mixture. Egg white contains an anti-nutrient called avidin. Avidin binds to the B vitamin biotin, preventing its absorption. First, we demonstrate that an egg-white diet was twice as deleterious as a protein-mixture diet. Second, we show that ingestion of egg-white diet drastically affected social behavior, triggering elevated levels of aggression within the colony. Lastly, we reveal that by adding biotin to the egg white diet we were able to lessen its detrimental effects. This latest result suggests that ants suffered biotin deficiency when fed the egg white diet. In conclusion, anti-nutrients were known to affect health and performance of animals, but this is the first study showing that anti-nutrients also lead to severe changes in behavior.	[Poissonnier, Laure-Anne; Dussutour, Audrey] Natl Ctr Sci Res, Res Ctr Anim Cognit, Toulouse, France; [Poissonnier, Laure-Anne; Dussutour, Audrey] Toulouse Univ, Toulouse, France; [Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); University of Sydney	Dussutour, A (corresponding author), Natl Ctr Sci Res, Res Ctr Anim Cognit, Toulouse, France.	dussutou@gmail.com	Poissonnier, Laure-Anne/GXW-1856-2022; Dussutour, Audrey/A-2399-2012	Dussutour, Audrey/0000-0002-1377-3550; Simpson, Stephen J./0000-0003-0256-7687	Agence Nationale de la Recherche [JSV7-0009-01]	Agence Nationale de la Recherche(French National Research Agency (ANR))	AD was supported by a grant from the "Agence Nationale de la Recherche 2011, Programme Jeunes Chercheurs, Reference number: JSV7-0009-01". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaye SZ, 2010, J EXP BIOL, V213, P3311, DOI 10.1242/jeb.046953; Arganda S, 2014, J INSECT PH IN PRESS; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; Bos N, 2012, J EVOLUTION BIOL, V25, P342, DOI 10.1111/j.1420-9101.2011.02425.x; Chapuisat M, 2002, P ROY SOC B-BIOL SCI, V269, P909, DOI 10.1098/rspb.2002.1962; Christeller JT, 2010, J ECON ENTOMOL, V103, P497, DOI 10.1603/EC09149; Christensen KL, 2010, NATURWISSENSCHAFTEN, V97, P941, DOI 10.1007/s00114-010-0705-8; Cohen AC, 1999, US Patent, Patent No. 5945271; Cook SC, 2010, BIOTROPICA, V42, P135, DOI 10.1111/j.1744-7429.2009.00616.x; Cook SC, 2010, ANIM BEHAV, V79, P429, DOI 10.1016/j.anbehav.2009.11.022; COOPER RA, 1992, ENTOMOL EXP APPL, V63, P123, DOI 10.1007/BF00343572; DADD RH, 1973, ANNU REV ENTOMOL, V18, P381, DOI 10.1146/annurev.en.18.010173.002121; Dussutour A, 2008, INSECT SOC, V55, P329, DOI 10.1007/s00040-008-1008-3; Dussutour A, 2008, J EXP BIOL, V211, P2224, DOI 10.1242/jeb.017509; Dussutour A, 2012, P ROY SOC B-BIOL SCI, V279, P2402, DOI 10.1098/rspb.2012.0051; Dussutour A, 2009, CURR BIOL, V19, P740, DOI 10.1016/j.cub.2009.03.015; Gilani GS, 2012, BRIT J NUTR, V108, pS315, DOI 10.1017/S0007114512002371; GLANCEY BM, 1981, INSECT SOC, V28, P395, DOI 10.1007/BF02224196; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; GREEN NM, 1970, BIOCHEM J, V118, P67, DOI 10.1042/bj1180067; Heinze J, 2010, CURR BIOL, V20, P249, DOI 10.1016/j.cub.2009.12.031; Hinchliffe G, 2010, J INSECT PHYSIOL, V56, P629, DOI 10.1016/j.jinsphys.2010.01.007; Holldobler B., 1990, pi; Kramer KJ, 2000, NAT BIOTECHNOL, V18, P670, DOI 10.1038/76531; Lee KP, 2007, J EXP BIOL, V210, P3236, DOI 10.1242/jeb.008060; LENOIR A, 1983, Z TIERPSYCHOL, V63, P213; Lenoir A, 2009, J CHEM ECOL, V35, P913, DOI 10.1007/s10886-009-9669-6; LEVINSON H. Z., 1967, Journal of Stored Products Research, V3, P345, DOI 10.1016/0022-474X(67)90037-9; Makkar HPS, 1993, OCCASIONAL PUBLICATI, V16, P69, DOI 10.1017/S0263967X00031086; Malone LA, 2004, APIDOLOGIE, V35, P655, DOI 10.1051/apido:2004063; Malone LA, 2002, APIDOLOGIE, V33, P447, DOI 10.1051/apido:2002030; Mann J, 2002, ESSENTIALS HUMAN NUT; McKay BE, 2004, J COMP NEUROL, V473, P86, DOI 10.1002/cne.20109; MORGAN TD, 1993, ENTOMOL EXP APPL, V69, P97, DOI 10.1007/BF02380637; Pasteels J.M., 1987, Experientia Supplementum (Basel), V54, P155; PETRALIA RS, 1980, CELL TISSUE RES, V206, P145, DOI 10.1007/BF00233615; Pirk CWW, 2010, APIDOLOGIE, V41, P62, DOI 10.1051/apido/2009055; RICKS BL, 1972, ENTOMOL EXP APPL, V15, P329, DOI 10.1007/BF00428298; Rueppell O, 2010, J EVOLUTION BIOL, V23, P1538, DOI 10.1111/j.1420-9101.2010.02022.x; SCHMIDHEMPEL P, 1985, BEHAV ECOL SOCIOBIOL, V17, P61, DOI 10.1007/BF00299430; Simpson S.J., 2012, NATURE NUTR; Simpson SJ, 2000, ADV STUD BEHAV, V29, P1, DOI 10.1016/S0065-3454(08)60102-3; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Wu G, 2013, AMINO ACIDS: BIOCHEMISTRY AND NUTRITION, P1, DOI 10.1201/b14661; Yossa R, 2015, REV AQUACULT, V7, P59, DOI 10.1111/raq.12053; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	47	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112801	10.1371/journal.pone.0112801	http://dx.doi.org/10.1371/journal.pone.0112801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392989	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300107
J	Sandor, N; Walter, FR; Bocsik, A; Santha, P; Schilling-Toth, B; Lener, V; Varga, Z; Kahan, Z; Deli, MA; Safrany, G; Hegyesi, H				Sandor, Nikolett; Walter, Fruzsina R.; Bocsik, Alexandra; Santha, Petra; Schilling-Toth, Boglarka; Lener, Violetta; Varga, Zoltan; Kahan, Zsuzsanna; Deli, Maria A.; Safrany, Geza; Hegyesi, Hargita			Low Dose Cranial Irradiation-Induced Cerebrovascular Damage Is Reversible in Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENDOTHELIAL PROGENITOR CELLS; IONIZING-RADIATION; RAT-BRAIN; X-IRRADIATION; PERMEABILITY; RADIOTHERAPY; MECHANISMS; CHILDHOOD; EXPOSURE	Background: High-dose radiation-induced blood-brain barrier breakdown contributes to acute radiation toxicity syndrome and delayed brain injury, but there are few data on the effects of low dose cranial irradiation. Our goal was to measure blood-brain barrier changes after low (0.1 Gy), moderate (2 Gy) and high (10 Gy) dose irradiation under in vivo and in vitro conditions. Methodology: Cranial irradiation was performed on 10-day-old and 10-week-old mice. Blood-brain barrier permeability for Evans blue, body weight and number of peripheral mononuclear and circulating endothelial progenitor cells were evaluated 1, 4 and 26 weeks postirradiation. Barrier properties of primary mouse brain endothelial cells co-cultured with glial cells were determined by measurement of resistance and permeability for marker molecules and staining for interendothelial junctions. Endothelial senescence was determined by senescence associated beta-galactosidase staining. Principle Findings: Extravasation of Evans blue increased in cerebrum and cerebellum in adult mice 1 week and in infant mice 4 weeks postirradiation at all treatment doses. Head irradiation with 10 Gy decreased body weight. The number of circulating endothelial progenitor cells in blood was decreased 1 day after irradiation with 0.1 and 2 Gy. Increase in the permeability of cultured brain endothelial monolayers for fluorescein and albumin was time-and radiation dose dependent and accompanied by changes in junctional immunostaining for claudin-5, ZO-1 and beta-catenin. The number of cultured brain endothelial and glial cells decreased from third day of postirradiation and senescence in endothelial cells increased at 2 and 10 Gy. Conclusion: Not only high but low and moderate doses of cranial irradiation increase permeability of cerebral vessels in mice, but this effect is reversible by 6 months. In-vitro experiments suggest that irradiation changes junctional morphology, decreases cell number and causes senescence in brain endothelial cells.	[Sandor, Nikolett; Schilling-Toth, Boglarka; Lener, Violetta; Safrany, Geza; Hegyesi, Hargita] Frederic Joliot Curie Natl Res Inst Radiobiol & R, Div Mol Radiobiol & Biodosimetry, Budapest, Hungary; [Walter, Fruzsina R.; Bocsik, Alexandra; Santha, Petra; Deli, Maria A.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, Biol Barriers Res Grp, H-6701 Szeged, Hungary; [Varga, Zoltan; Kahan, Zsuzsanna] Univ Szeged, Dept Oncotherapy, Szeged, Hungary; [Lener, Violetta; Hegyesi, Hargita] Semmelweis Univ, Fac Hlth Care, Dept Morphol & Physiol, H-1085 Budapest, Hungary; [Sandor, Nikolett] Semmelweis Univ, Doctoral Sch Pathol Sci, H-1085 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Semmelweis University; Semmelweis University	Hegyesi, H (corresponding author), Frederic Joliot Curie Natl Res Inst Radiobiol & R, Div Mol Radiobiol & Biodosimetry, Budapest, Hungary.	hegyesi.hargita@osski.hu	Deli, Mária A./I-2885-2019	Deli, Mária A./0000-0001-6084-6524; Hegyesi, Hargita/0000-0002-8800-5169	European Union [FP7/CEREBRAD-295552]; Hungarian Research Fund [OTKA K77766]; European Social Fund [TAMOP 4.2.4.A/2-11/1-2012-0001, TAMOP-4.2.2.A-11/1/KONV-2012-0052]	European Union(European Commission); Hungarian Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Social Fund(European Social Fund (ESF))	This research was supported by grants from the European Union (FP7/CEREBRAD-295552), the Hungarian Research Fund (OTKA K77766), and co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11/1-2012-0001 'National Excellence Program' and TAMOP-4.2.2.A-11/1/KONV-2012-0052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abraham CS, 1996, NEUROSCI LETT, V208, P85; Allen AR, 2014, INT J RADIAT BIOL, V90, P214, DOI 10.3109/09553002.2014.859761; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Asosingh K, 2007, J IMMUNOL, V178, P6482, DOI 10.4049/jimmunol.178.10.6482; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Burrell K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038366; CALVO W, 1988, BRIT J RADIOL, V61, P1043, DOI 10.1259/0007-1285-61-731-1043; Cho KH, 2010, INT J RADIAT ONCOL, V78, P390, DOI 10.1016/j.ijrobp.2009.08.029; Deli MA, 2000, NEUROREPORT, V11, P3931, DOI 10.1097/00001756-200011270-00064; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Deli MA, 2010, J ALZHEIMERS DIS, V22, P777, DOI 10.3233/JAD-2010-100759; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Diserbo M, 2002, CAN J PHYSIOL PHARM, V80, P670, DOI 10.1139/Y02-070; Eigenmann DE, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-33; El Assar M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00132; Erickson MA, 2013, J CEREBR BLOOD F MET, V33, P1500, DOI 10.1038/jcbfm.2013.135; Erusalimsky JD, 2009, EXP PHYSIOL, V94, P299, DOI 10.1113/expphysiol.2008.043133; Fauquette W, 2012, BRAIN RES, V1433, P114, DOI 10.1016/j.brainres.2011.11.022; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heissig B, 2005, J EXP MED, V202, P739, DOI 10.1084/jem.20050959; HICKS HH, 1967, J AM DENT ASSOC, V75, P1194, DOI 10.14219/jada.archive.1967.0354; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hwang SY, 2006, NEUROBIOL DIS, V21, P457, DOI 10.1016/j.nbd.2005.08.006; Jia D, 2010, RADIAT RES, V173, P579, DOI 10.1667/RR2030.1; Kataoka Y, 2006, J RADIAT RES, V47, P245, DOI 10.1269/jrr.0628; Kaya M, 2004, BRAIN RES, V1019, P105, DOI 10.1016/j.brainres.2004.05.102; Kim JH, 2008, J NEURO-ONCOL, V87, P279, DOI 10.1007/s11060-008-9520-x; Kinev AV, 2013, CANCER INVEST, V31, P359, DOI 10.3109/07357907.2013.789903; KOBAYASHI S, 1967, ELECTROEN CLIN NEURO, V23, P463, DOI 10.1016/0013-4694(67)90189-7; Kouloulias V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/401261; Kyrkanides S, 1999, J NEUROIMMUNOL, V95, P95, DOI 10.1016/S0165-5728(98)00270-7; Lee MO, 2012, ARTERIOSCL THROM VAS, V32, P343, DOI 10.1161/ATVBAHA.111.237651; Legros H, 2009, J CEREBR BLOOD F MET, V29, P1146, DOI 10.1038/jcbfm.2009.39; Li YQ, 1996, CANCER RES, V56, P5417; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu Y, 2010, AM J NEURORADIOL, V31, P383, DOI 10.3174/ajnr.A1801; LJUBIMOVA NV, 1991, BRIT J RADIOL, V64, P934, DOI 10.1259/0007-1285-64-766-934; Mao XW, 2010, RADIAT RES, V173, P486, DOI 10.1667/RR1728.1; Martins T, 2011, BRAIN RES, V1411, P28, DOI 10.1016/j.brainres.2011.07.013; Minamino T, 2008, FRONT BIOSCI-LANDMRK, V13, P2971, DOI 10.2741/2902; Murasawa S, 2005, PHYSIOLOGY, V20, P36, DOI 10.1152/physiol.00033.2004; Nakagawa S, 2007, CELL MOL NEUROBIOL, V27, P687, DOI 10.1007/s10571-007-9195-4; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; NAKATA H, 1995, ACTA NEUROCHIR, V136, P82, DOI 10.1007/BF01411440; Nordal RA, 2005, INT J RADIAT ONCOL, V62, P279, DOI 10.1016/j.ijrobp.2005.01.039; Park S, 2004, PLAST RECONSTR SURG, V113, P284, DOI 10.1097/01.PRS.0000091169.51035.A5; Patterson CE, 2000, ENDOTHELIUM-NEW YORK, V7, P287, DOI 10.3109/10623320009072215; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; REIDY MA, 1981, LAB INVEST, V44, P301; REINHOLD HS, 1990, INT J RADIAT ONCOL, V18, P37, DOI 10.1016/0360-3016(90)90264-K; REMLER MP, 1986, INT J RADIAT ONCOL, V12, P1965, DOI 10.1016/0360-3016(86)90133-1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; ROSEN EM, 1989, RADIAT RES, V117, P395, DOI 10.2307/3577346; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; RUBIN P, 1994, RADIOTHER ONCOL, V31, P51, DOI 10.1016/0167-8140(94)90413-8; SCHULTHEISS TE, 1995, INT J RADIAT ONCOL, V31, P1093, DOI 10.1016/0360-3016(94)00655-5; Serduc R, 2006, INT J RADIAT ONCOL, V64, P1519, DOI 10.1016/j.ijrobp.2005.11.047; SHELINE GE, 1980, INT J RADIAT ONCOL, V6, P1215, DOI 10.1016/0360-3016(80)90175-3; Skowronska-Gardas A, 2009, REV RECENT CLIN TRIA, V4, P42, DOI 10.2174/157488709787047567; SLATKIN DN, 1995, P NATL ACAD SCI USA, V92, P8783, DOI 10.1073/pnas.92.19.8783; Smibert E, 1996, BRIT J CANCER, V73, P825, DOI 10.1038/bjc.1996.145; Spiegler BJ, 2004, J CLIN ONCOL, V22, P706, DOI 10.1200/JCO.2004.05.186; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Ungvari Z, 2013, J GERONTOL A-BIOL, V68, P1443, DOI 10.1093/gerona/glt057; van Vulpen M, 2002, ONCOL REP, V9, P683; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Veszelka S, 2013, J ALZHEIMERS DIS, V36, P487, DOI 10.3233/JAD-120163; Wang Q, 2011, NEUROSCI LETT, V498, P78, DOI 10.1016/j.neulet.2011.04.067; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7; YAAR I, 1982, J NEUROL NEUROSUR PS, V45, P166, DOI 10.1136/jnnp.45.2.166; Yentrapalli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070024; YOSHII Y, 1982, ACTA NEUROCHIR, V64, P87, DOI 10.1007/BF01405622	79	44	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112397	10.1371/journal.pone.0112397	http://dx.doi.org/10.1371/journal.pone.0112397			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393626	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000347709300055
J	Cheng, TC; Lai, CS; Chung, MC; Kalyanam, N; Majeed, M; Ho, CT; Ho, YS; Pan, MH				Cheng, Tzu-Chun; Lai, Ching-Shu; Chung, Min-Ching; Kalyanam, Nagabhushanam; Majeed, Muhammed; Ho, Chi-Tang; Ho, Yuan-Soon; Pan, Min-Hsiung			Potent Anti-Cancer Effect of 3 '-Hydroxypterostilbene in Human Colon Xenograft Tumors	PLOS ONE			English	Article							CELL-CYCLE ARREST; CARCINOMA CELLS; PTEROSTILBENE; CANCER; APOPTOSIS; AUTOPHAGY; PATHWAYS; AGENTS; CHEMOPREVENTION; INDUCTION	Here we report that 3'-hydroxypterostilbene (HPSB), a natural pterostilbene analogue, was more potent than pterostilbene against the growth of human cancer cells (COLO 205, HCT-116, and HT-29) with measured IC50 values of 9.0, 40.2, and 70.9 mu M, respectively. We found that HPSB effectively inhibited the growth of human colon cancer cells by inducing apoptosis and autophagy. Autophagy occurred at an early stage and was observed through the formation of acidic vesicular organelles and microtubule-associated protein 1 light chain 3-II production. At the molecular levels, the results from western blot analysis showed that HPSB significantly down-regulated phosphatidylinositol 3-kinase (PI3K)/Akt and mitogen-activated protein kinases (MAPKs) signalings including decreased the phosphorylation of mammalian target of rapamycin (mTOR). Significant therapeutic effects were demonstrated in vivo by treating nude mice bearing COLO 205 tumor xenografts with HPSB (10 mg/kg i.p.). These inhibitory effects were accompanied by mechanistic down-regulation of the protein levels of cyclooxygenase-2 (COX-2), matrix metallopeptidase-9 (MMP-9), vascular endothelial growth factor (VEGF), and cyclin D1, as well as by the induction of apoptosis in colon tumors. Our findings suggest that HPSB could serve as a novel promising agent for colon cancer treatment.	[Cheng, Tzu-Chun; Ho, Yuan-Soon] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Lai, Ching-Shu; Chung, Min-Ching; Pan, Min-Hsiung] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10764, Taiwan; [Kalyanam, Nagabhushanam; Majeed, Muhammed] Sabinsa Corp, East Windsor, NJ USA; [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08903 USA; [Ho, Yuan-Soon] Taipei Med Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Ho, Yuan-Soon] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Ho, Yuan-Soon] Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan; [Pan, Min-Hsiung] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Taipei Medical University; National Taiwan University; Rutgers State University New Brunswick; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Ho, YS (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.	hoyuansn@tmu.edu.tw; mhpan@ntu.edu.tw	Pan, Min-Hsiung/AAT-8865-2021	Pan, Min-Hsiung/0000-0002-5188-7030	National Science Council [NSC 101-2628-B-022-001-MY4, 102-2628-B-002-053-MY3, NTU-103R7777]; Health and welfare surcharge of tobacco products [MOHW103-TD-B-111-01]	National Science Council(Ministry of Science and Technology, Taiwan); Health and welfare surcharge of tobacco products	This study was supported by the National Science Council NSC 101-2628-B-022-001-MY4, 102-2628-B-002-053-MY3, and NTU-103R7777 (for Dr. Pan) and by the Health and welfare surcharge of tobacco products MOHW103-TD-B-111-01 (for Dr. Ho). Sabinsa Corporation provided support in the form of salaries for authors NK & MM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Blommaart EF, 1997, HISTOCHEM J, V290, P1717; Chen RJ, 2012, J AGR FOOD CHEM, V60, P11533, DOI 10.1021/jf302778a; Chen WC, 2014, FOOD FUNCT, V5, P1856, DOI [10.1039/c4fo00145a, 10.1039/C4FO00145A]; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Dunn WJ, 1991, J CELL BIOL, V110, P1923; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Ferrer P, 2005, NEOPLASIA, V7, P37, DOI 10.1593/neo.04337; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; Hu Y, 2014, MICROBES INFECT; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kapoor S, 2013, AM J SURG, V205, P483, DOI 10.1016/j.amjsurg.2012.10.031; Kelloff GJ, 2000, J NUTR, V130, p467S, DOI 10.1093/jn/130.2.467S; KELLOFF GJ, 1994, CANCER EPIDEM BIOMAR, V3, P85; Ma ZJ, 2002, FITOTERAPIA, V73, P313, DOI 10.1016/S0367-326X(02)00074-6; Mukhtar E, 2012, CURR DRUG TARGETS, V13, P1831, DOI 10.2174/138945012804545489; Pan MH, 2008, CHEM SOC REV, V37, P2558, DOI 10.1039/b801558a; Pan MH, 2008, J AGR FOOD CHEM, V56, P7502, DOI 10.1021/jf800820y; Pan MH, 2008, MOL NUTR FOOD RES, V52, P43, DOI 10.1002/mnfr.200700380; Pan MH, 2007, J AGR FOOD CHEM, V55, P7777, DOI 10.1021/jf071520h; Pan MH, 2009, CARCINOGENESIS, V30, P1234, DOI 10.1093/carcin/bgp121; Rimando AM, 2002, J AGR FOOD CHEM, V50, P3453, DOI 10.1021/jf0116855; Sporn MB, 2000, CARCINOGENESIS, V21, P525, DOI 10.1093/carcin/21.3.525; Tolomeo M, 2005, INT J BIOCHEM CELL B, V37, P1709, DOI 10.1016/j.biocel.2005.03.004; Wang YS, 2012, AM J TRANSL RES, V4, P44; Zhang X, 2012, CELL PROLIFERAT, V45, P466, DOI 10.1111/j.1365-2184.2012.00833.x	26	32	32	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111814	10.1371/journal.pone.0111814	http://dx.doi.org/10.1371/journal.pone.0111814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389774	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400035
J	Dissinger, N; Shkriabai, N; Hess, S; Al-Saleem, J; Kvaratskhelia, M; Green, PL				Dissinger, Nathan; Shkriabai, Nikoloz; Hess, Sonja; Al-Saleem, Jacob; Kvaratskhelia, Mamuka; Green, Patrick L.			Identification and Characterization of HTLV-1 HBZ Post-Translational Modifications	PLOS ONE			English	Article							T-CELL LEUKEMIA; BZIP FACTOR; TRANSCRIPTIONAL ACTIVITY; VIRAL TRANSCRIPTION; TAX ONCOPROTEIN; C-JUN; PROTEIN; TRANSFORMATION; ONCOGENESIS; RETROVIRUS	Human T-cell leukemia virus type-1 (HTLV-1) is estimated to infect 15-25 million people worldwide, with several areas including southern Japan and the Caribbean basin being endemic. The virus is the etiological agent of debilitating and fatal diseases, for which there is currently no long-term cure. In the majority of cases of leukemia caused by HTLV-1, only a single viral gene, hbz, and its cognate protein, HBZ, are expressed and their importance is increasingly being recognized in the development of HTLV-1-associated disease. We hypothesized that HBZ, like other HTLV-1 proteins, has properties and functions regulated by post-translational modifications (PTMs) that affect specific signaling pathways important for disease development. To date, PTM of HBZ has not been described. We used an affinity-tagged protein and mass spectrometry method to identify seven modifications of HBZ for the first time. We examined how these PTMs affected the ability of HBZ to modulate several pathways, as measured using luciferase reporter assays. Herein, we report that none of the identified PTMs affected HBZ stability or its regulation of tested pathways.	[Dissinger, Nathan; Shkriabai, Nikoloz; Al-Saleem, Jacob; Kvaratskhelia, Mamuka; Green, Patrick L.] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Dissinger, Nathan; Al-Saleem, Jacob; Green, Patrick L.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Green, Patrick L.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Green, Patrick L.] Solove Res Inst, Columbus, OH USA; [Green, Patrick L.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH USA; [Shkriabai, Nikoloz; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Hess, Sonja] CALTECH, Beckman Inst, Proteome Explorat Lab, Pasadena, CA 91125 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; California Institute of Technology	Green, PL (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA.	green.466@osu.edu			National Cancer Institute National Institutes of Health [CA100730]; NATIONAL CANCER INSTITUTE [P01CA100730] Funding Source: NIH RePORTER	National Cancer Institute National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute National Institutes of Health CA100730 to PLG (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J, 2008, BLOOD, V112, P3788, DOI 10.1182/blood-2008-04-154286; Bangham CRM, 2005, ONCOGENE, V24, P6035, DOI 10.1038/sj.onc.1208970; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Borowiak M, 2013, CARCINOGENESIS, V34, P2664, DOI 10.1093/carcin/bgt221; Cavanagh MH, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-15; Clerc I, 2008, J BIOL CHEM, V283, P23903, DOI 10.1074/jbc.M803116200; Clerc I, 2009, VIROLOGY, V391, P195, DOI 10.1016/j.virol.2009.06.027; Durkin SS, 2006, J BIOL CHEM, V281, P31705, DOI 10.1074/jbc.M607011200; Gaudray G, 2002, J VIROL, V76, P12813, DOI 10.1128/JVI.76.24.12813-12822.2002; Griffiths JR, 2014, J AM SOC MASS SPECTR, V25, P767, DOI 10.1007/s13361-014-0835-x; Hagiya K, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-19; Hivin P, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-14; Jeong SJ, 2009, BIOCHEM BIOPH RES CO, V381, P294, DOI 10.1016/j.bbrc.2009.02.024; Kalli A, 2012, PROTEOMICS, V12, P21, DOI 10.1002/pmic.201100464; Kannian P, 2010, VIRUSES-BASEL, V2, P2037, DOI 10.3390/v2092037; Kesic M, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-105; Kuhlmann AS, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-92; Lamoliatte F, 2013, MOL CELL PROTEOMICS, V12, P2536, DOI 10.1074/mcp.M112.025569; LAROCCA D, 1989, BIOCHEM BIOPH RES CO, V163, P1006, DOI 10.1016/0006-291X(89)92322-X; Lemasson I, 2007, J VIROL, V81, P1543, DOI 10.1128/JVI.00480-06; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Lodewick J, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-75; Lodewick J, 2009, VIROLOGY, V386, P68, DOI 10.1016/j.virol.2008.12.043; Ma G, 2013, ONCOGENE, V32, P4222, DOI 10.1038/onc.2012.450; Marban C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-98; Matsumoto J, 2005, ONCOGENE, V24, P1001, DOI 10.1038/sj.onc.1208297; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Miyazaki M, 2007, J VIROL, V81, P5714, DOI 10.1128/JVI.02511-06; Mukai R, 2011, BIOCHEM BIOPH RES CO, V409, P328, DOI 10.1016/j.bbrc.2011.05.014; Nicot C, 2005, ONCOGENE, V24, P6026, DOI 10.1038/sj.onc.1208977; Philip S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004040; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Simonis N, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-26; Sugata K, 2012, BLOOD, V119, P434, DOI 10.1182/blood-2011-05-357459; Takatsuki K, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-16; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Tanaka-Nakanishi A, 2014, CANCER RES, V74, P188, DOI 10.1158/0008-5472.CAN-13-0436; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Zhao T, 2009, BLOOD, V113, P2755, DOI 10.1182/blood-2008-06-161729; Zhi HJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002025	45	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112762	10.1371/journal.pone.0112762	http://dx.doi.org/10.1371/journal.pone.0112762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389759	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000349144400125
J	Flierl, A; Oliveira, LMA; Falomir-Lockhart, LJ; Mak, SK; Hesley, J; Soldner, F; Arndt-Jovin, DJ; Jaenisch, R; Langston, JW; Jovin, TM; Schule, B				Flierl, Adrian; Oliveira, Luis M. A.; Falomir-Lockhart, Lisandro J.; Mak, Sally K.; Hesley, Jayne; Soldner, Frank; Arndt-Jovin, Donna J.; Jaenisch, Rudolf; Langston, J. William; Jovin, Thomas M.; Schuele, Birgitt			Higher Vulnerability and Stress Sensitivity of Neuronal Precursor Cells Carrying an Alpha-Synuclein Gene Triplication	PLOS ONE			English	Article							PARKINSONS-DISEASE PATIENT; NEURAL STEM-CELLS; COMPLEX-I; CALCIUM; DIFFERENTIATION; MITOCHONDRIA; ROS; ACCUMULATION; ASSOCIATION; APOPTOSIS	Parkinson disease (PD) is a multi-factorial neurodegenerative disorder with loss of dopaminergic neurons in the substantia nigra and characteristic intracellular inclusions, called Lewy bodies. Genetic predisposition, such as point mutations and copy number variants of the SNCA gene locus can cause very similar PD-like neurodegeneration. The impact of altered alpha-synuclein protein expression on integrity and developmental potential of neuronal stem cells is largely unexplored, but may have wide ranging implications for PD manifestation and disease progression. Here, we investigated if induced pluripotent stem cell-derived neuronal precursor cells (NPCs) from a patient with Parkinson's disease carrying a genomic triplication of the SNCA gene (SNCA-Tri). Our goal was to determine if these cells these neuronal precursor cells already display pathological changes and impaired cellular function that would likely predispose them when differentiated to neurodegeneration. To achieve this aim, we assessed viability and cellular physiology in human SNCA-Tri NPCs both under normal and environmentally stressed conditions to model in vitro gene-environment interactions which may play a role in the initiation and progression of PD. Human SNCA-Tri NPCs displayed overall normal cellular and mitochondrial morphology, but showed substantial changes in growth, viability, cellular energy metabolism and stress resistance especially when challenged by starvation or toxicant challenge. Knockdown of alpha-synuclein in the SNCA-Tri NPCs by stably expressed short hairpin RNA (shRNA) resulted in reversal of the observed phenotypic changes. These data show for the first time that genetic alterations such as the SNCA gene triplication set the stage for decreased developmental fitness, accelerated aging, and increased neuronal cell loss. The observation of this "stem cell pathology" could have a great impact on both quality and quantity of neuronal networks and could provide a powerful new tool for development of neuroprotective strategies for PD.	[Flierl, Adrian; Mak, Sally K.; Langston, J. William; Schuele, Birgitt] Parkinsons Inst, Sunnyvale, CA 94085 USA; [Oliveira, Luis M. A.; Falomir-Lockhart, Lisandro J.; Arndt-Jovin, Donna J.; Jovin, Thomas M.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Hesley, Jayne] Mol Devices LLC, Sunnyvale, CA USA; [Soldner, Frank; Jaenisch, Rudolf] MIT, Whitehead Inst, Cambridge, MA 02139 USA; [Soldner, Frank; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA USA	Max Planck Society; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Schule, B (corresponding author), Parkinsons Inst, Sunnyvale, CA 94085 USA.	bschuele@thepi.org	Demchuk, Andrew M/E-1103-2012; Falomir Lockhart, Lisandro Jorge/V-7730-2019; Oliveira, Luis M. A./I-7994-2014; Flierl, Adrian/W-3453-2019	Demchuk, Andrew M/0000-0002-4930-7789; Falomir Lockhart, Lisandro Jorge/0000-0003-4815-5768; Oliveira, Luis M. A./0000-0002-2958-181X; Schuele, Birgitt/0000-0002-9952-5776; Flierl, Adrian/0000-0003-0933-2493	California Institute for Regenerative Medicine [CIRM ET-01246]; Parkinson Alliance; Blume Foundation; German Ministry for Education and Science (BMBF grant) [315050]; Alexander von Humboldt Foundation; NATIONAL CANCER INSTITUTE [R01CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088538] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Parkinson Alliance; Blume Foundation; German Ministry for Education and Science (BMBF grant)(Federal Ministry of Education & Research (BMBF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by grants from the California Institute for Regenerative Medicine (CIRM ET-01246, J. W. L., B. S.), Parkinson Alliance (B. S., J. W. L.), and Blume Foundation (B. S.), and the German Ministry for Education and Science (BMBF grant #315050, T. M. J.). L. J. F. L. acknowledges support from the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboud AA, 2012, NEUROTOXICOLOGY, V33, P1443, DOI 10.1016/j.neuro.2012.10.009; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brown MK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00263; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Cali T, 2012, J BIOL CHEM, V287, P18478, DOI [10.1074/jbc.M111.304733, 10.1074/jbc.M111.302794]; Chen CT, 2010, BBA-GEN SUBJECTS, V1800, P257, DOI 10.1016/j.bbagen.2009.09.001; Chinta SJ, 2010, NEUROSCI LETT, V486, P235, DOI 10.1016/j.neulet.2010.09.061; Cho EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024027; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Enoksson M, 2005, BIOCHEM BIOPH RES CO, V327, P774, DOI 10.1016/j.bbrc.2004.12.067; Folmes CDL, 2012, CIRC RES, V110, P526, DOI 10.1161/RES.0b013e31824ae5c1; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Grimm S, 2012, BBA-MOL CELL RES, V1823, P327, DOI 10.1016/j.bbamcr.2011.11.018; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; HUNTER DR, 1976, J BIOL CHEM, V251, P5069; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Jahnke VE, 2009, AM J PHYSIOL-CELL PH, V296, pC1185, DOI 10.1152/ajpcell.00377.2008; Joo Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014203; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Lee SY, 2012, CANCER RES, V72, P3607, DOI 10.1158/0008-5472.CAN-12-0006; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Mak SK, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/140427; Mak SK, 2011, J PARKINSON DIS, V1, P175, DOI 10.3233/JPD-2011-11025; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Peterson LJ, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/401264; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Reyes JF, 2014, NEUROBIOL DIS; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Shanbhag R, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/382175; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Shen D, 2011, CELL BIOCHEM BIOPHYS, V60, P173, DOI 10.1007/s12013-010-9138-4; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snigdha S, 2012, NEUROSCI BULL, V28, P14, DOI 10.1007/s12264-012-1057-5; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Starkov AA, 2002, J NEUROCHEM, V83, P220, DOI 10.1046/j.1471-4159.2002.01153.x; Steindler DA, 2012, MODERN PATHOL, V25, P157, DOI 10.1038/modpathol.2011.165; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vega-Avila Elisa, 2011, Proc West Pharmacol Soc, V54, P10; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wanders RJA, 2006, ANNU REV BIOCHEM, V75, P295, DOI 10.1146/annurev.biochem.74.082803.133329; Wang XJ, 2011, FREE RADICAL BIO MED, V50, P1094, DOI 10.1016/j.freeradbiomed.2011.01.032; Winkler S, 2007, NEUROLOGY, V69, P1745, DOI 10.1212/01.wnl.0000275524.15125.f4; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Yin F, 2012, ANTIOXID REDOX SIGNA; Zundorf G, 2009, NEUROSCIENCE, V158, P610, DOI 10.1016/j.neuroscience.2008.10.015; Zundorf G, 2011, ANTIOXID REDOX SIGN, V14, P1275, DOI 10.1089/ars.2010.3359	65	59	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112413	10.1371/journal.pone.0112413	http://dx.doi.org/10.1371/journal.pone.0112413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390032	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400078
J	Menhofer, MH; Kubisch, R; Schreiner, L; Zorn, M; Foerster, F; Mueller, R; Raedler, JO; Wagner, E; Vollmar, AM; Zahler, S				Menhofer, Magdalena H.; Kubisch, Rebekka; Schreiner, Laura; Zorn, Matthias; Foerster, Florian; Mueller, Rolf; Raedler, Joachim O.; Wagner, Ernst; Vollmar, Angelika M.; Zahler, Stefan			The Actin Targeting Compound Chondramide Inhibits Breast Cancer Metastasis via Reduction of Cellular Contractility	PLOS ONE			English	Article							DRIVES INVASION; TUMOR-CELLS; CYTOSKELETON; MIGRATION; AGENTS; MYXOBACTERIA; PROTEOLYSIS; ANTIFUNGAL; ACTIVATION; MECHANISMS	Background: A major player in the process of metastasis is the actin cytoskeleton as it forms key structures in both invasion mechanisms, mesenchymal and amoeboid migration. We tested the actin binding compound Chondramide as potential anti-metastatic agent. Methods: In vivo, the effect of Chondramide on metastasis was tested employing a 4T1-Luc BALB/c mouse model. In vitro, Chondramide was tested using the highly invasive cancer cell line MDA-MB-231 in Boyden-chamber assays, fluorescent stainings, Western blot and Pull down assays. Finally, the contractility of MDA-MB-231 cells was monitored in 3D environment and analyzed via PIV analysis. Results: In vivo, Chondramide treatment inhibits metastasis to the lung and the migration and invasion of MDA-MB-231 cells is reduced by Chondramide in vitro. On the signaling level, RhoA activity is decreased by Chondramide accompanied by reduced MLC-2 and the stretch induced guanine nucleotide exchange factor Vav2 activation. At same conditions, EGF-receptor autophosphorylation, Akt and Erk as well as Rac1 are not affected. Finally, Chondramide treatment disrupted the actin cytoskeleton and decreased the ability of cells for contraction. Conclusions: Chondramide inhibits cellular contractility and thus represents a potential inhibitor of tumor cell invasion.	[Menhofer, Magdalena H.; Kubisch, Rebekka; Schreiner, Laura; Foerster, Florian; Wagner, Ernst; Vollmar, Angelika M.; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany; [Zorn, Matthias; Raedler, Joachim O.] Univ Munich, Dept Phys Soft Matter Phys & Biophys, Munich, Germany; [Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland, D-66123 Saarbrucken, Germany; [Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University	Zahler, S (corresponding author), Univ Munich, Dept Pharm, Munich, Germany.	stefan.zahler@cup.uni-muenchen.de	Müller, Rolf/B-1559-2008; Wagner, Ernst/ABB-5976-2020; Wagner, Ernst/A-7435-2012	Müller, Rolf/0000-0002-1042-5665; Wagner, Ernst/0000-0001-8413-0934; Wagner, Ernst/0000-0001-8413-0934; Zahler, Stefan/0000-0002-5140-7287	German Research Foundation (DFG) [FOR 1406, SFB1032]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was in part supported by grants from the German Research Foundation (http://www.dfg.de/): DFG FOR 1406: RM, EW, AV)) and by SFB1032 (SZ, JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham JS, 2006, CELL MOL LIFE SCI, V63, P2119, DOI 10.1007/s00018-006-6157-9; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Goswami S, 2004, CANCER RES, V64, P7664, DOI 10.1158/0008-5472.CAN-04-2027; Herrmann J, 2013, CHEMBIOCHEM, V14, P1573, DOI 10.1002/cbic.201300140; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; KUNZE B, 1995, J ANTIBIOT, V48, P1262, DOI 10.7164/antibiotics.48.1262; Lessey EC, 2012, BIOCHEMISTRY-US, V51, P7420, DOI 10.1021/bi300758e; Li J, 2004, ONCOGENE, V23, P9359, DOI 10.1038/sj.onc.1208039; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Molli PR, 2008, CLIN CANCER RES, V14, P6161, DOI 10.1158/1078-0432.CCR-07-5288; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nurnberg A, 2011, NAT REV CANCER, V11, P177, DOI 10.1038/nrc3003; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Rosel D, 2008, MOL CANCER RES, V6, P1410, DOI 10.1158/1541-7786.MCR-07-2174; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sasse F, 1998, J NATL CANCER I, V90, P1559, DOI 10.1093/jnci/90.20.1559; SCOTT VR, 1988, ANTIMICROB AGENTS CH, V32, P1154, DOI 10.1128/AAC.32.8.1154; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yoshioka K, 1999, CANCER RES, V59, P2004	28	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112542	10.1371/journal.pone.0112542	http://dx.doi.org/10.1371/journal.pone.0112542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391145	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400094
J	Viet, CT; Dang, D; Achdjian, S; Ye, Y; Katz, SG; Schmidt, BL				Viet, Chi T.; Dang, Dongmin; Achdjian, Stacy; Ye, Yi; Katz, Samuel G.; Schmidt, Brian L.			Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							REFRACTORY SOLID TUMORS; ORAL-CANCER PAIN; DNA METHYLATION; PHASE-II; OVARIAN-CANCER; LUNG-CANCER; CHEMOTHERAPY; CARBOPLATIN; TRIAL; METAANALYSES	Cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) reduces survival. In this study we hypothesized that methylation of key genes mediates cisplatin resistance. We determined whether a demethylating drug, decitabine, could augment the anti-proliferative and apoptotic effects of cisplatin on SCC-25/CP, a cisplatin-resistant tongue SCC cell line. We showed that decitabine treatment restored cisplatin sensitivity in SCC-25/CP and significantly reduced the cisplatin dose required to induce apoptosis. We then created a xenograft model with SCC-25/CP and determined that decitabine and cisplatin combination treatment resulted in significantly reduced tumor growth and mechanical allodynia compared to control. To establish a gene classifier we quantified methylation in cancer tissue of cisplatin-sensitive and cisplatin-resistant HNSCC patients. Cisplatin-sensitive and cisplatin-resistant patient tumors had distinct methylation profiles. When we quantified methylation and expression of genes in the classifier in HNSCC cells in vitro, we showed that decitabine treatment of cisplatin-resistant HNSCC cells reversed methylation and gene expression toward a cisplatin-sensitive profile. The study provides direct evidence that decitabine restores cisplatin sensitivity in in vitro and in vivo models of HNSCC. Combination treatment of cisplatin and decitabine significantly reduces HNSCC growth and HNSCC pain. Furthermore, gene methylation could be used as a biomarker of cisplatin-resistance.	[Viet, Chi T.; Schmidt, Brian L.] NYU, Dept Oral Maxillofacial Surg, New York, NY 10012 USA; [Viet, Chi T.; Dang, Dongmin; Achdjian, Stacy; Ye, Yi; Katz, Samuel G.; Schmidt, Brian L.] NYU, Bluestone Ctr Clin Res, New York, NY USA	New York University	Schmidt, BL (corresponding author), NYU, Dept Oral Maxillofacial Surg, New York, NY 10012 USA.	vietc01@nyu.edu		Schmidt, Brian/0000-0002-2409-8984	NIH [R01 DE19796]; Oral and Maxillofacial Surgery Foundation Research Support Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019796] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oral and Maxillofacial Surgery Foundation Research Support Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH R01 DE19796 and Oral and Maxillofacial Surgery Foundation Research Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amptoulach Sousana, 2011, Chemother Res Pract, V2011, P843019, DOI 10.1155/2011/843019; Appleton K, 2007, J CLIN ONCOL, V25, P4603, DOI 10.1200/JCO.2007.10.8688; Blum W, 2010, P NATL ACAD SCI USA, V107, P7473, DOI 10.1073/pnas.1002650107; Candelaria M, 2007, ANN ONCOL, V18, P1529, DOI 10.1093/annonc/mdm204; Cashen AF, 2010, J CLIN ONCOL, V28, P556, DOI 10.1200/JCO.2009.23.9178; Chang XF, 2010, CANCER RES, V70, P2870, DOI 10.1158/0008-5472.CAN-09-3427; Connelly ST, 2004, J PAIN, V5, P505, DOI 10.1016/j.jpain.2004.09.002; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Coronel J, 2010, MED ONCOLOGY; Daskalakis M, 2010, RECENT RESULTS CANC, V184, P131, DOI 10.1007/978-3-642-01222-8_10; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Fischer DJ, 2010, SUPPORT CARE CANCER, V18, P801, DOI 10.1007/s00520-009-0712-5; Glasspool RM, 2014, BRIT J CANCER, V110, P1923, DOI 10.1038/bjc.2014.116; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Kolokythas A, 2007, J PAIN, V8, P950, DOI 10.1016/j.jpain.2007.06.012; Marcu LG, 2012, J THEOR BIOL, V297, P41, DOI 10.1016/j.jtbi.2011.12.001; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Pignon JP, 2007, INT J RADIAT ONCOL, V69, pS112, DOI 10.1016/j.ijrobp.2007.04.088; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Plumb JA, 2000, CANCER RES, V60, P6039; Rezaee M, 2013, INT J RADIAT ONCOL, V87, P847, DOI 10.1016/j.ijrobp.2013.06.2037; Shi W, 2009, J CLIN ONCOL, V27, P6213, DOI 10.1200/JCO.2009.23.1670; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Stewart DJ, 2009, CLIN CANCER RES, V15, P3881, DOI 10.1158/1078-0432.CCR-08-2196; TEICHER BA, 1986, CANCER RES, V46, P4379; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; VERNHAM GA, 1994, CLIN OTOLARYNGOL, V19, P120, DOI 10.1111/j.1365-2273.1994.tb01194.x; Viet CT, 2012, J DENT RES, V91, P447, DOI 10.1177/0022034511424156; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Viet CT, 2014, CLIN CANC RES; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611	33	38	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112880	10.1371/journal.pone.0112880	http://dx.doi.org/10.1371/journal.pone.0112880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391133	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400136
J	Holt, M; Lea, T; Murphy, DA; Ellard, J; Rosengarten, M; Kippax, SC; De Wit, JBF				Holt, Martin; Lea, Toby; Murphy, Dean A.; Ellard, Jeanne; Rosengarten, Marsha; Kippax, Susan C.; De Wit, John B. F.			Australian Gay and Bisexual Men's Attitudes to HIV Treatment as Prevention in Repeated, National Surveys, 2011-2013	PLOS ONE			English	Article							PREEXPOSURE PROPHYLAXIS; SEX; ACCEPTABILITY; INITIATION; INFECTION; BELIEFS; ERA	Objective: Assess the acceptability of HIV treatment as prevention and early antiretroviral treatment among gay and bisexual men in Australia and any changes in attitudes over time. Methods: National, online, cross-sectional surveys of gay and bisexual men were repeated in 2011 and 2013. Changes in attitudes to HIV treatment over time were assessed with multivariate analysis of variance. The characteristics of men who agreed that HIV treatment prevented transmission and thought that early treatment was necessary were identified with multivariate logistic regression. Results: In total, 2599 HIV-negative, untested and HIV-positive men participated (n = 1283 in 2011 and n = 1316 in 2013). Attitudes changed little between 2011 and 2013; most participants remained sceptical about the preventative benefits of HIV treatment. In 2013, only 2.6% of men agreed that HIV treatment prevented transmission; agreement was associated with being HIV-positive, having an HIV-positive regular partner, and having received HIV post-exposure prophylaxis. In contrast, 71.8% agreed that early antiretroviral treatment is necessary; younger men were more likely and HIV-positive men and participants with HIV-positive partners were much less likely to agree with this. Conclusions: Promoting the individual health benefits of HIV treatment rather than its preventative benefits remains more acceptable to Australian gay and bisexual men.	[Holt, Martin; Lea, Toby; Murphy, Dean A.; Rosengarten, Marsha; De Wit, John B. F.] UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [Murphy, Dean A.] Australian Federat AIDS Org, Sydney, NSW, Australia; [Ellard, Jeanne] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Rosengarten, Marsha] Univ London, Dept Sociol, London, England; [Kippax, Susan C.] UNSW Australia, Social Policy Res Ctr, Sydney, NSW, Australia; [De Wit, John B. F.] Univ Utrecht, Utrecht, Netherlands	University of New South Wales Sydney; La Trobe University; University of London; University of New South Wales Sydney; Utrecht University	Holt, M (corresponding author), UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia.	m.holt@unsw.edu.au	Holt, Martin/X-6482-2019	Holt, Martin/0000-0002-2586-8274; Murphy, Dean/0000-0003-2752-7091	GoldStar award; UNSW Australia	GoldStar award; UNSW Australia	The PrEPARE Project was funded by a GoldStar award and a Research Promotion Grant from UNSW Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], C RETR OPP INF BOST; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Commonwealth of Australia, 2014, 7 NAT HIV STRAT 2014; de Wit JBF, 2014, SEX HEALTH, V11, P137, DOI 10.1071/SH13142; Ezzy DM, 1998, INT J STD AIDS, V9, P579, DOI 10.1258/0956462981921152; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2013, AIDS BEHAV, V17, P2156, DOI 10.1007/s10461-012-0313-z; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Imrie J, 2007, LANCET, V370, P10, DOI 10.1016/S0140-6736(07)61026-5; Kalichman SC, 2010, HIV MED, V11, P502, DOI 10.1111/j.1468-1293.2009.00818.x; Kippax S, 2003, SOC SCI MED, V57, P1, DOI 10.1016/S0277-9536(02)00303-9; Mao LM, 2013, AIDS CARE, V25, P1375, DOI 10.1080/09540121.2013.766304; Mao LM, 2013, AIDS BEHAV, V17, P1362, DOI 10.1007/s10461-012-0406-8; Montaner JSG, 2011, LANCET, V378, P208, DOI 10.1016/S0140-6736(11)60821-0; NSW Health & New South Wales Ministry of Health, 2012, NSW HIV STRAT 2012 2; Queensland Health, 2013, QUEENSL HIV STRAT 20; Rodger AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097340; Smith AMA, 2003, AUST NZ J PUBL HEAL, V27, P138, DOI 10.1111/j.1467-842X.2003.tb00801.x; STEVENS JP, 1980, PSYCHOL BULL, V88, P728, DOI 10.1037/0033-2909.88.3.728; Van de Ven P, 2000, AIDS CARE, V12, P171, DOI 10.1080/09540120050001841; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Zablotska IB, 2011, SEX HEALTH, V8, P272, DOI 10.1071/SH10125	25	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112349	10.1371/journal.pone.0112349	http://dx.doi.org/10.1371/journal.pone.0112349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386943	gold, Green Submitted, Green Published			2022-12-26	WOS:000345250400057
J	Lippi, G; Salvagno, GL; Danese, E; Skafidas, S; Tarperi, C; Guidi, GC; Schena, F				Lippi, Giuseppe; Salvagno, Gian Luca; Danese, Elisa; Skafidas, Spyros; Tarperi, Cantor; Guidi, Gian Cesare; Schena, Federico			Mean Platelet Volume (MPV) Predicts Middle Distance Running Performance	PLOS ONE			English	Article							RICH PLASMA; HEMOGLOBIN CONCENTRATION; EXERCISE PERFORMANCE; RECREATIONAL FEMALE; DETERMINANTS; SIZE; PHYSIOLOGY; ASPIRIN; GEL	Background: Running economy and performance in middle distance running depend on several physiological factors, which include anthropometric variables, functional characteristics, training volume and intensity. Since little information is available about hematological predictors of middle distance running time, we investigated whether some hematological parameters may be associated with middle distance running performance in a large sample of recreational runners. Methods: The study population consisted in 43 amateur runners (15 females, 28 males; median age 47 years), who successfully concluded a 21.1 km half-marathon at 75-85% of their maximal aerobic power (VO(2)max). Whole blood was collected 10 min before the run started and immediately thereafter, and hematological testing was completed within 2 hours after sample collection. Results: The values of lymphocytes and eosinophils exhibited a significant decrease compared to pre-run values, whereas those of mean corpuscular volume (MCV), platelets, mean platelet volume (MPV), white blood cells (WBCs), neutrophils and monocytes were significantly increased after the run. In univariate analysis, significant associations with running time were found for pre-run values of hematocrit, hemoglobin, mean corpuscular hemoglobin (MCH), red blood cell distribution width (RDW), MPV, reticulocyte hemoglobin concentration (RetCHR), and post-run values of MCH, RDW, MPV, monocytes and RetCHR. In multivariate analysis, in which running time was entered as dependent variable whereas age, sex, blood lactate, body mass index, VO(2)max, mean training regimen and the hematological parameters significantly associated with running performance in univariate analysis were entered as independent variables, only MPV values before and after the trial remained significantly associated with running time. After adjustment for platelet count, the MPV value before the run (p = 0.042), but not thereafter (p = 0.247), remained significantly associated with running performance. Conclusion: The significant association between baseline MPV and running time suggest that hyperactive platelets may exert some pleiotropic effects on endurance performance.	[Lippi, Giuseppe] Acad Hosp Parma, Lab Clin Chem & Hematol, Parma, Italy; [Salvagno, Gian Luca; Danese, Elisa; Guidi, Gian Cesare] Univ Verona, Dept Life & Reprod Sci, Lab Clin Biochem, I-37100 Verona, Italy; [Skafidas, Spyros] CeRiSM Ctr Mt Sport & Hlth, Rovereto, TN, Italy; [Tarperi, Cantor; Schena, Federico] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy	University of Parma; University Hospital of Parma; University of Verona; University of Verona	Lippi, G (corresponding author), Acad Hosp Parma, Lab Clin Chem & Hematol, Parma, Italy.	glippi@ao.pr.it	Guidi, Gian Cesare/AAG-8463-2019; Salvagno, Gian Luca/R-3857-2016; Danese, Elisa/N-2848-2016; Lippi, Giuseppe/X-7198-2018	Guidi, Gian Cesare/0000-0002-4682-7834; Danese, Elisa/0000-0002-2454-0410; Lippi, Giuseppe/0000-0001-9523-9054; SALVAGNO, GIAN LUCA/0000-0003-0487-9051				Andia I, 2014, BRIT MED BULL, V110, P99, DOI 10.1093/bmb/ldu007; Bakovic D, 2013, CLIN PHYSIOL FUNCT I, V33, P30, DOI 10.1111/j.1475-097X.2012.01156.x; BRANDON LJ, 1995, SPORTS MED, V19, P268, DOI 10.2165/00007256-199519040-00004; Calbet JAL, 2006, RESP PHYSIOL NEUROBI, V151, P132, DOI 10.1016/j.resp.2006.01.014; Cho HC, 2012, NEUROSCI LETT, V519, P78, DOI 10.1016/j.neulet.2012.05.025; Colkesen Y, 2012, CLIN CHEM LAB MED, V50, P631, DOI 10.1515/CCLM.2011.806; Del Coso J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057602; Everts PA, 2008, EUR SURG RES, V40, P203, DOI 10.1159/000110862; Fanning J, 2007, J MINIM INVAS GYN, V14, P633, DOI 10.1016/j.jmig.2007.05.014; Gardner MJ, 2007, INT ORTHOP, V31, P309, DOI 10.1007/s00264-006-0174-z; Guthikonda S, 2008, J AM COLL CARDIOL, V52, P743, DOI 10.1016/j.jacc.2008.05.031; Hamid MSA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090538; Hilberg T, 2008, THROMB RES, V122, P77, DOI 10.1016/j.thromres.2007.08.018; Jones AM, 2013, SPORTS MED S1, V44, pS35; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Joyner MJ, 2003, BRIT J SPORT MED, V37, P190, DOI 10.1136/bjsm.37.3.190; KANSTRUP IL, 1984, MED SCI SPORT EXER, V16, P256; Kasuya N, 2002, ATHEROSCLEROSIS, V161, P225, DOI 10.1016/S0021-9150(01)00629-3; Kennedy G, 2006, BLOOD COAGUL FIBRIN, V17, P89, DOI 10.1097/01.mbc.0000214705.80997.73; Knechtle B, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-248; Knechtle B, 2011, PHYSICIAN SPORTSMED, V39, P158, DOI 10.3810/psm.2011.05.1907; KNUDSEN JB, 1982, SCAND J HAEMATOL, V29, P425; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Kuffler DP, 2013, MOL NEUROBIOL, V48, P315, DOI 10.1007/s12035-013-8494-7; Li NL, 2007, ARTERIOSCL THROM VAS, V27, P407, DOI 10.1161/01.ATV.0000253906.19648.ac; Lippi G, 2010, BLOOD TRANSFUS, V10, P377; Lippi G, 2006, CRIT REV CL LAB SCI, V43, P349, DOI 10.1080/10408360600755313; Lippi Giuseppe, 2014, Adv Hematol, V2014, P192173, DOI 10.1155/2014/192173; Mangalpally KKR, 2010, J THROMB THROMBOLYS, V30, P251, DOI 10.1007/s11239-010-0489-x; Mei-Dan O, 2010, PHYSICIAN SPORTSMED, V38, P127, DOI 10.3810/psm.2010.12.1835; Midgley AW, 2007, SPORTS MED, V37, P857, DOI 10.2165/00007256-200737100-00003; Mishra A, 2012, CURR PHARM BIOTECHNO, V13, P1185, DOI 10.2174/138920112800624283; Otto JM, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-33; Petidis K, 2013, J HYPERTENS, V31, DOI [10.1097/HJH.0b013e32836434ca, 10.1097/HJH.0b013e32836434ba]; Raeissadat SA, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/191525; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Wasterlain AS, 2013, AM J SPORT MED, V41, P186, DOI 10.1177/0363546512466383; Whittaker JP, 2013, MED SCI SPORT EXER, V45, P342, DOI 10.1249/MSS.0b013e31827039db; Williams C, 1983, Br J Sports Med, V17, P152; World Anti-Doping Agency, 2014 PROH LIST; Yilmaz MB, 2004, J THROMB THROMBOLYS, V17, P115, DOI 10.1023/B:THRO.0000037666.01018.8c	42	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112892	10.1371/journal.pone.0112892	http://dx.doi.org/10.1371/journal.pone.0112892			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386658	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400100
J	Shen, CJ; Yue, RQ; Yang, YJ; Zhang, L; Sun, T; Tie, SG; Wang, HZ				Shen, Chenjia; Yue, Runqing; Yang, Yanjun; Zhang, Lei; Sun, Tao; Tie, Shuanggui; Wang, Huizhong			OsARF16 Is Involved in Cytokinin-Mediated Inhibition of Phosphate Transport and Phosphate Signaling in Rice (Oryza sativa L.)	PLOS ONE			English	Article							AUXIN RESPONSE FACTOR; ACID-PHOSPHATASE; TRANSCRIPTION FACTOR; CELL-DIVISION; STARVATION RESPONSE; ROOT-FORMATION; ARABIDOPSIS; GENE; EXPRESSION; REGULATOR	Background: Plant responses to phytohormone stimuli are the most important biological features for plants to survive in a complex environment. Cytokinin regulates growth and nutrient homeostasis, such as the phosphate (Pi) starvation response and Pi uptake in plants. However, the mechanisms underlying how cytokinin participates in Pi uptake and Pi signaling are largely unknown. In this study, we found that OsARF16 is required for the cytokinin response and is involved in the negative regulation of Pi uptake and Pi signaling by cytokinin. Principal Findings: The mutant osarf16 showed an obvious resistance to exogenous cytokinin treatment and the expression level of the OsARF16 gene was considerably up-regulated by cytokinin. Cytokinin (6-BA) application suppressed Pi uptake and the Pi starvation response in wild-type Nipponbare (NIP) and all these responses were compromised in the osarf16 mutant. Our data showed that cytokinin inhibits the transport of Pi from the roots to the shoots and that OsARF16 is involved in this process. The Pi content in the osarf16 mutant was much higher than in NIP under 6-BA treatment. The expressions of PHOSPHATE TRANSPORTER1 (PHT1) genes, phosphate (Pi) starvation-induced (PSI) genes and purple PAPase genes were higher in the osarf16 mutant than in NIP under cytokinin treatment. Conclusion: Our results revealed a new biological function for OsARF16 in the cytokinin-mediated inhibition of Pi uptake and Pi signaling in rice.	[Shen, Chenjia; Yang, Yanjun; Sun, Tao; Wang, Huizhong] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China; [Yue, Runqing; Tie, Shuanggui] Henan Acad Agr Sci, Zhengzhou 450002, Peoples R China; [Zhang, Lei] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	Hangzhou Normal University; Henan Academy of Agricultural Sciences; Washington State University	Shen, CJ (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China.	shencj@hznu.edu.cn; tieshuanggui@126.com; whz62@163.com			National Natural Science Foundation of China [31401935]; Zhejiang Provincial Natural Science Foundation of China [LQ14C060001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was funded by the National Natural Science Foundation of China (31401935) and Zhejiang Provincial Natural Science Foundation of China under Grant No. LQ14C060001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2011, P NATL ACAD SCI USA, V108, P20242, DOI 10.1073/pnas.1111902108; Ai PH, 2009, PLANT J, V57, P798, DOI 10.1111/j.1365-313X.2008.03726.x; An LJ, 2012, PLANT J, V72, P474, DOI 10.1111/j.1365-313X.2012.05094.x; Bielach A, 2012, PHILOS T R SOC B, V367, P1469, DOI 10.1098/rstb.2011.0233; Bozzo GG, 2006, PLANT CELL ENVIRON, V29, P303, DOI 10.1111/j.1365-3040.2005.01422.x; Chang L, 2013, J EXP BOT, V64, P5021, DOI 10.1093/jxb/ert291; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Du LM, 2007, GENOMICS, V89, P697, DOI 10.1016/j.ygeno.2007.02.001; Essigmann B, 1998, P NATL ACAD SCI USA, V95, P1950, DOI 10.1073/pnas.95.4.1950; Franco-Zorrilla JM, 2002, PLANT J, V32, P353, DOI 10.1046/j.1365-313X.2002.01431.x; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Ito Y, 2006, GENE, V382, P57, DOI 10.1016/j.gene.2006.06.020; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karthikeyan AS, 2002, PLANT PHYSIOL, V130, P221, DOI 10.1104/pp.020007; Kitomi Y, 2011, PLANT J, V67, P472, DOI 10.1111/j.1365-313X.2011.04610.x; Laplaze L, 2007, PLANT CELL, V19, P3889, DOI 10.1105/tpc.107.055863; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Marhavy P, 2014, CURR BIOL, V24, P1031, DOI 10.1016/j.cub.2014.04.002; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Perilli S, 2013, PLANT CELL, V25, P4469, DOI 10.1105/tpc.113.116632; Ribot C, 2008, PLANTA, V227, P1025, DOI 10.1007/s00425-007-0677-x; Robinson WD, 2012, J EXP BOT, V63, P6531, DOI 10.1093/jxb/ers309; Sakamoto T, 2013, PLANT J, V73, P676, DOI 10.1111/tpj.12071; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shen CJ, 2013, PLANT CELL ENVIRON, V36, P607, DOI 10.1111/pce.12001; Shin H, 2006, PLANT J, V45, P712, DOI 10.1111/j.1365-313X.2005.02629.x; Sun SB, 2012, PLANT PHYSIOL, V159, P1571, DOI 10.1104/pp.112.196345; Tian JL, 2012, J INTEGR PLANT BIOL, V54, P631, DOI 10.1111/j.1744-7909.2012.01143.x; Trull MC, 1998, PLANTA, V206, P544, DOI 10.1007/s004250050431; Vandenbussche F, 2013, AM J BOT, V100, P215, DOI 10.3732/ajb.1200264; Wang C, 2009, PLANT J, V57, P895, DOI 10.1111/j.1365-313X.2008.03734.x; Wang SK, 2014, NEW PHYTOL, V201, P91, DOI 10.1111/nph.12499; Wang XM, 2010, PLANT CELL PHYSIOL, V51, P380, DOI 10.1093/pcp/pcq004; Wang XM, 2006, PLANT CELL ENVIRON, V29, P1924, DOI 10.1111/j.1365-3040.2006.01568.x; Wu B, 2011, MOL BIOL REP, V38, P3189, DOI 10.1007/s11033-010-9990-8; Yang DL, 2013, MOL PLANT, V6, P675, DOI 10.1093/mp/sst056; Zhang WJ, 2013, CURR BIOL, V23, P1979, DOI 10.1016/j.cub.2013.08.008	47	30	37	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112906	10.1371/journal.pone.0112906	http://dx.doi.org/10.1371/journal.pone.0112906			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386911	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400104
J	Sun, ZQ; Meng, HL; Li, J; Wang, JF; Li, Q; Wang, Y; Zhang, YS				Sun, Zhiqiang; Meng, Hailin; Li, Jing; Wang, Jianfeng; Li, Qian; Wang, Yong; Zhang, Yansheng			Identification of Novel Knockout Targets for Improving Terpenoids Biosynthesis in Saccharomyces cerevisiae	PLOS ONE			English	Article							CONSTRAINT-BASED MODELS; ESCHERICHIA-COLI; QUANTITATIVE PREDICTION; CELLULAR-METABOLISM; COBRA TOOLBOX; BUDDING YEAST; EXPRESSION; GENE; MITOCHONDRIAL; PATHWAY	Many terpenoids have important pharmacological activity and commercial value; however, application of these terpenoids is often limited by problems associated with the production of sufficient amounts of these molecules. The use of Saccharomyces cerevisiae (S. cerevisiae) for the production of heterologous terpenoids has achieved some success. The objective of this study was to identify S. cerevisiae knockout targets for improving the synthesis of heterologous terpeniods. On the basis of computational analysis of the S. cerevisiae metabolic network, we identified the knockout sites with the potential to promote terpenoid production and the corresponding single mutant was constructed by molecular manipulations. The growth rates of these strains were measured and the results indicated that the gene deletion had no adverse effects. Using the expression of amorphadiene biosynthesis as a testing model, the gene deletion was assessed for its effect on the production of exogenous terpenoids. The results showed that the dysfunction of most genes led to increased production of amorphadiene. The yield of amorphadiene produced by most single mutants was 8-10-fold greater compared to the wild type, indicating that the knockout sites can be engineered to promote the synthesis of exogenous terpenoids.	[Sun, Zhiqiang; Li, Jing; Li, Qian; Zhang, Yansheng] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Peoples R China; [Meng, Hailin; Wang, Jianfeng; Wang, Yong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Meng, Hailin] Chinese Acad Sci, Guangzhou Inst Adv Technol, GIAT HKU Joint Ctr Synthet Biol Engn Res, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	yongwang@sibs.ac.cn; zhangys@wbgcas.cn			National Science and Technology Program of China [2012AA02A704]; Grant for One Hundred Talents Program of the Chinese Academy of Sciences [Y129441R01]; "973'' project of China [2012CB721104]	National Science and Technology Program of China; Grant for One Hundred Talents Program of the Chinese Academy of Sciences; "973'' project of China(National Basic Research Program of China)	This work was supported by the National Science and Technology Program of China during the 25th-year plan period (grant no. 2012AA02A704), the Grant for One Hundred Talents Program of the Chinese Academy of Sciences to YZ (grant no. Y129441R01) and the "973'' project of China to YW (grant no. 2012CB721104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera J, 2001, CURR GENET, V39, P273, DOI 10.1007/s002940100213; Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Albers E, 2003, J BIOL CHEM, V278, P10264, DOI 10.1074/jbc.M211692200; Arigoni D, 1997, P NATL ACAD SCI USA, V94, P10600, DOI 10.1073/pnas.94.20.10600; Asadollahi MA, 2008, BIOTECHNOL BIOENG, V99, P666, DOI 10.1002/bit.21581; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Castegna A, 2010, J BIOL CHEM, V285, P17359, DOI 10.1074/jbc.M109.097188; Claeyssen E, 2007, PHYTOCHEMISTRY, V68, P709, DOI 10.1016/j.phytochem.2006.12.001; Contreras-Shannon V, 2005, J BIOL CHEM, V280, P4469, DOI 10.1074/jbc.M410140200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; Garcia-Campusano F, 2009, CAN J MICROBIOL, V55, P368, DOI [10.1139/W08-150, 10.1139/w08-150]; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Kaplan RS, 1996, BIOCHEM BIOPH RES CO, V226, P657, DOI 10.1006/bbrc.1996.1411; Ketchum REB, 1996, PLANT CELL TISS ORG, V46, P9, DOI 10.1007/BF00039691; Kim H, 2011, MICROBIOL-SGM, V157, P2658, DOI 10.1099/mic.0.052506-0; Lindahl AL, 2006, BIOTECHNOL LETT, V28, P571, DOI 10.1007/s10529-006-0015-6; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; McCammon MT, 2003, ARCH BIOCHEM BIOPHYS, V419, P222, DOI 10.1016/j.abb.2003.08.022; Meng HL, 2011, BIOTECHNOL BIOPROC E, V16, P205, DOI 10.1007/s12257-010-0329-z; MURAKAMI H, 1990, J BIOCHEM, V108, P859, DOI 10.1093/oxfordjournals.jbchem.a123293; NEGM FB, 1979, PLANT PHYSIOL, V64, P69, DOI 10.1104/pp.64.1.69; Newman JD, 2006, BIOTECHNOL BIOENG, V95, P684, DOI 10.1002/bit.21017; Oswald M, 2007, FEMS YEAST RES, V7, P413, DOI 10.1111/j.1567-1364.2006.00172.x; Ozaydin B, 2012, METABOLIC ENG; Paddon CJ, 2013, NATURE; Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019; Penalosa-Ruiz G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045702; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schoendorf A, 2001, P NATL ACAD SCI USA, V98, P1501, DOI 10.1073/pnas.98.4.1501; Schwartz K, 2012, GENETICS, V191, P621, DOI 10.1534/genetics.112.140053; SWINDELL CS, 1994, BIOORG MED CHEM LETT, V4, P1531, DOI 10.1016/S0960-894X(01)80527-8; Takahashi S, 2007, BIOTECHNOL BIOENG, V97, P170, DOI 10.1002/bit.21216; Toivari MH, 2004, APPL ENVIRON MICROB, V70, P3681, DOI 10.1128/aem.70.6.3681-3686.2004; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Zhang YS, 2011, PLANT BIOTECHNOL J, V9, P445, DOI 10.1111/j.1467-7652.2010.00556.x; Zomorrodi AR, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-178	42	23	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112615	10.1371/journal.pone.0112615	http://dx.doi.org/10.1371/journal.pone.0112615			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386654	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400072
J	Gul, T; Islam, S; Shah, RA; Khan, I; Khalid, A; Shafie, S				Gul, Taza; Islam, Saeed; Shah, Rehan Ali; Khan, Ilyas; Khalid, Asma; Shafie, Sharidan			Heat Transfer Analysis of MHD Thin Film Flow of an Unsteady Second Grade Fluid Past a Vertical Oscillating Beltl	PLOS ONE			English	Article							HOMOTOPY ASYMPTOTIC METHOD; ADOMIAN DECOMPOSITION METHOD; RELIABLE TREATMENT; STARTING SOLUTIONS; MICROFLUIDICS; CONVECTION	This article aims to study the thin film layer flowing on a vertical oscillating belt. The flow is considered to satisfy the constitutive equation of unsteady second grade fluid. The governing equation for velocity and temperature fields with subjected initial and boundary conditions are solved by two analytical techniques namely Adomian Decomposition Method (ADM) and Optimal Homotopy Asymptotic Method (OHAM). The comparisons of ADM and OHAM solutions for velocity and temperature fields are shown numerically and graphically for both the lift and drainage problems. It is found that both these solutions are identical. In order to understand the physical behavior of the embedded parameters such as Stock number, frequency parameter, magnetic parameter, Brinkman number and Prandtl number, the analytical results are plotted graphically and discussed.	[Gul, Taza; Islam, Saeed] Abdul Wali Khan Univ, Dept Math, Mardan Khyber Pakhtunkhw, Pakistan; [Shah, Rehan Ali] Univ Engn & Technol, Dept Math, Peshawar Khyber Pakhtunk, Pakistan; [Khan, Ilyas] Majmaah Univ, Coll Engn, Dept Basic Sci, Majmaah, Saudi Arabia; [Khalid, Asma; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Utm Johor Bahru, Johor, Malaysia	Majmaah University; Universiti Teknologi Malaysia	Shafie, S (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Utm Johor Bahru, Johor, Malaysia.	sharidan@utm.my	Saeed, Islam/AAD-6067-2020; Gul, Taza/R-7774-2019; Khan, Ilyas/C-8770-2019	Saeed, Islam/0000-0001-5263-4871; Gul, Taza/0000-0003-1376-8345; Khan, Ilyas/0000-0002-2056-9371				Adomian G., 1994, COATINGS; Adomian G, 1992, MATH COMPUT MODEL, V13, P287; Ali F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085099; Ancey C, 2007, J NON-NEWTON FLUID, V142, P4, DOI 10.1016/j.jnnfm.2006.05.005; CHERRUAULT Y, 1989, KYBERNETES, V18, P31, DOI 10.1108/eb005812; CHERRUAULT Y, 1993, MATH COMPUT MODEL, V18, P103, DOI 10.1016/0895-7177(93)90233-O; Fetecau C, 2006, INT J ENG SCI, V44, P788, DOI 10.1016/j.ijengsci.2006.04.010; Fetecau C, 2005, INT J ENG SCI, V43, P781, DOI 10.1016/j.ijengsci.2004.12.009; Griffiths RW, 2000, ANNU REV FLUID MECH, V32, P477, DOI 10.1146/annurev.fluid.32.1.477; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097552; Gul T, 2013, J APPL MATH, DOI 10.1155/2013/707286; HAN CD, 1978, POLYM ENG SCI, V18, P1019, DOI 10.1002/pen.760181309; Kamran AM, 2012, APPL MATH COMPUT, P10413; Khan NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095423; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Mabood F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083581; Marinca V, 2008, CENT EUR J PHYS, V6, P648, DOI [10.2478/s11534-008-0061-x, 10.2478/S11534-008-0061-x]; Marinca V, 2008, INT COMMUN HEAT MASS, V35, P710, DOI 10.1016/j.icheatmasstransfer.2008.02.010; Marinca V, 2009, APPL MATH LETT, V22, P245, DOI 10.1016/j.aml.2008.03.019; Miladinova S, 2004, J NON-NEWTON FLUID, V122, P69, DOI 10.1016/j.jnnfm.2004.01.021; Qasim M, 2013, ALEX ENG J, V52, P571, DOI 10.1016/j.aej.2013.08.004; Qasim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083930; Qasim M, 2012, Z NATURFORSCH A, V67, P195, DOI 10.5560/ZNA.2012-0006; Samiulhaq, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088766; Shah AR, 2011, J KSIAM, P201; Squires TM, 2005, REV MOD PHYS, V77, P977, DOI 10.1103/RevModPhys.77.977; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Wang SW, 2008, PHYS LETT A, V372, P3046, DOI 10.1016/j.physleta.2008.01.024; Wang SW, 2011, INT J HEAT FLUID FL, V32, P88, DOI 10.1016/j.ijheatfluidflow.2010.10.005; Wazwaz AM, 2005, APPL MATH COMPUT, V166, P652, DOI 10.1016/j.amc.2004.06.059; Wazwaz AM, 2005, APPL MATH COMPUT, V161, P543, DOI 10.1016/j.amc.2003.12.048; Weinstein SJ, 2004, ANNU REV FLUID MECH, V36, P29, DOI 10.1146/annurev.fluid.36.050802.122049; Zhao ML, 2014, APPL MATH MODEL, V38, P2345, DOI 10.1016/j.apm.2013.10.053; Zhao ML, 2014, J APPL MATH, DOI 10.1155/2014/489279; Zhao ML, 2013, J NON-NEWTON FLUID, V201, P135, DOI 10.1016/j.jnnfm.2013.09.002	35	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e103843	10.1371/journal.pone.0103843	http://dx.doi.org/10.1371/journal.pone.0103843			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383797	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700001
J	Hsu, YH; Huang, CF; Tu, MC; Hua, MS				Hsu, Yen-Hsuan; Huang, Ching-Feng; Tu, Min-Chien; Hua, Mau-Sun			The Clinical Utility of Informants' Appraisals on Prospective and Retrospective Memory in Patients with Early Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; OLDER-ADULTS; LATENT STRUCTURE; EVERYDAY MEMORY; NORMATIVE DATA; QUESTIONNAIRE PRMQ; EARLY DEMENTIA; SELF-REPORTS; COMPLAINTS; INTENTIONS	Increasing studies suggest the importance of including prospective memory measures in clinical evaluation of dementia due to its sensitivity and functional relevance. The Prospective and Retrospective Memory Questionnaire (PRQM) is originally a self-rated memory inventory that offers a direct comparison between prospective and episodic memory. However, the informant's report has been recognized as a more valid source of cognitive complaints. We thus aimed to examine the validity of the informant-rated form of the PRMQ in assessing memory function of the patients and in detecting individuals with early dementia. The informants of 140 neurological outpatients with memory complaints completed the Taiwan version of the PRMQ. Tests of prospective memory, short-term memory, and general cognitive ability were also administered to non-demented participants and patients with early stages of Alzheimer's disease (AD). Results showed significant relationships between the PRMQ ratings and objective cognitive measures, and showed that higher ratings on the PRMQ were associated with increasing odds of greater dementia severity. Receiver operative characteristic (ROC) curves showed an adequate ability of the PRMQ to identify patients with dementia (93% sensitivity and 84% specificity). Hierarchical regression revealed that the PRMQ has additional explanatory power for dementia status after controlling for age, education and objective memory test results, and that the prospective memory subscale owns predictive value for dementia beyond the retrospective memory subscale. The present study demonstrated the external validity and diagnostic value of informants' evaluation of their respective patients' prospective and retrospective memory functioning, and highlighted the important role of prospective memory in early dementia detection. The proxy-version of the PRMQ is a useful tool that captures prospective and episodic memory problems in patients with early AD, in combination with standardized cognitive testing.	[Hsu, Yen-Hsuan; Hua, Mau-Sun] Natl Taiwan Univ, Coll Sci, Dept Psychol, Taipei 10764, Taiwan; [Hsu, Yen-Hsuan; Huang, Ching-Feng; Tu, Min-Chien] Buddhist Tzu Chi Med Fdn, Taichung Tzu Chi Hosp, Dept Neurol, Taichung, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Psychiat, Taipei 10764, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Neurol, Taipei 10764, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Coll Med, Grad Inst Brain & Mind Sci, Taipei 10764, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan	National Taiwan University; Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Hua, MS (corresponding author), Natl Taiwan Univ, Coll Sci, Dept Psychol, Taipei 10764, Taiwan.	huams@ntu.edu.tw			National Science Council, Taipei, Taiwan [NSC102-2410-H-002-051-MY3]	National Science Council, Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by a grant from National Science Council, Taipei, Taiwan (NSC102-2410-H-002-051-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2011, RADIOLOGY, V258, P853, DOI 10.1148/radiol.10101284; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Blanco-Campal A, 2009, J INT NEUROPSYCH SOC, V15, P154, DOI 10.1017/S1355617708090127; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Carr DB, 2000, NEUROLOGY, V55, P1724, DOI 10.1212/WNL.55.11.1724; Clune-Ryberg M, 2011, BRAIN INJURY, V25, P819, DOI 10.3109/02699052.2011.589790; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Cornish IM, 2000, BRIT J PSYCHOL, V91, P427, DOI 10.1348/000712600161916; Cosentino S, 2007, CORTEX, V43, P1004, DOI 10.1016/S0010-9452(08)70697-X; Costa A, 2010, NEUROPSYCHOLOGY, V24, P327, DOI 10.1037/a0018015; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; Crawford JR, 2006, BRIT J CLIN PSYCHOL, V45, P83, DOI 10.1348/014466505X28748; CROOK TH, 1990, PSYCHOL AGING, V5, P48, DOI 10.1037/0882-7974.5.1.48; Delprado J, 2012, J INT NEUROPSYCH SOC, V18, P295, DOI 10.1017/S135561771100172X; Dieckmann P, 2006, ERGONOMICS, V49, P526, DOI 10.1080/00140130600568782; DOBBS AR, 1987, CAN J PSYCHOL, V41, P209, DOI 10.1037/h0084152; Dong YH, 2013, J ALZHEIMERS DIS, V35, P159, DOI 10.3233/JAD-122026; Duchek JM, 2006, NEUROPSYCHOLOGY, V20, P633, DOI 10.1037/0894-4105.20.6.633; Eschen A, 2009, BRAIN IMPAIR, V10, P59, DOI 10.1375/brim.10.1.59; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Heffernan TM, 2012, DRUG ALCOHOL DEPEN, V120, P1, DOI 10.1016/j.drugalcdep.2011.06.010; Hsu YH, 2011, ARCH CLIN NEUROPSYCH, V26, P240, DOI 10.1093/arclin/acr012; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Isella V, 2006, J NEUROL NEUROSUR PS, V77, P166, DOI 10.1136/jnnp.2005.069765; Jones S, 2006, NEUROPSYCHOLOGY, V20, P144, DOI 10.1037/0894-4105.20.2.144; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Karantzoulis S, 2009, J INT NEUROPSYCH SOC, V15, P407, DOI 10.1017/S1355617709090596; Kazui H, 2005, DEMENT GERIATR COGN, V19, P331, DOI 10.1159/000084559; Kinsella GJ, 2007, NEUROPSYCHOL REHABIL, V17, P688, DOI 10.1080/09602010600892824; KOSS E, 1993, ARCH NEUROL-CHICAGO, V50, P92, DOI 10.1001/archneur.1993.00540010086023; Kvavilashvili L, 1998, APPL COGNITIVE PSYCH, V12, P533, DOI 10.1002/(SICI)1099-0720(1998120)12:6<533::AID-ACP538>3.0.CO;2-1; Lin Ker-Neng, 2012, Acta Neurol Taiwan, V21, P180; Martins SP, 2008, ARQ NEURO-PSIQUIAT, V66, P318, DOI 10.1590/S0004-282X2008000300006; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Piauilino DC, 2010, MEMORY, V18, P413, DOI 10.1080/09658211003742672; Rabin LA, 2012, J AM GERIATR SOC, V60, P1128, DOI 10.1111/j.1532-5415.2012.03956.x; Razavi M, 2013, COMP 2 INFORM QUESTI; Ready RE, 2004, ALZ DIS ASSOC DIS, V18, P11, DOI 10.1097/00002093-200401000-00003; Roberts JL, 2009, DEMENT GERIATR COGN, V28, P95, DOI 10.1159/000234911; Ronnlund M, 2011, J GENET PSYCHOL, V172, P266, DOI 10.1080/00221325.2010.538450; Salthouse TA, 2004, MEM COGNITION, V32, P1133, DOI 10.3758/BF03196887; Schnitzspahn KM, 2013, DEV PSYCHOL, V49, P1544, DOI 10.1037/a0030579; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Singer JJ, 2006, BEHAV GENET, V36, P18, DOI 10.1007/s10519-005-9011-1; Smith G, 2000, MEMORY, V8, P311, DOI 10.1080/09658210050117735; Smith GE, 1996, PSYCHOL AGING, V11, P272, DOI 10.1037/0882-7974.11.2.272; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Thompson C, 2010, J INT NEUROPSYCH SOC, V16, P318, DOI 10.1017/S1355617709991354; Troyer AK, 2007, J INT NEUROPSYCH SOC, V13, P365, DOI 10.1017/S1355617707070452; Van der Elst W, 2008, ARCH CLIN NEUROPSYCH, V23, P787, DOI 10.1016/j.acn.2008.09.002; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263; Woods SP, 2009, J INT NEUROPSYCH SOC, V15, P42, DOI 10.1017/S1355617708090012; Zeintl M, 2007, PSYCHOL AGING, V22, P826, DOI 10.1037/0882-7974.22.4.826; Zeintl M, 2006, DEMENT GERIATR COGN, V22, P209, DOI 10.1159/000094915; Zhuang L, 2012, NEUROLOGY, V79, P748, DOI 10.1212/WNL.0b013e3182661f4d	64	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112210	10.1371/journal.pone.0112210	http://dx.doi.org/10.1371/journal.pone.0112210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT3DP	25383950	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700039
J	Ruan, J; Zheng, H; Fu, WG; Zhao, P; Su, N; Luo, RC				Ruan, Jian; Zheng, Hang; Fu, Wenguang; Zhao, Peng; Su, Ning; Luo, Rongcheng			Increased Expression of Cathepsin L: A Novel Independent Prognostic Marker of Worse Outcome in Hepatocellular Carcinoma Patients	PLOS ONE			English	Article							IN-VITRO; PROGRESSION; APOPTOSIS; INVASION; CELLS	Objectives: To investigate the expression and role of Cathepsin L (CTSL) in Hepatocellular carcinoma (HCC) tissue and cell line (MHCC-97H), and to evaluate the clinical and prognostic significance of CTSL protein in patients with HCC. Methods: The expression of CTSL was examined in HCC tissue and MHCC-97H cells by Western-blotting, Real-time PCR and immunohistochemical staining. Cell growth curve assay and colony formation assay were used to verify the effect of CTSL on the proliferation and tumor progression ability of MHCC-97H cells. Tumor formation assay in nude mice was used to analyze the effect of CTSL on the tumorigenicity of MHCC-97H cells. Results: The status of CTSL protein in carcinoma tissues is much higher than that in paracarcinoma tissues. The overall survival of the patients with high CTSL expression was significantly shorter than the low CTSL expression group. high CTSL expression was significantly correlated with advanced clinical staging, histological grade and tumor recurrence. In vitro experiments demonstrated that over-expression of CTSL in MHCC-97H cells promoted cell proliferation and tumor progression ability. Down-regulation of CTSL showed the opposite effects. Over-expression of CTSL increase the tumorigenicity of MHCC-97H cells by in vivo experiments. Moreover, multivariate analysis suggested that CTSL expression might be an independent prognostic indicator for the survival of HCC patients after curative surgery. Conclusions: CTSL might involve in the development and progression of HCC as a oncogene, and thereby may be a valuable prognostic marker for HCC patients.	[Ruan, Jian; Zheng, Hang; Luo, Rongcheng] Southern Med Univ, Tradit Chinese Med Integrated Hosp, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Fu, Wenguang] Luzhou Med Coll, Affiliated Hosp, Dept Hepatobiliary Surg, Luzhou, Sichuan, Peoples R China; [Zhao, Peng] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Su, Ning] Guangzhou Chest Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southwest Medical University; Zhejiang University	Ruan, J (corresponding author), Southern Med Univ, Tradit Chinese Med Integrated Hosp, Ctr Canc, Guangzhou, Guangdong, Peoples R China.	software23@163.com; luorc0001@126.com	ruan, jian/AAY-3629-2020; WENGUANG, FU/AAI-1142-2019; fu, wenguang/ABI-7883-2020	ruan, jian/0000-0003-1354-4720; 	National Natural Science Foundation of China [81001212]; Science and Technology Foundation of Zhejiang Province [2012C33011]; Foundation of State Key Laboratory of Oncology in South China [HN2011-03]; Zhejiang Provincial Chinese Medicine Research Foundation [2010ZB062, 2011ZQ012]; Foundation of Zhejiang Provincial Educational Committee [Y201019175]; Natural Science Foundation of Guangdong [s2012010008209]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Zhejiang Province; Foundation of State Key Laboratory of Oncology in South China; Zhejiang Provincial Chinese Medicine Research Foundation; Foundation of Zhejiang Provincial Educational Committee; Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This project is supported by the National Natural Science Foundation of China (Grant No. 81001212), The Science and Technology Foundation of Zhejiang Province (Grant No. 2012C33011), Foundation of State Key Laboratory of Oncology in South China (Grant No. HN2011-03), Zhejiang Provincial Chinese Medicine Research Foundation (Grant No. 2010ZB062, 2011ZQ012), Foundation of Zhejiang Provincial Educational Committee (Grant No. Y201019175), and Natural Science Foundation of Guangdong (Grant No. s2012010008209). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capocaccia R, 2007, AM J GASTROENTEROL, V102, P1661, DOI 10.1111/j.1572-0241.2007.01337.x; CHAUHAN SS, 1991, CANCER RES, V51, P1478; Colella R, 2003, BIOTECH HISTOCHEM, V78, P101, DOI 10.1080/10520290310001593856; Jagodic M, 2005, NEOPLASMA, V52, P1; Jean D, 2006, ONCOGENE, V25, P1474, DOI 10.1038/sj.onc.1209196; Kane S E, 1990, Semin Cancer Biol, V1, P127; Kenig S, 2011, APOPTOSIS, V16, P671, DOI 10.1007/s10495-011-0600-6; KIRSCHKE H, 1977, EUR J BIOCHEM, V74, P293, DOI 10.1111/j.1432-1033.1977.tb11393.x; Levicar N, 2003, CANCER GENE THER, V10, P141, DOI 10.1038/sj.cgt.7700546; Macabeo-Ong M, 2003, ORAL ONCOL, V39, P638, DOI 10.1016/S1368-8375(03)00034-4; Miyamoto K, 2011, INT J ONCOL, V39, P1109, DOI 10.3892/ijo.2011.1127; Niedergethmann M, 2004, PANCREAS, V29, P204, DOI 10.1097/00006676-200410000-00005; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; Strojnik T, 2005, CANCER DETECT PREV, V29, P448, DOI 10.1016/j.cdp.2005.07.006; Sullivan S, 2009, INT J CANCER, V125, P54, DOI 10.1002/ijc.24275; Wille A, 2004, BIOL CHEM, V385, P665, DOI 10.1515/BC.2004.082; Xu X., 2009, Experimental Oncology, V31, P102; Yan JA, 2010, J INT MED RES, V38, P1913, DOI 10.1177/147323001003800604; Yang Z, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-8; Zajc I, 2006, ANTICANCER RES, V26, P3357; Zheng X, 2009, AM J PHYSIOL-CELL PH, V296, pC65, DOI 10.1152/ajpcell.00082.2008	22	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112136	10.1371/journal.pone.0112136	http://dx.doi.org/10.1371/journal.pone.0112136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384089	Green Submitted, gold, Green Published			2022-12-26	WOS:000344816700032
J	Brun, PJ; Grijalva, A; Rausch, R; Watson, E; Yuen, JJ; Das, BC; Shudo, K; Kagechika, H; Leibel, RL; Blaner, WS				Brun, Pierre-Jacques; Grijalva, Ambar; Rausch, Richard; Watson, Elizabeth; Yuen, Jason J.; Das, Bhaskar C.; Shudo, Koichi; Kagechika, Hiroyuki; Leibel, Rudolph L.; Blaner, William S.			Retinoic acid receptor signaling is required to maintain glucose-stimulated insulin secretion and beta-cell mass	FASEB JOURNAL			English	Article						glucagon; retinoid; dominant-negative RAR; pancreatic islet; Cre recombinase	DOMINANT-NEGATIVE FORM; VITAMIN-A-DEFICIENCY; GENE-EXPRESSION; PANCREATIC-ISLETS; BINDING PROTEINS; THYROID-HORMONE; TRANSGENIC MICE; MESSENGER-RNA; RAT; ALPHA	Retinoic acid signaling is required for maintaining a range of cellular processes, including cell differentiation, proliferation, and apoptosis. We investigated the actions of all-trans-retinoic acid (atRA) signaling in pancreatic beta-cells of adult mice. atRA signaling was ablated in beta-cells by overexpressing a dominant-negative retinoic acid receptor (RAR)-alpha mutant (RARdn) using an inducible Cre-Lox system under the control of the pancreas duodenal homeobox gene promoter. Our studies establish that hypomorphism for RAR in beta-cells leads to an age-dependent decrease in plasma insulin in the fed state and in response to a glucose challenge. Glucose-stimulated insulin secretion was also impaired in islets isolated from mice expressing RARdn. Among genes that are atRA responsive, Glut2 and Gck mRNA levels were decreased in isolated islets from RARdn-expressing mice. Histologic analyses of RARdn-expressing pancreata revealed a decrease in beta-cell mass and insulin per beta-cell 1 mo after induction of the RARdn. Our results indicate that atRA signaling mediated by RARs is required in the adult pancreas for maintaining both beta-cell function and mass, and provide insights into molecular mechanisms underlying these actions.-Brun, P.-J., Grijalva, A., Rausch, R., Watson, E., Yuen, J. J., Das, B. C., Shudo, K., Kagechika, H., Leibel, R. L., Blaner, W. S. Retinoic acid receptor signaling is required to maintain glucose-stimulated insulin secretion and b-cell mass.	[Brun, Pierre-Jacques; Yuen, Jason J.; Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Rausch, Richard; Watson, Elizabeth; Leibel, Rudolph L.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Grijalva, Ambar] Columbia Univ Coll Phys & Surg, Inst Human Nutr, New York, NY 10032 USA; [Das, Bhaskar C.] Univ Kansas, Med Ctr, Dept Med, Kansas City, KS 66103 USA; [Shudo, Koichi] Res Fdn Itsuu Lab, Tokyo, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan	Columbia University; Columbia University; Columbia University; University of Kansas; University of Kansas Medical Center; Tokyo Medical & Dental University (TMDU)	Blaner, WS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.	wsb2@columbia.edu		Kagechika, Hiroyuki/0000-0002-6747-1013	U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism Grant [RC2-AA019413]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK068437, R01-DK079221, R01-DK052431, P30-DK063608]; Japan Society for Promotion of Science Core-to-Core Program; Russell Berrie Foundation; A. Advanced Research Networks of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063608, R01DK068437, P30DK026687, R01DK079221, R01DK052431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019413, R21AA021336] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22136013] Funding Source: KAKEN	U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism Grant; NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Japan Society for Promotion of Science Core-to-Core Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Russell Berrie Foundation; A. Advanced Research Networks of Japan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	These studies were supported by U.S. National Institutes of Health (NIH) National Institute on Alcohol Abuse and Alcoholism Grant RC2-AA019413 and NIH National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK068437, R01-DK079221, R01-DK052431, and P30-DK063608, the Japan Society for Promotion of Science Core-to-Core Program, A. Advanced Research Networks of Japan, and grants from the Russell Berrie Foundation.	Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Blumentrath J, 2001, CELL BIOCHEM FUNCT, V19, P159, DOI 10.1002/cbf.907; Cabrera-Valladares G, 1999, ENDOCRINOLOGY, V140, P3091, DOI 10.1210/en.140.7.3091; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; CHERTOW BS, 1989, RES COMMUN CHEM PATH, V63, P27; CHERTOW BS, 1987, J CLIN INVEST, V79, P163, DOI 10.1172/JCI112778; CHERTOW BS, 1983, DIABETES, V32, P568, DOI 10.2337/diabetes.32.6.568; CHERTOW BS, 1993, DIABETES, V42, P1109, DOI 10.2337/diabetes.42.8.1109; CHERTOW BS, 1989, DIABETES, V38, P1544, DOI 10.2337/diabetes.38.12.1544; CLARK AR, 1995, BIOCHEM J, V309, P863, DOI 10.1042/bj3090863; Das BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010004; Dokmanovic-Chouinard M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000137; Du AP, 2009, DIABETES, V58, P2059, DOI 10.2337/db08-0987; EIZIRIK DL, 1989, ENDOCRINOLOGY, V125, P752, DOI 10.1210/endo-125-2-752; FERNANDEZMEJIA C, 1992, ENDOCRINOLOGY, V130, P1660, DOI 10.1210/en.130.3.1660; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gudas L. J., 1994, RETINOIDS BIOL CHEM, P443; Gudas LJ, 2012, BBA-MOL CELL BIOL L, V1821, P213, DOI 10.1016/j.bbalip.2011.08.002; Hunter CS, 2013, DIABETES, V62, P875, DOI 10.2337/db12-0952; Kane MA, 2010, P NATL ACAD SCI USA, V107, P21884, DOI 10.1073/pnas.1008859107; Kappen C, 2009, INT J DEV BIOL, V53, P935, DOI 10.1387/ijdb.082819ck; KATO M, 1985, P NATL ACAD SCI USA, V82, P2488, DOI 10.1073/pnas.82.8.2488; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Mangelsdorf David J., 1994, P319; Matthews KA, 2004, J NUTR, V134, P1958, DOI 10.1093/jn/134.8.1958; Meier JJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE717, DOI 10.1152/ajpendo.00315.2010; Miyazaki S, 2010, DIABETES, V59, P2854, DOI 10.2337/db09-1897; National Research Council, 2011, GUIDE CARE USE LAB A; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Perez RJ, 2013, EXP CELL RES, V319, P2196, DOI 10.1016/j.yexcr.2013.05.032; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajaii F, 2008, DEV BIOL, V316, P371, DOI 10.1016/j.ydbio.2008.01.041; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Ravnskjaer K, 2005, ENDOCRINOLOGY, V146, P3266, DOI 10.1210/en.2004-1430; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Ross, 2006, MODERN NUTR HLTH DIS, P351; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; Somenzi G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000836; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tsutusmi A, 2000, BIOCHEM BIOPH RES CO, V278, P229, DOI 10.1006/bbrc.2000.3786; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Yanagitani A, 2004, HEPATOLOGY, V40, P366, DOI 10.1002/hep.20335	45	37	37	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					671	683		10.1096/fj.14-256743	http://dx.doi.org/10.1096/fj.14-256743			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25389133	Green Published			2022-12-26	WOS:000349370400028
J	Kondoh, D; Tateno, H; Hirabayashi, J; Yasumoto, Y; Nakao, R; Oishi, K				Kondoh, Daisuke; Tateno, Hiroaki; Hirabayashi, Jun; Yasumoto, Yuki; Nakao, Reiko; Oishi, Katsutaka			Molecular Clock Regulates Daily alpha 1-2-Fucosylation of the Neural Cell Adhesion Molecule (NCAM) within Mouse Secondary Olfactory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; FIRING-RATE; N-GLYCANS; IN-VITRO; RAT; EXPRESSION; RHYTHMS; FUCOSE	The circadian clock regulates various behavioral and physiological rhythms in mammals. Circadian changes in olfactory functions such as neuronal firing in the olfactory bulb (OB) and olfactory sensitivity have recently been identified, although the underlying molecular mechanisms remain unknown. We analyzed the temporal profiles of glycan structures in the mouseOB using a high-density microarray that includes 96 lectins, because glycoconjugates play important roles in the nervous system such as neurite outgrowth and synaptogenesis. Sixteen lectin signals significantly fluctuated in the OB, and the intensity of all three that had high affinity for alpha 1-2-fucose (alpha 1-2Fuc) glycan in the microarray was higher during the nighttime. Histochemical analysis revealed that alpha 1-2Fuc glycan is located in a diurnal manner in the lateral olfactory tract that comprises axon bundles of secondary olfactory neurons. The amount of alpha 1-2Fuc glycan associated with the major target glycoprotein neural cell adhesion molecule (NCAM) varied in a diurnal fashion, although the mRNA and protein expression of Ncam1 did not. The mRNA and protein expression of Fut1, a alpha 1-2-specific fucosyltransferase gene, was diurnal in the OB. Daily fluctuation of the alpha 1-2Fuc glycan was obviously damped in homozygous Clock mutant mice with disrupted diurnal Fut1 expression, suggesting that the molecular clock governs rhythmic alpha 1-2-fucosylation in secondary olfactory neurons. These findings suggest the possibility that the molecular clock is involved in the diurnal regulation of olfaction via alpha 1-2-fucosylation in the olfactory system.	[Kondoh, Daisuke; Yasumoto, Yuki; Nakao, Reiko; Oishi, Katsutaka] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Tsukuba, Ibaraki 3058566, Japan; [Kondoh, Daisuke] Obihiro Univ Agr & Vet Med, Lab Vet Anat, Dept Basic Vet Med, Obihiro, Hokkaido 0808555, Japan; [Tateno, Hiroaki; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058568, Japan; [Yasumoto, Yuki; Oishi, Katsutaka] Tokyo Univ Sci, Grad Sch Sci & Technol, Dept Appl Biol Sci, Noda, Chiba 2788510, Japan; [Oishi, Katsutaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Kashiwa, Chiba 2778562, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Obihiro University of Agriculture & Veterinary Medicine; National Institute of Advanced Industrial Science & Technology (AIST); Tokyo University of Science; University of Tokyo	Oishi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Biol Clock Res Grp, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-ooishi@aist.go.jp	Hirabayashi, Jun/M-3998-2018; Kondoh, Daisuke/D-6312-2017; Tateno, Hiroaki/M-2706-2018; Oishi, Katsutaka/L-6906-2018	Hirabayashi, Jun/0000-0002-8571-359X; Kondoh, Daisuke/0000-0002-3015-5156; Tateno, Hiroaki/0000-0003-3006-1659; Oishi, Katsutaka/0000-0002-4870-0837	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25350179]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-Aid for Scientific Research (C) KAKENHI 25350179 (to K. O.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Aujard F, 2001, NEUROSCIENCE, V106, P255, DOI 10.1016/S0306-4522(01)00285-8; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Corthell JT, 2013, NEUROSCIENCE, V247, P234, DOI 10.1016/j.neuroscience.2013.05.040; Corthell JT, 2012, NEUROSCIENCE, V222, P38, DOI 10.1016/j.neuroscience.2012.06.070; DAMJANOV I, 1987, LAB INVEST, V57, P5; Glass JD, 2003, NEUROSCIENCE, V117, P203, DOI 10.1016/S0306-4522(02)00817-5; GOODRUM JF, 1984, J NEUROSCI, V4, P1830; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Granados-Fuentes D, 2011, J BIOL RHYTHM, V26, P552, DOI 10.1177/0748730411420247; Hirabayashi J, 2013, CHEM SOC REV, V42, P4443, DOI 10.1039/c3cs35419a; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kalovidouris SA, 2005, J AM CHEM SOC, V127, P1340, DOI 10.1021/ja044631v; Kondoh D, 2010, J MORPHOL, V271, P1197, DOI 10.1002/jmor.10864; KRUG M, 1994, BRAIN RES, V643, P130, DOI 10.1016/0006-8993(94)90018-3; KRUG M, 1991, BRAIN RES, V540, P237, DOI 10.1016/0006-8993(91)90513-U; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Lorenzini CGA, 1997, NEUROBIOL LEARN MEM, V68, P317, DOI 10.1006/nlme.1997.3798; Matthies H, 1996, BRAIN RES, V725, P276, DOI 10.1016/0006-8993(96)00406-4; Mordel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058457; MULLER L, 1985, NEUROSCIENCE, V14, P875, DOI 10.1016/0306-4522(85)90150-2; Munn RGK, 2012, HIPPOCAMPUS, V22, P1325, DOI 10.1002/hipo.20969; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Murrey HE, 2009, BIOCHEMISTRY-US, V48, P7261, DOI 10.1021/bi900640x; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Perlson E, 2013, J BIOL CHEM, V288, P27812, DOI 10.1074/jbc.M113.465088; PESTEAN A, 1995, NEUROSCI LETT, V195, P117, DOI 10.1016/0304-3940(95)11795-X; Plendl J, 1998, ACTA ANAT, V161, P234; POHLE W, 1987, BRAIN RES, V410, P245, DOI 10.1016/0006-8993(87)90321-0; Prosser RA, 2003, J NEUROSCI, V23, P652, DOI 10.1523/JNEUROSCI.23-02-00652.2003; Ronn LCB, 1998, EXP GERONTOL, V33, P853, DOI 10.1016/S0531-5565(98)00040-0; Salazar I, 2003, BRAIN RES, V979, P15, DOI 10.1016/S0006-8993(03)02835-X; Tateno H, 2011, J BIOL CHEM, V286, P20345, DOI 10.1074/jbc.M111.231274; Tisay KT, 2002, J COMP NEUROL, V443, P213, DOI 10.1002/cne.10107; Treloar H, 1997, J NEUROBIOL, V32, P643, DOI 10.1002/(SICI)1097-4695(19970620)32:7<643::AID-NEU1>3.0.CO;2-4; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Zamze S, 1998, EUR J BIOCHEM, V258, P243, DOI 10.1046/j.1432-1327.1998.2580243.x; Zhao H, 2005, NEUROSCIENCE, V132, P519, DOI 10.1016/j.neuroscience.2005.01.012	41	4	4	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36158	36165		10.1074/jbc.M114.571141	http://dx.doi.org/10.1074/jbc.M114.571141			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25384980	hybrid, Green Published			2022-12-26	WOS:000346897900042
J	Matas, E; Bau, L; Martinez-Iniesta, M; Romero-Pinel, L; Mane, MA; Cobo-Calvo, A; Martinez-Yelamos, S				Matas, Elisabet; Bau, Laura; Martinez-Iniesta, Maria; Romero-Pinel, Lucia; Alba Mane, M.; Cobo-Calvo, Alvaro; Martinez-Yelamos, Sergio			Baseline MxA mRNA Expression Predicts Interferon Beta Response in Multiple Sclerosis Patients	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; THERAPY; SIGNATURE; MULTICENTER; DISABILITY; RELEVANCE; EFFICACY; CRITERIA; MS	Background: Myxovirus resistance protein A (MxA) is a molecule induced after interferon-beta injection, mostly used to evaluate its bioactivity. There is little available data on clinical utility of baseline MxA mRNA status. The objective of the study is to investigate whether baseline MxA mRNA expression can predict relapse and disease progression in multiple sclerosis patients treated with interferon-beta. Methods: Baseline blood samples were obtained before the first interferon-beta dose was administered to evaluate MxA mRNA expression using real-time polymerase chain reaction (PCR). Demographic and clinical variables were prospectively recorded to define treatment responder and non responder groups. Results: 104 patients were included in the study. Baseline MxA mRNA expression was significantly lower in the group of patients who met the definition of responders (1.07 vs 1.95, Student t test, p<0.0001). A threshold of 1.096 was established using Receiver Operating Characteristic analysis to differentiate between responders and non-responders (sensitivity 73.9%, specificity 69.0%). Survival analysis using this threshold showed that time to next relapse (p<0.0001) and to EDSS progression (p = 0.01) were significantly higher in patients with lower MxA titers. Conclusion: The results suggest that baseline MxA mRNA levels may be useful for predicting whether multiple sclerosis patients will respond or not to interferon-beta treatment.	[Matas, Elisabet; Bau, Laura; Romero-Pinel, Lucia; Alba Mane, M.; Cobo-Calvo, Alvaro; Martinez-Yelamos, Sergio] Hosp Univ Bellvitge IDIBELL, Dept Neurol, Multiple Sclerosis Unit, Barcelona, Spain; [Martinez-Iniesta, Maria] Inst Catala Oncol IDIBELL, Translat Res Lab, Barcelona, Spain; [Alba Mane, M.] Univ Rovira & Virgili, Dept Neurol, Joan Univ Hosp 23, E-43007 Tarragona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat Rovira i Virgili	Matas, E (corresponding author), Hosp Univ Bellvitge IDIBELL, Dept Neurol, Multiple Sclerosis Unit, Barcelona, Spain.	ematas@bellvitgehospital.cat	ROMERO-PINEL, Lucia/ABH-3560-2020; VILA, Laura BAU/ABH-3568-2020; MARTÍNEZ-YÉLAMOS, Sergio/ABH-3087-2020; MARTÍN, Elisabet MATAS/ABH-3565-2020	Romero Pinel, Lucia/0000-0001-8054-0565; MARTINEZ YELAMOS, SERGIO/0000-0001-9889-2040; Cobo-Calvo, Alvaro/0000-0002-2574-0721; Martinez-Iniesta, Maria/0000-0001-6252-6671	Convenio de Investigacion, Dep. de Salut, Generalitat de Catalunya [352/05]	Convenio de Investigacion, Dep. de Salut, Generalitat de Catalunya	This work was supported by the Convenio de Investigacion, Dep. de Salut, Generalitat de Catalunya (grant number 352/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bertolotto A, 2001, J IMMUNOL METHODS, V256, P141, DOI 10.1016/S0022-1759(01)00434-3; Comabella M, 2009, BRAIN, V132, P3353, DOI 10.1093/brain/awp228; CONFAVREUX C, 1992, J NEUROL NEUROSUR PS, V55, P671, DOI 10.1136/jnnp.55.8.671; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Feng X, 2002, J NEUROIMMUNOL, V129, P205, DOI 10.1016/S0165-5728(02)00182-0; Francis G, 2001, NEUROLOGY, V56, P1628; Hesse D, 2007, MULT SCLER, V13, pS37; Hesse D, 2009, NEUROLOGY, V73, P372, DOI 10.1212/WNL.0b013e3181b04c98; Hundeshagen A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-140; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Malucchi S, 2008, NEUROLOGY, V70, P1119, DOI 10.1212/01.wnl.0000304040.29080.7b; Malucchi S, 2011, J NEUROL, V258, P895, DOI 10.1007/s00415-010-5844-5; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rio J, 2002, ANN NEUROL, V52, P400, DOI 10.1002/ana.10290; Rudick RA, 1997, NEUROLOGY, V49, P358, DOI 10.1212/WNL.49.2.358; Rudick RA, 2004, ANN NEUROL, V56, P548, DOI 10.1002/ana.20224; SCHUMACHER GA, 1965, ANN NY ACAD SCI, V122, P552; Serana F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094794; Sominanda A, 2008, J NEUROL NEUROSUR PS, V79, P57, DOI 10.1136/jnnp.2007.122549; Sominanda A, 2007, MULT SCLER, V13, P208, DOI 10.1177/1352458506070762; Sottini A., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P14; van Baarsen LGM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001927; van der Voort LF, 2010, NEUROLOGY, V75, P1228, DOI 10.1212/WNL.0b013e3181f6c556; Verweij CL, 2013, DISCOV MED, V15, P51	28	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112758	10.1371/journal.pone.0112758	http://dx.doi.org/10.1371/journal.pone.0112758			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396411	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500088
J	Gu, HF; Nie, YX; Tong, QZ; Tang, YL; Zeng, Y; Jing, KQ; Zheng, XL; Liao, DF				Gu, Hong-Feng; Nie, Ya-Xiong; Tong, Qiao-Zhen; Tang, Ya-Ling; Zeng, Yang; Jing, Kai-Quan; Zheng, Xi-Long; Liao, Duan-Fang			Epigallocatechin-3-Gallate Attenuates Impairment of Learning and Memory in Chronic Unpredictable Mild Stress-Treated Rats by Restoring Hippocampal Autophagic Flux	PLOS ONE			English	Article							ALZHEIMERS-DISEASE MODEL; NEURODEGENERATIVE DISEASES; TRANSGENIC MICE; MOUSE MODEL; TAU PATHOLOGY; EGCG; CELLS; GALLATE; DEFICITS; ACCUMULATION	Epigallocatechin gallate (EGCG) is a major polyphenol in green tea with beneficial effects on the impairment in learning and memory. Autophagy is a cellular process that protects neurons from stressful conditions. The present study was designed to investigate whether EGCG can rescue chronic unpredictable mild stress (CUMS)-induced cognitive impairment in rats and whether its protective effect involves improvement of autophagic flux. As expected, our results showed that CUMS significantly impaired memory performance and inhibited autophagic flux as indicated by elevated LC3-II and p62 protein levels. At the same time, we observed an increased neuronal loss and activated mammalian target of rapamycin (mTOR)/p70 ribosomal protein S6 kinase (p70S6k) signaling in the CA1 regions. Interestingly, chronic treatment with EGCG (25 mg/kg, i.p.) significantly improved those behavioral alterations, attenuated histopathological abnormalities in hippocampal CA1 regions, reduced amyloid beta1-42 (A beta(1-42)) levels, and restored autophagic flux. However, blocking autophagic flux with chloroquine, an inhibitor of autophagic flux, reversed these effects of EGCG. Taken together, these findings suggest that the impaired autophagy in CA1 regions of CUMS rats may contribute to learning and memory impairment. Therefore, we conclude that EGCG attenuation of CUMS-induced learning and memory impairment may be through rescuing autophagic flux.	[Gu, Hong-Feng; Tang, Ya-Ling] Univ South China, Dept Physiol, Hengyang, Peoples R China; [Gu, Hong-Feng; Tang, Ya-Ling] Univ South China, Inst Neurosci, Hengyang, Peoples R China; [Gu, Hong-Feng; Tong, Qiao-Zhen; Zheng, Xi-Long] Hunan Univ Chinese Med, Div Stem Cell Regulat & Applicat, State Key Lab Chinese Med Powder & Med Innovat Hu, Changsha, Hunan, Peoples R China; [Nie, Ya-Xiong; Zeng, Yang; Jing, Kai-Quan] Univ South China, Dept Neurol, Affiliated Hosp 1, Hengyang, Peoples R China; [Zheng, Xi-Long; Liao, Duan-Fang] Univ Calgary, Fac Med, Smooth Muscle Res Grp, Dept Biochem & Mol Biol,Libin Cardiovasc Inst Alb, Calgary, AB, Canada	University of South China; University of South China; Hunan University of Chinese Medicine; University of South China; Libin Cardiovascular Institute Of Alberta; University of Calgary	Liao, DF (corresponding author), Univ Calgary, Fac Med, Smooth Muscle Res Grp, Dept Biochem & Mol Biol,Libin Cardiovasc Inst Alb, Calgary, AB, Canada.	dfliao66@aliyun.com		Zheng, Xi-Long/0000-0002-0889-1827	National Natural Science Foundation of China [81170278]; Nature Science Foundation of Hunan Province [08JJ3036]; construct program of the key discipline in hunan province, China (Basic Medicine Sciences in University of South China); Foundation of Hunan Educational Committee [09C835]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); construct program of the key discipline in hunan province, China (Basic Medicine Sciences in University of South China); Foundation of Hunan Educational Committee	This work was supported by grants from the National Natural Science Foundation of China (grant no. 81170278), http://www.nsfc.gov.cn/; the Nature Science Foundation of Hunan Province (08JJ3036), http://www.hnst.gov.cn/; the construct program of the key discipline in hunan province, China (Basic Medicine Sciences in University of South China), http://gov.hnedu.cn/; the Nature Science Foundation of Hunan Province (08JJ3036) and the Foundation of Hunan Educational Committee (09C835), http://gov.hnedu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglade P, 1997, HISTOL HISTOPATHOL, V12, P25; Cai J, 2014, J NUTR BIOCHEM, V25, P716, DOI 10.1016/j.jnutbio.2014.02.012; Carroll JC, 2011, J NEUROSCI, V31, P14436, DOI 10.1523/JNEUROSCI.3836-11.2011; Castilla-Ortega E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025522; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Chu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065367; Han J, 2012, AUTOPHAGY, V8, P812, DOI 10.4161/auto.19471; Hashimoto K, 2008, ANTICANCER RES, V28, P1713; Huang CH, 2009, MOL NUTR FOOD RES, V53, P1156, DOI 10.1002/mnfr.200800592; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Jiang P, 2013, PSYCHONEUROENDOCRINO, V38, P2091, DOI 10.1016/j.psyneuen.2013.03.017; Kim HS, 2013, J BIOL CHEM, V288, P22693, DOI 10.1074/jbc.M113.477505; Koo JW, 2003, FASEB J, V17, P1556, DOI 10.1096/fj.02-1032fje; Kuang X, 2012, EUR J PHARMACOL, V676, P51, DOI 10.1016/j.ejphar.2011.11.037; Li CW, 2013, EXP BIOL MED, V238, P744, DOI 10.1177/1535370213493705; Liang JH, 2014, NEUROSCI BULL, V30, P308, DOI 10.1007/s12264-013-1418-8; Lim J, 2012, J BIOL CHEM, V287, P23271, DOI 10.1074/jbc.M112.364281; Ling DJ, 2011, ACTA NEUROPATHOL, V121, P183, DOI 10.1007/s00401-010-0772-0; Liu MY, 2014, MOL NEUROBIOL, V49, P1350, DOI 10.1007/s12035-013-8608-2; Mohammadi HS, 2014, BEHAV BRAIN RES, V270, P196, DOI 10.1016/j.bbr.2014.05.015; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Nassif M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-78; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Parganlija D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095288; Peairs A, 2010, CELL MOL IMMUNOL, V7, P123, DOI 10.1038/cmi.2010.1; Pervanidou P, 2010, PROG BRAIN RES, V182, P149, DOI 10.1016/S0079-6123(10)82005-9; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Rezai-Zadeh K, 2008, BRAIN RES, V1214, P177, DOI 10.1016/j.brainres.2008.02.107; Rossi M, 2009, J CELL SCI, V122, P3330, DOI 10.1242/jcs.048181; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang P, 2013, AUTOPHAGY, V9, P604, DOI 10.4161/auto.23459; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Xie J, 2010, NEUROSCI LETT, V479, P26, DOI 10.1016/j.neulet.2010.05.020; Yang DS, 2011, AUTOPHAGY, V7, P788, DOI 10.4161/auto.7.7.15596; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087161; Zhu ZY, 2013, J NEUROSCI, V33, P13138, DOI 10.1523/JNEUROSCI.4790-12.2013	41	50	50	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112683	10.1371/journal.pone.0112683	http://dx.doi.org/10.1371/journal.pone.0112683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393306	gold, Green Submitted, Green Published			2022-12-26	WOS:000347709300086
J	Miosic, S; Thill, J; Milosevic, M; Gosch, C; Pober, S; Molitor, C; Ejaz, S; Rompel, A; Stich, K; Halbwirth, H				Miosic, Silvija; Thill, Jana; Milosevic, Malvina; Gosch, Christian; Pober, Sabrina; Molitor, Christian; Ejaz, Shaghef; Rompel, Annette; Stich, Karl; Halbwirth, Heidi			Dihydroflavonol 4-Reductase Genes Encode Enzymes with Contrasting Substrate Specificity and Show Divergent Gene Expression Profiles in Fragaria Species	PLOS ONE			English	Article							FRUIT-DEVELOPMENT; X ANANASSA; STRAWBERRY; BIOSYNTHESIS; SYNTHASE; ACHENES	During fruit ripening, strawberries show distinct changes in the flavonoid classes that accumulate, switching from the formation of flavan 3-ols and flavonols in unripe fruits to the accumulation of anthocyanins in the ripe fruits. In the common garden strawberry (Fragariaxananassa) this is accompanied by a distinct switch in the pattern of hydroxylation demonstrated by the almost exclusive accumulation of pelargonidin based pigments. In Fragaria vesca the proportion of anthocyanins showing one (pelargonidin) and two (cyanidin) hydroxyl groups within the B-ring is almost equal. We isolated two dihydroflavonol 4-reductase (DFR) cDNA clones from strawberry fruits, which show 82% sequence similarity. The encoded enzymes revealed a high variability in substrate specificity. One enzyme variant did not accept DHK (with one hydroxyl group present in the B-ring), whereas the other strongly preferred DHK as a substrate. This appears to be an uncharacterized DFR variant with novel substrate specificity. Both DFRs were expressed in the receptacle and the achenes of both Fragaria species and the DFR2 expression profile showed a pronounced dependence on fruit development, whereas DFR1 expression remained relatively stable. There were, however, significant differences in their relative rates of expression. The DFR1/DFR2 expression ratio was much higher in the Fragariaxananassa and enzyme preparations from F.xananassa receptacles showed higher capability to convert DHK than preparations from F. vesca. Anthocyanin concentrations in the F.xananassa cultivar were more than twofold higher and the cyanidin: pelargonidin ratio was only 0.05 compared to 0.51 in the F. vesca cultivar. The differences in the fruit colour of the two Fragaria species can be explained by the higher expression of DFR1 in F.xananassa as compared to F. vesca, a higher enzyme efficiency (Kcat/Km values) of DFR1 combined with the loss of F3'H activity late in fruit development of F.xananassa.	[Miosic, Silvija; Thill, Jana; Milosevic, Malvina; Gosch, Christian; Pober, Sabrina; Stich, Karl; Halbwirth, Heidi] Vienna Univ Technol, Inst Chem Engn, A-1040 Vienna, Austria; [Molitor, Christian; Rompel, Annette] Univ Vienna, Fak Chem, Inst Biophys Chem, Vienna, Austria; [Ejaz, Shaghef] Bahauddin Zakariya Univ, Dept Hort, Multan, Pakistan	Technische Universitat Wien; University of Vienna; Bahauddin Zakariya University	Halbwirth, H (corresponding author), Vienna Univ Technol, Inst Chem Engn, A-1040 Vienna, Austria.	hhalb@mail.zserv.tuwien.ac.at	Ejaz, Shaghef/J-1617-2014; Molitor, Christian/S-2178-2018	Molitor, Christian/0000-0003-1685-0141; Halbwirth, Heidi/0000-0001-9059-5850; Haselmair-Gosch, Christian/0000-0003-3231-0962; Ejaz, Shaghef/0000-0003-4018-9189; Rompel, Annette/0000-0002-5919-0553	Austrian Science Fund (FWF) [V18-B03, P24331-B16]; Austrian Science Fund (FWF) [P 24331] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Investigations were supported by a grant from the Austrian Science Fund (FWF, www.fwf.ac.at): [Projects V18-B03 and P24331-B16]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaby K, 2005, J AGR FOOD CHEM, V53, P4032, DOI 10.1021/jf048001o; Aharoni A, 2002, J EXP BOT, V53, P2073, DOI 10.1093/jxb/erf026; Almeida JRM, 2007, ARCH BIOCHEM BIOPHYS, V465, P61, DOI 10.1016/j.abb.2007.04.040; Araguez I, 2013, J PROTEOMICS, V83, P160, DOI 10.1016/j.jprot.2013.03.016; Chandra A, 2001, J AGR FOOD CHEM, V49, P3515, DOI 10.1021/jf010389p; Cheng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072017; CLAUDOT AC, 1992, PHYTOCHEMISTRY, V31, P3377, DOI 10.1016/0031-9422(92)83689-V; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Gosch C, 2003, EUR J HORTIC SCI, V68, P144; Halbwirth H, 2006, PLANT SCI, V170, P587, DOI 10.1016/j.plantsci.2005.10.013; Halbwirth H, 2006, J AGR FOOD CHEM, V54, P1479, DOI 10.1021/jf0524170; Halbwirth H, 2009, J AGR FOOD CHEM, V57, P4983, DOI 10.1021/jf900121z; Harborne J.B., 1967, COMP BIOCH FLAVONOID; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Inagaki Y, 1999, GENE, V226, P181, DOI 10.1016/S0378-1119(98)00571-X; Johnson ET, 1999, PLANT J, V19, P81, DOI 10.1046/j.1365-313X.1999.00502.x; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; MEYER P, 1987, NATURE, V330, P677, DOI 10.1038/330677a0; Moyano E, 1998, PLANT PHYSIOL, V117, P711, DOI 10.1104/pp.117.2.711; Nakanishi K., 1999, COMPREHENSIVE NATURA, V1, P713; Petit P, 2007, J MOL BIOL, V368, P1345, DOI 10.1016/j.jmb.2007.02.088; Pfaffl MW, 2004, BIOSPEKTRUM, V01, P92; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; SANDERMANN H, 1972, J BIOL CHEM, V247, P5123; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SONDHEIMER E, 1956, NATURE, V178, P648, DOI 10.1038/178648a0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thill J, 2013, PLANT PHYSL BIOCH; Thill J, 2013, PLANT PHYSIOL BIOCH, V72, P72, DOI 10.1016/j.plaphy.2013.03.019; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221	36	28	36	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112707	10.1371/journal.pone.0112707	http://dx.doi.org/10.1371/journal.pone.0112707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393679	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300089
J	Srivastava, R; Srivastava, G; Dilcher, DL				Srivastava, Rashmi; Srivastava, Gaurav; Dilcher, David L.			Coryphoid Palm Leaf Fossils from the Maastrichtian-Danian of Central India with Remarks on Phytogeography of the Coryphoideae (Arecaceae)	PLOS ONE			English	Article							GLOBAL BIOGEOGRAPHY; SHEDS LIGHT; DIVERSIFICATION; EVOLUTION; GENUS; CLASSIFICATION; TRANSITION; PALEOCENE; VOLCANISM; PATTERNS	Premise of research: A large number of fossil coryphoid palm wood and fruits have been reported from the Deccan Intertrappean beds of India. We document the oldest well-preserved and very rare costapalmate palm leaves and inflorescence like structures from the same horizon. Methodology: A number of specimens were collected from Maastrichtian-Danian sediments of the Deccan Intertrappean beds, Ghughua, near Umaria, Dindori District, Madhya Pradesh, India. The specimens are compared with modern and fossil taxa of the family Arecaceae. Pivotal results: Sabalites dindoriensis sp. nov. is described based on fossil leaf specimens including basal to apical parts. These are the oldest coryphoid fossil palm leaves from India as well as, at the time of deposition, from the Gondwana-derived continents. Conclusions: The fossil record of coryphoid palm leaves presented here and reported from the Eurasian localities suggests that this is the oldest record of coryphoid palm leaves from India and also from the Gondwana-derived continents suggesting that the coryphoid palms were well established and wide spread on both northern and southern hemispheres by the Maastrichtian-Danian. The coryphoid palms probably dispersed into India from Europe via Africa during the latest Cretaceous long before the Indian Plate collided with the Eurasian Plate.	[Srivastava, Rashmi; Srivastava, Gaurav] Birbal Sahni Inst Paleobot, Cenozo Palaeoflorist Lab, Lucknow 226007, Uttar Pradesh, India; [Dilcher, David L.] Indiana Univ, Dept Geol, Bloomington, IN 47405 USA	Department of Science & Technology (India); Birbal Sahni Institute of Palaeobotany (BSIP); Indiana University System; Indiana University Bloomington	Srivastava, R (corresponding author), Birbal Sahni Inst Paleobot, Cenozo Palaeoflorist Lab, 53 Univ Rd, Lucknow 226007, Uttar Pradesh, India.	rashmi57.bsip@gmail.com	Srivastava, Gaurav/A-1384-2019	Srivastava, Gaurav/0000-0001-7498-4338				Ambwani K., 1990, GEOPHYTOLOGY, V19, P70; [Anonymous], 1982, TERT RES; [Anonymous], HERB CAT; Asmussen CB, 2006, BOT J LINN SOC, V151, P15, DOI 10.1111/j.1095-8339.2006.00521.x; ASMUSSEN CB, 2000, MONOCOTS SYSTEMATICS, P525; Baker WJ, 2013, J BIOGEOGR, V40, P286, DOI 10.1111/j.1365-2699.2012.02794.x; Baker WJ, 2013, J BIOGEOGR, V40, P274, DOI 10.1111/j.1365-2699.2012.02795.x; BANDE M.B., 1992, PALAEOBOTANIST, V40, P275; Bande MB, 1982, PALEOBOTANIST, V30, P303; Barman G, 1970, SCI CULT, V36, P63; BERRY E.W., 1914, US GEOL SURV PROF PA, V84, P5; Bjorholm S, 2006, BOT J LINN SOC, V151, P113, DOI 10.1111/j.1095-8339.2006.00527.x; Bjorholm S, 2005, GLOBAL ECOL BIOGEOGR, V14, P423, DOI 10.1111/j.1466-822x.2005.00167.x; Bonde S.D., 2008, PALAEOBOTANIST, V57, P141, DOI DOI 10.1016/S0034-6667(97)00012-2; Bonde SD, 1986, BIOVIGYANAM, V12, P89; Bonde SD, 1986, BIOVIGYANAM, V12, P113; Chase Mark W., 2006, Aliso, V22, P63; Chatterjee S, 2013, GONDWANA RES, V23, P238, DOI 10.1016/j.gr.2012.07.001; Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; Couvreur TLP, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-44; Cripps JA, 2005, PALAEOGEOGR PALAEOCL, V216, P303, DOI 10.1016/j.palaeo.2004.11.007; Daghlian CP, 1976, PALAEONTOGR ABT B, V166B, P44; Davis JI, 2006, TAXON, V55, P857, DOI 10.2307/25065681; Dransfield J., 2008, GENERA PALMARUM THE; Dransfield John, 2005, Kew Bulletin, V60, P559; El-Saadawi W, 2004, REV PALAEOBOT PALYNO, V129, P199, DOI 10.1016/j.revpalbo.2004.02.001; El-Soughier Maher I., 2011, Palaeoworld, V20, P75, DOI 10.1016/j.palwor.2010.09.016; Ezcurra MD, 2012, SYST BIOL, V61, P553, DOI 10.1093/sysbio/syr115; Gibbons M, 2003, POCKET GUIDE PALMS; Govaerts R., 2005, World checklist of palms; GULERIA J.S., 1999, PALEOBOTANIST, V47, P68; Guleria JS., 2005, PALEOBOTANIST, V54, P61; Guleria JS, 2000, HIMAL GEOL, V21, P43; HERNGREEN G F W, 1981, Pollen et Spores, V23, P441; HERNGREEN GFW, 1996, AM ASS STRATIGR PALY, V3, P1157; Hofmann C, 2000, EARTH PLANET SC LETT, V180, P13, DOI 10.1016/S0012-821X(00)00159-X; Huzioka K., 1970, J MINING COLL AKITA, V4, P1; Jacobs BF, 2004, PHILOS T R SOC B, V359, P1573, DOI 10.1098/rstb.2004.1533; Jay AE, 2008, J GEOL SOC LONDON, V165, P177, DOI 10.1144/0016-76492006-062; JONES DL, 1995, PALMS THROUGHOUT WOR; Kapoor R, 1987, B INDIAN GEOLOGISTS, V20, P17; Kar R. K., 1998, GEOPHYTOLOGY, V27, P17; Keller G, 2009, EARTH PLANET SC LETT, V282, P10, DOI 10.1016/j.epsl.2009.02.016; Khosla A, 2003, J ASIAN EARTH SCI, V21, P895, DOI 10.1016/S1367-9120(02)00092-5; Khosla SC, 1999, MICROPALEONTOLOGY, V45, P319, DOI 10.2307/1486140; KULKARNI A R, 1977, Geophytology, V7, P208; Kulkarni AR, 2004, CURR SCI INDIA, V86, P1598; KUMARAN KPN, 1994, REV PALAEOBOT PALYNO, V81, P337, DOI 10.1016/0034-6667(94)90117-1; Kvacek J, 2004, REV PALAEOBOT PALYNO, V128, P323, DOI 10.1016/S0034-6667(03)00154-4; Lakhanpal R.N., 1983, GEOLOGY INDUS SUTURE, P179; Lakhanpal R.N., 1984, PALAEOBOTANIST, V31, P201; LAKHANPAL RN, 1964, CURR SCI INDIA, V33, P276; Lakhanpal RN, 1982, PALEOBOTANIST, V30, P279; Lakhanpal RN, 1976, CATALOGUE INDIAN FOS; Mabberley D. J, 2005, PLANT BOOK PORTABLE; MAHABALE TS, 1968, CURR SCI INDIA, V37, P158; Mahesh Prasad, 2006, Phytomorphology, V56, P9; Manchester SR, 2010, INT J PLANT SCI, V171, P679, DOI 10.1086/653688; Marmi J, 2010, REV PALAEOBOT PALYNO, V163, P73, DOI 10.1016/j.revpalbo.2010.10.007; Mathur AK, 1996, PALAEONTOLOGIA INDIC, V1, P1; Mehrotra R. C., 2007, Journal of the Palaeontological Society of India, V52, P159; Mehrotra R.C., 2000, PALAEOBOTANIST, V49, P255; Mehrotra RC, 2003, GEOBIOS-LYON, V36, P83, DOI 10.1016/S0016-6995(02)00107-9; Mohabey DM, 1986, MEMOIR GEOLOGICAL SO, V37, P363; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Paul SK, 2007, CURR SCI INDIA, V92, P727; Punyasena SW, 2008, J BIOGEOGR, V35, P117, DOI 10.1111/j.1365-2699.2007.01773.x; Rao GV, 1989, P SPEC IND GEOPH C P; READ R W, 1972, Taxon, V21, P129, DOI 10.2307/1219237; Sahni B, 1964, REVISON INDIAN FOS 3; Sahni B., 1934, CURR SCI INDIA, V3, P134; Samant B, 2009, J BIOSCIENCES, V34, P811, DOI 10.1007/s12038-009-0064-9; Samant B., 2005, GONDWANA GEOLOGICAL, V8, P151; SAPORTA G., 1865, ANN SCI NATURELLES B, V5, P5; SHETE R H, 1980, Palaeontographica Abteilung B Palaeophytologie, V172, P117; Shete RH, 1985, J INDIAN BOT SOC, V64, P45; Sheth HC, 2001, GEOPHYS RES LETT, V28, P3513, DOI 10.1029/2001GL012921; Shukla P.N., 1997, PALAEOBOTANIST, V46, P127; Singh MC, 2012, J GEOL SOC INDIA, V79, P287, DOI 10.1007/s12594-012-0042-y; Singh RR, 2012, J GEOL SOC INDIA, V79, P85, DOI 10.1007/s12594-012-0008-0; Smith A.G., 1994, ATLAS MESOZOIC CENOZ; Srivastava G, 2012, J EARTH SYST SCI, V121, P747, DOI 10.1007/s12040-012-0179-5; Srivastava R., 2011, GEOL SOC AM MEM, V77, P281; Srivastava R, 2005, CATALOGUE CENOZOIC T; Srivastava R, 1991, CATALOGUE FOSSIL PLA; Survey of India, 1950, TOP 64A; Svenning JC, 2008, J BIOGEOGR, V35, P394, DOI 10.1111/j.1365-2699.2007.01841.x; Tomlinson PB, 2006, BOT J LINN SOC, V151, P5, DOI 10.1111/j.1095-8339.2006.00520.x; Tomlinson PB, 1990, STRUCTURAL BIOL PALM; TRIVEDI BS, 1971, CURR SCI INDIA, V40, P526; VENKATESAN TR, 1993, EARTH PLANET SC LETT, V119, P181, DOI 10.1016/0012-821X(93)90015-2; Walther GR, 2007, GLOBAL ECOL BIOGEOGR, V16, P801, DOI 10.1111/j.1466-8238.2007.00328.x; Woodward F. I., 1988, CLIMATE PLANT DISTRI; Zhou WJ, 2013, SCI CHINA EARTH SCI, V56, P1493, DOI 10.1007/s11430-013-4681-7	94	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111738	10.1371/journal.pone.0111738	http://dx.doi.org/10.1371/journal.pone.0111738			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25394208	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300021
J	Grattan, LE; Glimcher, PW				Grattan, Lauren E.; Glimcher, Paul W.			Absence of Spatial Tuning in the Orbitofrontal Cortex	PLOS ONE			English	Article							ORBITAL PREFRONTAL CORTEX; MONKEY SUPERIOR COLLICULUS; INTRAPARIETAL NEURONS; REWARD PREFERENCE; RESPONSES; CHOICES; REPRESENTATION; COMPUTATION; LESIONS; FIELDS	There is limited data in the literature to explicitly support the notion that neurons in OFC are truly action-independent in their coding. We set out to specifically test the hypothesis that OFC value-related neurons in area 13 m of the monkey do not carry information about the action required to obtain that reward - that activity in this area represents reward values in an abstract and action-independent manner. To accomplish that goal we had two monkeys select and execute saccadic eye movements to 81 locations in the visual field for three different kinds of juice rewards. Our detailed analysis of the response fields indicates that these neurons are insensitive to the amplitude or direction of the saccade required to obtain these rewards. Our data thus validate earlier proposals that neurons of 13 m in the OFC encode subjective value independent of the saccadic action required to obtain that reward.	[Grattan, Lauren E.; Glimcher, Paul W.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Glimcher, PW (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	glimcher@cns.nyu.edu			NIH/NEI [R01EY010536]; NATIONAL EYE INSTITUTE [R01EY010536] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The NIH/NEI grant R01EY010536 provided financial support for this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLIS LL, 1995, NEUROSCIENCE, V64, P801, DOI 10.1016/0306-4522(94)00449-F; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Gnadt JW, 1996, VISION RES, V36, P3525, DOI 10.1016/0042-6989(96)00049-1; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Kennerley SW, 2009, J NEUROPHYSIOL, V102, P3352, DOI 10.1152/jn.00273.2009; Levy I, 2011, J NEUROSCI, V31, P118, DOI 10.1523/JNEUROSCI.3214-10.2011; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; MOORS J, 1979, EXP BRAIN RES, V35, P333; MORECRAFT RJ, 1992, J COMP NEUROL, V323, P341, DOI 10.1002/cne.903230304; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Padoa-Schioppa C, 2007, ANN NY ACAD SCI, V1121, P232, DOI 10.1196/annals.1401.011; Padoa-Schioppa C, 2008, NAT NEUROSCI, V11, P95, DOI 10.1038/nn2020; Padoa-Schioppa C, 2011, ANN NY ACAD SCI, V1239, P130, DOI 10.1111/j.1749-6632.2011.06262.x; Padoa-Schioppa C, 2011, ANNU REV NEUROSCI, V34, P333, DOI 10.1146/annurev-neuro-061010-113648; Platt ML, 1997, J NEUROPHYSIOL, V78, P1574, DOI 10.1152/jn.1997.78.3.1574; Platt ML, 1998, EXP BRAIN RES, V121, P65, DOI 10.1007/s002210050438; Pritchard TC, 2007, ANN NY ACAD SCI, V1121, P121, DOI 10.1196/annals.1401.007; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tsujimoto S, 2009, J NEUROSCI, V29, P2569, DOI 10.1523/JNEUROSCI.5777-08.2009; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Walton ME, 2010, NEURON, V65, P927, DOI 10.1016/j.neuron.2010.02.027; Wunderlich K, 2010, P NATL ACAD SCI USA, V107, P15005, DOI 10.1073/pnas.1002258107	29	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112750	10.1371/journal.pone.0112750	http://dx.doi.org/10.1371/journal.pone.0112750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386837	Green Published, gold			2022-12-26	WOS:000345250400089
J	Jin, J; Sui, BW; Gou, JX; Liu, JS; Tang, X; Xu, H; Zhang, Y; Jin, XQ				Jin, Jian; Sui, Bowen; Gou, Jingxin; Liu, Jingshuo; Tang, Xing; Xu, Hui; Zhang, Yu; Jin, Xiangqun			PSMA Ligand Conjugated PCL-PEG Polymeric Micelles Targeted to Prostate Cancer Cells	PLOS ONE			English	Article							BLOCK-COPOLYMER MICELLES; MEMBRANE ANTIGEN; DRUG-DELIVERY; NANOPARTICLES; EXPRESSION; BIODISTRIBUTION; EFFICACY; HYDROGEL; BEHAVIOR	In this content, a small molecular ligand of prostate specific membrane antigen (SMLP) conjugated poly (caprolactone) (PCL)-b-poly (ethylene glycol) (PEG) copolymers with different block lengths were synthesized to construct a satisfactory drug delivery system. Four different docetaxel-loaded polymeric micelles (DTX-PMs) were prepared by dialysis with particle sizes less than 60 nm as characterized by dynamic light scattering (DLS) and transmission electron microscope (TEM). Optimization of the prepared micelles was conducted based on short-term stability and drug-loading content. The results showed that optimized systems were able to remain stable over 7 days. Compared with Taxotere, DTX-PMs with the same ratio of hydrophilic/hydrophobic chain length displayed similar sustained release behaviors. The cytotoxicity of the optimized targeted DTX-PCL12K-PEG(5K)-SMLP micelles (DTX-PMs2) and non-targeted DTX-PCL12K-mPEG(5K) micelles (DTX-PMs1) were evaluated by MTT assays using prostate specific membrane antigen (PSMA) positive prostate adenocarcinoma cells (LNCaP). The results showed that the targeted micelles had a much lower IC50 than their non-targeted counterparts (48 h: 0.87 +/- 0.27 vs 13.48 +/- 1.03 mu g/ml; 72 h: 0.02 +/- 0.008 vs 1.35 +/- 0.54 mu g/ml). In vitro cellular uptake of PMs2 showed 5-fold higher fluorescence intensity than that of PMs1 after 4 h incubation. According to these results, the novel nano-sized drug delivery system based on DTX-PCL-PEG-SMLP offers great promise for the treatment of prostatic cancer.	[Jin, Jian; Sui, Bowen; Liu, Jingshuo; Jin, Xiangqun] Jilin Univ, Coll Pharm Sci, Dept Pharmaceut, Changchun 130023, Peoples R China; [Gou, Jingxin; Tang, Xing; Xu, Hui; Zhang, Yu] Shenyang Pharmaceut Univ, Dept Pharmaceut, Shenyang, Peoples R China	Jilin University; Shenyang Pharmaceutical University	Jin, XQ (corresponding author), Jilin Univ, Coll Pharm Sci, Dept Pharmaceut, Changchun 130023, Peoples R China.	jinxq@jlu.edu.cn						Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Bae SJ, 2005, MACROMOLECULES, V38, P5260, DOI 10.1021/ma050489m; Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Chung YM, 2002, BIOMACROMOLECULES, V3, P511, DOI 10.1021/bm0156431; Colombatti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004608; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Denmeade SR, 2003, PROSTATE, V54, P249, DOI 10.1002/pros.10199; Dhar S, 2008, J AM CHEM SOC, V130, P11467, DOI 10.1021/ja803036e; Esmaeili F, 2009, J PHARM SCI-US, V98, P2718, DOI 10.1002/jps.21599; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034; Ghosh A, 2004, J CELL BIOCHEM, V91, P528, DOI 10.1002/jcb.10661; Gou ML, 2009, J PHYS CHEM B, V113, P12928, DOI 10.1021/jp905781g; Gu PF, 2012, INT J NANOMED, V7, P109, DOI 10.2147/IJN.S27475; Haag R, 2004, ANGEW CHEM INT EDIT, V43, P278, DOI 10.1002/anie.200301694; Hinterwirth H, 2012, ANAL CHIM ACTA, V733, P90, DOI 10.1016/j.aca.2012.04.036; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Hu Y, 2004, BIOMACROMOLECULES, V5, P1756, DOI 10.1021/bm049845j; Huang W, 2010, ACTA BIOMATER, V6, P3927, DOI 10.1016/j.actbio.2010.04.021; ISRAELI RS, 1994, CANCER RES, V54, P1807; KATAOKA K, 1993, J CONTROL RELEASE, V24, P119; Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025; Li JM, 2012, J BIOMED NANOTECHNOL, V8, P809, DOI 10.1166/jbn.2012.1433; Liu CB, 2007, COLLOID SURFACE A, V302, P430, DOI 10.1016/j.colsurfa.2007.03.006; Maresca KP, 2009, J MED CHEM, V52, P347, DOI 10.1021/jm800994j; Murphy GP, 1998, CANCER-AM CANCER SOC, V83, P2259, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2259::AID-CNCR5>3.0.CO;2-T; Nie SF, 2011, INT J NANOMED, V6, P151, DOI 10.2147/IJN.S15057; Qi RG, 2011, J CONTROL RELEASE, V152, pE167, DOI 10.1016/j.jconrel.2011.08.067; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Samarajeewa S, 2013, MOL PHARMACEUT, V10, P1092, DOI 10.1021/mp3005897; Sanna V, 2011, MOL PHARMACEUT, V8, P748, DOI 10.1021/mp100360g; Savic R, 2006, J DRUG TARGET, V14, P343, DOI 10.1080/10611860600874538; Saxena V, 2013, J BIOMED NANOTECHNOL, V9, P1146, DOI 10.1166/jbn.2013.1632; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; Wang YJ, 2012, J BIOMED NANOTECHNOL, V8, P450, DOI 10.1166/jbn.2012.1390; Wolf P, 2010, PROSTATE, V70, P562, DOI 10.1002/pros.21090; Yamamichi F, 2012, UROLOGY, V80, DOI 10.1016/j.urology.2012.06.023; Zamani S, 2012, POLYMER, V53, P5723, DOI 10.1016/j.polymer.2012.09.051	41	34	34	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112200	10.1371/journal.pone.0112200	http://dx.doi.org/10.1371/journal.pone.0112200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386942	gold, Green Submitted, Green Published			2022-12-26	WOS:000345250400049
J	Ohri, SS; Mullins, A; Hetman, M; Whittemore, SR				Ohri, Sujata Saraswat; Mullins, Ashley; Hetman, Michal; Whittemore, Scott R.			Inhibition of GADD34, the Stress-Inducible Regulatory Subunit of the Endoplasmic Reticulum Stress Response, Does Not Enhance Functional Recovery after Spinal Cord Injury	PLOS ONE			English	Article							XBP1 MESSENGER-RNA; PROTEIN-SYNTHESIS; ER STRESS; APOPTOSIS; DEATH; ATF6	Activation of the endoplasmic reticulum stress response (ERSR) is a hallmark of various pathological diseases and/or traumatic injuries. Restoration of ER homeostasis can contribute to improvement in the functional outcome of these diseases. Using genetic and pharmacological inhibition of the PERK-CHOP arm of the ERSR, we recently demonstrated improvements in hindlimb locomotion after spinal cord injury (SCI) and implicated oligodendrocyte survival as a potential mechanism. Here, we investigated the contribution of stress-inducible PPP1R15A/GADD34, an ERSR signaling effector downstream of CHOP that dephosphorylates eIF2 alpha, in the pathogenesis of SCI. We show that although genetic ablation of GADD34 protects oligodendrocyte precursor cells (OPCs) against ER stress-mediated cell death in vitro and results in differential ERSR attenuation in vivo after SCI, there is no improvement in hindlimb locomotor function. Guanabenz, a FDA approved antihypertensive drug, was recently shown to reduce the burden of misfolded proteins in the ER by directly targeting GADD34. Guanabenz protected OPCs from ER stress-mediated cell death in vitro and attenuated the ERSR in vivo after SCI. However, guanabenz administration failed to rescue the locomotor deficits after SCI. These data suggest that deletion of GADD34 alone is not sufficient to improve functional recovery after SCI.	[Ohri, Sujata Saraswat; Mullins, Ashley; Hetman, Michal; Whittemore, Scott R.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA; [Ohri, Sujata Saraswat; Mullins, Ashley; Hetman, Michal; Whittemore, Scott R.] Univ Louisville, Dept Neurol Surg, Louisville, KY 40292 USA; [Hetman, Michal] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [Hetman, Michal; Whittemore, Scott R.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Whittemore, SR (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Louisville, KY 40292 USA.	swhittemore@louisville.edu			Kentucky Spinal Cord and Head Injury Research Trust [10-13]; Norton Healthcare; Commonwealth of Kentucky Challenge for Excellence;  [NS073584];  [NS054708];  [RR15576/GM103507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054708, R01NS073584] Funding Source: NIH RePORTER	Kentucky Spinal Cord and Head Injury Research Trust; Norton Healthcare; Commonwealth of Kentucky Challenge for Excellence; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NS073584, NS054708, RR15576/GM103507, Kentucky Spinal Cord and Head Injury Research Trust, 10-13, Norton Healthcare and the Commonwealth of Kentucky Challenge for Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HT, 1999, MOL CELL BIOL, V19, P7050; Almad A, 2011, NEUROTHERAPEUTICS, V8, P262, DOI 10.1007/s13311-011-0033-5; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; D'Antonio M, 2013, J EXP MED, V210, P821, DOI 10.1084/jem.20122005; D'Antonio M, 2009, J NEUROSCI RES, V87, P3241, DOI 10.1002/jnr.22066; Dincman TA, 2012, J NEUROSCI METH, V209, P219, DOI 10.1016/j.jneumeth.2012.06.017; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033; Han S, 2010, BRAIN, V133, P1026, DOI 10.1093/brain/awq034; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Hurlbert RJ, 2013, NEUROSURGERY, V72, P93, DOI 10.1227/NEU.0b013e31827765c6; Kojima E, 2003, FASEB J, V17, P1573, DOI 10.1096/fj.02-1184fje; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lin WS, 2008, AM J PATHOL, V173, P1508, DOI 10.2353/ajpath.2008.080449; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Magnuson DSK, 1999, EXP NEUROL, V156, P191, DOI 10.1006/exnr.1999.7016; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Monk KR, 2013, DIS MODEL MECH, V6, P135, DOI 10.1242/dmm.009217; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Ohri SS, 2013, NEUROBIOL DIS, V58, P29, DOI 10.1016/j.nbd.2013.04.021; Ohri SS, 2012, J NEUROTRAUM, V29, P579, DOI 10.1089/neu.2011.1940; Ohri SS, 2011, GLIA, V59, P1489, DOI 10.1002/glia.21191; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tator CH, 2006, NEUROSURGERY, V59, P957, DOI 10.1227/01.NEU.0000245591.16087.89; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Valenzuela V, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.8; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	42	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109703	10.1371/journal.pone.0109703	http://dx.doi.org/10.1371/journal.pone.0109703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386686	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400003
J	Rafiq, MT; Aziz, R; Yang, XE; Xiao, WD; Stoffella, PJ; Saghir, A; Azam, M; Li, TQ				Rafiq, Muhammad Tariq; Aziz, Rukhsanda; Yang, Xiaoe; Xiao, Wendan; Stoffella, Peter J.; Saghir, Aamir; Azam, Muhammad; Li, Tingqiang			Phytoavailability of Cadmium (Cd) to Pak Choi (Brassica chinensis L.) Grown in Chinese Soils: A Model to Evaluate the Impact of Soil Cd Pollution on Potential Dietary Toxicity	PLOS ONE			English	Article							ORYZA-SATIVA L.; EXCHANGE CAPACITY; HEAVY-METALS; RICE; ACCUMULATION; ACID; PHYTOEXTRACTION; PHYTOTOXICITY; VEGETABLES; CHROMIUM	Food chain contamination by soil cadmium (Cd) through vegetable consumption poses a threat to human health. Therefore, an understanding is needed on the relationship between the phytoavailability of Cd in soils and its uptake in edible tissues of vegetables. The purpose of this study was to establish soil Cd thresholds of representative Chinese soils based on dietary toxicity to humans and develop a model to evaluate the phytoavailability of Cd to Pak choi (Brassica chinensis L.) based on soil properties. Mehlich-3 extractable Cd thresholds were more suitable for Stagnic Anthrosols, Calcareous, Ustic Cambosols, Typic Haplustalfs, Udic Ferrisols and Periudic Argosols with values of 0.30, 0.25, 0.18, 0.16, 0.15 and 0.03 mg kg(-1), respectively, while total Cd is adequate threshold for Mollisols with a value of 0.86 mg kg(-1). A stepwise regression model indicated that Cd phytoavailability to Pak choi was significantly influenced by soil pH, organic matter, total Zinc and Cd concentrations in soil. Therefore, since Cd accumulation in Pak choi varied with soil characteristics, they should be considered while assessing the environmental quality of soils to ensure the hygienically safe food production.	[Rafiq, Muhammad Tariq; Aziz, Rukhsanda; Yang, Xiaoe; Xiao, Wendan; Li, Tingqiang] Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Rafiq, Muhammad Tariq] Int Islamic Univ, Dept Environm Sci, Islamabad, Pakistan; [Stoffella, Peter J.] Univ Florida, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Saghir, Aamir] Zhejiang Univ, Inst Stat, Hangzhou 310003, Zhejiang, Peoples R China; [Azam, Muhammad] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; International Islamic University, Pakistan; State University System of Florida; University of Florida; Zhejiang University; Zhejiang University	Li, TQ (corresponding author), Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecol Hlth, Hangzhou 310003, Zhejiang, Peoples R China.	litq@zju.edu.cn	Azam, Muhammad/AAX-5514-2020; Li, Tingqiang/B-2592-2017; Azam, Muhammad/AAZ-2627-2020	Li, Tingqiang/0000-0003-4448-4871; Xiao, Wendan/0000-0002-7188-4056; Saghir, Aamir/0000-0002-7988-7913	Ministry of Environmental Protection of China [2011467057]; ministry of Science and Technology of China [2012AA100605]; Fundamental Research Funds for the Central Universities of China	Ministry of Environmental Protection of China; ministry of Science and Technology of China(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by the Ministry of Environmental Protection of China (grant no. 2011467057), the ministry of Science and Technology of China (grant no. 2012AA100605), and by the Fundamental Research Funds for the Central Universities of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULLA M, 1990, BIOL TRACE ELEM RES, V23, P25, DOI 10.1007/BF02917176; Ali B, 2013, J PLANT GROWTH REGUL, V32, P604, DOI 10.1007/s00344-013-9328-6; Ali B, 2013, ECOTOX ENVIRON SAFE, V92, P271, DOI 10.1016/j.ecoenv.2013.02.006; Bo- HYL, 2013, INT J ENV RES PUB HE, V10, P5284, DOI 10.3390/ijerph10115284; Chapman PM, 2002, SCI TOTAL ENVIRON, V288, P131, DOI 10.1016/S0048-9697(01)01120-2; Chaturvedi R., 2006, LAB MANUAL PHYSICOCH; Chen HS, 2010, PEDOSPHERE, V20, P63, DOI 10.1016/S1002-0160(09)60283-6; Cui YJ, 2004, J ENVIRON SCI, V16, P962; Day P.R., 1965, METHODS SOIL ANAL 1, P545, DOI DOI 10.2134/AGRONMONOGR9.1.C43; de Villiers S, 2010, ENVIRON GEOCHEM HLTH, V32, P451, DOI 10.1007/s10653-010-9288-8; Di Salvatore M, 2009, J FOOD AGRIC ENVIRON, V7, P683; Du T.P., 2005, PRODUCT RES, V6, P139; Eriksson JE, 1996, ACTA AGR SCAND B-S P, V46, P240, DOI 10.1080/09064719609410957; FAO/WHO, 2003, 61 M JOINT FAO WHO E; Franz E, 2008, J FOOD PROTECT, V71, P2504, DOI 10.4315/0362-028X-71.12.2504; Ge Y, 2000, ENVIRON POLLUT, V107, P137, DOI 10.1016/S0269-7491(99)00119-0; GIORDANO PM, 1979, J ENVIRON QUAL, V8, P233, DOI 10.2134/jeq1979.00472425000800020020x; GU JG, 2003, J BASIC SCI ENG, V11, P143; Halim M, 2003, CHEMOSPHERE, V52, P265, DOI 10.1016/S0045-6535(03)00185-1; HENDERSHOT WH, 1986, SOIL SCI SOC AM J, V50, P605, DOI 10.2136/sssaj1986.03615995005000030013x; IARC, 1993, MON EV CARC RISKS HU, P119; Ide G, 1995, INT C HEAV MET ENV H, V2, P302; Jung MC, 1996, APPL GEOCHEM, V11, P53, DOI 10.1016/0883-2927(95)00075-5; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; KAMINEK M, 1992, TRENDS BIOTECHNOL, V10, P159, DOI 10.1016/0167-7799(92)90204-9; Kobayashi E, 2008, TOXICOL LETT, V179, P108, DOI 10.1016/j.toxlet.2008.04.013; Laura W, 2011, J AGR FOOD SYS COMM; Lebeau T, 2002, SCI TOTAL ENVIRON, V291, P73, DOI 10.1016/S0048-9697(01)01093-2; Li S, 2006, GEODERMA, V136, P260, DOI 10.1016/j.geoderma.2006.03.054; Liang ZF, 2013, ECOTOX ENVIRON SAFE, V93, P180, DOI 10.1016/j.ecoenv.2013.04.003; Liu JG, 2007, J HAZARD MATER, V143, P443, DOI 10.1016/j.jhazmat.2006.09.057; Liu L, 2009, J HAZARD MATER, V163, P563, DOI 10.1016/j.jhazmat.2008.07.004; Liu WT, 2010, J HAZARD MATER, V173, P737, DOI 10.1016/j.jhazmat.2009.08.147; Liu XQ, 2010, CHEMOSPHERE, V78, P1136, DOI 10.1016/j.chemosphere.2009.12.030; MAHLER RJ, 1978, J ENVIRON QUAL, V7, P274, DOI 10.2134/jeq1978.00472425000700020025x; McBride M, 2002, SOIL SCI, V15, P84; McCauley A., 2009, NUTR MANAG MODUL, V8, P1; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; MOYA JL, 1993, PHOTOSYNTH RES, V36, P75, DOI 10.1007/BF00016271; Nyitrai P, 2003, J PLANT PHYSIOL, V160, P1175, DOI 10.1078/0176-1617-00770; OLIVER DP, 1994, J ENVIRON QUAL, V23, P705, DOI 10.2134/jeq1994.00472425002300040013x; Rafiq MT, 2014, ECOTOX ENVIRON SAFE, V103, P101, DOI 10.1016/j.ecoenv.2013.10.016; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Romkens PFAM, 2009, ENVIRON POLLUT, V157, P2435, DOI 10.1016/j.envpol.2009.03.009; Ryan J, 2001, SOIL PLANT ANAL LAB, V2; Shentu JL, 2008, J AGR FOOD CHEM, V56, P6382, DOI 10.1021/jf800882q; Shute T, 2006, SCI TOTAL ENVIRON, V371, P63, DOI 10.1016/j.scitotenv.2006.07.034; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; Szteke B, 1995, INT C HEAV MET ENV H, V2, P228; Wang XL, 2005, SCI TOTAL ENVIRON, V350, P28, DOI 10.1016/j.scitotenv.2004.09.044; Wang XP, 2004, CHEMOSPHERE, V55, P811, DOI 10.1016/j.chemosphere.2003.12.003; Xiao WD, 2013, J ENVIRON QUAL, V42, P758, DOI 10.2134/jeq2012.0419; Xiao WD, 2013, J AGR FOOD CHEM, V61, P2925, DOI 10.1021/jf400467s; Yang JX, 2010, J ENVIRON SCI, V22, P1246, DOI 10.1016/S1001-0742(09)60245-X; Yang Y, 2009, J ENVIRON MANAGE, V90, P1117, DOI 10.1016/j.jenvman.2008.05.004; 顾继光, 2002, [生态科学, Ecologic Science], V21, P352	57	37	39	9	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111461	10.1371/journal.pone.0111461	http://dx.doi.org/10.1371/journal.pone.0111461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386790	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400018
J	Han, XX; Sun, SK; Zhao, M; Cheng, X; Chen, GZ; Lin, S; Guan, YF; Yu, XD				Han, Xiaoxi; Sun, Shengkun; Zhao, Ming; Cheng, Xiang; Chen, Guozhu; Lin, Song; Guan, Yifu; Yu, Xiaodan			Celastrol Stimulates Hypoxia-Inducible Factor-1 Activity in Tumor Cells by Initiating the ROS/Akt/p70S6K Signaling Pathway and Enhancing Hypoxia-Inducible Factor-1 alpha Protein Synthesis	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; ENDOTHELIAL GROWTH-FACTOR; UP-REGULATION; DNA-DAMAGE; AUTOPHAGY; ACTIVATION; EXPRESSION; BNIP3; HIF-1-ALPHA; INDUCTION	Celastrol, a tripterine derived from the traditional Chinese medicine plant Tripterygium wilfordii Hook F. ("Thunder of God Vine''), has been reported to have multiple effects, such as anti-inflammation, suppression of tumor angiogenesis, inhibition of tumor growth, induction of apoptosis and protection of cells against human neurodegenerative diseases. However, the mechanisms that underlie these functions are not well defined. In this study, we reported for the first time that Celastrol could induce HIF-1 alpha protein accumulation in multiple cancer cell lines in an oxygen-independent manner and that the enhanced HIF-1 alpha protein entered the nucleus and promoted the transcription of the HIF-1 target genes VEGF and Glut-1. Celastrol did not influence HIF-1 alpha transcription. Instead, Celastrol induced the accumulation of the HIF-1 alpha protein by inducing ROS and activating Akt/p70S6K signaling to promote HIF-1 alpha translation. In addition, we found that the activation of Akt by Celastrol was transient. With increased exposure time, inhibition of Hsp90 chaperone function by Celastrol led to the subsequent depletion of the Akt protein and thus to the suppression of Akt activity. Moreover, in HepG2 cells, the accumulation of HIF-1 alpha increased the expression of BNIP3, which induced autophagy. However, HIF-1 alpha and BNIP3 did not influence the cytotoxicity of Celastrol because the main mechanism by which Celastrol kills cancer cells is through stimulating ROS-mediated JNK activation and inducing apoptosis. Furthermore, our data showed that the dose required for Celastrol to induce HIF-1 alpha protein accumulation and enhance HIF-1 alpha transcriptional activation was below its cytotoxic threshold. A cytotoxic dose of Celastrol for cancer cells did not display cytotoxicity in LO2 normal human liver cells, which indicated that the novel functions of Celastrol in regulating HIF-1 signaling and inducing autophagy might be used in new applications, such as in anti-inflammation and protection of cells against human neurodegenerative diseases. Future studies regarding these applications are required.	[Han, Xiaoxi; Guan, Yifu] China Med Univ, Dept Biochem & Mol Biol, Shenyang, Peoples R China; [Sun, Shengkun] Gen Hosp PLA, Dept Urol, Beijing, Peoples R China; [Zhao, Ming; Cheng, Xiang; Chen, Guozhu; Lin, Song; Yu, Xiaodan] Cognit & Mental Hlth Res Ctr, Inst Basic Med Sci, Dept Cognit Sci, Beijing, Peoples R China	China Medical University; Chinese People's Liberation Army General Hospital	Guan, YF (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Shenyang, Peoples R China.	yfguan@mail.cmu.edu.cn; yuxd@bmi.ac.cn			"973'' Program of the Ministry of Science and Technology of China [2012CB518200]; National Natural Science Foundation of China [31371434]	"973'' Program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Grant 2012CB518200 from the "973'' Program of the Ministry of Science and Technology of China (to X. Yu) and by Grants 31371434 (to X. Yu) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Calixto Joao B., 2004, Planta Medica, V70, P93, DOI 10.1055/s-2004-815483; Chadli A, 2010, J BIOL CHEM, V285, P4224, DOI 10.1074/jbc.M109.081018; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen GZ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-170; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014153; Dai Y, 2009, INT J RADIAT ONCOL, V74, P1217, DOI 10.1016/j.ijrobp.2009.03.057; Deng YN, 2013, NEUROCHEM INT, V63, P1, DOI 10.1016/j.neuint.2013.04.005; Faust K, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-109; Gao N, 2002, J BIOL CHEM, V277, P31963, DOI 10.1074/jbc.M200082200; Ge PF, 2010, NEUROL RES, V32, P94, DOI 10.1179/016164109X12518779082273; Guo LL, 2012, BBA-MOL BASIS DIS, V1822, P852, DOI 10.1016/j.bbadis.2012.02.004; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, AUTOPHAGY, V2, P307, DOI 10.4161/auto.2947; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2009, J BIOL CHEM, V284, P5332, DOI 10.1074/jbc.M806653200; Huang LL, 2011, INT J MOL MED, V27, P407, DOI 10.3892/ijmm.2011.600; Jo H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010318; Kaluzova M, 2004, MOL CELL BIOL, V24, P5757, DOI 10.1128/MCB.24.13.5757-5766.2004; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Kim Y, 2011, CELL PHYSIOL BIOCHEM, V28, P175, DOI 10.1159/000331729; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Kurokawa T, 2003, BRIT J CANCER, V89, P1042, DOI 10.1038/sj.bjc.6601186; Lee HW, 2014, BMB REP; Lerman OZ, 2010, BLOOD, V116, P3669, DOI 10.1182/blood-2009-03-213629; Lin MT, 2008, J BIOL CHEM, V283, P15807, DOI 10.1074/jbc.M708933200; Liu XH, 1999, CLIN EXP METASTAS, V17, P687, DOI 10.1023/A:1006728119549; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mazure NM, 2009, AUTOPHAGY, V5, P868, DOI 10.4161/auto.9042; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Mou HB, 2011, TOXICOL IN VITRO, V25, P1027, DOI 10.1016/j.tiv.2011.03.023; O'Rourke JF, 1997, ONCOL RES, V9, P327; Obacz J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-93; Pang XF, 2010, CANCER RES, V70, P1951, DOI 10.1158/0008-5472.CAN-09-3201; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philipp S, 2006, EUR J HEART FAIL, V8, P347, DOI 10.1016/j.ejheart.2005.10.009; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Schnitzer SE, 2005, FEBS LETT, V579, P529, DOI 10.1016/j.febslet.2004.12.023; Sen Banerjee S, 2012, TOXICOL MECH METHOD, V22, P347, DOI 10.3109/15376516.2012.673088; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sha Min, 2013, Cancer Cell Int, V13, P50, DOI 10.1186/1475-2867-13-50; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Venkatesha SH, 2011, J BIOL CHEM, V286, P15138, DOI 10.1074/jbc.M111.226365; Walcott SE, 2010, COMP BIOCHEM PHYS A, V156, P285, DOI 10.1016/j.cbpa.2010.02.015; Wei W, 2007, CANCER LETT, V257, P145, DOI 10.1016/j.canlet.2007.08.009; Whitney LK, 2004, BRIT J CANCER, V91, pS50; Xie SR, 2012, PHYTOTHER RES, V26, P1133, DOI 10.1002/ptr.3696; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang T, 2009, J BIOL CHEM, V284, P35381, DOI 10.1074/jbc.M109.051532; Zhou YX, 2009, CHINESE MED J-PEKING, V122, P1666, DOI 10.3760/cma.j.issn.0366-6999.2009.14.012; Zhu H, 2010, J PHARMACOL EXP THER, V334, P489, DOI 10.1124/jpet.110.165654; Zhu H, 2010, CANCER INVEST, V28, P23, DOI 10.3109/07357900903095664	58	6	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112470	10.1371/journal.pone.0112470	http://dx.doi.org/10.1371/journal.pone.0112470			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383959	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700066
J	Ma, ZY; LeBard, DN; Loverde, SM; Sharp, KA; Klein, ML; Discher, DE; Finkel, TH				Ma, Zhengyu; LeBard, David N.; Loverde, Sharon M.; Sharp, Kim A.; Klein, Michael L.; Discher, Dennis E.; Finkel, Terri H.			TCR Triggering by pMHC Ligands Tethered on Surfaces via Poly(Ethylene Glycol) Depends on Polymer Length	PLOS ONE			English	Article							T-CELL-ACTIVATION; STEERED MOLECULAR-DYNAMICS; GRAPHICS PROCESSING UNITS; KINETICS; MODEL; SURFACTANTS; RECEPTORS; PROTEINS; COMPLEX; BINDING	Antigen recognition by T cells relies on the interaction between T cell receptor (TCR) and peptide-major histocompatibility complex (pMHC) at the interface between the T cell and the antigen presenting cell (APC). The pMHC-TCR interaction is two-dimensional (2D), in that both the ligand and receptor are membrane-anchored and their movement is limited to 2D diffusion. The 2D nature of the interaction is critical for the ability of pMHC ligands to trigger TCR. The exact properties of the 2D pMHC-TCR interaction that enable TCR triggering, however, are not fully understood. Here, we altered the 2D pMHC-TCR interaction by tethering pMHC ligands to a rigid plastic surface with flexible poly(ethylene glycol) (PEG) polymers of different lengths, thereby gradually increasing the ligands' range of motion in the third dimension. We found that pMHC ligands tethered by PEG linkers with long contour length were capable of activating T cells. Shorter PEG linkers, however, triggered TCR more efficiently. Molecular dynamics simulation suggested that shorter PEGs exhibit faster TCR binding on-rates and off-rates. Our findings indicate that TCR signaling can be triggered by surface-tethered pMHC ligands within a defined 3D range of motion, and that fast binding rates lead to higher TCR triggering efficiency. These observations are consistent with a model of TCR triggering that incorporates the dynamic interaction between T cell and antigen-presenting cell.	[Ma, Zhengyu] Nemours AI duPont Hosp Children, Dept Biomed Res, Wilmington, DE 19803 USA; [LeBard, David N.] Yeshiva Univ, Dept Chem, New York, NY 10033 USA; [Loverde, Sharon M.] CUNY Coll Staten Isl, Dept Chem, Staten Isl, NY 10301 USA; [Sharp, Kim A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Klein, Michael L.] Temple Univ, Inst Computat Mol Sci, Philadelphia, PA 19122 USA; [Klein, Michael L.] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; [Discher, Dennis E.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Finkel, Terri H.] Nemours Childrens Hosp, Dept Pediat, Orlando, FL USA; [Finkel, Terri H.] Univ Cent Florida, Coll Med, Dept Biomed Sci, Orlando, FL 32816 USA	Nemours Alfred I. duPont Hospital for Children; Yeshiva University; City University of New York (CUNY) System; College of Staten Island (CUNY); University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; State University System of Florida; University of Central Florida	Ma, ZY (corresponding author), Nemours AI duPont Hosp Children, Dept Biomed Res, Wilmington, DE 19803 USA.	zma@nemours.org		discher, dennis/0000-0001-6163-2229	NIH [1R21 AI087516, 1R21 AI078387, P20GM103464]; University of Pennsylvania Center for AIDS Research pilot grant [2-P30-AI-045008-11]; Children's Hospital of Philadelphia (CHOP); CHOP Research Institute; Nemours Foundation; Nemours Children's Hospital; NATIONAL CANCER INSTITUTE [F32CA134157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008, R21AI078387, R21AI087516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Center for AIDS Research pilot grant; Children's Hospital of Philadelphia (CHOP); CHOP Research Institute; Nemours Foundation; Nemours Children's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH 1R21 AI087516, NIH 1R21 AI078387, NIH P20GM103464, the University of Pennsylvania Center for AIDS Research pilot grant (2-P30-AI-045008-11), the Children's Hospital of Philadelphia (CHOP) and the CHOP Research Institute, and the Nemours Foundation and Nemours Children's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALON R, 1990, BIOCHEM BIOPH RES CO, V170, P1236, DOI 10.1016/0006-291X(90)90526-S; Anderson JA, 2008, J COMPUT PHYS, V227, P5342, DOI 10.1016/j.jcp.2008.01.047; Choudhuri K, 2007, SEMIN IMMUNOL, V19, P255, DOI 10.1016/j.smim.2007.04.005; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; Cuendet MA, 2011, PROTEINS, V79, P3007, DOI 10.1002/prot.23104; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Knapp B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011653; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LeBard DN, 2012, SOFT MATTER, V8, P2385, DOI 10.1039/c1sm06787g; Levine BG, 2011, J CHEM THEORY COMPUT, V7, P4135, DOI 10.1021/ct2005193; Li YC, 2010, J IMMUNOL, V184, P5959, DOI 10.4049/jimmunol.0900775; London CA, 2000, J IMMUNOL, V164, P265, DOI 10.4049/jimmunol.164.1.265; Ma ZY, 2008, PLOS BIOL, V6, P328, DOI 10.1371/journal.pbio.0060043; Ma ZY, 2008, FASEB J, V22, P1002, DOI 10.1096/fj.07-9331hyp; Ma ZY, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00217; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Oesterhelt F, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/006; Pardigon N, 1998, INT IMMUNOL, V10, P619, DOI 10.1093/intimm/10.5.619; Robert P, 2012, BIOPHYS J, V102, P248, DOI 10.1016/j.bpj.2011.11.4018; Rubenstein MC, 2003, POLYM PHYS; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; Shinoda W, 2007, MOL SIMULAT, V33, P27, DOI 10.1080/08927020601054050; Shinoda W, 2010, J PHYS CHEM B, V114, P6836, DOI 10.1021/jp9107206; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; van der Merwe PA, 2001, IMMUNITY, V14, P665, DOI 10.1016/S1074-7613(01)00155-8	32	18	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112292	10.1371/journal.pone.0112292	http://dx.doi.org/10.1371/journal.pone.0112292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383949	Green Published, gold			2022-12-26	WOS:000344816700047
J	Nagumo, Y; Iguchi-Manaka, A; Yamashita-Kanemaru, Y; Abe, F; Bernhardt, G; Shibuya, A; Shibuya, K				Nagumo, Yoko; Iguchi-Manaka, Akiko; Yamashita-Kanemaru, Yumi; Abe, Fumie; Bernhardt, Guenter; Shibuya, Akira; Shibuya, Kazuko			Increased CD112 Expression in Methylcholanthrene-Induced Tumors in CD155-Deficient Mice	PLOS ONE			English	Article							POLIOVIRUS RECEPTOR CD155; DNAM-1 CD226; ADHESION MOLECULE; TRANSCRIPTION FACTORS; FAMILY LIGANDS; NECTIN-2 CD112; CELL-ADHESION; PVR CD155; CANCER; IDENTIFICATION	Tumor recognition by immune effector cells is mediated by antigen receptors and a variety of adhesion and costimulatory molecules. The evidence accumulated since the identification of CD155 and CD112 as ligands for DNAM-1 in humans and mice has suggested that the interactions between DNAM-1 and its ligands play an important role in T cell- and natural killer (NK) cell-mediated recognition and lysis of tumor cells. We have previously demonstrated that methylcholanthrane (MCA) accelerates tumor development in DNAM-1-deficient mice, and the Cd155 level on MCA-induced tumors is significantly higher in DNAM-1-deficient mice than in wild-type (WT) mice. By contrast, Cd112 expression on the tumors is similar in WT and DNAM-1-deficient mice, suggesting that CD155 plays a major role as a DNAM-1 ligand in activation of T cells and NK cells for tumor immune surveillance. To address this hypothesis, we examined MCA-induced tumor development in CD155-deficient mice. Unexpectedly, we observed no significant difference in tumor development between WT and CD155-deficient mice. Instead, we found that Cd112 expression was significantly higher in the MCA-induced tumors of CD155-deficient mice than in those of WT mice. We also observed higher expression of DNAM-1 and lower expression of an inhibitory receptor, TIGIT, on CD8(+) T cells in CD155-deficient mice. These results suggest that modulation of the expression of receptors and CD112 compensates for CD155 deficiency in immune surveillance against MCA-induced tumors.	[Nagumo, Yoko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Nagumo, Yoko; Iguchi-Manaka, Akiko; Yamashita-Kanemaru, Yumi; Abe, Fumie; Shibuya, Akira; Shibuya, Kazuko] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan; [Iguchi-Manaka, Akiko] Univ Tsukuba, Fac Med, Dept Breast & Endocrine Surg, Tsukuba, Ibaraki, Japan; [Yamashita-Kanemaru, Yumi; Abe, Fumie; Shibuya, Akira] Univ Tsukuba, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tsukuba, Ibaraki, Japan; [Shibuya, Akira] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Bernhardt, Guenter] Hannover Med Sch, Inst Immunol, Hannover, Germany	University of Tsukuba; University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba; Hannover Medical School	Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki, Japan.	ashibuya@md.tsukuba.ac.jp; kazukos@md.tsukuba.ac.jp	Bernhardt, Günter/F-6946-2012	Bernhardt, Günter/0000-0002-0510-2853; Iguchi, Akiko/0000-0002-0338-130X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24249021, 25114701]; Grants-in-Aid for Scientific Research [25293091] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant Number 24249021 and 25114701 to AS and KS, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Fuchs A, 2004, J IMMUNOL, V172, P3994, DOI 10.4049/jimmunol.172.7.3994; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Iwasaki A, 2002, J INFECT DIS, V186, P585, DOI 10.1086/342682; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu J, 2012, J IMMUNOL, V188, P5511, DOI 10.4049/jimmunol.1200324; Lopez M, 1998, BLOOD, V92, P4602, DOI 10.1182/blood.V92.12.4602.424k21_4602_4611; Lui WY, 2006, J CELL PHYSIOL, V207, P144, DOI 10.1002/jcp.20545; Maier MK, 2007, EUR J IMMUNOL, V37, P2214, DOI 10.1002/eji.200737072; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; Nabekura T, 2011, P NATL ACAD SCI USA, V108, pE34, DOI 10.1073/pnas.1018806108; Nabekura T, 2010, P NATL ACAD SCI USA, V107, P18593, DOI 10.1073/pnas.1005582107; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; Sakamoto KM, 2009, CLIN CANCER RES, V15, P2583, DOI 10.1158/1078-0432.CCR-08-1137; Seth S, 2011, J BIOL CHEM, V286, P39153, DOI 10.1074/jbc.M111.264697; Seth S, 2011, P NATL ACAD SCI USA, V108, pE32, DOI 10.1073/pnas.1017969108; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Tahara-Hanaoka S, 2005, BIOCHEM BIOPH RES CO, V329, P996, DOI 10.1016/j.bbrc.2005.02.067; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; WANG PL, 1992, J IMMUNOL, V148, P2600; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674	33	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112415	10.1371/journal.pone.0112415	http://dx.doi.org/10.1371/journal.pone.0112415			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384044	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700059
J	Mansour, W; Nakasone, MA; von Delbruck, M; Yu, ZL; Krutauz, D; Reis, N; Kleifeld, O; Sommer, T; Fushman, D; Glickman, MH				Mansour, Wissam; Nakasone, Mark A.; von Delbrueck, Maximilian; Yu, Zanlin; Krutauz, Daria; Reis, Noa; Kleifeld, Oded; Sommer, Thomas; Fushman, David; Glickman, Michael H.			Disassembly of Lys(11) and Mixed Linkage Polyubiquitin Conjugates Provides Insights into Function of Proteasomal Deubiquitinases Rpn11 and Ubp6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; UBIQUITINATED PROTEINS ACTIVATE; 26S PROTEASOME; CRYSTAL-STRUCTURE; ENZYME USP14; REGULATORY PARTICLE; SUBUNIT RPN11; CHAINS; DEGRADATION; BINDING	Protein homeostasis is largely dependent on proteolysis by the ubiquitin-proteasome system. Diverse polyubiquitin modifications are reported to target cellular proteins to the proteasome. At the proteasome, deubiquitination is an essential preprocessing event that contributes to degradation efficiency. We characterized the specificities of two proteasome-associated deubiquitinases (DUBs), Rpn11 and Ubp6, and explored their impact on overall proteasome DUB activity. This was accomplished by constructing a panel of well defined ubiquitin (Ub) conjugates, including homogeneous linkages of varying lengths as well as a heterogeneously modified target. Rpn11 and Ubp6 processed Lys(11) and Lys(63) linkages with comparable efficiencies that increased with chain length. In contrast, processing of Lys(48) linkages by proteasome was inversely correlated to chain length. Fluorescently labeled tetra-Ub chains revealed endo-chain preference for Ubp6 acting on Lys(48) and random action for Rpn11. Proteasomes were more efficient at deconjugating identical substrates than their constituent DUBs by roughly 2 orders of magnitude. Incorporation into proteasomes significantly enhanced enzymatic efficiency of Rpn11, due in part to alleviation of the autoinhibitory role of its C terminus. The broad specificity of Rpn11 could explain how proteasomes were more effective at disassembling a heterogeneously modified conjugate compared with homogeneous Lys(48)-linked chains. The reduced ability to disassemble homogeneous Lys(48)-linked chains longer than 4 Ub units may prolong residency time on the proteasome.	[Mansour, Wissam; Nakasone, Mark A.; Yu, Zanlin; Krutauz, Daria; Reis, Noa; Glickman, Michael H.] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Nakasone, Mark A.; Fushman, David] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; [von Delbrueck, Maximilian; Sommer, Thomas] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Kleifeld, Oded] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia	Technion Israel Institute of Technology; University System of Maryland; University of Maryland College Park; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Monash University	Glickman, MH (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	glickman@tx.technion.ac.il	Nakasone, Mark A./ABD-2173-2021	Nakasone, Mark A./0000-0002-1362-191X; Glickman, Michael/0000-0002-1222-8104; Yu, Zanlin/0000-0001-8381-8788	National Institutes of Health [GM065334, GM095755]; USA-Israel Binational Science Foundation; Deutsch-Israel Program grant; ISF council for higher education outstanding minority (VATAT) fellowship; Fulbright postdoctoral fellowship; Aly Kaufman Fellowship Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095755, R01GM065334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USA-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Deutsch-Israel Program grant; ISF council for higher education outstanding minority (VATAT) fellowship; Fulbright postdoctoral fellowship; Aly Kaufman Fellowship Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM065334 (to D. F.) and GM095755 (to D. F. and M. H. G.). This work was also supported by a USA-Israel Binational Science Foundation grant (to D. F. and M. H. G.) and a Deutsch-Israel Program grant (to T. S. and M. H. G.).; Supported in part by an ISF council for higher education outstanding minority (VATAT) fellowship.; Supported in part by a Fulbright postdoctoral fellowship and the Aly Kaufman Fellowship Trust.	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Bagola K, 2013, MOL CELL, V50, P528, DOI 10.1016/j.molcel.2013.04.005; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Berndsen CE, 2011, ANAL BIOCHEM, V418, P102, DOI 10.1016/j.ab.2011.06.034; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Butler LR, 2012, EMBO J, V31, P3918, DOI 10.1038/emboj.2012.232; Cannon J, 2012, ANAL CHEM, V84, P10121, DOI 10.1021/ac302675y; Castaneda CA, 2013, STRUCTURE, V21, P1168, DOI 10.1016/j.str.2013.04.029; Chandra A, 2010, CURR GENET, V56, P543, DOI 10.1007/s00294-010-0321-3; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; D'Arcy P, 2012, INT J BIOCHEM CELL B, V44, P1729, DOI 10.1016/j.biocel.2012.07.011; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Dikic I, 2009, NAT STRUCT MOL BIOL, V16, P1208, DOI 10.1038/nsmb1209-1209; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Feng L, 2010, J BIOL CHEM, V285, P30982, DOI 10.1074/jbc.M110.135392; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Fushman David, 2011, F1000 Biol Rep, V3, P26, DOI 10.3410/B3-26; Gallery M, 2007, MOL CANCER THER, V6, P262, DOI 10.1158/1535-7163.MCT-06-0542; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 2004, PLOS BIOL, V2, P25, DOI 10.1371/journal.pbio.0020013; Glickman MH, 2000, MOL B INT U, V12, P71; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Inobe T, 2014, CURR OPIN STRUC BIOL, V24, P156, DOI 10.1016/j.sbi.2014.02.002; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; Jung H, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.28; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HT, 2009, EMBO J, V28, P1867, DOI 10.1038/emboj.2009.115; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Komander D, 2010, SUBCELL BIOCHEM, V54, P69, DOI 10.1007/978-1-4419-6676-6_6; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kraut DA, 2007, TRENDS CELL BIOL, V17, P419, DOI 10.1016/j.tcb.2007.06.008; Kravtsova-Ivantsiv Y, 2013, ANGEW CHEM INT EDIT, V52, P192, DOI 10.1002/anie.201205656; Krutauz D, 2014, NAT CHEM BIOL, V10, P664, DOI [10.1038/NCHEMBIO.1574, 10.1038/nchembio.1574]; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Lee Byung-Hoon, 2012, Curr Protoc Chem Biol, V4, P311, DOI 10.1002/9780470559277.ch120078; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Leggett David S., 2005, V301, P57; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; Lingaraju GM, 2014, NATURE, V512, P161, DOI 10.1038/nature13566; Liu NN, 2014, SCI REP-UK, V4, DOI 10.1038/srep05240; Locke M, 2014, BIOCHEM J, V459, P205, DOI 10.1042/BJ20120662; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Nag DK, 2012, VIRUS RES, V165, P103, DOI 10.1016/j.virusres.2012.01.009; Nakasone MA, 2013, STRUCTURE, V21, P727, DOI 10.1016/j.str.2013.02.019; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Pathare GR, 2014, P NATL ACAD SCI USA, V111, P2984, DOI 10.1073/pnas.1400546111; Patterson-Fortin J, 2010, J BIOL CHEM, V285, P30971, DOI 10.1074/jbc.M110.135319; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Qin S, 2009, NUCLEIC ACIDS RES, V37, P1843, DOI 10.1093/nar/gkn1049; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Rogov VV, 2012, CHEMBIOCHEM, V13, P959, DOI 10.1002/cbic.201200045; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Sato Y, 2008, NATURE, V455, P358, DOI 10.1038/nature07254; Schaefer JB, 2011, J BIOL CHEM, V286, P45186, DOI 10.1074/jbc.M111.310094; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Volk S, 2005, METHOD ENZYMOL, V399, P3, DOI 10.1016/S0076-6879(05)99001-0; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Worden EJ, 2014, NAT STRUCT MOL BIOL, V21, P220, DOI 10.1038/nsmb.2771; Wu N, 2013, INT J MOL SCI, V14, P10749, DOI 10.3390/ijms140610749; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Ziv I, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009753	101	33	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 20	2015	290	8					4688	4704		10.1074/jbc.M114.568295	http://dx.doi.org/10.1074/jbc.M114.568295			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0QY	25389291	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000350042000013
J	Gupta, SD; Gable, K; Alexaki, A; Chandris, P; Proia, RL; Dunn, TM; Harmon, JM				Gupta, Sita D.; Gable, Kenneth; Alexaki, Aikaterini; Chandris, Panagiotis; Proia, Richard L.; Dunn, Teresa M.; Harmon, Jeffrey M.			Expression of the ORMDLS, Modulators of Serine Palmitoyltransferase, Is Regulated by Sphingolipids in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme; Lipid Metabolism; Metabolic Regulation; Serine Palmitoyltransferase; Sphingolipid	PROTEINS MEDIATE; GENE; ORM2; BIOSYNTHESIS; ACCUMULATION; HOMEOSTASIS; INHIBITION; SUBUNITS; ASTHMA	Background: In contrast to their yeast orthologues, the mechanism by which mammalian ORMDLs regulate serine palmitoyltransferase is not understood. Results: Overexpression of serine palmitoyltransferase in HEK293 cells results in increased long-chain base synthesis and an activity-dependent increase in ORMDL expression. Conclusion: A product of ceramide synthase mediates regulation of ORMDL expression and inhibition of serine palmitoyltransferase. Significance: Serine palmitoyltransferase activity indirectly regulates ORMDL expression. The relationship between serine palmitoyltransferase (SPT) activity and ORMDL regulation of sphingolipid biosynthesis was investigated in mammalian HEK293 cells. Each of the three human ORMDLs reduced the increase in long-chain base synthesis seen after overexpression of wild-type SPT or SPT containing the C133W mutation in hLCB1, which produces the non-catabolizable sphingoid base, 1-deoxySa. ORMDL-dependent repression of sphingoid base synthesis occurred whether SPT was expressed as individual subunits or as a heterotrimeric single-chain SPT fusion protein. Overexpression of the single-chain SPT fusion protein under the control of a tetracycline-inducible promoter in stably transfected cells resulted in increased endogenous ORMDL expression. This increase was not transcriptional; there was no significant increase in any of the ORMDL mRNAs. Increased ORMDL protein expression required SPT activity since overexpression of a catalytically inactive SPT with a mutation in hLCB2a had little effect. Significantly, increased ORMDL expression was also blocked by myriocin inhibition of SPT as well as fumonisin inhibition of the ceramide synthases, suggesting that increased expression is a response to a metabolic signal. Moreover, blocking ORMDL induction with fumonisin treatment resulted in significantly greater increases in in vivo SPT activity than was seen when ORMDLs were allowed to increase, demonstrating the physiological significance of this response.	[Gupta, Sita D.; Gable, Kenneth; Dunn, Teresa M.] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA; [Harmon, Jeffrey M.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol, Bethesda, MD 20814 USA; [Alexaki, Aikaterini; Chandris, Panagiotis; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Harmon, JM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pharmacol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	jeffrey.harmon@usuhs.edu	Proia, Richard L/A-7908-2012	Harmon, Jeffrey/0000-0001-7833-931X; Alexaki, Aikaterini/0000-0003-2511-8569; Proia, Richard/0000-0003-0456-1270; CHANDRIS, PANAGIOTIS/0000-0002-6484-462X	Uniformed Services University [R071KD, CO75PI]; National Institutes of Health [R01NS072446, R21HD080181]; Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056018, ZIADK056016, ZIADK056014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072446] Funding Source: NIH RePORTER	Uniformed Services University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Uniformed Services University Grants R071KD and CO75PI, by National Institutes of Health Grants R01NS072446 and R21HD080181, and by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.	Akhabir L, 2011, RESPIROLOGY, V16, P396, DOI 10.1111/j.1440-1843.2011.01939.x; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Gable K, 2010, J BIOL CHEM, V285, P22844, DOI 10.1074/jbc.M110.122259; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; Halapi E, 2010, EUR J HUM GENET, V18, P902, DOI 10.1038/ejhg.2010.38; Han G, 2009, P NATL ACAD SCI USA, V106, P8186, DOI 10.1073/pnas.0811269106; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Harmon JM, 2013, J BIOL CHEM, V288, P10144, DOI 10.1074/jbc.M113.451526; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Jin R, 2012, INT J BIOCHEM CELL B, V44, P1174, DOI 10.1016/j.biocel.2012.04.007; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Miller M, 2012, P NATL ACAD SCI USA, V109, P16648, DOI 10.1073/pnas.1204151109; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Qiu RF, 2013, FEBS J, V280, P2014, DOI 10.1111/febs.12225; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Taouji S, 2013, J BIOL CHEM, V288, P17190, DOI 10.1074/jbc.M112.409185; Tsegaye Y, 2007, J BIOL CHEM, V282, P28195, DOI 10.1074/jbc.M705074200; WANG E, 1991, J BIOL CHEM, V266, P14486; Worgall TS, 2013, SCI TRANSL MED, V5; Zhuang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060630; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200; [No title captured]	29	33	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					90	98		10.1074/jbc.M114.588236	http://dx.doi.org/10.1074/jbc.M114.588236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25395622	Green Published, hybrid			2022-12-26	WOS:000347231200009
J	Ding, L; Kim, MJ; Kanchi, KL; Dees, ND; Lu, C; Griffith, M; Fenstermacher, D; Sung, H; Miller, CA; Goetz, B; Wendl, MC; Griffith, O; Cornelius, LA; Linette, GP; McMichael, JF; Sondak, VK; Fields, RC; Ley, TJ; Mule, JJ; Wilson, RK; Weber, JS				Ding, Li; Kim, Minjung; Kanchi, Krishna L.; Dees, Nathan D.; Lu, Charles; Griffith, Malachi; Fenstermacher, David; Sung, Hyeran; Miller, Christopher A.; Goetz, Brian; Wendl, Michael C.; Griffith, Obi; Cornelius, Lynn A.; Linette, Gerald P.; McMichael, Joshua F.; Sondak, Vernon K.; Fields, Ryan C.; Ley, Timothy J.; Mule, James J.; Wilson, Richard K.; Weber, Jeffrey S.			Clonal Architectures and Driver Mutations in Metastatic Melanomas	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; SOMATIC MUTATIONS; BRAF MUTATIONS; GENOME; CANCER; SENESCENCE; NEVI; RESOLUTION; LANDSCAPE; EVOLUTION	To reveal the clonal architecture of melanoma and associated driver mutations, whole genome sequencing (WGS) and targeted extension sequencing were used to characterize 124 melanoma cases. Significantly mutated gene analysis using 13 WGS cases and 15 additional paired extension cases identified known melanoma genes such as BRAF, NRAS, and CDKN2A, as well as a novel gene EPHA3, previously implicated in other cancer types. Extension studies using tumors from another 96 patients discovered a large number of truncation mutations in tumor suppressors (TP53 and RB1), protein phosphatases (e.g., PTEN, PTPRB, PTPRD, and PTPRT), as well as chromatin remodeling genes (e.g., ASXL3, MLL2, and ARID2). Deep sequencing of mutations revealed subclones in the majority of metastatic tumors from 13 WGS cases. Validated mutations from 12 out of 13 WGS patients exhibited a predominant UV signature characterized by a high frequency of C->T transitions occurring at the 39 base of dipyrimidine sequences while one patient (MEL9) with a hypermutator phenotype lacked this signature. Strikingly, a subclonal mutation signature analysis revealed that the founding clone in MEL9 exhibited UV signature but the secondary clone did not, suggesting different mutational mechanisms for two clonal populations from the same tumor. Further analysis of four metastases from different geographic locations in 2 melanoma cases revealed phylogenetic relationships and highlighted the genetic alterations responsible for differential drug resistance among metastatic tumors. Our study suggests that clonal evaluation is crucial for understanding tumor etiology and drug resistance in melanoma.	[Ding, Li; Kanchi, Krishna L.; Dees, Nathan D.; Lu, Charles; Griffith, Malachi; Miller, Christopher A.; Wendl, Michael C.; Griffith, Obi; McMichael, Joshua F.; Ley, Timothy J.; Wilson, Richard K.] Washington Univ, Genome Inst, St Louis, MO USA; [Ding, Li; Griffith, Obi; Cornelius, Lynn A.; Linette, Gerald P.; Ley, Timothy J.] Washington Univ, Dept Med, St Louis, MO USA; [Ding, Li; Griffith, Malachi; Wilson, Richard K.] Washington Univ, Dept Genet, St Louis, MO USA; [Ding, Li; Linette, Gerald P.; Fields, Ryan C.; Ley, Timothy J.; Wilson, Richard K.] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Kim, Minjung; Fenstermacher, David; Sung, Hyeran; Sondak, Vernon K.; Mule, James J.; Weber, Jeffrey S.] H Lee Moffitt Canc Ctr & Res Inst, Donald A Adam Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA; [Goetz, Brian; Cornelius, Lynn A.; Fields, Ryan C.] Washington Univ, Dept Surg, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); H Lee Moffitt Cancer Center & Research Institute; Washington University (WUSTL)	Weber, JS (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Donald A Adam Comprehens Melanoma Res Ctr, Tampa, FL 33612 USA.	Jeffrey.weber@moffitt.org	Griffith, Malachi/P-1285-2014; Wilson, Richard K./AAF-4139-2019; Griffith, Obi/P-1286-2014	Griffith, Malachi/0000-0002-6388-446X; Wilson, Richard K./0000-0002-1992-1358; Cornelius, Lynn A/0000-0002-6329-2819; Griffith, Obi/0000-0002-0843-4271; Miller, Christopher/0000-0003-4266-6700; Kim, Minjung/0000-0002-5682-6640	Donald A. Adam Comprehensive Melanoma Research Center; Melanoma Inc. Foundation; Come Out Swinging Inc. Foundation	Donald A. Adam Comprehensive Melanoma Research Center; Melanoma Inc. Foundation; Come Out Swinging Inc. Foundation	This work was supported by the Donald A. Adam Comprehensive Melanoma Research Center. The authors gratefully thank the Our Mark on Melanoma Inc. Foundation and the Come Out Swinging Inc. Foundation for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer J, 2007, J INVEST DERMATOL, V127, P179, DOI 10.1038/sj.jid.5700490; Bennett DC, 2003, ONCOGENE, V22, P3063, DOI 10.1038/sj.onc.1206446; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Grafstrom E, 2005, CLIN CANCER RES, V11, P2991, DOI 10.1158/1078-0432.CCR-04-1731; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Kamb A, 1994, Nat Genet, V8, P23; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Koboldt DC, 2012, GENOME RES; Larson DE, 2011, BIOINFORMATICS; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Prickett TD, NAT GENET, V43, P1119; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smalley KSM, 2010, J INVEST DERMATOL, V130, P28, DOI 10.1038/jid.2009.177; Stark MS, 2012, NAT GENET, V44, P165, DOI 10.1038/ng.1041; Turajlic S, GENOME RES, V22, P196; Turajlic S, 2012, GENOME RES, V22, P196, DOI 10.1101/gr.125591.111; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	44	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111153	10.1371/journal.pone.0111153	http://dx.doi.org/10.1371/journal.pone.0111153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393105	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300011
J	Dossena, M; Bedini, G; Rusmini, P; Giorgetti, E; Canazza, A; Tosetti, V; Salsano, E; Sagnelli, A; Mariotti, C; Gellera, C; Navone, SE; Marfia, G; Alessandri, G; Corsi, F; Parati, EA; Pareyson, D; Poletti, A				Dossena, Marta; Bedini, Gloria; Rusmini, Paola; Giorgetti, Elisa; Canazza, Alessandra; Tosetti, Valentina; Salsano, Ettore; Sagnelli, Anna; Mariotti, Caterina; Gellera, Cinzia; Navone, Stefania Elena; Marfia, Giovanni; Alessandri, Giulio; Corsi, Fabio; Parati, Eugenio Agostino; Pareyson, Davide; Poletti, Angelo			Human Adipose-Derived Mesenchymal Stem Cells as a New Model of Spinal and Bulbar Muscular Atrophy	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; ELONGATED POLYGLUTAMINE TRACT; REPEAT ANDROGEN RECEPTOR; SMOOTH-MUSCLE-CELLS; MOTOR-NEURONS; STROMAL CELLS; 5-ALPHA-REDUCTASE TYPE-2; REGENERATIVE MEDICINE; INTERNATIONAL-SOCIETY; EXPRESSION	Spinal and bulbar muscular atrophy (SBMA) or Kennedy's disease is an X-linked CAG/polyglutamine expansion motoneuron disease, in which an elongated polyglutamine tract (polyQ) in the N-terminal androgen receptor (ARpolyQ) confers toxicity to this protein. Typical markers of SBMA disease are ARpolyQ intranuclear inclusions. These are generated after the ARpolyQ binds to its endogenous ligands, which promotes AR release from chaperones, activation and nuclear translocation, but also cell toxicity. The SBMA mouse models developed so far, and used in preclinical studies, all contain an expanded CAG repeat significantly longer than that of SBMA patients. Here, we propose the use of SBMA patients adipose-derived mesenchymal stem cells (MSCs) as a new human in vitro model to study ARpolyQ toxicity. These cells have the advantage to express only ARpolyQ, and not the wild type AR allele. Therefore, we isolated and characterized adipose-derived MSCs from three SBMA patients (ADSC from Kennedy's patients, ADSCK) and three control volunteers (ADSCs). We found that both ADSCs and ADSCKs express mesenchymal antigens, even if only ADSCs can differentiate into the three typical cell lineages (adipocytes, chondrocytes and osteocytes), whereas ADSCKs, from SBMA patients, showed a lower growth potential and differentiated only into adipocyte. Moreover, analysing AR expression on our mesenchymal cultures we found lower levels in all ADSCKs than ADSCs, possibly related to negative pressures exerted by toxic ARpolyQ in ADSCKs. In addition, with proteasome inhibition the ARpolyQ levels increased specifically in ADSCKs, inducing the formation of HSP70 and ubiquitin positive nuclear ARpolyQ inclusions. Considering all of this evidence, SBMA patients adipose-derived MSCs cultures should be considered an innovative in vitro human model to understand the molecular mechanisms of ARpolyQ toxicity and to test novel therapeutic approaches in SBMA.	[Dossena, Marta; Bedini, Gloria; Canazza, Alessandra; Tosetti, Valentina; Navone, Stefania Elena; Marfia, Giovanni; Alessandri, Giulio; Parati, Eugenio Agostino] Fdn IRCCS Ist Neurol Carlo Besta, Unit Cerebrovasc Dis, Cellular Neurobiol Lab, Milan, Italy; [Rusmini, Paola; Giorgetti, Elisa; Poletti, Angelo] Univ Milan, Dipartimento Sci Farmacol & Biomol, Ctr Interdipartimentale Malattie Neurodegenerat, Milan, Italy; [Giorgetti, Elisa] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Salsano, Ettore; Sagnelli, Anna; Pareyson, Davide] Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies Uni, Milan, Italy; [Mariotti, Caterina; Gellera, Cinzia] Fdn IRCCS Ist Neurol Carlo Besta, Dept Diagnost & Appl Technol, Unit Genet Neurodegenerat & Metab Dis, Milan, Italy; [Corsi, Fabio] Univ Milan, Div Surg, Dept Clin Sci, Luigi Sacco Hosp, Milan, Italy	IRCCS Istituto Neurologico Besta; University of Milan; University of Michigan System; University of Michigan; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; University of Milan; Luigi Sacco Hospital	Pareyson, D (corresponding author), Fdn IRCCS Ist Neurol Carlo Besta, Dept Clin Neurosci, Clin Cent & Peripheral Degenerat Neuropathies Uni, Milan, Italy.	davide.pareyson@istituto-besta.it; angelo.poletti@unimi.it	navone, stefania e/K-7264-2016; Gellera, Cinzia/J-7887-2016; Corsi, Fabio/ABH-9554-2020; navone, stefania/Y-4779-2019; Pareyson, Davide/K-5890-2016; Corsi, Fabio/E-9204-2017; Marfia, Giovanni/N-4650-2014; Parati, Eugenio Agostino/AAN-5893-2021; BEDINI, GLORIA/K-3012-2016; Dossena, Marta/I-2125-2012; Salsano, Ettore/I-7996-2018; Poletti, Angelo/A-9016-2011; Mariotti, Caterina/AAP-9425-2021; Marfia, Giovanni/AAB-8702-2020	navone, stefania e/0000-0002-0097-9146; Gellera, Cinzia/0000-0002-3582-665X; Corsi, Fabio/0000-0002-6469-4086; navone, stefania/0000-0002-0097-9146; Pareyson, Davide/0000-0001-6854-765X; Corsi, Fabio/0000-0002-6469-4086; Marfia, Giovanni/0000-0002-5849-7000; Parati, Eugenio Agostino/0000-0001-5020-6523; BEDINI, GLORIA/0000-0002-3653-427X; Salsano, Ettore/0000-0001-9167-1878; Poletti, Angelo/0000-0002-8883-0468; Mariotti, Caterina/0000-0003-2405-3564; Marfia, Giovanni/0000-0002-5849-7000; alessandri, giulio/0000-0002-1861-8461; Dossena, Marta/0000-0003-1717-8350; RUSMINI, PAOLA/0000-0001-9989-0733	Regione Lombardia; AriSLA Foundation Italy [ALS_HSPB8]; Telethon - Italy [GGP14039]; Italian Ministry of Labour, Health and Social Affairs (Convenzione Fondazione Mondino/UNIMI); Universita degli Studi di Milano; Fondazione CARIPLO [2008-2307]; Fondation Thierry Latran, France; Association Francaise contre les Myopathies	Regione Lombardia(Regione Lombardia); AriSLA Foundation Italy; Telethon - Italy(Fondazione Telethon); Italian Ministry of Labour, Health and Social Affairs (Convenzione Fondazione Mondino/UNIMI); Universita degli Studi di Milano; Fondazione CARIPLO(Fondazione Cariplo); Fondation Thierry Latran, France; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was funded by Regione Lombardia (to D.P., A.P., E.A.P.); AriSLA Foundation Italy (ALS_HSPB8 to A.P), Telethon - Italy (GGP14039 to A.P.); Italian Ministry of Labour, Health and Social Affairs (Convenzione Fondazione Mondino/UNIMI to A.P.); Universita degli Studi di Milano (to A.P.); Fondazione CARIPLO (2008-2307 to A.P.); Fondation Thierry Latran, France (to A.P.), Association Francaise contre les Myopathies (to A.P.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel A, 2001, HUM MOL GENET, V10, P107, DOI 10.1093/hmg/10.2.107; Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039; Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Avanzini MA, 2009, HAEMATOL-HEMATOL J, V94, P1649, DOI 10.3324/haematol.2009.006171; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Brooks BP, 1997, NEUROBIOL DIS, V3, P313, DOI 10.1006/nbdi.1997.0126; Brooks BP, 1998, J NEUROCHEM, V70, P1054; Casteilla L, 2006, DIABETES METAB, V32, P393, DOI 10.1016/S1262-3636(07)70297-5; Chazenbalk G, 2013, STEROIDS, V78, P920, DOI 10.1016/j.steroids.2013.05.001; Chevalier-Larsen ES, 2004, J NEUROSCI, V24, P4778, DOI 10.1523/JNEUROSCI.0808-04.2004; Chua JP, 2014, HUM MOL GENET, V23, P1376, DOI 10.1093/hmg/ddt527; Cortes CJ, 2014, NEURON, V82, P295, DOI 10.1016/j.neuron.2014.03.001; de la Garza-Rodea AS, 2012, CELL TRANSPLANT, V21, P153, DOI 10.3727/096368911X580554; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fischbeck KH, 1997, J INHERIT METAB DIS, V20, P152, DOI 10.1023/A:1005344403603; Grunseich C, 2014, ORAL DIS, V20, P6, DOI 10.1111/odi.12121; Grunseich C, 2014, NEUROBIOL DIS, V70, P12, DOI 10.1016/j.nbd.2014.05.038; Huang CK, 2013, BBA-MOL CELL RES, V1833, P1222, DOI 10.1016/j.bbamcr.2013.01.007; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Jordan CL, 2008, CURR OPIN PHARMACOL, V8, P752, DOI 10.1016/j.coph.2008.08.006; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; La Spada AR, 1998, HUM MOL GENET, V7, P959, DOI 10.1093/hmg/7.6.959; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Lieberman AP, 2014, CELL REP, V7, P774, DOI 10.1016/j.celrep.2014.02.008; Marra KG, 2011, METHODS MOL BIOL, V702, P261, DOI 10.1007/978-1-61737-960-4_19; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Piccioni F, 2002, FASEB J, V16, P1418, DOI 10.1096/fj.01-1035fje; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poletti A, 2004, FRONT NEUROENDOCRIN, V25, P1, DOI 10.1016/j.yfrne.2004.03.001; Poletti A, 2001, J NEUROENDOCRINOL, V13, P353, DOI 10.1046/j.1365-2826.2001.00635.x; Pozzi P, 2003, J NEUROENDOCRINOL, V15, P882, DOI 10.1046/j.1365-2826.2003.01074.x; Rocchi A, 2013, J MOL NEUROSCI, V50, P514, DOI 10.1007/s12031-013-9978-7; Rusmini P, 2007, NEUROBIOL AGING, V28, P1099, DOI 10.1016/j.neurobiolaging.2006.05.015; Rusmini P, 2013, NEUROBIOL AGING, V34, P2585, DOI 10.1016/j.neurobiolaging.2013.05.026; Simeoni S, 2000, HUM MOL GENET, V9, P133, DOI 10.1093/hmg/9.1.133; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Tsai MY, 2011, BIOCHEM BIOPH RES CO, V411, P477, DOI 10.1016/j.bbrc.2011.06.113; Wang C, 2010, TISSUE ENG PT A, V16, P1201, DOI 10.1089/ten.TEA.2009.0303; Yu ZG, 2006, AM J PATHOL, V168, P195, DOI 10.2353/ajpath.2006.050619	43	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112746	10.1371/journal.pone.0112746	http://dx.doi.org/10.1371/journal.pone.0112746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392924	Green Published, gold			2022-12-26	WOS:000347709300094
J	Greig, JA; Peng, H; Ohlstein, J; Medina-Jaszek, CA; Ahonkhai, O; Mentzinger, A; Grant, RL; Roy, S; Chen, SJ; Bell, P; Tretiakova, AP; Wilson, JM				Greig, Jenny A.; Peng, Hui; Ohlstein, Jason; Medina-Jaszek, C. Angelica; Ahonkhai, Omua; Mentzinger, Anne; Grant, Rebecca L.; Roy, Soumitra; Chen, Shu-Jen; Bell, Peter; Tretiakova, Anna P.; Wilson, James M.			Intramuscular Injection of AAV8 in Mice and Macaques Is Associated with Substantial Hepatic Targeting and Transgene Expression	PLOS ONE			English	Article							COAGULATION-FACTOR-IX; HEMOPHILIA-B DOGS; T-LYMPHOCYTE RESPONSES; MEDIATED GENE-TRANSFER; SKELETAL-MUSCLE; IN-VIVO; NEUTRALIZING ANTIBODIES; SUSTAINED EXPRESSION; BETA-GALACTOSIDASE; CLINICAL-TRIAL	Intramuscular (IM) administration of adeno-associated viral (AAV) vectors has entered the early stages of clinical development with some success, including the first approved gene therapy product in the West called Glybera. In preparation for broader clinical development of IM AAV vector gene therapy, we conducted detailed pre-clinical studies in mice and macaques evaluating aspects of delivery that could affect performance. We found that following IM administration of AAV8 vectors in mice, a portion of the vector reached the liver and hepatic gene expression contributed significantly to total expression of secreted transgenes. The contribution from liver could be controlled by altering injection volume and by the use of traditional (promoter) and non-traditional (tissue-specific microRNA target sites) expression control elements. Hepatic distribution of vector following IM injection was also noted in rhesus macaques. These pre-clinical data on AAV delivery should inform safe and efficient development of future AAV products.	[Greig, Jenny A.; Peng, Hui; Ohlstein, Jason; Medina-Jaszek, C. Angelica; Ahonkhai, Omua; Mentzinger, Anne; Grant, Rebecca L.; Roy, Soumitra; Chen, Shu-Jen; Bell, Peter; Tretiakova, Anna P.; Wilson, James M.] Univ Penn, Div Transfus Med, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA	University of Pennsylvania	Wilson, JM (corresponding author), Univ Penn, Div Transfus Med, Dept Pathol & Lab Med, Gene Therapy Program, TRL Suite 2000,125 South 31st St, Philadelphia, PA 19104 USA.	wilsonjm@mail.med.upenn.edu	Roy, Soumitra/B-9113-2008; Wilson, James M/F-9220-2011	Wilson, James M/0000-0002-9630-3131; Mentzinger, Anne/0000-0001-7364-4112	Bill & Melinda Gates Foundation [51061]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, grant number 51061 and URL http://www.gatesfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda VR, 2004, BLOOD, V103, P85, DOI 10.1182/blood-2003-05-1446; Balazs AB, 2013, NAT BIOTECHNOL, V31, P647, DOI 10.1038/nbt.2618; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Bell P, 2005, HISTOCHEM CELL BIOL, V124, P77, DOI 10.1007/s00418-005-0793-2; Bell P, 2006, MOL THER, V14, P34, DOI 10.1016/j.ymthe.2006.03.008; Brantly ML, 2009, P NATL ACAD SCI USA, V106, P16363, DOI 10.1073/pnas.0904514106; Breous E, 2011, GASTROENTEROLOGY, V141, P348, DOI 10.1053/j.gastro.2011.04.002; Breous E, 2009, HEPATOLOGY, V50, P612, DOI 10.1002/hep.23043; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Cao O, 2007, BLOOD, V110, P1132, DOI 10.1182/blood-2007-02-073304; CHMP EMA, 2012, GLYB EPAR ASS REP; Dobrzynski E, 2004, BLOOD, V104, P969, DOI 10.1182/blood-2004-03-0847; Dobrzynski E, 2006, P NATL ACAD SCI USA, V103, P4592, DOI 10.1073/pnas.0508685103; Flotte TR, 2011, HUM GENE THER, V22, P1239, DOI 10.1089/hum.2011.053; Gao GP, 2006, MOL THER, V13, P77, DOI 10.1016/j.ymthe.2005.08.017; Geisler A, 2011, GENE THER, V18, P199, DOI 10.1038/gt.2010.141; Geisler A, 2013, MOL THER, V21, P924, DOI 10.1038/mt.2012.276; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Glamann J, 2000, J VIROL, V74, P7158, DOI 10.1128/JVI.74.15.7158-7163.2000; Glamann J, 1998, J VIROL, V72, P585, DOI 10.1128/JVI.72.1.585-592.1998; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Herzog RW, 2002, HUM GENE THER, V13, P1281, DOI 10.1089/104303402760128513; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; Hoffman BE, 2007, HUM GENE THER, V18, P603, DOI 10.1089/hum.2007.042; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Karali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022166; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Limberis MP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006299; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Martino AT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006376; Meister G, 2007, CELL, V131, P25, DOI 10.1016/j.cell.2007.09.021; Mingozzi F, 2003, J CLIN INVEST, V111, P1347, DOI 10.1172/JCI200316887; Mount JD, 2002, BLOOD, V99, P2670, DOI 10.1182/blood.V99.8.2670; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Qiao C, 2011, GENE THER, V18, P403, DOI 10.1038/gt.2010.157; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Robinson JE, 2010, J VIROL, V84, P3443, DOI 10.1128/JVI.02617-09; Song SH, 2002, MOL THER, V6, P329, DOI 10.1006/mthe.2002.0673; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; Wang L, 2011, J THROMB HAEMOST, V9, P2009, DOI 10.1111/j.1538-7836.2011.04491.x; Wang LL, 2000, MOL THER, V1, P154, DOI 10.1006/mthe.2000.0031; Wang LL, 2005, BLOOD, V105, P3079, DOI 10.1182/blood-2004-10-3867; Wright JF, 2013, MOL THER, V21, pS210; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	53	33	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112268	10.1371/journal.pone.0112268	http://dx.doi.org/10.1371/journal.pone.0112268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393537	gold, Green Submitted, Green Published			2022-12-26	WOS:000347709300043
J	Shi, L; Yan, FH; Pan, ZL; Liu, B; Liu, HH; Wang, BS; Zhang, H; Yu, YY				Shi, Lei; Yan, Fuhua; Pan, Zilai; Liu, Bo; Liu, Huanhuan; Wang, Baisong; Zhang, Huan; Yu, Yingyan			Stomach Virtual Non-Enhanced CT with Second-Generation, Dual-Energy CT: A Preliminary Study	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; GASTRIC-CARCINOMA; IMAGE QUALITY; DIFFERENTIATION; TUMOR	Objectives: To compare the true non-enhanced (TNE) and virtual non-enhanced (VNE) data sets in patients who underwent gastric preoperative dual-energy CT (DECT) and to evaluate potential radiation dose reduction by omitting a TNE scan. Methods: A total of 74 patients underwent gastric DECT. The mean CT values, length, image quality and effective radiation doses for VNE and TNE images were compared. Results: There was no statistical difference in maximal thickness of gastric tumors and maximal diameter of enlarged lymph nodes among the TNE and VNE images (P>0.05). The mean CT value differences between TNE and VNE were statistically significant for all tissue types, except for aorta attenuation measurements (P<0.05), but the absolute differences were under 10 HU. Lower noise was found for VNE images than TNE images (P<0.01). Image quality of VNE was diagnostic but lower than that of TNE (P<0.01). The dose reduction achieved by omitting the TNE acquisition was 21.40 +/- 4.44%. Conclusion: VNE scan may potentially replace TNE as part of a multi-phase gastric preoperative staging imaging protocol with consequent saving in radiation dose.	[Shi, Lei; Yan, Fuhua; Pan, Zilai; Liu, Huanhuan; Zhang, Huan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai, Peoples R China; [Liu, Bo] Siemens Hlth Care, Shanghai, Peoples R China; [Wang, Baisong] Shanghai Jiao Tong Univ, Sch Med, Dept Biomed Stat, Shanghai, Peoples R China; [Yu, Yingyan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Digest Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Siemens AG; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yan, FH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Radiol, Shanghai, Peoples R China.	yfh11655@rjh.com.cn; huanzhangy@yahoo.com			fund of Shanghai science and technology development [134119a5900]; Medical Engineer cross subject [YG2012MS48]; NSFC [81171312]	fund of Shanghai science and technology development; Medical Engineer cross subject; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by fund of Shanghai science and technology development (No. 134119a5900), Medical Engineer cross subject (No. YG2012MS48), and NSFC (No. 81171312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett T, 2012, EUR J RADIOL, V81, P1438, DOI 10.1016/j.ejrad.2011.03.042; Behrendt FF, 2009, INVEST RADIOL, V44, P1, DOI 10.1097/RLI.0b013e31818c3d4b; Chen CY, 2007, RADIOLOGY, V242, P472, DOI 10.1148/radiol.2422051557; Coursey CA, 2010, RADIOGRAPHICS, V30, P1037, DOI 10.1148/rg.304095175; De Cecco CN, 2010, EUR RADIOL, V20, P2870, DOI 10.1007/s00330-010-1874-8; Fletcher JG, 2009, RADIOL CLIN N AM, V47, P41, DOI 10.1016/j.rcl.2008.10.003; Flohr TG, 2006, EUR RADIOL, V16, P256, DOI 10.1007/s00330-005-2919-2; Graser A, 2009, RADIOLOGY, V252, P433, DOI 10.1148/radiol.2522080557; Graser A, 2009, EUR RADIOL, V19, P13, DOI 10.1007/s00330-008-1122-7; Hong X, 2006, RADIOGRAPHICS, V26, P481, DOI 10.1148/rg.262055097; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Karlo C, 2011, EUR RADIOL, V21, P385, DOI 10.1007/s00330-010-1926-0; LIBSON E, 1985, COMPUT RADIOL, V9, P255, DOI 10.1016/0730-4862(85)90083-6; Menzel H, 2000, PUBLICATION EUROPEAN, P735; Mileto A, 2012, CLIN RADIOL, V67, P334, DOI 10.1016/j.crad.2011.09.004; Oliver JH, 1997, RADIOLOGY, V205, P709, DOI 10.1148/radiology.205.3.9393525; Park MS, 2002, RADIOLOGY, V223, P540, DOI 10.1148/radiol.2232010905; Toepker M, 2012, EUR J RADIOL, V81, pE398, DOI 10.1016/j.ejrad.2011.12.011; Yan C, 2009, J SURG ONCOL, V100, P205, DOI 10.1002/jso.21316; Yeh BM, 2009, AM J ROENTGENOL, V193, P47, DOI 10.2214/AJR.09.2592; Yu LF, 2009, MED PHYS, V36, P1019, DOI 10.1118/1.3077921; Zhang LJ, 2010, EUR RADIOL, V20, P2257, DOI 10.1007/s00330-010-1778-7	22	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112295	10.1371/journal.pone.0112295	http://dx.doi.org/10.1371/journal.pone.0112295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393001	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300047
J	Ueda, M; Nishitani, Y; Kaneko, Y; Omote, A				Ueda, Michihito; Nishitani, Yu; Kaneko, Yukihiro; Omote, Atsushi			Back-Propagation Operation for Analog Neural Network Hardware with Synapse Components Having Hysteresis Characteristics	PLOS ONE			English	Article							DEVICE	To realize an analog artificial neural network hardware, the circuit element for synapse function is important because the number of synapse elements is much larger than that of neuron elements. One of the candidates for this synapse element is a ferroelectric memristor. This device functions as a voltage controllable variable resistor, which can be applied to a synapse weight. However, its conductance shows hysteresis characteristics and dispersion to the input voltage. Therefore, the conductance values vary according to the history of the height and the width of the applied pulse voltage. Due to the difficulty of controlling the accurate conductance, it is not easy to apply the back-propagation learning algorithm to the neural network hardware having memristor synapses. To solve this problem, we proposed and simulated a learning operation procedure as follows. Employing a weight perturbation technique, we derived the error change. When the error reduced, the next pulse voltage was updated according to the back-propagation learning algorithm. If the error increased the amplitude of the next voltage pulse was set in such way as to cause similar memristor conductance but in the opposite voltage scanning direction. By this operation, we could eliminate the hysteresis and confirmed that the simulation of the learning operation converged. We also adopted conductance dispersion numerically in the simulation. We examined the probability that the error decreased to a designated value within a predetermined loop number. The ferroelectric has the characteristics that the magnitude of polarization does not become smaller when voltages having the same polarity are applied. These characteristics greatly improved the probability even if the learning rate was small, if the magnitude of the dispersion is adequate. Because the dispersion of analog circuit elements is inevitable, this learning operation procedure is useful for analog neural network hardware.	[Ueda, Michihito; Nishitani, Yu; Kaneko, Yukihiro; Omote, Atsushi] Panasonic Corp, Adv Res Div, Sora Ku, Kyoto, Japan	Panasonic	Ueda, M (corresponding author), Panasonic Corp, Adv Res Div, Sora Ku, Kyoto, Japan.	ueda.michihito@jp.panasonic.com		Kaneko, Yukihiro/0000-0003-0000-5840				Alibart F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3072; Bryson AE, 1969, APPL OPTIMAL CONTROL, P481; Coates A., 2013, INT C MACHINE LEARNI, P1337; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hu M., 2014, IEEE T NEURAL NETWOR; Ishii H., 1992, International Electron Devices Meeting 1992. Technical Digest (Cat. No.92CH3211-0), P435, DOI 10.1109/IEDM.1992.307395; JABRI M, 1992, IEEE T NEURAL NETWOR, V3, P154, DOI 10.1109/72.105429; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Kaneko Yukihiro, 2013, 2013 Symposium on VLSI Technology, pT238; Kaneko Y, 2011, APPL PHYS LETT, P99; Kaneko Y, 2014, IEEE T ELECTRON DEV, V61, P2827, DOI 10.1109/TED.2014.2331707; Kaneko Y, 2011, J APPL PHYS, V110, DOI 10.1063/1.3651098; Kato Y, 2008, JPN J APPL PHYS, V47, P2719, DOI 10.1143/JJAP.47.2719; Kuzum D, 2012, NANO LETT, V12, P2179, DOI 10.1021/nl201040y; Le QV, 2013, INT CONF ACOUST SPEE, P8595, DOI 10.1109/ICASSP.2013.6639343; MILLER SL, 1990, J APPL PHYS, V68, P6463, DOI 10.1063/1.346845; Nishitani Y, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729915; Nishitani Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CE06; Partzsch J, 2011, IEEE T NEURAL NETWOR, V22, P919, DOI 10.1109/TNN.2011.2134109; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Ueda M, 2011, J APPL PHYS, V110, DOI 10.1063/1.3653830; Wang CA, 1999, IEEE T NEURAL NETWOR, V10, P1511, DOI 10.1109/72.809097; Xia QF, 2009, NANO LETT, V9, P3640, DOI 10.1021/nl901874j; Yenpo Ho, 2009, Proceedings of the 2009 IEEE/ACM International Conference on Computer-Aided Design (ICCAD 2009), P485	24	4	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112659	10.1371/journal.pone.0112659	http://dx.doi.org/10.1371/journal.pone.0112659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393715	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300081
J	Wang, Y; Zhu, TT; Ke, SS; Fang, N; Irwin, DM; Lei, M; Zhang, JP; Shi, HZ; Zhang, SY; Wang, Z				Wang, Yao; Zhu, Tengteng; Ke, Shanshan; Fang, Na; Irwin, David M.; Lei, Ming; Zhang, Junpeng; Shi, Huizhen; Zhang, Shuyi; Wang, Zhe			The Great Roundleaf Bat (Hipposideros armiger) as a Good Model for Cold-Induced Browning of Intra-Abdominal White Adipose Tissue	PLOS ONE			English	Article							GENE-EXPRESSION; OBESITY; FAT; ADIPOCYTES; MICE; THERMOGENESIS; ANGIOGENESIS; ACCLIMATION; ACTIVATION; ABLATION	Background: Inducing beige fat from white adipose tissue (WAT) is considered to be a shortcut to weight loss and increasingly becoming a key area in research into treatments for obesity and related diseases. However, currently, animal models of beige fat are restricted to rodents, where subcutaneous adipose tissue (sWAT, benign WAT) is more liable to develop into the beige fat under specific activators than the intra-abdominal adipose tissue (aWAT, malignant WAT) that is the major source of obesity related diseases in humans. Methods: Here we induced beige fat by cold exposure in two species of bats, the great roundleaf bat (Hipposideros armiger) and the rickett's big-footed bat (Myotis ricketti), and compared the molecular and morphological changes with those seen in the mouse. Expression of thermogenic genes (Ucp1 and Pgc1a) was measured by RT-qPCR and adipocyte morphology examined by HE staining at three adipose locations, sWAT, aWAT and iBAT (interscapular brown adipose tissue). Results: Expression of Ucp1 and Pgc1a was significantly upregulated, by 729 and 23 fold, respectively, in aWAT of the great roundleaf bat after exposure to 10 degrees C for 7 days. Adipocyte diameters of WATs became significantly reduced and the white adipocytes became brown-like in morphology. In mice, similar changes were found in the sWAT, but much lower amounts of changes in aWAT were seen. Interestingly, the rickett's big-footed bat did not show such a tendency in beige fat. Conclusions: The great roundleaf bat is potentially a good animal model for human aWAT browning research. Combined with rodent models, this model should be helpful for finding therapies for reducing harmful aWAT in humans.	[Wang, Yao; Zhu, Tengteng; Ke, Shanshan; Fang, Na; Lei, Ming; Zhang, Junpeng; Shi, Huizhen; Zhang, Shuyi; Wang, Zhe] E China Normal Univ, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	East China Normal University; University of Toronto	Zhang, SY (corresponding author), E China Normal Univ, Inst Mol Ecol & Evolut, Shanghai 200062, Peoples R China.	syzhang@bio.ecnu.edu.cn; zwang@sat.ecnu.edu.cn	Wang, Yao/ABX-6690-2022	Wang, Yao/0000-0002-9631-8309; Irwin, David/0000-0001-6131-4933	State Education Ministry of China [20130076120017]; National Natural Science Foundation of China [31301191, 31172077, 91120001]; Chinese Academy of Sciences (CAS Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation); East China Normal University	State Education Ministry of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation); East China Normal University	This work was funded by grants from the State Education Ministry of China (No. 20130076120017), National Natural Science Foundation of China (No. 31301191, 31172077, 91120001), Chinese Academy of Sciences (CAS Cross-disciplinary Collaborative Teams Program for Science, Technology and Innovation) and East China Normal University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Belavy DL, 2014, INT J OBESITY, V38, P1478, DOI 10.1038/ijo.2014.26; Bray GA, 2004, INT J OBESITY, V28, P34, DOI 10.1038/sj.ijo.0802479; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Celedon JC, 2014, NAT MED, V20, P20, DOI 10.1038/nm.3433; Chau Y-Y, 2014, NATURE CELL BIOL; Cinti S, 2001, ADIPOSE ORGAN MORPHO, P319; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; DeMarco VG, 2014, NATURE REV ENDOCRINO; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P2151, DOI 10.1111/j.1572-0241.2005.00251.x; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Greenhill Claire, 2013, Nat Rev Endocrinol, V9, P566, DOI 10.1038/nrendo.2013.156; Hammarstedt A, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-42; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hayward J. S., 1967, MAMMALIAN HIBERNATIO, P346; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kaiser J, 2013, SCIENCE, V342, P1028, DOI 10.1126/science.342.6162.1028; Kim SG, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.035501; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lee P, 2012, J CLIN ENDOCRINOLOGY, V98, pE98; Lee YH, 2010, ATHEROSCLEROSIS, V213, P592, DOI 10.1016/j.atherosclerosis.2010.09.012; Lim S, 2012, NAT PROTOC, V7, P606, DOI 10.1038/nprot.2012.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; McArdle M. A, 2013, FRONTIERS ENDOCRINOL, V4; Nedergaard J, 2013, BBA-MOL CELL BIOL L, V1831, P943, DOI 10.1016/j.bbalip.2013.01.009; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Stier A, 2013, J EXP BIOL; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Wang Z, 2008, ZOOL STUD, V47, P215; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347	46	7	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112495	10.1371/journal.pone.0112495	http://dx.doi.org/10.1371/journal.pone.0112495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393240	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300060
J	Chauhan, A; Chauhan, D; Rout, C				Chauhan, Arun; Chauhan, Devesh; Rout, Chittaranjan			Role of Gist and PHOG Features in Computer-Aided Diagnosis of Tuberculosis without Segmentation	PLOS ONE			English	Article							TEXTURE FEATURES; CANCER-DETECTION; MAMMOGRAPHY; SCENE	Purpose: Effective diagnosis of tuberculosis (TB) relies on accurate interpretation of radiological patterns found in a chest radiograph (CXR). Lack of skilled radiologists and other resources, especially in developing countries, hinders its efficient diagnosis. Computer-aided diagnosis (CAD) methods provide second opinion to the radiologists for their findings and thereby assist in better diagnosis of cancer and other diseases including TB. However, existing CAD methods for TB are based on the extraction of textural features from manually or semi-automatically segmented CXRs. These methods are prone to errors and cannot be implemented in X-ray machines for automated classification. Methods: Gabor, Gist, histogram of oriented gradients (HOG), and pyramid histogram of oriented gradients (PHOG) features extracted from the whole image can be implemented into existing X-ray machines to discriminate between TB and non-TB CXRs in an automated manner. Localized features were extracted for the above methods using various parameters, such as frequency range, blocks and region of interest. The performance of these features was evaluated against textural features. Two digital CXR image datasets (8-bit DA and 14-bit DB) were used for evaluating the performance of these features. Results: Gist (accuracy 94.2% for DA, 86.0% for DB) and PHOG (accuracy 92.3% for DA, 92.0% for DB) features provided better results for both the datasets. These features were implemented to develop a MATLAB toolbox, TB-Xpredict, which is freely available for academic use at http://sourceforge.net/projects/tbxpredict/. This toolbox provides both automated training and prediction modules and does not require expertise in image processing for operation. Conclusion: Since the features used in TB-Xpredict do not require segmentation, the toolbox can easily be implemented in X-ray machines. This toolbox can effectively be used for the mass screening of TB in high-burden areas with improved efficiency.	[Chauhan, Arun; Rout, Chittaranjan] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India; [Chauhan, Devesh] Natl Inst TB & Resp Dis, Dept Radiol, New Delhi, India	Jaypee University of Information Technology	Rout, C (corresponding author), Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India.	chittaranjan.rout@juit.ac.in	Rout, Chandra Sekhar/P-9472-2016	Rout, Chandra Sekhar/0000-0003-4380-5549				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arzhaeva Y, 2009, PATTERN RECOGN, V42, P1768, DOI 10.1016/j.patcog.2009.01.016; Arzhaeva Y, 2009, LECT NOTES COMPUT SC, V5762, P724, DOI 10.1007/978-3-642-04271-3_88; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; Chan TE, 2000, J VIS COMMUN IMAGE R, V11, P130, DOI 10.1006/jvci.1999.0442; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dalal N., 2005, IEEE COMPUTER SOC C, V1, P886, DOI DOI 10.1109/CVPR.2005.177; Dean JC, 2006, AM J ROENTGENOL, V187, P20, DOI 10.2214/AJR.05.0111; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Ginneken BV, 2012, ANN M RAD SOC N AM; Global TB, 2012, GLOB TB CONTR REP 20; Grigorescu SE, 2002, IEEE T IMAGE PROCESS, V11, P1160, DOI 10.1109/TIP.2002.804262; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hogeweg L, 2010, LECT NOTES COMPUT SC, V6363, P650; Itti L, 2010, J VIS, V8, P734, DOI [10.1167/8.6.734, DOI 10.1167/8.6.734]; Ludwig O, 2009, 2009 12TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS (ITSC 2009), P432; Luisier F, 2007, IEEE T IMAGE PROCESS, V16, P593, DOI 10.1109/TIP.2007.891064; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Noble M, 2009, ARCH GYNECOL OBSTET, V279, P881, DOI 10.1007/s00404-008-0841-y; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shen R, 2010, IEEE T BIO-MED ENG, V57, P2646, DOI 10.1109/TBME.2010.2057509; Siagian C, 2007, IEEE T PATTERN ANAL, V29, P300, DOI 10.1109/TPAMI.2007.40; Tan JH, 2012, J MED SYST, V36, P2751, DOI 10.1007/s10916-011-9751-9; van Ginneken B, 2002, IEEE T MED IMAGING, V21, P139, DOI 10.1109/42.993132; Wong LP, 2005, P 3 APT TEL WORKSH K, V3, P210; Yang Y, 2008, IEEE IMAGE PROC, P1852, DOI 10.1109/ICIP.2008.4712139; ZWEIG MH, 1993, CLIN CHEM, V39, P561	34	44	45	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112980	10.1371/journal.pone.0112980	http://dx.doi.org/10.1371/journal.pone.0112980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390291	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400145
J	Lai, XQ; Chen, GD; Qiu, J; Wang, CX; Chen, LZ				Lai, Xingqiang; Chen, Guodong; Qiu, Jiang; Wang, Changxi; Chen, Lizhong			Recipient-Related Risk Factors for Graft Failure and Death in Elderly Kidney Transplant Recipients	PLOS ONE			English	Article							RENAL-ALLOGRAFT SURVIVAL; ACUTE REJECTION; AGE; CYTOMEGALOVIRUS; DIALYSIS; DISEASE; IMPROVEMENT; MORTALITY; DURATION; PATIENT	Background: Elderly patients with end-stage renal disease have become the fastest growing population of kidney transplant candidates in recent years. However, the risk factors associated with long-term outcomes in these patients remain unclear. Methods: We retrospectively analyzed 166 recipients aged 60 years or older who underwent primary deceased kidney transplantation between 2002 and 2013 in our center. The main outcomes included 1-, 3- and 5-year patient survival as well as overall and death-censored graft survival. The independent risk factors affecting graft and patient survival were analyzed using Cox regression analysis. Results: The 1-, 3-, 5-year death-censored graft survival rates were 93.6%, 89.4% and 83.6%, respectively. Based on the Cox multivariate analysis, panel reactive antibody (PRA). 5% [hazard ratio (HR) 4.295, 95% confidence interval (CI) 1.321-13.97], delayed graft function (HR 4.744, 95% CI 1.611-13.973) and acute rejection (HR 4.971, 95% CI 1.516-16.301) were independent risk factors for graft failure. The 1-, 3-, 5-year patient survival rates were 84.8%, 82.1% and 77.1%, respectively. Longer dialysis time (HR 1.011 for 1-month increase, 95% CI 1.002-1.020), graft loss (HR 3.501, 95% CI 1.559-7.865) and low-dose ganciclovir prophylaxis (1.5 g/d for 3 months) (HR 3.173, 95% CI 1.063-9.473) were risk factors associated with patient death. Conclusions: The five-year results show an excellent graft and patient survival in elderly kidney transplant recipients aged >= 60 years. PRA. 5%, delayed graft function, and acute rejection are risk factors for graft failure, while longer duration of dialysis, graft loss and low-dose ganciclovir prophylaxis are risk factors for mortality in elderly recipients. These factors represent potential targets for interventions aimed at improving graft and patient survival in elderly recipients.	[Lai, Xingqiang; Chen, Guodong; Qiu, Jiang; Wang, Changxi; Chen, Lizhong] Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Chen, LZ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Organ Transplant Ctr, Guangzhou 510275, Guangdong, Peoples R China.	clz@medmail.com.cn			5010 Clinical Research Project of Sun Yat-sen University [2007003]; National Natural Science Fund Youth Science project [81302549]	5010 Clinical Research Project of Sun Yat-sen University; National Natural Science Fund Youth Science project	This study was supported by the 5010 Clinical Research Project of Sun Yat-sen University (2007003) and the National Natural Science Fund Youth Science project (81302549). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed J, 2004, TRANSPLANTATION, V78, P1689, DOI 10.1097/01.TP.0000141364.85454.37; Brennan DC, 2001, J AM SOC NEPHROL, V12, P848, DOI 10.1681/ASN.V124848; Cainelli F, 2002, LANCET INFECT DIS, V2, P539, DOI 10.1016/S1473-3099(02)00370-5; Campbell TC, 1998, AM J CARDIOL, V82, p18T; Cardinal H, 2005, KIDNEY INT, V68, P345, DOI 10.1111/j.1523-1755.2005.00410.x; Danovitch GM, 2007, TRANSPLANTATION, V84, P285, DOI 10.1097/01.tp.0000275423.69689.dc; De Keyzer K, 2011, AM J KIDNEY DIS, V58, P118, DOI 10.1053/j.ajkd.2011.04.010; Doyle SE, 2000, KIDNEY INT, V57, P2144, DOI 10.1046/j.1523-1755.2000.00066.x; Fabrizii V, 2004, J AM SOC NEPHROL, V15, P1052, DOI 10.1097/01.ASN.0000120370.35927.40; Faravardeh A, 2013, TRANSPLANTATION, V96, P1089, DOI 10.1097/TP.0b013e3182a688e5; George MJ, 1997, AM J MED, V103, P106, DOI 10.1016/S0002-9343(97)80021-6; Goldfarb-Rumyantzev A, 2005, NEPHROL DIAL TRANSPL, V20, P167, DOI 10.1093/ndt/gfh541; Helantera I, 2014, TRANSPLANTATION, V98, P458, DOI 10.1097/TP.0000000000000085; Heldal K, 2009, TRANSPLANTATION, V87, P1045, DOI 10.1097/TP.0b013e31819cdddd; Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710; Johnson DW, 2000, TRANSPLANTATION, V69, P794; Kauffman HM, 2007, TRANSPLANTATION, V83, P404, DOI 10.1097/01.tp.0000251780.01031.81; Morales JM, 2012, NEPHROL DIAL TRANSPL, V27, piv39, DOI 10.1093/ndt/gfs544; Martins PNA, 2005, TRANSPLANTATION, V79, P127, DOI 10.1097/01.TP.0000146258.79425.04; McCullough KP, 2009, AM J TRANSPLANT, V9, P894, DOI 10.1111/j.1600-6143.2009.02566.x; Meier-Kriesche HU, 2000, KIDNEY INT, V58, P1311, DOI 10.1046/j.1523-1755.2000.00287.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Meier-Kriesche HU, 2001, TRANSPLANT P, V33, P3425, DOI 10.1016/S0041-1345(01)02477-0; Meier-Kriesche HU, 2001, TRANSPLANT P, V33, P1113, DOI 10.1016/S0041-1345(00)02452-0; Meier-Kriesche HU, 2001, KIDNEY INT, V59, P1539, DOI 10.1046/j.1523-1755.2001.0590041539.x; Moreso F, 2010, TRANSPL INT, V23, P907, DOI 10.1111/j.1432-2277.2010.01075.x; Oniscu GC, 2004, NEPHROL DIAL TRANSPL, V19, P945, DOI 10.1093/ndt/gfh022; Patel SJ, 2011, CLIN TRANSPLANT, V25, pE250, DOI 10.1111/j.1399-0012.2010.01393.x; Remport A, 2011, INT UROL NEPHROL, V43, P215, DOI 10.1007/s11255-009-9700-4; Roodnat JI, 1999, TRANSPLANTATION, V67, P576, DOI 10.1097/00007890-199902270-00015; TAO SC, 1989, INT J EPIDEMIOL, V18, pS159; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	33	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112938	10.1371/journal.pone.0112938	http://dx.doi.org/10.1371/journal.pone.0112938			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389964	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400144
J	Wallmann-Sperlich, B; Froboese, I				Wallmann-Sperlich, Birgit; Froboese, Ingo			Physical Activity during Work, Transport and Leisure in Germany - Prevalence and Socio-Demographic Correlates	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; ADULTS PARTICIPATION; TIME; RELIABILITY; TRENDS; OLDER; RISK	Background: This study aimed 1) to provide data estimates concerning overall moderate-and vigorous-intensity physical activity (MVPA) as well as MVPA during work, transport and leisure in Germany and 2) to investigate MVPA and possible associations with socio-demographic correlates. Methods: A cross-sectional telephone survey interviewed 2248 representative participants in the age of 18-65 years (1077 men; 42.4 +/- 13.4 years; body mass index: 25.3 +/- 4.5kg.m(-2)) regarding their self-reported physical activity across Germany. The Global Physical Activity Questionnaire was applied to investigate MVPA during work, transport and leisure and questions were answered concerning their demographics. MVPA was stratified by gender, age, body mass index, residential setting, educational and income level. To identify socio-demographic correlates of overall MVPA as well as in the domains, we used a series of linear regressions. Results: 52.8% of the sample achieved physical activity recommendations (53.7% men/52.1% women). Overall MVPA was highest in the age group 18-29 years (p<.05), in participants with 10 years of education (p<.05) and in participants with lowest income levels <1.500(sic) (p<.05). Regression analyses revealed that age, education and income were negatively associated with overall and work MVPA. Residential setting and education was positively correlated with transport MVPA, whereas income level was negatively associated with transport MVPA. Education was the only correlate for leisure MVPA with a positive association. Conclusions: The present data underlines the importance of a comprehensive view on physical activity engagement according to the different physical activity domains and discloses a need for future physical activity interventions that consider socio-demographic variables, residential setting as well as the physical activity domain in Germany.	[Wallmann-Sperlich, Birgit] Univ Wurzburg, Inst Sport Sci, D-97070 Wurzburg, Germany; [Wallmann-Sperlich, Birgit; Froboese, Ingo] German Sport Univ Cologne, Inst Hlth Promot & Clin Movement Sci, Cologne, Germany	University of Wurzburg; German Sport University Cologne	Wallmann-Sperlich, B (corresponding author), Univ Wurzburg, Inst Sport Sci, D-97070 Wurzburg, Germany.	birgit.sperlich@uni-wuerzburg.de			German Sport University; German Research Foundation (DFG); University of Wuerzburg	German Sport University; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	The ERGO insurance group AG (http://www.ergo.com/) funded the data collection. Data analysis and the preparation of the manuscript was possible through funding of the German Sport University within the research project Modulation of Metabolic Fluxes by Physical Activity Patterns and by the program "Equal Opportunities for Women in Research and Teaching" Bavarian State Government. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, J PHYS ACT HEALTH, V7, pS370; Armstrong T, 2006, J PUBLIC HEALTH-HEID, V14, P66, DOI 10.1007/s10389-006-0024-x; Arnadottir SA, 2009, SCAND J PUBLIC HEALT, V37, P409, DOI 10.1177/1403494809102776; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Beenackers MA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-116; Bicalho Paula Gonçalves, 2010, Rev. Saúde Pública, V44, P884, DOI 10.1590/S0034-89102010005000023; Borodulin K, 2007, PREV MED, V45, P157, DOI 10.1016/j.ypmed.2007.02.007; Brownson RC, 2000, AM J PUBLIC HEALTH, V90, P264, DOI 10.2105/AJPH.90.2.264; Bull FC, 2009, J PHYS ACT HEALTH, V6, P790, DOI 10.1123/jpah.6.6.790; Bundesministerium fur Ernahrung Landwirtschaft und Verbraucherschutz (BMELV) Bundesministerium fur Gesundheit (BMG), 2011, FORM DEUTSCHL IN GES; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1097; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hu G, 2002, MED SCI SPORT EXER, V34, P234, DOI 10.1097/00005768-200202000-00009; Jordan S, 2012, BUNDESGESUNDHEITSBLA, V55, P73, DOI 10.1007/s00103-011-1396-9; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Knuth AG, 2009, J PHYS ACT HEALTH, V6, P548, DOI 10.1123/jpah.6.5.548; Krug S, 2013, BUNDESGESUNDHEITSBLA, V56, P765, DOI 10.1007/s00103-012-1661-6; Kwasniewska M, 2010, PREV MED, V50, P257, DOI 10.1016/j.ypmed.2010.02.011; Kwasniewska M, 2010, PREV MED, V51, P482, DOI 10.1016/j.ypmed.2010.09.003; Lampert T, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P1357, DOI 10.1007/s00103-005-1169-4; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Mensink GBM., 1999, GESUNDHEITSWESEN, V61, P126; Meyer K, 2005, SOZ PRAVENTIV MED, V50, P218, DOI 10.1007/s00038-005-4093-3; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Reilly T, 2006, SPORTS MED, V36, P473, DOI 10.2165/00007256-200636060-00002; [Robert-Koch-Institut Institut RK], 2012, BEITR GES BUND; Rutten A, 2004, SOZ PRAVENTIV MED, V49, P281; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Sallis JF, 2000, RES Q EXERCISE SPORT, V71, pS1, DOI 10.1080/02701367.2000.11082780; Salmon J, 2000, PREV MED, V30, P191, DOI 10.1006/pmed.1999.0619; Schneider S, 2007, DEUT Z SPORTMED, V58, P433; Sjostrom M, 2006, J PUBLIC HEALTH-HEID, V14, P291, DOI 10.1007/s10389-006-0031-y; Steele R, 2003, J SCI MED SPORT, V6, P398, DOI 10.1016/S1440-2440(03)80266-9; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Van Dyck D, 2011, J URBAN HEALTH, V88, P154, DOI 10.1007/s11524-010-9536-3; Wallmann-Sperlich B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-196; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, 2011, GLOB STAT REP NONC D	40	25	25	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112333	10.1371/journal.pone.0112333	http://dx.doi.org/10.1371/journal.pone.0112333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390071	Green Submitted, gold, Green Published			2022-12-26	WOS:000349144400072
J	Hoque, ME; Ghuman, S; Coopoosmay, R; Van Hal, G				Hoque, Muhammad Ehsanu; Ghuman, Shanaz; Coopoosmay, Roger; Van Hal, Guido			Cervical Cancer Screening among University Students in South Africa: A Theory Based Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; RISK; PREVALENCE; KNOWLEDGE; BELIEFS; WOMEN	Introduction: Cervical cancer is a serious public health problem in South Africa. Even though the screening is free in health facilities in South Africa, the Pap smear uptake is very low. The objective of the study is to investigate the knowledge and beliefs of female university students in South Africa. Methods: A cross sectional study was conducted among university women in South Africa to elicit information about knowledge and beliefs, and screening history. Results: A total of 440 students completed the questionnaire. The average age of the participants was 20.39 years (SD = 1.71 years). Regarding cervical cancer, 55.2% (n = 243) had ever heard about it. Results indicated that only 15% (22/147) of the students who had ever had sex and had heard about cervical cancer had taken a Pap test. Pearson correlation analysis showed that cervical cancer knowledge had a significantly negative relationship with barriers to cervical cancer screening. Susceptibility and seriousness score were significantly moderately correlated with benefit and motivation score as well as barrier score. Self-efficacy score also had a moderate correlation with benefit and motivation score. Students who had had a Pap test showed a significantly lower score in barriers to being screened compared to students who had not had a Pap test. Conclusion: This study showed that educated women in South Africa lack complete information on cervical cancer. Students who had had a Pap test had significantly lower barriers to cervical cancer screening than those students who had not had a Pap test.	[Hoque, Muhammad Ehsanu] Univ KwaZulu Natal, Grad Sch Business & Leadership, Durban, South Africa; [Ghuman, Shanaz] Durban Univ Technol, Dept Environm Hlth, Durban, South Africa; [Coopoosmay, Roger] Mangosuthu Univ Technol, Dept Nat Conversat, Durban, South Africa; [Van Hal, Guido] Univ Antwerp, B-2020 Antwerp, Belgium	University of Kwazulu Natal; Durban University of Technology; Mangosuthu University of Technology; University of Antwerp	Hoque, ME (corresponding author), Univ KwaZulu Natal, Grad Sch Business & Leadership, Durban, South Africa.	hoque@ukzn.ac.za	Van Hal, Guido F/B-5948-2017	Van Hal, Guido F/0000-0002-4611-4076				Abotchie PN, 2009, INT J GYNECOL CANCER, V19, P412, DOI 10.1111/IGC.0b013e3181a1d6de; Blair AR, 2009, PRIMARY CARE, V36, P115, DOI 10.1016/j.pop.2008.10.001; Byrd TL, 2004, PREV MED, V38, P192, DOI 10.1016/j.ypmed.2003.09.017; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Collins SI, 2005, INT J CANCER, V114, P498, DOI 10.1002/ijc.20732; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Demirtas B, 2013, ASIAN PAC J CANCER P, V14, P333, DOI 10.7314/APJCP.2013.14.1.333; Fonn S, 2002, SAMJ S AFR MED J, V92, P148; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; Gollwitzer PM, 2006, ADV EXP SOC PSYCHOL, V38, P69, DOI 10.1016/S0065-2601(06)38002-1; Guner H, 2007, TURK J OBSTET GYNECO, V4, P11; Guvenc G, 2011, J ADV NURS, V67, P428, DOI 10.1111/j.1365-2648.2010.05450.x; Hoque E., 2009, Southern African Journal of Epidemiology & Infection, V24, P21; Hoque Monjurul, 2008, East Afr J Public Health, V5, P111; HPV center WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), HPV CTR WHO ICO INF; Hughes Cathy, 2009, Nurs Stand, V23, P48; Irwin MR, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403; Issah F, 2011, EUR J ONCOL NURS, V15, P67, DOI 10.1016/j.ejon.2010.06.003; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Maree JE, 2011, EUR J ONCOL NURS, V15, P118, DOI 10.1016/j.ejon.2010.06.008; McCaffery K, 2005, J MED SCREEN, V12, P134, DOI 10.1258/0969141054855238; Moscicki AB, 2008, J ADOLESCENT HEALTH, V43, pS1, DOI 10.1016/j.jadohealth.2008.07.008; National Department of Health, 2000, NAT GUID CERV CANC S; Philips Z, 2003, HEALTH EDUC RES, V18, P318, DOI 10.1093/her/cyf022; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Smith JS, 2003, LANCET, V361, P1159, DOI 10.1016/S0140-6736(03)12949-2; Tacken MAJB, 2007, EUR J PUBLIC HEALTH, V17, P178, DOI 10.1093/eurpub/ckl082; Twinn S, 2006, J CLIN NURS, V15, P1140, DOI 10.1111/j.1365-2702.2006.01497.x; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; World Health Organization, 2012, HUM PAP INF CERV CAN	32	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111557	10.1371/journal.pone.0111557	http://dx.doi.org/10.1371/journal.pone.0111557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25387105	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400021
J	Kalampoki, LG; Flytzanis, CN				Kalampoki, Lamprini G.; Flytzanis, Constantin N.			Cis-Regulatory Control of the Nuclear Receptor Coup-TF Gene in the Sea Urchin Paracentrotus lividus Embryo	PLOS ONE			English	Article							PROMOTER-TRANSCRIPTION FACTORS; RETINOIC ACID; DEVELOPMENTAL EXPRESSION; THYROID-HORMONE; SPCOUP-TF; MEMBER; IDENTIFICATION; SPECIFICATION; SUPERFAMILY; REPRESSION	Coup-TF, an orphan member of the nuclear receptor super family, has a fundamental role in the development of metazoan embryos. The study of the gene's regulatory circuit in the sea urchin embryo will facilitate the placement of this transcription factor in the well-studied embryonic Gene Regulatory Network (GRN). The Paracentrotus lividus Coup-TF gene (PlCoup-TF) is expressed throughout embryonic development preferentially in the oral ectoderm of the gastrula and the ciliary band of the pluteus stage. Two overlapping l genomic clones, containing three exons and upstream sequences of PlCoup-TF, were isolated from a genomic library. The transcription initiation site was determined and 59 deletions and individual segments of a 1930 bp upstream region were placed ahead of a GFP reporter cassette and injected into fertilized P. lividus eggs. Module a (2532 to 2232), was necessary and sufficient to confer ciliary band expression to the reporter. Comparison of P. lividus and Strongylocentrotus purpuratus upstream Coup-TF sequences, revealed considerable conservation, but none within module a. 59 and internal deletions into module a, defined a smaller region that confers ciliary band specific expression. Putative regulatory cis-acting elements (RE1, RE2 and RE3) within module a, were specifically bound by proteins in sea urchin embryonic nuclear extracts. Site-specific mutagenesis of these elements resulted in loss of reporter activity (RE1) or ectopic expression (RE2, RE3). It is proposed that sea urchin transcription factors, which bind these three regulatory sites, are necessary for spatial and quantitative regulation of the PlCoup-TF gene at pluteus stage sea urchin embryos. These findings lead to the future identification of these factors and to the hierarchical positioning of PlCoup-TF within the embryonic GRN.	[Kalampoki, Lamprini G.; Flytzanis, Constantin N.] Univ Patras, Dept Biol, Patras 26504, Greece	University of Patras	Flytzanis, CN (corresponding author), Univ Patras, Dept Biol, Patras 26504, Greece.	kostas@bcm.edu			'Alexander S. Onassis' Foundation; University of Patras; EU program ASSEMBLE	'Alexander S. Onassis' Foundation; University of Patras; EU program ASSEMBLE	LGK was supported by a graduate fellowship from'Alexander S. Onassis' Foundation. Support for this work was obtained by a 'Karatheodoris' grant from the University of Patras to CNF. The EU program ASSEMBLE supported CNF for a visit to Dr. Arnone's laboratory at Stazione Zoologica Napoli. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achatz G, 1997, MOL CELL BIOL, V17, P4914, DOI 10.1128/MCB.17.9.4914; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; Arnone MI, 1998, DEVELOPMENT, V125, P1381; Arnone MI, 1997, DEVELOPMENT, V124, P4649; Brown CT, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-70; Brown CT, 2002, DEV BIOL, V246, P86, DOI 10.1006/dbio.2002.0619; CALZONE FJ, 1988, GENE DEV, V2, P1074, DOI 10.1101/gad.2.9.1074; Cameron RA, 2004, GENE EXPR PATTERNS, V4, P205, DOI 10.1016/j.modgep.2003.08.007; CHAN SM, 1992, P NATL ACAD SCI USA, V89, P10568, DOI 10.1073/pnas.89.22.10568; Consales C, 2002, GENE, V287, P75, DOI 10.1016/S0378-1119(01)00891-5; COONEY AJ, 1993, J BIOL CHEM, V268, P4152; FJOSE A, 1995, MECH DEVELOP, V52, P233, DOI 10.1016/0925-4773(95)00404-O; FJOSE A, 1993, EMBO J, V12, P1403, DOI 10.1002/j.1460-2075.1993.tb05784.x; FLYTZANIS CN, 1985, DEV BIOL, V108, P431, DOI 10.1016/0012-1606(85)90046-6; HIROMI Y, 1993, DEVELOPMENT, V118, P1123; JONK LJC, 1994, MECH DEVELOP, V47, P81, DOI 10.1016/0925-4773(94)90098-1; Krishnan V, 1997, SCIENCE, V278, P1947, DOI 10.1126/science.278.5345.1947; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; LAUDET V, 1992, EMBO J, V11, P1003, DOI 10.1002/j.1460-2075.1992.tb05139.x; LUTZ B, 1994, DEVELOPMENT, V120, P25, DOI 10.1242/dev.120.1.25; MCMAHON AP, 1985, DEV BIOL, V108, P420, DOI 10.1016/0012-1606(85)90045-4; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; Oliveri P, 2004, CURR OPIN GENET DEV, V14, P351, DOI 10.1016/j.gde.2004.06.004; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; PEREIRA FA, 1995, J STEROID BIOCHEM, V53, P503, DOI 10.1016/0960-0760(95)00097-J; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; QIU YH, 1994, P NATL ACAD SCI USA, V91, P4451, DOI 10.1073/pnas.91.10.4451; Rizzo F, 2006, DEV BIOL, V300, P35, DOI 10.1016/j.ydbio.2006.08.012; Salas R, 2002, EUR J BIOCHEM, V269, P317, DOI 10.1046/j.0014-2956.2001.02655.x; Saudemont A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001259; Shan G, 2008, DEV BIOL, V322, P11, DOI 10.1016/j.ydbio.2008.06.034; Su YH, 2009, DEV BIOL, V329, P410, DOI 10.1016/j.ydbio.2009.02.029; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; vanderWees J, 1996, MECH DEVELOP, V54, P173, DOI 10.1016/0925-4773(95)00471-8; Vlahou A, 1996, DEVELOPMENT, V122, P521; Vlahou A, 2000, DEV BIOL, V218, P284, DOI 10.1006/dbio.1999.9456; Walton KD, 2006, DEV BIOL, V300, P153, DOI 10.1016/j.ydbio.2006.08.064; WANG LH, 1989, NATURE, V340, P163, DOI 10.1038/340163a0; Xu ND, 1996, MECH DEVELOP, V60, P151, DOI 10.1016/S0925-4773(96)00604-1; Zhou HM, 1998, J NEUROSCI, V18, P10438	42	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109274	10.1371/journal.pone.0109274	http://dx.doi.org/10.1371/journal.pone.0109274			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386650	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400002
J	Mauer, M; Glynn, E; Svarstad, E; Tondel, C; Gubler, MC; West, M; Sokolovskiy, A; Whitley, C; Najafian, B				Mauer, Michael; Glynn, Emily; Svarstad, Einar; Tondel, Camilla; Gubler, Marie-Claire; West, Michael; Sokolovskiy, Alexey; Whitley, Chester; Najafian, Behzad			Mosaicism of Podocyte Involvement Is Related to Podocyte Injury in Females with Fabry Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; FOOT PROCESS EFFACEMENT; ALPHA-GALACTOSIDASE; X-INACTIVATION; ENDOTHELIAL FENESTRATION; CLINICAL-MANIFESTATIONS; DIABETIC-NEPHROPATHY; OUTCOME SURVEY; RENAL-FAILURE; GENE	Background: Fabry disease. an X-linked deficiency of alpha-galactosidase A coded by the GLA gene, leads to intracellular globotriaosylceramide (GL-3) accumulation. Although less common than in males, chronic kidney disease, occurs in,similar to 15% of females. Recent studies highlight the importance of podocyte injury in Fabry nephropathy development and progression. We hypothesized that the greater the % of podocytes with active wild-type GLA gene (due to X-inactivation of the mutant copy) the less is the overall podocyte injury. Methods: Kidney biopsies from 12 treatment-naive females with Fabry disease, ages 15 (8-63), median [range], years were studied by electron microscopy and compared with 4 treatment-naive male patients. Results: In females, 51 (13-100)% of podocytes (PC) per glomerulus had no GL-3 inclusions, this consistent with a non-Fabry podocyte phenotype (NFPC). In PC with GL-3 inclusions [Fabry podocyte phenotype (FPC)], GL-3 volume density per podocyte was virtually identical in females and males, consistent with little or no cross-correction between FPC and NFPC. % NFPC per glomerulus (%NFPC/glom) correlated with age in females (r = 0.65, p = 0.02), suggesting a survival disadvantage for FPC over time. Age-adjusted %NFPC/glom was inversely related to foot process width (FPW) (r = 20.75, p = 0.007), an indicator of PC injury. GL-3 volume density in FPC in females correlated directly with FPW. Conclusions: These findings support important relationships between podocyte mosaicism and podocyte injury in female Fabry patients. Kidney biopsy, by providing information about podocyte mosaicism, may help to stratify females with Fabry disease for kidney disease risk and to guide treatment decisions.	[Mauer, Michael; Whitley, Chester] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mauer, Michael] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Glynn, Emily; Sokolovskiy, Alexey; Najafian, Behzad] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Svarstad, Einar] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Svarstad, Einar; Tondel, Camilla] Univ Bergen, Dept Clin Med, Bergen, Norway; [Tondel, Camilla] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Gubler, Marie-Claire] Univ Paris 05, Hop Necker Enfants Malad, AP HP, U983, Paris, France; [West, Michael] Dalhousie Univ, Dept Med, Div Nephrol, Halifax, NS, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Dalhousie University	Najafian, B (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	najafian@u.washington.edu	Mauer, Michael/ABD-5415-2020	Gubler, Marie-Claire/0000-0002-3526-5661; west, michael/0000-0003-4897-1378; Najafian, Behzad/0000-0002-0904-6721	NIH RDCRN U54 grant [5U54NS065768-04]; Genzyme; Sanofi Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065768] Funding Source: NIH RePORTER	NIH RDCRN U54 grant; Genzyme(Sanofi-AventisGenzyme Corporation); Sanofi Company; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an NIH RDCRN U54 grant (5U54NS065768-04) and an investigator initiated grant from Genzyme, a Sanofi Company. The funder provided support in the form of research grants for authors [BN, MM, and MLW], and travel support and honoraria for authors [BN, MM, CT, and MLW] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; [Anonymous], 2013, HUMAN GENE MUTATION; Ashton-Prolla P, 2000, J INVEST MED, V48, P227; Bekri S, 2005, NEPHRON CLIN PRACT, V101, pC33, DOI 10.1159/000085709; Deegan PB, 2006, J MED GENET, V43, P347, DOI 10.1136/jmg.2005.036327; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; Dobrovolny R, 2005, J MOL MED, V83, P647, DOI 10.1007/s00109-005-0656-2; Elstein D, 2012, GENE, V505, P266, DOI 10.1016/j.gene.2012.06.013; Eng CM, 1997, MOL MED, V3, P174, DOI 10.1007/BF03401671; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Gibas Andrea L, 2008, J Genet Couns, V17, P528, DOI 10.1007/s10897-008-9179-7; GUBLER MC, 1978, KIDNEY INT, V13, P223, DOI 10.1038/ki.1978.32; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; MacDermot KD, 2001, J MED GENET, V38, P769, DOI 10.1136/jmg.38.11.769; Maier EM, 2006, ACTA PAEDIATR, V95, P30, DOI 10.1080/08035320600618809; Matsusaka T, 2011, J AM SOC NEPHROL, V22, P1275, DOI 10.1681/ASN.2010090963; Mehta A, 2004, EUR J CLIN INVEST, V34, P236, DOI 10.1111/j.1365-2362.2004.01309.x; Migeon BR, 2006, JAMA-J AM MED ASSOC, V295, P1428, DOI 10.1001/jama.295.12.1428; Najafian B, 2013, PEDIATR NEPHROL, V28, P679, DOI 10.1007/s00467-012-2222-9; Najafian B, 2011, AM J NEPHROL, V33, P34, DOI 10.1159/000327075; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Pinto LLC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-14; Reiser J, 2013, ANNU REV MED, V64, P357, DOI 10.1146/annurev-med-050311-163340; Terryn W, 2013, NEPHROL DIAL TRANSPL, V28, P505, DOI 10.1093/ndt/gfs526; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; Topham PS, 1999, KIDNEY INT, V55, P1763, DOI 10.1046/j.1523-1755.1999.00407.x; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Valbuena C, 2008, VIRCHOWS ARCH, V453, P329, DOI 10.1007/s00428-008-0653-2; Wang CL, 2013, KIDNEY BLOOD PRESS R, V37, P221, DOI 10.1159/000350147; Wang RY, 2007, GENET MED, V9, P34, DOI 10.1097/GIM.0b013e31802d8321; Warnock DG, 2012, NEPHROL DIAL TRANSPL, V27, P1042, DOI 10.1093/ndt/gfr420; Warnock DG, 2014, J AM SOC NEPHROL; Whybra C, 2004, CLIN GENET, V65, P299, DOI 10.1111/j.1399-0004.2004.00219.x; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Wolf G, 2005, DIABETES, V54, P1626, DOI 10.2337/diabetes.54.6.1626; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5	38	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112188	10.1371/journal.pone.0112188	http://dx.doi.org/10.1371/journal.pone.0112188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386848	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400047
J	Raikwar, NS; Liu, KZ; Thomas, CP				Raikwar, Nandita S.; Liu, Kang Z.; Thomas, Christie P.			N-Terminal Cleavage and Release of the Ectodomain of Flt1 Is Mediated via ADAM10 and ADAM 17 and Regulated by VEGFR2 and the Flt1 Intracellular Domain	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; INTRAMEMBRANE PROTEOLYSIS; SIGNAL-TRANSDUCTION; ENDOTHELIAL-CELLS; TYROSINE KINASE; METALLOPROTEINASES; ANGIOGENESIS; PREECLAMPSIA; PATHWAYS; VARIANT	Flt is one of the cell surface VEGF receptors which can be cleaved to release an N-terminal extracellular fragment which, like alternately transcribed soluble Flt1 (sFlt1), can antagonize the effects of VEGF. In HUVEC and in HEK293 cells where Flt1 was expressed, metalloprotease inhibitors reduced Flt1 N-terminal cleavage. Overexpression of ADAM10 and ADAM17 increased cleavage while knockdown of ADAM10 and ADAM17 reduced N-terminal cleavage suggesting that these metalloproteases were responsible for Flt1 cleavage. Protein kinase C (PKC) activation increased the abundance and the cleavage of Flt1 but this did not require any residues within the intracellular portion of Flt1. ALLN, a proteasomal inhibitor, increased the abundance of Flt1 which was additive to the effect of PKC. Removal of the entire cytosolic region of Flt1 appeared to stimulate cleavage of Flt1 and Flt1 was no longer sensitive to ALLN suggesting that the cytosolic region contained a degradation domain. Knock down of c-CBL, a ring finger ubiquitin ligase, in HEK293 cells increased the expression of Flt1 although it did not appear to require a previously published tyrosine residue (1333Y) in the C-terminus of Flt1. Increasing VEGFR2 expression increased VEGF-stimulated sFlt1 expression and progressively reduced the cleavage of Flt1 with Flt1 staying bound to VEGFR2 as a heterodimer. Our results imply that secreted sFlt1 and cleaved Flt1 will tend to have local effects as a VEGF antagonist when released from cells expressing VEGFR2 and more distant effects when released from cells lacking VEGFR2.	[Raikwar, Nandita S.; Liu, Kang Z.; Thomas, Christie P.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Thomas, Christie P.] Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [Thomas, Christie P.] Univ Iowa, Coll Med, Dept Obstet, Iowa City, IA 52242 USA; [Thomas, Christie P.] Univ Iowa, Coll Med, Dept Mol & Cellular Biol, Iowa City, IA 52242 USA; [Thomas, Christie P.] Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Thomas, CP (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	christie-thomas@uiowa.edu		Thomas, Christie/0000-0002-5989-9685	American Society of Nephrology; National Institutes of Health [RO1 DK090053]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090053] Funding Source: NIH RePORTER	American Society of Nephrology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	New Directions Grant from the American Society of Nephrology; RO1 DK090053 from National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; Cross MJ, 2003, TRENDS BIOCHEM SCI, V28, P488, DOI 10.1016/S0968-0004(03)00193-2; Cudmore MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1977; Dang M, 2013, P NATL ACAD SCI USA, V110, P9776, DOI 10.1073/pnas.1307478110; Dunk C, 2001, AM J PATHOL, V158, P265, DOI 10.1016/S0002-9440(10)63965-X; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Kobayashi S, 2004, FASEB J; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Lal M, 2011, PHYSIOLOGY, V26, P34, DOI 10.1152/physiol.00028.2010; Lemjabbar-Alaoui H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017489; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V295, pF1440, DOI 10.1152/ajprenal.90239.2008; Raikwar NS, 2013, EXP CELL RES, V319, P2578, DOI 10.1016/j.yexcr.2013.07.005; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Sawano A, 1997, BIOCHEM BIOPH RES CO, V238, P487, DOI 10.1006/bbrc.1997.7327; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Thomas C, 2007, ANIMAL, V1, P1, DOI 10.1017/S1751731107658467; Yanez-Mo M, 2011, BIOCHEM SOC T, V39, P541, DOI 10.1042/BST0390541; Yoda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054412	29	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112794	10.1371/journal.pone.0112794	http://dx.doi.org/10.1371/journal.pone.0112794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387128	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400092
J	Sak, B; Petrzelkova, KJ; Kvetonova, D; Mynarova, A; Pomajbikova, K; Modry, D; Cranfield, MR; Mudakikwa, A; Kvac, M				Sak, Bohumil; Petrzelkova, Klara J.; Kvetonova, Dana; Mynarova, Anna; Pomajbikova, Katerina; Modry, David; Cranfield, Michael R.; Mudakikwa, Antoine; Kvac, Martin			Diversity of Microsporidia, Cryptosporidium and Giardia in Mountain Gorillas (Gorilla beringei beringei) in Volcanoes National Park, Rwanda	PLOS ONE			English	Article							FREE-RANGING GORILLAS; ENTEROCYTOZOON-BIENEUSI; ENCEPHALITOZOON-CUNICULI; MURIS INFECTION; GREAT APES; IDENTIFICATION; GENOTYPE; EPIDEMIOLOGY; PREVALENCE; DUODENALIS	Background: Infectious diseases represent the greatest threats to endangered species, and transmission from humans to wildlife under increased anthropogenic pressure has been always stated as a major risk of habituation. Aims: To evaluate the impact of close contact with humans on the occurrence of potentially zoonotic protists in great apes, one hundred mountain gorillas (Gorilla beringei beringei) from seven groups habituated either for tourism or for research in Volcanoes National Park, Rwanda were screened for the presence of microsporidia, Cryptosporidium spp. and Giardia spp. using molecular diagnostics. Results: The most frequently detected parasites were Enterocytozoon bieneusi found in 18 samples (including genotype EbpA, D, C, gorilla 2 and five novel genotypes gorilla 4-8) and Encephalitozoon cuniculi with genotype II being more prevalent (10 cases) compared to genotype I (1 case). Cryptosporidium muris (2 cases) and C. meleagridis (2 cases) were documented in great apes for the first time. Cryptosporidium sp. infections were identified only in research groups and occurrence of E. cuniculi in research groups was significantly higher in comparison to tourist groups. No difference in prevalence of E. bieneusi was observed between research and tourist groups. Conclusion: Although our data showed the presence and diversity of important opportunistic protists in Volcanoes gorillas, the source and the routes of the circulation remain unknown. Repeated individual sampling, broad sampling of other hosts sharing the habitat with gorillas and quantification of studied protists would be necessary to acquire more complex data.	[Sak, Bohumil; Petrzelkova, Klara J.; Kvetonova, Dana; Modry, David; Kvac, Martin] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic; [Petrzelkova, Klara J.] Acad Sci Czech Republ, Inst Vertebrate Biol, Vvi, Brno, Czech Republic; [Petrzelkova, Klara J.] Liberec Zoo, Liberec, Czech Republic; [Petrzelkova, Klara J.; Pomajbikova, Katerina; Modry, David] Univ Vet & Pharmaceut Sci, Fac Vet Med, Dept Pathol & Parasitol, Brno, Czech Republic; [Mynarova, Anna] Univ South Bohemia Ceske Budejovice, Fac Sci, Ceske Budejovice, Czech Republic; [Modry, David] Univ Vet & Pharmaceut Sci, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Cranfield, Michael R.] Karen C Drayer Wildlife Hlth Ctr, Gorilla Doctors, Davis, CA USA; [Mudakikwa, Antoine] Rwanda Dev Board, Kigali, Rwanda; [Kvac, Martin] Univ South Bohemia Ceske Budejovice, Fac Agr, Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; University of Veterinary Sciences Brno; University of South Bohemia Ceske Budejovice; University of Veterinary Sciences Brno; University of South Bohemia Ceske Budejovice	Sak, B (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Vvi, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	casio@paru.cas.cz	Jirků (Pomajbíková), Katerina/G-9858-2014; Kvac, Martin/G-7299-2014; Kvac, Martin/AAT-9533-2020; Modry, David/G-7815-2014; Petrzelkova, Klara Judita/G-7111-2014; Sak, Bohumil/G-9262-2014	Jirků (Pomajbíková), Katerina/0000-0001-5411-6082; Kvac, Martin/0000-0003-0013-6090; Modry, David/0000-0001-9649-6255; 	European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; European Social Fund; state budget of the Czech Republic [OPVK CZ.1.07/2.3.00/20.0300]; Grant Agency of the Czech Republic [206/09/0927]; Praemium Academiae award	European Regional Development Fund(European Commission); European Social Fund(European Social Fund (ESF)); state budget of the Czech Republic; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Praemium Academiae award	This work was supported by the project "CEITEC" - Central European Institute of Technology (CZ.1.05/1.1.00/02.0068) from the European Regional Development Fund, co-financed from the European Social Fund and the state budget of the Czech Republic (project OPVK CZ.1.07/2.3.00/20.0300), by a grant from the Grant Agency of the Czech Republic (206/09/0927), and by institutional support of Institute of Vertebrate Biology Academy of Sciences of the Czech Republic (RVO:68081766). K.J.P. was also supported by the Praemium Academiae award to Julius Lukes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitenmoser AC, 1999, PARASITOLOGY, V118, P447, DOI 10.1017/S0031182099004229; Buckholt MA, 2002, APPL ENVIRON MICROB, V68, P2595, DOI 10.1128/AEM.68.5.2595-2599.2002; Butynski Thomas M., 1998, P294, DOI 10.1002/9781444313598.ch12; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; CANNING EU, 1987, PARASITOL TODAY, V3, P267, DOI 10.1016/0169-4758(87)90103-7; Didier ES, 2006, CURR OPIN INFECT DIS, V19, P485, DOI 10.1097/01.qco.0000244055.46382.23; DIDIER ES, 1995, PARASITOLOGY, V111, P411, DOI 10.1017/S0031182000065914; Dubey JP, 2002, VET PATHOL, V39, P363, DOI 10.1354/vp.39-3-363; Franzen C., 2008, OPEN PARASITOL J, V2, P1, DOI [10.2174/1874421400802010001, DOI 10.2174/1874421400802010001]; Gatei W, 2002, EMERG INFECT DIS, V8, P204, DOI 10.3201/eid0802.010256; Gatei W, 2003, J CLIN MICROBIOL, V41, P1458, DOI 10.1128/JCM.41.4.1458-1462.2003; Gatei W, 2006, AM J TROP MED HYG, V75, P78, DOI 10.4269/ajtmh.2006.75.78; Gillespie TR, 2009, ECOHEALTH, V6, P557, DOI 10.1007/s10393-010-0283-4; Gillespie TR, 2008, YEARB PHYS ANTHROPOL, V51, P53, DOI 10.1002/ajpa.20949; Goldsmith ML, 2000, AM J PHYS ANTHROPOL, P161; Goldsmith ML, 2005, GORILLA J, V30, P14; Graczyk TK, 2002, J PARASITOL, V88, P905, DOI 10.1645/0022-3395(2002)088[0905:AGDGAA]2.0.CO;2; Graczyk TK, 2002, PARASITOL RES, V88, P926, DOI 10.1007/s00436-002-0693-5; Graczyk TK, 2001, PARASITOL RES, V87, P368, DOI 10.1007/s004360000337; Gray M, 2005, BIODIVERS CONSERV, V14, P2723, DOI 10.1007/s10531-005-8406-x; Harcourt AH, 2001, BIODIVERS CONSERV, V10, P1011, DOI 10.1023/A:1016680327755; Hofmannova L, 2014, VET PARASITOL, V205, P357, DOI 10.1016/j.vetpar.2014.07.008; Hogan JN, 2014, J WILDLIFE DIS, V50, P21, DOI 10.7589/2012-09-229; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Johnston AR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000683; Kasickova D, 2009, VET PARASITOL, V165, P125, DOI 10.1016/j.vetpar.2009.06.033; Katsumata T, 2000, AM J TROP MED HYG, V62, P70, DOI 10.4269/ajtmh.2000.62.70; KatzwinkelWladarsch S, 1996, TROP MED INT HEALTH, V1, P373, DOI 10.1046/j.1365-3156.1996.d01-51.x; Klailova M, 2010, AM J PRIMATOL, V72, P897, DOI 10.1002/ajp.20829; Kodadkova A, 2010, J PARASITOL, V96, P211, DOI 10.1645/GE-2212.1; Kotkova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060941; Kvac M, 2009, EMERG INFECT DIS, V15, P982, DOI [10.3201/eid1506.07621, 10.3201/eid1506.071621]; Li W, 2011, J CLIN MICROBIOL, V49, P4326, DOI 10.1128/JCM.05051-11; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Maekawa M, 2013, NAT RESOUR FORUM, V37, P127, DOI 10.1111/1477-8947.12020; Mathis A, 2005, CLIN MICROBIOL REV, V18, P423, DOI 10.1128/CMR.18.3.423-445.2005; Mudakikwa A., 2001, MOUNTAIN GORILLAS 3, P341; Muthusamy D, 2006, J CLIN MICROBIOL, V44, P632, DOI 10.1128/JCM.44.2.632-634.2006; Ng J, 2006, APPL ENVIRON MICROB, V72, P7548, DOI 10.1128/AEM.01352-06; Nichols Gordon, 2007, P79, DOI 10.1201/9781420052275.ch4; Nizeyi JB, 2002, PARASITOL RES, V88, P380, DOI 10.1007/s00436-001-0543-x; Nizeyi JB, 1999, J PARASITOL, V85, P1084, DOI 10.2307/3285672; OWIUNJI I, 2005, BIODIVERSITY S UNPUB; Petrasova J, 2011, INT J PARASITOL, V41, P1113, DOI 10.1016/j.ijpara.2011.06.010; PLUMPTRE AJ, 2001, MOUNTAIN GORILLAS 3, P361; Qi M, 2011, EXP PARASITOL, V128, P336, DOI 10.1016/j.exppara.2011.04.003; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reetz J, 1993, Tierarztl Prax, V21, P429; Rinder H., 2000, Mitteilungen der Oesterreichischen Gesellschaft fuer Tropenmedizin und Parasitologie, V22, P1; ROBBINS M, 2008, IUCN 2013 IUCN RED L; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; *RWAND DEV BOARD, 2011, HIGHL NAT PARK UNPUB; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Sak B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071840; Sak B, 2011, FOLIA PARASIT, V58, P81, DOI 10.14411/fp.2011.008; Sak B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001162; Sak B, 2011, J CLIN MICROBIOL, V49, P1064, DOI 10.1128/JCM.01147-10; Sak B, 2010, VET PARASITOL, V168, P196, DOI 10.1016/j.vetpar.2009.11.012; Salyer SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001597; Salzer JS, 2007, J PARASITOL, V93, P439, DOI 10.1645/GE-970R1.1; Santin M, 2011, RES VET SCI, V90, P363, DOI 10.1016/j.rvsc.2010.07.014; Sleeman JM, 2000, J ZOO WILDLIFE MED, V31, P322, DOI 10.1638/1042-7260(2000)031[0322:GPOMGG]2.0.CO;2; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanriverdi S, 2003, MOL BIOCHEM PARASIT, V130, P13, DOI 10.1016/S0166-6851(03)00138-5; Thellier M, 2008, PARASITE, V15, P349, DOI 10.1051/parasite/2008153349; Thompson RCA, 2004, WORLD CL PARASITES, V8, P1; VEDDER AL, 1984, AM J PRIMATOL, V7, P73, DOI 10.1002/ajp.1350070202; Wagnerova P, 2012, VET PARASITOL, V190, P573, DOI 10.1016/j.vetpar.2012.07.013; Waldron LS, 2010, EMERG INFECT DIS, V16, P2006, DOI 10.3201/eid1612.100715; WATTS DP, 1984, AM J PRIMATOL, V7, P323, DOI 10.1002/ajp.1350070403; WEBER R, 1992, AM REV RESPIR DIS, V146, P1603, DOI 10.1164/ajrccm/146.6.1603; Williamson EA, 2008, SCIENCE AND CONSERVATION IN AFRICAN FORESTS: THE BENEFITS OF LONG-TERM RESEARCH, P213; Williamson Elizabeth A., 2003, P25; Woodford MH, 2002, ORYX, V36, P153, DOI 10.1017/S0030605302000224; Zommers Z, 2013, CONSERV LETT, V6, P264, DOI 10.1111/j.1755-263X.2012.00288.x	77	34	36	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109751	10.1371/journal.pone.0109751	http://dx.doi.org/10.1371/journal.pone.0109751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386754	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400004
J	Schuler, E; Parris, TZ; Helou, K; Forssell-Aronsson, E				Schueler, Emil; Parris, Toshima Z.; Helou, Khalil; Forssell-Aronsson, Eva			Distinct microRNA Expression Profiles in Mouse Renal Cortical Tissue after Lu-177-octreotate Administration	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; IONIZING-RADIATION; RADIONUCLIDE THERAPY; RADIOLABELED SOMATOSTATIN; MIRNA EXPRESSION; MESSENGER-RNAS; KIDNEY TISSUE; HUMAN-CELLS; NUDE-MICE; DOSE-RATE	Aim: The aim of this study was to investigate the variation of the miRNA expression levels in normal renal cortical tissue after Lu-177-octreotate administration, a radiopharmaceutical used for treatment of neuroendocrine cancers. Methods: Female BALB/c nude mice were i.v. injected with 1.3, 3.6, 14, 45, or 140 MBq Lu-177-octreotate, while control animals received saline. The animals were killed at 24 h after injection and total RNA, including miRNA, was extracted from the renal cortical tissue and hybridized to the Mouse miRNA Oligo chip 4plex to identify differentially regulated miRNAs between exposed and control samples. Results: In total, 57 specific miRNAs were differentially regulated in the exposed renal cortical tissues with 1, 29, 21, 27, and 31 miRNAs identified per dose-level (0.13, 0.34, 1.3, 4.3, and 13 Gy, respectively). No miRNAs were commonly regulated at all dose levels. miR-194, miR-107, miR-3090, and miR-3077 were commonly regulated at 0.34, 1.3, 4.3, and 13 Gy. Strong effects on cellular mechanisms ranging from immune response to p53 signaling and cancer-related pathways were observed at the highest absorbed dose. Thirty-nine of the 57 differentially regulated miRNAs identified in the present study have previously been associated with response to ionizing radiation, indicating common radiation responsive pathways. Conclusion: In conclusion, the Lu-177-octreotate associated miRNA signatures were generally dose-specific, thereby illustrating transcriptional regulation of radiation responsive miRNAs. Taken together, these results imply the importance of miRNAs in early immunological responses in the kidneys following Lu-177-octreotate administration.	[Schueler, Emil; Forssell-Aronsson, Eva] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Canc C, Gothenburg, Sweden; [Parris, Toshima Z.; Helou, Khalil] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Oncol,Inst Clin Sci,Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Forssell-Aronsson, Eva] Sahlgrens Univ Hosp, Dept Med Phys & Biomed Engn, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital	Schuler, E (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Canc C, Gothenburg, Sweden.	emil.schuler@gu.se	Parris, Toshima/Q-5427-2018	Parris, Toshima/0000-0003-0834-5540; Forssell-Aronsson, Eva/0000-0002-7558-4368	Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE-a National Strategic Research Program at the University of Gothenburg; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Assar Gabrielsson Cancer Research Foundation; Lions cancer foundation; Adlerbertska Research Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE-a National Strategic Research Program at the University of Gothenburg; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Assar Gabrielsson Cancer Research Foundation; Lions cancer foundation; Adlerbertska Research Foundation	This study was supported by grants from the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE-a National Strategic Research Program at the University of Gothenburg, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Assar Gabrielsson Cancer Research Foundation, Lions cancer foundation, and the Adlerbertska Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; Barone R, 2005, J NUCL MED, V46, p99S; Bentzen SM, 2006, NAT REV CANCER, V6, P702, DOI 10.1038/nrc1950; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chaudhry MA, 2012, MOL BIOL REP, V39, P7549, DOI 10.1007/s11033-012-1589-9; Chaudhry MA, 2010, INT J RADIAT BIOL, V86, P569, DOI 10.3109/09553001003734568; Chen J, 2011, ONCOL REP, V25, P173, DOI 10.3892/or_00001058; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Dalmo J, 2012, ONCOL REP, V27, P174, DOI 10.3892/or.2011.1494; de Jong M, 2004, J NUCL MED, V45, P1168; Dickey JS, 2011, RADIAT ENVIRON BIOPH, V50, P491, DOI 10.1007/s00411-011-0386-5; Ferracin M, 2010, EXPERT REV MOL DIAGN, V10, P297, DOI 10.1586/ERM.10.11; Forssell-Aronsson E, 2013, NEUROENDOCRINOLOGY, V97, P86, DOI 10.1159/000336086; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Jacobs LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080844; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Joly-Tonetti N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-184; Kasinski AL, 2010, CURR OPIN MOL THER, V12, P147; Lambert B, 2004, RADIAT RES, V161, P607, DOI 10.1667/RR3105; Langen B, 2013, J NUCL MED, V54, P990, DOI 10.2967/jnumed.112.114462; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Loevinger R, 1988, MIRD PRIMER ABSORBED; Melis M, 2005, EUR J NUCL MED MOL I, V32, P1136, DOI 10.1007/s00259-005-1793-0; Melis M, 2007, NUCL MED BIOL, V34, P633, DOI 10.1016/j.nucmedbio.2007.05.002; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; Miller WH, 2005, CANCER BIOTHER RADIO, V20, P436, DOI 10.1089/cbr.2005.20.436; Moncayo R, 2005, EUR J NUCL MED MOL I, V32, P1131, DOI 10.1007/s00259-005-1885-x; Mueller AC, 2013, ONCOGENE, V32, P1164, DOI 10.1038/onc.2012.131; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Schuler E, 2014, NUCL MED BIOL, V41, P825, DOI 10.1016/j.nucmedbio.2014.07.010; Schuler E, 2014, NUCL MED BIOL, V41, P238, DOI 10.1016/j.nucmedbio.2013.12.001; Schuler E, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-29; Shkumatava A, 2009, GENE DEV, V23, P466, DOI 10.1101/gad.1745709; Simone NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006377; Svensson J, 2012, NUCL MED BIOL, V39, P756, DOI 10.1016/j.nucmedbio.2012.02.003; Templin T, 2012, INT J RADIAT BIOL, V88, P531, DOI 10.3109/09553002.2012.690549; Templin T, 2011, INT J RADIAT BIOL, V87, P653, DOI 10.3109/09553002.2010.549537; Vegt E, 2010, J NUCL MED, V51, P1049, DOI 10.2967/jnumed.110.075101; Wagner-Ecker M, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-25; Wan YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087782; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Williams J, 2003, SEMIN RADIAT ONCOL, V13, P182, DOI 10.1016/S1053-4296(03)00045-6	51	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112645	10.1371/journal.pone.0112645	http://dx.doi.org/10.1371/journal.pone.0112645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386939	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400077
J	Lin, LC; Vanier, DR; London, SE				Lin, Lynda C.; Vanier, David R.; London, Sarah E.			Social Information Embedded in Vocalizations Induces Neurogenomic and Behavioral Responses	PLOS ONE			English	Article							FEMALE ZEBRA-FINCHES; SONG CONTROL-SYSTEM; TAENIOPYGIA-GUTTATA; GENE-EXPRESSION; MATE CHOICE; AROMATASE EXPRESSION; ADULT FEMALE; BRAIN; ARC; DISCRIMINATION	Social cues facilitate relationships within communities. Zebra finches form long-term stable mate pairs and produce offspring within a multi-family, multi-generational community that can include hundreds of birds. Males use song to communicate in this complex environment. Males sing as part of their courtship display but also abundantly throughout each day, suggesting a role for their vocal signature outside of a reproductive context. One advantage of a vocal social cue is that it can be exchanged when birds are out of visual contact, as regularly occurs in a zebra finch community. Previous works have demonstrated that females hearing song are affected by their social relationship to the bird singing it, and the immediate social context. Here, we probed the question of whether or not the song itself carried social information, as would be expected from the situations when males sing outside of view of the female. We quantified behavioral and neurogenomic responses to two songs we predicted would have distinct "attractive'' qualities in adult females housed in either mixed sex or female-only social communities. Our results show that only mixed sex-housed females show distinctive behavioral and neurogenomic responses to attractive songs. These data are consistent with the idea that the acoustic properties of song carry social information, and that the current social situation modulates the neural and behavioral responses to these signals.	[Lin, Lynda C.; Vanier, David R.; London, Sarah E.] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [London, Sarah E.] Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA; [London, Sarah E.] Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	London, SE (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	london@uchicago.edu		London, Sarah/0000-0002-7839-2644	David Greenstone Fund; University of Chicago; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	David Greenstone Fund; University of Chicago(University of Chicago); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by The David Greenstone Fund and The University of Chicago (to SEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DJ, 2005, BEHAV BRAIN RES, V162, P108, DOI 10.1016/j.bbr.2005.03.016; Balzer AL, 1998, BEHAVIOUR, V135, P297, DOI 10.1163/156853998793066230; Blumstein D. T., 2007, QUANTIFYING BEHAV JW; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Brazas ML, 2002, ANIM COGN, V5, P91, DOI 10.1007/s10071-002-0136-9; Buchanan KL, 2003, P ROY SOC B-BIOL SCI, V270, P1149, DOI 10.1098/rspb.2003.2330; Caras ML, 2012, J NEUROSCI, V32, P17597, DOI 10.1523/JNEUROSCI.3938-12.2012; Martinez MC, 2012, NEUROBIOL LEARN MEM, V98, P165, DOI 10.1016/j.nlm.2012.05.007; Chen YC, 2005, J NEUROBIOL, V64, P4, DOI 10.1002/neu.20150; CLAYTON N, 1989, ANIM BEHAV, V38, P352, DOI 10.1016/S0003-3472(89)80096-X; Dong S, 2008, GENES BRAIN BEHAV, V7, P802, DOI 10.1111/j.1601-183X.2008.00423.x; Dong S, 2009, P NATL ACAD SCI USA, V106, P11364, DOI 10.1073/pnas.0812998106; Freking F, 2000, GEN COMP ENDOCR, V119, P140, DOI 10.1006/gcen.2000.7503; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Hauber ME, 2010, EMU, V110, P209, DOI 10.1071/MU10003; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Lauay C, 2005, J COMP NEUROL, V487, P119, DOI 10.1002/cne.20591; Lauay C, 2004, ANIM BEHAV, V68, P1249, DOI 10.1016/j.anbehav.2003.12.025; Leadbeater E, 2005, ANIM BEHAV, V70, P909, DOI 10.1016/j.anbehav.2005.02.007; Lohr B, 1998, J COMP PSYCHOL, V112, P36, DOI 10.1037/0735-7036.112.1.36; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; London SE, 2006, ENDOCRINOLOGY, V147, P5975, DOI 10.1210/en.2006-0154; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 2004, FRONT BIOSCI, V9, P63, DOI 10.2741/1201; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Neubauer RL, 1999, EVOL ECOL, V13, P365, DOI 10.1023/A:1006708826432; Nowicki S, 2005, AUK, V122, P1, DOI 10.1642/0004-8038(2005)122[0001:SAMCIB]2.0.CO;2; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Okuno Hiroyuki, 2004, Tanpakushitsu Kakusan Koso, V49, P411; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Riters LV, 2004, BEHAV BRAIN RES, V155, P307, DOI 10.1016/j.bbr.2004.05.002; Saldanha CJ, 2000, J COMP NEUROL, V423, P619, DOI 10.1002/1096-9861(20000807)423:4<619::AID-CNE7>3.0.CO;2-U; Sanders J, 2012, J NEUROSCI, V32, P12570, DOI 10.1523/JNEUROSCI.1131-12.2012; SHEN P, 1994, MOL BRAIN RES, V24, P227, DOI 10.1016/0169-328X(94)90136-8; SOSSINKA R, 1980, J EXP ZOOL, V211, P225, DOI 10.1002/jez.1402110211; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Svec LA, 2009, BEHAV BRAIN RES, V199, P298, DOI 10.1016/j.bbr.2008.12.006; Tchernichovski O, 1998, ANIM BEHAV, V55, P1003, DOI 10.1006/anbe.1997.0673; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Tomaszycki ML, 2005, ANIM BEHAV, V70, P785, DOI 10.1016/j.anbehav.2005.01.010; Tremere LA, 2011, J NEUROSCI, V31, P3271, DOI 10.1523/JNEUROSCI.4355-10.2011; VALLET E, 1995, ANIM BEHAV, V49, P1603, DOI 10.1016/0003-3472(95)90082-9; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Vignal C, 2005, EUR J NEUROSCI, V22, P949, DOI 10.1111/j.1460-9568.2005.04254.x; Vyas A, 2009, HORM BEHAV, V55, P50, DOI 10.1016/j.yhbeh.2008.08.005; Woodgate JL, 2012, ANIM BEHAV, V83, P773, DOI 10.1016/j.anbehav.2011.12.027; Woolley SC, 2008, PLOS BIOL, V6, P525, DOI 10.1371/journal.pbio.0060062	52	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112905	10.1371/journal.pone.0112905	http://dx.doi.org/10.1371/journal.pone.0112905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384071	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700104
J	Zhang, J; Yu, HC; Zhang, Y; Zhang, XS; Zheng, GX; Gao, Y; Wang, CX; Zhou, LQ				Zhang, Jian; Yu, Hongchen; Zhang, Yi; Zhang, Xiaoshi; Zheng, Guixin; Gao, Yang; Wang, Chuanxin; Zhou, Liqing			A Functional TNFAIP2 3 '-UTR rs8126 Genetic Polymorphism Contributes to Risk of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CANCER; CHINA; VARIANTS; PLCE1; ALPHA	Background: Accumulated evidences demonstrated that single nucleotide polymorphisms (SNPs) in mRNA 3'-untranslated region (3'-UTR) may impact microRNAs (miRNAs)-mediated expression regulation of oncogenes and tumor suppressors. There is a TNFAIP2 3'-UTR rs8126 T>C genetic variant which has been proved to be associated with head and neck cancer susceptibility. This SNP could disturb binding of miR-184 with TNFAIP2 mRNA and influence TNFAIP2 regulation. However, it is still unclear how this polymorphism is involved in development of esophageal squamous cell carcinoma (ESCC). Therefore, we hypothesized that the functional TNFAIP2 rs8126 SNP may affect TNFAIP2 expression and, thus, ESCC risk. Methods: We investigated the association between the TNFAIP2 rs8126 variant and ESCC risk as well as the functional relevance on TNFAIP2 expression in vivo. Genotypes were determined in a case-control set consisted of 588 ESCC patients and 600 controls. The allele-specific regulation on TNFAIP2 expression by the rs8126 SNP was examined in normal and cancerous tissue specimens of esophagus. Results: We found that individuals carrying the rs8126 CC or CT genotype had an OR of 1.89 (95%CI = 1.23-2.85, P = 0.003) or 1.38 (95%CI = 1.05-1.73, P = 0.017) for developing ESCC in Chinese compared with individual carrying the TT genotype. Carriers of the rs8126 CC and CT genotypes had significantly lower TNFAIP2 mRNA levels than those with the TT genotypes in normal esophagus tissues (P<0.05). Conclusions: Our data demonstrate that functional TNFAIP2 rs8126 genetic variant is a ESCC susceptibility SNP. These results support the hypothesis that genetic variants interrupting miRNA-mediated gene regulation might be important genetic modifiers of cancer risk.	[Zhang, Jian; Zhang, Yi; Zhang, Xiaoshi; Zheng, Guixin; Gao, Yang; Wang, Chuanxin] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China; [Yu, Hongchen] Shandong Univ, Qingdao Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Zhou, Liqing] Huaian 2 Hosp, Dept Radiat Oncol, Huaian, Jiangsu, Peoples R China	Shandong University; Shandong University	Wang, CX (corresponding author), Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China.	cxwangsd@163.com; zlq-hill@163.com						Abnet CC, 2012, HUM MOL GENET, V21, P2132, DOI 10.1093/hmg/dds029; Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Chen LC, 2011, MODERN PATHOL, V24, P175, DOI 10.1038/modpathol.2010.193; Cui R, 2009, GASTROENTEROLOGY, V137, P1768, DOI 10.1053/j.gastro.2009.07.070; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; HU JF, 1994, INT J CANCER, V57, P38, DOI 10.1002/ijc.2910570108; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Liu L, 2012, CARCINOGENESIS, V33, P119, DOI 10.1093/carcin/bgr250; Liu ZS, 2011, CARCINOGENESIS, V32, P1668, DOI 10.1093/carcin/bgr209; Ma Y, 2003, ONCOGENE, V22, P4924, DOI 10.1038/sj.onc.1206728; Park DJ, 2003, BLOOD, V102, P3727, DOI 10.1182/blood-2003-02-0412; Rusiniak ME, 2000, CANCER RES, V60, P1824; SARMA V, 1992, J IMMUNOL, V148, P3302; Venkitaraman AR, 2009, ANNU REV PATHOL-MECH, V4, P461, DOI 10.1146/annurev.pathol.3.121806.151422; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wu C, 2012, NAT GENET, V44, P1090, DOI 10.1038/ng.2411; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064973; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zhou LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064331	22	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e109318	10.1371/journal.pone.0109318	http://dx.doi.org/10.1371/journal.pone.0109318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383966	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700004
J	Rotllan, N; Chamorro-Jorganes, A; Araldi, E; Wanschel, AC; Aryal, B; Aranda, JF; Goedeke, L; Salerno, AG; Ramirez, CM; Sessa, WC; Suarez, Y; Fernandez-Hernando, C				Rotllan, Noemi; Chamorro-Jorganes, Aranzazu; Araldi, Elisa; Wanschel, Amarylis C.; Aryal, Binod; Aranda, Juan F.; Goedeke, Leigh; Salerno, Alessandro G.; Ramirez, Cristina M.; Sessa, William C.; Suarez, Yajaira; Fernandez-Hernando, Carlos			Hematopoietic Akt2 deficiency attenuates the progression of atherosclerosis	FASEB JOURNAL			English	Article						insulin resistance	INSULIN-RESISTANCE; MACROPHAGE ACTIVATION; KINASE-B; MICE; ANGIOGENESIS; POLARIZATION; DISEASE; METABOLISM; MIGRATION; CELLS	Atherosclerosis is the major cause of death and disability in diabetic and obese subjects with insulin resistance. Akt2, a phosphoinositide-dependent serine-threonine protein kinase, is highly express in insulin-responsive tissues; however, its role during the progression of atherosclerosis remains unknown. Thus, we aimed to investigate the contribution of Akt2 during the progression of atherosclerosis. Wefound that germ-line Akt2 deficient mice develop similar atherosclerotic plaques as wild-type mice despite higher plasma lipids and glucose levels. It is noteworthy that transplantation of bonemarrow cells isolated from Akt2(-/-) mice to Ldlr(-/-) mice results in marked reduction of the progression of atherosclerosis compared with Ldlr(-/-) mice transplanted with wild-type bone marrow cells. In vitro studies indicate that Akt2 is required for macrophage migration in response to proatherogenic cytokines (monocyte chemotactic protein-1 and macrophage colony-stimulating factor). Moreover, Akt2(-/-) macrophages accumulate less cholesterol and have an alternative activated orM2-type phenotype when stimulated with proinflammatory cytokines. Together, these results provide evidence that macrophage Akt2 regulates migration, the inflammatory response and cholesterol metabolism and suggest that targeting Akt2 in macrophages might be beneficial for treating atherosclerosis.	[Rotllan, Noemi; Chamorro-Jorganes, Aranzazu; Araldi, Elisa; Aryal, Binod; Aranda, Juan F.; Goedeke, Leigh; Ramirez, Cristina M.; Sessa, William C.; Suarez, Yajaira; Fernandez-Hernando, Carlos] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06510 USA; [Rotllan, Noemi; Chamorro-Jorganes, Aranzazu; Araldi, Elisa; Aryal, Binod; Aranda, Juan F.; Goedeke, Leigh; Ramirez, Cristina M.; Suarez, Yajaira; Fernandez-Hernando, Carlos] Yale Univ, Sch Med, Comparat Med Sect, Integrat Cell Signaling & Neurobiol Metab Program, New Haven, CT 06510 USA; [Rotllan, Noemi; Chamorro-Jorganes, Aranzazu; Araldi, Elisa; Wanschel, Amarylis C.; Aryal, Binod; Aranda, Juan F.; Goedeke, Leigh; Salerno, Alessandro G.; Ramirez, Cristina M.; Suarez, Yajaira; Fernandez-Hernando, Carlos] NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med, New York, NY USA; [Rotllan, Noemi; Chamorro-Jorganes, Aranzazu; Araldi, Elisa; Wanschel, Amarylis C.; Aryal, Binod; Aranda, Juan F.; Goedeke, Leigh; Salerno, Alessandro G.; Ramirez, Cristina M.; Suarez, Yajaira; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; Yale University; New York University; New York University; Yale University	Fernandez-Hernando, C (corresponding author), Yale Univ, Sch Med, Amistad Res Bldg,Room 337C,10 Amistad St, New Haven, CT 06510 USA.	carlos.fernandez@yale.edu	Aranda, Juan Francisco/S-6388-2018; Wanschel, Amarylis/B-3591-2019; Chamorro-Jorganes, Aranzazu/B-1871-2019; Ramírez, Cristina/A-6975-2016; Wanschel, Amarylis/A-8452-2013; Jorganes, Aranzazu Chamorro/N-7774-2019; Salerno, Alessandro G/A-7891-2013; Sessa, William C/B-6844-2011; Rotllan, Noemi/P-1375-2014; Ramírez, Cristina/ABI-1568-2020; Araldi, Elisa/AAZ-5946-2021; Vila, Noemi Rotllan/AAQ-8050-2020	Aranda, Juan Francisco/0000-0002-5598-2465; Wanschel, Amarylis/0000-0002-5603-7983; Chamorro-Jorganes, Aranzazu/0000-0002-3505-7221; Ramírez, Cristina/0000-0003-2589-0786; Wanschel, Amarylis/0000-0001-7307-915X; Jorganes, Aranzazu Chamorro/0000-0002-3505-7221; Salerno, Alessandro G/0000-0002-7688-5904; Sessa, William C/0000-0001-5759-1938; Rotllan, Noemi/0000-0002-0587-8045; Ramírez, Cristina/0000-0003-2589-0786; Vila, Noemi Rotllan/0000-0002-0587-8045; Araldi, Elisa/0000-0002-6596-6784; Goedeke, Leigh/0000-0002-7690-1572; Chamorro Jorganes, Aranzazu/0000-0003-2648-6945; Suarez, Yajaira/0000-0003-4549-2953	U.S.National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01HL107953, R01HL106063, R01HL105945, R01HL064793, R01HL061371]; NIH National Institute on Aging Grant [1F31AG043318]; Foundation Leducq Transatlantic Network of Excellence; Spanish Ministry (Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I-D+i); American Heart Association [12POST9780016]; Howard Hughes Medical Institute International Student Research Fellowship; Capes Foundation, Ministry of Education of Brazil, Brazil; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064793, R01HL105945, R01HL106063, R01HL061371, R01HL107953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG043318] Funding Source: NIH RePORTER	U.S.National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Aging Grant; Foundation Leducq Transatlantic Network of Excellence; Spanish Ministry (Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I-D+i); American Heart Association(American Heart Association); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); Capes Foundation, Ministry of Education of Brazil, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S.National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants R01HL107953 and R01HL106063 (to C.F.-H.), R01HL105945 (to Y.S.), R01HL064793 and R01HL061371 (to W.C.S.), and NIH National Institute on Aging Grant 1F31AG043318 (to L.G); a grant from the Foundation Leducq Transatlantic Network of Excellence (to C.F.-H.and W.C.S.); a postdoctoral fellowship from the Spanish Ministry (Programa Nacional de Movilidad de Recursos Humanos del Plan Nacional de I-D+i 2008-2011) (to N.R.); American Heart Association Grant 12POST9780016 (to C.M.R.); a Howard Hughes Medical Institute International Student Research Fellowship (to E.A.); and the Capes Foundation, Ministry of Education of Brazil, Brazil (to A.G.S.and A.C.W.).	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; Bae SS, 2003, J BIOL CHEM, V278, P49530, DOI 10.1074/jbc.M306782200; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chen J, 2010, BLOOD, V115, P4237, DOI 10.1182/blood-2009-11-255323; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519; Ding L, 2012, CELL METAB, V15, P861, DOI 10.1016/j.cmet.2012.04.020; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Gerszten RE, 2001, J BIOL CHEM, V276, P26846, DOI 10.1074/jbc.M011235200; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Gonzalez-Navarro H, 2008, ARTERIOSCL THROM VAS, V28, P2187, DOI 10.1161/ATVBAHA.108.175299; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Huang CX, 2013, J LIPID RES, V54, P1231, DOI 10.1194/jlr.M032482; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Li J, 2014, J CLIN INVEST, V124, P1483, DOI 10.1172/JCI72305; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Rensing KL, 2014, CARDIOVASC RES, V101, P277, DOI 10.1093/cvr/cvt252; Ridley AJ, 2008, J MICROSC-OXFORD, V231, P518, DOI 10.1111/j.1365-2818.2008.02064.x; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Tabas I, 2010, CIRC RES, V106, P58, DOI 10.1161/CIRCRESAHA.109.208488; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Vergadi E, 2014, J IMMUNOL, V192, P394, DOI 10.4049/jimmunol.1300959; Zhang BG, 2009, EUR J IMMUNOL, V39, P894, DOI 10.1002/eji.200838809; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	35	27	29	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					597	610		10.1096/fj.14-262097	http://dx.doi.org/10.1096/fj.14-262097			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25392271	Green Published			2022-12-26	WOS:000349370400022
J	van Stijn, CMW; Kim, J; Lusis, AJ; Barish, GD; Tangirala, RK				van Stijn, Caroline M. W.; Kim, Jason; Lusis, Aldons J.; Barish, Grant D.; Tangirala, Rajendra K.			Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response	FASEB JOURNAL			English	Article						adipokines; inflammation; metabolic disorder; macrophage activation; nuclear receptors	TYPE-2 DIABETIC-PATIENTS; INNATE IMMUNE-RESPONSE; ADIPOSE-TISSUE; ALTERNATIVE ACTIVATION; LIPID-METABOLISM; GENE-EXPRESSION; PPAR-GAMMA; INSULIN-RESISTANCE; TNF-ALPHA; INFLAMMATION	Adiponectin (APN), a pleiotropic adipokine that exerts anti-inflammatory, antidiabetic, and antiatherogenic effects through its receptors (AdipoRs), AdipoR1 and AdipoR2, is an important therapeutic target. Factors regulating AdipoR expression in monocyte/ macrophages are poorly understood, and the significance of polarized macrophage activation in controlling AdipoR expression and the APN-mediated inflammatory response has not been investigated. The aim of this study was to investigate whether the macrophage polarization phenotype controls the AdipoR expression and APN-mediated inflammatory response. With the use of mouse bone marrow and peritoneal macrophages, we demonstrate that classical activation (M1) of macrophages suppressed (40-60% of control) AdipoR expression, whereas alternative activation (M2) preserved it. Remarkably, the macrophage polarization phenotypes produced contrasting inflammatory responses to APN (EC50 5 mu g/ml). In M1 macrophages, APN induced proinflammatory cytokines, TNF-alpha, IL-6, and IL-12 (> 10-fold of control) and AdipoR levels. In contrast, in M2 macrophages, APN induced the anti-inflammatory cytokine IL-10 without altering AdipoR expression. Furthermore, M1 macrophages adapt to a cytokine environment by reversing AdipoR expression. APN induced AdipoR mRNA and protein expression by upregulating liver X receptor-alpha (LXR alpha) in macrophages. These results provide the first evidence that macrophage polarization is a key determinant regulating AdipoR expression and differential APN-mediated macrophage inflammatory responses, which can profoundly influence their pathogenic role in inflammatory and metabolic disorders.-van Stijn, C. M. W., Kim, J., Lusis, A. J., Barish, G. D., Tangirala, R. K. Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response.	[van Stijn, Caroline M. W.; Kim, Jason; Tangirala, Rajendra K.] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90095 USA; [Lusis, Aldons J.; Tangirala, Rajendra K.] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA; [Barish, Grant D.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine	Tangirala, RK (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, 675 Charles E Young Dr South,MRL 3-740, Los Angeles, CA 90095 USA.	rtangirala@mednet.ucla.edu			U.S. National Institutes of Health National Heart, Lung, and Blood Institute [R01-HL086566]; Dr. Alan Fogelman, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles; Carl and Roberta Deutsch Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086566] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Dr. Alan Fogelman, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles; Carl and Roberta Deutsch Family Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Peter Tontonoz for helpful discussion and Dr. Joey Liu, Diana Becerra, and Rima Boyajdian, for technical assistance. This work was supported by U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant R01-HL086566 (to R.K.T.); and from Dr. Alan Fogelman, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles. The authors also acknowledge support from the Carl and Roberta Deutsch Family Foundation.	Abke S, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-17; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Cheng X, 2012, J BIOL CHEM, V287, P36896, DOI 10.1074/jbc.M112.409516; Chinetti G, 2004, BIOCHEM BIOPH RES CO, V314, P151, DOI 10.1016/j.bbrc.2003.12.058; Ehling A, 2006, J IMMUNOL, V176, P4468, DOI 10.4049/jimmunol.176.7.4468; EZEKOWITZ RAB, 1986, BIOCHEM BIOPH RES CO, V136, P737; Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Holland WL, 2009, MOL PHARMACOL, V75, P740, DOI 10.1124/mol.109.054817; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Inukai K, 2005, AM J PHYSIOL-ENDOC M, V288, pE876, DOI 10.1152/ajpendo.00118.2004; Ivashkiv LB, 2011, EUR J IMMUNOL, V41, P2477, DOI 10.1002/eji.201141783; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kollias A, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-14; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Liu YF, 2007, ENDOCRINOLOGY, V148, P683, DOI 10.1210/en.2006-0708; Lovren F, 2010, AM J PHYSIOL-HEART C, V299, pH656, DOI 10.1152/ajpheart.00115.2010; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luo NL, 2013, ATHEROSCLEROSIS, V228, P124, DOI 10.1016/j.atherosclerosis.2013.02.026; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Ogunwobi OO, 2006, REGUL PEPTIDES, V134, P105, DOI 10.1016/j.regpep.2006.02.001; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Otake H, 2008, AM J CARDIOL, V101, P1, DOI 10.1016/j.amjcard.2007.07.041; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Park PH, 2007, J BIOL CHEM, V282, P21695, DOI 10.1074/jbc.M701419200; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Rovin BH, 2006, CLIN IMMUNOL, V120, P99, DOI 10.1016/j.clim.2006.01.010; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Staiger H, 2004, DIABETES, V53, P2195, DOI 10.2337/diabetes.53.9.2195; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709; Tan GD, 2005, DIABETOLOGIA, V48, P1585, DOI 10.1007/s00125-005-1835-y; Thakur V, 2006, AM J PHYSIOL-GASTR L, V290, pG998, DOI 10.1152/ajpgi.00553.2005; Tian L, 2012, ATHEROSCLEROSIS, V221, P66, DOI 10.1016/j.atherosclerosis.2011.12.014; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; van Stijn CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086404; Weigert J, 2008, FEBS LETT, V582, P1777, DOI 10.1016/j.febslet.2008.04.031; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamaguchi N, 2005, FEBS LETT, V579, P6821, DOI 10.1016/j.febslet.2005.11.019; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001	61	53	54	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					636	649		10.1096/fj.14-253831	http://dx.doi.org/10.1096/fj.14-253831			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25392268	Green Published			2022-12-26	WOS:000349370400025
J	Li, CC; Feng, M; Shi, ZB; Hao, Q; Song, XM; Wang, WJ; Zhao, Y; Jiao, S; Zhou, ZC				Li, Chuanchuan; Feng, Miao; Shi, Zhubing; Hao, Qian; Song, Xiaomin; Wang, Wenjia; Zhao, Yun; Jiao, Shi; Zhou, Zhaocai			Structural and Biochemical Insights into the Activation Mechanisms of Germinal Center Kinase OSR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANINE-RICH KINASE; CRYSTAL-STRUCTURE; STE20-RELATED KINASES; PROTEIN-KINASES; SPAK; WNK1; COTRANSPORTERS; HYPERTENSION; PATHWAY; COMPLEX	The oxidative stress-responsive 1 (OSR1) kinase belongs to the mammalian STE20-like kinase family. OSR1 is activated by with no lysine [K] (WNKs) kinases, and then it phosphorylates cation-coupled Cl-cotransporters, regulating ion homeostasis and cell volume in mammalian cells. However, the specific mechanisms of OSR1 activation remains poorly defined, largely due to its extremely low basal activity. Here, we dissect in detail the regulatory mechanisms of OSR1 activation from the aspects of autoinhibition, upstream kinase WNK, and the newly identified master regulator mouse protein-25 (MO25). Based on our structural and biochemical studies, we propose a "double lock" model, accounting for the tight autoinhibition of OSR1, an effect that has to be removed by WNK before MO25 further activates OSR1. Particularly, the conserved C-terminal (CCT) domain and alpha AL helix act together to strongly suppress OSR1 basal activity. WNKs bind to the CCT and trigger its conformational rearrangement to release the kinase domain of OSR1, allowing for MO25 binding and full activation. Finally, the regulatory mechanisms of OSR1 activation were further corroborated by cellular studies of OSR1-regulated cell volume control through WNK-OSR1 signaling pathway. Collectively, these results provide insights into the OSR1 kinase activation to facilitate further functional study.	[Li, Chuanchuan; Feng, Miao; Shi, Zhubing; Hao, Qian; Song, Xiaomin; Wang, Wenjia; Zhao, Yun; Jiao, Shi; Zhou, Zhaocai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai,State Key Lab Cell Bio, Shanghai 200031, Peoples R China; [Shi, Zhubing] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University	Jiao, S (corresponding author), Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jiaoshi@sibcb.ac.cn; zczhou@sibcb.ac.cn	Shi, Zhubing/F-9490-2010	Shi, Zhubing/0000-0002-9624-4960	973 program of the Ministry of Science and Technology of China [2012CB910204]; National Natural Science Foundation of China [31270808, 31300734, 31470736, 31470868]; Science and Technology Commission of Shanghai Municipality [11JC14140000, 13ZR1446400]; "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences	This work was supported by the 973 program of the Ministry of Science and Technology of China (2012CB910204), the National Natural Science Foundation of China (31270808, 31300734, 31470736, 31470868), the Science and Technology Commission of Shanghai Municipality (11JC14140000, 13ZR1446400), and the "Cross and Cooperation in Science and Technology Innovation Team" Project of the Chinese Academy of Sciences.	Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Cusick JK, 2006, BIOCHEM BIOPH RES CO, V340, P535, DOI 10.1016/j.bbrc.2005.12.033; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Delpire E, 2006, ACTA PHYSIOL, V187, P103, DOI 10.1111/j.1748-1716.2006.01565.x; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KB, 2012, PHYSIOL REV, V92, P1577, DOI 10.1152/physrev.00009.2012; Gagnon KB, 2011, CELL PHYSIOL BIOCHEM, V28, P1219, DOI 10.1159/000335854; Grimm PR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.402800; Hao Q, 2014, J STRUCT BIOL, V186, P224, DOI 10.1016/j.jsb.2014.04.005; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Latchoumycandane C, 2005, J PHARMACOL EXP THER, V313, P46, DOI 10.1124/jpet.104.078469; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Li YQ, 2004, EMBO J, V23, P1112, DOI 10.1038/sj.emboj.7600125; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Mehellou Y, 2013, BIOCHEM BIOPH RES CO, V431, P604, DOI 10.1016/j.bbrc.2012.12.113; Milburn CC, 2004, NAT STRUCT MOL BIOL, V11, P193, DOI 10.1038/nsmb716; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Nishida H, 2012, HYPERTENSION, V60, P981, DOI 10.1161/HYPERTENSIONAHA.112.201509; Nugent BM, 2012, J NEUROSCI, V32, P593, DOI 10.1523/JNEUROSCI.5415-11.2012; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Ponce-Coria J, 2014, J BIOL CHEM, V289, P17680, DOI 10.1074/jbc.M113.540518; Ponce-Coria J, 2012, AM J PHYSIOL-CELL PH, V303, pC1198, DOI 10.1152/ajpcell.00284.2012; Record CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011905; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Sengupta S, 2013, P NATL ACAD SCI USA, V110, P18826, DOI 10.1073/pnas.1318676110; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Villa F, 2007, EMBO REP, V8, P839, DOI 10.1038/sj.embor.7401048; Villa F, 2008, PROTEINS, V73, P1082, DOI 10.1002/prot.22238; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Vitari AC, 2005, BIOCHEM J, V391, P17, DOI 10.1042/BJ20051180; Yin HL, 2012, CELL MOL IMMUNOL, V9, P439, DOI 10.1038/cmi.2012.30; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zeqiraj E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000126	43	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35969	35978		10.1074/jbc.M114.592097	http://dx.doi.org/10.1074/jbc.M114.592097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25389294	Green Published, hybrid			2022-12-26	WOS:000346897900027
J	Gutsfeld, C; Olaru, ID; Vollrath, O; Lange, C				Gutsfeld, Christian; Olaru, Ioana D.; Vollrath, Oliver; Lange, Christoph			Attitudes about Tuberculosis Prevention in the Elimination Phase: A Survey among Physicians in Germany	PLOS ONE			English	Article							HEALTH-CARE WORKERS; STEM-CELL TRANSPLANTATION; MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS; PULMONARY TUBERCULOSIS; ANTIRETROVIRAL THERAPY; LATENT TUBERCULOSIS; UNITED-STATES; CLINICAL CHARACTERISTICS; RHEUMATOID-ARTHRITIS	Background: Targeted and stringent measures of tuberculosis prevention are necessary to achieve the goal of tuberculosis elimination in countries of low tuberculosis incidence. Methods: We ascertained the knowledge about tuberculosis risk factors and stringency of tuberculosis prevention measures by a standardized questionnaire among physicians in Germany involved in the care of individuals from classical risk groups for tuberculosis. Results: 510 physicians responded to the online survey. Among 16 risk factors immunosuppressive therapy, HIV-infection and treatment with TNF-antagonist were thought to be the most important risk factors for the development of tuberculosis in Germany. Exposure to a patient with tuberculosis ranked on the 10 th position. In the event of a positive tuberculin-skin-test or interferon-gamma release assay only 50%, 40%, 36% and 25% of physicians found that preventive chemotherapy was indicated for individuals undergoing tumor necrosis factor-antagonist therapy, close contacts of tuberculosis patients, HIV-infected individuals and migrants, respectively. Conclusions: A remarkably low proportion of individuals with latent infection with Mycobacterium tuberculosis belonging to classical risk groups for tuberculosis are considered candidates for preventive chemotherapy in Germany. Better knowledge about the risk for tuberculosis in different groups and more stringent and targeted preventive interventions will probably be necessary to achieve tuberculosis elimination in Germany.	[Gutsfeld, Christian; Olaru, Ioana D.; Lange, Christoph] Res Ctr Borstel, German Ctr Infect Res, Div Clin Infect Dis, TB Unit, Borstel, Germany; [Gutsfeld, Christian] Sachsenklin, Dept Psychosomat Med, Bad Lausick, Germany; [Vollrath, Oliver] Univ Hosp Schleswig Holstein, Inst Med Informat & Stat, Kiel, Germany; [Lange, Christoph] Med Univ Lubeck, D-23538 Lubeck, Germany; [Lange, Christoph] Univ Namibia, Dept Internal Med, Sch Med, Windhoek, Namibia; [Lange, Christoph] Karolinska Inst, Dept Med, Stockholm, Sweden	Forschungszentrum Borstel; German Center for Infection Research; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Namibia; Karolinska Institutet	Lange, C (corresponding author), Res Ctr Borstel, German Ctr Infect Res, Div Clin Infect Dis, TB Unit, Borstel, Germany.	clange@fz-borstel.de	Lange, Christoph/J-6289-2012	Lange, Christoph/0000-0002-9691-4741	German Center for Infection Research (DZIF)	German Center for Infection Research (DZIF)	The study was funded by the German Center for Infection Research (DZIF). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abgrall S, 2010, AIDS, V24, P763, DOI 10.1097/QAD.0b013e3283366747; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; BRUCE RM, 1977, ANN INTERN MED, V87, P574, DOI 10.7326/0003-4819-87-5-574; BUSH OB, 1965, AM REV RESPIR DIS, V92, P732; Calvert GM, 2003, OCCUP ENVIRON MED, V60, P122, DOI 10.1136/oem.60.2.122; Castaneda-Hernandez DM, 2013, TUBERCULOSIS, V93, P275, DOI 10.1016/j.tube.2013.02.001; Chee CBE, 2013, RESPIROLOGY, V18, P205, DOI 10.1111/resp.12002; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chia S, 1998, INT J TUBERC LUNG D, V2, P989; Cohn DL, 2006, REICHMAN HERSHFIELDS, P265; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577; de Bibiana JT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-833; de la Camara R, 2000, BONE MARROW TRANSPL, V26, P291, DOI 10.1038/sj.bmt.1702506; del Amo J, 2012, CLIN INFECT DIS, V54, P1364, DOI 10.1093/cid/cis203; Diel R, 2011, GESUNDHEITSWESEN, V73, P369, DOI 10.1055/s-0030-1256574; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Dorman SE, 2014, AM J RESP CRIT CARE, V189, P77, DOI 10.1164/rccm.201302-0365OC; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Erkens CGM, 2010, EUR RESPIR J, V36, P925, DOI 10.1183/09031936.00201609; European Centre for Disease Prevention and Control, 2010, PROGR TB EL; Fallab-Stubi CL, 1998, INT J TUBERC LUNG D, V2, P525; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Friedman LN, 1996, NEW ENGL J MED, V334, P828, DOI 10.1056/NEJM199603283341304; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Haldar P, 2013, THORAX, V68, P240, DOI 10.1136/thoraxjnl-2011-200956; Horsburgh CR, 2010, CHEST, V137, P401, DOI 10.1378/chest.09-0394; Karo B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-148; KATZ J, 1965, AM REV RESPIR DIS, V91, P345, DOI 10.1164/arrd.1965.91.3.345; Kim CH, 2014, INFECTION; Kim HA, 1998, CLIN EXP RHEUMATOL, V16, P9; Kollan C, 2011, DTSCH OST AIDS K HAN; Korner MM, 1997, CHEST, V111, P365, DOI 10.1378/chest.111.2.365; Ku SC, 2001, BONE MARROW TRANSPL, V27, P1293, DOI 10.1038/sj.bmt.1703092; Landry J, 2008, INT J TUBERC LUNG D, V12, P1352; Lange C, 2011, AM J RESP CRIT CARE, V183, P3, DOI 10.1164/rccm.201011-1881ED; Leung CC, 2011, EUR RESPIR J, V37, P690, DOI 10.1183/09031936.00079310; Liu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032158; LUNDIN AP, 1979, AM J MED, V67, P597, DOI 10.1016/0002-9343(79)90240-7; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; McAdam JM, 2009, EMERG INFECT DIS, V15, P1109, DOI 10.3201/eid1507.080410; Moran-Mendoza O, 2010, INT J TUBERC LUNG D, V14, P1112; Mulder C, 2012, EUR RESPIR J, V40, P1443, DOI 10.1183/09031936.00010612; Nienhaus A, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-9; PablosMendez A, 1997, AM J PUBLIC HEALTH, V87, P574, DOI 10.2105/AJPH.87.4.574; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pareek M, 2011, EUR RESPIR J, V37, P1175, DOI 10.1183/09031936.00105810; PICKLEMAN JR, 1975, JAMA-J AM MED ASSOC, V234, P744, DOI 10.1001/jama.234.7.744; Ringshausen FC, 2013, EUR RESP C BARC 7 11; Ringshausen FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082005; Ringshausen FC, 2011, CLIN VACCINE IMMUNOL, V18, P1176, DOI 10.1128/CVI.05058-11; Robert Koch Institute, 2013, BER EP TUB DEUTSCHL, P99; Schaberg T, 2012, Pneumologie, V66, P133, DOI 10.1055/s-0031-1291619; Scharlach M, 2013, EPIDEMIOLOGISCHES B; Sester M, 2014, AM J RESP CRIT CARE; Slater ML, 2013, AM J RESP CRIT CARE, V188, P1005, DOI 10.1164/rccm.201305-0831OC; STEIGER Z, 1976, AM J SURG, V131, P668, DOI 10.1016/0002-9610(76)90174-4; Torre-Cisneros J, 2009, CLIN INFECT DIS, V48, P1657, DOI 10.1086/599035; Valin N, 2005, INT J TUBERC LUNG D, V9, P528; VANDENBROEK J, 1993, INT J EPIDEMIOL, V22, P1159, DOI 10.1093/ije/22.6.1159; Veening G J, 1968, Bull Int Union Tuberc, V41, P169; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2009, GLOB TUB CONTR EP ST; Yamada T, 2006, ANN RHEUM DIS, V65, P1661, DOI 10.1136/ard.2005.047274	68	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112681	10.1371/journal.pone.0112681	http://dx.doi.org/10.1371/journal.pone.0112681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393241	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300084
J	Szalai, G; Xu, Y; Romero, R; Chaiworapongsa, T; Xu, ZH; Chiang, PJ; Ahn, H; Sundell, B; Plazyo, O; Jiang, Y; Olive, M; Wang, B; Jacques, SM; Qureshi, F; Tarca, AL; Erez, O; Dong, Z; Papp, Z; Hassan, SS; Hernandez-Andrade, E; Than, NG				Szalai, Gabor; Xu, Yi; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Zhonghui; Chiang, Po Jen; Ahn, Hyunyoung; Sundell, Birgitta; Plazyo, Olesya; Jiang, Yang; Olive, Mary; Wang, Bing; Jacques, Suzanne M.; Qureshi, Faisal; Tarca, Adi L.; Erez, Offer; Dong, Zhong; Papp, Zoltan; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor			In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; ANTI-ANGIOGENIC FACTORS; FOR-GESTATIONAL-AGE; HUMAN FETOPLACENTAL VASCULOGENESIS; FACTOR RECEPTOR-1 CONCENTRATION; MATERNAL INFLAMMATORY RESPONSE; SOLUBLE ENDOGLIN; METABOLIC CHARACTERISTICS; TYROSINE KINASE-1; OXIDATIVE STRESS	Objective: Soluble fms-like tyrosine kinase (sFlt)-1-e15a, a primate-specific sFlt-1-isoform most abundant in the human placenta in preeclampsia, can induce preeclampsia in mice. This study compared the effects of full-length human (h) sFlt-1-e15a with those of truncated mouse (m)sFlt-1(1-3) used in previous preeclampsia studies on pregnancy outcome and clinical symptoms in preeclampsia. Methods: Mice were injected with adenoviruses or fiber-mutant adenoviruses overexpressing hsFlt-1-e15a, msFlt-1(1-3) or control GFP under the CMV or CYP19A1 promoters on gestational day 8 (GD8) and GD11. Placentas and pups were delivered by cesarean section, and dams were monitored postpartum. Blood pressure was telemetrically recorded. Urine samples were collected with cystocentesis and examined for albumin/creatinine ratios. Tissue specimens were evaluated for transgene as well as endogenous mFlt-1 and msFlt-1-i13 expression. H&E-, Jones- and PAS-stained kidney sections were histopathologically examined. Placental GFP expression and aortic ring assays were investigated with confocal microscopy. Results: Mean arterial blood pressure (MAP) was elevated before delivery in hsFlt-1-e15a-treated mice compared to controls (GD18: Delta MAP = 7.8 mmHg, p = 0.009), while Delta MAP was 12.8 mmHg (GD18, p = 0.005) in msFlt-1(1-3)-treated mice. Urine albumin/creatinine ratio was higher in hsFlt-1-e15a-treated mice than in controls (GD18, p = 0.04; PPD8, p = 0.03), and msFlt-1(1-3)-treated mice had marked proteinuria postpartum (PPD8, p = 4x10(-5)). Focal glomerular changes were detected in hsFlt-1-e15a and msFlt-1(1-3)-treated mice. Aortic ring microvessel outgrowth was decreased in hsFlt-1-e15a (p = 0.007) and msFlt-1(1-3)-treated (p = 0.02) mice. Full-length msFlt-1-i13 expression was unique for the placenta. In hsFlt-1-e15a-treated mice, the number of pups (p = 0.046), total weight of living pups (p = 0.04) and maternal weights (p = 0.04) were higher than in controls. These differences were not observed in truncated msFlt-1(1-3)-treated mice. Conclusions: Truncated msFlt-1(1-3) simulated the preeclampsia-promoting effects of full-length hsFlt-1. MsFlt-1(1-3) had strong effect on maternal endothelium but not on placentas and embryos. In contrast, hsFlt-1-e15a induced preeclampsialike symptoms; however, it also increased litter size. In accord with the predominant placental expression of hsFlt-1-e15a and msFlt-1-i13, full-length sFlt-1 may have a role in the regulation of embryonic development. These observations point to the difference in the biological effects of full-length and truncated sFlt-1 and the changes in the effect of full-length sFlt-1 during pregnancy, and may have important implications in the management of preeclampsia.	[Szalai, Gabor; Xu, Yi; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Zhonghui; Chiang, Po Jen; Ahn, Hyunyoung; Sundell, Birgitta; Plazyo, Olesya; Jiang, Yang; Olive, Mary; Wang, Bing; Tarca, Adi L.; Dong, Zhong; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; [Szalai, Gabor; Xu, Yi; Romero, Roberto; Chaiworapongsa, Tinnakorn; Xu, Zhonghui; Chiang, Po Jen; Ahn, Hyunyoung; Sundell, Birgitta; Plazyo, Olesya; Jiang, Yang; Olive, Mary; Wang, Bing; Tarca, Adi L.; Dong, Zhong; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, US Dept HHS, Detroit, MI USA; [Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Hernandez-Andrade, Edgar; Than, Nandor Gabor] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Olive, Mary] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Jacques, Suzanne M.; Qureshi, Faisal] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Tarca, Adi L.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Erez, Offer] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Obstet & Gynecol, Soroka Univ Med Ctr, Beer Sheva, Israel; [Papp, Zoltan; Than, Nandor Gabor] Semmelweis Univ, Matern Private Dept, H-1085 Budapest, Hungary; [Than, Nandor Gabor] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Wayne State University; Wayne State University; Wayne State University; Ben Gurion University; Soroka Medical Center; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA.	romeror@mail.nih.gov; nthan@med.wayne.edu	Xu, Zhonghui/F-3353-2018; Than, Nandor G/N-1442-2016; Romero, Roberto/A-5268-2019	Xu, Zhonghui/0000-0002-6469-9178; Plazyo, Olesya/0000-0002-6859-7590; Romero, Roberto/0000-0002-4448-5121	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); NICHD, NIH [HHSN275201300006C]; NIH Center grant [P30CA22453]; Perinatology Research Branch (NICHD/NIH); Hungarian Academy of Sciences Momentum Grant [LP2014-7/2014]; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch (NICHD/NIH); Hungarian Academy of Sciences Momentum Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HHSN275201300006C. The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center grant P30CA22453 to the Karmanos Cancer Institute, Wayne State University, and the Perinatology Research Branch (NICHD/NIH). Manuscript writing was supported, in part, by the Hungarian Academy of Sciences Momentum Grant "LP2014-7/2014" (to N.G.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SL, 2002, DEV BIOL, V250, P358, DOI 10.1006/dbio.2002.0773; AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Ahn H, 2014, ULTRASOUND GUI UNPUB; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Ananth CV, 2007, OBSTET GYNECOL, V110, P128, DOI 10.1097/01.AOG.0000266983.77458.71; Ananth CV, 2007, AM J OBSTET GYNECOL, V197; Balogh A, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.023; Baumwell S, 2007, NEPHRON CLIN PRACT, V106, pC72, DOI 10.1159/000101801; Bdolah Y, 2005, CROAT MED J, V46, P728; Bergmann A, 2010, J CELL MOL MED, V14, P1857, DOI 10.1111/j.1582-4934.2009.00820.x; Berkane N, 2007, NEPHROL DIAL TRANSPL, V22, P2753, DOI 10.1093/ndt/gfm429; Blackwell S, 2003, J Matern Fetal Neonatal Med, V14, P241, DOI 10.1080/713606670; Blois SM, 2007, NAT MED, V13, P1450, DOI 10.1038/nm1680; BROSENS IA, 1977, CLIN OBSTET GYNAECOL, V4, P573; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Brosens I, 2010, HUM REPROD, V25, P569, DOI 10.1093/humrep/dep474; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Byers BD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.044; Bytautiene E, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.042; Bytautiene E, 2010, AM J PHYSIOL-HEART C, V298, pH189, DOI 10.1152/ajpheart.00792.2009; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Chaiworapongsa T, 2004, AM J OBSTET GYNECOL, V190, P1541, DOI 10.1016/j.ajog.2004.03.043; Chaiworapongsa T, 2005, J MATERN-FETAL NEO M, V17, P3, DOI 10.1080/14767050400028816; Chaiworapongsa T, 2002, AM J OBSTET GYNECOL, V187, P889, DOI 10.1067/mob.2002.127309; Chaiworapongsa T, 2010, ULTRASOUND OBST GYN, V35, P155, DOI 10.1002/uog.7491; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P41, DOI 10.1080/14767050701831397; Chaiworapongsa T, 2008, J MATERN-FETAL NEO M, V21, P25, DOI 10.1080/14767050701832833; Chaiworapongsa T, 2011, J MATERN-FETAL NEO M, V24, P1187, DOI 10.3109/14767058.2011.589932; Chaiworapongsa T, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.002; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Christiaens I, 2008, J REPROD IMMUNOL, V79, P50, DOI 10.1016/j.jri.2008.04.002; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; Cooper JC, 1996, BRIT J OBSTET GYNAEC, V103, P1191, DOI 10.1111/j.1471-0528.1996.tb09627.x; Costantine MM, 2010, OBSTET GYNECOL, V116, P114, DOI 10.1097/AOG.0b013e3181e10ebd; Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; Drost JT, 2010, MATURITAS, V67, P321, DOI 10.1016/j.maturitas.2010.08.002; Dynon K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045956; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Erez O, 2008, J MATERN-FETAL NEO M, V21, P345, DOI 10.1080/14767050802034859; Erez O, 2008, J MATERN-FETAL NEO M, V21, P855, DOI 10.1080/14767050802361872; Erez O, 2009, J MATERN-FETAL NEO M, V22, P672, DOI 10.1080/14767050902853117; Erez O, 2009, J MATERN-FETAL NEO M, V22, P662, DOI 10.1080/14767050902801751; Erlebacher A, 2010, TRENDS ENDOCRIN MET, V21, P428, DOI 10.1016/j.tem.2010.02.003; Eshkoli T, 2013, J MATERN-FETAL NEO M, V26, P116, DOI 10.3109/14767058.2012.722725; Espinoza J, 2006, J PERINAT MED, V34, P447, DOI 10.1515/JPM.2006.089; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fox KA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.083; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; GERRETSEN G, 1981, BRIT J OBSTET GYNAEC, V88, P876, DOI 10.1111/j.1471-0528.1981.tb02222.x; Gervasi M T, 2002, J Matern Fetal Neonatal Med, V11, P171, DOI 10.1080/713605490; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P1124, DOI 10.1067/mob.2001.117681; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P792, DOI 10.1067/mob.2001.117311; Girardi G, 2011, MOL IMMUNOL, V48, P1621, DOI 10.1016/j.molimm.2011.04.011; Gomez-Lopez N, 2013, AM J REPROD IMMUNOL, V69, P212, DOI 10.1111/aji.12074; Gotsch F, 2008, J MATERN-FETAL NEO M, V21, P389, DOI 10.1080/14767050802046069; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Han YM, 2008, BIOL REPROD, V79, P954, DOI 10.1095/biolreprod.108.069260; Hassan SS, 2009, J MATERN-FETAL NEO M, V22, P1183, DOI 10.3109/14767050903353216; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Hertig A, 2004, CLIN CHEM, V50, P1702, DOI 10.1373/clinchem.2004.036715; Hertig A, 2008, EUR J OBSTET GYN R B, V140, P138, DOI 10.1016/j.ejogrb.2007.09.007; Hertig A, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.006; Heydarian M, 2009, PLACENTA, V30, P250, DOI 10.1016/j.placenta.2008.12.010; Higgins JR, 1998, AM J OBSTET GYNECOL, V179, P464, DOI 10.1016/S0002-9378(98)70380-1; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; JACKSON MR, 1994, PLACENTA, V15, P341, DOI 10.1016/0143-4004(94)90002-7; Jauniaux E, 2003, PLACENTA, V24, pS86, DOI 10.1053/plac.2002.0932; Jauniaux E, 2003, AM J PATHOL, V162, P115, DOI 10.1016/S0002-9440(10)63803-5; Jauniaux E, 1999, HUM REPROD, V14, P2901, DOI 10.1093/humrep/14.11.2901; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jebbink J, 2011, HYPERTENSION, V58, P70, DOI 10.1161/HYPERTENSIONAHA.110.164079; Kaitu'u-Lino TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032509; Kalkunte S, 2009, J REPROD IMMUNOL, V83, P134, DOI 10.1016/j.jri.2009.08.006; Kamat A, 2005, ENDOCRINOLOGY, V146, P2481, DOI 10.1210/en.2004-1606; Karumanchi SA, 2007, AM J OBSTET GYNECOL, V196, P287, DOI 10.1016/j.ajog.2007.02.013; Karumanchi SA, 2005, KIDNEY INT, V67, P2101, DOI 10.1111/j.1523-1755.2005.00316.x; Katayama K, 2011, BIOMATERIALS, V32, P4185, DOI 10.1016/j.biomaterials.2011.02.038; Katz AB, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.029; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim SK, 2009, J PERINAT MED, V37, P543, DOI 10.1515/JPM.2009.106; Kim YM, 2006, HISTOPATHOLOGY, V49, P506, DOI 10.1111/j.1365-2559.2006.02542.x; Kim YW, 2013, J MOL MED, V91, P323, DOI 10.1007/s00109-013-1007-3; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Kondo K, 1998, GENE, V208, P297, DOI 10.1016/S0378-1119(98)00006-7; KRAAYENBRINK AA, 1993, AM J OBSTET GYNECOL, V169, P160, DOI 10.1016/0002-9378(93)90154-B; Kumasawa K, 2011, P NATL ACAD SCI USA, V108, P1451, DOI 10.1073/pnas.1011293108; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lam C, 2005, HYPERTENSION, V46, P1077, DOI 10.1161/01.HYP.0000187899.34379.b0; Lee J, 2011, HISTOPATHOLOGY, V59, P928, DOI 10.1111/j.1365-2559.2011.04038.x; Lee J, 2011, AM J REPROD IMMUNOL, V66, P510, DOI 10.1111/j.1600-0897.2011.01066.x; Lee J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016806, 10.1371/journal.pone.0020933]; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2005, CLIN OBSTET GYNECOL, V48, P372, DOI 10.1097/01.grf.0000160313.82606.d7; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; Li ZH, 2007, HYPERTENSION, V50, P686, DOI 10.1161/HYPERTENSIONAHA.107.092098; LONG PA, 1980, BRIT J OBSTET GYNAEC, V87, P13, DOI 10.1111/j.1471-0528.1980.tb04419.x; Lu F, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.064; Madsen-Bouterse SA, 2010, AM J REPROD IMMUNOL, V63, P73, DOI 10.1111/j.1600-0897.2009.00791.x; Mateus J, 2011, AM J PHYSIOL-HEART C, V301, pH1781, DOI 10.1152/ajpheart.00373.2011; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Maynard SE, 2005, PEDIATR RES, V57, p1R, DOI 10.1203/01.PDR.0000159567.85157.B7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard S, 2008, ANNU REV MED, V59, P61, DOI 10.1146/annurev.med.59.110106.214058; Maynard SE, 2011, SEMIN NEPHROL, V31, P33, DOI 10.1016/j.semnephrol.2010.10.004; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Mitchell MD, 2005, J CLIN ENDOCR METAB, V90, P4244, DOI 10.1210/jc.2004-2496; Mizuguchi H, 2001, GENE THER, V8, P730, DOI 10.1038/sj.gt.3301453; Moffett A, 2004, PLACENTA, V25, P1, DOI 10.1016/S0143-4004(03)00167-X; Moldenhauer JS, 2003, AM J OBSTET GYNECOL, V189, P1173, DOI 10.1067/S0002-9378(03)00576-3; Mole DR, 2008, PEDIATR NEPHROL, V23, P681, DOI 10.1007/s00467-007-0632-x; Moore AG, 2012, J MATERN-FETAL NEO M, V25, P2651, DOI 10.3109/14767058.2012.713055; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x; Muttukrishna S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018041; Myatt L, 2009, J THROMB HAEMOST, V7, P375, DOI 10.1111/j.1538-7836.2008.03259.x; Naccasha N, 2001, AM J OBSTET GYNECOL, V185, P1118, DOI 10.1067/mob.2001.117682; National Research Council of the National Academy of Sciences, 2011, GUID CAR US LAB AN; Ness RB, 1996, AM J OBSTET GYNECOL, V175, P1365, DOI 10.1016/S0002-9378(96)70056-X; Ogge G, 2011, J PERINAT MED, V39, P641, DOI [10.1515/JPM.2011.098, 10.1515/jpm.2011.098]; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P820, DOI 10.3109/14767050903366119; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P476, DOI 10.3109/14767050903216033; PAGE E W, 1948, Obstet Gynecol Surv, V3, P615, DOI 10.1097/00006254-194810000-00002; PAGE ERNEST W., 1949, CALIFORNIA MED, V70, P1; Paulesu L, 2010, CURR PHARM DESIGN, V16, P3601, DOI 10.2174/138161210793797933; Pijnenborg Robert, 2002, Reprod Biomed Online, V4 Suppl 3, P14; Powers RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013263; Preedy, 2012, HDB GROWTH GROWTH MO, P1867; Rana S, 2012, CIRCULATION, V125, P911, DOI 10.1161/CIRCULATIONAHA.111.054361; Rasmussen S, 2003, OBSTET GYNECOL, V101, P575, DOI 10.1016/S0029-7844(02)03071-5; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Redman CW, 2014, PLACENTA, V35, pS20, DOI 10.1016/j.placenta.2013.12.008; Redman CWG, 2012, PLACENTA, V33, pS48, DOI 10.1016/j.placenta.2011.12.006; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2000, PLACENTA, V21, P597, DOI 10.1053/plac.2000.0560; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Reimer T, 2013, J MATERN-FETAL NEO M, V26, P263, DOI 10.3109/14767058.2012.733747; Renaud SJ, 2011, PLACENTA, V32, pS130, DOI 10.1016/j.placenta.2010.12.017; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; Richani K, 2005, J PERINAT MED, V33, P296, DOI 10.1515/JPM.2005.052; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; ROBERTSON WB, 1967, J PATHOL BACTERIOL, V93, P581, DOI 10.1002/path.1700930219; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; ROMERO R, 1989, OBSTET GYNECOL, V73, P31; ROMERO R, 1990, J REPROD MED, V35, P235; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Romero R, 2012, J MATERN-FETAL NEO M, V25, P558, DOI 10.3109/14767058.2011.599083; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1384, DOI 10.3109/14767051003681121; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Sargent IL, 2003, J REPROD IMMUNOL, V59, P153, DOI 10.1016/S0165-0378(03)00044-5; Scholz CC, 2013, CURR OPIN PHARMACOL, V13, P646, DOI 10.1016/j.coph.2013.04.009; Sebire N J, 2005, J Obstet Gynaecol, V25, P117; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; SHARKEY AM, 1993, J REPROD FERTIL, V99, P609; Sharma S, 2010, J REPROD IMMUNOL, V85, P112, DOI 10.1016/j.jri.2010.01.002; Sherer DM, 2001, PLACENTA, V22, P1, DOI 10.1053/plac.2000.0588; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; SHIBUYA M, 1990, ONCOGENE, V5, P519; Shibuya M, 2011, P JPN ACAD B-PHYS, V87, P167, DOI 10.2183/pjab.87.167; Shiraishi S, 1996, PLACENTA, V17, P111, DOI 10.1016/S0143-4004(96)80004-X; Shore VH, 1997, PLACENTA, V18, P657, DOI 10.1016/S0143-4004(97)90007-2; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Silasi M, 2010, OBSTET GYN CLIN N AM, V37, P239, DOI 10.1016/j.ogc.2010.02.013; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Smith GCS, 2009, CURR OPIN OBSTET GYN, V21, P111, DOI 10.1097/GCO.0b013e328328cf7d; Staff AC, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.036; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki H, 2009, HYPERTENSION, V54, P1129, DOI 10.1161/HYPERTENSIONAHA.109.134668; Szalai G, 2014, FULL LENGHT HU UNPUB; TAFURI A, 1995, SCIENCE, V270, P630, DOI 10.1126/science.270.5236.630; Taylor RN, 1998, SEMIN REPROD ENDOCR, V16, P17, DOI 10.1055/s-2007-1016249; Terness P, 2007, AM J REPROD IMMUNOL, V58, P238, DOI 10.1111/j.1600-0897.2007.00510.x; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244; Thadhani R, 2011, CIRCULATION, V124, P940, DOI 10.1161/CIRCULATIONAHA.111.034793; Than NG, 2008, P NATL ACAD SCI USA, V105, P15819, DOI 10.1073/pnas.0807606105; Than NG, 2008, VIRCHOWS ARCH, V453, P387, DOI 10.1007/s00428-008-0658-x; Thomas CP, 2009, J CLIN ENDOCR METAB, V94, P2524, DOI 10.1210/jc.2009-0017; Thomas C, 2007, ANIMAL, V1, P1, DOI 10.1017/S1751731107658467; Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317; Vaisbuch E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.049; Vatten LJ, 2007, AM J OBSTET GYNECOL, V196, P239, DOI 10.1016/j.ajog.2006.10.909; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Verlohren S, 2012, CLIN SCI, V122, P43, DOI 10.1042/CS20110097; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Vuckovic M, 1996, J ANAT, V188, P361; Vuorela P, 2000, OBSTET GYNECOL, V95, P353, DOI 10.1016/S0029-7844(99)00565-7; Wang A, 2009, PHYSIOLOGY, V24, P147, DOI 10.1152/physiol.00043.2008; Wang HM, 2003, MOL REPROD DEV, V65, P123, DOI 10.1002/mrd.10308; Webster RR, 2008, PLACENTA, V29, P985, DOI 10.1016/j.placenta.2008.09.003; Weed S, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.003; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; WHEELER T, 1995, PLACENTA, V16, P289, DOI 10.1016/0143-4004(95)90115-9; Whitehead CL, 2011, BJOG-INT J OBSTET GY, V118, P1268, DOI 10.1111/j.1471-0528.2011.02962.x; Wilson JM, 1996, NEW ENGL J MED, V334, P1185, DOI 10.1056/NEJM199605023341809; Wilting J, 1996, DEV BIOL, V176, P76, DOI 10.1006/dbio.1996.9993; Xing AY, 2000, HUM GENE THER, V11, P167, DOI 10.1089/10430340050016247; Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203; Yamaguchi S, 2002, BIOCHEM BIOPH RES CO, V291, P554, DOI 10.1006/bbrc.2002.6478; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zenclussen AC, 2006, EUR J IMMUNOL, V36, P82, DOI 10.1002/eji.200535428; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	225	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110867	10.1371/journal.pone.0110867	http://dx.doi.org/10.1371/journal.pone.0110867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393290	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300004
J	Wu, S; Miller, T; Masanz, J; Coarr, M; Halgrim, S; Carrell, D; Clark, C				Wu, Stephen; Miller, Timothy; Masanz, James; Coarr, Matt; Halgrim, Scott; Carrell, David; Clark, Cheryl			Negation's Not Solved: Generalizability Versus Optimizability in Clinical Natural Language Processing	PLOS ONE			English	Article							CLASSIFICATION; ARCHITECTURE; SYSTEM; TEXT	A review of published work in clinical natural language processing (NLP) may suggest that the negation detection task has been "solved.'' This work proposes that an optimizable solution does not equal a generalizable solution. We introduce a new machine learning-based Polarity Module for detecting negation in clinical text, and extensively compare its performance across domains. Using four manually annotated corpora of clinical text, we show that negation detection performance suffers when there is no in-domain development (for manual methods) or training data (for machine learning-based methods). Various factors (e.g., annotation guidelines, named entity characteristics, the amount of data, and lexical and syntactic context) play a role in making generalizability difficult, but none completely explains the phenomenon. Furthermore, generalizability remains challenging because it is unclear whether to use a single source for accurate data, combine all sources into a single model, or apply domain adaptation methods. The most reliable means to improve negation detection is to manually annotate in-domain training data (or, perhaps, manually modify rules); this is a strategy for optimizing performance, rather than generalizing it. These results suggest a direction for future work in domain-adaptive and task-adaptive methods for clinical NLP.	[Wu, Stephen; Masanz, James] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA; [Miller, Timothy] Harvard Univ, Sch Med, Childrens Hosp Boston Informat Program, Boston, MA USA; [Coarr, Matt; Clark, Cheryl] Mitre Corp, Human Language Technol Dept, Bedford, MA 01730 USA; [Halgrim, Scott; Carrell, David] Grp Hlth Res Inst, Seattle, WA USA; [Wu, Stephen] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Mayo Clinic; Harvard University; Boston Children's Hospital; Harvard Medical School; MITRE Corporation; Oregon Health & Science University	Wu, S (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55902 USA.	wst@ohsu.edu			SHARPn (Strategic Health IT Advanced Research Projects) Area 4: Secondary Use of EHR Data Cooperative Agreement from the HHS Office of the National Coordinator, Washington, DC [DHHS 90TR000201]	SHARPn (Strategic Health IT Advanced Research Projects) Area 4: Secondary Use of EHR Data Cooperative Agreement from the HHS Office of the National Coordinator, Washington, DC	This work was supported in part by the SHARPn (Strategic Health IT Advanced Research Projects) Area 4: Secondary Use of EHR Data Cooperative Agreement from the HHS Office of the National Coordinator, Washington, DC. DHHS 90TR000201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright D, 2013, J AM MED INFORM ASS; [Anonymous], 2012, P 17 AUSTR DOC COMP; Cairns Brian L, 2011, AMIA Annu Symp Proc, V2011, P171; Chapman WW, 2013, STUD HEALTH TECHNOL, V192, P677, DOI 10.3233/978-1-61499-289-9-677; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Clark C, 2011, J AM MED INFORM ASSN, V18, P563, DOI 10.1136/amiajnl-2011-000164; Daume H., 2007, P 45 ANN M ASS COMP, P256; Elkin Peter L, 2005, BMC Med Inform Decis Mak, V5, P13, DOI 10.1186/1472-6947-5-13; Farkas Richard, 2010, P 14 C COMP NAT LANG, P1; Garla V, 2011, J AM MED INFORM ASSN, V18, P614, DOI 10.1136/amiajnl-2011-000093; Goldin I., 2003, P SIGAIR WORKSH TEXT; Harkema H, 2009, J BIOMED INFORM, V42, P839, DOI 10.1016/j.jbi.2009.05.002; Huang Y, 2007, J AM MED INFORM ASSN, V14, P304, DOI 10.1197/jamia.M2284; Morante R, 2012, COMPUT LINGUIST, V38, P223, DOI 10.1162/COLI_a_00095; Mutalik PG, 2001, J AM MED INFORM ASSN, V8, P598, DOI 10.1136/jamia.2001.0080598; Pighin D., 2010, P 14 C COMP NAT LANG, P223; RATNAPARKHI A, 1997, P 2 C EMP METH NAT L, P1; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Sohn Sunghwan, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P1; South Brett R, 2007, AMIA Annu Symp Proc, P1118; Uzuner O, 2011, J AM MED INFORM ASSN, V18, P552, DOI 10.1136/amiajnl-2011-000203; Vincze V, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S11-S9	22	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112774	10.1371/journal.pone.0112774	http://dx.doi.org/10.1371/journal.pone.0112774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393544	gold, Green Published			2022-12-26	WOS:000347709300101
J	Lipka, AE; Lu, F; Cherney, JH; Buckler, ES; Casler, MD; Costich, DE				Lipka, Alexander E.; Lu, Fei; Cherney, Jerome H.; Buckler, Edward S.; Casler, Michael D.; Costich, Denise E.			Accelerating the Switchgrass (Panicum virgatum L.) Breeding Cycle Using Genomic Selection Approaches	PLOS ONE			English	Article							PREDICTION; REGRESSION; ACCURACY; PLANT; TRAITS; REGULARIZATION; ASSOCIATION; ADAPTATION; MODELS	Switchgrass (Panicum virgatum L.) is a perennial grass undergoing development as a biofuel feedstock. One of the most important factors hindering breeding efforts in this species is the need for accurate measurement of biomass yield on a per-hectare basis. Genomic selection on simple-to-measure traits that approximate biomass yield has the potential to significantly speed up the breeding cycle. Recent advances in switchgrass genomic and phenotypic resources are now making it possible to evaluate the potential of genomic selection of such traits. We leveraged these resources to study the ability of three widely-used genomic selection models to predict phenotypic values of morphological and biomass quality traits in an association panel consisting of predominantly northern adapted upland germplasm. High prediction accuracies were obtained for most of the traits, with standability having the highest ten-fold cross validation prediction accuracy (0.52). Moreover, the morphological traits generally had higher prediction accuracies than the biomass quality traits. Nevertheless, our results suggest that the quality of current genomic and phenotypic resources available for switchgrass is sufficiently high for genomic selection to significantly impact breeding efforts for biomass yield.	[Lipka, Alexander E.; Lu, Fei; Buckler, Edward S.; Costich, Denise E.] Cornell Univ, Inst Genom Div, Ithaca, NY USA; [Cherney, Jerome H.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY USA; [Buckler, Edward S.; Costich, Denise E.] USDA ARS, Ithaca, NY 14853 USA; [Buckler, Edward S.] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY USA; [Casler, Michael D.] USDA ARS, Madison, WI USA; [Casler, Michael D.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA	Cornell University; Cornell University; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Lipka, AE (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	alipka@illinois.edu	Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Buckler, Edward/0000-0002-3100-371X	Department of Energy-United States Department of Agriculture Plant Feedstock Genomics for Bioenergy Program [DE-A102-07ER64454]; United States Department of Agriculture-Agricultural Research Services	Department of Energy-United States Department of Agriculture Plant Feedstock Genomics for Bioenergy Program; United States Department of Agriculture-Agricultural Research Services	This work was supported by Department of Energy-United States Department of Agriculture Plant Feedstock Genomics for Bioenergy Program Project Number DE-A102-07ER64454 (http://genomicscience.energy.gov/research/DOEUSDA/) and United States Department of Agriculture-Agricultural Research Services (http://www.ars.usda.gov/main/main.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Buckler Lab for Maize Genetics and Diversity, BUCKL LAB PHEN TOOLS; Casler MD, 2007, CROP SCI, V47, P2249, DOI 10.2135/cropsci2006.12.0780; Casler MD, 2004, CROP SCI, V44, P293, DOI 10.2135/cropsci2004.2930; Casler MD, 2012, SWITCHGRASS, P29, DOI [10.1007/978-1-4471-2903-5, DOI 10.1007/978-1-4471-2903-5_2]; CATHEY HM, 1990, USDA PLANT HARDINESS; Chandler K, 2013, CROP SCI, V53, P189, DOI 10.2135/cropsci2012.02.0129; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gianola D, 2013, GENETICS, V194, P573, DOI 10.1534/genetics.113.151753; Gilmour AR, 2009, ASREML USER GUIDE RE; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Holland JB, 2002, PL BRED RE, V22, P9; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Joint Genome Institute, 2014, PHYT 10 PAN VIRG V1; Kutner M., 2004, APPL LINEAR STAT MOD; Lipka AE, 2013, G3-GENES GENOM GENET, V3, P1287, DOI 10.1534/g3.113.006148; Lu F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003215; Martinez-Reyna JM, 2002, CROP SCI, V42, P1800, DOI 10.2135/cropsci2002.1800; Meuwissen THE, 2001, GENETICS, V157, P1819; Perrin R, 2008, BIOENERG RES, V1, P91, DOI 10.1007/s12155-008-9005-y; PORTER CL, 1966, ECOLOGY, V47, P980, DOI 10.2307/1935646; Resende MFR, 2012, GENETICS, V190, P1503, DOI 10.1534/genetics.111.137026; Resende MFR, 2012, NEW PHYTOL, V193, P617, DOI 10.1111/j.1469-8137.2011.03895.x; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Sanderson MA, 2006, CAN J PLANT SCI, V86, P1315, DOI 10.4141/P06-136; SAS Institute, 2012, SAS SYSTEM WINDOWS R; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Resende RMS, 2014, CROP SCI, V54, P143, DOI 10.2135/cropsci2013.05.0353; Stubbendieck J., 1992, N AM RANGE PLANTS, V4; Team RC, 2012, R LANG ENV STAT COMP; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vogel KP, 2011, BIOENERG RES, V4, P96, DOI 10.1007/s12155-010-9104-4; Vogel KP, 2014, J PLANT REGIST; Wolc A, 2011, GENET SEL EVOL, V43; Zhang YW, 2011, CROP SCI, V51, P2626, DOI 10.2135/cropsci2011.02.0104; Zhang YW, 2011, GENETICA, V139, P933, DOI 10.1007/s10709-011-9597-6; Zhao YuSheng, 2012, TAG Theoretical and Applied Genetics, V124, P769, DOI 10.1007/s00122-011-1745-y; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	43	43	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112227	10.1371/journal.pone.0112227	http://dx.doi.org/10.1371/journal.pone.0112227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390940	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400063
J	Liu, YM; Wu, HH; Kou, LH; Liu, XJ; Zhang, JZ; Guo, YP; Ma, EB				Liu, Yaoming; Wu, Haihua; Kou, Lihua; Liu, Xiaojian; Zhang, Jianzhen; Guo, Yaping; Ma, Enbo			Two Metallothionein Genes in Oxya chinensis: Molecular Characteristics, Expression Patterns and Roles in Heavy Metal Stress	PLOS ONE			English	Article							TYPE-2 METALLOTHIONEIN; ANTIOXIDANT ENZYMES; DIETARY-CADMIUM; CLONING; COPPER; HOMEOSTASIS; PROTECTION; DROSOPHILA; PROTEIN; FAMILY	Metallothioneins (MTs) are small, cysteine-rich, heavy metal-binding proteins involved in metal homeostasis and detoxification in living organisms. In the present study, we cloned two MT genes (OcMT1 and OcMT2) from Oxya chinensis, analyzed the expression patterns of the OcMT transcripts in different tissues and at varying developmental stages using realtime quantitative PCR (RT-qPCR), evaluated the functions of these two MTs using RNAi and recombinant proteins in an E. coli expression system. The full-length cDNAs of OcMT1 and OcMT2 encoded 40 and 64 amino acid residues, respectively. We found Cys-Cys, Cys-X-Cys and Cys-X-Y-Z-Cys motifs in OcMT1 and OcMT2. These motifs might serve as primary chelating sites, as in other organisms. These characteristics suggest that OcMT1 and OcMT2 may be involved in heavy metal detoxification by capturing the metals. Two OcMT were expressed at all developmental stages, and the highest levels were found in the eggs. Both transcripts were expressed in all eleven tissues examined, with the highest levels observed in the brain and optic lobes, followed by the fat body. The expression of OcMT2 was also relatively high in the ovaries. The functions of OcMT1 and OcMT2 were explored using RNA interference (RNAi) and different concentrations and treatment times for the three heavy metals. Our results indicated that mortality increased significantly from 8.5% to 16.7%, and this increase was both time-and dose-dependent. To evaluate the abilities of these two MT proteins to confer heavy metal tolerance to E. coli, the bacterial cells were transformed with pET-28a plasmids containing the OcMT genes. The optical densities of both the MT-expressing and control cells decreased with increasing concentrations of CdCl2. Nevertheless, the survival rates of the MT-overexpressing cells were higher than those of the controls. Our results suggest that these two genes play important roles in heavy metal detoxification in O. chinensis.	[Liu, Yaoming; Wu, Haihua; Kou, Lihua; Liu, Xiaojian; Zhang, Jianzhen; Ma, Enbo] Shanxi Univ, Inst Appl Biol, Taiyuan 030006, Shanxi, Peoples R China; [Guo, Yaping] Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China	Shanxi University; Shanxi University	Guo, YP (corresponding author), Shanxi Univ, Coll Life Sci, Taiyuan 030006, Shanxi, Peoples R China.	guoyp1955@163.com; maenbo2003@sxu.edu.cn			National Natural Science Foundation of China [31071980, 31201548, 31320103921, 31172161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31071980, 31201548, 31320103921 and 31172161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2004, BIOCHEM BIOPH RES CO, V323, P72, DOI 10.1016/j.bbrc.2004.08.056; Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Aras MA, 2011, ANTIOXID REDOX SIGN, V15, P2249, DOI 10.1089/ars.2010.3607; Atanesyan L, 2011, J BIOL INORG CHEM, V16, P1047, DOI 10.1007/s00775-011-0825-4; Banci L, 2010, NATURE, V465, P645, DOI 10.1038/nature09018; Brouwer M, 2002, J INORG BIOCHEM, V88, P228, DOI 10.1016/S0162-0134(01)00381-6; Capdevila M, 2011, J BIOL INORG CHEM, V16, P977, DOI 10.1007/s00775-011-0798-3; Carpene E, 2007, J TRACE ELEM MED BIO, V21, P35, DOI 10.1016/j.jtemb.2007.09.011; Chaturvedi AK, 2012, GENE, V499, P280, DOI 10.1016/j.gene.2012.03.001; CHUNG WP, 1991, J AM CHEM SOC, V113, P525, DOI 10.1021/ja00002a021; Coyle P, 2002, CELL MOL LIFE SCI, V59, P627, DOI 10.1007/s00018-002-8454-2; Dietz K. J., 1999, HEAVY METAL STRESS P, P73, DOI DOI 10.1007/978-3-662-07745-0_4; Domenech J, 2007, RES PROGR METALLOTHI, P11; DURLIAT M, 1995, BIOMETALS, V8, P339; Egli D, 2006, MOL CELL BIOL, V26, P2286, DOI 10.1128/MCB.26.6.2286-2296.2006; Egli D, 2003, EMBO J, V22, P100, DOI 10.1093/emboj/cdg012; Freisinger E, 2011, J BIOL INORG CHEM, V16, P1035, DOI 10.1007/s00775-011-0801-z; Gonzalez-Mendoza D, 2007, AQUAT TOXICOL, V83, P306, DOI 10.1016/j.aquatox.2007.05.005; Guo WJ, 2003, NEW PHYTOL, V159, P369, DOI 10.1046/j.1469-8137.2003.00813.x; Henkel G, 2004, CHEM REV, V104, P801, DOI 10.1021/cr020620d; Hensbergen PJ, 2000, COMP BIOCHEM PHYS C, V125, P17, DOI 10.1016/S0742-8413(99)00087-0; Hensbergen PJ, 2006, COMP BIOCH PHYSL C, V125, P17; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Langston W. J., 1998, METAL METABOLISM AQU, P219; Levin ED, 2006, PHYSIOL BEHAV, V87, P513, DOI 10.1016/j.physbeh.2005.11.014; Liang SH, 2009, COMP BIOCHEM PHYS C, V149, P349, DOI 10.1016/j.cbpc.2008.09.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manso Y, 2011, J BIOL INORG CHEM, V16, P1103, DOI 10.1007/s00775-011-0802-y; Mao H, 2012, AQUAT TOXICOL, V110, P208, DOI 10.1016/j.aquatox.2012.01.018; Maremanda KP, 2014, BIOCHEM BIOPH RES CO, V445, P591, DOI 10.1016/j.bbrc.2014.02.055; MARGOSHES M, 1957, J AM CHEM SOC, V79, P4813, DOI 10.1021/ja01574a064; MARTIN M, 1981, MAR POLLUT BULL, V12, P305, DOI 10.1016/0025-326X(81)90081-3; MAYO KE, 1982, CELL, V29, P99, DOI 10.1016/0092-8674(82)90094-0; Molto E, 2005, GENE, V361, P140, DOI 10.1016/j.gene.2005.07.026; Moulis JM, 2010, BIOMETALS, V23, P877, DOI 10.1007/s10534-010-9336-y; Mudalkar S, 2014, MOL BIOL REP, V41, P113, DOI 10.1007/s11033-013-2843-5; Nakamori T, 2010, ENVIRON POLLUT, V158, P1689, DOI 10.1016/j.envpol.2009.11.022; Nakano H, 2006, BIOL PHARM BULL, V29, P55, DOI 10.1248/bpb.29.55; Pan LQ, 2006, COMP BIOCHEM PHYS C, V144, P67, DOI 10.1016/j.cbpc.2006.06.001; Ren F, 2011, MOL BIOL REP, V38, P2383, DOI 10.1007/s11033-010-0372-z; Roesijadi G, 1996, TOXICOL APPL PHARM, V140, P356, DOI 10.1006/taap.1996.0231; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; SATO M, 1993, FREE RADICAL BIO MED, V14, P325, DOI 10.1016/0891-5849(93)90029-T; Sharma S, 2014, NEUROCHEM INT, V65, P40, DOI 10.1016/j.neuint.2013.12.009; Sharma S, 2013, INT J NANOMED, V8, P1477, DOI 10.2147/IJN.S42019; Sturzenbaum SR, 2001, J BIOL CHEM, V276, P34013, DOI 10.1074/jbc.M103605200; Tang T, 2011, COMP BIOCHEM PHYS B, V160, P81, DOI 10.1016/j.cbpb.2011.06.008; Thirumoorthy N, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-54; Trinchella F, 2008, GENE, V423, P48, DOI 10.1016/j.gene.2008.06.027; Usha B, 2009, MOL GENET GENOMICS, V281, P99, DOI 10.1007/s00438-008-0398-2; Vasak M, 2005, J TRACE ELEM MED BIO, V19, P13, DOI 10.1016/j.jtemb.2005.03.003; Viarengo A., 1999, AM J PHYSIOL, V277, P1612, DOI DOI 10.1152/AJPREGU.1999.277.6.R1612; West AK, 2008, NEUROTOXICOLOGY, V29, P489, DOI 10.1016/j.neuro.2007.12.006; Won EJ, 2012, ENVIRON SCI POLLUT R, V19, P2606, DOI 10.1007/s11356-012-0905-1; Xiang DF, 2013, AQUAT TOXICOL, V140, P1, DOI 10.1016/j.aquatox.2013.05.004; Yang JL, 2011, MOL BIOL REP, V38, P1567, DOI 10.1007/s11033-010-0265-1; Yang LF, 2014, TOXICOL LETT, V225, P333, DOI 10.1016/j.toxlet.2013.12.024; Yang Z, 2009, PLANT MOL BIOL, V70, P219, DOI 10.1007/s11103-009-9466-1; Yoshida M, 2005, TOXICOLOGY, V213, P74, DOI 10.1016/j.tox.2005.05.008; Zhang YP, 2014, ENVIRON ENTOMOL, V43, P171, DOI 10.1603/EN13025; Zhang YP, 2011, ECOTOX ENVIRON SAFE, V74, P1355, DOI 10.1016/j.ecoenv.2011.03.002	64	18	20	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112759	10.1371/journal.pone.0112759	http://dx.doi.org/10.1371/journal.pone.0112759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391131	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400124
J	McQuillan, HJ; Nakagawa, S; Mercer, AR				McQuillan, H. James; Nakagawa, Shinichi; Mercer, Alison R.			Juvenile Hormone Enhances Aversive Learning Performance in 2-Day Old Worker Honey Bees while Reducing Their Attraction to Queen Mandibular Pheromone	PLOS ONE			English	Article							CABBAGE-LOOPER MOTHS; APIS-MELLIFERA; BIOGENIC-AMINES; OLFACTORY MEMORY; NERVOUS-TISSUE; SEX-PHEROMONE; OCTOPAMINE; DROSOPHILA; RESPONSES; DOPAMINE	Previous studies have shown that exposing young worker bees (Apis mellifera) to queen mandibular pheromone (QMP) reduces their aversive learning performance, while enhancing their attraction to QMP. As QMP has been found to reduce the rate of juvenile hormone (JH) synthesis in worker bees, we examined whether aversive learning in 2-day old workers exposed to QMP from the time of adult emergence could be improved by injecting JH (10 mu g in a 2 mu l volume) into the haemolymph. We examined in addition, the effects of JH treatment on worker attraction to QMP, and on the levels of expression of amine receptor genes in the antennae, as well as in the mushroom bodies of the brain. We found that memory acquisition and 1-hour memory recall were enhanced by JH. In contrast, JH treatment reduced the bees' attraction towards a synthetic strip impregnated with QMP (Bee Boost). Levels of expression of the dopamine receptor gene Amdop1 were significantly lower in the mushroom bodies of JH-treated bees than in bees treated with vehicle alone (acetone diluted with bee ringer). Expression of the octopamine receptor gene, Amoa1, in this brain region was also affected by JH treatment, and in the antennae, Amoa1 transcript levels were significantly lower in JH-treated bees compared to controls. The results of this study suggest that QMP's effects on JH synthesis may contribute to reducing aversive learning performance and enhancing attraction to QMP in young worker bees.	[McQuillan, H. James; Nakagawa, Shinichi; Mercer, Alison R.] Univ Otago, Dept Zool, Dunedin, New Zealand	University of Otago	McQuillan, HJ (corresponding author), Univ Otago, Dept Zool, POB 56, Dunedin, New Zealand.	jamie.mcquillan@otago.ac.nz	Nakagawa, Shinichi/B-5571-2011	Nakagawa, Shinichi/0000-0002-7765-5182; Mercer, Alison/0000-0001-8110-4247	Royal Society of New Zealand Marsden Fund Grant [UOO0910]	Royal Society of New Zealand Marsden Fund Grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by a grant from the Royal Society of New Zealand Marsden Fund Grant UOO0910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025371; Amdam GV, 2010, EVOL DEV, V12, P428, DOI 10.1111/j.1525-142X.2010.00429.x; Beggs KT, 2007, P NATL ACAD SCI USA, V104, P2460, DOI 10.1073/pnas.0608224104; Berry JA, 2012, NEURON, V74, P530, DOI 10.1016/j.neuron.2012.04.007; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Geddes LH, 2013, LEARN MEMORY, V20, P399, DOI 10.1101/lm.030825.113; Grosmaitre X, 2001, CHEM SENSES, V26, P653, DOI 10.1093/chemse/26.6.653; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jarriault D, 2009, HORM BEHAV, V56, P185, DOI 10.1016/j.yhbeh.2009.04.005; Jassim O, 2000, J INSECT PHYSIOL, V46, P243, DOI 10.1016/S0022-1910(99)00176-6; JAYCOX ER, 1974, ANN ENTOMOL SOC AM, V67, P529, DOI 10.1093/aesa/67.4.529; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kosmidis I., 2007, BRGLM BIAS REDUCTION; LINN CE, 1994, COMP BIOCHEM PHYS C, V108, P87, DOI 10.1016/1367-8280(94)90093-0; LINN CE, 1994, COMP BIOCHEM PHYS C, V108, P99, DOI 10.1016/1367-8280(94)90094-9; LINN CE, 1986, ARCH INSECT BIOCHEM, V3, P161, DOI 10.1002/arch.940030206; McQuillan HJ, 2012, LEARN MEMORY, V19, P151, DOI 10.1101/lm.025353.111; McQuillan HJ, 2012, J COMP PHYSIOL A, V198, P753, DOI 10.1007/s00359-012-0745-y; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pophof B, 2000, J COMP PHYSIOL A, V186, P307, DOI 10.1007/s003590050431; Pophof B, 2002, J COMP PHYSIOL A, V188, P659, DOI 10.1007/s00359-002-0343-5; Rein J, 2013, J COMP PHYSIOL A, V199, P947, DOI 10.1007/s00359-013-0805-y; ROBINSON GE, 1987, GEN COMP ENDOCR, V66, P457, DOI 10.1016/0016-6480(87)90258-9; Schulz DJ, 2002, HORM BEHAV, V42, P222, DOI 10.1006/hbeh.2002.1806; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Sullivan JP, 2000, HORM BEHAV, V37, P1, DOI 10.1006/hbeh.1999.1552; Team RDC, 2012, R LANG ENV STAT COMP; Velarde RA, 2009, J INSECT PHYSIOL, V55, P59, DOI 10.1016/j.jinsphys.2008.10.006; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Vergoz V, 2009, P NATL ACAD SCI USA, V106, P20930, DOI 10.1073/pnas.0907563106; Winston M.L., 1991, BIOL HONEY BEE; Zhukovskaya MI, 2006, J INSECT PHYSIOL, V52, P76, DOI 10.1016/j.jinsphys.2005.09.005	42	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112740	10.1371/journal.pone.0112740	http://dx.doi.org/10.1371/journal.pone.0112740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390885	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400123
J	Otowa, T; Maher, BS; Aggen, SH; McClay, JL; van den Oord, EJ; Hettema, JM				Otowa, Takeshi; Maher, Brion S.; Aggen, Steven H.; McClay, Joseph L.; van den Oord, Edwin J.; Hettema, John M.			Genome-Wide and Gene-Based Association Studies of Anxiety Disorders in European and African American Samples	PLOS ONE			English	Article							METAANALYSIS; REPLICATION; POPULATION; NEUROTICISM; DISEASES; CANCER; BRCA2; PALB2; SCANS; RISK	Anxiety disorders (ADs) are common mental disorders caused by a combination of genetic and environmental factors. Since ADs are highly comorbid with each other, partially due to shared genetic basis, studying AD phenotypes in a coordinated manner may be a powerful strategy for identifying potential genetic loci for ADs. To detect these loci, we performed genome-wide association studies (GWAS) of ADs. In addition, as a complementary approach to single-locus analysis, we also conducted gene-and pathway-based analyses. GWAS data were derived from the control sample of the Molecular Genetics of Schizophrenia (MGS) project (2,540 European American and 849 African American subjects) genotyped on the Affymetrix GeneChip 6.0 array. We applied two phenotypic approaches: (1) categorical case-control comparisons (CC) based upon psychiatric diagnoses, and (2) quantitative phenotypic factor scores (FS) derived from a multivariate analysis combining information across the clinical phenotypes. Linear and logistic models were used to analyse the association with ADs using FS and CC traits, respectively. At the single locus level, no genome-wide significant association was found. A transpopulation gene-based meta-analysis across both ethnic subsamples using FS identified three genes (MFAP3L on 4q32.3, NDUFAB1 and PALB2 on 16p12) with genome-wide significance (false discovery rate (FDR] <5%). At the pathway level, several terms such as transcription regulation, cytokine binding, and developmental process were significantly enriched in ADs (FDR <5%). Our approaches studying ADs as quantitative traits and utilizing the full GWAS data may be useful in identifying susceptibility genes and pathways for ADs.	[Otowa, Takeshi; Aggen, Steven H.; Hettema, John M.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23284 USA; [Otowa, Takeshi] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Maher, Brion S.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [McClay, Joseph L.; van den Oord, Edwin J.] Virginia Commonwealth Univ, Ctr Biomarker Res & Personalized Med, Dept Pharm, Richmond, VA USA	Virginia Commonwealth University; University of Tokyo; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Virginia Commonwealth University	Hettema, JM (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat, Richmond, VA 23284 USA.	jhettema@vcu.edu	McClay, Joseph/C-9931-2009	McClay, Joseph/0000-0002-3628-2447	Japan Society for the Promotion of Science [21-8373]; NIH [R01MH087646]; NIMH Schizophrenia Genetics Initiative [U01s: MH046276, MH46289, MH46318, MGS Part 1 (MGS1) and Part 2 (MGS2) R01s: MH67257, MH59588, MH59571, MH59565, MH59587, MH60870, MH59566, MH59586, MH61675, MH60879]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH046289, U01MH046276, R01MH061675, R01MH060879, R01MH059566, R01MH067257, R01MH059586, R01MH059588, R01MH060870, U01MH046318, R01MH059571, R01MH059565, R01MH059587, R01MH087646] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Schizophrenia Genetics Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by NIH grant R01MH087646 (JMH). Samples and associated phenotype data for the MGS study were collected under the following grants: NIMH Schizophrenia Genetics Initiative U01s: MH046276 (CR Cloninger), MH46289 (C Kaufmann), and MH46318 (MT Tsuang); and MGS Part 1 (MGS1) and Part 2 (MGS2) R01s: MH67257 (NG Buccola), MH59588 (BJ Mowry), MH59571 (PV Gejman), MH59565 (Robert Freedman), MH59587 (F Amin), MH60870 (WF Byerley), MH59566 (DW Black), MH59586 (JM Silverman), MH61675 (DF Levinson), and MH60879 (CR Cloninger). TO was supported by a research fellowship from the Japan Society for the Promotion of Science (no. 21-8373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Becker J, 2012, EUR J HUM GENET, V20, P97, DOI 10.1038/ejhg.2011.156; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cheung CL, 2012, OSTEOPOROSIS INT, V23, P131, DOI 10.1007/s00198-011-1779-7; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Cowen DS, 2007, J NEUROCHEM, V101, P1161, DOI 10.1111/j.1471-4159.2006.04420.x; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Guffanti G, 2013, PSYCHONEUROENDOCRINO, V38, P3029, DOI 10.1016/j.psyneuen.2013.08.014; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Hettema JM, 2011, BIOL PSYCHIAT, V70, P888, DOI 10.1016/j.biopsych.2011.07.012; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; JARDINE R, 1984, Genetic Epidemiology, V1, P89, DOI 10.1002/gepi.1370010202; Kaabi B, 2006, AM J HUM GENET, V78, P543, DOI 10.1086/501072; Kang B, 2008, J PROTEOME RES, V7, P3507, DOI 10.1021/pr800238p; Kendler KS, 2007, PSYCHOL MED, V37, P453, DOI 10.1017/S0033291706009135; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kitagishi Y, 2012, INT J MOL MED, V30, P1255, DOI 10.3892/ijmm.2012.1152; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Logue MW, 2013, MOL PSYCHIATR, V18, P937, DOI 10.1038/mp.2012.113; Miller AH, 2013, DEPRESS ANXIETY, V30, P297, DOI 10.1002/da.22084; Muthen LK, 2006, MPLUS USERS GUIDE; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Otowa T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.89; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanders AR, 2010, AM J PSYCHIAT, V167, P854, DOI 10.1176/appi.ajp.2010.09071050; Sheppard Karen E., 2012, Critical Reviews in Oncogenesis, V17, P69; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Smoller JW, 2009, DEPRESS ANXIETY, V26, P965, DOI 10.1002/da.20623; Star S.A., 1949, STUDIES SOCIAL PSYCH, V1; Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85; Tesli M, 2010, AM J MED GENET B, V153B, P1276, DOI 10.1002/ajmg.b.31098; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; Walter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080326; Wang X, 2012, EUR J HUM GENET, V20, P469, DOI 10.1038/ejhg.2011.219; Webb BT, 2012, EUR J HUM GENET, V20, P1078, DOI 10.1038/ejhg.2012.47; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xie PX, 2013, BIOL PSYCHIAT, V74, P656, DOI 10.1016/j.biopsych.2013.04.013; Yang J, 2010, GENET EPIDEMIOL, V34, P254, DOI 10.1002/gepi.20456; Zhang QH, 2002, SCIENCE, V295, P1895	48	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112559	10.1371/journal.pone.0112559	http://dx.doi.org/10.1371/journal.pone.0112559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390645	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400098
J	Tastesen, HS; Ronnevik, AK; Borkowski, K; Madsen, L; Kristiansen, K; Liaset, B				Tastesen, Hanne Sorup; Ronnevik, Alexander Krokedal; Borkowski, Kamil; Madsen, Lise; Kristiansen, Karsten; Liaset, Bjorn			A Mixture of Cod and Scallop Protein Reduces Adiposity and Improves Glucose Tolerance in High-Fat Fed Male C57BL/6J Mice	PLOS ONE			English	Article							INSULIN-RESISTANT MEN; SKELETAL-MUSCLE; HIGH-CARBOHYDRATE; GLYCEMIC INDEX; WHEY-PROTEIN; BODY-WEIGHT; ACID CYCLE; DIET; THERMOGENESIS; SENSITIVITY	Low-protein and high-protein diets regulate energy metabolism in animals and humans. To evaluate whether different dietary protein sources modulate energy balance when ingested at average levels obesity-prone male C57BL/6J mice were pair-fed high-fat diets (67 energy percent fat, 18 energy percent sucrose and 15 energy percent protein) with either casein, chicken filet or a mixture of cod and scallop (1:1 on amino acid content) as protein sources. At equal energy intake, casein and cod/scallop fed mice had lower feed efficiency than chicken fed mice, which translated into reduced adipose tissue masses after seven weeks of feeding. Chicken fed mice had elevated hepatic triglyceride relative to casein and cod/scallop fed mice and elevated 4 h fasted plasma cholesterol concentrations compared to low-fat and casein fed mice. In casein fed mice the reduced adiposity was likely related to the observed three percent lower apparent fat digestibility compared to low-fat, chicken and cod/scallop fed mice. After six weeks of feeding an oral glucose tolerance test revealed that despite their lean phenotype, casein fed mice had reduced glucose tolerance compared to low-fat, chicken and cod/scallop fed mice. In a separate set of mice, effects on metabolism were evaluated by indirect calorimetry before onset of diet-induced obesity. Spontaneous locomotor activity decreased in casein and chicken fed mice when shifting from low-fat to high-fat diets, but cod/scallop feeding tended (P = 0.06) to attenuate this decrease. Moreover, at this shift, energy expenditure decreased in all groups, but was decreased to a greater extent in casein fed than in cod/scallop fed mice, indicating that protein sources regulated energy expenditure differently. In conclusion, protein from different sources modulates energy balance in C57BL/6J mice when given at normal levels. Ingestion of a cod/scallop-mixture prevented diet-induced obesity compared to intake of chicken filet and preserved glucose tolerance compared to casein intake.	[Tastesen, Hanne Sorup; Ronnevik, Alexander Krokedal; Borkowski, Kamil; Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Tastesen, Hanne Sorup; Ronnevik, Alexander Krokedal; Madsen, Lise; Liaset, Bjorn] Natl Inst Nutr & Seafood Res, Bergen, Norway	University of Copenhagen	Kristiansen, K (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	kk@bio.ku.dk; Bjorn.Liaset@nifes.no	Kristiansen, Karsten/J-5148-2014; Madsen, Lise/C-6246-2012	Kristiansen, Karsten/0000-0002-6024-0917; Madsen, Lise/0000-0003-4468-1947; Liaset, Bjorn/0000-0002-8652-7801	Norwegian Research Council [200515/I30]; National Institute of Nutrition and Seafood Research; Danish Council for Strategic Research [2101-08-0053]; Danish Dairy Research Foundation; Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation	Norwegian Research Council(Research Council of NorwayEuropean Commission); National Institute of Nutrition and Seafood Research; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Dairy Research Foundation; Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation)	This study was part of the Lean Seafood in the Prevention of the Metabolic Syndrome project which is financially supported by the Norwegian Research Council (Grant no. 200515/I30) and the National Institute of Nutrition and Seafood Research. Part of this work was also financially supported by the Danish Council for Strategic Research (Grant no. 2101-08-0053), the Danish Dairy Research Foundation, the Danish Natural Science Research Council, the Novo Nordisk Foundation and the Carlsberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson KJ, 2011, AM J CLIN NUTR, V93, P525, DOI 10.3945/ajcn.110.005850; ALLISON DB, 1995, DIABETES CARE, V18, P245, DOI 10.2337/diacare.18.2.245; An YP, 2013, J PROTEOME RES, V12, P3755, DOI 10.1021/pr400398b; Baer DJ, 2011, J NUTR, V141, P1489, DOI 10.3945/jn.111.139840; Belza A, 2013, AM J CLIN NUTR, V97, P980, DOI 10.3945/ajcn.112.047563; Binder E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074705; El Idrissi A, 2009, ADV EXP MED BIOL, V643, P207, DOI 10.1007/978-0-387-75681-3_21; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Fulgoni VL, 2008, AM J CLIN NUTR, V87, p1554S, DOI 10.1093/ajcn/87.5.1554S; Gilbert JA, 2011, NUTR METAB CARDIOVAS, V21, pB16, DOI 10.1016/j.numecd.2010.12.008; Guo Y, 2013, MOL CELLULAR PROTEOM; Hamilton TS, 1939, J NUTR, V17, P583, DOI 10.1093/jn/17.6.583; Hao Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1097, DOI 10.1152/ajpendo.00524.2011; Ibrahim MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025170; Johnston CS, 2004, J NUTR, V134, P586, DOI 10.1093/jn/134.3.586; Johnston CS, 2002, J AM COLL NUTR, V21, P55, DOI 10.1080/07315724.2002.10719194; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; KEVONIAN AV, 1984, J NUTR, V114, P543, DOI 10.1093/jn/114.3.543; Klaus S, 2005, J NUTR, V135, P1854, DOI 10.1093/jn/135.8.1854; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Larsen Thomas Meinert, 2010, N Engl J Med, V363, P2102, DOI 10.1056/NEJMoa1007137; Lavigne C, 2000, AM J PHYSIOL-ENDOC M, V278, pE491, DOI 10.1152/ajpendo.2000.278.3.E491; Lavigne C, 2001, AM J PHYSIOL-ENDOC M, V281, pE62, DOI 10.1152/ajpendo.2001.281.1.E62; LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2011, J BIOL CHEM, V286, P28382, DOI 10.1074/jbc.M111.234732; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lillefosse HH, 2014, J PROTEOME RES, V13, P2560, DOI 10.1021/pr500039t; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Ma T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021647; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Mariotti F, 2008, CRIT REV FOOD SCI, V48, P177, DOI 10.1080/10408390701279749; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MILLER DS, 1967, AM J CLIN NUTR, V20, P1212, DOI 10.1093/ajcn/20.11.1212; MILLER DS, 1962, J NUTR, V78, P255, DOI 10.1093/jn/78.3.255; Murakami T, 2010, AMINO ACIDS, V39, P427, DOI 10.1007/s00726-009-0458-x; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ouellet V, 2008, J NUTR, V138, P2386, DOI 10.3945/jn.108.092346; Ouellet V, 2007, DIABETES CARE, V30, P2816, DOI 10.2337/dc07-0273; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; ROBINSON SM, 1990, AM J CLIN NUTR, V52, P72, DOI 10.1093/ajcn/52.1.72; ROTHWELL NJ, 1983, METABOLISM, V32, P257, DOI 10.1016/0026-0495(83)90190-7; Shi J, 2011, INT DAIRY J, V21, P513, DOI 10.1016/j.idairyj.2011.03.006; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; Swan G, 2004, P NUTR SOC, V63, P505, DOI 10.1079/PNS2004381; Tastesen HS, 2014, AMINO ACIDS, V46, P1659, DOI 10.1007/s00726-014-1715-1; Tranberg B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071439; Tremblay F, 2005, DIABETES, V54, P2674, DOI 10.2337/diabetes.54.9.2674; Tremblay F, 2003, DIABETES, V52, P29, DOI 10.2337/diabetes.52.1.29; Tsuboyama-Kasaoka N, 2006, ENDOCRINOLOGY, V147, P3276, DOI 10.1210/en.2005-1007; van den Broek NMA, 2010, FASEB J, V24, P1354, DOI 10.1096/fj.09-143842; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41	57	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112859	10.1371/journal.pone.0112859	http://dx.doi.org/10.1371/journal.pone.0112859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390887	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400135
J	Wielputz, MO; Bardarova, D; Weinheimer, O; Kauczor, HU; Eichinger, M; Jobst, BJ; Eberhardt, R; Koenigkam-Santos, M; Puderbach, M; Heussel, CP				Wielpuetz, Mark O.; Bardarova, Diana; Weinheimer, Oliver; Kauczor, Hans-Ulrich; Eichinger, Monika; Jobst, Bertram J.; Eberhardt, Ralf; Koenigkam-Santos, Marcel; Puderbach, Michael; Heussel, Claus P.			Variation of Densitometry on Computed Tomography in COPD - Influence of Different Software Tools	PLOS ONE			English	Article							ITERATIVE RECONSTRUCTION; QUANTITATIVE-ANALYSIS; PULMONARY-EMPHYSEMA; CT; LUNG; QUANTIFICATION; DENSITY; REPRODUCIBILITY; PROGRESSION; INCREASE	Objectives: Quantitative multidetector computed tomography (MDCT) as a potential biomarker is increasingly used for severity assessment of emphysema in chronic obstructive pulmonary disease (COPD). Aim of this study was to evaluate the user-independent measurement variability between five different fully-automatic densitometry software tools. Material and Methods: MDCT and full-body plethysmography incl. forced expiratory volume in 1s and total lung capacity were available for 49 patients with advanced COPD (age = 64 +/- 9 years, forced expiratory volume in 1s = 31 +/- 6% predicted). Measurement variation regarding lung volume, emphysema volume, emphysema index, and mean lung density was evaluated for two scientific and three commercially available lung densitometry software tools designed to analyze MDCT from different scanner types. Results: One scientific tool and one commercial tool failed to process most or all datasets, respectively, and were excluded. One scientific and another commercial tool analyzed 49, the remaining commercial tool 30 datasets. Lung volume, emphysema volume, emphysema index and mean lung density were significantly different amongst these three tools (p < 0.001). Limits of agreement for lung volume were [-0.195, -0.052l], [-0.305, -0.131l], and [-0.123, -0.052l] with correlation coefficients of r = 1.00 each. Limits of agreement for emphysema index were [-6.2, 2.9%], [-27.0, 16.9%], and [-25.5, 18.8%], with r = 0.79 to 0.98. Correlation of lung volume with total lung capacity was good to excellent (r = 0.77 to 0.91, p< 0.001), but segmented lung volume (6.7 +/- 1.3 - 6.8 +/- 1.3l) were significantly lower than total lung capacity (7.7 +/- 1.7l, p<0.001). Conclusions: Technical incompatibilities hindered evaluation of two of five tools. The remaining three showed significant measurement variation for emphysema, hampering quantitative MDCT as a biomarker in COPD. Follow-up studies should currently use identical software, and standardization efforts should encompass software as well.	[Wielpuetz, Mark O.; Bardarova, Diana; Weinheimer, Oliver; Kauczor, Hans-Ulrich; Eichinger, Monika; Jobst, Bertram J.; Koenigkam-Santos, Marcel; Puderbach, Michael; Heussel, Claus P.] Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Wielpuetz, Mark O.; Bardarova, Diana; Weinheimer, Oliver; Kauczor, Hans-Ulrich; Eichinger, Monika; Jobst, Bertram J.; Koenigkam-Santos, Marcel; Puderbach, Michael; Heussel, Claus P.] Translat Lung Res Ctr Heidelberg, Heidelberg, Germany; [Wielpuetz, Mark O.; Bardarova, Diana; Kauczor, Hans-Ulrich; Eichinger, Monika; Jobst, Bertram J.; Koenigkam-Santos, Marcel; Puderbach, Michael; Heussel, Claus P.] Heidelberg Univ, Thoraxklin, Dept Diagnost & Intervent Radiol Nucl Med, Heidelberg, Germany; [Wielpuetz, Mark O.; Koenigkam-Santos, Marcel; Puderbach, Michael] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Eberhardt, Ralf] Heidelberg Univ, Dept Pneumol & Resp Crit Care Med, Thoraxklin, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Wielputz, MO (corresponding author), Univ Heidelberg Hosp, Dept Diagnost & Intervent Radiol, Heidelberg, Germany.	mark.wielpuetz@med.uni-heidelberg.de	Weinheimer, Oliver/AAN-3652-2021; Wielpütz, Mark Oliver/ADP-0499-2022; Wielpuetz, Mark/ABE-1790-2020; Kauczor, HU/AAX-6033-2021; Kauczor, Hans-Ulrich/AAU-5955-2021; Santos, Marcel Koenigkam/B-8177-2013	Wielpütz, Mark Oliver/0000-0001-6962-037X; Wielpuetz, Mark/0000-0001-6962-037X; Santos, Marcel Koenigkam/0000-0002-7160-4691	Bundesministerium fur Bildung und Forschung [82DZL00401, 82DZL00402, 82DZL00404]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from the Bundesministerium fur Bildung und Forschung (www.bmbf.de) to the German Center for Lung Research (DZL) (82DZL00401, 82DZL00402, 82DZL00404). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf H, 2010, EUR RADIOL, V20, P1878, DOI 10.1007/s00330-010-1749-z; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Choo JY, 2014, EUR RADIOL, V24, P799, DOI 10.1007/s00330-013-3078-5; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Coxson HO, 2009, AM J RESP CRIT CARE, V180, P588, DOI 10.1164/rccm.200901-0159PP; Coxson HO, 1999, AM J RESP CRIT CARE, V159, P851, DOI 10.1164/ajrccm.159.3.9805067; Coxson HO, 2005, ACAD RADIOL, V12, P1457, DOI 10.1016/j.acra.2005.08.013; de Hoop B, 2009, EUR RADIOL, V19, P800, DOI 10.1007/s00330-008-1229-x; Diciotti S, 2011, ACAD RADIOL, V18, P1403, DOI 10.1016/j.acra.2011.08.001; Garfield JL, 2012, INT J CHRONIC OBSTR, V7, P119, DOI 10.2147/COPD.S26419; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Gierada DS, 2010, ACAD RADIOL, V17, P146, DOI 10.1016/j.acra.2009.08.007; Gietema HA, 2007, RADIOLOGY, V244, P890, DOI 10.1148/radiol.2443061330; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; HARRIS EK, 1979, AM J CLIN PATHOL, V72, P374; Heussel CP, 2006, ROFO-FORTSCHR RONTG, V178, P987, DOI 10.1055/s-2006-926823; Heussel CP, 2010, EUR J RADIOL, V74, P473, DOI 10.1016/j.ejrad.2009.03.023; Heussel CP, 2009, EUR RADIOL, V19, P2391, DOI 10.1007/s00330-009-1437-z; Hoesein FAAM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-55; HOLM S, 1979, SCAND J STAT, V6, P65; Kauczor HU, 2013, LANCET RESP MED, V1, P95, DOI 10.1016/S2213-2600(13)70011-0; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; Ley-Zaporozhan J, 2008, EUR J RADIOL, V65, P228, DOI 10.1016/j.ejrad.2007.03.034; Ley-Zaporozhan J, 2010, J MAGN RESON IMAGING, V32, P1340, DOI 10.1002/jmri.22376; Madani A, 2010, RADIOLOGY, V257, P260, DOI 10.1148/radiol.10091446; Mets OM, 2012, EUR RADIOL, V22, P2103, DOI 10.1007/s00330-012-2489-z; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Oberoi S, 2014, AM J ROENTGENOL, V202, pW43, DOI 10.2214/AJR.13.11225; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Sciurba FC, 2010, NEW ENGL J MED, V363, P1233, DOI 10.1056/NEJMoa0900928; Shaker SB, 2004, ACTA RADIOL, V45, P424, DOI 10.1080/02841850410005642; Sieren JP, 2012, MED PHYS, V39, P5757, DOI 10.1118/1.4747342; Hoffman Eric A, 2006, Proc Am Thorac Soc, V3, P519, DOI 10.1513/pats.200603-086MS; Smith BM, 2013, J THORAC IMAG, V28, P280, DOI 10.1097/RTI.0b013e3182a0d805; Soejima K, 2000, AM J RESP CRIT CARE, V161, P1264, DOI 10.1164/ajrccm.161.4.9905040; Stoel Berend C, 2008, Proc Am Thorac Soc, V5, P919, DOI 10.1513/pats.200804-040QC; Weinheimer O., 2011, P 4 INT WORKSH PULM, P241; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798; Wielputz MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073142; Wielputz MO, 2013, J THORAC IMAG, V28, P104, DOI 10.1097/RTI.0b013e3182765785; Yuan R, 2007, CHEST, V132, P617, DOI 10.1378/chest.06-2325; Zaporozhan J, 2006, J COMPUT ASSIST TOMO, V30, P460, DOI 10.1097/00004728-200605000-00018	44	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112898	10.1371/journal.pone.0112898	http://dx.doi.org/10.1371/journal.pone.0112898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386874	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400103
J	Gainetdinov, IV; Skvortsova, YV; Stukacheva, EA; Bychenko, OS; Kondratieva, SA; Zinovieva, MV; Azhikina, TL				Gainetdinov, Ildar V.; Skvortsova, Yulia V.; Stukacheva, Elena A.; Bychenko, Oksana S.; Kondratieva, Sofia A.; Zinovieva, Marina V.; Azhikina, Tatyana L.			Expression Profiles of PIWIL2 Short Isoforms Differ in Testicular Germ Cell Tumors of Various Differentiation Subtypes	PLOS ONE			English	Article							POLYADENYLATION REGULATORY ELEMENTS; PRECANCEROUS STEM-CELLS; HUMAN CSTF-64 PROTEIN; DNA METHYLATION; RETINOIC ACID; NEURONAL DIFFERENTIATION; INTERACTING RNAS; GENOME BROWSER; COLON-CANCER; CARCINOMA	PIWI family proteins have recently emerged as essential contributors in numerous biological processes including germ cell development, stem cell maintenance and epigenetic reprogramming. Expression of some of the family members has been shown to be elevated in tumors. In particular, PIWIL2 has been probed as a potential neoplasia biomarker in many cancers in humans. Previously, PIWIL2 was shown to be expressed in most tumours as a set of its shorter isoforms. In this work, we demonstrated the presence of its 60 kDa (PL2L60A) and 80 kDa (PL2L80A) isoforms in testicular cancer cell lines. We also ascertained the transcriptional boundaries of mRNAs and alternative promoter regions for these PIWIL2 isoforms. Further, we probed a range of testicular germ cell tumor (TGCT) samples and found PIWIL2 to be predominantly expressed as PL2L60A in most of them. Importantly, the levels of both PL2L60A mRNA and protein products were found to vary depending on the differentiation subtype of TGCTs, i.e., PL2L60A expression is significantly higher in undifferentiated seminomas and appears to be substantially decreased in mixed and nonseminomatous TGCTs. The higher level of PL2L60A expression in undifferentiated TGCTs was further validated in the model system of retinoic acid induced differentiation in NT2/D1 cell line. Therefore, both PL2L60A mRNA and protein abundance could serve as an additional marker distinguishing between seminomas and nonseminomatous tumors with different prognosis and therapy approaches.	[Gainetdinov, Ildar V.; Skvortsova, Yulia V.; Stukacheva, Elena A.; Bychenko, Oksana S.; Kondratieva, Sofia A.; Zinovieva, Marina V.; Azhikina, Tatyana L.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Gainetdinov, IV (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	ildargv@gmail.com	Kondrateva, Sofia/ABB-3389-2020; Azhikina, Tatyana/X-8411-2018; Bychenko, Oksana/AAP-7635-2021; Skvortsova, Yulia/AAP-4597-2021	Skvortsova, Yuliya/0000-0002-7605-8570; Kondratieva, Sofia/0000-0002-1354-5275; Gainetdinov, Ildar/0000-0003-1719-043X	Russian Foundation for Basic Research [14-04-32314-mol_a, 11-04-12071-ofi-m]; program of the Presidium of the Russian Academy of Sciences "Molecular and Cellular Biology"	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); program of the Presidium of the Russian Academy of Sciences "Molecular and Cellular Biology"	This work was supported by the Russian Foundation for Basic Research (project nos. 14-04-32314-mol_a and 11-04-12071-ofi-m) and the program of the Presidium of the Russian Academy of Sciences "Molecular and Cellular Biology." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEN DP, 1979, NATURE, V282, P615, DOI 10.1038/282615a0; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1984, LAB INVEST, V50, P147; Bak Chong Won, 2011, Clin Exp Reprod Med, V38, P61, DOI 10.5653/cerm.2011.38.2.61; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; BRODEUR GM, 1976, CYTOBIOS, V16, P133; Canadillas JMP, 2003, EMBO J, V22, P2821, DOI 10.1093/emboj/cdg259; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen C, 2013, CANCER BIOMARK, V13, P315, DOI 10.3233/CBM-130360; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; Chieffi P, 2013, J CELL PHYSIOL, V228, P1641, DOI 10.1002/jcp.24328; Chieffi P, 2009, INT REV CEL MOL BIO, V278, P277, DOI 10.1016/S1937-6448(09)78006-2; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Cook MS, 2013, CURR TOP DEV BIOL, V102, P159, DOI 10.1016/B978-0-12-416024-8.00006-4; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Deka P, 2005, J MOL BIOL, V347, P719, DOI 10.1016/j.jmb.2005.01.046; Domansky AN, 2000, FEBS LETT, V472, P191, DOI 10.1016/S0014-5793(00)01460-5; Elkahloun AG, 1996, GENE CHROMOSOME CANC, V17, P205, DOI 10.1002/(SICI)1098-2264(199612)17:4<205::AID-GCC2>3.3.CO;2-#; EPSTEIN MA, 1965, J NATL CANCER I, V34, P231, DOI 10.1093/jnci/34.2.231; Esposito F, 2011, J PATHOL, V224, P110, DOI 10.1002/path.2846; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Ferreira HJ, 2013, EPIGENETICS, P9; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Franco R, 2008, J PATHOL, V214, P58, DOI 10.1002/path.2249; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Greither T, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-272; He G, 2010, AM J TRANSL RES, V2, P156; Heyn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047892; Hoei-Hansen CE, 2005, HISTOPATHOLOGY, V47, P48, DOI 10.1111/j.1365-2559.2005.02182.x; Honda S, 2014, METHODS MOL BIOL, V1093, P137, DOI 10.1007/978-1-62703-694-8_11; Honda S, 2013, RNA, V19, P1405, DOI 10.1261/rna.040428.113; Juliano C, 2011, ANNU REV GENET, V45, P447, DOI 10.1146/annurev-genet-110410-132541; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; KLEIN E, 1968, CANCER RES, V28, P1300; Klenov MS, 2011, P NATL ACAD SCI USA, V108, P18760, DOI 10.1073/pnas.1106676108; Lai F, 2014, CURR OPIN GENET DEV, V25, P38, DOI 10.1016/j.gde.2013.11.017; Le Thomas A, 2014, GENOME BIOL, V15, DOI 10.1186/gb4154; Le Thomas A, 2013, GENE DEV, V27, P390, DOI 10.1101/gad.209841.112; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Li DW, 2012, EXP BIOL MED, V237, P1231, DOI 10.1258/ebm.2012.011380; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Looijenga LHJ, 2014, VIRCHOWS ARCH, V464, P301, DOI 10.1007/s00428-013-1522-1; Looijenga LHJ, 2003, CANCER RES, V63, P2244; Lu YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030999; Luteijn MJ, 2013, NAT REV GENET, V14, P523, DOI 10.1038/nrg3495; Mani SR, 2013, MOL REPROD DEV, V80, P632, DOI 10.1002/mrd.22195; Mathioudakis N, 2012, RNA, V18, P2056, DOI 10.1261/rna.034181.112; MATTHAEI KI, 1983, EXP CELL RES, V143, P471, DOI 10.1016/0014-4827(83)90076-9; Mazaheri Zohreh, 2012, Avicenna Journal of Medical Biotechnology, V4, P55; Mei YP, 2013, CANCER LETT, V336, P46, DOI 10.1016/j.canlet.2013.04.008; MILLER WH, 1994, DIFFERENTIATION, V55, P145, DOI 10.1046/j.1432-0436.1994.5520145.x; Nikpour P, 2009, CANCER EPIDEMIOL, V33, P271, DOI 10.1016/j.canep.2009.06.011; Oh SJ, 2012, KOREAN J PATHOL, V46, P318, DOI 10.4132/KoreanJPathol.2012.46.4.318; Olovnikov I, 2012, CURR OPIN GENET DEV, V22, P164, DOI 10.1016/j.gde.2012.01.002; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Pan Y, 2012, CELL TISSUE RES, V350, P177, DOI 10.1007/s00441-012-1447-z; Pandey RR, 2013, P NATL ACAD SCI USA, V110, P16492, DOI 10.1073/pnas.1316316110; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Patil VS, 2013, CRIT REV BIOCH MOL B; Peng JC, 2013, CURR OPIN CELL BIOL, V25, P190, DOI 10.1016/j.ceb.2013.01.010; Plank JL, 2014, MOL CELL, V55, P5, DOI 10.1016/j.molcel.2014.06.015; PLEASURE SJ, 1992, J NEUROSCI, V12, P1802; PULVERTAFT RJV, 1964, LANCET, V1, P238; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; ROSFJORD E, 1994, BIOCHEM BIOPH RES CO, V203, P1795, DOI 10.1006/bbrc.1994.2395; Ross RJ, 2014, NATURE, V505, P353, DOI 10.1038/nature12987; Rougemaille M, 2010, ADV EXP MED BIOL, V702, P122, DOI 10.1007/978-1-4419-7841-7_10; Sambrook J., 2001, MOL CLONING LAB MANU; Sato K, 2013, ESSAYS BIOCHEM, V54, P39, DOI [10.1042/bse0540039, 10.1042/BSE0540039]; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shahali M, 2013, CELL J, V15, P250; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shukla S, 2011, NATURE, V479, P74, DOI 10.1038/nature10442; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Snow GE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-383; Stuwe E, 2014, GENE DEV, V28, P423, DOI 10.1101/gad.236414.113; Suzuki Ryusuke, 2012, Frontiers in Genetics, V3, P204, DOI 10.3389/fgene.2012.00204; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Wang QE, 2011, MUTAT RES-FUND MOL M, V708, P59, DOI 10.1016/j.mrfmmm.2011.02.001; Wang Y, 2012, INT J CLIN EXP PATHO, V5, P315; Watanabe T, 2011, SCIENCE, V332, P848, DOI 10.1126/science.1203919; Wu QL, 2010, BIOCHEM BIOPH RES CO, V396, P915, DOI 10.1016/j.bbrc.2010.05.022; Yakushev EY, 2013, BIOCHEMISTRY-MOSCOW+, V78, P585, DOI 10.1134/S0006297913060047; Yazarloo F, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0368-8; Ye Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013406; Yin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027154; Yin De-tao, 2011, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V46, P237; Zhang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041973	99	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112528	10.1371/journal.pone.0112528	http://dx.doi.org/10.1371/journal.pone.0112528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384072	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700077
J	Stefansson, TS; McDonald, BA; Willi, Y				Stefansson, Tryggvi S.; McDonald, Bruce A.; Willi, Yvonne			The Influence of Genetic Drift and Selection on Quantitative Traits in a Plant Pathogenic Fungus	PLOS ONE			English	Article							BARLEY SCALD PATHOGEN; POPULATION-STRUCTURE; FITNESS ATTRIBUTES; LOCAL ADAPTATION; EVOLUTIONARY; HERITABILITY; DIVERSITY; DIVERGENCE; MARKERS	Genetic drift and selection are ubiquitous evolutionary forces acting to shape genetic variation in populations. While their relative importance has been well studied in plants and animals, less is known about their relative importance in fungal pathogens. Because agro-ecosystems are more homogeneous environments than natural ecosystems, stabilizing selection may play a stronger role than genetic drift or diversifying selection in shaping genetic variation among populations of fungal pathogens in agro-ecosystems. We tested this hypothesis by conducting a Q(ST)/F-ST analysis using agricultural populations of the barley pathogen Rhynchosporium commune. Population divergence for eight quantitative traits (Q(ST)) was compared with divergence at eight neutral microsatellite loci (F-ST) for 126 pathogen strains originating from nine globally distributed field populations to infer the effects of genetic drift and types of selection acting on each trait. Our analyses indicated that five of the eight traits had Q(ST) values significantly lower than F-ST, consistent with stabilizing selection, whereas one trait, growth under heat stress (22 degrees C), showed evidence of diversifying selection and local adaptation (Q(ST)>F-ST). Estimates of heritability were high for all traits (means ranging between 0.55-0.84), and average heritability across traits was negatively correlated with microsatellite gene diversity. Some trait pairs were genetically correlated and there was significant evidence for a trade-off between spore size and spore number, and between melanization and growth under benign temperature. Our findings indicate that many ecologically and agriculturally important traits are under stabilizing selection in R. commune and that high within-population genetic variation is maintained for these traits.	[Stefansson, Tryggvi S.; McDonald, Bruce A.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Willi, Yvonne] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Neuchatel	Willi, Y (corresponding author), Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland.	yvonne.willi@unine.ch	McDonald, Bruce A/A-2748-2008	McDonald, Bruce A/0000-0002-5332-2172	ETH Zurich [TH-02 07-1]; Swiss National Science Foundation [PP00P3-123396]; Fondation Pierre Mercier pour la Science	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Pierre Mercier pour la Science	The research was supported by grants from ETH Zurich (TH-02 07-1 to YW and BAM), the Swiss National Science Foundation (PP00P3-123396 to YW), and the Fondation Pierre Mercier pour la Science (to YW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, FUNGAL GENET BIOL, V47, P828, DOI 10.1016/j.fgb.2010.07.002; Barrett LG, 2008, MOL ECOL, V17, P3401, DOI 10.1111/j.1365-294X.2008.03843.x; Bever JD, 1999, AM J BOT, V86, P1209, DOI 10.2307/2656768; Falconer D. S., 1996, INTRO QUANTITATIVE G; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HAMID AH, 1982, PHYTOPATHOLOGY, V72, P1166, DOI 10.1094/Phyto-72-1166; HILL JP, 1982, PHYTOPATHOLOGY, V72, P525, DOI 10.1094/Phyto-72-525; HOULE D, 1989, EVOLUTION, V43, P1767, DOI 10.1111/j.1558-5646.1989.tb02625.x; Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x; King KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072536; KNAPP SJ, 1989, GENETICS, V121, P891; Lamari L., 2002, ASSESS IMAGE ANAL SO; Lebarbenchon C, 2008, MOL ECOL, V17, P475, DOI 10.1111/j.1365-294X.2007.03375.x; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Leinonen T, 2013, NAT REV GENET, V14, P179, DOI 10.1038/nrg3395; Linde CC, 2009, MOL PHYLOGENET EVOL, V51, P454, DOI 10.1016/j.ympev.2009.03.002; Linde CC, 2005, MOL ECOL NOTES, V5, P546, DOI 10.1111/j.1471-8286.2005.00983.x; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; McKay JK, 2002, TRENDS ECOL EVOL, V17, P285, DOI 10.1016/S0169-5347(02)02478-3; Merila J, 2001, J EVOLUTION BIOL, V14, P892, DOI 10.1046/j.1420-9101.2001.00348.x; MILLER RG, 1968, ANN MATH STAT, V39, P567, DOI 10.1214/aoms/1177698418; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Murray GM, 2009, CURRENT POTENTIAL CO; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; SAS, 2008, SAS ONLINEDOC VERS 9; SHIPTON W A, 1974, Review of Plant Pathology, V53, P839; SPITZE K, 1993, GENETICS, V135, P367; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Stefansson TS, 2014, PLANT PATHOL, V63, P405, DOI 10.1111/ppa.12111; Stefansson TS, 2013, EVOL APPL, V6, P524, DOI 10.1111/eva.12039; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Thrall PH, 2011, EVOL APPL, V4, P200, DOI 10.1111/j.1752-4571.2010.00179.x; TURELLI M, 1984, THEOR POPUL BIOL, V25, P138, DOI 10.1016/0040-5809(84)90017-0; Van Buskirk J, 2006, EVOLUTION, V60, P2428, DOI 10.1111/j.0014-3820.2006.tb01879.x; Whitlock MC, 2008, MOL ECOL, V17, P1885, DOI 10.1111/j.1365-294X.2008.03712.x; Willi Y, 2006, ANNU REV ECOL EVOL S, V37, P433, DOI 10.1146/annurev.ecolsys.37.091305.110145; Willi Y, 2011, GENETICA, V139, P903, DOI 10.1007/s10709-011-9594-9; Willi Y, 2010, EVOL ECOL RES, V12, P761; Wright S, 1931, GENETICS, V16, P0097; Zaffarano PL, 2008, EVOLUTION, V62, P1418, DOI 10.1111/j.1558-5646.2008.00390.x; Zaffarano PL, 2006, PHYTOPATHOLOGY, V96, P941, DOI 10.1094/PHYTO-96-0941; Zaffarano PL, 2011, MYCOLOGIA, V103, P195, DOI 10.3852/10-119; Zhan J, 2006, MOL PLANT PATHOL, V7, P259, DOI 10.1111/J.1364-3703.2006.00336.X; Zhan J, 2005, MOL ECOL, V14, P2683, DOI 10.1111/j.1365-294X.2005.02638.x; Zhan JS, 2011, MOL ECOL, V20, P1689, DOI 10.1111/j.1365-294X.2011.05023.x	47	14	14	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112523	10.1371/journal.pone.0112523	http://dx.doi.org/10.1371/journal.pone.0112523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383967	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700075
J	Hu, JM; Chuenchor, W; Rokita, SE				Hu, Jimin; Chuenchor, Watchalee; Rokita, Steven E.			A Switch between One- and Two-electron Chemistry of the Human Flavoprotein Iodotyrosine Deiodinase Is Controlled by Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Enzyme Structure; Flavin Mononucleotide (FMN); Oxidation-Reduction (Redox); Thyroid; Dehalogenase; Flavoprotein; Iodotyrosine	ACYL-COA DEHYDROGENASE; ELECTRON-TRANSFER FLAVOPROTEIN; REDOX PROPERTIES; FLAVIN; REDUCTION; SITE; MECHANISM; PROTEIN; IDENTIFICATION; FLAVOENZYMES	Background: Iodotyrosine deiodinase utilizes FMN to maintain iodide homeostasis by reductive deiodination of iodotyrosine. Results: Crystallographic, pH, and redox studies demonstrate the role of substrate in organizing the active site for effective catalysis. Conclusion: Stepwise single electron transfer is promoted only after coordination of a halotyrosine within iodotyrosine deiodinase. Significance: A synergy between substrate selectivity and catalytic activity is created by the enzyme. Reductive dehalogenation is not typical of aerobic organisms but plays a significant role in iodide homeostasis and thyroid activity. The flavoprotein iodotyrosine deiodinase (IYD) is responsible for iodide salvage by reductive deiodination of the iodotyrosine derivatives formed as byproducts of thyroid hormone biosynthesis. Heterologous expression of the human enzyme lacking its N-terminal membrane anchor has allowed for physical and biochemical studies to identify the role of substrate in controlling the active site geometry and flavin chemistry. Crystal structures of human IYD and its complex with 3-iodo-l-tyrosine illustrate the ability of the substrate to provide multiple interactions with the isoalloxazine system of FMN that are usually provided by protein side chains. Ligand binding acts to template the active site geometry and significantly stabilize the one-electron-reduced semiquinone form of FMN. The neutral form of this semiquinone is observed during reductive titration of IYD in the presence of the substrate analog 3-fluoro-l-tyrosine. In the absence of an active site ligand, only the oxidized and two-electron-reduced forms of FMN are detected. The pH dependence of IYD binding and turnover also supports the importance of direct coordination between substrate and FMN for productive catalysis.	[Hu, Jimin; Chuenchor, Watchalee; Rokita, Steven E.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Rokita, Steven E.] Johns Hopkins Univ, Dept Chem, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; Johns Hopkins University	Rokita, SE (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	rokita@jhu.edu	Rokita, Steven E/C-4793-2009	Chuenchor, Watchalee/0000-0002-4366-9914	National Institutes of Health [RO1 DK084186]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant RO1 DK084186 (to S. E. R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afink G, 2008, J CLIN ENDOCR METAB, V93, P4894, DOI 10.1210/jc.2008-0865; ANDERSON RF, 1983, BIOCHIM BIOPHYS ACTA, V722, P158, DOI 10.1016/0005-2728(83)90169-X; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; BECKER DF, 1994, BIOCHEMISTRY-US, V33, P7082, DOI 10.1021/bi00189a010; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bowsher CG, 2011, BIOCHEMISTRY-US, V50, P1778, DOI 10.1021/bi1014562; Buss JM, 2012, PROTEIN SCI, V21, P351, DOI 10.1002/pro.2020; BYRON CM, 1989, BIOCHEMISTRY-US, V28, P8582, DOI 10.1021/bi00447a047; Clark W. M., 1960, OXIDATION REDUCTION; Cook G., 2007, FUNDAMENTALS PROTEIN, P325; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engst S, 1999, BIOCHEMISTRY-US, V38, P257, DOI 10.1021/bi9815041; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; Friedman JE, 2006, J BIOL CHEM, V281, P2812, DOI 10.1074/jbc.M510365200; GEMMILL CL, 1955, ARCH BIOCHEM BIOPHYS, V54, P359, DOI 10.1016/0003-9861(55)90048-5; Gnidehou S, 2004, FASEB J, V18, P1574, DOI 10.1096/fj.04-2023fje; Gnidehou S, 2006, THYROID, V16, P715, DOI 10.1089/thy.2006.16.715; GORELICK RJ, 1985, BIOCHEMISTRY-US, V24, P6830, DOI 10.1021/bi00345a015; GOSWAMI A, 1977, ENDOCRINOLOGY, V101, P331, DOI 10.1210/endo-101-2-331; GREEN WL, 1968, ENDOCRINOLOGY, V83, P336, DOI 10.1210/endo-83-2-336; GREENSTEIN JP, 1961, CHEMISTRY AMINO ACID, V1, P486; Hamill MJ, 2012, INT J MOL SCI, V13, P16899, DOI 10.3390/ijms131216899; Heroux A, 2009, BIOCHEMISTRY-US, V48, P3407, DOI 10.1021/bi8023042; Koziol J, 1971, METHOD ENZYMOL, V18, P235; Kunishima M, 1999, J AM CHEM SOC, V121, P4722, DOI 10.1021/ja990693n; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Massey V., 1991, P 10 INT S COM IT JU, P59; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; McTamney PM, 2009, J AM CHEM SOC, V131, P14212, DOI 10.1021/ja906642n; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; Moreno JC, 2008, NEW ENGL J MED, V358, P1811, DOI 10.1056/NEJMoa0706819; Nicola JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4948; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Panda SP, 2006, J BIOL CHEM, V281, P34246, DOI 10.1074/jbc.M601041200; Phatarphekar A, 2014, MOL BIOSYST, V10, P86, DOI 10.1039/c3mb70398c; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Rokita SE, 2013, HANDBOOK OF FLAVOPROTEINS, VOL 1: OXIDASES, DEHYDROGENASES AND RELATED SYSTEMS, P337; Rokita SE, 2010, BIOCHIMIE, V92, P1227, DOI 10.1016/j.biochi.2010.02.013; ROSENBERG IN, 1984, METHOD ENZYMOL, V107, P488; STRADINS J, 1993, J ELECTROANAL CHEM, V353, P57, DOI 10.1016/0022-0728(93)80286-Q; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Thomas SR, 2009, J BIOL CHEM, V284, P19659, DOI 10.1074/jbc.M109.013458; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; van den Heuvel RHH, 2000, J BIOL CHEM, V275, P14799, DOI 10.1074/jbc.275.20.14799; van den Heuvel RHH, 2002, METHOD ENZYMOL, V353, P177; Velazquez F, 2011, CHEM BIOL, V18, P1252, DOI 10.1016/j.chembiol.2011.08.003; Warner JR, 2007, BIOCHEMISTRY-US, V46, P13211, DOI 10.1021/bi701069n; Watson JA, 2008, CHEMBIOCHEM, V9, P504, DOI 10.1002/cbic.200700562; Yang KY, 2007, BIOCHEMISTRY-US, V46, P2289, DOI 10.1021/bi0616293; Zhou ZM, 1996, BIOCHEMISTRY-US, V35, P15980, DOI 10.1021/bi962124n	56	31	32	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					590	600		10.1074/jbc.M114.605964	http://dx.doi.org/10.1074/jbc.M114.605964			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25395621	Green Published, hybrid			2022-12-26	WOS:000347231200051
J	Bessho, M; Murase-Mishiba, Y; Imagawa, A; Terasaki, J; Hanafusa, T				Bessho, Megumi; Murase-Mishiba, Yuko; Imagawa, Akihisa; Terasaki, Jungo; Hanafusa, Toshiaki			Possible Contribution of Taurine to Distorted Glucagon Secretion in Intra-Islet Insulin Deficiency: A Metabolome Analysis Using a Novel alpha-Cell Model of Insulin-Deficient Diabetes	PLOS ONE			English	Article							GLUCOSE-INHIBITION; CHANNELS; HYPOGLYCEMIA; RELEASE; ADOLESCENTS; EXPRESSION; GLUTAMATE; INFUSION; ARGININE	Glycemic instability is a serious problem in patients with insulin-deficient diabetes, and it may be due in part to abnormal endogenous glucagon secretion. However, the intracellular metabolic mechanism(s) involved in the aberrant glucagon response under the condition of insulin deficiency has not yet been elucidated. To investigate the metabolic traits that underlie the distortion of glucagon secretion under insulin deficient conditions, we generated an alpha TC1-6 cell line with stable knockdown of the insulin receptor (IRKD), i.e., an in vitro alpha-cell model for insulin-deficient diabetes, which exhibits an abnormal glucagon response to glucose. A comprehensive metabolomic analysis of the IRKD alpha TC1-6 cells (IRKD cells) revealed some candidate metabolites whose levels differed markedly compared to those in control alpha TC1-6 cells, but also which could affect the glucagon release in IRKD cells. Of these candidates, taurine was remarkably increased in the IRKD cells and was identified as a stimulator of glucagon in alpha TC1-6 cells. Taurine also paradoxically exaggerated the glucagon secretion at a high glucose concentration in IRKD cells and islets with IRKD. These results indicate that the metabolic alterations induced by IRKD in alpha-cells, especially the increase of taurine, may lead to the distorted glucagon response in IRKD cells, suggesting the importance of taurine in the paradoxical glucagon response and the resultant glucose instability in insulin-deficient diabetes.	[Bessho, Megumi; Murase-Mishiba, Yuko; Imagawa, Akihisa; Terasaki, Jungo; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Osaka, Japan; [Imagawa, Akihisa] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka, Japan	Osaka Medical College; Osaka University	Murase-Mishiba, Y (corresponding author), Osaka Med Coll, Dept Internal Med 1, Osaka, Japan.	in1254@poh.osaka-med.ac.jp			KAKENHI from Japan Society for the Promotion of Science (JSPS) [25461367]; Grants-in-Aid for Scientific Research [25461367] Funding Source: KAKEN	KAKENHI from Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI from Japan Society for the Promotion of Science (JSPS) to YMM (25461367). No additional funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGENSTAL RM, 1983, DIABETES, V32, P398, DOI 10.2337/diabetes.32.5.398; Bessho M, 2013, DIABETES RES CLIN PR, V102, pE38, DOI 10.1016/j.diabres.2013.09.003; Bollyky J, 2007, J CLIN ENDOCR METAB, V92, P2879, DOI 10.1210/jc.2007-1312; Bres V, 2000, BRIT J PHARMACOL, V130, P1976, DOI 10.1038/sj.bjp.0703492; Chang RCC, 2001, NEUROCHEM INT, V38, P249, DOI 10.1016/S0197-0186(00)00082-6; Cherif H, 1996, J ENDOCRINOL, V151, P501, DOI 10.1677/joe.0.1510501; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200; El Idrissi A, 2008, AMINO ACIDS, V34, P321, DOI 10.1007/s00726-006-0396-9; Gaisano HY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00349; GERICH JE, 1975, J CLIN ENDOCR METAB, V41, P1178, DOI 10.1210/jcem-41-6-1178; GERICH JE, 1973, SCIENCE, V182, P171, DOI 10.1126/science.182.4108.171; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Greenbaum CJ, 2002, DIABETES, V51, P951, DOI 10.2337/diabetes.51.4.951; HAMAGUCHI K, 1990, DIABETES, V39, P415, DOI 10.2337/diabetes.39.4.415; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Hayashi M, 2001, J BIOL CHEM, V276, P43400, DOI 10.1074/jbc.M106244200; Henningsson R, 1998, AM J PHYSIOL-ENDOC M, V275, pE500, DOI 10.1152/ajpendo.1998.275.3.E500; Henningsson R, 2000, AM J PHYSIOL-ENDOC M, V279, pE95, DOI 10.1152/ajpendo.2000.279.1.E95; Ishihara H, 2003, NAT CELL BIOL, V5, P330, DOI 10.1038/ncb951; Kawamori D, 2011, DIABETES OBES METAB, V13, P21, DOI 10.1111/j.1463-1326.2011.01442.x; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; KULAKOWSKI EC, 1984, BIOCHEM PHARMACOL, V33, P2835, DOI 10.1016/0006-2952(84)90204-1; L'Amoreaux WJ, 2010, J BIOMED SCI S1, V17, pS1; Lambert IH, 2004, NEUROCHEM RES, V29, P27, DOI 10.1023/B:NERE.0000010433.08577.96; Leclerc I, 2011, DIABETOLOGIA, V54, P125, DOI 10.1007/s00125-010-1929-z; Leung YM, 2006, ENDOCRINOLOGY, V147, P2155, DOI 10.1210/en.2005-1249; Newsholme P, 2007, BIOCHEM SOC T, V35, P1180, DOI 10.1042/BST0351180; Paul GL, 1998, J NUTR, V128, P973, DOI 10.1093/jn/128.6.973; Porksen S, 2007, J CLIN ENDOCR METAB, V92, P2910, DOI 10.1210/jc.2007-0244; Reynolds C, 1997, DIABETES, V26, P36; Ribeiro RA, 2009, DIABETES-METAB RES, V25, P370, DOI 10.1002/dmrr.959; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Salehi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002165; Satoh H, 1998, GEN PHARMACOL-VASC S, V30, P451, DOI 10.1016/S0306-3623(97)00309-1; Siafarikas A, 2012, DIABETES CARE, V35, P1757, DOI 10.2337/dc11-2010; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Taborsky Gerald J Jr, 2010, J Diabetes Sci Technol, V4, P1338; TIMBRELL JA, 1995, GEN PHARMACOL-VASC S, V26, P453, DOI 10.1016/0306-3623(94)00203-Y; TOKUNAGA H, 1983, EUR J PHARMACOL, V87, P237, DOI 10.1016/0014-2999(83)90333-3; Tricarico D, 2000, BRIT J PHARMACOL, V130, P827, DOI 10.1038/sj.bjp.0703385; Unger RH, 2010, P NATL ACAD SCI USA, V107, P16009, DOI 10.1073/pnas.1006639107; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Yaekura K, 1998, AM J PHYSIOL-CELL PH, V274, pC513, DOI 10.1152/ajpcell.1998.274.2.C513; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014	47	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113254	10.1371/journal.pone.0113254	http://dx.doi.org/10.1371/journal.pone.0113254			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393115	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300145
J	Choi, JS; Kim, HO; Kim, EK; Suh, YJ; Yoon, JH; Moon, HJ; Kim, MJ				Choi, Ji Soo; Kim, Hyun Ok; Kim, Eun-Kyung; Suh, Young Joo; Yoon, Jung Hyun; Moon, Hee Jung; Kim, Min Jung			HER2 Expression in Fine Needle Aspirates of Lymph Nodes Detected by Preoperative Axillary Ultrasound in Breast Cancer Patients	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CLINICOPATHOLOGICAL PARAMETERS; PROTEIN OVEREXPRESSION; HER-2/NEU EXPRESSION; GENE AMPLIFICATION; ULTRASONOGRAPHY; THERAPY; IMPACT; CHEMOTHERAPY; TRASTUZUMAB	The purpose of this study was to assess the usefulness of HER2 levels in ultrasonographically guided fine-needle aspiration biopsy (US-FNA) aspirates of axillary lymph nodes (ALNs) in the determination of lymph node metastasis or the characterization of primary breast cancer, and to correlate the HER2 levels in US-FNA aspirates (FNA-HER2s) of metastatic ALNs with the HER2 statuses of corresponding primary breast cancers. An institutional review board approved the study. Between January and October 2010, 164 patients with 167 ALNs examined by US-FNA were included. FNA-HER2s of ALNs were measured by chemiluminescence immunoassay, and they were correlated with cytologic/final diagnoses. Receiver operating characteristics (ROC) curve analysis was performed to evaluate the diagnostic ability to differentiate benign and metastatic ALNs. Additionally, FNA-HER2s of metastatic ALNs were correlated with HER2 status and other clinicopathologic variables of the primary breast cancers. Among the 167 ALNs, 138 were metastatic and 29 were benign. The mean FNAHER2 (6.3 ng/ml) of metastatic ALNs was higher than that of benign ALNs. All 29 benign ALNs showed no measurable value of FNA-HER2 (0.0 ng/ml). The area under the ROC curves of FNA-HER2 of ALNs was 0.679 for the diagnosis of ALN metastasis. The FNA-HER2 statuses of 108 metastatic ALNs (79.4%) were concordant with the HER2 statuses of the corresponding primary breast cancers. In a subgroup analysis of HER2-positive cancers with ALN metastasis, distant metastasis was significantly associated with FNA-HER2-negativity of metastatic ALNs (P = 0.04). Although FNA-HER2 of ALNs did not improve the diagnostic performance of FNA cytology in preoperative diagnosis of ALN metastasis of overall patients, FNA-HER2-positive metastatic ALNs were significantly associated with HER2-positivity of primary breast cancers. Additionally, FNA-HER2 analysis of ALN may help to develop more personalized treatment protocol for breast cancer patients by determining the concordance or discordance of HER2 status between primary cancers and metastatic ALNs.	[Choi, Ji Soo; Kim, Eun-Kyung; Suh, Young Joo; Yoon, Jung Hyun; Moon, Hee Jung; Kim, Min Jung] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea; [Choi, Ji Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Hyun Ok] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Kim, MJ (corresponding author), Yonsei Univ, Coll Med, Res Inst Radiol Sci, Dept Radiol, Seoul, South Korea.	mines@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Moon, Hee Jung/0000-0002-5643-5885; Kim, Hyun Ok/0000-0002-4964-1963; Suh, Young Joo/0000-0002-2078-5832; Yoon, Jung Hyun/0000-0002-2100-3513	Basic Science Research Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea [2013R1A1A3013165]	Basic Science Research Program of the National Research Foundation of Korea - Ministry of Science, ICT & Future Planning, Republic of Korea	This study was supported by the Basic Science Research Program of the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (preparation of the manuscript grant 2013R1A1A3013165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama K, 2010, JPN J CLIN ONCOL, V40, P613, DOI 10.1093/jjco/hyq019; Banerjee M, 2004, J CLIN ONCOL, V22, P2567, DOI 10.1200/JCO.2004.11.141; Beatty BG, 2004, AM J CLIN PATHOL, V122, P246, DOI 10.1309/X8UP920UF4XM1C5C; BRYAN RM, 1986, BRIT J SURG, V73, P267, DOI 10.1002/bjs.1800730408; Choi JS, 2012, ULTRASOUND MED BIOL, V38, P1881, DOI 10.1016/j.ultrasmedbio.2012.07.011; Ciatto S, 2007, BREAST CANCER RES TR, V103, P85, DOI 10.1007/s10549-006-9355-0; Colomer R, 2004, ANN ONCOL, V15, P201, DOI 10.1093/annonc/mdh048; Cools-Lartigue J, 2012, WORLD J SURG, V36, P46, DOI 10.1007/s00268-011-1319-9; Deurloo EE, 2003, EUR J CANCER, V39, P1068, DOI 10.1016/S0959-8049(02)00748-7; Edgerton SM, 2003, APPL IMMUNOHISTO M M, V11, P214; Fraile M, 2000, ANN ONCOL, V11, P701, DOI 10.1023/A:1008377910967; Gong Y, 2005, CANCER-AM CANCER SOC, V103, P1763, DOI 10.1002/cncr.20987; Hicks DG, 2008, AM J CLIN PATHOL, V129, P263, DOI 10.1309/99AE032R9FM8WND1; Huang Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0966-8; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Jain A, 2008, ANN SURG ONCOL, V15, P462, DOI 10.1245/s10434-007-9623-1; Kim MJ, 2010, RADIOLOGY, V254, P691, DOI 10.1148/radiol.09091031; Koelliker SL, 2008, RADIOLOGY, V246, P81, DOI 10.1148/radiol.2463061463; Krishnamurthy S, 2002, CANCER, V95, P982, DOI 10.1002/cncr.10786; Lipton A, 2002, J CLIN ONCOL, V20, P1467, DOI 10.1200/JCO.20.6.1467; Lower EE, 2009, BREAST CANCER RES TR, V113, P301, DOI 10.1007/s10549-008-9931-6; Ludovini V, 2008, ANN ONCOL, V19, P883, DOI 10.1093/annonc/mdm585; Moore A, 2008, BRIT J RADIOL, V81, P630, DOI 10.1259/bjr/21933846; Muller V, 2003, INT J BIOL MARKER, V18, P13, DOI 10.1177/172460080301800103; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; NIEHANS GA, 1993, JNCI-J NATL CANCER I, V85, P1230, DOI 10.1093/jnci/85.15.1230; Park SH, 2011, ANN SURG ONCOL, V18, P738, DOI 10.1245/s10434-010-1347-y; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Ryu DW, 2012, J BREAST CANCER, V15, P71, DOI 10.4048/jbc.2012.15.1.71; Santinelli A, 2008, INT J CANCER, V122, P999, DOI 10.1002/ijc.23051; Seol H, 2012, MODERN PATHOL, V25, P938, DOI 10.1038/modpathol.2012.36; Shimizu C, 2000, J SURG ONCOL, V73, P17, DOI 10.1002/(SICI)1096-9098(200001)73:1<17::AID-JSO5>3.3.CO;2-U; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; van Rijk MC, 2006, ANN SURG ONCOL, V13, P31, DOI 10.1245/ASO.2005.01.024; Veronesi U, 1997, LANCET, V349, P1864, DOI 10.1016/S0140-6736(97)01004-0; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057248	38	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113065	10.1371/journal.pone.0113065	http://dx.doi.org/10.1371/journal.pone.0113065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393693	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300139
J	Robles, MD; Cutillas, C; Panei, CJ; Callejon, R				del Rosario Robles, Maria; Cutillas, Cristina; Javier Panei, Carlos; Callejon, Rocio			Morphological and Molecular Characterization of a New Trichuris Species (Nematoda- Trichuridae), and Phylogenetic Relationships of Trichuris Species of Cricetid Rodents from Argentina	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; RIBOSOMAL DNA-SEQUENCE; TRICHOSTRONGYLUS NEMATODA; ITS1-5.8S-ITS2 SEGMENT; WHIPWORM; RDNA; IDENTIFICATION; SIGMODONTINAE; REDESCRIPTION; SKRJABINI	Populations of Trichuris spp. isolated from six species of sigmodontine rodents from Argentina were analyzed based on morphological characteristics and ITS2 (rDNA) region sequences. Molecular data provided an opportunity to discuss the phylogenetic relationships among the Trichuris spp. from Noth and South America (mainly from Argentina). Trichuris specimens were identified morphologically as Trichuris pardinasi, T. navonae, Trichuris sp. and Trichuris new species, described in this paper. Sequences analyzed by Maximum Parsimony, Maximum Likelihood and Bayesian inference methods showed four main clades corresponding with the four different species regardless of geographical origin and host species. These four species from sigmodontine rodents clustered together and separated from Trichuris species isolated from murine and arvicoline rodents (outgroup). Different genetic lineages observed among Trichuris species from sigmodontine rodents which supported the proposal of a new species. Moreover, host distribution showed correspondence with the different tribes within the subfamily Sigmodontinae.	[del Rosario Robles, Maria] Univ Nacl La Plata, CCT CONICET La Plata, Ctr Estudios Parasitol & Vectores CEPAVE, La Plata, Buenos Aires, Argentina; [Cutillas, Cristina; Callejon, Rocio] Univ Seville, Fac Farm, Dept Microbiol & Parasitol, Seville, Spain; [Javier Panei, Carlos] Univ Nacl La Plata, Fac Ciencias Vet, La Plata, Buenos Aires, Argentina; [del Rosario Robles, Maria; Javier Panei, Carlos] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Sevilla; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Robles, MD (corresponding author), Univ Nacl La Plata, CCT CONICET La Plata, Ctr Estudios Parasitol & Vectores CEPAVE, La Plata, Buenos Aires, Argentina.	rosario@cepave.edu.ar	Callejón-Fernández, Rocío/K-8743-2014; Cutillas, Cristina/L-1738-2014	Callejón-Fernández, Rocío/0000-0002-6276-3818; Cutillas, Cristina/0000-0002-3886-1231	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-0924]; Proyecto de incentivos de la Universidad Nacional de La Plata [UNLP N 627]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Proyecto de incentivos de la Universidad Nacional de La Plata	The authors received no specific funding for this work. However, some grants contributed to the cost of sampling and laboratory supplies: Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-0924); Proyecto de incentivos de la Universidad Nacional de La Plata (UNLP N 627 and travel grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GR, 1998, SYST PARASITOL, V41, P87, DOI 10.1023/A:1006024128098; Anderson R. C., 2000, Nematode parasites of vertebrates: their development and transmission., DOI 10.1079/9780851994215.0000; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; BABERO BB, 1987, T AM MICROSC SOC, V106, P190, DOI 10.2307/3226320; BABERO BB, 1975, J PARASITOL, V61, P1061, DOI 10.2307/3279376; BABERO BB, 1990, MEM I OSWALDO CRUZ, V85, P211, DOI 10.1590/S0074-02761990000200012; BABERO BB, 1976, T AM MICROSC SOC, V95, P232, DOI 10.2307/3225071; BARUS V, 1975, Folia Parasitologica (Ceske Budejovice), V22, P207; Bonvicino C R, 2002, BRAZ J BIOL, V62, P1; Cafrune MM, 1999, J PARASITOL, V85, P961, DOI 10.2307/3285836; Callejon R, 2012, VET PARASITOL, V186, P350, DOI 10.1016/j.vetpar.2011.11.033; Callejon R, 2010, PARASITOL RES, V107, P631, DOI 10.1007/s00436-010-1908-9; CAMERON T. W. M., 1951, CANDIAN JOUR ZOOL, V29, P276, DOI 10.1139/z51-025; CAMPBELL AJD, 1995, INT J PARASITOL, V25, P359, DOI 10.1016/0020-7519(94)00116-6; CHANDLER AC, 1945, J PARASITOL, V31, P284, DOI 10.2307/3273006; CHANDLER ASA C., 1930, JOUR PARASITOL, V16, P198, DOI 10.2307/3271514; CHILTON NB, 1995, INT J PARASITOL, V25, P647, DOI 10.1016/0020-7519(94)00171-J; Cirignoli S, 2005, MAMIFEROS ARGENTINA, P166; Cirignoli Sebastián, 2011, Mastozool. neotrop., V18, P25; Crespo J. A., 1964, Neotropica, V10, P99; Cutillas C, 1995, EXP PARASITOL, V81, P621, DOI 10.1006/expr.1995.1159; Cutillas C, 1996, ACTA TROP, V62, P63, DOI 10.1016/S0001-706X(96)00019-8; Cutillas C, 2004, J PARASITOL, V90, P648, DOI 10.1645/GE-3295RN; Cutillas C, 2002, PARASITOL RES, V88, P574, DOI 10.1007/s00436-002-0596-5; Cutillas C, 2007, PARASITOL RES, V100, P383, DOI 10.1007/s00436-006-0275-z; de la Sancha NU, 2014, MAMMALIA, V78, P437, DOI 10.1515/mammalia-2013-0100; Robles María del Rosario, 2014, Mastozool. neotrop., V21, P67; Robles MD, 2011, J PARASITOL, V97, P319, DOI 10.1645/GE-2434.1; Epe C, 1997, RES VET SCI, V62, P17, DOI 10.1016/S0034-5288(97)90173-9; Feliu C, 2000, J PARASITOL, V86, P442, DOI 10.1645/0022-3395(2000)086[0442:GAMHIS]2.0.CO;2; Galazzo DE, 2002, CAN J ZOOL, V80, P2207, DOI 10.1139/Z02-198; Galliari Carlos A., 1996, Mastozoologia Neotropical, V3, P39; Gasser R, 1996, MOL CELL PROBE, V10, P99, DOI 10.1006/mcpr.1996.0014; GOMES DC, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000500004; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoste H, 1998, INT J PARASITOL, V28, P1251, DOI 10.1016/S0020-7519(98)00093-9; HOSTE H, 1995, INT J PARASITOL, V25, P75, DOI 10.1016/0020-7519(94)00085-3; Kikuchi S., 1974, J VET MED, V625, P1023; KIKUCHI S, 1974, J VET MED TOKYO, V625, P1082; KNIGHT RA, 1984, J PARASITOL, V70, P842, DOI 10.2307/3281784; Kramer Kristin M., 1999, Mammalian Species, V617, P1; Lent H., 1936, ANAIS ACAD BRASILEIR, V8, P319; Miller BR, 1996, INSECT MOL BIOL, V5, P93, DOI 10.1111/j.1365-2583.1996.tb00044.x; Morgan JAT, 1995, PARASITOLOGY, V111, P609, DOI 10.1017/S003118200007709X; Morini E. G., 1955, Publicaciones Mision de Estudios de Patologia Regional Argentina, V26, P83; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Nieberding C, 2004, P ROY SOC B-BIOL SCI, V271, P2559, DOI 10.1098/rspb.2004.2930; Nieberding CM, 2008, MOL PHYLOGENET EVOL, V47, P538, DOI 10.1016/j.ympev.2008.01.028; Oliveros R, 2000, PARASITOL RES, V86, P1008, DOI 10.1007/PL00008519; PARDINAS U., 2008, IUCN RED LIST THREAT; Pardinas UFJ, 2005, J MAMMAL, V86, P462, DOI 10.1644/1545-1542(2005)86[462:ANSOAR]2.0.CO;2; Pardinas UFJ, 2003, MAMM BIOL, V68, P129, DOI 10.1078/1616-5047-00075; Pardiñas Ulyses F. J., 2004, Mastozool. neotrop., V11, P211; Pardiuas U.F.J., 2006, MAMIFEROS ARGENTINA, P146; Patton J, 2008, IUCN RED LIST THREAT; Percequillo C, 2008, IUCN RED LIST THREAT; PFAFFENBERGER GS, 1989, P HELM SOC WASH, V56, P76; POLOP JJ, 1989, STUD NEOTROP FAUNA E, V24, P53, DOI 10.1080/01650528909360776; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; READ CLARK P., 1956, PROC HELMINTHOL SOC WASHINGTON, V23, P119; Reig O., 1987, FIELDIANA ZOOLOGY, V39, P347; Ringuelet R. A., 1961, Physis, V22, P151; Robles MDR, 2006, J PARASITOL, V92, P1053, DOI 10.1645/GE-827R.1; Robles MD, 2006, J PARASITOL, V92, P100, DOI 10.1645/GE-GE-552R.1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rossin MA, 2005, J PARASITOL, V91, P127, DOI 10.1645/GE-3383.1; SCHWARTZ BEN JAMIN, 1926, ARCH SCHIFFS U TROPEN HYG, V30, P544; SPAKULOVA M, 1994, SYST PARASITOL, V29, P113, DOI 10.1007/BF00009807; Steppan Scott J., 2007, University of California Publications in Zoology, V134, P799; Stevenson LA, 1996, INT J PARASITOL, V26, P1123, DOI 10.1016/S0020-7519(96)00064-1; Suriano D.M., 1994, Research and Reviews in Parasitology, V54, P39; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tenora F., 1997, Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis, V45, P19; Tenora F., 1993, Helminthologia (Bratislava), V30, P93; Teta Pablo, 2007, Mastozool. neotrop., V14, P279; TINER JD, 1950, J PARASITOL, V36, P350, DOI 10.2307/3273470; TODD KS, 1972, P HELM SOC WASH, V39, P203; Vargas J, 2008, IUCN RED LIST THREAT; Zhu XQ, 1998, PARASITOLOGY, V117, P155, DOI 10.1017/S0031182098002856	79	21	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112069	10.1371/journal.pone.0112069	http://dx.doi.org/10.1371/journal.pone.0112069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393618	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300030
J	Latham, AM; Kankanala, J; Fearnley, GW; Gage, MC; Kearney, MT; Homer-Vanniasinkam, S; Wheatcroft, SB; Fishwick, CWG; Ponnambalam, S				Latham, Antony M.; Kankanala, Jayakanth; Fearnley, Gareth W.; Gage, Matthew C.; Kearney, Mark T.; Homer-Vanniasinkam, Shervanthi; Wheatcroft, Stephen B.; Fishwick, Colin W. G.; Ponnambalam, Sreenivasan			In Silico Design and Biological Evaluation of a Dual Specificity Kinase Inhibitor Targeting Cell Cycle Progression and Angiogenesis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ENDOTHELIAL-CELLS; DEPENDENT KINASES; BRIVANIB ALANINATE; CRYSTAL-STRUCTURE; ACCURATE DOCKING; CDK1; DISCOVERY; TYROSINE; GLIDE	In Background: Protein kinases play a central role in tumor progression, regulating fundamental processes such as angiogenesis, proliferation and metastasis. Such enzymes are an increasingly important class of drug target with small molecule kinase inhibitors being a major focus in drug development. However, balancing drug specificity and efficacy is problematic with off-target effects and toxicity issues. Methodology: We have utilized a rational in silico-based approach to demonstrate the design and study of a novel compound that acts as a dual inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2) and cyclin-dependent kinase 1 (CDK1). This compound acts by simultaneously inhibiting pro-angiogenic signal transduction and cell cycle progression in primary endothelial cells. JK-31 displays potent in vitro activity against recombinant VEGFR2 and CDK1/cyclin B proteins comparable to previously characterized inhibitors. Dual inhibition of the vascular endothelial growth factor A (VEGF-A)-mediated signaling response and CDK1-mediated mitotic entry elicits anti-angiogenic activity both in an endothelial-fibroblast co-culture model and a murine ex vivo model of angiogenesis. Conclusions: We deduce that JK-31 reduces the growth of both human endothelial cells and human breast cancer cells in vitro. This novel synthetic molecule has broad implications for development of similar multi-kinase inhibitors with anti-angiogenic and anti-cancer properties. In silico design is an attractive and innovative method to aid such drug discovery.	[Latham, Antony M.; Fearnley, Gareth W.; Ponnambalam, Sreenivasan] Univ Leeds, Sch Mol & Cellular Biol, Endothelial Cell Biol Unit, Leeds LS2 9JT, W Yorkshire, England; [Kankanala, Jayakanth; Fishwick, Colin W. G.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Gage, Matthew C.; Kearney, Mark T.; Homer-Vanniasinkam, Shervanthi; Wheatcroft, Stephen B.] Univ Leeds, Fac Med & Hlth, Leeds Inst Cardiovasc & Metab Med, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Ponnambalam, S (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Endothelial Cell Biol Unit, Leeds LS2 9JT, W Yorkshire, England.	s.ponnambalam@leeds.ac.uk	, jayakanth/J-6949-2015	Gage, Matthew/0000-0002-6668-6573; Fishwick, Colin/0000-0003-1283-2181; Ponnambalam, Sreenivasan/0000-0002-4452-7619; Homer-Vanniasinkam, Shervanthi/0000-0001-6234-5053; KANKANALA, JAYAKANTH/0000-0002-9581-0844; Fearnley, Gareth William/0000-0002-9602-5071	Pfizer Global Inc.; ORSAS PhD award; British Heart Foundation	Pfizer Global Inc.; ORSAS PhD award; British Heart Foundation(British Heart Foundation)	This work was supported by a BBSRC-CASE PhD studentship from Pfizer Global Inc. (AML), an ORSAS PhD award (JK), and project grants from the British Heart Foundation (SP, MTK, SBW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2005, J MED CHEM, V48, P5655, DOI 10.1021/jm050533o; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Bashir T, 2005, NAT CELL BIOL, V7, P779, DOI 10.1038/ncb0805-779; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Boda K, 2006, J MED CHEM, V49, P5869, DOI 10.1021/jm050054p; Branca MA, 2005, NAT BIOTECHNOL, V23, P639, DOI 10.1038/nbt0605-639; Cai ZW, 2008, J MED CHEM, V51, P1976, DOI 10.1021/jm7013309; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Doree M, 2002, J CELL SCI, V115, P2461; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Emanuel S, 2005, CANCER RES, V65, P9038, DOI 10.1158/0008-5472.CAN-05-0882; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fearnley GW, 2014, METHOD ENZYMOL, V535, P265, DOI 10.1016/B978-0-12-397925-4.00016-X; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Haddad H, 2012, CURR TREAT OPTION ON, V13, P212, DOI 10.1007/s11864-012-0182-8; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Harris PA, 2008, J MED CHEM, V51, P4632, DOI 10.1021/jm800566m; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; Huang SL, 2007, BIOORG MED CHEM LETT, V17, P2179, DOI 10.1016/j.bmcl.2007.01.086; Huynh H, 2008, CLIN CANCER RES, V14, P6146, DOI 10.1158/1078-0432.CCR-08-0509; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kankanala J, 2012, BRIT J PHARMACOL, V166, P737, DOI 10.1111/j.1476-5381.2011.01801.x; Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Latham AM, 2012, BRIT J PHARMACOL, V165, P245, DOI 10.1111/j.1476-5381.2011.01545.x; Lee J, 2011, BIOORG MED CHEM LETT, V21, P4203, DOI 10.1016/j.bmcl.2011.05.081; Malinda KM, 1997, FASEB J, V11, P474, DOI 10.1096/fasebj.11.6.9194528; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Morphy R, 2010, J MED CHEM, V53, P1413, DOI 10.1021/jm901132v; Murphy EA, 2010, P NATL ACAD SCI USA, V107, P4299, DOI 10.1073/pnas.0909299107; Neubrand VE, 2012, J CELL SCI, V125, P1845, DOI 10.1242/jcs.102764; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Ponnambalam S, 2011, MOL NEUROBIOL, V43, P192, DOI 10.1007/s12035-011-8167-3; Potapova TA, 2009, MOL BIOL CELL, V20, P1737, DOI 10.1091/mbc.E08-07-0771; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Schmidberger JW, 2008, J MOL BIOL, V378, P284, DOI 10.1016/j.jmb.2008.02.035; Schonbrunn E, 2013, J MED CHEM, V56, P3768, DOI 10.1021/jm301234k; Squires MS, 2009, MOL CANCER THER, V8, P324, DOI 10.1158/1535-7163.MCT-08-0890; Tille JC, 2001, J PHARMACOL EXP THER, V299, P1073; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Tung JJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006601; Wang Q, 2011, CURR MED CHEM, V18, P2025, DOI 10.2174/092986711795590110; Wyatt PG, 2008, J MED CHEM, V51, P4986, DOI 10.1021/jm800382h; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6	51	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110997	10.1371/journal.pone.0110997	http://dx.doi.org/10.1371/journal.pone.0110997			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393739	gold, Green Published			2022-12-26	WOS:000347709300009
J	Hara, T; Matsui, H; Shimizu, H				Hara, Takeshi; Matsui, Hiroshi; Shimizu, Hironori			Suppression of Microbial Metabolic Pathways Inhibits the Generation of the Human Body Odor Component Diacetyl by Staphylococcus spp.	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; HUMAN AXILLA; SUCCINATE-DEHYDROGENASE; ENERGY-CHARGE; IDENTIFICATION; BIOSYNTHESIS; PERCEPTION; PRECURSORS; SUBTILIS; MALODOR	Diacetyl (2,3-butanedione) is a key contributor to unpleasant odors emanating from the axillae, feet, and head regions. To investigate the mechanism of diacetyl generation on human skin, resident skin bacteria were tested for the ability to produce diacetyl via metabolism of the main organic acids contained in human sweat. L-Lactate metabolism by Staphylococcus aureus and Staphylococcus epidermidis produced the highest amounts of diacetyl, as measured by high-performance liquid chromatography. Glycyrrhiza glabra root extract (GGR) and alpha-tocopheryl-L-ascorbate-2-O-phosphate diester potassium salt (EPC-K1), a phosphate diester of alpha-tocopherol and ascorbic acid, effectively inhibited diacetyl formation without bactericidal effects. Moreover, a metabolic flux analysis revealed that GGR and EPC-K1 suppressed diacetyl formation by inhibiting extracellular bacterial conversion of L-lactate to pyruvate or by altering intracellular metabolic flow into the citrate cycle, respectively, highlighting fundamentally distinct mechanisms by GGR and EPC-K1 to suppress diacetyl formation. These results provide new insight into diacetyl metabolism by human skin bacteria and identify a regulatory mechanism of diacetyl formation that can facilitate the development of effective deodorant agents.	[Hara, Takeshi; Matsui, Hiroshi; Shimizu, Hironori] Mandom Corp, Tech Dev Ctr, Osaka, Japan		Hara, T (corresponding author), Mandom Corp, Tech Dev Ctr, Osaka, Japan.	hara-t@mandom.co.jp			Mandom Corp.	Mandom Corp.	Financial support for this research was provided by Mandom Corp. The authors' employer (Mandom Corp.) played no role in the study design, data acquisition, or decision to publish.	[Anonymous], AUT MASS SPECTR DEC; [Anonymous], 2008, 082008 NIST; Ara K, 2006, CAN J MICROBIOL, V52, P357, DOI 10.1139/W05-130; ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Austin C, 2003, J STEROID BIOCHEM, V87, P105, DOI 10.1016/S0960-0760(03)00387-X; BENNETT G, 1965, J FOOD SCI, V30, P35, DOI 10.1111/j.1365-2621.1965.tb00259.x; Berg J, 2007, BIOCHEMISTRY-US, P428; CAPASSO F, 1983, J PHARM PHARMACOL, V35, P332, DOI 10.1111/j.2042-7158.1983.tb02949.x; DAILEY HA, 1976, J BACTERIOL, V127, P1286, DOI 10.1128/JB.127.3.1286-1291.1976; Dasari S, 2011, APPL ENVIRON MICROB, V77, P727, DOI 10.1128/AEM.01579-10; Diarra MS, 2013, BMC COMPLEM ALTERN M, V27, P13; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Garcia-Quintans N, 2008, APPL ENVIRON MICROB, V74, P1988, DOI 10.1128/AEM.01851-07; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Gaupp R, 2010, J BACTERIOL, V192, P2385, DOI 10.1128/JB.01472-09; GOETZ N, 1988, J SOC COSMET CHEM, V39, P1; GOWER DB, 1993, J ENDOCRINOL, V137, P167, DOI 10.1677/joe.0.1370167; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hara T, 2013, 22 C INT FED SOC COS, P213; Hara T, 2014, CHEM BIODIV IN PRESS; Hasegawa Y, 2004, CHEM BIODIVERS, V1, P2042, DOI 10.1002/cbdv.200490157; HEDERSTEDT L, 1980, J BACTERIOL, V144, P941, DOI 10.1128/JB.144.3.941-951.1980; James A G, 2004, Int J Cosmet Sci, V26, P149, DOI 10.1111/j.1467-2494.2004.00214.x; KANDA F, 1990, BRIT J DERMATOL, V122, P771, DOI 10.1111/j.1365-2133.1990.tb06265.x; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Kuribayashi Y, 1996, INT J TISSUE REACT, V18, P73; Kutyshenko VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028824; LABOWS JN, 1982, J SOC COSMET CHEM, V33, P193; Laden K, 1999, COSMET SCI TECHNOL S, V20, P1; LEYDEN JJ, 1981, J INVEST DERMATOL, V77, P413, DOI 10.1111/1523-1747.ep12494624; MARSHALL J, 1988, J APPL BACTERIOL, V65, P61, DOI 10.1111/j.1365-2672.1988.tb04318.x; MATSUURA H, 1990, BUNSEKI KAGAKU, V39, P405; Natsch A, 2004, CHEM BIODIVERS, V1, P1058, DOI 10.1002/cbdv.200490079; Natsch A, 2003, J BIOL CHEM, V278, P5718, DOI 10.1074/jbc.M210142200; OKU H, 1988, J BIOL CHEM, V263, P18386; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Poole K, 2012, J ANTIMICROB CHEMOTH, V67, P2069, DOI 10.1093/jac/dks196; REEVES HC, 1967, ANNU REV MICROBIOL, V21, P225, DOI 10.1146/annurev.mi.21.100167.001301; RENNIE PJ, 1991, BRIT J DERMATOL, V124, P596, DOI 10.1111/j.1365-2133.1991.tb04958.x; Sastry S.D., 1972, BIOCH APPL MASS SPEC, P1085; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; SHEN LC, 1968, BIOCHEMISTRY-US, V7, P4041, DOI 10.1021/bi00851a035; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Starkenmann C, 2005, CHEM BIODIVERS, V2, P705, DOI 10.1002/cbdv.200590048; STOCKLAND AE, 1969, J BACTERIOL, V100, P347, DOI 10.1128/JB.100.1.347-353.1969; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Swindell SR, 1996, APPL ENVIRON MICROB, V62, P2641, DOI 10.1128/AEM.62.7.2641-2643.1996; Takayama H, 2003, CIRC J, V67, P1046, DOI 10.1253/circj.67.1046; Troccaz M, 2004, CHEM BIODIVERS, V1, P1022, DOI 10.1002/cbdv.200490077; Tynecka Z, 1999, RES MICROBIOL, V150, P555, DOI 10.1016/S0923-2508(99)00102-3; WHITE DC, 1968, J BACTERIOL, V95, P2198, DOI 10.1128/JB.95.6.2198-2209.1968; ZENG XN, 1991, J CHEM ECOL, V17, P1469, DOI 10.1007/BF00983777	56	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111833	10.1371/journal.pone.0111833	http://dx.doi.org/10.1371/journal.pone.0111833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390046	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400036
J	Park, SJ; Jo, DS; Shin, JH; Kim, ES; Jo, YK; Choi, ES; Seo, HM; Kim, SH; Hwang, JJ; Jo, DG; Koh, JY; Cho, DH				Park, So Jung; Jo, Doo Sin; Shin, Ji Hyun; Kim, Eun Sung; Jo, Yoon Kyung; Choi, Eun Sun; Seo, Hae Mi; Kim, Sung Hyun; Hwang, Jung Jin; Jo, Dong-Gyu; Koh, Jae-Young; Cho, Dong-Hyung			Suppression of Cpn10 Increases Mitochondrial Fission and Dysfunction in Neuroblastoma Cells	PLOS ONE			English	Article							DYNAMIN-RELATED PROTEIN-1; PROTEOMIC ANALYSIS; CARDIAC MYOCYTES; GTPASE ACTIVITY; DRP1; HSP10; APOPTOSIS; PHOSPHORYLATION; KINASE; FUSION	To date, several regulatory proteins involved in mitochondrial dynamics have been identified. However, the precise mechanism coordinating these complex processes remains unclear. Mitochondrial chaperones regulate mitochondrial function and structure. Chaperonin 10 (Cpn10) interacts with heat shock protein 60 (HSP60) and functions as a cochaperone. In this study, we found that down-regulation of Cpn10 highly promoted mitochondrial fragmentation in SK-N-MC and SH-SY5Y neuroblastoma cells. Both genetic and chemical inhibition of Drp1 suppressed the mitochondrial fragmentation induced by Cpn10 reduction. Reactive oxygen species (ROS) generation in 3-NP-treated cells was markedly enhanced by Cpn10 knock down. Depletion of Cpn10 synergistically increased cell death in response to 3-NP treatment. Furthermore, inhibition of Drp1 recovered Cpn10-mediated mitochondrial dysfunction in 3-NP-treated cells. Moreover, an ROS scavenger suppressed cell death mediated by Cpn10 knockdown in 3-NP-treated cells. Taken together, these results showed that down-regulation of Cpn10 increased mitochondrial fragmentation and potentiated 3-NP-mediated mitochondrial dysfunction in neuroblastoma cells.	[Park, So Jung; Jo, Doo Sin; Shin, Ji Hyun; Kim, Eun Sung; Jo, Yoon Kyung; Choi, Eun Sun; Seo, Hae Mi; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept East West Med Sci, Yongin, South Korea; [Seo, Hae Mi] Kyung Hee Univ, Dept Genet Engn, Yongin, South Korea; [Kim, Sung Hyun] Kyung Hee Univ, Sch Med, Seoul, South Korea; [Hwang, Jung Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Innovat Canc Res,Asan Inst Life Sci, Seoul, South Korea; [Jo, Dong-Gyu] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea; [Koh, Jae-Young] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University; University of Ulsan; Asan Medical Center; Sungkyunkwan University (SKKU); University of Ulsan; Asan Medical Center	Cho, DH (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept East West Med Sci, Yongin, South Korea.	dhcho@khu.ac.kr	Koh, Jae-Young/C-9014-2011; Hwang, Jung Jin/F-3424-2014; Kim, Sung Hyun/AAI-8554-2020; Jo, Dong-Gyu/AAN-9278-2021	Koh, Jae-Young/0000-0002-4318-495X; Jo, Dong-Gyu/0000-0003-2271-1076; Kim, Sung Hyun/0000-0002-3166-9941	Korean Health 21 R&D Project and Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea [A092042, A120196]	Korean Health 21 R&D Project and Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korean Health 21 R&D Project and Korea-UK Collaborative Alzheimer's Disease Research Project, Ministry of Health & Welfare, Republic of Korea (A092042, A120196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cappello F, 2004, EUR J HISTOCHEM, V48, P261; Cappello F, 2003, CANCER LETT, V196, P35, DOI 10.1016/S0304-3835(03)00212-X; Cappello F, 2003, ANTICANCER RES, V23, P1325; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Cho DH, 2010, CELL MOL LIFE SCI, V67, P3435, DOI 10.1007/s00018-010-0435-2; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Chou CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049112; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Czarnecka AM, 2006, CANCER BIOL THER, V5, P714, DOI 10.4161/cbt.5.7.2975; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dobocan MC, 2009, J CELL PHYSIOL, V219, P470, DOI 10.1002/jcp.21702; Elwi AN, 2012, INT J BIOCHEM CELL B, V44, P1366, DOI 10.1016/j.biocel.2012.05.004; Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682; Ghobrial IM, 2005, BLOOD, V105, P3722, DOI 10.1182/blood-2004-10-3999; GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x; Han XJ, 2008, J CELL BIOL, V182, P573, DOI 10.1083/jcb.200802164; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Ishihara N, 2004, J CELL SCI, V117, P6535, DOI 10.1242/jcs.01565; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kageyama Y, 2011, CURR OPIN CELL BIOL, V23, P427, DOI 10.1016/j.ceb.2011.04.009; Karbowski M, 2011, CURR OPIN CELL BIOL, V23, P476, DOI 10.1016/j.ceb.2011.05.007; Khawaja X, 2004, J NEUROSCI RES, V75, P451, DOI 10.1002/jnr.10869; Lau S, 1997, CIRCULATION, V96, P2287; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Lin KM, 2004, FASEB J, V18, P1004, DOI 10.1096/fj.03-0348fje; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Obashi K, 2013, EUR J NEUROSCI, V38, P2350, DOI 10.1111/ejn.12263; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Park SJ, 2014, J BIOL CHEM, V289, P2195, DOI 10.1074/jbc.M113.492587; Qi X, 2011, MOL BIOL CELL, V22, P256, DOI 10.1091/mbc.E10-06-0551; Ray PS, 2001, FASEB J, V15, P393, DOI 10.1096/fj.00-0199com; Sadacharan SK, 2001, HISTOCHEM CELL BIOL, V116, P507, DOI 10.1007/s00418-001-0344-4; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Solesio ME, 2013, BRIT J PHARMACOL, V168, P63, DOI 10.1111/j.1476-5381.2012.01994.x; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x; Wilson TJ, 2013, NEUROBIOL DIS, V51, P13, DOI 10.1016/j.nbd.2012.01.009; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Yu TZ, 2011, ANTIOXID REDOX SIGN, V14, P425, DOI 10.1089/ars.2010.3284	49	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112130	10.1371/journal.pone.0112130	http://dx.doi.org/10.1371/journal.pone.0112130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390895	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400057
J	Vasconcelos, EJR; Nunes, VS; da Silva, MS; Segatto, M; Myler, PJ; Cano, MIN				Vasconcelos, Elton J. R.; Nunes, Vinicius S.; da Silva, Marcelo S.; Segatto, Marcela; Myler, Peter J.; Cano, Maria Isabel N.			The Putative Leishmania Telomerase RNA (LeishTER) Undergoes Trans-Splicing and Contains a Conserved Template Sequence	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE; TETRAHYMENA-TELOMERASE; TRYPANOSOMA-BRUCEI; CATALYTIC SUBUNIT; STRUCTURE PREDICTION; SECONDARY STRUCTURE; YEAST TELOMERASE; BIOCHEMICAL-PROPERTIES; COMPARATIVE GENOMICS; PARASITIC PROTOZOA	Telomerase RNAs (TERs) are highly divergent between species, varying in size and sequence composition. Here, we identify a candidate for the telomerase RNA component of Leishmania genus, which includes species that cause leishmaniasis, a neglected tropical disease. Merging a thorough computational screening combined with RNA-seq evidence, we mapped a non-coding RNA gene localized in a syntenic locus on chromosome 25 of five Leishmania species that shares partial synteny with both Trypanosoma brucei TER locus and a putative TER candidate-containing locus of Crithidia fasciculata. Using target-driven molecular biology approaches, we detected a similar to 2,100 nt transcript (LeishTER) that contains a 5' spliced leader (SL) cap, a putative 3' polyA tail and a predicted C/D box snoRNA domain. LeishTER is expressed at similar levels in the logarithmic and stationary growth phases of promastigote forms. A 5'SL capped LeishTER co-immunoprecipitated and co-localized with the telomerase protein component (TERT) in a cell cycle-dependent manner. Prediction of its secondary structure strongly suggests the existence of a bona fide single-stranded template sequence and a conserved C[U/C]GUCA motif-containing helix II, representing the template boundary element. This study paves the way for further investigations on the biogenesis of parasite TERT ribonucleoproteins (RNPs) and its role in parasite telomere biology.	[Vasconcelos, Elton J. R.; Myler, Peter J.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Nunes, Vinicius S.; da Silva, Marcelo S.; Segatto, Marcela; Cano, Maria Isabel N.] Univ Estadual Paulista, Dept Genet Inst Biociencias, Botucatu, SP, Brazil; [da Silva, Marcelo S.] Univ Estadual Campinas UNICAMP, Campinas, SP, Brazil; [Myler, Peter J.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Myler, Peter J.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA	Center for Infectious Disease Research; Universidade Estadual de Campinas; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Myler, PJ (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	peter.myler@seattlebiomed.org; micano@ibb.unesp.br	Vasconcelos, Elton/O-5593-2014; Nunes, Vinicius/W-7200-2019; Cano, Maria Isabel/A-4020-2008; Cano, Maria Isabel/M-7691-2019; da Silva, Marcelo Santos/N-4145-2014; Myler, Peter John/AAR-9535-2021	Vasconcelos, Elton/0000-0001-5130-6622; Nunes, Vinicius/0000-0002-1400-0680; Cano, Maria Isabel/0000-0001-9798-6627; da Silva, Marcelo Santos/0000-0003-4203-9299; Reis, AlessanRSS/0000-0001-8486-7469	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Brazil [2012/50263-5]; National Institute of Allergy and Infectious Diseases PHS Grant [R01 AI103858]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI103858] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Allergy and Infectious Diseases PHS Grant; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-FAPESP, Brazil to MINC [GRANT 2012/50263-5]. National Institute of Allergy and Infectious Diseases PHS Grant to PJM [GRANT R01 AI103858]. VSN, MS and MSS received post-doctoral and doctoral fellowships, respectively, from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP. EJRV is a post-doctoral fellow from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq, Brazil [PDE 202223/2012-4]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambit A, 2011, EUKARYOT CELL, V10, P1429, DOI 10.1128/EC.05118-11; Armbruster BN, 2001, MOL CELL BIOL, V21, P7775, DOI 10.1128/MCB.21.22.7775-7786.2001; AUTEXIER C, 1995, GENE DEV, V9, P2227, DOI 10.1101/gad.9.18.2227; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; BLACKBURN EH, 1984, CELL, V36, P447, DOI 10.1016/0092-8674(84)90238-1; Cano MIN, 1999, P NATL ACAD SCI USA, V96, P3616, DOI 10.1073/pnas.96.7.3616; Cano MIN, 2001, TRENDS PARASITOL, V17, P425, DOI 10.1016/S1471-4922(01)02014-1; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chakrabarti K, 2007, RNA, V13, P1923, DOI 10.1261/rna.751807; Chapon C, 1997, RNA, V3, P1337; Chen JL, 2004, P NATL ACAD SCI USA, V101, P14683, DOI 10.1073/pnas.0406204101; Chiurillo MA, 2002, MEM I OSWALDO CRUZ, V97, P343, DOI 10.1590/S0074-02762002000300011; Chiurillo MA, 2000, EXP PARASITOL, V94, P248, DOI 10.1006/expr.2000.4499; Conte FF, 2005, INT J PARASITOL, V35, P1435, DOI 10.1016/j.ijpara.2005.05.011; Counter CM, 1997, P NATL ACAD SCI USA, V94, P9202, DOI 10.1073/pnas.94.17.9202; Cros MJ, 2011, RNA, V17, P1947, DOI 10.1261/rna.2844911; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Egan ED, 2012, RNA, V18, P1747, DOI 10.1261/rna.034629.112; Egan ED, 2010, MOL CELL BIOL, V30, P2775, DOI 10.1128/MCB.00151-10; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Fu GL, 1998, NUCLEIC ACIDS RES, V26, P2161, DOI 10.1093/nar/26.9.2161; Giardini MA, 2011, EXP PARASITOL, V127, P243, DOI 10.1016/j.exppara.2010.08.001; Giardini MA, 2006, PARASITOL RES, V98, P447, DOI 10.1007/s00436-005-0036-4; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Gupta SK, 2013, FEBS LETT, V587, P1399, DOI 10.1016/j.febslet.2013.03.017; Harmanci AO, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-108; HUANG J, 1991, MOL CELL BIOL, V11, P3180, DOI 10.1128/MCB.11.6.3180; Hukezalie KR, 2013, FEBS J, V280, P3194, DOI 10.1111/febs.12272; Jackson AP, 2010, MOL BIOL EVOL, V27, P33, DOI 10.1093/molbev/msp214; Kachouri-Lafond R, 2009, FEBS LETT, V583, P3605, DOI 10.1016/j.febslet.2009.10.034; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Kolev NG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001090; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Laurentino EC, 2004, MOL BIOCHEM PARASIT, V137, P81, DOI 10.1016/j.molbiopara.2004.05.001; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Longhese MP, 2010, EMBO J, V29, P2864, DOI 10.1038/emboj.2010.165; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; MUHICH ML, 1988, MOL CELL BIOL, V8, P3837, DOI 10.1128/MCB.8.9.3837; Munoz DP, 2004, NUCLEIC ACIDS RES, V32, P5214, DOI 10.1093/nar/gkh864; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Noel JF, 2012, NUCLEIC ACIDS RES, V40, P5625, DOI 10.1093/nar/gks200; Proctor JR, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt174; Rastrojo A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-223; Requena JM, 2011, FRONT BIOSCI-LANDMRK, V16, P2069, DOI 10.2741/3840; Richards RJ, 2006, NUCLEIC ACIDS RES, V34, P816, DOI 10.1093/nar/gkj481; Rivas E, 1999, J MOL BIOL, V285, P2053, DOI 10.1006/jmbi.1998.2436; ROMERO DP, 1991, CELL, V67, P343, DOI 10.1016/0092-8674(91)90186-3; Sandhu R, 2013, CELL RES, V23, P537, DOI 10.1038/cr.2013.35; SOLARI AJ, 1980, CHROMOSOMA, V78, P239, DOI 10.1007/BF00328395; Sperschneider J, 2008, RNA, V14, P630, DOI 10.1261/rna.968808; Sykorova E, 2009, BIOL CELL, V101, P375, DOI 10.1042/BC20080205; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasconcelos EJR, 2012, MOL BIOCHEM PARASIT, V183, P140, DOI 10.1016/j.molbiopara.2012.02.009; VICKERMAN K, 1970, J CELL SCI, V6, P365; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wilusz JE, 2010, RNA, V16, P259, DOI 10.1261/rna.1907510; Xia JQ, 2000, MOL CELL BIOL, V20, P5196, DOI 10.1128/MCB.20.14.5196-5207.2000; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	70	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112061	10.1371/journal.pone.0112061	http://dx.doi.org/10.1371/journal.pone.0112061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391020	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400051
J	Yoshida, K; Yoshioka, M; Okamura, H; Moriyama, S; Kawazoe, K; Grenier, D; Hinode, D				Yoshida, Kaya; Yoshioka, Masami; Okamura, Hirohiko; Moriyama, Satomi; Kawazoe, Kazuyoshi; Grenier, Daniel; Hinode, Daisuke			Preventive Effect of Daiokanzoto (TJ-84) on 5-Fluorouracil-Induced Human Gingival Cell Death through the Inhibition of Reactive Oxygen Species Production	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; NITRIC-OXIDE; NALP3 INFLAMMASOME; HERBAL MEDICINE; KAMPO MEDICINE; ACTIVATION; EXPRESSION; IL-1-BETA; SECRETION; MUCOSITIS	Daiokanzoto (TJ-84) is a traditional Japanese herbal medicine (Kampo formulation). While many Kampo formulations have been reported to regulate inflammation and immune responses in oral mucosa, there is no evidence to show that TJ-84 has beneficial effects on oral mucositis, a disease resulting from increased cell death induced by chemotherapeutic agents such as 5-fluorouracil (5-FU). In order to develop effective new therapeutic strategies for treating oral mucositis, we investigated (i) the mechanisms by which 5-FU induces the death of human gingival cells and (ii) the effects of TJ-84 on biological events induced by 5-FU. 5-FU-induced lactate dehydrogenase (LDH) release and pore formation in gingival cells (Sa3 cell line) resulted in cell death. Incubating the cells with 5-FU increased the expression of nucleotide-binding domain and leucine-rich repeat containing PYD-3 (NLRP3) and caspase-1. The cleavage of caspase-1 was observed in 5-FU-treated cells, which was followed by an increased secretion of interleukin (IL)-1 beta. The inhibition of the NLRP3 pathway slightly decreased the effects of 5-FU on cell viability and LDH release, suggesting that NLRP3 may be in part involved in 5-FU-induced cell death. TJ-84 decreased 5-FU-induced LDH release and cell death and also significantly inhibited the depolarization of mitochondria and the up-regulation of 5-FU-induced reactive oxygen species (ROS) and nitric oxide (NO) production. The transcriptional factor, nuclear factor-kappa B (NF-kappa B) was not involved in the 5-FU-induced cell death in Sa3 cells. In conclusion, we provide evidence suggesting that the increase of ROS production in mitochondria, rather than NLRP3 activation, was considered to be associated with the cell death induced by 5-FU. The results also suggested that TJ-84 may attenuate 5-FU-induced cell death through the inhibition of mitochondrial ROS production.	[Yoshida, Kaya] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Healthcare Educ, Tokushima 770, Japan; [Yoshioka, Masami] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Hlth Sci & Social Welf, Tokushima 770, Japan; [Okamura, Hirohiko] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Histol & Oral Histol, Tokushima 770, Japan; [Moriyama, Satomi; Hinode, Daisuke] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Hyg & Oral Hlth Sci, Tokushima 770, Japan; [Kawazoe, Kazuyoshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Clin Pharm, Tokushima 770, Japan; [Grenier, Daniel] Univ Laval, Fac Dent, Oral Ecol Res Grp, Quebec City, PQ, Canada	Tokushima University; Tokushima University; Tokushima University; Tokushima University; Laval University	Yoshida, K (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Healthcare Educ, Tokushima 770, Japan.	kaya@tokushima-u.ac.jp	Okamura, Hirohiko/I-5917-2019; Grenier, Daniel/E-5557-2015	Okamura, Hirohiko/0000-0002-3254-5238; Grenier, Daniel/0000-0003-0878-4674; Yoshida, Kaya/0000-0002-3202-0634	Ministry of Education, Culture, Sports, Science & Technology (MEXT) [24390471]	Ministry of Education, Culture, Sports, Science & Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Grant-in-Aid for Scientific Research (B), Ministry of Education, Culture, Sports, Science & Technology (MEXT) (DH, 24390471). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2008, BIOL PHARM BULL, V31, P1141, DOI 10.1248/bpb.31.1141; Ara T, 2010, BIOL PHARM BULL, V33, P611, DOI 10.1248/bpb.33.611; Arifa RDN, 2014, AM J PATHOL, V184, P2023, DOI 10.1016/j.ajpath.2014.03.012; Belibasakis GN, 2013, INNATE IMMUN-LONDON, V19, P3, DOI 10.1177/1753425912444767; Bostanci N, 2011, CELL IMMUNOL, V270, P88, DOI 10.1016/j.cellimm.2011.04.002; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Brune B, 1998, EUR J PHARMACOL, V351, P261, DOI 10.1016/S0014-2999(98)00274-X; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Das S K, 1989, J Assoc Physicians India, V37, P647; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; DREIZEN S, 1983, ORAL SURG ORAL MED O, V55, P113, DOI 10.1016/0030-4220(83)90164-0; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Elting LS, 1997, CLIN INFECT DIS, V25, P247, DOI 10.1086/514550; Fata F, 1999, CANCER-AM CANCER SOC, V86, P1129, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1129::AID-CNCR5>3.0.CO;2-4; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hernandez-Cuellar E, 2012, J IMMUNOL, V189, P5113, DOI 10.4049/jimmunol.1202479; Hiroshima Y, 2010, J PERIODONTAL RES, V45, P79, DOI 10.1111/j.1600-0765.2009.01203.x; Jabaut J, 2013, FREE RADICAL BIO MED, V60, P233, DOI 10.1016/j.freeradbiomed.2013.01.025; Kono Toru, 2010, World J Oncol, V1, P232, DOI 10.4021/wjon263w; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lawlor KE, 2014, BBA-GEN SUBJECTS, V1840, P1433, DOI 10.1016/j.bbagen.2013.08.014; Lee BC, 2014, BBA-MOL BASIS DIS, V1842, P446, DOI 10.1016/j.bbadis.2013.05.017; Liao J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436206; Liao J, 2013, PHARM BIOL, V51, P1538, DOI 10.3109/13880209.2013.801995; MAJNO G, 1995, AM J PATHOL, V146, P3; Masters SL, 2012, IMMUNITY, V37, P1009, DOI 10.1016/j.immuni.2012.08.027; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Okada K, 2007, AM J PHYSIOL-GASTR L, V292, pG1450, DOI 10.1152/ajpgi.00302.2006; Okamoto M, 2010, J BIOL CHEM, V285, P6477, DOI 10.1074/jbc.M109.064907; Okamura H, 2013, FEBS LETT, V587, P48, DOI 10.1016/j.febslet.2012.10.041; Ouyang XS, 2013, BBA-MOL BASIS DIS, V1832, P979, DOI 10.1016/j.bbadis.2013.03.020; Peterson DE, 2011, ANN ONCOL, V22, pvi78, DOI 10.1093/annonc/mdr391; Saadeh CE, 2005, PHARMACOTHERAPY, V25, P540, DOI 10.1592/phco.25.4.540.61035; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Sonis ST, 2010, ORAL DIS, V16, P597, DOI 10.1111/j.1601-0825.2010.01681.x; Sonis SL, 2002, CRIT REV ORAL BIOL M, V13, P380, DOI 10.1177/154411130201300502; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Takuma K, 2001, J BIOL CHEM, V276, P48093, DOI 10.1074/jbc.M108622200; Tang T, 2007, EUR J PHARMACOL, V567, P177, DOI 10.1016/j.ejphar.2007.02.033; Tassi S, 2010, P NATL ACAD SCI USA, V107, P9789, DOI 10.1073/pnas.1000779107; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Watanabe K, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq067; Wright TH, 2009, CANCER BIOL THER, V8, P923, DOI 10.4161/cbt.8.10.8146; Wu ZQ, 2010, BIOMED PHARMACOTHER, V64, P589, DOI 10.1016/j.biopha.2010.06.006; Yamamoto M, 2000, GASTROENTEROLOGY, V118, P380, DOI 10.1016/S0016-5085(00)70220-4; Yilmaz O, 2010, CELL MICROBIOL, V12, P188, DOI 10.1111/j.1462-5822.2009.01390.x; Yoshino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082834; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	52	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112689	10.1371/journal.pone.0112689	http://dx.doi.org/10.1371/journal.pone.0112689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389767	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400119
J	Zhang, QF; Shi, YZ; Ma, LF; Yi, XY; Ruan, JY				Zhang, Qunfeng; Shi, Yuanzhi; Ma, Lifeng; Yi, Xiaoyun; Ruan, Jianyun			Metabolomic Analysis Using Ultra-Performance Liquid Chromatography-Quadrupole-Time of Flight Mass Spectrometry (UPLC-Q-TOF MS) Uncovers the Effects of Light Intensity and Temperature under Shading Treatments on the Metabolites in Tea	PLOS ONE			English	Article							CAMELLIA-SINENSIS; FLAVONOID BIOSYNTHESIS; GREEN TEA; ANTHOCYANIN BIOSYNTHESIS; EXPRESSION; ACCUMULATION; PHENOLICS; ENZYMES; GENES; COLOR	To investigate the effect of light intensity and temperature on the biosynthesis and accumulation of quality-related metabolites, field grown tea plants were shaded by Black Net and Nano-insulating Film (with additional 2-4 degrees C cooling effect) with un-shaded plants as a control. Young shoots were subjected to UPLC-Q-TOF MS followed by multivariate statistical analysis. Most flavonoid metabolites (mainly flavan-3-ols,flavonols and their glycosides) decreased significantly in the shading treatments, while the contents of chlorophyll, beta-carotene, neoxanthin and free amino acids, caffeine, benzoic acid derivatives and phenylpropanoids increased. Comparison between two shading treatments indicated that the lower temperature under Nano shading decreased flavonols and their glycosides but increased accumulation of flavan-3-ols and proanthocyanidins. The comparison also showed a greater effect of temperature on galloylation of catechins than light intensity. Taken together, there might be competition for substrates between the up-and down-stream branches of the phenylpropanoid/flavonoid pathway, which was influenced by light intensity and temperature.	[Zhang, Qunfeng] Chinese Acad Agr Sci, Grad Sch, Beijing 100081, Peoples R China; [Zhang, Qunfeng; Shi, Yuanzhi; Ma, Lifeng; Yi, Xiaoyun; Ruan, Jianyun] Chinese Acad Agr Sci, Tea Res Inst, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Graduate School, CAAS; Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS	Ruan, JY (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Hangzhou 310058, Zhejiang, Peoples R China.	jruan@mail.tricaas.com		shi, yuanzhi/0000-0002-7234-0341	Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System [CARS 23]; Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology	Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System; Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology	The work was supported financially by the Ministry of Agriculture of China through the Earmarked Fund for China Agriculture Research System (CARS 23) and the Chinese Academy of Agricultural Sciences through an Innovation Project for Agricultural Sciences and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma A, 2012, PLANTA, V236, P1067, DOI 10.1007/s00425-012-1650-x; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Cheynier V, 2013, PLANT PHYSIOL BIOCH, V72, P1, DOI 10.1016/j.plaphy.2013.05.009; Cohen SD, 2012, J EXP BOT, V63, P2655, DOI 10.1093/jxb/err449; Cohen SD, 2010, CRIT REV FOOD SCI, V50, P620, DOI 10.1080/10408390802603441; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Deng WW, 2013, PLANT GROWTH REGUL, V71, P295, DOI 10.1007/s10725-013-9828-1; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Eungwanichayapant PD, 2009, PLANT PHYSIOL BIOCH, V47, P94, DOI 10.1016/j.plaphy.2008.11.002; Fraser K, 2013, FOOD RES INT, V53, P827, DOI 10.1016/j.foodres.2012.10.015; Fujimura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023426; Harbowy ME, 1997, CRIT REV PLANT SCI, V16, P415, DOI 10.1080/713608154; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jayasekera S, 2014, FOOD CHEM, V152, P546, DOI 10.1016/j.foodchem.2013.12.005; Jiang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062315; Kalili KM, 2011, J SEP SCI, V34, P854, DOI 10.1002/jssc.201000811; Koricheva J, 1998, OIKOS, V83, P212, DOI 10.2307/3546833; Ku KM, 2010, J AGR FOOD CHEM, V58, P418, DOI 10.1021/jf902929h; Lee JE, 2011, J AGR FOOD CHEM, V59, P10579, DOI 10.1021/jf202304z; Lee JE, 2010, J AGR FOOD CHEM, V58, P10582, DOI 10.1021/jf102415m; Lee LS, 2013, J AGR FOOD CHEM, V61, P332, DOI 10.1021/jf304161y; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Liu YJ, 2012, J BIOL CHEM, V287, P44406, DOI 10.1074/jbc.M112.403071; Lo SCC, 1998, PLANT PHYSIOL, V116, P979, DOI 10.1104/pp.116.3.979; Lovdal T, 2010, PHYTOCHEMISTRY, V71, P605, DOI 10.1016/j.phytochem.2009.12.014; Lu JL, 2009, INT J FOOD SCI TECH, V44, P2505, DOI 10.1111/j.1365-2621.2009.02069.x; Mori K, 2005, SCI HORTIC-AMSTERDAM, V105, P319, DOI 10.1016/j.scienta.2005.01.032; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Punyasiri PAN, 2004, ARCH BIOCHEM BIOPHYS, V431, P22, DOI 10.1016/j.abb.2004.08.003; Rodriguez-Amaya PD, 2001, GUIDE CAROTENOID ANA, P1; Sandmann G, 2006, METAB ENG, V8, P291, DOI 10.1016/j.ymben.2006.01.005; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tounekti T, 2013, CRIT REV PLANT SCI, V32, P192, DOI 10.1080/07352689.2012.747384; Vrhovsek U, 2012, J AGR FOOD CHEM, V60, P8831, DOI 10.1021/jf2051569; Wang LY, 2011, EUR FOOD RES TECHNOL, V233, P1049, DOI 10.1007/s00217-011-1588-4; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V141, P7, DOI 10.1016/j.scienta.2012.04.013; Wang YS, 2012, SCI HORTIC-AMSTERDAM, V133, P72, DOI 10.1016/j.scienta.2011.10.017; Yang YY, 2013, RUSS J PLANT PHYSL+, V60, P91, DOI 10.1134/S1021443712060180	38	78	84	10	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112572	10.1371/journal.pone.0112572	http://dx.doi.org/10.1371/journal.pone.0112572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390340	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400103
J	Li, ST; Li, LN; Lee, G; Zhang, H				Li, Shoutao; Li, Lina; Lee, Gordon; Zhang, Hao			A Hybrid Search Algorithm for Swarm Robots Searching in an Unknown Environment	PLOS ONE			English	Article								This paper proposes a novel method to improve the efficiency of a swarm of robots searching in an unknown environment. The approach focuses on the process of feeding and individual coordination characteristics inspired by the foraging behavior in nature. A predatory strategy was used for searching; hence, this hybrid approach integrated a random search technique with a dynamic particle swarm optimization (DPSO) search algorithm. If a search robot could not find any target information, it used a random search algorithm for a global search. If the robot found any target information in a region, the DPSO search algorithm was used for a local search. This particle swarm optimization search algorithm is dynamic as all the parameters in the algorithm are refreshed synchronously through a communication mechanism until the robots find the target position, after which, the robots fall back to a random searching mode. Thus, in this searching strategy, the robots alternated between two searching algorithms until the whole area was covered. During the searching process, the robots used a local communication mechanism to share map information and DPSO parameters to reduce the communication burden and overcome hardware limitations. If the search area is very large, search efficiency may be greatly reduced if only one robot searches an entire region given the limited resources available and time constraints. In this research we divided the entire search area into several subregions, selected a target utility function to determine which subregion should be initially searched and thereby reduced the residence time of the target to improve search efficiency.	[Li, Shoutao; Li, Lina] Jilin Univ, Coll Commun Engn, Changchun 130023, Jilin Province, Peoples R China; [Lee, Gordon] San Diego State Univ, Dept Elect & Comp Engn, San Diego, CA 92182 USA; [Zhang, Hao] Jilin Univ, Coll Comp Sci & Technol, Symbol Computat & Knowledge Engn Minist Educ, Changchun 130023, Peoples R China	Jilin University; California State University System; San Diego State University; Jilin University	Zhang, H (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Symbol Computat & Knowledge Engn Minist Educ, Changchun 130023, Peoples R China.	zhangh@jlu.edu.cn	Zhang, Hao/AAR-8325-2020	Zhang, Hao/0000-0002-2058-7123				BO A, 2012, AUTOMATED NEGOTIATIO, P262; Cai Y, 2013, INT J ROBOT AUTOM, V28, DOI [10.2316/Journal.206.2013.4.206-3769, DOI 10.2316/JOURNAL.206.2013.4.206-3769]; Darvishzadah A, 2011, THESIS U CALIFORNIA; Darvishzadeh A., 2014, P 2014 C COMP GEN EV, P169; Das Sharma K, 2014, MACH VISION APPL, V25, P405, DOI 10.1007/s00138-013-0515-z; Geoffrey AH, 2010, 37 CARN MELL U; Guizzo E., 2011, GOOGLES SELF DRIVING; Hoff N. R., 2010, 2010 IEEE International Conference on Robotics and Biomimetics (ROBIO), P123, DOI 10.1109/ROBIO.2010.5723314; Kruijff G-JM, 2014, FIELD SERVICE ROBOTI, P111, DOI DOI 10.1007/978-3-642-40686-7_8; Nanjanath M, 2010, ROBOT AUTON SYST, V58, P900, DOI 10.1016/j.robot.2010.03.011; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Sheh R, 2014, SPRINGER TRACTS ADV, V92, P127; Sisso I, 2010, IEEE T ROBOT, V26, P1032, DOI 10.1109/TRO.2010.2073050; Tang Q, 2013, LNCS, V7928, P64; Wang P, 2014, ADV MECH ENG, P1; Wood JG, 2011, SEARCH TRACKING UNKN; Zhang JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021787	17	3	4	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111970	10.1371/journal.pone.0111970	http://dx.doi.org/10.1371/journal.pone.0111970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386855	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400033
J	Lin, WC; Licht, S				Lin, Wan-Chen; Licht, Stuart			Poly(Ethylene Glycol) as a Scaffold for High-Affinity Open-Channel Blockers of the Mouse Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article							CONGENITAL MYASTHENIC SYNDROME; SINGLE-CHANNEL; MOLECULAR COMPLEXITY; ACTIVATION; BLOCKADE; KINETICS; INHIBITION; CURRENTS; THERAPY; BINDING	High-affinity blockers for an ion channel often have complex molecular structures that are synthetically challenging and/or laborious. Here we show that high-affinity blockers for the mouse nicotinic acetylcholine receptor (AChR) can be prepared from a structurally simple material, poly(ethylene glycol) (PEG). The PEG-based blockers (PQ1-5), comprised of a flexible octa(ethylene glycol) scaffold and two terminal quaternary ammonium groups, exert low-tosub-micromolar affinities for the open AChR pore (measured via single-channel analysis of AChRs expressed in human embryonic kidney cells). PQ1-5 are comparable in pore-binding affinity to the strongest AChR open-channel blockers previously reported, which have complex molecular structures. These results suggest a general approach for designing potent open-channel blockers from a structurally flexible polymer. This design strategy involves simple synthetic procedures and does not require detailed information about the structure of an ion-channel pore.	[Lin, Wan-Chen; Licht, Stuart] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Licht, S (corresponding author), Sanofi US, Div Oncol, Cambridge, MA 02139 USA.	stuart.licht@sanofi.com	Lin, Wan-Chen/S-5121-2019	Lin, Wan-Chen/0000-0001-7842-3036	MIT Department of Chemistry; Beckman Foundation	MIT Department of Chemistry; Beckman Foundation	Funding provided by MIT Department of Chemistry; Beckman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akk G, 2003, J PHYSIOL-LONDON, V551, P155, DOI 10.1113/jphysiol.2003.043885; AMADOR M, 1991, SYNAPSE, V7, P207, DOI 10.1002/syn.890070305; BAKRY NM, 1982, MOL PHARMACOL, V22, P63; BERTZ SH, 1981, J AM CHEM SOC, V103, P3599, DOI 10.1021/ja00402a071; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Bufler J, 1996, J PHYSIOL-LONDON, V495, P83, DOI 10.1113/jphysiol.1996.sp021575; CARTER AA, 1993, BIOPHYS J, V65, P840, DOI 10.1016/S0006-3495(93)81103-2; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; DiFrancesco D, 2006, PHARMACOL RES, V53, P399, DOI 10.1016/j.phrs.2006.03.006; Engel AG, 2007, NEUROTHERAPEUTICS, V4, P252, DOI 10.1016/j.nurt.2007.01.001; Gussin HA, 2006, J AM CHEM SOC, V128, P15701, DOI 10.1021/ja064324k; Harper CM, 2003, NEUROLOGY, V60, P1710, DOI 10.1212/01.WNL.0000061483.11417.1B; HENDRICKSON JB, 1987, J CHEM INF COMP SCI, V27, P63, DOI 10.1021/ci00054a004; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Kramer RH, 1998, NATURE, V395, P710, DOI 10.1038/27227; Lin WC, 2008, BIOCHEMISTRY-US, V47, P9163, DOI 10.1021/bi800737j; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; MARSHALL CG, 1991, J PHYSIOL-LONDON, V433, P73, DOI 10.1113/jphysiol.1991.sp018415; Militante J, 2008, MOL PHARMACOL, V74, P764, DOI 10.1124/mol.108.047134; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; NEHER E, 1978, J PHYSIOL-LONDON, V277, P153, DOI 10.1113/jphysiol.1978.sp012267; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; NOJIMA H, 1993, J PHARM PHARMACOL, V45, P309, DOI 10.1111/j.2042-7158.1993.tb05558.x; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Salamone FN, 1999, J PHYSIOL-LONDON, V516, P315, DOI 10.1111/j.1469-7793.1999.0315v.x; Sonawane ND, 2008, CHEM BIOL, V15, P718, DOI 10.1016/j.chembiol.2008.05.015; Tantama M, 2008, J AM CHEM SOC, V130, P15766, DOI 10.1021/ja805868x; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Valles AS, 2007, NEUROREPORT, V18, P45, DOI 10.1097/01.wnr.0000246323.66438.94	33	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112088	10.1371/journal.pone.0112088	http://dx.doi.org/10.1371/journal.pone.0112088			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386750	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400039
J	Song, L; Liu, JX; Jin, XT; Li, ZY; Zhao, MR; Liu, WP				Song, Li; Liu, Jianxin; Jin, Xiaoting; Li, Zhuoyu; Zhao, Meirong; Liu, Weiping			p, p '-Dichlorodiphenyldichloroethylene Induces Colorectal Adenocarcinoma Cell Proliferation through Oxidative Stress	PLOS ONE			English	Article							HEDGEHOG SIGNALING PATHWAY; WNT/BETA-CATENIN PATHWAY; SONIC HEDGEHOG; ADIPOSE-TISSUE; COLON-CANCER; PESTICIDE LEVELS; BETA-CATENIN; EXPRESSION; ROS; EXPOSURE	p, p'-Dichlorodiphenyldichloroethylene (DDE), the major metabolite of Dichlorodiphenyltrichloroethane (DDT), is an organochlorine pollutant and associated with cancer progression. The present study investigated the possible effects of p, p'-DDE on colorectal cancer and the involved molecular mechanism. The results indicated that exposure to low concentrations of p, p'-DDE from 10(-10) to 10(-7) M for 96 h markedly enhanced proliferations of human colorectal adenocarcinoma cell lines. Moreover, p, p'-DDE exposure could activate Wnt/beta-catenin and Hedgehog/Gli1 signaling cascades, and the expression level of c-Myc and cyclin D1 was significantly increased. Consistently, p, p'-DDE-induced cell proliferation along with upregulated c-Myc and cyclin D1 were impeded by beta-catenin siRNA or Gli1 siRNA. In addition, p, p'-DDE was able to activate NADPH oxidase, generate reactive oxygen species (ROS) and reduce GSH content, superoxide dismutase (SOD) and calatase (CAT) activities. Treatment with antioxidants prevented p, p'-DDE-induced cell proliferation and signaling pathways of Wnt/beta-catenin and Hedgehog/Gli1. These results indicated that p, p'-DDE promoted colorectal cancer cell proliferation through Wnt/beta-catenin and Hedgehog/Gli1 signalings mediated by oxidative stress. The finding suggests an association between p, p'-DDE exposure and the risk of colorectal cancer progression.	[Song, Li; Liu, Jianxin; Jin, Xiaoting; Li, Zhuoyu] Shanxi Univ, Natl Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan, Peoples R China; [Song, Li; Liu, Weiping] Zhejiang Univ, Coll Environm & Resource Sci, MOE Key Lab Environm Remediat & Ecosyst Hlth, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zhuoyu] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Zhao, Meirong] Zhejiang Univ Technol, Res Ctr Environm Sci, Hangzhou, Zhejiang, Peoples R China	Shanxi University; Zhejiang University; Zhejiang Chinese Medical University; Zhejiang University of Technology	Li, ZY (corresponding author), Shanxi Univ, Natl Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan, Peoples R China.	lzy@sxu.edu.cn; Wliu@zju.edu.cn	Liu, Weiping/E-9208-2010	Liu, Weiping/0000-0002-1173-892X	National Natural Sciences Foundation of China [31271516, 21207084]; Research Fund for the Doctoral Program of Higher Education of China [20111401110011]; China Postdoctoral Science Foundation [2012M521178]; Natural Sciences Foundation of Shanxi [2014011027-5]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Sciences Foundation of Shanxi	This work was supported by the National Natural Sciences Foundation of China (No. 31271516, No. 21207084), Research Fund for the Doctoral Program of Higher Education of China (20111401110011), China Postdoctoral Science Foundation (2012M521178) and Natural Sciences Foundation of Shanxi (2014011027-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Arrebola JP, 2012, ENVIRON RES, V112, P40, DOI 10.1016/j.envres.2011.10.006; Bazensky Ivy, 2007, Medsurg Nurs, V16, P46; Beard J, 2006, SCI TOTAL ENVIRON, V355, P78, DOI 10.1016/j.scitotenv.2005.02.022; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; CALDWELL GG, 1981, CANCER, V48, P774, DOI 10.1002/1097-0142(19810801)48:3<774::AID-CNCR2820480319>3.0.CO;2-T; Chen Kun, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P479; Coant N, 2010, MOL CELL BIOL, V30, P2636, DOI 10.1128/MCB.01194-09; Colosio C, 2003, NEUROTOXICOLOGY, V24, P577, DOI 10.1016/S0161-813X(03)00055-X; Dai RL, 2011, NEUROCHEM RES, V36, P67, DOI 10.1007/s11064-010-0264-6; De Jager C, 2006, J ANDROL, V27, P16, DOI 10.2164/jandrol.05121; Ducarouge B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079335; El-Tawil AM, 2010, WORLD J GASTROENTERO, V16, P3475, DOI 10.3748/wjg.v16.i28.3475; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Galassi S, 2008, SCI TOTAL ENVIRON, V390, P45, DOI 10.1016/j.scitotenv.2007.09.029; Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685; Gunasekaran K, 2005, TROP MED INT HEALTH, V10, P160, DOI 10.1111/j.1365-3156.2004.01369.x; HOAR SK, 1985, LANCET, V1, P1277; Howsam M, 2004, ENVIRON HEALTH PERSP, V112, P1460, DOI 10.1289/ehp.7143; Jaga K, 1999, ARCH ENVIRON HEALTH, V54, P217; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juhasz A, 2009, FREE RADICAL RES, V43, P523, DOI 10.1080/10715760902918683; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kim MJ, 2010, BIOCHEM PHARMACOL, V80, P2092, DOI 10.1016/j.bcp.2010.08.014; Korswagen HC, 2006, DEV CELL, V10, P687, DOI 10.1016/j.devcel.2006.05.007; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li J, 2008, TOXICOL LETT, V183, P65, DOI 10.1016/j.toxlet.2008.10.002; Lobjois V, 2004, DEV BIOL, V273, P195, DOI 10.1016/j.ydbio.2004.05.031; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Mrema EJ, 2013, TOXICOLOGY, V307, P74, DOI 10.1016/j.tox.2012.11.015; Oniscu A, 2004, J PATHOL, V203, P909, DOI 10.1002/path.1591; Polakis P, 2000, GENE DEV, V14, P1837; Ribas-Fito N, 2003, PEDIATRICS, V111, pE580, DOI 10.1542/peds.111.5.e580; Rocha-Amador D, 2009, NEUROTOXICOLOGY, V30, P1149, DOI 10.1016/j.neuro.2009.09.003; Rogan WJ, 2005, LANCET, V366, P763, DOI 10.1016/S0140-6736(05)67182-6; Shi YQ, 2010, TOXICOL LETT, V193, P79, DOI 10.1016/j.toxlet.2009.12.008; Shi YQ, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/181282; Soliman AS, 1997, ARCH ENVIRON HEALTH, V52, P409, DOI 10.1080/00039899709602219; Son YO, 2012, TOXICOL APPL PHARM, V264, P153, DOI 10.1016/j.taap.2012.07.028; Song L, 2014, TOXICOL LETT, V229, P284, DOI 10.1016/j.toxlet.2014.06.003; Song Y, 2008, TOXICOLOGY, V253, P53, DOI 10.1016/j.tox.2008.08.013; Song Y, 2011, TOXICOL LETT, V202, P55, DOI 10.1016/j.toxlet.2011.01.020; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Waliszewski SM, 2011, B ENVIRON CONTAM TOX, V87, P539, DOI 10.1007/s00128-011-0341-9; Wang H, 2012, ASIAN PAC J CANCER P, V13, P2319, DOI 10.7314/APJCP.2012.13.5.2319; Wang N, 2011, CHEMOSPHERE, V84, P964, DOI 10.1016/j.chemosphere.2011.05.062; Wang X, 2012, TOXICOL APPL PHARM, V262, P11, DOI 10.1016/j.taap.2012.04.014; Watson AJM, 2011, DIGEST DIS, V29, P222, DOI 10.1159/000323926; Wilmink ABM, 1997, DIS COLON RECTUM, V40, P483, DOI 10.1007/BF02258397; Xia YP, 2012, NEUROSCIENCE, V209, P1, DOI 10.1016/j.neuroscience.2012.02.019; Yang J, 2013, NEOPLASMA, V60, P364, DOI 10.4149/neo_2013_048; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yoshikawa K, 2009, J GASTROENTEROL, V44, P1113, DOI 10.1007/s00535-009-0110-2; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang DY, 2013, MOL CELL BIOCHEM, V374, P13, DOI 10.1007/s11010-012-1498-1; Zhang Z, 2011, TOXICOL APPL PHARM, V256, P114, DOI 10.1016/j.taap.2011.07.016	59	18	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112700	10.1371/journal.pone.0112700	http://dx.doi.org/10.1371/journal.pone.0112700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386960	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400085
J	Good, DW; Khan, A; Hammer, S; Scanlan, P; Shu, WM; Phipps, S; Parson, SH; Stewart, GD; Reuben, R; McNeill, SA				Good, Daniel W.; Khan, Ashfaq; Hammer, Steven; Scanlan, Paul; Shu, Wenmiao; Phipps, Simon; Parson, Simon H.; Stewart, Grant D.; Reuben, Robert; McNeill, S. Alan			Tissue Quality Assessment Using a Novel Direct Elasticity Assessment Device (The E-Finger): A Cadaveric Study of Prostatectomy Dissection	PLOS ONE			English	Article							ASSISTED RADICAL PROSTATECTOMY; METAANALYSIS; CANCER; SURGERY	Introduction: Minimally invasive radical prostatectomy (RP) (robotic and laparoscopic), have brought improvements in the outcomes of RP due to improved views and increased degrees of freedom of surgical devices. Robotic and laparoscopic surgeries do not incorporate haptic feedback, which may result in complications secondary to inadequate tissue dissection (causing positive surgical margins, rhabdosphincter damage, etc). We developed a micro-engineered device (6 mm 2 sized) [E-finger]) capable of quantitative elasticity assessment, with amplitude ratio, mean ratio and phase lag representing this. The aim was to assess the utility of the device in differentiating peri-prostatic tissue types in order to guide prostate dissection. Material and Methods: Two embalmed and 2 fresh frozen cadavers were used in the study. Baseline elasticity values were assessed in bladder, prostate and rhabdosphincter of pre-dissected embalmed cadavers using the micro-engineered device. A measurement grid was created to span from the bladder, across the prostate and onto the rhabdosphincter of fresh frozen cadavers to enable a systematic quantitative elasticity assessment of the entire area by 2 independent assessors. Tissue was sectioned along each row of elasticity measurement points, and stained with haematoxylin and eosin (H&E). Image analysis was performed with Image Pro Premier to determine the histology at each measurement point. Results: Statistically significant differences in elasticity were identified between bladder, prostate and sphincter in both embalmed and fresh frozen cadavers (p = <0.001). Intra-class correlation (ICC) reliability tests showed good reliability (average ICC = 0.851). Sensitivity and specificity for tissue identification was 77% and 70% respectively to a resolution of 6 mm(2). Conclusions: This cadaveric study has evaluated the ability of our elasticity assessment device to differentiate bladder, prostate and rhabdosphincter to a resolution of 6 mm 2. The results provide useful data for which to continue to examine the use of elasticity assessment devices for tissue quality assessment with the aim of giving haptic feedback to surgeons performing complex surgery.	[Good, Daniel W.; Phipps, Simon; Stewart, Grant D.; McNeill, S. Alan] Univ Edinburgh, Western Gen Hosp, Edinburgh Urol Canc Grp, Edinburgh EH2 4XU, Midlothian, Scotland; [Hammer, Steven; Scanlan, Paul; Shu, Wenmiao; Reuben, Robert] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh, Midlothian, Scotland; [Khan, Ashfaq; Parson, Simon H.] Univ Edinburgh, Dept Anat, Edinburgh EH2 4XU, Midlothian, Scotland; [Good, Daniel W.; Phipps, Simon; Stewart, Grant D.; McNeill, S. Alan] NHS Lothian, Western Gen Hosp, Dept Urol, Edinburgh, Midlothian, Scotland	University of Edinburgh; Heriot Watt University; University of Edinburgh; University of Edinburgh	Good, DW (corresponding author), Univ Edinburgh, Western Gen Hosp, Edinburgh Urol Canc Grp, Edinburgh EH2 4XU, Midlothian, Scotland.	daniel.good@ed.ac.uk	Hammer, Steven J/L-1430-2016	Hammer, Steven J/0000-0002-5091-3161; Shu, Wenmiao/0000-0002-1220-361X; Stewart, Grant D./0000-0003-3188-9140; Reuben, Bob/0000-0003-3686-2131; Parson, Simon/0000-0002-8848-8738	Engineering and Physical Sciences Research Council (UK) [EP/I020101/1]; EPSRC [EP/I019472/1, EP/I020101/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I019472/1, EP/I020101/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council (UK): Grant Ref: EP/I020101/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboumarzouk OM, 2012, BJU INT, V110, P1414, DOI 10.1111/j.1464-410X.2012.11106.x; Ahn BM, 2010, UROLOGY, V76, P1007, DOI 10.1016/j.urology.2010.02.025; Burnett AL, 1998, J UROLOGY, V160, P1301, DOI 10.1016/S0022-5347(01)62521-7; Carson WC, 2011, MED ENG PHYS, V33, P302, DOI 10.1016/j.medengphy.2010.10.013; Culmer P, 2012, INT J MED ROBOT COMP, V8, P146, DOI 10.1002/rcs.1421; Ferlay J, 2010, GLOBOCAN 2008 V1 2 C; Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Good DW, 2013, BJU INT; Hammer S, 2012, DISTINGUISHING TISSU; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Hoyt K, 2008, CANCER BIOMARK, V4, P213, DOI 10.3233/CBM-2008-44-505; Javed S, 2013, BJU INT; Lakshmanan V, 2008, ST HEAL T, V133, P166; McNeill SA, 2013, BJU INT; Novara G, 2012, EUR UROL, V62, P382, DOI 10.1016/j.eururo.2012.05.047; OELRICH TM, 1980, AM J ANAT, V158, P229, DOI 10.1002/aja.1001580211; Patel VR, 2011, EUR UROL, V59, P702, DOI 10.1016/j.eururo.2011.01.032; Peng QY, 2011, IEEE ENG MED BIO, P8515, DOI 10.1109/IEMBS.2011.6092101; Phipps S, 2005, UROLOGY, V66, P447, DOI 10.1016/j.urology.2005.03.017; Reisaeter LA, 2014, ACTA RADIOL; van der Meijden OAJ, 2009, SURG ENDOSC, V23, P1180, DOI 10.1007/s00464-008-0298-x	22	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112872	10.1371/journal.pone.0112872	http://dx.doi.org/10.1371/journal.pone.0112872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384014	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700101
J	Gu, Y; Chen, X; Shang, CW; Singh, K; Barzegar, M; Mahdavian, E; Salvatore, BA; Jiang, SX; Huang, SL				Gu, Ying; Chen, Xin; Shang, Chaowei; Singh, Karnika; Barzegar, Mansoureh; Mahdavian, Elahe; Salvatore, Brian A.; Jiang, Shanxiang; Huang, Shile			Fusarochromanone Induces G(1) Cell Cycle Arrest and Apoptosis in COS7 and HEK293 Cells	PLOS ONE			English	Article							BCL-2 PROTEIN FAMILY; KASHIN-BECK-DISEASE; TIBIAL DYSCHONDROPLASIA; FUSARIUM-EQUISETI; BROILER-CHICKENS; PHASE ARREST; DEATH; MECHANISMS; MYCOTOXIN; TRICHOTHECENES	Fusarochromanone (FC101), a mycotoxin produced by the fungus Fusarium equiseti, is frequently observed in the contaminated grains and feedstuffs, which is toxic to animals and humans. However, the underlying molecular mechanism remains to be defined. In this study, we found that FC101 inhibited cell proliferation and induced cell death in COS7 and HEK293 cells in a concentration-dependent manner. Flow cytometric analysis showed that FC101 induced G(1) cell cycle arrest and apoptosis in the cells. Concurrently, FC101 downregulated protein expression of cyclin D1, cyclin-dependent kinases (CDK4 and CDK6), and Cdc25A, and upregulated expression of the CDK inhibitors (p21(Cip1) and p27(Kip1)), resulting in hypophosphorylation of Rb. FC101 also inhibited protein expression of Bcl-2, Bcl-xL, Mcl-1 and survivin, and induced expression of BAD, leading to activation of caspase 3 and cleavage of PARP, indicating caspase-dependent apoptosis. However, Z-VAD-FMK, a pan-caspase inhibitor, only partially prevented FC101-induced cell death, implying that FC101 may induce cell death through both caspase-dependent and -independent mechanisms. Our results support the notion that FC101 executes its toxicity at least by inhibiting cell proliferation and inducing cell death.	[Gu, Ying; Chen, Xin; Jiang, Shanxiang] Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China; [Gu, Ying; Chen, Xin; Shang, Chaowei; Singh, Karnika; Barzegar, Mansoureh; Huang, Shile] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Shreveport, LA USA; [Shang, Chaowei; Huang, Shile] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; [Mahdavian, Elahe; Salvatore, Brian A.] Louisiana State Univ, Dept Chem & Phys, Shreveport, LA 71105 USA	Nanjing Agricultural University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Jiang, SX (corresponding author), Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China.	nauvy@sina.com; shuan1@lsuhsc.edu	Huang, Shile/I-1632-2019; Barzegar, Mansoureh/ABB-7572-2021	Huang, Shile/0000-0002-3239-1072; 	National Natural Science Foundation of China [090600253]; National Institutes of Health (National Cancer Institute [NCI]) [CA115414]; National Institutes of Health (National Institute of General Medical Sciences [NIGMS]) [5P20RR016456-11]; National Institutes of Health (National Center for Research Resources [NCRR]) [8 P20 GM103424-11]; American Cancer Society [RSG-08-135-01-CNE]; Nanjing Agricultural University; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center; NATIONAL CANCER INSTITUTE [R01CA115414] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (National Cancer Institute [NCI])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (National Institute of General Medical Sciences [NIGMS])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (National Center for Research Resources [NCRR])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Cancer Society(American Cancer Society); Nanjing Agricultural University; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the grants from National Natural Science Foundation of China (No. 090600253, Shanxiang Jiang), National Institutes of Health (National Cancer Institute [NCI] CA115414, Shile Huang; National Institute of General Medical Sciences [NIGMS] 5P20RR016456-11, Thomas R. Klei/Elahe Mahdavian; National Center for Research Resources [NCRR] 8 P20 GM103424-11, Thomas R. Klei/Elahe Mahdavian), American Cancer Society (RSG-08-135-01-CNE, Shile Huang), Nanjing Agricultural University, and the Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS HK, 1989, MYCOPATHOLOGIA, V105, P143, DOI 10.1007/BF00437246; Abid-Essefi S, 2003, TOXICOLOGY, V192, P237, DOI 10.1016/S0300-483X(03)00329-9; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Dreau D, 2007, ANTI-CANCER DRUG, V18, P897; Fang HQ, 2012, APOPTOSIS, V17, P895, DOI 10.1007/s10495-012-0724-3; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Furmanski BD, 2009, MICROSC MICROANAL, V15, P545, DOI 10.1017/S1431927609090825; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; KROGH P, 1989, APPL ENVIRON MICROB, V55, P3184, DOI 10.1128/AEM.55.12.3184-3188.1989; Lavecchia A, 2012, MINI-REV MED CHEM, V12, P62, DOI 10.2174/138955712798868940; LEE YW, 1985, APPL ENVIRON MICROB, V50, P102, DOI 10.1128/AEM.50.1.102-107.1985; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu J, 2012, TOXICOL LETT, V211, P164, DOI 10.1016/j.toxlet.2012.03.800; Mahdavian E, 2014, INT J MOL MED, V34, P880, DOI 10.3892/ijmm.2014.1842; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Minervini F, 2004, TOXICOL IN VITRO, V18, P21, DOI 10.1016/S0887-2333(03)00130-9; Minervini Fiorenza, 1992, Natural Toxins, V1, P15, DOI 10.1002/nt.2620010105; MIROCHA CJ, 1989, APPL ENVIRON MICROB, V55, P254, DOI 10.1128/AEM.55.1.254-255.1989; Morrison E, 2002, MYCOPATHOLOGIA, V153, P49, DOI 10.1023/A:1015201709070; ORTH MW, 1994, VET PATHOL, V31, P403, DOI 10.1177/030098589403100401; Patsoukis N, 2012, CELL CYCLE, V11, P4305, DOI 10.4161/cc.22135; PENG A, 1992, J TOXICOL ENV HEALTH, V35, P79, DOI 10.1080/15287399209531597; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sudre P, 2001, INT ORTHOP, V25, P175, DOI 10.1007/s002640000179; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tang L, 2013, CELL CYCLE, V12, P2665, DOI 10.4161/cc.25728; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; WALSER MM, 1988, AVIAN DIS, V32, P84, DOI 10.2307/1590953; Wang Y, 2012, TOXICOL LETT, V209, P186, DOI 10.1016/j.toxlet.2011.12.011; WU W, 1993, AVIAN DIS, V37, P302, DOI 10.2307/1591653; XIE WP, 1989, APPL ENVIRON MICROB, V55, P794, DOI 10.1128/AEM.55.4.794-797.1989; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xui XD, 2008, INT J MOL MED, V21, P145; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112641	10.1371/journal.pone.0112641	http://dx.doi.org/10.1371/journal.pone.0112641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384025	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700085
J	Parr, C; Mirzaei, N; Christian, M; Sastre, M				Parr, Callum; Mirzaei, Nazanin; Christian, Mark; Sastre, Magdalena			Activation of the Wnt/beta-catenin pathway represses the transcription of the beta-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter	FASEB JOURNAL			English	Article						GSK3; Alzheimer's disease; DKK-1; sFRP-1	WNT SIGNALING PATHWAY; TAU-PHOSPHORYLATION; FUNCTIONAL INTERACTION; ALZHEIMERS-DISEASE; PPAR-GAMMA; DICKKOPF-1; INHIBITION; EXPRESSION; INDUCTION; MECHANISM	Alterations in the Wnt signaling pathway have been implicated in Alzheimer's disease; however, its role in the processing of the amyloid precursor protein remains unknown. In this study, activation of the Wnt pathway by overexpression of the agonist Wnt3a or beta-catenin or by inhibition of glycogen kinase synthase-3 in N2a cells resulted in a reduction in Ab levels and in the activity and expression of BACE1 (beta-APP cleaving enzyme). Conversely, inhibition of the pathway by transfection of the antagonists secreted frizzled receptor protein-1 or dickkopf-1 produced the opposite effects. Chromatin immunoprecipitation analysis demonstrated that b-catenin binds specifically to regions within the promoter of BACE1 containing putative T-cell factor/lymphoid enhancer binding factor-1 (TCF/LEF) motifs, consistent with canonical Wnt target regulation. Furthermore, cells transfected with b-catenin mutants incapable of binding to TCF/LEF increased BACE1 gene promoter activity. Interestingly, TCF4 knockdown reversed the effects of Wnt3a activation on BACE1 transcription. We found that TCF4 binds to the same region on BACE1 promoter following Wnt3a stimulation, indicating that TCF4 functions as a transcriptional repressor of BACE1 gene. In conclusion, Wnt/beta-catenin stimulation may repress BACE1 transcription via binding of TCF4 to BACE1 gene, and therefore, activation of the Wnt pathway may hold the key to new treatments of Alzheimer disease.-Parr, C., Mirzaei, N., Christian, M., and Sastre, M. Activation of the Wnt/ b-catenin pathway represses the transcription of the b-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.	[Parr, Callum; Mirzaei, Nazanin; Sastre, Magdalena] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London W12 0NN, England; [Christian, Mark] Univ Warwick, Warwick Med Sch, Div Metab & Vasc Hlth, Coventry CV4 7AL, W Midlands, England	Imperial College London; University of Warwick	Sastre, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Brain Sci, Du Cane Rd, London W12 0NN, England.	m.sastre@imperial.ac.uk		Christian, Mark/0000-0002-1616-4179; Parr, Callum/0000-0002-4454-5577				Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker Nick, 2008, V468, P5, DOI 10.1007/978-1-59745-249-6_1; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80; Brinkmeler ML, 2007, DEV BIOL, V311, P396, DOI 10.1016/j.ydbio.2007.08.046; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Chacon MA, 2008, J CELL PHYSIOL, V217, P215, DOI 10.1002/jcp.21497; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; De Ferrari GV, 2007, P NATL ACAD SCI USA, V104, P9434, DOI 10.1073/pnas.0603523104; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; Galceran J, 2000, DEVELOPMENT, V127, P469; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Heneka MT, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-22; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Katsouri L, 2011, J ALZHEIMERS DIS, V25, P151, DOI 10.3233/JAD-2011-101356; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Killick R, 2014, MOL PSYCHIATR, V19, P88, DOI 10.1038/mp.2012.163; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Ly PTT, 2013, J CLIN INVEST, V123, P224, DOI 10.1172/JCI64516; Magdesian MH, 2008, J BIOL CHEM, V283, P9359, DOI 10.1074/jbc.M707108200; Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Moon RT, 1997, TRENDS GENET, V13, P256, DOI 10.1016/S0168-9525(97)01196-7; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Purro SA, 2012, J NEUROSCI, V32, P3492, DOI 10.1523/JNEUROSCI.4562-11.2012; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Rosi MC, 2010, J NEUROCHEM, V112, P1539, DOI 10.1111/j.1471-4159.2009.06566.x; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Scali C, 2006, NEUROBIOL DIS, V24, P254, DOI 10.1016/j.nbd.2006.06.016; Smartt HJM, 2012, GUT, V61, P1306, DOI 10.1136/gutjnl-2011-300817; Vacik T, 2011, CELL CYCLE, V10, P4199, DOI 10.4161/cc.10.24.18465; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang J, 2000, ONCOGENE, V19, P1843, DOI 10.1038/sj.onc.1203503; Wexler EM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002282; Wisniewska MB, 2013, NEUROCHEM RES, V38, P1144, DOI 10.1007/s11064-013-0980-9; Yang G, 2006, J INVEST DERMATOL, V126, P2490, DOI 10.1038/sj.jid.5700470; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang YW, 2009, NEURON, V64, P328, DOI 10.1016/j.neuron.2009.08.036	46	55	57	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					623	635		10.1096/fj.14-253211	http://dx.doi.org/10.1096/fj.14-253211			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25384422				2022-12-26	WOS:000349370400024
J	Leon-Paravic, CG; Figueroa, VA; Guzman, DJ; Valderrama, CF; Vallejos, AA; Fiori, MC; Altenberg, GA; Reuss, L; Retamal, MA				Leon-Paravic, Carmen G.; Figueroa, Vania A.; Guzman, Diego J.; Valderrama, Carlos F.; Vallejos, Antonio A.; Fiori, Mariana C.; Altenberg, Guillermo A.; Reuss, Luis; Retamal, Mauricio A.			Carbon Monoxide (CO) Is a Novel Inhibitor of Connexin Hemichannels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ENDOTHELIAL-CELLS; PROTEIN CARBONYLATION; ION CHANNELS; CX46 HEMICHANNELS; STRESS; DECARBONYLATION; PERMEATION; MOLECULES; MECHANISM; RELEASE	Hemichannels (HCs) are hexamers of connexins that can form gap-junction channels at points of cell contacts or "free HCs" at non-contacting regions. HCs are involved in paracrine and autocrine cell signaling, and under pathological conditions may induce and/or accelerate cell death. Therefore, studies of HC regulation are of great significance. Nitric oxide affects the activity of Cx43 and Cx46 HCs, whereas carbon monoxide (CO), another gaseous transmitter, modulates the activity of several ion channels, but its effect on HCs has not been explored. We studied the effect of CO donors (CORMs) on Cx46 HCs expressed in Xenopus laevis oocytes using two-electrode voltage clamp and on Cx43 and Cx46 expressed in HeLa cells using a dye-uptake technique. CORM-2 inhibited Cx46 HC currents in a concentration-dependent manner. The C-terminal domain and intracellular Cys were not necessary for the inhibition. The effect of CORM-2 was not prevented by guanylyl-cyclase, protein kinase G, or thioredoxin inhibitors, and was not due to endocytosis of HCs. However, the effect of CORM-2 was reversed by reducing agents that act extracellularly. Additionally, CO inhibited dye uptake of HeLa cells expressing Cx43 or Cx46, and MCF-7 cells, which endogenously express Cx43 and Cx46. Because CORM-2 carbonylates Cx46 in vitro and induces conformational changes, a direct effect of that CO on Cx46 is possible. The inhibition of HCs could help to understand some of the biological actions of CO in physiological and pathological conditions.	[Leon-Paravic, Carmen G.; Figueroa, Vania A.; Guzman, Diego J.; Valderrama, Carlos F.; Vallejos, Antonio A.; Retamal, Mauricio A.] Clin Alemana Univ Desarrollo, Fac Med, Ctr Fisiol Celular & Integrat, Santiago 7690000, Chile; [Fiori, Mariana C.; Altenberg, Guillermo A.; Reuss, Luis; Retamal, Mauricio A.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Fiori, Mariana C.; Altenberg, Guillermo A.; Reuss, Luis; Retamal, Mauricio A.] Texas Tech Univ, Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Universidad del Desarrollo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Retamal, MA (corresponding author), Clin Alemana Univ Desarrollo, Fac Med, Ctr Fisiol Celular & Integrat, Ave Las Condes 12438, Santiago 7690000, Chile.	mretamal@udd.cl		Figueroa Ipinza, Vania A./0000-0002-2953-9507; Altenberg, Guillermo/0000-0002-8932-740X; Retamal, Mauricio A./0000-0003-2562-6686	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; American Heart Association; Texas Affiliate Inc. [14GRNT18750014]; Fondecyt Grant [1120214]; Anillo Grant [ACT1104]; Centro de costo Grant [23400077]; Fondecyt [3130577]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Texas Affiliate Inc.; Fondecyt Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Anillo Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Centro de costo Grant; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1 and American Heart Association, Texas Affiliate Inc. Grant 14GRNT18750014 (to G. A. A.), Fondecyt Grant 1120214 and Anillo Grant ACT1104 (to M. A. R.), Centro de costo Grant 23400077 (to C. G. L.), and Fondecyt Grant 3130577 (to V. F.).	ADACHI K, 1982, J BIOL CHEM, V257, P5738; Althaus M, 2009, AM J RESP CELL MOL, V41, P639, DOI 10.1165/rcmb.2008-0458OC; Banerjee D, 2010, INT J CANCER, V127, P839, DOI 10.1002/ijc.25107; Burr DB, 2011, EXP EYE RES, V92, P251, DOI 10.1016/j.exer.2011.02.003; Cattaruzza M, 2008, CIRC RES, V102, P273, DOI 10.1161/CIRCRESAHA.108.172148; Chi JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032531; Dahl G, 2013, NEUROPHARMACOLOGY, V75, P583, DOI 10.1016/j.neuropharm.2013.02.019; Desmard M, 2012, ANTIOXID REDOX SIGN, V16, P153, DOI 10.1089/ars.2011.3959; Dong DL, 2008, EUR J PHARMACOL, V590, P99, DOI 10.1016/j.ejphar.2008.05.042; Dong DL, 2007, HYPERTENSION, V50, P643, DOI 10.1161/HYPERTENSIONAHA.107.096057; Fiori MC, 2012, J BIOL CHEM, V287, P40826, DOI 10.1074/jbc.M112.383281; Griffiths HR, 2014, REDOX BIOL, V2, P430, DOI 10.1016/j.redox.2014.01.010; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Gullotta F, 2012, IUBMB LIFE, V64, P378, DOI 10.1002/iub.1015; Johnstone SR, 2012, J MEMBRANE BIOL, V245, P319, DOI 10.1007/s00232-012-9453-3; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Kar R, 2012, ARCH BIOCHEM BIOPHYS, V524, P2, DOI 10.1016/j.abb.2012.03.008; Klaassen LJ, 2012, BRAIN RES, V1487, P25, DOI 10.1016/j.brainres.2012.04.059; Kronengold J, 2012, J MEMBRANE BIOL, V245, P453, DOI 10.1007/s00232-012-9457-z; Liang GSL, 2005, ANN NEUROL, V57, P749, DOI 10.1002/ana.20459; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Orellana JA, 2012, ADV EXP MED BIOL, V740, P777, DOI 10.1007/978-94-007-2888-2_34; Padgaonkar VA, 1997, EXP EYE RES, V65, P435, DOI 10.1006/exer.1997.0356; Peers C, 2011, EXP PHYSIOL, V96, P836, DOI 10.1113/expphysiol.2011.059063; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Retamal MA, 2006, P NATL ACAD SCI USA, V103, P4475, DOI 10.1073/pnas.0511118103; Retamal MA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00080; Retamal MA, 2010, AM J PHYSIOL-CELL PH, V298, pC132, DOI 10.1152/ajpcell.00258.2009; Retamal MA, 2009, AM J PHYSIOL-CELL PH, V296, pC1356, DOI 10.1152/ajpcell.00054.2009; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Sanchez HA, 2010, J GEN PHYSIOL, V136, P47, DOI 10.1085/jgp.201010433; Schalper KA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00237; Stehberg J, 2012, FASEB J, V26, P3649, DOI 10.1096/fj.11-198416; Telezhkin V, 2011, PFLUG ARCH EUR J PHY, V461, P665, DOI 10.1007/s00424-011-0924-7; Wang K, 2012, J BIOL CHEM, V287, P15786, DOI 10.1074/jbc.M111.313171; Wang N, 2013, BBA-BIOMEMBRANES, V1828, P35, DOI 10.1016/j.bbamem.2012.07.002; Wilkinson WJ, 2009, BRIT J PHARMACOL, V158, P862, DOI 10.1111/j.1476-5381.2009.00354.x; Wilkinson WJ, 2011, J PHYSIOL-LONDON, V589, P3055, DOI 10.1113/jphysiol.2011.206706; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Wong CM, 2013, FREE RADICAL BIO MED, V65, P1126, DOI 10.1016/j.freeradbiomed.2013.09.005	41	25	26	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36150	36157		10.1074/jbc.M114.602243	http://dx.doi.org/10.1074/jbc.M114.602243			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25384983	Green Published, hybrid			2022-12-26	WOS:000346897900041
J	Santos, JRA; Holanda, RA; Frases, S; Bravim, M; Araujo, GD; Santos, PC; Costa, MC; Ribeiro, MJA; Ferreira, GF; Baltazar, LM; Miranda, AS; Oliveira, DB; Santos, CMA; Fontes, ACL; Gouveia, LF; Resende-Stoianoff, MA; Abrahao, JS; Teixeira, AL; Paixao, TA; Souza, DG; Santos, DA				Alves Santos, Julliana Ribeiro; Holanda, Rodrigo Assuncao; Frases, Susana; Bravim, Mayara; Araujo, Glauber de S.; Santos, Patricia Campi; Costa, Marliete Carvalho; Andrade Ribeiro, Maira Juliana; Ferreira, Gabriella Freitas; Baltazar, Ludmila Matos; Miranda, Aline Silva; Oliveira, Danilo Bretas; Araujo Santos, Carolina Maria; Lima Fontes, Alide Caroline; Gouveia, Ludmila Ferreira; Resende-Stoianoff, Maria Aparecida; Abrahao, Jonatas Santos; Teixeira, Antonio Lucio; Paixao, Tatiane Alves; Souza, Danielle G.; Santos, Daniel Assis			Fluconazole Alters the Polysaccharide Capsule of Cryptococcus gattii and Leads to Distinct Behaviors in Murine Cryptococcosis	PLOS ONE			English	Article							IN-VIVO; AZOLE RESISTANCE; AMPHOTERICIN-B; CANDIDA-ALBICANS; NEOFORMANS; SUSCEPTIBILITY; GENE; HETERORESISTANCE; ITRACONAZOLE; VIRULENCE	Cryptococcus gattii is an emergent human pathogen. Fluconazole is commonly used for treatment of cryptococcosis, but the emergence of less susceptible strains to this azole is a global problem and also the data regarding fluconazole-resistant cryptococcosis are scarce. We evaluate the influence of fluconazole on murine cryptococcosis and whether this azole alters the polysaccharide (PS) from cryptococcal cells. L27/01 strain of C. gattii was cultivated in high fluconazole concentrations and developed decreased drug susceptibility. This phenotype was named L27/01(F), that was less virulent than L27/01 in mice. The physical, structural and electrophoretic properties of the PS capsule of L27/01(F) were altered by fluconazole. L27/01(F) presented lower antiphagocytic properties and reduced survival inside macrophages. The L27/01(F) did not affect the central nervous system, while the effect in brain caused by L27/01 strain began after only 12 hours. Mice infected with L27/01(F) presented lower production of the pro-inflammatory cytokines, with increased cellular recruitment in the lungs and severe pulmonary disease. The behavioral alterations were affected by L27/01, but no effects were detected after infection with L27/01(F). Our results suggest that stress to fluconazole alters the capsule of C. gattii and influences the clinical manifestations of cryptococcosis.	[Alves Santos, Julliana Ribeiro; Holanda, Rodrigo Assuncao; Santos, Patricia Campi; Costa, Marliete Carvalho; Andrade Ribeiro, Maira Juliana; Ferreira, Gabriella Freitas; Baltazar, Ludmila Matos; Oliveira, Danilo Bretas; Araujo Santos, Carolina Maria; Lima Fontes, Alide Caroline; Gouveia, Ludmila Ferreira; Resende-Stoianoff, Maria Aparecida; Abrahao, Jonatas Santos; Souza, Danielle G.; Santos, Daniel Assis] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Frases, Susana; Bravim, Mayara; Araujo, Glauber de S.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil; [Frases, Susana; Araujo, Glauber de S.] Inst Nacl Metrol Normalizacao & Qualidade Ind INM, Lab Biotecnol LABIO, Rio De Janeiro, Brazil; [Miranda, Aline Silva; Teixeira, Antonio Lucio] Univ Fed Minas Gerais, Fac Med, Lab Interdisciplinar Invest Med, Belo Horizonte, MG, Brazil; [Paixao, Tatiane Alves] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Rio de Janeiro; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Santos, DA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil.	das@ufmg.br	Teixeira, Antonio L/N-3315-2014; Ferreira, Gabriella Freitas/AAG-5267-2021; HOLANDA, RODRIGO/Q-8505-2019; Miranda, Aline Silva de/AFM-2106-2022; Freitas, Gabriella/AAD-9831-2020; Santos, Patricia/HGB-1720-2022; de Sousa Araújo, Glauber Ribeiro/AAT-5085-2021; Santos, Julliana/W-1289-2019; Abrahão, Jônatas/B-3895-2015; de Matos Baltazar, Ludmila/I-4323-2017; Frases, Susana/W-9502-2019; Costa, Marliete Carvalho/AAL-6126-2020; Paixao, Tatiane/A-2871-2013; Campi Santos, Patricia/C-3788-2018	Teixeira, Antonio L/0000-0002-9621-5422; HOLANDA, RODRIGO/0000-0002-1698-5663; Miranda, Aline Silva de/0000-0003-2811-7924; de Sousa Araújo, Glauber Ribeiro/0000-0002-5478-9006; Santos, Julliana/0000-0001-6918-1186; Abrahão, Jônatas/0000-0001-9420-1791; de Matos Baltazar, Ludmila/0000-0002-4255-3047; Frases, Susana/0000-0001-5875-9886; Costa, Marliete Carvalho/0000-0003-0381-9225; Santos, Daniel Assis/0000-0002-1108-5666; Paixao, Tatiane/0000-0001-8284-9902; Campi Santos, Patricia/0000-0003-1201-025X; Resende Stoianoff, Maria Aparecida/0000-0002-6220-1321	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Pesquisa (CNPq); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (UFMG)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (UFMG)	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Pesquisa (CNPq) and Pro-Reitoria de Pesquisa da Universidade Federal de Minas Gerais (UFMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Fuoli L, 2014, BRIT J HAEMATOL, V166, P471, DOI 10.1111/bjh.12896; Alvarado-Ramirez E, 2008, REV IBEROAM MICOL, V25, P150, DOI 10.1016/S1130-1406(08)70035-4; Santos JRA, 2012, ANTIMICROB AGENTS CH, V56, P2553, DOI 10.1128/AAC.06098-11; Araujo GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029561; Bryan RA, 2005, EUKARYOT CELL, V4, P465, DOI 10.1128/EC.4.2.465-475.2005; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chang YC, 1996, INFECT IMMUN, V64, P1977, DOI 10.1128/IAI.64.6.1977-1983.1996; Chen SCA, 2012, CLIN INFECT DIS, V55, P789, DOI 10.1093/cid/cis529; Chen YC, 2001, J CLIN MICROBIOL, V39, P4042, DOI 10.1128/JCM.39.11.4042-4051.2001; Chowdhary A, 2011, J MED MICROBIOL, V60, P961, DOI 10.1099/jmm.0.029025-0; Clinical and Laboratory Standards Institute, 2008, M27A3 CLIN LAB STAND; Cordero RJB, 2011, INFECT IMMUN, V79, P4990, DOI 10.1128/IAI.05789-11; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Espinel-Ingroff A, 2012, ANTIMICROB AGENTS CH, V56, P5898, DOI 10.1128/AAC.01115-12; Ferreira GF, 2013, J ANTIMICROB CHEMOTH, V68, P1801, DOI 10.1093/jac/dkt114; Fohrer C, 2006, INT J ANTIMICROB AG, V27, pS25, DOI 10.1016/j.ijantimicag.2006.03.016; Frases S, 2008, EUKARYOT CELL, V7, P319, DOI 10.1128/EC.00378-07; Frases S, 2009, BIOPHYS J, V97, P937, DOI 10.1016/j.bpj.2009.04.043; Garcia-Rivera J, 2004, EUKARYOT CELL, V3, P385, DOI 10.1128/EC.3.2.385-392.2004; Gast CE, 2013, ANTIMICROB AGENTS CH, V57, P5478, DOI 10.1128/AAC.02287-12; Gullo FP, 2013, EUR J CLIN MICROBIOL, V32, P1377, DOI 10.1007/s10096-013-1915-8; Jain N, 2009, CELL MICROBIOL, V11, P1716, DOI 10.1111/j.1462-5822.2009.01384.x; Johnston SA, 2013, CELL MICROBIOL, V15, P403, DOI 10.1111/cmi.12067; JOSEPHHORNE T, 1995, ANTIMICROB AGENTS CH, V39, P1526, DOI 10.1128/AAC.39.7.1526; Khan ZU, 2009, INT J ANTIMICROB AG, V33, P559, DOI 10.1016/j.ijantimicag.2008.11.007; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; Marr KA, 1998, ANTIMICROB AGENTS CH, V42, P2584, DOI 10.1128/AAC.42.10.2584; Marr KA, 2001, ANTIMICROB AGENTS CH, V45, P52, DOI 10.1128/AAC.45.1.52-59.2001; Matos CS, 2012, EUR J CLIN MICROBIOL, V31, P1647, DOI 10.1007/s10096-011-1488-3; Maxeiner JH, 2007, NAT PROTOC, V2, P105, DOI 10.1038/nprot.2007.8; Mendes FES, 2010, EUR J CLIN MICROBIOL, V29, P1525, DOI 10.1007/s10096-010-1034-8; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Ngamskulrungroj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016076; Nimrichter L, 2007, EUKARYOT CELL, V6, P1400, DOI 10.1128/EC.00122-07; Nosanchuk JD, 1999, ANTIMICROB AGENTS CH, V43, P233, DOI 10.1093/jac/43.2.233; Pedroso V. S. P., 2010, Journal of Neuroparasitology, V1, pN100402, DOI 10.4303/jnp/N100402; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P117, DOI 10.1128/JCM.01747-08; Pedroso VSP, 2013, MYCOPATHOLOGIA, V176, P191, DOI 10.1007/s11046-013-9679-3; Rakeman JL, 2005, J CLIN MICROBIOL, V43, P3324, DOI 10.1128/JCM.43.7.3324-3333.2005; Rex JH, 1997, CLIN INFECT DIS, V24, P235, DOI 10.1093/clinids/24.2.235; Sanguinetti M, 2006, INFECT IMMUN, V74, P1352, DOI 10.1128/IAI.74.2.1352-1359.2006; Santos DA, 2010, MYCOPATHOLOGIA, V169, P247, DOI 10.1007/s11046-009-9261-1; Saracli MA, 2006, MYCOSES, V49, P124, DOI 10.1111/j.1439-0507.2006.01203.x; Selmecki A, 2008, MOL MICROBIOL, V68, P624, DOI 10.1111/j.1365-2958.2008.06176.x; Sionov E, 2013, ANTIMICROB AGENTS CH, V57, P5127, DOI 10.1128/AAC.00694-13; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Sionov E, 2009, ANTIMICROB AGENTS CH, V53, P2804, DOI 10.1128/AAC.00295-09; Smith RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088875; Souza DG, 2000, BRIT J PHARMACOL, V131, P1800, DOI 10.1038/sj.bjp.0703756; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres-Rodriguez JM, 2008, REV IBEROAM MICOL, V25, P27, DOI 10.1016/S1130-1406(08)70007-X; Wilder JA, 2002, AM J RESP CELL MOL, V26, P306, DOI 10.1165/ajrcmb.26.3.4479; Zaragoza O, 2008, CELL MICROBIOL, V10, P2043, DOI 10.1111/j.1462-5822.2008.01186.x	55	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112669	10.1371/journal.pone.0112669	http://dx.doi.org/10.1371/journal.pone.0112669			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392951	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300082
J	Gudro, I; Valeika, V; Sirvaityte, J				Gudro, Ilze; Valeika, Virgilijus; Sirvaityte, Justa			Short Term Preservation of Hide Using Vacuum: Influence on Properties of Hide and of Processed Leather	PLOS ONE			English	Article							CATTLE HIDES; TANNAGE	The objective of this work was to investigate vacuum influence on hide preservation time and how it affects hide structure. It was established that vacuum prolongs the storage time without hide tissue putrefaction up to 21 days when the storage temperature is 4 degrees C. The microorganisms act for all storage times, but the action is weak and has no observable influence on the quality of hide during the time period mentioned. The hide shrinkage temperature decrease is negligible, which shows that breaking of intermolecular bonds does not occur. Optical microscopy, infrared spectroscopy and differential scanning calorimetry also did not show any structural changes which can influence the quality of leather produced from such hide. The qualitative indexes of wet blue processed under laboratory conditions and of leather produced during industrial trials are presented. Indexes such as chromium compounds exhaustion, content of chromium in leather, content of soluble matter in dichloromethane, strength properties, and shrinkage temperature were determined. Properties of the leather produced from vacuumed hide under industrial conditions conformed to the requirements of shoe upper leather.	[Gudro, Ilze] Riga Tech Univ, Text Mat Technol & Design Inst, Riga, Latvia; [Valeika, Virgilijus] Kaunas Univ Technol, Dept Phys & Inorgan Chem, Kaunas, Lithuania; [Sirvaityte, Justa] Kaunas Univ Technol, Dept Polymer Chem & Technol, Kaunas, Lithuania	Riga Technical University; Kaunas University of Technology; Kaunas University of Technology	Sirvaityte, J (corresponding author), Kaunas Univ Technol, Dept Polymer Chem & Technol, Kaunas, Lithuania.	justa.sirvaityte@ktu.lt	Valeika, Virgilijus/A-5544-2008	Valeika, Virgilijus/0000-0003-4974-7626				[Anonymous], 2008, 4048 ISO; [Anonymous], 2003, 3376 EN ISO; [Anonymous], 2006, 4684 EN ISO; [Anonymous], Pat. USSR, Patent No. 767649; [Anonymous], 2008, 4044 ISO; [Anonymous], 2009, 53982 ISO; [Anonymous], 2002, 3380 ISO; Bailey DG, 2001, J AM LEATHER CHEM AS, V96, P382; Bailey DG, 1999, J AM LEATHER CHEM AS, V94, P259; Bienkewicz K., 1983, PHYS CHEM LEATHER MA; Covington T, 2009, TANNING CHEMISTRY: THE SCIENCE OF LEATHER, P1; Didato DT, 2008, J AM LEATHER CHEM AS, V103, P383; Dinc A, 1990, ACTA PHARM TURCICA, V32, P149; Golovtejeva A., 1982, LAB PRAKTIKUM TECHNO; HOPKINS WJ, 1981, J AM LEATHER CHEM AS, V76, P134; Iyappan K, 2013, ENVIRON SCI POLLUT R, V20, P6324, DOI 10.1007/s11356-013-1683-0; Kanagaraj J, 2005, J CLEAN PROD, V13, P825, DOI 10.1016/j.jclepro.2004.02.040; Kanagaraj J, 2002, J SCI IND RES INDIA, V61, P339; Kannan KC, 2010, J AM LEATHER CHEM AS, V105, P360; Kavkazov JL, 1950, VZAIMODEISTVYJE VLAG, P58; Kutianin GI, 1974, IZVESTIYA VUZ O, V17, P60; LINDNER W, 1990, INT BIODETERIOR, V26, P195, DOI 10.1016/0265-3036(90)90059-G; Liu CK, 2011, J AM LEATHER CHEM AS, V106, P76; Naghski J, 1966, J AM LEATHER CHEM AS, V61, P64; Sharma PK, 2006, HARYANA AGR U J RES, V26, P1; Sivakumar V, 2010, OZONE-SCI ENG, V32, P449, DOI 10.1080/01919512.2010.515524; Song JA, 2011, J CLEAN PROD, V19, P325, DOI 10.1016/j.jclepro.2010.10.011; Sundar VJ, 2009, DESALIN WATER TREAT, V11, P314, DOI 10.5004/dwt.2009.865; Tricys V, 2003, J SOC LEATH TECH CH, V87, P78; Valeika V, 2000, J SOC LEATH TECH CH, V84, P165; Valeika V, 2013, J SOC LEATH TECH CH, V97, P101; Valeika V, 2010, MATER SCI-MEDZG, V16, P330; Vankar PS, 2009, DESALINATION, V249, P158, DOI 10.1016/j.desal.2008.08.011; Vankar PS, 2009, J HAZARD MATER, V163, P207, DOI 10.1016/j.jhazmat.2008.06.090; Vijayalakshmi K, 2009, J SCI IND RES INDIA, V68, P699; Wen HX, 2007, J SOC LEATH TECH CH, V91, P196; Zaides A., 1964, BIOKHIMIYA, V5	37	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112783	10.1371/journal.pone.0112783	http://dx.doi.org/10.1371/journal.pone.0112783			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393637	gold, Green Submitted, Green Published			2022-12-26	WOS:000347709300102
J	Kubrak, OI; Kucerova, L; Theopold, U; Nassel, DR				Kubrak, Olga I.; Kucerova, Lucie; Theopold, Ulrich; Nassel, Dick R.			The Sleeping Beauty: How Reproductive Diapause Affects Hormone Signaling, Metabolism, Immune Response and Somatic Maintenance in Drosophila melanogaster	PLOS ONE			English	Article							INSULIN-LIKE PEPTIDE; MOSQUITO CULEX-PIPIENS; EXTENDS LIFE-SPAN; GENE-EXPRESSION; INSECT DIAPAUSE; OVERWINTERING DIAPAUSE; CAENORHABDITIS-ELEGANS; NUTRIENT AVAILABILITY; CLIMATIC ADAPTATION; CELL-PROLIFERATION	Some organisms can adapt to seasonal and other environmental challenges by entering a state of dormancy, diapause. Thus, insects exposed to decreased temperature and short photoperiod enter a state of arrested development, lowered metabolism, and increased stress resistance. Drosophila melanogaster females can enter a shallow reproductive diapause in the adult stage, which drastically reduces organismal senescence, but little is known about the physiology and endocrinology associated with this dormancy, and the genes involved in its regulation. We induced diapause in D. melanogaster and monitored effects over 12 weeks on dynamics of ovary development, carbohydrate and lipid metabolism, as well as expression of genes involved in endocrine signaling, metabolism and innate immunity. During diapause food intake diminishes drastically, but circulating and stored carbohydrates and lipids are elevated. Gene transcripts of glucagonand insulin-like peptides increase, and expression of several target genes of these peptides also change. Four key genes in innate immunity can be induced by infection in diapausing flies, and two of these, drosomycin and cecropin A1, are upregulated by diapause independently of infection. Diapausing flies display very low mortality, extended lifespan and decreased aging of the intestinal epithelium. Many phenotypes induced by diapause are reversed after one week of recovery from diapause conditions. Furthermore, mutant flies lacking specific insulin-like peptides (dilp5 and dilp2-3) display increased diapause incidence. Our study provides a first comprehensive characterization of reproductive diapause in D. melanogaster, and evidence that glucagon- and insulin-like signaling are among the key regulators of the altered physiology during this dormancy.	[Kubrak, Olga I.; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Kucerova, Lucie; Theopold, Ulrich] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Nassel, DR (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se	Kucerova, Lucie/N-1176-2016; Theopold, Ulrich/P-7205-2015	Kucerova, Lucie/0000-0002-6382-4467; Theopold, Ulrich/0000-0002-1009-8254	Swedish Research Council [VR-2012-3715, VR-2010-5988, VR-2010-5742]; Knut and Alice Wallenberg Foundation [KAW2012.0058]; Swedish Foundation for International Cooperation in Research and Higher Education [IG2011-2042]; Swedish Institute [00197/2012]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for International Cooperation in Research and Higher Education; Swedish Institute	The work was supported by the following: Swedish Research Council (projects VR-2012-3715, VR-2010-5988 and VR-2010-5742) to D.R.N., U.T. and Soren Nylin, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; The Knut and Alice Wallenberg Foundation (KAW2012.0058; Soren Nylin), https://www.wallenberg.com/kaw/en; Swedish Foundation for International Cooperation in Research and Higher Education (IG2011-2042) to U.T., http://www.stint.se/en/; and The Swedish Institute (Visby Program: 00197/2012) to O.I.K., https://eng.si.se/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2007, FLY, V1, P307, DOI 10.4161/fly.5532; Anaka M, 2008, J NEUROGENET, V22, P243, DOI 10.1080/01677060802309629; Antonova Y., 2012, INSECT ENDOCRINOL, P63, DOI DOI 10.1016/B978-0-12-384749-2.10002-0; Ayyaz A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00098; Bai H, 2012, AGING CELL, V11, P978, DOI 10.1111/acel.12000; Baker DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-242; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bednarova A, 2013, COMP BIOCHEM PHYS A, V164, P91, DOI 10.1016/j.cbpa.2012.10.012; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Borycz J, 2008, J EXP BIOL, V211, P3454, DOI 10.1242/jeb.021162; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003721; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chippendale GM, 1966, J INSECT PHYSL, V13, P995; Choi NH, 2011, P NATL ACAD SCI USA, V108, P18702, DOI 10.1073/pnas.1109348108; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Crowe JH, 2007, ADV EXP MED BIOL, V594, P143; Danks HV, 2000, J INSECT PHYSIOL, V46, P837, DOI 10.1016/S0022-1910(99)00204-8; Dantoft W, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-99; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Demontis F, 2010, CELL, V143, P813, DOI 10.1016/j.cell.2010.10.007; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Emerson KJ, 2009, J COMP PHYSIOL A, V195, P825, DOI 10.1007/s00359-009-0460-5; Emerson KJ, 2009, TRENDS GENET, V25, P217, DOI 10.1016/j.tig.2009.03.009; Engstrom Y, 1999, DEV COMP IMMUNOL, V23, P345, DOI 10.1016/S0145-305X(99)00016-6; Ewart GD, 1998, METHOD ENZYMOL, V292, P213; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Flatt T, 2013, Q REV BIOL, V88, P185, DOI 10.1086/671484; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gasque G, 2013, SCI REP, V3, DOI DOI 10.1038/SREP02120; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Hahn DA, 2007, J INSECT PHYSIOL, V53, P760, DOI 10.1016/j.jinsphys.2007.03.018; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hamasaka Y, 2006, J COMP NEUROL, V494, P314, DOI 10.1002/cne.20807; Huser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047518; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; King R. C., 1970, OVARIAN DEV DROSOPHI; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; Krstic D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077904; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; LEFEVERE KS, 1989, J INSECT PHYSIOL, V35, P121, DOI 10.1016/0022-1910(89)90045-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Nassel DR, 2010, PROG NEUROBIOL, V92, P42, DOI 10.1016/j.pneurobio.2010.04.010; Nylin S, 2013, PHYSIOL ENTOMOL, V38, P96, DOI 10.1111/phen.12014; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Okamoto N, 2009, DEV CELL, V17, P885, DOI 10.1016/j.devcel.2009.10.008; Okamura T, 2007, MOL BIOL CELL, V18, P1519, DOI 10.1091/mbc.E06-10-0909; Owusu-Ansah E, 2014, DIS MODEL MECH, V7, P343, DOI 10.1242/dmm.012989; Padmanabha D., 2014, TRENDS ENDOCRINOL ME; Park MS, 2008, J INSECT PHYSIOL, V54, P386, DOI 10.1016/j.jinsphys.2007.10.011; Poelchau MF, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0143; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Puig O, 2006, CELL CYCLE, V5, P503, DOI 10.4161/cc.5.5.2501; Ragland GJ, 2011, J EXP BIOL, V214, P3948, DOI 10.1242/jeb.061085; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Rajan A, 2011, DEV CELL, V21, P29, DOI 10.1016/j.devcel.2011.06.034; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; SAUNDERS DS, 1990, GEN COMP ENDOCR, V79, P174, DOI 10.1016/0016-6480(90)90102-R; SAUNDERS DS, 1990, J BIOL RHYTHM, V5, P315, DOI 10.1177/074873049000500404; Schiesari L, 2011, FEBS LETT, V585, P1450, DOI 10.1016/j.febslet.2011.02.026; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Shimada Y, 2011, DEV BIOL, V355, P250, DOI 10.1016/j.ydbio.2011.04.022; Sim C, 2009, INSECT MOL BIOL, V18, P325, DOI 10.1111/j.1365-2583.2009.00872.x; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sim C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00189; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stoffolano JG, 2013, ANNU REV ENTOMOL, V58, P205, DOI 10.1146/annurev-ento-120811-153653; Storey K.B., 1991, P64; Storey KR, 2010, TOP CURR GENET, V21, P227, DOI 10.1007/978-3-642-12422-8_13; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Toivonen JM, 2009, MOL CELL ENDOCRINOL, V299, P39, DOI 10.1016/j.mce.2008.07.005; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; WILLIAMS KD, 1993, HEREDITY, V71, P312, DOI 10.1038/hdy.1993.141; Wong R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006063; WU CF, 1977, J GEN PHYSIOL, V69, P705, DOI 10.1085/jgp.69.6.705; Zaidman-Remy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017231	114	85	88	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113051	10.1371/journal.pone.0113051	http://dx.doi.org/10.1371/journal.pone.0113051			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393614	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300138
J	Skamel, C; Aller, SG; Waffo, AB				Skamel, Claudia; Aller, Stephen G.; Waffo, Alain Bopda			In Vitro Evolution and Affinity-Maturation with Coliphage Q beta Display	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; PHAGE DISPLAY; READ-THROUGH; COAT PROTEIN; RNA; PEPTIDE; MECHANISMS; ANTIBODIES; STRAND; SITE	The Escherichia coli bacteriophage, Q beta (Coliphage Q beta), offers a favorable alternative to M13 for in vitro evolution of displayed peptides and proteins due to high mutagenesis rates in Qb RNA replication that better simulate the affinity maturation processes of the immune response. We describe a benchtop in vitro evolution system using Qb display of the VP1 G-H loop peptide of foot-and-mouth disease virus (FMDV). DNA encoding the G-H loop was fused to the A1 minor coat protein of Qb resulting in a replication-competent hybrid phage that efficiently displayed the FMDV peptide. The surface-localized FMDV VP1 G-H loop cross-reacted with the anti-FMDV monoclonal antibody (mAb) SD6 and was found to decorate the corners of the Q beta icosahedral shell by electron microscopy. Evolution of Q beta-displayed peptides, starting from fully degenerate coding sequences corresponding to the immunodominant region of VP1, allowed rapid in vitro affinity maturation to SD6 mAb. Q beta selected under evolutionary pressure revealed a non-canonical, but essential epitope for mAb SD6 recognition consisting of an Arg-Gly tandem pair. Finally, the selected hybrid phages induced polyclonal antibodies in guinea pigs with good affinity to both FMDV and hybrid Q beta-G-H loop, validating the requirement of the tandem pair epitope. Q beta-display emerges as a novel framework for rapid in vitro evolution with affinity-maturation to molecular targets.	[Skamel, Claudia] Univ Freiburg, Agcy Technol Transfer, Campus Technol Freiburg CTF GmbH, D-79106 Freiburg, Germany; [Skamel, Claudia] Univ Med Ctr Freiburg, Freiburg, Germany; [Aller, Stephen G.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL USA; [Aller, Stephen G.] Univ Alabama Birmingham, Struct Biol Ctr, Birmingham, AL USA; [Waffo, Alain Bopda] Alabama State Univ, Dept Biol Sci, Montgomery, AL 36101 USA	University of Freiburg; University of Freiburg; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Waffo, AB (corresponding author), Alabama State Univ, Dept Biol Sci, Montgomery, AL 36101 USA.	abopdawaffo@alasu.edu		Bopda Waffo, Alain/0000-0002-0811-4649; Aller, Stephen/0000-0003-0379-5534	Deutsche Forschungsgemeinschaft [DFG-BI521/2-3]; CNBR of ASU [NSF-CREST (HRD-1241701)]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008591] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CNBR of ASU; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the Deutsche Forschungsgemeinschaft for grant # DFG-BI521/2-3 and the CNBR of ASU for grant # NSF-CREST (HRD-1241701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MH, 1959, BACTERIOPHAGES, P473; Azzazy HME, 2002, CLIN BIOCHEM, V35, P425, DOI 10.1016/S0009-9120(02)00343-0; BARRERA I, 1993, J MOL BIOL, V232, P512, DOI 10.1006/jmbi.1993.1407; BEEKWILDER MJ, 1995, J MOL BIOL, V247, P903, DOI 10.1006/jmbi.1995.0189; Beer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045472; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; Bollback JP, 2001, J MOL EVOL, V52, P117, DOI 10.1007/s002390010140; BROWN F, 1961, NATURE, V192, P1163, DOI 10.1038/1921163a0; Brown F, 1999, ARCH VIROL, P179; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Domingo E, 1999, VIRUS RES, V62, P169, DOI 10.1016/S0168-1702(99)00042-8; Domingo E, 2001, QUASISPECIES RNA VIR, P173; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; FURUSE K, 1983, J GEN VIROL, V64, P2039, DOI 10.1099/0022-1317-64-9-2039; Furuse K., 1987, PHAGE ECOLOGY, P87; GSCHWENDER HH, 1969, BIOCHIM BIOPHYS ACTA, V190, P454, DOI 10.1016/0005-2787(69)90094-X; HOFSTETTER H, 1974, BIOCHIM BIOPHYS ACTA, V374, P238, DOI 10.1016/0005-2787(74)90366-9; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Kahn S, 2002, CAN VET J, V43, P349; Kozlovska TM, 1996, INTERVIROLOGY, V39, P9, DOI 10.1159/000150469; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Mack K, 1996, ANAL BIOCHEM, V242, P73, DOI 10.1006/abio.1996.0430; Marvin DA, 1998, CURR OPIN STRUC BIOL, V8, P150, DOI 10.1016/S0959-440X(98)80032-8; Ouchterlony O., 1978, HDB EXPT IMMUNOLOGY; PACE NR, 1966, SCIENCE, V153, P64, DOI 10.1126/science.153.3731.64; Petrenko VA, 2000, PROTEIN ENG, V13, P589, DOI 10.1093/protein/13.8.589; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51, DOI 10.21775/cimb.013.051; Rumnieks J, 2011, PROTEIN SCI, V20, P1707, DOI 10.1002/pro.704; SCHUSTER P, 1994, COMPUT CHEM, V18, P295, DOI 10.1016/0097-8485(94)85025-9; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SHAKLEE PN, 1988, VIROLOGY, V163, P209, DOI 10.1016/0042-6822(88)90250-4; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Smith GP, 1985, SCIENCE, V234, P211; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; TANIGUCHI T, 1978, NATURE, V274, P223, DOI 10.1038/274223a0; van Meerten D, 2001, J GEN VIROL, V82, P1797, DOI 10.1099/0022-1317-82-7-1797; van Rooy I, 2012, EUR J PHARM SCI, V45, P330, DOI 10.1016/j.ejps.2011.11.015; Vasiljeva I, 1998, FEBS LETT, V431, P7, DOI 10.1016/S0014-5793(98)00716-9; Verdaguer N, 1998, J VIROL, V72, P739, DOI 10.1128/JVI.72.1.739-748.1998; WEBER K, 1975, RNA PHAGES, P51; WEINER AM, 1971, NATURE-NEW BIOL, V234, P206, DOI 10.1038/newbio234206a0; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7	47	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113069	10.1371/journal.pone.0113069	http://dx.doi.org/10.1371/journal.pone.0113069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393763	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300140
J	Staines, K; Hunt, LG; Young, JR; Butter, C				Staines, Karen; Hunt, Lawrence G.; Young, John R.; Butter, Colin			Evolution of an Expanded Mannose Receptor Gene Family	PLOS ONE			English	Article							MEDIATED PHAGOCYTOSIS; DENDRITIC CELLS; DOWN-REGULATION; LECTIN; MACROPHAGES; BINDING; INVOLVEMENT; CYTOKINES; DOMAIN; RNA	Sequences of peptides from a protein specifically immunoprecipitated by an antibody, KUL01, that recognises chicken macrophages, identified a homologue of the mammalian mannose receptor, MRC1, which we called MRC1L-B. Inspection of the genomic environment of the chicken gene revealed an array of five paralogous genes, MRC1L-A to MRC1L-E, located between conserved flanking genes found either side of the single MRC1 gene in mammals. Transcripts of all five genes were detected in RNA from a macrophage cell line and other RNAs, whose sequences allowed the precise definition of spliced exons, confirming or correcting existing bioinformatic annotation. The confirmed gene structures were used to locate orthologues of all five genes in the genomes of two other avian species and of the painted turtle, all with intact coding sequences. The lizard genome had only three genes, one orthologue of MRC1L-A and two orthologues of the MRC1L-B antigen gene resulting from a recent duplication. The Xenopus genome, like that of most mammals, had only a single MRC1-like gene at the corresponding locus. MRC1L-A and MRC1L-B genes had similar cytoplasmic regions that may be indicative of similar subcellular migration and functions. Cytoplasmic regions of the other three genes were very divergent, possibly indicating the evolution of a new functional repertoire for this family of molecules, which might include novel interactions with pathogens.	[Staines, Karen; Hunt, Lawrence G.; Young, John R.; Butter, Colin] Pirbright Inst, Compton, England		Butter, C (corresponding author), Pirbright Inst, Compton, England.	colin.butter@avianimmunology.org			BBSRC (Biotechnology and Biological Sciences Research Council) [BBS/E/I/00001423]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001423, BBS/E/I/00001705] Funding Source: researchfish; BBSRC [BBS/E/I/00001423, BBS/E/I/00001705] Funding Source: UKRI	BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the BBSRC (Biotechnology and Biological Sciences Research Council) under grant number BBS/E/I/00001423 as part of the Institute Strategic Programme Grant to the Avian Viral Diseases Programme at the Pirbright Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barten R, 2001, TRENDS IMMUNOL, V22, P52, DOI 10.1016/S1471-4906(00)01802-0; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Diaz-Silvestre H, 2005, MICROB PATHOGENESIS, V39, P97, DOI 10.1016/j.micpath.2005.06.002; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; HARRIS N, 1992, BLOOD, V80, P2363; Hedges SB, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-64; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Kaiser P, 2005, J INTERF CYTOK RES, V25, P467, DOI 10.1089/jir.2005.25.467; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KIM SJ, 1992, GENOMICS, V14, P721, DOI 10.1016/S0888-7543(05)80174-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martinez-Pomares L, 1999, IMMUNOL LETT, V65, P9, DOI 10.1016/S0165-2478(98)00117-5; Martinez-Pomares L, 1998, J BIOL CHEM, V273, P23376, DOI 10.1074/jbc.273.36.23376; Mast J, 1998, VET IMMUNOL IMMUNOP, V61, P343, DOI 10.1016/S0165-2427(97)00152-9; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Meyer LR ZA, 2012, NUCL ACIDS RES; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Milone MC, 1998, J IMMUNOL, V161, P2391; Mishra PK, 2013, INFECT IMMUN, V81, P1052, DOI 10.1128/IAI.01176-12; Moody A, 2000, J VIROL METHODS, V85, P55, DOI 10.1016/S0166-0934(99)00156-1; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Pradet-Balade B, 2002, EMBO J, V21, P5711, DOI 10.1093/emboj/cdf565; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Reading PC, 2000, J VIROL, V74, P5190, DOI 10.1128/JVI.74.11.5190-5197.2000; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandoval Ignacio V., 1994, Trends in Cell Biology, V4, P292, DOI 10.1016/0962-8924(94)90220-8; Schweizer A, 2000, J BIOL CHEM, V275, P29694, DOI 10.1074/jbc.M000571200; Shibata Y, 1997, J IMMUNOL, V159, P2462; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Staines K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051799; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TAYLOR ME, 1990, J BIOL CHEM, V265, P12156; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Tesar DB, 2008, MOL BIOL CELL, V19, P1587, DOI 10.1091/mbc.E07-09-0972; TIETZE C, 1982, J CELL BIOL, V92, P417, DOI 10.1083/jcb.92.2.417; Tregaskes CA, 1996, IMMUNOGENETICS, V44, P212, DOI 10.1007/BF02602587; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Upham JP, 2010, J VIROL, V84, P3730, DOI 10.1128/JVI.02148-09; Vautier S, 2012, CYTOKINE, V58, P89, DOI 10.1016/j.cyto.2011.08.031; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Yamamoto Y, 1997, INFECT IMMUN, V65, P1077, DOI 10.1128/IAI.65.3.1077-1082.1997; Zelensky AN, 2003, PROTEINS, V52, P466, DOI 10.1002/prot.10626; Zhang JM, 2005, MOL BIOL CELL, V16, P824, DOI 10.1091/mbc.e04-06-0463	51	30	30	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110330	10.1371/journal.pone.0110330	http://dx.doi.org/10.1371/journal.pone.0110330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390371	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000349144400013
J	Dong, LL; Duan, WW; Chen, JL; Sun, H; Qiao, CH; Xia, CM				Dong, Lanlan; Duan, Wenwen; Chen, Jinglei; Sun, Huan; Qiao, Chunhua; Xia, Chao-ming			An Artemisinin Derivative of Praziquantel as an Orally Active Antischistosomal Agent	PLOS ONE			English	Article							SCHISTOSOMA-JAPONICUM; MANSONI; CHEMOTHERAPY; ARTEMETHER; RESISTANCE; MECHANISMS; JUVENILE; ANALOGS	Background: Schistosomiasis is a major health problem in tropical and sub-tropical areas caused by species of trematode belonging to the genus Schistosoma. The treatment and control of this disease has been relying on the use of a single drug praziquantel. However, the drug resistance concern urged the development of new drugs against schistosoma. Here, we report our systematic biological evaluation of DW-3-15, a new lead compound developed based on our conjugation design rationale as an effective anti-schistosomal agent. Methodology/Principal Findings: The antischistosomal activity of DW-3-15 was systematically evaluated in S. japonicum infected mouse model for its stage-sensitivity and dose response. The results revealed that DW-3-15 exhibited 60-85% worm reduction rate against different development stage of worm. Scanning electron microscopy (SEM) observation indicated that DW-3-15 may damage to the tegument of male schistosomes. Conclusions/Significance: Our results demonstrated that DW-3-15 showed potent anti-schistosomal activities in vivo. The results strongly support our conjugation design strategy of artemisinin analogs and further development of DW-3-15 as a new lead compound as anti-schistosomal agent.	[Dong, Lanlan; Duan, Wenwen; Chen, Jinglei; Sun, Huan; Qiao, Chunhua; Xia, Chao-ming] Soochow Univ, Coll Med Sci, Suzhou, Peoples R China	Soochow University - China	Qiao, CH (corresponding author), Soochow Univ, Coll Med Sci, Suzhou, Peoples R China.	qiaochunhua@suda.edu.cn; xiachaoming@suda.edu.cn			National 863 Program of China [2012AA0203006]; Priority Academic Program Development of Jiangsu Higher Education Institutions; "333" Project of Jiangsu Province; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National 863 Program of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; "333" Project of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This project is funded by National 863 Program of China (NO. 2012AA0203006) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors are indebted to the financial support from "333" Project of Jiangsu Province. This project is also sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; ANDREWS P, 1985, PHARMACOL THERAPEUT, V29, P129, DOI 10.1016/0163-7258(85)90020-8; Botros S, 2005, INT J PARASITOL, V35, P787, DOI 10.1016/j.ijpara.2005.02.005; Botros S, 2003, ANTIMICROB AGENTS CH, V47, P3853, DOI 10.1128/AAC.47.12.3853-3858.2003; Caffrey CR, 2007, CURR OPIN CHEM BIOL, V11, P433, DOI 10.1016/j.cbpa.2007.05.031; Cioli D, 2004, INT J PARASITOL, V34, P979, DOI 10.1016/j.ijpara.2004.05.001; Doenhoff MJ, 2008, CURR OPIN INFECT DIS, V21, P659, DOI 10.1097/QCO.0b013e328318978f; Dong YX, 2010, BIOORG MED CHEM LETT, V20, P2481, DOI 10.1016/j.bmcl.2010.03.001; Duan WW, 2012, BIOORG MED CHEM LETT, V22, P1587, DOI 10.1016/j.bmcl.2011.12.133; El Ridi R, 2010, ANTIMICROB AGENTS CH, V54, P3383, DOI 10.1128/AAC.00173-10; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Huang JG, 2010, DRUG METAB PHARMACOK, V25, P487, DOI 10.2133/dmpk.DMPK-10-RG-041; Keiser J, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000350; Laurent SAL, 2008, EUR J ORG CHEM, V2008, P895, DOI 10.1002/ejoc.200700975; Meunier B, 2010, ACCOUNTS CHEM RES, V43, P1444, DOI 10.1021/ar100070k; Patra M, 2013, J MED CHEM, V56, P9192, DOI 10.1021/jm401287m; Patra M, 2012, J MED CHEM, V55, P8790, DOI 10.1021/jm301077m; Pica-Mattoccia L, 2007, EXP PARASITOL, V115, P344, DOI 10.1016/j.exppara.2006.09.017; Portela J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001474; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; Utzinger J, 2001, INT J PARASITOL, V31, P1549, DOI 10.1016/S0020-7519(01)00297-1; Utzinger J, 2001, ACTA TROP, V80, P9, DOI 10.1016/S0001-706X(01)00138-3; Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/eoph.5.2.263.26469; XIAO SH, 1987, CHINESE MED J-PEKING, V100, P759; Xiao SH, 2000, PARASITOL INT, V49, P25, DOI 10.1016/S1383-5769(00)00029-5; Xiao SH, 2009, PARASITOL RES, V106, P131, DOI 10.1007/s00436-009-1640-5; YOLLES TK, 1947, J PARASITOL, V33, P419, DOI 10.2307/3273678; You J, 1994, CHIN J PARASITIC DIS, V7, P50	30	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112163	10.1371/journal.pone.0112163	http://dx.doi.org/10.1371/journal.pone.0112163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386745	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400046
J	Tsai, YC; Chiu, YW; Kuo, HT; Chen, SC; Hwang, SJ; Chen, TH; Kuo, MC; Chen, HC				Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Chen, Szu-Chia; Hwang, Shang-Jyh; Chen, Tzu-Hui; Kuo, Mei-Chuan; Chen, Hung-Chun			Fluid Overload, Pulse Wave Velocity, and Ratio of Brachial Pre-Ejection Period to Ejection Time in Diabetic and Non-Diabetic Chronic Kidney Disease	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; BIOIMPEDANCE SPECTROSCOPY; ARTERIAL STIFFNESS; VOLUME OVERLOAD; MORTALITY; ULTRAFILTRATION; ASSOCIATION; PARAMETER; INDEX; MANAGEMENT	Fluid overload is one of the characteristics in chronic kidney disease (CKD). Changes in extracellular fluid volume are associated with progression of diabetic nephropathy. Not only diabetes but also fluid overload is associated with cardiovascular risk factors The aim of the study was to assess the interaction between fluid overload, diabetes, and cardiovascular risk factors, including arterial stiffness and left ventricular function in 480 patients with stages 4-5 CKD. Fluid status was determined by bioimpedance spectroscopy method, Body Composition Monitor. Brachial-ankle pulse wave velocity (baPWV), as a good parameter of arterial stiffness, and brachial pre-ejection period (bPEP)/brachial ejection time (bET), correlated with impaired left ventricular function were measured by ankle-brachial index (ABI)-form device. Of all patients, 207 (43.9%) were diabetic and 240 (50%) had fluid overload. For non-diabetic CKD, fluid overload was associated with being female (beta = -2.87, P = 0.003), heart disease (beta = 2.69, P = 0.04), high baPWV (beta = 0.27, P = 0.04), low hemoglobin (beta = -1.10, P<0.001), and low serum albumin (beta = -5.21, P<0.001) in multivariate analysis. For diabetic CKD, fluid overload was associated with diuretics use (beta = 3.69, P = 0.003), high mean arterial pressure (beta = 0.14, P = 0.01), low bPEP/ET (beta = -0.19, P = 0.03), low hemoglobin (beta = -1.55, P = 0.001), and low serum albumin (beta = -9.46, P<0.001). In conclusion, baPWV is associated with fluid overload in non-diabetic CKD and bPEP/bET is associated with fluid overload in diabetic CKD. Early and accurate assessment of these associated cardiovascular risk factors may improve the effects of entire care in late CKD.	[Tsai, Yi-Chun; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chen, Tzu-Hui] Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Chiu, Yi-Wen; Kuo, Hung-Tien; Chen, Szu-Chia; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Municipal Hsiaokang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hwang, Shang-Jyh] Natl Hlth Res Inst, Inst Populat Sci, Miaoli, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; National Health Research Institutes - Taiwan	Kuo, MC (corresponding author), Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan.	mechku@cc.kmu.edu.tw	蘇, 河名/AAE-9843-2019	Kuo, Hung-Tien/0000-0002-9931-4354	Kaohsiung Medical University Faculty of Renal Care; Kaohsiung Medical University Research Foundation [KMU-Q103011]	Kaohsiung Medical University Faculty of Renal Care; Kaohsiung Medical University Research Foundation	Dr. Tsai's research was supported by the Kaohsiung Medical University Faculty of Renal Care and a grant from the Kaohsiung Medical University Research Foundation (KMU-Q103011). The author(s) received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CH, 1998, J AM COLL CARDIOL, V32, P1221, DOI 10.1016/S0735-1097(98)00374-X; Chen SC, 2012, AM J MED SCI, V344, P457, DOI 10.1097/MAJ.0b013e31825141bf; Chen SC, 2011, NEPHROL DIAL TRANSPL, V26, P1895, DOI 10.1093/ndt/gfq639; Chen SC, 2010, CIRC J, V74, P2206, DOI 10.1253/circj.CJ-10-0273; Chen SC, 2010, HYPERTENS RES, V33, P492, DOI 10.1038/hr.2010.24; Crepaldi C, 2009, CONTRIB NEPHROL, V163, P1, DOI 10.1159/000223772; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Kim WJ, 2012, ATHEROSCLEROSIS, V225, P237, DOI 10.1016/j.atherosclerosis.2012.08.034; Kimoto E, 2003, DIABETES, V52, P448, DOI 10.2337/diabetes.52.2.448; Levey AS, 1999, MORE ACCURATE; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Moody WE, 2013, HEART, V99, P365, DOI 10.1136/heartjnl-2012-302818; Movilli E, 2007, NEPHROL DIAL TRANSPL, V22, P3547, DOI 10.1093/ndt/gfm466; Paniagua R, 2010, NEPHROL DIAL TRANSPL, V25, P551, DOI 10.1093/ndt/gfp395; Saran R, 2006, KIDNEY INT, V69, P1222, DOI 10.1038/sj.ki.5000186; Su HM, 2009, AM J HYPERTENS, V22, P871, DOI 10.1038/ajh.2009.94; Tsai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082566; Tsai YC, 2014, AM J KIDNEY DIS, V63, P68, DOI 10.1053/j.ajkd.2013.06.011; Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037; TUCKER BJ, 1991, KIDNEY INT, V39, P1176, DOI 10.1038/ki.1991.149; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; Wieskotten S, 2008, PHYSIOL MEAS, V29, P639, DOI 10.1088/0967-3334/29/5/009; WIZEMANN V, 1995, NEPHROL DIAL TRANSPL, V10, P2114; WIZEMANN V, 1995, ARTIF ORGANS, V19, P416, DOI 10.1111/j.1525-1594.1995.tb02352.x; Wizemann V, 2008, WHOLE BODY SPECTROSC; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253; Zheng D, 2009, CORRELATION BETWEEN	32	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111000	10.1371/journal.pone.0111000	http://dx.doi.org/10.1371/journal.pone.0111000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386836	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400012
J	Abrahams, AC; Habib, SM; Dendooven, A; Riser, BL; van der Veer, JW; Toorop, RJ; Betjes, MGH; Verhaar, MC; Watson, CJE; Nguyen, TQ; Boer, WH				Abrahams, Alferso C.; Habib, Sayed M.; Dendooven, Amelie; Riser, Bruce L.; van der Veer, Jan Willem; Toorop, Raechel J.; Betjes, Michiel G. H.; Verhaar, Marianne C.; Watson, Christopher J. E.; Nguyen, Tri Q.; Boer, Walther H.			Patients with Encapsulating Peritoneal Sclerosis Have Increased Peritoneal Expression of Connective Tissue Growth Factor (CCN2), Transforming Growth Factor-beta 1, and Vascular Endothelial Growth Factor	PLOS ONE			English	Article							TGF-BETA; MORPHOLOGIC CHANGES; FACTOR CTGF/CCN2; GENE-EXPRESSION; MEMBRANE; CTGF; TGF-BETA-1; INHIBITOR; CYTOKINES; FIBROSIS	Introduction: Encapsulating peritoneal sclerosis (EPS) is a devastating complication of peritoneal dialysis (PD). The pathogenesis is not exactly known and no preventive strategy or targeted medical therapy is available. CCN2 has both pro-fibrotic and pro-angiogenic actions and appears an attractive target. Therefore, we studied peritoneal expression of CCN2, as well as TGFb1 and VEGF, in different stages of peritoneal fibrosis. Materials and methods: Sixteen PD patients were investigated and compared to 12 hemodialysis patients and four pre-emptively transplanted patients. Furthermore, expression was investigated in 12 EPS patients in comparison with 13 PD and 12 non-PD patients without EPS. Peritoneal tissue was taken during kidney transplantation procedure or during EPS surgery. In a subset of patients, CCN2 protein levels in peritoneal effluent and plasma were determined. Samples were examined by qPCR, histology, immunohistochemistry, and ELISA. Results: Peritoneal CCN2 expression was 5-fold higher in PD patients compared to pre-emptively transplanted patients (P<0.05), but did not differ from hemodialysis patients. Peritoneal expression of TGF beta 1 and VEGF were not different between the three groups; neither was peritoneal thickness. Peritoneum of EPS patients exhibited increased expression of CCN2 (35-fold, P<0.001), TGF beta 1 (24-fold, P<0.05), and VEGF (77-fold, P<0.001) compared to PD patients without EPS. In EPS patients, CCN2 protein was mainly localized in peritoneal endothelial cells and fibroblasts. CCN2 protein levels were significantly higher in peritoneal effluent of EPS patients compared to levels in dialysate of PD patients (12.0 +/- 4.5 vs. 0.91 +/- 0.92 ng/ml, P<0.01), while plasma CCN2 levels were not increased. Conclusions: Peritoneal expression of CCN2, TGF beta 1, and VEGF are significantly increased in EPS patients. In early stages of peritoneal fibrosis, only CCN2 expression is slightly increased. Peritoneal CCN2 overexpression in EPS patients is a locally driven response. The potential of CCN2 as biomarker and target for CCN2-inhibiting agents to prevent or treat EPS warrants further study.	[Abrahams, Alferso C.; van der Veer, Jan Willem; Verhaar, Marianne C.; Boer, Walther H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands; [Habib, Sayed M.; Betjes, Michiel G. H.] Erasmus MC, Dept Internal Med, Div Nephrol & Transplantat, Rotterdam, Netherlands; [Dendooven, Amelie; Nguyen, Tri Q.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Riser, Bruce L.] Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, Chicago, IL 60064 USA; [Toorop, Raechel J.] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Watson, Christopher J. E.] Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England; [Watson, Christopher J. E.] Cambridge NIHR Biomed Res Ctr, Cambridge, England	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Chicago Medical School; Rosalind Franklin University Medical & Science; Utrecht University; Utrecht University Medical Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Abrahams, AC (corresponding author), Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands.	A.C.Abrahams@umcutrecht.nl	Verhaar, Marianne/AAM-6788-2020; Dendooven, Amélie/AAC-1192-2021; Nguyen, Tri/A-9508-2009; Nguyen, Tri Q/AAN-9673-2021	Verhaar, Marianne/0000-0002-3276-6428; Nguyen, Tri/0000-0001-6475-0706; Nguyen, Tri Q/0000-0001-6475-0706; Watson, Christopher/0000-0002-0590-4901; Dendooven, Amelie/0000-0002-9900-7952; Betjes, Michiel/0000-0001-9435-6208; boer, walther/0000-0001-5048-2755	Dutch Kidney Foundation [C10.2344]; Clinical Evidence Council grant from Baxter Healthcare [10CECEU1007]	Dutch Kidney Foundation; Clinical Evidence Council grant from Baxter Healthcare	This study was supported by a grant from the Dutch Kidney Foundation (C10.2344) and a Clinical Evidence Council grant from Baxter Healthcare (10CECEU1007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SG, 2010, CLIN J AM SOC NEPHRO, V5, P1420, DOI 10.2215/CJN.09321209; Barreto DL, 2013, AM J KIDNEY DIS, V62, P823, DOI 10.1053/j.ajkd.2013.01.031; Braun N, 2009, NEPHRON CLIN PRACT, V113, pC88, DOI 10.1159/000228540; Braun N, 2012, PLOS ONE, V7; Dendooven A, 2011, BIOMARKERS, V16, P289, DOI 10.3109/1354750X.2011.561366; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DIPAOLO N, 1986, NEPHRON, V44, P204, DOI 10.1159/000183987; DOBBIE JW, 1989, BLOOD PURIFICAT, V7, P74, DOI 10.1159/000169580; Habib SM, 2011, NETH J MED, V69, P500; Habib SM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-203; Hall-Glenn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030562; Hall-Glenn F, 2011, CELL MOL LIFE SCI, V68, P3209, DOI 10.1007/s00018-011-0782-7; Honda K, 2005, PERITON DIALYSIS INT, V25, pS19; Honda K, 1996, NEPHRON, V72, P171, DOI 10.1159/000188837; Honda K, 2008, CLIN J AM SOC NEPHRO, V3, P720, DOI 10.2215/CJN.03630807; Io H, 2004, KIDNEY INT, V65, P1927, DOI 10.1111/j.1523-1755.2004.00599.x; Katz LH, 2013, EXPERT OPIN THER TAR, V17, P743, DOI 10.1517/14728222.2013.782287; Kawaguchi Y, 2000, PERITON DIALYSIS INT, V20, pS43; Kawanishi H, 2005, PERITON DIALYSIS INT, V25, pS39; Korte MR, 2011, NAT REV NEPHROL, V7, P528, DOI 10.1038/nrneph.2011.93; Krediet RT, 2013, NAT REV NEPHROL, V9, P419, DOI 10.1038/nrneph.2013.99; La Milia V, 2010, J NEPHROL, V23, P633; Leask A, 2009, J CELL COMMUN SIGNAL, V3, P89, DOI 10.1007/s12079-009-0037-7; Leung JCK, 2009, NEPHROL DIAL TRANSPL, V24, P458, DOI 10.1093/ndt/gfn524; Liu FY, 2007, CHINESE MED J-PEKING, V120, P231, DOI 10.1097/00029330-200702010-00012; Liu LM, 2009, PERITON DIALYSIS INT, V29, P508; Liu Y, 2014, RENAL FAILURE, V36, P292, DOI 10.3109/0886022X.2013.844645; Loureiro J, 2011, J AM SOC NEPHROL, V22, P1682, DOI 10.1681/ASN.2010111197; Margetts PJ, 2003, PERITON DIALYSIS INT, V23, P530; Margetts PJ, 2005, PERITON DIALYSIS INT, V25, pS15; Margetts PJ, 2001, J AM SOC NEPHROL, V12, P2029, DOI 10.1681/ASN.V12102029; Mateijsen MAM, 1999, PERITON DIALYSIS INT, V19, P517; Mizutani M, 2010, AM J PHYSIOL-RENAL, V298, pF721, DOI 10.1152/ajprenal.00368.2009; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Pardali E, 2009, FRONT BIOSCI-LANDMRK, V14, P4848, DOI 10.2741/3573; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; POLLOCK CA, 1989, AM J NEPHROL, V9, P198, DOI 10.1159/000167965; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Riser BL, 2012, J CELL COMMUN SIGNAL, V6, P97, DOI 10.1007/s12079-012-0164-4; Riser BL, 2009, AM J PATHOL, V174, P1725, DOI 10.2353/ajpath.2009.080241; Sakamoto N, 2005, INT J MOL MED, V15, P907; Sampimon DE, 2010, PERITON DIALYSIS INT, V30, P163, DOI 10.3747/pdi.2009.00022; Summers AM, 2009, PERITON DIALYSIS INT, V29, P499; Tanabe K, 2007, KIDNEY INT, V71, P227, DOI 10.1038/sj.ki.5002040; Tsoutsman T, 2013, J MOL CELL CARDIOL, V62, P164, DOI 10.1016/j.yjmcc.2013.05.019; Wang QJ, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-4; Wang X, 2010, NEPHROL DIAL TRANSPL, V25, P399, DOI 10.1093/ndt/gfp480; Williams JD, 2002, J AM SOC NEPHROL, V13, P470, DOI 10.1681/ASN.V132470; Williams JD, 2003, KIDNEY INT, V64, pS43, DOI 10.1046/j.1523-1755.2003.08805.x; Xiao L, 2010, THER APHER DIAL, V14, P27, DOI 10.1111/j.1744-9987.2009.00701.x; Yoshimura A, 2011, CURR TOP MICROBIOL, V350, P127, DOI 10.1007/82_2010_87; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Zarrinkalam KH, 2003, KIDNEY INT, V64, P331, DOI 10.1046/j.1523-1755.2003.00069.x; Zweers MM, 1999, J LAB CLIN MED, V134, P124, DOI 10.1016/S0022-2143(99)90116-6	55	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112050	10.1371/journal.pone.0112050	http://dx.doi.org/10.1371/journal.pone.0112050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384022	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700029
J	Lee, YH; Petkova, AP; Konkar, AA; Granneman, JG				Lee, Yun-Hee; Petkova, Anelia P.; Konkar, Anish A.; Granneman, James G.			Cellular origins of cold-induced brown adipocytes in adult mice	FASEB JOURNAL			English	Article						lineage tracing; adipogenesis; innervation; tyrosine hydroxylase; Myf5	WHITE ADIPOSE-TISSUE; ADIPOGENIC NICHE; FAT-CELLS; IDENTIFICATION; MOUSE; PROLIFERATION; DISTINCT; REVEALS; THERMOGENESIS; MACROPHAGES	This work investigated how cold stress induces the appearance of brown adipocytes (BAs) in brown and white adipose tissues (WATs) of adult mice. In interscapular brown adipose tissue (iBAT), cold exposure increased proliferation of endothelial cells and interstitial cells expressing platelet-derived growth factor receptor, a polypeptide (PDGFR alpha) by 3-to 4-fold. Surprisingly, brown adipogenesis and angiogenesis were largely restricted to the dorsal edge of iBAT. Although cold stress did not increase proliferation in inguinal white adipose tissue (ingWAT), the percentage of BAs, defined as multilocular adipocytes that express uncoupling protein 1, rose from undetectable to 30% of total adipocytes. To trace the origins of cold-induced BAs, we genetically tagged PDGFR(alpha+) cells and adipocytes prior to cold exposure, using Pdgfra-Cre recombinase estrogen receptor T2 fusion protein (CreER(T2)) and adiponectin-CreER(T2), respectively. In iBAT, cold stress triggered the proliferation and differentiation of PDGFR(alpha+) cells into BAs. In contrast, all newly observed BAs in ingWAT (5207 out of 5207) were derived from unilocular adipocytes tagged by adiponectin-CreER(T2)-mediated recombination. Surgical denervation of iBAT reduced cold-induced brown adipogenesis by > 85%, whereas infusion of norepinephrine (NE) mimicked the effects of cold in warm-adapted mice. NE-induced de novo brown adipogenesis in iBAT was eliminated in mice lacking beta 1-adrenergic receptors. These observations identify a novel tissue niche for brown adipogenesis in iBAT and further define depotspecific mechanisms of BA recruitment.	[Lee, Yun-Hee; Petkova, Anelia P.; Konkar, Anish A.; Granneman, James G.] Wayne State Univ, Sch Med, Ctr Integrat Metab & Endocrine Res, Detroit, MI 48201 USA	Wayne State University	Granneman, JG (corresponding author), Wayne State Univ, Sch Med, Ctr Integrat Metab & Endocrine Res, Detroit, MI 48201 USA.	jgranne@med.wayne.edu			NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076629, P30DK020572, R01DK062292] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA022453, P30 CA022453] Funding Source: Medline; NIDDK NIH HHS [R01DK62292, R01 DK076629, R01 DK062292, R01DK76629, P30 DK020572] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Blondin DP, 2014, J CLIN ENDOCR METAB, V99, pE438, DOI 10.1210/jc.2013-3901; Bronnikov G, 1999, ENDOCRINOLOGY, V140, P4185, DOI 10.1210/en.140.9.4185; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; BUKOWIECKI LJ, 1986, AM J PHYSIOL, V250, pC880, DOI 10.1152/ajpcell.1986.250.6.C880; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FOSTER DO, 1979, CAN J PHYSIOL PHARM, V57, P257, DOI 10.1139/y79-039; GELOEN A, 1992, AM J PHYSIOL, V263, pR1176, DOI 10.1152/ajpregu.1992.263.6.R1176; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gouon-Evans V, 2002, MOL ENDOCRINOL, V16, P2618, DOI 10.1210/me.2001-0337; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; GRANNEMAN JG, 1984, METABOLISM, V33, P257, DOI 10.1016/0026-0495(84)90047-7; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HIMMSHAGEN J, 1990, FASEB J, V4, P2890, DOI 10.1096/fasebj.4.11.2199286; HIMMSHAGGEN J, 1969, J PHYSIOL-LONDON, V205, P393, DOI 10.1113/jphysiol.1969.sp008973; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Konkar AA, 2000, MOL PHARMACOL, V57, P252; Lee YH, 2014, CELL CYCLE, V13, P184, DOI 10.4161/cc.27647; Lee YH, 2012, ADIPOCYTE, V1, P230, DOI 10.4161/adip.20804; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Master SR, 2002, MOL ENDOCRINOL, V16, P1185, DOI 10.1210/me.16.6.1185; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Muzik Otto, 2012, Front Endocrinol (Lausanne), V3, P15, DOI 10.3389/fendo.2012.00015; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Sanchez-Gurmaches J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5099; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; SCHNEIDERPICARD G, 1980, J LIPID RES, V21, P600; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	59	182	185	1	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2015	29	1					286	299		10.1096/fj.14-263038	http://dx.doi.org/10.1096/fj.14-263038			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AY1UX	25392270	Green Published			2022-12-26	WOS:000347378600027
J	Magalhaes, WF; Seixas, VC; Paiva, PC; Elias, R				Magalhaes, Wagner F.; Seixas, Victor Correa; Paiva, Paulo Cesar; Elias, Rodolfo			The Multitentaculate Cirratulidae of the Genera Cirriformia and Timarete (Annelida: Polychaeta) from Shallow Waters of Brazil	PLOS ONE			English	Article							COAST	A large number multitentaculate cirratulids have been described worldwide but most are only known through the original descriptions. Type material, voucher and recently collected specimens from Brazil were revisited in order to reveal their true identity and confirm the records of widely distributed species in this region. Six species are described, three of which are new, Cirriformia capixabensis sp. nov., Cirriformia chicoi sp. nov. and Timarete ceciliae sp. nov. COI and 16S sequences were obtained and used for inter-specific comparisons. Timarete caribous is reported from several localities along the Brazilian coast and a new synonym, Cirratulus melanacanthus, is proposed. The species Timarete oculata, originally described from Brazil and lumped into the Timarete filigera species complex, is herein revalidated and redescribed. The occurrence of the species Timarete filigera and Cirriformia tentaculata is not confirmed from the Brazilian coast. Descriptions, illustrations and a key to genera and species are provided.	[Magalhaes, Wagner F.] Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA; [Seixas, Victor Correa; Paiva, Paulo Cesar] Univ Fed Rio de Janeiro, Dept Zool, Rio De Janeiro, Brazil; [Elias, Rodolfo] Univ Nacl Mar del Plata, Dept Ciencias Marinas, Mar Del Plata, Buenos Aires, Argentina	University of Hawaii System; University of Hawaii Manoa; Universidade Federal do Rio de Janeiro; National University of Mar del Plata	Magalhaes, WF (corresponding author), Univ Hawaii Manoa, Dept Biol, Honolulu, HI 96822 USA.	wagnerfm@hawaii.edu	Seixas, Victor Correa/M-6934-2019; Magalhães, Wagner F/G-6458-2016; Paiva, Paulo C/I-6174-2012; de Paiva, Paulo Cesar/N-1234-2019	Seixas, Victor Correa/0000-0002-2067-9490; Magalhães, Wagner F/0000-0002-9285-4008; Paiva, Paulo C/0000-0003-1061-6549; de Paiva, Paulo Cesar/0000-0003-1061-6549	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The work was supported by the following: PP VS - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral A.C.Z., 2006, CATALOGO ESPECIES AN CATALOGO ESPECIES AN; Blake J.A., 1996, TAXONOMIC ATLAS BE 3, V6, P263; BLAKE JA, 1975, T AM MICROSC SOC, V94, P179, DOI 10.2307/3224978; Cinar ME, 2007, SCI MAR, V71, P755; Cinar ME, 2009, J NAT HIST, V43, P2283, DOI 10.1080/00222930903094654; DAY J. H., 1962, PROC ZOOL SOC LONDON, V139, P627; Ehlers E., 1897, ERGEBNISSE HAMBURGER, V3, P1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Grube A.E., 1873, JAHRESBERICHT SCHLES, V50, P59; Grube AE, 1859, ANNULATA ORSTEDIAN 3, P105; Grube AE, 1869, BESCHREIBUNGEN NEUER, P484; Hansen G.A., 1882, MEMOIRES COURONNES M, V44, P1; Hartman O, 1959, OCCAS PAP A HANCOCK; HARTMAN OLGA, 1966, OCCAS PAP BERNICE PAVAHI BISHOP MUS, V23, P163; Hartman Olga, 1942, PROC U S NATION MUS, V92, P101; HARTMAN OLGA, 1948, ARKIV ZOOL [STOCKHOLM], V42A, P1; HARTMAN OLGA, 1956, BULL AMER MUS NAT HIST, V109, P239; Imajima M., 1964, OCCASIONAL PAPER, V26, P1; Kinberg J.G.H., 1866, STOCKHOLM, V23, P337; KIRKEGAARD J B, 1981, Steenstrupia, V7, P261; Magalhaes Wagner F., 2010, Zootaxa, V2625, P53; Montagu G, 1808, T LINN SOC LOND, V9, P81, DOI DOI 10.1111/J.1096-3642.1804.TB00282.X; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Petersen ME, 1999, HYDROBIOLOGIA, V402, P107, DOI 10.1023/A:1003736408195; Quatrefages A, 1866, ANNELIDES GEPHYRIENS, V2, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TREADWELL A[ARON] L., 1936, ZOOLOGICA [NEW YORK], V21, P49; Treadwell A.L., 1932, REV MUS PAULISTA, V17, P1; Verrill A. E., 1900, T CONNECTICUT ACAD A, V10, P595, DOI [10.5962/bhl.part.7035, DOI 10.5962/BHL.PART.7035]; WILSON DOUGLAS P., 1936, JOUR MARINE BIOL ASSOC UNITED KINGDOM, V20, P567; Zanol J, 2010, MOL PHYLOGENET EVOL, V55, P660, DOI 10.1016/j.ympev.2009.12.024	32	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112727	10.1371/journal.pone.0112727	http://dx.doi.org/10.1371/journal.pone.0112727			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393759	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300090
J	Peng, J; Lai, ZG; Fang, ZL; Xing, S; Hui, K; Hao, C; Jin, Q; Qi, Z; Shen, WJ; Dong, QN; Bing, ZH; Fu, DL				Peng, Jia; Lai, Zuo Gui; Fang, Zhang Lian; Xing, Shen; Hui, Kang; Hao, Chen; Jin, Qi; Qi, Zhou; Shen, Wang Jin; Dong, Qian Nian; Bing, Zhou Han; Fu, Deng Lian			Dimethyloxalylglycine Prevents Bone Loss in Ovariectomized C57BL/6J Mice through Enhanced Angiogenesis and Osteogenesis	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; CONSTITUTIVELY ACTIVE FORM; BIOACTIVE GLASS SCAFFOLDS; GROWTH-FACTOR EXPRESSION; MARROW STROMAL CELLS; STEM-CELLS; POSTMENOPAUSAL OSTEOPOROSIS; CALVARIAL DEFECTS; ENGINEERED BONE; MINERAL DENSITY	Hypoxia-inducible factor 1-alpha (HIF-1 alpha) plays a critical role in angiogenesis-osteogenesis coupling during bone development and bone regeneration. Previous studies have shown that 17 beta-estradiol activates the HIF-1 alpha signaling pathway and that mice with conditional activation of the HIF-1 alpha signaling pathway in osteoblasts are protected from ovariectomy (OVX)-induced bone loss. In addition, it has been shown that hypoxia facilitates the osteogenic differentiation of mesenchymal stem cells (MSCs) and modulates Wnt/beta-catenin signaling. Therefore, we hypothesized that activation of the HIF-1 alpha signaling pathway by hypoxia-mimicking agents would prevent bone loss due to estrogen deficiency. In this study, we confirmed the effect of dimethyloxalylglycine (DMOG), a hypoxia-mimicking agent, on the HIF-1 alpha signaling pathway and investigated the effect of DMOG on MSC osteogenic differentiation and the Wnt/beta-catenin signaling pathway. We then investigated the effect of DMOG treatment on OVX-induced bone loss. Female C57BL/6J mice were divided into sham, OVX, OVX+ L-DMOG (5 mg/kg/day), and OVX+ H-DMOG (20 mg/kg/day) groups. At sacrifice, static and dynamic bone histomorphometry were performed with micro computed tomography (micro-CT) and undecalcified sections, respectively. Bone strength was assessed with the three-point bending test, and femur vessels were reconstructed and analyzed by micro-CT. Serum vascular endothelial growth factor (VEGF), osteocalcin, and C-terminal telopeptides of collagen type(CTX) were measured by ELISA. Tartrate-resistant acid phosphatase staining was used to assess osteoclast formation. Alterations in the HIF-1 alpha and Wnt/beta-catenin signaling pathways in the bone were detected by western blot. Our results showed that DMOG activated the HIF-1 alpha signaling pathway, which further activated the Wnt/beta-catenin signaling pathway and enhanced MSC osteogenic differentiation. The micro-CT results showed that DMOG treatment improved trabecular bone density and restored the bone microarchitecture and blood vessels in OVX mice. Bone strength was also partly restored in DMOGtreated OVX mice. Dynamic bone histomorphometric analysis of the femur metaphysic revealed that DMOG increased the mineralizing surface, mineral apposition rate, and bone formation rate. The serum levels of VEGF and osteocalcin were higher in DMOG-treated OVX mice. However, there were no significant differences in serum CTX or in the number of tartrate-resistant acid phosphatase-stained cells between DMOG-treated OVX mice and OVX mice. Western blot results showed that DMOG administration partly rescued the decrease in HIF-1 alpha and beta-catenin expression following ovariectomy. Collectively, these results indicate that DMOG prevents bone loss due to ovariectomy in C57BL/6J mice by enhancing angiogenesis and osteogenesis, which are associated with activated HIF-1 alpha and Wnt/beta-catenin signaling pathways.	[Peng, Jia; Lai, Zuo Gui; Fang, Zhang Lian; Xing, Shen; Hui, Kang; Hao, Chen; Jin, Qi; Qi, Zhou; Shen, Wang Jin; Dong, Qian Nian; Bing, Zhou Han; Fu, Deng Lian] Jiao Tong Univ, Shanghai Inst Traumatol & Orthopaed, Shanghai Key Lab Prevent & Treatment Bone & Joint, Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China; [Lai, Zuo Gui] Shang Dong Univ, Qian Fo Shan Hosp, Dept Orthopaed, Jinan, Peoples R China; [Fang, Zhang Lian] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed, Suzhou, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Fu, DL (corresponding author), Jiao Tong Univ, Shanghai Inst Traumatol & Orthopaed, Shanghai Key Lab Prevent & Treatment Bone & Joint, Ruijin Hosp,Sch Med, Shanghai 200030, Peoples R China.	china_boneres@163.com	Hui, Kang/GYJ-5601-2022		Natural Science Foundation of China [81371958, 81061160510]; Basic Key Project of Science and Technology Commission of Shanghai Municipality [12JC1408200]; Scientific and Technological Support Program in Biological Medicine of Science and Technology Commission of Shanghai Municipality [13431900702]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Key Project of Science and Technology Commission of Shanghai Municipality; Scientific and Technological Support Program in Biological Medicine of Science and Technology Commission of Shanghai Municipality	Deng Lian Fu received funds from Natural Science Foundation of China (No. 81371958, 81061160510), the Basic Key Project of Science and Technology Commission of Shanghai Municipality (12JC1408200), and the Scientific and Technological Support Program in Biological Medicine of Science and Technology Commission of Shanghai Municipality (13431900702) http://www.nsfc.gov.cn/ http://www.stcsm.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidwell JP, 2013, CURR OSTEOPOROS REP, V11, P117, DOI 10.1007/s11914-013-0139-2; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; Chapurlat RD, 2009, OSTEOPOROSIS INT, V20, P1299, DOI 10.1007/s00198-009-0899-9; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ding H, 2014, STEM CELLS DEV, V23, P990, DOI 10.1089/scd.2013.0486; Ding WG, 2011, CONNECT TISSUE RES, V52, P25, DOI 10.3109/03008201003783011; Donneys A, 2013, BONE, V52, P318, DOI 10.1016/j.bone.2012.10.014; Fan W, 2010, BIOMATERIALS, V31, P3580, DOI 10.1016/j.biomaterials.2010.01.083; Farberg AS, 2012, BONE, V50, P1184, DOI 10.1016/j.bone.2012.01.019; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Grewal BS, 2014, J ORTHOP, V11, P5, DOI 10.1016/j.jor.2013.12.005; Griffith JF, 2010, RADIOLOGY, V254, P739, DOI 10.1148/radiol.09090608; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; Ishii K, 2009, NAT MED, V15, P259, DOI 10.1038/nm.1910; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jia P, 2012, J ORTHOP RES, V30, P1843, DOI 10.1002/jor.22133; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Li L, 2013, CELL MOL BIOL, V59, P1889, DOI 10.1170/225; Liu LZ, 2011, STEM CELLS DEV, V20, P1961, DOI 10.1089/scd.2010.0453; Liu XD, 2007, ZHONGHUA WAI KE ZA Z, V45, P1274; Liu YQ, 2012, J CLIN INVEST, V122, P3101, DOI 10.1172/JCI61209; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mekraldi S, 2003, BONE, V32, P630, DOI 10.1016/S8756-3282(03)00099-1; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Patel TH, 2005, CARDIOVASC RES, V68, P144, DOI 10.1016/j.cardiores.2005.05.002; Poynter JA, 2011, SURGERY, V150, P278, DOI 10.1016/j.surg.2011.06.006; Pufe T, 2007, CALCIFIED TISSUE INT, V80, P184, DOI 10.1007/s00223-006-0275-0; Qu B, 2014, OSTEOPOROSIS INT, V25, P1853, DOI 10.1007/s00198-014-2699-0; Qu ZH, 2008, BIOCHEM BIOPH RES CO, V370, P332, DOI 10.1016/j.bbrc.2008.03.092; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Rey S, 2009, P NATL ACAD SCI USA, V106, P20399, DOI 10.1073/pnas.0911921106; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rossini M, 2013, CALCIFIED TISSUE INT, V93, P121, DOI 10.1007/s00223-013-9749-z; Senel K, 2013, ARCH MED SCI, V9, P709, DOI 10.5114/aoms.2013.36896; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Shih TTF, 2004, RADIOLOGY, V233, P121, DOI 10.1148/radiol.2331031509; Shin DH, 2007, CANCER LETT, V255, P107, DOI 10.1016/j.canlet.2007.03.026; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Spencer GJ, 2006, J CELL SCI, V119, P1283, DOI 10.1242/jcs.02883; Stewart R, 2011, J ORTHOP TRAUMA, V25, P472, DOI 10.1097/BOT.0b013e31822588d8; Sun Y, 2013, CELL PHYSIOL BIOCHEM, V31, P579, DOI 10.1159/000350078; Takaku M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042964; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vogt MT, 1997, J BONE MINER RES, V12, P283, DOI 10.1359/jbmr.1997.12.2.283; Wagegg M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046483; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Weng TJ, 2014, J BONE MINER RES, V29, P820, DOI 10.1002/jbmr.2087; Wu CT, 2013, ACTA BIOMATER, V9, P9159, DOI 10.1016/j.actbio.2013.06.026; Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042; Xu XJ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/534352; Yang N, 2013, J BONE MINER RES, V28, P559, DOI 10.1002/jbmr.1798; Yen ML, 2005, MOL PHARMACOL, V68, P1061, DOI 10.1124/mol.104.010082; Yun SP, 2009, AM J PHYSIOL-CELL PH, V296, pC317, DOI 10.1152/ajpcell.00415.2008; Zelzer E, 1998, EMBO J, V17, P5085, DOI 10.1093/emboj/17.17.5085; Zhang WB, 2012, J ORTHOP SCI, V17, P289, DOI 10.1007/s00776-012-0206-z; Zhao HX, 2010, BASIC RES CARDIOL, V105, P109, DOI 10.1007/s00395-009-0044-0; Zhao Q, 2012, BONE, V50, P763, DOI 10.1016/j.bone.2011.12.003; Zou DH, 2012, BIOMATERIALS, V33, P2097, DOI 10.1016/j.biomaterials.2011.11.053; Zou DH, 2011, BIOMATERIALS, V32, P9707, DOI 10.1016/j.biomaterials.2011.09.005; Zou DH, 2011, STEM CELLS, V29, P1380, DOI 10.1002/stem.693	71	50	59	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112744	10.1371/journal.pone.0112744	http://dx.doi.org/10.1371/journal.pone.0112744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25394221	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300093
J	Potuckova, E; Hruskova, K; Bures, J; Kovarikova, P; Spirkova, IA; Pravdikova, K; Kolbabova, L; Hergeselova, T; Haskova, P; Jansova, H; Machacek, M; Jirkovska, A; Richardson, V; Lane, DJR; Kalinowski, DS; Richardson, DR; Vavrova, K; Simunek, T				Potuckova, Eliska; Hruskova, Katerina; Bures, Jan; Kovarikova, Petra; Spirkova, Iva A.; Pravdikova, Katerina; Kolbabova, Lucie; Hergeselova, Tereza; Haskova, Pavlina; Jansova, Hana; Machacek, Miloslav; Jirkovska, Anna; Richardson, Vera; Lane, Darius J. R.; Kalinowski, Danuta S.; Richardson, Des R.; Vavrova, Katerina; Simunek, Tomas			Structure-Activity Relationships of Novel Salicylaldehyde Isonicotinoyl Hydrazone (SIH) Analogs: Iron Chelation, Anti-Oxidant and Cytotoxic Properties	PLOS ONE			English	Article							EFFECTIVE ANTIPROLIFERATIVE AGENTS; ATOMIC PHYSICOCHEMICAL PARAMETERS; SELECTIVE ANTITUMOR-ACTIVITY; OXIDATIVE STRESS; QUANTITATIVE STRUCTURE; OVERLOAD DISEASE; LABILE IRON; IN-VIVO; PYRIDOXAL; POTENT	Salicylaldehyde isonicotinoyl hydrazone (SIH) is a lipophilic, tridentate iron chelator with marked anti-oxidant and modest cytotoxic activity against neoplastic cells. However, it has poor stability in an aqueous environment due to the rapid hydrolysis of its hydrazone bond. In this study, we synthesized a series of new SIH analogs (based on previously described aromatic ketones with improved hydrolytic stability). Their structure-activity relationships were assessed with respect to their stability in plasma, iron chelation efficacy, redox effects and cytotoxic activity against MCF-7 breast adenocarcinoma cells. Furthermore, studies assessed the cytotoxicity of these chelators and their ability to afford protection against hydrogen peroxide-induced oxidative injury in H9c2 cardiomyoblasts. The ligands with a reduced hydrazone bond, or the presence of bulky alkyl substituents near the hydrazone bond, showed severely limited biological activity. The introduction of a bromine substituent increased ligand-induced cytotoxicity to both cancer cells and H9c2 cardiomyoblasts. A similar effect was observed when the phenolic ring was exchanged with pyridine (i.e., changing the ligating site from O, N, O to N, N, O), which led to pro-oxidative effects. In contrast, compounds with long, flexible alkyl chains adjacent to the hydrazone bond exhibited specific cytotoxic effects against MCF-7 breast adenocarcinoma cells and low toxicity against H9c2 cardiomyoblasts. Hence, this study highlights important structure-activity relationships and provides insight into the further development of aroylhydrazone iron chelators with more potent and selective anti-neoplastic effects.	[Potuckova, Eliska; Hruskova, Katerina; Bures, Jan; Kovarikova, Petra; Spirkova, Iva A.; Pravdikova, Katerina; Kolbabova, Lucie; Hergeselova, Tereza; Haskova, Pavlina; Jansova, Hana; Machacek, Miloslav; Jirkovska, Anna; Vavrova, Katerina; Simunek, Tomas] Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic; [Richardson, Vera; Lane, Darius J. R.; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Bosch Inst, Mol Pharmacol & Pathol Program, Sydney, NSW 2006, Australia; [Richardson, Vera; Lane, Darius J. R.; Kalinowski, Danuta S.; Richardson, Des R.] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	Charles University Prague; University of Sydney; University of Sydney	Vavrova, K (corresponding author), Charles Univ Prague, Fac Pharm Hradec Kralove, Hradec Kralove, Czech Republic.	Katerina.Vavrova@faf.cuni.cz; Tomas.Simunek@faf.cuni.cz	Hašková, Pavlína/ABC-6019-2021; Simunek, Tomas/A-3938-2008; Jansova, Hana/S-5847-2017; Vavrova, Katerina/A-2895-2008; Jirkovska, Anna/E-8419-2012; Sterbova, Petra/T-5493-2017; Machacek, Miloslav/T-3378-2017	Simunek, Tomas/0000-0001-5464-4176; Jansova, Hana/0000-0002-5377-518X; Vavrova, Katerina/0000-0002-8502-4372; Jirkovska, Anna/0000-0002-0131-6010; Sterbova, Petra/0000-0002-1242-5706; Machacek, Miloslav/0000-0001-7221-5914; Richardson, Des/0000-0002-5506-3274; Richardson, Des/0000-0003-0960-6415; Haskova, Pavlina/0000-0002-1179-8885; Kalinowski, Danuta/0000-0002-9303-7405; Lane, Darius/0000-0001-8725-6903	Charles University in Prague [GAUK 299511, SVV 260065, 260062]; Czech Science Foundation [13-15008S]; European Social Fund; State Budget of the Czech Republic [CZ.1.07/2.3.00/30.0061]; National Health and Medical Research Council Australia (NHMRC) [632778]; Cancer Institute New South Wales [08/ECF/1-30, 10/ECF/2 18]; NHMRC of Australia [1013810]; NHMRC [571123]	Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic); European Social Fund(European Social Fund (ESF)); State Budget of the Czech Republic; National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by the Charles University in Prague (www.cuni.cz; projects GAUK 299511, SVV 260065 and 260062), the Czech Science Foundation (www.gacr.cz; grant 13-15008S), and the European Social Fund and the State Budget of the Czech Republic (www.msmt.cz; Operational Program CZ.1.07/2.3.00/30.0061). This work was also funded by a Project Grant from the National Health and Medical Research Council Australia (NHMRC; www.nhmrc.gov.au) to D.R.R. [Grant 632778]; a NHMRC Senior Principal Research Fellowship to D.R.R. [Grant 571123]; and a Cancer Institute New South Wales (cancerinstitute.org.au) Early Career Development Fellowship to D.S.K. [Grant 08/ECF/1-30]. D.J.R.L. thanks the Cancer Institute New South Wales for an Early Career Fellowship [10/ECF/2 18] and the NHMRC of Australia for an Early Career Postdoctoral Fellowship [1013810]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010; BAKER E, 1992, HEPATOLOGY, V15, P492, DOI 10.1002/hep.1840150323; Becker E, 1999, J LAB CLIN MED, V134, P510, DOI 10.1016/S0022-2143(99)90173-7; Becker EM, 2003, BRIT J PHARMACOL, V138, P819, DOI 10.1038/sj.bjp.0705089; Bendova P, 2010, CHEM RES TOXICOL, V23, P1105, DOI 10.1021/tx100125t; Berndt C, 2010, BIOCHEM J, V432, P295, DOI 10.1042/BJ20100996; Bernhardt PV, 2008, J BIOL INORG CHEM, V13, P107, DOI 10.1007/s00775-007-0300-4; BROTO P, 1984, EUR J MED CHEM, V19, P71; Chaston TB, 2004, CLIN CANCER RES, V10, P7365, DOI 10.1158/1078-0432.CCR-04-0865; Chaston TB, 2003, J BIOL INORG CHEM, V8, P427, DOI 10.1007/s00775-002-0434-3; Chaston TB, 2003, CLIN CANCER RES, V9, P402; Cooper CE, 1996, J BIOL CHEM, V271, P20291, DOI 10.1074/jbc.271.34.20291; DUBOIS JE, 1992, INORG CHEM, V31, P853, DOI 10.1021/ic00031a030; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; EDWARD JT, 1988, J CHEM ENG DATA, V33, P538, DOI 10.1021/je00054a044; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Fillebeen C, 2010, J HEPATOL, V53, P995, DOI 10.1016/j.jhep.2010.04.044; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Glickstein H, 2006, BLOOD, V108, P3195, DOI 10.1182/blood-2006-05-020867; GUTTERIDGE JMC, 1979, BIOCHEM J, V184, P469, DOI 10.1042/bj1840469; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Horackova M, 2000, CARDIOVASC RES, V47, P529, DOI 10.1016/S0008-6363(00)00088-2; Hruskova K, 2011, CHEM RES TOXICOL, V24, P290, DOI 10.1021/tx100359t; Jiang XP, 2010, ANTICANCER RES, V30, P759; Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kitazawa M, 1999, BBA-GEN SUBJECTS, V1473, P400, DOI 10.1016/S0304-4165(99)00203-2; Klimtova Ivona, 2003, Acta Medica (Hradec Kralove), V46, P163; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Kovarikova P, 2008, J PHARMACEUT BIOMED, V47, P360, DOI 10.1016/j.jpba.2008.01.011; Lane DJR, 2014, BBA-REV CANCER, V1845, P166, DOI 10.1016/j.bbcan.2014.01.005; Lawen A, 2013, ANTIOXID REDOX SIGN, V18, P2473, DOI 10.1089/ars.2011.4271; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Mackova E, 2012, CHEM-BIOL INTERACT, V197, P69, DOI 10.1016/j.cbi.2012.03.010; Merlot AM, 2013, ANTIOXID REDOX SIGN, V18, P973, DOI 10.1089/ars.2012.4540; Mladenka P, 2009, CHEM RES TOXICOL, V22, P208, DOI 10.1021/tx800331j; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; PONKA P, 1979, FEBS LETT, V97, P317, DOI 10.1016/0014-5793(79)80111-8; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Richardson D, 1989, Biol Met, V2, P69, DOI 10.1007/BF01129203; Richardson DR, 2009, BBA-GEN SUBJECTS, V1790, P702, DOI 10.1016/j.bbagen.2008.04.003; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Richardson DR, 1997, BLOOD, V89, P3025, DOI 10.1182/blood.V89.8.3025; RICHARDSON DR, 1991, BIOCHIM BIOPHYS ACTA, V1091, P294, DOI 10.1016/0167-4889(91)90192-Z; RICHARDSON DR, 1995, BLOOD, V86, P4295, DOI 10.1182/blood.V86.11.4295.bloodjournal86114295; RICHARDSON DR, 1994, J LAB CLIN MED, V124, P660; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; Simunek T, 2008, BRIT J PHARMACOL, V155, P138, DOI 10.1038/bjp.2008.236; Simunek T, 2005, J MOL CELL CARDIOL, V39, P345, DOI 10.1016/j.yjmcc.2005.05.008; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; VISWANADHAN VN, 1989, J CHEM INF COMP SCI, V29, P163, DOI 10.1021/ci00063a006; VITOLO LMW, 1990, INORG CHIM ACTA, V170, P171; WALKER RA, 1986, J PATHOL, V148, P217, DOI 10.1002/path.1711480305; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868; Zhang XZ, 2012, ELECTROANAL, V24, P1878, DOI 10.1002/elan.201200192	61	16	18	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112059	10.1371/journal.pone.0112059	http://dx.doi.org/10.1371/journal.pone.0112059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393531	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300029
J	Schroter, M; Rusch, GM; Barton, DN; Blumentrath, S; Norden, B				Schroter, Matthias; Rusch, Graciela M.; Barton, David N.; Blumentrath, Stefan; Norden, Bjorn			Ecosystem Services and Opportunity Costs Shift Spatial Priorities for Conserving Forest Biodiversity	PLOS ONE			English	Article							TRADE-OFFS; PROTECTED AREAS; CONSERVATION; STRATEGIES; PAYMENTS; BENEFITS; SCIENCE	Inclusion of spatially explicit information on ecosystem services in conservation planning is a fairly new practice. This study analyses how the incorporation of ecosystem services as conservation features can affect conservation of forest biodiversity and how different opportunity cost constraints can change spatial priorities for conservation. We created spatially explicit cost-effective conservation scenarios for 59 forest biodiversity features and five ecosystem services in the county of Telemark (Norway) with the help of the heuristic optimisation planning software, Marxan with Zones. We combined a mix of conservation instruments where forestry is either completely (non-use zone) or partially restricted (partial use zone). Opportunity costs were measured in terms of foregone timber harvest, an important provisioning service in Telemark. Including a number of ecosystem services shifted priority conservation sites compared to a case where only biodiversity was considered, and increased the area of both the partial (+36.2%) and the non-use zone (+3.2%). Furthermore, opportunity costs increased (+6.6%), which suggests that ecosystem services may not be a side-benefit of biodiversity conservation in this area. Opportunity cost levels were systematically changed to analyse their effect on spatial conservation priorities. Conservation of biodiversity and ecosystem services trades off against timber harvest. Currently designated nature reserves and landscape protection areas achieve a very low proportion (9.1%) of the conservation targets we set in our scenario, which illustrates the high importance given to timber production at present. A trade-off curve indicated that large marginal increases in conservation target achievement are possible when the budget for conservation is increased. Forty percent of the maximum hypothetical opportunity costs would yield an average conservation target achievement of 79%.	[Schroter, Matthias] Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands; [Schroter, Matthias; Rusch, Graciela M.; Barton, David N.; Blumentrath, Stefan; Norden, Bjorn] NINA, Trondheim, Norway	Wageningen University & Research; Norwegian Institute Nature Research	Schroter, M (corresponding author), Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands.	matthias.schroter@wur.nl	Schröter, Matthias/B-8883-2017; Nordén, Björn/B-4956-2012	Schröter, Matthias/0000-0003-0207-7311; Nordén, Björn/0000-0002-2739-9774; Blumentrath, Stefan/0000-0001-6675-1331; Rusch, Graciela/0000-0003-3769-8345	European Research Council [263027]; Research Council of Norway (Yggdrasil grant); European Union's Seventh Programme for research, technological development and demonstration (POLICYMIX project) [244065]; project ECOSERVICE (Approaches for integrated assessment of forest ecosystem services under large scale bioenergy utilization) - Research Council of Norway, RCN [233641/E50]	European Research Council(European Research Council (ERC)European Commission); Research Council of Norway (Yggdrasil grant)(Research Council of Norway); European Union's Seventh Programme for research, technological development and demonstration (POLICYMIX project); project ECOSERVICE (Approaches for integrated assessment of forest ecosystem services under large scale bioenergy utilization) - Research Council of Norway, RCN	MS received funding from the European Research Council under grant 263027 ('Ecospace'), and from the Research Council of Norway (Yggdrasil grant). GMR, DNB and SB received funding from the European Union's Seventh Programme for research, technological development and demonstration under grant agreement No. 244065 (POLICYMIX project (http://policymix.nina.no)). BN was supported by the project ECOSERVICE (Approaches for integrated assessment of forest ecosystem services under large scale bioenergy utilization) financed by the Research Council of Norway, RCN grant no 233641/E50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 1999, NATL ATLAS NORWAY VE; Barton DN, 2009, J ENVIRON MANAGE, V90, P901, DOI 10.1016/j.jenvman.2008.02.010; Barton DN, 2013, SOC NATUR RESOUR, V26, P1185, DOI 10.1080/08941920.2013.799727; Bengtsson J, 2003, AMBIO, V32, P389, DOI 10.1639/0044-7447(2003)032[0389:RRADL]2.0.CO;2; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carwardine J, 2010, CONSERV BIOL, V24, P1529, DOI 10.1111/j.1523-1739.2010.01535.x; Carwardine J, 2009, CONSERV LETT, V2, P3, DOI 10.1111/j.1755-263X.2008.00042.x; Certain G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018930; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Chan KMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024378; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Directorate for Nature Management, 2007, DN HDB, V13; Egoh B, 2007, ECOL ECON, V63, P714, DOI 10.1016/j.ecolecon.2007.04.007; Egoh BN, 2014, J APPL ECOL, V51, P899, DOI 10.1111/1365-2664.12251; Egoh BN, 2011, J ENVIRON MANAGE, V92, P1642, DOI 10.1016/j.jenvman.2011.01.019; Egoh BN, 2010, CONSERV BIOL, V24, P1021, DOI 10.1111/j.1523-1739.2009.01442.x; Eigenbrod F, 2009, P ROY SOC B-BIOL SCI, V276, P2903, DOI 10.1098/rspb.2009.0528; European Commission, 2014, 2014080 EUR COMM; Faith D, AUST ZOOL IN PRESS, DOI [10.7882/az.2014.7031, DOI 10.7882/AZ.2014.7031]; Faith D. P., 2012, F1000RESEARCH; Faith D. P, 1995, BIODIVERSITY REGIONA; Fisher B, 2011, CONSERV LETT, V4, P443, DOI 10.1111/j.1755-263X.2011.00198.x; Framstad E, 2002, EVALUERING SKOGVERNE, P146; Framstad E, 2010, 535 NINA; Framstad E., 2012, 888 NINA; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; GJERDE I, 2002, MILJOREGISTRERING SK; Gotmark F, 2013, FOREST ECOL MANAG, V306, P292, DOI 10.1016/j.foreco.2013.06.014; Granhus A, 2014, BAEREKRAFTIG SKOGBRU, P90; Haines-Young R., 2010, PROPOSAL COMMON INT; Hanski I, 2011, AMBIO, V40, P248, DOI 10.1007/s13280-011-0147-3; Hauer G, 2010, ECOL MODEL, V221, P2590, DOI 10.1016/j.ecolmodel.2010.07.013; Izquierdo AE, 2012, FORESTS, V3, P764, DOI 10.3390/f3030764; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Kalas J.A., 2010, 2010 NORWEGIAN RED L; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larigauderie A, 2012, CURR OPIN ENV SUST, V4, P101, DOI 10.1016/j.cosust.2012.01.007; Lindenmayer DB, 2006, BIOL CONSERV, V131, P433, DOI 10.1016/j.biocon.2006.02.019; Luck G., 2012, F1000RESEARCH; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Makino A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078986; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Meteorological Institute, 2012, MONTHL NORM VAL; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Nalle D. J., 2004, Journal of Environmental Economics and Management, V48, P997, DOI 10.1016/j.jeem.2004.01.001; NFLI, 2010, AR AR5; NFLI, 2013, MILJ SKOG; Norden B, 2012, FOREST ECOL MANAG, V270, P35, DOI 10.1016/j.foreco.2012.01.014; Norwegian Environmental Agency, 2013, NAT; Opdam P, 2006, LANDSCAPE URBAN PLAN, V75, P322, DOI 10.1016/j.landurbplan.2005.02.015; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Pichancourt JB, 2014, GLOBAL CHANGE BIOL, V20, P382, DOI 10.1111/gcb.12345; Reyers B, 2012, LANDSCAPE ECOL, V27, P1121, DOI 10.1007/s10980-012-9761-0; Reyers B, 2012, BIOSCIENCE, V62, P503, DOI 10.1525/bio.2012.62.5.12; Ring I., 2011, INSTRUMENT MIXES BIO, P98; Rusch GM, 2013, BEST PRACTICE GUIDEL; Sarkar S, 2002, J BIOSCIENCES, V27, P299, DOI 10.1007/BF02704961; Schroter-Schlaack C, 2014, Z WIRTSCHAFTSGEOGR, V58, P98; Schroter M, 2014, CONSERV LETT, V7, P514, DOI 10.1111/conl.12091; Schroter M, 2014, ECOL INDIC, V36, P539, DOI 10.1016/j.ecolind.2013.09.018; Skjeggedal T, 2010, FRIVILLIG VERN SKOG; Sogaard G, 2012, 22012 NFLI; SSB, 2012, STAT ARB 2012; Venter O, 2009, SCIENCE, V326, P1368, DOI 10.1126/science.1180289; Watts ME, 2009, ENVIRON MODELL SOFTW, V24, P1513, DOI 10.1016/j.envsoft.2009.06.005; Wilson K.A., 2010, MARXAN GOOD PRACTICE, P18	73	36	36	2	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112557	10.1371/journal.pone.0112557	http://dx.doi.org/10.1371/journal.pone.0112557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393951	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300068
J	Sobotka, KS; Morley, C; Ong, T; Polglase, GR; Aridas, JDS; Miller, SL; Schmolzer, GM; Klingenberg, C; Moss, TJM; Jenkin, G; Hooper, SB				Sobotka, Kristina S.; Morley, Colin; Ong, Tracey; Polglase, Graeme R.; Aridas, James D. S.; Miller, Suzanne L.; Schmoelzer, Georg M.; Klingenberg, Claus; Moss, Timothy J. M.; Jenkin, Graham; Hooper, Stuart B.			Circulatory Responses to Asphyxia Differ if the Asphyxia Occurs In Utero or Ex Utero in Near-Term Lambs	PLOS ONE			English	Article							LEFT-VENTRICULAR OUTPUT; FETAL CARDIAC-OUTPUT; HEART-RATE; RHESUS MONKEYS; HYPOXIA; RESUSCITATION; VENTILATION; NEWBORN; SHEEP; AFFERENT	Background: A cornerstone of neonatal resuscitation teaching suggests that a rapid vagal-mediated bradycardia is one of the first signs of perinatal compromise. As this understanding is based primarily on fetal studies, we investigated whether the heart rate and blood pressure response to total asphyxia is influenced by whether the animal is in utero or ex utero. Methods: Fetal sheep were instrumented at similar to 139 days of gestation and then asphyxiated by umbilical cord occlusion until mean arterial blood pressure decreased to similar to 20 mmHg. Lambs were either completely submerged in amniotic fluid (in utero; n = 8) throughout the asphyxia or were delivered and then remained ex utero (ex utero; n = 8) throughout the asphyxia. Heart rate and arterial blood pressure were continuously recorded. Results: Heart rate was higher in ex utero lambs than in utero lambs. Heart rates in in utero lambs rapidly decreased, while heart rates in ex utero lambs initially increased following cord occlusion (for similar to 1.5 min) before they started to decrease. Mean arterial pressure initially increased then decreased in both groups. Conclusions: Heart rate response to asphyxia was markedly different depending upon whether the lamb was in utero or ex utero. This indicates that the cardiovascular responses to perinatal asphyxia are significantly influenced by the newborn's local environment. As such, based solely on heart rate, the stage and severity of a perinatal asphyxic event may not be as accurate as previously assumed.	[Sobotka, Kristina S.; Ong, Tracey; Polglase, Graeme R.; Aridas, James D. S.; Miller, Suzanne L.; Schmoelzer, Georg M.; Moss, Timothy J. M.; Jenkin, Graham; Hooper, Stuart B.] Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia; [Morley, Colin; Schmoelzer, Georg M.] Royal Womens Hosp, Melbourne, Vic, Australia; [Polglase, Graeme R.; Miller, Suzanne L.; Moss, Timothy J. M.; Jenkin, Graham; Hooper, Stuart B.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia; [Klingenberg, Claus] Univ Hosp North Norway, Dept Pediat, Tromso, Norway; [Klingenberg, Claus] Univ Tromso, Fac Hlth Sci, Pediat Res Grp, Tromso, Norway	Monash University; Monash University; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sobotka, KS (corresponding author), Monash Univ, Ritchie Ctr, Melbourne, Vic 3004, Australia.	kristina.sobotka@monash.edu	Schmölzer, Georg M/E-7883-2010; Moss, Timothy/A-6633-2008; Klingenberg, Claus/AAH-4467-2019	Schmölzer, Georg M/0000-0001-9798-2415; Moss, Timothy/0000-0002-9408-4027; Morley, Colin/0000-0001-5388-0214; Hooper, Stuart/0000-0003-1676-4825; Polglase, Graeme/0000-0002-8906-614X; Miller, Suzanne/0000-0002-0451-8304	National Health and Medical Research Council (NHMRC) of Australia [384100, 1026890, APP1043294, 545921]; Rebecca L. Cooper Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation; Victorian Government's Operational Infrastructure Support Program	Funding was provided by the National Health and Medical Research Council (NHMRC) of Australia program grant (No. 384100), fellowship (GRP: 1026890, TJM: APP1043294, SBH: 545921), a Rebecca L. Cooper Medical Research Foundation Fellowship (GRP) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSONS K, 1964, J PEDIATR-US, V65, P807, DOI 10.1016/S0022-3476(64)80002-0; ADAMSONS K, 1963, J PHYSIOL-LONDON, V169, P679, DOI 10.1113/jphysiol.1963.sp007288; ANDERSON PAW, 1987, J PHYSIOL-LONDON, V387, P297, DOI 10.1113/jphysiol.1987.sp016574; ANDERSON PAW, 1986, J PHYSIOL-LONDON, V372, P557, DOI 10.1113/jphysiol.1986.sp016025; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; BRADY JP, 1966, J PHYSIOL-LONDON, V184, P631, DOI 10.1113/jphysiol.1966.sp007936; DANIEL SS, 1966, J PEDIATR-US, V68, P45, DOI 10.1016/S0022-3476(66)80421-3; DAWES GS, 1963, J PHYSIOL-LONDON, V169, P167, DOI 10.1113/jphysiol.1963.sp007248; Dawes GS, 1968, FOETAL NEONATAL PHYS; GILBERT RD, 1980, AM J PHYSIOL, V238, pH80, DOI 10.1152/ajpheart.1980.238.1.H80; GIUSSANI DA, 1993, J PHYSIOL-LONDON, V461, P431, DOI 10.1113/jphysiol.1993.sp019521; Gooden Brett A., 1994, Integrative Physiological and Behavioral Science, V29, P6, DOI 10.1007/BF02691277; Kattwinkel J, 2011, NEONATAL RESUSCITATI; KIRKPATRICK SE, 1976, AM J PHYSIOL, V231, P495, DOI 10.1152/ajplegacy.1976.231.2.495; Klingenberg C, 2013, ARCH DIS CHILD-FETAL, V98, pF222, DOI 10.1136/archdischild-2012-301787; PURVES MJ, 1966, J PHYSIOL-LONDON, V185, P60, DOI 10.1113/jphysiol.1966.sp007972; ROMERO T, 1972, AM J PHYSIOL, V222, P1285, DOI 10.1152/ajplegacy.1972.222.5.1285; RUDOLPH AM, 1976, AM J OBSTET GYNECOL, V124, P183, DOI 10.1016/S0002-9378(16)33296-3; SHADDY RE, 1988, PEDIATR RES, V24, P577, DOI 10.1203/00006450-198811000-00008; STAHLMAN M, 1967, AM J PHYSIOL, V213, P899, DOI 10.1152/ajplegacy.1967.213.4.899; TCHOBROUTSKY C, 1969, RESP PHYSIOL, V8, P108, DOI 10.1016/0034-5687(69)90048-6	21	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112264	10.1371/journal.pone.0112264	http://dx.doi.org/10.1371/journal.pone.0112264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393411	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300042
J	Toledo, KA; Fermino, ML; Andrade, CD; Riul, TB; Alves, RT; Muller, VDM; Russo, RR; Stowell, SR; Cummings, RD; Aquino, VH; Dias-Baruffi, M				Toledo, Karina Alves; Fermino, Marise Lopes; Andrade, Camillo del Cistia; Riul, Thalita Bachelli; Alves, Renata Tome; Menjon Muller, Vanessa Danielle; Russo, Raquel Rinaldi; Stowell, Sean R.; Cummings, Richard D.; Aquino, Victor Hugo; Dias-Baruffi, Marcelo			Galectin-1 Exerts Inhibitory Effects during DENV-1 Infection	PLOS ONE			English	Article							DENGUE VIRUS-INFECTION; MONOCYTE-DERIVED MACROPHAGES; PROMOTES HIV-1 INFECTIVITY; REGULATED EXPRESSION; GLYCAN MICROARRAYS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; IMMUNITY; LECTINS; STABILIZATION	Dengue virus (DENV) is an enveloped RNA virus that is mosquito-transmitted and can infect a variety of immune and non-immune cells. Response to infection ranges from asymptomatic disease to a severe disorder known as dengue hemorrhagic fever. Despite efforts to control the disease, there are no effective treatments or vaccines. In our search for new antiviral compounds to combat infection by dengue virus type 1 (DENV-1), we investigated the role of galectin-1, a widely-expressed mammalian lectin with functions in cell-pathogen interactions and immunoregulatory properties. We found that DENV-1 infection of cells in vitro exhibited caused decreased expression of Gal-1 in several different human cell lines, suggesting that loss of Gal-1 is associated with virus production. In test of this hypothesis we found that exogenous addition of human recombinant Gal-1 (hrGal-1) inhibits the virus production in the three different cell types. This inhibitory effect was dependent on hrGal-1 dimerization and required its carbohydrate recognition domain. Importantly, the inhibition was specific for hrGal-1, since no effect was observed using recombinant human galectin-3. Interestingly, we found that hrGal-1 directly binds to dengue virus and acts, at least in part, during the early stages of DENV-1 infection, by inhibiting viral adsorption and its internalization to target cells. To test the in vivo role of Gal-1 in DENV infection, Gal-1-deficient-mice were used to demonstrate that the expression of endogenous Galectin-1 contributes to resistance of macrophages to in vitro-infection with DENV-1 and it is also important to physiological susceptibility of mice to in vivo infection with DENV-1. These results provide novel insights into the functions of Gal-1 in resistance to DENV infection and suggest that Gal-1 should be explored as a potential antiviral compound.	[Toledo, Karina Alves] Univ Estadual Paulista UNESP FCL Assis, Dept Biol Sci, Assis, Brazil; [Fermino, Marise Lopes; Andrade, Camillo del Cistia; Riul, Thalita Bachelli; Alves, Renata Tome; Menjon Muller, Vanessa Danielle; Russo, Raquel Rinaldi; Aquino, Victor Hugo; Dias-Baruffi, Marcelo] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, Brazil; [Stowell, Sean R.; Cummings, Richard D.] Emory Univ, Sch Med, Atlanta, GA USA	Universidade de Sao Paulo; Emory University	Dias-Baruffi, M (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, Brazil.	mdbaruff@fcfrp.usp.br	Riul, Thalita Bachelli/G-7500-2014; Baruffi, Marcelo D/I-7199-2015; Toledo, Karina Alves/C-9452-2012; Muller, Vanessa/J-8722-2013; Aquino, Victor Hugo/C-1922-2012	Riul, Thalita Bachelli/0000-0002-4298-6475; Baruffi, Marcelo D/0000-0002-2039-1884; Toledo, Karina Alves/0000-0001-7212-6794; Aquino, Victor Hugo/0000-0003-1910-0776	Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [23038.039425-42/2008]; Conselho Nacional de Pesquisa e Desenvolvimento Cientifico e Tecnologico (CNPq) [576322/2008-3, 487351/2012-6]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07340-1]	Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Pesquisa e Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES - Grant 23038.039425-42/2008), Conselho Nacional de Pesquisa e Desenvolvimento Cientifico e Tecnologico (CNPq - Grants: 576322/2008-3 and 487351/2012-6) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Grant 2013/07340-1) to MDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Arthur CM, 2014, CURR OPIN CHEM BIOL, V18, P55, DOI 10.1016/j.cbpa.2013.12.017; Agis-Juarez RA, 2009, J GEN VIROL, V90, P2893, DOI 10.1099/vir.0.013433-0; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Beaumier CM, 2013, TRANSL RES, V162, P144, DOI 10.1016/j.trsl.2013.03.006; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Cedeno-Laurent F, 2012, CLIN IMMUNOL, V142, P107, DOI 10.1016/j.clim.2011.09.011; Cho M, 1996, BIOCHEMISTRY-US, V35, P13081, DOI 10.1021/bi961181d; CHO MJ, 1995, J BIOL CHEM, V270, P5198, DOI 10.1074/jbc.270.10.5198; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Garner OB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000993; Gauthier S, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-105; dos Santos HWG, 2008, J MED VIROL, V80, P1426, DOI 10.1002/jmv.21203; Gonzalez MI, 2005, INT J IMMUNOPATH PH, V18, P615, DOI 10.1177/039463200501800402; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Halstead Scott B, 2002, Rev Cubana Med Trop, V54, P171; Horie H, 2005, CURR DRUG TARGETS, V6, P385, DOI 10.2174/1389450054021954; Hughes RC, 1997, BIOCHEM SOC T, V25, P1194, DOI 10.1042/bst0251194; Ip PP, 2010, J IMMUNOL, V184, P5705, DOI 10.4049/jimmunol.0903484; Kami K, 2005, CURR DRUG TARGETS, V6, P395, DOI 10.2174/1389450054021918; Kato T, 2005, CURR DRUG TARGETS, V6, P407, DOI 10.2174/1389450054021846; Koishi AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051089; Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007; Lee JY, 2007, BIOL PHARM BULL, V30, P2043, DOI 10.1248/bpb.30.2043; Levroney EL, 2005, J IMMUNOL, V175, P413, DOI 10.4049/jimmunol.175.1.413; Lim JW, 2003, INT J BIOCHEM CELL B, V35, P1284, DOI 10.1016/S1357-2725(03)00051-7; Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535; Muller VDM, 2012, TOXICON, V59, P507, DOI 10.1016/j.toxicon.2011.05.021; Mercier S, 2008, VIROLOGY, V371, P121, DOI 10.1016/j.virol.2007.09.034; Moreno-Altamirano MMB, 2007, INTERVIROLOGY, V50, P237, DOI 10.1159/000100567; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; NaTHNaC, 2009, DENG FEV; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Ouellet M, 2005, J IMMUNOL, V174, P4120, DOI 10.4049/jimmunol.174.7.4120; Poisa-Beiro L, 2009, J IMMUNOL, V183, P6600, DOI 10.4049/jimmunol.0801726; Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12; Rajasagi NK, 2012, J IMMUNOL, V188, P4631, DOI 10.4049/jimmunol.1103063; Reynolds JL, 2012, J NEUROIMMUNE PHARM, V7, P673, DOI 10.1007/s11481-012-9379-7; Reynolds JL, 2012, J IMMUNOL, V188, P3757, DOI 10.4049/jimmunol.1102276; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Salatino M, 2008, EXPERT OPIN BIOL TH, V8, P45, DOI 10.1517/14712598.8.1.45; Sato S, 2012, ANN NY ACAD SCI, V1253, P133, DOI 10.1111/j.1749-6632.2012.06475.x; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; St-Pierre C, 2012, ANTIMICROB AGENTS CH, V56, P154, DOI 10.1128/AAC.05595-11; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Stowell SR, 2014, NAT CHEM BIOL, V10, P470, DOI [10.1038/nchembio.1525, 10.1038/NCHEMBIO.1525]; Stowell SR, 2010, NAT MED, V16, P295, DOI 10.1038/nm.2103; Stowell SR, 2009, MOL BIOL CELL, V20, P1408, DOI 10.1091/mbc.E08-07-0786; Stowell SR, 2009, J BIOL CHEM, V284, P4989, DOI 10.1074/jbc.M808925200; Thijssen VL, 2014, GLYCOBIOLOGY, V24, P915, DOI 10.1093/glycob/cwu048; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vervaeke P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074035; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Warke RV, 2008, J GEN VIROL, V89, P1605, DOI 10.1099/vir.0.2008/000968-0; Warke RV, 2003, J VIROL, V77, P11822, DOI 10.1128/JVI.77.21.11822-11832.2003; Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025; Yang ML, 2011, J VIROL, V85, P10010, DOI 10.1128/JVI.00301-11; Zuniga E, 2001, INFECT IMMUN, V69, P6804, DOI 10.1128/IAI.69.11.6804-6812.2001	64	32	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112474	10.1371/journal.pone.0112474	http://dx.doi.org/10.1371/journal.pone.0112474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392933	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300058
J	Dejong, CA; Wilson, JY				Dejong, Chris A.; Wilson, Joanna Y.			The Cytochrome P450 Superfamily Complement (CYPome) in the Annelid Capitella teleta	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; GENE SUPERFAMILY; SP-I; EVOLUTION; P450; EXPRESSION; SEQUENCE; ANNOTATION; POLYCHAETE; ALIGNMENT	The Cytochrome P450 super family (CYP) is responsible for a wide range of functions in metazoans, having roles in both exogenous and endogenous substrate metabolism. Annelids are known to metabolize polycyclic aromatic hydrocarbons (PAHs) and produce estrogen. CYPs are postulated to be key enzymes in these processes in annelids. In this study, the CYP complement (CYPome) of the annelid Capitella teleta has been robustly identified and annotated with the genome assembly available. Phylogenetic analyses were performed to understand the evolutionary relationships between CYPs in C. teleta and other species. Predictions of which CYPs are potentially involved in both PAH metabolism and steroidogensis were made based on phylogeny. Annotation of 84 full length and 12 partial CYP sequences predicted a total of 96 functional CYPs in C. teleta. A further 13 CYP fragments were found but these may be pseudogenes. The C. teleta CYPome contained 24 novel CYP families and seven novel CYP subfamilies within existing families. A phylogenetic analysis identified that the C. teleta sequences were found in 9 of the 11 metazoan CYP clans. Two CYPs, CYP3071A1 and CYP3072A1, did not cluster with any metazoan CYP clans. We found xenobiotic response elements (XREs) upstream of C. teleta CYPs related to vertebrate CYP1 (CYP3060A1, CYP3061A1) and from families with reported transcriptional upregulation in response to PAH exposure (CYP4, CYP331). C. teleta had a CYP51A1 with similar to 65% identity to vertebrate CYP51A1 sequences and has been predicted to have lanosterol 14 alpha-demethylase activity. CYP376A1, CYP3068A1, CYP3069A1, and CYP3070A1 were the most appropriate candidates for steroidogenesis genes based on their phylogeny and warrant further analyses, though no specific aromatase (estrogen synthesis) candidates were found. Presence of XREs upstream of C. teleta CYPs may indicate a functional aryl hydrocarbon receptor in C. teleta and candidate CYPs for studies of PAH metabolism.	[Dejong, Chris A.; Wilson, Joanna Y.] McMaster Univ, Dept Biol, Hamilton, ON, Canada	McMaster University	Wilson, JY (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	joanna.wilson@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada Discovery and Accelerator Program [2011R00152]; Ontario Ministry of Research and Innovation Early Researcher Award [ER10-07-197]	Natural Sciences and Engineering Research Council of Canada Discovery and Accelerator Program; Ontario Ministry of Research and Innovation Early Researcher Award(Ministry of Research and Innovation, Ontario)	Natural Sciences and Engineering Research Council of Canada Discovery and Accelerator Program (grant #2011R00152; http://www.nserc-crsng.gc.ca/index_eng.asp) and Ontario Ministry of Research and Innovation Early Researcher Award (ER10-07-197; http://www.ontario.ca/ministry-research-innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bach L, 2005, AQUAT TOXICOL, V74, P307, DOI 10.1016/j.aquatox.2005.06.002; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Baker ME, 2011, BIOCHEM PHARMACOL, V82, P1, DOI 10.1016/j.bcp.2011.03.008; Baker ME, 2011, MOL CELL ENDOCRINOL, V334, P14, DOI 10.1016/j.mce.2010.07.013; Baldwin WS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-169; Blake JA, 2009, ZOOSYMPOSIA, V2, P25, DOI 10.11646/zoosymposia.2.1.6; BRADFIELD JY, 1991, P NATL ACAD SCI USA, V88, P4558, DOI 10.1073/pnas.88.10.4558; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; Callard GV, 2011, J STEROID BIOCHEM, V127, P176, DOI 10.1016/j.jsbmb.2011.03.022; DENISON MS, 1988, J BIOL CHEM, V263, P17221; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garcia-Alonso J, 2005, INVERTEBR REPROD DEV, V48, P95, DOI 10.1080/07924259.2005.9652175; GARDNER WS, 1979, WATER AIR SOIL POLL, V11, P339, DOI 10.1007/BF00296591; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Goldstone JV, 2008, CELL BIOL TOXICOL, V24, P483, DOI 10.1007/s10565-008-9107-5; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Hahn ME, 1998, COMP BIOCHEM PHYS C, V120, P67, DOI 10.1016/S0742-8413(98)00007-3; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Janer G, 2007, ECOTOXICOLOGY, V16, P145, DOI 10.1007/s10646-006-0110-4; Kalsotra A, 2004, TOXICOL APPL PHARM, V199, P295, DOI 10.1016/j.taap.2003.12.033; Keay J, 2009, ENDOCRINOLOGY, V150, P1731, DOI 10.1210/en.2008-1338; Kozu S, 2006, DEV BIOL, V294, P497, DOI 10.1016/j.ydbio.2006.03.015; Lamb DC, 1998, FEBS LETT, V425, P263, DOI 10.1016/S0014-5793(98)00247-6; Lee R.F., 1980, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V179, P29; Lee RF, 1998, COMP BIOCHEM PHYS C, V121, P173, DOI 10.1016/S0742-8413(98)10037-3; Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827; Li B, 2004, BIOCHEM BIOPH RES CO, V325, P510, DOI 10.1016/j.bbrc.2004.10.066; Linke-Gamenick I, 2000, MAR ECOL PROG SER, V203, P191, DOI 10.3354/meps203191; Maddison WP, 2011, MESQUITE MODULAR SYS; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; Nebert DW, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0431; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0474; Nelson DR, 2011, BBA-PROTEINS PROTEOM, V1814, P14, DOI 10.1016/j.bbapap.2010.08.008; Nelson David R., 2009, Human Genomics, V4, P59; Nelson DR, 2003, ARCH BIOCHEM BIOPHYS, V409, P18, DOI 10.1016/S0003-9861(02)00553-2; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Reitzel AM, 2010, MOL BIOL EVOL, V27, P2211, DOI 10.1093/molbev/msq129; Rendic S, 1997, DRUG METAB REV, V29, P413, DOI 10.3109/03602539709037591; Rupasinghe S, 2006, FEBS LETT, V580, P6338, DOI 10.1016/j.febslet.2006.10.043; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANDERS HL, 1980, J MAR RES, V38, P265; Selck H, 2003, ENVIRON TOXICOL CHEM, V22, P2364, DOI 10.1897/02-272; Sezutsu H, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0428; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sun YV, 2004, NUCLEIC ACIDS RES, V32, P4512, DOI 10.1093/nar/gkh782; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Twan WH, 2003, BIOL REPROD, V68, P2255, DOI 10.1095/biolreprod.102.012450; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Verslycke T, 2006, MOL PHYLOGENET EVOL, V40, P760, DOI 10.1016/j.ympev.2006.04.017; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Wu MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030288	64	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e107728	10.1371/journal.pone.0107728	http://dx.doi.org/10.1371/journal.pone.0107728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390889	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400003
J	Greiner, TU; Hyotylainen, T; Knip, M; Backhed, F; Oresic, M				Greiner, Thomas U.; Hyotylainen, Tuulia; Knip, Mikael; Backhed, Fredrik; Oresic, Matej			The Gut Microbiota Modulates Glycaemic Control and Serum Metabolite Profiles in Non-Obese Diabetic Mice	PLOS ONE			English	Article							NOD MOUSE; AUTOIMMUNE; SUPPRESSION; METAGENOME; CHILDREN; DISEASE; TWINS; RISK	Islet autoimmunity in children who later progress to type 1 diabetes is preceded by dysregulated serum metabolite profiles, but the origin of these metabolic changes is unknown. The gut microbiota affects host metabolism and changes in its composition contribute to several immune-mediated diseases; however, it is not known whether the gut microbiota is involved in the early metabolic disturbances in progression to type 1 diabetes. We rederived non-obese diabetic ( NOD) mice as germ free to explore the potential role of the gut microbiota in the development of diabetic autoimmunity and to directly investigate whether the metabolic profiles associated with the development of type 1 diabetes can be modulated by the gut microbiota. The absence of a gut microbiota in NOD mice did not affect the overall diabetes incidence but resulted in increased insulitis and levels of interferon gamma and interleukin 12; these changes were counterbalanced by improved peripheral glucose metabolism. Furthermore, we observed a markedly increased variation in blood glucose levels in the absence of a microbiota in NOD mice that did not progress to diabetes. Additionally, germ-free NOD mice had a metabolite profile similar to that of pre-diabetic children. Our data suggest that germ-free NOD mice have reduced glycaemic control and dysregulated immunologic and metabolic responses.	[Greiner, Thomas U.; Backhed, Fredrik] Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Greiner, Thomas U.; Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovascular & Metab Res, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Hyotylainen, Tuulia; Oresic, Matej] VTT Tech Res Ctr Finland, Espoo, Finland; [Hyotylainen, Tuulia; Oresic, Matej] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Knip, Mikael] Univ Helsinki, Childrens Hosp, Helsinki, Finland; [Knip, Mikael] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Knip, Mikael] Univ Helsinki, Diabet & Obes Res Program, Helsinki, Finland; [Knip, Mikael] Folkhalsan Res Ctr, Helsinki, Finland; [Knip, Mikael] Tampere Univ Hosp, Dept Pediat, Tampere, Finland; [Backhed, Fredrik] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Receptol & Enteroendocrinol, Copenhagen, Denmark	University of Gothenburg; University of Gothenburg; VTT Technical Research Center Finland; Steno Diabetes Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Folkhalsan Research Center; Tampere University; Tampere University Hospital; Novo Nordisk Foundation; University of Copenhagen	Backhed, F (corresponding author), Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden.	fredrik.backhed@wlab.gu.se; mtjo@steno.dk	Knip, Mikael/AAL-3773-2020; Hyötyläinen, Tuulia/AAP-6266-2020; Backhed, Fredrik/ABE-6613-2020; Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020	Backhed, Fredrik/0000-0002-4871-8818; Oresic, Matej/0000-0002-2856-9165; Hyotylainen, Tuulia/0000-0002-1389-8302; Knip, Mikael/0000-0003-0474-0033	Human Frontier of Science Program [RGY64/2008]; Juvenile Diabetes Research Foundation [36-2008-919]; European Community [HEALTH-2008-202013, HEALTH-2011-277713]; Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (SyMMyS) [250114]; Swedish Research Council; Swedish Child Diabetes Foundation; Swedish Foundation for Strategic Research; LUA-ALF grant from Vastra Gotalandsregionen	Human Frontier of Science Program(Human Frontier Science Program); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Community(European Commission); Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (SyMMyS); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Child Diabetes Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); LUA-ALF grant from Vastra Gotalandsregionen	This work was supported by the Human Frontier of Science Program (RGY64/2008 to FB and MO), Juvenile Diabetes Research Foundation (36-2008-919 to MO and FB), DIAPREPP and BETABAT projects of the Seventh Framework Program of the European Community (HEALTH-2008-202013 and HEALTH-2011-277713, respectively, to MO), Academy of Finland Centre of Excellence in Molecular Systems Immunology and Physiology Research (SyMMyS, 2012-2017, Decision No. 250114 to MO and MK), The Swedish Research Council, The Swedish Child Diabetes Foundation, Swedish Foundation for Strategic Research and a LUA-ALF grant from Vastra Gotalandsregionen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam C, 2011, DIABETOLOGIA, V54, P1398, DOI 10.1007/s00125-011-2097-5; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; BARNETT AH, 1981, DIABETOLOGIA, V20, P87, DOI 10.1007/BF00262007; Ben Nasr M, 2014, PHARM RES; Bjorksten B, 2009, CURR OPIN ALLERGY CL, V9, P185, DOI 10.1097/ACI.0b013e32832abfc2; Caesar R, 2012, GUT, V61, P1701, DOI 10.1136/gutjnl-2011-301689; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Castillo S, 2011, ANAL CHEM, V83, P3058, DOI 10.1021/ac103308x; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Fujihira K, 2000, DIABETES, V49, P1998, DOI 10.2337/diabetes.49.12.1998; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; Herold KC, 2013, NAT REV IMMUNOL, V13, P243, DOI 10.1038/nri3422; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kilkkinen A, 2006, DIABETOLOGIA, V49, P66, DOI 10.1007/s00125-005-0078-2; Knip M, 2005, PEDIAT ADOL, V10, P1; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lernmark A, 2013, NAT REV ENDOCRINOL, V9, P92, DOI 10.1038/nrendo.2012.237; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nygren H, 2011, METHODS MOL BIOL, V708, P247, DOI 10.1007/978-1-61737-985-7_15; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Trembleau S, 2003, J IMMUNOL, V170, P5491, DOI 10.4049/jimmunol.170.11.5491; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yang ZD, 2002, J IMMUNOL, V168, P6479, DOI 10.4049/jimmunol.168.12.6479	44	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110359	10.1371/journal.pone.0110359	http://dx.doi.org/10.1371/journal.pone.0110359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390735	Green Submitted, gold, Green Published			2022-12-26	WOS:000349144400014
J	Kumar, S; Shabi, TS; Goormaghtigh, E				Kumar, Saroj; Shabi, Thankaraj Salammal; Goormaghtigh, Erik			A FTIR Imaging Characterization of Fibroblasts Stimulated by Various Breast Cancer Cell Lines	PLOS ONE			English	Article							TRANSFORM-INFRARED-SPECTROSCOPY; STROMAL FIBROBLASTS; INFORMATION-CONTENT; CIRCULAR-DICHROISM; TUMOR; GROWTH; METASTASIS; SPECTRA; TISSUE; MICROENVIRONMENT	It is well known that the microenvironment plays a major role in breast cancer progression. Yet, the mechanism explaining the transition from normal fibroblasts to cancer-stimulated fibroblasts remains to be elucidated. Here we report a FTIR imaging study of the effects of three different breast cancer cell lines on normal fibroblasts in culture. Fibroblast activation process was monitored by FTIR imaging and spectra compared by multivariate statistical analyses. Principal component analysis evidenced that the fibroblasts stimulated by these cancer cell lines grouped together and remained distinctly separated from normal fibroblasts indicating a modified different chemical composition in the cancer-stimulated fibroblasts. Similar changes in fibroblasts were induced by the various breast cancer cell lines belonging to different sub-types. Most significant changes were observed in the region of 2950 and 1230 cm(-1), possibly related to changes in lipids and in the 1230 cm(-1) area assigned to phosphate vibrations (nucleotides). Interestingly, the cancer-cell induced changes in the fibroblasts also occurred when there was no possible direct contact between the two cell lines in the co-culture. When contact was possible, the spectral changes were similar, suggesting that soluble factors but not direct cell-cell interactions were responsible for fibroblast activation. Overall, the results indicate that IR imaging could be used in the future for analyzing the microenvironment of breast tumors.	[Kumar, Saroj; Goormaghtigh, Erik] Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium; [Shabi, Thankaraj Salammal] Zhejiang Univ, Dept Polymer Sci & Engn, Organ Semicond Lab, Hangzhou, Zhejiang, Peoples R China	Universite Libre de Bruxelles; Zhejiang University	Kumar, S (corresponding author), Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium.	sarojgupta.k@gmail.com; egoor@ulb.ac.be		Goormaghtigh, Erik/0000-0002-2071-2262; Kumar, Saroj/0000-0001-7029-1163	Brain Back to Brussels (I.S.R.I.B., Belgium); Vetenskapsradet (Swedish Research Council); National Fund for Scientific Research [FRFC 2.4533.10, 2.4527.10, 2.4526.12, T.0155.13]; National Fund for Scientific Research (Belgium)	Brain Back to Brussels (I.S.R.I.B., Belgium); Vetenskapsradet (Swedish Research Council)(Swedish Research Council); National Fund for Scientific Research; National Fund for Scientific Research (Belgium)(Fonds de la Recherche Scientifique - FNRS)	The authors are grateful to Brain Back to Brussels (I.S.R.I.B., Belgium) and Vetenskapsradet (Swedish Research Council) for postdoctoral fellowships to S Kumar. This research was also supported by grants from the National Fund for Scientific Research (FRFC 2.4533.10, 2.4527.10, 2.4526.12 and T.0155.13) provided to E. Goormaghtigh. E Goormaghtigh is Director of Research with the National Fund for Scientific Research (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rakan MA, 2013, J PATHOL, V231, P457, DOI 10.1002/path.4256; Barcellos-Hoff MH, 2005, BREAST CANCER RES, V7, P33, DOI 10.1186/bcr972; Bassan P, 2013, ANALYST, V138, P4139, DOI 10.1039/c3an00363a; Bassan P, 2013, ANALYST, V138, P144, DOI 10.1039/c2an36090j; Benard A, 2014, ANALYST, V139, P1044, DOI 10.1039/c3an01454a; Bergner N, 2013, ANALYST, V138, P3983, DOI 10.1039/c3an00326d; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bogomolny E, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717186; Boydston-White S, 2006, BBA-BIOMEMBRANES, V1758, P908, DOI 10.1016/j.bbamem.2006.04.018; De Wever O, 2003, J PATHOL, V200, P429, DOI 10.1002/path.1398; Derenne A., 2013, ENCY BIOPHYSICS, P1074, DOI [10.1007/978-3-642-16712-6_558, DOI 10.1007/978-3-642-16712-6_558]; Derenne A, 2014, BBA-MOL CELL BIOL L, V1841, P1200, DOI 10.1016/j.bbalip.2013.10.010; Derenne A, 2013, ANALYST, V138, P3998, DOI 10.1039/c3an00225j; Derenne A, 2013, BBA-MOL BASIS DIS, V1832, P46, DOI 10.1016/j.bbadis.2012.10.010; Derenne A, 2012, ANALYST, V137, P3255, DOI 10.1039/c2an35116a; Derenne A, 2011, ANALYST, V136, P1134, DOI 10.1039/c0an00872a; Derenne A, 2010, SPECTROSC-INT J, V24, P55, DOI 10.1155/2010/910694; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Farlay D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028736; Gaigneaux A, 2006, APPL SPECTROSC, V60, P1022, DOI 10.1366/000370206778397416; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; GOORMAGHTIGH E, 1994, SPECTROCHIM ACTA A, V50, P2137; Goormaghtigh E., 2013, ENCY BIOPHYSICS, P1074; Goormaghtigh E, 2009, BBA-PROTEINS PROTEOM, V1794, P1332, DOI 10.1016/j.bbapap.2009.06.007; Holton SE, 2011, BIOPHYS J, V101, P1513, DOI 10.1016/j.bpj.2011.07.055; Holton SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096878; Holton SE, 2011, ANALYST, V136, P2953, DOI 10.1039/c1an15112f; Ingber DE, 2008, SEMIN CANCER BIOL, V18, P356, DOI 10.1016/j.semcancer.2008.03.016; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Katz-Brull R, 2002, CANCER RES, V62, P1966; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Khamis ZI, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/574025; Khamis ZI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/723650; Kumar S, 2013, ANALYST, V138, P4058, DOI 10.1039/c3an00241a; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lasch P, 2006, BBA-BIOMEMBRANES, V1758, P814, DOI 10.1016/j.bbamem.2006.06.008; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Mourant JR, 2003, BIOPHYS J, V85, P1938, DOI 10.1016/S0006-3495(03)74621-9; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen TT, 2014, ANALYST, V139, P2482, DOI 10.1039/c3an00353a; Noreen R, 2013, ANAL BIOANAL CHEM, V405, P8729, DOI 10.1007/s00216-013-7337-8; Oberg KA, 2004, EUR J BIOCHEM, V271, P2937, DOI 10.1111/j.1432-1033.2004.04220.x; Olsen CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-444; PAGET S, 1989, CANCER METAST REV, V8, P98; Pevsner A, 2001, APPL SPECTROSC, V55, P1502, DOI 10.1366/0003702011953720; Radisky ES, 2007, REV ENDOCR METAB DIS, V8, P279, DOI 10.1007/s11154-007-9037-1; Sadlonova A, 2007, AM J PATHOL, V170, P1064, DOI 10.2353/ajpath.2007.060031; SCHOR SL, 1986, INT J CANCER, V37, P831, DOI 10.1002/ijc.2910370606; Studebaker AW, 2008, CANCER RES, V68, P9087, DOI 10.1158/0008-5472.CAN-08-0400; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Verdonck M, 2013, ANALYST, V138, P4083, DOI 10.1039/c3an00246b; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Whelan DR, 2013, J BIOPHOTONICS, V6, P775, DOI 10.1002/jbio.201200112; Whelan DR, 2013, ANALYST, V138, P3891, DOI 10.1039/c3an00316g; Zhang L, 2003, APPL SPECTROSC, V57, P14, DOI 10.1366/000370203321165151	59	34	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111137	10.1371/journal.pone.0111137	http://dx.doi.org/10.1371/journal.pone.0111137			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390361	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400019
J	Liu, J; Nie, HR; Xu, ZL; Niu, X; Guo, SC; Yin, JH; Guo, F; Li, G; Wang, Y; Zhang, CQ				Liu, Ji; Nie, Huarong; Xu, Zhengliang; Niu, Xin; Guo, Shangchun; Yin, Junhui; Guo, Fei; Li, Gang; Wang, Yang; Zhang, Changqing			The Effect of 3D Nanofibrous Scaffolds on the Chondrogenesis of Induced Pluripotent Stem Cells and Their Application in Restoration of Cartilage Defects	PLOS ONE			English	Article							OSTEOCHONDRAL DEFECTS; CULTURE-CONDITIONS; DIFFERENTIATION; INDUCTION; TERATOMAS; KNEE	The discovery of induced pluripotent stem cells (iPSCs) rendered the reprogramming of terminally differentiated cells to primary stem cells with pluripotency possible and provided potential for the regeneration and restoration of cartilage defect. Chondrogenic differentiation of iPSCs is crucial for their application in cartilage tissue engineering. In this study we investigated the effect of 3D nanofibrous scaffolds on the chondrogenesis of iPSCs and articular cartilage defect restoration. Super-hydrophilic and durable mechanic polycaprolactone (PCL)/gelatin scaffolds were fabricated using two separate electrospinning processes. The morphological structure and mechanical properties of the scaffolds were characterized. The chondrogenesis of the iPSCs in vitro and the restoration of the cartilage defect was investigated using scanning electron microscopy (SEM), the Cell Counting Kit-8 (CCK-8), histological observation, RT-qPCR, and western blot analysis. iPSCs on the scaffolds expressed higher levels of chondrogenic markers than the control group. In an animal model, cartilage defects implanted with the scaffold-cell complex exhibited an enhanced gross appearance and histological improvements, higher cartilage-specific gene expression and protein levels, as well as subchondral bone regeneration. Therefore, we showed scaffolds with a 3D nanofibrous structure enhanced the chondrogenesis of iPSCs and that iPSC-containing scaffolds improved the restoration of cartilage defects to a greater degree than did scaffolds alone in vivo.	[Liu, Ji; Xu, Zhengliang; Niu, Xin; Guo, Shangchun; Yin, Junhui; Wang, Yang; Zhang, Changqing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Dept Orthopaed Surg, Shanghai 200030, Peoples R China; [Nie, Huarong; Guo, Fei] Nanchang Univ, Sch Mat Sci & Engn, Inst Polymers, Nanchang, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Sch Biomed Sci,,Stem Cells & Regenerat Program, Li Ka Shing Inst Hlth Sci,Dept Orthopaed & Trauma, Shatin, Hong Kong, Peoples R China	Shanghai Jiao Tong University; Nanchang University; Chinese University of Hong Kong; Prince of Wales Hospital	Wang, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Sch Med, Dept Orthopaed Surg, Shanghai 200030, Peoples R China.	wangy63cn@126.com; zhangcq@sjtu.edu.cn	Li, Gang/J-7830-2018; Guo, Shang-Chun/M-6246-2018	Li, Gang/0000-0002-3981-2239; Guo, Shang-Chun/0000-0001-6285-6750; , Fei/0000-0003-2397-8629; zhang, changqing/0000-0002-7408-4126				BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; Carr AJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008152; Chew SY, 2006, CURR PHARM DESIGN, V12, P4751, DOI 10.2174/138161206779026326; Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027; Clair Benjamin L, 2009, Foot Ankle Spec, V2, P179, DOI 10.1177/1938640009342272; Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109; Fecek C, 2008, TISSUE ENG PT A, V14, P1403, DOI [10.1089/ten.tea.2007.0293, 10.1089/tea.2007.0293]; Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hoemann CD, 2010, AM J SPORT MED, V38, P1845, DOI 10.1177/0363546510369547; Jukes JM, 2008, TISSUE ENG PT A, V14, P135, DOI 10.1089/ten.a.2006.0397; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kim MS, 2010, MACROMOL BIOSCI, V10, P91, DOI 10.1002/mabi.200900168; Lee SJ, 2008, BIOMATERIALS, V29, P2891, DOI 10.1016/j.biomaterials.2008.03.032; Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37; Nakayama N, 2003, J CELL SCI, V116, P2015, DOI 10.1242/jcs.00417; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Payne KA, 2010, OSTEOARTHR CARTILAGE, V18, P705, DOI 10.1016/j.joca.2010.01.011; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78; Spector M, 2006, SWISS MED WKLY, V136, P293; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tanaka H, 2004, J CELL BIOCHEM, V93, P454, DOI 10.1002/jcb.20171; Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6; Toh WS, 2007, STEM CELLS, V25, P950, DOI 10.1634/stemcells.2006-0326; Toh WS, 2009, J CELL MOL MED, V13, P3570, DOI 10.1111/j.1582-4934.2009.00762.x; Toh Wei Seong, 2007, V407, P333, DOI 10.1007/978-1-59745-536-7_23; Toh WS, 2005, GROWTH FACTORS, V23, P313, DOI 10.1080/08977190500252763; Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687; Wakitani S, 2004, CELL TRANSPLANT, V13, P331, DOI 10.3727/000000004783983891; Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024; Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P2; Yang XC, 2010, J BIOMED MATER RES A, V93A, P247, DOI 10.1002/jbm.a.32535; Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x; zur Nieden NI, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-1	42	12	12	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111566	10.1371/journal.pone.0111566	http://dx.doi.org/10.1371/journal.pone.0111566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389965	Green Published, gold			2022-12-26	WOS:000349144400024
J	Murakami, M; Oki, T				Murakami, Michio; Oki, Taikan			Estimated Dietary Intake of Radionuclides and Health Risks for the Citizens of Fukushima City, Tokyo, and Osaka after the 2011 Nuclear Accident	PLOS ONE			English	Article							POWER-PLANT ACCIDENT; CANCER INCIDENCE; ADULT RESIDENTS; RADIATION; RADIOCESIUM; POPULATION; PREFECTURE; DEPOSITION; TRANSPORT; JAPAN	The radionuclides released from the Fukushima Daiichi nuclear power plant in 2011 pose a health risk. In this study, we estimated the 1st-year average doses resulting from the intake of iodine 131 (I-131) and cesium 134 and 137 (Cs-134 and Cs-137) in drinking water and food ingested by citizens of Fukushima City (similar to 50 km from the nuclear power plant; outside the evacuation zone), Tokyo (similar to 230 km), and Osaka (similar to 580 km) after the accident. For citizens in Fukushima City, we considered two scenarios: Case 1, citizens consumed vegetables bought from markets; Case 2, citizens consumed vegetables grown locally (conservative scenario). The estimated effective doses of Cs-134 and Cs-137 agreed well with those estimated through market basket and food-duplicate surveys. The average thyroid equivalent doses due to ingestion of 131 I for adults were 840 mu Sv (Case 1) and 2700 mSv (Case 2) in Fukushima City, 370 mSv in Tokyo, and 16 mSv in Osaka. The average effective doses due to 134 Cs and 137 Cs were 19, 120, 6.1, and 1.9 mu Sv, respectively. The doses estimated in this study were much lower than values reported by the World Health Organization and the United Nations Scientific Committee on the Effects of Atomic Radiation, whose assessments lacked validation and full consideration of regional trade in foods, highlighting the importance of including regional trade. The 95th percentile effective doses were 2-3 times the average values. Lifetime attributable risks (LARs) of thyroid cancers due to ingestion were 2.3-39 X 10(-6) (Case 1) and 10-98 X 10(-6) (Case 2) in Fukushima City, 0.95-14 X 10(-6) in Tokyo, and 0.11-1.3 X 10(-6) in Osaka. The contributions of LARs of thyroid cancers due to ingestion were 7.5%-12% of all exposure (Case 1) and 12%-30% (Case 2) in Fukushima City.	[Murakami, Michio; Oki, Taikan] Univ Tokyo, Inst Ind Sci, Meguro, Tokyo, Japan; [Murakami, Michio; Oki, Taikan] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Murakami, M (corresponding author), Univ Tokyo, Inst Ind Sci, Meguro, Tokyo, Japan.	michio@iis.u-tokyo.ac.jp	Oki, Taikan/E-5778-2010	Oki, Taikan/0000-0003-4067-4678	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	"Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency	This study was supported by a "Core Research for Evolutionary Science and Technology (CREST)" grant from the Japan Science and Technology Agency, http://www.jst.go.jp/kisoken/crest/en/index.html.MM and TO receive the funding. The funder had no role in study design, data collection and analysis, discussion to publish, or preparation of the manuscript.	Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; Amano H, 2012, J ENVIRON RADIOACTIV, V111, P42, DOI 10.1016/j.jenvrad.2011.10.019; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Brenner AV, 2011, ENVIRON HEALTH PERSP, V119, P933, DOI 10.1289/ehp.1002674; Center for Cancer Control and Information Services National Cancer Center Japan, 2013, CANC INC 1975 2008; Christoudias T, 2013, ATMOS CHEM PHYS, V13, P1425, DOI 10.5194/acp-13-1425-2013; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Evangeliou N, 2013, ENVIRON SCI TECHNOL, V47, P5803, DOI 10.1021/es400372u; Fukushima Prefecture, 2010, STAT FOREST IND FUKU; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; Harada KH, 2013, ENVIRON SCI TECHNOL, V47, P2520, DOI 10.1021/es304128t; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; International Commission on Radiological Protection (ICRP), 1983, ANN ICRP, V38, P11; Izumo Y, 2001, MINISTRY HLTH LABOUR; Japan Water Works Association, 2011, STAT TAP WAT 2009 FY; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Koizumi Akio, 2012, Environmental Health and Preventive Medicine, V17, P292, DOI 10.1007/s12199-011-0251-9; Kosaka K, 2012, WATER RES, V46, P4397, DOI 10.1016/j.watres.2012.05.055; Kuroda M, 2010, APPETITE, V54, P538, DOI 10.1016/j.appet.2010.02.010; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Michio M, 2012, SEISAM KENKYU, V64, P359; Ministry of Agriculture Forestry and Fisheries, 2011, BAS DAT SPEC FOR PRO; Ministry of Agriculture Forestry and Fisheries, 2013, FOOD DEM SUPPL 2010; Ministry of Agriculture Forestry and Fisheries, 2010, STAT SURV MILK DAIR; Ministry of Agriculture Forestry and Fisheries, 2011, STAT SURV CULT ACR F; Ministry of Agriculture Forestry and Fisheries, 2011, STAT AN PROD DISTR 2; Ministry of Agriculture Forestry and Fisheries, 2011, CROP PROD STAT 2009; Ministry of Agriculture Forestry and Fisheries, 2012, CROP PROD STAT; Ministry of Agriculture Forestry and Fisheries, 2008, CENS AGR FOR 2005; Ministry of Agriculture Forestry and Fisheries, 2007, STAT SURV LIV 2006; Ministry of Agriculture Forestry and Fisheries, 2013, FISH AQ IND PROD STA; Ministry of Agriculture Forestry and Fisheries, 2013, CROP STAT 2011; Ministry of Health and Welfare, 2012, NAT HLTH NUTR SURV J; Mullenders L, 2009, NAT REV CANCER, V9, P596, DOI 10.1038/nrc2677; Murakami M, 2013, J JPN SOC WATER ENV, V36, P322; Murakami M, 2012, CHEMOSPHERE, V87, P1355, DOI 10.1016/j.chemosphere.2012.02.028; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098; Nakamura T, 1996, JPN J FOOD CHEM, V3, P141; National Research Council of the National Academies NRC, 2006, HLTH RISKS EXP LOW L; Nuclear Safety Commission of Japan, 1998, CONTR IND LEV ING FO; Ota T., 2009, JPN J HLTH PHYS, V44, P80, DOI DOI 10.5453/JHPS.44.80; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; RUSSELL WL, 1982, P NATL ACAD SCI-BIOL, V79, P542, DOI 10.1073/pnas.79.2.542; Statistics Bureau of Japan, 2011, NAT POP CENS 2010; Statistics Bureau of Japan, 2011, GEN MORT 2010; Sugiyama H, 2007, J HEALTH SCI, V53, P107, DOI 10.1248/jhs.53.107; Suzuki K, 2006, MEM OSAKA KYOIKU U S, V54, P27; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, SOURC EFF RISKS ION; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, ANN A EP STUD RAD CA, V1; Working Group on Radionuclides Pharmaceutical Affairs and Food Sanitation Council, 2011, EST CONTR RAD INT EX; Working Group on Radionuclides Pharmaceutical Affairs and Food Sanitation Council, 2011, REV NEW STAND RAD FO; World Health Organization, 2012, PREL DOS EST NUCL AC; World Health Organization, 2013, HLTH RISK ASS NUCL A; Yasutaka T, 2013, CHEMOSPHERE, V93, P1222, DOI 10.1016/j.chemosphere.2013.06.083; Yoshida-Ohuchi H, 2013, RADIAT PROT DOSIM, V154, P385, DOI 10.1093/rpd/ncs245	56	24	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112791	10.1371/journal.pone.0112791	http://dx.doi.org/10.1371/journal.pone.0112791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390339	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400127
J	Sunaga, D; Tanno, M; Kuno, A; Ishikawa, S; Ogasawara, M; Yano, T; Miki, T; Miura, T				Sunaga, Daisuke; Tanno, Masaya; Kuno, Atsushi; Ishikawa, Satoko; Ogasawara, Makoto; Yano, Toshiyuki; Miki, Takayuki; Miura, Tetsuji			Accelerated Recovery of Mitochondrial Membrane Potential by GSK-3 beta Inactivation Affords Cardiomyocytes Protection from Oxidant-Induced Necrosis	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CELL-DEATH; VENTRICULAR MYOCYTES; SIGNALING PATHWAYS; RAT HEARTS; REPERFUSION; ISCHEMIA; ERYTHROPOIETIN; SUPEROXIDE; MYOCARDIUM	Loss of mitochondrial membrane potential (Delta Psi(m)) is known to be closely linked to cell death by various insults. However, whether acceleration of the Delta Psi(m) recovery process prevents cell necrosis remains unclear. Here we examined the hypothesis that facilitated recovery of Delta Psi(m) contributes to cytoprotection afforded by activation of the mitochondrial ATP-sensitive K+ (mK(ATP)) channel or inactivation of glycogen synthase kinase-3 beta (GSK-3 beta). DYm of H9c2 cells was determined by tetramethylrhodamine ethyl ester (TMRE) before or after 1-h exposure to antimycin A (AA), an inducer of reactive oxygen species (ROS) production at complex III. Opening of the mitochondrial permeability transition pore (mPTP) was determined by mitochondrial loading of calcein. AA reduced Delta Psi(m) to 15 +/- 1% of the baseline and induced calcein leak from mitochondria. Delta Psi(m) was recovered to 51 +/- 3% of the baseline and calcein-loadable mitochondria was 6 +/- 1% of the control at 1 h after washout of AA. mKATP channel openers improved the Delta Psi(m) recovery and mitochondrial calcein to 73 +/- 2% and 30 +/- 7%, respectively, without change in Delta Psi(m) during AA treatment. Activation of the mKATP channel induced inhibitory phosphorylation of GSK-3 beta and suppressed ROS production, LDH release and apoptosis after AA washout. Knockdown of GSK-3 beta and pharmacological inhibition of GSK-3 beta mimicked the effects of mKATP channel activation. ROS scavengers administered at the time of AA removal also improved recovery of Delta Psi(m). These results indicate that inactivation of GSK-3 beta directly or indirectly by mKATP channel activation facilitates recovery of DYm by suppressing ROS production and mPTP opening, leading to cytoprotection from oxidant stress-induced cell death.	[Sunaga, Daisuke; Tanno, Masaya; Kuno, Atsushi; Ishikawa, Satoko; Ogasawara, Makoto; Yano, Toshiyuki; Miki, Takayuki; Miura, Tetsuji] Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan	Sapporo Medical University	Miura, T (corresponding author), Sapporo Med Univ, Sch Med, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan.	miura@sapmed.ac.jp		KUNO, ATSUSHI/0000-0001-6873-1297	Japanese Society for the Promotion of Science [23501086]; Chugai Pharmaceutical Co. Ltd.; Grants-in-Aid for Scientific Research [26461133] Funding Source: KAKEN	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chugai Pharmaceutical Co. Ltd.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Society for the Promotion of Science Grants-in-Aid for Scientific Research #23501086 (to T. Miura) and a grant from Chugai Pharmaceutical Co. Ltd. Neither funder played any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Chanoit G, 2011, CARDIOVASC DRUG THER, V25, P299, DOI 10.1007/s10557-011-6310-z; Dang VC, 2006, AM J PHYSIOL-HEART C, V290, pH1808, DOI 10.1152/ajpheart.00772.2005; Di Lisa F, 1998, BBA-BIOENERGETICS, V1366, P69, DOI 10.1016/S0005-2728(98)00121-2; Diaz F, 2012, MOL CELL BIOL, V32, P415, DOI 10.1128/MCB.06051-11; Dost T, 2008, BASIC RES CARDIOL, V103, P378, DOI 10.1007/s00395-008-0718-z; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; GRIFFITHS EJ, 1995, BIOCHEM J, V307, P93, DOI 10.1042/bj3070093; Hausenloy DJ, 2002, CARDIOVASC RES, V55, P534, DOI 10.1016/S0008-6363(02)00455-8; ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Itoh T, 2012, J MOL CELL CARDIOL, V53, P870, DOI 10.1016/j.yjmcc.2012.10.001; Javadov SA, 2003, J PHYSIOL-LONDON, V549, P513, DOI 10.1113/jphysiol.2003.034231; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kerr PM, 1999, AM J PHYSIOL-HEART C, V276, pH496, DOI 10.1152/ajpheart.1999.276.2.H496; King TD, 2008, NEUROTOX RES, V14, P367, DOI 10.1007/BF03033861; Korde AS, 2011, FREE RADICAL BIO MED, V50, P945, DOI 10.1016/j.freeradbiomed.2011.01.010; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Miura T, 2012, CARDIOVASC RES, V94, P181, DOI 10.1093/cvr/cvr302; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Ohori K, 2008, AM J PHYSIOL-HEART C, V295, pH2079, DOI 10.1152/ajpheart.00092.2008; Ozcan C, 2002, AM J PHYSIOL-HEART C, V282, pH531, DOI 10.1152/ajpheart.00552.2001; Pasdois P, 2008, AM J PHYSIOL-HEART C, V294, pH2088, DOI 10.1152/ajpheart.01345.2007; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Sasaki N, 2000, CIRCULATION, V101, P439, DOI 10.1161/01.CIR.101.4.439; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Tanno M, 2014, J BIOL CHEM, V3; Terashima Y, 2010, J MOL CELL CARDIOL, V49, P762, DOI 10.1016/j.yjmcc.2010.08.001; Tominaga H, 2008, AM J PHYSIOL-HEART C, V295, pH105, DOI 10.1152/ajpheart.01307.2007; Viola HM, 2007, CIRC RES, V100, P1036, DOI 10.1161/01.RES.0000263010.19273.48; Viola HM, 2010, J MOL CELL CARDIOL, V49, P875, DOI 10.1016/j.yjmcc.2010.07.015; Waypa GB, 2013, AM J RESP CRIT CARE, V187, P424, DOI 10.1164/rccm.201207-1294OC; Yano T, 2011, HYPERTENSION, V57, P110, DOI 10.1161/HYPERTENSIONAHA.110.158469; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	38	26	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112529	10.1371/journal.pone.0112529	http://dx.doi.org/10.1371/journal.pone.0112529			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390651	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400092
J	Company, N; Nadal, A; Ruiz, C; Pla, M				Company, Nuri; Nadal, Anna; Ruiz, Cristina; Pla, Maria			Production of Phytotoxic Cationic alpha-Helical Antimicrobial Peptides in Plant Cells Using Inducible Promoters	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENOME-WIDE ANALYSIS; STRESS-RESPONSE; TRANSCRIPTOME ANALYSIS; ABIOTIC STRESS; REPRODUCTIVE DEVELOPMENT; GENE-EXPRESSION; RICE; TOLERANCE; TOBACCO	Synthetic linear antimicrobial peptides with cationic alpha-helical structures, such as BP100, have potent and specific activities against economically important plant pathogenic bacteria. They are also recognized as valuable therapeutics and preservatives. However, highly active BP100 derivatives are often phytotoxic when expressed at high levels as recombinant peptides in plants. Here we demonstrate that production of recombinant phytotoxic peptides in transgenic plants is possible by strictly limiting transgene expression to certain tissues and conditions, and specifically that minimization of this expression during transformation and regeneration of transgenic plants is essential to obtain viable plant biofactories. On the basis of whole-genome transcriptomic data available online, we identified the Os.hsp82 promoter that fulfilled this requirement and was highly induced in response to heat shock. Using this strategy, we generated transgenic rice lines producing moderate yields of severely phytotoxic BP100 derivatives on exposure to high temperature. In addition, a threshold for gene expression in selected tissues and stages was experimentally established, below which the corresponding promoters should be suitable for driving the expression of recombinant phytotoxic proteins in genetically modified plants. In view of the growing transcriptomics data available, this approach is of interest to assist promoter selection for specific purposes.	[Company, Nuri; Nadal, Anna; Ruiz, Cristina; Pla, Maria] Univ Girona, Inst Food & Agr Technol, Girona, Spain	Universitat de Girona	Pla, M (corresponding author), Univ Girona, Inst Food & Agr Technol, Girona, Spain.	maria.pla@udg.edu	Nadal, Anna/K-3029-2017; Pla, Maria/K-5170-2017	Nadal, Anna/0000-0003-1917-9277; Pla, Maria/0000-0003-4382-5494	Spanish Ministerio de Economia y Competitividad [AGL2010-17181/AGR]; Generalitat de Catalunya	Spanish Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	This work was financially supported by the Spanish Ministerio de Economia y Competitividad (reference AGL2010-17181/AGR). The research group belongs to 2014SGR697, recognized by the Catalonian Government. N.C. and C.R. received fellowships from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Badosa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085515; BLUMENTHAL C, 1990, AUST J PLANT PHYSIOL, V17, P37, DOI 10.1071/PP9900037; Breitler JC, 2004, PLANT BIOTECHNOL J, V2, P417, DOI 10.1111/j.1467-7652.2004.00086.x; Cavallarin L, 1998, MOL PLANT MICROBE IN, V11, P218, DOI 10.1094/MPMI.1998.11.3.218; Chang PFL, 2007, PLANT SCI, V172, P64, DOI 10.1016/j.plantsci.2006.07.017; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Civan P, 2009, GENOME, V52, P294, DOI 10.1139/G09-001; Company N, 2014, PLANT BIOTECHNOL J, V12, P81, DOI 10.1111/pbi.12119; Conley AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-48; CORNELISSEN BJC, 1987, NUCLEIC ACIDS RES, V15, P6799, DOI 10.1093/nar/15.17.6799; Dai ZY, 2000, TRANSGENIC RES, V9, P43, DOI 10.1023/A:1008922404834; Dubey S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-648; Efeoglu B, 2009, GAZI U J SCI, V22, P67; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ginzberg I, 2009, J EXP BOT, V60, P4411, DOI 10.1093/jxb/erp281; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Ham D-J, 2013, MOL BIOL REP, P1; Hieno A, 2013, NUCLEIC ACIDS RES, P1; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2009, FEBS J, V276, P3148, DOI 10.1111/j.1742-4658.2009.07033.x; Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021; Jung YJ, 2012, PLANT BIOTECHNOL REP, V6, P39, DOI 10.1007/s11816-011-0193-0; Kang K, 2011, PLANT J, V66, P247, DOI 10.1111/j.1365-313X.2011.04486.x; Khurana N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054418; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Li YF, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-153; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lopez-Garcia B, 2002, APPL ENVIRON MICROB, V68, P2453, DOI 10.1128/AEM.68.5.2453-2460.2002; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mittal D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040899; Monroc S, 2006, PEPTIDES, V27, P2567, DOI 10.1016/j.peptides.2006.04.019; Monroc S, 2006, PEPTIDES, V27, P2575, DOI 10.1016/j.peptides.2006.05.001; Montesinos E, 2008, CHEM BIODIVERS, V5, P1225, DOI 10.1002/cbdv.200890111; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nadal A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-159; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Ouyang YD, 2009, PLANT MOL BIOL, V70, P341, DOI 10.1007/s11103-009-9477-y; Qin DD, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-432; Qu AL, 2013, BIOCHEM BIOPH RES CO, V432, P203, DOI 10.1016/j.bbrc.2013.01.104; Rajasekaran K., 2012, SMALL WONDERS PEPTID; Ramessar Koreen, 2008, Phytochemistry Reviews, V7, P579, DOI 10.1007/s11101-008-9087-3; Rasche S., 2011, Open Biotechnology Journal, V5, P1; Rerksiri W, 2013, SCI WORLD J, DOI 10.1155/2013/397401; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Sambrook J., 2001, MOL CLONING LAB MANU; Sarkar NK, 2014, PLANT MOL BIOL, V84, P125, DOI 10.1007/s11103-013-0123-3; Sarkar NK, 2013, CELL STRESS CHAPERON, V18, P427, DOI 10.1007/s12192-012-0395-6; Sarkar NK, 2013, CELL STRESS CHAPERON, V18, P321, DOI 10.1007/s12192-012-0384-9; Sarkar NK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-393; Sharma R, 2009, FEBS J, V276, P6301, DOI 10.1111/j.1742-4658.2009.07338.x; Siddique M, 2008, CELL STRESS CHAPERON, V13, P183, DOI 10.1007/s12192-008-0032-6; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-95; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Todaka D, 2012, RICE, V5, DOI 10.1186/1939-8433-5-6; Torrent M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-5; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaquero C, 1999, P NATL ACAD SCI USA, V96, P11128, DOI 10.1073/pnas.96.20.11128; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wakasa Y, 2013, BIOTECHNOL J, V8, P1133, DOI 10.1002/biot.201300065; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Yamakawa H, 2010, PLANT CELL PHYSIOL, V51, P795, DOI 10.1093/pcp/pcq034; Yamamoto YY, 2008, NUCLEIC ACIDS RES, V36, pD977, DOI 10.1093/nar/gkm785; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1; Zhang XW, 2013, GENE, V530, P185, DOI 10.1016/j.gene.2013.08.048; Zheng LQ, 2009, PLANT PHYSIOL, V151, P262, DOI 10.1104/pp.109.141051	78	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e109990	10.1371/journal.pone.0109990	http://dx.doi.org/10.1371/journal.pone.0109990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387106	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400007
J	Lee, B; Zhou, X; Riching, K; Eliceiri, KW; Keely, PJ; Guelcher, SA; Weaver, AM; Jiang, Y				Lee, Byoungkoo; Zhou, Xin; Riching, Kristin; Eliceiri, Kevin W.; Keely, Patricia J.; Guelcher, Scott A.; Weaver, Alissa M.; Jiang, Yi			A Three-Dimensional Computational Model of Collagen Network Mechanics	PLOS ONE			English	Article							I COLLAGEN; EXTRACELLULAR-MATRIX; ELASTICITY; DYNAMICS; FIBRILS; DEFORMATION; RHEOLOGY	Extracellular matrix (ECM) strongly influences cellular behaviors, including cell proliferation, adhesion, and particularly migration. In cancer, the rigidity of the stromal collagen environment is thought to control tumor aggressiveness, and collagen alignment has been linked to tumor cell invasion. While the mechanical properties of collagen at both the single fiber scale and the bulk gel scale are quite well studied, how the fiber network responds to local stress or deformation, both structurally and mechanically, is poorly understood. This intermediate scale knowledge is important to understanding cell-ECM interactions and is the focus of this study. We have developed a three-dimensional elastic collagen fiber network model (bead-and-spring model) and studied fiber network behaviors for various biophysical conditions: collagen density, crosslinker strength, crosslinker density, and fiber orientation (random vs. prealigned). We found the best-fit crosslinker parameter values using shear simulation tests in a small strain region. Using this calibrated collagen model, we simulated both shear and tensile tests in a large linear strain region for different network geometry conditions. The results suggest that network geometry is a key determinant of the mechanical properties of the fiber network. We further demonstrated how the fiber network structure and mechanics evolves with a local formation, mimicking the effect of pulling by a pseudopod during cell migration. Our computational fiber network model is a step toward a full biomechanical model of cellular behaviors in various ECM conditions.	[Lee, Byoungkoo; Jiang, Yi] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA; [Zhou, Xin] Chinese Acad Sci, Grad Univ, Sch Phys, Beijing, Peoples R China; [Riching, Kristin; Eliceiri, Kevin W.; Keely, Patricia J.] Univ Wisconsin, Lab Cell & Mol Biol, Lab Opt & Computat Instrumentat, Madison, WI USA; [Riching, Kristin; Eliceiri, Kevin W.; Keely, Patricia J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Riching, Kristin; Keely, Patricia J.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI USA; [Guelcher, Scott A.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [Weaver, Alissa M.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	University System of Georgia; Georgia State University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; Vanderbilt University	Jiang, Y (corresponding author), Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA.	yjiang12@gsu.edu	Eliceiri, Kevin/ABD-4516-2020	Eliceiri, Kevin/0000-0001-8678-670X; Jiang, Yi/0000-0002-7519-6365	National Institutes of Health [5U01CA143069]; NATIONAL CANCER INSTITUTE [U01CA143069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (www.nih.gov), 5U01CA143069. BL, KR, KWE, SAG, PJK, AW, and YJ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004748; Arevalo RC, 2010, BIOPHYS J, V99, pL65, DOI 10.1016/j.bpj.2010.08.008; Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100; Buehler MJ, 2008, J MECH BEHAV BIOMED, V1, P59, DOI 10.1016/j.jmbbm.2007.04.001; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236; Califano JP, 2008, CELL MOL BIOENG, V1, P122, DOI 10.1007/s12195-008-0022-x; Chandran PL, 2006, J BIOMECH ENG-T ASME, V128, P259, DOI 10.1115/1.2165699; Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X; Czirok A, 2006, CURR TOP DEV BIOL, V73, P237, DOI 10.1016/S0070-2153(05)73008-8; Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022; Dunn SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080516; Gautieri A, 2011, NANO LETT, V11, P757, DOI 10.1021/nl103943u; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Graham JS, 2004, EXP CELL RES, V299, P335, DOI 10.1016/j.yexcr.2004.05.022; Head DA, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.061907; Huisman EM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.208103; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kadler Karl, 2004, Birth Defects Res C Embryo Today, V72, P1, DOI 10.1002/bdrc.20002; Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; LEVITT M, 1983, J MOL BIOL, V170, P723, DOI 10.1016/S0022-2836(83)80129-6; Lopez-Garcia MDC, 2010, BIO-MED MATER ENG, V20, P361, DOI 10.3233/BME-2010-0649; Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003; Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110; Nedelec F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/427; Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Riching KM, 2014, BIOPHYS J IN PRESS; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471; Rubinstein M, 1997, MACROMOLECULES, V30, P8036, DOI 10.1021/ma970364k; Samani A, 2007, PHYS MED BIOL, V52, P1565, DOI 10.1088/0031-9155/52/6/002; Sandersius SA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015002; SILVER FH, 1980, J BIOL CHEM, V255, P9427; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; van der Rijt JAJ, 2006, MACROMOL BIOSCI, V6, P697, DOI 10.1002/mabi.200600063; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wozniak MA, 2005, BIOL PROCED ONLINE, V7, P144, DOI 10.1251/bpo112; Yang L, 2008, BIOPHYS J, V94, P2204, DOI 10.1529/biophysj.107.111013; Yang L, 2007, J BIOMED MATER RES A, V82A, P160, DOI 10.1002/jbm.a.31127; Zahalak GI, 2000, BIOPHYS J, V79, P2369, DOI 10.1016/S0006-3495(00)76482-4	51	47	48	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111896	10.1371/journal.pone.0111896	http://dx.doi.org/10.1371/journal.pone.0111896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386649	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400030
J	Bell, AJ; Gallagher, A; Mottram, T; Lake, A; Kane, EV; Lightfoot, T; Roman, E; Jarrett, RF				Bell, Adam J.; Gallagher, Alice; Mottram, Timothy; Lake, Annette; Kane, Eleanor V.; Lightfoot, Tracy; Roman, Eve; Jarrett, Ruth F.			Germ-Line Transmitted, Chromosomally Integrated HHV-6 and Classical Hodgkin Lymphoma	PLOS ONE			English	Article							HUMAN-HERPESVIRUS 6; BLOOD MONONUCLEAR-CELLS; BARR-VIRUS EBV; NO EVIDENCE; VARIANT-A; HUMAN-HERPESVIRUS-6; INFECTIONS; DISEASE; POPULATION; GENOME	A unique feature of both human herpesvirus 6A and B (HHV-6A and B) among human herpesviruses is their ability to integrate into chromosomal telomeres. In some individuals integrated viral genomes are present in the germ-line and result in the vertical transmission of HHV-6; however, little is known about the disease associations of germ-line transmitted, chromosomally integrated HHV-6 (ciHHV-6). Recent publications suggest that HHV-6 is associated with classical Hodgkin lymphoma (cHL). Here we examine the prevalence of ciHHV-6 in 936 cases of cHL and 563 controls by screening with a duplex TaqMan assay and confirming with droplet digital PCR. ciHHV-6 was detected in 10/563 (1.8%) controls and in all but one individual the virus was HHV-6B. Amongst cases 16/936 (1.7%) harboured ciHHV-6, thus demonstrating no association between ciHHV-6 and risk of cHL.	[Bell, Adam J.; Gallagher, Alice; Mottram, Timothy; Lake, Annette; Jarrett, Ruth F.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland; [Kane, Eleanor V.; Lightfoot, Tracy; Roman, Eve] Univ York, Dept Hlth Sci, Epidemiol & Canc Stat Grp, York YO10 5DD, N Yorkshire, England	University of Glasgow; University of York - UK	Bell, AJ (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.	a.bell.3@research.gla.ac.uk	Jarrett, Ruth F/A-5570-2012	Jarrett, Ruth/0000-0003-0390-3478; Kane, Eleanor/0000-0002-7438-9982; Roman, Eve/0000-0001-7603-3704; Mottram, Timothy/0000-0001-9013-3664	Medical Research Council [G0801822]; HHV-6 Foundation; MRC [G0801822] Funding Source: UKRI; Medical Research Council [1036080] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); HHV-6 Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council grant number G0801822, and a donation from the HHV-6 Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle SW, 1996, J CLIN MICROBIOL, V34, P3223, DOI 10.1128/JCM.34.12.3223-3225.1996; Ablashi D, 2014, ARCH VIROL, V159, P863, DOI 10.1007/s00705-013-1902-5; Alexander FE, 2000, BRIT J CANCER, V82, P1117, DOI 10.1054/bjoc.1999.1049; Alexander FE, 2003, INT J CANCER, V107, P298, DOI 10.1002/ijc.11156; Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Bates M, 2009, J MED VIROL, V81, P779, DOI 10.1002/jmv.21455; Boutolleau D, 2006, J CLIN VIROL, V35, P257, DOI 10.1016/j.jcv.2005.08.002; Chang ET, 2004, CANCER EPIDEM BIOMAR, V13, P1361; Clark Duncan A, 2008, Herpes, V15, P28; Daibata M, 1999, BLOOD, V94, P1545, DOI 10.1182/blood.V94.5.1545.417a25_1545_1549; Daibata M, 2000, BLOOD, V95, P1108; DEWHURST S, 1993, J CLIN MICROBIOL, V31, P416, DOI 10.1128/JCM.31.2.416-418.1993; Gallagher A, 2003, INT J CANCER, V104, P624, DOI 10.1002/ijc.10979; Gallagher A, 2002, INT J CANCER, V101, P259, DOI 10.1002/ijc.10603; Geraudie B, 2012, J CLIN VIROL, V53, P151, DOI 10.1016/j.jcv.2011.10.017; Hall CB, 2006, J INFECT DIS, V193, P1063, DOI 10.1086/503434; Hall CB, 2004, J PEDIATR-US, V145, P472, DOI 10.1016/j.jpeds.2004.06.017; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huang Y, 2014, NUCLEIC ACIDS RES, V42, P315, DOI 10.1093/nar/gkt840; Hubacek P, 2013, FOLIA MICROBIOL, V58, P87, DOI 10.1007/s12223-012-0180-z; Leibovitch EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092328; Leong HN, 2007, J MED VIROL, V79, P45, DOI 10.1002/jmv.20760; LUPPI M, 1993, J MED VIROL, V40, P44, DOI 10.1002/jmv.1890400110; Nacheva EP, 2008, J MED VIROL, V80, P1952, DOI 10.1002/jmv.21299; Roberts CH, 2014, GENOME MED, V6, DOI 10.1186/gm537; Sedlak RH, 2014, CLIN CHEM, V60, P765, DOI 10.1373/clinchem.2013.217240; Siddon A, 2012, BRIT J HAEMATOL, V158, P635, DOI 10.1111/j.1365-2141.2012.09206.x; Strenger V, 2013, BRIT J HAEMATOL, V161, P594, DOI 10.1111/bjh.12257; Tavakoli NP, 2007, J CLIN MICROBIOL, V45, P3972, DOI 10.1128/JCM.01692-07; TORELLI G, 1995, J MED VIROL, V46, P178, DOI 10.1002/jmv.1890460303; Ward KN, 2005, J MED VIROL, V76, P563, DOI 10.1002/jmv.20399; Willett EV, 2007, EPIDEMIOLOGY, V18, P130, DOI 10.1097/01.ede.0000248899.47399.78; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	34	18	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112642	10.1371/journal.pone.0112642	http://dx.doi.org/10.1371/journal.pone.0112642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384040	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000344816700086
J	Eichmiller, JJ; Bajer, PG; Sorensen, PW				Eichmiller, Jessica J.; Bajer, Przemyslaw G.; Sorensen, Peter W.			The Relationship between the Distribution of Common Carp and Their Environmental DNA in a Small Lake	PLOS ONE			English	Article							WATER; ABUNDANCE; CAPTURE; EDNA; BIODIVERSITY; EFFICIENCY	Although environmental DNA (eDNA) has been used to infer the presence of rare aquatic species, many facets of this technique remain unresolved. In particular, the relationship between eDNA and fish distribution is not known. We examined the relationship between the distribution of fish and their eDNA (detection rate and concentration) in a lake. A quantitative PCR (qPCR) assay for a region within the cytochrome b gene of the common carp (Cyprinus carpio or 'carp'), an ubiquitous invasive fish, was developed and used to measure eDNA in Lake Staring (MN, USA), in which both the density of carp and their distribution have been closely monitored for several years. Surface water, sub-surface water, and sediment were sampled from 22 locations in the lake, including areas frequently used by carp. In water, areas of high carp use had a higher rate of detection and concentration of eDNA, but there was no effect of fish use on sediment eDNA. The detection rate and concentration of eDNA in surface and sub-surface water were not significantly different (p >= 0.5), indicating that eDNA did not accumulate in surface water. The detection rate followed the trend: high-use water > low-use water > sediment. The concentration of eDNA in sediment samples that were above the limit of detection were several orders of magnitude greater than water on a per mass basis, but a poor limit of detection led to low detection rates. The patchy distribution of eDNA in the water of our study lake suggests that the mechanisms that remove eDNA from the water column, such as decay and sedimentation, are rapid. Taken together, these results indicate that effective eDNA sampling methods should be informed by fish distribution, as eDNA concentration was shown to vary dramatically between samples taken less than 100 m apart.	[Eichmiller, Jessica J.; Bajer, Przemyslaw G.; Sorensen, Peter W.] Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Eichmiller, JJ (corresponding author), Univ Minnesota, Minnesota Aquat Invas Species Res Ctr, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	eich0146@umn.edu		Sorensen, Peter/0000-0003-0321-1279	Minnesota Environment and Natural Resources Trust Fund	Minnesota Environment and Natural Resources Trust Fund	Funding for this project was provided by the Minnesota Environment and Natural Resources Trust Fund as recommended by the Legislative-Citizen Commission on Minnesota Resources (LCCMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberg J. J., 2013, 20131080 US GEOL SUR; Bajer PG, 2011, FISHERIES MANAG ECOL, V18, P497, DOI 10.1111/j.1365-2400.2011.00805.x; Bajer PG, 2012, N AM J FISH MANAGE, V32, P817, DOI 10.1080/02755947.2012.690822; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bayley PB, 2002, T AM FISH SOC, V131, P435, DOI 10.1577/1548-8659(2002)131<0435:CEOABE>2.0.CO;2; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; CROSS DG, 1975, J FISH BIOL, V7, P349, DOI 10.1111/j.1095-8649.1975.tb04609.x; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Domanico MJ, 1997, CAN J FISH AQUAT SCI, V54, P1865, DOI 10.1139/cjfas-54-8-1865; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Goldberg CS, 2013, FRESHW SCI, V32, P792, DOI 10.1899/13-046.1; Haugland RA, 2005, WATER RES, V39, P559, DOI 10.1016/j.watres.2004.11.011; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Lodge DM, 2012, MOL ECOL, V21, P2555, DOI 10.1111/j.1365-294X.2012.05600.x; Mahon AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058316; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; MESA MG, 1989, T AM FISH SOC, V118, P644, DOI 10.1577/1548-8659(1989)118<0644:EMADME>2.3.CO;2; Moyer GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103767; Mumy KL, 2004, J MICROBIOL METH, V57, P259, DOI 10.1016/j.mimet.2004.01.013; Olson ZH, 2012, WILDLIFE RES, V39, P629, DOI 10.1071/WR12114; Pietramellara G, 2009, BIOL FERT SOILS, V45, P219, DOI 10.1007/s00374-008-0345-8; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Simon M, 2002, AQUAT MICROB ECOL, V28, P175, DOI 10.3354/ame028175; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tikel D, 1996, MOL ECOL, V5, P456, DOI 10.1111/j.1365-294X.1996.tb00337.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; U.S. Fish and Wildlife Service, 2013, QUAL ASS PROJ PLAN Q	35	110	119	10	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112611	10.1371/journal.pone.0112611	http://dx.doi.org/10.1371/journal.pone.0112611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383965	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700084
J	Fink, DM; Connor, AL; Kelley, PM; Steele, MM; Hollingsworth, MA; Tempero, RM				Fink, Darci M.; Connor, Alicia L.; Kelley, Philip M.; Steele, Maria M.; Hollingsworth, Michael A.; Tempero, Richard M.			Nerve Growth Factor Regulates Neurolymphatic Remodeling during Corneal Inflammation and Resolution	PLOS ONE			English	Article							ARTERIAL DIFFERENTIATION; NEUROTROPHIC FACTORS; LYMPHATIC VESSELS; SIGNALING PATHWAY; TOPICAL TREATMENT; VEGF; EXPRESSION; NGF; INNERVATION; LYMPHANGIOGENESIS	The cellular and physiologic mechanisms that regulate the resolution of inflammation remain poorly defined despite their widespread importance in improving inflammatory disease outcomes. We studied the resolution of two cardinal signs of inflammation-pain and swelling-by investigating molecular mechanisms that regulate neural and lymphatic vessel remodeling during the resolution of corneal inflammation. A mouse model of corneal inflammation and wound recovery was developed to study this process in vivo. Administration of nerve growth factor (NGF) increased pain sensation and inhibited neural remodeling and lymphatic vessel regression processes during wound recovery. A complementary in vivo approach, the corneal micropocket assay, revealed that NGF-laden pellets stimulated lymphangiogenesis and increased protein levels of VEGF-C. Adult human dermal lymphatic endothelial cells did not express canonical NGF receptors TrkA and p75(NTR) or activate downstream MAPK-or Akt-pathway effectors in the presence of NGF, although NGF treatment increased their migratory and tubulogenesis capacities in vitro. Blockade of the VEGF-R2/R3 signaling pathway ablated NGF-mediated lymphangiogenesis in vivo. These findings suggest a hierarchical relationship with NGF functioning upstream of the VEGF family members, particularly VEGF-C, to stimulate lymphangiogenesis. Taken together, these studies show that NGF stimulates lymphangiogenesis and that NGF may act as a pathogenic factor that negatively regulates the normal neural and lymphatic vascular remodeling events that accompany wound recovery.	[Fink, Darci M.; Steele, Maria M.; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Connor, Alicia L.; Kelley, Philip M.; Tempero, Richard M.] Boys Town Natl Res Hosp, Dept Genet, Omaha, NE 68131 USA; [Tempero, Richard M.] Boys Town Natl Res Hosp, Dept Otolaryngol, Omaha, NE 68131 USA	University of Nebraska System; University of Nebraska Medical Center; Boys Town National Research Hospital; Boys Town National Research Hospital	Tempero, RM (corresponding author), Boys Town Natl Res Hosp, Dept Genet, 555 North 30th St, Omaha, NE 68131 USA.	richard.tempero@boystown.org		Steele, Maria/0000-0003-0186-2633; Fink, Darci/0000-0002-7587-3063	National Institutes of Health; National Eye Institute [R01-EY021571]; National Institute of General Medical Sciences [5 P20 RR018788-08]; University of Nebraska Medical Center Office of Graduate Studies; NATIONAL CANCER INSTITUTE [P30CA036727, P50CA127297, U54CA163120, T32CA009476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY021571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103471, P30GM110768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Nebraska Medical Center Office of Graduate Studies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the following: National Institutes of Health (www. nih. gov), National Eye Institute, R01-EY021571 (RT) and National Institutes of Health, National Institute of General Medical Sciences, 5 P20 RR018788-08 (RT). Fellowship support was provided by the University of Nebraska Medical Center Office of Graduate Studies (www. unmc. edu/gradstudies) (DF, MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001875; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Blanco-Mezquita T, 2013, INVEST OPHTH VIS SCI, V54, P3880, DOI 10.1167/iovs.12-10816; Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; Bock F, 2009, INVEST OPHTH VIS SCI, V50, P2095, DOI 10.1167/iovs.07-1129; Bonini S, 2000, OPHTHALMOLOGY, V107, P1347, DOI 10.1016/S0161-6420(00)00163-9; Bouvree K, 2012, CIRC RES, V111, P437, DOI 10.1161/CIRCRESAHA.112.269316; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Calza L, 2001, P NATL ACAD SCI USA, V98, P4160, DOI 10.1073/pnas.051626998; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Cellini M, 2006, OPHTHALMIC RES, V38, P177, DOI 10.1159/000092626; Chauvet S, 2013, CELL MOL LIFE SCI, V70, P1685, DOI 10.1007/s00018-013-1278-4; de Castro F, 1998, EUR J NEUROSCI, V10, P146, DOI 10.1046/j.1460-9568.1998.00037.x; Donaghy M, 2003, PRACTICAL NEUROLOGY, V3, P40, DOI DOI 10.1046/J.1474-7766.2003.00121.X; Entschladen F, 2008, SEMIN CANCER BIOL, V18, P171, DOI 10.1016/j.semcancer.2007.12.004; Entschladen F, 2006, MED HYPOTHESES, V67, P33, DOI 10.1016/j.mehy.2006.01.015; Esquenazi S, 2005, INVEST OPHTH VIS SCI, V46, P3121, DOI 10.1167/iovs.05-0241; Ferrari G, 2013, INVEST OPHTH VIS SCI, V54, P813, DOI 10.1167/iovs.11-8379; Gelfand MV, 2009, TRENDS CELL BIOL, V19, P99, DOI 10.1016/j.tcb.2009.01.001; Jee D, 2012, CURR EYE RES, V37, P408, DOI 10.3109/02713683.2011.632108; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Joo MJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P1338, DOI 10.1001/archopht.122.9.1338; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kelley PM, 2013, AM J PATHOL, V182, P2418, DOI 10.1016/j.ajpath.2013.02.025; Kelley PM, 2011, LAB INVEST, V91, P1643, DOI 10.1038/labinvest.2011.121; Kim EC, 2010, INVEST OPHTH VIS SCI, V51, P4569, DOI 10.1167/iovs.09-4937; Lambiase A, 2000, ARCH OPHTHALMOL-CHIC, V118, P1446; Lambiase A, 1998, INVEST OPHTH VIS SCI, V39, P1272; Lambiase A, 2011, ARCH ITAL BIOL, V149, P283, DOI 10.4449/aib.v149i2.1363; Lambiase A, 2003, ARCH ITAL BIOL, V141, P141; Lambiase A, 1998, NEW ENGL J MED, V338, P1174, DOI 10.1056/NEJM199804233381702; Lambiase A, 2000, INVEST OPHTH VIS SCI, V41, P1063; Lambiase A, 2012, INVEST OPHTH VIS SCI, V53, P8280, DOI 10.1167/iovs.12-10593; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Li WL, 2013, DEV CELL, V24, P359, DOI 10.1016/j.devcel.2013.01.009; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Marfurt CF, 1998, EXP EYE RES, V66, P437, DOI 10.1006/exer.1997.0445; MARFURT CF, 1989, INVEST OPHTH VIS SCI, V30, P461; Mauro Cellini, 2007, J Med Case Rep, V1, P124, DOI 10.1186/1752-1947-1-124; McKenna CC, 2011, INVEST OPHTH VIS SCI, V52, P30, DOI 10.1167/iovs.10-5902; Melani M, 2010, ANNU REV CELL DEV BI, V26, P639, DOI 10.1146/annurev.cellbio.093008.093324; Mukouyama Y, 2002, CELL, V109, P693, DOI 10.1016/S0092-8674(02)00757-2; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Nakamura K, 2011, MOL CELL NEUROSCI, V46, P498, DOI 10.1016/j.mcn.2010.12.002; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; Quaegebeur A, 2011, NEURON, V71, P406, DOI 10.1016/j.neuron.2011.07.013; Rossi S, 2012, ARCH ITAL BIOL, V150, P15, DOI 10.4449/aib.v150i1.1382; Samii A, 1999, NEUROSCI LETT, V262, P159, DOI 10.1016/S0304-3940(99)00064-6; Saygili E, 2011, BIOCHEM BIOPH RES CO, V410, P62, DOI 10.1016/j.bbrc.2011.05.105; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seo K, 2001, J Vet Sci, V2, P125; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Sornelli F, 2010, MOL VIS, V16, P1439; Sweat RS, 2014, MICROCIRCULATION; Tan MH, 2006, CORNEA, V25, P352, DOI 10.1097/01.ico.0000176609.42838.df; Woo HM, 2005, EXP EYE RES, V80, P633, DOI 10.1016/j.exer.2004.11.013; You LT, 2000, INVEST OPHTH VIS SCI, V41, P692; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; ZANDER E, 1951, J ANAT, V85, P68	62	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112737	10.1371/journal.pone.0112737	http://dx.doi.org/10.1371/journal.pone.0112737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383879	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700091
J	Maniscalco, JM; Springer, AM; Parker, P; Adkison, MD				Maniscalco, John M.; Springer, Alan M.; Parker, Pamela; Adkison, Milo D.			A Longitudinal Study of Steller Sea Lion Natality Rates in the Gulf of Alaska with Comparisons to Census Data	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; EUMETOPIAS-JUBATUS; ROBUST DESIGN; REPRODUCTIVE-PERFORMANCE; ATTENDANCE PATTERNS; MODEL SELECTION; AGE STRUCTURE; POPULATIONS; HYPOTHESIS; PARAMETERS	Steller sea lion (Eumetopias jubatus) numbers in the Western Distinct Population Segment are beginning to recover following the dramatic decline that began in the 1970s and ended around the turn of the century. Low female reproductive rates (natality) may have contributed to the decline and remain an issue of concern for this population. During the 2000s we found high natality among Steller sea lions in the Gulf of Alaska indicating a healthy population. This study extends these previous estimates over an additional three years and tests for interannual variations and long-term trends. We further examine the proportions of pups to adult females observed on the rookery and nearby haulouts during the birthing season to assess whether census data can be used to estimate natality. Open robust design multistate models were built and tested using Program MARK to estimate survival, resighting, and state transition probabilities in addition to other parameters dependent on whether or not a female gave birth in the previous year. Natality was estimated at 70% with some evidence of interannual variation but a long-term increasing or decreasing trend was not supported by the data. Bootstrap and regression comparisons of census data with natality estimates revealed no correlation between the two methods suggesting that census data are not an appropriate proxy for natality in this species. Longitudinal studies of individual animals are an appropriate method for estimating vital rates in species with variable detection over time such as the Steller sea lion. This work indicates that natality remains high in this region and is consistent with a population in recovery.	[Maniscalco, John M.; Parker, Pamela] Alaska SeaLife Ctr, Dept Sci, Seward, AK 99664 USA; [Maniscalco, John M.; Springer, Alan M.; Adkison, Milo D.] Univ Alaska Fairbanks, Inst Marine Sci, Fairbanks, AK USA	University of Alaska System; University of Alaska Fairbanks	Maniscalco, JM (corresponding author), Alaska SeaLife Ctr, Dept Sci, Seward, AK 99664 USA.	johnm@alaskasealife.org			U.S. federal grant through the National Marine Fisheries Service - NOAA Award [NA09NMF4390169]	U.S. federal grant through the National Marine Fisheries Service - NOAA Award	This study was funded by U.S. federal grant appropriations through the National Marine Fisheries Service - NOAA Award NA09NMF4390169 (https://grantsonline.rdc.noaa.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1971, P 2 INT S INF THEOR, P267, DOI DOI 10.2307/2334537; BELL G, 1980, AM NAT, V116, P45, DOI 10.1086/283611; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Calkins Donald G., 1994, P119; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Dabin W, 2004, CAN J ZOOL, V82, P1043, DOI 10.1139/Z04-079; DEMASTER D, 2002, AKSG0202 U AL SEA GR; DOIDGE DW, 1984, J ZOOL, V202, P449, DOI 10.1111/j.1469-7998.1984.tb05095.x; EBERHARDT LL, 1985, J WILDLIFE MANAGE, V49, P997, DOI 10.2307/3801386; Eberhardt LL, 2005, MAR MAMMAL SCI, V21, P728, DOI 10.1111/j.1748-7692.2005.tb01262.x; Fritz L, 2013, NMFSAFSC251 NOAA US; Fritz L, 2005, NMFSAFSC183 NOAA US; Gerber LR, 2001, MAMMAL REV, V31, P131, DOI 10.1046/j.1365-2907.2001.00081.x; Gibbens J, 2010, J MAMMAL, V91, P510, DOI 10.1644/08-MAMM-A-377.1; GILMARTIN W G, 1976, Journal of Wildlife Diseases, V12, P104; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Hastings KK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00215.1; Holmes EE, 2007, ECOL APPL, V17, P2214, DOI 10.1890/07-0508.1; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jemison LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070167; Kaplan CC, 2008, MAR MAMMAL SCI, V24, P443, DOI 10.1111/j.1748-7692.2008.00203.x; KASTELEIN R A, 1991, Aquatic Mammals, V17, P91; Kendall WL, 2012, ECOLOGY, V93, P913, DOI 10.1890/11-1538.1; Kendall WL, 2002, ECOLOGY, V83, P3276; Kendall WL, 1997, ECOLOGY, V78, P563; Kendall WL, 2003, ECOLOGY, V84, P1058, DOI 10.1890/0012-9658(2003)084[1058:AMCMFM]2.0.CO;2; Kucey L, 2005, THESIS U BRIT COLUMB; Loughlin TR., 1998, BIOSPH CONSER NAT WI, V1, P91, DOI [10.20798/biospherecons.1.2_91, DOI 10.20798/BIOSPHERECONS.1.2_91]; LUNN NJ, 1994, J ANIM ECOL, V63, P827, DOI 10.2307/5260; Maniscalco JM, 2006, J MAMMAL, V87, P304, DOI 10.1644/05-MAMM-A-163R2.1; Maniscalco JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096328; Maniscalco JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010076; Maniscalco JM, 2009, MAR MAMMAL SCI, V25, P206, DOI 10.1111/j.1748-7692.2008.00247.x; Maniscalco John M., 2008, Aquatic Mammals, V34, P277, DOI 10.1578/AM.34.3.2008.277; Maschner HDG, 2014, FISH FISH, V15, P634, DOI 10.1111/faf.12038; McKenzie J, 2005, J MAMMAL, V86, P1237, DOI 10.1644/05-MAMM-A-085R.1; Melin SR, 2012, MAR MAMMAL SCI, V28, P751, DOI 10.1111/j.1748-7692.2011.00538.x; Milette LL, 2003, CAN J ZOOL, V81, P340, DOI 10.1139/Z03-008; National Research Council, 2003, DECL STELL SEA LION; Pitcher KW, 2007, FISH B-NOAA, V105, P102; PITCHER KW, 1981, J MAMMAL, V62, P599, DOI 10.2307/1380406; Pitcher KW, 1998, CAN J ZOOL, V76, P2075, DOI 10.1139/cjz-76-11-2075; Pitcher KW, 2001, J MAMMAL, V82, P1047, DOI 10.1644/1545-1542(2001)082<1047:SATVIT>2.0.CO;2; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; Taylor RL, 2012, ECOL MODEL, V243, P73, DOI 10.1016/j.ecolmodel.2012.06.013; TESTA JW, 1987, CAN J ZOOL, V65, P1091, DOI 10.1139/z87-173; Trites Andrew W., 2006, Aquatic Mammals, V32, P85, DOI 10.1578/AM.32.1.2006.85; Trites AW, 2003, MAMMAL REV, V33, P3, DOI 10.1046/j.1365-2907.2003.00009.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WITHROW DE, 1982, THESIS U WASHINGTON; Wolf N, 2008, ECOL APPL, V18, P1932, DOI 10.1890/07-1254.1; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x	55	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111523	10.1371/journal.pone.0111523	http://dx.doi.org/10.1371/journal.pone.0111523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383865	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700019
J	Liang, HW; Liu, MH; Yan, X; Zhou, Y; Wang, WG; Wang, XL; Fu, Z; Wang, N; Zhang, SY; Wang, YB; Zen, K; Zhang, CY; Hou, DX; Li, J; Chen, X				Liang, Hongwei; Liu, Minghui; Yan, Xin; Zhou, Yong; Wang, Wengong; Wang, Xueliang; Fu, Zheng; Wang, Nan; Zhang, Suyang; Wang, Yanbo; Zen, Ke; Zhang, Chen-Yu; Hou, Dongxia; Li, Jing; Chen, Xi			miR-193a-3p Functions as a Tumor Suppressor in Lung Cancer by Down-regulating ERBB4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; SIGNALING NETWORK; DNA METHYLATION; EXPRESSION; MICRORNAS; PROLIFERATION; APOPTOSIS; TARGET; CELLS; MIR-9-3	ERBB4, one of four ErbB receptor tyrosine kinase family members, plays an important role in the etiology and progression of lung cancer. In this study, we found that the ERBB4 protein levels were consistently up-regulated in lung cancer tissues, whereas the mRNA levels varied randomly, suggesting that a post-transcriptional mechanism was involved in regulating ERBB4 expression. Because microRNAs are powerful post-transcriptional regulators of gene expression, we used bioinformatic analyses to search for microRNAs that can potentially target ERBB4. Weidentified specific targeting sites for miR-193a-3p in the 3'-UTR of ERBB4. We further identified an inverse correlation between miR-193a-3p levels and ERBB4 protein levels, but not mRNA levels, in lung cancer tissue samples. By overexpressing or knocking down miR-193a-3p in lung cancer cells, we experimentally confirmed that miR-193a-3p directly recognizes the 3'-UTR of the ERBB4 transcript and regulates ERBB4 expression. Furthermore, the biological consequences of the targeting of ERBB4 by miR-193a-3p were examined in vitro via cell proliferation, invasion, and apoptosis assays and in vivo using a mouse xenograft tumor model. We demonstrated that the repression of ERBB4 by miR-193a-3p suppressed proliferation and invasion and promoted apoptosis in lung cancer cells and that miR-193a-3p exerted an anti-tumor effect by negatively regulating ERBB4 in xenograft mice. Taken together, our findings provide the first clues regarding the role of miR-193a-3p as a tumor suppressor in lung cancer through the inhibition of ERBB4 translation.	[Liang, Hongwei; Liu, Minghui; Wang, Xueliang; Fu, Zheng; Wang, Nan; Zhang, Suyang; Wang, Yanbo; Zen, Ke; Zhang, Chen-Yu; Hou, Dongxia; Li, Jing; Chen, Xi] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Sch Med, Ctr Comprehens Canc, Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Xin] Nanjing Univ, Clin Canc Inst, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yong; Wang, Wengong] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Thorac & Cardiovasc Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Hou, DX (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	dxhou128@nju.edu.cn; jingli220@nju.edu.cn; xichen@nju.edu.cn			National Basic Research Program of China (973 Program) [2014CB542300]; National Natural Science Foundation of China [81101330, 31271378, 81250044]; Natural Science Foundation of Jiangsu Province [BK2012014]; Research Special Fund for Public Welfare Industry of Health [201302018]; program for New Century Excellent Talents in University from the Ministry of Education, China [NCET-12-0261]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Research Special Fund for Public Welfare Industry of Health; program for New Century Excellent Talents in University from the Ministry of Education, China	This work was supported by National Basic Research Program of China (973 Program) Grant 2014CB542300; National Natural Science Foundation of China Grants 81101330, 31271378, and 81250044; Natural Science Foundation of Jiangsu Province Grant BK2012014; and Research Special Fund for Public Welfare Industry of Health Grant 201302018. This work was also supported by the program for New Century Excellent Talents in University from the Ministry of Education, China, Grant NCET-12-0261.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aurisicchio L, 2012, J CELL PHYSIOL, V227, P3381, DOI 10.1002/jcp.24037; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen Dan, 2013, J Oral Maxillofac Res, V4, pe2, DOI 10.5037/jomr.2013.4102; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Du LQ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-75; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Furger C, 1998, CANCER RES, V58, P1773; Gao XN, 2011, ONCOGENE, V30, P3416, DOI 10.1038/onc.2011.62; Gilbertson R, 2001, GENE CHROMOSOME CANC, V31, P288, DOI 10.1002/gcc.1146; Gilbertson RJ, 1998, CANCER RES, V58, P3932; Gilbertson RJ, 1997, CANCER RES, V57, P3272; Gilbertson RJ, 2002, CLIN CANCER RES, V8, P3054; Gilmour LMR, 2001, CANCER RES, V61, P2169; Graber HU, 1999, INT J CANCER, V84, P24, DOI 10.1002/(SICI)1097-0215(19990219)84:1<24::AID-IJC5>3.0.CO;2-2; Guz M, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/218169; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harpole DH, 1995, CLIN CANCER RES, V1, P659; Haugen DRF, 1996, CANCER RES, V56, P1184; HE L, 2004, NAT REV GENET, V5, P522; Heist RS, 2012, CANCER CELL, V21; Heller G, 2012, CLIN CANCER RES, V18, P1619, DOI 10.1158/1078-0432.CCR-11-2450; Iliopoulos D, 2011, CANCER RES, V71, P5144, DOI 10.1158/0008-5472.CAN-11-0425; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kang SM, 2014, EXP BIOL MED, V239, P1505, DOI 10.1177/1535370214533887; Klapper LN, 2000, ADV CANCER RES, V77, P25; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kwon JE, 2013, APOPTOSIS, V18, P896, DOI 10.1007/s10495-013-0841-7; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li B, 2014, AM J CANCER RES, V4, P161; Lyne JC, 1997, CANCER J SCI AM, V3, P21; Ma KL, 2012, J BIOL CHEM, V287, P5639, DOI 10.1074/jbc.M111.291229; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; Merimsky O, 2002, EUR J CANCER, V38, P1335, DOI 10.1016/S0959-8049(02)00075-8; Merimsky O, 2001, ANN ONCOL, V12, P1127, DOI 10.1023/A:1011665216616; Nakano H, 2013, INT J ONCOL, V42, P1875, DOI 10.3892/ijo.2013.1896; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Noh Hyangsoon, 2011, Genes Cancer, V2, P140, DOI 10.1177/1947601911408888; Paatero Ilkka, 2008, Recent Pat DNA Gene Seq, V2, P27; Ramalingam SS, 2011, CA-CANCER J CLIN, V61, P91, DOI 10.3322/caac.20102; Salvi A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-162; Schneider PM, 2000, BRIT J CANCER, V83, P473, DOI 10.1054/bjoc.2000.1287; Srinivasan R, 1999, CLIN CANCER RES, V5, P2877; Starr A, 2006, INT J CANCER, V119, P269, DOI 10.1002/ijc.21818; Tahiri A, 2014, CARCINOGENESIS, V35, P76, DOI 10.1093/carcin/bgt333; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Walter BA, 2013, J CANCER, V4, P350, DOI 10.7150/jca.6394; Wang JL, 2013, CELL PHYSIOL BIOCHEM, V32, P1707, DOI 10.1159/000356605; Wang XC, 2010, AM J MED SCI, V340, P385, DOI 10.1097/MAJ.0b013e3181e892a0; Watson JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053417; Yong FL, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-280; Yu T., 2014, ONCOGENE IN PRESS; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	56	78	82	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					926	940		10.1074/jbc.M114.621409	http://dx.doi.org/10.1074/jbc.M114.621409			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25391651	Green Published, hybrid			2022-12-26	WOS:000347778200027
J	Bancroft, T; Bouaouina, M; Roberts, S; Lee, M; Calderwood, DA; Schwartz, M; Simons, M; Sessa, WC; Kyriakides, TR				Bancroft, Tara; Bouaouina, Mohamed; Roberts, Sophia; Lee, Monica; Calderwood, David A.; Schwartz, Martin; Simons, Michael; Sessa, William C.; Kyriakides, Themis R.			Up-regulation of Thrombospondin-2 in Akt1-null Mice Contributes to Compromised Tissue Repair Due to Abnormalities in Fibroblast Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Angiogenesis; Fibroblast; Thrombospondin; Wound Healing; TSP	NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; IN-VIVO; ANGIOGENESIS INHIBITOR; VASCULAR MATURATION; BLOOD-FLOW; ACTIVATION; EXPRESSION; AKT1; MIGRATION	Background: TSP2 and Akt1 exert opposite effects on tissue repair. Results: Akt1 KO mice display defects in fibroblast morphology and adhesion due to diminished Rac activation, which is a result of increased TSP2 expression. Loss of TSP2 rescues these defects. Conclusion: TSP2 contributes to compromised tissue repair in Akt1 KO mice. Significance: These data support a novel, NO-independent TSP2 regulatory mechanism in fibroblasts. Vascular remodeling is essential for tissue repair and is regulated by multiple factors, including thrombospondin-2 (TSP2) and hypoxia/VEGF-induced activation of Akt. In contrast to TSP2 knock-out (KO) mice, Akt1 KO mice have elevated TSP2 expression and delayed tissue repair. To investigate the contribution of increased TSP2 to Akt1 KO mice phenotypes, we generated Akt1/TSP2 double KO (DKO) mice. Full-thickness excisional wounds in DKO mice healed at an accelerated rate when compared with Akt1 KO mice. Isolated dermal Akt1 KO fibroblasts expressed increased TSP2 and displayed altered morphology and defects in migration and adhesion. These defects were rescued in DKO fibroblasts or after TSP2 knockdown. Conversely, the addition of exogenous TSP2 to WT cells induced cell morphology and migration rates that were similar to those of Akt1 KO cells. Akt1 KO fibroblasts displayed reduced adhesion to fibronectin with manganese stimulation when compared with WT and DKO cells, revealing an Akt1-dependent role for TSP2 in regulating integrin-mediated adhesions; however, this effect was not due to changes in 1 integrin surface expression or activation. Consistent with these results, Akt1 KO fibroblasts displayed reduced Rac1 activation that was dependent upon expression of TSP2 and could be rescued by a constitutively active Rac mutant. Our observations show that repression of TSP2 expression is a critical aspect of Akt1 function in tissue repair.	[Bancroft, Tara; Kyriakides, Themis R.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Bouaouina, Mohamed; Calderwood, David A.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Lee, Monica; Calderwood, David A.; Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Schwartz, Martin] Yale Univ, Sch Med, Dept Cardiol, New Haven, CT 06520 USA; [Kyriakides, Themis R.] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT 06520 USA; [Bancroft, Tara; Roberts, Sophia; Lee, Monica; Calderwood, David A.; Schwartz, Martin; Simons, Michael; Sessa, William C.; Kyriakides, Themis R.] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Kyriakides, TR (corresponding author), Vasc Biol & Therapeut Program, 10 Amistad St, New Haven, CT 06520 USA.	themis.kyriakides@yale.edu	Sessa, William C/B-6844-2011; Simons, Michael/G-8553-2014; Calderwood, David A/AAC-6954-2019	Sessa, William C/0000-0001-5759-1938; Simons, Michael/0000-0003-0348-7734; Calderwood, David A/0000-0002-0791-4142; Roberts, Sophia/0000-0003-1062-9913	National Institutes of Health [HL 107205]; American Cancer Society [RSG-12-053-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107205, R01HL075092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 107205 (to T. R. K., W. C. S., M. S., and M. A. S.). This work was also supported by American Cancer Society Grant RSG-12-053-01 (to D. A. C.).	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Agah A, 2005, AM J PATHOL, V167, P81, DOI 10.1016/S0002-9440(10)62955-0; Agah A, 2004, MATRIX BIOL, V22, P539, DOI 10.1016/j.matbio.2003.09.004; Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Bialkowska K, 2003, J BIOL CHEM, V278, P33342, DOI 10.1074/jbc.M301217200; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; BORNSTEIN P, 1992, FASEB J, V6, P3290, DOI 10.1096/fasebj.6.14.1426766; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Bornstein P, 2009, J CELL COMMUN SIGNAL, V3, P189, DOI 10.1007/s12079-009-0060-8; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chittenden TW, 2006, DEV CELL, V10, P783, DOI 10.1016/j.devcel.2006.03.012; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Diez H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032715; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hynes RO, 2004, MATRIX BIOL, V23, P333, DOI 10.1016/j.matbio.2004.08.001; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Kimura K, 2006, INVEST OPHTH VIS SCI, V47, P4323, DOI 10.1167/iovs.05-1508; Krady MM, 2008, AM J PATHOL, V173, P879, DOI 10.2353/ajpath.2008.080128; Kyriakides TR, 1999, J INVEST DERMATOL, V113, P782, DOI 10.1046/j.1523-1747.1999.00755.x; Kyriakides TR, 1998, J CELL BIOL, V140, P419, DOI 10.1083/jcb.140.2.419; Kyriakides TR, 2001, AM J PATHOL, V159, P1255, DOI 10.1016/S0002-9440(10)62512-6; Kyriakides TR, 1998, J HISTOCHEM CYTOCHEM, V46, P1007, DOI 10.1177/002215549804600904; Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449; Lanahan AA, 2006, PHYSIOL GENOMICS, V27, P380, DOI 10.1152/physiolgenomics.00145.2006; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; Linnerth-Petrik NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094595; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Liu SX, 2010, J CELL SCI, V123, P3674, DOI 10.1242/jcs.070672; MacLauchlan S, 2011, P NATL ACAD SCI USA, V108, pE1137, DOI 10.1073/pnas.1104357108; MacLauchlan S, 2009, J HISTOCHEM CYTOCHEM, V57, P301, DOI 10.1369/jhc.2008.952689; Marnmoto A, 2008, CURR OPIN HEMATOL, V15, P228, DOI 10.1097/MOH.0b013e3282fa7445; Oganesian A, 2008, MOL BIOL CELL, V19, P563, DOI 10.1091/mbc.E07-07-0649; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Ridley AJ, 2004, CELL, V116, P357, DOI 10.1016/S0092-8674(04)00123-0; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Schaffer MR, 1996, J SURG RES, V63, P237, DOI 10.1006/jsre.1996.0254; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Sessa WC, 2009, J THROMB HAEMOST, V7, P35, DOI 10.1111/j.1538-7836.2009.03424.x; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Skaletz-Rorowski Adriane, 2004, Semin Vasc Med, V4, P395, DOI 10.1055/s-2004-869596; Somanath PR, 2008, ANGIOGENESIS, V11, P277, DOI 10.1007/s10456-008-9111-7; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Somanath PR, 2009, J CELL PHYSIOL, V218, P394, DOI 10.1002/jcp.21612; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200; WERNERFELMAYER G, 1990, J EXP MED, V172, P1599, DOI 10.1084/jem.172.6.1599; Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024; Yu J, 2005, P NATL ACAD SCI USA, V102, P10999, DOI 10.1073/pnas.0501444102; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200	71	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					409	422		10.1074/jbc.M114.618421	http://dx.doi.org/10.1074/jbc.M114.618421			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389299	Green Published, hybrid			2022-12-26	WOS:000347231200036
J	Bello, B; Zhang, XY; Liu, CL; Yang, ZE; Yang, ZR; Wang, QH; Zhao, G; Li, FG				Bello, Babatunde; Zhang, Xueyan; Liu, Chuanliang; Yang, Zhaoen; Yang, Zuoren; Wang, Qianhua; Zhao, Ge; Li, Fuguang			Cloning of Gossypium hirsutum Sucrose Non-Fermenting 1-Related Protein Kinase 2 Gene (GhSnRK2) and Its Overexpression in Transgenic Arabidopsis Escalates Drought and Low Temperature Tolerance	PLOS ONE			English	Article							ABSCISIC-ACID; SIGNAL-TRANSDUCTION; SALT TOLERANCE; CROSS-TALK; STRESS; PROLINE; VIRUS; WHEAT; DEHYDRATION; ACTIVATION	The molecular mechanisms of stress tolerance and the use of modern genetics approaches for the improvement of drought stress tolerance have been major focuses of plant molecular biologists. In the present study, we cloned the Gossypium hirsutum sucrose non-fermenting 1-related protein kinase 2 (GhSnRK2) gene and investigated its functions in transgenic Arabidopsis. We further elucidated the function of this gene in transgenic cotton using virus-induced gene silencing (VIGS) techniques. We hypothesized that GhSnRK2 participates in the stress signaling pathway and elucidated its role in enhancing stress tolerance in plants via various stress-related pathways and stress-responsive genes. We determined that the subcellular localization of the GhSnRK2-green fluorescent protein (GFP) was localized in the nuclei and cytoplasm. In contrast to wild-type plants, transgenic plants overexpressing GhSnRK2 exhibited increased tolerance to drought, cold, abscisic acid and salt stresses, suggesting that GhSnRK2 acts as a positive regulator in response to cold and drought stresses. Plants overexpressing GhSnRK2 displayed evidence of reduced water loss, turgor regulation, elevated relative water content, biomass, and proline accumulation. qRT-PCR analysis of GhSnRK2 expression suggested that this gene may function in diverse tissues. Under normal and stress conditions, the expression levels of stress-inducible genes, such as AtRD29A, AtRD29B, AtP5CS1, AtABI3, AtCBF1, and AtABI5, were increased in the GhSnRK2-overexpressing plants compared to the wildtype plants. GhSnRK2 gene silencing alleviated drought tolerance in cotton plants, indicating that VIGS technique can certainly be used as an effective means to examine gene function by knocking down the expression of distinctly expressed genes. The results of this study suggested that the GhSnRK2 gene, when incorporated into Arabidopsis, functions in positive responses to drought stress and in low temperature tolerance.	[Bello, Babatunde; Zhang, Xueyan; Liu, Chuanliang; Yang, Zhaoen; Yang, Zuoren; Wang, Qianhua; Zhao, Ge; Li, Fuguang] Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, FG (corresponding author), Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Beijing 100193, Peoples R China.	aylifug@163.com	Yang, Zuoren/AAF-5040-2020	Yang, Zuoren/0000-0001-5898-6309	Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China [U1303282]	Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Program of Joint Funds (Sinkiang) of the National Natural Science Foundation of China (Grant No. U1303282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Chinnusamy V, 2005, CROP SCI, V45, P437, DOI 10.2135/cropsci2005.0437; Cho K, 2009, BIOCHEM BIOPH RES CO, V379, P649, DOI 10.1016/j.bbrc.2008.12.107; Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coello P, 2012, J EXP BOT, V63, P913, DOI 10.1093/jxb/err320; Dainty J., 1976, Encyclopedia of Plant Physiology, New Series, Volume 2. Transport in plants II. Part A. Cells. [Luttge, U.; Pitman, M.G. (Editors)]., P12; Das R, 2010, CURR GENOMICS, V11, P2, DOI 10.2174/138920210790217981; Duan JZ, 2012, PLANT SCI, V196, P143, DOI 10.1016/j.plantsci.2012.08.003; EVERARD JD, 1994, PLANT PHYSIOL, V106, P281, DOI 10.1104/pp.106.1.281; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Gao XQ, 2011, JOVE-J VIS EXP, DOI 10.3791/2938; Genoud T, 1999, TRENDS PLANT SCI, V4, P503, DOI 10.1016/S1360-1385(99)01498-3; Granier C, 1999, PLANT PHYSIOL, V119, P609, DOI 10.1104/pp.119.2.609; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Hawes MC, 2000, TRENDS PLANT SCI, V5, P128, DOI 10.1016/S1360-1385(00)01556-9; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Jonak C, 2002, TRENDS PLANT SCI, V7, P457, DOI 10.1016/S1360-1385(02)02331-2; KISHOR PBK, 1995, PLANT PHYSIOL, V108, P1387, DOI 10.1104/pp.108.4.1387; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Kumar N, 2006, INDIAN J CROP SCI, V1, P8; LEVITT J., 1980, RESPONSE PLANT ENV S; Li C, 2013, INT J MOL SCI, V14, P21983, DOI 10.3390/ijms141121983; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Mishra NS, 2006, ARCH BIOCHEM BIOPHYS, V452, P55, DOI 10.1016/j.abb.2006.05.001; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Pareek A, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P1, DOI 10.1007/978-90-481-3112-9; Parida AK, 2007, PLANT BIOTECHNOL REP, V1, P37, DOI 10.1007/s11816-006-0004-1; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Sevengor S, 2011, AFR J AGR RES, V6, P4920; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Steponkus P.L., 1993, ADV LOW TEMPERATURE, V2, P211; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; TYREE MT, 1972, J EXP BOT, V23, P267, DOI 10.1093/jxb/23.1.267; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; Wang X, 2004, PLANT SCI, V167, P1183, DOI 10.1016/j.plantsci.2004.03.011; Wang ZQ, 2007, J PLANT PHYSIOL, V164, P695, DOI 10.1016/j.jplph.2006.05.001; Wurzinger B, 2011, PLANT SIGNAL BEHAV, V6, P8, DOI 10.4161/psb.6.1.14012; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yasar F, 2008, RUSS J PLANT PHYSL+, V55, P782, DOI 10.1134/S1021443708060071; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Younis ME, 2009, PLANT OMICS, V2, P197; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	56	18	25	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112269	10.1371/journal.pone.0112269	http://dx.doi.org/10.1371/journal.pone.0112269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393623	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300044
J	Carrillo-Larco, RM; Bernabe-Ortiz, A; Miranda, JJ				Carrillo-Larco, Rodrigo M.; Bernabe-Ortiz, Antonio; Jaime Miranda, J.			Short Sleep Duration and Childhood Obesity: Cross-Sectional Analysis in Peru and Patterns in Four Developing Countries	PLOS ONE			English	Article							BODY-MASS INDEX; AUSTRALIAN CHILDREN; EARLY-LIFE; OVERWEIGHT; ASSOCIATION; ADOLESCENTS; RISK; METAANALYSIS; WEIGHT; TRENDS	Background: We aimed to describe the patterns of nutritional status and sleep duration in children from Ethiopia, India, Peru and Vietnam; to assess the association between short sleep duration and overweight and obesity, and if this was similar among boys and girls in Peru. Methods and Findings: Analysis of the Young Lives Study, younger cohort, third round. In Ethiopia there were 1,999 observations, 2,011, 2,052 and 2,000 in India, Peru and Vietnam, respectively. Analyses included participants with complete data for sleep duration, BMI, sex and age; missing data: 5.9% (Ethiopia), 4.1% (India), 6.0% (Peru) and 4.5% (Vietnam). Exposure was sleep duration per day: short (<10 hours) versus regular (10-11 hours). Outcome was overweight and obesity. Multivariable analyses were conducted using a hierarchical approach to assess the effect of variables at different levels. Overweight/obesity prevalence was 0.5%/0.2% (Ethiopia), 1.3%/0.3% (India), 6.1%/2.8% (Vietnam), and 15.8%/5.4% (Peru). Only Peruvian data was considered to explore the association between short sleep duration and overweight and obesity, with 1,929 children, aged 7.960.3 years, 50.3% boys. Short and regular sleep duration was 41.6% and 55.6%, respectively. Multivariable models showed that obesity was 64% more prevalent among children with short sleep duration, an estimate that lost significance after controlling for individual-and family-related variables (PR: 1.15; 95% CI: 0.81-1.64). Gender was an effect modifier of the association between short sleep duration and overweight (p = 0.030) but not obesity (p = 0.533): the prevalence ratio was greater than one across all the models for boys, yet it was less than one for girls. Conclusions: Childhood overweight and obesity have different profiles across developing settings. In a sample of children living in resource-limited settings in Peru there is no association between short sleep duration and obesity; the crude association was slightly attenuated by children-related variables but strongly diminished by family-related variables.	[Carrillo-Larco, Rodrigo M.; Bernabe-Ortiz, Antonio; Jaime Miranda, J.] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.] Univ Peruana Cayetano Heredia, Sch Med, Dept Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Carrillo-Larco, RM (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	rodrigo.carrillo@upch.pe		Carrillo-Larco, Rodrigo M./0000-0002-2090-1856; Miranda, J. Jaime/0000-0002-4738-5468; Bernabe-Ortiz, Antonio/0000-0002-6834-1376	National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases [268200900033C-1-0-1]	National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases	RMC-L, AB-O, JJM and the CRONICAS Center of Excellence in Chronic Diseases were supported by the National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases ( Project Number 268200900033C-1-0-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Álvarez-Dongo Doris, 2012, Rev. perú. med. exp. salud publica, V29, P303; Bagley EJ, 2013, J PEDIATR PSYCHOL, V38, P775, DOI 10.1093/jpepsy/jst031; Barnett I, 2013, INT J EPIDEMIOL, V42, P701, DOI 10.1093/ije/dys082; Bayer O, 2009, SLEEP, V32, P1183, DOI 10.1093/sleep/32.9.1183; Bell JF, 2010, ARCH PEDIAT ADOL MED, V164, P840, DOI 10.1001/archpediatrics.2010.143; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carter PJ, 2011, BMJ, V342; Chaput JP, 2006, INT J OBESITY, V30, P1080, DOI 10.1038/sj.ijo.0803291; Chaput JP, 2011, CAN J PUBLIC HEALTH, V102, P369, DOI 10.1007/BF03404179; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Clifford LM, 2012, SLEEP MED, V13, P1102, DOI 10.1016/j.sleep.2012.06.019; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Diethelm K, 2011, INT J PEDIATR OBES, V6, pE114, DOI 10.3109/17477166.2011.566338; Eisenmann JC, 2006, ACTA PAEDIATR, V95, P956, DOI 10.1080/08035250600731965; El-Sheikh M, 2013, HEALTH PSYCHOL, V32, P849, DOI 10.1037/a0030413; Gaina A, 2004, J EPIDEMIOL, V14, P1, DOI 10.2188/jea.14.1; Hart CN, 2011, PEDIATR CLIN N AM, V58, P715, DOI 10.1016/j.pcl.2011.03.007; Huong Thi Le, 2013, Health, V5, P24; Jarrin DC, 2013, INT J OBESITY, V37, P552, DOI 10.1038/ijo.2013.4; Jiang F, 2009, J PEDIATR-US, V154, P814, DOI 10.1016/j.jpeds.2008.12.043; Kohyama J, 2011, PEDIATR INT, V53, P649, DOI 10.1111/j.1442-200X.2010.03318.x; Lumeng JC, 2007, PEDIATRICS, V120, P1020, DOI 10.1542/peds.2006-3295; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; National Sleep Foundation, 2014, MUCH SLEEP DO WE REA; Pileggi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066680; Raj M, 2007, NATL MED J INDIA, V20, P288; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Sekine M, 2002, CHILD CARE HLTH DEV, V28, P163, DOI 10.1046/j.1365-2214.2002.00260.x; Sekine Michikazu, 2002, J Epidemiol, V12, P237; Shi ZM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-609; Spruyt K, 2011, PEDIATRICS, V127, pE345, DOI 10.1542/peds.2010-0497; Taveras EM, 2008, ARCH PEDIAT ADOL MED, V162, P305, DOI 10.1001/archpedi.162.4.305; Univesiry of Oxford, 2014, U OXF TECHN NOT; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Wells JCK, 2000, J THEOR BIOL, V202, P65, DOI 10.1006/jtbi.1999.1044; Wing YK, 2009, PEDIATRICS, V124, pE994, DOI 10.1542/peds.2008-3602; Zerfu Mesfin, 2006, Ethiop Med J, V44, P347	38	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112433	10.1371/journal.pone.0112433	http://dx.doi.org/10.1371/journal.pone.0112433			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393729	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300056
J	Fronza, M; Caetano, GF; Leite, MN; Bitencourt, CS; Paula-Silva, FWG; Andrade, TAM; Frade, MAC; Merfort, I; Faccioli, LH				Fronza, Marcio; Caetano, Guilherme F.; Leite, Marcel N.; Bitencourt, Claudia S.; Paula-Silva, Francisco W. G.; Andrade, Thiago A. M.; Frade, Marco A. C.; Merfort, Irmgard; Faccioli, Lucia H.			Hyaluronidase Modulates Inflammatory Response and Accelerates the Cutaneous Wound Healing	PLOS ONE			English	Article							GROWTH-FACTORS; ANGIOGENIC OLIGOSACCHARIDES; FIBROBLAST MOTILITY; SKIN HOMEOSTASIS; PPAR-BETA/DELTA; RAT SKIN; RECEPTOR; REPAIR; BETA; MECHANISMS	Hyaluronidases are enzymes that degrade hyaluronan an important constituent of the extracellular matrix. They have been used as a spreading agent, improving the absorption of drugs and facilitating the subcutaneous infusion of fluids. Here, we investigated the influence of bovine testes hyaluronidase (HYAL) during cutaneous wound healing in in vitro and in vivo assays. We demonstrated in the wound scratch assay that HYAL increased the migration and proliferation of fibroblasts in vitro at low concentration, e.g. 0.1 U HYAL enhanced the cell number by 20%. HYAL presented faster and higher reepithelialization in in vivo full-thickness excisional wounds generated on adult Wistar rats back skin already in the early phase at 2nd day post operatory compared to vehicle-control group. Wound closured area observed in the 16 U and 32 U HYAL treated rats reached 38% and 46% compared to 19% in the controls, respectively. Histological and biochemical analyses supported the clinical observations and showed that HYAL treated wounds exhibited increased granulation tissue, diminished edema formation and regulated the inflammatory response by modulating the release of pro and anti-inflammatory cytokines, growth factor and eicosanoids mediators. Moreover, HYAL increased gene expression of peroxisome proliferator-activated receptors (PPAR) gamma and PPAR beta/delta, the collagen content in the early stages of healing processes as well as angiogenesis. Altogether these data revealed that HYAL accelerates wound healing processes and might be beneficial for treating wound disorders.	[Fronza, Marcio; Bitencourt, Claudia S.; Paula-Silva, Francisco W. G.; Faccioli, Lucia H.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil; [Caetano, Guilherme F.; Leite, Marcel N.; Andrade, Thiago A. M.; Frade, Marco A. C.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Div Dermatol, BR-14049 Ribeirao Preto, SP, Brazil; [Merfort, Irmgard] Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, D-79106 Freiburg, Germany; [Fronza, Marcio] Univ Vila Velha, Dept Farm, Vila Velha, ES, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Freiburg; Centro Universitario Vila Velha	Faccioli, LH (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxicol & Bromatol, BR-14049 Ribeirao Preto, SP, Brazil.	faccioli@fcfrp.usp.br	Leite, Marcel Nani/D-1135-2015; Caetano, Guilherme F/D-8223-2013; Lucia, Faccioli/G-8976-2015; Caetano, Guilherme/V-8978-2019; Faccioli, Lúcia Helena/AGH-5297-2022; Andrade, Thiago Antônio Moretti/G-9359-2012; Fronza, Marcio/B-8607-2014; de Paula e Silva, Francisco Wanderley Garcia Garcia/D-1712-2012; Frade, Marco Andrey Cipriani/G-1165-2012	Leite, Marcel Nani/0000-0002-2121-8688; Lucia, Faccioli/0000-0002-4999-8305; Faccioli, Lúcia Helena/0000-0002-4999-8305; Andrade, Thiago Antônio Moretti/0000-0003-3788-2847; Fronza, Marcio/0000-0002-7316-8598; de Paula e Silva, Francisco Wanderley Garcia Garcia/0000-0001-8559-532X; Frade, Marco Andrey Cipriani/0000-0003-2700-5971	Sao Paulo Research Foundation (FAPESP) [2011/23992-3, 2009/07169-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful to the Sao Paulo Research Foundation (FAPESP, grant # 2011/23992-3 and grant # 2009/07169-5) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L, 2011, BRIT J OPHTHALMOL, V95, P1345, DOI 10.1136/bjo.2010.188789; Andrade TAM, 2011, BRAZ J MED BIOL RES, V44, P1036, DOI 10.1590/S0100-879X2011007500116; Aoki T, 2012, TRENDS PHARMACOL SCI, V33, P304, DOI 10.1016/j.tips.2012.02.004; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Birch M, 2005, METH MOLEC MED, V117, P223; Bitencourt CS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-3; BROWN LF, 1992, J EXP MED, V176, P1375, DOI 10.1084/jem.176.5.1375; Buonomo R, 2012, J CELL PHYSIOL, V227, P2106, DOI 10.1002/jcp.22944; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Chong HC, 2009, J CELL BIOL, V184, P817, DOI 10.1083/jcb.200809028; Dechert TA, 2006, WOUND REPAIR REGEN, V14, P252, DOI 10.1111/j.1743-6109.2006.00119.x; Dunn AL, 2010, EXPERT OPIN BIOL TH, V10, P127, DOI 10.1517/14712590903490382; Dygai AM, 2013, B EXP BIOL MED+, V154, P388, DOI 10.1007/s10517-013-1957-z; Dygai AM, 2013, B EXP BIOL MED+, V154, P329, DOI 10.1007/s10517-013-1943-5; El-Safory NS, 2010, CARBOHYD POLYM, V81, P165, DOI 10.1016/j.carbpol.2010.02.047; FDA, 2006, GUID IND CHRON CUT U; Fronza M, 2009, J ETHNOPHARMACOL, V126, P463, DOI 10.1016/j.jep.2009.09.014; Futagami A, 2002, LAB INVEST, V82, P1503, DOI 10.1097/01.LAB.0000035024.75914.39; Ghazi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048351; Green JA, 2004, AM J PHYSIOL-CELL PH, V287, pC373, DOI 10.1152/ajpcell.00509.2003; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027; Icre G, 2006, J INVEST DERM SYMP P, V11, P30, DOI 10.1038/sj.jidsymp.5650007; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Kapoor M, 2007, PROSTAG LEUKOTR ESS, V76, P103, DOI 10.1016/j.plefa.2006.11.006; Kemparaju K, 2006, CELL BIOCHEM FUNCT, V24, P7, DOI 10.1002/cbf.1261; Knight E, 2010, J CLIN PATHOL, V63, P846, DOI 10.1136/jcp.2010.076828; Lee A, 2010, DERMATOL SURG, V36, P1071, DOI 10.1111/j.1524-4725.2010.01585.x; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lu L, 2005, J AM COLL SURGEONS, V201, P391, DOI 10.1016/j.jamcollsurg.2005.03.032; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Minatel DG, 2009, LASER SURG MED, V41, P433, DOI 10.1002/lsm.20789; Montagner A, 2011, J INVEST DERMATOL, V131, P2154; Nelson AM, 2013, J INVEST DERMATOL, V133, P881, DOI 10.1038/jid.2012.398; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; Pessini AC, 2001, TOXICON, V39, P1495, DOI 10.1016/S0041-0101(01)00122-2; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; SATTAR A, 1994, J INVEST DERMATOL, V103, P576, DOI 10.1111/1523-1747.ep12396880; Schreml S, 2010, J AM ACAD DERMATOL, V63, P866, DOI 10.1016/j.jaad.2009.10.048; Shih B, 2010, WOUND REPAIR REGEN, V18, P139, DOI 10.1111/j.1524-475X.2009.00553.x; Shukla A, 1998, BIOCHEM BIOPH RES CO, V244, P434, DOI 10.1006/bbrc.1998.8286; Siebert N, 2011, LAB INVEST, V91, P1753, DOI 10.1038/labinvest.2011.125; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Souza DG, 2001, BRIT J PHARMACOL, V134, P985, DOI 10.1038/sj.bjp.0704336; Tan NS, 2001, GENE DEV, V15, P3263, DOI 10.1101/gad.207501; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	55	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112297	10.1371/journal.pone.0112297	http://dx.doi.org/10.1371/journal.pone.0112297			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393024	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300048
J	Green, JWM; Stastna, JJ; Orbidans, HE; Harvey, SC				Green, James W. M.; Stastna, Jana J.; Orbidans, Helen E.; Harvey, Simon C.			Highly Polygenic Variation in Environmental Perception Determines Dauer Larvae Formation in Growing Populations of Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; NATURAL VARIATION; PHENOTYPIC PLASTICITY; EVOLUTION; DIVERSITY; PHEROMONE; PREFERENCE	Background: Determining how complex traits are genetically controlled is a requirement if we are to predict how they evolve and how they might respond to selection. This requires understanding how distinct, and often more simple, life history traits interact and change in response to environmental conditions. In order to begin addressing such issues, we have been analyzing the formation of the developmentally arrested dauer larvae of Caenorhabditis elegans under different conditions. Results: We find that 18 of 22 previously identified quantitative trait loci (QTLs) affecting dauer larvae formation in growing populations, assayed by determining the number of dauer larvae present at food patch exhaustion, can be recovered under various environmental conditions. We also show that food patch size affects both the ability to detect QTLs and estimates of effect size, and demonstrate that an allele of nath-10 affects dauer larvae formation in growing populations. To investigate the component traits that affect dauer larvae formation in growing populations we map, using the same introgression lines, QTLs that affect dauer larvae formation in response to defined amounts of pheromone. This identifies 36 QTLs, again demonstrating the highly polygenic nature of the genetic variation underlying dauer larvae formation. Conclusions: These data indicate that QTLs affecting the number of dauer larvae at food exhaustion in growing populations of C. elegans are highly reproducible, and that nearly all can be explained by variation affecting dauer larvae formation in response to defined amounts of pheromone. This suggests that most variation in dauer larvae formation in growing populations is a consequence of variation in the perception of the food and pheromone environment (i.e. chemosensory variation) and in the integration of these cues.	[Green, James W. M.; Stastna, Jana J.; Orbidans, Helen E.; Harvey, Simon C.] Canterbury Christ Church Univ, Sch Human & Life Sci, Biomol Res Grp, Canterbury, Kent, England	Canterbury Christ Church University	Harvey, SC (corresponding author), Canterbury Christ Church Univ, Sch Human & Life Sci, Biomol Res Grp, Canterbury, Kent, England.	simon.harvey@canterbury.ac.uk			Canterbury Christ Church University (CCCU); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Canterbury Christ Church University (CCCU); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JG was supported by a PhD Scholarship from Canterbury Christ Church University (CCCU). CCCU had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No external funding was received for this study.	Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Bose N, 2014, CURR BIOL, V24, P1536, DOI 10.1016/j.cub.2014.05.045; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Diaz SA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-46; Doroszuk A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp528; Duveau F, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001230; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Glater EE, 2014, G3-GENES GENOM GENET, V4, P265, DOI 10.1534/g3.113.008649; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Green JWM, 2013, HEREDITY, V111, P306, DOI 10.1038/hdy.2013.50; Green JWM, 2012, NEMATOLOGY, V14, P165, DOI 10.1163/138855411X584115; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; Harvey SC, 2009, J EXP ZOOL PART B, V312B, P224, DOI 10.1002/jez.b.21287; Harvey SC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-15; Hodgkin J, 1997, GENETICS, V146, P149; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Kammenga JE, 2008, TRENDS GENET, V24, P178, DOI 10.1016/j.tig.2008.01.001; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kaufmann K, 2010, NAT REV GENET, V11, P830, DOI 10.1038/nrg2885; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Li Y, 2010, GENETICS, V186, P405, DOI 10.1534/genetics.110.119677; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; Maydan JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-62; Mayer MG, 2011, P ROY SOC B-BIOL SCI, V278, P2784, DOI 10.1098/rspb.2010.2760; McGrath PT, 2011, NATURE, V477, P321, DOI 10.1038/nature10378; Moczek AP, 2010, PHILOS T R SOC B, V365, P593, DOI 10.1098/rstb.2009.0263; Pantin F, 2011, PLANT PHYSIOL, V156, P803, DOI 10.1104/pp.111.176289; Petersen C, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-4; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Rajon E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1552; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Rodriguez M, 2012, EXP GERONTOL, V47, P581, DOI 10.1016/j.exger.2012.05.005; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; Shao HF, 2010, MAMM GENOME, V21, P276, DOI 10.1007/s00335-010-9267-5; Snoek LB, 2014, G3-GENES GENOM GENET, V4, P1813, DOI 10.1534/g3.114.013151; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stewart MR, 2005, GENETICS, V169, P1985, DOI 10.1534/genetics.104.035329; Stiernagle Theresa, 2006, WormBook, P1; Terpstra IR, 2010, PLANT PHYSIOL, V154, P1067, DOI 10.1104/pp.110.159996; Tomkins JL, 2007, TRENDS ECOL EVOL, V22, P522, DOI 10.1016/j.tree.2007.09.002; Viney ME, 2003, DEV GROWTH DIFFER, V45, P389, DOI 10.1046/j.1440-169X.2003.00703.x	47	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112830	10.1371/journal.pone.0112830	http://dx.doi.org/10.1371/journal.pone.0112830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393108	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300110
J	Lansdorp-Vogelaar, I; Fedewa, S; Lin, CC; Virgo, KS; Jemal, A				Lansdorp-Vogelaar, Iris; Fedewa, Stacey; Lin, Chun Chieh; Virgo, Katherine S.; Jemal, Ahmedin			Utilization of Surveillance after Polypectomy in the Medicare Population - A Cohort Study	PLOS ONE			English	Article							COLORECTAL-CANCER; UNITED-STATES; NATIONAL-SURVEY; COLONOSCOPY; POLYPS; PREVENTION; PREVALENCE; DIAGNOSIS; RISK	Background: Surveillance in patients with previous polypectomy was underused in the Medicare population in 1994. This study investigates whether expansion of Medicare reimbursement for colonoscopy screening in high-risk individuals has reduced the inappropriate use of surveillance. Methods: We used Kaplan-Meier analysis to estimate time to surveillance and polyp recurrence rates for Medicare beneficiaries with a colonoscopy with polypectomy between 1998 and 2003 who were followed through 2008 for receipt of surveillance colonoscopy. Generalized Estimating Equations were used to estimate risk factors for: 1) failing to undergo surveillance and 2) polyp recurrence among these individuals. Analyses were stratified into three 2-year cohorts based on baseline colonoscopy date. Results: Medicare beneficiaries undergoing a colonoscopy with polypectomy in the 1998-1999 (n = 4,136), 2000-2001 (n = 3,538) and 2002-2003 (n = 4,655) cohorts had respective probabilities of 30%, 26% and 20% (p<0.001) of subsequent surveillance events within 3 years. At the same time, 58%, 52% and 45% (p<0.001) of beneficiaries received a surveillance event within 5 years. Polyp recurrence rates after 5 years were 36%, 30% and 26% (p<0.001) respectively. Older age (>= 70 years), female gender, later cohort (2000-2001 & 2002-2003), and severe comorbidity were the most important risk factors for failure to undergo a surveillance event. Male gender and early cohort (1998-1999) were the most important risk factors for polyp recurrence. Conclusions: Expansion of Medicare reimbursement for colonoscopy screening in high-risk individuals has not reduced underutilization of surveillance in the Medicare population. It is important to take action now to improve this situation, because polyp recurrence is substantial in this population.	[Lansdorp-Vogelaar, Iris] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Fedewa, Stacey; Lin, Chun Chieh; Jemal, Ahmedin] Amer Canc Soc, Intramural Res Dept, Atlanta, GA 30329 USA; [Fedewa, Stacey] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Virgo, Katherine S.] Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA	Erasmus University Rotterdam; Erasmus MC; American Cancer Society; Emory University; Rollins School Public Health; Emory University	Lansdorp-Vogelaar, I (corresponding author), Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	i.vogelaar@erasmusmc.nl	Virgo, Katherine S/AAG-3188-2021	Virgo, Katherine S/0000-0002-2069-0585; Fedewa, Stacey/0000-0002-3624-6382	National Cancer Institute at the National Institutes of Health [U01-CA-097426, U01-CA-115953, U01-CA-152959]; American Cancer Society's Intramural Research Department; NATIONAL CANCER INSTITUTE [U01CA152959, U01CA097426, U01CA115953] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society's Intramural Research Department(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Cancer Institute at the National Institutes of Health (grant numbers U01-CA-097426, U01-CA-115953, U01-CA-152959 to IL-V) (www.cancer.gov); and American Cancer Society's Intramural Research Department (www.cancer.org). The funding sources had no role in study design, data collection, and analysis, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.	Amonkar MM, 2005, CANCER EPIDEM BIOMAR, V14, P417, DOI 10.1158/1055-9965.EPI-04-0342; Boolchand V, 2006, ANN INTERN MED, V145, P654, DOI 10.7326/0003-4819-145-9-200611070-00007; Brenner H, 2012, J CLIN ONCOL, V30, P2969, DOI 10.1200/JCO.2011.41.3377; Cooper GS, 2013, CANCER-AM CANCER SOC, V119, P1800, DOI 10.1002/cncr.27990; de Jonge V, 2011, ENDOSCOPY, V43, P560, DOI 10.1055/s-0030-1256306; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Forsberg AM, 2012, SCAND J GASTROENTERO, V47, P184, DOI 10.3109/00365521.2011.647062; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Kim DH, 2011, NAT REV GASTRO HEPAT, V8, P129, DOI 10.1038/nrgastro.2011.19; Ko CW, 2011, GASTROINTEST ENDOSC, V73, P447, DOI 10.1016/j.gie.2010.07.044; Laiyemo AO, 2009, CLIN GASTROENTEROL H, V7, P562, DOI 10.1016/j.cgh.2008.12.009; Lieberman DA, 2005, GASTROINTEST ENDOSC, V62, P875, DOI 10.1016/j.gie.2005.06.037; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Mysliwiec PA, 2004, ANN INTERN MED, V141, P264, DOI 10.7326/0003-4819-141-4-200408170-00006; Pickhardt PJ, 2004, RADIOLOGY, V232, P784, DOI 10.1148/radiol.2323031614; Ransohoff DF, 2011, DIGEST DIS SCI, V56, P2623, DOI 10.1007/s10620-011-1791-y; Rim SH, 2009, CANCER-AM CANCER SOC, V115, P1967, DOI 10.1002/cncr.24216; Schenck AP, 2007, CANCER EPIDEM BIOMAR, V16, P2118, DOI 10.1158/1055-9965.EPI-07-0123; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Warren Joan L, 2002, Med Care, V40, pIV; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Winawer SJ, 2006, CA-CANCER J CLIN, V56, P143, DOI 10.3322/canjclin.56.3.143; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	26	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110937	10.1371/journal.pone.0110937	http://dx.doi.org/10.1371/journal.pone.0110937			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393312	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300005
J	Tsuboko, S; Kimura, T; Shinya, M; Suehiro, Y; Okuyama, T; Shimada, A; Takeda, H; Naruse, K; Kubo, T; Takeuchi, H				Tsuboko, Satomi; Kimura, Tetsuaki; Shinya, Minori; Suehiro, Yuji; Okuyama, Teruhiro; Shimada, Atsuko; Takeda, Hiroyuki; Naruse, Kiyoshi; Kubo, Takeo; Takeuchi, Hideaki			Genetic Control of Startle Behavior in Medaka Fish	PLOS ONE			English	Article							ORYZIAS-LATIPES; LENGTH POLYMORPHISMS; GENOME EVOLUTION; DRAFT GENOME; LINKAGE MAP; PERSONALITY; RESOURCE; STIMULUS; STRAINS; PROJECT	Genetic polymorphisms are thought to generate intraspecific behavioral diversities, both within and among populations. The mechanisms underlying genetic control of behavioral properties, however, remain unclear in wild-type vertebrates, including humans. To explore this issue, we used diverse inbred strains of medaka fish (Oryzias latipes) established from the same and different local populations. Medaka exhibit a startle response to a visual stimulus (extinction of illumination) by rapidly bending their bodies (C-start) 20-ms after the stimulus presentation. We measured the rates of the response to repeated stimuli (1-s interval, 40 times) among four inbred strains, HNI-I, HNI-II, HO5, and Hd-rR-II1, and quantified two properties of the startle response: sensitivity (response rate to the first stimulus) and attenuation of the response probability with repeated stimulus presentation. Among the four strains, the greatest differences in these properties were detected between HNI-II and Hd-rR-II1. HNI-II exhibited high sensitivity (approximately 80%) and no attenuation, while Hd-rR-II1 exhibited low sensitivity (approximately 50%) and almost complete attenuation after only five stimulus presentations. Our findings suggested behavioral diversity of the startle response within a local population as well as among different populations. Linkage analysis with F2 progeny between HNI-II and Hd-rR-II1 detected quantitative trait loci (QTL) highly related to attenuation, but not to sensitivity, with a maximum logarithm of odds score of 11.82 on linkage group 16. The three genotypes (homozygous for HNI-II and Hd-rR-II1 alleles, and heterozygous) at the marker nearest the QTL correlated with attenuation. Our findings are the first to suggest that a single genomic region might be sufficient to generate individual differences in startle behavior between wild-type strains. Further identification of genetic polymorphisms that define the behavioral trait will contribute to our understanding of the neural mechanisms underlying behavioral diversity, allowing us to investigate the adaptive significance of intraspecific behavioral polymorphisms of the startle response.	[Tsuboko, Satomi; Suehiro, Yuji; Okuyama, Teruhiro; Shimada, Atsuko; Takeda, Hiroyuki; Kubo, Takeo; Takeuchi, Hideaki] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Kimura, Tetsuaki; Okuyama, Teruhiro; Naruse, Kiyoshi] Natl Inst Basic Biol, Lab Bioresources, Okazaki, Aichi 444, Japan; [Kimura, Tetsuaki; Naruse, Kiyoshi] Natl Inst Basic Biol, Ctr Interuniv Biobackup Project, Okazaki, Aichi 444, Japan; [Shinya, Minori] Natl Inst Genet, Genet Strains Res Ctr, Mishima, Shizuoka 411, Japan; [Shinya, Minori] Keio Univ, Dept Biol, Yokohama, Kanagawa 223, Japan; [Suehiro, Yuji] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Keio University; Tokyo Women's Medical University	Takeuchi, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	takeuchi@bs.s.u-tokyo.ac.jp	Takeuchi, Hideaki/W-6739-2018; KUBO, TAKEO/G-4951-2014; TAKEDA, HIROYUKI/G-4950-2014; Tsuboko-Ishii, Satomi/J-2713-2019	Takeuchi, Hideaki/0000-0001-6610-3895; Tsuboko-Ishii, Satomi/0000-0003-4374-6200; Naruse, Kiyoshi/0000-0001-9185-3495; Kubo, Takeo/0000-0002-5914-5269	National Institute for Basic Biology Priority Collaborative Research Project [10-104]; MEXT;  [23650162]	National Institute for Basic Biology Priority Collaborative Research Project; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by the National Institute for Basic Biology Priority Collaborative Research Project (10-104, http://www.nibb.ac.jp/en/collabo/collabo.html), Grant-in-Aid for Challenging Exploratory Research (23650162, http://www.jsps.go.jp/english/e-grants/grants01.html), Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network, https://www.hokatsu-nou.nips.ac.jp/), the Graduate Program for Leaders in Life Innovation (GPLLI) at the University of Tokyo Life Innovation Leading Graduate School from MEXT (to ST, http://square.umin.ac.jp/gplli/en/index.html), and Grant-in-Aid for a Japan Society for Promotion of Science (JSPS) fellowship (to ST, YS, and TO, http://www.jsps.go.jp/english/e-pd/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan B, 2008, NUCLEIC ACIDS RES, V36, pD747, DOI 10.1093/nar/gkm765; Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Ansai S, 2014, DEV GROWTH DIFFER, V56, P98, DOI 10.1111/dgd.12104; Ansai S, 2013, GENETICS, V193, P739, DOI 10.1534/genetics.112.147645; Bergmuller R, 2010, TRENDS ECOL EVOL, V25, P504, DOI 10.1016/j.tree.2010.06.012; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; EATON RC, 1981, J COMP PHYSIOL, V144, P521, DOI 10.1007/BF01326837; Eaton RC., 1984, NEURAL MECH STARTLE, DOI [10.1007/978-1-4899-2286-1, DOI 10.1007/978-1-4899-2286-1]; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint J, 2003, J NEUROBIOL, V54, P46, DOI 10.1002/neu.10161; GLOWA JR, 1994, BEHAV GENET, V24, P79, DOI 10.1007/BF01067931; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; GWILLIAM GF, 1963, BIOL BULL, V125, P470, DOI 10.2307/1539360; Hirayama M, 2010, GENE, V457, P13, DOI 10.1016/j.gene.2010.02.012; Hyodo-Taguchi Y, 1996, FISH BIOL J MEDAKA, V8, P11; Hyodo-Taguchi Y., 1990, INBRED STRAINS MEDAK, P129; HYODOTAGUCHI Y, 1983, J RADIAT RES, V24, P221, DOI 10.1269/jrr.24.221; Imada H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011248; Ishikawa Y, 1999, BRAIN BEHAV EVOLUT, V53, P2, DOI 10.1159/000006577; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Katsumura T, 2009, GENE, V443, P170, DOI 10.1016/j.gene.2009.04.017; Kimura T, 2005, GENE, V363, P24, DOI 10.1016/j.gene.2005.07.043; Kimura T, 2007, GENETICS, V177, P2379, DOI 10.1534/genetics.106.068460; Kimura T, 2012, G3-GENES GENOM GENET, V2, P1317, DOI 10.1534/g3.112.003236; Kimura T, 2010, BIOTECHNIQUES, V49, P582, DOI 10.2144/000113467; Kobayashi Daisuke, 2008, Briefings in Functional Genomics & Proteomics, V7, P415, DOI 10.1093/bfgp/eln044; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Matsuda M, 2007, P NATL ACAD SCI USA, V104, P3865, DOI 10.1073/pnas.0611707104; Matsumoto Y, 2006, GENE, V371, P268, DOI 10.1016/j.gene.2005.12.005; Matsumoto Yoshifumi, 2009, BMC Res Notes, V2, P88, DOI 10.1186/1756-0500-2-88; Michelena P, 2010, P ROY SOC B-BIOL SCI, V277, P1093, DOI 10.1098/rspb.2009.1926; Naruse K, 2000, GENETICS, V154, P1773; Ochiai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071685; Okuyama T, 2014, SCIENCE, V343, P91, DOI 10.1126/science.1244724; Okuyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066597; Perez-Escudero A, 2014, NAT METHODS; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; RUSSELL EM, 1967, ANIM BEHAV, V15, P574, DOI 10.1016/0003-3472(67)90061-9; Sasado T, 2010, EXP ANIM TOKYO, V59, P13, DOI 10.1538/expanim.59.13; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Spivakov M, 2014, G3-GENES GENOM GENET, V4, P433, DOI 10.1534/g3.113.008722; Takeda H, 2008, DEV GROWTH DIFFER, V50, pS157, DOI 10.1111/j.1440-169X.2008.00992.x; Webster MM, 2011, BIOL REV, V86, P759, DOI 10.1111/j.1469-185X.2010.00169.x; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1	47	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112527	10.1371/journal.pone.0112527	http://dx.doi.org/10.1371/journal.pone.0112527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393539	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300064
J	Zhang, Y; Maignien, L; Stadnitskaia, A; Boeckx, P; Xiao, X; Boon, N				Zhang, Yu; Maignien, Lois; Stadnitskaia, Alina; Boeckx, Pascal; Xiao, Xiang; Boon, Nico			Stratified Community Responses to Methane and Sulfate Supplies in Mud Volcano Deposits: Insights from an In Vitro Experiment	PLOS ONE			English	Article							CONTINUOUS HIGH-PRESSURE; ANAEROBIC OXIDATION; CONTINENTAL-MARGIN; REDUCING BACTERIA; NE ATLANTIC; CADIZ; DEEP; GULF; SEA; PROKARYOTES	Numerous studies on marine prokaryotic communities have postulated that a process of anaerobic oxidation of methane (AOM) coupled with sulfate reduction (SR) is the main methane sink in the world's oceans. AOM has also been reported in the deep biosphere. But the responses of the primary microbial players in eliciting changes in geochemical environments, specifically in methane and sulfate supplies, have yet to be fully elucidated. Marine mud volcanoes (MVs) expel a complex fluid mixture of which methane is the primary component, forming an environment in which AOM is a common phenomenon. In this context, we attempted to identify how the prokaryotic community would respond to changes in methane and sulfate intensities, which often occur in MV environments in the form of eruptions, diffusions or seepage. We applied an integrated approach, including (i) biochemical surveys of pore water originated from MV, (ii) in vitro incubation of mud breccia, and (iii) prokaryotic community structure analysis. Two distinct AOM regions were clearly detected. One is related to the sulfate methane transition zone (SMTZ) at depth of 30-55 cm below the sea floor (bsf); the second is at 165-205 cm bsf with ten times higher rates of AOM and SR. This finding contrasts with the sulfide concentrations in pore waters and supports the suggestion that potential AOM activity below the SMTZ might be an important methane sink that is largely ignored or underestimated in oceanic methane budget calculations. Moreover, the incubation conditions below the SMTZ favor the growth of methanotrophic archaeal group ANME-2 compared to ANME-1, and promote the rapid growth and high diversity of bacterial communities. These incubation conditions also promote the increase of richness in bacterial communities. Our results provide direct evidence of the mechanisms by which deep AOM processes can affect carbon cycling in the deep biosphere and global methane biochemistry.	[Zhang, Yu; Xiao, Xiang] Shanghai Jiao Tong Univ, State Key Lab Ocean Engn, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Zhang, Yu; Maignien, Lois; Boon, Nico] Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium; [Stadnitskaia, Alina] Royal Netherlands Inst Sea Res, Dept Marine Geol & Chem Oceanog, Texel, Netherlands; [Boeckx, Pascal] Univ Ghent, Lab Appl Phys Chem, B-9000 Ghent, Belgium	Shanghai Jiao Tong University; Ghent University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Ghent University	Xiao, X (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Ocean Engn, State Key Lab Microbial Metab, Shanghai 200030, Peoples R China.	xoxiang@sjtu.edu.cn; Nico.Boon@ugent.be	, yu/GYD-8364-2022; xiao, xiang/GWU-6035-2022; Boon, Nico/B-4083-2011	, yu/0000-0002-0379-7882; Boon, Nico/0000-0002-7734-3103	Natural Science Foundation of China [41102211, 91228201]; National High-Tech Program of China [2012AA092103]; Bijzonder Onderzoeks Fonds of Ghent University [BOF08/DOC/016, BOF09/GOA/005]; European Science Foundation MicroSYSTEMS supported by Fonds voor Wetenschappelijk Onderzoek [506G.0656.05]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Program of China(National High Technology Research and Development Program of China); Bijzonder Onderzoeks Fonds of Ghent University(Ghent University); European Science Foundation MicroSYSTEMS supported by Fonds voor Wetenschappelijk Onderzoek	This work was supported by Natural Science Foundation of China (grant numbers 41102211 and 91228201), National High-Tech Program of China (grant number 2012AA092103), Bijzonder Onderzoeks Fonds of Ghent University (grant number BOF08/DOC/016, BOF09/GOA/005), European Science Foundation MicroSYSTEMS supported by Fonds voor Wetenschappelijk Onderzoek (grant number 506G.0656.05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanov GG, 1998, P ODP SCI RESULTS, V160; [Anonymous], 1936, B AM ASS PETROL GEOL, V20, P258; Beheydt D, 2005, RAPID COMMUN MASS SP, V19, P1365, DOI 10.1002/rcm.1907; Blumenberg M, 2004, P NATL ACAD SCI USA, V101, P11111, DOI 10.1073/pnas.0401188101; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borin S, 2009, P NATL ACAD SCI USA, V106, P9151, DOI 10.1073/pnas.0811984106; Coolen MJL, 2002, SCIENCE, V296, P2407, DOI 10.1126/science.1071893; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Gardner JM, 2001, GEOPHYS RES LETT, V28, P339, DOI 10.1029/2000GL012141; Girguis PR, 2005, APPL ENVIRON MICROB, V71, P3725, DOI 10.1128/AEM.71.7.3725-3733.2005; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Hallam SJ, 2004, SCIENCE, V305, P1457, DOI 10.1126/science.1100025; Ivanov MK, 2001, HYDROCARBON SEEPS DE; Jorgensen BB, 2012, P NATL ACAD SCI USA, V109, P15976, DOI 10.1073/pnas.1213639109; Kallmeyer J, 2012, P NATL ACAD SCI USA, V109, P16213, DOI 10.1073/pnas.1203849109; Kenyon NH, 2000, MULTIDISCIPLINARY ST; Kenyon NH, 2001, GEOLOGICAL PROCESSES; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; Lane DJ, 1991, NUCL ACID TECHNIQUES, P142; Leon R, 2006, DEEP-SEA RES PT II, V53, P1464, DOI 10.1016/j.dsr2.2006.04.009; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Manz W, 1998, FEMS MICROBIOL ECOL, V25, P43; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Mazurenko LL, 2002, TERRA NOVA, V14, P321, DOI 10.1046/j.1365-3121.2002.00428.x; Niemann H, 2006, GEOCHIM COSMOCHIM AC, V70, P5336, DOI 10.1016/j.gca.2006.08.010; Niemann H, 2006, NATURE, V443, P854, DOI 10.1038/nature05227; PACE NR, 1986, CELL, V45, P325, DOI 10.1016/0092-8674(86)90315-6; Pagaling E, 2014, ISME J, V8, P19, DOI 10.1038/ismej.2013.150; Parkes RJ, 2009, ENVIRON MICROBIOL, V11, P3140, DOI 10.1111/j.1462-2920.2009.02018.x; Parkes RJ, 2005, NATURE, V436, P390, DOI 10.1038/nature03796; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002; Pernthaler A, 2008, P NATL ACAD SCI USA, V105, P7052, DOI 10.1073/pnas.0711303105; Pinheiro LM, 2003, MAR GEOL, V195, P131, DOI 10.1016/S0025-3227(02)00685-0; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Rossel PE, 2011, GEOCHIM COSMOCHIM AC, V75, P164, DOI 10.1016/j.gca.2010.09.031; Stadnitskaia A, 2008, MAR GEOL, V255, P1, DOI 10.1016/j.margeo.2007.11.006; Stadnitskaia A, 2007, BIO PETROLEUM GEOCHE; Stadnitskaia A, 2006, MAR PETROL GEOL, V23, P281, DOI 10.1016/j.marpetgeo.2005.11.001; Van Rooij D, 2010, MARINE GEOLOGY; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Zhang Y, 2010, BIORESOURCE TECHNOL, V101, P3132, DOI 10.1016/j.biortech.2009.11.103	43	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113004	10.1371/journal.pone.0113004	http://dx.doi.org/10.1371/journal.pone.0113004			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393146	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300134
J	Razavi, M; Shepard, DS; Suaya, JA; Stason, WB				Razavi, Moaven; Shepard, Donald S.; Suaya, Jose A.; Stason, William B.			Postoperative Staphylococcus aureus Infections in Medicare Beneficiaries	PLOS ONE			English	Article							RISK-FACTORS; MRSA	Staphylococcus aureus (S. aureus) infections are important because of their increasing frequency, resistance to antibiotics, and high associated rates of disabilities and deaths. We examined the incidence and correlates of S. aureus infections following 219,958 major surgical procedures in a 5% random sample of fee-for-service Medicare beneficiaries from 2004-2007. Of these surgical patients, 0.3% had S. aureus infections during the hospitalizations when index surgical procedures were performed; and 1.7% and 2.3%, respectively, were hospitalized with infections within 60 days or 180 days following admissions for index surgeries. S. aureus infections occurred within 180 days in 1.9% of patients following coronary artery bypass graft surgery, 2.3% following hip surgery, and 5.9% following gastric or esophageal surgery. Of patients first hospitalized with any major infection reported during the first 180 days after index surgery, 15% of infections were due to S. aureus, 18% to other documented organisms, and no specific organism was reported on claim forms in 67%. Patient-level predictors of S. aureus infections included transfer from skilled nursing facilities or chronic hospitals and comorbid conditions (e. g., diabetes, congestive heart failure, chronic obstructive pulmonary disease, and chronic renal disease). In a logarithmic regression, elective index admissions with S. aureus infection stayed 130% longer than comparable patients without that infection. Within 180 days of the index surgery, 23.9% of patients with S. aureus infection and 10.6% of patients without this infection had died. In a multivariate logistic regression of death within 180 days of admission for the index surgery with adjustment for demographics, co-morbidities, and other risks, S. aureus was associated with a 42% excess risk of death. Due to incomplete documentation of organisms in Medicare claims, these statistics may underestimate the magnitude of S. aureus infection. Nevertheless, this study generated a higher rate of S. aureus infections than previous studies.	[Razavi, Moaven; Shepard, Donald S.; Stason, William B.] Brandeis Univ, Heller Sch Social Policy & Management, Schneider Inst Hlth Policy, Waltham, MA 02453 USA; [Suaya, Jose A.] GlaxoSmithKline, Philadelphia, PA USA	Brandeis University; GlaxoSmithKline	Shepard, DS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Schneider Inst Hlth Policy, Waltham, MA 02453 USA.	shepard@brandeis.edu			GlaxoSmithKline Biologicals SA; GlaxoSmithKline	GlaxoSmithKline Biologicals SA(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline Biologicals SA funded this study/research. GlaxoSmithKline Biologicals SA also undertook all costs associated with the development and publication of this manuscript. GlaxoSmithKline provided support in the form of salary for author JAS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Brandeis University received funding from GlaxoSmithKline Biologicals SA to fund part of the cost of this study.	Anderson DJ, 2010, INFECT CONT HOSP EP, V31, P701, DOI 10.1086/653205; Awad SS, 2009, AM J SURG, V198, P607, DOI 10.1016/j.amjsurg.2009.07.010; Centers for Medicare and Medicaid Services (CMS), 2013, CHR COND DAT WAR MED; Fowler VG, 2005, CIRCULATION, V112, pI358, DOI 10.1161/CIRCULATIONAHA.104.525790; Fukuta Y, 2012, INFECT CONT HOSP EP, V33, P1219, DOI 10.1086/668420; Goyal N, 2012, J KNEE SURG, V25, P37, DOI 10.1055/s-0031-1286194; Gupta K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053674; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hortal J, 2009, INTENS CARE MED, V35, P1518, DOI 10.1007/s00134-009-1523-3; Huotari K, 2006, INFECT CONT HOSP EP, V27, P1324, DOI 10.1086/509840; Ramarathnam V, 2013, AM J INFECT CONTROL, V41, P625, DOI 10.1016/j.ajic.2012.08.005; Ray GT, 2012, J CLIN MICROBIOL, V50, P1950, DOI 10.1128/JCM.00134-12; Shams WE, 2004, ORTHOPEDICS, V27, P565; Tadros MA, 2013, AM J INFECT CONTROL, V41, P509, DOI 10.1016/j.ajic.2012.07.016; ter Gunne AFP, 2010, SPINE, V35, P1323, DOI 10.1097/BRS.0b013e3181bcde61; Vilchez F, 2011, CLIN MICROBIOL INFEC, V17, P439, DOI 10.1111/j.1469-0691.2010.03244.x; Wallace WC, 2000, AM SURGEON, V66, P874	17	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e110133	10.1371/journal.pone.0110133	http://dx.doi.org/10.1371/journal.pone.0110133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389782	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400011
J	Zhang, JQ; Meng, SY; Rao, GY				Zhang, Jian-Qiang; Meng, Shi-Yong; Rao, Guang-Yuan			Phylogeography of Rhodiola kirilowii (Crassulaceae): A Story of Miocene Divergence and Quaternary Expansion	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; CHLOROPLAST INTERGENIC REGIONS; GENETIC CONSEQUENCES; POPULATION-GROWTH; HABITAT FRAGMENTATION; RAPID RADIATION; TRNL-F; DNA; EVOLUTION; UPLIFT	The evolution and current distribution of the Sino-Tibetan flora have been greatly affected by historical geological events, such as the uplift of the Qinghai-Tibetan Plateau (QTP), and Quaternary climatic oscillations. Rhodiola kirilowii, a perennial herb with its distribution ranging from the southeastern QTP and the Hengduan Mountains (HM) to adjacent northern China and central Asia, provides an excellent model to examine and disentangle the effect of both geological orogeny and climatic oscillation on the evolutionary history of species with such distribution patterns. We here conducted a phylogeographic study using sequences of two chloroplast fragments (trnL-F and trnS-G) and internal transcribed spacers in 29 populations of R. kirilowii. A total of 25 plastid haplotypes and 12 ITS ribotypes were found. Molecular clock estimation revealed deep divergence between the central Asian populations and other populations from the HM and northern China; this split occurred ca. 2.84 million year ago. The majority of populations from the mountains of northern China were dominated by a single haplotype or ribotype, while populations of the HM harbored both high genetic diversity and high haplotype diversity. This distribution pattern indicates that HM was either a diversification center or a refugium for R. kirilowii during the Quaternary climatic oscillations. The present distribution of this species on mountains in northern China may have resulted from a rapid glacial population expansion from the HM. This expansion was confirmed by the mismatch distribution analysis and negative Tajima's D and Fu's FS values, and was dated to ca. 168 thousand years ago. High genetic diversity and population differentiation in both plastid and ITS sequences were revealed; these imply restricted gene flow between populations. A distinct isolation-by-distance pattern was suggested by the Mantel test. Our results show that in old lineages, populations may harbour divergent genetic forms that are sufficient to maintain or even increase overall genetic diversity despite fragmentation and low within-population variation.	[Zhang, Jian-Qiang; Meng, Shi-Yong; Rao, Guang-Yuan] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China	Peking University	Rao, GY (corresponding author), Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China.	rao@pku.edu.cn		Meng, Shiyong/0000-0002-6855-2990	National Natural Science Foundation of China [31470313]; China Scholarship Council [201206010113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was supported by National Natural Science Foundation of China (Grant no. 31470313). JQZ has been supported by a scholarship for exchanging PhD candidates from the China Scholarship Council (No. 201206010113) for his studies at the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2008, MOL ECOL, V17, P5177, DOI 10.1111/j.1365-294X.2008.03971.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boufford D. E., 2004, HOTSPOTS REVISITED E, P159; Boufford D. E., 2000, HOTSPOTS EARTHS BIOL, P338; CARSON HL, 1990, TRENDS ECOL EVOL, V5, P228, DOI 10.1016/0169-5347(90)90137-3; Chen ST, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-58; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frei ES, 2012, ALPINE BOT, V122, P23, DOI 10.1007/s00035-012-0103-2; Fu K. T., 2001, FLORA CHINA, V8, P202, DOI DOI 10.11646/PHYTOTAXA.292.2.5; Fu YX, 1997, GENETICS, V147, P915; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gao QB, 2012, BOT J LINN SOC, V168, P204, DOI 10.1111/j.1095-8339.2011.01193.x; Gao YD, 2013, MOL PHYLOGENET EVOL, V68, P443, DOI 10.1016/j.ympev.2013.04.026; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; Hamilton MB, 1999, MOL ECOL, V8, P521; HARPENDING HC, 1994, HUM BIOL, V66, P591; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hou Y, 2013, J HERED, V105, P101; Hou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024497; Jia DR, 2012, NEW PHYTOL, V194, P1123, DOI 10.1111/j.1469-8137.2012.04115.x; Jia DR, 2011, BIOL J LINN SOC, V102, P37, DOI 10.1111/j.1095-8312.2010.01553.x; Li B.Y., 1987, J MT RES, V5, P74; Li BY., 1989, J MOUNTAIN RES, V7, P13; Li J., 1995, UPLIFT QINGHAI XIZAN; Li L, 2013, MOL ECOL, V22, P5237, DOI 10.1111/mec.12466; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; LIU KB, 1988, QUATERNARY SCI REV, V7, P1, DOI 10.1016/0277-3791(88)90089-3; Liu L, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085920, 10.1371/journal.pone.0088791]; Liu PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048970; Mayr E., 1942, P1; Mayuzumi S, 2004, SYST BOT, V29, P587, DOI 10.1600/0363644041744329; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Meng LH, 2008, J SYST EVOL, V46, P32, DOI 10.3724/SP.J.1002.2008.07026; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schneider S, 1999, GENETICS, V152, P1079; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Shimono Y, 2009, AM J BOT, V96, P728, DOI 10.3732/ajb.0800242; SINGH JS, 1987, BOT REV, V53, P80, DOI 10.1007/BF02858183; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Sun Hang, 2002, Acta Botanica Yunnanica, V24, P273; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Tang L.Y., 1996, ACTA MICROPALAEONTOL, V44, P872; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang LY, 2009, J INTEGR PLANT BIOL, V51, P698, DOI 10.1111/j.1744-7909.2009.00818.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang W, 1993, VASCULAR PLANTS HENG, V1; Wang W., 1994, VASCULAR PLANTS HENG, V2; Wang W.-T., 1992, ACTA PHYTOTAXONOMICA, V30, P97; WANG WT, 1992, ACTA PHYTOTAXON SIN, V30, P1, DOI DOI 10.4324/9780429500190-1; Wang YJ, 2007, ANN BOT-LONDON, V99, P311, DOI 10.1093/aob/mcl259; WILSON E O, 1992; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wu, 1980, VEGETATION CHINA; Wu ZY, 1987, FLORA XIZANGICA, P874; Wu ZY, 1988, J JPN BOT, V63, P1; Xu TT, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-194; Yamane K, 2006, DNA RES, V13, P197, DOI 10.1093/dnares/dsl012; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; YOUNG AG, 1993, HEREDITY, V71, P277, DOI 10.1038/hdy.1993.136; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang JQ, 2014, MOL PHYLOGENET EVOL, V77, P147, DOI 10.1016/j.ympev.2014.04.013; Zhang JQ, 2014, SYST BOT, V39, P441, DOI 10.1600/036364414X680753; Zhang Q, 2005, ACTA PHYTOTAXON SIN, V43, P503, DOI 10.1360/aps040148; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009; Zhang YH, 2010, MOL PHYLOGENET EVOL, V57, P1162, DOI 10.1016/j.ympev.2010.08.033; Zheng D, 1996, SCI CHINA SER D, V39, P410	97	20	20	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112923	10.1371/journal.pone.0112923	http://dx.doi.org/10.1371/journal.pone.0112923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389750	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400143
J	Cai, M; Zhou, YH; Zhou, B; Lou, SJ				Cai, Ming; Zhou, Yuehui; Zhou, Bin; Lou, Shujie			Hypoxic Conditioned Medium from Rat Cerebral Cortical Cells Enhances the Proliferation and Differentiation of Neural Stem Cells Mainly through PI3-K/Akt Pathways	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; NEURONAL DIFFERENTIATION; EXPRESSION; NEUROGENESIS; OXYGEN; BDNF; VEGF; RECEPTORS; MIGRATION; ISCHEMIA	Purpose: To investigate the effects of hypoxic conditioned media from rat cerebral cortical cells on the proliferation and differentiation of neural stem cells (NSCs) in vitro, and to study the roles of PI3-K/Akt and JNK signal transduction pathways in these processes. Methods: Cerebral cortical cells from neonatal Sprague-Dawley rat were cultured under hypoxic and normoxic conditions; the supernatant was collected and named 'hypoxic conditioned medium' (HCM) and 'normoxic conditioned medium' (NCM), respectively. We detected the protein levels (by ELISA) of VEGF and BDNF in the conditioned media and mRNA levels (by RT-PCR) in cerebral cortical cells. The proliferation (number and size of neurospheres) and differentiation (proportion of neurons and astrocytes over total cells) of NSCs was assessed. LY294002 and SP600125, inhibitors of PI3-K/Akt and JNK, respectively, were applied, and the phosphorylation levels of PI3-K/Akt and JNK were measured by western blot. Results: The protein levels and mRNA expressions of VEGF and BDNF in 4% HCM and 1% HCM were both higher than that of those in NCM. The efficiency and speed of NSCs proliferation was enhanced in 4% HCM compared with 1% HCM. The highest percentage of neurons and lowest percentage of astrocytes was found in 4% HCM. However, the enhancement of NSCs proliferation and differentiation into neurons accelerated by 4% HCM was inhibited by LY294002 and SP600125, with LY294002 having a stronger inhibitory effect. The increased phosphorylation levels of PI3-K, Akt and JNK in 4% HCM were blocked by LY294002 and SP600125. Conclusions: 4% HCM could promote NSCs proliferation and differentiation into high percentage of neurons, these processes may be mainly through PI3-K/Akt pathways.	[Cai, Ming; Zhou, Yuehui; Lou, Shujie] Shanghai Univ Sport, Shanghai Key Lab Human Sport Competence Dev & Mai, Shanghai, Peoples R China; [Zhou, Bin] E Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC USA	Shanghai University of Sport; University of North Carolina; East Carolina University	Lou, SJ (corresponding author), Shanghai Univ Sport, Shanghai Key Lab Human Sport Competence Dev & Mai, Shanghai, Peoples R China.	shujielou319@163.com			National Natural Science Foundation of China [30870349]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by National Natural Science Foundation of China (No. 30870349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Chanyshev B, 2012, MOL CELL BIOCHEM, V363, P167, DOI 10.1007/s11010-011-1169-7; Chavez-Valdez R, 2014, NEUROSCIENCE, V260, P106, DOI 10.1016/j.neuroscience.2013.12.023; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Dahl A, 2003, RAPID COMMUN MASS SP, V17, P2195, DOI 10.1002/rcm.1183; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; De Filippis L, 2011, CELL MOL LIFE SCI, V68, P2831, DOI 10.1007/s00018-011-0723-5; Demaurex N, 2009, NAT NEUROSCI, V12, P819, DOI 10.1038/nn0709-819; Fournier NM, 2012, NEUROPHARMACOLOGY, V63, P642, DOI 10.1016/j.neuropharm.2012.04.033; Gincberg G, 2012, BRIT MED BULL, V104, P7, DOI 10.1093/bmb/lds024; Go HS, 2009, NEUROIMMUNOMODULAT, V16, P365, DOI 10.1159/000228911; Greenberg DA, 2013, CELL MOL LIFE SCI, V70, P1753, DOI 10.1007/s00018-013-1282-8; Han Y, 2010, STEM CELLS, V28, P799, DOI 10.1002/stem.316; Helan M, 2014, J MOL CELL CARDIOL, V68, P89, DOI 10.1016/j.yjmcc.2014.01.006; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hogins J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025633; Horie N, 2008, CELL MOL NEUROBIOL, V28, P833, DOI 10.1007/s10571-007-9237-y; Hu JG, 2012, J MOL NEUROSCI, V46, P644, DOI 10.1007/s12031-011-9652-x; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jun EK, 2014, INT J MOL SCI, V15, P605, DOI 10.3390/ijms15010605; Kaneko Y, 2003, OPHTHALMIC RES, V35, P268, DOI 10.1159/000072148; Kanzawa T, 2006, ONCOGENE, V25, P3638, DOI 10.1038/sj.onc.1209414; Lameu C, 2012, J BIOL CHEM, V287, P29690, DOI 10.1074/jbc.M111.338095; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022901; Licht T, 2013, CELL MOL LIFE SCI, V70, P1727, DOI 10.1007/s00018-013-1280-x; Lo Furno D, 2013, J CELL PHYSIOL, V228, P2109, DOI 10.1002/jcp.24386; Mani N, 2010, J NEUROSCI RES, V88, P248, DOI 10.1002/jnr.22197; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Margaritescu O, 2011, ROM J MORPHOL EMBRYO, V52, P1283; Miller GE, 2006, P NATL ACAD SCI USA, V103, P5496, DOI 10.1073/pnas.0506312103; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Pizzuti A, 2011, ARCH ITAL BIOL, V149, P113, DOI 10.4449/aib.v149i1.1266; Rodgers EE, 2002, INT J DEV NEUROSCI, V20, P187, DOI 10.1016/S0736-5748(02)00047-3; Samoilov M, 2014, ACTA HISTOCHEM, V116, P949, DOI 10.1016/j.acthis.2014.03.009; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Spinella F, 2014, CARCINOGENESIS, V35, P840, DOI 10.1093/carcin/bgu018; Sun JQ, 2010, DEV DYNAM, V239, P2345, DOI 10.1002/dvdy.22377; Thomas K, 2005, CURR BIOL, V15, pR262, DOI 10.1016/j.cub.2005.03.023; Tonchev AB, 2011, ARCH ITAL BIOL, V149, P225, DOI 10.4449/aib.v149i2.1368; Uchida S, 2000, J NEUROSCI RES, V62, P585, DOI 10.1002/1097-4547(20001115)62:4<585::AID-JNR13>3.0.CO;2-U; Wada T, 2006, J NEUROSCI, V26, P6803, DOI 10.1523/JNEUROSCI.0526-06.2006; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Xu CS, 2013, SCI WORLD J, DOI 10.1155/2013/417413; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Ye PP, 2014, INT J MED SCI, V11, P17, DOI 10.7150/ijms.7329; Yung HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017894; Zhang K, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00005	49	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111938	10.1371/journal.pone.0111938	http://dx.doi.org/10.1371/journal.pone.0111938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386685	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400031
J	Wernet, MF; Klovstad, M; Clandinin, TR				Wernet, Mathias F.; Klovstad, Martha; Clandinin, Thomas R.			A Drosophila Toolkit for the Visualization and Quantification of Viral Replication Launched from Transgenic Genomes	PLOS ONE			English	Article							SINDBIS-VIRUS; SUPERINFECTION EXCLUSION; GENE-EXPRESSION; DENGUE VIRUS; INTERFERENCE; PROTEIN; CELLS; RNAI; ALPHAVIRUSES; VECTORS	Arthropod RNA viruses pose a serious threat to human health, yet many aspects of their replication cycle remain incompletely understood. Here we describe a versatile Drosophila toolkit of transgenic, self-replicating genomes ('replicons') from Sindbis virus that allow rapid visualization and quantification of viral replication in vivo. We generated replicons expressing Luciferase for the quantification of viral replication, serving as useful new tools for large-scale genetic screens for identifying cellular pathways that influence viral replication. We also present a new binary system in which replication-deficient viral genomes can be activated 'in trans', through co-expression of an intact replicon contributing an RNA- dependent RNA polymerase. The utility of this toolkit for studying virus biology is demonstrated by the observation of stochastic exclusion between replicons expressing different fluorescent proteins, when co-expressed under control of the same cellular promoter. This process is analogous to 'superinfection exclusion' between virus particles in cell culture, a process that is incompletely understood. We show that viral polymerases strongly prefer to replicate the genome that encoded them, and that almost invariably only a single virus genome is stochastically chosen for replication in each cell. Our in vivo system now makes this process amenable to detailed genetic dissection. Thus, this toolkit allows the cell-type specific, quantitative study of viral replication in a genetic model organism, opening new avenues for molecular, genetic and pharmacological dissection of virus biology and tool development.	[Wernet, Mathias F.; Klovstad, Martha; Clandinin, Thomas R.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Clandinin, TR (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	trc@stanford.edu			Helen Hay Whitney Foundation; National Institutes of Health Director's Pioneer Award [DP1 OD003530]; National Institutes of Health of the United States of America [R21NS081507]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081507] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003530] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Institutes of Health Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a post-doctoral fellowship from the Helen Hay Whitney Foundation (www. hhwf. org) to MFW; a National Institutes of Health Director's Pioneer Award (DP1 OD003530) to TRC; an R21NS081507 grant to TRC of the National Institutes of Health of the United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RH, 1985, J VIROL, V54, P351, DOI 10.1128/JVI.54.2.351-357.1985; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREDENBEEK PJ, 1993, J VIROL, V67, P6439, DOI 10.1128/JVI.67.11.6439-6446.1993; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Claus C, 2007, J GEN VIROL, V88, P2769, DOI 10.1099/vir.0.83092-0; Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004; Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436; Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DITTMAR D, 1982, J GEN VIROL, V59, P273, DOI 10.1099/0022-1317-59-2-273; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Frolova E, 1997, J VIROL, V71, P248, DOI 10.1128/JVI.71.1.248-258.1997; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; GEIGENMULLERGNIRKE U, 1991, P NATL ACAD SCI USA, V88, P3253, DOI 10.1073/pnas.88.8.3253; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hardy RW, 2005, J VIROL, V79, P4630, DOI 10.1128/JVI.79.8.4630-4639.2005; Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114; Hopkins KC, 2013, GENE DEV, V27, P1511, DOI 10.1101/gad.215384.113; Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12; Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7; JOHNSTON RE, 1974, J VIROL, V14, P1076, DOI 10.1128/JVI.14.5.1076-1082.1974; Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; LEMM JA, 1993, J VIROL, V67, P1916, DOI 10.1128/JVI.67.4.1916-1926.1993; LEVIS R, 1986, CELL, V44, P137, DOI 10.1016/0092-8674(86)90492-7; LEVIS R, 1990, J VIROL, V64, P1726, DOI 10.1128/JVI.64.4.1726-1733.1990; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Marshall JM, 2009, PLOS MED, V6, P164, DOI 10.1371/journal.pmed.1000020; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Niklasson B., 1988, ARBOVIRUSES EPIDEMIO, VIV, P168; Noueiry AO, 2007, J VIROL, V81, P11992, DOI 10.1128/JVI.01358-07; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Olson KE, 2000, INSECT MOL BIOL, V9, P57, DOI 10.1046/j.1365-2583.2000.00162.x; Patel RK, 2012, J VIROL, V86, P3595, DOI 10.1128/JVI.06625-11; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x; Schlesinger, 1986, TOGAVIRIDAE FLAVIVIR, P35, DOI 10.1007/978-1-4757-0785-4_3; SCHLESINGER S, 1993, TRENDS BIOTECHNOL, V11, P18, DOI 10.1016/0167-7799(93)90070-P; Schlesinger S, 1999, CURR OPIN BIOTECH, V10, P434, DOI 10.1016/S0958-1669(99)00006-3; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; STOLLAR V, 1973, J VIROL, V11, P592, DOI 10.1128/JVI.11.4.592-595.1973; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WEISS B, 1989, J VIROL, V63, P5310, DOI 10.1128/JVI.63.12.5310-5318.1989; Wernet MF, 2014, CURR BIOL, V24, pR107, DOI 10.1016/j.cub.2013.12.009; XIONG C, 1989, SCIENCE, V243, P1188, DOI 10.1126/science.2922607; Xu J, 2014, DEV COMP IMMUNOL, V42, P67, DOI 10.1016/j.dci.2013.05.002; Zhu YP, 2008, RNA BIOL, V5, P65, DOI 10.4161/rna.5.2.6044; Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001; Zou G, 2009, J VIROL, V83, P11765, DOI 10.1128/JVI.01205-09	59	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112092	10.1371/journal.pone.0112092	http://dx.doi.org/10.1371/journal.pone.0112092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386852	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400040
J	Joya, X; Garcia-Algar, O; Vall, O; Pujades, C				Joya, Xavier; Garcia-Algar, Oscar; Vall, Oriol; Pujades, Cristina			Transient Exposure to Ethanol during Zebrafish Embryogenesis Results in Defects in Neuronal Differentiation: An Alternative Model System to Study FASD	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; SONIC HEDGEHOG; MOTOR-NEURONS; HINDBRAIN DEVELOPMENT; PRENATAL EXPOSURE; CRITICAL PERIODS; STEM-CELLS; IN-VIVO; EXPRESSION; PROTEIN	Background: The exposure of the human embryo to ethanol results in a spectrum of disorders involving multiple organ systems, including the impairment of the development of the central nervous system (CNS). In spite of the importance for human health, the molecular basis of prenatal ethanol exposure remains poorly understood, mainly to the difficulty of sample collection. Zebrafish is now emerging as a powerful organism for the modeling and the study of human diseases. In this work, we have assessed the sensitivity of specific subsets of neurons to ethanol exposure during embryogenesis and we have visualized the sensitive embryonic developmental periods for specific neuronal groups by the use of different transgenic zebrafish lines. Methodology/Principal Findings: In order to evaluate the teratogenic effects of acute ethanol exposure, we exposed zebrafish embryos to ethanol in a given time window and analyzed the effects in neurogenesis, neuronal differentiation and brain patterning. Zebrafish larvae exposed to ethanol displayed small eyes and/or a reduction of the body length, phenotypical features similar to the observed in children with prenatal exposure to ethanol. When neuronal populations were analyzed, we observed a clear reduction in the number of differentiated neurons in the spinal cord upon ethanol exposure. There was a decrease in the population of sensory neurons mainly due to a decrease in cell proliferation and subsequent apoptosis during neuronal differentiation, with no effect in motoneuron specification. Conclusion: Our investigation highlights that transient exposure to ethanol during early embryonic development affects neuronal differentiation although does not result in defects in early neurogenesis. These results establish the use of zebrafish embryos as an alternative research model to elucidate the molecular mechanism(s) of ethanol-induced developmental toxicity at very early stages of embryonic development.	[Joya, Xavier; Garcia-Algar, Oscar; Vall, Oriol] Inst Hosp Mar Invest Med, Unitat Recerca Infancia & Entorn, Barcelona, Spain; [Joya, Xavier; Garcia-Algar, Oscar; Vall, Oriol] Inst Carlos III, Programa RETICS, Red Salud Maternoinfantil & Desarrollo SAMID, Madrid, Spain; [Garcia-Algar, Oscar; Vall, Oriol] Univ Autonoma Barcelona, Dept Pediat Ginecol & Obstet & Med Prevent, Bellaterra, Spain; [Pujades, Cristina] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain	Autonomous University of Barcelona; Pompeu Fabra University	Pujades, C (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Parc Recerca Biomed Barcelona, Barcelona, Spain.	cristina.pujades@upf.edu	Pujades, Cristina/F-7908-2014	Pujades, Cristina/0000-0001-6423-7451; GARCIA-ALGAR, OSCAR/0000-0001-5708-4362	Fondo de Investigaciones Sanitarias (FIS) [PI10/02593, PI13/01135]; Red de Salud Materno-Infantil y del Desarrollo (SAMID) from the Instituto Carlos III (Spain) [RD12/0026/0003]; Mutua Madrilena [AP150572014]; Neuroscience Program at IMIM (Institut Hospital del Mar d'Investigacions Mediques); Generalitat de Catalunya (Spain) [2009SGR1388, 2014SGR584]; Spanish Ministry of Economy and Competitiveness [BFU2012-31994]	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Red de Salud Materno-Infantil y del Desarrollo (SAMID) from the Instituto Carlos III (Spain); Mutua Madrilena; Neuroscience Program at IMIM (Institut Hospital del Mar d'Investigacions Mediques); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by grants from Fondo de Investigaciones Sanitarias (FIS) (PI10/02593; PI13/01135) and Red de Salud Materno-Infantil y del Desarrollo (SAMID) (RD12/0026/0003) from the Instituto Carlos III (Spain), a grant from Mutua Madrilena (AP150572014), intramural funding of the Neuroscience Program at IMIM (Institut Hospital del Mar d'Investigacions Mediques), partially supported by Generalitat de Catalunya (Spain) (2009SGR1388; 2014SGR584) and from Spanish Ministry of Economy and Competitiveness (BFU2012-31994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL EL, 1986, LANCET, V2, P1222; Ahlgren SC, 2002, P NATL ACAD SCI USA, V99, P10476, DOI 10.1073/pnas.162356199; Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; Aoto K, 2008, BIRTH DEFECTS RES A, V82, P224, DOI 10.1002/bdra.20447; Arenzana FJ, 2006, NEUROTOXICOL TERATOL, V28, P342, DOI 10.1016/j.ntt.2006.02.001; Astley SJ, 1996, J PEDIATR-US, V129, P33, DOI 10.1016/S0022-3476(96)70187-7; Benz J, 2009, PAED CHILD HEALT-CAN, V14, P231, DOI 10.1093/pch/14.4.231; Bilotta J, 2004, NEUROTOXICOL TERATOL, V26, P737, DOI 10.1016/j.ntt.2004.06.011; Blader P, 1998, DEV BIOL, V201, P185, DOI 10.1006/dbio.1998.8995; Calzolari S, 2014, EMBO J, V33, P686, DOI 10.1002/embj.201386003; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Church MW, 1997, ALCOHOL CLIN EXP RES, V21, P495; CLARREN SK, 1978, J PEDIATR-US, V92, P64, DOI 10.1016/S0022-3476(78)80072-9; Coffey CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053991; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Dlugos CA, 2003, PHARMACOL BIOCHEM BE, V74, P471, DOI 10.1016/S0091-3057(02)01026-2; DRISCOLL CD, 1990, NEUROTOXICOL TERATOL, V12, P231, DOI 10.1016/0892-0362(90)90094-S; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Flentke GR, 2014, ALCOHOL CLIN EXP RES, V38, P1255, DOI 10.1111/acer.12360; Gemma S, 2007, NEUROSCI BIOBEHAV R, V31, P221, DOI 10.1016/j.neubiorev.2006.06.018; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Giles S, 2008, REPROD TOXICOL, V25, P224, DOI 10.1016/j.reprotox.2007.11.014; GUERRI C, 1990, NEUROCHEM RES, V15, P559, DOI 10.1007/BF00966217; Guo S, 2004, GENES BRAIN BEHAV, V3, P63, DOI 10.1046/j.1601-183X.2003.00053.x; Heaton MB, 1999, DEV NEUROSCI-BASEL, V21, P444, DOI 10.1159/000017412; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; JONES KL, 1973, LANCET, V2, P999; Kalberg WO, 2006, ALCOHOL CLIN EXP RES, V30, P2037, DOI 10.1111/j.1530-0277.2006.00250.x; Kanungo J, 2009, BIOCHEM BIOPH RES CO, V386, P263, DOI 10.1016/j.bbrc.2009.06.038; Kashyap B, 2007, VISUAL NEUROSCI, V24, P409, DOI 10.1017/S0952523807070423; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; Loucks EJ, 2009, BIRTH DEFECTS RES A, V85, P556, DOI 10.1002/bdra.20564; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Marrs JA, 2010, ALCOHOL, V44, P707, DOI 10.1016/j.alcohol.2009.03.004; McCarthy N, 2013, DEVELOPMENT, V140, P3254, DOI 10.1242/dev.094938; McGraw HF, 2008, J NEUROSCI, V28, P12558, DOI 10.1523/JNEUROSCI.2079-08.2008; Ogony JW, 2013, STEM CELLS DEV, V22, P2196, DOI 10.1089/scd.2012.0513; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; PENNINGTON SN, 1983, NEUROBEH TOXICOL TER, V5, P259; Pinto-Teixeira F, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00033; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Reimers MJ, 2006, NEUROTOXICOL TERATOL, V28, P497, DOI 10.1016/j.ntt.2006.05.007; Reimers MJ, 2004, NEUROTOXICOL TERATOL, V26, P769, DOI 10.1016/j.ntt.2004.06.012; Sapede D, 2012, J NEUROSCI, V32, P16424, DOI 10.1523/JNEUROSCI.3686-12.2012; Sato T, 2006, GENESIS, V44, P136, DOI 10.1002/gene.20196; Simmons RW, 2002, ALCOHOL CLIN EXP RES, V26, P1412, DOI 10.1097/01.ALC.0000030563.14827.29; STAISEY NL, 1983, J STUD ALCOHOL, V44, P262, DOI 10.15288/jsa.1983.44.262; STREISSGUTH AP, 1980, SCIENCE, V209, P353, DOI 10.1126/science.6992275; Stromland K, 2002, ALCOHOL ALCOHOLISM, V37, P2, DOI 10.1093/alcalc/37.1.2; SULIK KK, 1981, SCIENCE, V214, P936, DOI 10.1126/science.6795717; SULIK KK, 1988, DEVELOPMENT, V103, P213; Swartz ME, 2014, ALCOHOL CLIN EXP RES, V38, P694, DOI 10.1111/acer.12286; Sylvain NJ, 2011, NEUROTOXICOL TERATOL, V33, P313, DOI 10.1016/j.ntt.2010.12.001; Sylvain NJ, 2010, NEUROTOXICOL TERATOL, V32, P472, DOI 10.1016/j.ntt.2010.03.001; Talens-Visconti R, 2011, STEM CELLS DEV, V20, P327, DOI 10.1089/scd.2010.0037; TANABE Y, 1995, CURR BIOL, V5, P651, DOI 10.1016/S0960-9822(95)00130-8; Tingling JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069560; Vangipuram SD, 2012, ALCOHOL CLIN EXP RES, V36, P788, DOI 10.1111/j.1530-0277.2011.01682.x; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Zhang CJ, 2014, NEUROTOXICOL TERATOL, V44, P70, DOI 10.1016/j.ntt.2014.06.001; Zhang CJ, 2013, BIRTH DEFECTS RES A, V97, P8, DOI 10.1002/bdra.23099; Zhang CJ, 2011, BIRTH DEFECTS RES A, V91, P129, DOI 10.1002/bdra.20766; Zhou FC, 2011, ALCOHOL CLIN EXP RES, V35, P735, DOI 10.1111/j.1530-0277.2010.01391.x	65	29	29	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112851	10.1371/journal.pone.0112851	http://dx.doi.org/10.1371/journal.pone.0112851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383948	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700100
J	Singh, P; Zheng, XL				Singh, Pavneet; Zheng, Xi-Long			Dual Regulation of Myocardin Expression by Tumor Necrosis Factor-alpha in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							MESSENGER-RNA STABILITY; NF-KAPPA-B; TNF-ALPHA; GENE-EXPRESSION; ACTIVATION; PROLIFERATION; INDUCTION; ATHEROSCLEROSIS; DIFFERENTIATION; TRISTETRAPROLIN	De-differentiation of vascular smooth muscle cells (VSMCs) plays a critical role in the development of atherosclerosis, a chronic inflammatory disease involving various cytokines such as tumor necrosis factor-alpha (TNF alpha). Myocardin is a co-factor of serum response factor (SRF) and is considered to be the master regulator of VSMC differentiation. It binds to SRF and regulates the expression of contractile proteins in VSMCs. Myocardin is also known to inhibit VSMC proliferation by inhibiting the NF-kappa B pathway, whereas TNF alpha is known to activate the NF-kappa B pathway in VSMCs. NF-kappa B activation has also been shown to inhibit myocardin expression and smooth muscle contractile marker genes. However, it is not definitively known whether TNF alpha regulates the expression and activity of myocardin in VSMCs. The current study aimed to investigate the role of TNF alpha in regulating myocardin and VSMC function. Our studies showed that TNF alpha down-regulated myocardin expression and activity in cultured VSMCs by activating the NF-kappa B pathway, resulting in decreased VSMC contractility and increased VSMC proliferation. Surprisingly, we also found that TNF alpha prevented myocardin mRNA degradation, and resulted in a further significant increase in myocardin expression and activity in differentiated VSMCs. Both the NF-kappa B and p44/42 MAPK pathways were involved in TNF alpha regulation of myocardin, which further increased the contractility of VSMCs. These differential effects of TNF alpha on myocardin seemingly depended on whether VSMCs were in a differentiated or dedifferentiated state. Taken together, our results demonstrate that TNF alpha differentially regulates myocardin expression and activity, which may play a key role in regulating VSMC functions.	[Singh, Pavneet; Zheng, Xi-Long] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp,Libin Cardiovasc Inst Alber, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	Zheng, XL (corresponding author), Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Smooth Muscle Res Grp,Libin Cardiovasc Inst Alber, Calgary, AB, Canada.	xlzheng@ucalgary.ca		Zheng, Xi-Long/0000-0002-0889-1827	Canadian Institutes of Health Research [CIHR MOP-119511]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institutes of Health Research (CIHR MOP-119511 to X.-L. Z.) (http://www.cihr-irsc.gc.ca/e/193.html). X.-L.Z. is the recipient of a Senior Scholar Award of Alberta Innovates - Health Solutions (AIHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2013, J CEREBR BLOOD F MET, V33, P1564, DOI 10.1038/jcbfm.2013.109; Armstrong SJ, 2008, NEUROSCI LETT, V439, P42, DOI 10.1016/j.neulet.2008.04.091; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chen J, 2011, ARTERIOSCL THROM VAS, V31, P368, DOI 10.1161/ATVBAHA.110.218149; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Croft D, 1999, AM J PATHOL, V154, P1149, DOI 10.1016/S0002-9440(10)65367-9; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Deptala A, 1998, CYTOMETRY, V33, P376, DOI 10.1002/(SICI)1097-0320(19981101)33:3<376::AID-CYTO13>3.0.CO;2-Q; Gordon D, 1987, AM J CARDIOL, V59, p44A; Goto K, 2009, J PHARMACOL SCI, V110, P437, DOI 10.1254/jphs.09081FP; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; HAYES MP, 1995, CYTOKINE, V7, P427, DOI 10.1006/cyto.1995.0058; Henness S, 2006, AM J PHYSIOL-LUNG C, V290, pL1283, DOI 10.1152/ajplung.00367.2005; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Huang ZF, 2000, BIOCHEM PHARMACOL, V59, P187, DOI 10.1016/S0006-2952(99)00312-3; Jiang YL, 2010, J CELL PHYSIOL, V225, P506, DOI 10.1002/jcp.22230; Jones Edward, 2007, J Inflamm (Lond), V4, P23, DOI 10.1186/1476-9255-4-23; Le Roy F, 2001, J BIOL CHEM, V276, P48473, DOI 10.1074/jbc.M107482200; Lee SJ, 2011, MOL MED REP, V4, P337, DOI 10.3892/mmr.2011.420; Li SH, 2001, CIRC RES, V89, P517, DOI 10.1161/hh1801.097165; LIBBY P, 1992, NOUV REV FR HEMATOL, V34, pS47; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; NG SB, 1994, J BIOL CHEM, V269, P19021; Ohama T, 2007, AM J PHYSIOL-GASTR L, V292, pG1429, DOI 10.1152/ajpgi.00315.2006; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Perez-Ortin JE, 2013, J MOL BIOL, V425, P3750, DOI 10.1016/j.jmb.2013.02.029; POBER JS, 1990, PHYSIOL REV, V70, P427, DOI 10.1152/physrev.1990.70.2.427; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sachs A, 1990, CURR OPIN CELL BIOL, V2, P1092, DOI 10.1016/0955-0674(90)90161-7; Selzman CH, 1999, ANN THORAC SURG, V67, P1227, DOI 10.1016/S0003-4975(99)00252-0; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Taurin S, 2009, J BIOL CHEM, V284, P33789, DOI 10.1074/jbc.M109.048983; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yin H, 2011, J CELL PHYSIOL, V226, P1897, DOI 10.1002/jcp.22519; Yoshida T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000230	40	12	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112120	10.1371/journal.pone.0112120	http://dx.doi.org/10.1371/journal.pone.0112120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384061	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700031
J	Zhou, Z; Hu, TS; Xu, ZH; Lin, ZH; Zhang, ZS; Feng, T; Zhu, LC; Rong, YP; Shen, H; Luk, JM; Zhang, XW; Qin, N				Zhou, Zheng; Hu, Taishan; Xu, Zhiheng; Lin, Zhaohu; Zhang, Zhisen; Feng, Teng; Zhu, Liangcheng; Rong, Yiping; Shen, Hong; Luk, John M.; Zhang, Xiongwen; Qin, Ning			Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides	FASEB JOURNAL			English	Article						disulfide cyclization; HCC xenograft; TEAD-YAP crystal structure	ORGAN SIZE CONTROL; YES-ASSOCIATED PROTEIN; TRANSCRIPTION FACTORS; CELL-PROLIFERATION; SIGNALING PATHWAY; APOPTOSIS; VALIDATION; STABILITY; MUTATION; ROLES	Hippo signaling pathway is emerging as a novel target for anticancer therapy because it plays key roles in organ size control and tumorigenesis. As the downstream effectors, Yes-associated protein (YAP)transcriptional enhancer activation domain family member (TEAD) association is essential for YAP-driven oncogenic activity, while TEAD is largely dispensable for normal tissue growth. We present the design of YAP-like peptides (17mer) to occupy the interface 3 on TEAD. Introducing cysteines at YAP sites 87 and 96 can induce disulfide formation, as confirmed by crystallography. The engineered peptide significantly improves the potency in disrupting YAP-TEAD interaction in vitro. To confirm that blocking YAP-TEAD complex formation by directly targeting on TEAD is a valid approach, we report a significant reduction in tumor growth rate in a hepatocellular carcinoma xenograft model after introducing the dominant-negative mutation (Y406H) of TEAD1 to abolish YAP-TEAD interaction. Our results suggest that targeting TEAD is a promising strategy against YAP-induced oncogenesis.-Zhou, Z., Hu, T., Xu, Z., Lin, Z., Zhang, Z., Feng, T., Zhu, L., Rong, Y., Shen, H., Luk, J. M., Zhang, X., Qin, N. Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides.	[Zhou, Zheng; Hu, Taishan; Xu, Zhiheng; Lin, Zhaohu; Zhang, Zhisen; Feng, Teng; Zhu, Liangcheng; Rong, Yiping; Shen, Hong; Luk, John M.; Zhang, Xiongwen; Qin, Ning] Roche Innovat Ctr Shanghai, Shanghai 201203, Peoples R China		Zhou, Z (corresponding author), Roche Innovat Ctr Shanghai, Bldg 5,Lane 720,Cai Lun Rd, Shanghai 201203, Peoples R China.	joe.zhou.jz2@roche.com	Luk, John/A-4085-2008	Luk, John/0000-0002-6323-7940				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562; Daniels DS, 2007, J AM CHEM SOC, V129, P14578, DOI 10.1021/ja0772445; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fossdal R, 2004, HUM MOL GENET, V13, P975, DOI 10.1093/hmg/ddh106; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gentilucci L, 2010, CURR PHARM DESIGN, V16, P3185, DOI 10.2174/138161210793292555; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hilman D, 2011, MOL BIOL EVOL, V28, P2403, DOI 10.1093/molbev/msr065; Hruby VJ, 2002, NAT REV DRUG DISCOV, V1, P847, DOI 10.1038/nrd939; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lu J, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/187070; Luk JM, 2014, NAT MED, V20, P587, DOI 10.1038/nm.3593; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Park HW, 2013, TRENDS PHARMACOL SCI, V34, P581, DOI 10.1016/j.tips.2013.08.006; Pernot M, 2011, EXPERT OPIN DRUG MET, V7, P793, DOI 10.1517/17425255.2011.574126; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Pobbati AV, 2012, STRUCTURE, V20, P1135, DOI 10.1016/j.str.2012.04.004; Roxin A, 2012, FUTURE MED CHEM, V4, P1601, DOI [10.4155/FMC.12.75, 10.4155/fmc.12.75]; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; Stanger BZ, 2012, GENE DEV, V26, P1263, DOI 10.1101/gad.196501.112; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tschaharganeh DF, 2013, GASTROENTEROLOGY, V144, P1530, DOI 10.1053/j.gastro.2013.02.009; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang ZZ, 2014, ACS MED CHEM LETT, V5, P993, DOI 10.1021/ml500160m; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	50	96	102	2	37	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					724	732		10.1096/fj.14-262980	http://dx.doi.org/10.1096/fj.14-262980			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25384421				2022-12-26	WOS:000349370400032
J	Barnes, M; van Rensburg, G; Li, WM; Mehmood, K; Mackedenski, S; Chan, CM; King, DT; Miller, AL; Lee, CH				Barnes, Mark; van Rensburg, Gerrit; Li, Wai-Ming; Mehmood, Kashif; Mackedenski, Sebastian; Chan, Ching-Man; King, Dustin T.; Miller, Andrew L.; Lee, Chow H.			Molecular Insights into the Coding Region Determinant-binding Protein-RNA Interaction through Site-directed Mutagenesis in the Heterogeneous Nuclear Ribonucleoprotein-K-homology Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA; RNA-binding Protein; RNA Metabolism; RNA Processing; RNA Turnover; RNA-Protein Interaction	MYC MESSENGER-RNA; C-MYC; CRD-BP; CELL-MIGRATION; CANCER-CELLS; IN-VITRO; GROWTH; IMP1; ENDORIBONUCLEASE; IDENTIFICATION	Background: Coding region determinant-binding protein (CRD-BP) interacts physically with oncogenic mRNAs. Results: Point mutation in the K-homology (KH) domains of CRD-BP abolishes its RNA-binding ability. Conclusion: Two KH domains of CRD-BP are required for efficient binding to oncogenic mRNAs and for granule formation in zebrafish embryos. Significance: Learning how the KH domains interact with mRNAs is crucial for understanding oncogenic function of CRD-BP. The ability of its four heterogeneous nuclear RNP-K-homology (KH) domains to physically associate with oncogenic mRNAs is a major criterion for the function of the coding region determinant-binding protein (CRD-BP). However, the particular RNA-binding role of each of the KH domains remains largely unresolved. Here, we mutated the first glycine to an aspartate in the universally conserved GXXG motif of the KH domain as an approach to investigate their role. Our results show that mutation of a single GXXG motif generally had no effect on binding, but the mutation in any two KH domains, with the exception of the combination of KH3 and KH4 domains, completely abrogated RNA binding in vitro and significantly retarded granule formation in zebrafish embryos, suggesting that any combination of at least two KH domains cooperate in tandem to bind RNA efficiently. Interestingly, we found that any single point mutation in one of the four KH domains significantly impacted CRD-BP binding to mRNAs in HeLa cells, suggesting that the dynamics of the CRD-BP-mRNA interaction vary over time in vivo. Furthermore, our results suggest that different mRNAs bind preferentially to distinct CRD-BP KH domains. The novel insights revealed in this study have important implications on the understanding of the oncogenic mechanism of CRD-BP as well as in the future design of inhibitors against CRD-BP function.	[Barnes, Mark; van Rensburg, Gerrit; Li, Wai-Ming; Mehmood, Kashif; Mackedenski, Sebastian; King, Dustin T.; Lee, Chow H.] Univ No British Columbia, Chem Program, Prince George, BC V2N 4Z9, Canada; [Chan, Ching-Man; Miller, Andrew L.] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Chan, Ching-Man; Miller, Andrew L.] Hong Kong Univ Sci & Technol, Key State Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Miller, Andrew L.] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Northern British Columbia; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Marine Biological Laboratory - Woods Hole	Lee, CH (corresponding author), Univ No British Columbia, Chem Program, 3333 Univ Way, Prince George, BC V2N 4Z9, Canada.	chow.lee@unbc.ca		Miller, Andrew/0000-0003-0237-317X; King, Dustin/0000-0003-1775-2885	Natural Sciences and Engineering Research Council [227158]; University of Northern British Columbia; French National Research Agency/Hong Kong Research Grants Council Joint Research Scheme [A-HKUST601/13]; Natural Sciences and Engineering Research Council; British Columbia Cancer Agency	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Northern British Columbia; French National Research Agency/Hong Kong Research Grants Council Joint Research Scheme(French National Research Agency (ANR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); British Columbia Cancer Agency	This work was supported in part by Discovery Grant 227158 from Natural Sciences and Engineering Research Council (to C. H. L.), University of Northern British Columbia research project awards (to M. B., G. V. R., K. M., and S. M.), and the French National Research Agency/Hong Kong Research Grants Council Joint Research Scheme A-HKUST601/13 (to A. L. M.).; Recipient of Natural Sciences and Engineering Research Council undergraduate student research awards and a British Columbia Cancer Agency summer studentship.	Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; BERNSTEIN PL, 1992, GENE DEV, V6, P642, DOI 10.1101/gad.6.4.642; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Coulis CM, 2000, MOL PHARMACOL, V57, P485, DOI 10.1124/mol.57.3.485; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Git A, 2002, RNA, V8, P1319, DOI 10.1017/S135583820202705X; Gu W, 2008, MOL CELL BIOL, V28, P4963, DOI 10.1128/MCB.00266-08; Gutschner T, 2014, HEPATOLOGY, V59, P1900, DOI 10.1002/hep.26997; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hamilton KE, 2013, CARCINOGENESIS, V34, P2647, DOI 10.1093/carcin/bgt217; Hansen TVO, 2004, MOL CELL BIOL, V24, P4448, DOI 10.1128/MCB.24.10.4448-4464.2004; Hollingworth D, 2012, NUCLEIC ACIDS RES, V40, P6873, DOI 10.1093/nar/gks368; Ioannidis P, 2005, J BIOL CHEM, V280, P20086, DOI 10.1074/jbc.M410036200; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kim Wan-Cheol, 2010, Int J Biochem Mol Biol, V1, P12; King DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091585; Leeds P, 1997, ONCOGENE, V14, P1279, DOI 10.1038/sj.onc.1201093; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Lin Q, 1997, J BIOL CHEM, V272, P27274, DOI 10.1074/jbc.272.43.27274; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Mongroo PS, 2011, CANCER RES, V71, P2172, DOI 10.1158/0008-5472.CAN-10-3295; Nielsen FC, 2002, J CELL SCI, V115, P2087; Nielsen J, 2004, NUCLEIC ACIDS RES, V32, P4368, DOI 10.1093/nar/gkh754; Nielsen J, 2003, BIOCHEM J, V376, P383, DOI 10.1042/BJ20030943; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Noubissi FK, 2009, CANCER RES, V69, P8572, DOI 10.1158/0008-5472.CAN-09-1500; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; PROKIPCAK RD, 1994, J BIOL CHEM, V269, P9261; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sparanese D, 2007, NUCLEIC ACIDS RES, V35, P1209, DOI 10.1093/nar/gkl1148; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Tafech A, 2007, BBA-GENE STRUCT EXPR, V1769, P49, DOI 10.1016/j.bbaexp.2006.11.009; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Wachter K, 2013, BIOL CHEM, V394, P1077, DOI 10.1515/hsz-2013-0111; Webb SE, 1997, DEV BIOL, V192, P78, DOI 10.1006/dbio.1997.8724; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Yaniv K, 2003, DEVELOPMENT, V130, P5649, DOI 10.1242/dev.00810; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhou Y, 2002, J MOL BIOL, V318, P1175, DOI 10.1016/S0022-2836(02)00238-3	43	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					625	639		10.1074/jbc.M114.614735	http://dx.doi.org/10.1074/jbc.M114.614735			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389298	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000347231200054
J	Guo, S; Ling, F; Hou, J; Wang, JN; Fu, GM; Gong, ZY				Guo, Song; Ling, Feng; Hou, Juan; Wang, Jinna; Fu, Guiming; Gong, Zhenyu			Mosquito Surveillance Revealed Lagged Effects of Mosquito Abundance on Mosquito-Borne Disease Transmission: A Retrospective Study in Zhejiang, China	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; CLIMATE-CHANGE; DENGUE-FEVER; MALARIA; INFECTION; WEATHER; IMPACT; POPULATIONS; OUTBREAK; VECTORS	Mosquito-borne diseases (MBDs) are still threats to public health in Zhejiang. In this study, the associations between the time-lagged mosquito capture data and MBDs incidence over five years were used to examine the potential effects of mosquito abundance on patterns of MBDs epidemiology in Zhejiang during 2008-2012. Light traps were used to collect adult mosquitoes at 11 cities. Correlation tests with and without time lag were performed to investigate the correlations between MBDs incidence rates and mosquito abundance by month. Selected MBDs consisted of Japanese encephalitis (JE), dengue fever (DF) and malaria. A Poisson regression analysis was performed by using a generalized estimating equations (GEE) approach, and the most parsimonious model was selected based on the quasi-likelihood based information criterion (QICu). We identified five mosquito species and the constituent ratio of Culex pipiens pallens, Culex tritaeniorhynchus, Aedes albopictus, Anopheles sinensis and Armigeres subalbatus was 66.73%, 21.47%, 6.72%, 2.83% and 2.25%, respectively. The correlation analysis without and with time lag showed that Culex mosquito abundance at a lag of 0 or 1 month was positively correlated with JE incidence during 2008-2012, Ae. albopictus abundance at a lag of 1 month was positively correlated with DF incidence in 2009, and An. sinensis abundance at a lag of 0-2 months was positively correlated with malaria incidence during 2008-2010. The Poisson regression analysis showed each 0.1 rise of monthly mosquito abundance corresponded to a positive increase of MBD cases for the period of 2008-2012. The rise of mosquito abundance with a lag of 0-2 months increased the risk of human MBDs infection in Zhejiang. Our study provides evidence that mosquito monitoring could be a useful early warning tool for the occurrence and transmission of MBDs.	[Guo, Song; Ling, Feng; Hou, Juan; Wang, Jinna; Fu, Guiming; Gong, Zhenyu] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Gong, ZY (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	zhygong@cdc.zj.cn			Project of the State Scientific & Technological Development of the 12th Five Year Plan grant of China [2012ZX10004219]	Project of the State Scientific & Technological Development of the 12th Five Year Plan grant of China	This work was supported by the Project of the State Scientific & Technological Development of the 12th Five Year Plan grant of China (2012ZX10004219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrane YA, 2012, ANN NY ACAD SCI, V1249, P204, DOI 10.1111/j.1749-6632.2011.06432.x; Andrew NR, 2013, PEERJ, V1, DOI 10.7717/peerj.11; Angelini P, 2010, EUROSURVEILLANCE, V15, P11; Bai L, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-10; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Chuang TW, 2011, J MED ENTOMOL, V48, P669, DOI 10.1603/ME10246; Dhiman RC, 2010, PARASITOL RES, V106, P763, DOI 10.1007/s00436-010-1767-4; Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601; Erickson RA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034003; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Gosselin Pierre, 2005, Int J Health Geogr, V4, P21, DOI 10.1186/1476-072X-4-21; Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025; Griffith KS, 2007, JAMA-J AM MED ASSOC, V297, P2264, DOI 10.1001/jama.297.20.2264; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Gubler DJ, 2010, VECTOR BIOLOGY, ECOLOGY AND CONTROL, P39, DOI 10.1007/978-90-481-2458-9_4; Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x; Jiang T, 2009, ZHEJIANG PREY MED, V21, P30; Kabilan Lalitha, 2004, Indian Journal of Pediatrics, V71, P609, DOI 10.1007/BF02724120; KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1; Lebl K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-129; Lee SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068512; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Liu QY, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-224; Lu L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-395; Martins-Campos KM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-351; de Barros FSM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022388; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Petric D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-187; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6; Ruiz MO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-19; Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396; Tadei WP, 1998, AM J TROP MED HYG, V59, P325, DOI 10.4269/ajtmh.1998.59.325; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Wang HY, 2009, JPN J INFECT DIS, V62, P331; Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755; Xie Rong-hui, 2009, Zhonghua Yufang Yixue Zazhi, V43, P282, DOI 10.3760/cma.j.issn.0253-9624.2009.04.004; Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182; Yan J, 2005, CHINESE J VIROL, V22, P339; Yin JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074228; Yip K., 1998, Parassitologia (Rome), V40, P29; Zeller H, 2013, CLIN MICROBIOL INFEC, V19, P693, DOI 10.1111/1469-0691.12230; Zhang Hai-lin, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P428; Zhao XF, 2013, TROP BIOMED, V30, P267; Zheng YY, 2012, REV MED VIROL, V22, P301, DOI 10.1002/rmv.1710	48	14	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112975	10.1371/journal.pone.0112975	http://dx.doi.org/10.1371/journal.pone.0112975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393834	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300129
J	Ma, JQ; Yan, ZP; Luo, JJ; Liu, QX; Wang, JH; Qiu, SJ				Ma, Jingqin; Yan, Zhiping; Luo, Jianjun; Liu, Qingxin; Wang, Jianhua; Qiu, Shijing			Rational Classification of Portal Vein Thrombosis and Its Clinical Significance	PLOS ONE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNT; VENOUS THROMBOSIS; MANAGEMENT; CIRRHOSIS; THERAPY; CT; DIAGNOSIS; FEATURES; ARTICLE; ADULTS	Portal vein thrombosis (PVT) is commonly classified into acute (symptom duration <60 days and absence of portal carvernoma and portal hypertension) and chronic types. However, the rationality of this classification has received little attention. In this study, 60 patients (40 men and 20 women) with PVT were examined using contrast-enhanced computed tomography (CT). The percentage of vein occlusion, including portal vein (PV) and superior mesenteric vein (SMV), was measured on CT image. Of 60 patients, 17 (28.3%) met the criterion of acute PVT. Symptoms occurred more frequently in patients with superior mesenteric vein thrombosis (SMVT) compared to those without SMVT (p<0.001). However, there was no significant difference in PV occlusion between patients with and without symptoms. The frequency of cavernous transformation was significantly higher in patients with complete PVT than those with partial PVT (p<0.001). Complications of portal hypertension were significantly associated with cirrhosis (p<0.001) rather than with the severity of PVT and presence of cavernoma. These results suggest that the severity of PVT is only associated with the formation of portal cavernoma but unrelated to the onset of symptoms and the development of portal hypertension. We classified PVT into complete and partial types, and each was subclassified into with and without portal cavernoma. In conclusion, neither symptom duration nor cavernous transformation can clearly distinguish between acute and chronic PVT. The new classification system can determine the pathological alterations of PVT, patency of portal vein and outcome of treatment in a longitudinal study.	[Ma, Jingqin; Yan, Zhiping; Luo, Jianjun; Liu, Qingxin; Wang, Jianhua] Fudan Univ, Zhongshan Hosp, Dept Intervent Radiol, Shanghai 200433, Peoples R China; [Qiu, Shijing] Henry Ford Hosp, Bone & Mineral Res Lab, Detroit, MI 48202 USA	Fudan University; Henry Ford Health System; Henry Ford Hospital	Yan, ZP (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Intervent Radiol, Shanghai 200433, Peoples R China.	yan.zhiping@zs-hospital.sh.cn		Ma, Jing-Qin/0000-0002-8755-3411				Amarapurkar P, 2013, INDIAN J GASTROENTER; Amitrano L, 2007, AM J GASTROENTEROL, V102, P2464, DOI 10.1111/j.1572-0241.2007.01477.x; Bauer J, 2006, LIVER TRANSPLANT, V12, P1544, DOI 10.1002/lt.20869; BELLI L, 1986, ANN SURG, V203, P286, DOI 10.1097/00000658-198603000-00012; BLUM U, 1995, RADIOLOGY, V195, P153, DOI 10.1148/radiology.195.1.7892458; Boyer TD, 2005, J VASC INTERV RADIOL, V16, P615, DOI 10.1097/01.RVI.0000157297.91510.21; Brancatelli G, 2007, EUR J RADIOL, V61, P57, DOI 10.1016/j.ejrad.2006.11.003; Chattopadhyay S, 2012, WORLD J GASTROENTERO, V18, P6177, DOI 10.3748/wjg.v18.i43.6177; Chawla Y, 2009, ALIMENT PHARM THER, V30, P881, DOI 10.1111/j.1365-2036.2009.04116.x; Condat B, 2000, HEPATOLOGY, V32, P466, DOI 10.1053/jhep.2000.16597; Condat B, 2006, NAT CLIN PRACT GASTR, V3, P505, DOI 10.1038/ncpgasthep0577; DEGAETANO AM, 1995, AM J ROENTGENOL, V165, P1151, DOI 10.2214/ajr.165.5.7572494; Delgado MG, 2012, CLIN GASTROENTEROL H, V10, P776, DOI 10.1016/j.cgh.2012.01.012; Garcia-Tsao G, 2010, NEW ENGL J MED, V362, P823, DOI 10.1056/NEJMra0901512; Hall TC, 2011, WORLD J SURG, V35, P2510, DOI 10.1007/s00268-011-1198-0; Hoekstra J, 2009, NETH J MED, V67, P46; Hollingshead M, 2005, J VASC INTERV RADIOL, V16, P651, DOI 10.1097/01.RVI.0000156265.79960.86; James AW, 2009, ARCH SURG-CHICAGO, V144, P520, DOI 10.1001/archsurg.2009.81; Jamieson NV, 2000, TRANSPLANTATION, V69, P1772, DOI 10.1097/00007890-200005150-00006; Kim HS, 2005, J VASC INTERV RADIOL, V16, P1685, DOI 10.1097/01.RVI.0000182156.71059.B7; Kumar S, 2001, NEW ENGL J MED, V345, P1683, DOI 10.1056/NEJMra010076; Lee HK, 2008, ABDOM IMAGING, V33, P72, DOI 10.1007/s00261-007-9200-x; Luca A, 2012, RADIOLOGY, V265, P124, DOI 10.1148/radiol.12112236; Luca A, 2011, GUT, V60, P846, DOI 10.1136/gut.2010.228023; Luo JJ, 2011, J VASC INTERV RADIOL, V22, P61, DOI 10.1016/j.jvir.2010.07.028; Malkowski P, 2003, HEPATO-GASTROENTEROL, V50, P2098; NONAMI T, 1992, HEPATOLOGY, V16, P1195, DOI 10.1016/0270-9139(92)90014-Z; Ogren M, 2006, WORLD J GASTROENTERO, V12, P2115; Parikh S, 2010, AM J MED, V123, P111, DOI 10.1016/j.amjmed.2009.05.023; Plessier A, 2010, HEPATOLOGY, V51, P210, DOI 10.1002/hep.23259; Ponziani FR, 2010, WORLD J GASTROENTERO, V16, P143, DOI 10.3748/wjg.v16.i2.143; Ponziani FR, 2012, WORLD J GASTROENTERO, V18, P5014, DOI 10.3748/wjg.v18.i36.5014; Primignani M, 2010, DIGEST LIVER DIS, V42, P163, DOI 10.1016/j.dld.2009.08.003; Qi XS, 2012, CLIN RES HEPATOL GAS, V36, P561, DOI 10.1016/j.clinre.2012.05.021; Qi XS, 2012, DIGEST DIS SCI, V57, P1072, DOI 10.1007/s10620-011-1975-5; Qi XS, 2010, HEPATOLOGY, V51, P1089, DOI 10.1002/hep.23397; Sarin SK, 2002, SEMIN LIVER DIS, V22, P43, DOI 10.1055/s-2002-23206; Senzolo M, 2006, ALIMENT PHARM THER, V23, P767, DOI 10.1111/j.1365-2036.2006.02820.x; Sheen CL, 2000, QJM-MON J ASSOC PHYS, V93, P531, DOI 10.1093/qjmed/93.8.531; Spaander MCW, 2013, J THROMB HAEMOST, V11, P452, DOI 10.1111/jth.12121; STIEBER AC, 1991, ANN SURG, V213, P199, DOI 10.1097/00000658-199103000-00003; Valla DC, 2000, J HEPATOL, V32, P865, DOI 10.1016/S0168-8278(00)80259-7; Valla DC, 2011, VASCULAR LIVER DISEASE: MECHANISMS AND MANAGEMENT, P183, DOI 10.1007/978-1-4419-8327-5_12; Walser EM, 1998, J VASC INTERV RADIOL, V9, P119, DOI 10.1016/S1051-0443(98)70493-2; Webster GJM, 2005, ALIMENT PHARM THER, V21, P1, DOI 10.1111/j.1365-2036.2004.02301.x; Wu J, 2013, ANN VASC SURG; Yerdel MA, 2000, TRANSPLANTATION, V69, P1873, DOI 10.1097/00007890-200005150-00023	47	20	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112501	10.1371/journal.pone.0112501	http://dx.doi.org/10.1371/journal.pone.0112501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393320	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300062
J	Montag, C; Haase, L; Seidel, D; Bayerl, M; Gallinat, J; Herrmann, U; Dannecker, K				Montag, Christiane; Haase, Laura; Seidel, Dorothea; Bayerl, Martin; Gallinat, Juergen; Herrmann, Uwe; Dannecker, Karin			A Pilot RCT of Psychodynamic Group Art Therapy for Patients in Acute Psychotic Episodes: Feasibility, Impact on Symptoms and Mentalising Capacity	PLOS ONE			English	Article							EMOTIONAL AWARENESS SCALE; GERMAN VERSION; SCHIZOPHRENIA; MIND; DEFICITS; PSYCHOPATHOLOGY; MENTALIZATION; PSYCHOTHERAPY; ALEXITHYMIA; DEPRESSION	This pilot study aimed to evaluate the feasibility of an assessor-blind, randomised controlled trial of psychodynamic art therapy for the treatment of patients with schizophrenia, and to generate preliminary data on the efficacy of this intervention during acute psychotic episodes. Fifty-eight inpatients with DSM-diagnoses of schizophrenia were randomised to either 12 twice-weekly sessions of psychodynamic group art therapy plus treatment as usual or to standard treatment alone. Primary outcome criteria were positive and negative psychotic and depressive symptoms as well as global assessment of functioning. Secondary outcomes were mentalising function, estimated with the Reading the mind in the eyes test and the Levels of emotional awareness scale, self-efficacy, locus of control, quality of life and satisfaction with care. Assessments were made at baseline, at post-treatment and at 12 weeks' follow-up. At 12 weeks, 55% of patients randomised to art therapy, and 66% of patients receiving treatment as usual were examined. In the per-protocol sample, art therapy was associated with a significantly greater mean reduction of positive symptoms and improved psychosocial functioning at post-treatment and follow-up, and with a greater mean reduction of negative symptoms at follow-up compared to standard treatment. The significant reduction of positive symptoms at post-treatment was maintained in an attempted intention-to-treat analysis. There were no group differences regarding depressive symptoms. Of secondary outcome parameters, patients in the art therapy group showed a significant improvement in levels of emotional awareness, and particularly in their ability to reflect about others' emotional mental states. This is one of the first randomised controlled trials on psychodynamic group art therapy for patients with acute psychotic episodes receiving hospital treatment. Results prove the feasibility of trials on art therapy during acute psychotic episodes and justify further research to substantiate preliminary positive results regarding symptom reduction and the recovery of mentalising function.	[Montag, Christiane; Haase, Laura; Seidel, Dorothea; Bayerl, Martin; Gallinat, Juergen] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Seidel, Dorothea; Herrmann, Uwe; Dannecker, Karin] Weissensee Sch Art Kunsthochschule Berlin Weissen, Art Therapy Dept, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Montag, C (corresponding author), Charite, Dept Psychiat & Psychotherapy, Campus Mitte, D-13353 Berlin, Germany.	christiane.montag@charite.de		Montag, Christiane/0000-0002-3307-276X	Weissensee School of Art	Weissensee School of Art	The study was financially supported by the Weissensee School of Art. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baslet G, 2009, J NERV MENT DIS, V197, P655, DOI 10.1097/NMD.0b013e3181b3b20f; Boelte S, 2009, READING MIND EYES TE; Bora E, 2009, ACTA PSYCHIAT SCAND, V120, P253, DOI 10.1111/j.1600-0447.2009.01414.x; Brent B, 2009, J CLIN PSYCHOL, V65, P803, DOI 10.1002/jclp.20615; Brooker J., 2007, USE ART WORK ART PSY; Brune M, 2007, SCHIZOPHR RES, V92, P151, DOI 10.1016/J.SCHRES.2007.01.006; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; Crawford MJ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e846; Crawford MJ, 2007, EVID-BASED MENT HEAL, V10, P69, DOI 10.1136/ebmh.10.3.69; Dannecker K, 2010, PSYCHE ASTHETIK TRAN; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; First M.B., 2016, STRUCTURED CLIN INTE; Fonagy P., 2002, AFFEKTREGULIERUNG ME; Franklin M., 1992, ART THERAPY J AM ART, V9, P78, DOI [10.1080/07421656.1992.10758941, DOI 10.1080/07421656.1992.10758941]; Franks M, 2007, INT J ART THERAPY FO, V12, P3, DOI DOI 10.1080/17454830701265188; Gold C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004025.pub2; GREEN BL, 1987, HOSP COMMUNITY PSYCH, V38, P988; Greenwood H, 2012, WHAT ASPEKTS ART THE; Guhne U, 2012, NERVENARZT, V83, P855, DOI 10.1007/s00115-011-3472-7; Harrow M, 2009, PSYCHIAT RES, V168, P186, DOI 10.1016/j.psychres.2008.06.002; Heenan D, 2006, DISABIL SOC, V21, P179, DOI 10.1080/09687590500498143; HELMCHEN H, 1995, NERVENARZT, V66, P231; Heubrock D, 1992, Z DIFFER DIAGNOSTISC, V13, P161; Karterud S., 2004, THER COMMUNITIES, V25, P43, DOI DOI 10.1080/08039480410006304; Kidd DC, 2013, SCIENCE, V342, P377, DOI 10.1126/science.1239918; Kircher TTJ, 2007, NEUROIMAGE, V34, P281, DOI 10.1016/j.neuroimage.2006.08.044; Korver-Nieberg N, 2014, PSYCHOL PSYCHOTHER-T, V87, P127, DOI 10.1111/papt.12010; Krampen G., 1991, FRAGEBOGEN KOMPETENZ; LANE RD, 1990, J PERS ASSESS, V55, P124, DOI 10.1207/s15327752jpa5501&2_12; LANE RD, 1987, AM J PSYCHIAT, V144, P133; Leech NL., 2015, IBM SPSS INTERMEDIAT; LEHRL S, 1995, ACTA NEUROL SCAND, V91, P335, DOI 10.1111/j.1600-0404.1995.tb07018.x; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Levenson H., 1981, RES LOCUS CONTROL CO, P1, DOI DOI 10.1016/B978-0-12-443201-7.50006-3; Little RJ, 2012, STAT MED, V31, P3433, DOI 10.1002/sim.5519; Lysaker PH, 2011, PSYCHOL PSYCHOTHER-T, V84, P58, DOI 10.1348/147608310X520436; MacBeth A, 2011, PSYCHOL PSYCHOTHER-T, V84, P42, DOI 10.1348/147608310X530246; Mahony J., 1992, ART THERAPY HDB, P173; Mo SL, 2008, PSYCHIAT RES, V157, P21, DOI 10.1016/j.psychres.2006.04.002; Montag C, 2011, PSYCHIAT RES, V186, P203, DOI 10.1016/j.psychres.2010.09.006; Moritz S, 2007, CURR OPIN PSYCHIATR, V20, P619, DOI 10.1097/YCO.0b013e3282f0b8ed; MUESER KT, 1990, PSYCHOL MED, V20, P253, DOI 10.1017/S003329170001758X; Muller MJ, 1999, J PSYCHIATR RES, V33, P433, DOI 10.1016/S0022-3956(99)00018-7; National Research Council, 2010, PREVENTION TREATMENT; Navratil L, 1965, SCHIZOPHRENIE KUNST; Or MB, 2010, ART PSYCHOTHER, V37, P319, DOI 10.1016/j.aip.2010.05.007; Patterson S., 2011, INT J ART THER, V16, P70, DOI [https://doi.org/10.1080/17454832.2011.604038, DOI 10.1080/17454832.2011.604038]; Patterson S, 2011, J MENT HEALTH, V20, P328, DOI 10.3109/09638237.2011.556163; Persons RW, 2009, INT J OFFENDER THER, V53, P433, DOI 10.1177/0306624X08320208; Prinzhorn H., 1922, BILDNEREI GEISTESKRA; Pukrop R, 1999, NERVENARZT, V70, P41, DOI 10.1007/s001150050399; Richardson P., 2007, J MENT HEALTH, V16, P483, DOI [DOI 10.1080/09638230701483111, https://doi.org/10.1080/09638230701483111]; Riedel-Heller SG, 2012, PSYCHOTHER PSYCH MED, V62, P425, DOI 10.1055/s-0032-1327676; Rohricht F, 2006, PSYCHOL MED, V36, P669, DOI 10.1017/S0033291706007161; Ruddy R, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003728.pub2; Sarra N, 1998, ART PSYCHOTHERAPY GR; Sass H, 2003, MANUAL PSYCHISCHER S; Schaverien Joy, 1997, ART PSYCHOTHERAPY PS; SCHMIDT J, 1989, PSYCHOTHER PSYCH MED, V39, P248; Spaniol S, 2001, ART PSYCHOTHER, V28, P221, DOI 10.1016/S0197-4556(01)00108-3; Springham N., 2012, INT J ART THERAPY, V17, P115, DOI [10.1080/17454832.2012.734835, DOI 10.1080/17454832.2012.734835]; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Subic-Wrana C, 2005, PSYCHOSOM MED, V67, P483, DOI 10.1097/01.psy.0000160461.19239.13; Subic-Wrana C, 2001, PSYCHOTHERAPEUT, V46, P176, DOI 10.1007/s002780100157; Subic-Wrana C, 2011, INT J PSYCHOANAL, V92, P289, DOI 10.1111/j.1745-8315.2011.00392.x; Subic-Wrana C, 2010, PSYCHOSOM MED, V72, P404, DOI 10.1097/PSY.0b013e3181d35e83; Teglbjaerg HS, 2011, PSYCHOPATHOLOGY, V44, P314, DOI 10.1159/000325025; Ulrich G, 2007, ACTA PSYCHIAT SCAND, V116, P362, DOI 10.1111/j.1600-0447.2007.01073.x; van Ginkel J. R, 2014, SPSS SYNTAX APPLYING; van Ginkel JR, 2014, MULTIVAR BEHAV RES, V49, P78, DOI 10.1080/00273171.2013.855890; van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003; Vauth R, 2004, PSYCHIAT RES, V128, P155, DOI 10.1016/j.psychres.2004.05.018; Wright CC, 2003, J CLIN EPIDEMIOL, V56, P833, DOI 10.1016/S0895-4356(03)00155-0; [郑日昌 Zheng Richang], 2005, [心理学报, Acta Psychologica Sinica], V37, P403	77	45	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112348	10.1371/journal.pone.0112348	http://dx.doi.org/10.1371/journal.pone.0112348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393414	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300053
J	Petrovova, M; Tkadlec, J; Dvoracek, L; Streitova, E; Licha, I				Petrovova, Miroslava; Tkadlec, Jan; Dvoracek, Lukas; Streitova, Eliska; Licha, Irena			NAD(P)H-Hydrate Dehydratase- A Metabolic Repair Enzyme and Its Role in Bacillus subtilis Stress Adaptation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; REGULATORY NETWORK; SIGMA-B; GENES; DEHYDROGENASE; BIOSYNTHESIS; ACTIVATION; PROTEOMICS; RESPONSES; REGULON	Background: One of the strategies for survival stress conditions in bacteria is a regulatory adaptive system called general stress response (GSR), which is dependent on the SigB transcription factor in Bacillus sp. The GSR is one of the largest regulon in Bacillus sp., including about 100 genes; however, most of the genes that show changes in expression during various stresses have not yet been characterized or assigned a biochemical function for the encoded proteins. Previously, we characterized the Bacillus subtilis168 osmosensitive mutant, defective in the yxkO gene (encoding a putative ribokinase), which was recently assigned in vitro as an ADP/ATP-dependent NAD(P) H-hydrate dehydratase and was demonstrated to belong to the SigB operon. Methods and Results: We show the impact of YxkO on the activity of SigB-dependent Pctc promoter and adaptation to osmotic and ethanol stress and potassium limitation respectively. Using a 2DE approach, we compare the proteomes of WT and mutant strains grown under conditions of osmotic and ethanol stress. Both stresses led to changes in the protein level of enzymes that are involved in motility (flagellin), citrate cycle (isocitrate dehydrogenase, malate dehydrogenase), glycolysis (phosphoglycerate kinase), and decomposition of Amadori products (fructosamine-6-phosphate deglycase). Glutamine synthetase revealed a different pattern after osmotic stress. The patterns of enzymes for branched amino acid metabolism and cell wall synthesis (L-alanine dehydrogenase, aspartate-semialdehyde dehydrogenase, ketol-acid reductoisomerase) were altered after ethanol stress. Conclusion: We performed the first characterization of a Bacillus subtilis168 knock-out mutant in the yxkO gene that encodes a metabolite repair enzyme. We show that such enzymes could play a significant role in the survival of stressed cells.	[Petrovova, Miroslava; Tkadlec, Jan; Dvoracek, Lukas; Streitova, Eliska; Licha, Irena] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic; [Tkadlec, Jan; Streitova, Eliska] Charles Univ Prague, Dept Med Microbiol, Fac Med 2, Prague, Czech Republic	Charles University Prague; Charles University Prague	Licha, I (corresponding author), Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague, Czech Republic.	licha@natur.cuni.cz	Tkadlec, Jan/ABD-9485-2020; /Q-9263-2017	/0000-0002-9930-4607; Tkadlec, Jan/0000-0002-0892-924X	Ministry of Education, Youth and Sports of the Czech Republic [LC06066]; Charles University by project of Specific University Research [SVV-2014-260081]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University by project of Specific University Research	The study was supported by projects of Ministry of Education, Youth and Sports of the Czech Republic (LC06066) and by the Charles University by project of Specific University Research (SVV-2014-260081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Perez M, 2010, J BACTERIOL, V192, P755, DOI 10.1128/JB.00826-09; Belitsky BR, 2008, J BACTERIOL, V190, P1224, DOI 10.1128/JB.01780-07; BENSON AK, 1992, J BACTERIOL, V174, P749, DOI 10.1128/jb.174.3.749-757.1992; BOYLAN SA, 1993, J BACTERIOL, V175, P3957, DOI 10.1128/JB.175.13.3957-3963.1993; BOYLAN SA, 1993, J BACTERIOL, V175, P7931, DOI 10.1128/JB.175.24.7931-7937.1993; CUTTING SM, 1990, MOL BIOL METHODS BAC; De Mendoza D, 2002, BACILLUS ITS CLOSEST; Deppe VM, 2011, APPL MICROBIOL BIOT, V90, P399, DOI 10.1007/s00253-010-3083-4; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Gaidenko TA, 2006, J BACTERIOL, V188, P6387, DOI 10.1128/JB.00691-06; Gunka K, 2012, MOL MICROBIOL, V85, P213, DOI 10.1111/j.1365-2958.2012.08105.x; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Hoper D, 2006, PROTEOMICS, V6, P1550, DOI 10.1002/pmic.200500197; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; Jers C, 2010, MOL MICROBIOL, V77, P287, DOI 10.1111/j.1365-2958.2010.07227.x; Mader U, 2004, J BACTERIOL, V186, P2240, DOI 10.1128/JB.186.8.2240-2252.2004; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; Mascher T, 2003, MOL MICROBIOL, V50, P1591, DOI 10.1046/j.1365-2958.2003.03786.x; Mironova R, 2001, MOL MICROBIOL, V39, P1061, DOI 10.1046/j.1365-2958.2001.02304.x; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; OPPENHEIMER NJ, 1974, BIOCHEMISTRY-US, V13, P4685, DOI 10.1021/bi00720a002; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Prabhakar P, 1998, ARCH BIOCHEM BIOPHYS, V360, P195, DOI 10.1006/abbi.1998.0939; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201; RAY C, 1985, J BACTERIOL, V163, P610, DOI 10.1128/JB.163.2.610-614.1985; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shumilin IA, 2012, STRUCTURE, V20, P1715, DOI 10.1016/j.str.2012.07.016; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; Ulanova D, 2007, FOLIA MICROBIOL, V52, P203, DOI 10.1007/BF02931299; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; YOSHIDA A, 1975, ARCH BIOCHEM BIOPHYS, V169, P298, DOI 10.1016/0003-9861(75)90344-6; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110; Zhang RG, 2002, J STRUCT BIOL, V139, P161, DOI 10.1016/S1047-8477(02)00532-4; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005	38	10	10	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112590	10.1371/journal.pone.0112590	http://dx.doi.org/10.1371/journal.pone.0112590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393291	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300076
J	Underwood, MJ; Rosen, S; Engas, A; Eriksen, E				Underwood, Melanie J.; Rosen, Shale; Engas, Arill; Eriksen, Elena			Deep Vision: An In-Trawl Stereo Camera Makes a Step Forward in Monitoring the Pelagic Community	PLOS ONE			English	Article							MANAGEMENT; FISHERIES; SYSTEM	Ecosystem surveys are carried out annually in the Barents Sea by Russia and Norway to monitor the spatial distribution of ecosystem components and to study population dynamics. One component of the survey is mapping the upper pelagic zone using a trawl towed at several depths. However, the current technique with a single codend does not provide fine-scale spatial data needed to directly study species overlaps. An in-trawl camera system, Deep Vision, was mounted in front of the codend in order to acquire continuous images of all organisms passing. It was possible to identify and quantify of most young-of-the-year fish (e.g. Gadus morhua, Boreogadus saida and Reinhardtius hippoglossoides) and zooplankton, including Ctenophora, which are usually damaged in the codend. The system showed potential for measuring the length of small organisms and also recorded the vertical and horizontal positions where individuals were imaged. Young-of-the-year fish were difficult to identify when passing the camera at maximum range and to quantify during high densities. In addition, a large number of fish with damaged opercula were observed passing the Deep Vision camera during heaving; suggesting individuals had become entangled in meshes farther forward in the trawl. This indicates that unknown numbers of fish are probably lost in forward sections of the trawl and that the heaving procedure may influence the number of fish entering the codend, with implications for abundance indices and understanding population dynamics. This study suggests modifications to the Deep Vision and the trawl to increase our understanding of the population dynamics.	[Underwood, Melanie J.; Rosen, Shale; Engas, Arill; Eriksen, Elena] Inst Marine Res, N-5024 Bergen, Norway; [Underwood, Melanie J.; Engas, Arill] Univ Bergen, Dept Biol, Bergen, Norway	Institute of Marine Research - Norway; University of Bergen	Underwood, MJ (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	melanie.underwood@imr.no	; Rosen, Shale/E-9444-2017	Underwood, Melanie/0000-0002-7752-5548; Rosen, Shale/0000-0002-5857-1637	Barents Sea Research programme at the Institute of Marine Research and Scantrol AS	Barents Sea Research programme at the Institute of Marine Research and Scantrol AS	The authors would like to acknowledge support provided by the Barents Sea Research programme at the Institute of Marine Research and Scantrol AS. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, FUNDAMENTALS ECOLOGY; [Anonymous], 2004, IMR PINRO JOINT REPO, V2; Blaxter Jhs, 1959, ICES J MAR SCI, V24, P472, DOI [10.1093/icesjms/24.3.472, DOI 10.1093/ICESJMS/24.3.472]; Dolgov A.V., 2011, BARENTS SEA ECOSYSTE, P438; Engas A, 1997, FISH RES, V29, P295, DOI 10.1016/S0165-7836(96)00545-0; Eriksen E., 2012, BARENTS SEA ECOSYSTE, P557; Eriksen E., 2013, MONITORING STRATEGY; Eriksen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033050; GODO OR, 1993, ICES MAR SC, V196, P196; Hylen A., 1995, PRECISION RELEVANCE, P146; Link JS, 2011, FISH FISH, V12, P152, DOI 10.1111/j.1467-2979.2011.00411.x; Madsen N, 2012, FISH RES, V123, P16, DOI 10.1016/j.fishres.2011.11.016; Michalsen K, 2013, MAR BIOL RES, V9, P932, DOI 10.1080/17451000.2013.775459; Mjanger H., 2003, HDB PROVETAKING FISK; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pitcher TJ, 2009, MAR POLICY, V33, P223, DOI 10.1016/j.marpol.2008.06.002; Rosen S, 2013, FISH RES, V148, P64, DOI 10.1016/j.fishres.2013.08.002; Rosen S, 2013, CAN J FISH AQUAT SCI, V70, P1456, DOI 10.1139/cjfas-2013-0124; SKJOLDAL HR, 1989, BIOMASS YIELDS GEOGR, P241; Williams K, 2010, FISH B-NOAA, V108, P352; Winger Paul D., 2010, P67	21	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112304	10.1371/journal.pone.0112304	http://dx.doi.org/10.1371/journal.pone.0112304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393121	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300049
J	Wakie, TT; Evangelista, PH; Jarnevich, CS; Laituri, M				Wakie, Tewodros T.; Evangelista, Paul H.; Jarnevich, Catherine S.; Laituri, Melinda			Mapping Current and Potential Distribution of Non-Native Prosopis juliflora in the Afar Region of Ethiopia	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; THRESHOLD SELECTION; INVASION; PREDICTION; IMPACTS; MODELS; ACCURACY; MESQUITE; BIOLOGY; VALLEY	We used correlative models with species occurrence points, Moderate Resolution Imaging Spectroradiometer (MODIS) vegetation indices, and topo-climatic predictors to map the current distribution and potential habitat of invasive Prosopis juliflora in Afar, Ethiopia. Time-series of MODIS Enhanced Vegetation Indices (EVI) and Normalized Difference Vegetation Indices (NDVI) with 250 m(2) spatial resolution were selected as remote sensing predictors for mapping distributions, while WorldClim bioclimatic products and generated topographic variables from the Shuttle Radar Topography Mission product (SRTM) were used to predict potential infestations. We ran Maxent models using non-correlated variables and the 143 species-occurrence points. Maxent generated probability surfaces were converted into binary maps using the 10-percentile logistic threshold values. Performances of models were evaluated using area under the receiver-operating characteristic (ROC) curve (AUC). Our results indicate that the extent of P. juliflora invasion is approximately 3,605 km(2) in the Afar region (AUC = 0.94), while the potential habitat for future infestations is 5,024 km(2) (AUC = 0.95). Our analyses demonstrate that time-series of MODIS vegetation indices and species occurrence points can be used with Maxent modeling software to map the current distribution of P. juliflora, while topo-climatic variables are good predictors of potential habitat in Ethiopia. Our results can quantify current and future infestations, and inform management and policy decisions for containing P. juliflora. Our methods can also be replicated for managing invasive species in other East African countries.	[Wakie, Tewodros T.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Wakie, Tewodros T.; Evangelista, Paul H.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Jarnevich, Catherine S.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Laituri, Melinda] Colorado State Univ, Dept Ecosyst Sci & Sustainabil, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; United States Department of the Interior; United States Geological Survey; Colorado State University	Wakie, TT (corresponding author), Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA.	tewodros@lamar.colostate.edu	Evangelista, Paul/D-2315-2016		National Needs Fellowship program of the National Institute of Food and Agriculture; U.S. Department of Agriculture [2010-03280]; U.S. Forest Service International Program	National Needs Fellowship program of the National Institute of Food and Agriculture; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); U.S. Forest Service International Program(United States Department of Agriculture (USDA)United States Forest Service)	Tewodros Wakie acknowledges support from the National Needs Fellowship program of the National Institute of Food and Agriculture, U.S. Department of Agriculture (Award Number-2010-03280). Additional funding was provided by the U.S. Forest Service International Program (http://www. fs.fed.us/global/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abule E, 2007, J ARID ENVIRON, V70, P253, DOI 10.1016/j.jaridenv.2006.12.008; Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; Bean WT, 2012, ECOGRAPHY, V35, P250, DOI 10.1111/j.1600-0587.2011.06545.x; Bradley BA, 2012, ECOL MODEL, V244, P57, DOI 10.1016/j.ecolmodel.2012.06.019; BROWN AF, 1929, FLORA SUDAN; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Choge SK, 2007, WATER SA, V33, P419; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coppock D., 2005, AGROPASTORALISTS WRA; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; EPA, 2010, AF NAT REG STAT PROG AF NAT REG STAT PROG; Escalante Tania, 2013, TIP Revista Especializada en Ciencias Quimico-Biologicas, V16, P5; ESRI, 2012, DESKT REL 10; Ethiopian Flora Network, 2010, INV PLANTS; Evangelista PH, 2008, DIVERS DISTRIB, V14, P808, DOI 10.1111/j.1472-4642.2008.00486.x; Evangelista PH, 2009, REMOTE SENS-BASEL, V1, P519, DOI 10.3390/rs1030519; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gallaher T, 2010, PAC SCI, V64, P489, DOI 10.2984/64.4.489; Gormley A, 2011, USING PRESENCE ONLY; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Huete AR, 1997, REMOTE SENS ENVIRON, V59, P440, DOI 10.1016/S0034-4257(96)00112-5; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Kebede Fanuel, 2012, Endangered Species Research, V17, P237, DOI 10.3354/esr00416; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Li WK, 2010, INT J REMOTE SENS, V31, P2227, DOI 10.1080/01431161003702245; Lillesand T., 1987, REMOTE SENSING IMAGE; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Mauremootoo J. R., 2006, BIOCONTROL NEWS INFO, V27, P37; Pasiecznik NM, 2001, PROSOPIS JULIFLORA P; Peterson AT, 2011, ECOLOGICAL NICHE GEO; PFE IIRR and DF, 2010, PAST LAND LAND TEN A; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Reiss H, 2011, MAR ECOL PROG SER, V442, P71, DOI 10.3354/meps09391; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Salah O., 2011, AFR J FOOD SCI TECHN, V2, P79; Schachtschneider K, 2013, PLANT ECOL, V214, P597, DOI 10.1007/s11258-013-0192-z; SCHRODER B, 2006, ROC PLOTTING AUC CAL; Sharma GP, 2005, CURR SCI INDIA, V88, P726; Shiferaw H, 2004, J ARID ENVIRON, V58, P135, DOI 10.1016/j.jaridenv.2003.08.011; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; SYSTAT, 2008, VERS 11; Tikssa M, 2009, AFRICAN J ECOLOGY, V48, P21; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; van Klinken RD, 2006, BIOL INVASIONS, V8, P727, DOI 10.1007/s10530-005-3427-7; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vina A, 2006, REMOTE SENS ENVIRON, V112, P2160; von Wehrden H, 2009, FOLIA GEOBOT, V44, P211, DOI 10.1007/s12224-009-9042-0; Ward DF, 2007, BIOL INVASIONS, V9, P723, DOI 10.1007/s10530-006-9072-y; Wardlow B, 2013, INT J REMOTE SENS, V31, P805; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Witt ABR, 2010, GCB BIOENERGY, V2, P321, DOI 10.1111/j.1757-1707.2010.01063.x; Zimmermann H, 2006, BIOCONTROL NEWS INFO, V27, P6; Zimmermann H, 2011, AUSTRAL ECOL, V36, P870, DOI 10.1111/j.1442-9993.2010.02230.x; ZOLLNER D, 1986, FOREST ECOL MANAG, V16, P223, DOI 10.1016/0378-1127(86)90022-8	64	45	47	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112854	10.1371/journal.pone.0112854	http://dx.doi.org/10.1371/journal.pone.0112854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393396	Green Published, gold			2022-12-26	WOS:000347709300114
J	Burns, RT; Pechenik, JA; Biggers, WJ; Scavo, G; Lehman, C				Burns, Robert T.; Pechenik, Jan A.; Biggers, William J.; Scavo, Gia; Lehman, Christopher			The B Vitamins Nicotinamide (B-3) and Riboflavin (B-2) Stimulate Metamorphosis in Larvae of the Deposit-Feeding Polychaete Capitella teleta: Implications for a Sensory Ligand-Gated Ion Channel	PLOS ONE			English	Article							URCHIN HOLOPNEUSTES-PURPURASCENS; HORMONE-ACTIVE COMPOUNDS; SP-I ANNELIDA; NITRIC-OXIDE; DELAYED METAMORPHOSIS; SETTLEMENT CUE; CHEMICAL CUES; SEA; SEROTONIN; SEDIMENT	Marine sediments can contain B vitamins, presumably incorporated from settled, decaying phytoplankton and microorganisms associated with decomposition. Because B vitamins may be advantageous for the energetically intensive processes of metamorphosis, post-metamorphic growth, and reproduction, we tested several B vitamins to determine if they would stimulate larvae of the deposit-feeding polychaete Capitella teleta to settle and metamorphose. Nicotinamide and riboflavin individually stimulated larvae of Capitella teleta to settle and metamorphose, generally within 1-2 hours at nicotinamide concentrations as low as 3 mu M and riboflavin concentrations as low as 50 mu M. More than 80% of the larvae metamorphosed within 30 minutes at a nicotinamide concentration of 7 mu M. The pyridine channel agonist pyrazinecarboxamide also stimulated metamorphosis at very low concentrations. In contrast, neither lumichrome, thiamine HCl, pyridoxine HCl, nor vitamin B-12 stimulated larvae of Capitella teleta to metamorphose at concentrations as high as 500 mu M. Larvae also did not metamorphose in response to either nicotinamide or pyrazinecarboxamide in calcium-free seawater or with the addition of 4-acetylpyridine, a competitive inhibitor of the pyridine receptor. Together, these results suggest that larvae of Capitella teleta are responding to nicotinamide and riboflavin via a chemosensory pyridine receptor similar to that previously reported to be present on crayfish chela and involved with food recognition. Our data are the first to implicate B vitamins as possible natural chemical settlement cues for marine invertebrate larvae.	[Burns, Robert T.; Pechenik, Jan A.] Tufts Univ, Dept Biol, Medford, MA 02155 USA; [Biggers, William J.; Scavo, Gia; Lehman, Christopher] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA	Tufts University; Wilkes University	Burns, RT (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	robert.burns@tufts.edu			Howard Hughes Medical Institute; Wilkes University Mentoring Task Force grant; Wilkes University; Tufts FRAC	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wilkes University Mentoring Task Force grant; Wilkes University; Tufts FRAC	This work was supported in part by funding from the Howard Hughes Medical Institute to the Biology Department of Wilkes University and Wilkes University Mentoring Task Force grant to WB, GS, and CL. Wilkes University and Tufts FRAC funded the publication of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTNER H, 1986, CELL TISSUE RES, V244, P537; BALOUN AJ, 1984, BIOL BULL, V167, P124, DOI 10.2307/1541342; Biggers WJ, 2012, INVERTEBR REPROD DEV, V56, P1, DOI 10.1080/07924259.2011.588006; Biggers WJ, 1999, BIOL BULL, V196, P187, DOI 10.2307/1542564; BIGGERS WJ, 1992, INVERTEBR REPROD DEV, V22, P39, DOI 10.1080/07924259.1992.9672255; Bishop CD, 2001, BIOL BULL, V201, P394, DOI 10.2307/1543617; Bishop CD, 2001, J EXP ZOOL, V289, P374, DOI 10.1002/jez.1019; Bishop CD, 2008, EVOL DEV, V10, P288, DOI 10.1111/j.1525-142X.2008.00238.x; Blake JA, 2009, ZOOSYMPOSIA, V2, P25, DOI 10.11646/zoosymposia.2.1.6; Brown MR, 1999, J APPL PHYCOL, V11, P247, DOI 10.1023/A:1008075903578; BUTMAN CA, 1988, NATURE, V333, P771, DOI 10.1038/333771a0; CARR WES, 1987, ENVIRON HEALTH PERSP, V71, P31, DOI 10.2307/3430411; Cohen RA, 1999, J EXP MAR BIOL ECOL, V240, P1, DOI 10.1016/S0022-0981(99)00047-7; Comes S, 2007, DEV BIOL, V306, P772, DOI 10.1016/j.ydbio.2007.04.016; DUBILIER N, 1988, BIOL BULL, V174, P30, DOI 10.2307/1541756; ECKELBARGER KJ, 1987, B BIOL SOC WASH, V7, P62; Giovannoni SJ, 2012, P NATL ACAD SCI USA, V109, P13888, DOI 10.1073/pnas.1211722109; GOTTHOLD ML, 1974, COMP BIOCHEM PHYSIOL, V48, P307, DOI 10.1016/0305-0491(74)90208-9; GRASSLE JP, 1976, SCIENCE, V192, P567, DOI 10.1126/science.1257794; GREMARE A, 1988, J EXP MAR BIOL ECOL, V123, P147, DOI 10.1016/0022-0981(88)90166-9; Hadfield MG, 2001, CRC MAR SCI, P431; HATT H, 1987, NEUROSCI LETT, V73, P137, DOI 10.1016/0304-3940(87)90007-3; HATT H, 1985, CHEM SENSES, V10, P317, DOI 10.1093/chemse/10.3.317; HATT H, 1984, J COMP PHYSIOL, V154, P855, DOI 10.1007/BF00610686; KATO T, 1975, EXPERIENTIA, V31, P433, DOI 10.1007/BF02026361; Launay JM, 1996, J BIOL CHEM, V271, P3141, DOI 10.1074/jbc.271.6.3141; Leise EM, 2001, AM ZOOL, V41, P258, DOI 10.1668/0003-1569(2001)041[0258:SANORM]2.0.CO;2; Lindsay SM, 2009, ZOOSYMPOSIA, V2, P339, DOI 10.11646/zoosymposia.2.1.24; MARSH AG, 1990, MAR ECOL PROG SER, V67, P301, DOI 10.3354/meps067301; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Meunier N, 2009, CHEM SENSES, V34, P441, DOI 10.1093/chemse/bjp019; Mitra S, 2012, APPL BIOCHEM BIOTECH, V166, P1991, DOI 10.1007/s12010-012-9626-7; OHWADA K, 1972, Marine Chemistry, V1, P61, DOI 10.1016/0304-4203(72)90007-2; Panzeca C, 2009, ESTUAR COAST SHELF S, V85, P223, DOI 10.1016/j.ecss.2009.08.016; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PAWLIK JR, 1986, J EXP MAR BIOL ECOL, V102, P301, DOI 10.1016/0022-0981(86)90183-8; PECHENIK JA, 1991, J EXP MAR BIOL ECOL, V151, P17, DOI 10.1016/0022-0981(91)90012-L; PECHENIK JA, 1990, OPHELIA, V32, P63, DOI 10.1080/00785236.1990.10422025; Pechenik JA, 2007, BIOL BULL-US, V213, P160, DOI 10.2307/25066632; Pellegrino M, 2009, J EXP BIOL, V212, P1973, DOI 10.1242/jeb.023036; Ricker T, 2011, INTEGR COMP BIOL, V51, pE243; Rittschof D, 1998, BIOFOULING, V12, P31, DOI 10.1080/08927019809378344; Sanudo-Wilhelmy SA, 2012, P NATL ACAD SCI USA, V109, P14041, DOI 10.1073/pnas.1208755109; SIMS GK, 1992, APPL ENVIRON MICROB, V58, P3423, DOI 10.1128/AEM.58.10.3423-3425.1992; Swanson RL, 2006, MAR ECOL PROG SER, V314, P1, DOI 10.3354/meps314001; Swanson RL, 2012, MAR BIOL, V159, P915, DOI 10.1007/s00227-011-1869-2; Swanson RL, 2004, BIOL BULL-US, V206, P161, DOI 10.2307/1543640; Thiyagarajan V, 2005, J EXP MAR BIOL ECOL, V323, P70, DOI 10.1016/j.jembe.2005.03.001; Tsukamoto S, 1999, EUR J BIOCHEM, V264, P785, DOI 10.1046/j.1432-1327.1999.00642.x; TSUTSUMI H, 1990, MAR ECOL PROG SER, V63, P157, DOI 10.3354/meps063157; WOODIN SA, 1991, AM ZOOL, V31, P797	51	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e109535	10.1371/journal.pone.0109535	http://dx.doi.org/10.1371/journal.pone.0109535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390040	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400006
J	Rapin, N; Johns, K; Martin, L; Warnecke, L; Turner, JM; Bollinger, TK; Willis, CKR; Voyles, J; Misra, V				Rapin, Noreen; Johns, Kirk; Martin, Lauren; Warnecke, Lisa; Turner, James M.; Bollinger, Trent K.; Willis, Craig K. R.; Voyles, Jamie; Misra, Vikram			Activation of Innate Immune-Response Genes in Little Brown Bats (Myotis lucifugus) Infected with the Fungus Pseudogymnoascus destructans	PLOS ONE			English	Article							RESERVOIR HOSTS; EXPRESSION; VIRUS; ABUNDANCE; PATHOGEN; INSIGHTS; PROTEIN	Recently bats have been associated with the emergence of diseases, both as reservoirs for several new viral diseases in humans and other animals and, in the northern Americas, as hosts for a devastating fungal disease that threatens to drive several bat species to regional extinction. However, despite these catastrophic events little Information is available on bat defences or how they interact with their pathogens. Even less is known about the response of bats to infection during torpor or long-term hibernation. Using tissue samples collected at the termination of an experiment to explore the pathogenesis of White Nose Syndrome in Little Brown Bats, we determined if hibernating bats infected with the fungus Pseudogymnoascus destructans could respond to infection by activating genes responsible for innate immune and stress responses. Lesions due to fungal infection and, in some cases, secondary bacterial infections, were restricted to the skin. However, we were unable to obtain sufficient amounts of RNA from these sites. We therefore examined lungs for response at an epithelial surface not linked to the primary site of infection. We found that bats responded to infection with a significant increase in lungs of transcripts for Cathelicidin (an anti-microbial peptide) as well as the immune modulators tumor necrosis factor alpha and interleukins 10 and 23. In conclusion, hibernating bats can respond to experimental Pseudogymnoascus destructans infection by activating expression of innate immune response genes.	[Rapin, Noreen; Johns, Kirk; Martin, Lauren; Misra, Vikram] Univ Saskatchewan, Western Coll Vet Med, Dept Microbiol, Saskatoon, SK S7N 0W0, Canada; [Warnecke, Lisa; Turner, James M.; Willis, Craig K. R.] Univ Winnipeg, Dept Biol, Winnipeg, MB R3B 2E9, Canada; [Bollinger, Trent K.] Univ Saskatchewan, Western Coll Vet Med, Dept Pathol, Saskatoon, SK S7N 0W0, Canada; [Voyles, Jamie] New Mexico Inst Min & Technol, Dept Biol, Socorro, NM USA	University of Saskatchewan; University of Winnipeg; University of Saskatchewan; New Mexico Institute of Mining Technology	Misra, V (corresponding author), Univ Saskatchewan, Western Coll Vet Med, Dept Microbiol, Saskatoon, SK S7N 0W0, Canada.	Vikram.misra@usask.ca	Misra, Vikram/AAC-4266-2020	Misra, Vikram/0000-0001-6818-7156; Turner, James/0000-0001-8699-7750; Willis, Craig/0000-0002-0985-8607	Fish and Wildlife Service grant; Natural Sciences and Engineering Research Council (Discovery) grant; Postdoc Programme of the DAAD, German Academic Exchange Service	Fish and Wildlife Service grant; Natural Sciences and Engineering Research Council (Discovery) grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Postdoc Programme of the DAAD, German Academic Exchange Service	Funding for this study was provided by a Fish and Wildlife Service grant to CRKW, TB and VM and by a Natural Sciences and Engineering Research Council (Discovery) grant to VM and a fellowship within the Postdoc Programme of the DAAD, German Academic Exchange Service (to LW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bouma HR, 2010, J LEUKOCYTE BIOL, V88, P619, DOI 10.1189/jlb.0310174; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Che CY, 2013, INT J OPHTHALMOL-CHI, V6, P30, DOI 10.3980/j.issn.2222-3959.2013.01.06; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Dobson AP, 2005, SCIENCE, V310, P628, DOI 10.1126/science.1120872; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Du WJ, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-40; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Kunz TH, 2003, BAT ECOLOGY, P3; Lehmann J, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-20; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Ma SN, 2013, J NEUROIMMUNOL, V257, P28, DOI 10.1016/j.jneuroim.2013.01.007; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Mascarelli PE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-117; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Moore MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058976; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; O'Shea TJ, 2014, EMERG INFECT DIS, V20, P741, DOI 10.3201/eid2005.130539; Park K, 2011, J BIOL CHEM, V286, P34121, DOI 10.1074/jbc.M111.250431; Piccolo MTS, 1999, EXP MOL PATHOL, V66, P220, DOI 10.1006/exmp.1999.2263; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Stawski C, 2014, J ZOOL, V292, P86, DOI 10.1111/jzo.12105; Till G O, 1983, Agents Actions Suppl, V12, P383; Toussirot Eric, 2012, Inflammation & Allergy Drug Targets, V11, P159; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Vijaykrishna D, 2007, J VIROL, V81, P4012, DOI 10.1128/JVI.02605-06; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Werner JL, 2011, INFECT IMMUN, V79, P3966, DOI 10.1128/IAI.05493-11; Wibbelt G, 2007, J GEN VIROL, V88, P2651, DOI 10.1099/vir.0.83045-0; Wynne JW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003651; Zelante T, 2009, MED MYCOL, V47, pS162, DOI 10.1080/13693780802140766; Zhen AW, 2013, HEPATOLOGY, V58, P1315, DOI 10.1002/hep.26490	45	20	20	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112285	10.1371/journal.pone.0112285	http://dx.doi.org/10.1371/journal.pone.0112285			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391018	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400069
J	Verhagen, JH; van Dijk, JGB; Vuong, O; Bestebroer, T; Lexmond, P; Klaassen, M; Fouchier, RAM				Verhagen, Josanne H.; van Dijk, Jacintha G. B.; Oanh Vuong; Bestebroer, Theo; Lexmond, Pascal; Klaassen, Marcel; Fouchier, Ron A. M.			Migratory Birds Reinforce Local Circulation of Avian Influenza Viruses	PLOS ONE			English	Article							A VIRUSES; WILD BIRDS; STABLE-ISOTOPES; EVOLUTION; INFECTION; SURVEILLANCE; SONGBIRDS; PATTERNS; RESIDENT; ECOLOGY	Migratory and resident hosts have been hypothesized to fulfil distinct roles in infectious disease dynamics. However, the contribution of resident and migratory hosts to wildlife infectious disease epidemiology, including that of low pathogenic avian influenza virus (LPAIV) in wild birds, has largely remained unstudied. During an autumn H3 LPAIV epizootic in free-living mallards (Anas platyrhynchos) - a partially migratory species - we identified resident and migratory host populations using stable hydrogen isotope analysis of flight feathers. We investigated the role of migratory and resident hosts separately in the introduction and maintenance of H3 LPAIV during the epizootic. To test this we analysed (i) H3 virus kinship, (ii) temporal patterns in H3 virus prevalence and shedding and (iii) H3-specific antibody prevalence in relation to host migratory strategy. We demonstrate that the H3 LPAIV strain causing the epizootic most likely originated from a single introduction, followed by local clonal expansion. The H3 LPAIV strain was genetically unrelated to H3 LPAIV detected both before and after the epizootic at the study site. During the LPAIV epizootic, migratory mallards were more often infected with H3 LPAIV than residents. Low titres of H3-specific antibodies were detected in only a few residents and migrants. Our results suggest that in this LPAIV epizootic, a single H3 virus was present in resident mallards prior to arrival of migratory mallards followed by a period of virus amplification, importantly associated with the influx of migratory mallards. Thus migrants are suggested to act as local amplifiers rather than the often suggested role as vectors importing novel strains from afar. Our study exemplifies that a multifaceted interdisciplinary approach offers promising opportunities to elucidate the role of migratory and resident hosts in infectious disease dynamics in wildlife.	[Verhagen, Josanne H.; Oanh Vuong; Bestebroer, Theo; Lexmond, Pascal; Fouchier, Ron A. M.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [van Dijk, Jacintha G. B.; Klaassen, Marcel] Netherlands Inst Ecol, NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Klaassen, Marcel] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic 3217, Australia	Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Verhagen, JH (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	j.h.verhagen@erasmusmc.nl	Fouchier, Ron A/A-1911-2014; Klaassen, Marcel/B-4325-2008; KNAW, NIOO-KNAW/A-4320-2012	Fouchier, Ron A/0000-0001-8095-2869; Klaassen, Marcel/0000-0003-3907-9599; Verhagen, Josanne/0000-0003-3133-5228; KNAW, NIOO-KNAW/0000-0002-3835-159X	Dutch Ministry of Economic Affairs; Netherlands Organization for Scientific Research (NWO) [820.01.018]; NIAID NIH [HHSN266200700010C]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NIAID NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by grants from the Dutch Ministry of Economic Affairs, the Netherlands Organization for Scientific Research (NWO; grant 820.01.018) and contract NIAID NIH HHSN266200700010C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; [Anonymous], 2014, P R SOC B, DOI DOI 10.1098/RSPB.2014.0098.WILD-BIRD-0RIGIN; Boyd H., 1975, DUCK WINGS STUDY DUC; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Daoust PY, 2013, VET PATHOL, V50, P548, DOI 10.1177/0300985812469633; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Fouchier RAM, 2009, REV SCI TECH OIE, V28, P49, DOI 10.20506/rst.28.1.1863; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hill NJ, 2012, MOL ECOL, V21, P5986, DOI 10.1111/j.1365-294X.2012.05735.x; Hirst GK, 1943, J EXP MED, V78, p4O7, DOI 10.1084/jem.78.5.407; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Hofle U, 2012, AVIAN PATHOL, V41, P547, DOI 10.1080/03079457.2012.744447; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hoye BJ, 2012, METHODS ECOL EVOL, V3, P162, DOI 10.1111/j.2041-210X.2011.00135.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Kuiken T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0990; Lack David, 1943, BRIT BIRDS, V37, P122; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Latorre-Margalef N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0098; Leighton FA, 2002, REV SCI TECH OIE, V21, P187; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Payne-Gallwey R, 1886, BOOK DUCK DECOYS THE; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rappole JH, 2003, J APPL MICROBIOL, V94, p47S; Scott D.A., 1996, WETL INTL PUBL, V41; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; van Dijk JGB, 2014, J AVIAN BIOL, V45, P103, DOI 10.1111/j.1600-048X.2013.00232.x; van Dijk JGB, 2014, J ANIM ECOL, V83, P266, DOI 10.1111/1365-2656.12131; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Westgeest KB, 2014, J VIROL, V88, P2844, DOI 10.1128/JVI.02163-13	41	23	24	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112366	10.1371/journal.pone.0112366	http://dx.doi.org/10.1371/journal.pone.0112366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391154	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400076
J	Park, B; Jung, KW; Oh, CM; Choi, KS; Suh, M; Jun, JK				Park, Boyoung; Jung, Kyu-Won; Oh, Chang-Mo; Choi, Kui Son; Suh, Mina; Jun, Jae Kwan			Factors Associated with Alcohol Consumption in Hepatitis B Carriers: A Nationwide Study in the Republic of Korea	PLOS ONE			English	Article							RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; SOCIOECONOMIC-STATUS; VIRAL-HEPATITIS; DISEASE; INEQUALITIES; RELIABILITY; EDUCATION; SYNERGISM	This study was conducted to investigate the prevalence of alcohol consumption and identify the sociodemographic factors associated with alcohol consumption among individuals with hepatitis B virus(HBV) infection. We used data from the Korean National Health and Nutrition Examination Surveys, a nationwide survey conducted between 2007 and 2011. "Monthly alcohol consumption'' was defined as having consumed alcohol at least once per month during the past year, and "high-risk alcohol consumption'' was defined as having consumed alcohol twice or more per week and, for males, having consumed at least 60 g of alcohol on one occasion or, for females, having consumed at least 40 g of alcohol on more than one occasion. The prevalence of monthly alcohol consumption was 53.2%, and that of high-risk alcohol consumption was 11.8% among HBV carriers. Less education was associated with both monthly and high-risk alcohol consumption(OR = 1.75 [95% CI = 1.02-3.02] for monthly alcohol consumption among those with less than a high school education; OR = 2.48 [95% CI = 1.19-5.17] for high-risk alcohol consumption among those with less than a high school education and OR = 2.02 [95% CI = 1.12-3.64] among those with a high school education). Additionally, smoking and being male increased the risk of alcohol consumption, and older age and having a normal body mass index decreased the risk. HBV carriers who were less educated, overweight, and smokers were more likely to consume alcohol or meet criteria for high-risk drinking. Health policies and intervention programs aimed at promoting a generally healthy lifestyle in HBV carriers should consider educational inequalities and alcohol consumption.	[Park, Boyoung; Jung, Kyu-Won; Oh, Chang-Mo; Choi, Kui Son; Suh, Mina; Jun, Jae Kwan] Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, South Korea	National Cancer Center - Korea (NCC)	Jun, JK (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang Si, South Korea.	jkjun@ncc.re.kr			National Cancer Center of Korea [1310232]	National Cancer Center of Korea	This study was supported by a Grant-in-Aid for Cancer Research and Control from the National Cancer Center of Korea (#1310232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2004, BMJ-BRIT MED J, V329, P1080, DOI 10.1136/bmj.329.7474.1080; Bialecki ES, 2005, EUR J GASTROEN HEPAT, V17, P485, DOI 10.1097/00042737-200505000-00003; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; BROWNSON RC, 1994, EPIDEMIOLOGY, V5, P545; Chae Hee Bok, 2009, Korean J Hepatol, V15 Suppl 6, pS13, DOI 10.3350/kjhep.2009.15.S6.S13; Chan HLY, 2011, J GASTROEN HEPATOL, V26, P131, DOI 10.1111/j.1440-1746.2010.06544.x; Cho ER, 2010, CANCER EPIDEMIOL, V34, P713, DOI 10.1016/j.canep.2010.09.003; Chuang SC, 2010, CANCER EPIDEM BIOMAR, V19, P1261, DOI 10.1158/1055-9965.EPI-09-1297; Donato F, 2002, AM J EPIDEMIOL, V155, P323, DOI 10.1093/aje/155.4.323; Ekholm O, 2008, EUR J CLIN NUTR, V62, P286, DOI 10.1038/sj.ejcn.1602728; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fong C. W., 2007, SMJ Singapore Medical Journal, V48, P1091; Grant JD, 2012, ALCOHOL CLIN EXP RES, V36, P1412, DOI 10.1111/j.1530-0277.2012.01752.x; Hassan MM, 2002, HEPATOLOGY, V36, P1206, DOI 10.1053/jhep.2002.36780; Huerta MC, 2010, SOC SCI MED, V71, P143, DOI 10.1016/j.socscimed.2010.03.022; KCDC, 2005, 4 KOR NAT HLTH NUTR; Khang YH, 2004, INT J EPIDEMIOL, V33, P299, DOI 10.1093/ije/dyg244; Koh K., 2000, HLTH WELFARE POLICY, V6, P77; Korean Association for the Study of Liver, 2011, TREATM GUID CHRON HE; Lee EH, 2010, ASIAN PAC J CANCER P, V11, P1305; Liaw YF, 2009, J HEPATOL, V51, P403, DOI 10.1016/j.jhep.2009.04.003; Noh DK, 2012, ASIAN PAC J CANCER P, V13, P731, DOI 10.7314/APJCP.2012.13.2.731; Park B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068315; Park B, 2012, VACCINE, V30, P5844, DOI 10.1016/j.vaccine.2012.07.022; Schroder H, 2004, EUR J NUTR, V43, P77, DOI 10.1007/s00394-004-0443-9; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Stroffolini T, 2010, LIVER INT, V30, P867, DOI 10.1111/j.1478-3231.2010.02261.x; TENCONI MT, 1992, EUR J EPIDEMIOL, V8, P763, DOI 10.1007/BF00145317; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Woitas-Slubowska Donata, 2010, Central European Journal of Public Health, V18, P179; World Health Organization, 2000, INT GUID MON ALC CON; Yuan JM, 2004, CANCER, V101, P1009, DOI 10.1002/cncr.20427; Zakhari S, 2013, J GASTROEN HEPATOL, V28, P18, DOI 10.1111/jgh.12207; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e110144	10.1371/journal.pone.0110144	http://dx.doi.org/10.1371/journal.pone.0110144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387237	Green Submitted, gold, Green Published			2022-12-26	WOS:000345250400008
J	Zhang, CH; Walters, D; Kovacs, JM				Zhang, Chunhua; Walters, Dan; Kovacs, John M.			Applications of Low Altitude Remote Sensing in Agriculture upon Farmers' Requests- A Case Study in Northeastern Ontario, Canada	PLOS ONE			English	Article							MULTITEMPORAL POLARIMETRIC RADARSAT-2; QUICKBIRD SATELLITE IMAGERY; UNMANNED AERIAL VEHICLE; PRECISION AGRICULTURE; HYPERSPECTRAL IMAGERY; MANAGEMENT ZONES; YIELD; AIRBORNE; PLATFORM; TRENDS	With the growth of the low altitude remote sensing (LARS) industry in recent years, their practical application in precision agriculture seems all the more possible. However, only a few scientists have reported using LARS to monitor crop conditions. Moreover, there have been concerns regarding the feasibility of such systems for producers given the issues related to the post-processing of images, technical expertise, and timely delivery of information. The purpose of this study is to showcase actual requests by farmers to monitor crop conditions in their fields using an unmanned aerial vehicle (UAV). Working in collaboration with farmers in northeastern Ontario, we use optical and near-infrared imagery to monitor fertilizer trials, conduct crop scouting and map field tile drainage. We demonstrate that LARS imagery has many practical applications. However, several obstacles remain, including the costs associated with both the LARS system and the image processing software, the extent of professional training required to operate the LARS and to process the imagery, and the influence from local weather conditions (e. g. clouds, wind) on image acquisition all need to be considered. Consequently, at present a feasible solution for producers might be the use of LARS service provided by private consultants or in collaboration with LARS scientific research teams.	[Zhang, Chunhua] Algoma Univ, Dept Geog & Geol, Sault Ste Marie, ON, Canada; [Walters, Dan; Kovacs, John M.] Nipissing Univ, Dept Geog, North Bay, ON, Canada	Algoma University; Nipissing University	Zhang, CH (corresponding author), Algoma Univ, Dept Geog & Geol, Sault Ste Marie, ON, Canada.	chunhua.zhang@algomau.ca	Kovacs, John/B-3641-2008; Zhang, Chunhua/O-6602-2014	Kovacs, John/0000-0002-0520-3996; Zhang, Chunhua/0000-0001-6685-0137	Northern Ontario Heritage Fund Corporation of Canada [920161]	Northern Ontario Heritage Fund Corporation of Canada	Funding for this project was provided by a grant (project #920161) awarded to John M. Kovacs and Dan Walters from the Northern Ontario Heritage Fund Corporation of Canada (http://nohfc.ca/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berni JAJ, 2009, IEEE T GEOSCI REMOTE, V47, P722, DOI 10.1109/TGRS.2008.2010457; Blackmore S, 2000, COMPUT ELECTRON AGR, V26, P37, DOI 10.1016/S0168-1699(99)00075-7; Blackmore S, 2003, BIOSYST ENG, V84, P455, DOI 10.1016/S1537-5110(03)00038-2; Blann KL, 2009, CRIT REV ENV SCI TEC, V39, P909, DOI 10.1080/10643380801977966; Cable JW, 2014, REMOTE SENS-BASEL, V6, P2343, DOI 10.3390/rs6032343; Cable JW, 2014, REMOTE SENS-BASEL, V6, P2372, DOI 10.3390/rs6032372; Chang JY, 2003, AGRON J, V95, P1447, DOI 10.2134/agronj2003.1447; DeTar WR, 2008, T ASABE, V51, P463, DOI 10.13031/2013.24388; Diker K., 2004, Precision Agriculture, V5, P435, DOI 10.1007/s11119-004-5318-9; Flowers M, 2005, AGRON J, V97, P968, DOI 10.2134/agronj2004.0224; Godwin RJ, 2003, BIOSYST ENG, V84, P533, DOI 10.1016/S1537-5110(02)00282-9; Gomez-Candon D, 2011, PRECIS AGRIC, V12, P876, DOI 10.1007/s11119-011-9228-3; Honkavaara E, 2013, REMOTE SENS-BASEL, V5, P5006, DOI 10.3390/rs5105006; Hunt E. R., 2008, P 17 WT PEC MEM REM, V17, P18; Hunt E. Raymond Jr, 2005, Precision Agriculture, V6, P359, DOI 10.1007/s11119-005-2324-5; Hunt ER, 2010, REMOTE SENS-BASEL, V2, P290, DOI 10.3390/rs2010290; Inman D, 2008, AGRON J, V100, P60, DOI 10.2134/agronj2007.0020; Inoue Y, 2000, INT J REMOTE SENS, V21, P379, DOI 10.1080/014311600210894; Keener H. M., 2000, Land application of agricultural, industrial, and municipal by-products, P315; Lelong CCD, 1998, REMOTE SENS ENVIRON, V66, P179, DOI 10.1016/S0034-4257(98)00049-2; Link J, 2013, COMPUT ELECTRON AGR, V94, P20, DOI 10.1016/j.compag.2013.03.003; Lopez-Lozano R, 2009, AGR FOREST METEOROL, V149, P1307, DOI 10.1016/j.agrformet.2009.03.001; Mamo M, 1998, J PROD AGRIC, V11, P469, DOI 10.2134/jpa1998.0469; Pena JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077151; McSorley R, 1996, J NEMATOL, V28, P655; Primicerio J, 2012, PRECIS AGRIC, V13, P517, DOI 10.1007/s11119-012-9257-6; Ryo S, 2007, BIOSYST ENG, V96, P301; Seelan SK, 2003, REMOTE SENS ENVIRON, V88, P157, DOI 10.1016/j.rse.2003.04.007; Shanahan JF, 2001, AGRON J, V93, P583, DOI 10.2134/agronj2001.933583x; Spaling H, 1995, AGR ECOSYST ENVIRON, V53, P299; SPARKS AN, 1979, FLA ENTOMOL, V62, P82, DOI 10.2307/3494083; Stratton ML, 1998, BOOK SOIL P, P43; Swain KC, 2010, T ASABE, V53, P21; Swain KC, 2007, J APPL REMOTE SENS, V1, DOI 10.1117/1.2824287; Torres-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058210; WIEGAND CL, 1994, REMOTE SENS ENVIRON, V49, P212, DOI 10.1016/0034-4257(94)90017-5; Wilson JM, 2014, TLS-TIMES LIT SUPPL, P6; Yang C, 2006, T ASABE, V49, P1599, DOI 10.13031/2013.22034; Yang C, 2004, T ASAE, V47, P915, DOI 10.13031/2013.16111; Yang C, 2000, T ASAE, V43, P1927, DOI 10.13031/2013.3098; Yang Chenghai, 2004, Precision Agriculture, V5, P445, DOI 10.1007/s11119-004-5319-8; Yang CH, 2006, PRECIS AGRIC, V7, P33, DOI 10.1007/s11119-005-6788-0; Yang CH, 2013, P IEEE, V101, P582, DOI 10.1109/JPROC.2012.2196249; Yang Chenghai, 1999, Precision Agriculture, V1, P67, DOI 10.1023/A:1009917617316; Zarco-Tejada PJ, 2013, AGR FOREST METEOROL, V171, P281, DOI 10.1016/j.agrformet.2012.12.013; Zarco-Tejada PJ, 2012, REMOTE SENS ENVIRON, V117, P322, DOI 10.1016/j.rse.2011.10.007; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5; ZUCKER L. A, 1998, OHIO STATE U EXTENSI, V871- 98	48	49	53	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112894	10.1371/journal.pone.0112894	http://dx.doi.org/10.1371/journal.pone.0112894			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386696	Green Submitted, gold, Green Published			2022-12-26	WOS:000345250400101
J	Guo, G; Wang, L; Liu, HX; Randall, T				Guo, Guang; Wang, Lin; Liu, Hexuan; Randall, Thomas			Genomic Assortative Mating in Marriages in the United States	PLOS ONE			English	Article							BIOLOGICAL PATHWAYS; 5 DECADES; HEIGHT; LOCI; ASSOCIATION; DISORDERS; C6ORF217; VARIANTS; TRENDS; ADULT	Assortative mating in phenotype in human marriages has been widely observed. Using genome-wide genotype data from the Framingham Heart study (FHS; number of married couples = 989) and Health Retirement Survey (HRS; number of married couples = 3,474), this study investigates genomic assortative mating in human marriages. Two types of genomic marital correlations are calculated. The first is a correlation specific to a single married couple "averaged'' over all available autosomal single-nucleotide polymorphism (SNPs). In FHS, the average married-couple correlation is 0.0018 with p=3x10(-5); in HRS, it is 0.0017 with p=7.13x10(-13). The marital correlation among the positively assorting SNPs is 0.001 (p=.0043) in FHS and 0.015 (p=1.66x10(-24)) in HRS. The sizes of these estimates in FHS and HRS are consistent with what are suggested by the distribution of the allelic combination. The study also estimated SNP-specific correlation "averaged'' over all married couples. Suggestive evidence is reported. Future studies need to consider a more general form of genomic assortment, in which different allelic forms in homologous genes and non-homologous genes result in the same phenotype.	[Guo, Guang; Liu, Hexuan] Univ N Carolina, Dept Sociol, Chapel Hill, NC 27599 USA; [Guo, Guang; Liu, Hexuan] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Guo, Guang] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Wang, Lin] Duke Univ, Ctr Child & Family Policy, Durham, NC USA; [Randall, Thomas] NIEHS, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Guo, G (corresponding author), Univ N Carolina, Dept Sociol, Chapel Hill, NC 27599 USA.	guang_guo@unc.edu			National Institutes of Health [RC1 DA029425-01]; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA029425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding provided by Challenge Grant RC1 DA029425-01, National Institutes of Health, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Amann-Zalcenstein D, 2006, EUR J HUM GENET, V14, P1111, DOI 10.1038/sj.ejhg.5201675; Cherlin CJ, 2009, MARRIAGE GO ROUND ST; Domingue BW, 2014, P NATL ACAD SCI USA, V111, P7996, DOI 10.1073/pnas.1321426111; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; HEATH AC, 1985, BEHAV GENET, V15, P15, DOI 10.1007/BF01071929; Hindorff L., 2013, CATALOG PUBLISHED GE; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; LEWONTIN R, 1968, EUGEN QUART, V15, P141, DOI 10.1080/19485565.1968.9987764; Ma JW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046096, 10.1371/journal.pone.0041560]; MARE RD, 1991, AM SOCIOL REV, V56, P15, DOI 10.2307/2095670; MERIKANGAS KR, 1982, ARCH GEN PSYCHIAT, V39, P1173; NIELSEN J, 1964, BRIT J PSYCHIAT, V110, P683, DOI 10.1192/bjp.110.468.683; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; Pearson Karl, 1903, BIOMETRIKA, V2, P481; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qian ZC, 1998, DEMOGRAPHY, V35, P279, DOI 10.2307/3004036; Qian ZC, 2007, AM SOCIOL REV, V72, P68, DOI 10.1177/000312240707200104; RAMSOY NR, 1966, AM SOCIOL REV, V31, P773, DOI 10.2307/2091657; Risch N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r132; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036; Searle S.R., 1971, LINEAR MODELS; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Slonimsky A, 2010, SCHIZOPHR RES, V120, P159, DOI 10.1016/j.schres.2010.03.041; Smits J, 2009, SOC FORCES, V88, P227; Speakman JR, 2007, AM J CLIN NUTR, V86, P316, DOI 10.1093/ajcn/86.2.316; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Torche F, 2010, DEMOGRAPHY, V47, P481; VANDENBERG SG, 1972, BEHAV GENET, V2, P127, DOI 10.1007/BF01065686; Volkening K, 2010, AMYOTROPH LATERAL SC, V11, P97, DOI 10.3109/17482960902995584; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wright S, 1921, GENETICS, V6, P144	37	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112322	10.1371/journal.pone.0112322	http://dx.doi.org/10.1371/journal.pone.0112322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384046	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700049
J	Li, XZ; Rui, JP; Xiong, JB; Li, JB; He, ZL; Zhou, JZ; Yannarell, AC; Mackie, RI				Li, Xiangzhen; Rui, Junpeng; Xiong, Jingbo; Li, Jiabao; He, Zhili; Zhou, Jizhong; Yannarell, Anthony C.; Mackie, Roderick I.			Functional Potential of Soil Microbial Communities in the Maize Rhizosphere	PLOS ONE			English	Article							ZEA-MAYS; DIVERSITY; GROWTH; BT	Microbial communities in the rhizosphere make significant contributions to crop health and nutrient cycling. However, their ability to perform important biogeochemical processes remains uncharacterized. Here, we identified important functional genes that characterize the rhizosphere microbial community to understand metabolic capabilities in the maize rhizosphere using the GeoChip-based functional gene array method. Significant differences in functional gene structure were apparent between rhizosphere and bulk soil microbial communities. Approximately half of the detected gene families were significantly (p<0.05) increased in the rhizosphere. Based on the detected gyrB genes, Gammaproteobacteria, Betaproteobacteria, Firmicutes, Bacteroidetes and Cyanobacteria were most enriched in the rhizosphere compared to those in the bulk soil. The rhizosphere niche also supported greater functional diversity in catabolic pathways. The maize rhizosphere had significantly enriched genes involved in carbon fixation and degradation (especially for hemicelluloses, aromatics and lignin), nitrogen fixation, ammonification, denitrification, polyphosphate biosynthesis and degradation, sulfur reduction and oxidation. This research demonstrates that the maize rhizosphere is a hotspot of genes, mostly originating from dominant soil microbial groups such as Proteobacteria, providing functional capacity for the transformation of labile and recalcitrant organic C, N, P and S compounds.	[Li, Xiangzhen; Mackie, Roderick I.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61820 USA; [Li, Xiangzhen; Li, Jiabao] Chinese Acad Sci, Chengdu Inst Biol, Environm Microbiol Key Lab Sichuan Prov, Key Lab Environm & Appl Microbiol,CAS, Chengdu, Sichuan, Peoples R China; [Rui, Junpeng] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Key Lab Mt Ecol Restorat & Bioresource Utilizat,C, Beijing 100864, Sichuan, Peoples R China; [Xiong, Jingbo] Sch Marine Sci, Ningbo, Zhejiang, Peoples R China; [He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Yannarell, Anthony C.] Univ Illinois, Dept Nat Resources & Environm Sci, Urbana, IL USA; [Mackie, Roderick I.] Univ Illinois, Dept Anim Sci, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Mackie, RI (corresponding author), Univ Illinois, Energy Biosci Inst, Urbana, IL 61820 USA.	r-mackie@illinois.edu	吴, 昊/AAB-1620-2020; He, Zhili/C-2879-2012; Liu, Jia-Bao/C-7850-2015; li, jia/GVT-7587-2022; Yannarell, Anthony/AAA-1720-2019	He, Zhili/0000-0001-8225-7333; Liu, Jia-Bao/0000-0002-9620-7692; 	Energy Biosciences Institute, Environmental Impact and Sustainability of Feedstock Production Program at the University of Illinois, Urbana; National Natural Science Foundation of China [41371268, 41301272]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB15010000]	Energy Biosciences Institute, Environmental Impact and Sustainability of Feedstock Production Program at the University of Illinois, Urbana; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the Energy Biosciences Institute, Environmental Impact and Sustainability of Feedstock Production Program at the University of Illinois, Urbana (http://www.energybiosciencesinstitute.org/program_project/environmental-impact-and-sustainability-feedstock-production). The author RJ was also supported from the National Natural Science Foundation of China (41371268, 41301272) (http://www.nsfc.gov.cn/publish/portal1/), Strategic Priority Research Program of the Chinese Academy of Sciences (XDB15010000) (http://english.cas.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2010, SOIL BIOL BIOCHEM, V42, P2276, DOI 10.1016/j.soilbio.2010.08.029; ASMAR F, 1995, PLANT SOIL, V172, P117, DOI 10.1007/BF00020865; Bonkowski M, 2000, EUR J SOIL BIOL, V36, P135, DOI 10.1016/S1164-5563(00)01059-1; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; Dohrmann AB, 2013, ISME J, V7, P37, DOI 10.1038/ismej.2012.77; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Velasco AGV, 2013, APPL SOIL ECOL, V68, P46, DOI 10.1016/j.apsoil.2013.03.010; HANWAY JJ, 1963, AGRON J, V55, P487, DOI 10.2134/agronj1963.00021962005500050024x; He ZL, 2012, CURR OPIN BIOTECH, V23, P460, DOI 10.1016/j.copbio.2011.12.021; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Kersten P, 2007, FUNGAL GENET BIOL, V44, P77, DOI 10.1016/j.fgb.2006.07.007; Li XZ, 2014, SOIL BIOL BIOCHEM, V68, P392, DOI 10.1016/j.soilbio.2013.10.017; Mahmood T, 1997, BIOL FERT SOILS, V24, P323, DOI 10.1007/s003740050251; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; Mendes LW, 2014, ISME J, V8, P1577, DOI 10.1038/ismej.2014.17; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Philippot L, 2002, APPL ENVIRON MICROB, V68, P6121, DOI 10.1128/AEM.68.12.6121-6128.2002; Singh BK, 2004, TRENDS MICROBIOL, V12, P386, DOI 10.1016/j.tim.2004.06.008; Wang HB, 2011, J PROTEOME RES, V10, P932, DOI 10.1021/pr100981r; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	22	98	107	12	185	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112609	10.1371/journal.pone.0112609	http://dx.doi.org/10.1371/journal.pone.0112609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383887	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700083
J	Linder, B; Hirmer, A; Gal, A; Ruther, K; Bolz, HJ; Winkler, C; Laggerbauer, B; Fischer, U				Linder, Bastian; Hirmer, Anja; Gal, Andreas; Ruether, Klaus; Bolz, Hanno Joern; Winkler, Christoph; Laggerbauer, Bernhard; Fischer, Utz			Identification of a PRPF4 Loss-of-Function Variant That Abrogates U4/U6.U5 Tri-snRNP Integration and Is Associated with Retinitis Pigmentosa	PLOS ONE			English	Article							SPLICING FACTOR GENES; DEVELOPMENTAL DISORDER; RECYCLING FACTOR; MUTATIONS; RNA; PROTEIN; SPLICEOSOME; CYCLOPHILIN; EXPRESSIVITY; COMPONENT	Pre-mRNA splicing by the spliceosome is an essential step in the maturation of nearly all human mRNAs. Mutations in six spliceosomal proteins, PRPF3, PRPF4, PRPF6, PRPF8, PRPF31 and SNRNP200, cause retinitis pigmentosa (RP), a disease characterized by progressive photoreceptor degeneration. All splicing factors linked to RP are constituents of the U4/U6. U5 tri-snRNP subunit of the spliceosome, suggesting that the compromised function of this particle may lead to RP. Here, we report the identification of the p.R192H variant of the tri-snRNP factor PRPF4 in a patient with RP. The mutation affects a highly conserved arginine residue that is crucial for PRPF4 function. Introduction of a corresponding mutation into the zebrafish homolog of PRPF4 resulted in a complete loss of function in vivo. A series of biochemical experiments suggested that p.R192H disrupts the binding interface between PRPF4 and its interactor PRPF3. This interferes with the ability of PRPF4 to integrate into the tri-snRNP, as shown in a human cell line and in zebrafish embryos. These data suggest that the p.R192H variant of PRPF4 represents a functional null allele. The resulting haploinsufficiency of PRPF4 compromises the function of the tri-snRNP, reinforcing the notion that this spliceosomal particle is of crucial importance in the physiology of the retina.	[Linder, Bastian; Hirmer, Anja; Laggerbauer, Bernhard; Fischer, Utz] Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany; [Gal, Andreas] Univ Med Ctr Hamburg Eppendorf, Dept Human Genet, Hamburg, Germany; [Ruether, Klaus] St Gertrauden Hosp, Dept Ophthalmol, Berlin, Germany; [Bolz, Hanno Joern] Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Bolz, Hanno Joern] Bioscientia Ctr Human Genet, Ingelheim, Germany; [Winkler, Christoph] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	University of Wurzburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Cologne; National University of Singapore	Fischer, U (corresponding author), Univ Wurzburg, Dept Biochem, D-97070 Wurzburg, Germany.	utz.fischer@biozentrum.uni-wuerzburg.de	Linder, Bastian/W-4923-2019; Winkler, Christoph/G-4822-2012; Fischer, Utz/A-4090-2016; Fischer, Utz/AAT-8422-2020; Linder, Bastian/G-5111-2012	Linder, Bastian/0000-0003-1203-3136; Fischer, Utz/0000-0002-1465-6591; Fischer, Utz/0000-0002-1465-6591; Winkler, Christoph/0000-0003-4688-6241	German Research Foundation (DFG); Academic Research Fund (AcRF) grant of the Ministry of Education, Singapore [T207B3107]; German ProRetina Foundation; Graduiertenkolleg GK [1048]; University of Wuerzburg in the funding programme Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Academic Research Fund (AcRF) grant of the Ministry of Education, Singapore(Ministry of Education, Singapore); German ProRetina Foundation; Graduiertenkolleg GK(German Research Foundation (DFG)); University of Wuerzburg in the funding programme Open Access Publishing	This work was supported by German Research Foundation (DFG) grants to U. Fischer and an Academic Research Fund (AcRF) grant (T207B3107) of the Ministry of Education, Singapore to C. Winkler. B. Linder and A. Hirmer received fellowships from the German ProRetina Foundation and the Graduiertenkolleg GK 1048, respectively. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ayadi L, 1998, J MOL BIOL, V284, P673, DOI 10.1006/jmbi.1998.2183; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; Benaglio P, 2014, MOL VIS, V20, P843; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Chen X, 2014, HUM MOL GENET, V23, P2926, DOI 10.1093/hmg/ddu005; Choi YH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039927, 10.1371/journal.pone.0046688]; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Cvackova Z, 2014, HUM MUTAT, V35, P308, DOI 10.1002/humu.22481; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; EVANS K, 1995, BRIT J OPHTHALMOL, V79, P841, DOI 10.1136/bjo.79.9.841; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Galej Wojciech P, 2013, Nature, V493, P638, DOI 10.1038/nature11843; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Horowitz DS, 1997, RNA, V3, P1374; Horowitz DS, 2002, EMBO J, V21, P470, DOI 10.1093/emboj/21.3.470; HU J, 1994, NUCLEIC ACIDS RES, V22, P1724, DOI 10.1093/nar/22.9.1724; Huranova M, 2009, HUM MOL GENET, V18, P2014, DOI 10.1093/hmg/ddp125; Jia YC, 2012, CELL, V148, P296, DOI 10.1016/j.cell.2011.11.057; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Linder B, 2011, HUM MOL GENET, V20, P368, DOI 10.1093/hmg/ddq473; Maubaret CG, 2011, INVEST OPHTH VIS SCI, V52, P9304, DOI 10.1167/iovs.11-8372; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Mordes D, 2006, MOL VIS, V12, P1259; Nag A, 2012, RNA BIOL, V9, P0; Pasternack SM, 2013, AM J HUM GENET, V92, P81, DOI 10.1016/j.ajhg.2012.10.022; Raghunathan PL, 1998, SCIENCE, V279, P857, DOI 10.1126/science.279.5352.857; Tanackovic G, 2011, AM J HUM GENET, V88, P643, DOI 10.1016/j.ajhg.2011.04.008; Tanackovic G, 2011, HUM MOL GENET, V20, P2116, DOI 10.1093/hmg/ddr094; Teigelkamp S, 1998, RNA, V4, P127; Trede NS, 2007, P NATL ACAD SCI USA, V104, P6608, DOI 10.1073/pnas.0701919104; Vaclavik V, 2010, MOL VIS, V16, P467; Venturini G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003040; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Zhao C, 2009, AM J HUM GENET, V85, P617, DOI 10.1016/j.ajhg.2009.09.020	40	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111754	10.1371/journal.pone.0111754	http://dx.doi.org/10.1371/journal.pone.0111754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383878	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700020
J	Makino, A; Abe, M; Murate, M; Inaba, T; Yilmaz, N; Hullin-Matsuda, F; Kishimoto, T; Schieber, NL; Taguchi, T; Arai, H; Anderluh, G; Parton, RG; Kobayashi, T				Makino, Asami; Abe, Mitsuhiro; Murate, Motohide; Inaba, Takehiko; Yilmaz, Neval; Hullin-Matsuda, Francoise; Kishimoto, Takuma; Schieber, Nicole L.; Taguchi, Tomohiko; Arai, Hiroyuki; Anderluh, Gregor; Parton, Robert G.; Kobayashi, Toshihide			Visualization of the heterogeneous membrane distribution of sphingomyelin associated with cytokinesis, cell polarity, and sphingolipidosis	FASEB JOURNAL			English	Article						lipid binding protein; lipid raft; membrane lipids; sphingolipid; toxins	PORE-FORMING TOXIN; ATOMIC-FORCE MICROSCOPY; LIPID PHASE COEXISTENCE; EQUINATOXIN-II; PLASMA-MEMBRANE; EPITHELIAL-CELLS; ACID SPHINGOMYELINASE; ELECTRON-MICROSCOPY; ACTINIA-EQUINA; SEA-ANEMONE	Sphingomyelin (SM) is a major sphingolipid in mammalian cells and is reported to form specific lipid domains together with cholesterol. However, methods to examine the membrane distribution of SM are limited. We demonstrated in model membranes that fluorescent protein conjugates of 2 specific SM-binding toxins, lysenin (Lys) and equinatoxin II (EqtII), recognize different membrane distributions of SM; Lys exclusively binds clustered SM, whereas EqtII preferentially binds dispersed SM. Freeze-fracture immunoelectron microscopy showed that clustered but not dispersed SM formed lipid domains on the cell surface. Glycolipids and the membrane concentration of SM affect the SM distribution pattern on the plasma membrane. Using derivatives of Lys and EqtII as SM distribution-sensitive probes, we revealed the exclusive accumulation ofSM clusters in the midbody at the time of cytokinesis. Interestingly, apical membranes of differentiated epithelial cells exhibited dispersed SM distribution, whereas SM was clustered in basolateral membranes. Clustered but not dispersed SM was absent from the cell surface of acid sphingomyelinase-deficient Niemann-Pick type A cells. These data suggest that both the SM content and membrane distribution are crucial for pathophysiological events bringing therapeutic perspective in the role of SM membrane distribution.	[Makino, Asami; Abe, Mitsuhiro; Murate, Motohide; Inaba, Takehiko; Yilmaz, Neval; Hullin-Matsuda, Francoise; Kishimoto, Takuma; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Hullin-Matsuda, Francoise; Kobayashi, Toshihide] Univ Lyon, INSERM, U1060, Villeurbanne, France; [Schieber, Nicole L.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Taguchi, Tomohiko; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Anderluh, Gregor] Univ Ljubljana, Natl Inst Chem, Ljubljana, Slovenia; [Anderluh, Gregor] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia	RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Queensland; University of Queensland; University of Tokyo; National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana	Kobayashi, T (corresponding author), RIKEN, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kobayasi@riken.jp	KOBAYASHI, TOSHIHIDE/S-8313-2019; Kobayashi, Toshihide/B-6298-2015; Carmen, Team1/Y-7382-2019; Kishimoto, Takuma/AAP-1813-2021; Hullin-Matsuda, Françoise/N-3880-2017; Abe, Mitsuhiro/C-3602-2017; Taguchi, Tomohiko/I-5014-2019; Anderluh, Gregor/C-6905-2014; Parton, Robert/C-5673-2009	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kobayashi, Toshihide/0000-0002-4811-7270; Carmen, Team1/0000-0003-4234-1746; Hullin-Matsuda, Françoise/0000-0002-6042-2841; Taguchi, Tomohiko/0000-0003-0464-6370; Anderluh, Gregor/0000-0002-9916-8465; Lab, Carmen/0000-0002-5935-3236; Abe, Mitsuhiro/0000-0002-6244-1771; Parton, Robert/0000-0002-7494-5248; Inaba, Takehiko/0000-0002-8770-4662; Schieber, Nicole L./0000-0002-3212-5057	Lipid Dynamics Program	Lipid Dynamics Program	The authors are grateful to R. Nakazawa for DNA sequence analysis and S. Jones for critical reading. They thank Dr. T. Watanabe and Carl Zeiss Microscopy Co. Ltd., Japan, for structured illumination microscopy images, and also thank the members of T. K.' s laboratory for their support, critical reading, and discussion. This work was supported by Lipid Dynamics Program, Cellular System Program and Integrated Lipidology Programof RIKEN, Grants-in-Aid for Scientific Research 23790115 (to A. M.), 23590251 (to M. M.), 24770135 (to T. Ki.), 23460081 (to F. H.-M.), and 22390018 and 25293015 (to T. Ko.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Naito Foundation. This work was supported by fellowships and a grant from the National Health and Medical Research Council of Australia (to R. G. P., Grants 569542 and 1037320). The authors acknowledge the facilities as well as the scientific and technical assistance of the Australian Microscopy & Microanalysis Research Facility at the Centre for Microscopy and Microanalysis, The University of Queensland. G. A. acknowledges the support of the Slovenian Research Agency.	Abe M, 2014, BBA-MOL CELL BIOL L, V1841, P720, DOI 10.1016/j.bbalip.2013.07.003; Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Akashi K, 1996, BIOPHYS J, V71, P3242, DOI 10.1016/S0006-3495(96)79517-6; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Barlic A, 2004, J BIOL CHEM, V279, P34209, DOI 10.1074/jbc.M313817200; Bezombes C, 2001, FASEB J, V15, P297; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boesen-de Cock JGR, 1998, J BIOL CHEM, V273, P7560, DOI 10.1074/jbc.273.13.7560; Bohdanowicz M, 2013, PHYSIOL REV, V93, P69, DOI 10.1152/physrev.00002.2012; BRADY RO, 1966, P NATL ACAD SCI USA, V55, P366, DOI 10.1073/pnas.55.2.366; Carquin M, 2014, J LIPID RES, V55, P1331, DOI 10.1194/jlr.M048538; CHALVARDJIAN A, 1970, ANAL BIOCHEM, V36, P225, DOI 10.1016/0003-2697(70)90352-0; De Colibus L, 2012, STRUCTURE, V20, P1498, DOI 10.1016/j.str.2012.06.011; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; De Maria R, 1998, J EXP MED, V187, P897, DOI 10.1084/jem.187.6.897; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Feigenson GW, 2001, BIOPHYS J, V80, P2775, DOI 10.1016/S0006-3495(01)76245-5; Fujimoto K, 1997, HISTOCHEM CELL BIOL, V107, P87, DOI 10.1007/s004180050092; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Galvan C, 2008, MOL BIOL CELL, V19, P509, DOI 10.1091/mbc.E07-05-0439; Garcia PS, 2012, TOXICON, V60, P724, DOI 10.1016/j.toxicon.2012.05.018; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Hubbard A L, 1991, Semin Cell Biol, V2, P365; Hullin-Matsuda F, 2007, J LIPID RES, V48, P1997, DOI 10.1194/jlr.M700154-JLR200; Ikenouchi J, 2013, J CELL SCI, V126, P3585, DOI 10.1242/jcs.122325; Ikenouchi J, 2012, J BIOL CHEM, V287, P9525, DOI 10.1074/jbc.M111.327064; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Kirschnek S, 2000, J BIOL CHEM, V275, P27316; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Kiyokawa E, 2004, BIOCHEMISTRY-US, V43, P9766, DOI 10.1021/bi049561j; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Lawrence JC, 2003, BIOPHYS J, V84, P1827, DOI 10.1016/S0006-3495(03)74990-X; Levade T, 1999, BBA-MOL CELL BIOL L, V1438, P1, DOI 10.1016/S1388-1981(99)00038-4; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Marsh D., 2013, HDB LIPID BILAYERS, DOI 10.1201/9781420088335-8; Maulik PR, 1996, BIOCHEMISTRY-US, V35, P8025, DOI 10.1021/bi9528356; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Mizuno H, 2011, CHEM SCI, V2, P1548, DOI 10.1039/c1sc00169h; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Murate M, 2010, BIOCHEMISTRY-US, V49, P4732, DOI 10.1021/bi100007u; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; Perry GLW, 2004, ENVIRON MODELL SOFTW, V19, P559, DOI 10.1016/j.envsoft.2003.07.004; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Rojko N, 2014, BIOPHYS J, V106, P1630, DOI 10.1016/j.bpj.2013.11.4507; Sahai E, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-14; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schon P, 2008, BIOPHYS J, V95, P691, DOI 10.1529/biophysj.108.129981; SCHOENENBERGER CA, 1994, J CELL SCI, V107, P527; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; SIMONS K, 1992, COLD SPRING HARB SYM, V57, P611, DOI 10.1101/SQB.1992.057.01.067; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Singh B, 2014, ANNU REV PHYSIOL, V76, P275, DOI 10.1146/annurev-physiol-021113-170406; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000391; Uchida Y, 2011, P NATL ACAD SCI USA, V108, P15846, DOI 10.1073/pnas.1109101108; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x; Wang T, 2012, BIOCHEMISTRY-US, V51, P74, DOI 10.1021/bi2011652; Yachi R, 2012, GENES CELLS, V17, P720, DOI 10.1111/j.1365-2443.2012.01621.x; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamaji-Hasegawa A, 2003, J BIOL CHEM, V278, P22762, DOI 10.1074/jbc.M213209200; Yilmaz N, 2013, BIOPHYS J, V105, P1397, DOI 10.1016/j.bpj.2013.07.052; Yuan CB, 2002, BIOPHYS J, V82, P2526, DOI 10.1016/S0006-3495(02)75596-3; ZACHOWSKI A, 1993, BIOCHEM J, V294, P1; Zha XH, 1998, J CELL BIOL, V140, P39, DOI 10.1083/jcb.140.1.39	78	61	62	1	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					477	493		10.1096/fj.13-247585	http://dx.doi.org/10.1096/fj.13-247585			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25389132	hybrid			2022-12-26	WOS:000349370400013
J	Li, C; Mpollo, MSEM; Gonsalves, CS; Tahara, SM; Malik, P; Kalra, VK				Li, Chen; Mpollo, Marthe-Sandrine Eiymo Mwa; Gonsalves, Caryn S.; Tahara, Stanley M.; Malik, Punam; Kalra, Vijay K.			Peroxisome Proliferator-activated Receptor-alpha-mediated Transcription of miR-199a2 Attenuates Endothelin-1 Expression via Hypoxia-inducible Factor-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SICKLE-CELL-DISEASE; PLACENTA GROWTH-FACTOR; PULMONARY-HYPERTENSION; GENE-EXPRESSION; BLOOD-PRESSURE; KNOCKOUT MICE; CANCER-CELLS; FACTOR-I; RISK; CONTRIBUTES	Endothelin-1, a potent vasoconstrictor, plays an important role in pulmonary hypertension (PH) in sickle cell disease (SCD). Our previous studies show that higher levels of placenta growth factor (PlGF), secreted by erythroid precursor cells, correlate with increased plasma levels of endothelin-1 (ET-1) and other functional markers of PH in SCD. PlGF-mediated ET-1 expression occurs via activation of hypoxia-inducible factor-1 alpha (HIF-1 alpha). However, relatively less is understood regarding how PlGF-mediated expression of HIF-1 alpha and its downstream effector ET-1 are post-transcriptionally regulated. Herein, we show that PlGF treatment of endothelial cells resulted in reduced levels of miR-199a2, which targeted the 3'-UTR of HIF-1 alpha mRNA and concomitantly led to augmented ET-1 expression. Plasma levels of miR-199a2 in SCD subjects were significantly lower with reciprocally high levels of plasma ET-1, unlike unaffected controls. This observation provided a molecular link between miR-199a2 and high levels of ET-1 in SCD. Furthermore, we show that miR-199a2 located in the DNM3os transcription unit was co-transcriptionally regulated by peroxisome proliferator-activated receptor alpha (PPAR alpha). Binding of the latter to PPAR alpha cis-elements in the promoter of DNM3os was demonstrated by promoter mutational analysis and ChIP. Additionally, we show that fenofibrate, a PPAR alpha agonist, increased the expression of miR-199a2 and DNM3os; the former was responsible for reduced expression of HIF-1 alpha and ET-1. In vivo studies of fenofibrate-fed Berkeley sickle mice resulted in increased levels of miR-199a2 and reduced levels of ET-1 in lung tissues. Our studies provide a potential therapeutic approach whereby fenofibrate-induced miR-199a2 expression can ameliorate PH by reduction of ET-1 levels.	[Li, Chen; Gonsalves, Caryn S.; Kalra, Vijay K.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Tahara, Stanley M.] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Mpollo, Marthe-Sandrine Eiymo Mwa; Malik, Punam] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA	University of Southern California; University of Southern California; Cincinnati Children's Hospital Medical Center	Malik, P (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.	Punam.Malik@cchmc.org; vkalra@usc.edu		Tahara, Stanley/0000-0001-5097-0927	National Institutes of Health [RO1-HL111372, P30-DK048522]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL111372 (to V. K. K. and P. M.) and P30-DK048522 (to the University of Southern California Research Center for Liver Disease).	Ataga KI, 2007, HAEMATOLOGICA, V93, P20, DOI 10.3324/haematol.11763; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Chen Y, 2013, DIABETES, V62, P261, DOI 10.2337/db11-0413; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Desvignes T, 2014, RNA BIOL, V11, P281, DOI 10.4161/rna.28141; Ding G, 2013, MOL CELL BIOCHEM, V384, P173, DOI 10.1007/s11010-013-1795-3; el Azzouzi H, 2013, CELL METAB, V18, P341, DOI 10.1016/j.cmet.2013.08.009; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Glineur C, 2013, ARTERIOSCL THROM VAS, V33, P621, DOI 10.1161/ATVBAHA.112.300665; Gonsalves C. S., 2014, MOL CELL BIOL, DOI [10.1128/MCB.01199-14, DOI 10.1128/MCB.01199-14]; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Hsu LL, 2007, BLOOD, V109, P3088, DOI 10.1182/blood-2006-08-039438; Hu J, 1998, BIOCHEM BIOPH RES CO, V245, P894, DOI 10.1006/bbrc.1998.8543; Kang J, 2009, ANAL BIOCHEM, V386, P251, DOI 10.1016/j.ab.2008.12.021; Kedzierski RM, 2001, ANNU REV PHARMACOL, V41, P851, DOI 10.1146/annurev.pharmtox.41.1.851; Kim KS, 2006, J IMMUNOL, V177, P7211, DOI 10.4049/jimmunol.177.10.7211; Kisanuki YY, 2010, HYPERTENSION, V56, P121, DOI 10.1161/HYPERTENSIONAHA.109.138701; Klings ES, 2008, AM J HEMATOL, V83, P4, DOI 10.1002/ajh.21083; Klings ES, 2014, AM J RESP CRIT CARE, V189, P727, DOI 10.1164/rccm.201401-0065ST; KOUREMBANAS S, 1991, J CLIN INVEST, V88, P1054, DOI 10.1172/JCI115367; Lalloyer F, 2010, ARTERIOSCL THROM VAS, V30, P894, DOI 10.1161/ATVBAHA.108.179689; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Loebel DAF, 2005, GENOMICS, V85, P782, DOI 10.1016/j.ygeno.2005.02.001; Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI; Minniti CP, 2009, BRIT J HAEMATOL, V147, P737, DOI 10.1111/j.1365-2141.2009.07906.x; Morris CR, 2008, BLOOD, V111, P402, DOI 10.1182/blood-2007-04-081703; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Nourale M, 2013, HAEMATOLOGICA, V98, P464, DOI 10.3324/haematol.2012.068965; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Patel N, 2008, BLOOD, V112, P856, DOI 10.1182/blood-2007-12-130567; Patel N, 2011, BIOCHEM J, V434, P473, DOI 10.1042/BJ20101585; Patel N, 2010, J BIOL CHEM, V285, P16713, DOI 10.1074/jbc.M110.101691; Patel N, 2009, BLOOD, V113, P1129, DOI 10.1182/blood-2008-07-169821; Pereira ER, 2014, J BIOL CHEM, V289, P3352, DOI 10.1074/jbc.M113.507194; Perelman N, 2003, BLOOD, V102, P1506, DOI 10.1182/blood-2002-11-3422; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rybicki AC, 1998, BLOOD, V92, P2594, DOI 10.1182/blood.V92.7.2594.2594_2594_2596; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Sundaram N, 2010, BLOOD, V116, P109, DOI 10.1182/blood-2009-09-244830; Watanabe T, 2008, DEV DYNAM, V237, P3738, DOI 10.1002/dvdy.21787; Wood KC, 2013, ARTERIOSCL THROM VAS, V33, P1861, DOI 10.1161/ATVBAHA.112.301068; Yamashita K, 2001, J BIOL CHEM, V276, P12645, DOI 10.1074/jbc.M011344200; Zhang X, 2014, CIRCULATION, V129, P1650, DOI 10.1161/CIRCULATIONAHA.113.005296; Zhou JD, 2012, J BIOL CHEM, V287, P35161, DOI 10.1074/jbc.M112.367367	46	25	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36031	36047		10.1074/jbc.M114.600775	http://dx.doi.org/10.1074/jbc.M114.600775			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25389292	Green Published, hybrid			2022-12-26	WOS:000346897900032
J	Borne, Y; Fagerberg, B; Persson, M; Sallsten, G; Forsgard, N; Hedblad, B; Barregard, L; Engstrom, G				Borne, Yan; Fagerberg, Bjorn; Persson, Margaretha; Sallsten, Gerd; Forsgard, Niklas; Hedblad, Bo; Barregard, Lars; Engstrom, Gunnar			Cadmium Exposure and Incidence of Diabetes Mellitus - Results from the Malmo Diet and Cancer Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; BONE-MINERAL DENSITY; ENVIRONMENTAL EXPOSURE; CARDIOVASCULAR-DISEASE; PROSPECTIVE COHORT; URINARY CADMIUM; CARBON-MONOXIDE; BREAST-CANCER; POPULATION; RISK	Background: Cadmium is a pollutant with multiple adverse health effects: renal dysfunction, osteoporosis and fractures, cancer, and probably cardiovascular disease. Some studies have reported associations between cadmium and impaired fasting glucose and diabetes. However, this relationship is controversial and there is a lack of longitudinal studies. Objectives: To examine prospectively whether cadmium in blood is associated with incidence of diabetes mellitus. Methods: The study population consists of 4585 subjects without history of diabetes (aged 46 to 67 years, 60% women), who participated in the Malmo Diet and Cancer study during 1991-1994. Blood cadmium levels were estimated from hematocrit and cadmium concentrations in erythrocytes. Incident cases of diabetes were identified from national and local diabetes registers. Results: Cadmium concentrations in blood were not associated with blood glucose and insulin levels at the baseline examination. However, cadmium was positively associated with HbA1c in former smokers and current smokers. During a mean follow-up of 15.2 +/- 4.2 years, 622 (299 men and 323 women) were diagnosed with new-onset of diabetes. The incidence of diabetes was not significantly associated with blood cadmium level at baseline, neither in men or women. The hazard ratio (4th vs 1st quartile) was 1.11 (95% confidence interval 0.82-1.49), when adjusted for potential confounders. Conclusions: Elevated blood cadmium levels are not associated with increased incidence of diabetes. The positive association between HbA1c and blood cadmium levels has a likely explanation in mechanisms related to erythrocyte turnover and smoking.	[Borne, Yan; Persson, Margaretha; Hedblad, Bo; Engstrom, Gunnar] Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo, Malmo, Sweden; [Fagerberg, Bjorn] Sahlgrens Univ Hosp, Wallenberg Lab, Sahlgrenska Ctr Cardiovasc & Metab Res, Gothenburg, Sweden; [Fagerberg, Bjorn] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden; [Persson, Margaretha] Skane Univ Hosp, Emergency Dept, Clin Res Unit, Malmo, Sweden; [Sallsten, Gerd; Barregard, Lars] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Sallsten, Gerd; Barregard, Lars] Univ Gothenburg, Gothenburg, Sweden; [Forsgard, Niklas] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden	Lund University; Skane University Hospital; Sahlgrenska University Hospital; University of Gothenburg; Lund University; Skane University Hospital; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital	Borne, Y (corresponding author), Lund Univ, Skane Univ Hosp, Dept Clin Sci Malmo, Malmo, Sweden.	yan.borne@med.lu.se	b, y/AAG-3349-2019	Engstrom, Gunnar/0000-0002-8618-9152; Persson, Margaretha/0000-0001-8188-5792	Swedish Research Council [2011-3891]; Swedish Heart-Lung Foundation [20130249, 20120364]; Swedish Council for Working Life and Social Research (FAS); Region Vastra Gotaland; Sahlgrenska University Hospital; Region Skane; Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Region Vastra Gotaland; Sahlgrenska University Hospital; Region Skane; Lund University	This study was supported by the Swedish Research Council (2011-3891), the Swedish Heart-Lung Foundation (20130249; 20120364); Swedish Council for Working Life and Social Research (FAS), and the regional agreement on medical training and clinical research (ALF) between Region Vastra Gotaland and Sahlgrenska University Hospital and ALF between Region Skane and Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2014, ENVIRON HEALTH PERSP, V122, P431, DOI 10.1289/ehp.1307110; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barregard L, 2013, ENVIRON RES, V121, P104, DOI 10.1016/j.envres.2012.11.005; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; BEUTLER E, 1975, BLOOD, V46, P253; Borne Y, 2011, EUR J HEART FAIL, V13, P1355, DOI 10.1093/eurjhf/hfr127; Cho YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075087, 10.1371/journal.pone.0081560]; Edwards JR, 2009, TOXICOL APPL PHARM, V238, P289, DOI 10.1016/j.taap.2009.03.007; Engstrom A, 2012, BONE, V50, P1372, DOI 10.1016/j.bone.2012.03.018; Engstrom A, 2011, J BONE MINER RES, V26, P486, DOI 10.1002/jbmr.224; Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663; Fagerberg B, 2012, J INTERN MED, V272, P601, DOI 10.1111/j.1365-2796.2012.02578.x; Furne JK, 2003, J LAB CLIN MED, V142, P52, DOI 10.1016/S0022-2143(03)00086-6; Hedblad B, 2000, DIABETIC MED, V17, P299, DOI 10.1046/j.1464-5491.2000.00280.x; International Agency for Research on Cancer, 2012, IARC MON EV CAR RI C; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Julin B, 2012, BRIT J CANCER, V107, P895, DOI 10.1038/bjc.2012.311; Julin B, 2012, CANCER RES, V72, P1459, DOI 10.1158/0008-5472.CAN-11-0735; KJELLSTROM T, 1978, ENVIRON RES, V16, P248, DOI 10.1016/0013-9351(78)90160-3; Maahs DM, 2010, ENDOCRIN METAB CLIN, V39, P481, DOI 10.1016/j.ecl.2010.05.011; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Melander O, 2012, JAMA-J AM MED ASSOC, V308, P1469, DOI 10.1001/jama.2012.12998; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; MODAN M, 1988, DIABETES CARE, V11, P422, DOI 10.2337/diacare.11.5.422; Moon SS, 2013, DIABETIC MED, V30, pe143, DOI 10.1111/dme.12103; Navas-Acien A, 2009, AM J EPIDEMIOL, V170, P1156, DOI 10.1093/aje/kwp248; Nordberg GF, 2007, HANDBOOK ON THE TOXICOLOGY OF METALS, 3RD EDITION, P445, DOI 10.1016/B978-012369413-3/50078-1; PANZER S, 1982, BLOOD, V59, P1348; Schwartz GG, 2003, DIABETES CARE, V26, P468, DOI 10.2337/diacare.26.2.468; Staessen JA, 1999, LANCET, V353, P1140, DOI 10.1016/S0140-6736(98)09356-8; Swaddiwudhipong W, 2012, ENVIRON RES, V112, P194, DOI 10.1016/j.envres.2011.10.004; Swaddiwudhipong W, 2010, ENVIRON RES, V110, P612, DOI 10.1016/j.envres.2010.06.002; Swaddiwudhipong Witaya, 2010, Journal of the Medical Association of Thailand, V93, P231; Tellez-Plaza M, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0356-2; Tellez-Plaza M, 2012, ENVIRON HEALTH PERSP, V120, P1017, DOI 10.1289/ehp.1104352; The Swedish Chemical Agency, 2011, 111 SWED CHEM AG; WHO (World Health Organization), 2011, 73 WHO JOINT FAOWHO	37	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112277	10.1371/journal.pone.0112277	http://dx.doi.org/10.1371/journal.pone.0112277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393737	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300045
J	Flamme, I; Oehme, F; Ellinghaus, P; Jeske, M; Keldenich, J; Thuss, U				Flamme, Ingo; Oehme, Felix; Ellinghaus, Peter; Jeske, Mario; Keldenich, Joerg; Thuss, Uwe			Mimicking Hypoxia to Treat Anemia: HIF-Stabilizer BAY 85-3934 (Molidustat) Stimulates Erythropoietin Production without Hypertensive Effects	PLOS ONE			English	Article							INDUCIBLE FACTOR ACTIVATION; CHRONIC KIDNEY-DISEASE; PROLYL HYDROXYLASE; GENE-EXPRESSION; CHUVASH POLYCYTHEMIA; DOMAIN PROTEINS; GROWTH-FACTOR; IN-VIVO; 4-HYDROXYLASE; INHIBITION	Oxygen sensing by hypoxia-inducible factor prolyl hydroxylases (HIF-PHs) is the dominant regulatory mechanism of erythropoietin (EPO) expression. In chronic kidney disease (CKD), impaired EPO expression causes anemia, which can be treated by supplementation with recombinant human EPO (rhEPO). However, treatment can result in rhEPO levels greatly exceeding the normal physiological range for endogenous EPO, and there is evidence that this contributes to hypertension in patients with CKD. Mimicking hypoxia by inhibiting HIF-PHs, thereby stabilizing HIF, is a novel treatment concept for restoring endogenous EPO production. HIF stabilization by oral administration of the HIF-PH inhibitor BAY 85-3934 (molidustat) resulted in dose-dependent production of EPO in healthy Wistar rats and cynomolgus monkeys. In repeat oral dosing of BAY 85-3934, hemoglobin levels were increased compared with animals that received vehicle, while endogenous EPO remained within the normal physiological range. BAY 85-3934 therapy was also effective in the treatment of renal anemia in rats with impaired kidney function and, unlike treatment with rhEPO, resulted in normalization of hypertensive blood pressure in a rat model of CKD. Notably, unlike treatment with the antihypertensive enalapril, the blood pressure normalization was achieved without a compensatory activation of the renin-angiotensin system. Thus, BAY 85-3934 may provide an approach to the treatment of anemia in patients with CKD, without the increased risk of adverse cardiovascular effects seen for patients treated with rhEPO. Clinical studies are ongoing to investigate the effects of BAY 85-3934 therapy in patients with renal anemia.	[Flamme, Ingo] Bayer Pharma AG, Global Drug Discovery, Acute Care Res, Cardiol Hematol, Wuppertal, Germany; [Oehme, Felix] Bayer Pharma AG, Global Biol, Biotech Dev, Wuppertal, Germany; [Ellinghaus, Peter] Bayer Pharma AG, Global Biomarkers, Clin Sci, Wuppertal, Germany; [Jeske, Mario] Bayer Pharma AG, Global Chem Prod Dev, Wuppertal, Germany; [Keldenich, Joerg; Thuss, Uwe] Bayer Pharma AG, Global Early Dev, Drug Metab & Pharmacokinet, Wuppertal, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals; Bayer AG; Bayer Healthcare Pharmaceuticals	Flamme, I (corresponding author), Bayer Pharma AG, Global Drug Discovery, Acute Care Res, Cardiol Hematol, Wuppertal, Germany.	ingo.flamme@bayer.com			Bayer Pharma AG	Bayer Pharma AG	This study was funded by Bayer Pharma AG. All the authors are employees of Bayer Pharma AG. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	ABBRECHT PH, 1972, J APPL PHYSIOL, V32, P54, DOI 10.1152/jappl.1972.32.1.54; Arsenault PR, 2013, J BIOL CHEM, V288, P33571, DOI 10.1074/jbc.M113.482364; Asikainen TM, 2005, FREE RADICAL BIO MED, V38, P1002, DOI 10.1016/j.freeradbiomed.2004.12.004; Bao WK, 2010, J CARDIOVASC PHARM, V56, P147, DOI 10.1097/FJC.0b013e3181e2bfef; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Boettcher M.-F., 2013, J AM SOC NEPHROL, V24, p347A; Briet M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000128; Brookhart MA, 2008, J AM SOC NEPHROL, V19, P1389, DOI 10.1681/ASN.2007111181; Brookhart MA, 2011, AM J EPIDEMIOL, V173, P768, DOI 10.1093/aje/kwq423; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Deng AH, 2010, AM J PHYSIOL-RENAL, V299, pF1365, DOI 10.1152/ajprenal.00153.2010; Denny WA, 2012, J MED CHEM, V55, P2943, DOI 10.1021/jm300314a; Dunn A, 2007, AM J MED SCI, V334, P65, DOI 10.1097/MAJ.0b013e318095a4ae; ECKARDT KU, 1989, AM J PHYSIOL, V256, pF942, DOI 10.1152/ajprenal.1989.256.5.F942; Ellinghaus P, 2005, J THORAC CARDIOV SUR, V129, P1383, DOI 10.1016/j.jtcvs.2004.08.031; Elliott J, 2009, ADV CHRONIC KIDNEY D, V16, P94, DOI 10.1053/j.ackd.2008.12.004; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Formenti F, 2010, P NATL ACAD SCI USA, V107, P12722, DOI 10.1073/pnas.1002339107; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; Grabe DW, 2007, AM J HEALTH-SYST PH, V64, pS8, DOI 10.2146/ajhp070182; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Hickey MM, 2007, J CLIN INVEST, V117, P3879, DOI 10.1172/JCI32614; Ivan M, 2002, P NATL ACAD SCI USA, V99, P13459, DOI 10.1073/pnas.192342099; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Johnson DW, 2007, NEPHROLOGY, V12, P321, DOI 10.1111/j.1440-1797.2007.00810.x; KATO A, 1994, RENAL FAILURE, V16, P645, DOI 10.3109/08860229409044892; Koulouridis I, 2013, AM J KIDNEY DIS, V61, P44, DOI 10.1053/j.ajkd.2012.07.014; Kramer BK, 1997, KIDNEY INT, V51, P444, DOI 10.1038/ki.1997.59; Krapf R, 2009, CLIN J AM SOC NEPHRO, V4, P470, DOI 10.2215/CJN.05040908; Kurt B, 2013, J AM SOC NEPHROL, V24, P433, DOI 10.1681/ASN.2012080791; Laitala A, 2012, BLOOD, V120, P3336, DOI 10.1182/blood-2012-07-441824; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Macdougall IC, 2013, J AM SOC NEPHROL, V24, p413A; MASCHIO G, 1995, NEPHROL DIAL TRANSPL, V10, P74, DOI 10.1093/ndt/10.supp2.74; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Muchnik E, 2011, EXPERT OPIN INV DRUG, V20, P645, DOI 10.1517/13543784.2011.566861; NAGANO N, 1990, J PHARM PHARMACOL, V42, P758, DOI 10.1111/j.2042-7158.1990.tb07016.x; Nangaku M, 2006, SEMIN NEPHROL, V26, P261, DOI 10.1016/j.semnephrol.2006.06.001; Neutel JM, 2013, CARDIOVASC THER, V31, P251, DOI 10.1111/1755-5922.12015; Oehme F, 2004, ANAL BIOCHEM, V330, P74, DOI 10.1016/j.ab.2004.03.066; Oehme F, 2002, BIOCHEM BIOPH RES CO, V296, P343, DOI 10.1016/S0006-291X(02)00862-8; Potter C, 2004, CELL CYCLE, V3, P164; Priyadarshi A, 2002, KIDNEY INT, V61, P542, DOI 10.1046/j.1523-1755.2002.00140.x; Querbes W, 2012, BLOOD, V120, P1916, DOI 10.1182/blood-2012-04-423715; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; Rinaudo D, 2000, BIOTECHNIQUES, V29, P218, DOI 10.2144/00292bm03; Sandner P, 1996, PFLUG ARCH EUR J PHY, V431, P905, DOI 10.1007/s004240050084; SARTOR RB, 1989, INFECT IMMUN, V57, P1177, DOI 10.1128/IAI.57.4.1177-1185.1989; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SHIMIZU S, 1994, ACTA PHYSIOL SCAND, V151, P225, DOI 10.1111/j.1748-1716.1994.tb09741.x; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Song YR, 2010, NEPHROL DIAL TRANSPL, V25, P77, DOI 10.1093/ndt/gfp454; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; SUZUKI S, 1995, COMP BIOCHEM PHYS C, V112, P15, DOI 10.1016/0742-8413(95)00075-5; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Thede K., 2008, Patent Application, Patent No. [2008067871, WO, 2008067871 A1]; Unger EF, 2010, NEW ENGL J MED, V362, P189, DOI 10.1056/NEJMp0912328; Wang G L, 1996, Curr Opin Hematol, V3, P156; Warnecke C, 2008, EXP CELL RES, V314, P2016, DOI 10.1016/j.yexcr.2008.03.003; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wenger RH, 2010, AM J PHYSIOL-RENAL, V298, pF1287, DOI 10.1152/ajprenal.00736.2009; Yoon D, 2010, J MOL MED, V88, P523, DOI 10.1007/s00109-010-0599-0; Yu XF, 2012, NEPHROLOGY, V17, P58, DOI 10.1111/j.1440-1797.2011.01498.x	71	115	129	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111838	10.1371/journal.pone.0111838	http://dx.doi.org/10.1371/journal.pone.0111838			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392999	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300023
J	Hatta, K; Guo, J; Ludke, A; Dhingra, S; Singh, K; Huang, ML; Weisel, RD; Li, RK				Hatta, Kota; Guo, Jian; Ludke, Ana; Dhingra, Sanjiv; Singh, Kaustabh; Huang, Ming-Li; Weisel, Richard D.; Li, Ren-Ke			Expression of CNPY2 in Mouse Tissues: Quantification and Localization	PLOS ONE			English	Article							REGULATORY LIGHT-CHAIN; PROTEIN; CANOPY1; CELLS; MSAP; MIR	Canopy FGF signaling regulator 2 (CNPY2) is a FGF21-modulated protein containing a saposin B- type domain. In vitro studies have shown CNPY2 is able to enhance neurite outgrowth in neurons and stabilize the expression of low density lipoprotein receptor in macrophages and hepatocytes. However, no in vivo data are available on the normal expression of CNPY2 and information is lacking on which cell types express this protein in tissues. To address this, the present study examined CNPY2 expression at the mRNA and protein levels. Quantitative PCR and ELISA examination of mouse tissues showed that CNPY2 varies between organs, with the highest expression in the heart, lung and liver. Immunohistochemistry detected CNPY2 in a variety of cell types including skeletal, cardiac and smooth muscle myocytes, endothelial cells and epithelial cells. CNPY2 was also detectable in mouse blood and human and mouse uteri. These data demonstrate CNPY2 is widely distributed in tissues and suggest the protein has biological functions that have yet to be identified. Using these new observations we discuss possible functions of the protein.	[Hatta, Kota; Guo, Jian; Ludke, Ana; Dhingra, Sanjiv; Singh, Kaustabh; Weisel, Richard D.; Li, Ren-Ke] Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada; [Hatta, Kota; Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Huang, Ming-Li] Harbin Med Univ, Affiliated Hosp 1, Dept Gynecol & Obstet, Harbin, Peoples R China	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Harbin Medical University	Li, RK (corresponding author), Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada.	renkeli@uhnresearch.ca	Dhingra, Sanjiv/D-8766-2014; Hatta, Kota/E-9073-2014	Dhingra, Sanjiv/0000-0002-2664-7633; Hatta, Kota/0000-0003-4677-4215; Li, Ren-Ke/0000-0002-2584-060X	Canadian Institutes of Health Research Fredrick Banting	Canadian Institutes of Health Research Fredrick Banting(Canadian Institutes of Health Research (CIHR))	KH is supported by a Canadian Institutes of Health Research Fredrick Banting and Charles Best Canada Graduate Scholarships Doctoral Award. AL is supported by a Heart & Stroke Foundation Research Fellowship Award. RKL holds the Canadian Research Chair in Cardiac Regeneration. This work was supported by a Canadian Institutes of Health Research grant to RKL ( MOP 86661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, MICROSCOPY IMMUNOHIS; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Bornhauser BC, 2003, J BIOL CHEM, V278, P35412, DOI 10.1074/jbc.M306271200; Bornhauser BC, 2005, CELL MOL LIFE SCI, V62, P1260, DOI 10.1007/s00018-005-5055-x; Byers SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035538; Clayberger C, 2003, CURR OPIN IMMUNOL, V15, P560, DOI 10.1016/S0952-7915(03)00097-9; Cooke Roger, 2011, Biophys Rev, V3, P33; Dib H, 2012, PROTEOMICS, V12, P2547, DOI 10.1002/pmic.201200060; Enquobahrie DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.022; Gerber SA, 2003, BRIT J CANCER, V88, P1453, DOI 10.1038/sj.bjc.6600907; Do HT, 2012, J BIOL CHEM, V287, P12602, DOI 10.1074/jbc.M112.341248; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Josephson MP, 2011, BIOCHEM BIOPH RES CO, V416, P367, DOI 10.1016/j.bbrc.2011.11.044; LI CY, 1987, J HISTOCHEM CYTOCHEM, V35, P1457, DOI 10.1177/35.12.2824601; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; Midde K, 2013, J BIOL CHEM, V288, P7012, DOI 10.1074/jbc.M112.434209; Monks J, 2009, J MAMMARY GLAND BIOL, V14, P159, DOI 10.1007/s10911-009-9121-0; Olsson PA, 1999, J BIOL CHEM, V274, P36288, DOI 10.1074/jbc.274.51.36288; Porzionato A, 2010, J HISTOCHEM CYTOCHEM, V58, P825, DOI 10.1369/jhc.2010.956300; Pryhuber GS, 1998, MOL GENET METAB, V64, P217, DOI 10.1006/mgme.1998.2722; Sutherland C, 2012, J BIOL CHEM, V287, P24064, DOI 10.1074/jbc.M112.371609; Tsukita S, 1997, TRENDS BIOCHEM SCI, V22, P53, DOI 10.1016/S0968-0004(96)10071-2; Vaccaro AM, 1999, NEUROCHEM RES, V24, P307, DOI 10.1023/A:1022530508763; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	25	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111370	10.1371/journal.pone.0111370	http://dx.doi.org/10.1371/journal.pone.0111370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393402	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300015
J	Huang, K; Wang, SQ; Zhou, L; Wang, HM; Zhang, JH; Yan, JH; Zhao, L; Wang, YF; Shi, PL				Huang, Kun; Wang, Shaoqiang; Zhou, Lei; Wang, Huimin; Zhang, Junhui; Yan, Junhua; Zhao, Liang; Wang, Yanfen; Shi, Peili			Impacts of Diffuse Radiation on Light Use Efficiency across Terrestrial Ecosystems Based on Eddy Covariance Observation in China	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; LEYMUS-CHINENSIS STEPPE; WATER-USE EFFICIENCY; NET ECOSYSTEM; CARBON-DIOXIDE; CO2 EXCHANGE; GRASSLAND ECOSYSTEMS; PRIMARY PRODUCTIVITY; FOREST ECOSYSTEMS; MIXED FOREST	Ecosystem light use efficiency (LUE) is a key factor of production models for gross primary production (GPP) predictions. Previous studies revealed that ecosystem LUE could be significantly enhanced by an increase on diffuse radiation. Under large spatial heterogeneity and increasing annual diffuse radiation in China, eddy covariance flux data at 6 sites across different ecosystems from 2003 to 2007 were used to investigate the impacts of diffuse radiation indicated by the cloudiness index (CI) on ecosystem LUE in grassland and forest ecosystems. Our results showed that the ecosystem LUE at the six sites was significantly correlated with the cloudiness variation (0.24 <= R-2 <= 0.85), especially at the Changbaishan temperate forest ecosystem (R-2 = 0.85). Meanwhile, the CI values appeared more frequently between 0.8 and 1.0 in two subtropical forest ecosystems (Qianyanzhou and Dinghushan) and were much larger than those in temperate ecosystems. Besides, cloudiness thresholds which were favorable for enhancing ecosystem carbon sequestration existed at the three forest sites, respectively. Our research confirmed that the ecosystem LUE at the six sites in China was positively responsive to the diffuse radiation, and the cloudiness index could be used as an environmental regulator for LUE modeling in regional GPP prediction.	[Huang, Kun; Wang, Shaoqiang; Zhou, Lei; Wang, Huimin; Shi, Peili] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China; [Huang, Kun; Wang, Yanfen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhang, Junhui] Chinese Acad Sci, Inst Appl Ecol, Shenyang 110016, Peoples R China; [Yan, Junhua] Chinese Acad Sci, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China; [Zhao, Liang] Chinese Acad Sci, Northwest Plateau Inst Biol, Xining 810001, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Northwest Institute of Plateau Biology, CAS	Wang, SQ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China.	sqwang@igsnrr.ac.cn	Zhao, Liang/T-9147-2019; wang, huimin/HDM-8421-2022; Peili, SHi/AAT-6450-2021	shi, pei li/0000-0002-1120-0003; wang, yan fen/0000-0001-5666-9289	CAS for Strategic Priority Research Program [XDA05050602]; National Basic Research Program of China (973Program) [2010CB833503]; Key Project in the National Science & Technology Pillar Program of China [2013BAC03B00]	CAS for Strategic Priority Research Program; National Basic Research Program of China (973Program)(National Basic Research Program of China); Key Project in the National Science & Technology Pillar Program of China	This research was jointly supported by the CAS for Strategic Priority Research Program (Grant No. XDA05050602), National Basic Research Program of China (973Program) (Grant No. 2010CB833503) and the Key Project in the National Science & Technology Pillar Program of China (Grant No. 2013BAC03B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Cai WW, 2014, J GEOPHYS RES-BIOGEO, V119, P110, DOI 10.1002/2013JG002456; Canadell JG, 2000, ECOSYSTEMS, V3, P115, DOI 10.1007/s100210000014; Carrara A, 2003, AGR FOREST METEOROL, V119, P209, DOI 10.1016/S0168-1923(03)00120-5; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Farquhar GD, 2003, SCIENCE, V299, P1997, DOI 10.1126/science.1080681; Feddema JJ, 2005, SCIENCE, V310, P1674, DOI 10.1126/science.1118160; Fu Pinde, 1999, P 19 ANN ESRI USER C; Fu Y, 2009, BIOGEOSCIENCES, V6, P2879, DOI 10.5194/bg-6-2879-2009; Fu YL, 2006, AGR FOREST METEOROL, V137, P234, DOI 10.1016/j.agrformet.2006.02.009; Fu YL, 2006, SCI CHINA SER D, V49, P196, DOI 10.1007/s11430-006-8196-3; Garbulsky MF, 2010, GLOBAL ECOL BIOGEOGR, V19, P253, DOI 10.1111/j.1466-8238.2009.00504.x; Gu LH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001242; Gu LH, 2003, SCIENCE, V299, P2035, DOI 10.1126/science.1078366; Guan DX, 2006, AGR FOREST METEOROL, V137, P138, DOI 10.1016/j.agrformet.2006.02.003; He MZ, 2013, AGR FOREST METEOROL, V173, P28, DOI 10.1016/j.agrformet.2013.01.003; Heald CL, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009092; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Kim SW, 2005, J GEOPHYS RES-ATMOS, P110; King DA, 2011, REMOTE SENS ENVIRON, V115, P1653, DOI 10.1016/j.rse.2011.02.024; Letts MG, 2005, ECOSCIENCE, V12, P53, DOI 10.2980/i1195-6860-12-1-53.1; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Misson L, 2005, AGR FOREST METEOROL, V129, P69, DOI 10.1016/j.agrformet.2004.11.008; MONTEITH JL, 1977, PHILOS T ROY SOC B, V281, P277, DOI 10.1098/rstb.1977.0140; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Niyogi D, 2007, NAT HAZARDS, V42, P345, DOI 10.1007/s11069-006-9085-y; Ogutu BO, 2013, AGR FOREST METEOROL, V174, P158, DOI 10.1016/j.agrformet.2013.02.016; Oliphant AJ, 2011, AGR FOREST METEOROL, V151, P781, DOI 10.1016/j.agrformet.2011.01.005; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Raupach MR, 2008, BIOGEOSCIENCES, V5, P1601, DOI 10.5194/bg-5-1601-2008; Ren XL, 2013, ANN GEOPHYS-GERMANY, V31, P277, DOI 10.5194/angeo-31-277-2013; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schiermeier Q, 2006, NATURE, V442, P854, DOI 10.1038/442854a; Shi PL, 2006, SCI CHINA SER D, V49, P207, DOI 10.1007/s11430-006-8207-4; Sims DA, 2008, REMOTE SENS ENVIRON, V112, P1633, DOI 10.1016/j.rse.2007.08.004; Turner DP, 2006, TELLUS B, V58, P476, DOI 10.1111/j.1600-0889.2006.00221.x; Turner DP, 2003, GLOBAL CHANGE BIOL, V9, P383, DOI 10.1046/j.1365-2486.2003.00573.x; Urban O, 2007, GLOBAL CHANGE BIOL, V13, P157, DOI 10.1111/j.1365-2486.2006.01265.x; Veroustraete F, 2002, REMOTE SENS ENVIRON, V83, P376, DOI 10.1016/S0034-4257(02)00043-3; Wang Y., 2012, PLOS ONE, V7; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wen XF, 2010, BIOGEOSCIENCES, V7, P357, DOI 10.5194/bg-7-357-2010; Wu CY, 2010, REMOTE SENS ENVIRON, V114, P2925, DOI 10.1016/j.rse.2010.07.012; Wu CY, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013023; Xiao JF, 2008, AGR FOREST METEOROL, V148, P1827, DOI 10.1016/j.agrformet.2008.06.015; Xiao XM, 2004, REMOTE SENS ENVIRON, V89, P519, DOI 10.1016/j.rse.2003.11.008; Yang YT, 2013, J GEOPHYS RES-BIOGEO, V118, P590, DOI 10.1002/jgrg.20056; Yu GR, 2008, GLOBAL CHANGE BIOL, V14, P2555, DOI 10.1111/j.1365-2486.2008.01663.x; Yu GR, 2006, AGR FOREST METEOROL, V137, P125, DOI 10.1016/j.agrformet.2006.02.011; Yu GR, 2013, GLOBAL CHANGE BIOL, V19, P798, DOI 10.1111/gcb.12079; Yu GR, 2008, NEW PHYTOL, V177, P927, DOI 10.1111/j.1469-8137.2007.02316.x; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; Zhang M, 2011, AGR FOREST METEOROL, V151, P803, DOI 10.1016/j.agrformet.2011.01.011	55	14	15	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e110988	10.1371/journal.pone.0110988	http://dx.doi.org/10.1371/journal.pone.0110988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393629	gold, Green Submitted, Green Published			2022-12-26	WOS:000347709300008
J	Schrauwen, I; Barber, RM; Schatzberg, SJ; Siniard, AL; Corneveaux, JJ; Porter, BF; Vernau, KM; Keesler, RI; Matiasek, K; Flegel, T; Miller, AD; Southard, T; Mariani, CL; Johnson, GC; Huentelman, MJ				Schrauwen, Isabelle; Barber, Renee M.; Schatzberg, Scott J.; Siniard, Ashley L.; Corneveaux, Jason J.; Porter, Brian F.; Vernau, Karen M.; Keesler, Rebekah I.; Matiasek, Kaspar; Flegel, Thomas; Miller, Andrew D.; Southard, Teresa; Mariani, Christopher L.; Johnson, Gayle C.; Huentelman, Matthew J.			Identification of Novel Genetic Risk Loci in Maltese Dogs with Necrotizing Meningoencephalitis and Evidence of a Shared Genetic Risk across Toy Dog Breeds	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ANTIGEN CLASS-II; PUG DOGS; MULTIPLE-SCLEROSIS; INTERLEUKIN-7 RECEPTOR; ASSOCIATION; DELTA; EXPRESSION; DISORDERS; LINKAGE	Necrotizing meningoencephalitis (NME) affects toy and small breed dogs causing progressive, often fatal, inflammation and necrosis in the brain. Genetic risk loci for NME previously were identified in pug dogs, particularly associated with the dog leukocyte antigen (DLA) class II complex on chromosome 12, but have not been investigated in other susceptible breeds. We sought to evaluate Maltese and Chihuahua dogs, in addition to pug dogs, to identify novel or shared genetic risk factors for NME development. Genome-wide association testing of single nucleotide polymorphisms (SNPs) in Maltese dogs with NME identified 2 regions of genome-wide significance on chromosomes 4 (chr4:74522353T>A, p = 8.1x10(-7)) and 15 (chr15:53338796A>G, p = 1.5x10(-7)). Haplotype analysis and fine-mapping suggests that ILR7 and FBXW7, respectively, both important for regulation of immune system function, could be the underlying associated genes. Further evaluation of these regions and the previously identified DLA II locus across all three breeds, revealed an enrichment of nominal significant SNPs associated with chromosome 15 in pug dogs and DLA II in Maltese and Chihuahua dogs. Meta-analysis confirmed effect sizes the same direction in all three breeds for both the chromosome 15 and DLA II loci (p = 8.6x10(-11) and p = 2.5x10(-7), respectively). This suggests a shared genetic background exists between all breeds and confers susceptibility to NME, but effect sizes might be different among breeds. In conclusion, we identified the first genetic risk factors for NME development in the Maltese, chromosome 4 and chromosome 15, and provide evidence for a shared genetic risk between breeds associated with chromosome 15 and DLA II. Last, DLA II and IL7R both have been implicated in human inflammatory diseases of the central nervous system such as multiple sclerosis, suggesting that similar pharmacotherapeutic targets across species should be investigated.	[Schrauwen, Isabelle; Siniard, Ashley L.; Corneveaux, Jason J.; Huentelman, Matthew J.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA; [Schrauwen, Isabelle] Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; [Barber, Renee M.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA USA; [Schatzberg, Scott J.] Anim Neurol & Imaging Ctr, Algodones, NM USA; [Porter, Brian F.] Texas A&M Univ, Dept Vet Pathol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA; [Vernau, Karen M.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Keesler, Rebekah I.] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Matiasek, Kaspar] Univ Munich, Sect Clin & Comparat Neuropathol, Munich, Germany; [Flegel, Thomas] Univ Leipzig, Dept Small Anim Med, D-04109 Leipzig, Germany; [Miller, Andrew D.; Southard, Teresa] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Mariani, Christopher L.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA; [Johnson, Gayle C.] Univ Missouri, Dept Vet Pathobiol, Vet Med Diagnost Lab, Columbia, MO USA	Translational Genomics Research Institute; University of Antwerp; University System of Georgia; University of Georgia; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Davis; Utrecht University; University of Munich; Leipzig University; Cornell University; University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia	Huentelman, MJ (corresponding author), Translat Genom Res Inst, Neurogen Div, Phoenix, AZ 85004 USA.	mhuentelman@tgen.org	Schrauwen, Isabelle/H-5908-2019; Mariani, Christopher/H-8971-2019; Fiumefreddo, Andrea/T-2977-2019	Schrauwen, Isabelle/0000-0001-7310-6082; Mariani, Christopher/0000-0003-3228-6536; Matiasek, Kaspar/0000-0001-5021-3280; Flegel, Thomas/0000-0001-9892-0224	American Kennel Club Canine Health Foundation [01455]; Morris Animal Foundation [D10CA-406]	American Kennel Club Canine Health Foundation; Morris Animal Foundation	This study was supported by the American Kennel Club Canine Health Foundation (01455) (http://www.akcchf.org/) and the Morris Animal Foundation (D10CA-406) (http://www.morrisanimalfoundation.org/). IS is a postdoctoral fellow of the FWO-Vlaanderen (http://www.fwo.be/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2677; Barber RM, 2012, J VET INTERN MED, V26, P962, DOI 10.1111/j.1939-1676.2012.00954.x; Barber RM, 2010, J VET INTERN MED, V24, P372, DOI 10.1111/j.1939-1676.2009.0466.x; Barber RM, 2011, J HERED, V102, pS40, DOI 10.1093/jhered/esr048; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cantile C, 2001, VET PATHOL, V38, P119, DOI 10.1354/vp.38-1-119; Cooper JJ, 2014, J VET INTERN MED, V28, P198, DOI 10.1111/jvim.12233; CORDY DR, 1989, VET PATHOL, V26, P191, DOI 10.1177/030098588902600301; Greer KA, 2010, TISSUE ANTIGENS, V76, P110, DOI 10.1111/j.1399-0039.2010.01484.x; Greer KA, 2009, RES VET SCI, V86, P438, DOI 10.1016/j.rvsc.2008.10.002; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Higgins RJ, 2008, VET PATHOL, V45, P336, DOI 10.1354/vp.45-3-336; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hu W, 2009, SEMIN IMMUNOPATHOL, V31, P439, DOI 10.1007/s00281-009-0178-z; Levine JM, 2008, J VET INTERN MED, V22, P961, DOI 10.1111/j.1939-1676.2008.0137.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lopez-Herrera G, AM J HUM GENET, V90, P986; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Pedersen N, 2011, J VET DIAGN INVEST, V23, P68, DOI 10.1177/104063871102300110; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schatzberg SJ, 2005, J VET INTERN MED, V19, P553, DOI 10.1892/0891-6640(2005)19[553:PCRSFD]2.0.CO;2; STALIS IH, 1995, VET PATHOL, V32, P230, DOI 10.1177/030098589503200303; Talarico LR, 2010, J SMALL ANIM PRACT, V51, P138, DOI 10.1111/j.1748-5827.2009.00823.x; Tranchevent LC, 2008, NUCLEIC ACIDS RES, V36, pW377, DOI 10.1093/nar/gkn325; Tsai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00321; Tsai VWW, 2011, J NEUROSCI, V31, P17612, DOI 10.1523/JNEUROSCI.3449-11.2011; Valente T, 2013, NEUROBIOL AGING, V34, P2110, DOI 10.1016/j.neurobiolaging.2013.02.007; von Praun F, 2006, VET RADIOL ULTRASOUN, V47, P260, DOI 10.1111/j.1740-8261.2006.00137.x; Young BD, 2009, J VET INTERN MED, V23, P527, DOI 10.1111/j.1939-1676.2009.0306.x	31	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112755	10.1371/journal.pone.0112755	http://dx.doi.org/10.1371/journal.pone.0112755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393235	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300097
J	Yumnam, B; Jhala, YV; Qureshi, Q; Maldonado, JE; Gopal, R; Saini, S; Srinivas, Y; Fleischer, RC				Yumnam, Bibek; Jhala, Yadvendradev V.; Qureshi, Qamar; Maldonado, Jesus E.; Gopal, Rajesh; Saini, Swati; Srinivas, Y.; Fleischer, Robert C.			Prioritizing Tiger Conservation through Landscape Genetics and Habitat Linkages	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; PANTHERA-TIGRIS; COMPUTER-PROGRAM; PATERNITY INFERENCE; RECENT MIGRATION; CIRCUIT-THEORY; F-STATISTICS; SOFTWARE; ECOLOGY; FLOW	Even with global support for tiger (Panthera tigris) conservation their survival is threatened by poaching, habitat loss and isolation. Currently about 3,000 wild tigers persist in small fragmented populations within seven percent of their historic range. Identifying and securing habitat linkages that connect source populations for maintaining landscape-level gene flow is an important long-term conservation strategy for endangered carnivores. However, habitat corridors that link regional tiger populations are often lost to development projects due to lack of objective evidence on their importance. Here, we use individual based genetic analysis in combination with landscape permeability models to identify and prioritize movement corridors across seven tiger populations within the Central Indian Landscape. By using a panel of 11 microsatellites we identified 169 individual tigers from 587 scat and 17 tissue samples. We detected four genetic clusters within Central India with limited gene flow among three of them. Bayesian and likelihood analyses identified 17 tigers as having recent immigrant ancestry. Spatially explicit tiger occupancy obtained from extensive landscape-scale surveys across 76,913 km(2) of forest habitat was found to be only 21,290 km(2). After accounting for detection bias, the covariates that best explained tiger occupancy were large, remote, dense forest patches; large ungulate abundance, and low human footprint. We used tiger occupancy probability to parameterize habitat permeability for modeling habitat linkages using least-cost and circuit theory pathway analyses. Pairwise genetic differences (F-ST) between populations were better explained by modeled linkage costs (r>0.5, p<0.05) compared to Euclidean distances, which was in consonance with observed habitat fragmentation. The results of our study highlight that many corridors may still be functional as there is evidence of contemporary migration. Conservation efforts should provide legal status to corridors, use smart green infrastructure to mitigate development impacts, and restore habitats where connectivity has been lost.	[Yumnam, Bibek; Jhala, Yadvendradev V.; Qureshi, Qamar; Saini, Swati; Srinivas, Y.] Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India; [Maldonado, Jesus E.; Fleischer, Robert C.] Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC USA; [Maldonado, Jesus E.] Natl Museum Nat Hist, Smithsonian Inst, Dept Vertebrate Zool, Washington, DC 20560 USA; [Gopal, Rajesh] Natl Tiger Conservat Author, New Delhi 110011, India	Wildlife Institute of India; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; National Tiger Conservation Authority, Government of India	Jhala, YV (corresponding author), Wildlife Inst India, Dehra Dun 248001, Uttar Pradesh, India.	jhalay@wii.gov.in	Maldonado, Jesus/AIE-8664-2022; Jhala, Yadvendradev/AAL-9711-2020	Maldonado, Jesus/0000-0002-4282-1072; Yellapu, Srinivas/0000-0002-5412-4717	National Tiger Conservation Authority; Fulbright Fellowship; Wildlife Institute of India	National Tiger Conservation Authority(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of IndiaNational Tiger Conservation Authority, Government of India); Fulbright Fellowship; Wildlife Institute of India	Funding provided by the National Tiger Conservation Authority: YVJ QQ, Fulbright Fellowship: BY, Wildlife Institute of India: YVJ BY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; Banerjee K, 2012, J MAMMAL, V93, P1420, DOI 10.1644/11-MAMM-A-231.1; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BEERLI P, 2008, MIGRATE N VERSION 3; Beerli Peter, 2009, V17, P42; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Castilho CS, 2011, MAMM BIOL, V76, P476, DOI 10.1016/j.mambio.2010.08.002; Chandran MDS, 1997, CURR SCI INDIA, V73, P146; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Check E, 2006, NATURE, V441, P927, DOI 10.1038/441927a; Clark TW, 1996, CONSERV BIOL, V10, P940, DOI 10.1046/j.1523-1739.1996.10040940.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Dinerstein E, 2007, BIOSCIENCE, V57, P508, DOI 10.1641/B570608; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Dutta T, 2013, EVOL APPL, V6, P949, DOI 10.1111/eva.12078; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; ELZIRIK E, 2001, MOL ECOL, V10, P65, DOI DOI 10.1046/J.1365-294X.2001.01144.X; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandes A., 2012, COAL MINING IS TRASH; Forest Survey of India, 2009, IND STAT FOR REP; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Gittleman JL, 2001, CONSERV BIOL SER, V5, P1; Goossens B, 2013, RAFFLES B ZOOL, P43; Gopal R, 2010, ORYX, V44, P383, DOI 10.1017/S0030605310000529; Goudet J., 2002, FSTAT PROGRAM ESTIMA; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; HANSKI I, 1997, METAPOPULATION BIOL; Hanski I, 1999, METAPOPULATION ECOLO; Hardy OJ, 2003, GENETICS, V163, P1467; Harihar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040105; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Henry P, 2009, MOL ECOL, V18, P3173, DOI 10.1111/j.1365-294X.2009.04266.x; Hines J., 2006, PRESENCE2 SOFTWARE E; Jhala Y, 2011, J APPL ECOL, V48, P14, DOI 10.1111/j.1365-2664.2010.01901.x; JHALA YV, 2013, TR08001 MIN ENV FOR; JHALA YV, 2009, TECHNICAL PUBLICATIO; JHALA YV, 2011, TR2011003 MIN ENV FO; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karanth KU, 2005, CONSERV BIOL SER, V9, P373; Karanth KU, 2000, J ZOOL, V250, P255; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; KENNEY JS, 1995, CONSERV BIOL, V9, P1127, DOI 10.1046/j.1523-1739.1995.9051116.x-i1; Kimura M., 1953, ANNU REP NAT I GENET, V3, P62; Linkie M, 2006, J APPL ECOL, V43, P576, DOI 10.1111/j.1365-2664.2006.01153.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luo SJ, 2004, PLOS BIOL, V2, P2275, DOI 10.1371/journal.pbio.0020442; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marker LL, 2008, J HERED, V99, P2, DOI 10.1093/jhered/esm081; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Misra VN, 2001, J BIOSCIENCES, V26, P491, DOI 10.1007/BF02704749; Mondol S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0496; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; Narain S.P., 2005, JOINING DOTS REPORT; NAVIDI W, 1992, AM J HUM GENET, V50, P347; Noss R.F., 1987, Conservation Biology, V1, P159, DOI 10.1111/j.1523-1739.1987.tb00024.x; PABLA HS, 2011, TECHNICAL REPORT; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Panwar H.S., 1987, P110; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; PINJARKAR V, 2011, TIMES INDIA; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK., 2010, DOCUMENTATION STRUCT; Proctor MF, 2005, P ROY SOC B-BIOL SCI, V272, P2409, DOI 10.1098/rspb.2005.3246; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; Quintero JD, 2010, SMART GREEN INFRASTR; RAMACHANDRAN R, 2011, HINDU; Rangarajan M., 2006, INDIAS WILDLIFE HIST; Rangarajan Mahesh, 1996, FENCING FOREST CONSE; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; Reding DM, 2013, LANDSCAPE ECOL, V28, P471, DOI 10.1007/s10980-012-9844-y; RODRIGUEZ E, 2005, JET PROPULSION LAB P; Rosenberg NA, 2001, GENETICS, V159, P699; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sanderson E., 2006, SETTING PRIORITIES C; Savage WK, 2010, MOL ECOL, V19, P3301, DOI 10.1111/j.1365-294X.2010.04718.x; Savicky P, 2009, PSPEARMAN SPEARMANS; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Seidensticker J., 2010, BIOL CONSERVATION WI; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Sharma S, 2013, ECOL EVOL, V3, P48, DOI 10.1002/ece3.432; Slate J, 2000, MOL ECOL, V9, P801, DOI 10.1046/j.1365-294x.2000.00930.x; SLATKIN M, 1995, GENETICS, V139, P457; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; SMITH JLD, 1991, CONSERV BIOL, V5, P484, DOI 10.1111/j.1523-1739.1991.tb00355.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Spear SF, 2010, MOL ECOL, V19, P3576, DOI 10.1111/j.1365-294X.2010.04657.x; Storz JF, 2002, EVOLUTION, V56, P154; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Sunquist Mel, 1999, P5; Surovell T, 2005, P NATL ACAD SCI USA, V102, P6231, DOI 10.1073/pnas.0501947102; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VATTAKAVEN J, 2010, FRAGMENTATION THREAT; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILCOX BA, 1985, AM NAT, V125, P879, DOI 10.1086/284386; Williamson JE, 2002, MOL ECOL NOTES, V2, P110, DOI 10.1046/j.1471-8286.2002.00163.x; Wilson GA, 2003, GENETICS, V163, P1177; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Wu JH, 2009, CONSERV GENET, V10, P567, DOI 10.1007/s10592-008-9571-8; *WWF IND, 2012, RET TIG KOP MADH PRA; [No title captured]	148	74	75	2	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111207	10.1371/journal.pone.0111207	http://dx.doi.org/10.1371/journal.pone.0111207			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393234	gold, Green Published			2022-12-26	WOS:000347709300012
J	Bodewes, R; Hapsari, R; Garcia, AR; Contreras, GJS; van de Bildt, MWG; de Graaf, M; Kuiken, T; Osterhaus, ADME				Bodewes, Rogier; Hapsari, Rebriarina; Garcia, Ana Rubio; Contreras, Guillermo J. Sanchez; van de Bildt, Marco W. G.; de Graaf, Miranda; Kuiken, Thijs; Osterhaus, Albert D. M. E.			Molecular Epidemiology of Seal Parvovirus, 1988-2014	PLOS ONE			English	Article							PHOCINE DISTEMPER OUTBREAK; B19; EVOLUTION; IDENTIFICATION; VITULINA; GENUS	A novel parvovirus was discovered recently in the brain of a harbor seal (Phoca vitulina) with chronic meningo-encephalitis. Phylogenetic analysis of this virus indicated that it belongs to the genus Erythroparvovirus, to which also human parvovirus B19 belongs. In the present study, the prevalence, genetic diversity and clinical relevance of seal parvovirus (SePV) infections was evaluated in both harbor and grey seals (Halichoerus grypus) that lived in Northwestern European coastal waters from 1988 to 2014. To this end, serum and tissue samples collected from seals were tested for the presence of seal parvovirus DNA by real-time PCR and the sequences of the partial NS gene and the complete VP2 gene of positive samples were determined. Seal parvovirus DNA was detected in nine (8%) of the spleen tissues tested and in one (0.5%) of the serum samples tested, including samples collected from seals that died in 1988. Sequence analysis of the partial NS and complete VP2 genes of nine SePV revealed multiple sites with nucleotide substitutions but only one amino acid change in the VP2 gene. Estimated nucleotide substitution rates per year were 2.00x10(-4) for the partial NS gene and 1.15x10(-4) for the complete VP2 gene. Most samples containing SePV DNA were co-infected with phocine herpesvirus 1 or PDV, so no conclusions could be drawn about the clinical impact of SePV infection alone. The present study is one of the few in which the mutation rates of parvoviruses were evaluated over a period of more than 20 years, especially in a wildlife population, providing additional insights into the genetic diversity of parvoviruses.	[Bodewes, Rogier; Hapsari, Rebriarina; van de Bildt, Marco W. G.; de Graaf, Miranda; Kuiken, Thijs; Osterhaus, Albert D. M. E.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Garcia, Ana Rubio; Contreras, Guillermo J. Sanchez] Seal Rehabil & Res Ctr, Pieterburen, Netherlands; [Osterhaus, Albert D. M. E.] Viroclin Biosci BV, Rotterdam, Netherlands; [Osterhaus, Albert D. M. E.] Univ Vet Med, Res Ctr Emerging Infect & Zoonoses, Hannover, Germany; [Osterhaus, Albert D. M. E.] Artemis One Hlth, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Veterinary Medicine Hannover, Foundation	Bodewes, R (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	r.bodewes@erasmusmc.nl	de Graaf, Miranda/K-1262-2018; Hapsari, Rebriarina/CAF-2350-2022; de Graaf, Miranda/AFM-6878-2022	de Graaf, Miranda/0000-0002-7831-0098; Hapsari, Rebriarina/0000-0001-8367-063X; de Graaf, Miranda/0000-0002-7831-0098; Sanchez Contreras, Guillermo J./0000-0002-7664-2531; Bodewes, Rogier/0000-0002-0689-7889; Kuiken, Thijs/0000-0001-5501-9049	Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; Virgo consortium	Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany; Virgo consortium	This work was financially supported in part by a grant from the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony, Germany, and the Virgo consortium. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Allison AB, 2013, J VIROL, V87, P2342, DOI 10.1128/JVI.02428-12; Bodewes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079259; Bonvicini F, 2011, J CLIN MICROBIOL, V49, P3514, DOI 10.1128/JCM.00854-11; Bossart GD, 2001, CRC HDB MARINE MAMMA, P394; Broliden K, 2006, J INTERN MED, V260, P285, DOI 10.1111/j.1365-2796.2006.01697.x; Cotmore SF, 2007, ADV VIRUS RES, V70, P183, DOI 10.1016/S0065-3527(07)70005-2; Cotmore SF, 2014, ARCH VIROL, V159, P1239, DOI 10.1007/s00705-013-1914-1; Dietz R, 2013, ICES J MAR SCI, V70, P186, DOI 10.1093/icesjms/fss144; Douvoyiannis M, 2009, CLIN INFECT DIS, V48, P1713, DOI 10.1086/599042; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Goodman SJ, 1998, MOL BIOL EVOL, V15, P104, DOI 10.1093/oxfordjournals.molbev.a025907; Green SW, 2000, VIROLOGY, V269, P105, DOI 10.1006/viro.2000.0215; Greer LL, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P729, DOI 10.1201/9781420041637.ch32; Heegaard ED, 2002, CLIN MICROBIOL REV, V15, P485, DOI 10.1128/CMR.15.3.485-505.2002; International Committee on Taxonomy of Viruses, 2013, VIR TAX 2013 REL; Jensen T, 2002, SCIENCE, V297, P209, DOI 10.1126/science.1075343; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kerr JR, 2000, ANN RHEUM DIS, V59, P672, DOI 10.1136/ard.59.9.672; Manning A, 2007, J INFECT DIS, V195, P1345, DOI 10.1086/513280; Martina BEE, 2002, VET REC, V150, P572, DOI 10.1136/vr.150.18.572; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Nollens HH, 2006, VIROLOGY, V349, P316, DOI 10.1016/j.virol.2006.01.020; Norja P, 2008, J VIROL, V82, P6427, DOI 10.1128/JVI.00471-08; OSTERHAUS ADME, 1988, NATURE, V335, P20, DOI 10.1038/335020a0; OSTERHAUS ADME, 1990, VET MICROBIOL, V23, P343, DOI 10.1016/0378-1135(90)90165-R; OSULLIVAN MG, 1994, J CLIN INVEST, V93, P1571, DOI 10.1172/JCI117136; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rijks JM, 2008, VET PATHOL, V45, P516, DOI 10.1354/vp.45-4-516; Rijks JM, 2005, EMERG INFECT DIS, V11, P1945, DOI 10.3201/eid1112.050596; Rijks JM, 2008, THESIS ERASMUS U ROT; Shackelton LA, 2006, J VIROL, V80, P3666, DOI 10.1128/JVI.80.7.3666-3669.2006; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Suzuki M, 2009, J VIROL, V83, P10975, DOI 10.1128/JVI.00273-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trilateral Seal Expert Group (TSEG), 2013, AER SURV HARB SEALS; VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996; Yoo BC, 1999, VIROLOGY, V253, P250, DOI 10.1006/viro.1998.9518; Zehender G, 2010, INFECT GENET EVOL, V10, P215, DOI 10.1016/j.meegid.2009.11.011	41	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112129	10.1371/journal.pone.0112129	http://dx.doi.org/10.1371/journal.pone.0112129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390639	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400056
J	Guichard, S; Guis, H; Tran, A; Garros, C; Balenghien, T; Kriticos, DJ				Guichard, Sylvain; Guis, Helene; Tran, Annelise; Garros, Claire; Balenghien, Thomas; Kriticos, Darren J.			Worldwide Niche and Future Potential Distribution of Culicoides imicola, a Major Vector of Bluetongue and African Horse Sickness Viruses	PLOS ONE			English	Article							CLIMATE-CHANGE; BITING MIDGES; DIPTERA-CERATOPOGONIDAE; PHYLOGENETIC ANALYSIS; SATELLITE IMAGERY; EUROPE; TEMPERATURE; AUSTRALIA; MODELS; MAP	We modelled the ecoclimatic niche of Culicoides imicola, a major arthropod vector of midge-borne viral pathogens affecting ruminants and equids, at fine scale and on a global extent, so as to provide insight into current and future risks of disease epizootics, and increase current knowledge of the species' ecology. Based on the known distribution and ecology of C. imicola, the species' response to monthly climatic conditions was characterised using CLIMEX with 109 spatial resolution climatic datasets. The species' climatic niche was projected worldwide and under future climatic scenarios. The validated model highlights the role of irrigation in supporting the occurrence of C. imicola in arid regions. In Europe, the modelled potential distribution of C. imicola extended further West than its reported distribution, raising questions regarding ongoing process of colonization and non-climatic habitat factors. The CLIMEX model highlighted similar ecological niches for C. imicola and the Australasian C. brevitarsis raising questions on biogeography and biosecurity. Under the climate change scenarios considered, its' modelled potential distribution could expand northward in the Northern hemisphere, whereas in Africa its range may contract in the future. The biosecurity risks from bluetongue and African horse sickness viruses need to be re-evaluated in regions where the vector's niche is suitable. Under a warmer climate, the risk of vector-borne epizootic pathogens such as bluetongue and African horse sickness viruses are likely to increase as the climate suitability for C. imicola shifts poleward, especially in Western Europe.	[Guichard, Sylvain; Tran, Annelise] Cirad, UR AGIRs, F-34398 Montpellier, France; [Guichard, Sylvain; Kriticos, Darren J.] Univ Minnesota, InSTePP, St Paul, MN 55108 USA; [Guis, Helene; Garros, Claire; Balenghien, Thomas] Cirad, UMR CMAEE, F-34398 Montpellier, France; [Guis, Helene; Garros, Claire; Balenghien, Thomas] INRA, CMAEE UMR1309, F-34398 Montpellier, France; [Tran, Annelise] Cirad, TETIS UMR15, F-34398 Montpellier, France; [Kriticos, Darren J.] CSIRO, Agr Flagship & Biosecur Flagship, Canberra, ACT 2601, Australia	CIRAD; University of Minnesota System; University of Minnesota Twin Cities; CIRAD; INRAE; AgroParisTech; CIRAD; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Kriticos, DJ (corresponding author), Univ Minnesota, InSTePP, St Paul, MN 55108 USA.	darren.kriticos@csiro.au	Garros, Claire/C-2715-2011; Guichard, Sylvain/F-8706-2011; Kriticos, Darren J/A-4170-2008	Kriticos, Darren J/0000-0003-2599-8105; Guis, Helene/0000-0002-0355-0898; Tran, Annelise/0000-0001-5463-332X	Project "Climate Change and Impact Research: the Mediterranean Environment (CIRCE)"; European Commission's 6th Framework Programme; HarvestChoice project; Commonwealth Scientific and Industrial Research Organization (CSIRO); University of Minnesota; Bill and Melinda Gates Foundation; EU [FP7-261504]; Ministe re de l'agriculture, de l'agroalimentaire et de la foret	Project "Climate Change and Impact Research: the Mediterranean Environment (CIRCE)"; European Commission's 6th Framework Programme(European Commission); HarvestChoice project; Commonwealth Scientific and Industrial Research Organization (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); University of Minnesota(University of Minnesota System); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EU(European Commission); Ministe re de l'agriculture, de l'agroalimentaire et de la foret	This work was jointly funded by the Project "Climate Change and Impact Research: the Mediterranean Environment (CIRCE)", European Commission's 6th Framework Programme and also by HarvestChoice project with support of the Commonwealth Scientific and Industrial Research Organization (CSIRO), the University of Minnesota and the Bill and Melinda Gates Foundation. This study was partially funded by EU grant FP7-261504 EDENext and is catalogued by the EDENext Steering Committee as EDENext000 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission. H. Guis, T. Balenghien and C. Garros were funded by the Ministe re de l'agriculture, de l'agroalimentaire et de la foret. The authors acknowledged J. C. Dellecolle and T. Baldet for providing unpublished data and valuable comments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014236; ALLINGHAM PG, 1991, J MED ENTOMOL, V28, P878, DOI 10.1093/jmedent/28.6.878; Baylis M, 1998, ARCH VIROL, P137; Baylis M, 1999, J S AFR VET ASSOC, V70, P80; Borkent A., 2013, WORLD SPECIES BITING; Calistri P, 2003, J VET MED B, V50, P132, DOI 10.1046/j.1439-0442.2003.00513.x; Conte A, 2003, J VET MED B, V50, P139, DOI 10.1046/j.1439-0450.2003.00632.x; Conte A, 2009, J APPL ECOL, V46, P1332, DOI 10.1111/j.1365-2664.2009.01723.x; Diarra M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-147; Diouf ND, 2013, VET REC, V172, P152, DOI 10.1136/vr.101083; Du Toit R. M., 1944, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V19, P7; Dyce A, 2000, ARBOVIRUS RES AUSTR, V8, P133; Eagles D, 2013, PREV VET MED, V110, P312, DOI 10.1016/j.prevetmed.2013.02.022; Garcia-Saenz A, 2011, MED VET ENTOMOL, V25, P113, DOI 10.1111/j.1365-2915.2010.00904.x; Goldarazena A, 2008, VET REC, V162, P820, DOI 10.1136/vr.162.25.820; Grubler A, 2001, NATURE, V412, P15, DOI 10.1038/35083752; Guis H, 2012, J R SOC INTERFACE, V9, P339, DOI 10.1098/rsif.2011.0255; IPCC, 2000, SPECIAL REPORT EMISS; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kirkland PD, 2004, VETER ITAL SER, V40, P47; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kriticos Darren J., 2013, NeoBiota, V18, P1; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Linton YM, 2002, MED VET ENTOMOL, V16, P139, DOI 10.1046/j.1365-2915.2002.00356.x; Lo Iacono G, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0194; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Mardulyn P, 2013, MOL ECOL, V22, P2456, DOI 10.1111/mec.12264; Matsumoto Y, 2009, J MED ENTOMOL, V46, P1099, DOI 10.1603/033.046.0517; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; Mellor PS, 2009, BIOL ANIM INFECT, P1; Morag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033610; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; MURRAY MD, 1987, AUST J ZOOL, V35, P575, DOI 10.1071/ZO9870575; Paweska JT, 2002, MED VET ENTOMOL, V16, P10, DOI 10.1046/j.1365-2915.2002.00334.x; Perrin A, 2006, MED VET ENTOMOL, V20, P219, DOI 10.1111/j.1365-2915.2006.00616.x; Purse BV, 2007, J APPL ECOL, V44, P1231, DOI 10.1111/j.1365-2664.2007.01342.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Sedda L, 2012, P ROY SOC B-BIOL SCI, V279, P2354, DOI 10.1098/rspb.2011.2555; Sellers R.F., 1993, Revue Scientifique et Technique Office International des Epizooties, V12, P733; Shelford VE, 1918, SCIENCE, V48, P225, DOI 10.1126/science.48.1235.225; Shelford VE, 1913, BIOL BULL-US, V25, P79, DOI 10.2307/1535970; SHELFORD VE, 1963, ECOLOGY N AM; Siebert S, 2005, HYDROL EARTH SYST SC, V9, P535, DOI 10.5194/hess-9-535-2005; St George TD, 2001, HIST BLUETONGUE AKAB; Stocker F, 2013, SUMMARY POLICYMAKERS; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R W, 2007, CLIMEX VERSION 3 USE; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; van der Ploeg RR, 1999, SOIL SCI SOC AM J, V63, P1055, DOI 10.2136/sssaj1999.6351055x; Velthuis AGJ, 2010, PREV VET MED, V93, P294, DOI 10.1016/j.prevetmed.2009.11.007; Venail R., 2012, P77; Venter GJ, 2009, MED VET ENTOMOL, V23, P367, DOI 10.1111/j.1365-2915.2009.00829.x; VENTER GJ, 1994, ONDERSTEPOORT J VET, V61, P327; WALKER AR, 1977, B ENTOMOL RES, V67, P217, DOI 10.1017/S0007485300011032; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Wittman EJ, 2001, REV SCI TECH OIE, V20, P731, DOI 10.20506/rst.20.3.1306	59	52	53	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112491	10.1371/journal.pone.0112491	http://dx.doi.org/10.1371/journal.pone.0112491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391148	Green Published, gold			2022-12-26	WOS:000349144400088
J	Legagneux, P; Suffice, P; Messier, JS; Lelievre, F; Tremblay, JA; Maisonneuve, C; Saint-Louis, R; Bety, J				Legagneux, Pierre; Suffice, Pauline; Messier, Jean-Sebastien; Lelievre, Frederick; Tremblay, Junior A.; Maisonneuve, Charles; Saint-Louis, Richard; Bety, Joel			High Risk of Lead Contamination for Scavengers in an Area with High Moose Hunting Success	PLOS ONE			English	Article							ISOTOPE RATIOS; CALIFORNIA CONDORS; BULLET FRAGMENTS; EXPOSURE; AMMUNITION; BIRDS; SHOT; INGESTION; DEER; PREDATORS	Top predators and scavengers are vulnerable to pollutants, particularly those accumulated along the food chain. Lead accumulation can induce severe disorders and alter survival both in mammals (including humans) and in birds. A potential source of lead poisoning in wild animals, and especially in scavengers, results from the consumption of ammunition residues in the tissues of big game killed by hunters. For two consecutive years we quantified the level lead exposure in individuals of a sentinel scavenger species, the common raven (Corvus corax), captured during the moose (Alces alces) hunting season in eastern Quebec, Canada. The source of the lead contamination was also determined using stable isotope analyses. Finally, we identified the different scavenger species that could potentially be exposed to lead by installing automatic cameras targeting moose gut piles. Blood lead concentration in ravens increased over time, indicating lead accumulation over the moose- hunting season. Using a contamination threshold of 100 mg. L 21, more than 50% of individuals were lead- contaminated during the moose hunting period. Lead concentration was twice as high in one year compared to the other, matching the number of rifle- shot moose in the area. Non-contaminated birds exhibited no ammunition isotope signatures. The isotope signature of the lead detected in contaminated ravens tended towards the signature from lead ammunition. We also found that black bears (Ursus americanus), golden eagles and bald eagles (Aquila chrysaetos and Haliaeetus leucocephalus, two species of conservation concern) scavenged heavily on moose viscera left by hunters. Our unequivocal results agree with other studies and further motivate the use of non-toxic ammunition for big game hunting.	[Legagneux, Pierre; Suffice, Pauline; Messier, Jean-Sebastien; Saint-Louis, Richard; Bety, Joel] Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ, Canada; [Legagneux, Pierre; Suffice, Pauline; Messier, Jean-Sebastien; Saint-Louis, Richard; Bety, Joel] Univ Quebec, Ctr Etudes Nord, Rimouski, PQ, Canada; [Lelievre, Frederick; Maisonneuve, Charles] Minist Dev Durable Environm Faune & Parcs, Quebec City, PQ, Canada; [Tremblay, Junior A.] Environm Canada, Sci & Technol Branch, Quebec City, PQ, Canada	University of Quebec; University of Quebec; Environment & Climate Change Canada	Legagneux, P (corresponding author), Univ Quebec, Dept Biol Chim & Geog, Rimouski, PQ, Canada.	legagneux@gmail.com	Tremblay, Junior A./AAX-7353-2020	Tremblay, Junior A./0000-0003-4930-0939; Bety, Joel/0000-0002-8775-6411; Legagneux, Pierre/0000-0002-6366-0554	Ministere du Developpement Durable, de l'Environnement, de la Faune et des Parcs; Fondation de la faune du Quebec; Universite ' du Quebec a Rimouski	Ministere du Developpement Durable, de l'Environnement, de la Faune et des Parcs; Fondation de la faune du Quebec; Universite ' du Quebec a Rimouski	This study was supported by the Ministere du Developpement Durable, de l'Environnement, de la Faune et des Parcs; the Fondation de la faune du Quebec (Programme "Protection, mise en valeur et amenagement des habitats fauniques", and Programme "Faune en danger"), and the Universite ' du Quebec a Rimouski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery D, 2009, REGULATION LEAD BASE, P161; Aznar JC, 2008, ENVIRON POLLUT, V156, P76, DOI 10.1016/j.envpol.2007.12.037; Bedrosian B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051978; Bellrose FC, 1959, B ILL NAT HIST SURV, V27; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Burger J, 2000, J TOXICOL ENV HEAL B, V3, P59, DOI 10.1080/109374000281096; Burger J, 2004, ECOTOX ENVIRON SAFE, V57, P136, DOI 10.1016/S0147-6513(03)00035-6; Cade TJ, 2007, J WILDLIFE MANAGE, V71, P2125, DOI 10.2193/2007-084; Carson EA, 2000, J FORENSIC SCI, V45, P515; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Clark AJ, 2003, ECOTOXICOLOGY, V12, P23, DOI 10.1023/A:1022576510445; Couture A, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18591; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Fisher IJ, 2006, BIOL CONSERV, V131, P421, DOI 10.1016/j.biocon.2006.02.018; Gordon JN, 2002, BRIT J CLIN PHARMACO, V53, P451, DOI 10.1046/j.1365-2125.2002.01580.x; GRASMAN KA, 1995, ARCH ENVIRON CON TOX, V28, P161, DOI 10.1007/BF00217611; Grund Marrett D., 2010, Human-Wildlife Interactions, V4, P257; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; Kelly TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017656; Kendall RJ, 1996, ENVIRON TOXICOL CHEM, V15, P4, DOI 10.1002/etc.5620150103; Knott Jeff, 2009, Conservation Evidence, V6, P71; Krone O., 2009, INGESTION LEAD SPENT; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; Lambertucci SA, 2010, ENVIRON SCI TECHNOL, V44, P7759, DOI 10.1021/es102667c; Levesque B, 2003, OCCUP ENVIRON MED, V60, P693, DOI 10.1136/oem.60.9.693; Lindboe M, 2012, FOOD ADDIT CONTAM A, V29, P1052, DOI 10.1080/19440049.2012.680201; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Pain Deborah J., 2009, P99, DOI 10.4080/ilsa.2009.0108; Pain DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010315; PAIN DJ, 1993, IBIS, V135, P379, DOI 10.1111/j.1474-919X.1993.tb02109.x; PAIN DJ, 1988, B ENVIRON CONTAM TOX, V40, P159, DOI 10.1007/BF01881033; PAIN DJ, 1990, ENVIRON POLLUT, V66, P273, DOI 10.1016/0269-7491(90)90007-Y; Pariseau J, 2009, MAR POLLUT BULL, V58, P503, DOI 10.1016/j.marpolbul.2008.12.011; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; Rogers TA, 2012, J WILDLIFE MANAGE, V76, P575, DOI 10.1002/jwmg.277; Scheuhammer AM, 2003, ENVIRON TOXICOL CHEM, V22, P2585, DOI 10.1897/02-361; Scheuhammer AM, 1998, ECOTOXICOLOGY, V7, P37, DOI 10.1023/A:1008855617453; SCHEUHAMMER AM, 1987, ENVIRON POLLUT, V46, P263, DOI 10.1016/0269-7491(87)90173-4; Scheuhammer AM, 1996, ECOTOXICOLOGY, V5, P279, DOI 10.1007/BF00119051; Schmitz OJ, 2006, ECOLOGY, V87, P1432, DOI 10.1890/0012-9658(2006)87[1432:PHLEOE]2.0.CO;2; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Stauber E, 2010, J AVIAN MED SURG, V24, P279, DOI 10.1647/2009-006.1; Thomas VG, 2009, SCI TOTAL ENVIRON, V407, P3494, DOI 10.1016/j.scitotenv.2009.02.003; Tsuji LJS, 2008, SCI TOTAL ENVIRON, V393, P291, DOI 10.1016/j.scitotenv.2008.01.022; Wayland M, 1999, ENVIRON POLLUT, V104, P341, DOI 10.1016/S0269-7491(98)00201-2; White C, 2005, ECOLOGY, V86, P1057, DOI 10.1890/03-3185; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x	52	37	38	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111546	10.1371/journal.pone.0111546	http://dx.doi.org/10.1371/journal.pone.0111546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389754	gold, Green Published			2022-12-26	WOS:000349144400023
J	Morrison, PK; Bing, C; Harris, PA; Maltin, CA; Grove-White, D; Argo, CM				Morrison, Philippa K.; Bing, Chen; Harris, Patricia A.; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline Mcg.			Preliminary Investigation into a Potential Role for Myostatin and Its Receptor (ActRIIB) in Lean and Obese Horses and Ponies	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; REAL-TIME PCR; GENE-EXPRESSION; ADIPOSE-TISSUE; DIFFERENTIATION; MICE; INHIBITION; PROTEINS; IIB	Obesity is a widespread problem across the leisure population of horses and ponies in industrialised nations. Skeletal muscle is a major contributor to whole body resting energy requirements and communicates with other tissues through the secretion of myokines into the circulation. Myostatin, a myokine and negative regulator of skeletal muscle mass, has been implicated in obesity development in other species. This study evaluated gene and protein expression of myostatin and its receptor, ActRIIB in adipose tissues and skeletal muscles and serum myostatin concentrations in six lean and six obese animals to explore putative associations between these factors and obesity in horses and ponies. Myostatin mRNA expression was increased while ActRIIB mRNA was decreased in skeletal muscles of obese animals but these differences were absent at the protein level. Myostatin mRNA was increased in crest fat of obese animals but neither myostatin nor ActRIIB proteins were detected in this tissue. Mean circulating myostatin concentrations were significantly higher in obese than in lean groups; 4.98 ng/ml (+/- 62.71) and 9.00 ng/ml (+/- 62.04) for the lean and obese groups, respectively. In addition, there was a significant positive association between these levels and myostatin gene expression in skeletal muscles (average R-2 = 0.58; p<0.05). Together, these results provide further basis for the speculation that myostatin and its receptor may play a role in obesity in horses and ponies.	[Morrison, Philippa K.; Bing, Chen; Maltin, Charlotte A.; Grove-White, Dai; Argo, Caroline Mcg.] Univ Liverpool, Fac Hlth & Life Sci, Dept Obes & Endocrinol, Wirral L64 7TE, Merseyside, England; [Harris, Patricia A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Melton Mowbray, Leics, England	Mars; WALTHAM Petcare Science Institute	Argo, CM (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford, Surrey, England.	c.argo@surrey.ac.uk		Morrison, Philippa/0000-0003-4187-0371; Argo, Caroline/0000-0002-8279-6350	WALTHAM	WALTHAM	This research was funded by a PhD Scholarship from WALTHAM. The funders (with the exception of Patricia A. Harris, co-author and collaborator), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, GENES GENOM, V33, P245, DOI 10.1007/s13258-010-0114-6; Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; Argo CM, 2012, VET J; Baumann A. P., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P8; Bogaert L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-24; Bruynsteen L, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-240; Carter RA, 2009, EQUINE VET J, V41, P171, DOI 10.2746/042516408X342975; Carter RA, 2009, VET J, V179, P204, DOI 10.1016/j.tvjl.2008.02.029; Cleasby ME, 2014, LOCAL OVEREXPRESSION, pE814; Dall'Olio S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/542945; Dilger AC, 2010, ANIM SCI J, V81, P586, DOI 10.1111/j.1740-0929.2010.00776.x; Dugdale AHA, 2012, VET J; Fournier B, 2012, MOL CELL BIOL, V32, P2871, DOI 10.1128/MCB.06575-11; Giles SL, 2014, PEERJ, V2, DOI 10.7717/peerj.299; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Guo YF, 2008, ACTA BIOCH BIOPH SIN, V40, P426, DOI 10.1111/j.1745-7270.2008.00418.x; Hamrick MW, 2006, INT J OBESITY, V30, P868, DOI 10.1038/sj.ijo.0803200; Harker I.J., 2011, J EQUINE VET SCI, V31, P253, DOI [10.1016/j.jevs.2011.03.058, DOI 10.1016/J.JEVS.2011.03.058]; Hill EW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-552; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hirai S, 2007, DOMEST ANIM ENDOCRIN, V32, P1, DOI 10.1016/j.domaniend.2005.12.001; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Joulia D, 2003, EXP CELL RES, V286, P263, DOI 10.1016/S0014-4827(03)00074-0; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Kohnke JR., 1992, FEEDING NUTR MAKING, P163; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lyons JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012928; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morrison PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100810; Owers R, 2013, EQUINE VET J, V45, P5, DOI 10.1111/evj.12008; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shan TZ, 2013, FASEB J, V27, P1981, DOI 10.1096/fj.12-225755; Smith IJ, 2010, J CELL BIOCHEM, V111, P1059, DOI 10.1002/jcb.22796; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; WEBB AI, 1979, EQUINE VET J, V11, P39, DOI 10.1111/j.2042-3306.1979.tb01295.x; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4	40	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112621	10.1371/journal.pone.0112621	http://dx.doi.org/10.1371/journal.pone.0112621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390640	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400110
J	Dahlberg, CJ; Ehrlen, J; Hylander, K				Dahlberg, C. Johan; Ehrlen, Johan; Hylander, Kristoffer			Performance of Forest Bryophytes with Different Geographical Distributions Transplanted across a Topographically Heterogeneous Landscape	PLOS ONE			English	Article							SOLAR-RADIATION; SPECIES DISTRIBUTION; DISTRIBUTION MODELS; POPULATION-GROWTH; COMPLEX TERRAIN; RANGE-LIMIT; CLIMATE; EDGE; TEMPERATURE; TOLERANCE	Most species distribution models assume a close link between climatic conditions and species distributions. Yet, we know little about the link between species' geographical distributions and the sensitivity of performance to local environmental factors. We studied the performance of three bryophyte species transplanted at south- and north-facing slopes in a boreal forest landscape in Sweden. At the same sites, we measured both air and ground temperature. We hypothesized that the two southerly distributed species Eurhynchium angustirete and Herzogiella seligeri perform better on south- facing slopes and in warm conditions, and that the northerly distributed species Barbilophozia lycopodioides perform better on north-facing slopes and in relatively cool conditions. The northern, but not the two southern species, showed the predicted relationship with slope aspect. However, the performance of one of the two southern species was still enhanced by warm temperatures. An important reason for the inconsistent results can be that microclimatic gradients across landscapes are complex and influenced by many climate-forcing factors. Therefore, comparing only north- and south-facing slopes might not capture the complexity of microclimatic gradients. Population growth rates and potential distributions are the integrated results of all vital rates. Still, the study of selected vital rates constitutes an important first step to understand the relationship between population growth rates and geographical distributions and is essential to better predict how climate change influences species distributions.	[Dahlberg, C. Johan; Ehrlen, Johan; Hylander, Kristoffer] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden	Stockholm University	Dahlberg, CJ (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	johan.dahlberg@su.se	Dahlberg, Carl Johan/AAA-4465-2022	Dahlberg, Carl Johan/0000-0003-0271-3306; Ehrlen, Johan/0000-0001-8539-8967	Strategic Research Programme EkoKlim	Strategic Research Programme EkoKlim	This work was supported by Strategic Research Programme EkoKlim (http://www.zoologi.su.se/ekoklim). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Andersson G, 1912, NORRLANDSKA FLORANS; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Artdatabanken SLU, 2011, ARTPORTALEN RAPPORTS; Ashcroft MB, 2012, INT J CLIMATOL, V32, P2134, DOI 10.1002/joc.2428; Astrom M, 2007, ECOLOGY, V88, P749, DOI 10.1890/06-0613; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bennie J, 2006, J ECOL, V94, P355, DOI 10.1111/j.1365-2745.2006.01104.x; Breckle S.W, 2002, WALTERS VEGETATION E; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Crandall-Stotler B., 2009, BRYOPHYTE BIOL, P1; Crozier LG, 2004, OECOLOGIA, V141, P148, DOI 10.1007/s00442-004-1634-z; Dahlgren JP, 2010, ECOL LETT, V13, pE7, DOI 10.1111/j.1461-0248.2010.01460.x; Damsholt K, 2002, ILLUSTRATED FLORA NO; DAVISON AW, 1977, J ECOL, V65, P523, DOI 10.2307/2259498; Despland E, 1997, AM J BOT, V84, P928, DOI 10.2307/2446283; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; ERIKSSON O, 1988, J ECOL, V76, P522, DOI 10.2307/2260610; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Frahm Jan-Peter, 2001, Lindbergia, V26, P97; FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656; Fridley JD, 2009, J APPL METEOROL CLIM, V48, P1033, DOI 10.1175/2008JAMC2084.1; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Gaston KJ, 2009, P R SOC B, V276, P1395, DOI 10.1098/rspb.2008.1480; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Geiger R., 2003, CLIMATE NEAR GROUND; Gilman SE, 2006, OECOLOGIA, V148, P270, DOI 10.1007/s00442-006-0372-9; Gimenez-Benavides L, 2008, ECOGRAPHY, V31, P731, DOI 10.1111/j.0906-7590.2008.05509.x; Goffinet B., 2009, BRYOPHYTE BIOL, V2, P55, DOI DOI 10.1017/CBO9780511754807.003; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hagglund B., 1982, HANDLEDNING BONITERI; Hampe A, 2005, OECOLOGIA, V143, P377, DOI 10.1007/s00442-004-1811-0; Hampe A, 2011, ANNU REV ECOL EVOL S, V42, P313, DOI 10.1146/annurev-ecolsys-102710-145015; Hiesey W., 1971, EXPT STUDIES NATURE; Hill MO, 2006, J BRYOL, V28, P198, DOI 10.1179/174328206X119998; Huang SL, 2008, PHYS GEOGR, V29, P158, DOI 10.2747/0272-3646.29.2.158; Hutchinson G.E., 1978, INTRO POPULATION ECO; Hylander K, 2005, ECOL APPL, V15, P674, DOI 10.1890/04-0570; Hylander K, 2005, J APPL ECOL, V42, P518, DOI 10.1111/j.1365-2664.2005.01033.x; Kurschner H, 1999, CRYPTOGAM BRYOL, V20, P17, DOI 10.1016/S1290-0796(99)80004-2; Lomolino MV, 2006, BIOGEOGRAPHY; Lonnell N, 2014, ECOGRAPHY, V37, P591, DOI 10.1111/j.1600-0587.2013.00530.x; MAGUIRE B, 1973, AM NAT, V107, P213, DOI 10.1086/282827; Mossberg B, 2012, NYA NORDISKA FLORAN; Mrascner JW, 1990, ANGERINANRANDS HORA; NAULT A, 1993, J ECOL, V81, P101, DOI 10.2307/2261228; Normand S, 2009, GLOBAL ECOL BIOGEOGR, V18, P437, DOI 10.1111/j.1466-8238.2009.00451.x; OKLAND RH, 1995, J ECOL, V83, P697, DOI 10.2307/2261637; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; PROCTOR M. C. F., 2009, BRYOPHYTE BIOL, P237; Proctor MCF., 2011, BRYOPHYTE ECOLOGY CL, P35, DOI [10.1017/CBO9780511779701.004, DOI 10.1111/J.1442-9993.2012.02409.X]; R Core Team, 2021, R LANGUAGE ENV STAT; RADCLIFFE JE, 1981, NEW ZEAL J AGR RES, V24, P55, DOI 10.1080/00288233.1981.10420871; Ribbing J, 2007, J PHARMACOKINET PHAR, V34, P485, DOI 10.1007/s10928-007-9057-1; RORISON IH, 1986, PLANT CELL ENVIRON, V9, P49, DOI 10.1111/1365-3040.ep11612961; Sanford E, 2006, ECOLOGY, V87, P2882, DOI 10.1890/0012-9658(2006)87[2882:LTGFAT]2.0.CO;2; Schmalholz M, 2011, ECOGRAPHY, V34, P637, DOI 10.1111/j.1600-0587.2010.06652.x; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Slack N.G., 2011, BRYOPHYTE ECOLOGY CL, P3; Soderstrom L, 1981, WAHLENBERGIA, V7, P141; Svenning JC, 2013, AM J BOT, V100, P1266, DOI 10.3732/ajb.1200469; Swedish Meteorological and Hydrological Institute, 2013, KLIM DAT DAT MED NOR; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tuhkanen S., 1980, CLIMATIC PARAMETERS; Van der Veken S, 2007, J ECOL, V95, P343, DOI 10.1111/j.1365-2745.2006.01208.x; Van der Veken S, 2012, BASIC APPL ECOL, V13, P10, DOI 10.1016/j.baae.2011.10.007; Vanderpoorten A, 2009, INTRODUCTION TO BRYOPHYTES, P1, DOI 10.1017/CBO9780511626838; Vercauteren N, 2013, J APPL METEOROL CLIM, V52, P1208, DOI 10.1175/JAMC-D-12-0115.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; Wood AJ, 2007, BRYOLOGIST, V110, P163, DOI 10.1639/0007-2745(2007)110[163:IENFIB]2.0.CO;2; Zimmermann NE, 2009, P NATL ACAD SCI USA, V106, P19723, DOI 10.1073/pnas.0901643106	73	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112943	10.1371/journal.pone.0112943	http://dx.doi.org/10.1371/journal.pone.0112943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387233	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400106
J	Reolon, LA; Martello, CL; Schrank, IS; Ferreira, HB				Reolon, Luciano Antonio; Martello, Carolina Lumertz; Schrank, Irene Silveira; Ferreira, Henrique Bunselmeyer			Survey of Surface Proteins from the Pathogenic Mycoplasma hyopneumoniae Strain 7448 Using a Biotin Cell Surface Labeling Approach	PLOS ONE			English	Article							PLASMINOGEN-BINDING PROTEINS; CILIUM ADHESIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; IMMUNOGENIC PROTEINS; ENZOOTIC PNEUMONIA; PORCINE CILIA; SWINE; HEPARIN; IDENTIFICATION; FIBRONECTIN	The characterization of the repertoire of proteins exposed on the cell surface by Mycoplasma hyopneumoniae (M. hyopneumoniae), the etiological agent of enzootic pneumonia in pigs, is critical to understand physiological processes associated with bacterial infection capacity, survival and pathogenesis. Previous in silico studies predicted that about a third of the genes in the M. hyopneumoniae genome code for surface proteins, but so far, just a few of them have experimental confirmation of their expression and surface localization. In this work, M. hyopneumoniae surface proteins were labeled in intact cells with biotin, and affinity-captured biotin-labeled proteins were identified by a gel-based liquid chromatographytandem mass spectrometry approach. A total of 20 gel slices were separately analyzed by mass spectrometry, resulting in 165 protein identifications corresponding to 59 different protein species. The identified surface exposed proteins better defined the set of M. hyopneumoniae proteins exposed to the host and added confidence to in silico predictions. Several proteins potentially related to pathogenesis, were identified, including known adhesins and also hypothetical proteins with adhesin-like topologies, consisting of a transmembrane helix and a large tail exposed at the cell surface. The results provided a better picture of the M. hyopneumoniae cell surface that will help in the understanding of processes important for bacterial pathogenesis. Considering the experimental demonstration of surface exposure, adhesion-like topology predictions and absence of orthologs in the closely related, non-pathogenic species Mycoplasma flocculare, several proteins could be proposed as potential targets for the development of drugs, vaccines and/or immunodiagnostic tests for enzootic pneumonia.	[Martello, Carolina Lumertz; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Genom Estrutural & Func, Porto Alegre, RS, Brazil; [Reolon, Luciano Antonio; Schrank, Irene Silveira] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Microrganismos Diazotrof, Porto Alegre, RS, Brazil; [Reolon, Luciano Antonio; Schrank, Irene Silveira; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Programa Posgrad Biol Celular & Mol, Porto Alegre, RS, Brazil; [Schrank, Irene Silveira; Ferreira, Henrique Bunselmeyer] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Biol Mol & Biotecnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Ferreira, HB (corresponding author), Univ Fed Rio Grande do Sul, Ctr Biotecnol, Lab Genom Estrutural & Func, Porto Alegre, RS, Brazil.	Henrique@cbiot.ufrgs.br	Ferreira, Henrique B/H-4189-2012	Ferreira, Henrique B/0000-0003-3611-6040	MCT/CNPq; FAPERGS	MCT/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was funding from MCT/CNPq and FAPERGS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Hearn M, 2008, INFECT IMMUN, V76, P170, DOI 10.1128/IAI.01913-06; Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x; AMASS SF, 1994, J AM VET MED ASSOC, V204, P102; Bogema DR, 2012, MBIO, V3, DOI 10.1128/mBio.00282-11; Bogema DR, 2011, J BIOL CHEM, V286, P41217, DOI 10.1074/jbc.M111.226084; Burnett TA, 2006, MOL MICROBIOL, V60, P669, DOI 10.1111/j.1365-2958.2006.05139.x; Cacciotto C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-225; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chou SY, 1997, BIOCHEM MOL BIOL INT, V41, P821; Cordwell SJ, 2006, CURR OPIN MICROBIOL, V9, P320, DOI 10.1016/j.mib.2006.04.008; Corona L, 2013, VET MICROBIOL, V167, P434, DOI 10.1016/j.vetmic.2013.08.024; Cullen PA, 2005, INFECT IMMUN, V73, P4853, DOI 10.1128/IAI.73.8.4853-4863.2005; DEBEY MC, 1994, INFECT IMMUN, V62, P5312, DOI 10.1128/IAI.62.12.5312-5318.1994; Deutscher AT, 2012, J PROTEOME RES, V11, P1924, DOI 10.1021/pr201115v; Deutscher AT, 2010, MOL MICROBIOL, V78, P444, DOI 10.1111/j.1365-2958.2010.07345.x; Djordjevic SP, 2004, INFECT IMMUN, V72, P2791, DOI 10.1128/IAI.72.5.2791-2802.2004; Fadiel A, 2007, FRONT BIOSCI-LANDMRK, V12, P2020, DOI 10.2741/2207; FREY J, 1994, MICROB PATHOGENESIS, V17, P313, DOI 10.1006/mpat.1994.1077; Hall RE, 1999, MICROB PATHOGENESIS, V27, P145, DOI 10.1006/mpat.1999.0293; Hopfe M, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-46; Jenkins C, 2008, J BACTERIOL, V190, P2206, DOI 10.1128/JB.01685-07; Jenkins C, 2007, MICROBIOL-SGM, V153, P1455, DOI 10.1099/mic.0.2006/004937-0; Kobisch M, 1996, REV SCI TECH OIE, V15, P1569, DOI 10.20506/rst.15.4.983; Krasteva I, 2014, VET MICROBIOL, V168, P116, DOI 10.1016/j.vetmic.2013.10.025; Krause DC, 1996, MOL MICROBIOL, V20, P247, DOI 10.1111/j.1365-2958.1996.tb02613.x; Maes D, 2008, VET MICROBIOL, V126, P297, DOI 10.1016/j.vetmic.2007.09.008; Maes D, 1996, VET QUART, V18, P104, DOI 10.1080/01652176.1996.9694628; Matic JN, 2003, GENE, V319, P99, DOI 10.1016/S0378-1119(03)00798-4; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; Piersma SR, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-17; Pinto PM, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-45; Pinto PM, 2007, VET MICROBIOL, V121, P83, DOI 10.1016/j.vetmic.2006.11.018; Raymond BBA, 2013, J PROTEOME RES, V12, P5891, DOI 10.1021/pr400903s; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Seidler NW, 2013, ADV EXP MED BIOL, V985, P149, DOI 10.1007/978-94-007-4716-6_5; Seymour LM, 2012, CELL MICROBIOL, V14, P81, DOI 10.1111/j.1462-5822.2011.01702.x; Seymour LM, 2010, J BIOL CHEM, V285, P33971, DOI 10.1074/jbc.M110.104463; Siqueira FM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-175; Tacchi JL, 2014, J PROTEOME RES, V13, P2920, DOI 10.1021/pr500087c; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Thomas C, 2013, MICROBIOL-SGM, V159, P352, DOI 10.1099/mic.0.061184-0; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Wilton J, 2009, MOL MICROBIOL, V71, P566, DOI 10.1111/j.1365-2958.2008.06546.x; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; You Xiao-xing, 2006, J Zhejiang Univ Sci B, V7, P342, DOI 10.1631/jzus.2006.B0342; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; ZHANG QJ, 1994, INFECT IMMUN, V62, P1616, DOI 10.1128/IAI.62.5.1616-1622.1994; ZIELINSKI GC, 1993, AM J VET RES, V54, P1262	51	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112596	10.1371/journal.pone.0112596	http://dx.doi.org/10.1371/journal.pone.0112596			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386928	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400070
J	Takahashi, K; Matafonov, A; Sumarriva, K; Ito, H; Lauhan, C; Zemel, D; Tsuboi, N; Chen, J; Reynolds, A; Takahashi, T				Takahashi, Keiko; Matafonov, Anton; Sumarriva, Katherine; Ito, Hideyuki; Lauhan, Colette; Zemel, Dana; Tsuboi, Nobuo; Chen, Jin; Reynolds, Albert; Takahashi, Takamune			CD148 Tyrosine Phosphatase Promotes Cadherin Cell Adhesion	PLOS ONE			English	Article							ACTIN CYTOSKELETON; BETA-CATENIN; P120 CATENIN; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; ADHERENS JUNCTIONS; ENDOTHELIAL-CELLS; RAC1 ACTIVATION; ETA SUPPRESSES; GROWTH-FACTOR	CD148 is a transmembrane tyrosine phosphatase that is expressed at cell junctions. Recent studies have shown that CD148 associates with the cadherin/catenin complex and p120 catenin (p120) may serve as a substrate. However, the role of CD148 in cadherin cell-cell adhesion remains unknown. Therefore, here we addressed this issue using a series of stable cells and cell-based assays. Wild-type (WT) and catalytically inactive (CS) CD148 were introduced to A431D (lacking classical cadherins), A431D/E-cadherin WT (expressing wild-type E-cadherin), and A431D/E-cadherin 764AAA (expressing p120-uncoupled E-cadherin mutant) cells. The effects of CD148 in cadherin adhesion were assessed by Ca2+ switch and cell aggregation assays. Phosphorylation of E-cadherin/catenin complex and Rho family GTPase activities were also examined. Although CD148 introduction did not alter the expression levels and complex formation of E-cadherin, p120, and beta-catenin, CD148 WT, but not CS, promoted cadherin contacts and strengthened cell-cell adhesion in A431D/E-cadherin WT cells. This effect was accompanied by an increase in Rac1, but not RhoA and Cdc42, activity and largely diminished by Rac1 inhibition. Further, we demonstrate that CD148 reduces the tyrosine phosphorylation of p120 and beta-catenin; causes the dephosphorylation of Y529 suppressive tyrosine residue in Src, a well-known CD148 site, increasing Src activity and enhancing the phosphorylation of Y228 (a Src kinase site) in p120, in E-cadherin contacts. Consistent with these findings, CD148 dephosphorylated both p120 and beta-catenin in vitro. The shRNA-mediated CD148 knockdown in A431 cells showed opposite effects. CD148 showed no effects in A431D and A431D/E-cadherin 764AAA cells. In aggregate, these findings provide the first evidence that CD148 promotes E-cadherin adhesion by regulating Rac1 activity concomitant with modulation of p120, beta-catenin, and Src tyrosine phosphorylation. This effect requires E-cadherin and p120 association.	[Takahashi, Keiko; Matafonov, Anton; Sumarriva, Katherine; Ito, Hideyuki; Lauhan, Colette; Zemel, Dana; Tsuboi, Nobuo; Chen, Jin; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Chen, Jin; Reynolds, Albert; Takahashi, Takamune] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Takahashi, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	takamune.takahashi@vanderbilt.edu		Chen, Jin/0000-0002-5557-2079; Peters, Katherine/0000-0002-8872-9271	National Institute of Diabetes and Digestive and Kidney Disease grant (NIDDK) [DK38517, DK97332]; National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) [HL109715]; NATIONAL CANCER INSTITUTE [R01CA177681] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097332, P30DK020593, R01DK038517] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease grant (NIDDK); National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institute of Diabetes and Digestive and Kidney Disease grant (NIDDK) DK38517 and DK97332 (to TT) (http://www.niddk.nih.gov/Pages/default.aspx); National Institutes of Health National Heart, Lung, and Blood Institute (NHLBI) HL109715 to TT) (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; Autschbach F, 1999, TISSUE ANTIGENS, V54, P485, DOI 10.1034/j.1399-0039.1999.540506.x; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chabot C, 2009, MOL CELL BIOL, V29, P241, DOI 10.1128/MCB.01374-08; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Daniel JM, 1997, BIOESSAYS, V19, P883, DOI 10.1002/bies.950191008; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; de la Fuente-Garcia MA, 1998, BLOOD, V91, P2800, DOI 10.1182/blood.V91.8.2800.2800_2800_2809; Fukuyama T, 2006, ONCOGENE, V25, P8, DOI 10.1038/sj.onc.1209010; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Giampietro C, 2012, BLOOD, V119, P2159, DOI 10.1182/blood-2011-09-381012; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Holsinger LJ, 2002, ONCOGENE, V21, P7067, DOI 10.1038/sj.onc.1205858; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Iuliano R, 2003, CANCER RES, V63, P882; KANNER SB, 1991, MOL CELL BIOL, V11, P713, DOI 10.1128/MCB.11.2.713; Katsumoto TR, 2013, J CLIN INVEST, V123, P2037, DOI 10.1172/JCI66397; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Mariner DJ, 2001, J BIOL CHEM, V276, P28006, DOI 10.1074/jbc.M102443200; Massa A, 2004, ANN NY ACAD SCI, V1030, P264, DOI 10.1196/annals.1329.033; Miyashita Y, 2007, J BIOL CHEM, V282, P11540, DOI 10.1074/jbc.M608351200; Mukherjee M, 2012, EMBO J, V31, P1308, DOI 10.1038/emboj.2011.496; Nakagawa M, 2001, J CELL SCI, V114, P1829; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Oas RG, 2013, MOL BIOL CELL, V24, P704, DOI 10.1091/mbc.E12-06-0471; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Pang JH, 2005, J BIOL CHEM, V280, P3043, DOI 10.1074/jbc.M412148200; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Reynolds AB, 2014, ONCOGENE, V33, P4537, DOI 10.1038/onc.2013.416; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Sacco F, 2009, J BIOL CHEM, V284, P22048, DOI 10.1074/jbc.M109.002758; Smith AL, 2012, MOL BIOL CELL, V23, P99, DOI 10.1091/mbc.E11-06-0497; Spring K, 2012, BLOOD, V120, P2745, DOI 10.1182/blood-2011-12-398040; Takahashi K, 2012, P NATL ACAD SCI USA, V109, P1985, DOI 10.1073/pnas.1106171109; Takahashi T, 1999, J AM SOC NEPHROL, V10, P2135; Takahashi T, 2006, BLOOD, V108, P1234, DOI 10.1182/blood-2005-10-4296; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038; Trapasso F, 2004, CARCINOGENESIS, V25, P2107, DOI 10.1093/carcin/bgh224; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Tsuboi N, 2008, BIOCHEM J, V413, P193, DOI 10.1042/BJ20071317; Valls G, 2012, J CELL SCI, V125, P5288, DOI 10.1242/jcs.101030; Watanabe T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003020; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xu YR, 1997, J BIOL CHEM, V272, P13463, DOI 10.1074/jbc.272.21.13463; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zebda N, 2013, J BIOL CHEM, V288, P18290, DOI 10.1074/jbc.M112.432757; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659	61	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112753	10.1371/journal.pone.0112753	http://dx.doi.org/10.1371/journal.pone.0112753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386896	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400090
J	Byun, YS; Tibrewal, S; Kim, E; Yco, L; Sarkar, J; Ivanir, Y; Liu, CY; Sano, CM; Jain, S				Byun, Yong-Soo; Tibrewal, Sapna; Kim, Eunjae; Yco, Lisette; Sarkar, Joy; Ivanir, Yair; Liu, Chia-Yang; Sano, Cecile M.; Jain, Sandeep			Keratocytes Derived from Spheroid Culture of Corneal Stromal Cells Resemble Tissue Resident Keratocytes	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ALDEHYDE DEHYDROGENASE; EXTRACELLULAR-MATRIX; PROTEIN EXPRESSION; NERVE REGENERATION; EPITHELIAL-CELLS; COLLAGEN XVIII; MOUSE CORNEA; PHENOTYPE; FIBROBLASTS	Purpose: Corneal stromal cells transform to precursor cells in spheroid culture. We determined whether keratocytes derived from spheroid culture of murine corneal stromal cells resemble tissue resident keratocytes. Methods: Spheroid culture was performed by seeding dissociated stromal cells onto ultra-low attachment plates containing serum-free mesenchymal stem cell culture medium. Spheroids were characterized with phenotype specific markers and stemness transcription factor genes. Spheroids and adherent cells in culture were induced to differentiate to keratocytes using keratocyte induction medium (KIM) and compared with tissue resident keratocytes. Results: Stromal cells formed spheroids in ultra-low attachment plates, but not in polystyrene tissue culture dishes. Keratocan expression and abundance was significantly higher in spheroids as compared to adherent cells whereas alpha-smooth muscle actin (alpha-SMA) was significantly lower. As compared to adherent culture-derived cells, the expressions of keratocan, aldehyde dehydrogenase (ALDH3A1) and alpha-SMA in spheroid-derived cells approximated much more closely the levels of these genes in tissue resident keratocytes. Of the stemness genes, Nanog and Oct4 were upregulated in the spheroids. Conclusion: Stemness transcription factor genes are upregulated in spheroids. Keratocytes derived from spheroids resemble tissue resident keratocytes, thus increasing manifolds the quantity of these cells for in-vitro experiments.	[Byun, Yong-Soo; Tibrewal, Sapna; Kim, Eunjae; Yco, Lisette; Sarkar, Joy; Ivanir, Yair; Sano, Cecile M.; Jain, Sandeep] Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, Corneal Neurobiol Lab, Chicago, IL 60607 USA; [Byun, Yong-Soo] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Catholic Inst Visual Sci, Seoul, South Korea; [Yco, Lisette] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Liu, Chia-Yang] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Catholic University of Korea; University of Hawaii System; University of Hawaii Manoa; University System of Ohio; University of Cincinnati	Jain, S (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, Corneal Neurobiol Lab, Chicago, IL 60607 USA.	jains@uic.edu		Byun, Yong-Soo/0000-0002-7264-0723; Liu, Chia-yang/0000-0002-8398-5516	National Eye Institute (NEI) [R01EY023656, P30EY001792]; Midwest Eye Banks; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY001792, R01EY023656] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Midwest Eye Banks; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (NEI) Grant R01EY023656 (SJ), NEI core grant P30EY001792, Midwest Eye Banks (SJ), and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azar DT, 2010, CORNEA, V29, P321, DOI 10.1097/ICO.0b013e3181b1165d; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Blanco-Mezquita JT, 2011, INVEST OPHTH VIS SCI, V52, P8505, DOI 10.1167/iovs.11-8194; Chang JYF, 2013, STEM CELL RES, V11, P990, DOI 10.1016/j.scr.2013.06.008; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Chase LG, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt8; Chaudhary S, 2012, CORNEA, V31, P1460, DOI 10.1097/ICO.0b013e318247b60e; Chien Y, 2012, BIOMATERIALS, V33, P8003, DOI 10.1016/j.biomaterials.2012.07.029; Du YD, 2005, STEM CELLS, V23, P1266, DOI 10.1634/stemcells.2004-0256; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Funderburgh ML, 2008, MOL VIS, V14, P308; Gao C, 2002, MOL CANCER RES, V1, P12; GARANA RMR, 1992, INVEST OPHTH VIS SCI, V33, P3271; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Horswill MA, 2008, EXP EYE RES, V86, P586, DOI 10.1016/j.exer.2008.01.003; Jester JV, 2005, INVEST OPHTH VIS SCI, V46, P2369, DOI 10.1167/iovs.04-1225; Jester JV, 2003, EXP EYE RES, V77, P581, DOI 10.1016/S0014-4835(03)00188-X; Kawakita T, 2004, INVEST OPHTH VIS SCI, V45, P3507, DOI 10.1167/iovs.04-0266; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Mimura T, 2008, MOL VIS, V14, P197; Mohan RR, 2003, EXP EYE RES, V76, P71, DOI 10.1016/S0014-4835(02)00251-8; Namavari A, 2012, INVEST OPHTH VIS SCI, V53, P4575, DOI 10.1167/iovs.12-9760; Netto MV, 2006, J REFRACT SURG, V22, P562; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Olschlager V, 2009, ARZNEIMITTEL-FORSCH, V59, P146, DOI 10.1055/s-0031-1296378; Pei Y, 2006, EXP EYE RES, V83, P1063, DOI 10.1016/j.exer.2006.05.011; Ryan DG, 2003, INVEST OPHTH VIS SCI, V44, P4255, DOI 10.1167/iovs.03-0578; Sakimoto T, 2008, FEBS LETT, V582, P3674, DOI 10.1016/j.febslet.2008.09.052; Scott SG, 2011, EXP EYE RES, V93, P898, DOI 10.1016/j.exer.2011.10.004; Shaheen BS, 2014, SURV OPHTHALMOL, V59, P263, DOI 10.1016/j.survophthal.2013.09.002; Sommer CA, 2013, J CELL PHYSIOL, V228, P267, DOI 10.1002/jcp.24155; Song BJ, 2011, J PROTEOMICS, V74, P2691, DOI 10.1016/j.jprot.2011.05.013; Stramer BM, 2003, INVEST OPHTH VIS SCI, V44, P4237, DOI 10.1167/iovs.02-1188; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Weiswald LB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-106; Wilson SE, 1997, J REFRACT SURG, V13, P171; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; YANOFF M, 1977, INVEST OPHTH VIS SCI, V16, P269; Yeh SI, 2010, CURR EYE RES, V35, P799, DOI 10.3109/02713683.2010.494239; Yoshida S, 2005, INVEST OPHTH VIS SCI, V46, P1653, DOI 10.1167/iovs.04-1405; Yoshida S, 2006, STEM CELLS, V24, P2714, DOI 10.1634/stemcells.2006-0156; Young RD, 2009, INVEST OPHTH VIS SCI, V50, P4155, DOI 10.1167/iovs.09-3561	48	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112781	10.1371/journal.pone.0112781	http://dx.doi.org/10.1371/journal.pone.0112781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384043	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700095
J	Huuskes, BM; Wise, AF; Cox, AJ; Lim, EX; Payne, NL; Kelly, DJ; Samuel, CS; Ricardo, SD				Huuskes, Brooke M.; Wise, Andrea F.; Cox, Alison J.; Lim, Ee X.; Payne, Natalie L.; Kelly, Darren J.; Samuel, Chrishan S.; Ricardo, Sharon D.			Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy	FASEB JOURNAL			English	Article						interstitial kidney injury; macrophage infiltration; transforming growth factor-beta; myofibroblast differentiation; collagen deposition; matrix metalloproteinase	ACUTE KIDNEY INJURY; UNILATERAL URETERAL OBSTRUCTION; ISCHEMIA-REPERFUSION INJURY; STROMAL CELLS; TUBULOINTERSTITIAL FIBROSIS; INTERSTITIAL FIBROSIS; MATRIX METALLOPROTEINASES; MOLECULE-1 EXPRESSION; MYOCARDIAL-INFARCTION; RELAXIN DECREASES	Chronic kidney disease (CKD) results from the development of fibrosis, ultimately leading to endstage renal disease (ESRD). Although human bone marrow-derived mesenchymal stem cells (MSCs) can accelerate renal repair following acute injury, the establishment of fibrosis during CKD may affect their potential to influence regeneration capacity. Here we tested the novel combination of MSCs with the antifibrotic serelaxin to repair and protect the kidney 7 d post-unilateral ureteral obstruction (UUO), when fibrosis is established. Male C57BL6 mice were sham-operated or UUO-inured (n = 4-6) and received vehicle, MSCs (1 3 106), serelaxin (0.5 mg/ kg per d), or the combination of both. In vivo tracing studies with luciferin/ enhanced green fluorescent protein (eGFP)-taggedMSCs showed specific localization in the obstructed kidney where they remained for 36 h. Combination therapy conferred significant protection from UUO-induced fibrosis, as indicated by hydroxyproline analysis (P < 0.001 vs. vehicle, P < 0.05 vs. MSC or serelaxin alone). This was accompanied by preserved structural architecture, decreased tubular epithelial injury (P < 0.01 vs. MSCs alone), macrophage infiltration, and myofibroblast localization in the kidney (both P < 0.01 vs. vehicle). Combination therapy also stimulated matrix metalloproteinase (MMP)-2 activity over either treatment alone (P < 0.05 vs. either treatment alone). These results suggest that the presence of an antifibrotic in conjunction with MSCsameliorates established kidneyfibrosis and augments tissue repair to a greater extent than either treatment alone.-	[Huuskes, Brooke M.; Wise, Andrea F.; Lim, Ee X.; Ricardo, Sharon D.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia; [Cox, Alison J.; Kelly, Darren J.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Payne, Natalie L.] Monash Univ, ARMI, Clayton, Vic 3800, Australia	Monash University; Monash University; St Vincent's Hospital Melbourne; University of Melbourne; Australian Regenerative Medicine Institute; Monash University	Ricardo, SD (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia.	chrishan.samuel@monash.edu; sharon.ricardo@monash.edu		Kelly, Darren/0000-0003-4850-3929; Wise, Andrea F./0000-0002-9387-4465; Ricardo, Sharon/0000-0003-1724-3669				Ali G, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-75; Alikhan MA, 2011, AM J PATHOL, V179, P1243, DOI 10.1016/j.ajpath.2011.05.037; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Bennett RG, 2014, LIVER INT, V34, P416, DOI 10.1111/liv.12247; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bitto A, 2013, CLIN SCI, V125, P575, DOI 10.1042/CS20130105; BOHLE A, 1987, AM J NEPHROL, V7, P421, DOI 10.1159/000167514; Braga TT, 2012, MOL MED, V18, P1231, DOI 10.2119/molmed.2012.00131; Burst VR, 2010, NEPHRON EXP NEPHROL, V114, pE107, DOI 10.1159/000262318; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Cochrane AL, 2005, J AM SOC NEPHROL, V16, P3623, DOI 10.1681/ASN.2004090771; Danielson LA, 2006, J AM SOC NEPHROL, V17, P1325, DOI 10.1681/ASN.2005121307; Eun LY, 2011, TISSUE CELL, V43, P238, DOI 10.1016/j.tice.2011.04.002; Formigli L, 2007, J CELL MOL MED, V11, P1087, DOI 10.1111/j.1582-4934.2007.00111.x; Garber SL, 2003, AM J NEPHROL, V23, P8, DOI 10.1159/000066302; Garber SL, 2001, KIDNEY INT, V59, P876, DOI 10.1046/j.1523-1755.2001.059003876.x; Goldsmith LT, 2009, ANN NY ACAD SCI, V1160, P130, DOI 10.1111/j.1749-6632.2008.03800.x; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Hewitson TD, 2007, ENDOCRINOLOGY, V148, P660, DOI 10.1210/en.2006-0814; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hossain MA, 2011, BIOCHEMISTRY-US, V50, P1368, DOI 10.1021/bi1013968; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Imberti B, 2007, J AM SOC NEPHROL, V18, P2921, DOI 10.1681/ASN.2006121318; Jeyabalan A, 2007, ADV EXP MED BIOL, V612, P65; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Lekawanvijit S, 2012, AM J PHYSIOL-HEART C, V302, pH1884, DOI 10.1152/ajpheart.00967.2011; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YL, 2012, CELL IMMUNOL, V276, P144, DOI 10.1016/j.cellimm.2012.05.001; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Masterson R, 2004, NEPHROL DIAL TRANSPL, V19, P544, DOI 10.1093/ndt/gfg598; Medina A, 2002, PEDIATR NEPHROL, V17, P1005, DOI 10.1007/s00467-002-0979-y; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Mookerjee I, 2009, FASEB J, V23, P1219, DOI 10.1096/fj.08-120857; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Payne NL, 2013, CELL TRANSPLANT, V22, P1409, DOI 10.3727/096368912X657620; Perico N, 2005, KIDNEY INT, V68, pS21, DOI 10.1111/j.1523-1755.2005.09804.x; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Puri TS, 2010, AM J PHYSIOL-RENAL, V298, pF1024, DOI 10.1152/ajprenal.00384.2009; Reinders MEJ, 2014, CURR OPIN ORGAN TRAN, V19, P54, DOI 10.1097/MOT.0000000000000032; Reinders MEJ, 2013, STEM CELL TRANSL MED, V2, P107, DOI 10.5966/sctm.2012-0114; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Ronco P, 2007, SEMIN NEPHROL, V27, P352, DOI 10.1016/j.semnephrol.2007.02.006; Roy L, 2013, KIDNEY INT, V84, P570, DOI 10.1038/ki.2013.103; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2009, CURR OPIN NEPHROL HY, V18, P9, DOI 10.1097/MNH.0b013e32831b7096; Samuel CS, 2004, KIDNEY INT, V65, P2054, DOI 10.1111/j.1523-1755.2004.00628.x; Samuel CS, 2002, FASEB J, V16, P121, DOI 10.1096/fj.02-0449fje; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Semedo P, 2009, INT IMMUNOPHARMACOL, V9, P677, DOI 10.1016/j.intimp.2008.12.008; Takamiya Y, 2013, NEPHROL DIAL TRANSPL, V28, P55, DOI 10.1093/ndt/gfs387; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Togel F, 2008, AM J PHYSIOL-RENAL, V295, pF315, DOI 10.1152/ajprenal.00098.2008; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Ueno T, 2013, KIDNEY INT, V84, P297, DOI 10.1038/ki.2013.81; van Dijk A, 2011, STEM CELL RES, V7, P219, DOI 10.1016/j.scr.2011.06.003; van Timmeren MM, 2006, AM J PHYSIOL-RENAL, V291, pF456, DOI 10.1152/ajprenal.00403.2005; Wise AF, 2014, AM J PHYSIOL-RENAL, V306, pF1222, DOI 10.1152/ajprenal.00675.2013; Wise AF, 2012, NEPHROLOGY, V17, P1, DOI 10.1111/j.1440-1797.2011.01501.x; WOESSNER JF, 1995, METHOD ENZYMOL, V248, P510; Xing L, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt489; Yoshida T, 2012, NEPHROL DIAL TRANSPL, V27, P2190, DOI 10.1093/ndt/gfr618; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zhang PL, 2008, KIDNEY INT, V73, P608, DOI 10.1038/sj.ki.5002697; Zhang Y, 2012, EUR J HEART FAIL, V14, P549, DOI 10.1093/eurjhf/hfs011; Zhao L, 1999, ENDOCRINOLOGY, V140, P445, DOI 10.1210/en.140.1.445	76	51	52	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					540	553		10.1096/fj.14-254789	http://dx.doi.org/10.1096/fj.14-254789			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25395452				2022-12-26	WOS:000349370400017
J	Wickramaratne, S; Boldry, EJ; Buehler, C; Wang, YC; Distefano, MD; Tretyakova, NY				Wickramaratne, Susith; Boldry, Emily J.; Buehler, Charles; Wang, Yen-Chih; Distefano, Mark D.; Tretyakova, Natalia Y.			Error-prone Translesion Synthesis Past DNA-Peptide Cross-links Conjugated to the Major Groove of DNA via C5 of Thymidine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; POLYMERASE-ETA; REPLICATION BYPASS; MAMMALIAN-CELLS; ALZHEIMERS-DISEASE; UVRABC NUCLEASE; LESION BYPASS; LOW FIDELITY; Y-FAMILY; IN-VITRO	DNA-protein cross-links (DPCs) are exceptionally bulky, structurally diverse DNA adducts formed in cells upon exposure to endogenous and exogenous bis-electrophiles, reactive oxygen species, and ionizing radiation. If not repaired, DPCs can induce toxicity and mutations. It has been proposed that the protein component of a DPC is proteolytically degraded, giving rise to smaller DNA-peptide conjugates, which can be subject to nucleotide excision repair and replication bypass. In this study, polymerase bypass of model DNA-peptide conjugates structurally analogous to the lesions induced by reactive oxygen species and DNA methyltransferase inhibitors was examined. DNA oligomers containing site-specific DNA-peptide conjugates were generated by copper-catalyzed [3 + 2] Huisgen cyclo-addition between an alkyne-functionalized C5-thymidine in DNA and an azide-containing 10-mer peptide. The resulting DNA-peptide conjugates were subjected to steady-state kinetic experiments in the presence of recombinant human lesion bypass polymerases kappa and eta, followed by PAGE-based assays to determine the catalytic efficiency and the misinsertion frequency opposite the lesion. We found that human polymerase kappa and eta can incorporate A, G, C, or T opposite the C5-dT-conjugated DNA-peptide conjugates, whereas human polymerase eta preferentially inserts G opposite the lesion. Furthermore, HPLC-ESI--MS/MS sequencing of the extension products has revealed that post-lesion synthesis was highly error-prone, resulting in mutations opposite the adducted site or at the + 1 position from the adduct and multiple deletions. Collectively, our results indicate that replication bypass of peptides conjugated to the C5 position of thymine by human translesion synthesis polymerases leads to large numbers of base substitution and frame-shift mutations.	[Wickramaratne, Susith; Boldry, Emily J.; Distefano, Mark D.; Tretyakova, Natalia Y.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Wickramaratne, Susith; Boldry, Emily J.; Distefano, Mark D.; Tretyakova, Natalia Y.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Wickramaratne, Susith; Buehler, Charles; Wang, Yen-Chih; Distefano, Mark D.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Tretyakova, NY (corresponding author), Univ Minnesota, Mason Canc Ctr, 2231 6th St SE,2-147 CCRB, Minneapolis, MN 55455 USA.	trety001@umn.edu			National Institutes of Health [CA100670, ES023350]; University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE [R01CA100670, P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Masonic Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100670 and ES023350. This work was also supported by a Brainstorm Award from the University of Minnesota Masonic Cancer Center.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Baker DJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702856200; Barker S, 2005, ANAL BIOCHEM, V344, P204, DOI 10.1016/j.ab.2005.06.039; Barker S, 2005, MUTAT RES-REV MUTAT, V589, P111, DOI 10.1016/j.mrrev.2004.11.003; Bau DT, 2002, ENVIRON HEALTH PERSP, V110, P753, DOI 10.1289/ehp.02110s5753; Becherel OJ, 2001, P NATL ACAD SCI USA, V98, P8566, DOI 10.1073/pnas.141113398; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Charlton TS, 1999, FREE RADICAL BIO MED, V27, P254, DOI 10.1016/S0891-5849(99)00030-1; Cho SH, 2013, CHEM RES TOXICOL, V26, P1005, DOI 10.1021/tx400145e; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; Chvalova K, 2007, NUCLEIC ACIDS RES, V35, P1812, DOI 10.1093/nar/gkm032; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DeFlora S, 1996, MUTAT RES-REV GENET, V366, P197, DOI 10.1016/S0165-1110(96)00043-7; DIZDAROGLU M, 1989, CANCER RES, V49, P3463; Dizdaroglu M, 2012, FREE RADICAL RES, V46, P382, DOI 10.3109/10715762.2011.653969; Duxin JP, 2014, CELL, V159, P346, DOI 10.1016/j.cell.2014.09.024; Efrati E, 1997, J BIOL CHEM, V272, P2559; Fersht A., 1999, STRUCTURE MECH PROTE, P103; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Geacintov N. E., 2010, CHEM BIOL DNA DAMAGE, P299; Gherezghiher TB, 2013, J PROTEOME RES, V12, P2151, DOI 10.1021/pr3011974; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hang B, 2003, MUTAT RES-FUND MOL M, V531, P191, DOI 10.1016/j.mrfmmm.2003.07.006; Huang H, 2010, BIOCHEMISTRY-US, V49, P6155, DOI 10.1021/bi100364f; Ide H, 2011, MUTAT RES-FUND MOL M, V711, P113, DOI 10.1016/j.mrfmmm.2010.12.007; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Klug AR, 2012, CHEM RES TOXICOL, V25, P755, DOI 10.1021/tx300011w; Kotapati S, 2012, J BIOL CHEM, V287, P38800, DOI 10.1074/jbc.M112.396788; Kuo HK, 2007, CANCER RES, V67, P8248, DOI 10.1158/0008-5472.CAN-07-1038; Kurtz AJ, 2003, J BIOL CHEM, V278, P5970, DOI 10.1074/jbc.M212012200; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Loeber RL, 2009, CHEM RES TOXICOL, V22, P1151, DOI 10.1021/tx900078y; Lovell MA, 2007, NUCLEIC ACIDS RES, V35, P7497, DOI 10.1093/nar/gkm821; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Marini F, 2003, J BIOL CHEM, V278, P32014, DOI 10.1074/jbc.M305646200; Martin LJ, 2008, J NEUROPATH EXP NEUR, V67, P377, DOI 10.1097/NEN.0b013e31816ff780; Matsuda T, 2001, J MOL BIOL, V312, P335, DOI 10.1006/jmbi.2001.4937; Matsuda T, 2000, NATURE, V404, P1011, DOI 10.1038/35010014; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Michaelson-Richie ED, 2010, J PROTEOME RES, V9, P4356, DOI 10.1021/pr1000835; Minko IG, 2005, BIOCHEMISTRY-US, V44, P3000, DOI 10.1021/bi0478805; Minko IG, 2002, P NATL ACAD SCI USA, V99, P1905, DOI 10.1073/pnas.042700399; Minko IG, 2008, CHEM RES TOXICOL, V21, P1983, DOI 10.1021/tx800174a; Morimoto S, 1998, BIOORG MED CHEM LETT, V8, P865, DOI 10.1016/S0960-894X(98)00124-3; Nakano T, 2007, MOL CELL, V28, P147, DOI 10.1016/j.molcel.2007.07.029; Novakova O, 2003, NUCLEIC ACIDS RES, V31, P6450, DOI 10.1093/nar/gkg863; Ohashi E, 2000, GENE DEV, V14, P1589; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; PERMANA PA, 1994, CARCINOGENESIS, V15, P1031, DOI 10.1093/carcin/15.5.1031; Quievryn G, 2000, CARCINOGENESIS, V21, P1573, DOI 10.1093/carcin/21.8.1573; Reardon JT, 2006, CELL CYCLE, V5, P1366, DOI 10.4161/cc.5.13.2892; Reardon JT, 2006, P NATL ACAD SCI USA, V103, P4056, DOI 10.1073/pnas.0600538103; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Sabo A, 2014, COLD SPRING HARB PER, V4; SMITH SS, 1992, P NATL ACAD SCI USA, V89, P4744, DOI 10.1073/pnas.89.10.4744; Stover JS, 2006, CHEM RES TOXICOL, V19, P1506, DOI 10.1021/tx0601455; Tretyakova NY, 2013, BIOCHEMISTRY-US, V52, P3171, DOI 10.1021/bi400273m; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Yamanaka K, 2011, J BACTERIOL, V193, P3815, DOI 10.1128/JB.01550-10; Yamanaka K, 2010, CHEM RES TOXICOL, V23, P689, DOI 10.1021/tx900449u; Yeo JE, 2014, ACS CHEM BIOL, V9, P1860, DOI 10.1021/cb5001795; Zahn RK, 1999, MECH AGEING DEV, V108, P99, DOI 10.1016/S0047-6374(98)00151-1; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4717, DOI 10.1093/nar/28.23.4717; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4138, DOI 10.1093/nar/28.21.4138; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zhao LL, 2012, J BIOL CHEM, V287, P35516, DOI 10.1074/jbc.M112.403253; Zhao LL, 2012, ANGEW CHEM INT EDIT, V51, P5466, DOI 10.1002/anie.201109004	74	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					775	787		10.1074/jbc.M114.613638	http://dx.doi.org/10.1074/jbc.M114.613638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25391658	hybrid, Green Published			2022-12-26	WOS:000347778200008
J	Caohuy, H; Yang, QF; Eudy, Y; Ha, TA; Xu, AE; Glover, M; Frizzell, RA; Jozwik, C; Pollard, HB				Caohuy, Hung; Yang, Qingfeng; Eudy, Yvonne; Ha, Thien-An; Xu, Andrew E.; Glover, Matthew; Frizzell, Raymond A.; Jozwik, Catherine; Pollard, Harvey B.			Activation of 3-Phosphoinositide-dependent Kinase 1 (PDK1) and Serum-and Glucocorticoid-induced Protein Kinase 1 (SGK1) by Short-chain Sphingolipid C4-ceramide Rescues the Trafficking Defect of Delta F508-Cystic Fibrosis Transmembrane Conductance Regulator (Delta F508-CFTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTIC-FIBROSIS; NATURAL CERAMIDE; ENDOCYTIC TRAFFICKING; POTENT INHIBITOR; CELL-DEATH; CFTR; PHOSPHORYLATION; 1-PHOSPHATE; CHANNELS; 3-KINASE	Cystic fibrosis (CF) is due to a folding defect in the CF transmembrane conductance regulator (CFTR) protein. The most common mutation, Delta F508, prevents CFTR from trafficking to the apical plasma membrane. Here we show that activation of the PDK1/SGK1 signaling pathway with C4-ceramide (C4-CER), a non-toxic small molecule, functionally corrects the trafficking defect in both cultured CF cells and primary epithelial cell explants from CF patients. The mechanism of C4-CER action involves a series of mutual autophosphorylation and phosphorylation events between PDK1 and SGK1. Detailed mechanistic studies indicate that C4-CER initially induces autophosphorylation of SGK1 at Ser(422). SGK1[Ser(P)(422)] and C4-CER coincidently bind PDK1 and permit PDK1 to autophosphorylate at Ser(241). Then PDK1[Ser(P)(241)] phosphorylates SGK1[Ser(P)(422)] at Thr(256) to generate fully activated SGK1[Ser(422), Thr(P)(256)]. SGK1[Ser(P)(422), Thr(P)(256)] phosphorylates and inactivates the E3 ubiquitin ligase Nedd4-2. Delta F508-CFTR is thus free to traffic to the plasma membrane. Importantly, C4-CER-mediated activation of both PDK1 and SGK1 is independent of the PI3K/Akt/mammalian target of rapamycin signaling pathway. Physiologically, C4-CER significantly increases maturation and stability of Delta F508-CFTR (t1/2 similar to 10 h), enhances cAMP-activated chloride secretion, and suppresses hypersecretion of interleukin-8 (IL-8). We suggest that candidate drugs for CF directed against the PDK1/SGK1 signaling pathway, such as C4-CER, provide a novel therapeutic strategy for a life-limiting disorder that affects one child, on average, each day.	[Caohuy, Hung; Yang, Qingfeng; Eudy, Yvonne; Ha, Thien-An; Xu, Andrew E.; Jozwik, Catherine; Pollard, Harvey B.] Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Glover, Matthew; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15224 USA	Uniformed Services University of the Health Sciences - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Caohuy, H (corresponding author), Uniformed Serv Univ Hlth Sci, Sch Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	hung.caohuy@usuhs.edu; harvey.pollard@usuhs.edu	Yang, Heroine/GRY-2630-2022		National Institutes of Health [RO1-DK-35051, NO1-HV-28187]; Cystic Fibrosis Foundation Grant [CAOHUY11G0]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Grant; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK-35051 and NO1-HV-28187 (to H. P.). This work was also supported by Cystic Fibrosis Foundation Grant CAOHUY11G0 (to H. C.).	ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Ardail D, 2002, BBA-MOL CELL BIOL L, V1583, P305, DOI 10.1016/S1388-1981(02)00252-4; Babenko N., 2010, WEBMEDCENTRAL APOPTO, V1; Bhattacharyya S, 2011, J BIOL CHEM, V286, P11604, DOI 10.1074/jbc.M110.198390; Bielawska A, 1996, J BIOL CHEM, V271, P12646, DOI 10.1074/jbc.271.21.12646; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Chen H, 2001, BIOCHEMISTRY-US, V40, P11851, DOI 10.1021/bi010743c; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Conese Massimo, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P8; Davis PB, 1996, AM J RESP CRIT CARE, V154, P1229, DOI 10.1164/ajrccm.154.5.8912731; Dechecchi MC, 2007, AM J RESP CELL MOL, V36, P615, DOI 10.1165/rcmb.2006-0200OC; EIDELMAN O, 1992, P NATL ACAD SCI USA, V89, P5562, DOI 10.1073/pnas.89.12.5562; Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; GomezMunoz A, 1997, BIOCHEM J, V325, P435, DOI 10.1042/bj3250435; Graf C, 2009, ANAL BIOCHEM, V384, P166, DOI 10.1016/j.ab.2008.09.008; Guilbault C, 2008, AM J RESP CELL MOL, V38, P47, DOI 10.1165/rcmb.2007-0036OC; Guilbault C, 2009, AM J RESP CELL MOL, V41, P100, DOI 10.1165/rcmb.2008-0279OC; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; JI L, 1995, FEBS LETT, V358, P211, DOI 10.1016/0014-5793(94)01428-4; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060118; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Pakladok T, 2013, CELL PHYSIOL BIOCHEM, V31, P785, DOI 10.1159/000350096; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pedemonte N, 2011, METHODS MOL BIOL, V741, P13, DOI 10.1007/978-1-61779-117-8_2; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Riordan JR, 1999, AM J HUM GENET, V64, P1499, DOI 10.1086/302429; Rottner M, 2007, FASEB J, V21, P2939, DOI 10.1096/fj.06-7614com; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sato JD, 2007, CELL PHYSIOL BIOCHEM, V20, P91, DOI 10.1159/000104157; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sheppard Karen E., 2012, Critical Reviews in Oncogenesis, V17, P69; Sherk AB, 2008, CANCER RES, V68, P7475, DOI 10.1158/0008-5472.CAN-08-1047; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Srivastava M, 2004, P NATL ACAD SCI USA, V101, P7693, DOI 10.1073/pnas.0402030101; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wijesinghe DS, 2009, J LIPID RES, V50, P1986, DOI 10.1194/jlr.M800367-JLR200; Yatomi Y, 1996, BIOCHEMISTRY-US, V35, P626, DOI 10.1021/bi9515533	58	20	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					35953	35968		10.1074/jbc.M114.598649	http://dx.doi.org/10.1074/jbc.M114.598649			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25384981	Green Published, hybrid			2022-12-26	WOS:000346897900026
J	Lai, PMR; Dasenbrock, H; Du, R				Lai, Pui Man Rosalind; Dasenbrock, Hormuzdiyar; Du, Rose			The Association between Meteorological Parameters and Aneurysmal Subarachnoid Hemorrhage: A Nationwide Analysis	PLOS ONE			English	Article							BLOOD-PRESSURE; VITAMIN-D; BAROMETRIC-PRESSURE; CLIMATIC CONDITIONS; SEASONAL-VARIATION; RUPTURE; TEMPERATURE; RISK; IMMUNITY; WEATHER	Prior research has suggested that regional weather patterns impact the risk of rupture of cerebral aneurysms, but the findings in the literature have been inconsistent. Furthermore, no nationwide analysis to date has examined the association between meteorological factors and the post-procedural outcomes of patients after the treatment for ruptured cerebral aneurysms. The purpose of this study was to use a nationwide sample to analyze the association between specific meteorological parameters-temperature, precipitation, sunlight, and humidity-and hospital admission rate for and outcome after aneurysmal subarachnoid hemorrhage. Patients were identified using the Nationwide Inpatient Sample (2001-2010): Those with an ICD-9 diagnosis code for subarachnoid hemorrhage and a procedural code for aneurysm repair were included. Climate data were obtained from the State of the Climate Report 2010 released by the National Climatic Data Center. Multivariate regression models were constructed to analyze the association between average state monthly temperature, precipitation, and percent possible sunlight, as well as relative morning humidity and both monthly hospital admission rate, adjusted for annual state population in millions, and in-hospital mortality. 16,970 admissions were included from 723 hospitals across 41 states. Decreased daily sunlight and lower relative humidity were associated with an increased rate of admission for ruptured cerebral aneurysms (p<0.001), but had no association with differential inpatient mortality. No significant changes in these observed associations were seen when multivariate analyses were constructed. This is the first nationwide study to suggest that decreased sunlight and lower relative humidity are associated with admission for ruptured cerebral aneurysms. While it has been postulated that external atmospheric factors may cause hormonal and homeostatic changes that impact the risk of rupture of cerebral aneurysms, additional research is needed to confirm and further understand these relationships.	[Lai, Pui Man Rosalind; Dasenbrock, Hormuzdiyar; Du, Rose] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Lai, Pui Man Rosalind; Dasenbrock, Hormuzdiyar; Du, Rose] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Du, R (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	rdu@partners.org	Lai, Rosalind/AAG-3680-2021; Du, Rose/AAJ-2873-2020; Du, Rose/I-5402-2012	Du, Rose/0000-0003-2641-6496				Abe T, 2008, J CLIN NEUROSCI, V15, P1005, DOI 10.1016/j.jocn.2007.07.081; Ali Y, 2008, CLIN NEUROL NEUROSUR, V110, P462, DOI 10.1016/j.clineuro.2008.02.001; Amrein K, 2014, CRIT CARE, V18, DOI 10.1186/cc13790; Beseoglu K, 2008, NEUROSURGERY, V62, P1033, DOI 10.1227/01.neu.0000325864.91584.c7; BRENNAN PJ, 1982, BMJ-BRIT MED J, V285, P919, DOI 10.1136/bmj.285.6346.919; Buxton N, 2001, J NEUROSURG, V95, P391, DOI 10.3171/jns.2001.95.3.0391; Chalouhi N, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/271582; CHYATTE D, 1994, J NEUROSURG, V81, P525, DOI 10.3171/jns.1994.81.4.0525; Cowperthwaite MC, 2011, NEUROSURGERY, V68, P132, DOI 10.1227/NEU.0b013e3181fe23a1; de Craen AJM, 2005, INT J GERIATR PSYCH, V20, P269, DOI 10.1002/gps.1277; Fang CW, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000842; Feigin VL, 2002, EUR J NEUROL, V9, P511, DOI 10.1046/j.1468-1331.2002.00455.x; Gill RS, 2013, WORLD NEUROSURG, V79, P136, DOI 10.1016/j.wneu.2012.06.020; Hashiguchi N, 2013, INDOOR AIR, V23, P430, DOI 10.1111/ina.12039; Hewison M, 2012, CLIN ENDOCRINOL, V76, P315, DOI 10.1111/j.1365-2265.2011.04261.x; Hughes MA, 2010, BRIT J NEUROSURG, V24, P396, DOI 10.3109/02688697.2010.499154; Inagawa T, 2000, J NEUROSURG, V93, P958, DOI 10.3171/jns.2000.93.6.0958; Jeong Tae Seok, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P152, DOI 10.7461/jcen.2013.15.3.152; Kent ST, 2013, ANN NEUROL, V73, P32, DOI 10.1002/ana.23737; Kirkness CJ, 2008, NEUROCRIT CARE, V8, P380, DOI 10.1007/s12028-007-9034-y; Koffijberg H, 2008, J NEUROL NEUROSUR PS, V79, P294, DOI 10.1136/jnnp.2007.123901; Landers AT, 1997, BRIT J NEUROSURG, V11, P191, DOI 10.1080/02688699746230; Law H. Y., 2009, Hong Kong Medical Journal, V15, P85; LEJEUNE JP, 1994, STROKE, V25, P338, DOI 10.1161/01.STR.25.2.338; Leow L, 2011, RESPIROLOGY, V16, P611, DOI 10.1111/j.1440-1843.2011.01924.x; Lindgren AE, 2014, ANN MED; Luykx JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030497; McDonald RJ, 2012, AM J NEURORADIOL, V33, P1663, DOI 10.3174/ajnr.A3059; Modesti PA, 2013, HYPERTENSION, V61, P908, DOI 10.1161/HYPERTENSIONAHA.111.00315; Muroi C, 2004, ACTA NEUROCHIR, V146, P659, DOI 10.1007/s00701-004-0278-4; Neidert MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081621; OVERLACK A, 1987, HYPERTENSION, V9, P139, DOI 10.1161/01.HYP.9.2.139; Oyoshi T, 1999, NEUROL MED-CHIR, V39, P585, DOI 10.2176/nmc.39.585; Piters WAAD, 2013, J NEUROL, V260, P614, DOI 10.1007/s00415-012-6687-z; Rostand SG, 1997, HYPERTENSION, V30, P150, DOI 10.1161/01.HYP.30.2.150; Setzer M, 2007, SURG NEUROL, V67, P264, DOI 10.1016/j.surneu.2006.06.060; Slatina Enes, 2012, Mater Sociomed, V24, P232, DOI 10.5455/msm.2012.24.232-237; Takagi H, 2005, J VASC SURG, V41, P735, DOI 10.1016/j.jvs.2005.01.011; TAKAHASHI E., 1957, HUMAN BIOL, V29, P139; Tamez H, 2013, CURR OPIN NEPHROL HY, V22, P204, DOI 10.1097/MNH.0b013e32835d919b; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; TSEMENTZIS SA, 1991, ACTA NEUROCHIR, V111, P80, DOI 10.1007/BF01400492; VINALL PE, 1994, EPIDEMIOLOGY, V5, P302, DOI 10.1097/00001648-199405000-00008; Vulekovic P, 2011, ACTA NEUROCHIR, V153, P1313, DOI 10.1007/s00701-011-1017-2	44	17	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112961	10.1371/journal.pone.0112961	http://dx.doi.org/10.1371/journal.pone.0112961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393630	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300127
J	Chen, L; Perks, KL; Stick, SM; Kicic, A; Larcombe, AN; Zosky, G				Chen, Ling; Perks, Kara L.; Stick, Stephen M.; Kicic, Anthony; Larcombe, Alexander N.; Zosky, Graeme			House Dust Mite Induced Lung Inflammation Does Not Alter Circulating Vitamin D Levels	PLOS ONE			English	Article							D DEFICIENCY; IMMUNE REGULATION; ALLERGIC-ASTHMA; DISEASE; MECHANISMS; CELLS; CHALLENGE; AIRWAYS; MODELS; MOUSE	Low circulating levels of 25-hydroxyvitaminD [25(OH)D] are associated with chronic lungDiseases such as asthma. However, it is unclear whether vitaminD is involved inDisease pathogenesis or is modified by the inflammation associated with theDisease process. We hypothesized that allergic inflammationDecreases the level of circulating 25(OH)D and tested this using a mice model of houseDust mite (HDM) induced allergic airway inflammation. Cellular influx was measured in bronchoalvelar lavage (BAL) fluid, and allergic sensitization and 25(OH)D levels were measured in serum. Exposure to HDM caused a robust inflammatory response in the lung that was enhanced by prior influenza infection. These responses were not associated with any change in circulating levels of 25(OH)D. TheseData suggest that alterations in circulating 25(OH)D levels induced by Th-2Driven inflammation are unlikely to explain the cross-sectional epidemiological association between vitaminDDeficiency and asthma.	[Chen, Ling; Zosky, Graeme] Univ Tasmania, Fac Hlth, Sch Med, Hobart, Tas, Australia; [Perks, Kara L.] Harry Perkins Inst Med Res, Nedlands, WA, Australia; [Stick, Stephen M.; Kicic, Anthony; Larcombe, Alexander N.] Univ Western Australia, Telethon Kids Inst, Subiaco, WA, Australia	University of Tasmania; Harry Perkins Institute of Medical Research; Telethon Kids Institute; University of Western Australia	Chen, L (corresponding author), Univ Tasmania, Fac Hlth, Sch Med, Hobart, Tas, Australia.	L.Chen@utas.edu.au	Larcombe, Alexander/AAG-8533-2019; Perks, Kara/O-8701-2014; Kicic, Anthony/ABA-1252-2021; Stick, Stephen/GZG-7584-2022; Zosky, Graeme/B-2048-2014; Stick, Stephen/AAA-5945-2021	Larcombe, Alexander/0000-0003-4196-4482; Kicic, Anthony/0000-0002-0008-9733; Stick, Stephen/0000-0002-5386-8482; Chen, Ling/0000-0003-1897-9264; Perks, Kara/0000-0001-5511-3844; Zosky, Graeme/0000-0001-9039-0302	NHMRC project, Australia [1042235, 1026494]	NHMRC project, Australia	This work was supported by NHMRC project grants (1042235 and 1026494), Australia (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PH, 2008, MOL CELL ENDOCRINOL, V285, P1, DOI 10.1016/j.mce.2007.12.018; BERGER U, 1988, J CLIN ENDOCR METAB, V67, P607, DOI 10.1210/jcem-67-3-607; Birrell MA, 2010, EUR RESPIR J, V36, P1220, DOI 10.1183/09031936.00069110; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, p[52, e55]; Cantorna MT, 2008, MOL ASPECTS MED, V29, P369, DOI 10.1016/j.mam.2008.04.004; Chandra P, 2007, PHOTODERMATOL PHOTO, V23, P179, DOI 10.1111/j.1600-0781.2007.00302.x; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Ding C, 2010, J INTERN MED, V268, P501, DOI 10.1111/j.1365-2796.2010.02267.x; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Duncan A, 2012, AM J CLIN NUTR, V95, P64, DOI 10.3945/ajcn.111.023812; Finklea JD, 2011, ADV NUTR, V2, P244, DOI 10.3945/an.111.000398; Foong RE, 2013, NUTRIENTS, V5, P2880, DOI 10.3390/nu5082880; Ginde AA, 2009, CURR ALLERGY ASTHM R, V9, P81, DOI 10.1007/s11882-009-0012-7; Gould HJ, 2003, ANNU REV IMMUNOL, V21, P579, DOI 10.1146/annurev.immunol.21.120601.141103; Gregory LG, 2009, CLIN EXP ALLERGY, V39, P1597, DOI 10.1111/j.1365-2222.2009.03302.x; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Horvat JC, 2010, J IMMUNOL, V184, P4159, DOI 10.4049/jimmunol.0902287; Hypponen E, 2004, ANN NY ACAD SCI, V1037, P84, DOI 10.1196/annals.1337.013; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Maezawa Y, 2004, CLIN EXP IMMUNOL, V135, P12, DOI 10.1111/j.1365-2249.2004.02337.x; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Overbergh L, 2000, CLIN EXP IMMUNOL, V120, P139, DOI 10.1046/j.1365-2249.2000.01204.x; Overbergh L, 2006, J CLIN ENDOCR METAB, V91, P3566, DOI 10.1210/jc.2006-0678; Phan JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092163; Poon AH, 2004, AM J RESP CRIT CARE, V170, P967, DOI 10.1164/rccm.200403-412oc; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Sundaram ME, 2012, ADV NUTR, V3, P517, DOI 10.3945/an.112.002162; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Zosky GR, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-15; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	32	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112589	10.1371/journal.pone.0112589	http://dx.doi.org/10.1371/journal.pone.0112589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391140	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400106
J	Feng, GD; Zhao, Y; Tian, X; Gao, ZQ				Feng, Guodong; Zhao, Yang; Tian, Xu; Gao, Zhiqiang			A New 3-Dimensional Dynamic Quantitative Analysis System of Facial Motion: An Establishment and Reliability Test	PLOS ONE			English	Article							VIDEO; EPIDEMIOLOGY	This study aimed to establish a 3-dimensional dynamic quantitative facial motion analysis system, and then determine its accuracy and test-retest reliability. The system could automatically reconstruct the motion of the observational points. Standardized T-shaped rod and L-shaped rods were used to evaluate the static and dynamic accuracy of the system. Nineteen healthy volunteers were recruited to test the reliability of the system. The average static distance error measurement was 0.19 mm, and the average angular error was 0.29 degrees. The measuring results decreased with the increase of distance between the cameras and objects, 80 cm of which was considered to be optimal. It took only 58 seconds to perform the full facial measurement process. The average intra-class correlation coefficient for distance measurement and angular measurement was 0.973 and 0.794 respectively. The results demonstrated that we successfully established a practical 3-dimensional dynamic quantitative analysis system that is accurate and reliable enough to meet both clinical and research needs.	[Gao, Zhiqiang] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Gao, ZQ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing 100730, Peoples R China.	talllee@sina.com			National Natural Science Foundation of China [81341031]; Chinese National Science & Technology Pillar Program during the 12th Five-year Plan Period [2012BAI12B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Science & Technology Pillar Program during the 12th Five-year Plan Period	This study was supported by the National Natural Science Foundation of China (Grant No. 81341031) and Chinese National Science & Technology Pillar Program during the 12th Five-year Plan Period (Grant No. 2012BAI12B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chee G H, 2000, Facial Plast Surg, V16, P315, DOI 10.1055/s-2000-15547; De Diego-Sastre JI, 2005, REV NEUROLOGIA, V41, P287, DOI 10.33588/rn.4105.2004593; Feng GD, 2012, ORL J OTO-RHINO-LARY, V74, P220, DOI 10.1159/000340045; Frey M, 1994, Eur Arch Otorhinolaryngol, pS182; Frey M, 1999, PLAST RECONSTR SURG, V104, P2032, DOI 10.1097/00006534-199912000-00013; Gao H, 2007, MARKER BASED FACIAL; Gao Y, 2014, IEEE T IND ELECTRON, V61, P2088, DOI 10.1109/TIE.2013.2262760; Gross MM, 1996, ANGLE ORTHOD, V66, P189; Hontanilla B, 2008, J PLAST RECONSTR AES, V61, P18, DOI 10.1016/j.bjps.2007.03.037; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Kang TS, 2002, OTOL NEUROTOL, V23, P767, DOI 10.1097/00129492-200209000-00026; Mehta RP, 2008, OTOLARYNG HEAD NECK, V138, P468, DOI 10.1016/j.otohns.2007.12.017; Monini S, 2010, ACTA OTORHINOLARYNGO, V30, P198; Neely JG, 2010, LARYNGOSCOPE, V120, P1038, DOI 10.1002/lary.20868; PALETZ JL, 1994, PLAST RECONSTR SURG, V93, P784, DOI 10.1097/00006534-199404000-00020; Salgado Moses D, 2010, Facial Plast Surg Clin North Am, V18, P351, DOI 10.1016/j.fsc.2010.01.011; Somia NN, 2000, CLIN BIOMECH, V15, P766, DOI 10.1016/S0268-0033(00)00062-0; Trotman CA, 1996, ANGLE ORTHOD, V66, P195; Tzou CHJ, 2012, ANN PLAS SURG, V69, P173, DOI 10.1097/SAP.0b013e3182223d96; Zhao SC, 2013, NEUROCOMPUTING, V119, P101, DOI 10.1016/j.neucom.2012.04.042	21	3	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e113115	10.1371/journal.pone.0113115	http://dx.doi.org/10.1371/journal.pone.0113115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390881	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400147
J	Hamilton, B; Manzella, A; Schmidt, K; DiMarco, V; Butler, JS				Hamilton, Brooke; Manzella, Alexander; Schmidt, Karyn; DiMarco, Victoria; Butler, J. Scott			Analysis of Non-Typeable Haemophilous influenzae VapC1 Mutations Reveals Structural Features Required for Toxicity and Flexibility in the Active Site	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; 18S RIBOSOMAL-RNA; PIN-DOMAIN; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; PLASMID MAINTENANCE; PROTEIN; CLEAVAGE; ENDONUCLEASE; RIBONUCLEASE	Bacteria have evolved mechanisms that allow them to survive in the face of a variety of stresses including nutrient deprivation, antibiotic challenge and engulfment by predator cells. A switch to dormancy represents one strategy that reduces energy utilization and can render cells resistant to compounds that kill growing bacteria. These persister cells pose a problem during treatment of infections with antibiotics, and dormancy mechanisms may contribute to latent infections. Many bacteria encode toxin-antitoxin (TA) gene pairs that play an important role in dormancy and the formation of persisters. VapBC gene pairs comprise the largest of the Type II TA systems in bacteria and they produce a VapC ribonuclease toxin whose activity is inhibited by the VapB antitoxin. Despite the importance of VapBC TA pairs in dormancy and persister formation, little information exists on the structural features of VapC proteins required for their toxic function in vivo. Studies reported here identified 17 single mutations that disrupt the function of VapC1 from non-typeable H. influenzae in vivo. 3-D modeling suggests that side chains affected by many of these mutations sit near the active site of the toxin protein. Phylogenetic comparisons and secondary mutagenesis indicate that VapC1 toxicity requires an alternative active site motif found in many proteobacteria. Expression of the antitoxin VapB1 counteracts the activity of VapC1 mutants partially defective for toxicity, indicating that the antitoxin binds these mutant proteins in vivo. These findings identify critical chemical features required for the biological function of VapC toxins and PIN-domain proteins.	[Hamilton, Brooke; Manzella, Alexander; DiMarco, Victoria; Butler, J. Scott] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Schmidt, Karyn; Butler, J. Scott] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Butler, J. Scott] Univ Rochester, Med Ctr, Ctr RNA Biol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Butler, JS (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	scott_butler@urmc.rochester.edu		Manzella, Alexander/0000-0002-9808-8498	National Institutes of Health [GM-099731]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM-099731 to JSB, http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahidjo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021738; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Anantharaman Vivek, 2006, RNA Biol, V3, P18; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Arcus VL, 2005, TRENDS MICROBIOL, V13, P360, DOI 10.1016/j.tim.2005.06.008; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; Bunker RD, 2008, PROTEINS, V72, P510, DOI 10.1002/prot.22048; Cline SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032199; Clissold PM, 2000, CURR BIOL, V10, pR888, DOI 10.1016/S0960-9822(00)00858-7; Daines DA, 2007, J BACTERIOL, V189, P5041, DOI 10.1128/JB.00290-07; Dienemann C, 2011, J MOL BIOL, V414, P713, DOI 10.1016/j.jmb.2011.10.024; Fasani RA, 2013, P NATL ACAD SCI USA, V110, pE2528, DOI 10.1073/pnas.1301023110; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; JAFFE A, 1985, J BACTERIOL, V163, P841; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lamanna AC, 2009, P NATL ACAD SCI USA, V106, P14259, DOI 10.1073/pnas.0905403106; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Mate MJ, 2012, NUCLEIC ACIDS RES, V40, P3245, DOI 10.1093/nar/gkr1167; Mattison K, 2006, J BIOL CHEM, V281, P37942, DOI 10.1074/jbc.M605198200; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; Miallau L, 2009, J BIOL CHEM, V284, P276, DOI 10.1074/jbc.M805061200; Miller J.H., 1972, EXPT MOL GENETICS; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Sharp JD, 2012, J BIOL CHEM; Takeshita D, 2007, PROTEINS, V68, P980, DOI 10.1002/prot.21351; Takeshita D, 2006, ACTA CRYSTALLOGR F, V62, P656, DOI 10.1107/S1744309106020057; van Kessel Julia C., 2008, V435, P203, DOI 10.1007/978-1-59745-232-8_15; Winther KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3796; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Zhu L, 2010, J BIOL CHEM, V285, P39732, DOI 10.1074/jbc.M110.163105	40	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112921	10.1371/journal.pone.0112921	http://dx.doi.org/10.1371/journal.pone.0112921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391136	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400142
J	Vahtera, V; Edgecombe, GD				Vahtera, Varpu; Edgecombe, Gregory D.			First Molecular Data and the Phylogenetic Position of the Millipede-Like Centipede Edentistoma octosulcatum Tomosvary, 1882 (Chilopoda: Scolopendromorpha: Scolopendridae)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MORPHOLOGY; BLOCKS	Edentistoma octosulcatum Tomosvary, 1882, is a rare, superficially millipede-like centipede known only from Borneo and the Philippines. It is unique within the order Scolopendromorpha for its slow gait, robust tergites, and highly modified gizzard and mandible morphology. Not much is known about the biology of the species but it has been speculated to be arboreal with a possibly vegetarian diet. Until now its phylogenetic position within the subfamily Otostigminae has been based only on morphological characters, being variably ranked as a monotypic tribe (Arrhabdotini) or classified with the Southeast Asian genus Sterropristes Attems, 1934. The first molecular data for E. octosulcatum sourced from a newly collected specimen from Sarawak were analysed with and without morphology. Parsimony analysis of 122 morphological characters together with two nuclear and two mitochondrial loci resolves Edentistoma as sister group to three Indo-Australian species of Rhysida, this clade in turn grouping with Ethmostigmus, whereas maximum likelihood and parsimony analyses of the molecular data on their own ally Edentistoma with species of Otostigmus. A position of Edentistoma within Otostigmini (rather than being its sister group as predicted by the Arrhabdotini hypothesis) is consistently retrieved under different analytical conditions, but support values within the subfamily remain low for most nodes. The species exhibits strong pushing behaviour, suggestive of burrowing habits. Evidence against a suggested vegetarian diet is provided by observation of E. octosulcatum feeding on millipedes in the genus Trachelomegalus.	[Vahtera, Varpu] Univ Turku, Dept Biol, Zool Museum, SF-20500 Turku, Finland; [Vahtera, Varpu] Univ Helsinki, Zool Unit, Finnish Museum Nat Hist, Helsinki, Finland; [Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	University of Turku; University of Helsinki; Natural History Museum London	Vahtera, V (corresponding author), Univ Turku, Dept Biol, Zool Museum, SF-20500 Turku, Finland.	varpu.vahtera@utu.fi		Edgecombe, Gregory/0000-0002-9591-8011; Vahtera, Varpu/0000-0002-6710-6358	University of Helsinki, Finland	University of Helsinki, Finland	Funding for the field and laboratory work as well as VV's personal salary was provided by University of Helsinki, Finland, postdoctoral research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attems CG, 1930, MYRUAPODA 2 SCOLOPEN; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgecombe GD, 2011, TREATISE ZOOLOGY ANA, V1, P392, DOI DOI 10.1163/9789004188266_; Edgecombe GD, 2012, ZOOL J LINN SOC-LOND, V166, P768, DOI 10.1111/j.1096-3642.2012.00860.x; Edgecombe Gregory D., 2009, Soil Organisms, V81, P295; Edgecombe GD, 2008, CLADISTICS, V24, P872, DOI 10.1111/j.1096-0031.2008.00220.x; Farris JS, 1996, CLADISTICS, V12, P99, DOI 10.1111/j.1096-0031.1996.tb00196.x; Hazebroek HP, 2002, GUIDE GUNUNG MULU NA; Joshi J, 2011, MOL PHYLOGENET EVOL, V60, P287, DOI 10.1016/j.ympev.2011.04.024; Koch Markus, 2010, International Journal of Myriapodology, V3, P51, DOI 10.1163/187525410X12578602960344; Koch M, 2009, ZOOL SCR, V38, P269, DOI 10.1111/j.1463-6409.2008.00372.x; LEWIS J G E, 1981, Entomologist's Monthly Magazine, V117, P245; Lewis J. G. E., 1981, BIOL CENTIPEDES; Manton S. M., 1965, Journal of the Linnean Society London Zoology, V46, P251; Miller M.A., 2010, P GAT COMP ENV WORKS; MINELLI A, 2006, CHILOBASE WEB RESOUR; Muadsub S, 2012, ZOOTAXA, P35; Schileyko AA, 1997, ENTOMOL SCAND, P33; Schileyko Arkadiy A., 1992, Arthropoda Selecta, V1, P5; Stamatakis A, 2014, BIOINFORMATICS; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Vahtera V, 2013, INVERTEBR SYST, V27, P578, DOI 10.1071/IS13035; Vahtera V, 2012, ZOOMORPHOLOGY, V131, P225, DOI 10.1007/s00435-012-0157-0; Vahtera V, 2012, CLADISTICS, V28, P4, DOI 10.1111/j.1096-0031.2011.00361.x; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Wheeler WC, 2014, POY VERSION 5 PHYLOG	29	7	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112461	10.1371/journal.pone.0112461	http://dx.doi.org/10.1371/journal.pone.0112461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389773	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400083
J	Wang, WY; Komatsu, K; Huang, YX; Wu, J; Zhang, WH; Lee, JY; Miyata, M; Xu, HD; Li, JD				Wang, Wenzhuo Y.; Komatsu, Kensei; Huang, Yuxian; Wu, Jing; Zhang, Wenhong; Lee, Ji-Yun; Miyata, Masanori; Xu, Haidong; Li, Jian-Dong			CYLD Negatively Regulates Nontypeable Haemophilus influenzae-Induced IL-8 Expression via Phosphatase MKP-1-Dependent Inhibition of ERK	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-SUPPRESSOR CYLD; STREPTOCOCCUS-PNEUMONIAE; SIGNALING PATHWAYS; IMMUNE-RESPONSE; KINASE PATHWAY; UP-REGULATION; OTITIS-MEDIA; INFLAMMATION; PROTEIN	Nontypeable Haemophilus influenzae (NTHi), a Gram-negative bacterium, is the primary cause of otitis media in children and the exacerbation of chronic obstructive pulmonary disease in adults. A hallmark of both diseases is an overactive inflammatory response, including the upregulation of chemokines, such as interleukin-8 (IL-8). An appropriate inflammatory response is essential for eradicating pathogens. However, excessive inflammation can cause host tissue damage. Therefore, expression of IL-8 must be tightly regulated. We previously reported that NTHi induces IL-8 expression in an ERK-dependent manner. We also have shown that the deubiquitinase cylindromatosis (CYLD) suppresses NTHi-induced inflammation. However, the underlying molecular mechanism of how CYLD negatively regulates ERK-mediated IL-8 production is largely unknown. Here, we examine both human lung epithelial A549 cells and lung of Cyld(-/-) mice to show that CYLD specifically targets the activation of ERK. Interestingly, CYLD enhances NTHi-induced upregulation of another negative regulator, MAP Kinase Phosphatase-1 (MKP-1), which, in turn, leads to reduced ERK activation and subsequent suppression of IL-8. Taken together, the CYLD suppression of ERK-dependent IL-8 via MKP-1 may bring novel insights into the tight regulation of inflammatory responses and also lead to innovative therapeutic strategies for controlling these responses by targeting key negative regulators of inflammation.	[Wang, Wenzhuo Y.; Komatsu, Kensei; Lee, Ji-Yun; Miyata, Masanori; Xu, Haidong; Li, Jian-Dong] Georgia State Univ, Ctr Inflammat Immun & Infect, Inst Biomed Sci, Atlanta, GA 30303 USA; [Wang, Wenzhuo Y.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Huang, Yuxian; Wu, Jing; Zhang, Wenhong] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Huang, Yuxian] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Viral Hepatitis, Shanghai 200433, Peoples R China	University System of Georgia; Georgia State University; University of Rochester; Fudan University; Fudan University	Huang, YX (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	yxhuang@fudan.edu.cn; jdli@gsu.edu	Wu, Jing/GQI-1843-2022; Komatsu, Kensei/AAO-6492-2021	Wu, Jing/0000-0002-1224-0912; Li, Jian-Dong/0000-0002-5593-050X; Komatsu, Kensei/0000-0001-7418-3805	National Institutes of Health [DC005843, DC004562, GM107529]; National Natural Science Foundation of China [30972635]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004562, R01DC013833, R01DC005843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institutes of Health (http://www.nih.gov) DC005843, DC004562 and GM107529 to J. D. L., and National Natural Science Foundation of China (http://www.nsfc.gov.cn) 30972635 to Y. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SM, 2006, BIOCHEM SOC T, V34, P1018, DOI 10.1042/BST0341018; [Anonymous], BIOESSAYS, V34, P142; Arguedas A, 2010, INT J PEDIATR OTORHI, V74, P1419, DOI 10.1016/j.ijporl.2010.09.022; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chartrand SA, 1998, PEDIATR ANN, V27, P86, DOI 10.3928/0090-4481-19980201-06; Comalada M, 2012, EUR J IMMUNOL, V42, P1938, DOI 10.1002/eji.201242441; de Oliveira S, 2013, J IMMUNOL, V190, P4349, DOI 10.4049/jimmunol.1203266; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Gates GA, 1996, OTOLARYNG HEAD NECK, V114, P525, DOI 10.1016/S0194-5998(96)70243-7; Ito M, 2010, INT J PEDIATR OTORHI, V74, P901, DOI 10.1016/j.ijporl.2010.05.008; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Koga T, 2008, J BIOL CHEM, V283, P12546, DOI 10.1074/jbc.M710518200; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2674; Komatsu K, 2008, BIOCHEM BIOPH RES CO, V377, P763, DOI 10.1016/j.bbrc.2008.10.091; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lim JH, 2007, IMMUNITY, V27, P349, DOI 10.1016/j.immuni.2007.07.011; Lim JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1776; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; McCullough SD, 2014, AM J RESP CELL MOL B; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Minino Arialdi M, 2002, Natl Vital Stat Rep, V50, P1; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Pannem RR, 2014, CARCINOGENESIS, V35, P461, DOI 10.1093/carcin/bgt335; Poulikakos PI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001948; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rubinstein AL, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-34; Sakai A, 2007, FEBS J, V274, P3655, DOI 10.1111/j.1742-4658.2007.05899.x; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wancket LM, 2012, LIFE SCI, V90, P237, DOI 10.1016/j.lfs.2011.11.017; Wang BN, 2003, INFECT IMMUN, V71, P5523, DOI 10.1128/IAI.71.10.5523-5530.2003; Wang BN, 2002, J BIOL CHEM, V277, P949, DOI 10.1074/jbc.M107484200; Wang WZY, 2012, CELL MOL IMMUNOL, V9, P131, DOI 10.1038/cmi.2011.65; Yoshida H, 2005, J BIOL CHEM, V280, P41111, DOI 10.1074/jbc.M509526200	44	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112516	10.1371/journal.pone.0112516	http://dx.doi.org/10.1371/journal.pone.0112516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389768	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400089
J	Underhill, K; Morrow, KM; Colleran, CM; Holcomb, R; Operario, D; Calabrese, SK; Galarraga, O; Mayer, KH				Underhill, Kristen; Morrow, Kathleen M.; Colleran, Christopher M.; Holcomb, Richard; Operario, Don; Calabrese, Sarah K.; Galarraga, Omar; Mayer, Kenneth H.			Access to Healthcare, HIV/STI Testing, and Preferred Pre-Exposure Prophylaxis Providers among Men Who Have Sex with Men and Men Who Engage in Street-Based Sex Work in the US	PLOS ONE			English	Article							HIV PREVENTION; ANTIRETROVIRAL PROPHYLAXIS; INTERIM GUIDANCE; YOUNG MEN; QUALITATIVE RESEARCH; PREP ACCEPTABILITY; LIMITED KNOWLEDGE; UNITED-STATES; BISEXUAL MEN; CONDOM-USE	Background: Pre-exposure prophylaxis (PrEP) is a promising strategy for HIV prevention among men who have sex with men (MSM) and men who engage in sex work. But access will require routine HIV testing and contacts with healthcare providers. This study investigated men's healthcare and HIV testing experiences to inform PrEP implementation. Methods: We conducted 8 focus groups (n = 38) in 2012 and 56 in-depth qualitative interviews in 2013-14 with male sex workers (MSWs) (n = 31) and other MSM (n = 25) in Providence, RI. MSWs primarily met clients in street-based sex work venues. Facilitators asked participants about access to healthcare and HIV/STI testing, healthcare needs, and preferred PrEP providers. Results: MSWs primarily accessed care in emergency rooms (ERs), substance use clinics, correctional institutions, and walk-in clinics. Rates of HIV testing were high, but MSWs reported low access to other STI testing, low insurance coverage, and unmet healthcare needs including primary care, substance use treatment, and mental health services. MSM not engaging in sex work were more likely to report access to primary and specialist care. Rates of HIV testing among these MSM were slightly lower, but they reported more STI testing, more insurance coverage, and fewer unmet needs. Preferred PrEP providers for both groups included primary care physicians, infectious disease specialists, and psychiatrists. MSWs were also willing to access PrEP in substance use treatment and ER settings. Conclusions: PrEP outreach efforts for MSWs and other MSM should engage diverse providers in many settings, including mental health and substance use treatment, ERs, needle exchanges, correctional institutions, and HIV testing centers. Access to PrEP will require financial assistance, but can build on existing healthcare contacts for both populations.	[Underhill, Kristen] Yale Univ, Yale Law Sch, Yale Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA; [Morrow, Kathleen M.; Colleran, Christopher M.] Miriam Hosp, Centers Behav & Prevent Med, Providence, RI 02906 USA; [Holcomb, Richard] Project Weber, Providence, RI USA; [Operario, Don; Galarraga, Omar] Brown Univ, Sch Publ Hlth, Providence, RI 02912 USA; [Calabrese, Sarah K.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA USA	Yale University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Yale University; Fenway Health	Underhill, K (corresponding author), Yale Univ, Yale Law Sch, Yale Ctr Interdisciplinary Res AIDS, New Haven, CT 06520 USA.	kristen.underhill@yale.edu	Galarraga, Omar/N-1622-2019	Galarraga, Omar/0000-0002-9985-9266	National Institute of Mental Health [5K01MH093273]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R25HD045810, K24HD062645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020031, K01MH093273, K01MH103080, P30MH062294] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institute of Mental Health, #5K01MH093273 (PI: Underhill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NVIVO 9; [Anonymous], MMWR; Awad GH, 2004, AIDS EDUC PREV, V16, P115, DOI 10.1521/aeap.16.2.115.29397; Bacon O, 2006, SEX TRANSM DIS, V33, P228, DOI 10.1097/01.olq.0000204914.91923.ad; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Ballester-Arnal R, 2014, CURR HIV-AIDS REP, V11, P72, DOI 10.1007/s11904-013-0195-3; Baral SD, 2014, LANCET; Bernstein KT, 2008, ARCH INTERN MED, V168, P1458, DOI 10.1001/archinte.168.13.1458; Beyrer C, 2012, LANCET, V380, P424, DOI 10.1016/S0140-6736(12)61022-8; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brooks RA, 2012, AIDS PATIENT CARE ST, V26, P87, DOI 10.1089/apc.2011.0283; Brooks RA, 2011, AIDS CARE, V23, P1136, DOI 10.1080/09540121.2011.554528; Brunsberg SA, 2012, SEX RES SOC POLICY, V9, P125, DOI 10.1007/s13178-012-0085-2; Bush S, 2014, 9 INT C HIV TREATM P; CDC, 2010, PREL RES 1 SAF STUD; CDC, 2011, CDC FACT SHEET HIV A; Centers for Disease Control and Prevention, 2021, PREEXP PROPH PREV HI; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohan D, 2006, SEX TRANSM INFECT, V82, P418, DOI 10.1136/sti.2006.020628; Cohen RA, 2014, HLTH INSURANCE COVER; Denzin N.K., 2005, HDB QUALITATIVE RES, P1, DOI DOI 10.1017/CBO9781107415324.004; Edelstein Z, 2014, 9 INT C HIV TREATM P, P494; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Food and Drug Administration, 2012, TRUV PREP FACT SHEET; Galea JT, 2011, INT J STD AIDS, V22, P256, DOI 10.1258/ijsa.2009.009255; Gilead Sciences Inc, 2013, TRUVADA PREEXP PROPH; Gilead Sciences Inc, 2012, TRUV RISK EV MIT STR; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grov C, 2014, SEX RES SOC POLICY, V11, P176, DOI 10.1007/s13178-014-0151-z; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Horberg M, 2013, AM J PREV MED, V44, pS125, DOI 10.1016/j.amepre.2012.09.039; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Hosek SG, 2013, JAIDS-J ACQ IMM DEF, V62, P447, DOI 10.1097/QAI.0b013e3182801081; Kaiser Family Foundation, 2014, AV SINGL PREM ENR EM; Kaiser Family Foundation, 2014, AV PERS MONTHL PREM; Kempf M.C., 2020, WEEXPAND PREP DEMONS; Koblin BA, 2011, JAIDS-J ACQ IMM DEF, V58, P319, DOI 10.1097/QAI.0b013e31822b76d2; Koester KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071546; Krakower D, 2014, AIDS BEHAV, V18, P1712, DOI 10.1007/s10461-014-0839-3; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Lankenau SE, 2005, INT J DRUG POLICY, V16, P10, DOI 10.1016/j.drugpo.2004.07.006; Liu A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001613; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Mansergh G, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001286; McKinnon LR, 2014, SEX TRANSM INFECT, V90, P237, DOI 10.1136/sextrans-2013-051310; McKirnan DJ, 2013, HEALTH EDUC BEHAV, V40, P32, DOI 10.1177/1090198111436340; Mera RM, 2013, 53 INT C ANT AG CHEM; Mimiaga MJ, 2007, SEX TRANSM DIS, V34, P113, DOI 10.1097/01.olq.0000225327.13214.bf; Mimiaga MJ, 2009, J URBAN HEALTH, V86, P54, DOI 10.1007/s11524-008-9316-5; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Newman PA, 2004, AM J PUBLIC HEALTH, V94, P1998, DOI 10.2105/AJPH.94.11.1998; Oster Alexandra M., 2011, Morbidity and Mortality Weekly Report, V60, P694; Patel V, 2014, 9 INT C HIV TREATM P; Ponterotto JG, 2005, J COUNS PSYCHOL, V52, P126, DOI 10.1037/0022-0167.52.2.126; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P353, DOI 10.1097/00007435-199808000-00006; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Santos GM, 2013, JAIDS-J ACQ IMM DEF, V63, pE167, DOI 10.1097/QAI.0b013e318294de80; Scott J, 2005, J INTERPERS VIOLENCE, V20, P320, DOI 10.1177/0886260504270334; Smith D. K., 2012, Morbidity and Mortality Weekly Report, V61, P586; Smith DK, 2013, MMWR-MORBID MORTAL W, V62, P463; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Underhill K, 2012, AM PUBL HLTH ASS 140; Underhill K, 2014, AM PUBL HLTH ASS 142; Underhill K, 2012, 19 INT AIDS C WASH D; Underhill K, 2014, 2014 NAT STD PREV C; Underhill K, 2014, 9 INT C HIV TREATM P; Underhill K, 2014, AIDS BEHAV, V18, P241, DOI 10.1007/s10461-013-0498-9; Underhill K, 2012, AM J LAW MED, V38, P607, DOI 10.1177/009885881203800402; Underhill K, 2010, JAIDS-J ACQ IMM DEF, V55, P8, DOI 10.1097/QAI.0b013e3181e8efe4; Williams ML, 2006, AIDS EDUC PREV, V18, P204, DOI 10.1521/aeap.2006.18.3.204; Wingood GM, 2013, JAIDS-J ACQ IMM DEF, V63, pS95, DOI 10.1097/QAI.0b013e3182920126; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7	76	56	56	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112425	10.1371/journal.pone.0112425	http://dx.doi.org/10.1371/journal.pone.0112425			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AT9MC	25386746	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400060
J	Camilo, LM; Avila, MB; Cruz, LFS; Ribeiro, GCM; Spieth, PM; Reske, AA; Amato, M; Giannella-Neto, A; Zin, WA; Carvalho, AR				Camilo, Luciana M.; Avila, Mariana B.; Cruz, Luis Felipe S.; Ribeiro, Gabriel C. M.; Spieth, Peter M.; Reske, Andreas A.; Amato, Marcelo; Giannella-Neto, Antonio; Zin, Walter A.; Carvalho, Alysson R.			Positive End-Expiratory Pressure and Variable Ventilation in Lung-Healthy Rats under General Anesthesia	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; LEFT-VENTRICULAR PERFORMANCE; PROTECTIVE MECHANICAL VENTILATION; TIDAL VOLUMES; GAS-EXCHANGE; ATELECTASIS FORMATION; ARTERIAL OXYGENATION; ABDOMINAL-SURGERY; PORCINE MODEL; INJURY	Objectives: Variable ventilation (VV) seems to improve respiratory function in acute lung injury and may be combined with positive end-expiratory pressure (PEEP) in order to protect the lungs even in healthy subjects. We hypothesized that VV in combination with moderate levels of PEEP reduce the deterioration of pulmonary function related to general anesthesia. Hence, we aimed at evaluating the alveolar stability and lung protection of the combination of VV at different PEEP levels. Design: Randomized experimental study. Setting: Animal research facility. Subjects: Forty-nine male Wistar rats (200-270 g). Interventions: Animals were ventilated during 2 hours with protective low tidal volume (VT) in volume control ventilation (VCV) or VV and PEEP adjusted at the level of minimum respiratory system elastance (Ers), obtained during a decremental PEEP trial subsequent to a recruitment maneuver, and 2 cmH(2)O above or below of this level. Measurements and Main Results: Ers, gas exchange and hemodynamic variables were measured. Cytokines were determined in lung homogenate and plasma samples and left lung was used for histologic analysis and diffuse alveolar damage scoring. A progressive time-dependent increase in Ers was observed independent on ventilatory mode or PEEP level. Despite of that, the rate of increase of Ers and lung tissue IL-1 beta concentration were significantly lower in VV than in VCV at the level of the PEEP of minimum Ers. A significant increase in lung tissue cytokines (IL-6, IL-1 beta, CINC-1 and TNFalpha) as well as a ventral to dorsal and cranial to caudal reduction in aeration was observed in all ventilated rats with no significant differences among groups. Conclusions: VV combined with PEEP adjusted at the level of the PEEP of minimal Ers seemed to better prevent anesthesia-induced atelectasis and might improve lung protection throughout general anesthesia.	[Camilo, Luciana M.; Avila, Mariana B.; Cruz, Luis Felipe S.; Zin, Walter A.; Carvalho, Alysson R.] Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Lab Resp Physiol, BR-21941901 Rio De Janeiro, Brazil; [Ribeiro, Gabriel C. M.; Carvalho, Alysson R.] Univ Fed Rio de Janeiro, Alberto Luis Coimbra Inst Postgrad & Res Engn, Biomed Engn Program, Lab Pulm Engn, Rio De Janeiro, Brazil; [Spieth, Peter M.] Tech Univ Dresden, Dept Anesthesiol & Intens Care Med, Pulm Engn Grp, Dresden, Germany; [Reske, Andreas A.] Univ Leipzig, Dept Anesthesiol & Intens Care Med, D-04109 Leipzig, Germany; [Amato, Marcelo] Univ Sao Paulo, Hosp Clin, Div Pulm, Cardio Pulm Dept, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Technische Universitat Dresden; Leipzig University; Universidade de Sao Paulo	Carvalho, AR (corresponding author), Univ Fed Rio de Janeiro, Carlos Chagas Filho Inst Biophys, Lab Resp Physiol, BR-21941901 Rio De Janeiro, Brazil.	acarvalho@biof.ufrj.br	Carvalho, Alysson/AAF-1022-2019; Spieth, Peter/C-2928-2011; Avila, Mariana/ABH-1358-2021; CAMILO, LUCIANA MOISES/W-7144-2019; Ribeiro, Gabriel Motta/AAG-7479-2020; Reske, Andreas W/E-8141-2010; Zin, Walter A/H-8220-2013	Ribeiro, Gabriel Motta/0000-0001-5982-8863; Reske, Andreas W/0000-0002-2759-0245; Zin, Walter A/0000-0001-8226-9123; Spieth, Peter/0000-0003-3953-3253; Carvalho, Alysson/0000-0003-2708-7735	Brazilian Council for Scientific and Technological Development (CNPq); Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation (FAPERJ)	Brazilian Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The work was supported by grants from the Brazilian Council for Scientific and Technological Development (CNPq) and Carlos Chagas Filho Rio de Janeiro State Research Supporting Foundation (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellardine CL, 2006, CRIT CARE MED, V34, P439, DOI 10.1097/01.CCM.0000196208.01682.87; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; Boker A, 2004, ANESTHESIOLOGY, V100, P608, DOI 10.1097/00000542-200403000-00022; Boker A, 2002, AM J RESP CRIT CARE, V165, P456, DOI 10.1164/ajrccm.165.4.2108006; Carvalho AR, 2013, ANESTH ANALG, V116, P677, DOI 10.1213/ANE.0b013e318254230b; Carvalho ARS, 2006, CRIT CARE, V10, DOI 10.1186/cc5030; Do Anesthesia H, 2013, ANESTHESIOLOGY; Duggan M, 2005, ANESTHESIOLOGY, V102, P838, DOI 10.1097/00000542-200504000-00021; Duggan M, 2007, CURR OPIN ANESTHESIO, V20, P37, DOI 10.1097/ACO.0b013e328011d7e5; Frank JA, 2008, THORAX, V63, P147, DOI 10.1136/thx.2007.079608; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Hedenstierna G, 2000, J CLIN MONITOR COMP, V16, P329, DOI 10.1023/A:1011491231934; Hedenstierna G, 2000, Minerva Anestesiol, V66, P293; Hedenstierna G, 2012, COMPR PHYSIOL, V2, P69, DOI 10.1002/cphy.c080111; HUEMER G, 1994, CHEST, V106, P67, DOI 10.1378/chest.106.1.67; Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104; Imberger G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007922.pub2; Jaber S, 2012, ANAESTHESIA, V67, P999, DOI 10.1111/j.1365-2044.2012.07218.x; JARDIN F, 1981, NEW ENGL J MED, V304, P387, DOI 10.1056/NEJM198102123040703; Kowalski S, 2013, CAN J ANESTH, V60, P502, DOI 10.1007/s12630-013-9899-5; Krebs J, 2011, RESP PHYSIOL NEUROBI, V178, P323, DOI 10.1016/j.resp.2011.07.006; Kumar A, 1973, Crit Care Med, V1, P181, DOI 10.1097/00003246-197307000-00001; LUTCH JS, 1972, ANN INTERN MED, V76, P193, DOI 10.7326/0003-4819-76-2-193; Ma BS, 2011, J APPL PHYSIOL, V110, P1319, DOI 10.1152/japplphysiol.01364.2010; MEAD J, 1970, J APPL PHYSIOL, V28, P596, DOI 10.1152/jappl.1970.28.5.596; Mead J, 1959, J APPL PHYSL; Mutch WAC, 2000, BRIT J ANAESTH, V84, P197, DOI 10.1093/oxfordjournals.bja.a013403; Mutch WAC, 2000, CRIT CARE MED, V28, P2457, DOI 10.1097/00003246-200007000-00045; NEIDHART PP, 1988, INTENS CARE MED, V14, P471; Neumann P, 1998, J APPL PHYSIOL, V85, P1533, DOI 10.1152/jappl.1998.85.4.1533; Ng CSH, 2009, CRIT CARE, V13, DOI 10.1186/cc7719; Pecchiari M, 2013, ANESTHESIOLOGY; ROBOTHAM JL, 1980, AM REV RESPIR DIS, V121, P677; Rothen HU, 1999, BRIT J ANAESTH, V82, P551, DOI 10.1093/bja/82.4.551; Rothen HU, 1998, BRIT J ANAESTH, V81, P681, DOI 10.1093/bja/81.5.681; Rouby JJ, 2007, CRIT CARE, V11, DOI 10.1186/cc6183; Rusca M, 2003, ANESTH ANALG, V97, P1835, DOI 10.1213/01.ANE.0000087042.02266.F6; SANTOS RLB, 1992, J APPL PHYSIOL, V72, P1985, DOI 10.1152/jappl.1992.72.5.1985; SEEGER W, 1993, EUR RESPIR J, V6, P971; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; Shimabukuro DW, 2009, ANESTHESIOLOGY, V110, P214, DOI 10.1097/ALN.0b013e3181945b63; Spieth PM, 2007, INTENS CARE MED, V33, P308, DOI 10.1007/s00134-006-0428-7; Spieth PM, 2009, AM J RESP CRIT CARE, V179, P684, DOI 10.1164/rccm.200806-975OC; Suki B, 1998, NATURE, V393, P127, DOI 10.1038/30130; SUTER PM, 1975, NEW ENGL J MED, V292, P284, DOI 10.1056/NEJM197502062920604; Thammanomai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053934; TOBIN MJ, 1983, CHEST, V84, P286, DOI 10.1378/chest.84.3.286; Vassilakopoulos T, 2008, CRIT CARE MED, V36, P1009, DOI 10.1097/CCM.0B013E3181650592; Vlahakis NE, 2000, J APPL PHYSIOL, V89, P2490, DOI 10.1152/jappl.2000.89.6.2490; WALLIS TW, 1983, J APPL PHYSIOL, V54, P1039, DOI 10.1152/jappl.1983.54.4.1039; Wolff G, 1992, POLYMORPHOUS VENTILA, P235; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860	53	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110817	10.1371/journal.pone.0110817	http://dx.doi.org/10.1371/journal.pone.0110817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383882	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700011
J	Selvik, LKM; Rao, S; Steigedal, TS; Haltbakk, I; Misund, K; Bruland, T; Prestvik, WS; Laegreid, A; Thommesen, L				Selvik, Linn-Karina M.; Rao, Shalini; Steigedal, Tonje S.; Haltbakk, Ildri; Misund, Kristine; Bruland, Torunn; Prestvik, Wenche S.; Laegreid, Astrid; Thommesen, Liv			Salt-Inducible Kinase 1 (SIK1) Is Induced by Gastrin and Inhibits Migration of Gastric Adenocarcinoma Cells	PLOS ONE			English	Article							C-FOS GENE; ADRENOCORTICAL TUMOR-CELLS; BREAST-CANCER; MOLECULAR MECHANISMS; SIGNALING PATHWAYS; EPITHELIAL-CELLS; CLASS IIHDAC; AGS CELLS; EXPRESSION; TRANSCRIPTION	Salt-inducible kinase 1 (SIK1/Snf1lk) belongs to the AMP-activated protein kinase (AMPK) family of kinases, all of which play major roles in regulating metabolism and cell growth. Recent studies have shown that reduced levels of SIK1 are associated with poor outcome in cancers, and that this involves an invasive cellular phenotype with increased metastatic potential. However, the molecular mechanism(s) regulated by SIK1 in cancer cells is not well explored. The peptide hormone gastrin regulates cellular processes involved in oncogenesis, including proliferation, apoptosis, migration and invasion. The aim of this study was to examine the role of SIK1 in gastrin responsive adenocarcinoma cell lines AR42J, AGS-G(R) and MKN45. We show that gastrin, known to signal through the Gq/G(11)-coupled CCK2 receptor, induces SIK1 expression in adenocarcinoma cells, and that transcriptional activation of SIK1 is negatively regulated by the Inducible cAMP early repressor (ICER). We demonstrate that gastrin-mediated signalling induces phosphorylation of Liver Kinase 1B (LKB1) Ser-428 and SIK1 Thr-182. Ectopic expression of SIK1 increases gastrin-induced phosphorylation of histone deacetylase 4 (HDAC4) and enhances gastrin-induced transcription of c-fos and CRE-, SRE-, AP1-and NF-kappa B-driven luciferase reporter plasmids. We also show that gastrin induces phosphorylation and nuclear export of HDACs. Next we find that siRNA mediated knockdown of SIK1 increases migration of the gastric adenocarcinoma cell line AGS-G(R). Evidence provided here demonstrates that SIK1 is regulated by gastrin and influences gastrin elicited signalling in gastric adenocarcinoma cells. The results from the present study are relevant for the understanding of molecular mechanisms involved in gastric adenocarcinomas.	[Selvik, Linn-Karina M.; Rao, Shalini; Steigedal, Tonje S.; Haltbakk, Ildri; Misund, Kristine; Bruland, Torunn; Laegreid, Astrid] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Trondheim, Norway; [Selvik, Linn-Karina M.; Rao, Shalini; Prestvik, Wenche S.; Thommesen, Liv] Sor Trondelag Univ Coll, Dept Technol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Thommesen, L (corresponding author), Sor Trondelag Univ Coll, Dept Technol, Trondheim, Norway.	Liv.Thommesen@ntnu.no	Bluland, Torunn/AAT-5730-2021	Steigedal, Tonje S./0000-0002-8427-0117; Bruland, Torunn/0000-0002-1568-2476	Norwegian Cancer Association; Cancer Fund at St. Olavs Hospital, Trondheim, Norway	Norwegian Cancer Association; Cancer Fund at St. Olavs Hospital, Trondheim, Norway	This work was supported by the Norwegian Cancer Association and the Cancer Fund at St. Olavs Hospital, Trondheim, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Finsterwald C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054545; Fjeldbo CS, 2012, AM J PHYSIOL-GASTR L, V302, pG21, DOI 10.1152/ajpgi.00197.2011; Fu A, 2008, CELL CYCLE, V7, P3823, DOI 10.4161/cc.7.24.7241; Kanyo R, 2009, ENDOCRINOLOGY; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Khan ZE, 2003, GASTROENTEROLOGY, V125, P510, DOI 10.1016/S0016-5085(03)00908-9; Kinoshita Y, 1998, GASTROENTEROLOGY, V115, P93, DOI 10.1016/S0016-5085(98)70369-5; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kowanetz M, 2008, J CELL BIOL, V182, P655, DOI 10.1083/jcb.200804107; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Lin XZ, 2001, MOL ENDOCRINOL, V15, P1264, DOI 10.1210/me.15.8.1264; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Misund K, 2007, J CELL BIOCHEM, V101, P1532, DOI 10.1002/jcb.21267; Misund K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076234; Mousses S, 2003, GENOME RES, V13, P2341, DOI 10.1101/gr.1478703; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Noble PJM, 2003, AM J PHYSIOL-GASTR L, V284, pG75, DOI 10.1152/ajpgi.00300.2002; Norsett KG, 2011, AM J PHYSIOL-GASTR L, V301, pG446, DOI 10.1152/ajpgi.00527.2010; Pan XF, 2005, BIOCHEM BIOPH RES CO, V337, P1052, DOI 10.1016/j.bbrc.2005.09.155; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; Seternes OM, 1998, BBA-GENE STRUCT EXPR, V1395, P345, DOI 10.1016/S0167-4781(97)00189-9; SEVA C, 1994, REGUL PEPTIDES, V52, P31, DOI 10.1016/0167-0115(94)90018-3; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Steigedal TS, 2007, AM J PHYSIOL-GASTR L, V292, pG1062, DOI 10.1152/ajpgi.00287.2006; Steigedal TS, 2013, IN VITRO CELL DEV-AN, V49, P162, DOI 10.1007/s11626-013-9588-2; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Thommesen L, 2000, J BIOL CHEM, V275, P4244, DOI 10.1074/jbc.275.6.4244; Thommesen L, 2001, AM J PHYSIOL-ENDOC M, V281, pE1316, DOI 10.1152/ajpendo.2001.281.6.E1316; Todisco A, 2001, AM J PHYSIOL-GASTR L, V280, pG298, DOI 10.1152/ajpgi.2001.280.2.G298; Todisco A, 1997, AM J PHYSIOL-GASTR L, V273, pG891, DOI 10.1152/ajpgi.1997.273.4.G891; Tomita H, 2011, GASTROENTEROLOGY, V140, P879, DOI 10.1053/j.gastro.2010.11.037; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Varro A, 2002, GASTROENTEROLOGY, V123, P271, DOI 10.1053/gast.2002.34162; Varro A, 2002, GUT, V50, P827, DOI 10.1136/gut.50.6.827; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Watson F, 2001, J BIOL CHEM, V276, P7661, DOI 10.1074/jbc.M006697200; WHALEY PD, 1995, ENDOCRINOLOGY, V136, P3046, DOI 10.1210/en.136.7.3046; Wroblewski LE, 2002, BIOCHEM J, V365, P873, DOI 10.1042/BJ20020068; ZHOU QJ, 1995, J VIROL, V69, P4323, DOI 10.1128/JVI.69.7.4323-4330.1995; Zhuang ZG, 2006, MOL CANCER RES, V4, P843, DOI 10.1158/1541-7786.MCR-06-0118; Zhuang Zhi-Gang, 2007, Zhonghua Yi Xue Za Zhi, V87, P81	51	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112485	10.1371/journal.pone.0112485	http://dx.doi.org/10.1371/journal.pone.0112485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384047	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700068
J	Akhter, F; Khan, MS; Singh, S; Ahmad, S				Akhter, Firoz; Khan, M. Salman; Singh, Sarika; Ahmad, Saheem			An Immunohistochemical Analysis to Validate the Rationale behind the Enhanced Immunogenicity of D-Ribosylated Low Density Lipo-Protein	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; INTIMA-MEDIA THICKNESS; IMMUNE-COMPLEXES; HUMAN DNA; AUTOIMMUNE-RESPONSE; MODIFIED LDL; LIPOPROTEIN; SUPEROXIDE; ANTIBODIES; RECOGNITION	Advanced glycation end products (AGEs) are thought to contribute to the abnormal lipoprotein profiles and increased risk of cardiovascular disease in patients with diabetes and renal failure. D-ribose is one of the naturally occurring pentose monosaccharide present in all living cells and is a key component of numerous biomolecules involved in many important metabolic pathways. Formation of D-ribose derived glycated low density lipoprotein (LDL) has been previously demonstrated but no studies have been performed to assess the immune complex deposition in the kidney of rabbits immunized with glycated LDL. In this study, LDL was glycated with D-ribose, and it was further used as an immunogen for immunizing NZW female rabbits. The results showed that female rabbits immunized with D-ribose modified LDL induced antibodies as detected by direct binding and competitive ELISA. The modified LDL was found to be highly immunogenic eliciting high titer immunogen-specific antibodies, while the native forms were moderately immunogenic. The induced antibodies from modified LDL exhibited wide range of heterogeneity in recognizing various proteins and amino acids conformers. Furthermore, our histopathological results illustrated the deposits of immune complex in glomerular basement membrane in rabbits immunized with D-ribose-LDL.	[Akhter, Firoz] Integral Univ, Dept Bioengn, Lucknow, Uttar Pradesh, India; [Akhter, Firoz; Khan, M. Salman; Ahmad, Saheem] Integral Univ, Dept Biosci, Lucknow, Uttar Pradesh, India; [Singh, Sarika] Cent Drug Res Inst, Dept Toxicol, Lucknow 226001, Uttar Pradesh, India	Integral University; Integral University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Khan, MS (corresponding author), Integral Univ, Dept Biosci, Lucknow, Uttar Pradesh, India.	contactskhan@gmail.com; ahmadsaheem@gmail.com	Ahmad, Saheem/T-2609-2019; Ahmad, Saheem/R-7016-2017; SINGH, SARIKA/AAO-7571-2021; Akhter, Firoz/AAD-2281-2022	Ahmad, Saheem/0000-0003-1215-0279; Ahmad, Saheem/0000-0003-1215-0279; Akhter, Firoz/0000-0002-8836-601X; Khan, M. Salman/0000-0001-9716-8165				Ahmad MI, 2011, INDIAN J BIOCHEM BIO, V48, P290; Ahmad S, 2014, BIOCHEM BIOPH RES CO, V407, P568; Ahmad S, 2014, J CLIN TRANSL ENDOCR, V1, P66, DOI 10.1016/j.jcte.2014.05.002; Ahmad S, 2014, GLYCOBIOLOGY, V24, P979, DOI 10.1093/glycob/cwu057; Ahmad S, 2014, GLYCOBIOLOGY, V24, P281, DOI 10.1093/glycob/cwt109; Ahmad S, 2013, INT J BIOL MACROMOL, V62, P167, DOI 10.1016/j.ijbiomac.2013.08.037; Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Akanji AO, 2002, CLIN CHIM ACTA, V317, P171, DOI 10.1016/S0009-8981(01)00792-6; Akhter F, 2013, S AFR J BOT, V88, P265, DOI 10.1016/j.sajb.2013.06.024; Akhter F, 2013, INT J BIOL MACROMOL, V58, P206, DOI 10.1016/j.ijbiomac.2013.03.036; Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; AZEVEDO M, 1988, FREE RADICAL RES COM, V4, P331, DOI 10.3109/10715768809066899; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gillery P, 2014, CLIN CHEM LAB MED, V52, P33, DOI 10.1515/cclm-2012-0880; Goding JW, 1976, IMMUOL METHODS, V20, P241; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; HALLIWELL B, 1981, FEBS LETT, V128, P347, DOI 10.1016/0014-5793(81)80114-7; Hashim A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/729393; Iqbal D, 2014, PHYTOTHER RES, V28, P899, DOI 10.1002/ptr.5077; KELLER PJ, 1988, BIOCHEMISTRY-US, V27, P1117, DOI 10.1021/bi00404a006; KORTLANDT W, 1992, DIABETOLOGIA, V35, P202, DOI 10.1007/BF00400918; Kummu O, 2013, ANTIOXID REDOX SIGN, V19, P1047, DOI 10.1089/ars.2012.4535; Lapolla A, 2005, CLIN BIOCHEM, V38, P103, DOI 10.1016/j.clinbiochem.2004.09.007; LIU KT, 1982, CHEM-BIOL INTERACT, V41, P39, DOI 10.1016/0009-2797(82)90015-1; Lopes-Virella MF, 2007, ATHEROSCLEROSIS, V190, P359, DOI 10.1016/j.atherosclerosis.2006.02.007; Lopes-Virella MF, 2011, DIABETES, V60, P582, DOI 10.2337/db10-0915; Lopes-Virella MF, 2010, CLIN IMMUNOL, V134, P55, DOI 10.1016/j.clim.2009.04.001; Lundberg AM, 2010, CLIN IMMUNOL, V134, P5, DOI 10.1016/j.clim.2009.07.016; Mironova M, 1997, CLIN IMMUNOL IMMUNOP, V85, P73, DOI 10.1006/clin.1997.4404; Moinuddin, 2012, ENVIRON TOXICOL, V29, P68; Mustafa I, 2012, DIABETES RES CLIN PR, V95, P98, DOI 10.1016/j.diabres.2011.09.018; Rahim M, 2014, COLLOID SURFACE B, V117, P473, DOI 10.1016/j.colsurfb.2013.12.008; Saad AF, 2006, J LIPID RES, V47, P1975, DOI 10.1194/jlr.M600064-JLR200; Shahab U, 2014, CHEM-BIOL INTERACT, V219, P229, DOI 10.1016/j.cbi.2014.06.012; Shahab U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053205; Shahab U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031199; Shahab U, 2012, IUBMB LIFE, V64, P340, DOI 10.1002/iub.1008; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; YAGI K, 1987, CHEM PHYS LIPIDS, V45, P337, DOI 10.1016/0009-3084(87)90071-5; Yishak AA, 2006, NEPHROL DIAL TRANSPL, V21, P93, DOI 10.1093/ndt/gfi103	42	38	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113144	10.1371/journal.pone.0113144	http://dx.doi.org/10.1371/journal.pone.0113144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393017	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300144
J	Azevedo, MF; Nie, CQ; Elsworth, B; Charnaud, SC; Sanders, PR; Crabb, BS; Gilson, PR				Azevedo, Mauro F.; Nie, Catherine Q.; Elsworth, Brendan; Charnaud, Sarah C.; Sanders, Paul R.; Crabb, Brendan S.; Gilson, Paul R.			Plasmodium falciparum Transfected with Ultra Bright NanoLuc Luciferase Offers High Sensitivity Detection for the Screening of Growth and Cellular Trafficking Inhibitors	PLOS ONE			English	Article							RED-BLOOD-CELLS; MALARIA PARASITES; PROTEIN EXPORT; FIREFLY LUCIFERASE; PROMOTER ACTIVITY; VIRULENCE; ERYTHROCYTES; LOCALIZATION; EXPRESSION; MEMBRANE	Drug discovery is a key part of malaria control and eradication strategies, and could benefit from sensitive and affordable assays to quantify parasite growth and to help identify the targets of potential anti-malarial compounds. Bioluminescence, achieved through expression of exogenous luciferases, is a powerful tool that has been applied in studies of several aspects of parasite biology and high throughput growth assays. We have expressed the new reporter NanoLuc (Nluc) luciferase in Plasmodium falciparum and showed it is at least 100 times brighter than the commonly used firefly luciferase. Nluc brightness was explored as a means to achieve a growth assay with higher sensitivity and lower cost. In addition we attempted to develop other screening assays that may help interrogate libraries of inhibitory compounds for their mechanism of action. To this end parasites were engineered to express Nluc in the cytoplasm, the parasitophorous vacuole that surrounds the intraerythrocytic parasite or exported to the red blood cell cytosol. As proof-of-concept, these parasites were used to develop functional screening assays for quantifying the effects of Brefeldin A, an inhibitor of protein secretion, and Furosemide, an inhibitor of new permeation pathways used by parasites to acquire plasma nutrients.	[Azevedo, Mauro F.; Nie, Catherine Q.; Elsworth, Brendan; Charnaud, Sarah C.; Sanders, Paul R.; Crabb, Brendan S.; Gilson, Paul R.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Elsworth, Brendan; Charnaud, Sarah C.; Crabb, Brendan S.; Gilson, Paul R.] Monash Univ, Melbourne, Vic 3004, Australia; [Crabb, Brendan S.] Univ Melbourne, Melbourne, Vic, Australia	Burnet Institute; Monash University; University of Melbourne	Gilson, PR (corresponding author), Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia.	gilson@burnet.edu.au	; Azevedo, Mauro/H-6180-2012	Charnaud, Sarah/0000-0002-9029-9696; Azevedo, Mauro/0000-0002-5233-2037	National Health and Medical Research Council [637406, APP1068287, APP1021560]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council Grants 637406, APP1068287 and APP1021560 awarded to BSC and PRG (URL:www.nhmrc.gov.au). The authors gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Azevedo MF, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-20; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Boddey JA, 2013, TRAFFIC, V14, P532, DOI 10.1111/tra.12053; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bouyer G, 2011, BLOOD, V118, P2305, DOI 10.1182/blood-2011-01-329300; Bullen HE, 2012, J BIOL CHEM, V287, P7871, DOI 10.1074/jbc.M111.328591; Burghaus PA, 2001, J BIOL CHEM, V276, P26838, DOI 10.1074/jbc.M100111200; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Che PL, 2012, ASSAY DRUG DEV TECHN, V10, P61, DOI 10.1089/adt.2011.0378; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Cui L, 2008, EXP PARASITOL, V120, P80, DOI 10.1016/j.exppara.2008.05.003; de Azevedo MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040981; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Duranton C, 2004, J GEN PHYSIOL, V123, P417, DOI 10.1085/jgp.200308919; Ekland EH, 2011, FASEB J, V25, P3583, DOI 10.1096/fj.11-187401; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Elsworth B, 2014, CELL MICROBIOL, V16, P355, DOI 10.1111/cmi.12261; Fernandez-Becerra C, 2003, EXP PARASITOL, V103, P88, DOI 10.1016/S0014-4894(03)00065-1; Frank M, 2006, J BIOL CHEM, V281, P9942, DOI 10.1074/jbc.M513067200; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; GOONEWARDENE R, 1993, P NATL ACAD SCI USA, V90, P5234, DOI 10.1073/pnas.90.11.5234; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hasenkamp S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-58; Hasenkamp S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-210; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horrocks P, 1999, MOL BIOCHEM PARASIT, V99, P77, DOI 10.1016/S0166-6851(98)00182-0; Huber SM, 2002, EMBO J, V21, P22, DOI 10.1093/emboj/21.1.22; Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725; Khan T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-369; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Lucantoni L, 2013, ANTIMICROB AGENTS CH, V57, P6050, DOI 10.1128/AAC.00870-13; Lucumi E, 2010, ANTIMICROB AGENTS CH, V54, P3597, DOI 10.1128/AAC.00431-10; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; MAKLER MT, 1993, AM J TROP MED HYG, V48, P205, DOI 10.4269/ajtmh.1993.48.205; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Marti M, 2013, CURR OPIN MICROBIOL, V16, P445, DOI 10.1016/j.mib.2013.04.010; Militello KT, 2003, PARASITOL RES, V89, P154, DOI 10.1007/s00436-002-0721-5; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Pasini EM, 2013, MOL CELL PROTEOMICS, V12, P426, DOI 10.1074/mcp.M112.021238; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Ooij C, 2008, PLOS PATHOG, V4; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wickham ME, 2001, EMBO J, V20, P5636, DOI 10.1093/emboj/20.20.5636; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	56	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112571	10.1371/journal.pone.0112571	http://dx.doi.org/10.1371/journal.pone.0112571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392998	Green Published, gold			2022-12-26	WOS:000347709300071
J	Schaeffer, S; Harper, A; Raja, R; Jaiswal, P; Dhingra, A				Schaeffer, Scott; Harper, Artemus; Raja, Rajani; Jaiswal, Pankaj; Dhingra, Amit			Comparative Analysis of Predicted Plastid-Targeted Proteomes of Sequenced Higher Plant Genomes	PLOS ONE			English	Article							ARABIDOPSIS; PROTEINS; REVEALS; ANNOTATION; MITOCHONDRIAL; CHLOROPLASTS; EVOLUTION; TRANSPORT; RESOURCE; BLAST2GO	Plastids are actively involved in numerous plant processes critical to growth, development and adaptation. They play a primary role in photosynthesis, pigment and monoterpene synthesis, gravity sensing, starch and fatty acid synthesis, as well as oil, and protein storage. We applied two complementary methods to analyze the recently published apple genome (Malus x domestica) to identify putative plastid-targeted proteins, the first using TargetP and the second using a custom workflow utilizing a set of predictive programs. Apple shares roughly 40% of its 10,492 putative plastid-targeted proteins with that of the Arabidopsis (Arabidopsis thaliana) plastid-targeted proteome as identified by the Chloroplast 2010 project and similar to 57% of its entire proteome with Arabidopsis. This suggests that the plastid-targeted proteomes between apple and Arabidopsis are different, and interestingly alludes to the presence of differential targeting of homologs between the two species. Co-expression analysis of 2,224 genes encoding putative plastid-targeted apple proteins suggests that they play a role in plant developmental and intermediary metabolism. Further, an inter-specific comparison of Arabidopsis, Prunus persica (Peach), Malus x domestica (Apple), Populus trichocarpa (Black cottonwood), Fragaria vesca (Woodland Strawberry), Solanum lycopersicum (Tomato) and Vitis vinifera (Grapevine) also identified a large number of novel species-specific plastid-targeted proteins. This analysis also revealed the presence of alternatively targeted homologs across species. Two separate analyses revealed that a small subset of proteins, one representing 289 protein clusters and the other 737 unique protein sequences, are conserved between seven plastid-targeted angiosperm proteomes. Majority of the novel proteins were annotated to play roles in stress response, transport, catabolic processes, and cellular component organization. Our results suggest that the current state of knowledge regarding plastid biology, preferentially based on model systems is deficient. New plant genomes are expected to enable the identification of potentially new plastid-targeted proteins that will aid in studying novel roles of plastids.	[Schaeffer, Scott; Harper, Artemus; Dhingra, Amit] Washington State Univ, Dept Hort, Pullman, WA 99164 USA; [Schaeffer, Scott; Dhingra, Amit] Washington State Univ, Mol Plant Sci Grad Program, Pullman, WA 99164 USA; [Raja, Rajani; Jaiswal, Pankaj] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Washington State University; Washington State University; Oregon State University	Dhingra, A (corresponding author), Washington State Univ, Dept Hort, Pullman, WA 99164 USA.	adhingra@wsu.edu	Dhingra, Amit/AAX-9566-2020; Jaiswal, Pankaj/R-4214-2019; Jaiswal, Pankaj/H-7599-2016; Dhingra, Amit/E-7369-2010	Dhingra, Amit/0000-0002-4464-2502; Jaiswal, Pankaj/0000-0002-1005-8383; Jaiswal, Pankaj/0000-0002-1005-8383; Schaeffer, Scott/0000-0002-8904-2594	United States Department of Agriculture National Institute of Food and Agriculture [2009-05031]; National Institutes of Health Training Grant [T32 GM008336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008336] Funding Source: NIH RePORTER	United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research and support for AH was funded in part by United States Department of Agriculture National Institute of Food and Agriculture Grant # 2009-05031 to AD. Support for SS was provided by National Institutes of Health Training Grant number T32 GM008336 to AD as co-applicant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barsan C, 2010, J EXP BOT, V61, P2413, DOI 10.1093/jxb/erq070; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; Boyer J, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-5; Camara B, 1995, INT REV CYTOL, V163, P175, DOI 10.1016/S0074-7696(08)62211-1; Chen MH, 2004, PLANT PHYSIOL, V135, P1367, DOI 10.1104/pp.104.042184; CLIJSTER.H, 1969, QUAL PLANT MATER VEG, V19, P129, DOI 10.1007/BF01101148; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fischer K, 2002, TRENDS PLANT SCI, V7, P345, DOI 10.1016/S1360-1385(02)02291-4; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Friis C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012253; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Janssen BJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-16; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; KEEGSTRA K, 1989, ANNU REV PLANT PHYS, V40, P471, DOI 10.1146/annurev.pp.40.060189.002351; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; KISS JZ, 1989, PLANTA, V177, P198, DOI 10.1007/BF00392808; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; KREUZ K, 1984, EUR J BIOCHEM, V141, P531, DOI 10.1111/j.1432-1033.1984.tb08225.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kutschera U, 2005, THEOR BIOSCI, V124, P1, DOI 10.1016/j.thbio.2005.04.001; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Liu YS, 2004, P NATL ACAD SCI USA, V101, P9897, DOI 10.1073/pnas.0400935101; Lu Y, 2011, PLANT PHYSIOL, V155, P1589, DOI 10.1104/pp.110.170118; Lukjancenko O, 2012, MICROB ECOL, V63, P651, DOI 10.1007/s00248-011-9948-y; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; METTAL U, 1988, EUR J BIOCHEM, V170, P613, DOI 10.1111/j.1432-1033.1988.tb13741.x; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; PHAN CT, 1973, EXPERIENTIA, V29, P1555, DOI 10.1007/BF01943915; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Robinson N, 1988, PLANT PHYSIOL, V87; Rochaix JD, 1997, TRENDS PLANT SCI, V2, P419, DOI 10.1016/S1360-1385(97)90025-X; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schein AI, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e82; Schemenewitz A, 2007, P NATL ACAD SCI USA, V104, P8538, DOI 10.1073/pnas.0702058104; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van Wijk KJ, 2011, PLANT PHYSIOL, V155, P1578, DOI 10.1104/pp.111.172932; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wang Yong-Qiang, 2013, J Exp Bot, V64, P949, DOI 10.1093/jxb/ers375; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	66	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112870	10.1371/journal.pone.0112870	http://dx.doi.org/10.1371/journal.pone.0112870			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393533	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300115
J	Yonemura, S				Yonemura, Shigenobu			Differential Sensitivity of Epithelial Cells to Extracellular Matrix in Polarity Establishment	PLOS ONE			English	Article							ZONULA OCCLUDENS; TIGHT JUNCTION; ALPHA-CATENIN; MORPHOGENESIS; CULTURES; RAC1; IDENTIFICATION; ORIENTATION; RECRUITMENT; REVERSAL	Establishment of apical-basal polarity is crucial for epithelial sheets that form a compartment in the body, which function to maintain the environment in the compartment. Effects of impaired polarization are easily observed in three-dimensional (3D) culture systems rather than in two-dimensional (2-D) culture systems. Although the mechanisms for establishing the polarity are not completely understood, signals from the extracellular matrix (ECM) are considered to be essential for determining the basal side and eventually generating polarity in the epithelial cells. To elucidate the common features and differences in polarity establishment among various epithelial cells, we analyzed the formation of epithelial apical-basal polarity using three cell lines of different origin: MDCK II cells (dog renal tubules), EpH4 cells (mouse mammary gland), and R2/7 cells (human colon) expressing wild-type alpha-catenin (R2/7 alpha-Cate cells). These cells showed clear apical-basal polarity in 2-D cultures. In 3-D cultures, however, each cell line displayed different responses to the same ECM. In MDCK II cells, spheroids with a single lumen formed in both Matrigel and collagen gel. In R2/7 alpha-Cate cells, spheroids showed similar apical-basal polarity as that seen in MDCK II cells, but had multiple lumens. In EpH4 cells, the spheroids displayed an apical-basal polarity that was opposite to that seen in the other two cell types in both ECM gels, at least during the culture period. On the other hand, the three cell lines showed the same apical-basal polarity both in 2-D cultures and in 3-D cultures using the hanging drop method. The three lines also had similar cellular responses to ECM secreted by the cells themselves. Therefore, appropriate culture conditions should be carefully determined in advance when using various epithelial cells to analyze cell polarity or 3-D morphogenesis.	[Yonemura, Shigenobu] RIKEN Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo, Japan; [Yonemura, Shigenobu] Japan Sci & Technol Agcy, CREST, Kobe, Hyogo, Japan	RIKEN; Japan Science & Technology Agency (JST)	Yonemura, S (corresponding author), RIKEN Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo, Japan.	yonemura@cdb.riken.jp			CREST grant from the (JST) Japan Science and Technology Agency	CREST grant from the (JST) Japan Science and Technology Agency	SY was supported by a CREST grant for "Elucidation of a novel unified epithelial system defined by the reciprocal regulation of cell-cell adhesion and the apical cytoskeleton and its use for manipulating the epithelial barrier'' from the (JST) Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/crest/en/project/35/e35_09.html). There is no grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEMIYA S, 1979, J EXP ZOOL, V210, P177, DOI 10.1002/jez.1402100120; BARKER G, 1981, Q J EXP PHYSIOL CMS, V66, P61, DOI 10.1113/expphysiol.1981.sp002529; CHAMBARD M, 1981, J CELL BIOL, V91, P157, DOI 10.1083/jcb.91.1.157; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Hayashi K, 1999, J CELL SCI, V112, P1149; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Miyake Y, 2006, EXP CELL RES, V312, P1637, DOI 10.1016/j.yexcr.2006.01.031; Myllymaki SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019453; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Niemann C, 1998, J CELL BIOL, V143, P533, DOI 10.1083/jcb.143.2.533; O'Brien LE, 2006, METHOD ENZYMOL, V406, P676, DOI 10.1016/S0076-6879(06)06053-8; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; REICHMANN E, 1989, J CELL BIOL, V108, P1127, DOI 10.1083/jcb.108.3.1127; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; WANG AZ, 1990, J CELL SCI, V95, P153; Watabe-Uchida M, 1998, J CELL BIOL, V142, P847, DOI 10.1083/jcb.142.3.847; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	29	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112922	10.1371/journal.pone.0112922	http://dx.doi.org/10.1371/journal.pone.0112922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393292	Green Published, gold			2022-12-26	WOS:000347709300123
J	Fahmy, K; Akber, M; Cai, XL; Koul, A; Hayder, A; Baumgartner, S				Fahmy, Khalid; Akber, Mira; Cai, Xiaoli; Koul, Aabid; Hayder, Awais; Baumgartner, Stefan			alpha Tubulin 67C and Ncd Are Essential for Establishing a Cortical Microtubular Network and Formation of the Bicoid mRNA Gradient in Drosophila	PLOS ONE			English	Article							IN-VIVO ANALYSIS; ALPHA-TUBULIN; MITOTIC SPINDLE; POSTERIOR LOCALIZATION; MORPHOGEN GRADIENT; AXIS SPECIFICATION; VESICLE TRANSPORT; PROTEIN; ORGANIZATION; OOCYTE	The Bicoid (Bcd) protein gradient in Drosophila serves as a paradigm for gradient formation in textbooks. To explain the generation of the gradient, the ARTS model, which is based on the observation of a bcd mRNA gradient, proposes that the bcd mRNA, localized at the anterior pole at fertilization, migrates along microtubules (MTs) at the cortex to the posterior to form a bcd mRNA gradient which is translated to form a protein gradient. To fulfil the criteria of the ARTS model, an early cortical MT network is thus a prerequisite. We report hitherto undiscovered MT activities in the early embryo important for bcd mRNA transport: (i) an early and omnidirectional MT network exclusively at the anterior cortex of early nuclear cycle embryos showing activity during metaphase and anaphase only, (ii) long MTs up to 50 mm extending into the yolk at blastoderm stage to enable basal-apical transport. The cortical MT network is not anchored to the actin cytoskeleton. The posterior transport of the mRNA via the cortical MT network critically depends on maternally-expressed alpha Tubulin67C and the minus-end motor Ncd. In either mutant, cortical transport of the bcd mRNA does not take place and the mRNA migrates along another yet undisclosed interior MT network, instead. Our data strongly corroborate the ARTS model and explain the occurrence of the bcd mRNA gradient.	[Fahmy, Khalid; Akber, Mira; Cai, Xiaoli; Koul, Aabid; Hayder, Awais; Baumgartner, Stefan] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Baumgartner, S (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	Stefan.Baumgartner@med.lu.se	Baumgartner, Stefan/A-5879-2011	Baumgartner, Stefan/0000-0001-5320-8321	Swedish Research Council; Eric Philipp Sorensen Stiftelse; Olle Engkvist Foundation; Medical Faculty of Lund; Swedish Research Council and Hereditas	Swedish Research Council(Swedish Research CouncilEuropean Commission); Eric Philipp Sorensen Stiftelse; Olle Engkvist Foundation; Medical Faculty of Lund; Swedish Research Council and Hereditas	SB received funding from the Swedish Research Council, the Eric Philipp Sorensen Stiftelse, the Olle Engkvist Foundation, and the Medical Faculty of Lund. KF received funding from the Swedish Research Council and Hereditas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2010, BIOPHYS J, V99, pL33, DOI 10.1016/j.bpj.2010.05.031; BAKER J, 1993, J CELL BIOL, V122, P113, DOI 10.1083/jcb.122.1.113; Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094; BRE MH, 1987, J CELL BIOL, V105, P1283, DOI 10.1083/jcb.105.3.1283; Callaini G, 1997, CELL MOTIL CYTOSKEL, V37, P300; Callaini G, 1996, DEV BIOL, V176, P199, DOI 10.1006/dbio.1996.0127; Castle BT, 2011, CELL MOL BIOENG, V4, P116, DOI 10.1007/s12195-010-0157-4; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; Combs PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071820; Cui J, 2013, DEV BIOL, V383, P121, DOI 10.1016/j.ydbio.2013.08.013; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; ENDOW SA, 1994, J CELL SCI, V107, P859; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1993, DEV DROSOPHILA MELAN, V1, P149; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; Gaspar I, 2009, CELL MOTIL CYTOSKEL, V66, P68, DOI 10.1002/cm.20334; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Inoue YH, 2000, J CELL BIOL, V149, P153, DOI 10.1083/jcb.149.1.153; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Januschke J, 2006, DEVELOPMENT, V133, P129, DOI 10.1242/dev.02179; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; KOMMA DJ, 1995, P NATL ACAD SCI USA, V92, P11884, DOI 10.1073/pnas.92.25.11884; KOMMA DJ, 1991, EMBO J, V10, P419, DOI 10.1002/j.1460-2075.1991.tb07963.x; Komma DJ, 1997, J CELL SCI, V110, P229; Lemos CL, 2000, EMBO J, V19, P3668, DOI 10.1093/emboj/19.14.3668; Lipshitz HD, 2009, NAT REV MOL CELL BIO, V10, P509, DOI 10.1038/nrm2730; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; MATTHEWS KA, 1989, DEV BIOL, V132, P45, DOI 10.1016/0012-1606(89)90203-0; MATTHEWS KA, 1993, DEVELOPMENT, V117, P977; Matthies HJG, 1999, J CELL BIOL, V147, P1137, DOI 10.1083/jcb.147.6.1137; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Page AW, 1996, J CELL SCI, V109, P1707; Parton RM, 2011, J CELL BIOL, V194, P121, DOI 10.1083/jcb.201103160; Petkova MD, 2014, CURR BIOL, V24, P1283, DOI 10.1016/j.cub.2014.04.028; Rabinowitz M, 1941, J MORPHOL, V69, P1, DOI 10.1002/jmor.1050690102; Rand MD, 2010, INSECT BIOCHEM MOLEC, V40, P792, DOI 10.1016/j.ibmb.2010.07.007; RIPOCHE J, 1994, P NATL ACAD SCI USA, V91, P1878, DOI 10.1073/pnas.91.5.1878; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; SALLES FJ, 1994, SCIENCE, V266, P1996, DOI 10.1126/science.7801127; Sawin KE, 2006, YEAST, V23, P1001, DOI 10.1002/yea.1404; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; Sigaut L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003629; SPIEGELMAN BM, 1979, CELL, V16, P239, DOI 10.1016/0092-8674(79)90002-3; Spirov A, 2009, DEVELOPMENT, V136, P605, DOI 10.1242/dev.031195; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; Venkei Z, 2005, MOL GENET GENOMICS, V273, P283, DOI 10.1007/s00438-005-1109-x; Venkei Z, 2006, J CELL SCI, V119, P3238, DOI 10.1242/jcs.03039; WARN RM, 1990, CELL MOTIL CYTOSKEL, V17, P34, DOI 10.1002/cm.970170106; WEHLAND J, 1983, J CELL BIOL, V97, P1467, DOI 10.1083/jcb.97.5.1467; Weil TT, 2008, CURR BIOL, V18, P1055, DOI 10.1016/j.cub.2008.06.046; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	62	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112053	10.1371/journal.pone.0112053	http://dx.doi.org/10.1371/journal.pone.0112053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390693	Green Published, gold			2022-12-26	WOS:000349144400050
J	Kadala, A; Charreton, M; Jakob, I; Cens, T; Rousset, M; Chahine, M; Le Conte, Y; Charnet, P; Collet, C				Kadala, Aklesso; Charreton, Mercedes; Jakob, Ingrid; Cens, Thierry; Rousset, Matthieu; Chahine, Mohamed; Le Conte, Yves; Charnet, Pierre; Collet, Claude			Pyrethroids Differentially Alter Voltage-Gated Sodium Channels from the Honeybee Central Olfactory Neurons	PLOS ONE			English	Article							ROOT GANGLION NEURONS; APIS-MELLIFERA L.; XENOPUS OOCYTES; DROSOPHILA-MELANOGASTER; BINDING-SITES; ION CHANNELS; INSECTICIDES; MODULATION; DELTAMETHRIN; TETRAMETHRIN	The sensitivity of neurons from the honey bee olfactory system to pyrethroid insecticides was studied using the patch-clamp technique on central 'antennal lobe neurons' (ALNs) in cell culture. In these neurons, the voltage-dependent sodium currents are characterized by negative potential for activation, fast kinetics of activation and inactivation, and the presence of cumulative inactivation during train of depolarizations. Perfusion of pyrethroids on these ALN neurons submitted to repetitive stimulations induced (1) an acceleration of cumulative inactivation, and (2) a marked slowing of the tail current recorded upon repolarization. Cypermethrin and permethrin accelerated cumulative inactivation of the sodium current peak in a similar manner and tetramethrin was even more effective. The slow-down of channel deactivation was markedly dependent on the type of pyrethroid. With cypermethrin, a progressive increase of the tail current amplitude along with successive stimulations reveals a traditionally described use-dependent recruitment of modified sodium channels. However, an unexpected decrease in this tail current was revealed with tetramethrin. If one considers the calculated percentage of modified channels as an index of pyrethroids effects, ALNs are significantly more susceptible to tetramethrin than to permethrin or cypermethrin for a single depolarization, but this difference attenuates with repetitive activity. Further comparison with peripheral neurons from antennae suggest that these modifications are neuron type specific. Modeling the sodium channel as a multi-state channel with fast and slow inactivation allows to underline the effects of pyrethroids on a set of rate constants connecting open and inactivated conformations, and give some insights to their specificity. Altogether, our results revealed a differential sensitivity of central olfactory neurons to pyrethroids that emphasize the ability for these compounds to impair detection and processing of information at several levels of the bees olfactory pathway.	[Kadala, Aklesso; Charreton, Mercedes; Jakob, Ingrid; Le Conte, Yves; Collet, Claude] INRA, UR Abeilles & Environm 406, Avignon, France; [Cens, Thierry; Rousset, Matthieu; Charnet, Pierre] Univ Montpellier 2, CNRS, Ctr Rech Biochim Macromol, UMR 5237, Montpellier, France; [Chahine, Mohamed] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Charreton, Mercedes; Le Conte, Yves; Collet, Claude] UMT Protect Abeilles Environm, Avignon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Laval University	Collet, C (corresponding author), INRA, UR Abeilles & Environm 406, Avignon, France.	claude.collet@avignon.inra.fr	Cens, Thierry/M-3337-2017; Le Conte, Yves/AAP-2379-2021; Le Conte, Yves M/B-3246-2016; Le Conte, Yves/M-4442-2018	Cens, Thierry/0000-0002-4109-2779; Le Conte, Yves/0000-0002-8466-5370; Le Conte, Yves M/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370; Charnet, Pierre/0000-0003-4692-528X; Rousset, Matthieu/0000-0003-2064-2791	French National Research Agency (Bee-channels) [ANR-13-BSV7-0010]	French National Research Agency (Bee-channels)(French National Research Agency (ANR))	This work received financial support from the French National Research Agency (ANR-13-BSV7-0010, Bee-channels). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blair NT, 2003, J NEUROSCI, V23, P10338; Bloomquist JR, 1996, ANNU REV ENTOMOL, V41, P163, DOI 10.1146/annurev.en.41.010196.001115; Breckenridge CB, 2009, NEUROTOXICOLOGY, V30, pS17, DOI 10.1016/j.neuro.2009.09.002; BROWN LD, 1987, TOXICOL APPL PHARM, V89, P305, DOI 10.1016/0041-008X(87)90150-5; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Choi JS, 2006, TOXICOL APPL PHARM, V211, P233, DOI 10.1016/j.taap.2005.06.022; Collet C, 2009, PFLUG ARCH EUR J PHY, V458, P601, DOI 10.1007/s00424-009-0642-6; COX RL, 1984, ENVIRON ENTOMOL, V13, P375, DOI 10.1093/ee/13.2.375; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Derst C, 2006, BIOCHEM BIOPH RES CO, V339, P939, DOI 10.1016/j.bbrc.2005.11.096; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; GAMMON DW, 1981, PESTIC BIOCHEM PHYS, V15, P181, DOI 10.1016/0048-3575(81)90084-5; Ginsburg K, 1999, BRAIN RES, V847, P38, DOI 10.1016/S0006-8993(99)02029-6; Hildebrand ME, 2004, J PHARMACOL EXP THER, V308, P805, DOI 10.1124/jpet.103.058792; Kadala A, 2011, NEUROTOXICOLOGY, V32, P320, DOI 10.1016/j.neuro.2011.02.007; KAISSLING KE, 1986, ANNU REV NEUROSCI, V9, P121, DOI 10.1146/annurev.ne.09.030186.001005; Khambay B.P., 2005, COMPREHENSIVE MOL IN, V6, P1, DOI [10.1016/B0-44-451924-6/00075-2, DOI 10.1016/B0-44-451924-6/00075-2]; Lee D, 1999, MOL PHARMACOL, V55, P584; Lee SH, 1999, INSECT BIOCHEM MOLEC, V29, P185, DOI 10.1016/S0965-1748(98)00122-2; LUCAS P, 1992, PESTIC BIOCHEM PHYS, V43, P103, DOI 10.1016/0048-3575(92)90024-T; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Narahashi T, 2002, MINI-REV MED CHEM, V2, P419, DOI 10.2174/1389557023405927; Neal AP, 2010, TOXICOL SCI, V116, P604, DOI 10.1093/toxsci/kfq139; O'Reilly AO, 2006, BIOCHEM J, V396, P255, DOI 10.1042/BJ20051925; O'Reilly AO, 2014, PEST MANAG SCI, V70, P369, DOI 10.1002/ps.3561; ODOWD DK, 1995, J NEUROSCI, V15, P4005; Olson RO, 2008, INSECT BIOCHEM MOLEC, V38, P604, DOI 10.1016/j.ibmb.2008.01.003; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; SALGADO VL, 1993, MOL PHARMACOL, V43, P626; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Smith TJ, 1998, NEUROTOXICOLOGY, V19, P823; Smith TJ, 1998, ARCH INSECT BIOCHEM, V38, P126, DOI 10.1002/(SICI)1520-6327(1998)38:3&lt;126::AID-ARCH3&gt;3.0.CO;2-Q; Soderlund DM, 2010, PESTIC BIOCHEM PHYS, V97, P78, DOI 10.1016/j.pestbp.2009.06.010; Song JH, 1996, J PHARMACOL EXP THER, V277, P445; Song JH, 1996, BRAIN RES, V708, P29, DOI 10.1016/0006-8993(95)01239-7; Tabarean IV, 1998, J PHARMACOL EXP THER, V284, P958; Tabarean IV, 2001, J PHARMACOL EXP THER, V299, P988; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tan JG, 2002, J NEUROSCI, V22, P5300; TATEBAYASHI H, 1994, J PHARMACOL EXP THER, V270, P595; TAYLOR KS, 1987, APIDOLOGIE, V18, P243, DOI 10.1051/apido:19870304; Thompson HM, 2003, ECOTOXICOLOGY, V12, P317, DOI 10.1023/A:1022575315413; Vais H, 2000, J GEN PHYSIOL, V115, P305, DOI 10.1085/jgp.115.3.305; Vais H, 2003, MOL PHARMACOL, V64, P914, DOI 10.1124/mol.64.4.914; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; Zhou T, 2011, PESTIC BIOCHEM PHYS, V100, P35, DOI 10.1016/j.pestbp.2011.02.001	49	16	17	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112194	10.1371/journal.pone.0112194	http://dx.doi.org/10.1371/journal.pone.0112194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390654	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400062
J	Kelker, MS; Berry, C; Evans, SL; Pai, R; McCaskill, DG; Wang, NX; Russell, JC; Baker, MD; Yang, C; Pflugrath, JW; Wade, M; Wess, TJ; Narva, KE				Kelker, Matthew S.; Berry, Colin; Evans, Steven L.; Pai, Reetal; McCaskill, David G.; Wang, Nick X.; Russell, Joshua C.; Baker, Matthew D.; Yang, Cheng; Pflugrath, J. W.; Wade, Matthew; Wess, Tim J.; Narva, Kenneth E.			Structural and Biophysical Characterization of Bacillus thuringiensis Insecticidal Proteins Cry34Ab1 and Cry35Ab1	PLOS ONE			English	Article							SPHAERICUS BINARY TOXIN; WESTERN CORN-ROOTWORM; MOBILITY-MASS-SPECTROMETRY; PORE-FORMING TOXIN; CRYSTAL-STRUCTURE; EQUINATOXIN-II; LYSINIBACILLUS-SPHAERICUS; SOLUBLE FORM; PURIFICATION; COMPONENTS	Bacillus thuringiensis strains are well known for the production of insecticidal proteins upon sporulation and these proteins are deposited in parasporal crystalline inclusions. The majority of these insect-specific toxins exhibit three domains in the mature toxin sequence. However, other Cry toxins are structurally and evolutionarily unrelated to this three-domain family and little is known of their three dimensional structures, limiting our understanding of their mechanisms of action and our ability to engineer the proteins to enhance their function. Among the non-three domain Cry toxins, the Cry34Ab1 and Cry35Ab1 proteins from B. thuringiensis strain PS149B1 are required to act together to produce toxicity to the western corn rootworm (WCR) Diabrotica virgifera virgifera Le Conte via a pore forming mechanism of action. Cry34Ab1 is a protein of similar to 14 kDa with features of the aegerolysin family (Pfam06355) of proteins that have known membrane disrupting activity, while Cry35Ab1 is a similar to 44 kDa member of the toxin_10 family (Pfam05431) that includes other insecticidal proteins such as the binary toxin BinA/BinB. The Cry34Ab1/Cry35Ab1 proteins represent an important seed trait technology having been developed as insect resistance traits in commercialized corn hybrids for control of WCR. The structures of Cry34Ab1 and Cry35Ab1 have been elucidated to 2.15 angstrom and 1.80 angstrom resolution, respectively. The solution structures of the toxins were further studied by small angle X-ray scattering and native electrospray ion mobility mass spectrometry. We present here the first published structure from the aegerolysin protein domain family and the structural comparisons of Cry34Ab1 and Cry35Ab1 with other pore forming toxins.	[Kelker, Matthew S.; Evans, Steven L.; Pai, Reetal; McCaskill, David G.; Wang, Nick X.; Russell, Joshua C.; Narva, Kenneth E.] LLC, Dow AgroSci, Indianapolis, IN 46285 USA; [Berry, Colin; Baker, Matthew D.] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Yang, Cheng; Pflugrath, J. W.] Rigaku Americas Corp, The Woodlands, TX USA; [Wess, Tim J.; Narva, Kenneth E.] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Rigaku Corporation; Cardiff University	Kelker, MS (corresponding author), LLC, Dow AgroSci, Indianapolis, IN 46285 USA.	mskelker@dow.com	Berry, Colin/A-4338-2010; Russell, Joshua C/G-6985-2015; Baker, Matthew/B-4850-2011	Berry, Colin/0000-0002-9943-548X; Russell, Joshua C/0000-0002-4193-9204; Baker, Matthew/0000-0001-6950-204X; McCaskill, David/0000-0001-6244-3067; Narva, Kenneth/0000-0001-8094-6418; Plummer, Beverley/0000-0002-6559-7237	E.I. DuPont de Nemours & Co., The Dow Chemical Company; Northwestern University; U.S. DOE [DE-AC02-06CH11357]; NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	E.I. DuPont de Nemours & Co., The Dow Chemical Company; Northwestern University; U.S. DOE(United States Department of Energy (DOE)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this work were performed at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) located at Sector 5 of the Advanced Photon Source (APS). DND-CAT is supported by E.I. DuPont de Nemours & Co., The Dow Chemical Company and Northwestern University. Use of the APS, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba T, 2006, PROTEINS, V63, P243, DOI 10.1002/prot.20843; Akiba T, 2009, J MOL BIOL, V386, P121, DOI 10.1016/j.jmb.2008.12.002; Alvarez C, 2009, TOXICON, V54, P1135, DOI 10.1016/j.toxicon.2009.02.022; [Anonymous], 2012, US EPA CURRENT PREVI; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Baum JA, 2004, APPL ENVIRON MICROB, V70, P4889, DOI 10.1128/AEM.70.8.4889-4898.2004; Berne S, 2009, PROTEIN SCI, V18, P694, DOI 10.1002/pro.85; Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008; Birck C, 2004, J MOL BIOL, V344, P1409, DOI 10.1016/j.jmb.2004.10.007; Boonyos P, 2010, BMB REP, V43, P23, DOI 10.5483/BMBRep.2010.43.1.023; BROADWELL AH, 1987, APPL ENVIRON MICROB, V53, P1333, DOI 10.1128/AEM.53.6.1333-1337.1987; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Campuzano I, 2012, ANAL CHEM, V84, P1026, DOI 10.1021/ac202625t; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; DeLano WL, 2006, PYMOL V 0 99RC6; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Donovan WP, 2000, BACILLUS THURINGIENS; Ellis RT, 2002, APPL ENVIRON MICROB, V68, P1137, DOI 10.1128/AEM.68.3.1137-1145.2002; Eswar N., 2006, COMP PROTEIN STRUCTU; Gao Y, 2004, J AGR FOOD CHEM, V52, P8057, DOI 10.1021/jf048744+; Herman RA, 2002, J ECON ENTOMOL, V95, P635, DOI 10.1603/0022-0493-95.3.635; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hire RS, 2009, J INVERTEBR PATHOL, V101, P106, DOI 10.1016/j.jip.2009.03.005; Jones GW, 2007, FASEB J, V21, P4112, DOI 10.1096/fj.07-8913com; Jones RT, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-141; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kale A, 2013, INSECT BIOCHEM MOLEC, V43, P1045, DOI 10.1016/j.ibmb.2013.07.011; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Konijnenberg A, 2013, BBA-PROTEINS PROTEOM, V1834, P1239, DOI 10.1016/j.bbapap.2012.11.013; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; Kunthic T, 2011, BMB REP, V44, P674, DOI 10.5483/BMBRep.2011.44.10.674; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI H, 2013, PLOS ONE, V8; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Masson L, 2004, BIOCHEMISTRY-US, V43, P12349, DOI 10.1021/bi048946z; Mechaly AE, 2009, ACTA CRYSTALLOGR F, V65, P357, DOI 10.1107/S1744309109007064; Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Moellenbeck DJ, 2001, NAT BIOTECHNOL, V19, P668, DOI 10.1038/90282; Narva KE, 2014, ADV INSECT PHYSL; Narva KE, 2013, ADV BIOCHEM ENG BIOT, V136, P135, DOI 10.1007/10_2013_195; NIELSENLEROUX C, 1992, EUR J BIOCHEM, V210, P585, DOI 10.1111/j.1432-1033.1992.tb17458.x; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Palma L, 2014, TOXINS, V6, P1490, DOI 10.3390/toxins6051490; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Promdonkoy B, 2008, CURR MICROBIOL, V56, P334, DOI 10.1007/s00284-007-9065-9; Revina LP, 2005, CAN J MICROBIOL, V51, P141, DOI 10.1139/w04-121; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Rossjohn J, 1997, EMBO J, V16, P3426, DOI 10.1093/emboj/16.12.3426; RUPAR MJ, 2003, NUCL ACIDS ENCODING; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schnepf HE, 2005, APPL ENVIRON MICROB, V71, P1765, DOI 10.1128/AEM.71.4.1765-1774.2005; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Shvartsburg AA, 1996, CHEM PHYS LETT, V261, P86, DOI 10.1016/0009-2614(96)00941-4; Squires C.H., 2004, BIOPROCESS INT, V2004, P54; Srisucharitpanit K, 2014, PROTEINS; Srisucharitpanit K, 2012, PROTEIN EXPRES PURIF, V82, P368, DOI 10.1016/j.pep.2012.02.009; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xu CC, 2014, TOXINS, V6, P2732, DOI 10.3390/toxins6092732; Yanagihara I, 2010, J BIOL CHEM, V285, P16267, DOI 10.1074/jbc.M109.074526	65	50	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112555	10.1371/journal.pone.0112555	http://dx.doi.org/10.1371/journal.pone.0112555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390338	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400097
J	Kwon, MS; Vorobyev, V; Moe, D; Parkkola, R; Hamalainen, H				Kwon, Myoung Soo; Vorobyev, Victor; Moe, Dagfinn; Parkkola, Riitta; Hamalainen, Heikki			Brain Structural Correlates of Risk-Taking Behavior and Effects of Peer Influence in Adolescents	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; IMAGE REGISTRATION; MATURATION; ENGAGEMENT; PASSENGERS; CHILDHOOD; CHILDREN	Adolescents are characterized by impulsive risky behavior, particularly in the presence of peers. We discriminated high and low risk-taking male adolescents aged 18-19 years by assessing their propensity for risky behavior and vulnerability to peer influence with personality tests, and compared structural differences in gray and white matter of the brain with voxel-based morphometry (VBM) and diffusion tensor imaging (DTI), respectively. We also compared the brain structures according to the participants' actual risk-taking behavior in a simulated driving task with two different social conditions making up a peer competition situation. There was a discrepancy between the self-reported personality test results and risky driving behavior (running through an intersection with traffic lights turning yellow, chancing a collision with another vehicle). Comparison between high and low risk-taking adolescents according to personality test results revealed no significant difference in gray matter volume and white matter integrity. However, comparison according to actual risk-taking behavior during task performance revealed significantly higher white matter integrity in the high risk-taking group, suggesting that increased risky behavior during adolescence is not necessarily attributed to the immature brain as conventional wisdom says.	[Kwon, Myoung Soo; Vorobyev, Victor; Hamalainen, Heikki] Univ Turku, Ctr Cognit Neurosci, Dept Psychol, Turku, Finland; [Moe, Dagfinn] SINTEF Technol & Soc, Dept Transport Res, Trondheim, Norway; [Parkkola, Riitta] Tampere Univ Hosp, Dept Radiol, Tampere, Finland	University of Turku; SINTEF; Tampere University; Tampere University Hospital	Kwon, MS (corresponding author), Univ Turku, Ctr Cognit Neurosci, Dept Psychol, Turku, Finland.	mskwon@utu.fi	Vorobyev, Vitaly/H-9799-2018; Kwon, Myoung Soo/C-3922-2008; Parkkola, Riitta/AAZ-1341-2020	Vorobyev, Vitaly/0000-0002-6660-868X; Moe, Dagfinn/0000-0002-3277-4882	Norwegian Public Roads Administration (NPRA); Finnish Transport Safety Agency (Trafi)	Norwegian Public Roads Administration (NPRA); Finnish Transport Safety Agency (Trafi)	This study was supported by the Norwegian Public Roads Administration (NPRA, http://www.vegvesen.no/): HH; Finnish Transport Safety Agency (Trafi, http://www.trafi.fi/): HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluja A, 2010, J PERS ASSESS, V92, P416, DOI 10.1080/00223891.2010.497406; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Berns GS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006773; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Casey BJ, 2008, DEV REV, V28, P62, DOI [10.1016/j.dr.2007.08.003, 10.1196/annals.1440.010]; Casey BJ, 2011, J RES ADOLESCENCE, V21, P21, DOI 10.1111/j.1532-7795.2010.00712.x; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Caviness VS, 1996, CEREB CORTEX, V6, P726, DOI 10.1093/cercor/6.5.726; Chassin L., 2009, HDB ADOLESCENT PSYCH, V1, P723, DOI DOI 10.1002/9780470479193.ADLPSY001022; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Crone EA, 2012, NAT REV NEUROSCI, V13, P636, DOI 10.1038/nrn3313; Epstein R, 2007, SCI AM MIND, V18, P56; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Geier CF, 2013, HORM BEHAV, V64, P333, DOI 10.1016/j.yhbeh.2013.02.008; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Jacobus J, 2013, PSYCHOL ADDICT BEHAV, V27, P431, DOI 10.1037/a0028235; JERNIGAN TL, 1991, BRAIN, V114, P2037, DOI 10.1093/brain/114.5.2037; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Marengo D, 2012, TRANSPORT RES F-TRAF, V15, P480, DOI 10.1016/j.trf.2012.04.001; Mirman JH, 2012, J ADOLESCENT HEALTH, V50, P634, DOI 10.1016/j.jadohealth.2011.10.256; Mishra S, 2011, PERS INDIV DIFFER, V50, P869, DOI 10.1016/j.paid.2010.11.037; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Mohammadi S, 2013, MAGN RESON MED, V70, P358, DOI 10.1002/mrm.24467; Mohammadi S, 2010, MAGN RESON MED, V64, P1047, DOI 10.1002/mrm.22501; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; O'Brien L, 2011, J RES ADOLESCENCE, V21, P747, DOI 10.1111/j.1532-7795.2011.00738.x; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Pluim JPW, 2000, IEEE T MED IMAGING, V19, P809, DOI 10.1109/42.876307; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Romer D, 2011, DEVELOPMENTAL SCI, V14, P1119, DOI 10.1111/j.1467-7687.2011.01061.x; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Schneider S, 2012, AM J PSYCHIAT, V169, P39, DOI 10.1176/appi.ajp.2011.11030489; Silveri MM, 2006, MAGN RESON IMAGING, V24, P833, DOI 10.1016/j.mri.2006.03.012; Simons-Morton B, 2005, ACCIDENT ANAL PREV, V37, P973, DOI 10.1016/j.aap.2005.04.014; Smith AR, 2013, HORM BEHAV, V64, P323, DOI 10.1016/j.yhbeh.2013.03.006; Somerville LH, 2010, BRAIN COGNITION, V72, P124, DOI 10.1016/j.bandc.2009.07.003; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Williams JM, 1999, J ADOLESCENCE, V22, P157, DOI 10.1006/jado.1998.0208; Zimring F.E., 1998, AM YOUTH VIOLENCE; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	51	36	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112780	10.1371/journal.pone.0112780	http://dx.doi.org/10.1371/journal.pone.0112780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389976	gold, Green Published			2022-12-26	WOS:000349144400126
J	Loffredo, S; Staiano, RI; Granata, F; Costantino, V; Borriello, F; Frattini, A; Lepore, MT; Mangoni, A; Marone, G; Triggiani, M				Loffredo, Stefania; Staiano, Rosaria I.; Granata, Francescopaolo; Costantino, Valeria; Borriello, Francesco; Frattini, Annunziata; Lepore, Maria Teresa; Mangoni, Alfonso; Marone, Gianni; Triggiani, Massimo			Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes	PLOS ONE			English	Article							HUMAN LUNG MACROPHAGES; INVARIANT NKT CELLS; KILLER T-CELLS; ALPHA-GALACTOSYLCERAMIDE; ANTIGEN PRESENTATION; DENDRITIC CELLS; ACTIVATION; GLYCOLIPIDS; CD1D; HETEROGENEITY	Monocytes are major effector cells of innate immunity and recognize several endogenous and exogenous molecules due to the expression of wide spectrum of receptors. Among them, the MHC class I-like molecule CD1d interacts with glycolipids and presents them to iNKT cells, mediating their activation. Simplexide belongs to a novel class of glycolipids isolated from marine sponges and is structurally distinct from other immunologically active glycolipids. In this study we have examined the effects of simplexide on cytokine and chemokine release from human monocytes. Simplexide induces a concentration and time-dependent release of IL-6, CXCL8, TNF-alpha and IL-10 and increases the expression of IL6, CXCL8 and IL10 mRNA. Cytokine and chemokine release induced by simplexide from monocytes is dependent on CD1d since: i) a CD1d antagonist, 1,2-bis (diphenylphosphino) ethane [DPPE]- polyethylene glycolmonomethylether [PEG], specifically blocks simplexide-induced activation of monocytes; ii) CD1d knockdown inhibits monocyte activation by simplexide and iii) simplexide induces cytokine production from CD1d-transfected but not parental C1R cell line Finally, we have shown that simplexide also induces iNKT cell expansion in vitro. Our results demonstrate that simplexide, apart from activating iNKT cells, induces the production of cytokines and chemokines from human monocytes by direct interaction with CD1d.	[Loffredo, Stefania; Staiano, Rosaria I.; Granata, Francescopaolo; Borriello, Francesco; Frattini, Annunziata; Lepore, Maria Teresa; Marone, Gianni] Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy; [Loffredo, Stefania; Staiano, Rosaria I.; Granata, Francescopaolo; Borriello, Francesco; Frattini, Annunziata; Lepore, Maria Teresa; Marone, Gianni] Univ Naples Federico II, Ctr Basic & Clin Immunol Res CISI, Naples, Italy; [Costantino, Valeria; Mangoni, Alfonso] Univ Naples Federico II, Dept Pharm, NeaNAT Grp, Naples, Italy; [Triggiani, Massimo] Univ Salerno, Div Allergy & Clin Immunol, I-84100 Salerno, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Salerno	Marone, G (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Naples, Italy.	marone@unina.it	Mangoni, Alfonso/A-3554-2012; Costantino, Valeria/AAN-1960-2020; Triggiani, Massimo/K-8271-2016	Mangoni, Alfonso/0000-0003-3910-6518; Costantino, Valeria/0000-0001-8723-9505; Triggiani, Massimo/0000-0001-7318-2093; Lepore, Maria Teresa/0000-0002-4701-6902; Borriello, Francesco/0000-0001-9074-4828	Ministero dell'Universita e della Ricerca; Regione Campania; CISI Lab project; CREME project; TIMING project; European Union [311848]	Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Regione Campania(Regione Campania); CISI Lab project; CREME project; TIMING project; European Union(European Commission)	This work was supported by grants from the Ministero dell'Universita e della Ricerca (MT, and GM), the Regione Campania (GM), CISI Lab project, CREME project, TIMING project and European Union's Seventh Framework Programme FP7/2007-2013 under grant agreement nu 311848 (BlueGenics) (AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Banchet-Cadeddu A, 2011, ORG BIOMOL CHEM, V9, P3080, DOI 10.1039/c0ob00975j; Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bas S, 2008, J IMMUNOL, V180, P1158, DOI 10.4049/jimmunol.180.2.1158; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Colgan SP, 1999, P NATL ACAD SCI USA, V96, P13938, DOI 10.1073/pnas.96.24.13938; Costantino V, 2004, CURR MED CHEM, V11, P1671, DOI 10.2174/0929867043364973; Costantino V, 1996, TETRAHEDRON, V52, P1573, DOI 10.1016/0040-4020(95)00986-8; Costantino V, 1999, BIOORG MED CHEM LETT, V9, P271, DOI 10.1016/S0960-894X(98)00719-7; Fattorusso E, 1997, PROG CHEM ORG NAT PR, V72, P215; Gadola SD, 2002, J IMMUNOL, V168, P5514, DOI 10.4049/jimmunol.168.11.5514; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Granata F, 2010, J IMMUNOL, V184, P5232, DOI 10.4049/jimmunol.0902501; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kobayashi E, 1995, ONCOL RES, V7, P529; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Kunii N, 2009, CANCER SCI, V100, P1092, DOI 10.1111/j.1349-7006.2009.01135.x; Lombardi V, 2010, J IMMUNOL, V184, P2107, DOI 10.4049/jimmunol.0901208; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; MORITA M, 1995, J MED CHEM, V38, P2176, DOI 10.1021/jm00012a018; Motohashi S, 2009, J IMMUNOL, V182, P2492, DOI 10.4049/jimmunol.0800126; Nieuwenhuis EES, 2005, EXP DERMATOL, V14, P250, DOI 10.1111/j.0906-6705.2005.00289.x; Olszak T, 2014, NATURE; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Tefit JN, 2010, METHODS MOL BIOL, V626, P149, DOI 10.1007/978-1-60761-585-9_11; Triggiani M, 2009, INT ARCH ALLERGY IMM, V150, P144, DOI 10.1159/000218117; Tyznik AJ, 2011, CHEM BIOL, V18, P1620, DOI 10.1016/j.chembiol.2011.10.015; Venkataswamy MM, 2009, J IMMUNOL, V183, P1644, DOI 10.4049/jimmunol.0900858; Wu D, 2006, P NATL ACAD SCI USA, V103, P3972, DOI 10.1073/pnas.0600285103; Wu D, 2008, BIOORGAN MED CHEM, V16, P1073, DOI 10.1016/j.bmc.2007.10.026; Yue SC, 2005, P NATL ACAD SCI USA, V102, P11811, DOI 10.1073/pnas.0503366102; Yue SC, 2010, J IMMUNOL, V184, P268, DOI 10.4049/jimmunol.0800924; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111326	10.1371/journal.pone.0111326	http://dx.doi.org/10.1371/journal.pone.0111326			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390653	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400020
J	Rahman, M; Jubair, M; Alam, MT; Weppelmann, TA; Azarian, T; Salemi, M; Sakharuk, IA; Rashid, MH; Johnson, JA; Yasmin, M; Morris, JG; Ali, A				Rahman, Mustafizur; Jubair, Mohammad; Alam, Meer T.; Weppelmann, Thomas A.; Azarian, Taj; Salemi, Marco; Sakharuk, Ilya A.; Rashid, Mohammed H.; Johnson, Judith A.; Yasmin, Mahmuda; Morris, J. Glenn, Jr.; Ali, Afsar			High-Frequency Rugose Exopolysaccharide Production by Vibrio cholerae Strains Isolated in Haiti	PLOS ONE			English	Article							EL-TOR; RESISTANCE; VARIANTS; ECOLOGY; GENES	In October, 2010, epidemic cholera was reported for the first time in Haiti in over 100 years. Establishment of cholera endemicity in Haiti will be dependent in large part on the continued presence of toxigenic Vibrio cholerae O1 in aquatic reservoirs. The rugose phenotype of Vibrio cholerae, characterized by exopolysaccharide production that confers resistance to environmental stress, is a potential contributor to environmental persistence. Using a microbiologic medium promoting high-frequency conversion of smooth to rugose (S-R) phenotype, 80 (46.5%) of 172 Vibrio cholerae strains isolated from clinical and environmental sources in Haiti were able to convert to a rugose phenotype. Toxigenic Vibrio cholerae O1 strains isolated at the beginning of the epidemic (2010) were significantly less likely to shift to a rugose phenotype than clinical strains isolated in 2012/2013, or environmental strains. Frequency of rugose conversion was influenced by incubation temperature and time. Appearance of the biofilm produced by a Haitian clinical rugose strain (altered biotype El Tor HC16R) differed from that of a typical El Tor rugose strain (N16961R) by confocal microscopy. On whole-genome SNP analysis, there was no phylogenetic clustering of strains showing an ability to shift to a rugose phenotype. Our data confirm the ability of Haitian clinical (and environmental) strains to shift to a protective rugose phenotype, and suggest that factors such as temperature influence the frequency of transition to this phenotype.	[Rahman, Mustafizur; Jubair, Mohammad; Alam, Meer T.; Weppelmann, Thomas A.; Azarian, Taj; Salemi, Marco; Sakharuk, Ilya A.; Rashid, Mohammed H.; Johnson, Judith A.; Morris, J. Glenn, Jr.; Ali, Afsar] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Azarian, Taj] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA; [Salemi, Marco; Johnson, Judith A.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Yasmin, Mahmuda] Univ Dhaka, Dept Microbiol, Dhaka, Bangladesh	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Dhaka	Ali, A (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.	aali@epi.ufl.edu	Azarian, Taj/H-5772-2019; alam, Meer Taifur/AAQ-1435-2020	Azarian, Taj/0000-0002-8611-5241; alam, Meer Taifur/0000-0002-0703-740X	Department of Defense [C0654_12_UN]; National Institutes of Health (NIH) [RO1 AI097405]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039129, R01AI097405] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a Department of Defense grant (C0654_12_UN) awarded to AA, and National Institutes of Health (NIH) grant RO1 AI097405 awarded to JGM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MT, 2014, EMERG INFECT DIS, V20, P356, DOI 10.3201/eid2003.131293; Ali A, 2000, INFECT IMMUN, V68, P1967, DOI 10.1128/IAI.68.4.1967-1974.2000; Ali A, 2002, APPL ENVIRON MICROB, V68, P5773, DOI 10.1128/AEM.68.11.5773-5778.2002; Ali A, 2011, EMERG INFECT DIS, V17, P699, DOI 10.3201/eid1704.101973; Anriany YA, 2001, APPL ENVIRON MICROB, V67, P4048, DOI 10.1128/AEM.67.9.4048-4056.2001; Beyenal H, 2004, J MICROBIOL METH, V59, P395, DOI 10.1016/j.mimet.2004.08.003; COLWELL RR, 1985, BIO-TECHNOL, V3, P817, DOI 10.1038/nbt0985-817; Colwell RR, 1994, VIBRIO CHOLERAE CHOL; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Grau BL, 2005, J BACTERIOL, V187, P2519, DOI 10.1128/JB.187.7.2519-2525.2005; Jubair M, 2014, PLOS ONE, V9; Jubair M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045187; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Morris JG, 2011, EMERG INFECT DIS, V17, P2099, DOI 10.3201/eid1711.111109; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Reidl J, 2002, FEMS MICROBIOL REV, V26, P125, DOI 10.1111/j.1574-6976.2002.tb00605.x; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wai SN, 1998, APPL ENVIRON MICROB, V64, P3648; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2009, TRENDS MICROBIOL, V17, P109, DOI 10.1016/j.tim.2008.12.004	30	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112853	10.1371/journal.pone.0112853	http://dx.doi.org/10.1371/journal.pone.0112853			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390633	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400134
J	Sanchez-Pages, S; Rodriguez-Ruiz, C; Turiegano, E				Sanchez-Pages, Santiago; Rodriguez-Ruiz, Claudia; Turiegano, Enrique			Facial Masculinity: How the Choice of Measurement Method Enables to Detect Its Influence on Behaviour	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; PERCEIVED ATTRACTIVENESS; GEOMETRIC MORPHOMETRICS; COMPETITIVE AROUSAL; TESTOSTERONE LEVELS; MENSTRUAL-CYCLE; FACES; SYMMETRY; PREFERENCES; COOPERATION	Recent research has explored the relationship between facial masculinity, human male behaviour and males' perceived features (i.e. attractiveness). The methods of measurement of facial masculinity employed in the literature are quite diverse. In the present paper, we use several methods of measuring facial masculinity to study the effect of this feature on risk attitudes and trustworthiness. We employ two strategic interactions to measure these two traits, a first-price auction and a trust game. We find that facial width-to-height ratio is the best predictor of trustworthiness, and that measures of masculinity which use Geometric Morphometrics are the best suited to link masculinity and bidding behaviour. However, we observe that the link between masculinity and bidding in the first-price auction might be driven by competitiveness and not by risk aversion only. Finally, we test the relationship between facial measures of masculinity and perceived masculinity. As a conclusion, we suggest that researchers in the field should measure masculinity using one of these methods in order to obtain comparable results. We also encourage researchers to revise the existing literature on this topic following these measurement methods.	[Sanchez-Pages, Santiago] Univ Barcelona, Dept Teor Econ, Barcelona, Spain; [Sanchez-Pages, Santiago] Edinburgh Sch Econ, Edinburgh, Midlothian, Scotland; [Rodriguez-Ruiz, Claudia; Turiegano, Enrique] Univ Barcelona, Dept Teor Econ, Barcelona, Spain	University of Barcelona; University of Edinburgh; University of Barcelona	Turiegano, E (corresponding author), Univ Barcelona, Dept Teor Econ, Barcelona, Spain.	enrique.turiegano@uam.es	Turiegano, Enrique/M-8679-2013; Rodriguez-Ruiz, Claudia/A-7914-2015	Turiegano, Enrique/0000-0003-4620-7894; Rodriguez-Ruiz, Claudia/0000-0002-2284-1682				Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bhasin S, 2003, GROWTH HORM IGF RES, V13, pS63, DOI 10.1016/S1096-6374(03)00058-3; Boothroyd LG, 2013, EVOL PSYCHOL-US, V11, P1044, DOI 10.1177/147470491301100508; Burriss RP, 2007, ARCH SEX BEHAV, V36, P377, DOI 10.1007/s10508-006-9136-1; Campo S, 2011, REV ECON STUD, V78, P112, DOI 10.1093/restud/rdq001; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Danel D, 2007, J COMP PSYCHOL, V121, P221, DOI 10.1037/0735-7036.121.2.221; Dave C, 2010, J RISK UNCERTAINTY, V41, P219, DOI 10.1007/s11166-010-9103-z; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Edelstein RS, 2010, HORM BEHAV, V57, P230, DOI 10.1016/j.yhbeh.2009.11.007; Eisenegger C, 2011, TRENDS COGN SCI, V15, P263, DOI 10.1016/j.tics.2011.04.008; Enlow D.H., 1996, ESSENTIAL FACIAL GRO, V1; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Gangestad SW, 2010, EVOL HUM BEHAV, V31, P412, DOI 10.1016/j.evolhumbehav.2010.06.001; Gangestad SW, 2003, EVOL HUM BEHAV, V24, P231, DOI 10.1016/S1090-5138(03)00017-5; Garbarino E, 2011, J RISK UNCERTAINTY, V42, P1, DOI 10.1007/s11166-010-9109-6; Geniole SN, 2013, EVOL PSYCHOL-US, V11, P1027; Gomez-Valdes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052317; Hampson E, 2008, ARCH SEX BEHAV, V37, P133, DOI 10.1007/s10508-007-9263-3; Harrison C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067494; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Hines M, 2006, EUR J ENDOCRINOL, V155, pS115, DOI 10.1530/eje.1.02236; Honekopp J, 2011, PERS INDIV DIFFER, V51, P381, DOI 10.1016/j.paid.2010.05.003; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Huizenga HM, 2012, ORGAN BEHAV HUM DEC, V117, P332, DOI 10.1016/j.obhdp.2011.11.010; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Johnston VS, 2006, TRENDS COGN SCI, V10, P9, DOI 10.1016/j.tics.2005.11.003; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones BC, 2008, ARCH SEX BEHAV, V37, P78, DOI 10.1007/s10508-007-9268-y; Josephs RA, 2006, J PERS SOC PSYCHOL, V90, P999, DOI 10.1037/0022-3514.90.6.999; Kagel JC, 1995, HDB EXPT EC, V1, P501; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS296, DOI 10.1098/rsbl.2004.0163; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; KRISHNA V., 2002, AUCTION THEORY; Ku G, 2005, ORGAN BEHAV HUM DEC, V96, P89, DOI 10.1016/j.obhdp.2004.10.001; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lefevre CE, 2012, EVOL HUM BEHAV, V33, P623, DOI 10.1016/j.evolhumbehav.2012.03.002; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Macapagal Kathryn R, 2011, J Soc Evol Cult Psychol, V5, P92; Malhotra D, 2010, ORGAN BEHAV HUM DEC, V111, P139, DOI 10.1016/j.obhdp.2009.11.005; McClure SM, 2011, DECISION MAKING AFFE, P63; MILGROM PR, 1982, ECONOMETRICA, V50, P1089, DOI 10.2307/1911865; Moore FR, 2011, P ROY SOC B-BIOL SCI, V278, P774, DOI 10.1098/rspb.2010.1678; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Pearson M, 2013, GAME ECON BEHAV, V78, P1, DOI 10.1016/j.geb.2012.10.008; Pearson M, 2012, EXP ECON, V15, P510, DOI 10.1007/s10683-011-9311-7; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P229, DOI 10.1016/j.evolhumbehav.2004.04.003; Peters M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004138; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Roney JR, 2006, P ROY SOC B-BIOL SCI, V273, P2169, DOI 10.1098/rspb.2006.3569; Rubinow DR, 1996, AM J PSYCHIAT, V153, P974; Rupp HA, 2007, HORM BEHAV, V52, P581, DOI 10.1016/j.yhbeh.2007.07.015; Sanchez-Pages S, 2013, BEHAVIOUR, V150, P713, DOI 10.1163/1568539X-00003077; Sanchez-Pages S, 2010, PHYSIOL BEHAV, V99, P355, DOI 10.1016/j.physbeh.2009.11.013; Schaefer K, 2006, AM J PHYS ANTHROPOL, V129, P132, DOI 10.1002/ajpa.20224; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Schipper B, 2012, WORKING PAPERS U CAL; Schulz KM, 2009, HORM BEHAV, V55, P597, DOI 10.1016/j.yhbeh.2009.03.010; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; SCUTT D, 1996, SYMMETRY OVULATION W, V11, P2477; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Sisk CL, 2005, FRONT NEUROENDOCRIN, V26, P163, DOI 10.1016/j.yfrne.2005.10.003; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Thompson AE, 2013, CANADIAN J HUMAN SEX, V22, P5, DOI DOI 10.3138/cjhs.929; van den Bos W, 2008, JUDGM DECIS MAK, V3, P483; van den Bos W, 2013, J NEUROSCI, V33, P2137, DOI 10.1523/JNEUROSCI.3095-12.2013; Van Dongen S., 2012, SEX HORMONES, P293; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; Verdonck A, 1999, EUR J ORTHODONT, V21, P137, DOI 10.1093/ejo/21.2.137; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219; Yong E, 2012, NATURE, V485, P298, DOI 10.1038/485298a; Zar, 2011, BIOSTAT ANAL; Zheng ZG, 2011, P NATL ACAD SCI USA, V108, P16289, DOI 10.1073/pnas.1108312108; Zitzmann M, 2001, EUR J ENDOCRINOL, V144, P183, DOI 10.1530/eje.0.1440183	96	17	17	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112157	10.1371/journal.pone.0112157	http://dx.doi.org/10.1371/journal.pone.0112157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25389770	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400059
J	Shehzad, SA; Abbasi, FM; Hayat, T; Alsaadi, F				Shehzad, Sabir Ali; Abbasi, Fahad Munir; Hayat, Tasawar; Alsaadi, Fuad			MHD Mixed Convective Peristaltic Motion of Nanofluid with Joule Heating and Thermophoresis Effects	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; TRANSPORT; FLUID; DUFOUR; SORET; SLIP; ENCLOSURE; CHANNEL	The primary objective of present investigation is to introduce the novel aspect of thermophoresis in the mixed convective peristaltic transport of viscous nanofluid. Viscous dissipation and Joule heating are also taken into account. Problem is modeled using the lubrication approach. Resulting system of equations is solved numerically. Effects of sundry parameters on the velocity, temperature, concentration of nanoparticles and heat and mass transfer rates at the wall are studied through graphs. It is noted that the concentration of nanoparticles near the boundaries is enhanced for larger thermophoresis parameter. However reverse situation is observed for an increase in the value of Brownian motion parameter. Further, the mass transfer rate at the wall significantly decreases when Brownian motion parameter is assigned higher values.	[Shehzad, Sabir Ali] Comsats Inst Informat Technol, Dept Math, Sahiwal, Pakistan; [Abbasi, Fahad Munir; Hayat, Tasawar] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaadi, Fuad] King Abdulaziz Univ, Fac Engn, Dept Elect & Comp Engn, CSN Res Grp, Jeddah 21413, Saudi Arabia	COMSATS University Islamabad (CUI); Quaid I Azam University; King Abdulaziz University	Shehzad, SA (corresponding author), Comsats Inst Informat Technol, Dept Math, Sahiwal, Pakistan.	s.a.shehzad@hotmail.com	Hayat, Tasawar/E-9449-2015; Alsaadi, Fuad E/Q-6022-2018; Shehzad, Sabir Ali/J-3885-2014; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/Y-2524-2019; Abbasi, Fahad/A-3471-2013	Alsaadi, Fuad E/0000-0001-6420-3948; 	Deanship of Scientific Research King Abdulaziz University, Jeddah, Saudi Arabia [37-16-35-HiCi]	Deanship of Scientific Research King Abdulaziz University, Jeddah, Saudi Arabia	This paper is funded by the Deanship of Scientific Research King Abdulaziz University, Jeddah, Saudi Arabia under grant no. 37-16-35-HiCi. The funder has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi FM, 2014, J AEROSPACE ENG, V27, DOI 10.1061/(ASCE)AS.1943-5525.0000354; Abbasi FM, 2014, Z NATURFORSCH A, V69, P451, DOI 10.5560/ZNA.2014-0041; Abbasi FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105440; Akbar NS, 2014, INT COMMUN HEAT MASS, V58, P193, DOI 10.1016/j.icheatmasstransfer.2014.08.036; Ali N, 2008, PHYS LETT A, V372, P1477, DOI 10.1016/j.physleta.2007.09.061; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Choi S.U.S., 1995, ASME, V66, P99, DOI DOI 10.1115/1.1532008; Eytan O, 1999, B MATH BIOL, V61, P221, DOI 10.1006/bulm.1998.0069; Hayat T, 2014, ARAB J SCI ENG, V39, P4341, DOI 10.1007/s13369-014-1163-y; Hayat T, 2014, J MOL LIQ, V194, P93, DOI 10.1016/j.molliq.2014.01.021; Hayat T, 2014, Z NATURFORSCH A, V69, P43, DOI 10.5560/ZNA.2013-0074; Hayat T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095070; Khanafer K, 2003, INT J HEAT MASS TRAN, V46, P3639, DOI 10.1016/S0017-9310(03)00156-X; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Kuznetsov AV, 2013, INT J HEAT MASS TRAN, V65, P682, DOI 10.1016/j.ijheatmasstransfer.2013.06.054; LEW HS, 1971, J BIOMECH, V4, P297, DOI 10.1016/0021-9290(71)90036-4; Mekheimer KS, 2013, INT J BIOMATH, V6, DOI 10.1142/S1793524513500265; Mekheimer KS, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/12/124702; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Rashidi MM, 2013, INT J HEAT MASS TRAN, V62, P515, DOI 10.1016/j.ijheatmasstransfer.2013.03.004; Rashidi MM, 2012, INT J THERM ENV ENG, V4, P13, DOI DOI 10.5383/IJTEE.04.01.003; Sheikholeslami M, 2014, SCI IRAN, V21, P203; Sheikholeslami M, 2014, J MOL LIQ, V193, P174, DOI 10.1016/j.molliq.2013.12.023; SrinivaS S, 2008, INT COMMUN HEAT MASS, V35, P514, DOI 10.1016/j.icheatmasstransfer.2007.08.011; SRIVASTAVA LM, 1988, RHEOL ACTA, V27, P428, DOI 10.1007/BF01332164; STROHMER H, 1994, FERTIL STERIL, V61, P972; Tripathi D, 2013, MATH COMPUT MODEL, V57, P1270, DOI 10.1016/j.mcm.2012.10.030; Turkyilmazoglu M, 2013, INT J MECH SCI, V77, P263, DOI 10.1016/j.ijmecsci.2013.10.011; Turkyilmazoglu M, 2012, CHEM ENG SCI, V84, P182, DOI 10.1016/j.ces.2012.08.029; Turkyilmazoglu M, 2014, COMPUT FLUIDS, V94, P139, DOI 10.1016/j.compfluid.2014.02.009	30	60	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111417	10.1371/journal.pone.0111417	http://dx.doi.org/10.1371/journal.pone.0111417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391147	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400022
J	Zhang, WS; Edwards, A; Flemington, E; Zhang, K				Zhang, Wensheng; Edwards, Andrea; Flemington, Erik; Zhang, Kun			Somatic Mutations Favorable to Patient Survival Are Predominant in Ovarian Carcinomas	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; SEMANTIC SIMILARITY; LYSOSOMES; RADIOTHERAPY; PROGNOSIS; SIGNATURE; DIAGNOSIS; PREDICTS; PROTEIN	Somatic mutation accumulation is a major cause of abnormal cell growth. However, some mutations in cancer cells may be deleterious to the survival and proliferation of the cancer cells, thus offering a protective effect to the patients. We investigated this hypothesis via a unique analysis of the clinical and somatic mutation datasets of ovarian carcinomas published by the Cancer Genome Atlas. We defined and screened 562 macro mutation signatures (MMSs) for their associations with the overall survival of 320 ovarian cancer patients. Each MMS measures the number of mutations present on the member genes (except for TP53) covered by a specific Gene Ontology (GO) term in each tumor. We found that somatic mutations favorable to the patient survival are predominant in ovarian carcinomas compared to those indicating poor clinical outcomes. Specially, we identified 19 (3) predictive MMSs that are, usually by a nonlinear dose-dependent effect, associated with good (poor) patient survival. The false discovery rate for the 19 "positive'' predictors is at the level of 0.15. The GO terms corresponding to these MMSs include "lysosomal membrane'' and "response to hypoxia'', each of which is relevant to the progression and therapy of cancer. Using these MMSs as features, we established a classification tree model which can effectively partition the training samples into three prognosis groups regarding the survival time. We validated this model on an independent dataset of the same disease (Log-rank p-value <2.3x10(-4)) and a dataset of breast cancer (Log-rank p-value <9.3x10(-23)). We compared the GO terms corresponding to these MMSs and those enriched with expression-based predictive genes. The analysis showed that the GO term pairs with large similarity are mainly pertinent to the proteins located on the cell organelles responsible for material transport and waste disposal, suggesting the crucial role of these proteins in cancer mortality.	[Zhang, Wensheng; Edwards, Andrea; Zhang, Kun] Xavier Univ Louisiana, Dept Comp Sci, New Orleans, LA USA; [Flemington, Erik] Tulane Canc Ctr, Tulane Sch Med, New Orleans, LA 70112 USA	Xavier University of Louisiana	Flemington, E (corresponding author), Tulane Canc Ctr, Tulane Sch Med, New Orleans, LA 70112 USA.	eflemin@tulane.edu; kzhang@xula.edu			National Institutes of Health [NIGMS-2G12MD007595]; US Department of Army [W911NF-12-1-0066]; Louisiana Cancer Research Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101046, R01AI106676] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Army; Louisiana Cancer Research Consortium; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Research reported in this publication was supported by a National Institutes of Health grant (NIGMS-2G12MD007595), an US Department of Army grant (W911NF-12-1-0066) and a seed grant from the Louisiana Cancer Research Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoudjit F, 2001, ONCOGENE, V20, P4995, DOI 10.1038/sj.onc.1204554; Aoudjit Fawzi, 2012, Chemother Res Pract, V2012, P283181, DOI 10.1155/2012/283181; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Berchuck A, 2005, CLIN CANCER RES, V11, P3686, DOI 10.1158/1078-0432.CCR-04-2398; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055037; Bunz F, 2008, PRINCIPLES CANC GENE, pxi; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cope L, 2013, GYNECOL ONCOL, V128, P500, DOI 10.1016/j.ygyno.2012.11.031; Dai W, 2013, CLIN CANCER RES, V19, P5788, DOI 10.1158/1078-0432.CCR-13-1217; Delfino KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058608; Engler DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030996; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Goff BA, 2000, CANCER, V89, P2068, DOI 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korosteleva O, 2009, CLIN STAT INTRO CLIN, pvii; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Li J, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-8; Li JA, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1043; Liu M, 2013, HISTOL HISTOPATHOL, V28, P481, DOI 10.14670/HH-28.481; Liu YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036383; Lopez-Lazaro M, 2010, MOL MED, V16, P144, DOI 10.2119/molmed.2009.00162; Mascolo M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-63; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Partheen K, 2006, EUR J CANCER, V42, P2846, DOI 10.1016/j.ejca.2006.06.026; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Repnik U, 2012, BBA-PROTEINS PROTEOM, V1824, P22, DOI 10.1016/j.bbapap.2011.08.016; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sawada G, 2013, ONCOL REP, V30, P1137, DOI 10.3892/or.2013.2597; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silwal-Pandit L, 2014, CLIN CANCER RES, V20, P3569, DOI 10.1158/1078-0432.CCR-13-2943; Sohn I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054089; Sohn I, 2012, GYNECOL ONCOL, V126, P103, DOI 10.1016/j.ygyno.2012.03.050; Tardy C, 2006, BBA-REV CANCER, V1765, P101, DOI 10.1016/j.bbcan.2005.11.003; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Therneau TM, 2000, MODELING SURVIVAL DA, pxiii; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Weinberg RA, 2007, BIOL CANC; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Wu JX, 2012, J BIOL CHEM, V287, P22919, DOI 10.1074/jbc.M112.351007; Yan ZJ, 2002, J BIOL CHEM, V277, P32379, DOI 10.1074/jbc.M203475200; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Zhang WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078868	57	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112561	10.1371/journal.pone.0112561	http://dx.doi.org/10.1371/journal.pone.0112561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390899	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400099
J	D'Souza, JW; Reddy, S; Goldsmith, LE; Shchaveleva, I; Marks, JD; Litwin, S; Robinson, MK				D'Souza, Jimson W.; Reddy, Smitha; Goldsmith, Lisa E.; Shchaveleva, Irina; Marks, James D.; Litwin, Samuel; Robinson, Matthew K.			Combining Anti-ERBB3 Antibodies Specific for Domain I and Domain III Enhances the Anti-Tumor Activity over the Individual Monoclonal Antibodies	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; METASTATIC BREAST-CANCER; FACTOR RECEPTOR; EXTRACELLULAR DOMAINS; TYROSINE KINASE; LIGAND-BINDING; TUMOR-GROWTH; CELL-LINES; HER3; ERBB3	Background: Inappropriate signaling through the epidermal growth factor receptor family (EGFR1/ERBB1, ERBB2/HER2, ERBB3/HER3, and ERBB4/HER4) of receptor tyrosine kinases leads to unregulated activation of multiple downstream signaling pathways that are linked to cancer formation and progression. In particular, ERBB3 plays a critical role in linking ERBB signaling to the phosphoinositide 3-kinase and Akt signaling pathway and increased levels of ERBB3-dependent signaling is also increasingly recognized as a mechanism for acquired resistance to ERBB-targeted therapies. Methods: We had previously reported the isolation of a panel of anti-ERBB3 single-chain Fv antibodies through use of phage-display technology. In the current study scFv specific for domain I (F4) and domain III (A5) were converted into human IgG1 formats and analyzed for efficacy. Results: Treatment of cells with an oligoclonal mixture of the A5/F4 IgGs appeared more effective at blocking both ligand-induced and ligand-independent signaling through ERBB3 than either single IgG alone. This correlated with improved ability to inhibit the cell growth both as a single agent and in combination with other ERBB-targeted therapies. Treatment of NCI-N87 tumor xenografts with the A5/F4 oligoclonal led to a statistically significant decrease in tumor growth rate that was further enhanced in combination with trastuzumab. Conclusion: These results suggest that an oligoclonal antibody mixture may be a more effective approach to downregulate ERBB3-dependent signaling.	[D'Souza, Jimson W.; Reddy, Smitha; Goldsmith, Lisa E.; Shchaveleva, Irina; Robinson, Matthew K.] Fox Chase Canc Ctr, Mol Therapeut Program, Philadelphia, PA 19111 USA; [Litwin, Samuel] Fox Chase Canc Ctr, Biostat & Bioinformat Facil, Philadelphia, PA 19111 USA; [Marks, James D.] Univ Calif San Francisco, Dept Anesthesia & Pharmaceut Chem, San Francisco, CA 94143 USA	Fox Chase Cancer Center; Fox Chase Cancer Center; University of California System; University of California San Francisco	Robinson, MK (corresponding author), Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	matthew.robinson@fccc.edu			American Cancer Society [MRSG-08-018-01-CDD]; NIH [CA09035, CA06927, P50 CA00588207]; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by American Cancer Society Grant MRSG-08-018-01-CDD (MKR), NIH post-doctoral training grant CA09035 (S.R., L.E.G.), NIH CORE Grant CA06927, and P50 CA00588207 (J.D.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIMANDI M, 1995, ONCOGENE, V10, P1813; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Baselga J, 2010, J CLIN ONCOL, V28, P1138, DOI 10.1200/JCO.2009.24.2024; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; Blackburn E, 2012, BREAST CANCER RES TR, V134, P53, DOI 10.1007/s10549-011-1908-1; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Campbell MR, 2010, CLIN CANCER RES, V16, P1373, DOI 10.1158/1078-0432.CCR-09-1218; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Garrett JT, 2013, CLIN CANCER RES, V19, P610, DOI 10.1158/1078-0432.CCR-12-2024; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Garrett JT, 2013, CANC RES; Gostring L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040023; Hettmann T, 2010, U3 1287 AMG 888 FULL; Horak E, 2005, CANCER BIOTHER RADIO, V20, P603, DOI 10.1089/cbr.2005.20.603; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Kani K, 2005, BIOCHEMISTRY-US, V44, P15842, DOI 10.1021/bi0515220; Lazrek Y, 2013, NEOPLASIA, V15, P335, DOI 10.1593/neo.121960; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Menendez JA, 2006, J CLIN ONCOL, V24, P3735, DOI 10.1200/JCO.2005.04.3489; Motoyama AB, 2002, CANCER RES, V62, P3151; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Ramakrishnan MS, 2009, MABS-AUSTIN, V1, P41, DOI 10.4161/mabs.1.1.7509; Robinson MK, 2008, BRIT J CANCER, V99, P1415, DOI 10.1038/sj.bjc.6604700; Robinson MK, 2011, CANC PRINCIPLES PRAC, P499; Rudnick SI, 2011, CANCER RES, V71, P2250, DOI 10.1158/0008-5472.CAN-10-2277; Sala G, 2012, ONCOGENE, V31, P1275, DOI 10.1038/onc.2011.322; Schaefer G, 2011, CANCER CELL, V20, P472, DOI 10.1016/j.ccr.2011.09.003; Schmiedel J, 2008, CANCER CELL, V13, P365, DOI 10.1016/j.ccr.2008.02.019; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Spangler JB, 2010, P NATL ACAD SCI USA, V107, P13252, DOI 10.1073/pnas.0913476107; Talavera A, 2009, CANCER RES, V69, P5851, DOI 10.1158/0008-5472.CAN-08-4518; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; van der Horst EH, 2005, INT J CANCER, V115, P519, DOI 10.1002/ijc.20867; Wakankar AA, 2010, BIOCONJUGATE CHEM, V21, P1588, DOI 10.1021/bc900434c; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhang K, 1996, J BIOL CHEM, V271, P3884	44	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112376	10.1371/journal.pone.0112376	http://dx.doi.org/10.1371/journal.pone.0112376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386657	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400058
J	Vicente-Dolera, N; Troadec, C; Moya, M; del Rio-Celestino, M; Pomares-Viciana, T; Bendahmane, A; Pico, B; Roman, B; Gomez, P				Vicente-Dolera, Nelly; Troadec, Christelle; Moya, Manuel; del Rio-Celestino, Mercedes; Pomares-Viciana, Teresa; Bendahmane, Abdelhafid; Pico, Belen; Roman, Belen; Gomez, Pedro			First TILLING Platform in Cucurbita pepo: A New Mutant Resource for Gene Function and Crop Improvement	PLOS ONE			English	Article							INDUCED MUTATIONS; DISCOVERY; POPULATION; TOOL	Although the availability of genetic and genomic resources for Cucurbita pepo has increased significantly, functional genomic resources are still limited for this crop. In this direction, we have developed a high throughput reverse genetic tool: the first TILLING (Targeting Induced Local Lesions IN Genomes) resource for this species. Additionally, we have used this resource to demonstrate that the previous EMS mutant population we developed has the highest mutation density compared with other cucurbits mutant populations. The overall mutation density in this first C. pepo TILLING platform was estimated to be 1/133 Kb by screening five additional genes. In total, 58 mutations confirmed by sequencing were identified in the five targeted genes, thirteen of which were predicted to have an impact on the function of the protein. The genotype/phenotype correlation was studied in a peroxidase gene, revealing that the phenotype of seedling homozygous for one of the isolated mutant alleles was albino. These results indicate that the TILLING approach in this species was successful at providing new mutations and can address the major challenge of linking sequence information to biological function and also the identification of novel variation for crop breeding.	[Vicente-Dolera, Nelly; Moya, Manuel; del Rio-Celestino, Mercedes; Pomares-Viciana, Teresa; Gomez, Pedro] IFAPA Ctr La Mojonera, La Mojonera, Almeria, Spain; [Troadec, Christelle; Bendahmane, Abdelhafid] INRA URGV, UMR1165, Unite Rech Genom Vegetale, Saclay Plant Sci, Evry, France; [Pico, Belen] Univ Politecn Valencia, Inst Conservat & Breeding Agr Biodivers COMAV UPV, Valencia 46022, Spain; [Roman, Belen] IFAPA Ctr Alameda del Obispo, Cordoba 14004, Spain	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universitat Politecnica de Valencia	Gomez, P (corresponding author), IFAPA Ctr La Mojonera, Camino San Nicolas 1, La Mojonera, Almeria, Spain.	pedro.gomez.j@juntadeandalucia.es	Del Río Celestino, Mercedes/C-3815-2016; Román, Belén/V-9092-2018; Román, Belén/ABG-8794-2020; PICO, BELEN/K-6517-2014	Del Río Celestino, Mercedes/0000-0001-9130-2669; Román, Belén/0000-0003-3796-5546; Román, Belén/0000-0003-3796-5546; PICO, BELEN/0000-0001-7761-990X; Bendahmane, Abdelhafid/0000-0003-3246-868X; TROADEC, Christelle/0000-0003-1927-7352	Spanish Project INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Almentaria) [RTA2011-00044C02-01]; ANR MELODY [ANR-11-BSV7-0024]; European Research Council (ERCSEXYPARTH); FEDER; FSE funds; Andalusian Institute of Agronomy Research IFAPA	Spanish Project INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Almentaria); ANR MELODY(French National Research Agency (ANR)); European Research Council (ERCSEXYPARTH)(European Research Council (ERC)); FEDER(European Commission); FSE funds; Andalusian Institute of Agronomy Research IFAPA	Financial support was provided by the Spanish Project INIA (Instituto Nacional de Investigacion y Tecnologia Agraria y Almentaria) RTA2011-00044C02-01, the ANR MELODY (ANR-11-BSV7-0024), the European Research Council (ERCSEXYPARTH), FEDER, and FSE funds. NVD has been awarded a grant by the Andalusian Institute of Agronomy Research IFAPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Boualem A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097963; Campa A., 1991, PEROXIDASES CHEM BIO, P25; Carpin S, 2001, PLANT CELL, V13, P511, DOI 10.1105/tpc.13.3.511; Carpin S, 1999, PLANT PHYSIOL, V120, P1; Chantreau M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-159; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Cosio C, 2009, PLANTA, V229, P823, DOI 10.1007/s00425-008-0876-0; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dalmais M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r43; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Elias Rana, 2009, BMC Res Notes, V2, P141, DOI 10.1186/1756-0500-2-141; Esteras C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-80; Gady ALF, 2012, MOL BREEDING, V29, P801, DOI 10.1007/s11032-011-9591-9; Gilchrist E, 2010, BRIEF FUNCT GENOMICS, V9, P103, DOI 10.1093/bfgp/elp059; Gonzalez Mireia, 2011, BMC Res Notes, V4, P289, DOI 10.1186/1756-0500-4-289; Greene EA, 2003, GENETICS, V164, P731; Kumar APK, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-38; Kurowska M, 2011, J APPL GENET, V52, P371, DOI 10.1007/s13353-011-0061-1; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Martin B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-147; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Obrero A, 2013, J AGR FOOD CHEM, V61, P6393, DOI 10.1021/jf4004576; Paris HS, 2003, THEOR APPL GENET, V106, P971, DOI 10.1007/S00122-002-1157-0; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Rigola D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004761; Schuller DJ, 1996, STRUCTURE, V4, P311, DOI 10.1016/S0969-2126(96)00035-4; Sisko M, 2003, PLANT SCI, V165, P663, DOI 10.1016/S0168-9452(03)00256-5; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; Till BJ, 2003, METH MOL B, V236, P205; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Vicente-Dolera N, 2014, SCI HORTIC-AMSTERDAM, V169, P14, DOI 10.1016/j.scienta.2014.01.045; Wang TL, 2012, PLANT BIOTECHNOL J, V10, P761, DOI 10.1111/j.1467-7652.2012.00708.x; Welinder KG, 2002, EUR J BIOCHEM, V269, P6063, DOI 10.1046/j.1432-1033.2002.03311.x; Whitwood W. N., 1978, Cucurbit Genetics Cooperative, P34; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103	42	20	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112743	10.1371/journal.pone.0112743	http://dx.doi.org/10.1371/journal.pone.0112743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386735	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400088
J	Zhou, CY; Li, G; Zhou, JJ; Han, N; Liu, ZH; Yin, J				Zhou, Chengyan; Li, Gang; Zhou, Jingjing; Han, Na; Liu, Zhihui; Yin, Jun			miR-107 Activates ATR/Chk1 Pathway and Suppress Cervical Cancer Invasion by Targeting MCL1	PLOS ONE			English	Article							MICRORNA; MIRNAS	MicroRNAs (miRNAs) are a class of single-stranded, non-coding RNAs of about 22 nucleotides in length. Increasing evidence implicates miRNAs may function as oncogenes or tumor suppressors. Here we showed that miR-107 directly targeted MCL1 and activated ATR/Chk1 pathway to inhibit proliferation, migration and invasiveness of cervical cancer cells. Moreover, we found that MCL1 was frequently up-regulated in cervical cancer, and knockdown of MCL1 markedly inhibited cancer cell proliferation, migration and invasion, whereas ectopic expression of MCL1 significantly enhances these properties. The restoration of MCL1 expression can counteract the effect of miR-107 on the cancer cells. Together, miR-107 is a new regulator of MCL1, and both miR-107 and MCL1 play important roles in the pathogenesis of cervical cancer. We have therefore identified a mechanism for ATR/Chk1 pathway which involves an increase in miR-107 leading to a decrease in MCL1. Correspondingly, our results revealed that miR-107 affected ATR/Chk1 signalling and gene expression, and implicated miR-107 as a therapeutic target in human cervical cancer. We also demonstrated that taxol attenuated migration and invasion in cervical cancer cells by activating the miR-107, in which miR-107 play an important role in regulating the expression of MCL1. Elucidation of this discovered MCL1 was directly regulated by miR-107 will greatly enhance our understanding of the mechanisms responsible for cervical cancer and will provide an additional arm for the development of anticancer therapies.	[Zhou, Chengyan; Zhou, Jingjing; Han, Na; Liu, Zhihui; Yin, Jun] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Key Lab Northeast Authent Mat Res & Dev Liaoning, Dev & Utilizat Key Lab Northeast Plant Mat, Shenyang 110016, Peoples R China; [Li, Gang] Harbin Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Harbin 150081, Peoples R China	Shenyang Pharmaceutical University; Harbin Medical University	Yin, J (corresponding author), Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Key Lab Northeast Authent Mat Res & Dev Liaoning, Dev & Utilizat Key Lab Northeast Plant Mat, Wenhua Rd 103, Shenyang 110016, Peoples R China.	junyin_good@163.com			National High Technology Research and Development Program of China (863 program) [2010AA023002]; National 12th Five-Year Scientific and Technical Support Program of China [2012BAI02B02]	National High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); National 12th Five-Year Scientific and Technical Support Program of China	This work was funded by National High Technology Research and Development Program of China (863 program) (2010AA023002) and the National 12th Five-Year Scientific and Technical Support Program of China (2012BAI02B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2013, CELL MOL NEUROBIOL, V33, P651, DOI 10.1007/s10571-013-9927-6; Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390; Hosaka K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3129; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Kanellopoulou C, 2009, P NATL ACAD SCI USA, V106, P1122, DOI 10.1073/pnas.0812210106; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Lamprecht B, 2010, NAT MED, V16, P571, DOI 10.1038/nm.2129; Lin CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2876; Liu J, 2008, CANCER RES, V68, P8871, DOI 10.1158/0008-5472.CAN-08-1972; Oakes SR, 2012, P NATL ACAD SCI USA, V109, P2766, DOI 10.1073/pnas.1104778108; Ojesina AI, 2014, NATURE, V506, P371, DOI 10.1038/nature12881; Pietrosiuk Agnieszka, 2004, Acta Pol Pharm, V61, P379; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Rob L, 2010, LANCET ONCOL, V11, P292, DOI 10.1016/S1470-2045(09)70191-3; Siciliano V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3364; Tai WT, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.18; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Xin JX, 2013, ONCOL LETT, V6, P1025, DOI 10.3892/ol.2013.1473; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Xue XC, 2014, EUR J IMMUNOL, V44, P673, DOI 10.1002/eji.201343717; Zhang HS, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1555	23	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111860	10.1371/journal.pone.0111860	http://dx.doi.org/10.1371/journal.pone.0111860			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386925	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400028
J	Li, XL; Sluijter, M; Doorduijn, EM; Kale, SP; McFerrin, H; Liu, YY; Li, Y; Mottamal, M; Yao, X; Du, FK; Gu, BH; Hoang, K; Nguyen, YH; Taylor, N; Stephens, CR; van Hall, T; Zhang, QJ				Li, Xiao-Lin; Sluijter, Marjolein; Doorduijn, Elien M.; Kale, Shubha P.; McFerrin, Harris; Liu, Yong-Yu; Li, Yan; Mottamal, Madhusoodanan; Yao, Xin; Du, Fengkun; Gu, Baihan; Hoang, Kim; Nguyen, Yen H.; Taylor, Nichelle; Stephens, Chelsea R.; van Hall, Thorbald; Zhang, Qian-Jin			Limited Density of an Antigen Presented by RMA-S Cells Requires B7-1/CD28 Signaling to Enhance T-Cell Immunity at the Effector Phase	PLOS ONE			English	Article							CANCER; CD80; COSTIMULATION; EXPRESSION; RECEPTOR; TAP; ACTIVATION; INDUCTION; ANTIBODY; THERAPY	The association of B7-1/CD28 between antigen presenting cells (APCs) and T-cells provides a second signal to proliferate and activate T-cell immunity at the induction phase. Many reports indicate that tumor cells transfected with B7-1 induced augmented antitumor immunity at the induction phase by mimicking APC function; however, the function of B7-1 on antitumor immunity at the effector phase is unknown. Here, we report direct evidence of enhanced T-cell antitumor immunity at the effector phase by the B7-1 molecule. Our experiments in vivo and in vitro indicated that reactivity of antigen-specific monoclonal and polyclonal T-cell effectors against a Lass5 epitope presented by RMA-S cells is increased when the cells expressed B7-1. Use of either anti-B7-1 or anti-CD28 antibodies to block the B7-1/CD28 association reduced reactivity of the T effectors against B7-1 positive RMA-S cells. Transfection of Lass5 cDNA into or pulse of Lass5 peptide onto B7-1 positive RMA-S cells overcomes the requirement of the B7-1/CD28 signal for T effector response. To our knowledge, the data offers, for the first time, strong evidence that supports the requirement of B7-1/CD28 secondary signal at the effector phase of antitumor T-cell immunity being dependent on the density of an antigenic peptide.	[Li, Xiao-Lin; Kale, Shubha P.; McFerrin, Harris; Li, Yan; Mottamal, Madhusoodanan; Yao, Xin; Du, Fengkun; Gu, Baihan; Hoang, Kim; Nguyen, Yen H.; Taylor, Nichelle; Stephens, Chelsea R.; Zhang, Qian-Jin] Xavier Univ, Dept Biol, New Orleans, LA 70125 USA; [Sluijter, Marjolein; Doorduijn, Elien M.; van Hall, Thorbald] Leiden Univ, Med Ctr, Leiden, Netherlands; [Liu, Yong-Yu] Univ Louisiana Monroe, Dept Basic Pharmaceut Sci, Monroe, LA USA; [Li, Yan] Hebei Univ, Coll Chem & Environm Sci, Baoding, Hebei Province, Peoples R China	Xavier University of Louisiana; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Louisiana System; University of Louisiana Monroe; Hebei University	Zhang, QJ (corresponding author), Xavier Univ, Dept Biol, New Orleans, LA 70125 USA.	qzhang2@xula.edu	van Hall, Thorbald/Y-5651-2018	van Hall, Thorbald/0000-0002-9115-558X; Liu, Yong-Yu/0000-0002-7968-0162	NIH (RCMI) [8G12MD007595]; Louisiana Cancer Research Consortium (LCRC); Xavier University's Center for Undergraduate Research (CUR); Dutch Cancer Society [UL2010-4785]; NIGMS [P20GM103424]; Louisiana Board of Regents Eminent Alumni Scholars Program, Kellogg Professorship IV in the Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103424] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007595] Funding Source: NIH RePORTER	NIH (RCMI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Cancer Research Consortium (LCRC); Xavier University's Center for Undergraduate Research (CUR); Dutch Cancer Society(KWF Kankerbestrijding); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Louisiana Board of Regents Eminent Alumni Scholars Program, Kellogg Professorship IV in the Arts and Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by funding from NIH (RCMI, 8G12MD007595), Louisiana Cancer Research Consortium (LCRC) and Xavier University's Center for Undergraduate Research (CUR) to Dr. Qian-Jin Zhang. Dr. Thorbald van Hallwas supported by Dutch Cancer Society (UL2010-4785). Dr. Harris McFerrin was supported by funding from the NIGMS (P20GM103424). This study was also supported by funding from Louisiana Board of Regents Eminent Alumni Scholars Program, Kellogg Professorship IV in the Arts and Sciences to Dr. Shubha P. Kale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anikeeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041466; Bai XF, 2001, J IMMUNOL, V167, P3936, DOI 10.4049/jimmunol.167.7.3936; Bixby DL, 1998, INT J CANCER, V78, P685, DOI 10.1002/(SICI)1097-0215(19981209)78:6<685::AID-IJC4>3.3.CO;2-3; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Boussiotis VA, 1996, IMMUNOL REV, V153, P5, DOI 10.1111/j.1600-065X.1996.tb00918.x; Boyerinas B, 2012, INT J CANCER, V130, P1787, DOI 10.1002/ijc.26190; Bueler H, 1996, MOL MED, V2, P545, DOI 10.1007/BF03401639; Chambers BJ, 1996, IMMUNITY, V5, P311, DOI 10.1016/S1074-7613(00)80257-5; CHEN LP, 1992, CELL, V71, P1093, DOI 10.1016/S0092-8674(05)80059-5; Cochran JR, 2001, TRENDS BIOCHEM SCI, V26, P304, DOI 10.1016/S0968-0004(01)01815-1; Dolfi DV, 2011, J IMMUNOL, V186, P4599, DOI 10.4049/jimmunol.1001972; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Germain RN, 1997, CURR BIOL, V7, pR640, DOI 10.1016/S0960-9822(06)00323-X; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; Kaufmann AM, 1997, CANCER GENE THER, V4, P377; Kelly JM, 2002, J IMMUNOL, V168, P4472, DOI 10.4049/jimmunol.168.9.4472; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; Li XL, 2009, IMMUNOLOGY, V128, P420, DOI 10.1111/j.1365-2567.2009.03127.x; Li XL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006385; Ly LV, 2013, J IMMUNOL, V190, P489, DOI 10.4049/jimmunol.1200135; Oliveira CC, 2011, EUR J IMMUNOL, V41, P3114, DOI 10.1002/eji.201141836; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; Ritz U, 2001, MOL MED, V7, P149, DOI 10.1007/BF03401948; ROBEY E, 1995, IMMUNOL TODAY, V16, P306, DOI 10.1016/0167-5699(95)80140-5; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; van Hall T, 2006, NAT MED, V12, P417, DOI 10.1038/nm1381; van Hall T, 2000, J EXP MED, V192, P483, DOI 10.1084/jem.192.4.483; VanGool SW, 1996, IMMUNOL REV, V153, P47; Wolpert EZ, 1997, P NATL ACAD SCI USA, V94, P11496, DOI 10.1073/pnas.94.21.11496; Wu Y, 1997, J EXP MED, V185, P1327, DOI 10.1084/jem.185.7.1327; Yu XZ, 2000, J IMMUNOL, V164, P4564, DOI 10.4049/jimmunol.164.9.4564; Zang XX, 2007, CLIN CANCER RES, V13, P5271, DOI 10.1158/1078-0432.CCR-07-1030	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e108192	10.1371/journal.pone.0108192	http://dx.doi.org/10.1371/journal.pone.0108192			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383875	Green Submitted, Green Published, gold			2022-12-26	WOS:000344816700002
J	Ksiazek, M; Mizgalska, D; Enghild, JJ; Scavenius, C; Thogersen, IB; Potempa, J				Ksiazek, Miroslaw; Mizgalska, Danuta; Enghild, Jan J.; Scavenius, Carsten; Thogersen, Ida B.; Potempa, Jan			Miropin, a Novel Bacterial Serpin from the Periodontopathogen Tannerella forsythia, Inhibits a Broad Range of Proteases by Using Different Peptide Bonds within the Reactive Center Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Infectious Disease; Periodontal Disease; Protease Inhibitor; Serine Protease; Serpin; Tannerella forsythia	NEUTROPHIL ELASTASE; SERINE PROTEASES; MECHANISM; TRYPSIN; ALPHA-1-ANTITRYPSIN; CHYMOTRYPSIN; SUPERFAMILY; INFECTIONS; PROTEINS; DISEASE	Background: Serpins are uncommon in bacteria; little is known about their function. Results: Serpin from T. forsythia (miropin) inhibits a broad array of proteases with divergent specificities. Conclusion: Miropin may allow T. forsythia to dwell in a highly proteolytic environment. Significance: Miropin is the first pathogen-derived serpin with the unusual ability to efficiently inhibit different proteases at several active sites. All prokaryotic genes encoding putative serpins identified to date are found in environmental and commensal microorganisms, and only very few prokaryotic serpins have been investigated from a mechanistic standpoint. Herein, we characterized a novel serpin (miropin) from the human pathogen Tannerella forsythia, a bacterium implicated in initiation and progression of human periodontitis. In contrast to other serpins, miropin efficiently inhibited a broad range of proteases (neutrophil and pancreatic elastases, cathepsin G, subtilisin, and trypsin) with a stoichiometry of inhibition of around 3 and second-order association rate constants that ranged from 2.7 x 10(4) (cathepsin G) to 7.1 x 10(5) m(-1)s(-1) (subtilisin). Inhibition was associated with the formation of complexes that were stable during SDS-PAGE. The unusually broad specificity of miropin for target proteases is achieved through different active sites within the reactive center loop upstream of the P1-P1 site, which was predicted from an alignment of the primary structure of miropin with those of well studied human and prokaryotic serpins. Thus, miropin is unique among inhibitory serpins, and it has apparently evolved the ability to inhibit a multitude of proteases at the expense of a high stoichiometry of inhibition and a low association rate constant. These characteristics suggest that miropin arose as an adaptation to the highly proteolytic environment of subgingival plaque, which is exposed continually to an array of host proteases in the inflammatory exudate. In such an environment, miropin may function as an important virulence factor by protecting bacterium from the destructive activity of neutrophil serine proteases. Alternatively, it may act as a housekeeping protein that regulates the activity of endogenous T. forsythia serine proteases.	[Ksiazek, Miroslaw; Mizgalska, Danuta; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, PL-30387 Krakow, Poland; [Enghild, Jan J.; Scavenius, Carsten; Thogersen, Ida B.] Aarhus Univ, Dept Mol Biol & Genet, Ctr Insoluble Prot Struct InSPIN, DK-8000 Aarhus, Denmark; [Enghild, Jan J.; Scavenius, Carsten; Thogersen, Ida B.] Aarhus Univ, Dept Mol Biol & Genet, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus, Denmark; [Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40202 USA	Jagiellonian University; Aarhus University; Aarhus University; University of Louisville	Ksiazek, M (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	ksiazek.miroslaw@gmail.com	Potempa, Jan/AAA-6850-2021; Scavenius, Carsten/Q-5941-2017	Enghild, Jan Johannes/0000-0001-9292-9172; Potempa, Jan/0000-0002-3600-7461; Scavenius, Carsten/0000-0002-4304-0681	National Institutes of Health [DE 09761, DE 022597]; National Science Center (NCN, Krakow, Poland) [2013/08/T/NZ1/00315, 2011/03/N/NZ1/00586]; NCN [2012/04/A/NZ1/00051]; European Commission [FP7-HEALTH-2010-261460, FP7-PEOPLE-2011-ITN-290246, FP7-HEALTH-F3-2012-306029]; Polish Ministry of Science and Higher Education [137/7.PR-EU/2011/2]; European Union [POIG.02.01.00-12-064/08]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761, R01DE022597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center (NCN, Krakow, Poland); NCN; European Commission(European CommissionEuropean Commission Joint Research Centre); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); European Union(European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants DE 09761 and DE 022597). This work was also supported by Grants 2013/08/T/NZ1/00315 (a doctoral scholarship) and 2011/03/N/NZ1/00586 from the National Science Center (NCN, Krakow, Poland; to M. K.) and by grants from the NCN (2012/04/A/NZ1/00051), European Commission (FP7-HEALTH-2010-261460 "Gums and Joints," FP7-PEOPLE-2011-ITN-290246 "RAPID," and FP7-HEALTH-F3-2012-306029 "TRIGGER"), and Polish Ministry of Science and Higher Education (project 137/7.PR-EU/2011/2; to J. P.). The Faculty of Biochemistry, Biophysics, and Biotechnology of the Jagiellonian University is a beneficiary of structural funds from the European Union (POIG.02.01.00-12-064/08).	Behle JH, 2006, INT DENT J, V56, P256; Belaaouaj A, 2002, MICROBES INFECT, V4, P1259, DOI 10.1016/S1286-4579(02)01654-4; Cabrita LD, 2007, J BIOL CHEM, V282, P26802, DOI 10.1074/jbc.M705020200; CARRELL RW, 1985, NATURE, V317, P730, DOI 10.1038/317730a0; Cerda-Costa N, 2011, MOL MICROBIOL, V79, P119, DOI 10.1111/j.1365-2958.2010.07434.x; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Dahl SW, 1996, J BIOL CHEM, V271, P25083, DOI 10.1074/jbc.271.41.25083; Dahlen JR, 1998, J BIOL CHEM, V273, P1851, DOI 10.1074/jbc.273.4.1851; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Djie MZ, 1996, BIOCHEMISTRY-US, V35, P11461, DOI 10.1021/bi952717i; Eggers CT, 2004, BIOCHEM J, V379, P107, DOI 10.1042/BJ20031790; Flemmig T F, 1999, Ann Periodontol, V4, P32, DOI 10.1902/annals.1999.4.1.32; Fox C H, 1992, Curr Opin Dent, V2, P5; Garcia R I, 2001, Ann Periodontol, V6, P71, DOI 10.1902/annals.2001.6.1.71; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huntington James A., 2001, Science Progress, V84, P125, DOI 10.3184/003685001783239032; Irving JA, 2003, STRUCTURE, V11, P387, DOI 10.1016/S0969-2126(03)00057-1; Irving JA, 2002, MOL BIOL EVOL, V19, P1881, DOI 10.1093/oxfordjournals.molbev.a004012; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Ivanov D, 2006, J BIOL CHEM, V281, P17246, DOI 10.1074/jbc.M601678200; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kang SH, 2006, MOL MICROBIOL, V60, P1344, DOI 10.1111/j.1365-2958.2006.05182.x; Kantyka T, 2011, BIOL CHEM, V392, P483, DOI 10.1515/BC.2011.044; Kantyka T, 2010, BIOCHIMIE, V92, P1644, DOI 10.1016/j.biochi.2010.06.004; Mailhot JM, 1998, J CLIN PERIODONTOL, V25, P578, DOI 10.1111/j.1600-051X.1998.tb02491.x; Mast AE, 1999, BLOOD, V94, P3922, DOI 10.1182/blood.V94.11.3922.423k33_3922_3927; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Ostergaard H, 2000, J BIOL CHEM, V275, P33272, DOI 10.1074/jbc.M004633200; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Peter J, 2000, CLIN CHEM, V46, P474; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; POTEMPA J, 1991, J BIOL CHEM, V266, P21482; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; Riewald M, 1996, J BIOL CHEM, V271, P14526, DOI 10.1074/jbc.271.24.14526; Roberts TH, 2004, J MOL EVOL, V59, P437, DOI 10.1007/s00239-004-2635-6; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Stanley P, 2006, BIOCHEM J, V400, P169, DOI 10.1042/BJ20060444; Tanaka S, 2011, BBA-PROTEINS PROTEOM, V1814, P299, DOI 10.1016/j.bbapap.2010.11.003; Wang CY, 2010, J MICROBIOL IMMUNOL, V43, P491, DOI 10.1016/S1684-1182(10)60076-X; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Zhang Q, 2007, EMBO REP, V8, P658, DOI 10.1038/sj.embor.7400986	47	38	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					658	670		10.1074/jbc.M114.601716	http://dx.doi.org/10.1074/jbc.M114.601716			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389290	hybrid, Green Published			2022-12-26	WOS:000347231200056
J	Chen, SJ; Hoffman, NE; Shanmughapriya, S; Bao, L; Keefer, K; Conrad, K; Merali, S; Takahashi, Y; Abraham, T; Hirschler-Laszkiewicz, I; Wang, JF; Zhang, XQ; Song, JL; Barrero, C; Shi, YG; Kawasawa, YI; Bayerl, M; Sun, TY; Barbour, M; Wang, HG; Madesh, M; Cheung, JY; Miller, BA				Chen, Shu-jen; Hoffman, Nicholas E.; Shanmughapriya, Santhanam; Bao, Lei; Keefer, Kerry; Conrad, Kathleen; Merali, Salim; Takahashi, Yoshinori; Abraham, Thomas; Hirschler-Laszkiewicz, Iwona; Wang, JuFang; Zhang, Xue-Qian; Song, Jianliang; Barrero, Carlos; Shi, Yuguang; Kawasawa, Yuka Imamura; Bayerl, Michael; Sun, Tianyu; Barbour, Mustafa; Wang, Hong-Gang; Madesh, Muniswamy; Cheung, Joseph Y.; Miller, Barbara A.			A Splice Variant of the Human Ion Channel TRPM2 Modulates Neuroblastoma Tumor Growth through Hypoxia-inducible Factor (HIF)-1/2 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; MITOCHONDRIAL CA2+ UPTAKE; OXIDATIVE STRESS; ADP-RIBOSE; CATION CHANNEL; HYDROGEN-PEROXIDE; INTRACELLULAR CALCIUM; CELL-PROLIFERATION; DOWN-REGULATION; CANCER-CELLS	The calcium-permeable ion channel TRPM2 is highly expressed in a number of cancers. In neuroblastoma, full-length TRPM2 (TRPM2-L) protected cells from moderate oxidative stress through increased levels of forkhead box transcription factor 3a (FOXO3a) and superoxide dismutase 2. Cells expressing the dominant negative short isoform (TRPM2-S) had reduced FOXO3a and superoxide dismutase 2 levels, reduced calcium influx in response to oxidative stress, and enhanced reactive oxygen species, leading to decreased cell viability. Here, in xenografts generated with SH-SY5Y neuroblastoma cells stably expressing TRPM2 isoforms, growth of tumors expressing TRPM2-S was significantly reduced compared with tumors expressing TRPM2-L. Expression of hypoxia-inducible factor (HIF)-1/2 alpha was significantly reduced in TRPM2-S-expressing tumor cells as was expression of target proteins regulated by HIF-1/2 alpha including those involved in glycolysis (lactate dehydrogenase A and enolase 2), oxidant stress (FOXO3a), angiogenesis (VEGF), mitophagy and mitochondrial function (BNIP3 and NDUFA4L2), and mitochondrial electron transport chain activity (cytochrome oxidase 4.1/4.2 in complex IV). The reduction in HIF-1/2 alpha was mediated through both significantly reduced HIF-1/2 alpha mRNA levels and increased levels of von Hippel-Lindau E3 ligase in TRPM2-S-expressing cells. Inhibition of TRPM2-L by pretreatment with clotrimazole or expression of TRPM2-S significantly increased sensitivity of cells to doxorubicin. Reduced survival of TRPM2-S-expressing cells after doxorubicin treatment was rescued by gain of HIF-1 or -2 alpha function. These data suggest that TRPM2 activity is important for tumor growth and for cell viability and survival following doxorubicin treatment and that interference with TRPM2-L function may be a novel approach to reduce tumor growth through modulation of HIF-1/2 alpha, mitochondrial function, and mitophagy.	[Chen, Shu-jen; Bao, Lei; Keefer, Kerry; Conrad, Kathleen; Takahashi, Yoshinori; Hirschler-Laszkiewicz, Iwona; Sun, Tianyu; Barbour, Mustafa; Wang, Hong-Gang; Miller, Barbara A.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura; Miller, Barbara A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Takahashi, Yoshinori; Kawasawa, Yuka Imamura; Wang, Hong-Gang] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Bayerl, Michael] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Coll Med, Inst Personalized Med, Hershey, PA 17033 USA; [Abraham, Thomas] Penn State Univ, Coll Med, Hershey, PA 17033 USA; [Hoffman, Nicholas E.; Shanmughapriya, Santhanam; Wang, JuFang; Zhang, Xue-Qian; Song, Jianliang; Madesh, Muniswamy; Cheung, Joseph Y.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA; [Hoffman, Nicholas E.; Shanmughapriya, Santhanam; Merali, Salim; Barrero, Carlos; Madesh, Muniswamy] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Cheung, Joseph Y.] Temple Univ, Sch Med, Dept Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Miller, BA (corresponding author), Penn State Univ, Milton S Hershey Med Ctr, Dept Pediat, POB 850, Hershey, PA 17033 USA.	bmiller3@psu.edu	Abraham, Thomas/J-7080-2014; Wang, Hong-Gang/A-3018-2015; Abraham, Thomas/AAJ-7950-2020; Shanmughapriya, Santhanam/P-2828-2017	Abraham, Thomas/0000-0003-0750-8774; Wang, Hong-Gang/0000-0003-0551-0571; Takahashi, Yoshinori/0000-0002-8004-4817; Barrero, Carlos/0000-0001-5779-6642; Shanmughapriya, Santhanam/0000-0003-1041-8198	National Institutes of Health [RO1-DK46778, RO1-HL86699, RO1-HL58672, RO1-HL74854]; Hyundai Hope-on-Wheels Foundation; Pennsylvania State University College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058672, R01HL074854, R01HL086699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hyundai Hope-on-Wheels Foundation; Pennsylvania State University College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK46778 (to B. A. M.), RO1-HL86699 (to M. M.), and RO1-HL58672 and RO1-HL74854 (to J. Y. C.). This work was also supported by grants from the Hyundai Hope-on-Wheels Foundation (to B. A. M.) and by the Four Diamonds Fund of the Pennsylvania State University College of Medicine.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bai JZ, 2010, NEUROTOXICOLOGY, V31, P204, DOI 10.1016/j.neuro.2010.01.001; Barlow AL, 2010, MICROSC MICROANAL, V16, P710, DOI 10.1017/S143192761009389X; Barrero CA, 2013, AM J RESP CRIT CARE, V188, P673, DOI 10.1164/rccm.201302-0342OC; Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC548, DOI 10.1152/ajpcell.00069.2012; Cheung JY, 1997, BLOOD, V89, P92, DOI 10.1182/blood.V89.1.92.92_92_100; Csanady L, 2010, J PHYSIOL-LONDON, V588, P1661, DOI 10.1113/jphysiol.2010.190223; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Du JY, 2009, P NATL ACAD SCI USA, V106, P7239, DOI 10.1073/pnas.0811725106; Duncan LM, 1998, CANCER RES, V58, P1515; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Faouzi M, 2014, HANDB EXP PHARMACOL, V222, P403, DOI 10.1007/978-3-642-54215-2_16; Feng SJ, 2013, P NATL ACAD SCI USA, V110, P11011, DOI 10.1073/pnas.1309531110; Fonfria E, 2005, J NEUROCHEM, V95, P715, DOI 10.1111/j.1471-4159.2005.03396.x; Fonfria E, 2004, BRIT J PHARMACOL, V143, P186, DOI 10.1038/sj.bjp.0705914; Fredlund E, 2008, BIOCHEM BIOPH RES CO, V366, P1054, DOI 10.1016/j.bbrc.2007.12.074; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gasser A, 2006, J BIOL CHEM, V281, P2489, DOI 10.1074/jbc.M506525200; Gilliam LAA, 2012, AM J PHYSIOL-CELL PH, V302, pC195, DOI 10.1152/ajpcell.00217.2011; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Gustafsson AB, 2011, PEDIATR CARDIOL, V32, P267, DOI 10.1007/s00246-010-9876-5; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hecquet CM, 2008, CIRC RES, V102, P347, DOI 10.1161/CIRCRESAHA.107.160176; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Hill K, 2004, N-S ARCH PHARMACOL, V370, P227, DOI 10.1007/s00210-004-0981-y; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Kang YJ, 1996, J BIOL CHEM, V271, P12610, DOI 10.1074/jbc.271.21.12610; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Kornmann B, 2013, CURR OPIN CELL BIOL, V25, P443, DOI 10.1016/j.ceb.2013.02.010; Lackner LL, 2013, P NATL ACAD SCI USA, V110, pE458, DOI 10.1073/pnas.1215232110; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MY, 2006, J BIOL CHEM, V281, P40429, DOI 10.1074/jbc.M606596200; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Maynard MA, 2007, CELL MOL LIFE SCI, V64, P2170, DOI 10.1007/s00018-007-7082-2; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Miller BA, 1999, J BIOL CHEM, V274, P20465, DOI 10.1074/jbc.274.29.20465; Miller BA, 2014, J BIOL CHEM, V289, P7615, DOI 10.1074/jbc.M113.533851; Miller BA, 2013, AM J PHYSIOL-HEART C, V304, pH1010, DOI 10.1152/ajpheart.00906.2012; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Mohlin S, 2013, NEOPLASIA, V15, P328, DOI 10.1593/neo.121706; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Noguera R, 2009, CLIN CANCER RES, V15, P7130, DOI 10.1158/1078-0432.CCR-09-0223; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Prawitt D, 2000, HUM MOL GENET, V9, P203, DOI 10.1093/hmg/9.2.203; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tong Q, 2006, J BIOL CHEM, V281, P9076, DOI 10.1074/jbc.M510422200; Toth B, 2010, J BIOL CHEM, V285, P30091, DOI 10.1074/jbc.M109.066464; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsavaler L, 2001, CANCER RES, V61, P3760; Uemura T, 2005, BIOCHEM BIOPH RES CO, V328, P1232, DOI 10.1016/j.bbrc.2005.01.086; Vadrot N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040879; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wang JF, 2011, AM J PHYSIOL-HEART C, V300, pH859, DOI 10.1152/ajpheart.00894.2010; Wehage E, 2002, J BIOL CHEM, V277, P23150, DOI 10.1074/jbc.M112096200; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Young MM, 2012, J BIOL CHEM, V287, P12455, DOI 10.1074/jbc.M111.309104; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	85	64	66	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36284	36302		10.1074/jbc.M114.620922	http://dx.doi.org/10.1074/jbc.M114.620922			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25391657	hybrid, Green Published			2022-12-26	WOS:000346897900052
J	Manoussakis, MN; Fragoulis, GE; Vakrakou, AG; Moutsopoulos, HM				Manoussakis, Menelaos N.; Fragoulis, George E.; Vakrakou, Aigli G.; Moutsopoulos, Haralampos M.			Impaired Clearance of Early Apoptotic Cells Mediated by Inhibitory IgG Antibodies in Patients with Primary Sjogren's Syndrome	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MANNOSE-BINDING LECTIN; IN-VITRO; CLASSIFICATION CRITERIA; RHEUMATOID-ARTHRITIS; PHAGOCYTIC CLEARANCE; AMERICAN-COLLEGE; EPITHELIAL-CELLS; NECROTIC CELLS; DAMAGE INDEX	Objectives: Deficient efferocytosis (i.e. phagocytic clearance of apoptotic cells) has been frequently reported in systemic lupus erythematosus (SLE). Todate, patients with primary Sjogren's syndrome (SS) have not been assessed for phagocytosis of apoptotic cells (ApoCell-phagocytosis) and of particulate targets (microbeads, MB-phagocytosis). Design: ApoCell-phagocytosis and MB-phagocytosis were comparatively assessed by flow cytometry in peripheral blood specimens and monocyte-derived macrophage (MDM) preparations from healthy blood donors (HBD) and consecutive SS, SLE and rheumatoid arthritis (RA) patients. Cross-admixture ApoCell-phagocytosis experiments were also performed using phagocytes from HBD or patients, and apoptotic cells pretreated with whole sera or purified serum IgG derived from patients or HBD. Results: Compared to HBD, approximately half of SS and SLE patients studied (but not RA) manifested significantly reduced ApoCell-phagocytosis (p<0.001) and MB-phagocytosis (p<0.003) by blood-borne phagocytes that correlated inversely with disease activity (p <= 0.004). In cross-admixture assays, healthy monocytes showed significantly reduced ApoCell-phagocytosis when fed with apoptotic cells that were pretreated with sera or purified serum IgG preparations from SS and SLE patients (p<0.0001, compared to those from HBD or RA). Such aberrant effect of the SS and SLE sera and IgG preparations correlated linearly with their content of IgG antibodies against apoptotic cells (p <= 0.0001). Phagocytic dysfunction maybe also present in certain SS and SLE patients, as supported by deficient capacity of MDM for ApoCell-phagocytosis and MB-phagocytosis under patients' serum-free conditions. Conclusion: Similarly to SLE, efferocytosis is frequently impaired in SS and is primarily due to the presence of inhibitory IgG anti-ApoCell antibodies and secondarily to phagocytes' dysfunction.	[Manoussakis, Menelaos N.; Fragoulis, George E.; Vakrakou, Aigli G.; Moutsopoulos, Haralampos M.] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece; [Manoussakis, Menelaos N.] Hellenic Pasteur Inst, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens	Manoussakis, MN (corresponding author), Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece.	menman@med.uoa.gr	Manoussakis, Menelaos/AAI-3348-2020	Manoussakis, Menelaos/0000-0001-6415-0946; Fragoulis, George/0000-0003-4932-7023	Hellenic Rheumatology Society [ERE141/10]; Propondis Foundation; Lillian Voudouri Foundation	Hellenic Rheumatology Society; Propondis Foundation; Lillian Voudouri Foundation	The study was supported by grants from the Hellenic Rheumatology Society (ERE141/10 to M.N.M), the Propondis Foundation (to A.G.V.) and the Lillian Voudouri Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Allina J, 2008, J AUTOIMMUN, V30, P238, DOI 10.1016/j.jaut.2007.10.003; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Bijl M, 2006, ANN RHEUM DIS, V65, P57, DOI 10.1136/ard.2005.035733; CASCIOLAROSEN LA, 1994, J EXP MED, V179, P1317, DOI 10.1084/jem.179.4.1317; Chen XW, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3230; Clancy RM, 2006, J CLIN INVEST, V116, P2413, DOI 10.1172/JCI27803; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Fragoulis GE, 2014, J AUTOIMMUN; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gantner F, 1997, BRIT J PHARMACOL, V121, P221, DOI 10.1038/sj.bjp.0701124; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gullstrand B, 2009, CLIN EXP IMMUNOL, V156, P303, DOI 10.1111/j.1365-2249.2009.03896.x; HAN HX, 1993, CELL TISSUE RES, V271, P407, DOI 10.1007/BF02913723; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; HOPKINSONWOOLLEY J, 1994, J CELL SCI, V107, P1159; Ioannidis JPA, 2002, ARTHRITIS RHEUM, V46, P741, DOI 10.1002/art.10221; Katsiari CG, 2010, SEMIN ARTHRITIS RHEU, V39, P491, DOI 10.1016/j.semarthrit.2008.11.002; Kenyon KD, 2011, J IMMUNOL, V187, P2101, DOI 10.4049/jimmunol.1003468; KIMBERLY RP, 1989, CLIN EXP RHEUMATOL, V7, pS103; Licht R, 2004, J AUTOIMMUN, V22, P139, DOI 10.1016/j.jaut.2003.11.003; Litvack ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017223; MAJNO G, 1995, AM J PATHOL, V146, P3; Manoussakis MN, 2010, J AUTOIMMUN, V35, P212, DOI 10.1016/j.jaut.2010.06.010; Manoussakis MN, 2004, ARTHRITIS RHEUM-US, V50, P882, DOI 10.1002/art.20093; Munoz LE, 2008, LUPUS, V17, P371, DOI 10.1177/0961203308089990; Munoz LE, 2009, ARTHRITIS RHEUM-US, V60, P1733, DOI 10.1002/art.24535; O'Brien BA, 2006, J AUTOIMMUN, V26, P104, DOI 10.1016/j.jaut.2005.11.006; Ogden CA, 2006, CURR DIRECT AUTOIMMU, V9, P120; Okuma A, 2013, IMMUNITY, V38, P450, DOI 10.1016/j.immuni.2012.11.016; Ramos-Casals M, 2009, RHEUMATOLOGY, V48, P65, DOI 10.1093/rheumatology/ken411; Reefman E, 2007, ARTHRITIS RHEUM, V56, P3399, DOI 10.1002/art.22947; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Salomonsson S, 2003, ARTHRITIS RHEUM-US, V48, P3187, DOI 10.1002/art.11311; Sarmiento LF, 2007, AUTOIMMUNITY, V40, P337, DOI 10.1080/08916930701356663; Selmi C, 2012, J AUTOIMMUN, V39, P34, DOI 10.1016/j.jaut.2011.11.005; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1108, P227, DOI 10.1196/annals.1422.025; Shoshan Y, 2001, J IMMUNOL, V167, P5963, DOI 10.4049/jimmunol.167.10.5963; SVENSSON BO, 1975, SCAND J IMMUNOL, V4, P145, DOI 10.1111/j.1365-3083.1975.tb02611.x; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tas SW, 2006, ANN RHEUM DIS, V65, P216, DOI 10.1136/ard.2005.037143; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Viorritto ICB, 2007, CLIN IMMUNOL, V122, P125, DOI 10.1016/j.clim.2006.07.012; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2007, ARTHRITIS RHEUM-US, V56, P2223, DOI 10.1002/art.22658; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022	50	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112100	10.1371/journal.pone.0112100	http://dx.doi.org/10.1371/journal.pone.0112100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396412	Green Submitted, gold, Green Published			2022-12-26	WOS:000345558500033
J	Lessin, G; Raudsepp, U; Stips, A				Lessin, Gennadi; Raudsepp, Urmas; Stips, Adolf			Modelling the Influence of Major Baltic Inflows on Near-Bottom Conditions at the Entrance of the Gulf of Finland	PLOS ONE			English	Article							CYANOBACTERIA BLOOMS; NITROGEN-FIXATION; DISSOLVED-OXYGEN; ECOSYSTEM MODEL; SEA; EUTROPHICATION; HYPOXIA; BALANCE; BASINS; STATE	A coupled hydrodynamic-biogeochemical model was implemented in order to estimate the effects of Major Baltic Inflows on the near-bottom hydrophysical and biogeochemical conditions in the northern Baltic Proper and the western Gulf of Finland during the period 1991-2009. We compared results of a realistic reference run to the results of an experimental run where Major Baltic Inflows were suppressed. Further to the expected overall decrease in bottom salinity, this modelling experiment confirms that in the absence of strong saltwater inflows the deep areas of the Baltic Proper would become more anoxic, while in the shallower areas (western Gulf of Finland) near-bottom average conditions improve. Our experiment revealed that typical estuarine circulation results in the sporadic emergence of short-lasting events of near-bottom anoxia in the western Gulf of Finland due to transport of water masses from the Baltic Proper. Extrapolating our results beyond the modelled period, we speculate that the further deepening of the halocline in the Baltic Proper is likely to prevent inflows of anoxic water to the Gulf of Finland and in the longer term would lead to improvement in near-bottom conditions in the Baltic Proper. Our results reaffirm the importance of accurate representation of salinity dynamics in coupled Baltic Sea models serving as a basis for credible hindcast and future projection simulations of biogeochemical conditions.	[Lessin, Gennadi] Plymouth Marine Lab, Plymouth, Devon, England; [Raudsepp, Urmas] Tallinn Univ Technol, Marine Syst Inst, EE-19086 Tallinn, Estonia; [Stips, Adolf] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, Water Res Unit, I-21020 Ispra, Italy	Plymouth Marine Laboratory; Tallinn University of Technology; European Commission Joint Research Centre; EC JRC ISPRA Site	Lessin, G (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England.	gle@pml.ac.uk		Raudsepp, Urmas/0000-0002-1037-5311	Natural Environment Research Council [NE/E011314/1, pml010010] Funding Source: researchfish; NERC [NE/E011314/1, pml010010] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 2001, BALT SEA SCI C STOCK; BIERMAN VJ, 1994, ESTUARIES, V17, P886, DOI 10.2307/1352756; Burchard H, 2004, OCEAN DYNAM, V54, P250, DOI 10.1007/s10236-003-0073-4; Burchard H., 2002, 20253 EN EUR; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3412, DOI 10.1021/es802762a; Conley DJ, 2009, ENVIRON SCI TECHNOL, V43, P3407, DOI 10.1021/es8027633; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Eilola K, 2011, J MARINE SYST, V88, P267, DOI 10.1016/j.jmarsys.2011.05.004; Eilola K, 2009, J MARINE SYST, V75, P163, DOI 10.1016/j.jmarsys.2008.08.009; Elken J, 2014, J MARINE SYST, V129, P47, DOI 10.1016/j.jmarsys.2013.04.015; Fischer H, 1996, J MARINE SYST, V9, P137, DOI 10.1016/S0924-7963(96)00046-2; Franck H., 1987, Gerlands Beitraege zur Geophysik, V96, P517; Gustafsson B. G., 2008, C82 GOT U EARTH SCI; Heiser U, 2001, MAR GEOL, V177, P151, DOI 10.1016/S0025-3227(01)00129-3; HELCOM, 2011, SEA ENV P; Hofmeister R, 2011, OCEAN MODEL, V39, P233, DOI 10.1016/j.ocemod.2011.04.007; Hong B, 2012, ECOL MODEL, V227, P117, DOI 10.1016/j.ecolmodel.2011.12.002; Janssen F, 1999, OCEAN DYNAM, V51, P5; Kahru M, 2000, MAR ECOL PROG SER, V207, P13, DOI 10.3354/meps207013; Kauppila P, 2001, FINNISH ENV, V472, P61; Laane A, 2002, TECHNICAL REPORT; Laine AO, 2007, J SEA RES, V57, P65, DOI 10.1016/j.seares.2006.08.003; Lehtoranta J, 2008, J MARINE SYST, V74, P495, DOI 10.1016/j.jmarsys.2008.04.001; Lessin G, 2012, IEEE OES BALT 2012 I; Lessin G, 2012, BALT INT S BALTIC 20, P1; Lessin G, 2014, J MARINE SYST, V129, P76, DOI 10.1016/j.jmarsys.2013.08.006; Liblik T, 2013, OCEAN SCI, V9, P917, DOI 10.5194/os-9-917-2013; Lundberg C, 2005, MAR POLLUT BULL, V50, P1185, DOI 10.1016/j.marpolbul.2005.04.029; MATTHAUS W, 1992, CONT SHELF RES, V12, P1375, DOI 10.1016/0278-4343(92)90060-W; Matthaus W., 2008, STATE EVOLUTION BALT, P265, DOI [10.1002/9780470283134.ch10, DOI 10.1002/9780470283134.CH10]; MATTHAUS W, 2006, HIST INVESTIGATION S; Meier HEM, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000521; Neumann T, 2000, J MARINE SYST, V25, P405, DOI 10.1016/S0924-7963(00)00030-0; Neumann T, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001450; Neumann T, 2008, J MARINE SYST, V74, P592, DOI 10.1016/j.jmarsys.2008.05.003; Olsonen R, 2007, ANN REPORT, V62; Pena MA, 2010, BIOGEOSCIENCES, V7, P933, DOI 10.5194/bg-7-933-2010; Pitkaenen H., 2008, V197, P285, DOI 10.1007/978-3-540-73524-3_13; Pohl C., 2008, STATE EVOLUTION BALT, P367; Raateoja M, 2005, AMBIO, V34, P188, DOI 10.1639/0044-7447(2005)034[0188:RCITSO]2.0.CO;2; Resplandy L, 2012, BIOGEOSCIENCES, V9, P5095, DOI 10.5194/bg-9-5095-2012; Schiewer U., 2008, ECOLOGICAL STUDIES, V197; Stigebrandt A, 2003, J SEA RES, V49, P243, DOI 10.1016/S1385-1101(03)00021-2; Umlauf L, 2005, CONT SHELF RES, V25, P795, DOI 10.1016/j.csr.2004.08.004; Vahtera E, 2007, AMBIO, V36, P186, DOI 10.1579/0044-7447(2007)36[186:IEFENC]2.0.CO;2; Yakushev EV, 2007, MAR CHEM, V107, P388, DOI 10.1016/j.marchem.2007.06.003; Yakushev EV, 2011, COMPUT GEOSCI-UK, V37, P398, DOI 10.1016/j.cageo.2011.01.001	47	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112881	10.1371/journal.pone.0112881	http://dx.doi.org/10.1371/journal.pone.0112881			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393720	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000347709300117
J	Probst, M; Hoeller, C; Ferenci, P; Staettermayer, AF; Beinhardt, S; Pehamberger, H; Kittler, H; Grabmeier-Pfistershammer, K				Probst, Martin; Hoeller, Christoph; Ferenci, Peter; Staettermayer, Albert F.; Beinhardt, Sandra; Pehamberger, Hubert; Kittler, Harald; Grabmeier-Pfistershammer, Katharina			IL28B Polymorphism Cannot Predict Response to Interferon Alpha Treatment in Patients with Melanoma	PLOS ONE			English	Article							COOPERATIVE-ONCOLOGY-GROUP; HIGH-RISK MELANOMA; HEPATITIS-C VIRUS; ADJUVANT THERAPY; GENETIC-VARIATION; DOSE INTERFERON-ALPHA-2B; TRIAL; EXPRESSION; GENOTYPE; STAGE	Background: Recent genome-wide association studies revealed the rs12979860 single nucleotide polymorphism (SNP) of the IL28B gene (CC genotype) to be the strongest pre-therapeutic predictor of therapy response to interferon alpha in patients with chronic hepatitis C infection. The favorable CC genotype is associated with significantly higher rates of sustained virologic response. No data exist on the role of IL28B polymorphism in interferon therapy of diseases other than viral hepatitis. Methods: A retrospective study involving 106 patients with melanoma who received low-or high-dose interferon therapy was performed. The CC and non-CC genotype of IL28B rs12979860 SNP were correlated with progression-free and overall survival. Results: 44 (41.5%) patients were CC and 62 (58.5%) non-CC. There was no statistically significant difference in age at diagnosis, melanoma type or localization, Breslow level or AJCC stage between CC and non-CC patients. During the observation period (6.43 +/- 4.66 years) disease progression occurred in 36 (34%) patients after 5.5 +/- 4.3 years. 43.2% (19) of patients with CC and 27.4% (17) of patients with non-CC genotype were affected (p = 0.091). Disease progression was more frequent in patients on high dose interferon therapy and with a worse AJCC stage. Conclusion: In contrast to classical risk factors like tumor thickness and clinical stage, IL28B polymorphism was not associated with progression-free or overall survival in patients with melanoma treated with interferon alpha.	[Probst, Martin; Grabmeier-Pfistershammer, Katharina] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria; [Hoeller, Christoph; Pehamberger, Hubert; Kittler, Harald] Med Univ Vienna, Dept Dermatol, Div Gen Dermatol, Vienna, Austria; [Ferenci, Peter; Staettermayer, Albert F.; Beinhardt, Sandra] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Kittler, H (corresponding author), Med Univ Vienna, Dept Dermatol, Div Gen Dermatol, Vienna, Austria.	harald.kittler@meduniwien.ac.at; katharina.pfistershammer@meduniwien.ac.at	Kittler, Harald/K-7574-2013; Kittler, Harald/AAK-1502-2020	Stattermayer, Albert/0000-0003-0737-4091; KITTLER, HARALD/0000-0002-0051-8016; Grabmeier-Pfistershammer, Katharina/0000-0003-0665-5414				Ascierto PA, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-76; Ascierto PA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-62; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Grob JJ, 1998, LANCET, V351, P1905, DOI 10.1016/S0140-6736(97)12445-X; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Ives NJ, 2007, J CLIN ONCOL, V25, P5426, DOI 10.1200/JCO.2007.12.0253; Jilg N., 2013, HEPATOLOGY; Kaufman HL, 2013, NAT REV CLIN ONCOL, V10, P588, DOI 10.1038/nrclinonc.2013.153; Kirkwood JM, 2000, J CLIN ONCOL, V18, P2444, DOI 10.1200/JCO.2000.18.12.2444; Kirkwood JM, 1996, J CLIN ONCOL, V14, P7, DOI 10.1200/JCO.1996.14.1.7; Kirkwood JM, 2004, CLIN CANCER RES, V10, P1670, DOI 10.1158/1078-0432.CCR-1103-3; Kirkwood JM, 2002, CANCER-AM CANCER SOC, V95, P1101, DOI 10.1002/cncr.10775; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Mocellin S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008955.pub2; Mocellin S, 2010, JNCI-J NATL CANCER I, V102, P493, DOI 10.1093/jnci/djq009; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Pehamberger H, 1998, J CLIN ONCOL, V16, P1425, DOI 10.1200/JCO.1998.16.4.1425; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski AT, 2014, MAYO CLIN PROC, V89, P429, DOI 10.1016/j.mayocp.2014.02.009; Stattermayer AF, 2014, ALIMENT PHARM THER, V39, P104, DOI 10.1111/apt.12547; Stattermayer AF, 2011, CLIN GASTROENTEROL H, V9, P344, DOI 10.1016/j.cgh.2010.07.019; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas E, 2012, GASTROENTEROLOGY, V142, P978, DOI 10.1053/j.gastro.2011.12.055; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wang WJ, 2008, CANCER IMMUNOL IMMUN, V57, P1315, DOI 10.1007/s00262-008-0466-9; Wang WJ, 2007, CLIN CANCER RES, V13, P1523, DOI 10.1158/1078-0432.CCR-06-1387; Weber F, 2007, WORLD J GASTROENTERO, V13, P4818, DOI 10.3748/wjg.v13.i36.4818	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112613	10.1371/journal.pone.0112613	http://dx.doi.org/10.1371/journal.pone.0112613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389973	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400108
J	Goulas, T; Cuppari, A; Garcia-Castellanos, R; Snipas, S; Glockshuber, R; Arolas, JL; Gomis-Ruth, FX				Goulas, Theodoros; Cuppari, Anna; Garcia-Castellanos, Raquel; Snipas, Scott; Glockshuber, Rudi; Arolas, Joan L.; Gomis-Rueth, F. Xavier			The pCri System: A Vector Collection for Recombinant Protein Expression and Purification	PLOS ONE			English	Article							HIGH CELL-DENSITY; ESCHERICHIA-COLI; MEMBRANE-PROTEINS; MESSENGER-RNA; MOLECULAR CHAPERONES; SECONDARY STRUCTURE; BINDING-PROTEIN; PICHIA-PASTORIS; FUSION; PREDICTION	A major bottleneck in structural, biochemical and biophysical studies of proteins is the need for large amounts of pure homogenous material, which is generally obtained by recombinant overexpression. Here we introduce a vector collection, the pCri System, for cytoplasmic and periplasmic/extracellular expression of heterologous proteins that allows the simultaneous assessment of prokaryotic and eukaryotic host cells (Escherichia coli, Bacillus subtilis, and Pichia pastoris). By using a single polymerase chain reaction product, genes of interest can be directionally cloned in all vectors within four different rare restriction sites at the 5' end and multiple cloning sites at the 3' end. In this way, a number of different fusion tags but also signal peptides can be incorporated at the N- and C-terminus of proteins, facilitating their expression, solubility and subsequent detection and purification. Fusion tags can be efficiently removed by treatment with site-specific peptidases, such as tobacco etch virus proteinase, thrombin, or sentrin specific peptidase 1, which leave only a few extra residues at the N- terminus of the protein. The combination of different expression systems in concert with the cloning approach in vectors that can fuse various tags makes the pCri System a valuable tool for high throughput studies.	[Goulas, Theodoros; Cuppari, Anna; Garcia-Castellanos, Raquel; Arolas, Joan L.; Gomis-Rueth, F. Xavier] CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Barcelona, Spain; [Snipas, Scott] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Glockshuber, Rudi] ETH, Inst Mol Biol & Biophys, Dept Biol, CH-8093 Zurich, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Sanford Burnham Prebys Medical Discovery Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Goulas, T (corresponding author), CSIC, Mol Biol Inst Barcelona, Proteolysis Lab, Barcelona Sci Pk,Helix Bldg, Barcelona, Spain.	thgcri@ibmb.csic.es; fxgr@ibmb.csic.es	Goulas, Theodoros/H-1951-2015	Goulas, Theodoros/0000-0002-6938-5493; Lopez Arolas, Joan/0000-0002-4198-5016; Garcia-Castellanos, Raquel/0000-0001-6225-5373; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Cuppari, Anna/0000-0002-7763-5747	European, Spanish, and Catalan agencies [FP7-HEALTH-2010-261460, FP7-PEOPLE-2011- ITN-290246, FP7-HEALTH-2012-306029-2, BFU2012-32862, CSD2006-00015, 2014SGR9]	European, Spanish, and Catalan agencies	This study was supported in part by grants from European, Spanish, and Catalan agencies (FP7-HEALTH-2010-261460 "Gums& Joints''; FP7-PEOPLE-2011- ITN-290246 "RAPID''; FP7-HEALTH-2012-306029-2 "TRIGGER''; BFU2012-32862; CSD2006-00015; and 2014SGR9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo I, 2011, GLYCOBIOLOGY, V21, P1349, DOI 10.1093/glycob/cwr074; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Arolas JL, 2011, ANGEW CHEM INT EDIT, V50, P10357, DOI 10.1002/anie.201103262; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Babu MM, 2002, BIOINFORMATICS, V18, P641, DOI 10.1093/bioinformatics/18.4.641; BANEYX F, 1992, ANN NY ACAD SCI, V665, P301, DOI 10.1111/j.1749-6632.1992.tb42593.x; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Butt TR, 2005, PROTEIN EXPRES PURIF, V43, P1, DOI 10.1016/j.pep.2005.03.016; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; de Marco A, 2007, NAT PROTOC, V2, P2632, DOI 10.1038/nprot.2007.400; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dvir H, 2009, PROTEIN EXPRES PURIF, V68, P28, DOI 10.1016/j.pep.2009.06.007; Esposito D, 2006, CURR OPIN BIOTECH, V17, P353, DOI 10.1016/j.copbio.2006.06.003; Fuhrmann M, 2004, PLANT MOL BIOL, V55, P869, DOI 10.1007/s11103-004-2150-6; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; HALL MN, 1982, NATURE, V295, P616, DOI 10.1038/295616a0; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harper S, 2011, METHODS MOL BIOL, V681, P259, DOI 10.1007/978-1-60761-913-0_14; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayat S, 2012, BIOINFORMATICS, V28, P516, DOI 10.1093/bioinformatics/btr710; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kefala Georgia, 2007, Journal of Structural and Functional Genomics, V8, P167, DOI 10.1007/s10969-007-9033-4; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lund PA, 2001, ADV MICROB PHYSIOL, V44, P93, DOI 10.1016/S0065-2911(01)44012-4; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Makrides SC, 1996, MICROBIOL REV, V60, P512, DOI 10.1128/MMBR.60.3.512-538.1996; Marrero A, 2006, J MOL BIOL, V361, P506, DOI 10.1016/j.jmb.2006.06.046; Maskos K, 2003, J MOL BIOL, V325, P495, DOI 10.1016/S0022-2836(02)01248-2; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nallamsetty S, 2006, PROTEIN EXPRES PURIF, V45, P175, DOI 10.1016/j.pep.2005.06.012; Nallamsetty S, 2007, NAT PROTOC, V2, P383, DOI 10.1038/nprot.2007.50; NEWBURY SF, 1987, CELL, V48, P297, DOI 10.1016/0092-8674(87)90433-8; Peroutka RJ, 2011, METHODS MOL BIOL, V705, P15, DOI 10.1007/978-1-61737-967-3_2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Porro D, 2005, MOL BIOTECHNOL, V31, P245, DOI 10.1385/MB:31:3:245; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Reverter D, 1997, FEBS LETT, V420, P7, DOI 10.1016/S0014-5793(97)01476-2; Reverter David, 2009, V497, P225, DOI 10.1007/978-1-59745-566-4_15; Roosild TP, 2005, SCIENCE, V307, P1317, DOI 10.1126/science.1106392; Sambrook J., 2001, MOL CLONING LAB MANU; Sanglas L, 2009, P NATL ACAD SCI USA, V106, P1743, DOI 10.1073/pnas.0812623106; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; SIMONEN M, 1993, MICROBIOL REV, V57, P109, DOI 10.1128/MMBR.57.1.109-137.1993; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Trang TPP, 2012, J BIOTECHNOL, V157, P167, DOI 10.1016/j.jbiotec.2011.10.006; Vergis JM, 2011, PROTEIN EXPRES PURIF, V78, P139, DOI 10.1016/j.pep.2011.04.011; Vincze T, 2003, NUCLEIC ACIDS RES, V31, P3688, DOI 10.1093/nar/gkg526; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Westers L, 2004, BBA-MOL CELL RES, V1694, P299, DOI 10.1016/j.bbamcr.2004.02.011; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; YEE L, 1992, BIO-TECHNOL, V10, P1550, DOI 10.1038/nbt1292-1550; Zhou FF, 2006, NAT PROTOC, V1, P1318, DOI 10.1038/nprot.2006.209	79	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112643	10.1371/journal.pone.0112643	http://dx.doi.org/10.1371/journal.pone.0112643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386923	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400076
J	Kim, TH; Lee, JH				Kim, Tae-Hyoung; Lee, Jae-Hyeok			Serum Uric Acid and Nigral Iron Deposition in Parkinson's Disease: A Pilot Study	PLOS ONE			English	Article							HUMAN BRAIN; ANTIOXIDANT; METABOLISM; URATE	Background: Uric acid (UA) is an endogenous antioxidant which is known to reduce oxidative stress and also chelate iron ion. Recent studies have provided evidence that UA may play a neuroprotective role in Parkinson's disease (PD). However, it is unknown whether UA relates to nigral iron deposition, which is a characteristic pathophysiological alteration in PD. The aim of this study was to determine the potential relationship of these two markers in patients with PD. Methods: A total of 30 patients of PD and 25 age-and gender-matched healthy controls underwent 3-Tesla MRI and laboratory tests including serum UA levels. We assessed iron levels by measuring phase shift values using susceptibility-weighted image. Mean phase shift values of the substantia nigra (SN), red nucleus, head of the caudate nucleus, globus pallidus, putamen, thalamus, and frontal white matter were calculated and correlated with serum UA levels. Results: Serum UA levels were significantly decreased in the PD patients than in the controls. Phase shift values in bilateral SN were significantly increased in the PD patients than in the controls. There was no significant correlation between serum UA levels and nigral phase shift values. Conclusions: As previous studies, low serum UA level and increased nigral iron content in the PD was reconfirmed in this study. However, we failed to find the relationship between these two markers. Our data suggest that serum UA may not be important determinant of nigral iron deposition in PD.	[Kim, Tae-Hyoung; Lee, Jae-Hyeok] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Dept Neurol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital	Lee, JH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Dept Neurol, Yangsan, South Korea.	jhlee.neuro@pusan.ac.kr			Pusan National University Yangsan Hospital	Pusan National University Yangsan Hospital(Pusan National University)	This study was supported by Pusan National University Yangsan Hospital (2014). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg D, 2006, MOVEMENT DISORD, V21, P1299, DOI 10.1002/mds.21020; Bowman GL, 2010, J ALZHEIMERS DIS, V19, P1331, DOI 10.3233/JAD-2010-1330; CHURCH WH, 1994, BRAIN RES BULL, V33, P419, DOI 10.1016/0361-9230(94)90285-2; Cipriani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037331; Constantinescu R, 2013, ACTA NEUROL SCAND, V127, pe8, DOI 10.1111/ane.12012; Crichton RR, 2011, J NEURAL TRANSM, V118, P301, DOI 10.1007/s00702-010-0470-z; DAVIES KJA, 1986, BIOCHEM J, V235, P747, DOI 10.1042/bj2350747; Du GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035397; Duan W, 2002, J NEUROCHEM, V80, P101, DOI 10.1046/j.0022-3042.2001.00676.x; Groger A, 2012, J NEURAL TRANSM, V119, P1523, DOI 10.1007/s00702-012-0873-0; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Huang XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022854; Jin LR, 2011, BRAIN, V134, P50, DOI 10.1093/brain/awq319; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Mounsey Ross B, 2012, Int J Cell Biol, V2012, P983245, DOI 10.1155/2012/983245; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Schlesinger I, 2008, MOVEMENT DISORD, V23, P1653, DOI 10.1002/mds.22139; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Shen L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003620; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Toncev G, 2002, EUR J NEUROL, V9, P221, DOI 10.1046/j.1468-1331.2002.00384.x; Yan SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031748; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zoccolella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040608	26	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112512	10.1371/journal.pone.0112512	http://dx.doi.org/10.1371/journal.pone.0112512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386854	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400068
J	Legrand, M; De Berardinis, B; Gaggin, HK; Magrini, L; Belcher, A; Zancla, B; Femia, A; Simon, M; Motiwala, S; Sambhare, R; Di Somma, S; Mebazaa, A; Vaidya, VS; Januzzi, JL				Legrand, Matthieu; De Berardinis, Benedetta; Gaggin, Hanna K.; Magrini, Laura; Belcher, Arianna; Zancla, Benedetta; Femia, Alexandra; Simon, Mandy; Motiwala, Shweta; Sambhare, Rasika; Di Somma, Salvatore; Mebazaa, Alexandre; Vaidya, Vishal S.; Januzzi, James L., Jr.		Global Res Acute Conditions Team G	Evidence of Uncoupling between Renal Dysfunction and Injury in Cardiorenal Syndrome: Insights from the BIONICS Study	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE KIDNEY INJURY; DECOMPENSATED HEART-FAILURE; CARDIAC-FAILURE; NGAL; BIOMARKERS	Objective: The objective of the study was to assess urinary biomarkers of renal injury for their individual or collective ability to predict Worsening renal function (WRF) in patients with acutely decompensated heart failure (ADHF). Methods: In a prospective, blinded international study, 87 emergency department (ED) patients with ADHF were evaluated with biomarkers of cardiac stretch (B type natriuretic peptide [BNP] and its amino terminal equivalent [NT-proBNP], ST2), biomarkers of renal function (creatinine, estimated glomerular filtration rate [eGFR]) and biomarkers of renal injury (plasma neutrophil gelatinase associated lipocalin [pNGAL], urine kidney injury molecule-1 [KIM-1], urine N-acetyl-beta-D-glucosaminidase [NAG], urine Cystatin C, urine fibrinogen). The primary endpoint was WRF. Results: 26% developed WRF; baseline characteristics of subjects who developed WRF were generally comparable to those who did not. Biomarkers of renal function and urine biomarkers of renal injury were not correlated, while urine biomarkers of renal injury correlated between each other. Biomarker concentrations were similar between patients with and without WRF except for baseline BNP. Although plasma NGAL was associated with the combined endpoint, none of the biomarker showed predictive accuracy for WRF. Conclusions: In ED patients with ADHF, urine biomarkers of renal injury did not predict WRF. Our data suggest that a weak association exists between renal dysfunction and renal injury in this setting.	[Legrand, Matthieu; Mebazaa, Alexandre] Grp Hosp St Louis Lariboisiere, AP HP, Dept Anesthesiol, F-75475 Paris, France; [Legrand, Matthieu; Mebazaa, Alexandre] Grp Hosp St Louis Lariboisiere, AP HP, Burn Unit, F-75475 Paris, France; [Legrand, Matthieu; Mebazaa, Alexandre] Univ Paris Diderot, Paris, France; [Legrand, Matthieu; Femia, Alexandra; Mebazaa, Alexandre] INSERM, U942, F-75475 Paris, France; [De Berardinis, Benedetta; Magrini, Laura; Zancla, Benedetta; Di Somma, Salvatore] Univ Roma La Sapienza, StAndrea Hosp, Dept Med Surg Sci & Translat Med, I-00185 Rome, Italy; [Gaggin, Hanna K.; Belcher, Arianna; Simon, Mandy; Motiwala, Shweta; Januzzi, James L., Jr.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Cardiol, Boston, MA USA; [Sambhare, Rasika; Vaidya, Vishal S.] Harvard Univ, Sch Med, Boston, MA USA; [Sambhare, Rasika; Vaidya, Vishal S.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Legrand, M (corresponding author), Grp Hosp St Louis Lariboisiere, AP HP, Dept Anesthesiol, F-75475 Paris, France.	matthieu.m.legrand@gmail.com	Januzzi, James/Y-2436-2019	Mebazaa, Alexandre/0000-0001-8715-7753	Astute; bioporto; BRAHMS; Roche Diagnostics; Siemens; Critical Diagnostics; BG Medicine; Singulex; Thermo Fisher; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017543] Funding Source: NIH RePORTER	Astute; bioporto; BRAHMS; Roche Diagnostics; Siemens(Siemens AG); Critical Diagnostics; BG Medicine; Singulex; Thermo Fisher; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Legrand consulted for Alere (lecture fees) and received support for research from Astute, bioporto and BRAHMS. Dr. Mebazaa served as board member for Critical Diagnostics, The Medicine Company, Cardiorentis, and Bayer and lectured for Alere, Bayer, Edwards Life Sciences, The Medicines Company, Novartis, Orion, Servier, Thermofisher, and Vifor Pharma. Dr. Januzzi received support for participation in review activities from Radiometer. His institution received grant support from Roche Diagnostics, Siemens, Critical Diagnostics, BG Medicine, Singulex, and Thermo Fisher. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Aghel A, 2010, J CARD FAIL, V16, P49, DOI 10.1016/j.cardfail.2009.07.003; Ahmad T, 2014, JACC HEART FAIL S, P2213; Alvelos M, 2011, CLIN J AM SOC NEPHRO, V6, P476, DOI 10.2215/CJN.06140710; Bart BA, 2012, NEW ENGL J MED, V367, P2296, DOI 10.1056/NEJMoa1210357; Breidthardt T, 2012, CRIT CARE, V16, DOI 10.1186/cc10600; Damman K, 2007, J CARD FAIL, V13, P599, DOI 10.1016/j.cardfail.2007.04.008; Damman K, 2011, J AM COLL CARDIOL, V57, P2233, DOI 10.1016/j.jacc.2010.10.065; Damman K, 2010, HEART, V96, P1297, DOI 10.1136/hrt.2010.194878; Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Hoffmann D, 2012, AM J PATHOL, V181, P818, DOI 10.1016/j.ajpath.2012.06.004; Jungbauer CG, 2011, EUR J HEART FAIL, V13, P1104, DOI 10.1093/eurjhf/hfr102; Lassus JPE, 2010, EUR HEART J, V31, P2791, DOI 10.1093/eurheartj/ehq293; Legrand M, 2014, CRIT CARE MED, V42, P2109, DOI 10.1097/CCM.0000000000000404; Legrand M, 2013, INTENS CARE MED, V39, P1861, DOI 10.1007/s00134-013-3061-2; Legrand M, 2013, ANESTHESIOLOGY, V118, P1446, DOI 10.1097/ALN.0b013e3182923e8a; Macdonald S, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-8; Maisel AS, 2011, EUR J HEART FAIL, V13, P846, DOI 10.1093/eurjhf/hfr087; Park M, 2013, BIOMARK INSIGHTS, V8, P15, DOI 10.4137/BMI.S11479; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; Royakkers AANM, 2011, INTENS CARE MED, V37, P493, DOI 10.1007/s00134-010-2087-y; Shrestha K, 2012, AM J CARDIOL, V110, P1329, DOI 10.1016/j.amjcard.2012.06.035; van Kimmenade RRJ, 2012, CLIN CHEM, V58, P127, DOI 10.1373/clinchem.2011.165720; Zamora E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051234	25	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112313	10.1371/journal.pone.0112313	http://dx.doi.org/10.1371/journal.pone.0112313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386851	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400054
J	Maugars, G; Dufour, S; Cohen-Tannoudji, J; Querat, B				Maugars, Gersende; Dufour, Sylvie; Cohen-Tannoudji, Joelle; Querat, Bruno			Multiple Thyrotropin beta-Subunit and Thyrotropin Receptor-Related Genes Arose during Vertebrate Evolution	PLOS ONE			English	Article							THYROID-STIMULATING HORMONE; GLYCOPROTEIN HORMONE; SEASONAL-CHANGES; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; TSH RECEPTOR; JAPANESE EEL; EXPRESSION; TELEOST; FISH	Thyroid-stimulating hormone (TSH) is composed of a specific beta subunit and an alpha subunit that is shared with the two pituitary gonadotropins. The three beta subunits derive from a common ancestral gene through two genome duplications (1R and 2R) that took place before the radiation of vertebrates. Analysis of genomic data from phylogenetically relevant species allowed us to identify an additional Tsh beta subunit-related gene that was generated through 2R. This gene, named Tsh beta 2, present in cartilaginous fish, little skate and elephant shark, and in early lobe-finned fish, coelacanth and lungfish, was lost in ray-finned fish and tetrapods. The absence of a second type of TSH receptor (Tshr) gene in these species suggests that both TSHs act through the same receptor. A novel Tsh beta sister gene, named Tsh beta 3, was generated through the third genomic duplication (3R) that occurred early in the teleost lineage. Tsh beta 3 is present in most teleost groups but was lostin tedraodontiforms. The 3R also generated a second Tshr, named Tshr beta. Interestingly, the new Tshr beta was translocated from its original chromosomic position after the emergence of eels and was then maintained in its new position. Tshr beta was lost in tetraodontiforms and in ostariophysians including zebrafish although the latter species have two TSHs, suggesting that TSHR beta may be dispensable. The tissue distribution of duplicated Tsh beta s and Tshrs was studied in the European eel. The endocrine thyrotropic function in the eel would be essentially mediated by the classical Tsh beta and Tshra, which are mainly expressed in the pituitary and thyroid, respectively. Tsh beta 3 and Tshr beta showed a similar distribution pattern in the brain, pituitary, ovary and adipose tissue, suggesting a possible paracrine/autocrine mode of action in these non-thyroidal tissues. Further studies will be needed to determine the binding specificity of the two receptors and how these two TSH systems are interrelated.	[Maugars, Gersende; Dufour, Sylvie] Univ Paris 04, Museum Natl Hist Nat, Biol Aquat Organisms & Ecosyst BOREA, Paris, France; [Maugars, Gersende; Dufour, Sylvie] Univ Paris 06, Paris, France; [Maugars, Gersende; Dufour, Sylvie] Univ Caen Basse Normandie, Caen, France; [Maugars, Gersende; Dufour, Sylvie] CNRS, Unite Mixte Rech UMR 7208, Paris, France; [Maugars, Gersende; Dufour, Sylvie] Inst Rech Dev IRD 207, Paris, France; [Cohen-Tannoudji, Joelle; Querat, Bruno] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Cohen-Tannoudji, Joelle; Querat, Bruno] CNRS, UMR 8251, Paris, France; [Cohen-Tannoudji, Joelle; Querat, Bruno] INSERM, Physiol Axe Gonadotrope U1133, Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Querat, B (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.	bruno.querat@univ-paris-diderot.fr	Quérat, Bruno/L-1843-2017	Quérat, Bruno/0000-0002-6765-1057; Maugars, Gersende/0000-0002-2090-6585				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Angers B, 2002, J MOL EVOL, V54, P501, DOI 10.1007/s00239-001-0041-x; Aroua S, 2012, GEN COMP ENDOCR, V175, P82, DOI 10.1016/j.ygcen.2011.10.002; Blair JE, 2005, MOL BIOL EVOL, V22, P2275, DOI 10.1093/molbev/msi225; Bodo E, 2010, ENDOCRINOLOGY, V151, P1633, DOI 10.1210/en.2009-0306; Chauvigne F, 2010, BIOL REPROD, V82, P1088, DOI 10.1095/biolreprod.109.082289; Chen JN, 2014, MOL PHYLOGENET EVOL, V70, P152, DOI 10.1016/j.ympev.2013.09.002; Choi JK, 2007, GENETICS, V175, P1607, DOI 10.1534/genetics.106.069047; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Davies TF, 2005, J CLIN INVEST, V115, P1972, DOI 10.1172/JCI26031; de Jesus EGT, 1998, GEN COMP ENDOCR, V112, P10, DOI 10.1006/gcen.1998.7103; Denver RJ, 2013, CURR TOP DEV BIOL, V103, P195, DOI 10.1016/B978-0-12-385979-2.00007-1; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dethleffsen K, 2003, MOL CELL NEUROSCI, V24, P380, DOI 10.1016/S1044-7431(03)00195-7; Dos Santos S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-332; Dos Santos S, 2009, ENDOCRINOLOGY, V150, P3815, DOI 10.1210/en.2008-1743; Duarte-Guterman P, 2014, GEN COMP ENDOCR, V203, P69, DOI 10.1016/j.ygcen.2014.03.015; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Goto-Kazeto R, 2003, FISH PHYSIOL BIOCHEM, V28, P339, DOI 10.1023/B:FISH.0000030578.25321.8f; Harewood L, 2010, GENOME RES, V20, P554, DOI 10.1101/gr.103622.109; Henkel CV, 2012, GENE, V511, P195, DOI 10.1016/j.gene.2012.09.064; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; INUI Y, 1985, GEN COMP ENDOCR, V60, P450, DOI 10.1016/0016-6480(85)90080-2; Kano S, 2010, INTEGR COMP BIOL, V50; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Klein JR, 2003, AUTOIMMUNITY, V36, P417, DOI 10.1080/08916930310001603019; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krassas GE, 2010, ENDOCR REV, V31, P702, DOI 10.1210/er.2009-0041; Krause G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052920; Kumar RS, 2000, MOL CELL ENDOCRINOL, V167, P1, DOI 10.1016/S0303-7207(00)00304-X; Lema SC, 2009, J ENDOCRINOL, V202, P43, DOI 10.1677/JOE-08-0472; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Liang D, 2013, MOL BIOL EVOL, V30, P1803, DOI 10.1093/molbev/mst072; Lu SM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-17; MacKenzie DS, 2009, GEN COMP ENDOCR, V161, P83, DOI 10.1016/j.ygcen.2008.12.010; Manchado M, 2008, GEN COMP ENDOCR, V155, P447, DOI 10.1016/j.ygcen.2007.07.011; Nakane Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3108; Oba Y, 2000, BIOCHEM BIOPH RES CO, V276, P258, DOI 10.1006/bbrc.2000.3410; Pasquier J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048931; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Ponce M, 2010, GEN COMP ENDOCR, V168, P431, DOI 10.1016/j.ygcen.2010.05.012; Querat B, 2000, BIOL REPROD, V63, P222, DOI 10.1095/biolreprod63.1.222; Querat B, 2004, BIOL REPROD, V70, P356, DOI 10.1095/biolreprod.103.022004; Rocha A, 2007, GEN COMP ENDOCR, V152, P89, DOI 10.1016/j.ygcen.2007.03.001; Rousseau Karine, 2012, P167; Stavreus Evers Anneli, 2012, Front Endocrinol (Lausanne), V3, P50, DOI 10.3389/fendo.2012.00050; Sudo R, 2014, J EXP ZOOL PART A, V321, P357, DOI 10.1002/jez.1861; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Tata JR, 1997, ADV DEV BIOL, V7, P37; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vischer HF, 2003, J MOL ENDOCRINOL, V30, P227, DOI 10.1677/jme.0.0300227; Wang Y, 2004, MOL CELL ENDOCRINOL, V220, P77, DOI 10.1016/j.mce.2004.03.007; Williams GR, 2011, ANN ENDOCRINOL-PARIS, V72, P68, DOI 10.1016/j.ando.2011.03.006; Williams R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086088; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097	61	26	27	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111361	10.1371/journal.pone.0111361	http://dx.doi.org/10.1371/journal.pone.0111361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386660	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400016
J	Shi, XH; Wang, SL; Zhang, YM; Wang, YC; Yang, Z; Zhou, X; Lei, ZY; Fan, DL				Shi, Xiao-hua; Wang, Shao-liang; Zhang, Yi-ming; Wang, Yi-cheng; Yang, Zhi; Zhou, Xin; Lei, Ze-yuan; Fan, Dong-li			Hydroxyapatite-Coated Sillicone Rubber Enhanced Cell Adhesion and It May Be through the Interaction of EF1 beta and gamma-Actin	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; SILICONE BREAST IMPLANTS; IN-VITRO; BONE-FORMATION; THIN-FILMS; SURFACE; ELONGATION; DEPOSITION; BINDING; LASER	Silicone rubber (SR) is a common soft tissue filler material used in plastic surgery. However, it presents a poor surface for cellular adhesion and suffers from poor biocompatibility. In contrast, hydroxyapatite (HA), a prominent component of animal bone and teeth, can promote improved cell compatibility, but HA is an unsuitable filler material because of the brittleness in mechanism. In this study, using a simple and economical method, two sizes of HA was applied to coat on SR to counteract the poor biocompatibility of SR. Surface and mechanical properties of SR and HA/SRs confirmed that coating with HA changes the surface topology and material properties. Analysis of cell proliferation and adhesion as well as measurement of the expression levels of adhesion related molecules indicated that HA-coated SR significantly increased cell compatibility. Furthermore, mass spectrometry proved that the biocompatibility improvement may be related to elongation factor 1-beta (EF1 beta)/gamma-actin adjusted cytoskeletal rearrangement.	[Shi, Xiao-hua; Wang, Shao-liang; Zhang, Yi-ming; Zhou, Xin; Lei, Ze-yuan; Fan, Dong-li] Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China; [Wang, Yi-cheng] Chongqing Armed Police Corps Hosp, Dept Plast & Cosmet Surg, Chongqing 400061, Peoples R China; [Yang, Zhi] Hainan Branch PLA Gen Hosp, Dept War Trauma Care, Sanya 572013, Hainan, Peoples R China	Army Medical University	Fan, DL (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Plast & Cosmet Surg, Chongqing 400037, Peoples R China.	fdltmmu@sina.com		Zhou, Xin/0000-0002-9324-4308	National Natural Science Foundation of China [81372075]; Third Military Medical University [2012XZH05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Third Military Medical University	This work was funded by a grant from National Natural Science Foundation of China (81372075) (http://www.nsfc.gov.cn/publish/portal0/default.htm), and a grant for Transformation of Scientific and Technological Achievements from Third Military Medical University (2012XZH05) (http://www.tmmu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryington MS, 2013, DENT MATER, V29, P514, DOI 10.1016/j.dental.2013.02.004; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; Chandanshive BB, 2013, MAT SCI ENG C-MATER, V33, P2981, DOI 10.1016/j.msec.2013.03.022; Citeau A, 2005, BIOMATERIALS, V26, P157, DOI 10.1016/j.biomaterials.2004.02.033; Thanh DTM, 2013, MAT SCI ENG C-MATER, V33, P2037, DOI 10.1016/j.msec.2013.01.018; Dunne CF, 2014, J BIOMATER APPL, V28, P767, DOI 10.1177/0885328213480534; Franco-Cea A, 2010, DEV BIOL, V345, P64, DOI 10.1016/j.ydbio.2010.06.027; Furukawa R, 2001, BBA-GEN SUBJECTS, V1527, P130, DOI 10.1016/S0304-4165(01)00157-X; Hauser J, 2009, J MATER SCI-MATER M, V20, P2541, DOI 10.1007/s10856-009-3826-x; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; Iskandar ME, 2013, J BIOMED MATER RES A, V101, P2340, DOI 10.1002/jbm.a.34530; Johnson I, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/37/375103; Kim BS, 2013, J BIOMED MATER RES B, V101, P1302, DOI 10.1002/jbm.b.32943; Koshino T, 2001, BIOMATERIALS, V22, P1579, DOI 10.1016/S0142-9612(00)00318-5; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; LEWIS DH, 1980, J PROSTHET DENT, V43, P426, DOI 10.1016/0022-3913(80)90215-2; Nelea V, 2004, APPL SURF SCI, V228, P346, DOI 10.1016/j.apsusc.2004.01.029; Park YJ, 2013, J CRANIOFAC SURG, V24, P632, DOI 10.1097/SCS.0b013e318270fb23; Peng F, 2013, J BIOMATER APPL, V27, P641, DOI 10.1177/0885328211419873; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; Puskas JE, 2012, WIRES NANOMED NANOBI, V4, P153, DOI 10.1002/wnan.164; Rojaee R, 2013, MAT SCI ENG C-MATER, V33, P3817, DOI 10.1016/j.msec.2013.05.014; Ruan Hongjiang, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P668; Siggelkow W, 2004, INT J ARTIF ORGANS, V27, P1100, DOI 10.1177/039139880402701214; Sisti KE, 2013, INT J PERIODONT REST, V33, P689, DOI 10.11607/prd.1151; Stankiewicz JA., 2010, OPER TECH OTOLARYNGO, V21, P147, DOI 10.1016/j.otot.2010.07.001; Tan F, 2012, BIOTECHNOL ADV, V30, P352, DOI 10.1016/j.biotechadv.2011.07.008; Thian ES, 2005, BIOMATERIALS, V26, P2947, DOI 10.1016/j.biomaterials.2004.07.058; van der Houwen EB, 2013, J MECH BEHAV BIOMED, V28, P47, DOI 10.1016/j.jmbbm.2013.07.002; VANNOORT R, 1979, J MATER SCI, V14, P197, DOI 10.1007/BF01028344; Wang SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098320; Yang Z, 2012, SPRAY PAINTING EQUIP; Zeplin PH, 2010, PLAST RECONSTR SURG, V126, P266, DOI 10.1097/PRS.0b013e3181dbc313; Zhang YM, 2009, AESTHET PLAST SURG, V33, P760, DOI 10.1007/s00266-009-9363-7	34	6	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111503	10.1371/journal.pone.0111503	http://dx.doi.org/10.1371/journal.pone.0111503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386892	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400019
J	Chang, HH; Chiang, YW; Lin, TK; Lin, GL; Lin, YY; Kau, JH; Huang, HH; Hsu, HL; Wang, JH; Sun, DS				Chang, Hsin-Hou; Chiang, Ya-Wen; Lin, Ting-Kai; Lin, Guan-Ling; Lin, You-Yen; Kau, Jyh-Hwa; Huang, Hsin-Hsien; Hsu, Hui-Ling; Wang, Jen-Hung; Sun, Der-Shan			Erythrocytic Mobilization Enhanced by the Granulocyte Colony-Stimulating Factor Is Associated with Reduced Anthrax-Lethal-Toxin-Induced Mortality in Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HEMATOPOIETIC GROWTH-FACTORS; G-CSF; MYELODYSPLASTIC SYNDROMES; ERYTHROPOIETIN; ANEMIA; COMBINATION; APOPTOSIS; ISCHEMIA; ANTIBODY	Anthrax lethal toxin (LT), one of the primary virulence factors of Bacillus anthracis, causes anthrax-like symptoms and death in animals. Experiments have indicated that levels of erythrocytopenia and hypoxic stress are associated with disease severity after administering LT. In this study, the granulocyte colony-stimulating factor (G-CSF) was used as a therapeutic agent to ameliorate anthrax-LT- and spore-induced mortality in C57BL/6J mice. We demonstrated that G-CSF promoted the mobilization of mature erythrocytes to peripheral blood, resulting in a significantly faster recovery from erythrocytopenia. In addition, combined treatment using G-CSF and erythropoietin tended to ameliorate B. anthracis-spore-elicited mortality in mice. Although specific treatments against LT-mediated pathogenesis remain elusive, these results may be useful in developing feasible strategies to treat anthrax.	[Chang, Hsin-Hou; Chiang, Ya-Wen; Lin, Ting-Kai; Sun, Der-Shan] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Chang, Hsin-Hou; Lin, Guan-Ling; Lin, You-Yen; Sun, Der-Shan] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Kau, Jyh-Hwa] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Huang, Hsin-Hsien; Hsu, Hui-Ling] Natl Def Med Ctr, Inst Prevent Med, Taipei, Taiwan; [Wang, Jen-Hung] Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; National Defense Medical Center; National Defense Medical Center; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Sun, DS (corresponding author), Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan.	dssun@mail.tcu.edu.tw	Chang, Hsin-Hou/B-6225-2012	Chang, Hsin-Hou/0000-0002-8731-3485	National Science Council [NSC 96-2311-B-320-005-MY3, NSC 99-2311-B-320-003-MY3]; Tzu-Chi University [610400130]	National Science Council(Ministry of Science and Technology, Taiwan); Tzu-Chi University	This work was supported by grants of National Science Council http://web1.nsc.gov.tw/mp.aspx (NSC 96-2311-B-320-005-MY3 and NSC 99-2311-B-320-003-MY3) and Tzu-Chi University http://www.tcu.edu.tw/ (610400130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2012, J CEREBR BLOOD F MET, V32, P1317, DOI 10.1038/jcbfm.2011.187; Alileche A, 2005, PLOS PATHOG, V1, P150, DOI 10.1371/journal.ppat.0010019; Baldo MP, 2011, CELL PHYSIOL BIOCHEM, V28, P33, DOI 10.1159/000331711; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Bessho M, 1997, EUR J HAEMATOL, V58, P265; Brossier F, 2001, TOXICON, V39, P1747, DOI 10.1016/S0041-0101(01)00161-1; Chang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071718; Chen PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059512; Chen WF, 2008, NEUROSCIENCE, V153, P31, DOI 10.1016/j.neuroscience.2008.01.062; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Comer JE, 2005, INFECT IMMUN, V73, P8275, DOI 10.1128/IAI.73.12.8275-8281.2005; DEBILI N, 1995, BLOOD, V86, P2516; Fang H, 2006, J IMMUNOL, V176, P6155, DOI 10.4049/jimmunol.176.10.6155; Fisher JW, 2003, EXP BIOL MED, V228, P1; Gaia S, 2006, J HEPATOL, V45, P13, DOI 10.1016/j.jhep.2006.02.018; Greenberg PL, 2009, BLOOD, V114, P2393, DOI 10.1182/blood-2009-03-211797; Hagemann C, 2001, CELL SIGNAL, V13, P863, DOI 10.1016/S0898-6568(01)00220-0; Harkness JE, 1995, CLIN PROCEDURES BIOL, P93; Hellstrom-Lindberg E, 2003, BRIT J HAEMATOL, V120, P1037, DOI 10.1046/j.1365-2141.2003.04153.x; HellstromLindberg E, 1997, BRIT J HAEMATOL, V99, P344, DOI 10.1046/j.1365-2141.1997.4013211.x; Hubel K, 2002, J INFECT DIS, V185, P1490, DOI 10.1086/340221; Jadersten M, 2005, BLOOD, V106, P803, DOI 10.1182/blood-2004-10-3872; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kau JH, 2005, J INFECT DIS, V192, P1465, DOI 10.1086/491477; Kau JH, 2002, CURR MICROBIOL, V44, P106, DOI 10.1007/s00284-001-0059-8; Kau JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014289; Kikuta T, 2000, EXP HEMATOL, V28, P311, DOI 10.1016/S0301-472X(99)00151-4; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; MORSTYN G, 1988, CANCER RES, V48, P5624; Mourez M, 2004, Rev Physiol Biochem Pharmacol, V152, P135; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Negrin RS, 1996, BLOOD, V87, P4076, DOI 10.1182/blood.V87.10.4076.bloodjournal87104076; NIJHOF W, 1994, ANN NY ACAD SCI, V718, P312; OGAWA M, 1976, BLOOD, V48, P407; Page AV, 2011, INFECT DIS CLIN N AM, V25, P803, DOI 10.1016/j.idc.2011.07.007; PARK K, 1991, Osaka City Medical Journal, V37, P123; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rankin SM, 2012, IMMUNOL LETT, V145, P47, DOI 10.1016/j.imlet.2012.04.009; Remacha AF, 1996, BONE MARROW TRANSPL, V17, P163; Sarma NJ, 2010, J VIS EXP; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; TROWBRIDGE IS, 1982, J CELL PHYSIOL, V112, P403, DOI 10.1002/jcp.1041120314; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wadhwa M, 2008, THROMB HAEMOSTASIS, V99, P863, DOI 10.1160/TH07-11-0703; Xiao BG, 2007, J CELL MOL MED, V11, P1272, DOI 10.1111/j.1582-4934.2007.00101.x	51	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111149	10.1371/journal.pone.0111149	http://dx.doi.org/10.1371/journal.pone.0111149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384016	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700013
J	Kim, J; Yin, T; Yin, M; Zhang, W; Shinozaki, K; Selak, MA; Pappan, KL; Lampe, JW; Becker, LB				Kim, Junhwan; Yin, Tai; Yin, Ming; Zhang, Wei; Shinozaki, Koichiro; Selak, Mary A.; Pappan, Kirk L.; Lampe, Joshua W.; Becker, Lance B.			Examination of Physiological Function and Biochemical Disorders in a Rat Model of Prolonged Asphyxia-Induced Cardiac Arrest followed by Cardio Pulmonary Bypass Resuscitation	PLOS ONE			English	Article							GLOBAL BRAIN ISCHEMIA; CELL INJURY; CARDIOPULMONARY BYPASS; LIPID-METABOLISM; HEART; PHOSPHOLIPIDS; REPERFUSION; DEATH; ACCUMULATION; DYSFUNCTION	Background: Cardiac arrest induces whole body ischemia, which causes damage to multiple organs particularly the heart and the brain. There is clinical and preclinical evidence that neurological injury is responsible for high mortality and morbidity of patients even after successful cardiopulmonary resuscitation. A better understanding of the metabolic alterations in the brain during ischemia will enable the development of better targeted resuscitation protocols that repair the ischemic damage and minimize the additional damage caused by reperfusion. Method: A validated whole body model of rodent arrest followed by resuscitation was utilized; animals were randomized into three groups: control, 30 minute asphyxial arrest, or 30 minutes asphyxial arrest followed by 60 min cardiopulmonary bypass (CPB) resuscitation. Blood gases and hemodynamics were monitored during the procedures. An untargeted metabolic survey of heart and brain tissues following cardiac arrest and after CPB resuscitation was conducted to better define the alterations associated with each condition. Results: After 30 min cardiac arrest and 60 min CPB, the rats exhibited no observable brain function and weakened heart function in a physiological assessment. Heart and brain tissues harvested following 30 min ischemia had significant changes in the concentration of metabolites in lipid and carbohydrate metabolism. In addition, the brain had increased lysophospholipid content. CPB resuscitation significantly normalized metabolite concentrations in the heart tissue, but not in the brain tissue. Conclusion: The observation that metabolic alterations are seen primarily during cardiac arrest suggests that the events of ischemia are the major cause of neurological damage in our rat model of asphyxia-CPB resuscitation. Impaired glycolysis and increased lysophospholipids observed only in the brain suggest that altered energy metabolism and phospholipid degradation may be a central mechanism in unresuscitatable brain damage.	[Kim, Junhwan; Yin, Tai; Yin, Ming; Zhang, Wei; Shinozaki, Koichiro; Selak, Mary A.; Lampe, Joshua W.; Becker, Lance B.] Univ Penn, Dept Emergency Med, Ctr Resuscitat Sci, Philadelphia, PA 19104 USA; [Pappan, Kirk L.] Metabolon Inc, Durham, NC USA	University of Pennsylvania; Pennsylvania Medicine; Metabolon	Kim, J (corresponding author), Univ Penn, Dept Emergency Med, Ctr Resuscitat Sci, Philadelphia, PA 19104 USA.	junhwan.kim@uphs.upenn.edu	Yin, Ming/ABA-8766-2020; Pappan, Kirk/AAV-5946-2021	Yin, Ming/0000-0003-4585-8732; Kim, Junhwan/0000-0002-1162-8616; Pappan, Kirk/0000-0002-2341-8798; Lampe, Joshua/0000-0001-6036-535X	National Institutes of Health [HL067630]; Metabolon, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Metabolon, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL067630. Metabolon, Inc., provided support in the form of a salary for author KLP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Adibhatla RM, 2006, FREE RADICAL BIO MED, V40, P376, DOI 10.1016/j.freeradbiomed.2005.08.044; Allen BS, 2012, EUR J CARDIO-THORAC, V41, P1155, DOI 10.1093/ejcts/ezr318; Allen BS, 2012, EUR J CARDIO-THORAC, V41, P1132, DOI 10.1093/ejcts/ezr315; ARNSDORF MF, 1981, CIRC RES, V49, P16, DOI 10.1161/01.RES.49.1.16; Bonventre JV, 1999, J AM SOC NEPHROL, V10, P404; Boutilier RG, 2001, J EXP BIOL, V204, P3171; BUJA LM, 1991, TRENDS CARDIOVAS MED, V1, P40, DOI 10.1016/1050-1738(91)90058-M; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Chen YS, 2008, CRIT CARE MED, V36, P2529, DOI 10.1097/CCM.0b013e318183f491; CHIEN KR, 1978, J BIOL CHEM, V253, P4809; CHIEN KR, 1984, CIRC RES, V54, P313, DOI 10.1161/01.RES.54.3.313; De Windt LJ, 1998, MOL CELL BIOCHEM, V180, P65, DOI 10.1023/A:1006886906105; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FARBER JL, 1981, AM J PATHOL, V102, P271; GROSS RW, 1992, TRENDS CARDIOVAS MED, V2, P115, DOI 10.1016/1050-1738(92)90016-L; Han F, 2010, RESUSCITATION, V81, P93, DOI 10.1016/j.resuscitation.2009.09.018; HEUSER D, 1985, BRIT J ANAESTH, V57, P23, DOI 10.1093/bja/57.1.23; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kristian T, 2004, CELL CALCIUM, V36, P221, DOI 10.1016/j.ceca.2004.02.016; Kubasiak LA, 2002, P NATL ACAD SCI USA, V99, P12825, DOI 10.1073/pnas.202474099; Liachenko S, 1998, STROKE, V29, P1229, DOI 10.1161/01.STR.29.6.1229; Liam BL, 1998, J THORAC CARDIOV SUR, V115, P1203, DOI 10.1016/S0022-5223(98)70422-2; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Madl Christian, 2004, Curr Opin Crit Care, V10, P213, DOI 10.1097/01.ccx.0000127542.32890.fa; MAN RYK, 1988, BRIT J PHARMACOL, V93, P412, DOI 10.1111/j.1476-5381.1988.tb11448.x; Mongardon N, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-45; Morimura N, 2011, RESUSCITATION, V82, P10, DOI 10.1016/j.resuscitation.2010.08.032; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nichol G, 2006, RESUSCITATION, V70, P381, DOI 10.1016/j.resuscitation.2006.01.018; Nieman DC, 2013, J PROTEOME RES, V12, P4577, DOI 10.1021/pr400717j; OPIE LH, 1990, CARDIOVASC DRUG THER, V4, P777, DOI 10.1007/BF00051275; PETRICH ER, 1996, EXS, V76, P115; Purdon AD, 2002, NEUROCHEM RES, V27, P1641, DOI 10.1023/A:1021635027211; Rau TF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047877, 10.1371/journal.pone.0040881]; Shin TG, 2011, CRIT CARE MED, V39, P1, DOI 10.1097/CCM.0b013e3181feb339; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; Starkov AA, 2004, CELL CALCIUM, V36, P257, DOI 10.1016/j.ceca.2004.02.012; STEENBERGEN C, 1984, J MOL CELL CARDIOL, V16, P605, DOI 10.1016/S0022-2828(84)80625-2; Stub D, 2011, CIRCULATION, V123, P1428, DOI 10.1161/CIRCULATIONAHA.110.988725; SUN DD, 1994, J NEUROCHEM, V62, P1921; van der Vusse G J, 1996, EXS, V76, P175; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Wang HYJ, 2010, RAPID COMMUN MASS SP, V24, P2057, DOI 10.1002/rcm.4620; Xie JL, 1997, CIRCULATION, V96, P683	48	18	18	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112012	10.1371/journal.pone.0112012	http://dx.doi.org/10.1371/journal.pone.0112012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383962	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700028
J	Kirkpatrick, RM; McGue, M; Iacono, WG; Miller, MB; Basu, S				Kirkpatrick, Robert M.; McGue, Matt; Iacono, William G.; Miller, Michael B.; Basu, Saonli			Results of a "GWAS Plus:" General Cognitive Ability Is Substantially Heritable and Massively Polygenic	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON SNPS EXPLAIN; LARGE PROPORTION; TWIN; INTELLIGENCE; STRATIFICATION; GENETICS; FAMILY; DNA	We carried out a genome-wide association study (GWAS) for general cognitive ability (GCA) plus three other analyses of GWAS data that aggregate the effects of multiple single-nucleotide polymorphisms (SNPs) in various ways. Our multigenerational sample comprised 7,100 Caucasian participants, drawn from two longitudinal family studies, who had been assessed with an age-appropriate IQ test and had provided DNA samples passing quality screens. We conducted the GWAS across similar to 2.5 million SNPs (both typed and imputed), using a generalized least-squares method appropriate for the different family structures present in our sample, and subsequently conducted gene-based association tests. We also conducted polygenic prediction analyses under five-fold cross-validation, using two different schemes of weighting SNPs. Using parametric bootstrapping, we assessed the performance of this prediction procedure under the null. Finally, we estimated the proportion of variance attributable to all genotyped SNPs as random effects with software GCTA. The study is limited chiefly by its power to detect realistic single-SNP or single-gene effects, none of which reached genome-wide significance, though some genomic inflation was evident from the GWAS. Unit SNP weights performed about as well as least-squares regression weights under cross-validation, but the performance of both increased as more SNPs were included in calculating the polygenic score. Estimates from GCTA were 35% of phenotypic variance at the recommended biological-relatedness ceiling. Taken together, our results concur with other recent studies: they support a substantial heritability of GCA, arising from a very large number of causal SNPs, each of very small effect. We place our study in the context of the literature-both contemporary and historical-and provide accessible explication of our statistical methods.	[Kirkpatrick, Robert M.; McGue, Matt; Iacono, William G.; Miller, Michael B.] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Basu, Saonli] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Kirkpatrick, RM (corresponding author), Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA.	rkirkpatrick2@vcu.edu		Basu, Saonli/0000-0003-1200-4546	NIH [AA09367, AA11886, DA05147, DA13240, DA024417, MH066140, R25DA026119]; University of Minnesota Graduate School; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA009367, R01AA009367, R01AA011886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013240, U01DA024417, R25DA026119, R01DA005147, R37DA005147, R01DA024417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Graduate School(University of Minnesota System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The reported research was made possible by NIH grants AA09367, AA11886, DA05147, DA13240, DA024417, and MH066140. While conducting the reported analyses and drafting the manuscript, the first author was supported by a Doctoral Dissertation Fellowship from the University of Minnesota Graduate School, and while finalizing the manuscript for publication, was supported by NIH grant R25DA026119. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Benjamin DJ, 2012, P NATL ACAD SCI USA, V109, P8026, DOI 10.1073/pnas.1120666109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Bouchard TJ, 2004, CURR DIR PSYCHOL SCI, V13, P148, DOI 10.1111/j.0963-7214.2004.00295.x; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; BUSE A, 1973, AM STAT, V27, P106, DOI 10.2307/2683631; Butcher LM, 2008, GENES BRAIN BEHAV, V7, P435, DOI 10.1111/j.1601-183X.2007.00368.x; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chabris CF, 2012, PSYCHOL SCI, V23, P1314, DOI 10.1177/0956797611435528; Dana J, 2004, J EDUC BEHAV STAT, V29, P317, DOI 10.3102/10769986029003317; Daniels J, 1998, AM J HUM GENET, V62, P1189, DOI 10.1086/301816; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Davis OSP, 2010, BEHAV GENET, V40, P759, DOI 10.1007/s10519-010-9350-4; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Deary IJ, 2012, ANNU REV PSYCHOL, V63, P453, DOI 10.1146/annurev-psych-120710-100353; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; FLYNN JR, 1987, PSYCHOL BULL, V101, P171, DOI 10.1037/0033-2909.101.2.171; FLYNN JR, 1984, PSYCHOL BULL, V95, P29, DOI 10.1037/0033-2909.95.1.29; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Gibson G, 2010, NAT GENET, V42, P558, DOI 10.1038/ng0710-558; Gottfredson LS, 2003, SCIENTIFIC STUDY OF GENERAL INTELLIGENCE: TRIBUTE TO ARTHUR R. J ENSEN, P293, DOI 10.1016/B978-008043793-4/50053-2; Herrnstein R J, 1994, BELL CURVE; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Iacono WG, 1999, DEV PSYCHOPATHOL, V11, P869, DOI 10.1017/S0954579499002369; Iacono WG, 2002, TWIN RES, V5, P482, DOI 10.1375/twin.5.5.482; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jensen A.R., 1998, G FACTOR SCI MENTAL; Keyes MA, 2009, TWIN RES HUM GENET, V12, P489, DOI 10.1375/twin.12.5.489; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li X, 2011, HUM HERED, V71, P67, DOI 10.1159/000324839; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McCulloch CE, 2011, BIOMETRICS, V67, P270, DOI 10.1111/j.1541-0420.2010.01435.x; Mcgue M, 2007, BEHAV GENET, V37, P449, DOI 10.1007/s10519-007-9142-7; Miller MB, 2012, TWIN RES HUM GENET, V15, P767, DOI 10.1017/thg.2012.62; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pan Y, 2011, PROG NEURO-PSYCHOPH, V35, P154, DOI 10.1016/j.pnpbp.2010.10.016; Payton A, 2006, GENES BRAIN BEHAV, V5, P44, DOI 10.1111/j.1601-183X.2006.00194.x; Plomin R, 2003, SCI STUDY GEN INTELL, P275; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rijsdijk FV, 2002, BEHAV GENET, V32, P199, DOI 10.1023/A:1016021128949; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sattler J. M., 1974, ASSESSMENT CHILDREN; Turkheimer E, 2011, RES HUM DEV, V8, P227, DOI 10.1080/15427609.2011.625321; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Visscher PM, 2010, TWIN RES HUM GENET, V13, P517, DOI 10.1375/twin.13.6.517; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	60	25	26	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112390	10.1371/journal.pone.0112390	http://dx.doi.org/10.1371/journal.pone.0112390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383866	Green Submitted, gold, Green Published			2022-12-26	WOS:000344816700055
J	Priplatova, L; Sebankova, B; Flegr, J				Priplatova, Lenka; Sebankova, Blanka; Flegr, Jaroslav			Contrasting Effect of Prepulse Signals on Performance of Toxoplasma-Infected and Toxoplasma-Free Subjects in an Acoustic Reaction Times Test	PLOS ONE			English	Article							STARTLE GATING DEFICITS; LATENT TOXOPLASMOSIS; PERSONALITY PROFILE; FATAL ATTRACTION; GONDII INFECTION; DECREASED LEVEL; ANIMAL BEHAVIOR; NOVELTY SEEKING; SCHIZOPHRENIA; DOPAMINE	Background: About 30% of people on Earth have latent toxoplasmosis. Infected subjects do not express any clinical symptoms, however, they carry dormant stages of parasite Toxoplasma for the rest of their life. This form of toxoplasmosis is mostly considered harmless, however, recent studies showed its specific effects on physiology, behaviour and its associations with various diseases, including psychiatric disorders such as schizophrenia. Individuals who suffer from schizophrenia have about 2.7 times higher prevalence of Toxoplasma-seropositivity than controls, which suggests that some traits characteristic of schizophrenic patients, including the sex difference in schizophrenia onset, decrease of grey matter density in specific brain areas and modification of prepulse inhibition of startle reaction could in fact be caused by toxoplasmosis for those patients who are Toxoplasma-seropositive. Methodology/Principal Findings: We measured the effect of prepulse inhibition/facilitation of the startle reaction on reaction times. The students, 170 women and 66 men, were asked to react as quickly as possible to a startling acoustic signal by pressing a computer mouse button. Some of the startling signals were without the prepulse, some were 20 msec. preceded by a short (20 msec.) prepulse signal of lower intensity. Toxoplasma-seropositive subjects had longer reaction times than the controls. Acoustic prepulse shorted the reaction times in all subjects. This effect of prepulse on reaction times was stronger in male subjects and increased with the duration of infection, suggesting that it represented a cumulative effect of latent toxoplasmosis, rather than a fading out after effect of past acute toxoplasmosis. Conclusions: Different sensitivity of Toxoplasma-seropositive and Toxoplasma-seronegative subjects on effect of prepulses on reaction times (the toxoplasmosis-prepulse interaction) suggested, but of course did not prove, that the alternations of prepulse inhibition of startle reaction observed in schizophrenia patients probably joined the list of schizophrenia symptoms that are in fact caused by latent toxoplasmosis.	[Priplatova, Lenka; Sebankova, Blanka; Flegr, Jaroslav] Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic	Charles University Prague	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Philosophy & Hist Sci, Prague, Czech Republic.	flegr@cesnet.cz	Šebánková, Blanka/GQH-0803-2022; Flegr, Jaroslav/A-1564-2008; Flegr, Jaroslav/AAG-7568-2021	Flegr, Jaroslav/0000-0002-0822-0126; Flegr, Jaroslav/0000-0002-0822-0126; Priplatova, Lenka/0000-0002-2860-3853	Charles University of Prague [GAUK 18810, UNCE 204004]; Grand Agency of the Czech Republic [P303/11/1398]	Charles University of Prague; Grand Agency of the Czech Republic	The authors' work was supported by the Charles University of Prague (GAUK 18810, grant UNCE 204004) and the Grand Agency of the Czech Republic (Grant No. P303/11/1398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdoy M, 2000, P ROY SOC B-BIOL SCI, V267, P1591, DOI 10.1098/rspb.2000.1182; Braff DL, 1999, AM J PSYCHIAT, V156, P596; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Cadenhead KS, 2000, AM J PSYCHIAT, V157, P1660, DOI 10.1176/appi.ajp.157.10.1660; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; FLEGR J, 1994, FOLIA PARASIT, V41, P122; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 1999, FOLIA PARASIT, V46, P22; Flegr J, 2005, FOLIA PARASIT, V52, P199, DOI 10.14411/fp.2005.026; Flegr J, 2013, PLOS ONE, V8; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2013, TRENDS PARASITOL, V29, P156, DOI 10.1016/j.pt.2013.01.007; Flegr J, 2013, J EXP BIOL, V216, P127, DOI 10.1242/jeb.073635; Flegr J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001389; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2010, FOLIA PARASIT, V57, P81, DOI 10.14411/fp.2010.010; FOSS JA, 1989, HUM FACTORS, V31, P319, DOI 10.1177/001872088903100306; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Gatkowska J, 2013, EXP PARASITOL, V133, P1, DOI 10.1016/j.exppara.2012.10.005; GRILLON C, 1992, BIOL PSYCHIAT, V32, P939, DOI 10.1016/0006-3223(92)90183-Z; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; Hodkova H, 2007, PARASITOLOGY, V134, P1329, DOI 10.1017/S0031182007002673; Holub D, 2013, ACTA PSYCHIAT SCAND, V127, P227, DOI 10.1111/acps.12031; Holub D, 2006, PSYCHIATRIE, V10, P66; Horacek J, 2012, WORLD J BIOL PSYCHIA; Horacek J, 2012, WORLD J BIOL PSYCHIA, V13, P501, DOI 10.3109/15622975.2011.573809; House PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023277; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Kodym P, 2007, CLIN MICROBIOL INFEC, V13, P40, DOI 10.1111/j.1469-0691.2006.01564.x; Kumari V, 2000, ARCH GEN PSYCHIAT, V57, P609, DOI 10.1001/archpsyc.57.6.609; Lindova J, 2010, FOLIA PARASIT, V57, P136, DOI 10.14411/fp.2010.017; Maslovat D, 2012, NEUROSCI LETT, V513, P243, DOI 10.1016/j.neulet.2012.02.052; McConkey GA, 2013, J EXP BIOL, V216, P113, DOI 10.1242/jeb.074153; Nikam SS, 2008, CURR OPIN INVEST DR, V9, P37; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Pearce BD, 2013, SCHIZOPHR RES, V150, P258, DOI 10.1016/j.schres.2013.07.028; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Rupp CI, 2010, CURR OPIN PSYCHIATR, V23, P97, DOI 10.1097/YCO.0b013e328336643f; Saklayen SS, 2004, J PHARMACOL EXP THER, V311, P342, DOI 10.1124/jpet.104.067991; Siegel S, 1988, NONPARAMETRIC STAT B, Vxxiii; Skallova A, 2006, PARASITOLOGY, V133, P525, DOI 10.1017/S0031182006000886; Skallova A, 2005, NEUROENDOCRINOL LETT, V26, P480; Strobl JS, 2012, J PARASITOL, V98, P1296, DOI 10.1645/GE-2760.1; Sun XJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-241; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P729, DOI 10.1093/schbul/sbl050; Torrey EF, 2007, SCHIZOPHRENIA BULL, V33, P727, DOI 10.1093/schbul/sbm026; Torrey EF, 2012, SCHIZOPHRENIA BULL, V38, P642, DOI 10.1093/schbul/sbs043; Turetsky BI, 2009, AM J PSYCHIAT, V166, P226, DOI 10.1176/appi.ajp.2008.07071210; Valls-Sole J, 1999, EXP BRAIN RES, V129, P49, DOI 10.1007/s002210050935; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; VALLSSOLE J, 1995, NEUROSCI LETT, V195, P97, DOI 10.1016/0304-3940(94)11790-P; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Vyas A, 2013, J EXP BIOL, V216, P120, DOI 10.1242/jeb.072983; Wang HL, 2006, ACTA PSYCHIAT SCAND, V114, P40, DOI 10.1111/j.1600-0447.2006.00780.x; Webster JP, 2007, SCHIZOPHRENIA BULL, V33, P752, DOI 10.1093/schbul/sbl073; Webster JP, 2013, J EXP BIOL, V216, P99, DOI 10.1242/jeb.074716; Willner P, 1997, INT CLIN PSYCHOPHARM, V12, P297, DOI 10.1097/00004850-199711000-00002; Xiao JC, 2013, MICROBES INFECT, V15, P74, DOI 10.1016/j.micinf.2012.10.016; Yolken RH, 2009, PARASITE IMMUNOL, V31, P706, DOI 10.1111/j.1365-3024.2009.01131.x; Zhou P, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-165	63	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112771	10.1371/journal.pone.0112771	http://dx.doi.org/10.1371/journal.pone.0112771			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384036	gold, Green Submitted, Green Published			2022-12-26	WOS:000344816700094
J	Wolfram, S; Nejstgaard, JC; Pohnert, G				Wolfram, Stefanie; Nejstgaard, Jens C.; Pohnert, Georg			Accumulation of Polyunsaturated Aldehydes in the Gonads of the Copepod Acartia tonsa Revealed by Tailored Fluorescent Probes	PLOS ONE			English	Article							CALANUS-HELGOLANDICUS; ALPHA,BETA,GAMMA,DELTA-UNSATURATED ALDEHYDES; HERBIVOROUS COPEPOD; DIATOMS; REPRODUCTION; RECRUITMENT; OXYLIPINS; ADDUCTS; GROWTH	Polyunsaturated aldehydes (PUAs) are released by several diatom species during predation. Besides other attributed activities, these oxylipins can interfere with the reproduction of copepods, important predators of diatoms. While intensive research has been carried out to document the effects of PUAs on copepod reproduction, little is known about the underlying mechanistic aspects of PUA action. Especially PUA uptake and accumulation in copepods has not been addressed to date. To investigate how PUAs are taken up and interfere with the reproduction in copepods we developed a fluorescent probe containing the alpha,beta,gamma,delta-unsaturated aldehyde structure element that is essential for the activity of PUAs as well as a set of control probes. We developed incubation and monitoring procedures for adult females of the calanoid copepod Acartia tonsa and show that the PUA derived fluorescent molecular probe selectively accumulates in the gonads of this copepod. In contrast, a saturated aldehyde derived probe of an inactive parent molecule was enriched in the lipid sac. This leads to a model for PUAs' teratogenic mode of action involving accumulation and covalent interaction with nucleophilic moieties in the copepod reproductive tissue. The teratogenic effect of PUAs can therefore be explained by a selective targeting of the molecules into the reproductive tissue of the herbivores, while more lipophilic but otherwise strongly related structures end up in lipid bodies.	[Wolfram, Stefanie; Pohnert, Georg] Univ Jena, Inst Inorgan & Analyt Chem, Jena, Germany; [Nejstgaard, Jens C.] Skidaway Inst Oceanog, Savannah, GA 31411 USA; [Nejstgaard, Jens C.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Dept Expt Limnol, Dept Expt Limnol 3, Stechlin, Germany	Friedrich Schiller University of Jena; University System of Georgia; University of Georgia; Skidaway Institute of Oceanography; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Nejstgaard, JC (corresponding author), Skidaway Inst Oceanog, Savannah, GA 31411 USA.	nejstgaard@igb-berlin.de; Georg.Pohnert@uni-jena.de	Nejstgaard, Jens/ABB-8903-2020; Pohnert, Georg/D-3721-2013	Nejstgaard, Jens/0000-0003-1236-0647; Pohnert, Georg/0000-0003-2351-6336	Lichtenberg Professorship Volkswagen Foundation; Stipend Studienstiftung des Deutschen Volkes; Skidaway Institute of Oceanography	Lichtenberg Professorship Volkswagen Foundation; Stipend Studienstiftung des Deutschen Volkes; Skidaway Institute of Oceanography	This work was supported by Lichtenberg Professorship Volkswagen Foundation and a Stipend Studienstiftung des Deutschen Volkes and by start-up grants from Skidaway Institute of Oceanography. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph S, 2004, J EXP BIOL, V207, P2935, DOI 10.1242/jeb.01105; Adolph S, 2003, TETRAHEDRON, V59, P3003, DOI 10.1016/S0040-4020(03)00382-X; Barglow KT, 2007, NAT METHODS, V4, P822, DOI 10.1038/NMETH1092; Buttino I, 2008, J EXP BIOL, V211, P1426, DOI 10.1242/jeb.015859; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Carvalho VM, 2000, CHEM RES TOXICOL, V13, P397, DOI 10.1021/tx9901682; Dutz J, 2008, LIMNOL OCEANOGR, V53, P225, DOI 10.4319/lo.2008.53.1.0225; Gonzalez G, 2013, ANIMAL DIVERSITY WEB; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Ianora A, 1996, MAR BIOL, V125, P279, DOI 10.1007/BF00346308; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Ianora A, 2003, PHYCOLOGIA, V42, P351, DOI 10.2216/i0031-8884-42-4-351.1; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Jonasdottir SH, 1996, MAR BIOL, V125, P743, DOI 10.1007/BF00349257; Jonasdottir SH, 2011, MAR BIOL, V158, P1943, DOI 10.1007/s00227-011-1705-8; KIORBOE T, 1987, J PLANKTON RES, V9, P525, DOI 10.1093/plankt/9.3.525; Koski M, 2008, MAR BIOL, V154, P719, DOI 10.1007/s00227-008-0965-4; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; Loureiro APM, 2000, CHEM RES TOXICOL, V13, P601, DOI 10.1021/tx000004h; Loureiro APM, 2004, CHEM RES TOXICOL, V17, P641, DOI 10.1021/tx034225+; Mauchline J., 1998, ADV MARINE BIOL, V33; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Paffenhofer GA, 2005, MAR ECOL PROG SER, V286, P293, DOI 10.3354/meps286293; Paffenhofer GA, 2002, MAR ECOL PROG SER, V227, P305, DOI 10.3354/meps227305; Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348; Pohnert G, 2000, ANGEW CHEM INT EDIT, V39, P4352, DOI 10.1002/1521-3773(20001201)39:23<4352::AID-ANIE4352>3.0.CO;2-U; Poulet SA, 2007, MAR BIOL, V152, P415, DOI 10.1007/s00227-007-0701-5; Poulet SA, 2006, MAR ECOL PROG SER, V308, P129, DOI 10.3354/meps308129; Poulet SA, 1995, MAR ECOL PROG SER, V129, P85, DOI 10.3354/meps129085; Sigolo CAO, 2007, CHEM RES TOXICOL, V20, P1099, DOI 10.1021/tx700111v; Sommer U, 2009, OECOLOGIA, V159, P207, DOI 10.1007/s00442-008-1193-9; Walter TC, 2014, WORMS ACARTIA ACANTH; Wichard T, 2008, PROG OCEANOGR, V77, P30, DOI 10.1016/j.pocean.2008.03.002; Wichard T, 2007, CHEMBIOCHEM, V8, P1146, DOI 10.1002/cbic.200700053; Yang Z, 2011, J PLANKTON RES, V33, P665, DOI 10.1093/plankt/fbq112; Young SC, 2010, ENVIRON MOL MUTAGEN, V51, P315, DOI 10.1002/em.20550; Zhu XC, 2010, CHEM RES TOXICOL, V23, P467, DOI 10.1021/tx900379a	37	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112522	10.1371/journal.pone.0112522	http://dx.doi.org/10.1371/journal.pone.0112522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383890	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700074
J	Kashlan, OB; Blobner, BM; Zuzek, Z; Tolino, M; Kleyman, TR				Kashlan, Ossama B.; Blobner, Brandon M.; Zuzek, Zachary; Tolino, Michael; Kleyman, Thomas R.			Na+ Inhibits the Epithelial Na+ Channel by Binding to a Site in an Extracellular Acidic Cleft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acid-sensing Ion Channel (ASIC); Allosteric Regulation; Epithelial Sodium Channel (ENaC); Hypertension; Ion Channel; Membrane Transport; Protein Cross-linking; Effector Specificity; pH-dependent Activation	CONSERVED CHARGED RESIDUES; SODIUM SELF-INHIBITION; OPEN PROBABILITY; ALPHA-SUBUNITS; GAMMA-SUBUNITS; BETA-SUBUNITS; THUMB DOMAINS; ENAC; EXPRESSION; RAT	Background: External Na+ inhibits ENaC. Results: Mutations centered about a key aspartate in an acidic cleft weakened Na+ inhibition and altered inhibitor selectivity. Conclusion: The acidic cleft hosts an inhibitory Na+ binding site. Significance: The acidic cleft harbors a key Na+ binding site for ENaC and perhaps sites for ligands that regulate other members of the ENaC/degenerin family. The epithelial Na+ channel (ENaC) has a key role in the regulation of extracellular fluid volume and blood pressure. ENaC belongs to a family of ion channels that sense the external environment. These channels have large extracellular regions that are thought to interact with environmental cues, such as Na+, Cl-, protons, proteases, and shear stress, which modulate gating behavior. We sought to determine the molecular mechanism by which ENaC senses high external Na+ concentrations, resulting in an inhibition of channel activity. Both our structural model of an ENaC subunit and the resolved structure of an acid-sensing ion channel (ASIC1) have conserved acidic pockets in the periphery of the extracellular region of the channel. We hypothesized that these acidic pockets host inhibitory allosteric Na+ binding sites. Through site-directed mutagenesis targeting the acidic pocket, we modified the inhibitory response to external Na+. Mutations at selected sites altered the cation inhibitory preference to favor Li+ or K+ rather than Na+. Channel activity was reduced in response to restraining movement within this region by cross-linking structures across the acidic pocket. Our results suggest that residues within the acidic pocket form an allosteric effector binding site for Na+. Our study supports the hypothesis that an acidic cleft is a key ligand binding locus for ENaC and perhaps other members of the ENaC/degenerin family.	[Kashlan, Ossama B.; Blobner, Brandon M.; Zuzek, Zachary; Tolino, Michael; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kashlan, OB (corresponding author), Univ Pittsburgh, Dept Med, 3550 Terrace St, Pittsburgh, PA 15261 USA.	obk2@pitt.edu			National Institutes of Health [R01 DK051391, R01 DK098204, K01 DK078734, P30 DK079307, T32 DK061296]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061296, R37DK051391, R01DK051391, P30DK079307, R01DK098204, K01DK078734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part by National Institutes of Health Grants R01 DK051391 (to T. R. K.), R01 DK098204 and K01 DK078734 (to O. B. K.), P30 DK079307, and T32 DK061296.	Anantharam A, 2006, J PHYSIOL-LONDON, V574, P333, DOI 10.1113/jphysiol.2006.109173; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bize V, 2007, AM J PHYSIOL-RENAL, V293, pF1137, DOI 10.1152/ajprenal.00100.2007; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Chen JX, 2013, AM J PHYSIOL-RENAL, V304, pF207, DOI 10.1152/ajprenal.00563.2012; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Condliffe SB, 2004, J BIOL CHEM, V279, P10085, DOI 10.1074/jbc.M313592200; Drummond HA, 2004, HYPERTENSION, V44, P643, DOI 10.1161/01.HYP.0000144465.56360.ad; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Edelheit O, 2014, FEBS J, V281, P2097, DOI 10.1111/febs.12765; Edelheit O, 2011, AM J PHYSIOL-RENAL, V300, pF887, DOI 10.1152/ajprenal.00648.2010; FUCHS W, 1977, J PHYSIOL-LONDON, V267, P137, DOI 10.1113/jphysiol.1977.sp011805; Grunder S, 2001, EUR J NEUROSCI, V13, P641, DOI 10.1046/j.1460-9568.2001.01426.x; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Horisberger JD., 2004, NEPHRON PHYSIOL, V96, P37, DOI [10.1159/000076406, DOI 10.1159/000076406]; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Ishikawa T, 1998, J GEN PHYSIOL, V111, P825, DOI 10.1085/jgp.111.6.825; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2006, J BIOL CHEM, V281, P8233, DOI 10.1074/jbc.M512293200; Kashlan OB, 2012, J BIOL CHEM, V287, P20720, DOI 10.1074/jbc.M112.358218; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kellenberger S, 1999, P NATL ACAD SCI USA, V96, P4170, DOI 10.1073/pnas.96.7.4170; Kellenberger S, 1998, J CLIN INVEST, V101, P2741, DOI 10.1172/JCI2837; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pearce D., 2014, CLIN J AM S IN PRESS; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Winarski KL, 2010, J BIOL CHEM, V285, P26088, DOI 10.1074/jbc.M110.149963	47	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					568	576		10.1074/jbc.M114.606152	http://dx.doi.org/10.1074/jbc.M114.606152			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25389295	Green Published, hybrid			2022-12-26	WOS:000347231200049
J	Tristan, CA; Ramos, A; Shahani, N; Emiliani, FE; Nakajima, H; Noeh, CC; Kato, Y; Takeuchi, T; Noguchi, T; Kadowaki, H; Sedlak, TW; Ishizuka, K; Ichijo, H; Sawa, A				Tristan, Carlos A.; Ramos, Adriana; Shahani, Neelam; Emiliani, Francesco E.; Nakajima, Hidemitsu; Noeh, Christopher C.; Kato, Yoshinori; Takeuchi, Tadayoshi; Noguchi, Takuya; Kadowaki, Hisae; Sedlak, Thomas W.; Ishizuka, Koko; Ichijo, Hidenori; Sawa, Akira			Role of Apoptosis Signal-regulating Kinase 1 (ASK1) as an Activator of the GAPDH-Siah1 Stress-Signaling Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Nuclear Translocation; Oxidative Stress; Protein Phosphorylation; Protein Translocation; Protein-Protein Interaction; Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH); Seven in absentia homolog 1 (Siah1); Apoptosis Signal-regulating Kinase 1 (ASK1)	GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; CARDIAC-HYPERTROPHY; CELL-DEATH; GAPDH; PROTEIN; TRANSLOCATION; MECHANISMS	Background: Apoptosis signal-regulating kinase 1 (ASK1), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and seven in absentia homolog 1 (Siah1) are molecules associated with stress-signaling cascades. Results: Identification of Siah1 as a substrate of ASK1 for activation of the GAPDH-Siah1 signaling cascade. Conclusion: ASK1 triggers the GAPDH-Siah1 stress-signaling cascade. Significance: This study provides insight into crosstalk among cell stress-signaling cascades. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) plays roles in both energy maintenance, and stress signaling by forming a protein complex with seven in absentia homolog 1 (Siah1). Mechanisms to coordinate its glycolytic and stress cascades are likely to be very important for survival and homeostatic control of any living organism. Here we report that apoptosis signal-regulating kinase 1 (ASK1), a representative stress kinase, interacts with both GAPDH and Siah1 and is likely able to phosphorylate Siah1 at specific amino acid residues (Thr-70/Thr-74 and Thr-235/Thr-239). Phosphorylation of Siah1 by ASK1 triggers GAPDH-Siah1 stress signaling and activates a key downstream target, p300 acetyltransferase in the nucleus. This novel mechanism, together with the established S-nitrosylation/oxidation of GAPDH at Cys-150, provides evidence of how the stress signaling involving GAPDH is finely regulated. In addition, the present results imply crosstalk between the ASK1 and GAPDH-Siah1 stress cascades.	[Tristan, Carlos A.; Ramos, Adriana; Shahani, Neelam; Emiliani, Francesco E.; Sedlak, Thomas W.; Ishizuka, Koko; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Noeh, Christopher C.; Kato, Yoshinori] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA; [Kato, Yoshinori] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Nakajima, Hidemitsu; Takeuchi, Tadayoshi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Osaka 5998531, Japan; [Noguchi, Takuya; Kadowaki, Hisae; Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1138654, Japan	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Osaka Metropolitan University; University of Tokyo	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA.	asawa1@jhmi.edu	Noguchi, Takuya/T-6767-2019; Ishizuka, Koko/L-2071-2014; Kadowaki, Hisae/ABD-3954-2020	Noguchi, Takuya/0000-0001-6187-6645; Nakajima, Hidemitsu/0000-0002-0441-1929; Ichijo, Hidenori/0000-0002-5005-6438; Kato, Yoshinori/0000-0002-6218-8710	United States Public Health Service [H-084018, MH-094268, MH-069853, MH-085226, MH-088753, MH-092443]; National Institutes of Health NRSA F31 Grant [1F31NS070459-01A1]; Stanley; RUSK; S-R foundations; NARSAD; Maryland Stem Cell Research Fund; Japan Society for the promotion of Science [22580339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085226, P50MH094268, RC1MH088753, R01MH069853, P20MH084018, R01MH092443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS070459, K08NS057824] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health NRSA F31 Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley; RUSK; S-R foundations; NARSAD(NARSAD); Maryland Stem Cell Research Fund; Japan Society for the promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by United States Public Health Service Grants MH-084018 (to A. S.), MH-094268 Silvo O. Conte Center (to A. S.), MH-069853 (to A. S.), MH-085226 (to A. S.), MH-088753 (to A. S.), MH-092443 (to A. S.), National Institutes of Health NRSA F31 Grant 1F31NS070459-01A1 (to C. T.), Stanley (to A. S.), RUSK (to A. S.), S-R foundations (to A. S.), NARSAD (to A. S. and N. S.), and Maryland Stem Cell Research Fund (A. S.). This work was also supported in part by Grant-in-aid 22580339 for Scientific Research from the Japan Society for the promotion of Science (to H. N).	Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Chiras D. D., 2010, HUMAN BIOL; Cho KJ, 2009, NEUROSCIENCE, V163, P1128, DOI 10.1016/j.neuroscience.2009.07.048; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Chuang DM, 1996, NAT MED, V2, P609, DOI 10.1038/nm0696-609; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hattori K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-9; Hayakawa Y, 2011, P NATL ACAD SCI USA, V108, P780, DOI 10.1073/pnas.1011418108; He XG, 2003, AM J PATHOL, V163, P243, DOI 10.1016/S0002-9440(10)63647-4; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Imoto K, 2006, DIABETES, V55, P1197, DOI 10.2337/db05-1187; Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32; Ishitani R, 1996, J PHARMACOL EXP THER, V278, P447; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Langley L. L., 1973, HOMEOSTASIS ORIGINS; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Oliveira AMM, 2007, LEARN MEMORY, V14, P564, DOI 10.1101/lm.656907; Ou XM, 2010, BIOL PSYCHIAT, V67, P855, DOI 10.1016/j.biopsych.2009.10.032; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Saunders PA, 1997, J NEUROCHEM, V69, P1820; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schulkin J, 2003, RETHINKING HOMEOSTAS; Schulkin J., 2004, ALLOSTASIS HOMEOSTAS; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024; Seong HA, 2011, J BIOL CHEM, V286, P31123, DOI 10.1074/jbc.M111.248674; Shahani N, 2012, BBA-GEN SUBJECTS, V1820, P736, DOI 10.1016/j.bbagen.2011.07.010; Shahani N, 2011, ANTIOXID REDOX SIGN, V14, P1493, DOI 10.1089/ars.2010.3580; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Takeda K, 2011, ANTIOXID REDOX SIGN, V15, P719, DOI 10.1089/ars.2010.3392; Tatton NA, 2000, EXP NEUROL, V166, P29, DOI 10.1006/exnr.2000.7489; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Tisdale EJ, 2001, J BIOL CHEM, V276, P2480, DOI 10.1074/jbc.M007567200; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Voet D., 2011, BIOCHEMISTRY; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Yu Y, 2011, J BIOL CHEM, V286, P15413, DOI 10.1074/jbc.M111.225946	49	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					56	64		10.1074/jbc.M114.596205	http://dx.doi.org/10.1074/jbc.M114.596205			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391652	Green Published, hybrid			2022-12-26	WOS:000347231200006
J	Dore, K; Labrecque, S; Tardif, C; De Koninck, P				Dore, Kim; Labrecque, Simon; Tardif, Christian; De Koninck, Paul			FRET-FLIM Investigation of PSD95-NMDA Receptor Interaction in Dendritic Spines; Control by Calpain, CaMKII and Src Family Kinase	PLOS ONE			English	Article							SYNAPTIC NMDA RECEPTORS; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; POSTSYNAPTIC DENSITY; HIPPOCAMPAL-NEURONS; CORTICAL-NEURONS; PSD-95 BINDING; PROTEIN PSD-95; VISUAL-CORTEX; NR2B SUBUNIT	Little is known about the changes in protein interactions inside synapses during synaptic remodeling, as their live monitoring in spines has been limited. We used a FRET-FLIM approach in developing cultured rat hippocampal neurons expressing fluorescently tagged NMDA receptor (NMDAR) and PSD95, two essential proteins in synaptic plasticity, to examine the regulation of their interaction. NMDAR stimulation caused a transient decrease in FRET between the NMDAR and PSD95 in spines of young and mature neurons. The activity of both CaMKII and calpain were essential for this effect in both developmental stages. Meanwhile, inhibition of Src family kinase (SFK) had opposing impacts on this decrease in FRET in young versus mature neurons. Our data suggest concerted roles for CaMKII, SFK and calpain activity in regulating activity-dependent separation of PSD95 from GluN2A or GluN2B. Finally, we found that calpain inhibition reduced spine growth that was caused by NMDAR activity, supporting the hypothesis that PSD95-NMDAR separation is implicated in synaptic remodeling.	[Dore, Kim; Labrecque, Simon; Tardif, Christian; De Koninck, Paul] Univ Laval, Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [De Koninck, Paul] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada	Laval University; Laval University	De Koninck, P (corresponding author), Univ Laval, Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada.	paul.dekoninck@neurosciences.ulaval.ca	Dore, Kim/AAN-1470-2021	Dore, Kim/0000-0001-6263-367X	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; CIHR Neurophysics Training grant; Fond de Recherche Nature et Technologie (Quebec); NSERC CREATE Training program in biophotonics	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR Neurophysics Training grant(Canadian Institutes of Health Research (CIHR)); Fond de Recherche Nature et Technologie (Quebec); NSERC CREATE Training program in biophotonics	Research was supported by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council of Canada (NSERC). KD was supported by a post-doctoral fellowship from NSERC and the CIHR Neurophysics Training grant. SL was supported by the CIHR Neurophysics Training grant. CT was supported by the Fond de Recherche Nature et Technologie (Quebec) and an NSERC CREATE Training program in biophotonics. PDK was a CIHR Young Investigator Awardee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Broussard JA, 2013, NAT PROTOC, V8, P265, DOI 10.1038/nprot.2012.147; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cousins SL, 2009, NEUROSCIENCE, V158, P89, DOI 10.1016/j.neuroscience.2007.12.051; Cousins SL, 2012, J BIOL CHEM, V287, P13465, DOI 10.1074/jbc.M111.292862; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Dong YN, 2006, J NEUROCHEM, V99, P206, DOI 10.1111/j.1471-4159.2006.04096.x; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Doshi Shachee, 2009, Front Biosci (Schol Ed), V1, P466, DOI 10.2741/e38; Dupuis JP, 2014, EMBO J; El Gaamouch F, 2012, J NEUROSCI, V32, P10767, DOI 10.1523/JNEUROSCI.5622-11.2012; Fan J, 2009, J NEUROSCI, V29, P10928, DOI 10.1523/JNEUROSCI.2491-09.2009; Gardoni F, 2006, EUR J NEUROSCI, V24, P2694, DOI 10.1111/j.1460-9568.2006.05140.x; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jourdi H, 2005, NEUROCHEM INT, V46, P31, DOI 10.1016/j.neuint.2004.07.002; Korkotian E, 2006, CELL CALCIUM, V40, P441, DOI 10.1016/j.ceca.2006.08.008; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Lin H, 2004, BIOCHEM BIOPH RES CO, V316, P501, DOI 10.1016/j.bbrc.2004.02.086; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Nault F, 2010, SPRINGER PROTOC HAND, P137, DOI 10.1007/978-1-60761-292-6_8; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Shiraishi Y, 2003, MOL CELL NEUROSCI, V22, P188, DOI 10.1016/S1044-7431(03)00037-X; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Tregidgo C, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2937212; Vinade L, 2001, SYNAPSE, V40, P302, DOI 10.1002/syn.1053; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu HY, 2007, J BIOL CHEM, V282, P20075, DOI 10.1074/jbc.M700624200; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yang QA, 2011, BRAIN RES BULL, V84, P137, DOI 10.1016/j.brainresbull.2010.12.009; Yuen EY, 2008, MOL PHARMACOL, V74, P360, DOI 10.1124/mol.108.046813; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200; Zadran S, 2010, MOL NEUROBIOL, V42, P143, DOI 10.1007/s12035-010-8145-1	46	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112170	10.1371/journal.pone.0112170	http://dx.doi.org/10.1371/journal.pone.0112170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393018	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300037
J	Gao, W; Zhou, P; Ma, XC; Tschudy-Seney, B; Chen, JM; Magner, NL; Revzin, A; Nolta, JA; Zern, MA; Duan, YY				Gao, Wei; Zhou, Ping; Ma, Xiaocui; Tschudy-Seney, Benjamin; Chen, Jiamei; Magner, Nataly L.; Revzin, Alexander; Nolta, Jan A.; Zern, Mark A.; Duan, Yuyou			Ethanol Negatively Regulates Hepatic Differentiation of hESC by Inhibition of the MAPK/ERK Signaling Pathway In Vitro	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEPATOCYTE-LIKE CELLS; EFFICIENT DIFFERENTIATION; LIVER DEVELOPMENT; PROGENITOR CELLS; ENDODERM; PANCREAS; GROWTH; SPECIFICATION; INACTIVATION	Background: Alcohol insult triggers complex events in the liver, promoting fibrogenic/inflammatory signals and in more advanced cases, aberrant matrix deposition. It is well accepted that the regenerative capacity of the adult liver is impaired during alcohol injury. The liver progenitor/stem cells have been shown to play an important role in liver regeneration -in response to various chronic injuries; however, the effects of alcohol on stem cell differentiation in the liver are not well understood. Methods: We employed hepatic progenitor cells derived from hESCs to study the impact of ethanol on hepatocyte differentiation by exposure of these progenitor cells to ethanol during hepatocyte differentiation. Results: We found that ethanol negatively regulated hepatic differentiation of hESC-derived hepatic progenitor cells in a dose-dependent manner. There was also a moderate cell cycle arrest at G1/S checkpoint in the ethanol treated cells, which is associated with a reduced level of cyclin D1 in these cells. Ethanol treatment specifically inhibited the activation of the ERK but not JNK nor the p38 MAP signaling pathway. At the same time, the WNT signaling pathway was also reduced in the cells exposed to ethanol. Upon evaluating the effects of the inhibitors of these two signaling pathways, we determined that the Erk inhibitor replicated the effects of ethanol on the hepatocyte differentiation and attenuated the WNT/beta-catenin signaling, however, inhibitors of WNT only partially replicated the effects of ethanol on the hepatocyte differentiation. Conclusion: Our results demonstrated that ethanol negatively regulated hepatic differentiation of hESC-derived hepatic progenitors through inhibiting the MAPK/ERK signaling pathway, and subsequently attenuating the WNT signaling pathway. Thus, our finding provides a novel insight into the mechanism by which alcohol regulates cell fate selection of hESC-derived hepatic progenitor cells, and the identified pathways may provide therapeutic targets aimed at promoting liver repair and regeneration during alcoholic injury.	[Gao, Wei] Hunan Univ, Coll Biol, Dept Biomed Engn, Changsha 410082, Hunan, Peoples R China; [Gao, Wei; Zhou, Ping; Ma, Xiaocui; Tschudy-Seney, Benjamin; Chen, Jiamei; Magner, Nataly L.; Nolta, Jan A.; Zern, Mark A.; Duan, Yuyou] Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA; [Gao, Wei; Zhou, Ping; Ma, Xiaocui; Tschudy-Seney, Benjamin; Chen, Jiamei; Magner, Nataly L.; Nolta, Jan A.; Zern, Mark A.; Duan, Yuyou] Univ Calif Davis, Med Ctr, Inst Regenerat Cures, Sacramento, CA 95817 USA; [Revzin, Alexander] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Chen, Jiamei] Shanghai Univ Tradit Chinese Med, Inst Liver Dis, Shuguang Hosp, Shanghai, Peoples R China	Hunan University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Shanghai University of Traditional Chinese Medicine	Zhou, P (corresponding author), Univ Calif Davis, Med Ctr, Dept Internal Med, Sacramento, CA 95817 USA.	ping.zhou@ucdmc.ucdavis.edu; yduan@ucdavis.edu	Duan, Yuyou/L-2301-2015	Duan, Yuyou/0000-0002-1402-7402; Nolta, Jan/0000-0003-4576-8542	National Institutes of Health (NIH) [DK075415, DK079977, DK073901]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073901, R01DK079977, R01DK075415] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the grants from National Institutes of Health (NIH) (grant number: DK075415 to MZ, DK079977 and DK073901 to AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI Y, 1994, HEPATOLOGY, V20, P453, DOI 10.1002/hep.1840200227; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Crosby HA, 1998, AM J PATHOL, V152, P771; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Deutsch G, 2001, DEVELOPMENT, V128, P871; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Duan YY, 2010, STEM CELLS, V28, P674, DOI 10.1002/stem.315; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Hoek JB, 2002, ALCOHOL, V27, P63, DOI 10.1016/S0741-8329(02)00215-X; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; KRISHAN A, 1975, J CELL BIOL, V66, P188, DOI 10.1083/jcb.66.1.188; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kubota H, 2000, P NATL ACAD SCI USA, V97, P12132, DOI 10.1073/pnas.97.22.12132; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Li J, 2010, CELL PROLIFERAT, V43, P333, DOI 10.1111/j.1365-2184.2010.00682.x; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lu T, 2014, GENET MOL RES, V13, P415, DOI 10.4238/2014.January.21.9; Magner NL, 2013, STEM CELLS, V31, P2095, DOI 10.1002/stem.1478; McCoy JP, 2002, CLIN LAB MED, P1403; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Monga SPS, 2003, GASTROENTEROLOGY, V124, P202, DOI 10.1053/gast.2003.50000; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagy LE, 2004, ANNU REV NUTR, V24, P55, DOI 10.1146/annurev.nutr.24.012003.132258; Neuman MG, 2003, ALCOHOL RES HEALTH, V27, P307; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Pal R, 2012, J CELL BIOCHEM, V113, P19, DOI 10.1002/jcb.23391; Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105; Rossi JM, 2001, GENE DEV, V15, P1998, DOI 10.1101/gad.904601; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Shirahashi H, 2004, CELL TRANSPLANT, V13, P197, DOI 10.3727/000000004783984016; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Tan JY, 2002, LIVER, V22, P365, DOI 10.1034/j.1600-0676.2002.01622.x; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; VandeVoort CA, 2011, ALCOHOL CLIN EXP RES, V35, P1534, DOI 10.1111/j.1530-0277.2011.01490.x; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300; Williams JM, 2010, AM J PATHOL, V176, P2732, DOI 10.2353/ajpath.2010.080486; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zaret KS, 2008, NAT REV GENET, V9, P329, DOI 10.1038/nrg2318; Zhang AB, 2010, J CELL BIOCHEM, V111, P469, DOI 10.1002/jcb.22729; Zhang LL, 2008, HEPATOLOGY, V48, P1598, DOI 10.1002/hep.22516	53	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112698	10.1371/journal.pone.0112698	http://dx.doi.org/10.1371/journal.pone.0112698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393427	gold, Green Submitted, Green Published			2022-12-26	WOS:000347709300087
J	Huang, XN; Shi, XL; Kotov, AA; Gu, FK				Huang, Xiaona; Shi, Xinlu; Kotov, Alexey A.; Gu, Fukang			Confirmation through Genetic Analysis of the Existence of Many Local Phyloclades of the Genus Simocephalus (Crustacea, Cladocera) in China	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; DAPHNIA; BIOGEOGRAPHY; CHYDORIDAE; ANOMOPODA	Previously, a series of Simocephalus taxa (Cladocera: Daphniidae) from China were described. Most were proposed to be junior synonyms in the last revision of the genus. Using original material from China and data from GenBank, we investigate the biodiversity and phylogeny of Simocephalus using sequences of the cytochrome c oxidase subunit I (COI) and the nuclear 18S genes. In both cases, neighbor-joining, maximum likelihood and Bayesian inference analyses led to highly congruent tree topologies. The grouping of the deeper clades agrees with the inter-generic classification of Orlova-Bienkowskaja (2001). Only the populations of S. serrulatus from Eurasia and North America seem to be closely related, and there are no other shared species between the two continents. Our study unambiguously confirms the existence of many lineages from the subgenera of Simocephalus (Echinocaudus) and Simocephalus s.str. in China, but their morphology needs to be reexamined by taking a wider range of characters (e.g., of female thoracic limbs and adult males) into consideration.	[Huang, Xiaona; Gu, Fukang] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Huang, Xiaona; Shi, Xinlu] Hangzhou Normal Univ, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China; [Kotov, Alexey A.] AN Severtsov Inst Ecol & Evolut, Moscow, Russia	East China Normal University; Hangzhou Normal University; Russian Academy of Sciences; Saratov Scientific Center of the Russian Academy of Sciences; Severtsov Institute of Ecology & Evolution	Huang, XN (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	nxxiaona@163.com	Kotov, Alexey A./B-1549-2010	Kotov, Alexey A./0000-0002-8863-6438	National Natural Science Foundation of China [31071880, 31272262]; Zhejiang Provincial Natural Science Foundation; Zhejiang Key Scientific & Technological Innovation Team Project [2010R50039-20]; Hangzhou Key Laboratory for Animal Adaptation and Evolution [20100333T05]; Russian foundation for Basic research [12-04-00207-a, 14-04-01149-a]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Key Scientific & Technological Innovation Team Project; Hangzhou Key Laboratory for Animal Adaptation and Evolution; Russian foundation for Basic research(Russian Foundation for Basic Research (RFBR))	The reagents, materials and analysis tools of this study was partly supported by the National Natural Science Foundation of China (Grant Nos. 31071880 and 31272262), Zhejiang Provincial Natural Science Foundation and Zhejiang Key Scientific & Technological Innovation Team Project (Grant Nos. 2010R50039-20), and Hangzhou Key Laboratory for Animal Adaptation and Evolution (Grant No. 20100333T05) and part of analysis tools of this study was partly supported by Russian foundation for Basic research (grants 12-04-00207-a and 14-04-01149-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2009, MOL PHYLOGENET EVOL, V50, P423, DOI 10.1016/j.ympev.2008.11.026; Bekker EI, 2012, ZOOTAXA, P1; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; Chen SZ, 1992, J HARBIN NORMAL U NA, V8, P91; Chiang XZ, 1974, SCI SURVEY REPORTS B, P127; Chiang XZ, 1979, FAUNA SINICA FRESHWA, P124; Connelly SJ, 2009, INTEGR COMP BIOL, V49, pE35; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Dumont H.J., 2002, GUIDES IDENTIFICATIO, V19, P1; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; FREY DG, 1987, HYDROBIOLOGIA, V145, P5, DOI 10.1007/BF02530260; FREY DG, 1982, ARCH HYDROBIOL, V93, P484; FREY DG, 1993, HYDROBIOLOGIA, V262, P145, DOI 10.1007/BF00010882; FRYER G, 1991, ZOOL J LINN SOC-LOND, V102, P163, DOI 10.1111/j.1096-3642.1991.tb00287.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hann BJ, 2003, J PALEOLIMNOL, V29, P135; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Jeffery NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018364; Jermakov NW, 1924, RABOTI VOLZHSKOJ BIO, V7, P151; Kohout J, 2014, BIOLOGIA, V69, P76, DOI 10.2478/s11756-013-0285-0; Kotov AA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-129; Martinez-Jeronimo F, 2008, ECOTOX ENVIRON SAFE, V71, P26, DOI 10.1016/j.ecoenv.2008.05.005; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Nogueira PFM, 2005, FRESHWATER BIOL, V50, P1560, DOI 10.1111/j.1365-2427.2005.01406.x; Orlova-Bienkowskaja MY, 2001, CLADOCERA ANOMOPODA, P1; Penton EH, 2004, MOL ECOL, V13, P97, DOI 10.1046/j.1365-294X.2003.02024.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prosser S, 2013, MOL ECOL RESOUR, V13, P1151, DOI 10.1111/1755-0998.12132; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sacherova V, 2003, BIOL J LINN SOC, V79, P629, DOI 10.1046/j.1095-8312.2003.00216.x; Shi Xin-lu, 1996, Acta Zootaxonomica Sinica, V21, P263; Shi XL, 2011, CHIN J OCEANOL LIMN, V29, P206, DOI 10.1007/s00343-011-0010-1; Shi XL, 1994, ACTA ZOOTAXONOMICA S, V19, P403; Smirnov NN, 1996, GUIDES IDENTIFICATIO, V11, P1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor DJ, 1998, EVOLUTION, V52, P1648, DOI 10.1111/j.1558-5646.1998.tb02245.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xu S, 2009, MOL ECOL, V18, P5161, DOI 10.1111/j.1365-294X.2009.04422.x; Xu You-qin, 2002, Journal of Fujian Teachers University Natural Science, V18, P66; Yi ZZ, 2009, ZOOL SCR, V38, P323, DOI 10.1111/j.1463-6409.2008.00371.x; Young SS, 2012, ZOOL STUD, V51, P222	44	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112808	10.1371/journal.pone.0112808	http://dx.doi.org/10.1371/journal.pone.0112808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393020	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300109
J	Reed, SM; Hagen, J; Muniz, VP; Rosean, TR; Borcherding, N; Sciegienka, S; Goeken, JA; Naumann, PW; Zhang, WZ; Tompkins, VS; Janz, S; Meyerholz, DK; Quelle, DE				Reed, Sara M.; Hagen, Jussara; Muniz, Viviane P.; Rosean, Timothy R.; Borcherding, Nick; Sciegienka, Sebastian; Goeken, J. Adam; Naumann, Paul W.; Zhang, Weizhou; Tompkins, Van S.; Janz, Siegfried; Meyerholz, David K.; Quelle, Dawn E.			NIAM-Deficient Mice Are Predisposed to the Development of Proliferative Lesions including B-Cell Lymphomas	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; MYC-INDUCED LYMPHOMAGENESIS; TUMOR SUPPRESSION; NUCLEAR INTERACTOR; TGF-BETA; CANCER PROGRESSION; HODGKIN LYMPHOMA; BREAST-CANCER; P53; MDM2	Nuclear Interactor of ARF and Mdm2 (NIAM, gene designation Tbrg1) is a largely unstudied inhibitor of cell proliferation that helps maintain chromosomal stability. It is a novel activator of the ARF-Mdm2-Tip60-p53 tumor suppressor pathway as well as other undefined pathways important for genome maintenance. To examine its predicted role as a tumor suppressor, we generated NIAM mutant (NIAM(m/m)) mice homozygous for a beta-galactosidase expressing gene-trap cassette in the endogenous gene. The mutant mice expressed significantly lower levels of NIAM protein in tissues compared to wild-type animals. Fifty percent of aged NIAM deficient mice (14 to 21 months) developed proliferative lesions, including a uterine hemangioma, pulmonary papillary adenoma, and a Harderian gland adenoma. No age-matched wild-type or NIAM(+/m) heterozygous animals developed lesions. In the spleen, NIAM(m/m) mice had prominent white pulp expansion which correlated with enhanced increased reactive lymphoid hyperplasia and evidence of systemic inflammation. Notably, 17% of NIAM mutant mice had splenic white pulp features indicating early B-cell lymphoma. This correlated with selective expansion of marginal zone B cells in the spleens of younger, tumor-free NIAM-deficient mice. Unexpectedly, basal p53 expression and activity was largely unaffected by NIAM loss in isolated splenic B cells. In sum, NIAM down-regulation in vivo results in a significant predisposition to developing benign tumors or early stage cancers. These mice represent an outstanding platform for dissecting NIAM's role in tumorigenesis and various anti-cancer pathways, including p53 signaling.	[Reed, Sara M.; Hagen, Jussara; Muniz, Viviane P.; Sciegienka, Sebastian; Quelle, Dawn E.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Reed, Sara M.; Quelle, Dawn E.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Muniz, Viviane P.; Quelle, Dawn E.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA USA; [Rosean, Timothy R.; Zhang, Weizhou; Janz, Siegfried] Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA USA; [Borcherding, Nick; Goeken, J. Adam; Naumann, Paul W.; Zhang, Weizhou; Tompkins, Van S.; Janz, Siegfried; Meyerholz, David K.; Quelle, Dawn E.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Quelle, DE (corresponding author), Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA.	dawn-quelle@uiowa.edu	Tompkins, Van/A-5757-2018; Meyerholz, David/J-8131-2019	Tompkins, Van/0000-0003-1279-8075; Meyerholz, David/0000-0003-1552-3253; Quelle, Dawn/0000-0001-8776-0122; Borcherding, Nicholas/0000-0003-1427-6342	NIH [5F30CA165736, 5T32AI007485]; NCI, University of Iowa Holden Comprehensive Cancer Center [P30CA086862, R01CA151354]; Oberley Award through the Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [F30CA165736, P30CA086862, R01CA151354] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795, T32GM007337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, University of Iowa Holden Comprehensive Cancer Center; Oberley Award through the Holden Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH through a pre-doctoral fellowship 5F30CA165736 (S.M.R.), pre-doctoral training grant 5T32AI007485 (T.R.R.), NCI Core Grant P30CA086862 in support of the University of Iowa Holden Comprehensive Cancer Center, and R01CA151354 (S.J.), as well as an Oberley Award through the Holden Comprehensive Cancer Center (S.J. and D.E.Q). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; BABALOLA GO, 1995, MOL REPROD DEV, V41, P133, DOI 10.1002/mrd.1080410203; Blum JL, 2011, BREAST CANCER RES TR, V125, P431, DOI 10.1007/s10549-010-1222-3; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Carter JH, 2003, ENVIRON HEALTH PERSP, V111, P53, DOI 10.1289/ehp.5442; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chiang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049305; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eckerle S, 2009, LEUKEMIA, V23, P2129, DOI 10.1038/leu.2009.161; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Garcia PB, 2014, SEMINARS CELL DEV BI; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Ghobrial IM, 2005, BLOOD, V105, P3722, DOI 10.1182/blood-2004-10-3999; Gostissa M, 2013, P NATL ACAD SCI USA, V110, P2934, DOI 10.1073/pnas.1222570110; Hagen J, 2008, HYBRIDOMA, V27, P159, DOI 10.1089/hyb.2007.0533; Hoenerhoff MJ, 2006, VET PATHOL, V43, P682, DOI 10.1354/vp.43-5-682; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang DD, 2013, CELL RES, V23, P739, DOI 10.1038/cr.2013.34; Kamijo T, 1999, CANCER RES, V59, P2217; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu Q, 2009, AM J PATHOL, V174, P153, DOI 10.2353/ajpath.2009.080555; Llanos S, 2001, NAT CELL BIOL, V3, P445, DOI 10.1038/35074506; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Martin-Caballero J, 2001, CANCER RES, V61, P6234; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Percy DH, 2007, PATHOLOGY LAB RODENT, P90; Reed SM, 2014, CELL CYCLE, V13, P1288, DOI 10.4161/cc.28202; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Senturk Emir, 2012, Genes Cancer, V3, P192, DOI 10.1177/1947601912457368; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Storz MN, 2003, J INVEST DERMATOL, V120, P865, DOI 10.1046/j.1523-1747.2003.12142.x; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Tompkins V, 2006, CELL CYCLE, V5, P641; Tompkins VS, 2007, J BIOL CHEM, V282, P1322, DOI 10.1074/jbc.M609612200; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang P, 2006, ONCOGENE, V25, P3708, DOI 10.1038/sj.onc.1209411; Ward JM, 2012, TOXICOL PATHOL, V40, P425, DOI 10.1177/0192623311431467; Watanabe T, 1996, LEUKEMIA LYMPHOMA, V21, P391, DOI 10.3109/10428199609093436; Wilda M, 2004, LEUKEMIA, V18, P584, DOI 10.1038/sj.leu.2403254; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786	72	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112126	10.1371/journal.pone.0112126	http://dx.doi.org/10.1371/journal.pone.0112126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393878	Green Submitted, gold, Green Published			2022-12-26	WOS:000347709300033
J	Roeske, TC; Scharff, C; Olson, CR; Nshdejan, A; Mello, CV				Roeske, Tina C.; Scharff, Constance; Olson, Christopher R.; Nshdejan, Arpik; Mello, Claudio V.			Long-Distance Retinoid Signaling in the Zebra Finch Brain	PLOS ONE			English	Article							X-RECEPTOR-GAMMA; PROTEIN-KINASE-C; HOMEOSTATIC SYNAPTIC PLASTICITY; RELATIONAL MEMORY DEFICIT; AVIAN FOREBRAIN NUCLEUS; VITAMIN-A-DEFICIENCY; BASAL GANGLIA; GENE-EXPRESSION; RAR-ALPHA; ADULT NEUROGENESIS	All-trans retinoic acid (ATRA), the main active metabolite of vitamin A, is a powerful signaling molecule that regulates large-scale morphogenetic processes during vertebrate embryonic development, but is also involved post-natally in regulating neural plasticity and cognition. In songbirds, it plays an important role in the maturation of learned song. The distribution of the ATRA-synthesizing enzyme, zRalDH, and of ATRA receptors (RARs) have been described, but information on the distribution of other components of the retinoid signaling pathway is still lacking. To address this gap, we have determined the expression patterns of two obligatory RAR co-receptors, the retinoid X receptors (RXR) alpha and gamma, and of the three ATRA-degrading cytochromes CYP26A1, CYP26B1, and CYP26C1. We have also studied the distribution of zRalDH protein using immunohistochemistry, and generated a refined map of ATRA localization, using a modified reporter cell assay to examine entire brain sections. Our results show that (1) ATRA is more broadly distributed in the brain than previously predicted by the spatially restricted distribution of zRalDH transcripts. This could be due to long-range transport of zRalDH enzyme between different nuclei of the song system: Experimental lesions of putative zRalDH peptide source regions diminish ATRA-induced transcription in target regions. (2) Four telencephalic song nuclei express different and specific subsets of retinoid-related receptors and could be targets of retinoid regulation; in the case of the lateral magnocellular nucleus of the anterior nidopallium (lMAN), receptor expression is dynamically regulated in a circadian and age-dependent manner. (3) High-order auditory areas exhibit a complex distribution of transcripts representing ATRA synthesizing and degrading enzymes and could also be a target of retinoid signaling. Together, our survey across multiple connected song nuclei and auditory brain regions underscores the prominent role of retinoid signaling in modulating the circuitry that underlies the acquisition and production of learned vocalizations.	[Roeske, Tina C.] CUNY, Hunter Coll, Dept Psychol, New York, NY 10065 USA; [Scharff, Constance; Nshdejan, Arpik] Free Univ Berlin, Dept Anim Behav, Berlin, Germany; [Olson, Christopher R.; Mello, Claudio V.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	City University of New York (CUNY) System; Hunter College (CUNY); Free University of Berlin; Oregon Health & Science University	Roeske, TC (corresponding author), CUNY, Hunter Coll, Dept Psychol, New York, NY 10065 USA.	christina.roeske@gmail.com	olson, Christopher/ABC-3812-2020; Scharff, Constance/HHN-0673-2022	olson, Christopher/0000-0002-8351-0633; Mello, Claudio/0000-0002-9826-8421	NIGMS NIH HHS [R24 GM092842] Funding Source: Medline; NINDS NIH HHS [F32 NS062609] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM092842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS062609] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKUTAGAWA E, 1994, P NATL ACAD SCI USA, V91, P12413, DOI 10.1073/pnas.91.26.12413; Andalman AS, 2009, P NATL ACAD SCI USA, V106, P12518, DOI 10.1073/pnas.0903214106; Aoto J, 2008, NEURON, V60, P308, DOI 10.1016/j.neuron.2008.08.012; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Aronov D, 2011, J NEUROSCI, V31, P16353, DOI 10.1523/JNEUROSCI.3009-11.2011; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; BAHN S, 1994, J NEUROSCI, V14, P5525; Bonnet E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003487; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; Charlesworth JD, 2012, NATURE, V486, P251, DOI 10.1038/nature11078; Chen L.W., 2012, NEUROPHARMACOLOGY; Chen N, 2008, J BIOL CHEM, V283, P20841, DOI 10.1074/jbc.M802314200; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chiang MY, 1998, NEURON, V21, P1353, DOI 10.1016/S0896-6273(00)80654-6; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Cossette SMM, 2004, DIFFERENTIATION, V72, P239, DOI 10.1111/j.1432-0436.2004.07205006.x; Crandall J, 2004, P NATL ACAD SCI USA, V101, P5111, DOI 10.1073/pnas.0306336101; Denisenko-Nehrbass NI, 2001, MOL BRAIN RES, V87, P246, DOI 10.1016/S0169-328X(01)00002-X; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Dopheide MM, 2008, PHARM BIOCH BEHAV; Dutar P, 1998, J NEUROPHYSIOL, V80, P1828, DOI 10.1152/jn.1998.80.4.1828; Dyall SC, 2010, J NEUROSCI RES, V88, P2091, DOI 10.1002/jnr.22390; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Etchamendy N, 2001, J NEUROSCI, V21, P6423, DOI 10.1523/JNEUROSCI.21-16-06423.2001; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Fujii H, 1997, EMBO J, V16, P4163, DOI 10.1093/emboj/16.14.4163; Funabiki Y, 2008, DEV NEUROBIOL, V68, P645, DOI 10.1002/dneu.20597; Gahr M, 1996, BRAIN RES, V712, P69, DOI 10.1016/0006-8993(95)01448-9; Gale SD, 2010, J CHEM NEUROANAT, V39, P124, DOI 10.1016/j.jchemneu.2009.07.003; Goldberg JH, 2012, NAT NEUROSCI, V15, P620, DOI 10.1038/nn.3047; HEERY DM, 1993, P NATL ACAD SCI USA, V90, P4281, DOI 10.1073/pnas.90.9.4281; HERMANN T, 1992, MOL ENDOCRINOL, V6, P1153, DOI 10.1210/me.6.7.1153; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Holzenberger M, 1997, J NEUROSCI, V17, P6974; Hoover F, 1998, J COMP NEUROL, V391, P204; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Jeong JK, 2005, J COMP NEUROL, V489, P23, DOI 10.1002/cne.20605; Kastner P, 1997, DEVELOPMENT, V124, P313; Kim YH, 2005, J NEUROBIOL, V65, P260, DOI 10.1002/neu.20192; Kittelberger JM, 1999, J NEUROSCI, V19, P9385; Klein R, 2014, CURR OPIN NEUROBIOL, V27, P16, DOI 10.1016/j.conb.2014.02.006; Kornyei Z, 2007, FASEB J, V21, P2496, DOI 10.1096/fj.06-7756com; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Maghsoodi B, 2008, P NATL ACAD SCI USA, V105, P16015, DOI 10.1073/pnas.0804801105; MANGELSDORF DJ, 1992, GENE DEV, V6, P329, DOI 10.1101/gad.6.3.329; Mello C V, 1997, Methods Mol Biol, V85, P205; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1995, J NEUROBIOL, V26, P145, DOI 10.1002/neu.480260112; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Mingaud F, 2008, J NEUROSCI, V28, P279, DOI 10.1523/JNEUROSCI.4065-07.2008; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; MOONEY R, 1992, J NEUROSCI, V12, P2464; Nakagomi M, 2013, PHARMACOL BIOCHEM BE, V104, P1, DOI 10.1016/j.pbb.2013.01.008; Nomoto M, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-8; Ochoa WF, 2003, BIOCHEMISTRY-US, V42, P8774, DOI 10.1021/bi034713g; Olveczky BP, 2011, J NEUROPHYSIOL, V106, P386, DOI 10.1152/jn.00018.2011; Olson CR, 2011, J COMP NEUROL, V519, P148, DOI 10.1002/cne.22510; Olson CR, 2010, MOL NUTR FOOD RES, V54, P489, DOI 10.1002/mnfr.200900246; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; Plane JM, 2008, EXP NEUROL; Poon MM, 2008, P NATL ACAD SCI USA, V105, P20303, DOI 10.1073/pnas.0807740105; Prather JF, 2013, HEARING RES, V305, P144, DOI 10.1016/j.heares.2013.06.007; Pytte CL, 2007, DEV NEUROBIOL, V67, P1699, DOI 10.1002/dneu.20520; Radominska-Pandya A, 2000, J BIOL CHEM, V275, P22324, DOI 10.1074/jbc.M907722199; Ransom J, 2013, J NEUROCHEM; Reijntjes S, 2004, DEV DYNAM, V230, P509, DOI 10.1002/dvdy.20025; Reijntjes S, 2003, GENE EXPR PATTERNS, V3, P621, DOI 10.1016/S1567-133X(03)00112-1; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Sarti F, 2013, J NEUROSCI, V33, P11440, DOI 10.1523/JNEUROSCI.1710-13.2013; Sarti F, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00016; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SELEIRO EAP, 1994, BIOCHEM J, V301, P283, DOI 10.1042/bj3010283; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; Shearer KD, 2012, J NEUROCHEM, V122, P789, DOI 10.1111/j.1471-4159.2012.07824.x; Shimozono S, 2013, NATURE, V496, P363, DOI 10.1038/nature12037; Smith D, 2001, CEREB CORTEX, V11, P894, DOI 10.1093/cercor/11.10.894; Terleph TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002854; Thompson CK, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00024; Thompson JA, 2007, J NEUROSCI, V27, P12308, DOI 10.1523/JNEUROSCI.2853-07.2007; Thompson JA, 2007, DEV NEUROBIOL, V67, P205, DOI 10.1002/dneu.20287; VATES GE, 1995, P NATL ACAD SCI USA, V92, P5139, DOI 10.1073/pnas.92.11.5139; Vignal C, 2005, EUR J NEUROSCI, V22, P949, DOI 10.1111/j.1460-9568.2005.04254.x; Wagner E, 2002, CEREB CORTEX, V12, P1244, DOI 10.1093/cercor/12.12.1244; Wagner E, 2006, EUR J NEUROSCI, V24, P329, DOI 10.1111/j.1460-9568.2006.04934.x; WAGNER M, 1992, DEVELOPMENT, V116, P55; Warren TL, 2012, J NEUROSCI, V32, P15414, DOI 10.1523/JNEUROSCI.1254-12.2012; Warren TL, 2011, J NEUROPHYSIOL, V106, P1806, DOI 10.1152/jn.00311.2011; Watanabe A, 2002, NEUROREPORT, V13, P127, DOI 10.1097/00001756-200201210-00030; Watanabe A, 2006, EUR J NEUROSCI, V23, P2447, DOI 10.1111/j.1460-9568.2006.04763.x; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; White RJ, 2007, PLOS BIOL, V5, P2522, DOI 10.1371/journal.pbio.0050304; Wietrzych M, 2005, LEARN MEMORY, V12, P318, DOI 10.1101/lm.89805; Williams H, 1999, TLS-TIMES LIT SUPPL, P16; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Wood WE, 2008, DEV NEUROBIOL; Woolley SMN, 2012, DEV PSYCHOBIOL, V54, P612, DOI 10.1002/dev.21014; XIAO JH, 1995, J BIOL CHEM, V270, P3001, DOI 10.1074/jbc.270.7.3001	103	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111722	10.1371/journal.pone.0111722	http://dx.doi.org/10.1371/journal.pone.0111722			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393898	Green Published, gold			2022-12-26	WOS:000347709300020
J	Wang, JN; Guo, WJ; Du, H; Yu, HT; Jiang, W; Zhu, T; Bai, XF; Wang, PZ				Wang, Junning; Guo, Weijuan; Du, Hong; Yu, Haitao; Jiang, Wei; Zhu, Ting; Bai, Xuefan; Wang, Pingzhong			Elevated Soluble CD163 Plasma Levels Are Associated with Disease Severity in Patients with Hemorrhagic Fever with Renal Syndrome	PLOS ONE			English	Article							HEMOGLOBIN SCAVENGER RECEPTOR; MONOCYTE SUBSET; EXPRESSION; PATHOGENESIS; MACROPHAGES; ACTIVATION; INFECTION; MARKER	Background: Hantaan virus is a major zoonotic pathogen that causesing hemorrhagic fever with renal syndrome (HFRS). Although HFRS pathogenesis has not been entirely elucidated, the importance of host-related immune responses in HFRS pathogenesis has been widely recognized. CD163, a monocyte and macrophage-specific scavenger receptor that plays a vital function in the hosts can reduce inflammation, is shed during activation as soluble CD163 (sCD163). The aim of this study was to investigate the pathological significance of sCD163 in patients with HFRS. Methods: Blood samples were collected from 81 hospitalized patients in Tangdu Hospital from October 2011 to January 2014 and from 15 healthy controls. The sCD163 plasma levels were measured using a sandwich ELISA, and the relationship between sCD163 and disease severity was analyzed. Furthermore, CD163 expression in 3 monocytes subset was analyzed by flow cytometry. Results: The results demonstrated that sCD163 plasma levels during the HFRS acute phase were significantly higher in patients than during the convalescent stage and the levels in the healthy controls (P<0.0001). The sCD163 plasma levels in the severe/critical group were higher than those in the mild/moderate group during the acute (P<0.0001). A Spearman correlation analysis indicated that the sCD163 levels were positively correlated with white blood cell, serum creatine, blood urea nitrogen levels, while they were negatively correlated with blood platelet levels in the HFRS patients. The monocyte subsets were significantly altered during the acute stage. Though the CD163 expression levels within the monocyte subsets were increased during the acute stage, the highest CD163 expression level was observed in the CD14++CD16+ monocytes when compared with the other monocyte subsets. Conclusion: sCD163 may be correlated with disease severity and the disease progression in HFRS patients; however, the underlying mechanisms should be explored further.	[Wang, Junning; Du, Hong; Yu, Haitao; Jiang, Wei; Zhu, Ting; Bai, Xuefan; Wang, Pingzhong] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Guo, Weijuan] Chang An Hosp, Dept Obstet & Gynecol, Xian, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Chang'an University	Bai, XF (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China.	xfbai2011@163.com; wangpz63@126.com			National Basic Research Program of China (973 Program) [2012CB518905]; National Natural Science Foundation of China [81373118]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (No. 2012CB518905) and National Natural Science Foundation of China (No. 81373118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MN, 2014, EUR J HAEMATOL; Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x; Barbosa RR, 2012, CLIN EXP IMMUNOL, V169, P263, DOI 10.1111/j.1365-2249.2012.04620.x; Buechler Christa, 2013, Inflammation & Allergy Drug Targets, V12, P391; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Burdo TH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000842; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Coulthard LR, 2012, CLIN EXP IMMUNOL, V170, P36, DOI 10.1111/j.1365-2249.2012.04626.x; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Du H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089740; Du H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-191; Etzerodt A, 2014, J BIOL CHEM, V289, P778, DOI 10.1074/jbc.M113.520213; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Frings W, 2002, FEBS LETT, V526, P93, DOI 10.1016/S0014-5793(02)03142-3; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ghigliotti G, 2013, DIS MARKERS, V34, P131, DOI 10.1155/2013/836849; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; Kazankov K, 2014, HEPATOLOGY, V60, P521, DOI 10.1002/hep.27129; Kjaergaard AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092331; Klingstrom J, 2006, J VIROL, V80, P8279, DOI 10.1128/JVI.00742-06; Koch S, 2010, CLIN EXP IMMUNOL, V161, P332, DOI 10.1111/j.1365-2249.2010.04177.x; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P15830, DOI 10.1074/jbc.M113.453290; Manigold T, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13937; Mendonca VRR, 2012, INFECT IMMUN, V80, P1445, DOI 10.1128/IAI.05933-11; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Mustonen J, 2013, ANTIVIR RES, V100, P589, DOI 10.1016/j.antiviral.2013.10.001; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Pedraza-Sanchez S, 2013, CLIN VACCINE IMMUNOL, V20, P962, DOI 10.1128/CVI.00609-12; PENTTINEN K, 1981, J INFECT DIS, V143, P15, DOI 10.1093/infdis/143.1.15; Possamai LA, 2010, WORLD J GASTROENTERO, V16, P1811, DOI 10.3748/wjg.v16.i15.1811; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Simoni J, 2006, ASAIO J, V52, P652, DOI 10.1097/01.mat.0000235282.89757.9f; Su LX, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/969875; Thomsen HH, 2013, ENDOCR CONNECT, V2, P216, DOI 10.1530/EC-13-0067; Tippett E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019968; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008; Wang PZ, 2012, J INT MED RES, V40, P648, DOI 10.1177/147323001204000227; Weaver LK, 2006, J LEUKOCYTE BIOL, V80, P26, DOI 10.1189/jlb.1205756; West SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052406; Wrigley BJ, 2013, EUR J CLIN INVEST, V43, P121, DOI 10.1111/eci.12023; Ye H, 2013, WORLD J GASTROENTERO, V19, P2818, DOI 10.3748/wjg.v19.i18.2818; Zhang DW, 2014, J SURG RES, V187, P605, DOI 10.1016/j.jss.2013.11.004; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092700; Zhang YS, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/697837	45	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112127	10.1371/journal.pone.0112127	http://dx.doi.org/10.1371/journal.pone.0112127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392926	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300034
J	Zou, TS; Williams, N; Ozkan, SB; Ghosh, K				Zou, Taisong; Williams, Nickolas; Ozkan, S. Banu; Ghosh, Kingshuk			Proteome Folding Kinetics Is Limited by Protein Halflife	PLOS ONE			English	Article							CONTACT ORDER; SPEED LIMIT; RATES; PREDICTION; STABILITY; TEMPERATURE; DOMAINS; CELLS; YEAST; SIZE	How heterogeneous are proteome folding timescales and what physical principles, if any, dictate its limits? We answer this by predicting copy number weighted folding speed distribution - using the native topology - for E. coli and Yeast proteome. E. coli and Yeast proteomes yield very similar distributions with average folding times of 100 milliseconds and 170 milliseconds, respectively. The topology-based folding time distribution is well described by a diffusion-drift mutation model on a flat-fitness landscape in free energy barrier between two boundaries: i) the lowest barrier height determined by the upper limit of folding speed and ii) the highest barrier height governed by the lower speed limit of folding. While the fastest time scale of the distribution is near the experimentally measured speed limit of 1 microsecond (typical of barrier-less folders), we find the slowest folding time to be around seconds (approximate to 8 seconds for Yeast distribution), approximately an order of magnitude less than the fastest halflife (approximately 2 minutes) in the Yeast proteome. This separation of timescale implies even the fastest degrading protein will have moderately high (96%) probability of folding before degradation. The overall agreement with the flat-fitness landscape model further hints that proteome folding times did not undergo additional major selection pressures - to make proteins fold faster - other than the primary requirement to "sufficiently beat the clock'' against its lifetime. Direct comparison between the predicted folding time and experimentally measured halflife further shows 99% of the proteome have a folding time less than their corresponding lifetime. These two findings together suggest that proteome folding kinetics may be bounded by protein halflife.	[Zou, Taisong; Ozkan, S. Banu] Arizona State Univ, Dept Phys, Ctr Biol Phys, Tempe, AZ 85287 USA; [Williams, Nickolas; Ghosh, Kingshuk] Univ Denver, Dept Phys & Astron, Denver, CO 80220 USA	Arizona State University; Arizona State University-Tempe; University of Denver	Ghosh, K (corresponding author), Univ Denver, Dept Phys & Astron, Denver, CO 80220 USA.	kghosh@du.edu	Ghosh, Kingshuk/C-6315-2015	Ghosh, Kingshuk/0000-0003-4976-0986	NSF [1149992]; ASU-CLAS; Direct For Biological Sciences [1149992] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ASU-CLAS; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KG acknowledges support from NSF (award number 1149992), and TZ and SBO acknowledge ASU-CLAS funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER D, 1994, BIOCHEMISTRY-US, V33, P7505, DOI 10.1021/bi00190a002; Batey S, 2006, P NATL ACAD SCI USA, V103, P18113, DOI 10.1073/pnas.0604580103; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Chan HS, 1998, NATURE, V392, P761, DOI 10.1038/33808; Ciryam P, 2013, P NATL ACAD SCI USA, V110, pE132, DOI 10.1073/pnas.1213624110; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; De Sancho D, 2011, PHYS CHEM CHEM PHYS, V13, P17030, DOI 10.1039/c1cp20402e; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Dinner AR, 2001, NAT STRUCT BIOL, V8, P21; Drew K, 2011, GENOME RES, V21, P1981, DOI 10.1101/gr.121475.111; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Ghosh K, 2007, J AM CHEM SOC, V129, P11920, DOI 10.1021/ja066785b; Ghosh K, 2010, BIOPHYS J, V99, P3996, DOI 10.1016/j.bpj.2010.10.036; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775; Guo MH, 2012, P NATL ACAD SCI USA, V109, P17863, DOI 10.1073/pnas.1201797109; Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615; Hyeon C, 2012, BIOPHYS J, V102, pL11, DOI 10.1016/j.bpj.2012.01.003; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; Mashaghi A, 2013, NATURE, V500, P98, DOI 10.1038/nature12293; Naganathan AN, 2010, P NATL ACAD SCI USA, V107, P8611, DOI 10.1073/pnas.1000988107; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Rollins GC, 2014, J AM CHEM SOC, V136, P11420, DOI 10.1021/ja5049434; Rustad M, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4767567; Sawle L, 2011, BIOPHYS J, V101, P217, DOI 10.1016/j.bpj.2011.05.059; Serohijos AWR, 2013, BIOPHYS J, V104, pL1, DOI 10.1016/j.bpj.2012.11.3838; Serohijos AWR, 2012, CELL REP, V2, P249, DOI 10.1016/j.celrep.2012.06.022; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wang T, 2004, J PHYS CHEM B, V108, P3694, DOI 10.1021/jp049652q; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zheng OY, 2008, PROTEIN SCI, V17, P1256, DOI 10.1110/ps.034660.108; Zou TS, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066011	36	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112701	10.1371/journal.pone.0112701	http://dx.doi.org/10.1371/journal.pone.0112701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393560	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300088
J	Gromov, P; Espinoza, JA; Talman, ML; Honma, N; Kroman, N; Wielenga, VT; Moreira, JMA; Gromova, I				Gromov, Pavel; Espinoza, Jaime A.; Talman, Maj-Lis; Honma, Naoko; Kroman, Niels; Wielenga, Vera Timmermans; Moreira, Jose M. A.; Gromova, Irina			FABP7 and HMGCS2 Are Novel Protein Markers for Apocrine Differentiation Categorizing Apocrine Carcinoma of the Breast	PLOS ONE			English	Article							RECEPTOR-NEGATIVE TUMORS; ANDROGEN RECEPTOR; EXPRESSION; CANCER; ESTROGEN; METABOLISM; LESIONS; EGFR; OVEREXPRESSION; TRANSCRIPTION	Apocrine carcinoma of the breast is a distinctive malignancy with unique morphological and molecular features, generally characterized by being negative for estrogen and progesterone receptors, and thus not electable for endocrine therapy. Despite the fact that they are morphologically distinct from other breast lesions, no standard molecular criteria are currently available for their diagnosis. Using gel-based proteomics in combination with mass spectrometry and immunohistochemistry we have identified two novel markers, HMGCS2 and FABP7 that categorize the entire breast apocrine differentiation spectrum from benign metaplasia and cysts to invasive stages. Expression of HMGCS2 and FABP7 is strongly associated with apocrine differentiation; their expression is retained by most invasive apocrine carcinomas (IAC) showing positive immunoreactivity in 100% and 78% of apocrine carcinomas, respectively, as compared to non-apocrine tumors (16.7% and 6.8%). The nuclear localization of FABP7 in tumor cells was shown to be associated with more aggressive stages of apocrine carcinomas. In addition, when added to the panel of apocrine biomarkers previously reported by our group: 15-PGDH, HMGCR and ACSM1, together they provide a signature that may represent a golden molecular standard for defining the apocrine phenotype in the breast. Moreover, we show that combining HMGCS2 to the steroidal profile (HMGCS2+/ Androgen Receptor (AR)+/Estrogen Receptor(ER)-/Progesteron Receptor (PR)-identifies IACs with a greater sensitivity (79%) as compared with the steroidal profile (AR+/ER-/PR-) alone (54%). We have also presented a detailed immunohistochemical analysis of breast apocrine lesions with a panel of antibodies against proteins which correspond to 10 genes selected from published transcriptomic signatures that currently characterize molecular apocrine subtype and shown that except for melanophilin that is overexpressed in benign apocrine lesions, these proteins were not specific for morphological apocrine differentiation in breast.	[Gromov, Pavel; Gromova, Irina] Danish Canc Soc, Res Ctr, Genome Integr Unit, Copenhagen, Denmark; [Espinoza, Jaime A.] Pontificia Univ Catolica Chile, Sch Med, Ctr Invest Translat Oncol, Dept Pathol, Santiago, Chile; [Talman, Maj-Lis; Wielenga, Vera Timmermans] Copenhagen Univ Hosp, Dept Pathol, Ctr Diagnost Invest, Copenhagen, Denmark; [Honma, Naoko] Tokyo Metropolitan Inst Gerontol, Res Team Geriatr Pathol, Tokyo, Japan; [Kroman, Niels] Copenhagen Univ Hosp, Dept Breast Surg, Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Fac Med & Hlth Sci, Dept Vet Dis Biol, Sect Mol Dis Biol, Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Fac Med & Hlth Sci, Dept Vet Dis Biol, Sinodanish Breast Canc Res Ctr, Copenhagen, Denmark	Danish Cancer Society; Pontificia Universidad Catolica de Chile; University of Copenhagen; Tokyo Metropolitan Institute of Gerontology; University of Copenhagen; University of Copenhagen; University of Copenhagen	Gromov, P (corresponding author), Danish Canc Soc, Res Ctr, Genome Integr Unit, Copenhagen, Denmark.	psg@cancer.dk		Espinoza, Jaime/0000-0002-0731-2715; Gromova, Irina/0000-0003-4357-5958; Moreira, Jose/0000-0002-9944-1214	Danish Cancer Society; John and Birthe Meyer Foundation; Kai Lange and Gundhild Kai Lange Fond; Lisa and Gudmund JArgensens Fond; Marketing Department at the Danish Cancer Society	Danish Cancer Society(Danish Cancer Society); John and Birthe Meyer Foundation; Kai Lange and Gundhild Kai Lange Fond; Lisa and Gudmund JArgensens Fond; Marketing Department at the Danish Cancer Society	This work was supported by grants from the Danish Cancer Society, the John and Birthe Meyer Foundation, the Kai Lange and Gundhild Kai Lange Fond, and the Lisa and Gudmund JArgensens Fond. The ear-marked support of the Marketing Department at the Danish Cancer Society through their fundraising activities on behalf of DCTB is greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshareeda AT, 2012, BREAST CANCER RES TR, V134, P519, DOI 10.1007/s10549-012-2083-8; BARTEK J, 1990, HISTOCHEM J, V22, P537, DOI 10.1007/BF01005976; Cabezon T, 2013, MOL CELL PROTEOMICS, V12, P381, DOI 10.1074/mcp.M112.019786; Celis JE, 2006, MOL CELL PROTEOMICS, V5, P462, DOI 10.1074/mcp.M500348-MCP200; CELIS JE, 2006, CELL BIOL LAB HDB, P165; Celis JE, 2008, MOL CELL PROTEOMICS, V7, P1795, DOI 10.1074/mcp.R800011-MCP200; Celis JE, 2007, MOL ONCOL, V1, P97, DOI 10.1016/j.molonc.2007.02.005; Celis JE, 2006, FEBS LETT, V580, P2935, DOI 10.1016/j.febslet.2006.03.080; Celis JE, 2009, MOL ONCOL, V3, P220, DOI 10.1016/j.molonc.2009.01.005; Celis JE, 2007, MOL ONCOL, V1, P1, DOI 10.1016/j.molonc.2007.02.003; Chia KM, 2011, NEOPLASIA, V13, P154, DOI 10.1593/neo.101324; Collins LC, 2011, MODERN PATHOL, V24, P924, DOI 10.1038/modpathol.2011.54; De Longueville F, 2005, INT J ONCOL, V27, P881; Dellapasqua S, 2013, CLIN BREAST CANCER, V13, P95, DOI 10.1016/j.clbc.2012.11.004; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Edwards TL, 2012, CANCER PREV RES, V5, P855, DOI 10.1158/1940-6207.CAPR-11-0459; Elayat G, 2009, BREAST J, V15, P475, DOI 10.1111/j.1524-4741.2009.00762.x; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Garay JP, 2012, AM J CANCER RES, V2, P434; Gasparini P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088525; Gatalica Z, 1997, PATHOL RES PRACT, V193, P753, DOI 10.1016/S0344-0338(97)80053-2; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Gromov P, 2008, MOL ONCOL, V2, P368, DOI 10.1016/j.molonc.2008.09.003; Gromov P, 2010, MOL ONCOL, V4, P65, DOI 10.1016/j.molonc.2009.11.003; Gromova I., 2006, CELL BIOL LAB HDB, P219, DOI DOI 10.1016/B978-012164730-8/50212-4; Guedj M, 2012, ONCOGENE, V31, P1196, DOI 10.1038/onc.2011.301; Honma N, 2007, HISTOPATHOLOGY, V50, P425, DOI 10.1111/j.1365-2559.2007.02636.x; Honma N, 2005, HISTOPATHOLOGY, V47, P195, DOI 10.1111/j.1365-2559.2005.02181.x; Honma N, 2006, APMIS, V114, P712, DOI 10.1111/j.1600-0463.2006.apm_434.x; Iggo RD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3036; Japaze H, 2005, BREAST, V14, P3, DOI 10.1016/j.breast.2004.06.003; Kaloshi G, 2007, J NEURO-ONCOL, V84, P245, DOI 10.1007/s11060-007-9377-4; Kostiuk MA, 2010, FASEB J, V24, P1914, DOI 10.1096/fj.09-149765; Lakhani SR, 2012, WHO CLASSIFICATION T; Lakis S, 2014, BREAST, V23, P234, DOI 10.1016/j.breast.2014.02.013; Lehmann-Che J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3421; Liang Y, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-97; Martinez-Outschoorn UE, 2012, CELL CYCLE, V11, P3964, DOI 10.4161/cc.22137; Martinez-Outschoorn UE, 2012, CELL CYCLE, V11, P3956, DOI 10.4161/cc.22136; Moinfar F, 2003, CANCER-AM CANCER SOC, V98, P703, DOI 10.1002/cncr.11532; Moll R, 1998, Subcell Biochem, V31, P205; Moreira JMA, 2005, MOL CELL PROTEOMICS, V4, P555, DOI 10.1074/mcp.M400205-MCP200; Naderi A, 2008, NEOPLASIA, V10, P542, DOI 10.1593/neo.08274; Niemeier LA, 2010, MODERN PATHOL, V23, P205, DOI 10.1038/modpathol.2009.159; O'Malley FP, 2008, HISTOPATHOLOGY, V52, P3, DOI 10.1111/j.1365-2559.2007.02888.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Page DL, 2005, BREAST, V14, P1, DOI 10.1016/j.breast.2004.06.002; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216; Rogowska-Wrzesinska A, 2013, J PROTEOMICS, V88, P4, DOI 10.1016/j.jprot.2013.01.010; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Safarpour D, 2014, AM J CANCER RES, V4, P353; Sanga S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-59; Sapp Michelle, 2003, Breast J, V9, P335, DOI 10.1046/j.1524-4741.2003.09422.x; Sasahara M, 2014, ANTICANCER RES, V34, P1261; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sckolnick M, 2013, J BIOL CHEM, V288, P29313, DOI 10.1074/jbc.M113.476929; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smathers Rebecca L., 2011, Human Genomics, V5, P170; Tanaka K, 2008, BREAST J, V14, P164, DOI 10.1111/j.1524-4741.2007.00548.x; Tang XY, 2010, PATHOL RES PRACT, V206, P98, DOI 10.1016/j.prp.2009.06.010; Tsutsumi Y, 2012, JPN J CLIN ONCOL, V42, P375, DOI 10.1093/jjco/hys034; Vainio P, 2011, AM J PATHOL, V178, P525, DOI 10.1016/j.ajpath.2010.10.002; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Vranic S, 2013, HISTOL HISTOPATHOL, V28, P1393, DOI 10.14670/HH-28.1393; Vranic S, 2011, ONCOL LETT, V2, P1131, DOI 10.3892/ol.2011.375; Vranic S, 2010, MODERN PATHOL, V23, P644, DOI 10.1038/modpathol.2010.50; Wang J, 2013, CANCER PREV RES, V6, P321, DOI 10.1158/1940-6207.CAPR-12-0304; Wells CA, 2007, J CLIN PATHOL, V60, P1313, DOI 10.1136/jcp.2006.040626; Yeganeh B, 2014, PHARM THER; Zhang H, 2010, BREAST CANCER RES TR, V121, P41, DOI 10.1007/s10549-009-0450-x	73	17	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112024	10.1371/journal.pone.0112024	http://dx.doi.org/10.1371/journal.pone.0112024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389781	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400047
J	Kornej, J; Dinov, B; Blann, AD; Rolf, S; Arya, A; Schmidl, J; Husser, D; Hindricks, G; Bollmann, A; Lip, GYH				Kornej, Jelena; Dinov, Borislav; Blann, Andrew D.; Rolf, Sascha; Arya, Arash; Schmidl, Josephine; Husser, Daniela; Hindricks, Gerhard; Bollmann, Andreas; Lip, Gregory Y. H.			Effects of Radiofrequency Catheter Ablation of Atrial Fibrillation on Soluble P-Selectin, Von Willebrand Factor and IL-6 in the Peripheral and Cardiac Circulation	PLOS ONE			English	Article							PLATELET ACTIVATION; ENDOTHELIAL DAMAGE; THROMBOGENESIS; INTERLEUKIN-6; MANAGEMENT	Background: Catheter ablation (CA) of atrial fibrillation (AF) is associated with inflammatory response, endothelial damage and with increased risk of thrombosis. However, whether these processes differ in peripheral and cardiac circulation is unknown. Methods: Plasma markers (von Willebrand factor (vWf), soluble P-selectin (sPsel) and interleukin-6 (IL-6)) were measured by ELISA at three time points in 80 patients (62610 years, 63% males, 41% paroxysmal AF) undergoing CA. These were at baseline - from femoral vein (FV) and left atrium (LA) before ablation; directly after ablation - from the pulmonary vein (PV), LA and FV; and 24 hours after procedure -from a cubital vein (CV). Results: The levels of vWF and IL6 - but not sP-sel - increased significantly 24h after procedure (p < 0.001). Baseline vWF was significantly associated with persistent AF (Beta = .303, p = 0.006 and Beta = .300, p = 0.006 for peripheral and cardiac levels, respectively), while persistent AF (Beta = .250, p = 0.031) and LAA flow pattern (Beta = .386, p < 0.001) remained associated with vWF in cardiac blood after ablation. Advanced age was significantly associated with IL6 levels at baseline and after ablation in peripheral and cardiac blood. There were no clinical, procedural or anti-coagulation characteristics associated with sP-sel levels in cardiac blood, while peripheral sP-sel levels were associated with hypertension before (Beta = 2.307, p = 0.007) and with persistent AF after ablation (Beta = 2.262, p = 0.020). Conclusions: vWF levels are higher in persistent AF and are associated with LAA rheological pattern after AF ablation. Increase of peripheral vWF and IL6 levels after procedure supports current AF ablation management with careful control of post-procedural anticoagulation to avoid ablation-related thromboembolism.	[Kornej, Jelena; Dinov, Borislav; Arya, Arash; Schmidl, Josephine; Husser, Daniela; Hindricks, Gerhard; Bollmann, Andreas] Univ Leipzig, Ctr Heart, Dept Electrophysiol, D-04109 Leipzig, Germany; [Kornej, Jelena; Blann, Andrew D.; Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham, W Midlands, England	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Birmingham	Kornej, J (corresponding author), Univ Leipzig, Ctr Heart, Dept Electrophysiol, D-04109 Leipzig, Germany.	jelena.kornej@gmx.de		Dinov, Borislav/0000-0003-1104-8491	German Cardiac Society St. Jude Medical Stipend	German Cardiac Society St. Jude Medical Stipend	JK was supported by the German Cardiac Society St. Jude Medical Stipend. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar JG, 2008, J AM COLL CARDIOL, V51, P1790, DOI 10.1016/j.jacc.2007.11.083; Bulava A, 2004, J INTERV CARD ELECTR, V10, P271, DOI 10.1023/B:JICE.0000026924.96281.be; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Conway DSG, 2002, CIRCULATION, V106, P1962, DOI 10.1161/01.CIR.0000033220.97592.9A; Davlouros PA, 2005, INT J CARDIOL, V102, P187, DOI 10.1016/j.ijcard.2004.04.010; Kaireviciute D, 2011, J THROMB HAEMOST, V9, P2345, DOI 10.1111/j.1538-7836.2011.04523.x; Kaireviciute D, 2010, THROMB HAEMOSTASIS, V104, P122, DOI 10.1160/TH09-12-0837; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Kerr R, 2001, BRIT J HAEMATOL, V115, P3, DOI 10.1046/j.1365-2141.2001.03061.x; Kornej J, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-49; Kornej J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044165; Kosiuk J, 2014, HEART RHYTHM, V11, P1934, DOI 10.1016/j.hrthm.2014.07.039; Li-Saw-Hee FL, 2000, STROKE, V31, P828, DOI 10.1161/01.STR.31.4.828; Lim HS, 2013, J AM COLL CARDIOL, V61, P852, DOI 10.1016/j.jacc.2012.11.046; LIP GYH, 1995, LANCET, V346, P1313, DOI 10.1016/S0140-6736(95)92339-X; Ma J, 2006, ACTA CARDIOL, V61, P339, DOI 10.2143/AC.61.3.2014838; Malmborg H, 2013, EUROPACE, V15, P1567, DOI 10.1093/europace/eut104; McCabe JM, 2008, PACE, V31, P1146, DOI 10.1111/j.1540-8159.2008.01155.x; Roldan V, 2003, EUR HEART J, V24, P1373, DOI 10.1016/S0195-668X(03)00239-2; Siklody CH, 2012, HEART RHYTHM, V9, P189, DOI 10.1016/j.hrthm.2011.09.017; Vizzardi E, 2009, INTERN EMERG MED, V4, P309, DOI 10.1007/s11739-009-0235-6	22	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111760	10.1371/journal.pone.0111760	http://dx.doi.org/10.1371/journal.pone.0111760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390649	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400032
J	Okuliarova, M; Kankova, Z; Bertin, A; Leterrier, C; Mostl, E; Zeman, M				Okuliarova, Monika; Kankova, Zuzana; Bertin, Aline; Leterrier, Christine; Mostl, Erich; Zeman, Michal			Maternally Derived Egg Hormones, Antibodies and Antimicrobial Proteins: Common and Different Pathways of Maternal Effects in Japanese Quail	PLOS ONE			English	Article							COTURNIX-COTURNIX-JAPONICA; YOLK TESTOSTERONE LEVELS; IMMUNE FUNCTION; DIVERGENT SELECTION; GREY PARTRIDGE; INNATE IMMUNITY; BARN SWALLOW; CHICKS; GROWTH; ANDROGENS	Avian eggs contain a variety of maternally-derived substances that can influence the development and performance of offspring. The levels of these egg compounds vary in relation to environmental and genetic factors, but little is known about whether there are correlative links between maternal substances in the egg underlying common and different pathways of maternal effects. In the present study, we investigated genetically determined variability and mutually adjusted deposition of sex hormones (testosterone-T, androstenedione-A(4) and progesterone-P-4), antibodies (IgY) and antimicrobial proteins (lysozyme) in eggs of Japanese quail (Coturnix japonica). We used different genetic lines that were independently selected for yolk T concentrations, duration of tonic immobility and social reinstatement behaviour, since both selections for behavioural traits (fearfulness and social motivation, respectively) produced considerable correlative responses in yolk androgen levels. A higher selection potential was found for increased rather than decreased yolk T concentrations, suggesting that there is a physiological minimum in egg T levels. Line differences in yolk IgY concentrations were manifested within each selection experiment, but no consistent inter-line pattern between yolk IgY and T was revealed. On the other hand, a consistent inverse inter-line pattern was recorded between yolk IgY and P-4 in both selections for behavioural traits. In addition, selections for contrasting fearfulness and social motivation were associated with changes in albumen lysozyme concentrations and an inverse inter-line pattern between the deposition of yolk IgY and albumen lysozyme was found in lines selected for the level of social motivation. Thus, our results demonstrate genetically-driven changes in deposition of yolk T, P-4, antibodies and albumen lysozyme in the egg. This genetic variability can partially explain mutually adjusted maternal deposition of sex hormones and immune-competent molecules but the inconsistent pattern of inter-line differences across all selections indicates that there are other underlying mechanisms, which require further studies.	[Okuliarova, Monika; Kankova, Zuzana; Zeman, Michal] Comenius Univ, Fac Nat Sci, Dept Anim Physiol & Ethol, Bratislava, Slovakia; [Bertin, Aline; Leterrier, Christine] Univ Tours, IFCE, INRA Val Loire, CNRS,UMR 7247,UMR Physiol Reprod & Comportements, Nouzilly, France; [Mostl, Erich] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Zeman, Michal] Slovak Acad Sci, Inst Anim Biochem & Genet, Ivanka Pri Dunaji, Slovakia	Comenius University Bratislava; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; University of Veterinary Medicine Vienna; Slovak Academy of Sciences	Okuliarova, M (corresponding author), Comenius Univ, Fac Nat Sci, Dept Anim Physiol & Ethol, Bratislava, Slovakia.	okuliarova@fns.uniba.sk	Okuliarova, Monika/S-4622-2017; Zeman, Michal/S-4175-2017; Zeman, M/L-2392-2019; Leterrier, Christine/AAY-7201-2020	Okuliarova, Monika/0000-0002-9186-7341; Zeman, M/0000-0002-2712-6805; 	Slovak Research and Development Agency [APVV 0047-10]; Scientific Grant Agency of the Ministry of Education of the Slovak Republic; Slovak Academy of Sciences (VEGA) [1/0686/12]	Slovak Research and Development Agency(Slovak Research and Development Agency); Scientific Grant Agency of the Ministry of Education of the Slovak Republic; Slovak Academy of Sciences (VEGA)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA))	This study was supported by the Slovak Research and Development Agency (APVV 0047-10) and the Scientific Grant Agency of the Ministry of Education of the Slovak Republic and of the Slovak Academy of Sciences (VEGA 1/0686/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertin A, 2009, BEHAVIOUR, V146, P757, DOI 10.1163/156853909X446190; BOARD RG, 1974, BIOL REV, V49, P15, DOI 10.1111/j.1469-185X.1974.tb01297.x; Bonisoli-Alquati A, 2010, BEHAV ECOL SOCIOBIOL, V64, P845, DOI 10.1007/s00265-010-0901-8; Buechler K, 2002, J ANIM ECOL, V71, P247, DOI 10.1046/j.1365-2656.2002.00591.x; Carmichael NL, 1998, APPL ANIM BEHAV SCI, V58, P353, DOI 10.1016/S0168-1591(97)00151-2; Cucco M, 2006, CAN J ZOOL, V84, P72, DOI 10.1139/Z05-179; Cucco M, 2008, GEN COMP ENDOCR, V156, P418, DOI 10.1016/j.ygcen.2007.12.010; Cucco M, 2007, COMP BIOCHEM PHYS A, V147, P1038, DOI 10.1016/j.cbpa.2007.03.014; Egbert JR, 2013, GEN COMP ENDOCR, V183, P53, DOI 10.1016/j.ygcen.2012.12.001; Faure JM, 2006, ARCH GEFLUGELKD, V70, P216; Gasparini J, 2007, J EVOLUTION BIOL, V20, P874, DOI 10.1111/j.1420-9101.2007.01315.x; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2007, J EXP ZOOL PART A, V307A, P91, DOI 10.1002/jez.a.340; Grindstaff JL, 2008, J EXP BIOL, V211, P654, DOI 10.1242/jeb.012344; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Groothuis TGG, 2006, J EVOLUTION BIOL, V19, P1304, DOI 10.1111/j.1420-9101.2005.01072.x; Groothuis TGG, 2005, BIOL LETTERS, V1, P78, DOI 10.1098/rsbl.2004.0233; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guesdon V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023941; Hamal KR, 2006, POULTRY SCI, V85, P1364, DOI 10.1093/ps/85.8.1364; Hargitai R, 2009, BEHAV ECOL SOCIOBIOL, V63, P869, DOI 10.1007/s00265-009-0727-4; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; Kankova Z, 2012, J EXP BIOL, V215, P617, DOI 10.1242/jeb.064030; Lennie Terry A, 2004, Biol Res Nurs, V5, P255, DOI 10.1177/1099800404263014; McGraw KJ, 2005, NATURWISSENSCHAFTEN, V92, P375, DOI 10.1007/s00114-005-0003-z; MILLS AD, 1991, J COMP PSYCHOL, V105, P25, DOI 10.1037/0735-7036.105.1.25; Morosinotto C, 2013, J AVIAN BIOL, V44, P427, DOI 10.1111/j.1600-048X.2013.00084.x; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Muller W, 2012, GEN COMP ENDOCR, V175, P337, DOI 10.1016/j.ygcen.2011.11.034; Muller W, 2005, P ROY SOC B-BIOL SCI, V272, P1971, DOI 10.1098/rspb.2005.3178; Muller W, 2004, FUNCT ECOL, V18, P719, DOI 10.1111/j.0269-8463.2004.00902.x; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Navara KJ, 2006, PHYSIOL BIOCHEM ZOOL, V79, P550, DOI 10.1086/501054; Okuliarova M, 2011, CONSEQUENCES DIVERGE, P39; Okuliarova M, 2011, COMP BIOCHEM PHYS A, V160, P81, DOI 10.1016/j.cbpa.2011.05.012; Okuliarova M, 2011, AM NAT, V177, P824, DOI 10.1086/659996; Okuliarova M, 2009, COMP BIOCHEM PHYS A, V154, P530, DOI 10.1016/j.cbpa.2009.08.012; OSSERMAN EF, 1966, J EXP MED, V124, P921, DOI 10.1084/jem.124.5.921; PALME R, 1993, P 5 S AN STER, P111; Peluc SI, 2012, J COMP PHYSIOL B, V182, P687, DOI 10.1007/s00360-011-0638-3; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Pitala N, 2009, J AVIAN BIOL, V40, P225, DOI 10.1111/j.1600-048X.2009.04452.x; Postma E, 2013, OECOLOGIA; Rutkowska J, 2005, HORM BEHAV, V47, P585, DOI 10.1016/j.yhbeh.2004.12.006; Ruuskanen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025360; Saino N, 2002, P ROY SOC B-BIOL SCI, V269, P1005, DOI 10.1098/rspb.2002.1992; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Saino N, 2003, P ROY SOC B-BIOL SCI, V270, P2485, DOI 10.1098/rspb.2003.2534; Sandell MI, 2009, J EXP BIOL, V212, P815, DOI 10.1242/jeb.022111; Schweitzer C, 2009, DEV PSYCHOBIOL, V51, P311, DOI 10.1002/dev.20370; Sellier N, 2007, BRIT POULTRY SCI, V48, P559, DOI 10.1080/00071660701592367; Shawkey MD, 2008, BEHAV ECOL, V19, P920, DOI 10.1093/beheco/arn019; Swierczewska Ewa, 2003, Animal Science Papers and Reports, V21, P63; Tobler M, 2010, BEHAV ECOL SOCIOBIOL, V64, P717, DOI 10.1007/s00265-009-0889-0; Tschirren B, 2005, J ANIM ECOL, V74, P675, DOI 10.1111/j.1365-2656.2005.00963.x; Tschirren B, 2004, P ROY SOC B-BIOL SCI, V271, P1371, DOI 10.1098/rspb.2004.2730; Tschirren B, 2009, AM NAT, V174, P557, DOI 10.1086/605379; von Engelhardt N, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 4: BIRDS, P91; ZEMAN M, 1986, BRIT POULTRY SCI, V27, P261, DOI 10.1080/00071668608416879	62	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112817	10.1371/journal.pone.0112817	http://dx.doi.org/10.1371/journal.pone.0112817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390303	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400133
J	Stewart, CE; Randall, RE; Adamson, CS				Stewart, Claire E.; Randall, Richard E.; Adamson, Catherine S.			Inhibitors of the Interferon Response Enhance Virus Replication In Vitro	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; VALLEY FEVER VIRUS; INNATE IMMUNITY; JAK2 INHIBITOR; INFLUENZA-A; CELL-LINES; VACCINE; PROTEIN; INDUCTION; LACKING	Virus replication efficiency is influenced by two conflicting factors, kinetics of the cellular interferon (IFN) response and induction of an antiviral state versus speed of virus replication and virus-induced inhibition of the IFN response. Disablement of a virus's capacity to circumvent the IFN response enables both basic research and various practical applications. However, such IFN-sensitive viruses can be difficult to grow to high-titer in cells that produce and respond to IFN. The current default option for growing IFN-sensitive viruses is restricted to a limited selection of cell-lines (e.g. Vero cells) that have lost their ability to produce IFN. This study demonstrates that supplementing tissue-culture medium with an IFN inhibitor provides a simple, effective and flexible approach to increase the growth of IFN-sensitive viruses in a cell-line of choice. We report that IFN inhibitors targeting components of the IFN response (TBK1, IKK2, JAK1) significantly increased virus replication. More specifically, the JAK1/2 inhibitor Ruxolitinib enhances the growth of viruses that are sensitive to IFN due to (i) loss of function of the viral IFN antagonist (due to mutation or species-specific constraints) or (ii) mutations/host cell constraints that slow virus spread such that it can be controlled by the IFN response. This was demonstrated for a variety of viruses, including, viruses with disabled IFN antagonists that represent live-attenuated vaccine candidates (Respiratory Syncytial Virus (RSV), Influenza Virus), traditionally attenuated vaccine strains (Measles, Mumps) and a slow-growing wild-type virus (RSV). In conclusion, supplementing tissue culture-medium with an IFN inhibitor to increase the growth of IFN-sensitive viruses in a cell-line of choice represents an approach, which is broadly applicable to research investigating the importance of the IFN response in controlling virus infections and has utility in a number of practical applications including vaccine and oncolytic virus production, virus diagnostics and techniques to isolate newly emerging viruses.	[Stewart, Claire E.; Randall, Richard E.; Adamson, Catherine S.] Univ St Andrews, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews	Adamson, CS (corresponding author), Univ St Andrews, Sch Biol, St Andrews KY16 9AJ, Fife, Scotland.	csa21@st-andrews.ac.uk		Adamson, Catherine/0000-0001-7673-5212; Randall, Richard/0000-0002-9304-6678	University of St Andrews; Wellcome Trust [087751/A/08/Z]; Wellcome Trust [101788/Z/13/Z] Funding Source: researchfish	University of St Andrews; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the University of St Andrews (CSA, CES) and the Wellcome Trust (grant 087751/A/08/Z) (RER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankamp B, 2011, J INFECT DIS, V204, pS533, DOI 10.1093/infdis/jir097; Bird BH, 2008, J VIROL, V82, P2681, DOI 10.1128/JVI.02501-07; Brennan B, 2011, J VIROL, V85, P10310, DOI 10.1128/JVI.05252-11; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chen S, 2010, VIROLOGY, V407, P247, DOI 10.1016/j.virol.2010.08.008; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; ENDERS JF, 1946, J IMMUNOL, V54, P283; Escobar-Zarate D, 2013, CANCER GENE THER, V20, P582, DOI 10.1038/cgt.2013.55; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; He B, 2002, VIROLOGY, V303, P15, DOI 10.1006/viro.2002.1738; Hedvat M, 2009, CANCER CELL, V16, P487, DOI 10.1016/j.ccr.2009.10.015; HILLEMAN MR, 1968, J AMER MED ASSOC, V206, P587, DOI 10.1001/jama.206.3.587; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; HOUSE C, 1989, VET MICROBIOL, V20, P99, DOI 10.1016/0378-1135(89)90033-3; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Killip MJ, 2013, J VIROL, V87, P4798, DOI 10.1128/JVI.03383-12; Kwilas S, 2009, J VIROL, V83, P10710, DOI 10.1128/JVI.00986-09; Luongo C, 2013, J VIROL, V87, P1985, DOI 10.1128/JVI.02769-12; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Mossler C, 2013, VACCINE, V31, P6194, DOI 10.1016/j.vaccine.2013.10.061; MOSCA JD, 1986, MOL CELL BIOL, V6, P2279, DOI 10.1128/MCB.6.6.2279; Naik S, 2009, EXPERT OPIN BIOL TH, V9, P1163, DOI 10.1517/14712590903170653; Pardanani A, 2009, LEUKEMIA, V23, P1441, DOI 10.1038/leu.2009.50; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Quintas-Cardama A, 2010, BLOOD, V115, P3109, DOI 10.1182/blood-2009-04-214957; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Teng MN, 2000, J VIROL, V74, P9317, DOI 10.1128/JVI.74.19.9317-9321.2000; Teng MN, 1999, J VIROL, V73, P466, DOI 10.1128/JVI.73.1.466-473.1999; Vaddi K, 2012, EXPERT OPIN PHARMACO, V13, P2397, DOI 10.1517/14656566.2012.732998; Young DF, 2009, J GEN VIROL, V90, P2731, DOI 10.1099/vir.0.013722-0; Young DF, 2003, J VIROL, V77, P2174, DOI 10.1128/JVI.77.3.2174-2181.2003	37	42	44	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112014	10.1371/journal.pone.0112014	http://dx.doi.org/10.1371/journal.pone.0112014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390891	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400045
J	Zhao, RL; Peng, XX; Li, Q; Song, W				Zhao, Ronglan; Peng, Xiaoxiang; Li, Qian; Song, Wei			Effects of Phosphorylatable Short Peptide-Conjugated Chitosan-Mediated IL-1Ra and igf-1 Gene Transfer on Articular Cartilage Defects in Rabbits	PLOS ONE			English	Article							GROWTH-FACTOR-I; INTERLEUKIN-1 RECEPTOR ANTAGONIST; MOLECULAR-WEIGHT; CS/DNA COMPLEX; CHONDROCYTES; DELIVERY; REPAIR; MODEL; MATRIX; VITRO	Previously, we reported an improvement in the transfection efficiency of the plasmid DNA-chitosan (pDNA/CS) complex by the utilization of phosphorylatable short peptide-conjugated chitosan ((SP)-S-p-CS). In this study, we investigated the effects of (SP)-S-p-CS-mediated gene transfection of interleukin-1 receptor antagonist protein (IL-1Ra) combined with insulin-like growth factor-1 (IGF-1) in rabbit chondrocytes and in a rabbit model of cartilage defects. pBudCE4.1-IL-1Ra+igf-1, pBudCE4.1-IL-1Ra and pBudCE4.1-igf-1 were constructed and combined with (SP)-S-p-CS to form pDNA/(SP)-S-p-CS complexes. These complexes were transfected into rabbit primary chondrocytes or injected into the joint cavity. Seven weeks after treatment, all rabbits were sacrificed and analyzed. High levels of IL-1Ra and igf-1 expression were detected both in the cell culture supernatant and in the synovial fluid. In vitro, the transgenic complexes caused significant proliferation of chondrocytes, promotion of glycosaminoglycan (GAG) and collagen II synthesis, and inhibition of chondrocyte apoptosis and nitric oxide (NO) synthesis. In vivo, the exogenous genes resulted in increased collagen II synthesis and reduced NO and GAG concentrations in the synovial fluid; histological studies revealed that pDNA/(SP)-S-p-CS treatment resulted in varying degrees of hyaline-like cartilage repair and Mankin score decrease. The co-expression of both genes produced greater effects than each single gene alone both in vitro and in vivo. The results suggest that (SP)-S-p-CS is a good candidate for use in gene therapy for the treatment of cartilage defects and that igf-1 and IL-1Ra co-expression produces promising biologic effects on cartilage defects.	[Zhao, Ronglan; Peng, Xiaoxiang; Li, Qian; Song, Wei] Weifang Med Univ, Dept Lab Med, Shandong Prov Key Lab Clin Lab Diagnost, Weifang, Shandong, Peoples R China	Weifang Medical University	Peng, XX (corresponding author), Weifang Med Univ, Dept Lab Med, Shandong Prov Key Lab Clin Lab Diagnost, Weifang, Shandong, Peoples R China.	pxx74@sina.com			Shandong Provincial Natural Science Foundation, China [ZR2012HQ034]; National Natural Science Foundation of China [81301737]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Shandong Provincial Natural Science Foundation, China (grant ZR2012HQ034) and National Natural Science Foundation of China (81301737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigoni M, 2013, J ORTHOP RES, V31, P315, DOI 10.1002/jor.22208; Cha MH, 2013, TISSUE ENG PT A, V19, P978, DOI [10.1089/ten.TEA.2012.0358, 10.1089/ten.tea.2012.0358]; Chen BA, 2010, EXP MOL MED, V42, P684, DOI 10.3858/emm.2010.42.10.067; Chen Song, 2014, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V28, P92; Cheng WD, 2013, INT ORTHOP, V37, P2065, DOI 10.1007/s00264-013-1990-6; Clark A, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/2/025015; Clutterbuck AL, 2009, ANN NY ACAD SCI, V1171, P428, DOI 10.1111/j.1749-6632.2009.04687.x; Gao YK, 2014, BIOMACROMOLECULES, V15, P1010, DOI 10.1021/bm401906p; Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073; Goodrich LR, 2007, J BONE JOINT SURG BR, V89B, P672, DOI 10.1302/0301-620X.89B5.18343; Haupt JL, 2005, J ORTHOP RES, V23, P118, DOI 10.1016/j.orthres.2004.06.020; He CX, 2012, BIOTECHNOL APPL BIOC, V59, P163, DOI 10.1002/bab.1001; Jia XX, 2007, MOL PHARM, V4, P199, DOI 10.1021/mp060091s; Kayabasi GK, 2013, J BIOMED MATER RES A, V101, P1353, DOI 10.1002/jbm.a.34430; Kwon JT, 2013, IRAN J PHARM RES, V12, P281; Layek B, 2013, INT J PHARMACEUT, V447, P182, DOI 10.1016/j.ijpharm.2013.02.052; Li YC, 2010, TISSUE ENG PART C-ME, V16, P1267, DOI [10.1089/ten.tec.2009.0682, 10.1089/ten.TEC.2009.0682]; Liu S, 2014, SENSORS-BASEL, V14, P3284, DOI 10.3390/s140203284; Lu CH, 2014, MOL THER, V22, P186, DOI 10.1038/mt.2013.165; Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515; Madry H, 2013, EUR CELLS MATER, V25, P229, DOI 10.22203/eCM.v025a17; Madry H, 2010, ARCH ORTHOP TRAUM SU, V130, P1311, DOI 10.1007/s00402-010-1130-3; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Marks PH, 2005, ARTHROSCOPY, V21, P1342, DOI 10.1016/j.arthro.2005.08.034; Nadzir MM, 2013, BIOTECHNOL LETT, V35, P295, DOI 10.1007/s10529-012-1071-8; Nixon AJ, 2005, GENE THER, V12, P177, DOI 10.1038/sj.gt.3302396; Park SC, 2013, INT J NANOMED, V8, P3663, DOI 10.2147/IJN.S50911; Peng XX, 2012, INT J MOL SCI, V13, P14344, DOI 10.3390/ijms131114344; Sarkar K, 2013, CARBOHYD POLYM, V98, P495, DOI 10.1016/j.carbpol.2013.06.006; Sarkar K, 2013, CARBOHYD POLYM, V92, P2048, DOI 10.1016/j.carbpol.2012.11.067; Shi JJ, 2013, ARTHROSCOPY, V29, P2001, DOI 10.1016/j.arthro.2013.09.076; Shi SL, 2014, J ORTHOP RES, V32, P54, DOI 10.1002/jor.22444; Shi SL, 2013, J CELL BIOCHEM, V114, P908, DOI 10.1002/jcb.24430; Shi SL, 2013, GROWTH FACTORS, V31, P32, DOI 10.3109/08977194.2012.750652; Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7; Sun B, 2010, INT J PHARMACEUT, V397, P206, DOI 10.1016/j.ijpharm.2010.07.006; Takada K, 2013, BIOMED REP, V1, P315, DOI 10.3892/br.2013.52; Tang S, 2014, CARBOHYD POLYM, V101, P104, DOI 10.1016/j.carbpol.2013.09.053; Tangsadthakun C, 2007, J BIOMAT SCI-POLYM E, V18, P147, DOI 10.1163/156856207779116694; Tsuchida AI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4107; Venkatesan JK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-211; Watson RS, 2013, GENE THER, V20, P670, DOI 10.1038/gt.2012.81; Whitmire RE, 2012, BIOMATERIALS, V33, P7665, DOI 10.1016/j.biomaterials.2012.06.101; Wu WJ, 2013, CYTOTECHNOLOGY, V65, P287, DOI 10.1007/s10616-012-9485-7; Xiang SN, 2012, BIOMATERIALS, V33, P6520, DOI 10.1016/j.biomaterials.2012.05.044; Yang J, 2013, MOL MED REP, V7, P998, DOI 10.3892/mmr.2012.1246; Zhang B, 2011, J CRANIOFAC SURG, V22, P711, DOI 10.1097/SCS.0b013e31820873c6; Zhao RL, 2011, INT J PHARMACEUT, V413, P254, DOI 10.1016/j.ijpharm.2011.04.039; Zhao Ronglan, 2010, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V24, P1372; Zuo A, 2008, INT J PHARMACEUT, V352, P302, DOI 10.1016/j.ijpharm.2007.10.042	50	7	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112284	10.1371/journal.pone.0112284	http://dx.doi.org/10.1371/journal.pone.0112284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390659	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400068
J	Piekarski, A; Khaldi, S; Greene, E; Lassiter, K; Mason, JG; Anthony, N; Bottje, W; Dridi, S				Piekarski, Alissa; Khaldi, Stephanie; Greene, Elizabeth; Lassiter, Kentu; Mason, James G.; Anthony, Nicholas; Bottje, Walter; Dridi, Sami			Tissue Distribution, Gender-and Genotype-Dependent Expression of Autophagy-Related Genes in Avian Species	PLOS ONE			English	Article							BLOOD CORTICOSTERONE RESPONSE; MULTIPLE SEQUENCE ALIGNMENT; JAPANESE-QUAIL; REGULATES AUTOPHAGY; MOLECULAR MACHINERY; MEDIATED AUTOPHAGY; PROTEINS; DISEASE; COMPLEX; TARGETS	As a result of the genetic selection of broiler (meat-type breeders) chickens for enhanced growth rate and lower feed conversion ratio, it has become necessary to restrict feed intake. When broilers are fed ad libitum, they would become obese and suffer from several health-related problems. A vital adaptation to starvation is autophagy, a self-eating mechanism for recycling cellular constituents. The autophagy pathway has witnessed dramatic growth in the last few years and extensively studied in yeast and mammals however, there is a paucity of information in avian (non-mammalian) species. Here we characterized several genes involved in autophagosome initiation and elongation in Red Jungle fowl (Gallus gallus) and Japanese quail (coturnix coturnix Japonica). Both complexes are ubiquitously expressed in chicken and quail tissues (liver, leg and breast muscle, brain, gizzard, intestine, heart, lung, kidney, adipose tissue, ovary and testis). Alignment analysis showed high similarity (50.7 to 91.5%) between chicken autophagy-related genes and their mammalian orthologs. Phylogenetic analysis demonstrated that the evolutionary relationship between autophagy genes is consistent with the consensus view of vertebrate evolution. Interestingly, the expression of autophagy-related genes is tissue- and gender-dependent. Furthermore, using two experimental male quail lines divergently selected over 40 generations for low (resistant, R) or high (sensitive, S) stress response, we found that the expression of most studied genes are higher in R compared to S line. Together our results indicate that the autophagy pathway is a key molecular signature exhibited gender specific differences and likely plays an important role in response to stress in avian species.	[Piekarski, Alissa; Khaldi, Stephanie; Greene, Elizabeth; Lassiter, Kentu; Mason, James G.; Anthony, Nicholas; Bottje, Walter; Dridi, Sami] Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville	Dridi, S (corresponding author), Univ Arkansas, Ctr Excellence Poultry Sci, Fayetteville, AR 72701 USA.	dridi@uark.edu	Dridi, Sami/Q-8207-2019		Arkansas state Start-up funding; Arkansas Bioscience 339 Institute (ABI) equipment grant;  [FY2012-15]	Arkansas state Start-up funding; Arkansas Bioscience 339 Institute (ABI) equipment grant; 	This study was supported by Arkansas state Start-up funding (to SD) and Arkansas Bioscience 339 Institute (ABI) equipment grant (to SD) and FY2012-15 (to WB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250; Coto-Montes A, 2009, J ANDROL, V30, P113, DOI 10.2164/jandrol.108.005355; Davis KA, 2008, POULTRY SCI, V87, P1303, DOI 10.3382/ps.2008-00083; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Bolanos JMG, 2014, ANIM REPROD SCI, V145, P40, DOI 10.1016/j.anireprosci.2014.01.001; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hasson SA, 2013, NATURE, V504, P291, DOI 10.1038/nature12748; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Huff GR, 2013, POULTRY SCI, V92, P603, DOI 10.3382/ps.2012-02518; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Malik SA, 2011, CELL CYCLE, V10, P2917, DOI 10.4161/cc.10.17.17067; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Rodriguez A, 2012, DIABETOLOGIA, V55, P3038, DOI 10.1007/s00125-012-2671-5; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Satterlee DG, 2006, POULTRY SCI, V85, P404, DOI 10.1093/ps/85.3.404; SATTERLEE DG, 1990, COMP BIOCHEM PHYS A, V95, P401, DOI 10.1016/0300-9629(90)90239-O; SATTERLEE DG, 1988, POULTRY SCI, V67, P25, DOI 10.3382/ps.0670025; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Slupecka M, 2014, DOMEST ANIM ENDOCRIN, V46, P12, DOI 10.1016/j.domaniend.2013.09.007; Sobolewska A, 2009, EUR J CELL BIOL, V88, P117, DOI 10.1016/j.ejcb.2008.09.004; Straface E, 2009, FEBS LETT, V583, P3448, DOI 10.1016/j.febslet.2009.09.052; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vega-Naredo I, 2009, AUTOPHAGY, V5, P1004, DOI 10.4161/auto.5.7.9610; Wang MJ, 2008, CIRCULATION, V118, pS38, DOI 10.1161/CIRCULATIONAHA.107.756890; Xia XC, 2010, J BONE MINER RES, V25, P2479, DOI 10.1002/jbmr.160; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yansong W., 2014, J CELL PHYSL; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	61	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112449	10.1371/journal.pone.0112449	http://dx.doi.org/10.1371/journal.pone.0112449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386921	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400063
J	Tembuyser, L; Tack, V; Zwaenepoel, K; Pauwels, P; Miller, K; Bubendorf, L; Kerr, K; Schuuring, E; Thunnissen, E; Dequeker, EMC				Tembuyser, Lien; Tack, Veronique; Zwaenepoel, Karen; Pauwels, Patrick; Miller, Keith; Bubendorf, Lukas; Kerr, Keith; Schuuring, Ed; Thunnissen, Erik; Dequeker, Elisabeth M. C.			The Relevance of External Quality Assessment for Molecular Testing for ALK Positive Non-Small Cell Lung Cancer: Results from Two Pilot Rounds Show Room for Optimization	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; IDENTIFICATION; GUIDELINE; GENE; EGFR; ADENOCARCINOMAS; REARRANGEMENTS; BIOMARKERS; MUTATION	Background and Purpose: Molecular profiling should be performed on all advanced non-small cell lung cancer with non-squamous histology to allow treatment selection. Currently, this should include EGFR mutation testing and testing for ALK rearrangements. ROS1 is another emerging target. ALK rearrangement status is a critical biomarker to predict response to tyrosine kinase inhibitors such as crizotinib. To promote high quality testing in non-small cell lung cancer, the European Society of Pathology has introduced an external quality assessment scheme. This article summarizes the results of the first two pilot rounds organized in 2012-2013. Materials and Methods: Tissue microarray slides consisting of cell-lines and resection specimens were distributed with the request for routine ALK testing using IHC or FISH. Participation in ALK FISH testing included the interpretation of four digital FISH images. Results: Data from 173 different laboratories was obtained. Results demonstrate decreased error rates in the second round for both ALK FISH and ALK IHC, although the error rates were still high and the need for external quality assessment in laboratories performing ALK testing is evident. Error rates obtained by FISH were lower than by IHC. The lowest error rates were observed for the interpretation of digital FISH images. Conclusion: There was a large variety in FISH enumeration practices. Based on the results from this study, recommendations for the methodology, analysis, interpretation and result reporting were issued. External quality assessment is a crucial element to improve the quality of molecular testing.	[Tembuyser, Lien; Tack, Veronique; Dequeker, Elisabeth M. C.] KU Leuven Univ Leuven, Biomed Qual Assurance Res Unit, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Zwaenepoel, Karen; Pauwels, Patrick] Univ Antwerp Hosp, Dept Pathol, Edegem, Belgium; [Miller, Keith] UK NEQAS ICC & ISH, London, England; [Bubendorf, Lukas] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Kerr, Keith] Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland; [Schuuring, Ed] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Thunnissen, Erik] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands	KU Leuven; University of Antwerp; University of Basel; University of Aberdeen; University of Groningen; Vrije Universiteit Amsterdam	Dequeker, EMC (corresponding author), KU Leuven Univ Leuven, Biomed Qual Assurance Res Unit, Dept Publ Hlth & Primary Care, Leuven, Belgium.	els.dequeker@med.kuleuven.be	Bubendorf, Lukas/G-5299-2015; Bubendorfl, Lukas/H-5880-2011	Bubendorf, Lukas/0000-0001-5970-1803; Tack, Veronique/0000-0001-8464-9541	Pfizer [ZL520506]	Pfizer(Pfizer)	This work was supported by an unrestricted grant from Pfizer: grant number ZL520506, www.pfizer.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackhall FH, 2014, J CLIN ONCOL, V32, P2780, DOI 10.1200/JCO.2013.54.5921; Cabillic F, 2014, J THORAC ONCOL, V9, P295, DOI 10.1097/JTO.0000000000000072; Cagle PT, 2013, ARCH PATHOL LAB MED, V137, P1191, DOI 10.5858/arpa.2013-0319-CR; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Conklin CMJ, 2013, J THORAC ONCOL, V8, P45, DOI 10.1097/JTO.0b013e318274a83e; Crystal AS, 2012, CLIN CANCER RES, V18, P4479, DOI 10.1158/1078-0432.CCR-12-1952; Dacic S, 2013, J CLIN PATHOL, V66, P870, DOI 10.1136/jclinpath-2012-201336; Deans ZC, 2013, J CLIN PATHOL, V66, P319, DOI 10.1136/jclinpath-2012-201227; Garrido P, 2012, CLIN TRANSL ONCOL, V14, P338, DOI 10.1007/s12094-012-0806-2; Gulley ML, 2007, ARCH PATHOL LAB MED, V131, P852; Han XH, 2013, VIRCHOWS ARCH, V463, P583, DOI 10.1007/s00428-013-1472-7; Heuckmann JM, 2012, CLIN CANCER RES, V18, P4682, DOI 10.1158/1078-0432.CCR-11-3260; International Organization for Standardization, 2012, 15189 ISO; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Mescam-Mancini L, 2014, LUNG CANCER, V83, P168, DOI 10.1016/j.lungcan.2013.11.019; Mino-Kenudson M, 2011, ARCH PATHOL LAB MED, V135, P655, DOI 10.1043/2011-0029-RAI.1; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Nordic Immunohistochemical Quality Control, 2013, LUNG AN LYMPH KIN AS; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Ruschoff J, 2010, VIRCHOWS ARCH, V457, P299, DOI 10.1007/s00428-010-0952-2; Sasaki T, 2011, CLIN CANCER RES, V17, P7213, DOI 10.1158/1078-0432.CCR-11-1404; Selinger CI, 2013, MODERN PATHOL, V26, P1545, DOI 10.1038/modpathol.2013.87; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stinchcombe TE, 2008, ONCOLOGIST, V13, P933, DOI 10.1634/theoncologist.2008-0019; Takeuchi K, 2009, CLIN CANCER RES, V15, P3143, DOI 10.1158/1078-0432.CCR-08-3248; Tembuyser L, 2014, J MOL DIAGN, V16, P371, DOI 10.1016/j.jmoldx.2014.01.003; Thunnissen E, 2014, VIRCHOWS ARCH, V464, P347, DOI 10.1007/s00428-014-1535-4; Thunnissen E, 2012, VIRCHOWS ARCH, V461, P245, DOI 10.1007/s00428-012-1281-4; Thunnissen E, 2011, J CLIN PATHOL, V64, P884, DOI 10.1136/jclinpath-2011-200163; van Krieken JH, 2013, VIRCHOWS ARCH, V462, P27, DOI 10.1007/s00428-012-1354-4; Yoshida A, 2011, J THORAC ONCOL, V6, P1677, DOI 10.1097/JTO.0b013e3182286d25; Zwaenepoel K, 2014, HISTOPATHOL IN PRESS	37	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112159	10.1371/journal.pone.0112159	http://dx.doi.org/10.1371/journal.pone.0112159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386659	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400044
J	Zhang, J; Sun, GQ; Sun, XD; Hou, Q; Li, MT; Huang, BX; Wang, HY; Jin, Z				Zhang, Juan; Sun, Gui-Quan; Sun, Xiang-Dong; Hou, Qiang; Li, Mingtao; Huang, Baoxu; Wang, Haiyan; Jin, Zhen			Prediction and Control of Brucellosis Transmission of Dairy Cattle in Zhejiang Province, China	PLOS ONE			English	Article							BOVINE BRUCELLOSIS; MODEL; EPIDEMIOLOGY; CONTROL/ERADICATION; MONGOLIA; DISEASE; REGION; INDIA; OVINE; HERDS	Brucellosis is a bacterial disease caused by brucella; mainly spread by direct contact transmission through the brucella carriers, or indirect contact transmission by the environment containing large quantities of bacteria discharged by the infected individuals. At the beginning of 21st century, the epidemic among dairy cows in Zhejiang province, began to come back and has become a localized prevalent epidemic. Combining the pathology of brucellosis, the reported positive data characteristics, and the feeding method in Zhejiang province, this paper establishes an SEIV dynamic model to excavate the internal transmission dynamics, fit the real disease situation, predict brucellosis tendency and assess control measures in dairy cows. By careful analysis, we give some quantitative results as follows. (1) The external input of dairy cows from northern areas may lead to high fluctuation of the number of the infectious cows in Zhejiang province that can reach several hundreds. In this case, the disease cannot be controlled and the infection situation cannot easily be predicted. Thus, this paper encourages cows farms to insist on self-supplying production of the dairy cows. (2) The effect of transmission rate of brucella in environment to dairy cattle on brucellosis spreading is greater than transmission rate of the infectious dairy cattle to susceptible cattle. The prevalence of the epidemic is mainly aroused by environment transmission. (3) Under certain circumstances, the epidemic will become a periodic phenomenon. (4) For Zhejiang province, besides measures that have already been adopted, sterilization times of the infected regions is suggested as twice a week, and should be combined with management of the birth rate of dairy cows to control brucellosis spread.	[Zhang, Juan] North Univ China, Sch Mech Engn, Taiyuan, Shanxi, Peoples R China; [Zhang, Juan; Sun, Gui-Quan; Li, Mingtao; Jin, Zhen] Shanxi Univ, Complex Syst Res Ctr, Taiyuan, Shanxi, Peoples R China; [Sun, Gui-Quan] Fudan Univ, Sch Math Sci, Shanghai 200433, Peoples R China; [Sun, Xiang-Dong; Huang, Baoxu] China Anim Hlth & Epidemiol Ctr, Lab Anim Epidemiol Surveillance, Qingdao, Shandong, Peoples R China; [Hou, Qiang] North Univ China, Dept Math, Taiyuan, Shanxi, Peoples R China; [Wang, Haiyan] Arizona State Univ, Sch Math & Nat Sci, Phoenix, AZ USA	North University of China; Shanxi University; Fudan University; China Animal Health & Epidemiology Center; North University of China; Arizona State University; Arizona State University-Downtown Phoenix	Jin, Z (corresponding author), Shanxi Univ, Complex Syst Res Ctr, Taiyuan, Shanxi, Peoples R China.	jinzhn@263.net	jin, zhen/B-6563-2015; Sun, Gui-Quan/Y-3606-2019; Sun, Gui-Quan/AAE-7769-2019	jin, zhen/0000-0002-9763-707X; Sun, Gui-Quan/0000-0002-1831-1603; Wang, Haiyan/0000-0002-5204-967X	National Natural Science Foundation of China [11171314, 11147015, 11301490]; Natural Science Foundation of Shan'Xi Province [2012021002-1]; specialized research fund for the doctoral program of higher education (preferential development) [20121420130001]; China Postdoctoral Science Foundation [2012M520814]; Shanghai Postdoctoral Science Foundation [13R21410100, IDRC104519-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shan'Xi Province(Natural Science Foundation of Shanxi Province); specialized research fund for the doctoral program of higher education (preferential development); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This research is supported by the National Natural Science Foundation of China under grants (11171314, 11147015, and 11301490), Natural Science Foundation of Shan'Xi Province grant no. 2012021002-1, The specialized research fund for the doctoral program of higher education (preferential development) no. 20121420130001, China Postdoctoral Science Foundation under grant no. 2012M520814, and Shanghai Postdoctoral Science Foundation under grant no. 13R21410100 and IDRC104519-010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainseba Bedr'Eddine, 2010, Journal of Biological Dynamics, V4, P2, DOI 10.1080/17513750903171688; ALTON GG, 1987, TROP ANIM HEALTH PRO, V19, P65, DOI 10.1007/BF02297320; Benkirane A, 2006, SMALL RUMINANT RES, V62, P19, DOI 10.1016/j.smallrumres.2005.07.032; BERCOVICH Z, 1992, PREV VET MED, V13, P277, DOI 10.1016/0167-5877(92)90042-E; Bercovich Z, 1998, VET QUART, V20, P81, DOI 10.1080/01652176.1998.9694845; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; England T, 2004, PREV VET MED, V63, P63, DOI 10.1016/j.prevetmed.2004.01.009; Fang Xie, 2009, Journal of Agricultural and Resource Economics, V34, P11; GONZALEZGUZMAN J, 1994, J MATH BIOL, V33, P211, DOI 10.1007/BF00160180; Hou Q, 2013, MATH BIOSCI, V242, P51, DOI 10.1016/j.mbs.2012.11.012; Jiao J., 2009, ANIM HUSB FEED SCI, V30, P170; Keeling M.J., 2008, MODELING INFECT DIS; Liu JP, 2009, PROGR VET MED, V30, P121; MacMillan A, 1990, CONVENTIONAL SEROLOG, P131; MacMillan A., 1994, CATTLE PRACT, V2, P469; Renukaradhya GJ, 2002, VET MICROBIOL, V90, P183, DOI 10.1016/S0378-1135(02)00253-5; Sandip R, 2011, PLOS NEGLECT TROP D, V5, pe1259; Shang DQ, 2002, VET MICROBIOL, V90, P165, DOI 10.1016/S0378-1135(02)00252-3; Sharp Merck, 2011, MERCK VET MAN BRUC C; Smits HL, 2005, INDIAN J MED RES, V122, P375; STEMSHORN BW, 1985, CAN J COMP MED, V49, P391; The Chinese Ministry of Agriculture, 2001, CHIN AN IND YB; Xu W., 2007, CHIN RURAL HLTH SERV, V27, P209; Zinsstag J, 2005, PREV VET MED, V69, P77, DOI 10.1016/j.prevetmed.2005.01.017; 徐卫民, 2009, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V43, P746	25	78	82	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e108592	10.1371/journal.pone.0108592	http://dx.doi.org/10.1371/journal.pone.0108592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386963	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400001
J	Seladi-Schulman, J; Campbell, PJ; Suppiah, S; Steel, J; Lowen, AC				Seladi-Schulman, Jill; Campbell, Patricia J.; Suppiah, Suganthi; Steel, John; Lowen, Anice C.			Filament-Producing Mutants of Influenza A/Puerto Rico/8/1934 (H1N1) Virus Have Higher Neuraminidase Activities than the Spherical Wild-Type	PLOS ONE			English	Article							A VIRUS; PARTICLE FORMATION; VIRAL MORPHOLOGY; M SEGMENT; IN-VIVO; HEMAGGLUTININ; M1; CONTACT; STRAINS; VIRIONS	Influenza virus exhibits two morphologies-spherical and filamentous. Strains that have been grown extensively in laboratory substrates are comprised predominantly of spherical virions while clinical or low passage isolates produce a mixture of spheres and filamentous virions of varying lengths. The filamentous morphology can be lost upon continued passage in embryonated chicken eggs, a common laboratory substrate for influenza viruses. The fact that the filamentous morphology is maintained in nature but lost in favor of a spherical morphology in ovo suggests that filaments confer a selective advantage within the infected host that is not necessary for growth in laboratory substrates. Indeed, we have recently shown that filament-producing variant viruses are selected upon passage of the spherical laboratory strain A/Puerto Rico/8/1934 (H1N1) [PR8] in guinea pigs. Toward determining the nature of the selective advantage conferred by filaments, we sought to identify functional differences between spherical and filamentous particles. We compared the wildtype PR8 virus to two previously characterized recombinant PR8 viruses in which single point mutations within M1 confer a filamentous morphology. Our results indicate that these filamentous PR8 mutants have higher neuraminidase activities than the spherical PR8 virus. Conversely, no differences were observed in HAU:PFU or HAU:RNA ratios, binding avidity, sensitivity to immune serum in hemagglutination inhibition assays, or virion stability at elevated temperatures. Based on these results, we propose that the pleomorphic nature of influenza virus particles is important for the optimization of neuraminidase functions in vivo.	[Seladi-Schulman, Jill; Campbell, Patricia J.; Suppiah, Suganthi; Steel, John; Lowen, Anice C.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Lowen, AC (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	anice.lowen@emory.edu			National Institutes of Health/National Institute of Allergy and Infectious Disease under Centers for Excellence in Influenza Research and Surveillance (CEIRS) [HHSN266200700006C]	National Institutes of Health/National Institute of Allergy and Infectious Disease under Centers for Excellence in Influenza Research and Surveillance (CEIRS)	This work was funded by the National Institutes of Health/National Institute of Allergy and Infectious Disease under Centers for Excellence in Influenza Research and Surveillance (CEIRS) contract number HHSN266200700006C (http://www.niaid.nih.gov/labsandresources/resources/ceirs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA GL, 1958, J GEN MICROBIOL, V19, P40, DOI 10.1099/00221287-19-1-40; Bialas KM, 2014, J VIROL, V88, P2227, DOI 10.1128/JVI.03354-13; Bourmakina SV, 2003, J GEN VIROL, V84, P517, DOI 10.1099/vir.0.18803-0; Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08; Burleigh LM, 2005, J VIROL, V79, P1262, DOI 10.1128/JVI.79.2.1262-1270.2005; Calder LJ, 2010, P NATL ACAD SCI USA, V107, P10685, DOI 10.1073/pnas.1002123107; Campbell PJ, 2014, J VIROL, V88, P3802, DOI 10.1128/JVI.03607-13; CHOPPIN PW, 1960, J EXP MED, V112, P945, DOI 10.1084/jem.112.5.945; Chou YY, 2011, J VIROL, V85, P11235, DOI 10.1128/JVI.05794-11; CHU CM, 1949, LANCET, V256, P602; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Elleman CJ, 2004, VIROLOGY, V321, P144, DOI 10.1016/j.virol.2003.12.009; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Gong LI, 2013, ELIFE, V2, DOI 10.7554/eLife.00631; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; KILBOURNE ED, 1960, J EXP MED, V111, P387, DOI 10.1084/jem.111.3.387; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Mitnaul LJ, 1996, J VIROL, V70, P873, DOI 10.1128/JVI.70.2.873-879.1996; MOSLEY VM, 1946, NATURE, V157, P263, DOI 10.1038/157263a0; MURTI KG, 1986, VIROLOGY, V149, P36, DOI 10.1016/0042-6822(86)90084-X; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Quinlivan M, 2005, J VIROL, V79, P8431, DOI 10.1128/JVI.79.13.8431-8439.2005; Roberts PC, 1998, P NATL ACAD SCI USA, V95, P5746, DOI 10.1073/pnas.95.10.5746; Roberts PC, 1998, VIROLOGY, V240, P127, DOI 10.1006/viro.1997.8916; Seladi-Schulman J, 2013, J VIROL, V87, P13343, DOI 10.1128/JVI.02004-13; SMIRNOV YA, 1991, ARCH VIROL, V118, P279, DOI 10.1007/BF01314038; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Vijayakrishnan S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003413; Webster R, 2002, WHO MANUAL ANIMAL IN	34	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112462	10.1371/journal.pone.0112462	http://dx.doi.org/10.1371/journal.pone.0112462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383873	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700064
J	Delcourt, N; Quevedo, C; Nonne, C; Fons, P; O'Brien, D; Loyaux, D; Diez, M; Autelitano, F; Guillemot, JC; Ferrara, P; Muriana, A; Callol, C; Herault, JP; Herbert, JM; Favre, G; Bono, F				Delcourt, Nicolas; Quevedo, Celia; Nonne, Christelle; Fons, Pierre; O'Brien, Donogh; Loyaux, Denis; Diez, Maria; Autelitano, Franois; Guillemot, Jean-Claude; Ferrara, Pascual; Muriana, Arantza; Callol, Carlos; Herault, Jean-Pascal; Herbert, Jean-Marc; Favre, Gilles; Bono, Francoise			Targeted Identification of Sialoglycoproteins in Hypoxic Endothelial Cells and Validation in Zebrafish Reveal Roles for Proteins in Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROPILIN-1; APOPTOSIS; GLYCANS	The formation of new vessels in the tumor, termed angiogenesis, is essential for primary tumor growth and facilitates tumor invasion and metastasis. Hypoxia has been described as one trigger of angiogenesis. Indeed, hypoxia, which is characterized by areas of low oxygen levels, is a hallmark of solid tumors arising from an imbalance between oxygen delivery and consumption. Hypoxic conditions have profound effects on the different components of the tumoral environment. For example, hypoxia is able to activate endothelial cells, leading to angiogenesis but also thereby initiating a cascade of reactions involving neutrophils, smooth muscle cells, and fibroblasts. In addition, hypoxia directly regulates the expression of many genes for which the role and the importance in the tumoral environment remain to be completely elucidated. In this study, we used a method to selectively label sialoglycoproteins to identify new membrane and secreted proteins involved in the adaptative process of endothelial cells by mass spectrometry-based proteomics. We used an in vitro assay under hypoxic condition to observe an increase of protein expression or modifications of glycosylation. Then the function of the identified proteins was assessed in a vasculogenesis assay in vivo by using a morpholino strategy in zebrafish. First, our approach was validated by the identification of sialoglycoproteins such as CD105, neuropilin-1, and CLEC14A, which have already been described as playing key roles in angiogenesis. Second, we identified several new proteins regulated by hypoxia and demonstrated for the first time the pivotal role of GLUT-1, TMEM16F, and SDF4 in angiogenesis.	[Delcourt, Nicolas; Nonne, Christelle; Fons, Pierre; Loyaux, Denis; Autelitano, Franois; Guillemot, Jean-Claude; Ferrara, Pascual; Herault, Jean-Pascal; Herbert, Jean-Marc; Bono, Francoise] Sanofi Res & Dev, F-31000 Toulouse, France; [O'Brien, Donogh] Donogh OBrien BioConsulting, F-18310 Les Poirioux, St Outrille, France; [Delcourt, Nicolas; Favre, Gilles] Univ Toulouse, INSERM UMR1037, Ctr Rech Cancerol Toulouse, F-31057 Toulouse, France; [Quevedo, Celia; Diez, Maria; Callol, Carlos] Biobide SL, San Sebastian 20009, Spain; [Quevedo, Celia; Muriana, Arantza] BBD BioPhenix SL Bionaturis Grp, San Sebastian 20009, Spain	Sanofi-Aventis; Sanofi France; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bono, F (corresponding author), Sanofi R&D, E2C, 195 Route Espagne, F-31000 Toulouse, France.	francoise.bono@sanofi.com	Diez, Maria Suarez/AAI-1354-2020; nonne, christelle/AAI-8775-2020; DELCOURT, Nicolas/H-2877-2016; FAVRE, Gilles/K-9189-2014	DELCOURT, Nicolas/0000-0001-8136-9392; FAVRE, Gilles/0000-0002-2344-1883; Autelitano, Francois/0000-0001-6269-2629				Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cassavaugh J, 2011, J CELL BIOCHEM, V112, P735, DOI 10.1002/jcb.22956; Chiche J, 2013, ANN ENDOCRINOL-PARIS, V74, P111, DOI 10.1016/j.ando.2013.02.004; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hanson SR, 2007, J AM CHEM SOC, V129, P7266, DOI 10.1021/ja0724083; Jensen PJ, 2006, J BIOL CHEM, V281, P13382, DOI 10.1074/jbc.M601881200; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kwapiszewska G, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-109; Laughlin ST, 2006, METHOD ENZYMOL, V415, P230, DOI 10.1016/S0076-6879(06)15015-6; Lee KY, 2002, NAT BIOTECHNOL, V20, P795, DOI 10.1038/nbt721; Lee P, 2002, P NATL ACAD SCI USA, V99, P10470, DOI 10.1073/pnas.162366299; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Martyn U, 2004, DEV DYNAM, V231, P33, DOI 10.1002/dvdy.20048; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Morcos PA, 2007, BIOCHEM BIOPH RES CO, V358, P521, DOI 10.1016/j.bbrc.2007.04.172; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Nagao K, 2011, BIOCHEM BIOPH RES CO, V407, P260, DOI 10.1016/j.bbrc.2011.03.017; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pan S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003251; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Prescher JA, 2006, CELL, V126, P851, DOI 10.1016/j.cell.2006.08.017; Rabuka D, 2006, J AM CHEM SOC, V128, P12078, DOI 10.1021/ja064619y; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Saxon E, 2001, ANNU REV CELL DEV BI, V17, P1, DOI 10.1146/annurev.cellbio.17.1.1; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Traiffort E, 2013, MOL ASPECTS MED, V34, P646, DOI 10.1016/j.mam.2012.10.011; Wang L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001161; Wykoff CC, 2000, ONCOGENE, V19, P6297, DOI 10.1038/sj.onc.1204012	41	18	18	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3405	3417		10.1074/jbc.M114.618611	http://dx.doi.org/10.1074/jbc.M114.618611			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25384978	Green Published, hybrid			2022-12-26	WOS:000349456000017
J	Alhouayek, M; Bottemanne, P; Subramanian, KV; Lambert, DM; Makriyannis, A; Cani, PD; Muccioli, GG				Alhouayek, Mireille; Bottemanne, Pauline; Subramanian, Kumar V.; Lambert, Didier M.; Makriyannis, Alexandros; Cani, Patrice D.; Muccioli, Giulio G.			N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis	FASEB JOURNAL			English	Article						endocannabinoid; 2-AG; Crohn's disease; PF-3845; N-acyltaurine	INFLAMMATORY-BOWEL-DISEASE; SODIUM-INDUCED COLITIS; ENDOCANNABINOID SYSTEM; VANILLOID RECEPTOR-1; SENSORY NEURONS; ALPHA; MODEL; INVOLVEMENT; PROTECTS; LIGANDS	N-Palmitoylethanolamine or palmitoylethanolamide (PEA) is an anti-inflammatory compound that was recently shown to exert peroxisome proliferatoractivated receptor-alpha-dependent beneficial effects on colon inflammation. The actions of PEA are terminated following hydrolysis by 2 enzymes: fatty acid amide hydrolase (FAAH), and the less-studied N-acylethanolaminehydrolyzing acid amidase (NAAA). This study aims to investigate the effects of inhibiting the enzymes responsible for PEA hydrolysis in colon inflammation in order to propose a potential therapeutic target for inflammatory bowel diseases (IBDs). Two murine models of IBD were used to assess the effects of NAAA inhibition, FAAH inhibition, and PEA on macroscopic signs of colon inflammation, macrophage/ neutrophil infiltration, and the expression of proinflammatory mediators in the colon, as well as on the colitis-related systemic inflammation. NAAA inhibition increases PEA levels in the colon and reduces colon inflammation and systemic inflammation, similarly to PEA. FAAH inhibition, however, does not increase PEA levels in the colon and does not affect the macroscopic signs of colon inflammation or immune cell infiltration. This is the first report of an anti-inflammatory effect of a systemically administered NAAA inhibitor. BecauseNAAA is the enzyme responsible for the control ofPEAlevels in the colon, we put forth this enzyme as a potential therapeutic target in chronic inflammation in general and IBDin particular.-Alhouayek, M., Bottemanne, P., Subramanian, K. V., Lambert, D. M., Makriyannis, A., Cani, P. D., and Muccioli, G. G. NAcylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.	[Alhouayek, Mireille; Bottemanne, Pauline; Muccioli, Giulio G.] Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, B-1200 Brussels, Belgium; [Alhouayek, Mireille; Lambert, Didier M.] Catholic Univ Louvain, Louvain Drug Res Inst, Med Chem Res Grp, B-1200 Brussels, Belgium; [Cani, Patrice D.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Subramanian, Kumar V.; Makriyannis, Alexandros] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Northeastern University	Muccioli, GG (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Bioanal & Pharmacol Bioact Lipids Res Grp, Av E Mounier 72 B1-72-01, B-1200 Brussels, Belgium.	giulio.muccioli@uclouvain.be	Alhouayek, Mireille/R-5058-2018; Makriyannis, Alexandros/GRF-1518-2022; D., Cani Patrice/M-8055-2016	Alhouayek, Mireille/0000-0002-9193-0718; Makriyannis, Alexandros/0000-0003-3272-3687; D., Cani Patrice/0000-0003-2040-2448; Bottemanne, Pauline/0000-0003-0414-4127; Muccioli, Giulio/0000-0002-1600-9259	ERC Starting Grant (European Research Council) [336452-ENIGMO]; FRS-FNRS, Belgium [CC 1.5.034.10, FRFC 2.4555.08]; IBD Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA003801, R37DA003801, P01DA009158] Funding Source: NIH RePORTER	ERC Starting Grant (European Research Council); FRS-FNRS, Belgium(Fonds de la Recherche Scientifique - FNRS); IBD Research Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Therese Timmerman and Owein Guillemot-Legris for their assistance. P.D.C. is a research associate from the FRS-FNRS (Fonds de la Recherche Scientifique), Belgium, and recipient of ERC Starting Grant 2013 (European Research Council, Starting Grant 336452-ENIGMO). G.G.M. is the recipient of a subsidy from the Fonds Speciaux de Recherches (Universite catholique de Louvain) and from the FRS-FNRS, Belgium (Grants CC 1.5.034.10 and FRFC 2.4555.08). A.M. is a postdoctoral researcher from the FRS-FNRS, Belgium. They are also grateful to the IBD Research Foundation for their kind financial support. The authors declare no conflicts of interest.	Ahn K, 2009, CHEM BIOL, V16, P411, DOI 10.1016/j.chembiol.2009.02.013; Alhouayek M, 2014, DRUG DISCOV TODAY, V19, P1632, DOI 10.1016/j.drudis.2014.06.007; Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Alhouayek M, 2012, TRENDS MOL MED, V18, P615, DOI 10.1016/j.molmed.2012.07.009; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Aviello G, 2008, J MOL MED, V86, P413, DOI 10.1007/s00109-008-0305-7; Berdyshev E, 1998, LIFE SCI, V63, pPL125, DOI 10.1016/S0024-3205(98)00324-5; Borrelli F, 2009, BEST PRACT RES CL EN, V23, P33, DOI 10.1016/j.beem.2008.10.003; BRADLEY PP, 1982, BLOOD, V60, P618; Capasso R, 2005, GASTROENTEROLOGY, V129, P941, DOI 10.1053/j.gastro.2005.06.018; Capasso R, 2001, BRIT J PHARMACOL, V134, P945, DOI 10.1038/sj.bjp.0704339; Conigliaro R, 2011, MINERVA MED, V102, P141; Costa B, 2002, BRIT J PHARMACOL, V137, P413, DOI 10.1038/sj.bjp.0704900; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Cuzzocrea S, 2004, LAB INVEST, V84, P1643, DOI 10.1038/labinvest.3700185; Cuzzocrea S, 2008, MOL PHARMACOL, V73, P323, DOI 10.1124/mol.107.041475; D'Agostino G, 2012, NEUROPSYCHOPHARMACOL, V37, P1784, DOI 10.1038/npp.2012.25; Darmani NA, 2005, NEUROPHARMACOLOGY, V48, P1154, DOI 10.1016/j.neuropharm.2005.01.001; Esposito G, 2014, GUT, V63, P1300, DOI 10.1136/gutjnl-2013-305005; Fegley D, 2005, J PHARMACOL EXP THER, V313, P352, DOI 10.1124/jpet.104.078980; Fichna J, 2012, NEUROGASTROENT MOTIL, V24, pe557, DOI 10.1111/j.1365-2982.2012.01999.x; Hesselink JMK, 2013, J PAIN RES, V6, P239, DOI 10.2147/JPR.S42417; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Izzo AA, 2008, J MOL MED, V86, P89, DOI 10.1007/s00109-007-0248-4; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Kimball ES, 2004, NEUROGASTROENT MOTIL, V16, P811, DOI 10.1111/j.1365-2982.2004.00549.x; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Lambert DM, 2007, CURR OPIN CLIN NUTR, V10, P735, DOI 10.1097/MCO.0b013e3282f00061; Lambert DM, 1999, BBA-MOL CELL BIOL L, V1440, P266, DOI 10.1016/S1388-1981(99)00132-8; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Long JZ, 2011, J LIPID RES, V52, P337, DOI 10.1194/jlr.M012153; Loria F, 2008, EUR J NEUROSCI, V28, P633, DOI 10.1111/j.1460-9568.2008.06377.x; Luongo L, 2013, CNS NEUROL DISORD-DR, V12, P45, DOI 10.2174/1871527311312010009; Marquez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006893; Mechoulam R, 2013, ANNU REV PSYCHOL, V64, P21, DOI 10.1146/annurev-psych-113011-143739; Melmed GY, 2010, NAT REV GASTRO HEPAT, V7, P110, DOI 10.1038/nrgastro.2009.218; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Muccio GG, 2008, ANAL BIOCHEM, V373, P220, DOI 10.1016/j.ab.2007.09.030; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Ponzano S, 2013, J MED CHEM, V56, P6917, DOI 10.1021/jm400739u; Riccardi L, 2009, SHOCK, V31, P308, DOI 10.1097/SHK.0b013e31818339e7; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Saghatelian A, 2006, BIOCHEMISTRY-US, V45, P9007, DOI 10.1021/bi0608008; Scuderi C, 2013, CNS NEUROL DISORD-DR, V12, P62, DOI 10.2174/1871527311312010011; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Storr MA, 2008, J MOL MED, V86, P925, DOI 10.1007/s00109-008-0359-6; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Suarez J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037729; Sugiura T, 2004, J NEUROSCI, V24, P9521, DOI 10.1523/JNEUROSCI.2639-04.2004; Szitter I, 2010, J MOL NEUROSCI, V42, P80, DOI 10.1007/s12031-010-9366-5; Tarzia G, 2006, CHEMMEDCHEM, V1, P130, DOI 10.1002/cmdc.200500017; Ueda N, 2001, J BIOL CHEM, V276, P35552, DOI 10.1074/jbc.M106261200; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Zhu C, 2011, MOL PHARMACOL, V79, P786, DOI 10.1124/mol.110.070201	58	79	80	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					650	661		10.1096/fj.14-255208	http://dx.doi.org/10.1096/fj.14-255208			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25384424	Green Published			2022-12-26	WOS:000349370400026
J	Martinez-Vega, R; Garrido, F; Partearroyo, T; Cediel, R; Zeisel, SH; Martinez-Alvarez, C; Varela-Moreiras, G; Varela-Nieto, I; Pajares, MA				Martinez-Vega, Raquel; Garrido, Francisco; Partearroyo, Teresa; Cediel, Rafael; Zeisel, Steven H.; Martinez-Alvarez, Concepcion; Varela-Moreiras, Gregorio; Varela-Nieto, Isabel; Pajares, Maria A.			Folic acid deficiency induces premature hearing loss through mechanisms involving cochlear oxidative stress and impairment of homocysteine metabolism	FASEB JOURNAL			English	Article						apoptosis; dietary restriction; hair cell loss; hyperhomocysteinemia; methionine cycle	GUINEA-PIG COCHLEA; INNER-EAR; S-METHYLTRANSFERASE; REACTIVE OXYGEN; METHIONINE METABOLISM; GLUTATHIONE SYNTHESIS; ADENOSINE KINASE; MICE; MOUSE; NOISE	Nutritional imbalance is emerging as a causative factor of hearing loss. Epidemiologic studies have linked hearing loss to elevated plasma total homocysteine (tHcy) and folate deficiency, and have shown that folate supplementation lowers tHcy levels potentially ameliorating age-related hearing loss. The purpose of this study was to address the impact of folate deficiency on hearing loss and to examine the underlying mechanisms. For this purpose, 2-mo-old C57BL/6J mice (Animalia Chordata Mus musculus) were randomly divided into 2 groups (n = 65 each) that were fed folate-deficient (FD) or standard diets for 8 wk. HPLC analysis demonstrated a 7-fold decline in serum folate and a 3-fold increase in tHcy levels. FD mice exhibited severe hearing loss measured by auditory brainstem recordings and TUNEL-positive-apoptotic cochlear cells. RT-quantitative PCR and Western blotting showed reduced levels of enzymes catalyzing homocysteine (Hcy) production and recycling, together with a 30% increase in protein homocysteinylation. Redox stress was demonstrated by decreased expression of catalase, glutathione peroxidase 4, and glutathione synthetase genes, increased levels of manganese superoxide dismutase, and NADPH oxidase-complex adaptor cytochrome b-245, alpha-polypeptide (p22phox) proteins, and elevated concentrations of glutathione species. Altogether, our findings demonstrate, for the first time, that the relationship between hyperhomocysteinemia induced by folate deficiency and premature hearing loss involves impairment of cochlear Hcy metabolism and associated oxidative stress.	[Martinez-Vega, Raquel; Garrido, Francisco; Cediel, Rafael; Varela-Nieto, Isabel; Pajares, Maria A.] UAM, CSIC, Inst Biomed Res Alberto Sols, Madrid 28029, Spain; [Martinez-Vega, Raquel; Cediel, Rafael; Varela-Nieto, Isabel] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Raras, Unidad 761, Madrid, Spain; [Partearroyo, Teresa; Varela-Moreiras, Gregorio] Univ CEU San Pablo, Dept Ciencias Farmaceut & Salud, Fac Farm, Madrid, Spain; [Cediel, Rafael] Univ Complutense Madrid, Fac Vet, Hosp Clin Vet, Madrid, Spain; [Zeisel, Steven H.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC USA; [Martinez-Alvarez, Concepcion] Univ Complutense Madrid, Fac Med, Dept Anat & Embriol Humana 1, Madrid, Spain; [Varela-Nieto, Isabel; Pajares, Maria A.] Inst Invest Sanitaria La Paz, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; San Pablo CEU University; Complutense University of Madrid; University of North Carolina; University of North Carolina Chapel Hill; Complutense University of Madrid	Varela-Nieto, I (corresponding author), UAM, CSIC, Inst Biomed Res Alberto Sols, Arturo Duperier 4, Madrid 28029, Spain.	ivarela@iib.uam.es	Partearroyo, Teresa/J-7322-2017; Cediel-Algovia, Rafael/L-5274-2018; Pajares, Maria Angeles/I-5952-2012; Varela-Nieto, Isabel/G-5289-2015	Partearroyo, Teresa/0000-0002-4401-1233; Cediel-Algovia, Rafael/0000-0003-4594-8105; Pajares, Maria Angeles/0000-0002-4714-9051; Varela-Nieto, Isabel/0000-0003-3077-0500; MARTINEZ ALVAREZ, MARIA CONCEPCION/0000-0002-8089-3173; VARELA-MOREIRAS, GREGORIO/0000-0001-5158-4999	Ministerio de Ciencia e Innovacion [BFU2009-08977, SAF2011-24391, PS09/0176]; European Union; National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [DK056350]; Puleva BioFoods; JAE-CSIC predoctoral program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Union(European Commission); National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Puleva BioFoods; JAE-CSIC predoctoral program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Estela Maldonado from Complutense University of Madrid, Silvia Murillo-Cuesta from the Noninvasive Neurofunctional Evaluation facility, and the team from the Genomics facility (both from IIBM, CSIC-UAM) for the technical support provided. The authors also warmly thank their colleagues at the Neurobiology of Hearing group for sharing unpublished data and helpful discussions. R.M.-V. is supported by a fellowship from the JAE-CSIC predoctoral program. This work was supported by grants from the Ministerio de Ciencia e Innovacion (BFU2009-08977 to M. A. P., SAF2011-24391 to I. V.-N., and PS09/01762 to C.M.-A.), the European Union (FP7-AFHELO and TARGEAR to I.V.-N.), U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (Grant DK056350 to S.H.Z.), and Puleva BioFoods (to I.V.-N., G.V.-M., and M.A.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Aburto MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030790; Attias J, 2012, AUDIOL NEURO-OTOL, V17, P309, DOI 10.1159/000339356; Banerjee R, 2012, J BIOL CHEM, V287, P4397, DOI 10.1074/jbc.R111.287995; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Cadoni G, 2004, ACTA OTO-LARYNGOL, V124, P608, DOI 10.1080/00016480410016216; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Delgado M, 2008, CELL MOL LIFE SCI, V65, P2080, DOI 10.1007/s00018-008-8201-4; Delgado M, 2014, ANTIOXID REDOX SIGN, V20, P2541, DOI 10.1089/ars.2013.5342; Dror AA, 2009, ANNU REV GENET, V43, P411, DOI 10.1146/annurev-genet-102108-134135; Durga J, 2006, NEUROBIOL AGING, V27, P482, DOI 10.1016/j.neurobiolaging.2005.03.002; Durga J, 2007, ANN INTERN MED, V146, P1, DOI 10.7326/0003-4819-146-1-200701020-00003; Emmett SD, 2014, MED HYPOTHESES, V82, P6, DOI 10.1016/j.mehy.2013.09.028; Feng H, 2011, MOL CELL BIOCHEM, V353, P291, DOI 10.1007/s11010-011-0798-1; Gok U, 2004, AURIS NASUS LARYNX, V31, P19, DOI 10.1016/j.anl.2003.09.001; Gonzalez B, 2003, BIOCHEM J, V370, P945, DOI 10.1042/BJ20021510; Gonzalez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050329; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; HORNE DW, 1988, CLIN CHEM, V34, P2357; Houston DK, 1999, AM J CLIN NUTR, V69, P564; Ison JR, 2007, JARO-J ASSOC RES OTO, V8, P539, DOI 10.1007/s10162-007-0098-3; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Jakubowski H, 2011, ADV CLIN CHEM, V55, P81, DOI 10.1016/B978-0-12-387042-1.00005-8; Jiang H, 2007, NEUROBIOL AGING, V28, P1605, DOI 10.1016/j.neurobiolaging.2006.06.025; JOHNSSON LG, 1972, ANN OTO RHINOL LARYN, V81, P364, DOI 10.1177/000348947208100307; Karli R, 2013, ACTA OTORHINOLARYNGO, V33, P243; Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009; Keithley EM, 2004, HEARING RES, V188, P21, DOI 10.1016/S0378-5955(03)00365-4; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kundu S, 2012, HEARING RES, V284, P42, DOI 10.1016/j.heares.2011.12.006; Kundu S, 2009, MOL CELL BIOCHEM, V332, P215, DOI 10.1007/s11010-009-0194-2; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Lasisi AO, 2010, OTOLARYNG HEAD NECK, V143, P826, DOI 10.1016/j.otohns.2010.08.031; Li X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026728; Li-Korotky HS, 2012, GERONTOLOGIST, V52, P265, DOI 10.1093/geront/gnr159; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Maestro-de-las-Casas C, 2013, BIRTH DEFECTS RES A, V97, P587, DOI 10.1002/bdra.23176; Makishima K., 1978, OTOLARYNGOLOGY, V86; Maldonado E, 2011, CELLS TISSUES ORGANS, V194, P406, DOI 10.1159/000323213; Massimo F, 2012, INT J AUDIOL, V51, P800, DOI 10.3109/14992027.2012.705904; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; Murillo-Cuesta S, 2012, MOL MED, V18, P260, DOI 10.2119/molmed.2011.00328; Nathaniel GN., 2008, OPEN ENZYME INHIBITI, V1, P34, DOI [10.2174/1874940200801010034, DOI 10.2174/1874940200801010034]; Ohlemiller KK, 2006, BRAIN RES, V1091, P89, DOI 10.1016/j.brainres.2006.03.017; Pajares MA, 2006, CELL MOL LIFE SCI, V63, P2792, DOI 10.1007/s00018-006-6249-6; Pajares MA, 2013, FEBS LETT, V587, P1711, DOI 10.1016/j.febslet.2013.04.034; Pajares Maria A, 2011, Adv Enzymol Relat Areas Mol Biol, V78, P449; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PUEL JL, 1991, HEARING RES, V51, P255, DOI 10.1016/0378-5955(91)90042-8; Quintana-Cabrera R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1722; Radi R, 2013, J BIOL CHEM, V288, P26464, DOI 10.1074/jbc.R113.472936; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rodriguez-de la Rosa L, 2012, NEUROBIOL DIS, V46, P476, DOI 10.1016/j.nbd.2012.02.013; Rodriguez-de la Rosa L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087536; ROSEN S, 1965, B NEW YORK ACAD MED, V41, P1052; Roth TN, 2011, EUR ARCH OTO-RHINO-L, V268, P1101, DOI 10.1007/s00405-011-1597-8; Sanchez-Alcazar JA, 2003, BIOCHEM J, V370, P609, DOI 10.1042/BJ20021623; Sanchez-Calderon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008699; Sliwinska-Kowalska M, 2012, NOISE HEALTH, V14, P274, DOI 10.4103/1463-1741.104893; Tabuchi K, 2011, CURR MED CHEM, V18, P4866, DOI 10.2174/092986711797535254; Tamura T., 1990, CONT ISSUES CLIN NU, V13, P121; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Tropitzsch A, 2014, TOXICOL LETT, V227, P203, DOI 10.1016/j.toxlet.2014.03.022; Uchida Y, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-35; Vlajkovic SM, 2013, HEARING RES, V304, P145, DOI 10.1016/j.heares.2013.07.012; Vlajkovic SM, 2011, EXP GERONTOL, V46, P905, DOI 10.1016/j.exger.2011.08.001; Vlajkovic SM, 2010, J NEUROSCI RES, V88, P2598, DOI 10.1002/jnr.22421; Yamada K, 2000, J NUTR, V130, P1894, DOI 10.1093/jn/130.8.1894	72	39	40	0	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					418	432		10.1096/fj.14-259283	http://dx.doi.org/10.1096/fj.14-259283			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25384423	Green Submitted, Green Published			2022-12-26	WOS:000349370400008
J	Arango-Gonzalez, B; Trifunovic, D; Sahaboglu, A; Kranz, K; Michalakis, S; Farinelli, P; Koch, S; Koch, F; Cottet, S; Janssen-Bienhold, U; Dedek, K; Biel, M; Zrenner, E; Euler, T; Ekstrom, P; Ueffing, M; Paquet-Durand, F				Arango-Gonzalez, Blanca; Trifunovic, Dragana; Sahaboglu, Ayse; Kranz, Katharina; Michalakis, Stylianos; Farinelli, Pietro; Koch, Susanne; Koch, Fred; Cottet, Sandra; Janssen-Bienhold, Ulrike; Dedek, Karin; Biel, Martin; Zrenner, Eberhart; Euler, Thomas; Ekstrom, Per; Ueffing, Marius; Paquet-Durand, Francois			Identification of a Common Non-Apoptotic Cell Death Mechanism in Hereditary Retinal Degeneration	PLOS ONE			English	Article							MOUSE MODEL; POLY(ADP-RIBOSE) POLYMERASE; PHOTORECEPTOR DEGENERATION; GUANOSINE-MONOPHOSPHATE; MICE LACKING; IN-SITU; RD; ACTIVATION; CASPASE-3; ROD	Cell death in neurodegenerative diseases is often thought to be governed by apoptosis; however, an increasing body of evidence suggests the involvement of alternative cell death mechanisms in neuronal degeneration. We studied retinal neurodegeneration using 10 different animal models, covering all major groups of hereditary human blindness (rd1, rd2, rd10, Cngb1 KO, Rho KO, S334ter, P23H, Cnga3 KO, cpfl1, Rpe65 KO), by investigating metabolic processes relevant for different forms of cell death. We show that apoptosis plays only a minor role in the inherited forms of retinal neurodegeneration studied, where instead, a non-apoptotic degenerative mechanism common to all mutants is of major importance. Hallmark features of this pathway are activation of histone deacetylase, poly-ADP-ribose-polymerase, and calpain, as well as accumulation of cyclic guanosine monophosphate and poly-ADP-ribose. Our work thus demonstrates the prevalence of alternative cell death mechanisms in inherited retinal degeneration and provides a rational basis for the design of mutation-independent treatments.	[Arango-Gonzalez, Blanca; Trifunovic, Dragana; Sahaboglu, Ayse; Farinelli, Pietro; Zrenner, Eberhart; Euler, Thomas; Ueffing, Marius; Paquet-Durand, Francois] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Kranz, Katharina; Janssen-Bienhold, Ulrike; Dedek, Karin] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-26111 Oldenburg, Germany; [Michalakis, Stylianos; Koch, Susanne; Koch, Fred; Biel, Martin] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Michalakis, Stylianos; Koch, Susanne; Koch, Fred; Biel, Martin] Univ Munich, Dept Pharm, Ctr Drug Res, Munich, Germany; [Farinelli, Pietro; Ekstrom, Per] Lund Univ, Dept Clin Sci, Div Ophthalmol, Lund, Sweden; [Cottet, Sandra] Inst Res Ophthalmol, Sion, Switzerland; [Zrenner, Eberhart; Euler, Thomas] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Carl von Ossietzky Universitat Oldenburg; University of Munich; University of Munich; Lund University; Eberhard Karls University of Tubingen	Arango-Gonzalez, B (corresponding author), Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany.	blanca.arango-gonzalez@klinikum.uni-tuebingen.de; francois.paquet-durand@klinikum.uni-tuebingen.de	Michalakis, Stylianos/W-2094-2018; Trifunovic, Dragana/ABB-8165-2020; Michalakis, Stylianos/M-4677-2019; Paquet-Durand, Francois/G-6709-2015; Arango-Gonzalez, Blanca/AAR-7427-2021; Trifunovic, Dragana/AAA-1823-2020; Farinelli, Pietro/G-8000-2017; Dedek, Karin/R-6948-2018; Biel, Martin/G-1175-2014	Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Paquet-Durand, Francois/0000-0001-7355-5742; Arango-Gonzalez, Blanca/0000-0002-9045-182X; Farinelli, Pietro/0000-0002-4242-3090; Dedek, Karin/0000-0003-1490-0141; Biel, Martin/0000-0002-9974-3052; Euler, Thomas/0000-0002-4567-6966; Koch, Susanne/0000-0001-9966-113X; Trifunovic, Dragana/0000-0003-3168-4196; Sahaboglu, Ayse/0000-0003-3241-0672	Kerstan Foundation; Deutsche Forschungsgemeinschaft [DFG PA1751/1-1, DFG PA1751/4-1]; Alcon Research Institute; European Commission [DRUGSFORD: HEALTH-F2-2012-304963, PANOPTES: NMP4-SL-2010-246180]; German Ministry of Education and Research [BMBF HOPE2 - FKZ 01GM1108A]; Centre for Integrative Neuroscience [CIN pool project] [2009-20]; Kronprinsessan Margaretas Arbetsnamnd (KMA); Stiftelsen Olle Engkvist Byggmastare; Swedish Research Council [2009-3855]; Stiftelsen for Synskadade i f.d. Malmohus lan	Kerstan Foundation(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alcon Research Institute(Novartis); European Commission(European CommissionEuropean Commission Joint Research Centre); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Centre for Integrative Neuroscience [CIN pool project]; Kronprinsessan Margaretas Arbetsnamnd (KMA); Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Stiftelsen for Synskadade i f.d. Malmohus lan	This work was supported by the Kerstan Foundation, Deutsche Forschungsgemeinschaft [DFG PA1751/1-1, 4-1], Alcon Research Institute, European Commission [DRUGSFORD: HEALTH-F2-2012-304963; PANOPTES: NMP4-SL-2010-246180], German Ministry of Education and Research [BMBF HOPE2 - FKZ 01GM1108A], Centre for Integrative Neuroscience [CIN pool project 2009-20], Kronprinsessan Margaretas Arbetsnamnd (KMA), Stiftelsen Olle Engkvist Byggmastare, The Swedish Research Council 2009-3855, and Stiftelsen for Synskadade i f.d. Malmohus lan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azadi S, 2006, MOL CELL NEUROSCI, V31, P759, DOI 10.1016/j.mcn.2006.01.001; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2001, INVEST OPHTH VIS SCI, V42, pS527; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Comitato A, 2014, INVEST OPHTH VIS SCI, V55, P3555, DOI 10.1167/iovs.14-13917; Dalke C, 2005, EXP EYE RES, V81, P503, DOI 10.1016/j.exer.2005.06.004; DEVENTE J, 1987, NEUROSCIENCE, V22, P361, DOI 10.1016/0306-4522(87)90226-0; Doonan F, 2003, J NEUROSCI, V23, P5723; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3; Gross OP, 2012, NEURON, V76, P370, DOI 10.1016/j.neuron.2012.07.029; Hafezi F, 1998, INVEST OPHTH VIS SCI, V39, P2239; Hamann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006616; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hao Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002065; Hauck SM, 2006, MOL CELL PROTEOMICS, V5, P324, DOI 10.1074/mcp.M500217-MCP200; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Jaumann M, 2012, NAT MED, V18, P252, DOI 10.1038/nm.2634; Joseph RM, 1996, INVEST OPHTH VIS SCI, V37, P2434; Kaur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022181; Keeler CE, 1924, P NATL ACAD SCI USA, V10, P329, DOI 10.1073/pnas.10.7.329; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Liu CD, 1999, J NEUROSCI, V19, P4778; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Marigo V, 2007, CELL CYCLE, V6, P652, DOI 10.4161/cc.6.6.4029; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Ogilvie JM, 1998, INVEST OPHTH VIS SCI, V39, P1713; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2011, HUM MOL GENET, V20, P941, DOI 10.1093/hmg/ddq539; Paquet-Durand F, 2010, J NEUROCHEM, V115, P930, DOI 10.1111/j.1471-4159.2010.06983.x; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rubakhin SS, 2013, CURR OPIN BIOTECH, V24, P95, DOI 10.1016/j.copbio.2012.10.021; Sahaboglu A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.12; Sahaboglu A, 2014, ADV EXP MED BIOL, V801, P463, DOI 10.1007/978-1-4614-3209-8_59; Sahaboglu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015495; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SANYAL S, 1973, Z ANAT ENTWICKLUNGS, V142, P219, DOI 10.1007/BF00519723; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; Shinde VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033266; Steinberg R. H., 1996, Investigative Ophthalmology and Visual Science, V37, pS698; Tiwari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059306; Trifunovic D, 2012, CURR MOL MED, V12, P598, DOI 10.2174/156652412800620048; Trifunovic D, 2010, J COMP NEUROL, V518, P3604, DOI 10.1002/cne.22416; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246; Yoshizawa K, 2002, GRAEF ARCH CLIN EXP, V240, P214, DOI 10.1007/s00417-002-0427-5; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P964, DOI 10.1167/iovs.03-0439	63	134	136	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112142	10.1371/journal.pone.0112142	http://dx.doi.org/10.1371/journal.pone.0112142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392995	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300035
J	Homs, M; Caballero, A; Gregori, J; Tabernero, D; Quer, J; Nieto, L; Esteban, R; Buti, M; Rodriguez-Frias, F				Homs, Maria; Caballero, Andrea; Gregori, Josep; Tabernero, David; Quer, Josep; Nieto, Leonardo; Esteban, Rafael; Buti, Maria; Rodriguez-Frias, Francisco			Clinical Application of Estimating Hepatitis B Virus Quasispecies Complexity by Massive Sequencing: Correlation between Natural Evolution and On-Treatment Evolution	PLOS ONE			English	Article							ANTIGEN SEROCONVERSION; CORE ANTIGEN; INFECTION; MUTATIONS; NUCLEOSIDE; NUCLEOTIDE; DIVERSITY; DYNAMICS; EPITOPES; THERAPY	Aim: To evaluate HBV quasispecies (QA) complexity in the preCore/Core regions in relation to HBeAg status, and explore QA changes under natural evolution and nucleoside analogue (NUC) treatment. Methods: Ultra-deep pyrosequencing of HBV preCore/Core regions in 30 sequential samples (baseline [ diagnosis], treatment-free, and treatment-nonresponse) from 10 retrospectively selected patients grouped according to HBeAg status over time: HBeAg+ (N = 4), HBeAg-(N = 2), and fluctuating HBeAg (transient seroreversion/seroconversion pattern) (N = 4). QA complexity was defined by Shannon entropy, mutation frequency, nucleotide diversity, and mutation frequency of amino acids (MfAA) in preCore and Core. Results: The QA was less complex in HBeAg+ than in HBeAg-or fluctuating HBeAg. High complexity in preCore was associated with decreased viral replication (preCore MfAA negatively correlated with HBV-DNA, p = 0.005). QA complexity in the treatment-free period negatively correlated with values seen during treatment. Specific variants were mainly selected in the Core region in HBeAg- and fluctuating HBeAg patients, suggesting higher immune pressure than in HBeAg+. Conclusions: The negative correlation between QA natural evolution and on-treatment evolution indicates the importance of pre-treatment QA study to predict QA changes in NUC nonresponders. Study of QA complexity could be useful for managing HBV infection.	[Homs, Maria; Gregori, Josep; Tabernero, David; Quer, Josep; Esteban, Rafael; Buti, Maria; Rodriguez-Frias, Francisco] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Homs, Maria; Caballero, Andrea; Tabernero, David; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Biochem, Liver Pathol Unit, E-08193 Barcelona, Spain; [Homs, Maria; Caballero, Andrea; Tabernero, David; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Microbiol, Liver Pathol Unit, E-08193 Barcelona, Spain; [Homs, Maria; Tabernero, David; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Microbiol, Virol Unit, E-08193 Barcelona, Spain; [Gregori, Josep; Quer, Josep] Hosp Valle De Hebron, Res Inst, Barcelona, Spain; [Esteban, Rafael; Buti, Maria] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Internal Med, Liver Unit, E-08193 Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Rodriguez-Frias, F (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain.	frarodri@vhebron.net	Quer, Josep/A-6741-2012; Rodriguez-Frias, Francisco/AAC-3507-2020; Gregori, Josep/J-2586-2015; Tabernero, David/AAB-3848-2019	Quer, Josep/0000-0003-0014-084X; Gregori, Josep/0000-0002-4253-8015; Tabernero, David/0000-0002-1146-4084; rodriguez-frias, francisco/0000-0002-9128-7013; Nieto, Leonardo/0000-0002-1336-5645; Buti Ferret, Maria/0000-0002-0732-3078; Homs, Maria/0000-0002-8370-8375; esteban, rafael/0000-0001-5280-392X; CABALLERO, ANDREA/0000-0003-2891-6347	Instituto de Salud Carlos III [PI12/01893]; European Regional Development Fund (ERDF)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission)	This study was funded by Instituto de Salud Carlos III (grant PI12/01893), cofinanced by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belnap DM, 2003, P NATL ACAD SCI USA, V100, P10884, DOI 10.1073/pnas.1834404100; Boni C, 2012, GASTROENTEROLOGY, V143, P963, DOI 10.1053/j.gastro.2012.07.014; Cabot B, 2000, J VIROL, V74, P805, DOI 10.1128/JVI.74.2.805-811.2000; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Cheng Y, 2013, GUT, V62, P1347, DOI 10.1136/gutjnl-2012-302408; Cheng Y, 2013, J HEPATOL, V58, P217, DOI 10.1016/j.jhep.2012.09.017; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Gregori J, 2014, BIOINFORMATICS, V30, P1104, DOI 10.1093/bioinformatics/btt768; Gregori J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083361; Homs M, 2012, WORLD J GASTROENTERO, V18, P6096, DOI 10.3748/wjg.v18.i42.6096; Homs M, 2011, NUCLEIC ACIDS RES, V39, P8457, DOI 10.1093/nar/gkr451; Homs M, 2011, ANTIVIR THER, V16, P37, DOI 10.3851/IMP1701; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Kidd-Ljunggren K, 2002, J GEN VIROL, V83, P1267, DOI 10.1099/0022-1317-83-6-1267; Lavocat F, 2013, J HEPATOL, V59, P684, DOI 10.1016/j.jhep.2013.05.038; Lim SG, 2007, GASTROENTEROLOGY, V133, P951, DOI 10.1053/j.gastro.2007.06.011; Liu F, 2011, GUT, V60, P1269, DOI 10.1136/gut.2010.226225; Margeridon-Thermet S, 2013, ANTIMICROB AGENTS CH, V57, P343, DOI 10.1128/AAC.01601-12; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Nasu A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024907; Nishijima N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035052; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Rodriguez-Frias F, 2013, WORLD J GASTROENTERO, V19, P6995, DOI 10.3748/wjg.v19.i41.6995; Rodriguez-Frias F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037874; RodriguezFrias F, 1995, HEPATOLOGY, V22, P1641, DOI 10.1016/0270-9139(95)90185-X; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Tedder RS, 2013, ANTIVIR THER, V18, P489, DOI 10.3851/IMP2655; Torre F, 2004, J MED VIROL, V72, P370, DOI 10.1002/jmv.20016; Wang HY, 2010, J VIROL, V84, P3454, DOI 10.1128/JVI.02164-09; Yousif M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095377	32	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112306	10.1371/journal.pone.0112306	http://dx.doi.org/10.1371/journal.pone.0112306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393280	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300050
J	Kumari, P; Choi, HL				Kumari, Priyanka; Choi, Hong L.			Seasonal Variability in Airborne Biotic Contaminants in Swine Confinement Buildings	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; CULTURE-INDEPENDENT CHARACTERIZATION; TETRACYCLINE RESISTANCE; RESPIRATORY SYMPTOMS; LIVESTOCK BUILDINGS; FARM-WORKERS; PIG; EXPOSURE; BACTERIA; DIVERSITY	Little is known about the seasonal dynamics of biotic contaminants in swine confinement buildings (SCBs). The biotic contaminants of seven SCBs were monitored during one visit in the winter and one during the summer. Paired-end Illumina sequencing of the 16S rRNA gene, V3 region, was used to examine seasonal shifts in bacterial community composition and diversity. The abundances of 16S rRNA genes and six tetracycline resistance genes (tetB, tetH, tetZ, tetO, tetQ, and tetW) were also quantified using real-time PCR. Bacterial abundances, community composition and diversity all showed strong seasonal patterns defined by winter peaks in abundance and diversity. Microclimatic variables of SCBs, particularly air speed, PM2.5 and total suspended particles (TSP) were found significantly correlated to abundances, community composition, and diversity of bacterial bioaerosols. Seasonal fluctuations were also observed for four tetracycline resistance genes, tetH, tetO, tetQ, and tetW. The frequency of occurrences of these resistance genes were significantly higher in samples collected during winter and was also significantly correlated with air speed, PM2.5 and TSP. Overall, our results indicate that biotic contaminants in SCBs exhibit seasonal trends, and these could be associated with the microclimatic variables of SCBs. The correlations established in the current study could be helpful in establishing better management strategies to minimize the potential health impacts on both livestock and humans working in this environment.	[Kumari, Priyanka; Choi, Hong L.] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea	Seoul National University (SNU)	Choi, HL (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea.	ulsoo8@snu.ac.kr		Kumari, Priyanka/0000-0001-9224-4966	Ministry of Agriculture, Food, and Rural Affairs (MAFRA) [312036-03-2-HD030]; Ministry of Trade, Industry and Energy (MOTIE) [2012-3020090040]	Ministry of Agriculture, Food, and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of Korea); Ministry of Trade, Industry and Energy (MOTIE)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) from the Ministry of Agriculture, Food, and Rural Affairs (MAFRA) through project no. 312036-03-2-HD030, and in part by Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry and Energy (MOTIE) through project no. 2012-3020090040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminov RI, 2001, APPL ENVIRON MICROB, V67, P22, DOI 10.1128/AEM.67.1.22-32.2001; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bent SJ, 2007, APPL ENVIRON MICROB, V73, P2399, DOI 10.1128/AEM.02383-06; Blake DP, 2003, J APPL MICROBIOL, V95, P428, DOI 10.1046/j.1365-2672.2003.01988.x; Cambra-Lopez M, 2010, ENVIRON POLLUT, V158, P1, DOI 10.1016/j.envpol.2009.07.011; CARPENTER GA, 1986, J AGR ENG RES, V33, P227, DOI 10.1016/S0021-8634(86)80038-5; Chang CW, 2001, APPL ENVIRON MICROB, V67, P155, DOI 10.1128/AEM.67.1.155-161.2001; Charavaryamath C, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-10; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; CHOUDAT D, 1994, SCAND J WORK ENV HEA, V20, P48, DOI 10.5271/sjweh.1429; CORMIER Y, 1990, AM IND HYG ASSOC J, V51, P304, DOI 10.1080/15298669091369709; Delsol AA, 2003, J APPL MICROBIOL, V95, P1226, DOI 10.1046/j.1365-2672.2003.02088.x; DONHAM K, 1989, BRIT J IND MED, V46, P31; Dosman JA, 2004, EUR RESPIR J, V24, P698, DOI 10.1183/09031936.04.00112102; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Forsberg KJ, 2014, NATURE, V509, P612, DOI 10.1038/nature13377; Gibbs SG, 2006, ENVIRON HEALTH PERSP, V114, P1032, DOI 10.1289/ehp.8910; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; HEEDERIK D, 1991, INT ARCH OCC ENV HEA, V62, P595, DOI 10.1007/BF00381114; Hong PY, 2012, ENVIRON MICROBIOL, V14, P1420, DOI 10.1111/j.1462-2920.2012.02726.x; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Israel-Assayag E, 2002, EUR RESPIR J, V19, P833, DOI 10.1183/09031936.02.02182001; Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Kilburn KH, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/565690; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kristiansen A, 2012, FEMS MICROBIOL ECOL, V80, P390, DOI 10.1111/j.1574-6941.2012.01305.x; Letourneau V, 2010, INT J HYG ENVIR HEAL, V213, P444, DOI 10.1016/j.ijheh.2010.09.008; Levy SB, 1999, ANTIMICROB AGENTS CH, V43, P1523, DOI 10.1128/AAC.43.6.1523; Ling AL, 2013, ENVIRON SCI TECHNOL, V47, P4046, DOI 10.1021/es400238g; Mackiewicz B, 1998, ANN AGR ENV MED, V5, P169; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; McKinney CW, 2010, ENVIRON SCI TECHNOL, V44, P6102, DOI 10.1021/es9038165; Ministry of Environment Republic of Korea, 2008, ENV STAT YB, V12; Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x; Nehme B, 2009, APPL ENVIRON MICROB, V75, P5445, DOI 10.1128/AEM.00726-09; Nonnenmann MW, 2010, J OCCUP ENVIRON HYG, V7, P693, DOI 10.1080/15459624.2010.526893; Oksanen J., 2007, COMMUN ECOL PACK, P631; ONEILL DH, 1992, J AGR ENG RES, V53, P23, DOI 10.1016/0021-8634(92)80072-Z; Otake S, 2010, VET MICROBIOL, V145, P198, DOI 10.1016/j.vetmic.2010.03.028; Pavilonis BT, 2013, ENVIRON RES, V122, P74, DOI 10.1016/j.envres.2012.12.008; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts MC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00384; Santamaria J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00252; Schinasi L, 2011, EPIDEMIOLOGY, V22, P208, DOI 10.1097/EDE.0b013e3182093c8b; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smit LAM, 2014, OCCUP ENVIRON MED, V71, P134, DOI 10.1136/oemed-2013-101485; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110	56	27	32	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112897	10.1371/journal.pone.0112897	http://dx.doi.org/10.1371/journal.pone.0112897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393011	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300120
J	Woitek, R; Dvorak, A; Weber, M; Seidl, R; Bettelheim, D; Schopf, V; Amann, G; Brugger, PC; Furtner, J; Asenbaum, U; Prayer, D; Kasprian, G				Woitek, Ramona; Dvorak, Anton; Weber, Michael; Seidl, Rainer; Bettelheim, Dieter; Schoepf, Veronika; Amann, Gabriele; Brugger, Peter C.; Furtner, Julia; Asenbaum, Ulrika; Prayer, Daniela; Kasprian, Gregor			MR-Based Morphometry of the Posterior Fossa in Fetuses with Neural Tube Defects of the Spine	PLOS ONE			English	Article							CHIARI-II MALFORMATION; COMPUTED TOMOGRAPHIC SIGNS; PRENATAL-DIAGNOSIS; BIFIDA; LEMON	Objectives: In cases of "spina bifida,'' a detailed prenatal imaging assessment of the exact morphology of neural tube defects (NTD) is often limited. Due to the diverse clinical prognosis and prenatal treatment options, imaging parameters that support the prenatal differentiation between open and closed neural tube defects (ONTDs and CNTDs) are required. This fetal MR study aims to evaluate the clivus-supraocciput angle (CSA) and the maximum transverse diameter of the posterior fossa (TDPF) as morphometric parameters to aid in the reliable diagnosis of either ONTDs or CNTDs. Methods: The TDPF and the CSA of 238 fetuses (20-37 GW, mean: 28.36 GW) with a normal central nervous system, 44 with ONTDS, and 13 with CNTDs (18-37 GW, mean: 24.3 GW) were retrospectively measured using T2-weighted 1.5 Tesla MR sequences. Results: Normal fetuses showed a significant increase in the TDPF (r = .956; p<.001) and CSA (r = .714; p<.001) with gestational age. In ONTDs the CSA was significantly smaller (p<.001) than in normal controls and CNTDs, whereas in CNTDs the CSA was not significantly smaller than in controls (p = .160). In both ONTDs and in CNTDs the TDPF was significantly different from controls (p<.001). Conclusions: The skull base morphology in fetuses with ONTDs differs significantly from cases with CNTDs and normal controls. This is the first study to show that the CSA changes during gestation and that it is a reliable imaging biomarker to distinguish between ONTDs and CNTDs, independent of the morphology of the spinal defect.	[Woitek, Ramona; Weber, Michael; Schoepf, Veronika; Furtner, Julia; Asenbaum, Ulrika; Prayer, Daniela; Kasprian, Gregor] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy Med, Vienna, Austria; [Dvorak, Anton] Publ Hosp Wiener Neustadt, Wiener Neustadt, Austria; [Seidl, Rainer] Med Univ Vienna, Dept Paediat & Adolescent Med, Vienna, Austria; [Bettelheim, Dieter] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Amann, Gabriele] Med Univ Vienna, Dept Clin Pathol, Vienna, Austria; [Brugger, Peter C.] Med Univ Vienna, Ctr Anat & Cell Biol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Woitek, R (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy Med, Vienna, Austria.	ramona.woitek@meduniwien.ac.at	Weber, Michael/L-9836-2016; Kasprian, Gregor/AAJ-5052-2020	Weber, Michael/0000-0002-8507-2219; Kasprian, Gregor/0000-0003-3858-3347; Woitek, Ramona/0000-0002-9146-9159; Schopf, Veronika/0000-0003-1937-4216; Furtner, Julia/0000-0001-8258-3681	Austrian National Bank ("Quantitative Morphometrie der fetalen Gehirnentwicklung fur Pathologiemodellierung und Diagnose'') [OeNB 14812]	Austrian National Bank ("Quantitative Morphometrie der fetalen Gehirnentwicklung fur Pathologiemodellierung und Diagnose'')	Funding was supported by the Austrian National Bank (OeNB 14812, "Quantitative Morphometrie der fetalen Gehirnentwicklung fur Pathologiemodellierung und Diagnose''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMPBELL J, 1987, OBSTET GYNECOL, V70, P247; Chaoui R, 2009, ULTRASOUND OBST GYN, V34, P249, DOI 10.1002/uog.7329; Chen SC, 2006, RADIOLOGY, V238, P997, DOI 10.1148/radiol.2383041283; D'Addario V, 2001, ULTRASOUND OBST GYN, V18, P146, DOI 10.1046/j.1469-0705.2001.00409.x; D'Addario V, 2008, J PERINAT MED, V36, P330, DOI 10.1515/JPM.2008.052; Fujisawa H, 2006, ACTA OBSTET GYN SCAN, V85, P1426, DOI 10.1080/00016340600645602; Grant RA, 2011, J NEUROSURG-PEDIATR, V7, P362, DOI 10.3171/2011.1.PEDS10234; Lachmann R, 2011, PRENATAL DIAG, V31, P103, DOI 10.1002/pd.2632; McLone DG, 2003, CHILD NERV SYST, V19, P540, DOI 10.1007/s00381-003-0792-3; MCLONE DG, 1989, PEDIATR NEUROSCI, V15, P1, DOI 10.1159/000120432; NAIDICH TP, 1980, RADIOLOGY, V134, P391, DOI 10.1148/radiology.134.2.7352218; NAIDICH TP, 1983, NEURORADIOLOGY, V25, P179, DOI 10.1007/BF00540232; NAIDICH TP, 1980, RADIOLOGY, V134, P657, DOI 10.1148/radiology.134.3.6965544; NAIDICH TP, 1980, RADIOLOGY, V134, P65, DOI 10.1148/radiology.134.1.7350637; Nishino A, 1998, SURG NEUROL, V49, P269, DOI 10.1016/S0090-3019(97)00180-8; Prayer D, 2004, PEDIATR RADIOL, V34, P685, DOI 10.1007/s00247-004-1246-0; Safra N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003646; Sarnat HB, 2008, HAND CLINIC, V87, P89, DOI 10.1016/S0072-9752(07)87006-0; Sarnat HB, 2004, PEDIATR DEVEL PATHOL, V7, P48, DOI 10.1007/s10024-003-2127-5; Stevenson Kevin L, 2004, Neurosurg Focus, V16, pE5; Thomas M, 2003, RADIOLOGY, V228, P206, DOI 10.1148/radiol.2281020448; Tortori-Donati P, 2005, PEDIAT NEURORADIOLOG; VANDENHOF MC, 1990, AM J OBSTET GYNECOL, V162, P322, DOI 10.1016/0002-9378(90)90378-K	23	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112585	10.1371/journal.pone.0112585	http://dx.doi.org/10.1371/journal.pone.0112585			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393279	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300075
J	Andolfi, L; Bourkoula, E; Migliorini, E; Palma, A; Pucer, A; Skrap, M; Scoles, G; Beltrami, AP; Cesselli, D; Lazzarino, M				Andolfi, Laura; Bourkoula, Eugenia; Migliorini, Elisa; Palma, Anita; Pucer, Anja; Skrap, Miran; Scoles, Giacinto; Beltrami, Antonio Paolo; Cesselli, Daniela; Lazzarino, Marco			Investigation of Adhesion and Mechanical Properties of Human Glioma Cells by Single Cell Force Spectroscopy and Atomic Force Microscopy	PLOS ONE			English	Article							LOW-GRADE GLIOMAS; CYTOSKELETON ORGANIZATION; CANCER; RECOGNITION; MANAGEMENT; MOTILITY	Active cell migration and invasion is a peculiar feature of glioma that makes this tumor able to rapidly infiltrate into the surrounding brain tissue. In our recent work, we identified a novel class of glioma-associated-stem cells (defined as GASC for high-grade glioma -HG-and Gasc for low-grade glioma -LG-) that, although not tumorigenic, act supporting the biological aggressiveness of glioma-initiating stem cells (defined as GSC for HG and Gsc for LG) favoring also their motility. Migrating cancer cells undergo considerable molecular and cellular changes by remodeling their cytoskeleton and cell interactions with surrounding environment. To get a better understanding about the role of the glioma-associated-stem cells in tumor progression, cell deformability and interactions between glioma-initiating stem cells and glioma-associated-stem cells were investigated. Adhesion of HG/LG-cancer cells on HG/LG-glioma-associated stem cells was studied by time-lapse microscopy, while cell deformability and cell-cell adhesion strengths were quantified by indentation measurements by atomic force microscopy and single cell force spectroscopy. Our results demonstrate that for both HG and LG glioma, cancer-initiatingstem cells are softer than glioma-associated-stem cells, in agreement with their neoplastic features. The adhesion strength of GSC on GASC appears to be significantly lower than that observed for Gsc on Gasc. Whereas, GSC spread and firmly adhere on Gasc with an adhesion strength increased as compared to that obtained on GASC. These findings highlight that the grade of glioma-associated-stem cells plays an important role in modulating cancer cell adhesion, which could affect glioma cell migration, invasion and thus cancer aggressiveness. Moreover this work provides evidence about the importance of investigating cell adhesion and elasticity for new developments in disease diagnostics and therapeutics.	[Andolfi, Laura; Lazzarino, Marco] CNR, Ist Officina Mat, Trieste, Italy; [Bourkoula, Eugenia; Palma, Anita; Pucer, Anja; Skrap, Miran; Scoles, Giacinto; Beltrami, Antonio Paolo; Cesselli, Daniela] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy; [Migliorini, Elisa; Pucer, Anja] Univ Grenoble 1, Dept Chim Mol Ingn & Interact Bio Mol, Grenoble, France; [Lazzarino, Marco] Cluster Biomed, Trieste, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Udine; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Andolfi, L (corresponding author), CNR, Ist Officina Mat, Trieste, Italy.	andolfi@iom.cnr.it	skrap, miran/AAB-1708-2022; Beltrami, Antonio/C-5291-2008; Andolfi, Laura/AAC-3357-2022; Migliorini, Elisa/AFU-5371-2022; Palma, Anita/K-7656-2016; Lazzarino, Marco/AAC-3446-2022; Migliorini, Elisa/O-7065-2019	skrap, miran/0000-0002-6592-6416; Beltrami, Antonio/0000-0002-0679-2710; Migliorini, Elisa/0000-0003-3264-2027; Palma, Anita/0000-0002-5971-3676; Migliorini, Elisa/0000-0003-3264-2027; Lazzarino, Marco/0000-0003-1077-6569; Andolfi, Laura/0000-0001-6380-6747; Cesselli, Daniela/0000-0002-0562-7852	European Union [270483]; FIRB Accordi di programma; ERC- 7FP SP 2 IDEAS QUIDPROQUO G.A. [269051]; AIRC 5 per mille Special program [12214]; Programma per la Cooperazione Transfrontaliera Italia-Slovenia;  [RBAP11Z4Z9]	European Union(European Commission); FIRB Accordi di programma(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); ERC- 7FP SP 2 IDEAS QUIDPROQUO G.A.; AIRC 5 per mille Special program(Fondazione AIRC per la ricerca sul cancro); Programma per la Cooperazione Transfrontaliera Italia-Slovenia; 	This work was supported by: European Union Seventh Framework Programme (FP7/2007-2013) no270483 FP7 ICT - FOCUS Single Molecule Activation and Computing; FIRB Accordi di programma 2011; title: "FIERCE - Find nEw moleculaR and CEllular targets against cancer'', Pr. RBAP11Z4Z9. 2012-2014; FIRB accordi di programma 2011 pr. RBAP11ETKA_007 "Nanotechnological approaches for tumor theragnostic''; Programma per la Cooperazione Transfrontaliera Italia-Slovenia 2007-2013, title: "Identificazione di nuovi marcatori di cellule staminali tumorali a scopo diagnostico e terapeutico''; AIRC 5 per mille Special program 2011, Pr. 12214, title: "Application of Advanced Nanotechnology in the Development of Cancer Diagnostics Tools''; Project ERC- 7FP SP 2 IDEAS QUIDPROQUO G.A. n. 269051, title: "Molecular nanotechnology for life science applications: quantitative interactomics for diagnostics, proteomics and quantitative oncology''. The funders had no role in the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rekabi Z, 2014, EXP CELL RES, V322, P21, DOI 10.1016/j.yexcr.2013.12.027; Albuschies J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01658; Bourkoula E, 2014, STEM CELLS, V32, P1239, DOI 10.1002/stem.1605; Bourne TD, 2010, NAT REV NEUROL, V6, P695, DOI 10.1038/nrneurol.2010.159; Dao L, 2012, EXP CELL RES, V318, P2155, DOI 10.1016/j.yexcr.2012.06.017; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006; Duffau H, 2009, CURR OPIN ONCOL, V21, P543, DOI 10.1097/CCO.0b013e3283305996; Efremov YM, 2013, J BIOMECH, V46, P1081, DOI 10.1016/j.jbiomech.2013.01.022; Franz CM, 2008, CELL MOL BIOENG, V1, P289, DOI 10.1007/s12195-008-0037-3; Friedrichs J, 2013, METHODS, V60, P169, DOI 10.1016/j.ymeth.2013.01.006; Helenius J, 2008, J CELL SCI, V121, P1785, DOI 10.1242/jcs.030999; Hills CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071819; Hosseini BH, 2009, P NATL ACAD SCI USA, V106, P17852, DOI 10.1073/pnas.0905384106; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; Kislin KL, 2009, NEOPLASIA, V11, P377, DOI 10.1593/neo.81572; Lekka M, 2012, MICRON, V43, P1259, DOI 10.1016/j.micron.2012.01.019; Lim TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045185; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mescola A, 2012, J MOL RECOGNIT, V25, P270, DOI 10.1002/jmr.2173; Migliorini E, 2013, BIOTECHNOL BIOENG, V110, P2301, DOI 10.1002/bit.24880; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Petrie JR, 2009, J CELL SCI, V125, P5917; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Plodinec M, 2012, NAT NANOTECHNOL, V7, P757, DOI [10.1038/nnano.2012.167, 10.1038/NNANO.2012.167]; Pogoda K, 2012, EUR BIOPHYS J BIOPHY, V41, P79, DOI 10.1007/s00249-011-0761-9; Prabhune M, 2012, MICRON, V43, P1267, DOI 10.1016/j.micron.2012.03.023; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Sanai N, 2011, J NEUROSURG, V115, P948, DOI [10.3171/2011.7.JNS101238, 10.3171/2011.7.JNS10238]; Sariisik E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057706; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Soffietti R, 2010, EUR J NEUROL, V17, P1124, DOI 10.1111/j.1468-1331.2010.03151.x; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Taubenberger A, 2007, MOL BIOL CELL, V18, P1634, DOI 10.1091/mbc.E06-09-0777; Tulla M, 2008, FEBS LETT, V582, P3520, DOI 10.1016/j.febslet.2008.09.022; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139	44	37	39	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112582	10.1371/journal.pone.0112582	http://dx.doi.org/10.1371/journal.pone.0112582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390644	Green Submitted, Green Published, gold			2022-12-26	WOS:000349144400104
J	Izzo, NJ; Staniszewski, A; To, L; Fa, M; Teich, AF; Saeed, F; Wostein, H; Walko, T; Vaswani, A; Wardius, M; Syed, Z; Ravenscroft, J; Mozzoni, K; Silky, C; Rehak, C; Yurko, R; Finn, P; Look, G; Rishton, G; Safferstein, H; Miller, M; Johanson, C; Stopa, E; Windisch, M; Hutter-Paier, B; Shamloo, M; Arancio, O; LeVine, H; Catalano, SM				Izzo, Nicholas J.; Staniszewski, Agnes; To, Lillian; Fa, Mauro; Teich, Andrew F.; Saeed, Faisal; Wostein, Harrison; Walko, Thomas, III; Vaswani, Anisha; Wardius, Meghan; Syed, Zanobia; Ravenscroft, Jessica; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Finn, Patricia; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Miller, Miles; Johanson, Conrad; Stopa, Edward; Windisch, Manfred; Hutter-Paier, Birgit; Shamloo, Mehrdad; Arancio, Ottavio; LeVine, Harry, III; Catalano, Susan M.			Alzheimer's Therapeutics Targeting Amyloid Beta 1-42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits	PLOS ONE			English	Article							INDUCED SYNAPTIC DEPRESSION; CELLULAR PRION PROTEIN; A-BETA; MOUSE MODEL; HUMAN BRAIN; FORMAZAN EXOCYTOSIS; HIPPOCAMPAL-NEURONS; BEHAVIORAL DEFICITS; NATURAL OLIGOMERS; SPINE NUMBER	Synaptic dysfunction and loss caused by age-dependent accumulation of synaptotoxic beta amyloid (Abeta) 1-42 oligomers is proposed to underlie cognitive decline in Alzheimer's disease (AD). Alterations in membrane trafficking induced by Abeta oligomers mediates reduction in neuronal surface receptor expression that is the basis for inhibition of electrophysiological measures of synaptic plasticity and thus learning and memory. We have utilized phenotypic screens in mature, in vitro cultures of rat brain cells to identify small molecules which block or prevent the binding and effects of Abeta oligomers. Synthetic Abeta oligomers bind saturably to a single site on neuronal synapses and induce deficits in membrane trafficking in neuronal cultures with an EC50 that corresponds to its binding affinity. The therapeutic lead compounds we have found are pharmacological antagonists of Abeta oligomers, reducing the binding of Abeta oligomers to neurons in vitro, preventing spine loss in neurons and preventing and treating oligomer-induced deficits in membrane trafficking. These molecules are highly brain penetrant and prevent and restore cognitive deficits in mouse models of Alzheimer's disease. Counter-screening these compounds against a broad panel of potential CNS targets revealed they are highly potent and specific ligands of the sigma-2/PGRMC1 receptor. Brain concentrations of the compounds corresponding to greater than 80% receptor occupancy at the sigma-2/PGRMC1 receptor restore cognitive function in transgenic hAPP Swe/Ldn mice. These studies demonstrate that synthetic and human-derived Abeta oligomers act as pharmacologically-behaved ligands at neuronal receptors -i.e. they exhibit saturable binding to a target, they exert a functional effect related to their binding and their displacement by small molecule antagonists blocks their functional effect. The first-in-class small molecule receptor antagonists described here restore memory to normal in multiple AD models and sustain improvement long-term, representing a novel mechanism of action for disease-modifying Alzheimer's therapeutics.	[Izzo, Nicholas J.; Wostein, Harrison; Walko, Thomas, III; Vaswani, Anisha; Wardius, Meghan; Syed, Zanobia; Ravenscroft, Jessica; Mozzoni, Kelsie; Silky, Colleen; Rehak, Courtney; Yurko, Raymond; Finn, Patricia; Look, Gary; Rishton, Gilbert; Safferstein, Hank; Catalano, Susan M.] Cognit Therapeut Inc, Pittsburgh, PA 15203 USA; [LeVine, Harry, III] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Miller, Miles; Johanson, Conrad; Stopa, Edward] Brown Univ, Warren Alpert Med Sch, Dept Pathol & Neurosurg, Providence, RI 02912 USA; [To, Lillian] Stanford Univ, Sch Med, Behav & Funct Neurosci Lab, Palo Alto, CA 94304 USA; [Windisch, Manfred] GmbH, NeuroScios, Graz, Austria; [Hutter-Paier, Birgit] QPS Austria, GmbH, Graz, Austria; [Staniszewski, Agnes; Fa, Mauro; Teich, Andrew F.; Saeed, Faisal; Arancio, Ottavio] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Staniszewski, Agnes; Fa, Mauro; Teich, Andrew F.; Saeed, Faisal; Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	University of Kentucky; Brown University; Stanford University; Columbia University; Columbia University	Izzo, NJ (corresponding author), Cognit Therapeut Inc, Pittsburgh, PA 15203 USA.	nizzo@cogrx.com	arancio, ottavio/AAB-7959-2019; Fà, Mauro/AAH-2749-2020	Fà, Mauro/0000-0002-8348-0382; Saeed, Faisal/0000-0003-1194-2792; arancio, ottavio/0000-0001-6335-164X; Teich, Andrew/0000-0002-1916-8490; Izzo, Nicholas/0000-0002-0196-2055; Johanson, Conrad/0000-0002-1297-5484; Catalano, Susan/0000-0001-7278-3233	National Institute on Aging [SC AG-37337]; National Institute of Neurological Diseases and Stroke [SC AG-37337, NS-083175, NS-49442]; Alzheimer's Drug Discovery Foundation [20100501]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049442, R43NS083175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R43AG037337] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by the National Institute on Aging [http://www.nia.nih.gov/]; (SC AG-37337), the National Institute of Neurological Diseases and Stroke [http://www.ninds.nih.gov/]; (SC, NS-083175; OA, NS-49442), and the Alzheimer's Drug Discovery Foundation [http://www.alzfdn.org]; (SC, 20100501). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao FX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.003; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Brody DL, 2008, SCIENCE, V321, P1221, DOI 10.1126/science.1161591; Calabrese B, 2007, MOL CELL NEUROSCI, V35, P183, DOI 10.1016/j.mcn.2007.02.006; Catalano SM, 2006, CURR TOP MED CHEM, V6, P597, DOI 10.2174/156802606776743066; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Faizi M, 2012, BRAIN BEHAV, V2, P142, DOI 10.1002/brb3.41; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fenili D, 2007, J MOL MED, V85, P603, DOI 10.1007/s00109-007-0156-7; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Fowler SW, 2014, J NEUROSCI, V34, P7871, DOI 10.1523/JNEUROSCI.0572-14.2014; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; Gortz P, 2004, BRAIN RES, V1018, P18, DOI 10.1016/j.brainres.2004.05.076; Haes AJ, 2005, J AM CHEM SOC, V127, P2264, DOI 10.1021/ja044087q; Havas D, 2011, J ALZHEIMERS DIS, V25, P231, DOI 10.3233/JAD-2011-101866; Herskovits AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067898; Hong HS, 2007, BRAIN RES, V1130, P223, DOI 10.1016/j.brainres.2006.10.093; Hong HS, 2009, J NEUROCHEM, V108, P1097, DOI 10.1111/j.1471-4159.2008.05866.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Izzo NJ, 2014, PLOS ONE, V10; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kam TI, 2013, J CLIN INVEST, V123, P2791, DOI 10.1172/JCI66827; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kessels HW, 2013, P NATL ACAD SCI USA, V110, P4033, DOI 10.1073/pnas.1219605110; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Klyubin I, 2011, NEUROBIOL AGING, V32, P614, DOI 10.1016/j.neurobiolaging.2009.04.005; KORNHUBER J, 1995, NEUROSCI LETT, V195, P137, DOI 10.1016/0304-3940(95)11785-U; Kreutzmann P, 2010, CELL MOL NEUROBIOL, V30, P979, DOI 10.1007/s10571-010-9528-6; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lesne Sylvain E, 2013, Int J Cell Biol, V2013, P950783, DOI 10.1155/2013/950783; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; LeVine H, 2004, ANAL BIOCHEM, V335, P81, DOI 10.1016/j.ab.2004.08.014; Liu Y., 1997, CHIN J VET MED, V2, P4; Liu YB, 2004, J NEUROCHEM, V91, P648, DOI 10.1111/j.1471-4159.2004.02751.x; Maezawa I, 2006, J NEUROCHEM, V98, P57, DOI 10.1111/j.1471-4159.2006.03862.x; Marcello E, 2008, EUR J PHARMACOL, V585, P109, DOI 10.1016/j.ejphar.2007.11.083; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Price P.J., 2001, PROTOCOLS NEURAL CEL, P255, DOI 10.1385/1-59259-207-4:255; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rana S, 2009, BIOORG MED CHEM LETT, V19, P670, DOI 10.1016/j.bmcl.2008.12.060; Reed MN, 2011, NEUROBIOL AGING, V32, P1784, DOI 10.1016/j.neurobiolaging.2009.11.007; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Ronicke R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003236; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shankar GM, 2009, NEUROBIOL DIS, V36, P293, DOI 10.1016/j.nbd.2009.07.021; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Shrestha BR, 2006, MOL CELL NEUROSCI, V33, P274, DOI 10.1016/j.mcn.2006.07.011; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Torre V, 1998, NEURAL CIRCUITS NETW, pviii; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Weidner AM, 2011, NEUROSCI LETT, V497, P1, DOI 10.1016/j.neulet.2011.03.082; Yamamoto N, 2007, J BIOL CHEM, V282, P2646, DOI 10.1074/jbc.M606202200; Yang T, 2013, ALZHEIMERS DEMENT, V9, P99, DOI 10.1016/j.jalz.2012.11.005; Zempel H, 2013, EMBO J, V32, P2920, DOI 10.1038/emboj.2013.207; Zempel H, 2012, NEURODEGENER DIS, V10, P64, DOI 10.1159/000332816; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	74	99	103	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111898	10.1371/journal.pone.0111898	http://dx.doi.org/10.1371/journal.pone.0111898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390368	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400037
J	Lerner, N; Beit-Yannai, E				Lerner, Natalie; Beit-Yannai, Elie			Cross-Talk between Ciliary Epithelium and Trabecular Meshwork Cells In-Vitro: A New Insight into Glaucoma	PLOS ONE			English	Article							AQUEOUS-HUMOR SECRETION; NECROSIS-FACTOR-ALPHA; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; OKADAIC ACID; MAP KINASES; ACTIVATION; INDUCTION	Purpose: It is assumed that the non-pigmented ciliary epithelium plays a role in regulating intraocular pressure via its neuroendocrine activities. To test this hypothesis, we investigated the effect on a human trabecular meshwork (TM) cell line (NTM) of co-culture with a human non-pigmented ciliary epithelium cell line (ODM-2). Methods: The cellular cross-talk between ODM-2 and NTM cells was studied in a co-culture system in which the two cell types were co-cultured for 5 to 60 min or 2, 4 and 8 h and then removed from the co-culture and analyzed. Analyses of the ERK and p38 mitogen-activated protein kinase (MAPK) pathways and of the activity of TM phosphatases and matrix metalloproteins (MMPs) were performed. Acid and alkaline phosphatase activity was determined by the DiFMUP (6, 8-difluoro-4-methylumbelliferyl phosphate) assay. MMP levels were determined by gelatin zymography. Results: Exposure of NTM cells to ODM-2 cells led to the activation of the MAPK signal transduction pathways in NTM cells within 5 min of co-culture. Phosphorylation of ERK1/ERK2 and p38 peaked at 10 and 15 min and then decreased over time. Interaction between ODM-2 and NTM cells promoted the expression of MMP-9 in the NTM cells after 4 h of co-culture. Conclusions: Our findings provide support for the hypothesis that crosstalk does indeed take place between ODM-2 and NTM cells. Future studies should be designed to determine the relationship between the MMP system, MAPK kinases and phosphatases. Manipulation of these signaling molecules and the related NTM signal transduction pathways may provide targets for developing improved treatments for glaucoma.	[Lerner, Natalie; Beit-Yannai, Elie] Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel	Ben Gurion University	Beit-Yannai, E (corresponding author), Ben Gurion Univ Negev, Dept Clin Biochem & Pharmacol, IL-84105 Beer Sheva, Israel.	bye@bgu.ac.il		Beit-Yannai, Elie/0000-0001-9347-822X				ALEXANDER JP, 1991, INVEST OPHTH VIS SCI, V32, P172; Aslan M, 2008, FREE RADICAL BIO MED, V45, P367, DOI 10.1016/j.freeradbiomed.2008.04.026; Beit-Yannai E, 2007, MED HYPOTHESES, V68, P299, DOI 10.1016/j.mehy.2006.05.067; Borkenstein A, 2013, MOL VIS, V19, P2306; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chang EE, 2012, OPHTHALMOLOGY, V119, P979, DOI 10.1016/j.ophtha.2011.11.003; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; COCAPRADOS M, 1986, P NATL ACAD SCI USA, V83, P8754, DOI 10.1073/pnas.83.22.8754; Dahlmann-Noor AH, 2010, DRUG DISCOV TODAY, V15, P287, DOI 10.1016/j.drudis.2010.02.007; De Groef L, 2013, INVEST OPHTH VIS SCI, V54, P7756, DOI 10.1167/iovs.13-13088; Garcia L, 2002, FEBS LETT, V523, P90, DOI 10.1016/S0014-5793(02)02950-2; GHOSH S, 1991, J CELL PHYSIOL, V149, P184, DOI 10.1002/jcp.1041490203; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Halliwell B, 2011, TRENDS PHARMACOL SCI, V32, P125, DOI 10.1016/j.tips.2010.12.002; Hashimoto A, 2005, BRAIN RES, V1033, P210, DOI 10.1016/j.brainres.2004.11.031; HOLLADAY K, 1992, MOL CARCINOGEN, V5, P16, DOI 10.1002/mc.2940050106; Hosseini M, 2006, INVEST OPHTH VIS SCI, V47, P1469, DOI 10.1167/iovs.05-0451; Huang Ping, 2009, J Ocul Biol Dis Infor, V2, P98; Inoue T, 2013, PROG RETIN EYE RES, V37, P1, DOI 10.1016/j.preteyeres.2013.05.002; Johnson TV, 2013, CURR OPIN PHARMACOL, V13, P78, DOI 10.1016/j.coph.2012.08.003; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Latarya G, 2012, INVEST OPHTH VIS SCI, V53, P1679, DOI 10.1167/iovs.11-9120; Li DQ, 2006, EXP EYE RES, V82, P588, DOI 10.1016/j.exer.2005.08.019; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Loeser RF, 2008, CURR OPIN RHEUMATOL, V20, P581, DOI 10.1097/BOR.0b013e3283090463; Marchenko ND, 2004, INT J BIOCHEM CELL B, V36, P942, DOI 10.1016/j.biocel.2003.12.007; MARTINVASALLO P, 1989, J CELL PHYSIOL, V141, P243, DOI 10.1002/jcp.1041410203; McKinnon Stuart J, 2008, Am J Manag Care, V14, pS20; Oh DJ, 2013, INVEST OPHTH VIS SCI, V54, P3309, DOI 10.1167/iovs.12-11362; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398; Pufe T, 2004, J PATHOL, V202, P367, DOI 10.1002/path.1527; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rao PV, 2014, J OCUL PHARMACOL TH, V30, P181, DOI 10.1089/jop.2013.0194; Rhim E.-M., 2011, J KOREAN ACAD CONSER, V36, P26, DOI [10.5395/JKACD.2011.36.1.26, DOI 10.5395/JKACD.2011.36.1.26]; Rietz A, 2012, BRIT J PHARMACOL, V166, P1225, DOI 10.1111/j.1476-5381.2012.01917.x; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Sanka K, 2007, INVEST OPHTH VIS SCI, V48, P2105, DOI 10.1167/iovs.06-1089; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; Sehgal I, 1998, CANCER RES, V58, P4288; Shmulevich A, 2009, CURR EYE RES, V34, P466, DOI 10.1080/02713680902916090; Stamer WD, 2011, J PROTEOMICS, V74, P796, DOI 10.1016/j.jprot.2011.02.024; Strouthidis NG, 2013, CURR OPIN PHARMACOL, V13, P83, DOI 10.1016/j.coph.2012.09.001; Takai Y, 2012, INVEST OPHTH VIS SCI, V53, P241, DOI 10.1167/iovs.11-8434; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Wang SK, 2014, CLIN OPHTHALMOL, V8, P883, DOI 10.2147/OPTH.S41000; WESTERMARCK J, 1994, CELL GROWTH DIFFER, V5, P1205; Wiederholt M, 1998, INVEST OPHTH VIS SCI, V39, P1012; Zhang X, 2006, EXP EYE RES, V82, P968, DOI 10.1016/j.exer.2005.11.001	50	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112259	10.1371/journal.pone.0112259	http://dx.doi.org/10.1371/journal.pone.0112259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389776	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400065
J	Ma, P; Gu, B; Xiong, W; Tan, BS; Geng, W; Li, J; Liu, HC				Ma, Pan; Gu, Bin; Xiong, Wei; Tan, Baosheng; Geng, Wei; Li, Jun; Liu, Hongchen			Glimepiride Promotes Osteogenic Differentiation in Rat Osteoblasts via the PI3K/Akt/eNOS Pathway in a High Glucose Microenvironment	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VEIN ENDOTHELIAL-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; INDUCED APOPTOSIS; CULTURED HUMAN; B ACTIVATION; KINASE-B; BONE; INSULIN; PROLIFERATION	Our previous studies demonstrated that glimepiride enhanced the proliferation and differentiation of osteoblasts and led to activation of the PI3K/Akt pathway. Recent genetic evidence shows that endothelial nitric oxide synthase (eNOS) plays an important role in bone homeostasis. In this study, we further elucidated the roles of eNOS, PI3K and Akt in bone formation by osteoblasts induced by glimepiride in a high glucose microenvironment. We demonstrated that high glucose (16.5 mM) inhibits the osteogenic differentiation potential and proliferation of rat osteoblasts. Glimepiride activated eNOS expression in rat osteoblasts cultured with two different concentrations of glucose. High glucose-induced osteogenic differentiation was significantly enhanced by glimepiride. Down-regulation of PI3K P85 levels by treatment with LY294002 (a PI3K inhibitor) led to suppression of P-eNOS and P-AKT expression levels, which in turn resulted in inhibition of RUNX2, OCN and ALP mRNA expression in osteoblasts induced by glimepiride at both glucose concentrations. ALP activity was partially inhibited by 10 mu M LY294002. Taken together, our results demonstrate that glimepiride-induced osteogenic differentiation of osteoblasts occurs via eNOS activation and is dependent on the PI3K/Akt signaling pathway in a high glucose microenvironment.	[Ma, Pan; Tan, Baosheng; Geng, Wei; Li, Jun] Capital Med Univ, Beijing Stomatol Hosp, Dept Oral Implantol, Beijing, Peoples R China; [Gu, Bin; Liu, Hongchen] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China; [Gu, Bin; Liu, Hongchen] Postgrad Mil Med Sch, Beijing, Peoples R China; [Xiong, Wei] Air Force Gen Hosp, Clin Aviat Med Ctr PLA, Beijing, Peoples R China	Capital Medical University; Chinese People's Liberation Army General Hospital; Air Force General Hospital PLA	Liu, HC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing 100853, Peoples R China.	liuhcpla@126.com			Beijing Capital Medical University Fund for Basic and Clinical Medicine Research [13JL83]; Beijing Stomatological Hospital of Capital Medical University Fund for Basic Research [14-09-09]	Beijing Capital Medical University Fund for Basic and Clinical Medicine Research; Beijing Stomatological Hospital of Capital Medical University Fund for Basic Research	This study was supported by Beijing Capital Medical University Fund for Basic and Clinical Medicine Research (no. 13JL83) and Beijing Stomatological Hospital of Capital Medical University Fund for Basic Research (no. 14-09-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal F, 2004, J PATHOL, V202, P503, DOI 10.1002/path.1536; Brenneisen P, 2002, BIOCHEM J, V365, P31, DOI 10.1042/BJ20020110; Chung DJ, 2013, J BONE MINER METAB, V31, P161, DOI 10.1007/s00774-012-0398-5; Das UN, 2002, EXP BIOL MED, V227, P88, DOI 10.1177/153537020222700202; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; de Paula FJA, 2010, DIABETES-METAB RES, V26, P622, DOI 10.1002/dmrr.1135; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Filippella MG, 2010, CLIN CASES MINER BON, V7, P126; Fujita T, 2004, J CELL BIOCHEM, V93, P374, DOI 10.1002/jcb.20192; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gramoun A, 2010, J CELL BIOCHEM, V111, P1020, DOI 10.1002/jcb.22791; Grassi F, 2006, ENDOCRINOLOGY, V147, P4392, DOI 10.1210/en.2006-0334; Guntur AR, 2011, J ENDOCRINOL, V211, P123, DOI 10.1530/JOE-11-0175; Helfrich MH, 1997, J BONE MINER RES, V12, P1108, DOI 10.1359/jbmr.1997.12.7.1108; Ho FM, 1999, J CELL BIOCHEM, V75, P258, DOI 10.1002/(SICI)1097-4644(19991101)75:2<258::AID-JCB8>3.0.CO;2-3; Jojima T, 2009, DIABETES OBES METAB, V11, P143, DOI 10.1111/j.1463-1326.2008.00923.x; Kurowski TG, 1999, DIABETES, V48, P658, DOI 10.2337/diabetes.48.3.658; Ma P, 2011, ARCH ORAL BIOL, V56, P307, DOI 10.1016/j.archoralbio.2010.10.009; Ma P, 2010, METABOLISM, V59, P359, DOI 10.1016/j.metabol.2009.08.003; Meng LD, 2008, ARCH PHARM RES, V31, P357, DOI [10.1007/s12272-001-1164-y, 10.1007/s00000-001-1164-y]; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Mukherjee A, 2012, MOL CELL BIOL, V32, P490, DOI 10.1128/MCB.06361-11; Muller G, 2001, BIOCHEMISTRY-US, V40, P14603, DOI 10.1021/bi0108352; Muller G, 2000, MOL MED, V6, P907, DOI 10.1007/BF03401827; Oku A, 2001, AM J PHYSIOL-ENDOC M, V280, pE816, DOI 10.1152/ajpendo.2001.280.5.E816; Rawat P, 2009, BIOORG MED CHEM LETT, V19, P4684, DOI 10.1016/j.bmcl.2009.06.074; Rodriguez E, 2004, ENDOCRINOLOGY, V145, P679, DOI 10.1210/en.2003-0755; Salani B, 2005, BIOCHEM BIOPH RES CO, V335, P832, DOI 10.1016/j.bbrc.2005.07.149; Sanchez G, 2008, CELL CYCLE, V7, P2299, DOI 10.4161/cc.6445; Saura M, 2010, THESCIENTIFICWORLDJO, V10, P624, DOI 10.1100/tsw.2010.58; Sun J, 2012, CELLS TISSUES ORGANS, V196, P510, DOI 10.1159/000339245; Thomas JE, 1997, J CELL BIOCHEM, V64, P182, DOI 10.1002/(SICI)1097-4644(199702)64:2<182::AID-JCB2>3.0.CO;2-T; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Vestergaard P, 2005, DIABETOLOGIA, V48, P1292, DOI 10.1007/s00125-005-1786-3; Wang JY, 2005, LIFE SCI, V76, P2257, DOI 10.1016/j.lfs.2004.12.003; Wei Q, 2005, J BIOL CHEM, V280, P18081, DOI 10.1074/jbc.M413607200; Zayzafoon M, 2002, J BIOL CHEM, V277, P37212, DOI 10.1074/jbc.M200129200; Zhang W, 2007, NUTRITION, V23, P762, DOI 10.1016/j.nut.2007.07.003	38	37	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112243	10.1371/journal.pone.0112243	http://dx.doi.org/10.1371/journal.pone.0112243			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391146	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400064
J	Mumm, CAS; Knornschild, M				Mumm, Christina A. S.; Knoernschild, Mirjam			The Vocal Repertoire of Adult and Neonate Giant Otters (Pteronura brasiliensis)	PLOS ONE			English	Article							COMMUNICATIVE COMPLEXITY; SOCIAL COMPLEXITY; PUP VOCALIZATIONS; RIVER OTTERS; GROUP-SIZE; BODY-SIZE; MUSTELIDAE; CARNIVORA; ORGANIZATION; EVOLUTION	Animals use vocalizations to exchange information about external events, their own physical or motivational state, or about individuality and social affiliation. Infant babbling can enhance the development of the full adult vocal repertoire by providing ample opportunity for practice. Giant otters are very social and frequently vocalizing animals. They live in highly cohesive groups, generally including a reproductive pair and their offspring born in different years. This basic social structure may vary in the degree of relatedness of the group members. Individuals engage in shared group activities and different social roles and thus, the social organization of giant otters provides a basis for complex and long-term individual relationships. We recorded and analysed the vocalizations of adult and neonate giant otters from wild and captive groups. We classified the adult vocalizations according to their acoustic structure, and described their main behavioural context. Additionally, we present the first description of vocalizations uttered in babbling bouts of new born giant otters. We expected to find 1) a sophisticated vocal repertoire that would reflect the species' complex social organisation, 2) that giant otter vocalizations have a clear relationship between signal structure and function, and 3) that the vocal repertoire of new born giant otters would comprise agespecific vocalizations as well as precursors of the adult repertoire. We found a vocal repertoire with 22 distinct vocalization types produced by adults and 11 vocalization types within the babbling bouts of the neonates. A comparison within the otter subfamily suggests a relation between vocal and social complexity, with the giant otters being the socially and vocally most complex species.	[Mumm, Christina A. S.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Knoernschild, Mirjam] Univ Ulm, Fac Nat Sci, Inst Expt Ecol, D-89069 Ulm, Germany; [Knoernschild, Mirjam] Smithsonian Trop Res Inst, Balboa, Panama	Ulm University; Ulm University; Smithsonian Institution; Smithsonian Tropical Research Institute	Mumm, CAS (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	Christina.mumm@uni-ulm.de		Higgs, Dennis/0000-0002-0771-4642; Knornschild, Mirjam/0000-0003-0448-9600	German Academic Exchange Service [D/10/520]; Landesgraduiertenforderung Baden-Wurttemberg [1104]	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Landesgraduiertenforderung Baden-Wurttemberg	The German Academic Exchange Service (https://www.daad.de/de/index.html) granted a short time stipend for graduate students to CASM, D/10/520, which covered the travelling expenses for the data collection in Peru from September 12th to December 8th in 2011. The Landesgraduiertenforderung Baden-Wurttemberg (https://www.studieninfo-bw.de/studieren/studienfinanzierung/stipendien/leistungsstipendien/landesgraduiertenfoerderung/) is funding the graduate study of CASM, funding number 1104, 2012-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonte C, 2011, THESIS CITY U NEW YO; [Anonymous], 1989, POPULATIONSOKOLOGIE; Arnold K, 2008, CURR BIOL, V18, pR202, DOI 10.1016/j.cub.2008.01.040; Ben-David M, 2005, ECOLOGY, V86, P1331, DOI 10.1890/04-0783; Blumstein DT, 2008, ANIM BEHAV, V76, P1055, DOI 10.1016/j.anbehav.2008.06.002; Blumstein DT, 2009, ETHOLOGY, V115, P1074, DOI 10.1111/j.1439-0310.2009.01691.x; Blumstein DT, 1997, AM NAT, V150, P179, DOI 10.1086/286062; Blundell GM, 2002, BEHAV ECOL, V13, P134, DOI 10.1093/beheco/13.1.134; Bouchet H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00390; Bradbury Jack W., 1998, pi; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; Charif RA, 2010, RAVEN PRO 1 4 USERS; Cheney DL, 2005, LINGUIST REV, V22, P135, DOI 10.1515/tlir.2005.22.2-4.135; Crockford C, 2005, BEHAVIOUR, V142, P397, DOI 10.1163/1568539054012047; Davenport LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011385; De Waal FBM, 2003, ANIMAL SOCIAL COMPLEXITY, P230; DUPLAIX N, 1980, TERRE VIE-REV ECOL A, V34, P495; Duplaix N, 2008, IUCN 2013 IUCN RED L; EHRET G, 1980, ADV STUD BEHAV, V11, P179, DOI 10.1016/S0065-3454(08)60118-7; Elowson AM, 1998, BEHAVIOUR, V135, P643, DOI 10.1163/156853998792897905; Elowson AM, 1998, TRENDS COGN SCI, V2, P31, DOI 10.1016/S1364-6613(97)01115-7; EsTEs J. A., 1980, MAMMAL SPECIES, V133, P1, DOI [10.2307/3503844, DOI 10.2307/3503844]; Evangelista E., 2011, IUCN OTTER SPEC GR B, V28, P5; Fant G., 1960, ACOUSTIC THEORY SPEE; Farago T., 2014, BIOCOMMUNICATION ANI, P41, DOI DOI 10.1007/978-94-007-7414-8_4; Fichtel C, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P29, DOI 10.1007/978-3-642-02624-9_2; Fischer J, 2001, ANIM BEHAV, V61, P925, DOI 10.1006/anbe.2000.1687; Fitch W. T., 1998, ACOUSTIC COMMUNICATI, P1; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2000, ZOOL-ANAL COMPLEX SY, V103, P40; Freeberg TM, 2006, PSYCHOL SCI, V17, P557, DOI 10.1111/j.1467-9280.2006.01743.x; Freeberg TM, 2012, PHILOS T R SOC B, V367, P1785, DOI 10.1098/rstb.2011.0213; GARSHELIS DL, 1984, CAN J ZOOL, V62, P2648, DOI 10.1139/z84-385; Gnoli Claudio, 1995, Hystrix, V7, P289; Green S, 1975, HDB BEHAV NEUROBIOLO, P73, DOI [10.1007/978-1-4615-9116-0, DOI 10.1007/978-1-4615-9116-0]; Groenendijk J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106202; Hajek F., 2008, GIANTS MADRE DIOS; Hammerschmidt K, 1998, ETHOLOGY, V104, P203; Hauser, 1996, EVOL COMMUN; Hussain SA, 1996, MAMMALIA, V60, P289, DOI 10.1515/mamm.1996.60.2.289; Hussain Syed Ainul, 2011, IUCN Otter Specialist Group Bulletin, V28, P63; Jansen DAWAM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-97; Knornschild M, 2006, NATURWISSENSCHAFTEN, V93, P451, DOI 10.1007/s00114-006-0127-9; Krams I, 2012, PHILOS T R SOC B, V367, P1879, DOI 10.1098/rstb.2011.0222; Kruuk H., 2006, OTTERS ECOLOGY BEHAV, DOI DOI 10.1093/ACPROF:OSO/9780198565871.001.0001; Kunc HP, 2007, AM NAT, V170, P617, DOI 10.1086/521233; Lariviere Serge, 2003, Mammalian Species, V720, P1, DOI 10.1644/720; Lariviere Serge, 2001, Mammalian Species, V650, P1, DOI 10.1644/1545-1410(2001)650<0001:AC>2.0.CO;2; Lariviere Serge, 1999, Mammalian Species, V608, P1, DOI 10.2307/3504420; Lariviere Serge, 2001, Mammalian Species, V671, P1, DOI 10.1644/1545-1410(2001)671<0001:AC>2.0.CO;2; Le Roux A, 2009, NATURWISSENSCHAFTEN, V96, P575, DOI 10.1007/s00114-008-0506-5; Lemasson A, 2013, NATURWISSENSCHAFTEN, V100, P275, DOI 10.1007/s00114-013-1022-9; Lemasson A, 2014, J MAMMAL, V95, P128, DOI 10.1644/12-MAMM-A-313.1; Leuchtenberger C, 2012, THESIS; Leuchtenberger C, 2008, SOCIOBIOLOGY, V52, P257; Leuchtenberger C, 2009, ETHOLOGY, V115, P210, DOI 10.1111/j.1439-0310.2008.01607.x; Machado MRB, 2004, THESIS; Manser MB, 2014, ADV STUD BEHAV, V46, P281, DOI 10.1016/B978-0-12-800286-5.00006-7; Manser MB, 2000, BEHAV ECOL SOCIOBIOL, V48, P429, DOI 10.1007/s002650000248; McComb K, 2005, BIOL LETTERS, V1, P381, DOI 10.1098/rsbl.2005.0366; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; MCSHANE LJ, 1995, J MAMMAL, V76, P414, DOI 10.2307/1382352; Mech L. David, 2003, P1; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; Mumm CAS, 2014, ANIM BEHAV, V88, P243, DOI 10.1016/j.anbehav.2013.12.005; Mundry R, 2007, ANIM BEHAV, V74, P965, DOI 10.1016/j.anbehav.2006.12.028; Pollard KA, 2012, PHILOS T R SOC B, V367, P1869, DOI 10.1098/rstb.2011.0221; Pollard KA, 2011, CURR BIOL, V21, P413, DOI 10.1016/j.cub.2011.01.051; Quaglietta L, 2014, J MAMMAL, V95, P140, DOI 10.1644/13-MAMM-A-073.1; Ramsier MA, 2012, PHILOS T R SOC B, V367, P1860, DOI 10.1098/rstb.2011.0219; Ribas C, 2012, THESIS; Riede T, 2007, J ACOUST SOC AM, V121, P1758, DOI 10.1121/1.2427115; Robbins RL, 2003, BEHAVIOUR, V140, P333, DOI 10.1163/156853903321826666; Schassburger R. M., 1993, VOCAL COMMUNICATION; SCHENCK C, 1995, Z SAUGETIERKD, V60, P310; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; Seyfarth RM, 2003, ANNU REV PSYCHOL, V54, P145, DOI 10.1146/annurev.psych.54.101601.145121; SEYFARTH RM, 1986, ANIM BEHAV, V34, P1640, DOI 10.1016/S0003-3472(86)80252-4; Seyfarth RM, 2010, ANIM BEHAV, V80, P3, DOI 10.1016/j.anbehav.2010.04.012; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P443, DOI 10.1007/s00265-005-0068-x; SIVASOTHI N, 1994, HYDROBIOLOGIA, V285, P151, DOI 10.1007/BF00005663; Snowdon CT, 2001, BEHAVIOUR, V138, P1235, DOI 10.1163/15685390152822193; Sykes-Gatz S, 2005, INT GAINT OTTER STUD; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; TEMBROCK G, 1976, BEHAV PROCESS, V1, P57, DOI 10.1016/0376-6357(76)90007-3; Ten Hwang Yeen, 2005, Mammalian Species, P1; Timmis W. H., 1971, INT ZOO YB, V11, P109, DOI DOI 10.1111/J.1748-1090.1971.TB01868.X; Titze IR, 1994, PRINCIPLES VOICE PRO; Tokuda I, 2002, J ACOUST SOC AM, V111, P2908, DOI 10.1121/1.1474440; Tyack PL, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P142; Rosas FCW, 2009, SOCIOBIOLOGY, V54, P919; Wilden I., 1998, Bioacoustics, V9, P171; Zuberbuhler K, 2002, ANIM BEHAV, V63, P293, DOI 10.1006/anbe.2001.1914	94	14	15	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112562	10.1371/journal.pone.0112562	http://dx.doi.org/10.1371/journal.pone.0112562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391142	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400100
J	Oneil, ST; Rahn, KC; Bump, JK				Oneil, Shawn T.; Rahn, Kasey C.; Bump, Joseph K.			Habitat Capacity for Cougar Recolonization in the Upper Great Lakes Region	PLOS ONE			English	Article							PUMA-CONCOLOR; MOUNTAIN LIONS; BLACK-HILLS; DISPERSAL; LANDSCAPE; MOVEMENTS; DYNAMICS; PATTERNS; SPACE; LYNX	Background: Recent findings indicate that cougars (Puma concolor) are expanding their range into the midwestern United States. Confirmed reports of cougar in Michigan, Minnesota, and Wisconsin have increased dramatically in frequency during the last five years, leading to speculation that cougars may re-establish in the Upper Great Lakes (UGL) region, USA. Recent work showed favorable cougar habitat in northeastern Minnesota, suggesting that the northern forested regions of Michigan and Wisconsin may have similar potential. Recolonization of cougars in the UGL states would have important ecological, social, and political impacts that will require effective management. Methodology/Principal Findings: Using Geographic Information Systems (GIS), we extended a cougar habitat model to Michigan and Wisconsin and incorporated primary prey densities to estimate the capacity of the region to support cougars. Results suggest that approximately 39% (>58,000 km(2)) of the study area could support cougars, and that there is potential for a population of approximately 500 or more animals. An exploratory validation of this habitat model revealed strong association with 58 verified cougar locations occurring in the study area between 2008 and 2013. Conclusions/Significance: Spatially explicit information derived from this study could potentially lead to estimation of a viable population, delineation of possible cougar-human conflict areas, and the targeting of site locations for current monitoring. Understanding predator-prey interactions, interspecific competition, and human-wildlife relationships is becoming increasingly critical as top carnivores continue to recolonize the UGL region.	[Oneil, Shawn T.; Rahn, Kasey C.; Bump, Joseph K.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University	Bump, JK (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	jkbump@mtu.edu		O'Neil, Shawn/0000-0002-0899-5220	School of Forest Resources and Environmental Science Ecosystem Science Center at Michigan Technological University	School of Forest Resources and Environmental Science Ecosystem Science Center at Michigan Technological University	This project was funded and supported by the School of Forest Resources and Environmental Science Ecosystem Science Center at Michigan Technological University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Charles R. Jr, 2010, P41; Anderson EM, 2006, P E COUG C 28 APR 20; BEIER P, 1995, J WILDLIFE MANAGE, V59, P228, DOI 10.2307/3808935; BEIER P, 1995, J MAMMAL, V76, P1056, DOI 10.2307/1382599; Beier Paul, 2010, P177; Beyer DE, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P65, DOI 10.1007/978-0-387-85952-1_5; Bolgiano C., 2005, E COUGAR HIST ACCOUN; Boyce MS, 1999, TRENDS ECOL EVOL, V14, P268, DOI 10.1016/S0169-5347(99)01593-1; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Clark DW, 2002, SOUTHEAST NAT, V1, P269, DOI 10.1656/1528-7092(2002)001[0269:ASORAO]2.0.CO;2; Conkin JA, 2013, J WILDLIFE MANAGE, V77, P931, DOI 10.1002/jwmg.560; Corona Research I, 2006, PUBL OP PERC MOUNT L; Cougar Management Guidelines Working Group, 2005, COUG MAN GUID; Davenport Mae A., 2010, Human Dimensions of Wildlife, V15, P373, DOI 10.1080/10871209.2010.507564; DelGiudice GD, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P155, DOI 10.1007/978-0-387-85952-1_10; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Donovan ML, 2004, MICHIGAN GAP ANAL FI; Fecske DM, 2008, N DAKOTA MOUNTAIN LI, P92; Geist V., 1998, DEER WORLD THEIR EVO; Glick HB, 2014, ECOL MODEL, V285, P78, DOI 10.1016/j.ecolmodel.2014.02.005; HALLS L, 1984, WHITE TAILED DEER EC; Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x; Henaux V, 2011, METHODS ECOL EVOL, V2, P489, DOI 10.1111/j.2041-210X.2011.00107.x; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; Johnson Kirk, 2002, Endangered Species Update, V19, P27; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Kertson BN, 2011, ECOL APPL, V21, P2866, DOI 10.1890/11-0947.1; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; LaRue MA, 2007, PREDICTING POTENTIAL; Larue MA, 2008, ECOL MODEL, V212, P372, DOI 10.1016/j.ecolmodel.2007.10.036; Larue MA, 2012, J WILDLIFE MANAGE, V76, P1364, DOI 10.1002/jwmg.396; Larue MA, 2011, ECOL MODEL, V222, P897, DOI 10.1016/j.ecolmodel.2010.11.017; Laundre JW, 2013, ORYX, V47, P96, DOI 10.1017/S0030605311001475; Laundre John W., 2010, P76; Linden DW, 2011, WILDLIFE SOC B, V35, P20, DOI 10.1002/wsb.3; Logan Kenneth A., 2010, P105; McDonald L, 2013, J ANIM ECOL, V82, P1120, DOI 10.1111/1365-2656.12145; Michigan Department of Natural Resources, 2013, CLICK MAP PROP 2006; Mladenoff DJ, 1997, BIOSCIENCE, V47, P21, DOI 10.2307/1313003; Murphy Kerry, 2010, P118; Murray BD, 2013, ECOLOGY, V94, P1317, DOI 10.1890/12-1582.1; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Potvin MJ, 2005, J WILDLIFE MANAGE, V69, P1660, DOI 10.2193/0022-541X(2005)69[1660:MAHAFW]2.0.CO;2; Quigley Howard, 2010, P59; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rosatte R, 2011, CAN FIELD NAT, V125, P116, DOI 10.22621/cfn.v125i2.1194; Ruth Toni K., 2010, P163; Saaty TL., 1980, ANAL HIERARCHY PROCE; Smallwood KS, 1997, ENVIRON CONSERV, V24, P283, DOI 10.1017/S0376892997000362; Smith JB, 2014, J WILDLIFE MANAGE, V78, P930, DOI 10.1002/jwmg.718; Sweanor Linda L., 2010, P190; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Teichman KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074663; Thompson DJ, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00028.1; Thompson DJ, 2005, J WILDLIFE MANAGE, V69, P818, DOI 10.2193/0022-541X(2005)069[0818:LDBASM]2.0.CO;2; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; U.S. Fish and Wildlife Service, 1982, E COUG REC PLAN; VERME LJ, 1989, J MAMMAL, V70, P438, DOI 10.2307/1381538; Vucetich J., 2014, OXFORD HDB ANIMAL ST; Washington Department of Fish and Wildlife, 2008, WASH DEP FISH WILDL; Wiedenhoeft JE, 2009, WISCONSIN WILDLIFE S, V19, P83; Wiedenhoeft JE, 2011, WISCONSIN WILDLIFE S, V21, P99; Wiedenhoeft JE, 2012, RARE MAMMAL OBSERVAT; Wiedenhoeft JE, 2010, WISCONSIN WILDLIFE S, V20, P103; Wiedenhoeft JE, 2013, WISCONSIN WILDLIFE S, V23, P93; Wilmers CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060590; Wilson S, 2010, WEST N AM NATURALIST, V70, P238, DOI 10.3398/064.070.0211; Wisconsin Cougar Working Group, 2010, WISC COUG R IN PRESS; Wisconsin Department of Natural Resources, 2013, EST FALL DEER POP 20; Wisconsin Department of Natural Resources, 2013, COURG WISC; Wydeven AP, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P87, DOI 10.1007/978-0-387-85952-1_6	75	7	8	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112565	10.1371/journal.pone.0112565	http://dx.doi.org/10.1371/journal.pone.0112565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389761	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400101
J	Rudat, C; Grieskamp, T; Rohr, C; Airik, R; Wrede, C; Hegermann, J; Herrmann, BG; Schuster-Gossler, K; Kispert, A				Rudat, Carsten; Grieskamp, Thomas; Roehr, Christian; Airik, Rannar; Wrede, Christoph; Hegermann, Jan; Herrmann, Bernhard G.; Schuster-Gossler, Karin; Kispert, Andreas			Upk3b Is Dispensable for Development and Integrity of Urothelium and Mesothelium	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IDENTIFICATION; LINEAGE; FIBROBLASTS; PROGENITORS; MEMBRANE; PLAQUES; MARKER; TBX18; FATE	The mesothelium, the lining of the coelomic cavities, and the urothelium, the inner lining of the urinary drainage system, are highly specialized epithelia that protect the underlying tissues from mechanical stress and seal them from the overlying fluid space. The development of these epithelia from simple precursors and the molecular characteristics of the mature tissues are poorly analyzed. Here, we show that uroplakin 3B (Upk3b), which encodes an integral membrane protein of the tetraspanin superfamily, is specifically expressed both in development as well as under homeostatic conditions in adult mice in the mesothelia of the body cavities, i.e., the epicardium and pericardium, the pleura and the peritoneum, and in the urothelium of the urinary tract. To analyze Upk3b function, we generated a creERT2 knock-in allele by homologous recombination in embryonic stem cells. We show that Upk3b creERT2 represents a null allele despite the lack of creERT2 expression from the mutated locus. Morphological, histological and molecular analyses of Upk3b-deficient mice did not detect changes in differentiation or integrity of the urothelium and the mesothelia that cover internal organs. Upk3b is coexpressed with the closely related Upk3a gene in the urothelium but not in the mesothelium, leaving the possibility of a functional redundancy between the two genes in the urothelium only.	[Rudat, Carsten; Grieskamp, Thomas; Roehr, Christian; Airik, Rannar; Schuster-Gossler, Karin; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany; [Wrede, Christoph; Hegermann, Jan] Hannover Med Sch, Inst Funct & Appl Anat, D-30623 Hannover, Germany; [Herrmann, Bernhard G.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Hannover Medical School; Hannover Medical School; Max Planck Society	Kispert, A (corresponding author), Hannover Med Sch, Inst Mol Biol, D-30623 Hannover, Germany.	kispert.andreas@mh-hannover.de	Airik, Rannar/AAS-7810-2021	Airik, Rannar/0000-0002-7055-6325	German Research Foundation; Hannover Medical School [KFO136]	German Research Foundation(German Research Foundation (DFG)); Hannover Medical School	This work was supported by grants from the German Research Foundation (DFG) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) to C.W., J.H. and A.K. and by a grant for the Clinical Research Group KFO136 to A.K. at Hannover Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2007, KIDNEY INT, V72, P1459, DOI 10.1038/sj.ki.5002589; Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Deng FM, 2002, J CELL BIOL, V159, P685, DOI 10.1083/jcb.200204102; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Greulich F, 2013, J DEV BIOL, V1, P32, DOI 10.3390/jdb1010032; Grieskamp T, 2011, CIRC RES, V108, P813, DOI 10.1161/CIRCRESAHA.110.228809; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Kanamori-Katayama M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025391; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mikawa T, 1996, DEV BIOL, V174, P221, DOI 10.1006/dbio.1996.0068; Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Norden J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045100; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Rudat C, 2012, CIRC RES, V111, P165, DOI 10.1161/CIRCRESAHA.112.273946; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shelton EL, 2013, J TISSUE ENG REGEN M, V7, P421, DOI 10.1002/term.528; STAEHELIN LA, 1972, J CELL BIOL, V53, P73, DOI 10.1083/jcb.53.1.73; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Winters NI, 2014, DEV BIOL, V391, P125, DOI 10.1016/j.ydbio.2014.04.003; Winters NI, 2012, DEVELOPMENT, V139, P2926, DOI 10.1242/dev.082396; Yung S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/484167; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2011, J CELL MOL MED, V15, P2781, DOI 10.1111/j.1582-4934.2011.01450.x	35	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112112	10.1371/journal.pone.0112112	http://dx.doi.org/10.1371/journal.pone.0112112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389758	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400053
J	Zhong, R; Allen, JD; Xiao, GH; Xie, Y				Zhong, Rui; Allen, Jeffrey D.; Xiao, Guanghua; Xie, Yang			Ensemble-Based Network Aggregation Improves the Accuracy of Gene Network Reconstruction	PLOS ONE			English	Article							INTEGRATIVE ANALYSIS; ESCHERICHIA-COLI; EXPRESSION; PROTEIN; SIGNATURE; DISCOVERY; CELLS; ZEB1	Reverse engineering approaches to constructing gene regulatory networks (GRNs) based on genome-wide mRNA expression data have led to significant biological findings, such as the discovery of novel drug targets. However, the reliability of the reconstructed GRNs needs to be improved. Here, we propose an ensemble-based network aggregation approach to improving the accuracy of network topologies constructed from mRNA expression data. To evaluate the performances of different approaches, we created dozens of simulated networks from combinations of gene-set sizes and sample sizes and also tested our methods on three Escherichia coli datasets. We demonstrate that the ensemble-based network aggregation approach can be used to effectively integrate GRNs constructed from different studies - producing more accurate networks. We also apply this approach to building a network from epithelial mesenchymal transition (EMT) signature microarray data and identify hub genes that might be potential drug targets. The R code used to perform all of the analyses is available in an R package entitled "ENA", accessible on CRAN (http://cran.r-project.org/web/packages/ENA/).	[Zhong, Rui; Allen, Jeffrey D.; Xiao, Guanghua; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Allen, Jeffrey D.; Xie, Yang] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xie, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA.	Yang.Xie@utsouthwestern.edu			NIH grant [5R01CA152301, 1R01CA172211]; Cancer Prevention Research Institute of Texas award [RP101251]; NATIONAL CANCER INSTITUTE [R01CA152301, R01CA172211] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants 5R01CA152301 and 1R01CA172211, and Cancer Prevention Research Institute of Texas award RP101251. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2012, BRIEF BIOINFORM, V13, P547, DOI 10.1093/bib/bbr076; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Breiman L, 1996, ANN STAT, V24, P2350; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Breitling Rainer, 2005, Journal of Bioinformatics and Computational Biology, V3, P1171, DOI 10.1142/S0219720005001442; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gabriel E, 2004, LECT NOTES COMPUT SC, V3241, P97; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Hase T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003361; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Kendall SD, 2005, CANCER RES, V65, P9824, DOI 10.1158/0008-5472.CAN-05-1543; Kojima T, 2012, ANN NY ACAD SCI, V1257, P85, DOI 10.1111/j.1749-6632.2012.06579.x; Koziol JA, 2010, FEBS LETT, V584, P941, DOI 10.1016/j.febslet.2010.01.031; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Liang F, 2009, CHAPMAN HALL CRC BIO; Lim J, 2006, STAT PROBABIL LETT, V76, P1705, DOI 10.1016/j.spl.2006.04.033; Liu J, 2013, GENET EPIDEMIOL, V37, P173, DOI 10.1002/gepi.21697; Ma SG, 2011, BIOSTATISTICS, V12, P763, DOI 10.1093/biostatistics/kxr004; Maki-Nevala S, 2013, GENE CHROMOSOME CANC, V52, P1141, DOI 10.1002/gcc.22109; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Nibbe RK, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000639; Pan W., 2002, GENOME BIOL, V3; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Peng LB, 2013, INT J CLIN EXP PATHO, V6, P1854; Penrose R, 1954, GEN INVERSE MATRICES, P406; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Rix U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077155; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Salgado H, 2012, METHODS MOL BIOL, V804, P179, DOI 10.1007/978-1-61779-361-5_10; Sangurdekar DP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r32; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Slavov N, 2009, P NATL ACAD SCI USA, V106, P4079, DOI 10.1073/pnas.0810803106; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sun XC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006667; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Wang XS, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-30; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Wiederhold E, 2009, MOL CELL PROTEOMICS, V8, P380, DOI 10.1074/mcp.M800372-MCP200; Xiao GH, 2011, J AM STAT ASSOC, V106, P61, DOI 10.1198/jasa.2010.ap09504; Xie Y, 2013, IMPLEMENTING REPROD; Xie Y, 2013, DYNAMIC DOCUMENTS R; Zhao H, 2013, CANCER RES, V73, P6149, DOI 10.1158/0008-5472.CAN-12-4617	52	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e106319	10.1371/journal.pone.0106319	http://dx.doi.org/10.1371/journal.pone.0106319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390635	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400002
J	Aghcheh, RK; Nemeth, Z; Atanasova, L; Fekete, E; Paholcsek, M; Sandor, E; Aquino, B; Druzhinina, IS; Karaffa, L; Kubicek, CP				Aghcheh, Razieh Karimi; Nemeth, Zoltan; Atanasova, Lea; Fekete, Erzsebet; Paholcsek, Melinda; Sandor, Erzsebet; Aquino, Benigno; Druzhinina, Irina S.; Karaffa, Levente; Kubicek, Christian P.			The VELVET A Orthologue VEL1 of Trichoderma reesei Regulates Fungal Development and Is Essential for Cellulase Gene Expression	PLOS ONE			English	Article							BIOMASS-DEGRADING ENZYMES; ASPERGILLUS-NIDULANS; SECONDARY METABOLISM; PENICILLIUM-CHRYSOGENUM; SEXUAL DEVELOPMENT; FILAMENTOUS FUNGI; VEA GENE; PROTEIN; LACTOSE; COMPLEX	Trichoderma reesei is the industrial producer of cellulases and hemicellulases for biorefinery processes. Their expression is obligatorily dependent on the function of the protein methyltransferase LAE1. The Aspergillus nidulans orthologue of LAE1 - LaeA - is part of the VELVET protein complex consisting of LaeA, VeA and VelB that regulates secondary metabolism and sexual as well as asexual reproduction. Here we have therefore investigated the function of VEL1, the T. reesei orthologue of A. nidulans VeA. Deletion of the T. reesei vel1 locus causes a complete and light-independent loss of conidiation, and impairs formation of perithecia. Deletion of vel1 also alters hyphal morphology towards hyperbranching and formation of thicker filaments, and with consequently reduced growth rates. Growth on lactose as a sole carbon source, however, is even more strongly reduced and growth on cellulose as a sole carbon source eliminated. Consistent with these findings, deletion of vel1 completely impaired the expression of cellulases, xylanases and the cellulase regulator XYR1 on lactose as a cellulase inducing carbon source, but also in resting mycelia with sophorose as inducer. Our data show that in T. reesei VEL1 controls sexual and asexual development, and this effect is independent of light. VEL1 is also essential for cellulase gene expression, which is consistent with the assumption that their regulation by LAE1 occurs by the VELVET complex.	[Aghcheh, Razieh Karimi; Atanasova, Lea; Aquino, Benigno; Druzhinina, Irina S.; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, Microbiol Grp, A-1060 Vienna, Austria; [Nemeth, Zoltan; Fekete, Erzsebet; Karaffa, Levente] Univ Debrecen, Fac Sci & Technol, Dept Biochem Engn, H-4032 Debrecen, Hungary; [Paholcsek, Melinda] Univ Debrecen, Fac Med, Dept Human Genet, H-4032 Debrecen, Hungary; [Sandor, Erzsebet] Inst Food Sci, Fac Agr & Food Sci & Environm Management, H-4032 Debrecen, Hungary; [Druzhinina, Irina S.] Vienna Univ Technol, Inst Chem Engn, Austrian Ctr Ind Biotechnol, A-1060 Vienna, Austria; [Kubicek, Christian P.] Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria	Technische Universitat Wien; University of Debrecen; University of Debrecen; Austrian Centre of Industrial Biotechnology; Technische Universitat Wien; Austrian Centre of Industrial Biotechnology	Kubicek, CP (corresponding author), Vienna Univ Technol, Inst Chem Engn, Res Div Biotechnol & Microbiol, Microbiol Grp, A-1060 Vienna, Austria.	christian.kubicek@gmail.com	Paholcsek, Melinda/AAR-4464-2020; Atanasova, Lea/AAK-4479-2021; Druzhinina, Irina S./AAK-7054-2021; Karaffa, Erzsébet/A-3547-2016	Atanasova, Lea/0000-0002-1751-277X; Druzhinina, Irina S./0000-0003-2821-5268; Karaffa, Erzsebet/0000-0001-8356-1716; Karimi Aghcheh, Razieh/0000-0003-0027-1030	Austrian Science Foundation [P 21266, I 1249]; EU; European Social Fund [TA MOP-4.2.2.A-11/1/KONV-2012-0043, TAMOP-4.2.4.A/2-11/1-2012-0001]; Hungarian Scientific Research Fund (OTKA) [K1006600]; Austrian Science Fund (FWF) [I 1249] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); EU(European Commission); European Social Fund(European Social Fund (ESF)); Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by grants of the Austrian Science Foundation (to CPK; P 21266 and I 1249), by the EU and co-financed by the European Social Fund under the project ENVIKUT (TA MOP-4.2.2.A-11/1/KONV-2012-0043), and also by the Hungarian Scientific Research Fund (OTKA Grant K1006600). LK is a recipient of a Bolyai Janos Research Scholarship. MP was supported by the EU and Hungary, co-financed by the European Social Fund in the framework of the TAMOP-4.2.4.A/2-11/1-2012-0001 'National Excellence Program.' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akel E, 2009, EUKARYOT CELL, V8, P1837, DOI 10.1128/EC.00162-09; Amaike S, 2009, EUKARYOT CELL, V8, P1051, DOI 10.1128/EC.00088-09; Arvas M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-616; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2008, FUNGAL GENET BIOL, V45, P127, DOI 10.1016/j.fgb.2007.06.001; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bischof R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-127; Bok JW, 2006, MOL MICROBIOL, V61, P1636, DOI 10.1111/j.1365-2958.2006.05330.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Chen CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044969; Chettri P, 2012, FUNGAL GENET BIOL, V49, P141, DOI 10.1016/j.fgb.2011.11.009; Dhingra S, 2012, EUKARYOT CELL, V11, P1531, DOI 10.1128/EC.00222-12; Dreyer J, 2007, APPL ENVIRON MICROB, V73, P3412, DOI 10.1128/AEM.00129-07; Duran RM, 2014, APPL MICROBIOL BIOT, V98, P5081, DOI 10.1007/s00253-014-5598-6; Fischer R, 2008, SCIENCE, V320, P1430, DOI 10.1126/science.1160123; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Ghassemi S, 2014, MOL MICROBIOL; Guangtao Z, 2009, J BIOTECHNOL, V139, P146, DOI 10.1016/j.jbiotec.2008.10.007; Hakkinen M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-134; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ivanova C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062631; Jiang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028291; Kamerewerd J, 2011, MICROBIOL-SGM, V157, P3036, DOI 10.1099/mic.0.051896-0; Karaffa L, 2013, APPL MICROBIOL BIOT, V97, P5447, DOI 10.1007/s00253-012-4667-y; Karimi-Aghcheh R, 2013, G3-GENES GENOM GENET, V3, P369, DOI 10.1534/g3.112.005140; Kim HS, 2002, FUNGAL GENET BIOL, V37, P72, DOI 10.1016/S1087-1845(02)00029-4; Kim HJ, 2014, FUNGAL GENET BIOL, V66, P33, DOI 10.1016/j.fgb.2014.02.011; Kubicek C. P, 2012, FUNGI LIGNOCELLULOSE; Kubicek CP, 2013, J BIOTECHNOL, V163, P133, DOI 10.1016/j.jbiotec.2012.05.020; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Laskowski-Peak MC, 2012, FUNGAL GENET BIOL, V49, P838, DOI 10.1016/j.fgb.2012.07.001; Le Crom S, 2009, P NATL ACAD SCI USA, V106, P16151, DOI 10.1073/pnas.0905848106; MACH RL, 1994, CURR GENET, V25, P567, DOI 10.1007/BF00351679; MANDELS M, 1978, PROCESS BIOCHEM, V13, P6; Merhej J, 2012, MOL PLANT PATHOL, V13, P363, DOI 10.1111/j.1364-3703.2011.00755.x; Metz B, 2011, EUKARYOT CELL, V10, P1527, DOI 10.1128/EC.05014-11; Mukherjee PK, 2010, APPL ENVIRON MICROB, V76, P2345, DOI 10.1128/AEM.02391-09; Myung K, 2012, PLANT PATHOL, V61, P152, DOI 10.1111/j.1365-3059.2011.02504.x; Park HS, 2012, MOL MICROBIOL, V86, P937, DOI 10.1111/mmi.12032; Patananan AN, 2013, J BIOL CHEM, V288, P14032, DOI 10.1074/jbc.M113.465765; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Purschwitz J, 2009, MOL GENET GENOMICS, V281, P35, DOI 10.1007/s00438-008-0390-x; RECHSTEINER M, 1987, TRENDS BIOCHEM SCI, V12, P390; Reyes-Dominguez Y, 2010, MOL MICROBIOL, V76, P1376, DOI 10.1111/j.1365-2958.2010.07051.x; Ries L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-541; Sarikaya-Bayram O, 2014, DEV CELL, V29, P406, DOI 10.1016/j.devcel.2014.03.020; Seiboth B, 2007, MOL MICROBIOL, V66, P890, DOI 10.1111/j.1365-2958.2007.05953.x; Seiboth Bernhard, 2007, Fungal Biology Reviews, V21, P42, DOI 10.1016/j.fbr.2007.02.006; Seiboth Bernhard, 2012, Subcell Biochem, V64, P367, DOI 10.1007/978-94-007-5055-5_18; Seiboth B, 2012, MOL MICROBIOL, V84, P1150, DOI 10.1111/j.1365-2958.2012.08083.x; Seidl V, 2009, P NATL ACAD SCI USA, V106, P13909, DOI 10.1073/pnas.0904936106; STERNBERG D, 1979, J BACTERIOL, V139, P761, DOI 10.1128/JB.139.3.761-769.1979; Stinnett SM, 2007, MOL MICROBIOL, V63, P242, DOI 10.1111/j.1365-2958.2006.05506.x; Tisch D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-613; Uzbas F, 2012, APPL MICROBIOL BIOT, V93, P1601, DOI 10.1007/s00253-011-3674-8; Vitikainen M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-441; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Yager L N, 1992, Biotechnology, V23, P19; Yang QQ, 2013, FUNGAL GENET BIOL, V50, P63, DOI 10.1016/j.fgb.2012.10.003; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214	64	64	66	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112799	10.1371/journal.pone.0112799	http://dx.doi.org/10.1371/journal.pone.0112799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386652	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400093
J	Lossl, P; Kolbel, K; Tanzler, D; Nannemann, D; Ihling, CH; Keller, MV; Schneider, M; Zaucke, F; Meiler, J; Sinz, A				Loessl, Philip; Koelbel, Knut; Taenzler, Dirk; Nannemann, David; Ihling, Christian H.; Keller, Manuel V.; Schneider, Marian; Zaucke, Frank; Meiler, Jens; Sinz, Andrea			Analysis of Nidogen-1/Laminin gamma 1 Interaction by Cross-Linking, Mass Spectrometry, and Computational Modeling Reveals Multiple Binding Modes	PLOS ONE			English	Article							LAMININ-NIDOGEN COMPLEX; PROTEIN SECONDARY STRUCTURE; BASEMENT-MEMBRANE PROTEIN; STRUCTURE PREDICTION; 1 CHAIN; IDENTIFICATION; DOMAINS; CHAPERONIN; FRAGMENTS; DATABASE	We describe the detailed structural investigation of nidogen-1/laminin gamma 1 complexes using full-length nidogen-1 and a number of laminin gamma 1 variants. The interactions of nidogen-1 with laminin variants gamma 1 LEb2-4, gamma 1 LEb2-4 N836D, gamma 1 short arm, and gamma 1 short arm N836D were investigated by applying a combination of (photo-) chemical cross-linking, high-resolution mass spectrometry, and computational modeling. In addition, surface plasmon resonance and ELISA studies were used to determine kinetic constants of the nidogen-1/laminin gamma 1 interaction. Two complementary cross-linking strategies were pursued to analyze solution structures of laminin gamma 1 variants and nidogen-1. The majority of distance information was obtained with the homobifunctional amine-reactive cross-linker bis(sulfosuccinimidyl) glutarate. In a second approach, UV-induced cross-linking was performed after incorporation of the diazirine-containing unnatural amino acids photo-leucine and photo-methionine into laminin gamma 1 LEb2-4, laminin gamma 1 short arm, and nidogen-1. Our results indicate that Asn-836 within laminin gamma 1 LEb3 domain is not essential for complex formation. Cross-links between laminin gamma 1 short arm and nidogen-1 were found in all protein regions, evidencing several additional contact regions apart from the known interaction site. Computational modeling based on the cross-linking constraints indicates the existence of a conformational ensemble of both the individual proteins and the nidogen-1/laminin gamma 1 complex. This finding implies different modes of interaction resulting in several distinct protein-protein interfaces.	[Loessl, Philip; Koelbel, Knut; Taenzler, Dirk; Ihling, Christian H.; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06108 Halle, Saale, Germany; [Nannemann, David; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Nannemann, David; Meiler, Jens] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37235 USA; [Keller, Manuel V.; Zaucke, Frank] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Schneider, Marian] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Res Grp Artificial Binding Prot, D-06108 Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Vanderbilt University; Vanderbilt University; University of Cologne; Martin Luther University Halle Wittenberg	Sinz, A (corresponding author), Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06108 Halle, Saale, Germany.	andrea.sinz@pharmazie.uni-halle.de	Zaucke, Frank/E-2077-2012; Zaucke, Frank/AAT-2688-2021	Meiler, Jens/0000-0001-8945-193X; Lossl, Philip/0000-0001-5062-7723; Nannemann, David/0000-0002-4946-3263	BMBF project; DFG [Si 867/13-1, 15-1, 16-1]; BMBF [Pro-Net-T3]; region of Saxony-Anhalt; NIH [R01 GM080403, R01 MH090192, R01 GM099842, R01 DK097376]; NSF [CHE 1305874]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, R01GM099842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090192] Funding Source: NIH RePORTER	BMBF project(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); region of Saxony-Anhalt; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	KK is funded by the BMBF project. AS acknowledges financial support from the DFG (projects Si 867/13-1, 15-1, and 16-1), the BMBF (Pro-Net-T3), and the region of Saxony-Anhalt. JM is funded through NIH (R01 GM080403, R01 MH090192, R01 GM099842, and R01 DK097376) and NSF (CHE 1305874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; AUMAILLEY M, 1989, EUR J BIOCHEM, V184, P241, DOI 10.1111/j.1432-1033.1989.tb15013.x; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Baumgartner R, 1996, J MOL BIOL, V257, P658, DOI 10.1006/jmbi.1996.0192; Bechtel M, 2012, FASEB J, V26, P3637, DOI 10.1096/fj.11-194597; BECK K, 1990, FASEB J, V4, P148, DOI 10.1096/fasebj.4.2.2404817; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; BOREK F, 1961, NATURE, V191, P1293, DOI 10.1038/1911293a0; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Butler JE, 2000, METHODS, V22, P4, DOI 10.1006/meth.2000.1031; Carafoli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042473; CARLIN B, 1981, J BIOL CHEM, V256, P5209; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; DZIADEK M, 1985, EMBO J, V4, P2513, DOI 10.1002/j.1460-2075.1985.tb03964.x; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GERL M, 1991, EUR J BIOCHEM, V202, P167, DOI 10.1111/j.1432-1033.1991.tb16358.x; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Guo X, 2008, ANAL CHEM, V80, P951, DOI 10.1021/ac701636w; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Ho MSP, 2008, MICROSC RES TECHNIQ, V71, P387, DOI 10.1002/jemt.20567; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; Hussain SA, 2011, EMBO REP, V12, P276, DOI 10.1038/embor.2011.3; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Kahraman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073411; Kalisman N, 2012, P NATL ACAD SCI USA, V109, P2884, DOI 10.1073/pnas.1119472109; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kolbel K, 2012, ANGEW CHEM INT EDIT, V51, P12602, DOI 10.1002/anie.201205308; Kohfeldt E, 1998, J MOL BIOL, V282, P99, DOI 10.1006/jmbi.1998.2004; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Leman JK, 2013, PROTEINS, V81, P1127, DOI 10.1002/prot.24258; Lossl P, 2014, METH MOL BIOL UNPUB; MANN K, 1988, EUR J BIOCHEM, V178, P71, DOI 10.1111/j.1432-1033.1988.tb14430.x; MAYER U, 1993, EMBO J, V12, P1879, DOI 10.1002/j.1460-2075.1993.tb05836.x; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Miosge N, 2002, MATRIX BIOL, V21, P611, DOI 10.1016/S0945-053X(02)00070-7; Muller MQ, 2010, ANAL CHEM, V82, P6958, DOI 10.1021/ac101241t; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Patel TR, 2014, MATRIX BIOL, V33, P60, DOI 10.1016/j.matbio.2013.07.009; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; Poschl E, 1996, EMBO J, V15, P5154, DOI 10.1002/j.1460-2075.1996.tb00899.x; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Ries A, 2001, EUR J BIOCHEM, V268, P5119, DOI 10.1046/j.0014-2956.2001.02437.x; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Salmivirta K, 2002, EXP CELL RES, V279, P188, DOI 10.1006/excr.2002.5611; SASAKI M, 1987, J BIOL CHEM, V262, P17111; Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058; Schaks S, 2012, BIOMACROMOLECULAR MA, P1; Sinz A, 2014, EXPERT REV PROTEOMIC, V16, P1; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stetefeld J, 1996, J MOL BIOL, V257, P644, DOI 10.1006/jmbi.1996.0191; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Takagi J, 2003, NATURE, V424, P969, DOI 10.1038/nature01873; TIMPL R, 1979, J BIOL CHEM, V254, P9933; TIMPL R, 1983, EUR J BIOCHEM, V137, P455, DOI 10.1111/j.1432-1033.1983.tb07849.x; Tunggal P, 2000, MICROSC RES TECHNIQ, V51, P214, DOI 10.1002/1097-0029(20001101)51:3<214::AID-JEMT2>3.0.CO;2-J; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	70	33	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112886	10.1371/journal.pone.0112886	http://dx.doi.org/10.1371/journal.pone.0112886			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387007	Green Submitted, gold, Green Published			2022-12-26	WOS:000345250400099
J	Wu, QQ; Zhang, JZ; Shi, J; Ge, ML; Li, XX; Shao, YQ; Yao, JF; Zheng, YZ				Wu, Qingqing; Zhang, Jizhou; Shi, Jun; Ge, Meili; Li, Xingxin; Shao, Yingqi; Yao, Jianfeng; Zheng, Yizhou			Increased Bone Marrow (BM) Plasma Level of Soluble CD30 and Correlations with BM Plasma Level of Interferon (IFN)-gamma, CD4/CD8 T-Cell Ratio and Disease Severity in Aplastic Anemia	PLOS ONE			English	Article							BRENTUXIMAB VEDOTIN SGN-35; VERSUS-HOST-DISEASE; IFN-GAMMA; IMMUNOSUPPRESSIVE THERAPY; NEGATIVE SELECTION; FLOW-CYTOMETRY; SERUM-LEVELS; TNF-ALPHA; EXPRESSION; LYMPHOMA	Idiopathic aplastic anemia (AA) is an immune-mediated bone marrow failure syndrome. Immune abnormalities such as decreased lymphocyte counts, inverted CD4/CD8 T-cell ratio and increased IFN-gamma-producing T cells have been found in AA. CD30, a surface protein belonging to the tumor necrosis factor receptor family and releasing from cell surface as a soluble form (sCD30) after activation, marks a subset of activated T cells secreting IFN-gamma when exposed to allogeneic antigens. Our study found elevated BM plasma levels of sCD30 in patients with SAA, which were closely correlated with disease severity, including absolute lymphocyte count (ALC) and absolute netrophil count (ANC). We also noted that sCD30 levels were positively correlated with plasma IFN-gamma levels and CD4/CD8 T-cell ratio in patients with SAA. In order to explain these phenomena, we stimulated T cells with alloantigen in vitro and found that CD30(+) T cells were the major source of IFN-gamma, and induced CD30(+) T cells from patients with SAA produced significantly more IFN-gamma than that from healthy individuals. In addition, increased proportion of CD8(+) T cells in AA showed enhanced allogeneic response by the fact that they expressed more CD30 during allogeneic stimulation. sCD30 levels decreased in patients responded to immunosuppressive therapy. In conclusion, elevated BM plasma levels of sCD30 reflected the enhanced CD30(+) T cell-mediated immune response in SAA. CD30 as a molecular marker that transiently expresses on IFN-gamma-producing T cells, may participate in mediating bone marrow failure in AA, which also can facilitate our understanding of AA pathogenesis to identify new therapeutic targets.	[Wu, Qingqing; Zhang, Jizhou; Shi, Jun; Ge, Meili; Li, Xingxin; Shao, Yingqi; Yao, Jianfeng; Zheng, Yizhou] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Severe Aplast Anemia Studying Program, State Key Lab Expt Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China; [Wu, Qingqing; Zhang, Jizhou; Shi, Jun; Ge, Meili; Li, Xingxin; Shao, Yingqi; Yao, Jianfeng; Zheng, Yizhou] Peking Union Med Coll, Tianjin 300020, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zheng, YZ (corresponding author), Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Severe Aplast Anemia Studying Program, State Key Lab Expt Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China.	zheng_yizhou@hotmail.com	Wu, Qingqing/AFU-3222-2022	Wu, Qingqing/0000-0002-1566-1253	National Public Health Grant Research Foundation of China [201202017]; Fundamental Research Funds for the Central Universities of China [2012N05]; National Basic Research Program [2010CB945204]; National Natural Science Foundation of China (NNSFC) [81330015]; NNSFC [81300388]	National Public Health Grant Research Foundation of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); NNSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the National Public Health Grant Research Foundation of China (no. 201202017) to Y.Z., http://www.nhfpc.gov.cn/zhuzhan/index.shtml; the Fundamental Research Funds for the Central Universities of China (no. 2012N05) to Y.Z., http://www.moe.gov.cn/; the National Basic Research Program (2010CB945204) to Y.Z., http://www.nsfc.gov.cn/; the National Natural Science Foundation of China (NNSFC, no. 81330015) to Z.H., http://www.nsfc.gov.cn/; and the NNSFC (no. 81300388) to M.G., http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALZONA M, 1994, J IMMUNOL, V153, P2861; Amakawa R, 1996, CELL, V84, P551, DOI 10.1016/S0092-8674(00)81031-4; Berro AI, 2004, J IMMUNOL, V173, P2174, DOI 10.4049/jimmunol.173.3.2174; Brodsky RA, 2005, LANCET, V365, P1647, DOI 10.1016/S0140-6736(05)66515-4; CALIGARISCAPPIO F, 1995, CLIN EXP RHEUMATOL, V13, P339; CAMITTA BM, 1979, BLOOD, V53, P504; Chan KW, 2002, J IMMUNOL, V169, P1784, DOI 10.4049/jimmunol.169.4.1784; Chen JC, 2007, J IMMUNOL, V178, P4159, DOI 10.4049/jimmunol.178.7.4159; Chen YB, 2012, BLOOD, V120, P691, DOI 10.1182/blood-2012-03-415422; Chiarle R, 1999, J IMMUNOL, V163, P194; Couriel D, 2004, CANCER-AM CANCER SOC, V101, P1936, DOI 10.1002/cncr.20613; Dummer W, 1997, BRIT J DERMATOL, V137, P185, DOI 10.1046/j.1365-2133.1997.18031887.x; ELLIS TM, 1993, J IMMUNOL, V151, P2380; Fanale MA, 2012, CLIN CANCER RES, V18, P248, DOI 10.1158/1078-0432.CCR-11-1425; Gerli R, 1995, CLIN EXP IMMUNOL, V102, P547; Goto M, 2013, BRIT J HAEMATOL, V160, P359, DOI 10.1111/bjh.12116; Hansen HP, 2000, J IMMUNOL, V165, P6703, DOI 10.4049/jimmunol.165.12.6703; Hirano N, 2005, BRIT J HAEMATOL, V128, P221, DOI 10.1111/j.1365-2141.2004.05317.x; Hirano N, 2003, BLOOD, V102, P4567, DOI 10.1182/blood-2002-11-3409; Hubel K, 2010, TRANSPL IMMUNOL, V23, P215, DOI 10.1016/j.trim.2010.07.001; Marsh JCW, 2009, BRIT J HAEMATOL, V147, P43, DOI 10.1111/j.1365-2141.2009.07842.x; Martinez OM, 1998, TRANSPLANTATION, V65, P1240, DOI 10.1097/00007890-199805150-00016; Mir SS, 2000, BLOOD, V96, P4307; Pro B, 2012, J CLIN ONCOL, V30, P2190, DOI 10.1200/JCO.2011.38.0402; Rezaei N, 2008, J CLIN IMMUNOL, V28, P78, DOI 10.1007/s10875-007-9135-6; Risitano AM, 2004, LANCET, V364, P355, DOI 10.1016/S0140-6736(04)16724-X; Risitano AM, 2002, BLOOD, V100, P178, DOI 10.1182/blood-2002-01-0236; Saraiva M, 2002, J EXP MED, V196, P829, DOI 10.1084/jem.20020319; Sasse S, 2013, LEUKEMIA LYMPHOMA, V54, P2144, DOI 10.3109/10428194.2013.775434; Scheinberg P, 2009, BRIT J HAEMATOL, V144, P206, DOI 10.1111/j.1365-2141.2008.07450.x; Schlaf G, 2007, HISTOL HISTOPATHOL, V22, P1269, DOI 10.14670/HH-22.1269; Sloand E, 2002, BLOOD, V100, P1185, DOI 10.1182/blood-2002-01-0035; Takamatsu H, 2009, J IMMUNOL, V182, P703, DOI 10.4049/jimmunol.182.1.703; Telford WG, 1997, CELL IMMUNOL, V182, P125, DOI 10.1006/cimm.1997.1228; Velasquez SY, 2013, TRANSPLANTATION, V96, P154, DOI 10.1097/TP.0b013e318296fd69; Younes A, 2010, NEW ENGL J MED, V363, P1812, DOI 10.1056/NEJMoa1002965; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470; Zeiser R, 2007, BLOOD, V109, P2225, DOI 10.1182/blood-2006-07-038455; Zeng WH, 2001, J CLIN INVEST, V108, P765, DOI 10.1172/JCI12687; ZOUMBOS NC, 1984, BRIT J HAEMATOL, V58, P95, DOI 10.1111/j.1365-2141.1984.tb06063.x	40	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e110787	10.1371/journal.pone.0110787	http://dx.doi.org/10.1371/journal.pone.0110787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383872	Green Submitted, gold, Green Published			2022-12-26	WOS:000344816700010
J	Croken, MM; Ma, YF; Markillie, LM; Taylor, RC; Orr, G; Weiss, LM; Kim, K				Croken, Matthew McKnight; Ma, Yanfen; Markillie, Lye Meng; Taylor, Ronald C.; Orr, Galya; Weiss, Louis M.; Kim, Kami			Distinct Strains of Toxoplasma gondii Feature Divergent Transcriptomes Regardless of Developmental Stage	PLOS ONE			English	Article							GENE-EXPRESSION; DATABASE; FAMILY	Using high through-put RNA sequencing, we assayed the transcriptomes of three different strains of Toxoplasma gondii representing three common genotypes under both in vitro tachyzoite and in vitro bradyzoite-inducing alkaline stress culture conditions. Strikingly, the differences in transcriptional profiles between the strains, RH, PLK, and CTG, is much greater than differences between tachyzoites and alkaline stressed in vitro bradyzoites. With an FDR of 10%, we identified 241 genes differentially expressed between CTG tachyzoites and in vitro bradyzoites, including 5 putative AP2 transcription factors. We also observed a close association between cell cycle regulated genes and differentiation. By Gene Set Enrichment Analysis (GSEA), there are a number of KEGG pathways associated with the in vitro bradyzoite transcriptomes of PLK and CTG, including pyrimidine metabolism and DNA replication. These functions are likely associated with cell-cycle arrest. When comparing mRNA levels between strains, we identified 1,526 genes that were differentially expressed regardless of culture-condition as well as 846 differentially expressed only in bradyzoites and 542 differentially expressed only in tachyzoites between at least two strains. Using GSEA, we identified that ribosomal proteins were expressed at significantly higher levels in the CTG strain than in either the RH or PLK strains. This association holds true regardless of life cycle stage.	[Croken, Matthew McKnight; Kim, Kami] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Ma, Yanfen; Weiss, Louis M.; Kim, Kami] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Markillie, Lye Meng; Orr, Galya] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Taylor, Ronald C.] Pacific NW Natl Lab, Div Biol Sci, Computat Biol & Bioinformat Grp, Richland, WA 99352 USA; [Weiss, Louis M.; Kim, Kami] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Yeshiva University; Albert Einstein College of Medicine	Weiss, LM (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	louis.weiss@einstein.yu.edu; kami.kim@einstein.yu.edu		Kim, Kami/0000-0003-3384-152X; Taylor, Ronald/0000-0001-9777-9767	National Institutes of Health (NIH) [AI095094]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087625, R01AI095094, P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by National Institutes of Health (NIH) grants AI095094 (LMW), AI087625 (KK), and by grant 40070 (LMW) from Environmental Molecular Sciences Laboratory (EMSL) Pacific Northwest National Laboratory. MMC was supported by the Training Program in Cellular and Molecular Biology and Genetics, funded by NIH T32 GM007491 awarded to the Albert Einstein College of Medicine. A portion of the research was performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Lab. This work was also supported in part by the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-051519). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000852; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-350; Behnke MS, 2011, P NATL ACAD SCI USA, V108, P9631, DOI 10.1073/pnas.1015338108; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Croken MM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-515; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Hutson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014057; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Khan A, 2005, NUCLEIC ACIDS RES, V33, P2980, DOI 10.1093/nar/gki604; Khan A, 2011, MBIO, V2, DOI 10.1128/mBio.00228-11; Kim K, 2008, MICROBES INFECT, V10, P978, DOI 10.1016/j.micinf.2008.07.015; Knoll LJ, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P521, DOI 10.1016/B978-0-12-396481-6.00015-5; Konrad C, 2014, INT J PARASITOL, V44, P139, DOI 10.1016/j.ijpara.2013.08.005; Lescault PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014463; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Radke JB, 2013, P NATL ACAD SCI USA, V110, P6871, DOI 10.1073/pnas.1300059110; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shanmugasundram A, 2013, NUCLEIC ACIDS RES, V41, pD706, DOI 10.1093/nar/gks1139; Sibley LD, 2009, PHILOS T R SOC B, V364, P2749, DOI 10.1098/rstb.2009.0087; Sinha A, 2014, NATURE, V507, P253, DOI 10.1038/nature12970; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; White MW, 2014, CELL MICROBIOL, V16, P466, DOI 10.1111/cmi.12267; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	34	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e111297	10.1371/journal.pone.0111297	http://dx.doi.org/10.1371/journal.pone.0111297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393307	gold, Green Submitted, Green Published			2022-12-26	WOS:000347709300014
J	Ding, FR; Zhang, XY; Li, XJ; Zhang, YQ; Li, BH; Ding, J				Ding, Fangrui; Zhang, Xiaoyan; Li, Xuejuan; Zhang, Yanqin; Li, Baihong; Ding, Jie			Mammalian Target of Rapamycin Complex 2 Signaling Pathway Regulates Transient Receptor Potential Cation Channel 6 in Podocytes	PLOS ONE			English	Article							TRPC6 EXPRESSION; BINDING PARTNER; UP-REGULATION; S6 KINASE; MTOR; CYTOSKELETON; RICTOR; PHOSPHORYLATION; CONTRIBUTES; INHIBITION	Transient receptor potential cation channel 6 (TRPC6) is a nonselective cation channel, and abnormal expression and gain of function of TRPC6 are involved in the pathogenesis of hereditary and nonhereditary forms of renal disease. Although the molecular mechanisms underlying these diseases remain poorly understood, recent investigations revealed that many signaling pathways are involved in regulating TRPC6. We aimed to examine the effect of the mammalian target of rapamycin (mTOR) complex (mTOR complex 1 [mTORC1] or mTOR complex 2 [mTORC2]) signaling pathways on TRPC6 in podocytes, which are highly terminally differentiated renal epithelial cells that are critically required for the maintenance of the glomerular filtration barrier. We applied both pharmacological inhibitors of mTOR and specific siRNAs against mTOR components to explore which mTOR signaling pathway is involved in the regulation of TRPC6 in podocytes. The podocytes were exposed to rapamycin, an inhibitor of mTORC1, and ku0063794, a dual inhibitor of mTORC1 and mTORC2. In addition, specific siRNA-mediated knockdown of the mTORC1 component raptor and the mTORC2 component rictor was employed. The TRPC6 mRNA and protein expression levels were examined via real-time quantitative PCR and Western blot, respectively. Additionally, fluorescence calcium imaging was performed to evaluate the function of TRPC6 in podocytes. Rapamycin displayed no effect on the TRPC6 mRNA or protein expression levels or TRPC6-dependent calcium influx in podocytes. However, ku0063794 down-regulated the TRPC6 mRNA and protein levels and suppressed TRPC6-dependent calcium influx in podocytes. Furthermore, knockdown of raptor did not affect TRPC6 expression or function, whereas rictor knockdown suppressed TRPC6 protein expression and TRPC6-dependent calcium influx in podocytes. These findings indicate that the mTORC2 signaling pathway regulates TRPC6 in podocytes but that the mTORC1 signaling pathway does not appear to exert an effect on TRPC6.	[Ding, Fangrui; Zhang, Xiaoyan; Li, Xuejuan; Zhang, Yanqin; Li, Baihong; Ding, Jie] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China	Peking University	Ding, J (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China.	djnc_5855@126.com		ZHANG, XIAOYAN/0000-0002-4060-2423	National Basic Research Program of China (973 Program) [2012CB517700]; National Nature Science Foundation of China [30830105, 81170657]; Nature Science Foundation of Beijing [7072080]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Beijing	The work was supported by the following: National Basic Research Program of China (973 Program, NO. 2012CB517700) JD; National Nature Science Foundation of China (NO. 30830105, 81170657) JD; and Nature Science Foundation of Beijing (NO. 7072080) JD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Goncharova EA, 2011, MOL CELL BIOL, V31, P2484, DOI 10.1128/MCB.01061-10; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jeruschke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055980; Jiang LN, 2011, EXP BIOL MED, V236, P184, DOI 10.1258/ebm.2010.010237; Kato H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064344; Kim EY, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-26; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Li Z, 2013, CELL PROLIFERAT, V46, P76, DOI 10.1111/cpr.12010; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Liu Meilian, 2011, Commun Integr Biol, V4, P382, DOI 10.4161/cib.4.4.15309; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Wang ZY, 2009, CELL PHYSIOL BIOCHEM, V24, P619, DOI 10.1159/000257517; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zhang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054918	33	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112972	10.1371/journal.pone.0112972	http://dx.doi.org/10.1371/journal.pone.0112972			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393730	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300128
J	Helps, SK; Bamford, S; Sonuga-Barke, EJS; Soderlund, GBW				Helps, Suzannah K.; Bamford, Susan; Sonuga-Barke, Edmund J. S.; Soderlund, Goran B. W.			Different Effects of Adding White Noise on Cognitive Performance of Sub-, Normal and Super-Attentive School Children	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; STOCHASTIC RESONANCE; LATENT STRUCTURE; BALANCE CONTROL; DELAY AVERSION; NETWORK MODEL; HYPERACTIVITY; STIMULATION; SENSITIVITY; DOPAMINE	Objectives: Noise often has detrimental effects on performance. However, because of the phenomenon of stochastic resonance (SR), auditory white noise (WN) can alter the "signal to noise'' ratio and improve performance. The Moderate Brain Arousal (MBA) model postulates different levels of internal "neural noise'' in individuals with different attentional capacities. This in turn determines the particular WN level most beneficial in each individual case-with one level of WN facilitating poor attenders but hindering super-attentive children. The objective of the present study is to find out if added WN affects cognitive performance differently in children that differ in attention ability. Methods: Participants were teacher-rated super-(N = 25); normal-(N = 29) and sub-attentive (N = 36) children (aged 8 to 10 years). Two non-executive function (EF) tasks (a verbal episodic recall task and a delayed verbal recognition task) and two EF tasks (a visuo-spatial working memory test and a Go-NoGo task) were performed under three WN levels. The non-WN condition was only used to control for potential differences in background noise in the group testing situations. Results: There were different effects of WN on performance in the three groups-adding moderate WN worsened the performance of super-attentive children for both task types and improved EF performance in sub-attentive children. The normal-attentive children's performance was unaffected by WN exposure. The shift from moderate to high levels of WN had little further effect on performance in any group. Significance: The predicted differential effect of WN on performance was confirmed. However, the failure to find evidence for an inverted U function challenges current theories. Alternative explanations are discussed. We propose that WN therapy should be further investigated as a possible non-pharmacological treatment for inattention.	[Helps, Suzannah K.; Bamford, Susan; Sonuga-Barke, Edmund J. S.] Univ Southampton, Dept Psychol, Inst Disorders Impulse & Attent, Southampton SO9 5NH, Hants, England; [Soderlund, Goran B. W.] Sogndal Univ Coll, Fac Teacher Educ & Sports, Sogndal, Norway; [Sonuga-Barke, Edmund J. S.] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium	University of Southampton; Ghent University	Sonuga-Barke, EJS (corresponding author), Univ Southampton, Dept Psychol, Inst Disorders Impulse & Attent, Southampton SO9 5NH, Hants, England.	ejb3@soton.ac.uk; goran.soderlund@hisf.no	Sonuga-Barke, Edmund j/D-9137-2011	Soderlund, Goran/0000-0002-5941-8431	Wellcome Trust [WT087749MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by Wellcome Trust grant reference WT087749MA, http://www.wellcome.ac.uk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abikoff H, 1996, J LEARN DISABIL, V29, P238, DOI 10.1177/002221949602900302; Barch DM, 2005, SCHIZOPHR RES, V77, P43, DOI 10.1016/j.schres.2004.12.019; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Barry RJ, 2010, CLIN NEUROPHYSIOL, V121, P1871, DOI 10.1016/j.clinph.2010.04.022; Barry RJ, 2009, BIOL PSYCHIAT, V66, P398, DOI 10.1016/j.biopsych.2009.04.027; Biederman J, 2008, J CLIN PSYCHIAT, V69, P1150, DOI 10.4088/JCP.v69n0715; Bitsakou P, 2008, J NEURAL TRANSM, V115, P261, DOI 10.1007/s00702-007-0828-z; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Breier JI, 2002, NEUROPSYCHOLOGY, V16, P28, DOI 10.1037//0894-4105.16.1.28; Broadbent D. E., 1958, EFFECTS NOISE BEHAV; Clarke AR, 2013, INT J PSYCHOPHYSIOL, V89, P314, DOI 10.1016/j.ijpsycho.2013.04.009; Coghill D, 2012, J CHILD PSYCHOL PSYC, V53, P469, DOI 10.1111/j.1469-7610.2011.02511.x; Dawes P, 2009, EAR HEARING, V30, P675, DOI 10.1097/AUD.0b013e3181b34cc5; Durlach NI, 2003, J ACOUST SOC AM, V114, P368, DOI 10.1121/1.1577562; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Frazier TW, 2007, ARCH CLIN NEUROPSYCH, V22, P197, DOI 10.1016/j.acn.2006.12.007; Geffner D, 1996, CHILD PSYCHIAT HUM D, V26, P169, DOI 10.1007/BF02353358; Gerjets P, 2002, Z KL PSYCH PSYCHOTH, V31, P99, DOI 10.1026//1616-3443.31.2.99; Graham J, 2011, EUR CHILD ADOLES PSY, V20, P17, DOI 10.1007/s00787-010-0140-6; Gray LC, 2002, INT J PEDIATR OTORHI, V66, P265, DOI 10.1016/S0165-5876(02)00251-3; Haslam N, 2006, AUST NZ J PSYCHIAT, V40, P639, DOI 10.1111/j.1440-1614.2006.01863.x; Hogan AM, 2005, DEVELOPMENTAL SCI, V8, P525, DOI 10.1111/j.1467-7687.2005.00444.x; KNUEPFER MM, 1991, CLIN EXP HYPERTENS A, V13, P505, DOI 10.3109/10641969109045066; Kobel M, 2009, EUR J PAEDIATR NEURO, V13, P516, DOI 10.1016/j.ejpn.2008.10.008; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Manjarrez E, 2007, NEUROSCI LETT, V415, P231, DOI 10.1016/j.neulet.2007.01.030; McDonnell MD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061105; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; McDonnell MD, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041107; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Mulavara AP, 2011, EXP BRAIN RES, V210, P303, DOI 10.1007/s00221-011-2633-z; Novak P, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-9; Palsson E, 2011, PSYCHOPHARMACOLOGY, V214, P675, DOI 10.1007/s00213-010-2074-6; Prince J, 2008, J CLIN PSYCHOPHARM, V28, pS39, DOI 10.1097/JCP.0b013e318174f92a; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Samoudi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029308; SCHAEFER CF, 1978, PAVLOVIAN J BIOL SCI, V13, P217; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sergeant JA, 2005, BIOL PSYCHIAT, V57, P1248, DOI 10.1016/j.biopsych.2004.09.010; Servan-Schreiber D, 1998, BIOL PSYCHIAT, V43, P713, DOI 10.1016/S0006-3223(97)00448-4; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Shidara M, 2005, EXP BRAIN RES, V163, P239, DOI 10.1007/s00221-005-2230-0; Sikstrom S, 2007, PSYCHOL REV, V114, P1047, DOI 10.1037/0033-295X.114.4.1047; Simonotto E, 1999, NEUROCOMPUTING, V26-7, P511, DOI 10.1016/S0925-2312(99)00042-9; Soderlund G, 2007, J CHILD PSYCHOL PSYC, V48, P840, DOI 10.1111/j.1469-7610.2007.01749.x; Soderlund GBW, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-55; Sonuga-Barke EJS, 2010, J AM ACAD CHILD PSY, V49, P345, DOI 10.1016/j.jaac.2009.12.018; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P387, DOI 10.1111/j.1469-7610.1992.tb00874.x; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P399, DOI 10.1111/j.1469-7610.1992.tb00875.x; Stansfeld SA, 2005, LANCET, V365, P1942, DOI 10.1016/S0140-6736(05)66660-3; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Stuart M., 1993, CHILDRENS PRINTED WO; SWANSON J, 2007, CATEGORICAL DIMENSIO; Tan HZ, 2003, J ACOUST SOC AM, V114, P3295, DOI 10.1121/1.1623788; Tomasi D, 2011, NEUROIMAGE, V54, P3101, DOI 10.1016/j.neuroimage.2010.10.060; Vandaele J, 2009, APPL COGN LINGUIST, V10, P1; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; Wells C, 2005, PSYCHOL SCI, V16, P313, DOI 10.1111/j.0956-7976.2005.01533.x; Westerberg H, 2004, CHILD NEUROPSYCHOL, V10, P155, DOI 10.1080/09297040490911014; Wiersema R, 2006, J CHILD PSYCHOL PSYC, V47, P560, DOI 10.1111/j.1469-7610.2005.01592.x; Wilkinson D, 2009, J NEUROPSYCHOL; Wilkinson D, 2008, EXP BRAIN RES, V189, P243, DOI 10.1007/s00221-008-1463-0; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Zeng FG, 2000, BRAIN RES, V869, P251, DOI 10.1016/S0006-8993(00)02475-6	68	40	42	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112768	10.1371/journal.pone.0112768	http://dx.doi.org/10.1371/journal.pone.0112768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AY6YT	25393410	Green Published, gold, Green Accepted			2022-12-26	WOS:000347709300100
J	Jiang, Y; Zhang, WT; Wang, MC; Kang, MY; Dong, MY				Jiang, Yuan; Zhang, Wentao; Wang, Mingchang; Kang, Muyi; Dong, Manyu			Radial Growth of Two Dominant Montane Conifer Tree Species in Response to Climate Change in North-Central China	PLOS ONE			English	Article							DIFFERENT ELEVATIONS; TIBETAN PLATEAU; GROWING-SEASON; PICEA-MEYERI; RING; TEMPERATURE; HISTORY; TRENDS; DATES	North-Central China is a region in which the air temperature has clearly increased for several decades. Picea meyeri and Larix principis-rupprechtii are the most dominant co-occurring tree species within the cold coniferous forest belt ranging vertically from 1800 m to 2800 m a.s.l. in this region. Based on a tree-ring analysis of 292 increment cores sampled from 146 trees at different elevations, this study aimed to examine if the radial growth of the two species in response to climate is similar, whether the responses are consistent along altitudinal gradients and which species might be favored in the future driven by the changing climate. The results indicated the following: (1) The two species grew in different rhythms at low and high elevation respectively; (2) Both species displayed inconsistent relationships between radial growth and climate data along altitudinal gradients. The correlation between radial growth and the monthly mean temperature in the spring or summer changed from negative at low elevation into positive at high elevation, whereas those between the radial growth and the total monthly precipitation displayed a change from positive into negative along the elevation gradient. These indicate the different influences of the horizontal climate and vertical mountainous climate on the radial growth of the two species; (3) The species-dependent different response to climate in radial growth appeared mainly in autumn of the previous year. The radial growth of L. principis-rupprechtii displayed negative responses both to temperature and to precipitation in the previous September, October or November, which was not observed in the radial growth of P. meyeri. (4) The radial growth of both species will tend to be increased at high elevation and limited at low elevation, and L. principis-rupprechtii might be more favored in the future, if the temperature keeps rising.	[Jiang, Yuan; Zhang, Wentao; Wang, Mingchang; Kang, Muyi; Dong, Manyu] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China; [Jiang, Yuan] Beijing Normal Univ, Key Lab Tradit Chinese Med Protect & Utilizat, Beijing 100875, Peoples R China; [Jiang, Yuan; Zhang, Wentao; Wang, Mingchang; Kang, Muyi] Beijing Normal Univ, Coll Resources Sci & Technol, Beijing 100875, Peoples R China; [Zhang, Wentao] Beijing Municipal Res Inst Environm Protect, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Municipal Research Institute of Environment	Zhang, WT (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource, Beijing 100875, Peoples R China.	ecozhangwt@gmail.com	jiang, anyi/GPT-0379-2022; Zhang, Wentao/AAI-1047-2019		National Natural Science Foundation of China [41171067, 41271059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (number 41171067 and 41271059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai J, 2011, ADV ATMOS SCI, V28, P564, DOI 10.1007/s00376-010-9219-8; Brauning A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020793; Cai QF, 2013, DENDROCHRONOLOGIA, V31, P311, DOI 10.1016/j.dendro.2012.07.003; Carrer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050755; [常锦峰 CHANG Jinfeng], 2009, [山地学报, Journal of Mountain Science], V27, P703; Cook E.R., 2005, PROGRAM ARSTAN TREE; Cook ER, 1990, METHODS DENDROCHRONO, DOI DOI 10.1007/978-94-015-7879-0; Cook ER, 1985, THESIS U ARIZONA TUC; Cui H, 2005, RES MOUNTAINS ECOLOG; [戴君虎 Dai Junhu], 2005, [第四纪研究, Quaternary Sciences], V25, P216; de Luis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083550; Domros M., 1988, CLIMATE CHINA, DOI 10.1007/978-3-642-73333-8; Dong MY, 2013, THEOR APPL CLIMATOL, V111, P693, DOI 10.1007/s00704-012-0706-y; Fang J., 2011, ATLAS WOODY PLANTS C, V1; Fang KY, 2009, IAWA J, V30, P443, DOI 10.1163/22941932-90000231; FRITTS H C, 1975, Tree-Ring Bulletin, V35, P31; Fritts H.C, 1976, TREE RINGS CLIMATE; Fritts HC, 1962, TREE RING B, V24, P9; Fritts HC., 1991, RECONSTRUCTION LARGE; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; He S, 1993, FLORA BEIJING; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Hughes MK, 2011, DEV PALEOENVIRON RES, V11, P17, DOI 10.1007/978-1-4020-5725-0_2; KIMBALL KD, 1988, CAN J FOREST RES, V18, P385, DOI 10.1139/x88-057; Knapp PA, 2012, GLOBAL PLANET CHANGE, V92-93, P257, DOI 10.1016/j.gloplacha.2012.06.002; Liang EY, 2001, TREES-STRUCT FUNCT, V15, P230, DOI 10.1007/s004680100097; Littell JS, 2008, ECOL MONOGR, V78, P349, DOI 10.1890/07-0712.1; Liu BH, 2010, CLIMATIC CHANGE, V99, P93, DOI 10.1007/s10584-009-9662-7; Liu HY, 2013, AGR FOREST METEOROL, V178, P1, DOI 10.1016/j.agrformet.2013.04.022; Liu L, 1996, VEGETATION HEBEI; Liu Y, 2003, CHINESE SCI BULL, V48, P1140, DOI 10.1360/02wd0455; Ma Z, 2001, VEGETATION SHANXI; National Soil Survey Office, 1995, ANN SOIL SPEC CHIN; Pallardy SG, 2008, PHYSIOLOGY OF WOODY PLANTS, 3RD EDITION, P1; Piao SL, 2011, GLOBAL CHANGE BIOL, V17, P3228, DOI 10.1111/j.1365-2486.2011.02419.x; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Piovesan G, 2005, ACTA OECOL, V27, P197, DOI 10.1016/j.actao.2005.01.001; Poulter B, 2013, AGR FOREST METEOROL, V178, P31, DOI 10.1016/j.agrformet.2012.12.006; Schweingruber F.H., 1989, TREE RINGS BASICS AP; SCHWEINGRUBER FH, 1987, NATURWISSENSCHAFTEN, V74, P205, DOI 10.1007/BF00424589; Shao X., 1994, ACTA GEOGRAPHICA SIN, V49, P174, DOI [10.11821/xb199402009, DOI 10.11821/XB199402009]; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Song YL, 2010, INT J CLIMATOL, V30, P33, DOI 10.1002/joc.1868; Soule PT, 2013, J ARID ENVIRON, V94, P87, DOI 10.1016/j.jaridenv.2013.02.005; Sun Y, 2010, SCI CHINA EARTH SCI, V53, P871, DOI 10.1007/s11430-010-0056-5; Therrell MD, 2006, CLIM DYNAM, V26, P677, DOI 10.1007/s00382-005-0108-2; Wieser G., 2007, Trees at their upper limit: treelife limitation at the Alpine timberline, P1; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Wu C.-Y., 1980, VEGETATION CHINA; Wu X, 1997, PROG GEOGR, V16, P51; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhang Wen-Tao, 2013, Chinese Journal of Plant Ecology, V37, P1142, DOI 10.3724/SP.J.1258.2013.00117; [朱海峰 Zhu Haifeng], 2004, [地理学报, Acta Geographica Sinica], V59, P863	55	20	23	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112537	10.1371/journal.pone.0112537	http://dx.doi.org/10.1371/journal.pone.0112537			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393738	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300066
J	Larsson, GL; Helenius, G; Sorbe, B; Karlsson, MG				Larsson, Gabriella Lillsunde; Helenius, Gisela; Sorbe, Bengt; Karlsson, Mats G.			Viral Load, Integration and Methylation of E2BS3 and 4 in Human Papilloma Virus (HPV) 16-Positive Vaginal and Vulvar Carcinomas	PLOS ONE			English	Article							RISK HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; PHYSICAL STATE; TYPE-16 DNA; IN-SITU; E2 PROTEIN; NATURAL-HISTORY; CPG METHYLATION; E6 PROMOTER; WOMEN	Objective: To investigate if viral load, integration and methylation of E2BS3 and 4 represent different ways of tumor transformation in vaginal and vulvar carcinoma and to elucidate its clinical impact. Methods: Fifty-seven samples, positive for HPV16, were selected for the study. Detection of viral load was made with realtime-PCR using copy numbers of E6 and integration was calculated from comparing E2 to E6-copies. Methylation of E2BS3 and 4 was analysed using bisulphite treatment of tumor DNA, followed by PCR and pyrosequencing. Results: Vaginal tumors were found to have a higher viral load (p=0.024) compared to vulvar tumors but a high copy number (> median value, 15 000) as well as high methylation (> 50%) was significantly (p=0.010 and p=0.045) associated with a worse cancer-specific survival rate in vulvar carcinoma, but not in vaginal carcinoma. Four groups could be defined for the complete series using a Cluster Two step analysis; (1) tumors holding episomal viral DNA, viral load below 150 000 copies not highly methylated (n=25, 46.3%); (2) tumors harboring episomal viral DNA and being highly methylated (>50%; n=6, 11.1%); (3) tumors with viral DNA fully integrated (n=11, 20.4%), and (4) tumors harboring episomal viral DNA and being medium-or unmethylated (< 50%) and having a high viral load (> total mean value 150 000; n=12, 22.2%). The completely integrated tumors were found to be distinct group, whilst some overlap between the groups with high methylation and high viral load was observed. Conclusion: HPV16-related integration, methylation in E2BS3 and 4 and viral load may represent different viral characteristics driving vaginal and vulvar carcinogenesis. HPV16-related parameters were found to be of clinical importance in the vulvar series only.	[Larsson, Gabriella Lillsunde; Helenius, Gisela; Karlsson, Mats G.] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden; [Larsson, Gabriella Lillsunde; Helenius, Gisela; Karlsson, Mats G.] Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Sorbe, Bengt] Orebro Univ Hosp, Dept Oncol, Orebro, Sweden	Orebro University; Orebro University; Orebro University	Larsson, GL (corresponding author), Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden.	gabriella.lillsunde-larsson@orebroll.se	Karlsson, Mats G/AAV-7542-2021	Karlsson, Mats G/0000-0001-6881-237X; Lillsunde Larsson, Gabriella/0000-0001-9992-266X	Orebro County Council Research Committee [OLL-324811, OLL-259341]	Orebro County Council Research Committee	The work was funded by the Orebro County Council Research Committee, OLL-324811 (GLL) and OLL-259341 (GLL), http://www.fou.nu/is/oll. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloul N, 1999, J GEN VIROL, V80, P29, DOI 10.1099/0022-1317-80-1-29; Andersson S, 2005, BRIT J CANCER, V92, P2195, DOI 10.1038/sj.bjc.6602648; [Anonymous], 2012, CANC INC SWED 2011; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; Bernard HU, 2002, ANTIVIR THER, V7, P219; Bhattacharjee B, 2006, GYNECOL ONCOL, V100, P372, DOI 10.1016/j.ygyno.2005.09.016; Chaiwongkot A, 2013, INT J CANCER, V132, P2087, DOI 10.1002/ijc.27906; Cheung JLK, 2013, GYNECOL ONCOL, V131, P374, DOI 10.1016/j.ygyno.2013.08.026; Collins SI, 2009, CANCER RES, V69, P3828, DOI 10.1158/0008-5472.CAN-08-3099; Constandinou-Williams C, 2010, CANCER EPIDEM BIOMAR, V19, P832, DOI 10.1158/1055-9965.EPI-09-0838; Cricca M, 2007, GYNECOL ONCOL, V106, P549, DOI 10.1016/j.ygyno.2007.05.004; Daniel B, 1997, J GEN VIROL, V78, P1095, DOI 10.1099/0022-1317-78-5-1095; DAS BC, 1992, J GEN VIROL, V73, P2327, DOI 10.1099/0022-1317-73-9-2327; Das D, 2010, VIROLOGY, V402, P197, DOI 10.1016/j.virol.2010.03.030; Das Ghosh D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044678; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Ding DC, 2009, EUR J OBSTET GYN R B, V147, P215, DOI 10.1016/j.ejogrb.2009.08.023; DOWHANICK JJ, 1995, J VIROL, V69, P7791, DOI 10.1128/JVI.69.12.7791-7799.1995; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Grodzki M, 2006, CANCER EPIDEM BIOMAR, V15, P820, DOI 10.1158/1055-9965.EPI-05-0864; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Johannsen E, 2013, VIROLOGY, V445, P205, DOI 10.1016/j.virol.2013.07.016; Josefsson AM, 2000, LANCET, V355, P2189, DOI 10.1016/S0140-6736(00)02401-6; Kalantari M, 2001, DIAGN MOL PATHOL, V10, P46, DOI 10.1097/00019606-200103000-00008; Kammer C, 2002, BRIT J CANCER, V86, P269, DOI 10.1038/sj.bjc.6600024; Kim K, 2003, J VIROL, V77, P12450, DOI 10.1128/JVI.77.23.12450-12459.2003; Kulmala SMA, 2006, J CLIN PATHOL, V59, P513, DOI 10.1136/jcp.2004.024570; Larsson GL, 2013, GYNECOL ONCOL, V129, P406, DOI 10.1016/j.ygyno.2013.02.004; Larsson GL, 2012, INT J GYNECOL CANCER, V22, P1413, DOI 10.1097/IGC.0b013e31826a0471; Mazumder D, 2011, GYNECOL ONCOL, V123, P597, DOI 10.1016/j.ygyno.2011.08.004; Mirabello L, 2013, INT J CANCER, V132, P1412, DOI 10.1002/ijc.27750; Moberg M, 2005, BRIT J CANCER, V92, P891, DOI 10.1038/sj.bjc.6602436; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Peitsaro P, 2002, J CLIN MICROBIOL, V40, P886, DOI 10.1128/JCM.40.3.886-891.2002; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Rajeevan MS, 2006, J VIROL METHODS, V138, P170, DOI 10.1016/j.jviromet.2006.08.012; ROMANCZUK H, 1990, J VIROL, V64, P2849, DOI 10.1128/JVI.64.6.2849-2859.1990; Ruutu MP, 2008, CLIN BIOCHEM, V41, P423, DOI 10.1016/j.clinbiochem.2007.12.014; Sathish N, 2004, GYNECOL ONCOL, V95, P363, DOI 10.1016/j.ygyno.2004.08.025; Saunier M, 2008, J CLIN MICROBIOL, V46, P3678, DOI 10.1128/JCM.01212-08; Shukla S, 2014, INDIAN J MED RES, V139, P531; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Sundstrom K, 2013, CANCER EPIDEM BIOMAR, V22, P150, DOI 10.1158/1055-9965.EPI-12-0953-T; TAN SH, 1994, J VIROL, V68, P6411, DOI 10.1128/JVI.68.10.6411-6420.1994; TAN SH, 1992, NUCLEIC ACIDS RES, V20, P251, DOI 10.1093/nar/20.2.251; Thain A, 1996, J VIROL, V70, P7233, DOI 10.1128/JVI.70.10.7233-7235.1996; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Tommasino M, 2014, SEMIN CANCER BIOL, V26, P13, DOI 10.1016/j.semcancer.2013.11.002; Valmary-Degano S, 2013, HUM PATHOL, V44, P992, DOI 10.1016/j.humpath.2012.08.019; Vinokurova S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024451; Wells SI, 2000, EMBO J, V19, P5762, DOI 10.1093/emboj/19.21.5762; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Xue Yuezhen, 2012, Open Virol J, V6, P163, DOI 10.2174/1874357901206010163; YEE C, 1985, AM J PATHOL, V119, P361; Ylitalo N, 2000, LANCET, V355, P2194, DOI 10.1016/S0140-6736(00)02402-8	57	10	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112839	10.1371/journal.pone.0112839	http://dx.doi.org/10.1371/journal.pone.0112839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393237	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300111
J	Wang, P; Lu, MC; Yu, CW; Yan, YH				Wang, Panchalli; Lu, Mei-Chun; Yu, Cheng-Wei; Yan, Yuan-Horng			Influence of the Time of Day and Fasting Duration on Glucose Level following a 1-Hour, 50-Gram Glucose Challenge Test in Pregnant Women	PLOS ONE			English	Article							GESTATIONAL DIABETES-MELLITUS; AL. CIRCADIAN VARIATION; CARE 2012/35/1578-1584; DIURNAL-VARIATION; WEIGHT-GAIN; LAST MEAL; TOLERANCE; POPULATION; DIAGNOSIS; HYPERGLYCEMIA	Background: Previous studies have shown that the time of day (TD) of glucose measurement and the fasting duration (FD) influence the glucose levels in adults. Few studies have examined the effects of the TD and FD on the glucose level following a 1-hour, 50-gram glucose challenge test (GCT) in pregnant women in screening for or diagnosing gestational diabetes mellitus (GDM). The objective of this study was to investigate the influence of the TD (morning, afternoon, night) and the FD (the time of the last food ingestion as follows: <= 1 hour, 1-2 hours, and >2 hours) by examining their combined effects on the glucose levels following a 50-gram GCT in pregnant women. Methods and Results: We analyzed the data of 1,454 non-diabetic pregnant Taiwanese women in a prospective study. Multiple linear regression and multiple logistic regression were used to estimate the relationships between the 9 TD-FD groups and the continuous and binary glucose levels (cut-off at 140 mg/dL) following a 50-gram GCT, after adjusting for maternal age, nulliparity, pre-pregnancy body mass index, and weight gain. Different TD and FD groups were associated with variable glucose responses to the 50-gram GCT, some of which were significant. The estimate coefficients (b) of the TDFD groups "night, <= 1 hr'' and "night, 1-2 hr'' revealed significantly lower glucose concentrations [b (95% confidence interval [CI]): -6.46 (-12.53, -0.38) and -6.85 (-12.50, -1.20)] compared with the "morning, >2 hr'' group. The TD-FD groups "afternoon, <= 1 hr'' and "afternoon, 1-2 hr'' showed significantly lower odds ratios (OR) of a positive GCT; the adjusted ORs (95% CI) were 0.54 (0.31-0.95) and 0.58 (0.35-0.96), respectively. Conclusions: Our findings demonstrate the importance of standardizing the TD and FD for the 1-hour, 50-gram GCT. In screening for and diagnosing GDM, the TD and FD are modifiable factors that should be considered in clinical practice and epidemiological studies.	[Wang, Panchalli; Lu, Mei-Chun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Obstet & Gynecol, Chiayi, Taiwan; [Lu, Mei-Chun; Yan, Yuan-Horng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan; [Yu, Cheng-Wei] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Nutr, Chiayi, Taiwan; [Yan, Yuan-Horng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan; [Yan, Yuan-Horng] Natl Taiwan Univ, Coll Publ Hlth, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan	National Taiwan University	Yan, YH (corresponding author), Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan.	d97841006@ntu.edu.tw						Aparicio NJ, 1998, AM J OBSTET GYNECOL, V178, P1059, DOI 10.1016/S0002-9378(98)70548-4; Baptiste-Roberts K, 2011, J WOMENS HEALTH, V20, P1847, DOI 10.1089/jwh.2010.2377; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; d'Emden M, 2014, DIABETES CARE, V37, pE30, DOI 10.2337/dc13-2234; Dokus K, 2013, DIABETES CARE, V36, pE38, DOI 10.2337/dc12-1658; Emberson JR, 2002, ANN CLIN BIOCHEM, V39, P493, DOI 10.1258/000456302320314511; Goldberg RJ, 2013, DIABETES CARE, V36, pE39, DOI 10.2337/dc12-2017; Goldberg RJ, 2012, DIABETES CARE, V35, P1578, DOI 10.2337/dc11-2217; Guillemette L, 2014, J CLIN ENDOCR METAB, V99, P1862, DOI 10.1210/jc.2013-4016; Hulman A, 2013, DIABETOLOGIA, V56, P294, DOI 10.1007/s00125-012-2770-3; JARRETT RJ, 1969, BRIT MED J, V2, P341, DOI 10.1136/bmj.2.5653.341; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082310; Lowe WL, 2014, DIABETIC MED, V31, P254, DOI 10.1111/dme.12352; MAYER KH, 1976, DIABETES, V25, P936, DOI 10.2337/diabetes.25.10.936; McElduff A, 2002, MED J AUSTRALIA, V176, P136, DOI 10.5694/j.1326-5377.2002.tb04327.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Miyakoshi K, 2003, DIABETES RES CLIN PR, V60, P63, DOI 10.1016/S0168-8227(02)00274-7; Moebus S, 2011, EUR J EPIDEMIOL, V26, P719, DOI 10.1007/s10654-011-9608-z; OSULLIVA.JB, 1966, AM J CLIN NUTR, V19, P345, DOI 10.1093/ajcn/19.5.345; Scholtens DM, 2014, DIABETES CARE, V37, P158, DOI 10.2337/dc13-0989; SERMER M, 1994, AM J OBSTET GYNECOL, V171, P607, DOI 10.1016/0002-9378(94)90072-8; Sommer C, 2014, INT J OBESITY, V38, P76, DOI 10.1038/ijo.2013.185; Tomedi LE, 2013, MATERN CHILD HLTH J; Troisi RJ, 2000, JAMA-J AM MED ASSOC, V284, P3157, DOI 10.1001/jama.284.24.3157; Worster Andrew, 2007, CJEM, V9, P111; Yee LM, 2011, J MATERN-FETAL NEO M, V24, P1102, DOI 10.3109/14767058.2010.546450; Yogev Y, 2004, AM J OBSTET GYNECOL, V191, P949, DOI 10.1016/j.ajog.2004.06.059	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112526	10.1371/journal.pone.0112526	http://dx.doi.org/10.1371/journal.pone.0112526			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393415	Green Submitted, gold, Green Published			2022-12-26	WOS:000347709300063
J	Chen, JC; Yang, ST; Lin, CY; Hsu, CJ; Tsai, CH; Su, JL; Tang, CH				Chen, Jui-Chieh; Yang, Shu-Ting; Lin, Chih-Yang; Hsu, Chin-Jung; Tsai, Chun-Hao; Su, Jen-Liang; Tang, Chih-Hsin			BMP-7 Enhances Cell Migration and alpha v beta 3 Integrin Expression via a c-Src-Dependent Pathway in Human Chondrosarcoma Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-7; METASTATIC PROSTATE-CANCER; CLINICAL-SIGNIFICANCE; GASTRIC-CANCER; UP-REGULATION; INVASION; CARCINOMA; APOPTOSIS; PI3K/AKT; TUMOR	Bone morphogenic protein (BMP)-7 is a member of the transforming growth factor (TGF)-beta superfamily, which is originally identified based on its ability to induce cartilage and bone formation. In recent years, BMP-7 is also defined as a potent promoter of cell motility, invasion, and metastasis. However, there is little knowledge of the role of BMP-7 and its cellular function in chondrosarcoma cells. In the present study, we investigated the biological impact of BMP-7 on cell motility using transwell assay. In addition, the intracellular signaling pathways were also investigated by pharmacological and genetic approaches. Our results demonstrated that treatment with exogenous BMP-7 markedly increased cell migration by activating c-Src/PI3K/Akt/IKK/NF-kappa B signaling pathway, resulting in the transactivation of alpha v beta 3 integrin expression. Indeed, abrogation of signaling activation, by chemical inhibition or expression of a kinase dead form of the protein attenuated BMP-7-induced expression of integrin alpha v beta 3 and cell migration. These findings may provide a useful tool for diagnostic/prognostic purposes and even therapeutically in late-stage chondrosarcoma as an anti-metastatic agent.	[Chen, Jui-Chieh] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan; [Chen, Jui-Chieh; Lin, Chih-Yang; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chen, Jui-Chieh; Su, Jen-Liang] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan; [Yang, Shu-Ting] China Med Univ, Sch Pharm, Taichung, Taiwan; [Hsu, Chin-Jung] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Hsu, Chin-Jung; Tsai, Chun-Hao] China Med Univ Hosp, Dept Orthoped Surg, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ, Dept Med, Taichung, Taiwan; [Tsai, Chun-Hao] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Su, Jen-Liang; Tang, Chih-Hsin] Asia Univ, Coll Hlth Sci, Dept Biotechnol, Taichung, Taiwan; [Su, Jen-Liang] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Su, Jen-Liang] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan	National Chiayi University; China Medical University Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan	Su, JL (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Miaoli County, Taiwan.	jlsu@nhri.org.tw; chtang@mail.cmu.edu.tw	é, çå/HCH-5712-2022; Tang, Chih Hsin/O-5212-2015; Tsai, Chun-Hao/H-3140-2013	Tang, Chih Hsin/0000-0002-7113-8352; Tsai, Chun-Hao/0000-0002-4428-3132	National Science Council of Taiwan [MOST 103-2628-B-039-002-MY3]; China Medical University Hospital [DMR-103-059]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital	This work was supported by grants from the National Science Council of Taiwan (MOST 103-2628-B-039-002-MY3) and China Medical University Hospital (DMR-103-059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarmo EL, 2008, ANN ONCOL, V19, P308, DOI 10.1093/annonc/mdm453; Alarmo EL, 2009, CANCER LETT, V275, P35, DOI 10.1016/j.canlet.2008.09.028; Aoki M, 2011, BRIT J CANCER, V104, P714, DOI 10.1038/sj.bjc.6606075; Araujo J, 2009, INT J CANCER, V124, P1, DOI 10.1002/ijc.23998; Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Boeuf S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-488; Breen MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072407; Buijs JT, 2009, CANCER LETT, V273, P177, DOI 10.1016/j.canlet.2008.05.044; Chen JC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/396839; Feeley BT, 2005, J BONE MINER RES, V20, P2189, DOI 10.1359/JBMR.050802; Fong YC, 2008, J CELL PHYSIOL, V217, P846, DOI 10.1002/jcp.21568; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Ganguly KK, 2013, CELL ADHES MIGR, V7, P251, DOI 10.4161/cam.23840; Ghert MA, 2002, J ORTHOP RES, V20, P834, DOI 10.1016/S0736-0266(01)00172-3; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Guo W, 1999, CLIN ORTHOP RELAT R, P175; Hao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090748; Kang MH, 2011, EXP CELL RES, V317, P1746, DOI 10.1016/j.yexcr.2011.04.006; Katsuno Y, 2008, ONCOGENE, V27, P6322, DOI 10.1038/onc.2008.232; Kazuo M, 2008, ANN SURG ONCOL, V15, P1530, DOI 10.1245/s10434-007-9746-4; Korpal M, 2010, EUR J CANCER, V46, P1232, DOI 10.1016/j.ejca.2010.02.040; Li W, 2013, TUMOR BIOL, V34, P669, DOI 10.1007/s13277-012-0594-x; Liu YN, 2012, INT J MOL MED, V29, P1016, DOI 10.3892/ijmm.2012.948; Maegdefrau U, 2012, EXP MOL PATHOL, V92, P74, DOI 10.1016/j.yexmp.2011.10.004; Masuda H, 2003, PROSTATE, V54, P268, DOI 10.1002/pros.10193; Megumi K, 2012, ANN SURG ONCOL, V19, P2066, DOI 10.1245/s10434-011-2024-5; Melisi D, 2008, MOL CANCER THER, V7, P829, DOI 10.1158/1535-7163.MCT-07-0337; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Ristiniemi J, 2007, J BONE JOINT SURG BR, V89B, P265, DOI 10.1302/0301-620X.89B2.18230; Rothhammer Tania, 2007, Cancer Biomarkers, V3, P111; Scully SP, 2000, CLIN ORTHOP RELAT R, P291; Shimizu T, 2012, BIOCHEM BIOPH RES CO, V417, P869, DOI 10.1016/j.bbrc.2011.12.064; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tang CH, 2012, BIOMEDICINE-TAIWAN, V2, P92, DOI 10.1016/j.biomed.2012.01.001; Wang ZH, 2013, CELL BIOCHEM BIOPHYS, V67, P567, DOI 10.1007/s12013-013-9543-6; Weber KL, 1998, J ORTHOPAED RES, V16, P8, DOI 10.1002/jor.1100160103; Wong WKP, 2005, AM J RESP CELL MOL, V33, P438, DOI 10.1165/rcmb.2005-0103OC; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Xu GH, 2013, DIGEST DIS SCI, V58, P1871, DOI 10.1007/s10620-013-2611-3; Ye L, 2011, FRONT BIOSCI-LANDMRK, V16, P865, DOI 10.2741/3725; Yeh YY, 2008, BIOCHEM PHARMACOL, V75, P1292, DOI 10.1016/j.bcp.2007.11.017; Yin MC, 2012, BIOMEDICINE-TAIWAN, V2, P2, DOI 10.1016/j.biomed.2011.12.001	44	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112636	10.1371/journal.pone.0112636	http://dx.doi.org/10.1371/journal.pone.0112636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390068	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400114
J	Khalil, H; Olsson, G; Ecke, F; Evander, M; Hjertqvist, M; Magnusson, M; Lofvenius, MO; Hornfeldt, B				Khalil, Hussein; Olsson, Gert; Ecke, Frauke; Evander, Magnus; Hjertqvist, Marika; Magnusson, Magnus; Lofvenius, Mikaell Ottosson; Hornfeldt, Birger			The Importance of Bank Vole Density and Rainy Winters in Predicting Nephropathia Epidemica Incidence in Northern Sweden	PLOS ONE			English	Article							HUMAN HANTAVIRUS INFECTIONS; PUUMALA VIRUS-INFECTION; CLETHRIONOMYS-GLAREOLUS; SEED PRODUCTION; CLIMATE; ANTIBODY; POPULATIONS; DYNAMICS; OUTBREAK; RODENTS	Pathogenic hantaviruses (family Bunyaviridae, genus Hantavirus) are rodent-borne viruses causing hemorrhagic fever with renal syndrome (HFRS) in Eurasia. In Europe, there are more than 10,000 yearly cases of nephropathia epidemica (NE), a mild form of HFRS caused by Puumala virus (PUUV). The common and widely distributed bank vole (Myodes glareolus) is the host of PUUV. In this study, we aim to explain and predict NE incidence in boreal Sweden using bank vole densities. We tested whether the number of rainy days in winter contributed to variation in NE incidence. We forecast NE incidence in July 2013-June 2014 using projected autumn vole density, and then considering two climatic scenarios: 1) rain-free winter and 2) winter with many rainy days. Autumn vole density was a strong explanatory variable of NE incidence in boreal Sweden in 1990-2012 (R-2 = 79%, p < 0.001). Adding the number of rainy winter days improved the model (R-2 = 84%, p < 0.05). We report for the first time that risk of NE is higher in winters with many rainy days. Rain on snow and ground icing may block vole access to subnivean space. Seeking refuge from adverse conditions and shelter from predators, voles may infest buildings, increasing infection risk. In a rainy winter scenario, we predicted 812 NE cases in boreal Sweden, triple the number of cases predicted in a rain-free winter in 2013/2014. Our model enables identification of high risk years when preparedness in the public health sector is crucial, as a rainy winter would accentuate risk.	[Khalil, Hussein; Olsson, Gert; Ecke, Frauke; Magnusson, Magnus; Hornfeldt, Birger] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Ecke, Frauke] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Evander, Magnus] Umea Univ, Dept Clin Microbiol, Div Virol, Umea, Sweden; [Hjertqvist, Marika] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Lofvenius, Mikaell Ottosson] Swedish Univ Agr Sci, Dept Forest Ecol & Management, S-90183 Umea, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Umea University; Swedish Institute for Infectious Disease Control; Swedish University of Agricultural Sciences	Khalil, H (corresponding author), Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	Hussein.khalil@slu.sei	Ecke, Frauke/AAW-6468-2021; Magnusson, Magnus/L-2072-2018; Evander, Magnus/AAF-5665-2019	Ecke, Frauke/0000-0003-4208-345X; Magnusson, Magnus/0000-0001-7275-9006; Evander, Magnus/0000-0001-6034-4807	Swedish Research Council Formas [221-2012-1568]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	Funding was received from Swedish Research Council Formas (grant no. 221-2012-1568: http://www.formas.5e/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; Chomel BB, 2007, EMERG INFECT DIS, V13, P6, DOI 10.3201/eid1301.060480; Clement J, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-1; Evander M, 2009, GLOB HLTH ACTION, DOI [10.3402/gha.v2i0.2020, DOI 10.3402/GHA.V2I0.2020]; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; HORNFELDT B, 1994, ECOLOGY, V75, P791, DOI 10.2307/1941735; JENSEN TS, 1982, OECOLOGIA, V54, P184, DOI 10.1007/BF00378391; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Klempa B, 2009, CLIN MICROBIOL INFEC, V15, P518, DOI 10.1111/j.1469-0691.2009.02848.x; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; Kuenzi AJ, 2001, AM J TROP MED HYG, V64, P137, DOI 10.4269/ajtmh.2001.64.137; Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-55; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; NIKLASSON B, 1995, AM J TROP MED HYG, V53, P134, DOI 10.4269/ajtmh.1995.53.134; Olsson GE, 2005, VECTOR-BORNE ZOONOT, V5, P315, DOI 10.1089/vbz.2005.5.315; Olsson GE, 2003, J WILDLIFE DIS, V39, P299, DOI 10.7589/0090-3558-39.2.299; Olsson GE, 2003, EMERG INFECT DIS, V9, P1395, DOI 10.3201/eid0911.030275; Olsson GE, 2010, VECTOR-BORNE ZOONOT, V10, P549, DOI 10.1089/vbz.2009.0138; Olsson GE, 2009, EMERG INFECT DIS, V15, P104, DOI 10.3201/eid1501.080502; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Pettersson L, 2008, EMERG INFECT DIS, V14, P808, DOI 10.3201/eid1405.071124; Porkert J, 1975, WINTER LYNX, V17; Public Health Agency of Sweden [Internet], 2014, FOLKH NEPHR EP STAT; R Core Team, 2021, R LANGUAGE ENV STAT; Settergren B, 2000, SCAND J INFECT DIS, V32, P125, DOI 10.1080/003655400750045204; Tersago K, 2009, EPIDEMIOL INFECT, V137, P250, DOI 10.1017/S0950268808000940; Tersago K, 2011, EPIDEMIOL INFECT, V139, P381, DOI 10.1017/S0950268810000956; Tkadlec E, 1998, EVOL ECOL, V12, P191, DOI 10.1023/A:1006583713042; Vaheri A, 2013, REV MED VIROL, V23, P35, DOI 10.1002/rmv.1722; Vanwambeke SO, 2007, ECOHEALTH, V4, P37, DOI 10.1007/s10393-007-0085-5; Voutilainen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039452; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Yahnke CJ, 2001, AM J TROP MED HYG, V65, P768, DOI 10.4269/ajtmh.2001.65.768	40	18	20	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111663	10.1371/journal.pone.0111663	http://dx.doi.org/10.1371/journal.pone.0111663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391132	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400028
J	Valente, G; Pitto, L; Testi, D; Seth, A; Delp, SL; Stagni, R; Viceconti, M; Taddei, F				Valente, Giordano; Pitto, Lorenzo; Testi, Debora; Seth, Ajay; Delp, Scott L.; Stagni, Rita; Viceconti, Marco; Taddei, Fulvia			Are Subject-Specific Musculoskeletal Models Robust to the Uncertainties in Parameter Identification?	PLOS ONE			English	Article							LOWER-LIMB; CONTACT FORCES; MUSCLE FORCES; NORMAL WALKING; MOMENT ARMS; HUMAN GAIT; IN-VIVO; JOINT; KNEE; HIP	Subject-specific musculoskeletal modeling can be applied to study musculoskeletal disorders, allowing inclusion of personalized anatomy and properties. Independent of the tools used for model creation, there are unavoidable uncertainties associated with parameter identification, whose effect on model predictions is still not fully understood. The aim of the present study was to analyze the sensitivity of subject-specific model predictions (i.e., joint angles, joint moments, muscle and joint contact forces) during walking to the uncertainties in the identification of body landmark positions, maximum muscle tension and musculotendon geometry. To this aim, we created an MRI-based musculoskeletal model of the lower limbs, defined as a 7-segment, 10-degree-of-freedom articulated linkage, actuated by 84 musculotendon units. We then performed a Monte-Carlo probabilistic analysis perturbing model parameters according to their uncertainty, and solving a typical inverse dynamics and static optimization problem using 500 models that included the different sets of perturbed variable values. Model creation and gait simulations were performed by using freely available software that we developed to standardize the process of model creation, integrate with OpenSim and create probabilistic simulations of movement. The uncertainties in input variables had a moderate effect on model predictions, as muscle and joint contact forces showed maximum standard deviation of 0.3 times body-weight and maximum range of 2.1 times body-weight. In addition, the output variables significantly correlated with few input variables (up to 7 out of 312) across the gait cycle, including the geometry definition of larger muscles and the maximum muscle tension in limited gait portions. Although we found subject-specific models not markedly sensitive to parameter identification, researchers should be aware of the model precision in relation to the intended application. In fact, force predictions could be affected by an uncertainty in the same order of magnitude of its value, although this condition has low probability to occur.	[Valente, Giordano; Pitto, Lorenzo; Taddei, Fulvia] Rizzoli Orthopaed Inst, Med Technol Lab, Bologna, Italy; [Testi, Debora] SCS Srl, BioComp Competence Ctr, Bologna, Italy; [Seth, Ajay; Delp, Scott L.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Delp, Scott L.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Stagni, Rita] Univ Bologna, Dept Elect Elect & Informat Engn, Bologna, Italy; [Viceconti, Marco] Univ Sheffield, Dept Mech Engn, Sheffield, S Yorkshire, England; [Viceconti, Marco] Univ Sheffield, INSIGNEO Inst Silico Med, Sheffield, S Yorkshire, England	IRCCS Istituto Ortopedico Rizzoli; Stanford University; Stanford University; University of Bologna; University of Sheffield; University of Sheffield	Valente, G (corresponding author), Rizzoli Orthopaed Inst, Med Technol Lab, Bologna, Italy.	valente@tecno.ior.it	Stagni, Rita/I-4070-2014; Valente, Giordano/C-9808-2019; Valente, Giordano/AAE-7225-2022; Viceconti, Marco/N-9164-2013; Viceconti, Marco/ABG-5546-2020; Stagni, Rita/ABD-8948-2020; Taddei, Fulvia/K-4537-2018	Stagni, Rita/0000-0002-3352-1406; Valente, Giordano/0000-0001-9340-8192; Valente, Giordano/0000-0001-9340-8192; Viceconti, Marco/0000-0002-2293-1530; Viceconti, Marco/0000-0002-2293-1530; Stagni, Rita/0000-0002-3352-1406; Pitto, Lorenzo/0000-0003-3044-5011; Taddei, Fulvia/0000-0002-8342-7434; Delp, Scott/0000-0002-9643-7551; Seth, Ajay/0000-0003-4217-1580	EU [FP7-ICT-248189, FP7-ICT-223865]; EU-funded VPHOP project [FP7-ICT-223865]	EU(European Commission); EU-funded VPHOP project	This study was supported by the EU-funded NMS Physiome project (FP7-ICT-248189), and supported in part by the EU-funded VPHOP project (FP7-ICT-223865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Debora Testi is employed by BioComputing Competence Centre, SCS s.r.l. BioComputing Competence Centre, SCS s.r.l. provided support in the form of salary for author DT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ackland DC, 2012, J BIOMECH, V45, P1463, DOI 10.1016/j.jbiomech.2012.02.023; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Benedetti MG, 1998, CLIN BIOMECH, V13, P204, DOI 10.1016/S0268-0033(97)00041-7; Besier TF, 2005, MED SCI SPORT EXER, V37, P1924, DOI 10.1249/01.mss.0000176686.18683.64; Blemker SS, 2005, ANN BIOMED ENG, V33, P1433; Buchanan TS, 2004, J APPL BIOMECH, V20, P367, DOI 10.1123/jab.20.4.367; Cappello A, 2005, IEEE T BIO-MED ENG, V52, P992, DOI 10.1109/TBME.2005.846728; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Carbone V, 2012, J BIOMECH, V45, P2476, DOI 10.1016/j.jbiomech.2012.06.026; Correa TA, 2012, GAIT POSTURE, V36, P194, DOI 10.1016/j.gaitpost.2012.02.014; Correa TA, 2011, J BIOMECH, V44, P2782, DOI 10.1016/j.jbiomech.2011.08.024; Correa TA, 2011, J BIOMECH, V44, P2096, DOI 10.1016/j.jbiomech.2011.05.023; Crossley KM, 2012, OSTEOARTHR CARTILAGE, V20, P1243, DOI 10.1016/j.joca.2012.07.011; De Groote F, 2010, J BIOMECH, V43, P1876, DOI 10.1016/j.jbiomech.2010.03.022; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Dumas R, 2005, IEEE T BIO-MED ENG, V52, P1756, DOI 10.1109/TBME.2005.855711; Erdemir A, 2007, CLIN BIOMECH, V22, P131, DOI 10.1016/j.clinbiomech.2006.09.005; Fernandez JW, 2006, EXP PHYSIOL, V91, P371, DOI 10.1113/expphysiol.2005.031047; Fregly Benjamin J, 2009, Int J Comput Vis Biomech, V2, P145; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Jonkers I, 2008, J BIOMECH, V41, P3405, DOI 10.1016/j.jbiomech.2008.09.011; Langenderfer JE, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838037; Lenaerts G, 2009, GAIT POSTURE, V30, P296, DOI 10.1016/j.gaitpost.2009.05.016; Lenaerts G, 2009, J BIOMECH, V42, P1246, DOI 10.1016/j.jbiomech.2009.03.037; LUNDBERG A, 1989, J BONE JOINT SURG BR, V71, P94, DOI 10.1302/0301-620X.71B1.2915016; Martelli S, 2014, COMPUT METHOD BIOMEC, V25, P1; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Pal S, 2007, ANN BIOMED ENG, V35, P1632, DOI 10.1007/s10439-007-9334-6; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Scheys L, 2008, GAIT POSTURE, V28, P640, DOI 10.1016/j.gaitpost.2008.04.010; Scheys L, 2006, LECT NOTES COMPUT SC, V4072, P58; Scheys L, 2011, J BIOMECH, V44, P1346, DOI 10.1016/j.jbiomech.2011.01.001; Tadde F, 2007, MED INFORM INTERNET, V32, P191, DOI 10.1080/14639230701231493; Taddei F, 2012, CLIN BIOMECH, V27, P273, DOI 10.1016/j.clinbiomech.2011.09.006; Valente G, 2013, J BIOMECH, V46, P2186, DOI 10.1016/j.jbiomech.2013.06.030; Valente G, 2012, P I MECH ENG H, V226, P161, DOI 10.1177/0954411911425863; van der Krogt MM, 2012, GAIT POSTURE, V36, P113, DOI 10.1016/j.gaitpost.2012.01.017; Wagner DW, 2013, ANN BIOMED ENG, V41, P1787, DOI 10.1007/s10439-013-0843-1; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Xiao M, 2010, J APPL BIOMECH, V26, P142, DOI 10.1123/jab.26.2.142	44	106	107	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112625	10.1371/journal.pone.0112625	http://dx.doi.org/10.1371/journal.pone.0112625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390896	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400111
J	Miranda-Dominguez, O; Mills, BD; Carpenter, SD; Grant, KA; Kroenke, CD; Nigg, JT; Fair, DA				Miranda-Dominguez, Oscar; Mills, Brian D.; Carpenter, Samuel D.; Grant, Kathleen A.; Kroenke, Christopher D.; Nigg, Joel T.; Fair, Damien A.			Connectotyping: Model Based Fingerprinting of the Functional Connectome	PLOS ONE			English	Article							RESTING-STATE NETWORKS; PREFRONTAL CORTEX; HUMAN BRAIN; CONNECTIVITY; EVOLUTION; MONKEYS; MOTION; AREAS	A better characterization of how an individual's brain is functionally organized will likely bring dramatic advances to many fields of study. Here we show a model-based approach toward characterizing resting state functional connectivity MRI (rs-fcMRI) that is capable of identifying a so-called "connectotype'', or functional fingerprint in individual participants. The approach rests on a simple linear model that proposes the activity of a given brain region can be described by the weighted sum of its functional neighboring regions. The resulting coefficients correspond to a personalized model-based connectivity matrix that is capable of predicting the timeseries of each subject. Importantly, the model itself is subject specific and has the ability to predict an individual at a later date using a limited number of non-sequential frames. While we show that there is a significant amount of shared variance between models across subjects, the model's ability to discriminate an individual is driven by unique connections in higher order control regions in frontal and parietal cortices. Furthermore, we show that the connectotype is present in non-human primates as well, highlighting the translational potential of the approach.	[Miranda-Dominguez, Oscar; Mills, Brian D.; Carpenter, Samuel D.; Grant, Kathleen A.; Kroenke, Christopher D.; Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Kroenke, Christopher D.; Fair, Damien A.] Oregon Hlth & Sci Univ, Adv Imaging Res Ctr, Portland, OR 97201 USA; [Kroenke, Christopher D.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA; [Kroenke, Christopher D.; Nigg, Joel T.; Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	Miranda-Dominguez, O (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.	miran045@umn.edu; faird@ohsu.edu	Miranda-Dominguez, Oscar/A-7412-2019	Miranda-Dominguez, Oscar/0000-0002-3622-0166	McDonnell Foundation Collaborative Activity Award [220020256]; Oregon Clinical and Translational Institute (OCTRI); Programa de Profesores en el Extranjero (PEX); Tecnologico de Monterrey [OD 11092, AA109431, AA13510, 1R01MH86654];  [R01 MH096773];  [K99/R00 MH091238]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086654, R01MH099064, K99MH091238, R01MH096773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760, U01AA013510] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007262] Funding Source: NIH RePORTER	McDonnell Foundation Collaborative Activity Award; Oregon Clinical and Translational Institute (OCTRI); Programa de Profesores en el Extranjero (PEX); Tecnologico de Monterrey; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by R01 MH096773 (Fair), K99/R00 MH091238 (Fair), McDonnell Foundation Collaborative Activity Award 220020256 (Petersen, PI, and Fair, site PI), Oregon Clinical and Translational Institute (OCTRI) (Fair), Programa de Profesores en el Extranjero (PEX), Tecnologico de Monterrey OD 11092 (Grant), AA109431 (Grant), AA13510 (Grant), and 1R01MH86654 (Nigg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BIEDERMAN J, 1992, ARCH GEN PSYCHIAT, V49, P728; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Chu C, 2011, MEASURING CONSISTENC, P41; Craddock RC, 2013, NEUROIMAGE, V82, P127, DOI 10.1016/j.neuroimage.2013.05.072; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Denys K, 2004, J COGNITIVE NEUROSCI, V16, P1505, DOI 10.1162/0898929042568505; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; First M.B., 2016, STRUCTURED CLIN INTE; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Friston KJ, 1993, HUM BRAIN MAPP, V1, P69, DOI DOI 10.1002/HBM.460010108; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Gates KM, 2012, NEUROIMAGE, V63, P310, DOI 10.1016/j.neuroimage.2012.06.026; Hansen P. C., 1994, Numerical Algorithms, V6, P1, DOI 10.1007/BF02149761; HANSEN PC, 1987, BIT, V27, P534, DOI 10.1007/BF01937276; Iyer SP, 2013, NEUROIMAGE, V75, P165, DOI 10.1016/j.neuroimage.2013.02.054; Kaas JH, 2006, CURR BIOL, V16, pR910, DOI 10.1016/j.cub.2006.09.057; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Markov NT, 2012, WEIGHTED DIRECTED IN; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Miranda-Dominguez O, 2014, J NEUROSCI, V34, P5552, DOI 10.1523/JNEUROSCI.4229-13.2014; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009; Paxinos G., 1999, RHESUS MONKEY BRAIN, DOI DOI 10.1016/J.CEJA.2021.100223; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Robertson G, 2006, WIDE RANGE ACHIEVEME; Ryali S, 2012, NEUROIMAGE, V59, P3852, DOI 10.1016/j.neuroimage.2011.11.054; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Seung S., 2012, CONNECTOME BRAINS WI; Smaers JB, 2011, BRAIN BEHAV EVOLUT, V77, P67, DOI 10.1159/000323671; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Essen D. C., 2004, VISUAL NEUROSCI, V1, P507; Van Essen DC, 2007, NEURON, V56, P209, DOI 10.1016/j.neuron.2007.10.015; Van Essen DC, 2004, NEUROIMAGE, V23, pS97, DOI 10.1016/j.neuroimage.2004.07.024; Varoquaux G., 2010, ARXIV10085071; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	50	110	110	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111048	10.1371/journal.pone.0111048	http://dx.doi.org/10.1371/journal.pone.0111048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386919	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400013
J	Montero, M; de la Fuente, S; Fonteriz, RI; Moreno, A; Alvarez, J				Montero, Mayte; de la Fuente, Sergio; Fonteriz, Rosalba I.; Moreno, Alfredo; Alvarez, Javier			Effects of Long-Term Feeding of the Polyphenols Resveratrol and Kaempferol in Obese Mice	PLOS ONE			English	Article							PROBE LEVEL DATA; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; PLANT FLAVONOIDS; RAT ADIPOCYTES; GINKGO-BILOBA; ACTIVATION; PREVENTION; CANCER; DIET	The effect of the intake of antioxidant polyphenols such as resveratrol and others on survival and different parameters of life quality has been a matter of debate in the last years. We have studied here the effects of the polyphenols resveratrol and kaempferol added to the diet in a murine model undergoing long-term hypercaloric diet. Using 50 mice for each condition, we have monitored weight, survival, biochemical parameters such as blood glucose, insulin, cholesterol, triglycerides and aspartate aminotransferase, neuromuscular coordination measured with the rotarod test and morphological aspect of stained sections of liver and heart histological samples. Our data show that mice fed since they are 3-months-old with hypercaloric diet supplemented with any of these polyphenols reduced their weight by about 5-7% with respect to the controls fed only with hypercaloric diet. We also observed that mice fed with any of the polyphenols had reduced levels of glucose, insulin and cholesterol, and better marks in the rotarod test, but only after 1 year of treatment, that is, during senescence. No effect was observed in the rest of the parameters studied. Furthermore, although treatment with hypercaloric diets induced large changes in the pattern of gene expression in liver, we found no significant changes in gene expression induced by the presence of any of the polyphenols. Thus, our data indicate that addition of resveratrol or kaempferol to mice food produces an initial decrease in weight in mice subjected to hypercaloric diet, but beneficial effects in other parameters such as blood glucose, insulin and cholesterol, and neuromuscular coordination, only appear after prolonged treatments.	[Alvarez, Javier] Univ Valladolid, Fac Med, IBGM, Dept Bioquim & Biol Mol & Fisiol, Valladolid, Spain; CSIC, Valladolid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Consejo Superior de Investigaciones Cientificas (CSIC)	Alvarez, J (corresponding author), Univ Valladolid, Fac Med, IBGM, Dept Bioquim & Biol Mol & Fisiol, Valladolid, Spain.	jalvarez@ibgm.uva.es	Alvarez, Javier/K-8210-2014; Montero, Mayte/K-8212-2014; Fonteriz, Rosalba I/L-1212-2014; Fonteriz, Rosalba/ABE-3175-2021	Alvarez, Javier/0000-0003-0636-5521; Montero, Mayte/0000-0001-7702-6653; Fonteriz, Rosalba I/0000-0001-8349-6264; Fonteriz, Rosalba/0000-0001-8349-6264; Moreno, Alfredo/0000-0002-7444-5198; De la Fuente, Sergio/0000-0001-7823-063X; , Sergio/0000-0002-8021-2390	Ministerio de Ciencia e Innovacion [BFU2008-01871, BFU 2011-25763]; Junta de Castilla y Leon [VA029A12, GR105]; Spanish Government	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Spanish Government(Spanish GovernmentEuropean Commission)	This work was supported by grants from Ministerio de Ciencia e Innovacion [BFU2008-01871 and BFU 2011-25763; (http://www.idi.mineco.gob.es/portal/site/MICINN/)] and from Junta de Castilla y Leon [VA029A12-1 and GR105, (http://www.educa.jcyl.es/educacyl/cm/universidad)]. Sergio de la Fuente had an FPI (Formacion de Personal Investigador) fellowship from the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Birt DF, 2001, PHARMACOL THERAPEUT, V90, P157, DOI 10.1016/S0163-7258(01)00137-1; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Canto C, 2011, NATURE, V477, P411; Couzin-Frankel J, 2011, SCIENCE, V334, P1194, DOI 10.1126/science.334.6060.1194; Da-Silva WS, 2007, DIABETES, V56, P767, DOI 10.2337/db06-1488; Do GM, 2011, MOL NUTR FOOD RES, V55, pS173, DOI 10.1002/mnfr.201100064; Garcia-Mediavilla V, 2007, EUR J PHARMACOL, V557, P221, DOI 10.1016/j.ejphar.2006.11.014; Gates MA, 2007, INT J CANCER, V121, P2225, DOI 10.1002/ijc.22790; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jarolim S, 2004, FEMS YEAST RES, V5, P169, DOI 10.1016/j.femsyr.2004.06.015; KUPPUSAMY UR, 1994, BIOCHEM PHARMACOL, V47, P521, DOI 10.1016/0006-2952(94)90184-8; KUPPUSAMY UR, 1992, BIOCHEM PHARMACOL, V44, P1307, DOI 10.1016/0006-2952(92)90531-M; LALONDE R, 1995, NEUROSCI RES, V22, P423, DOI 10.1016/0168-0102(95)00916-H; Lee YE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050412; Lombard DB, 2011, NATURE, V477, P410, DOI 10.1038/477410a; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Manach C, 2005, CURR OPIN LIPIDOL, V16, P77, DOI 10.1097/00041433-200502000-00013; Middleton E, 2000, PHARMACOL REV, V52, P673; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Nestel P, 2003, CURR OPIN LIPIDOL, V14, P3, DOI 10.1097/00041433-200302000-00002; Poulsen MM, 2013, DIABETES, V62, P1186, DOI 10.2337/db12-0975; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Watanabe CMH, 2001, P NATL ACAD SCI USA, V98, P6577, DOI 10.1073/pnas.111126298; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yu SF, 2006, BIOL PHARM BULL, V29, P2510, DOI 10.1248/bpb.29.2510	37	11	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112825	10.1371/journal.pone.0112825	http://dx.doi.org/10.1371/journal.pone.0112825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386805	gold, Green Published, Green Submitted			2022-12-26	WOS:000345250400095
J	Raffetseder, J; Pienaar, E; Blomgran, R; Eklund, D; Brodin, VP; Andersson, H; Welin, A; Lerm, M				Raffetseder, Johanna; Pienaar, Elsje; Blomgran, Robert; Eklund, Daniel; Brodin, Veronika Patcha; Andersson, Henrik; Welin, Amanda; Lerm, Maria			Replication Rates of Mycobacterium tuberculosis in Human Macrophages Do Not Correlate with Mycobacterial Antibiotic Susceptibility	PLOS ONE			English	Article							IN-VITRO; LATENT TUBERCULOSIS; INFECTED MICE; PERSISTENCE; OXYGEN; MODEL; ACID; DRUG; PYRAZINAMIDE; GRANULOMAS	The standard treatment of tuberculosis (TB) takes six to nine months to complete and this lengthy therapy contributes to the emergence of drug-resistant TB. TB is caused by Mycobacterium tuberculosis (Mtb) and the ability of this bacterium to switch to a dormant phenotype has been suggested to be responsible for the slow clearance during treatment. A recent study showed that the replication rate of a non-virulent mycobacterium, Mycobacterium smegmatis, did not correlate with antibiotic susceptibility. However, the question whether this observation also holds true for Mtb remains unanswered. Here, in order to mimic physiological conditions of TB infection, we established a protocol based on long-term infection of primary human macrophages, featuring Mtb replicating at different rates inside the cells. During conditions that restricted Mtb replication, the bacterial phenotype was associated with reduced acid-fastness. However, these phenotypically altered bacteria were as sensitive to isoniazid, pyrazinamide and ethambutol as intracellularly replicating Mtb. In support of the recent findings with M. smegmatis, we conclude that replication rates of Mtb do not correlate with antibiotic tolerance.	[Raffetseder, Johanna; Pienaar, Elsje; Blomgran, Robert; Eklund, Daniel; Brodin, Veronika Patcha; Andersson, Henrik; Welin, Amanda; Lerm, Maria] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Microbiol & Mol Med, SE-58185 Linkoping, Sweden	Linkoping University	Lerm, M (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Microbiol & Mol Med, SE-58185 Linkoping, Sweden.	maria.lerm@liu.se	Lerm, Maria/AAM-8705-2020; Lerm, Maria/AAA-1780-2020	Lerm, Maria/0000-0002-5092-9892; Andersson, Henrik/0000-0002-6020-5177; Eklund, Daniel/0000-0002-6045-4800; Raffetseder, Johanna/0000-0001-8871-2560; Blomgran, Robert/0000-0002-2767-8175	Bill & Melinda Gates Foundation; Swedish Research Council [2009-3821, 2012-3349]; Swedish International Development Cooperation Agency; Swedish Heart-Lung Foundation; King Oscar II Foundation; Carl Trygger Foundation; Clas Groschinsky Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); King Oscar II Foundation; Carl Trygger Foundation; Clas Groschinsky Foundation	The project was funded by the Bill & Melinda Gates Foundation (www.gatesfoundation.org), the Swedish Research Council (grant numbers 2009-3821 and 2012-3349, www.vr.se), the Swedish International Development Cooperation Agency (www.sida.se), the Swedish Heart-Lung Foundation (www.hjart-lungfonden.se), King Oscar II Foundation, Carl Trygger Foundation (www.carltryggersstiftelse.se), and the Clas Groschinsky Foundation (www.groschinsky.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Aly S, 2006, J PATHOL, V210, P298, DOI 10.1002/path.2055; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Caceres N, 2009, TUBERCULOSIS, V89, P175, DOI 10.1016/j.tube.2008.11.001; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; DHILLON J, 1989, ANTIMICROB AGENTS CH, V33, P1255, DOI 10.1128/AAC.33.8.1255; Eklund D, 2010, CLIN VACCINE IMMUNOL, V17, P513, DOI 10.1128/CVI.00446-09; Estrella JL, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00067; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Magliozzo RS, 1996, J AM CHEM SOC, V118, P11303, DOI 10.1021/ja962047j; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rastogi N, 1996, CURR MICROBIOL, V33, P167, DOI 10.1007/s002849900095; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Santi I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3470; Schon T, 2013, J INTERN MED, V273, P368, DOI 10.1111/joim.12031; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Vogt G, 2011, J CLIN INVEST, V121, P3889, DOI 10.1172/JCI57235; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Welin A, 2011, J INNATE IMMUN, V3, P508, DOI 10.1159/000325297; Welin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020302; YOUATT JEAN, 1960, AUSTRALIAN JOUR EXPTL BIOL AND MED SCI, V38, P331, DOI 10.1038/icb.1960.35; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Zabinski RF, 1997, J AM CHEM SOC, V119, P2331, DOI 10.1021/ja9639731; Zhang Y, 1999, J BACTERIOL, V181, P2044, DOI 10.1128/JB.181.7.2044-2049.1999; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	42	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112426	10.1371/journal.pone.0112426	http://dx.doi.org/10.1371/journal.pone.0112426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386849	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400061
J	Sparks, ME; Shelby, KS; Kuhar, D; Gundersen-Rindal, DE				Sparks, Michael E.; Shelby, Kent S.; Kuhar, Daniel; Gundersen-Rindal, Dawn E.			Transcriptome of the Invasive Brown Marmorated Stink Bug, Halyomorpha halys (Stal) (Heteroptera: Pentatomidae)	PLOS ONE			English	Article							HEMIPTERA-PENTATOMIDAE; AGGREGATION PHEROMONE; RHODNIUS-PROLIXUS; DESERT LOCUST; PROTEIN; RECOGNITION; SCAVENGER; FUNGI; BLAST; SUITE	Halyomorpha halys (Stal) (Heteroptera: Pentatomidae), the brown marmorated stink bug, is an invasive agricultural and nuisance pest rapidly expanding its incidence in North America. This voracious pest poses a significant threat to rural and urban agriculture, especially to specialty crops such as apples, grapes and ornamentals, as well as staple crops including soybean and corn. The object of this study was to generate transcript sequence resources for H. halys. RNA-seq libraries derived from distinct developmental stages and sexes were sequenced and assembled into 248,569 putatively unique transcripts (PUTs). PUTs were segmented into three disjoint tiers of varying reliability, with 4,794 classified as gold tier (highest quality), 16,878 as silver, and 14,357 as bronze. The gold-tier PUTs associated with 2,580 distinct non-redundant protein sequences from the NCBI NR database-1,785 of these (69%) mapped to annotated UniProtKB database proteins, from which 1,273 unique Pfam families and 459 unique Molecular Function GO terms were encountered. Of the silver tier's 6,527 PUTs associated with unique proteins, 4,193 mapped to UniProtKB (64%), from which 1,941 and 640 unique Pfam and Molecular Function GO terms were extracted. H. halys PUTs related to important life processes like immunity, endocrinology, reproduction, development, behavior, neurotransmission, neurotoxicity, olfaction, and small RNA pathways were validated through quantitative Real-Time PCR (qRT-PCR) for differential expression during distinct life stages (eggs, 2nd instar nymphs, 4th instar nymphs, female adults, male adults). PUTs similar to hypothetical proteins identified in symbiont microbes, including Pantoea and Nosema species, were more abundantly expressed in adults versus nymphs. These comprehensive H. halys transcriptomic resources can be utilized to aid development of novel control methodologies to disrupt life processes; to conduct reverse genetic screens to determine host gene function; and to design environmentally unobtrusive means to control host populations or target specific H. halys life stages, such as molecular biopesticides.	[Sparks, Michael E.; Kuhar, Daniel; Gundersen-Rindal, Dawn E.] USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA; [Shelby, Kent S.] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Gundersen-Rindal, DE (corresponding author), USDA ARS, Invas Insect Biocontrol & Behav Lab, Beltsville, MD 20705 USA.	dawn.gundersen-rindal@ars.usda.gov	; Shelby, Kent/E-1605-2011	Sparks, Michael/0000-0001-6251-8559; Shelby, Kent/0000-0001-9859-3497				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bansal R, 2014, ENVIRON ENTOMOL, V43, P617, DOI 10.1603/EN13341; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Broderick Nichole A., 2009, P13; Deffarari MS, 2013, BIOCHIM BIOPHYS ACTA, V1840, P396; Eleftherianos I, 2009, INSECT MOL BIOL, V18, P507, DOI 10.1111/j.1365-2583.2009.00899.x; Engels W., 1990, Advances in Invertebrate Reproduction, V5, P495; Garcia ES, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-33; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gouli V, 2012, PEST MANAG SCI, V68, P155, DOI 10.1002/ps.2310; Grabherr M. G., 2011, NAT BIOTECHNOL, V8, P469; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hrassnigg N, 2005, APIDOLOGIE, V36, P255, DOI 10.1051/apido:2005015; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Jiang H, 2011, INVERTEBRATE IMMUNIT, P163; Kanost MR, 2008, INSECT IMMUNOLOGY, P69, DOI 10.1016/B978-012373976-6.50006-9; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khrimian A, 2014, J NAT PROD, V77, P1708, DOI 10.1021/np5003753; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Matouskova P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086033; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; OZAWA M, 1993, J BIOL CHEM, V268, P699; Paluzzi JPV, 2012, PEPTIDES, V34, P127, DOI 10.1016/j.peptides.2011.10.025; Firmino AAP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085079; Renwick J, 2007, DEV COMP IMMUNOL, V31, P347, DOI 10.1016/j.dci.2006.06.007; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; Singh NK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083963, 10.1371/journal.pone.0073005]; Sparks ME, 2013, GENOME ANNOUNCEMENTS, V1; Sparks ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061190; Taylor CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090312; The Uniprot Consortium, 2012, NUCLEIC ACIDS RES, V41, pD43; van Kretschmar JBD, 2012, BELTW COTT C, P1090; Weber DC, 2014, J ECON ENTOMOL, V107, P1061, DOI 10.1603/EC13502; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wynant N, 2014, INSECT MOL BIOL, V23, P320, DOI 10.1111/imb.12083; Wynant N, 2014, J INSECT PHYSIOL, V64, P7, DOI 10.1016/j.jinsphys.2014.02.010; Xiong YH, 2013, INT J BIOL SCI, V9, P370, DOI 10.7150/ijbs.5929; Xu JW, 2014, BIOL INVASIONS, V16, P153, DOI 10.1007/s10530-013-0510-3; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang H, 2013, BIOCHEM BIOPH RES CO, V442, P105, DOI 10.1016/j.bbrc.2013.11.025; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	42	35	37	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111646	10.1371/journal.pone.0111646	http://dx.doi.org/10.1371/journal.pone.0111646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386688	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400024
J	Wang, XL; Wang, L; Wang, J; Jin, P; Liu, HX; Zheng, YH				Wang, Xiaoli; Wang, Lei; Wang, Jing; Jin, Peng; Liu, Hongxia; Zheng, Yonghua			Bacillus cereus AR156-Induced Resistance to Colletotrichum acutatum Is Associated with Priming of Defense Responses in Loquat Fruit	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; POSTHARVEST DISEASES; SYSTEMIC RESISTANCE; ROT	The effectiveness of a biocontrol agent Bacillus cereus AR156 for control of anthracnose rot caused by Colletotrichum acutatum in harvested loquat fruit and the possible mechanisms of its action have been investigated. Treatment of fruit with B. cereus AR156 resulted in lower disease incidence and smaller lesion diameters compared with that of untreated fruit. The treatment enhanced activities of defense-related enzymes including chitinase, beta-1, 3-glucanase, phenylalanine ammonialyase, peroxidase and polyphenoloxidase, and promoted accumulation of H2O2. Total phenolic content and 2,2-diphenyl-1-picrylhydrazyl radical scavenging activity were also increased by treatment. Transcripts of three defense-related genes were enhanced only in fruit undergoing both B. cereus AR156 treatment and C. acutatum inoculation compared with those receiving either intervention alone. These results suggest that the disease resistance against C. acutatum in loquat fruit is enhanced by B. cereus AR156 and that the induced resistance is associated with induction and priming of defense responses in the fruit.	[Wang, Xiaoli; Wang, Lei; Wang, Jing; Jin, Peng; Zheng, Yonghua] Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Wang, Xiaoli] Huaiyin Inst Technol, Coll Life Sci & Chem Engn, Huaian, Jiangsu, Peoples R China; [Liu, Hongxia] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Huaiyin Institute of Technology; Nanjing Agricultural University	Zheng, YH (corresponding author), Nanjing Agr Univ, Coll Food Sci & Technol, Nanjing, Jiangsu, Peoples R China.	zhengyh@njau.edu.cn			National Natural Science Foundation of China [31172003]; Special Fund for Agro-scientific Research in the Public Interest of China [201003073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China	This work was supported by the National Natural Science Foundation of China (31172003) and the Special Fund for Agro-scientific Research in the Public Interest of China (201003073). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1971, PLANT PHYSIOL, V47, P129, DOI 10.1104/pp.47.1.129; Ahn IP, 2011, MOL CELLS, V32, P7, DOI 10.1007/s10059-011-2209-6; Arrebola E, 2010, CROP PROT, V29, P369, DOI 10.1016/j.cropro.2009.08.001; Assis JS, 2001, POSTHARVEST BIOL TEC, V23, P33, DOI 10.1016/S0925-5214(01)00100-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao SF, 2008, J HORTIC SCI BIOTECH, V83, P816, DOI 10.1080/14620316.2008.11512466; Chan ZL, 2005, POSTHARVEST BIOL TEC, V36, P215, DOI 10.1016/j.postharvbio.2005.01.001; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen YF, 2005, ANN BOT-LONDON, V95, P901, DOI 10.1093/aob/mci100; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2011, TRENDS PLANT SCI, V16, P524, DOI 10.1016/j.tplants.2011.06.004; Ferreira RB, 2007, MOL PLANT PATHOL, V8, P677, DOI 10.1111/J.1364-3703.2007.00419.X; Gonzalez EM, 1999, J AGR FOOD CHEM, V47, P4068, DOI 10.1021/jf981325q; Guo JH, 2007, U S Patent, Patent No. [200710021376.0, 2007100213760]; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Jia ZH, 2010, BIOCHEM BIOPH RES CO, V396, P522, DOI 10.1016/j.bbrc.2010.04.131; Kinkema M, 2000, PLANT CELL, V12, P2339, DOI 10.1105/tpc.12.12.2339; KOCHBA J, 1977, PLANT CELL PHYSIOL, V18, P463, DOI 10.1093/oxfordjournals.pcp.a075455; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Larrauri JA, 1998, J AGR FOOD CHEM, V46, P2694, DOI 10.1021/jf980017p; Liu HX, 2005, POSTHARVEST BIOL TEC, V35, P263, DOI 10.1016/j.postharvbio.2004.08.006; Niu DD, 2011, MOL PLANT MICROBE IN, V24, P533, DOI 10.1094/MPMI-09-10-0213; Patterson BD, 2004, ANAL BIOCHEM, V139, P487; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; Shoresh M, 2005, PHYTOPATHOLOGY, V95, P76, DOI 10.1094/PHYTO-95-0076; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Taheri P, 2010, J PLANT PHYSIOL, V167, P201, DOI 10.1016/j.jplph.2009.08.003; Verhagen BWM, 2010, J EXP BOT, V61, P249, DOI 10.1093/jxb/erp295; Vicente AR, 2006, POSTHARVEST BIOL TEC, V40, P116, DOI 10.1016/j.postharvbio.2005.12.012; Wang CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052565; Wang KT, 2011, J PHYTOPATHOL, V159, P417, DOI 10.1111/j.1439-0434.2010.01782.x; Wang XL, 2013, FOOD CHEM, V136, P400, DOI 10.1016/j.foodchem.2012.09.032; Zhang SJ, 2009, J INTEGR PLANT BIOL, V51, P167, DOI 10.1111/j.1744-7909.2008.00763.x; Zhou XH, 2011, J FOOD SCI, V76, pM254, DOI 10.1111/j.1750-3841.2011.02160.x	38	7	8	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112494	10.1371/journal.pone.0112494	http://dx.doi.org/10.1371/journal.pone.0112494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386680	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400066
J	Yu, WY; Jiang, LH; Zheng, Y; Hu, XP; Luo, JH; Yang, W				Yu, Wenyue; Jiang, Lin-Hua; Zheng, Yang; Hu, Xupang; Luo, Jianhong; Yang, Wei			Inactivation of TRPM2 Channels by Extracellular Divalent Copper	PLOS ONE			English	Article							HEAVY-METALS; ION-CHANNEL; PORE REGION; OUTER PORE; ACIDIC PH; ZINC; INHIBITION; RECEPTORS; CALCIUM; IDENTIFICATION	Cu2+ is an essential metal ion that plays a critical role in the regulation of a number of ion channels and receptors in addition to acting as a cofactor in a variety of enzymes. Here, we showed that human melastatin transient receptor potential 2 (hTRPM2) channel is sensitive to inhibition by extracellular Cu2+. Cu2+ at concentrations as low as 3 mM inhibited the hTRPM2 channel completely and irreversibly upon washing or using Cu2+ chelators, suggesting channel inactivation. The Cu2+-induced inactivation was similar when the channels conducted inward or outward currents, indicating the permeating ions had little effect on Cu2+-induced inactivation. Furthermore, Cu2+ had no effect on singe channel conductance. Alanine substitution bysite-directed mutagenesis of His995 in the pore-forming region strongly attenuated Cu2+-induced channel inactivation, and mutation of several other pore residues to alanine altered the kinetics of channel inactivation by Cu2+. In addition, while introduction of the P1018L mutation is known to result in channel inactivation, exposure to Cu2+ accelerated the inactivation of this mutant channel. In contrast with the hTRPM2, the mouse TRPM2 (mTRPM2) channel, which contains glutamine at the position equivalent to His995, was insensitive to Cu2+. Replacement of His995 with glutamine in the hTRPM2 conferred loss of Cu2+-induced channel inactivation. Taken together, these results suggest that Cu2+ inactivates the hTRPM2 channel by interacting with the outer pore region. Our results also indicate that the amino acid residue difference in this region gives rise to species-dependent effect by Cu2+ on the human and mouse TRPM2 channels.	[Yu, Wenyue; Zheng, Yang; Hu, Xupang; Luo, Jianhong; Yang, Wei] Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Lin-Hua] Xinxiang Med Univ, Dept Physiol & Neurobiol, Xinxiang, Henan Province, Peoples R China; [Jiang, Lin-Hua] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds, W Yorkshire, England	Zhejiang University; Xinxiang Medical University; University of Leeds	Luo, JH (corresponding author), Zhejiang Univ, Sch Med, Zhejiang Prov Key Lab Neurobiol, Key Lab Med Neurobiol,Minist Hlth China,Dept Neur, Hangzhou 310003, Zhejiang, Peoples R China.	luojianhong@zju.edu.cn; yangwei@zju.edu.cn	Luo, jian/HGE-7331-2022; Jiang, Lin-Hua/AAU-1078-2020; Jiang, Lin-Hua/D-2030-2010	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411	National Basic Research Program of China [2013CB910204, 2014CB910300, 2010CB912002]; Natural Science Foundation of China [81371302, 31471118]; Zhejiang Province Qianjiang Talent Project [2012R10037]; Zhejiang University [2012FZA7014]; University of Leeds-Zhejiang University Strategic Collaboration Award	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Qianjiang Talent Project; Zhejiang University; University of Leeds-Zhejiang University Strategic Collaboration Award	This work was supported by National Basic Research Program of China (2013CB910204), Natural Science Foundation of China (81371302), Zhejiang Province Qianjiang Talent Project (2012R10037), and Zhejiang University basic research fund (2012FZA7014) to WY; University of Leeds-Zhejiang University Strategic Collaboration Award and Natural Science Foundation of China (31471118) to LHJ; and National Basic Research Program of China (2014CB910300 and 2010CB912002) to JHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2014, J TRACE ELEM MED BIO; Cao X, 2014, J GEN PHYSIOL, V143, P75, DOI 10.1085/jgp.201311025; CHELLY J, 1993, NAT GENET, V5, P317, DOI 10.1038/ng1293-317; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Coddou C, 2007, J BIOL CHEM, V282, P36879, DOI 10.1074/jbc.M706925200; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Ding XQ, 2010, ADV EXP MED BIOL, V664, P245, DOI 10.1007/978-1-4419-1399-9_28; Du JY, 2009, J GEN PHYSIOL, V134, P471, DOI 10.1085/jgp.200910254; Ellingsen DG, 2007, BIOMARKERS, V12, P497, DOI 10.1080/13547500701366496; Gavazzo P, 2000, J GEN PHYSIOL, V116, P311, DOI 10.1085/jgp.116.3.311; Gu QH, 2010, J APPL PHYSIOL, V108, P891, DOI 10.1152/japplphysiol.01371.2009; Haraguchi K, 2012, J NEUROSCI, V32, P3931, DOI 10.1523/JNEUROSCI.4703-11.2012; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Jiang LH, 2010, EXPERT OPIN THER TAR, V14, P973, DOI 10.1517/14728222.2010.510135; KISS T, 1994, PHARMACOL REV, V46, P245; Kocer G, 2013, BIOL TRACE ELEM RES, V153, P251, DOI 10.1007/s12011-013-9659-y; Laszlo C, 2009, J GEN PHYSIOL, V133, P189, DOI 10.1085/jgp.200810109; Liu X, 2008, MOL PHARMACOL, V73, P252, DOI 10.1124/mol.107.039651; Ma ZM, 2008, J GEN PHYSIOL, V131, P483, DOI 10.1085/jgp.200809980; Massullo P, 2006, SEMIN CELL DEV BIOL, V17, P654, DOI 10.1016/j.semcdb.2006.11.006; McGee TP, 2013, J NEUROSCI, V33, P13431, DOI 10.1523/JNEUROSCI.1908-13.2013; McHugh D, 2003, J BIOL CHEM, V278, P11002, DOI 10.1074/jbc.M210810200; Mei ZZ, 2006, AM J PHYSIOL-CELL PH, V291, pC1022, DOI 10.1152/ajpcell.00606.2005; Nilius Bernd, 2007, Bull Mem Acad R Med Belg, V162, P244; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Restrepo-Angulo I, 2010, J APPL TOXICOL, V30, P497, DOI 10.1002/jat.1556; Riera CE, 2007, AM J PHYSIOL-REG I, V293, pR626, DOI 10.1152/ajpregu.00286.2007; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Squitti R, 2012, J TRACE ELEM MED BIO, V26, P93, DOI 10.1016/j.jtemb.2012.04.012; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Tisato F, 2010, MED RES REV, V30, P708, DOI 10.1002/med.20174; Toth B, 2012, P NATL ACAD SCI USA, V109, P13440, DOI 10.1073/pnas.1204702109; Uchida K, 2011, ISLETS, V3, P209, DOI 10.4161/isl.3.4.16130; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yang Wei, 2013, Methods Mol Biol, V998, P257, DOI 10.1007/978-1-62703-351-0_20; Yang W, 2011, J BIOL CHEM, V286, P23789, DOI 10.1074/jbc.M111.247478; Yang W, 2010, J BIOL CHEM, V285, P30411, DOI 10.1074/jbc.M110.139774; Zeng B, 2012, BIOCHEM BIOPH RES CO, V424, P279, DOI 10.1016/j.bbrc.2012.06.107; Zou J, 2011, PFLUG ARCH EUR J PHY, V462, P293, DOI 10.1007/s00424-011-0957-y	41	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112071	10.1371/journal.pone.0112071	http://dx.doi.org/10.1371/journal.pone.0112071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386648	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000345250400037
J	Zhou, R; Wang, SS; Shi, CZ; Wang, WX; Zhao, H; Liu, R; Chen, LM; Zhou, B				Zhou, Rui; Wang, Shanshan; Shi, Chanzhen; Wang, Wenxin; Zhao, Heng; Liu, Rui; Chen, Limin; Zhou, Bin			Study on the Traffic Air Pollution inside and outside a Road Tunnel in Shanghai, China	PLOS ONE			English	Article							PARTICULATE MATTER PM2.5; EMISSIONS; VEHICLES; IMPACT	To investigate the vehicle induced air pollution situations both inside and outside the tunnel, the field measurement of the pollutants concentrations and its diurnal variations was performed inside and outside the Xiangyin tunnel in Shanghai from 13: 00 on April 24th to 13: 00 on April 25th, 2013. The highest hourly average concentrations of pollutants were quantified that CO, NO, NO2 and NOX inside the tunnel were 13.223 mg/m(3), 1.829 mg/m(3), 0.291 mg/m(3) and 3.029 mg/m(3), respectively, while the lowest ones were 3.086 mg/m(3), 0.344 mg/m(3), 0.080 mg/m(3) and 0.619 mg/m(3). Moreover, the concentrations of pollutants were higher during the daytime, and lower at night, which is relevant to the traffic conditions inside the tunnel. Pollutants concentrations inside the tunnel were much higher than those outside the tunnel. Then in a case of slow wind, the effect of wind is much smaller than the impact of pollution sources. Additionally, the PM2.5 concentrations climbed to the peak sharply (468.45 mu g/m(3)) during the morning rush hours. The concentrations of organic carbon (OC) and elemental carbon (EC) in PM2.5 inside the tunnel were 37.09-99.06 mu g/m(3) and 22.69-137.99 mu g/m(3), respectively. Besides, the OC/EC ratio ranged from 0.72 to 2.19 with an average value of 1.34. Compared with the results of other tunnel experiments in Guangzhou and Shenzhen, China, it could be inferred that the proportion of HDVs through the Xiangyin tunnel is relatively lower.	[Zhou, Rui; Shi, Chanzhen; Wang, Wenxin; Zhao, Heng; Liu, Rui; Chen, Limin; Zhou, Bin] Fudan Univ, Dept Environm Sci & Engn, Shanghai Key Lab Atmospher Particle Pollut & Prev, Shanghai 200433, Peoples R China; [Wang, Shanshan] Shanghai Univ Sci & Technol, Sch Environm & Architecture, Shanghai 200093, Peoples R China; [Zhou, Bin] Fudan Univ, Fudan Tyndall Ctr, Shanghai 200433, Peoples R China	Fudan University; University of Shanghai for Science & Technology; Fudan University	Wang, SS (corresponding author), Shanghai Univ Sci & Technol, Sch Environm & Architecture, Shanghai 200093, Peoples R China.	shanshan.wang@usst.edu.cn; binzhou@fudan.edu.cn	wang, wenxin/HGD-7043-2022	Wang, Shanshan/0000-0003-2590-9563	National Natural Science Foundation of China [21277029, 40975076, 41365010]; Science and Technology Commission of Shanghai Municipality [12231201001, 12DJ1400102]; China Meteorological Administration [GYHY201106045-8]; Shanghai Environmental Protection Bureau [2013-76, 2013-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); China Meteorological Administration; Shanghai Environmental Protection Bureau	This work was partially supported by the National Natural Science Foundation of China under grant No. 21277029, 40975076, 41365010, Science and Technology Commission of Shanghai Municipality (Grant: 12231201001, 12DJ1400102), and China Meteorological Administration (Grant: GYHY201106045-8). The authors are thankful for the great help from Shanghai Environmental Protection Bureau (Grant: 2013-76, 2013-03) and Design Institute of Urban Transport and Underground Space. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancelet T, 2011, ATMOS ENVIRON, V45, P4463, DOI 10.1016/j.atmosenv.2011.05.032; Beelen R, 2008, EPIDEMIOLOGY, V19, P702, DOI 10.1097/EDE.0b013e318181b3ca; Beevers SD, 2005, ATMOS ENVIRON, V39, P1, DOI 10.1016/j.atmosenv.2004.10.001; Brito J, 2013, ATMOS CHEM PHYS DISC, V13, P20839, DOI DOI 10.5194/ACPD-13-20839-2013; Chen CH, 2009, BIOMED ENVIRON SCI, V22, P210, DOI 10.1016/S0895-3988(09)60047-7; [程兴宏 CHENG Xinghong], 2007, [安全与环境学报, Journal of Safety and Environment], V7, P77; Cheng Y, 2006, ATMOS ENVIRON, V40, P4235, DOI 10.1016/j.atmosenv.2006.04.002; Cowie CT, 2012, ENVIRON SCI TECHNOL, V46, P2918, DOI 10.1021/es202686r; El Haddad I, 2009, ATMOS ENVIRON, V43, P6190, DOI 10.1016/j.atmosenv.2009.09.001; Gillies JA, 2001, ENVIRON SCI TECHNOL, V35, P1054, DOI 10.1021/es991320p; Grieshop AP, 2006, ATMOS ENVIRON, V40, pS287, DOI 10.1016/j.atmosenv.2006.03.064; Handler M, 2008, ATMOS ENVIRON, V42, P2173, DOI 10.1016/j.atmosenv.2007.11.054; He LY, 2008, ENVIRON SCI TECHNOL, V42, P4461, DOI 10.1021/es7022658; [刘川 Liu Chuan], 2012, [环境科学与技术, Enuivonmental Science and Technology], V35, P150; McKillup, 2006, STAT EXPLAINED INTRO, P44; Pio C, 2011, ATMOS ENVIRON, V45, P6121, DOI 10.1016/j.atmosenv.2011.08.045; Sandra S, 2007, ELEMENTARY STAT USIN, P166; Tian LW, 2011, CONTAM CONTR, V6, P30; Wang HK, 2008, SCI TOTAL ENVIRON, V398, P60, DOI 10.1016/j.scitotenv.2008.01.038; Wang J., 2009, CHINESE J UNDERGROUN, V5, P196; [薛佳平 Xue Jiaping], 2010, [环境科学研究, Research of Environmental Sciences], V23, P613; Yang F, 2004, TRANSPORT RES REC, P77; Yang L, 2011, THESIS TSINGHUA U; Zhao HJ, 2013, ATMOS POLLUT RES, V4, P427, DOI 10.5094/APR.2013.049; Zhu CS, 2010, ATMOS ENVIRON, V44, P2668, DOI 10.1016/j.atmosenv.2010.04.042	25	31	31	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112195	10.1371/journal.pone.0112195	http://dx.doi.org/10.1371/journal.pone.0112195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386920	Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400048
J	Macrae, FL; Evans, HL; Bridge, KI; Johnson, A; Scott, DJA; Ariens, RAS				Macrae, Fraser L.; Evans, Hannah Lee; Bridge, Katherine I.; Johnson, Anne; Scott, D. Julian A.; Ariens, Robert A. S.			Common FXIII and Fibrinogen Polymorphisms in Abdominal Aortic Aneurysms	PLOS ONE			English	Article							FACTOR-XIII GENE; ALPHA THR312ALA POLYMORPHISM; INTRALUMINAL THROMBUS; COAGULATION-FACTOR; PLASMA-FIBRINOGEN; MURAL THROMBUS; OLDER-ADULTS; RISK-FACTORS; B-SUBUNIT; ASSOCIATION	Introduction: Abdominal aortic aneurysms (AAA) are characterized by a progressive dilatation of the abdominal aorta, and are associated with a high risk of rupture once the dilatation exceeds 55 mm in diameter. A large proportion of AAA develops an intraluminal thrombus, which contributes to hypoxia, inflammation and tissue degradation. We have previously shown that patients with AAA produce clots with altered structure which is more resistant to fibrinolysis. The aim of this study was to investigate genetic polymorphisms of FXIII and fibrinogen in AAA to identify how changes to these proteins may play a role in the development of AAA. Methods: Subjects of Western/European descent, >= 55 years of age (520 AAA patients and 449 controls) were genotyped for five polymorphisms (FXIII-A Val34Leu, FXIII-B His95Arg, FXIII-B Splice Variant (intron K nt29576C-G), Fib-A Thr312Ala and Fib-B Arg448Lys) by RT-PCR. Data were analysed by chi(2) test and CubeX. Results: The FXIII-B Arg95 allele associated with AAA (Relative risk - 1.240, CI 1.093-1.407, P = 0.006). There was no association between FXIII-A Val34Leu, FXIII-B Splice Variant, Fib-A Thr312Ala or Fib-B Arg448Lys and AAA. FXIII-B His95Arg and FXIII-B Splice variant (intron K nt29576C-G) were in negative linkage disequilibrium (D' = -0.609, p = 0.011). Discussion: The FXIII-B Arg95 variant is associated with an increased risk of AAA. These data suggest a possible role for FXIII in AAA pathogenesis.	[Macrae, Fraser L.; Evans, Hannah Lee; Bridge, Katherine I.; Johnson, Anne; Scott, D. Julian A.; Ariens, Robert A. S.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Div Cardiovasc & Diabet Res, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England; [Bridge, Katherine I.; Johnson, Anne; Scott, D. Julian A.] Gen Infirm, Leeds Vasc Inst, Leeds LS1 3EX, W Yorkshire, England	University of Leeds; Leeds General Infirmary	Ariens, RAS (corresponding author), Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Div Cardiovasc & Diabet Res, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England.	r.a.s.ariens@leeds.ac.uk	Macrae, Fraser/AAN-8377-2021	Ariens, Robert/0000-0002-6310-5745; Macrae, Fraser/0000-0002-7092-0422	Garfield Weston trust; British Heart Foundation [FS/12/26/29395]; British Heart Foundation [RG/13/3/30104] Funding Source: researchfish	Garfield Weston trust; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	RASA and DJAS were supported by The Garfield Weston trust into diseases of the Heart. KIB was supported by The British Heart Foundation Clinical Research Training Fellowship, FS/12/26/29395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2008, BLOOD, V111, P643, DOI 10.1182/blood-2007-05-091231; Al-Barjas HS, 2006, ANGIOLOGY, V57, P607, DOI 10.1177/0003319706293132; Alcorn HG, 1996, ARTERIOSCL THROM VAS, V16, P963, DOI 10.1161/01.ATV.16.8.963; Ariens RAS, 2000, BLOOD, V96, P988, DOI 10.1182/blood.V96.3.988.015k57_988_995; BOARD PG, 1993, BLOOD REV, V7, P229, DOI 10.1016/0268-960X(93)90010-2; Carrell TWG, 2006, VASCULAR, V14, P9, DOI 10.2310/6670.2006.00008; Catto AJ, 1999, BLOOD, V93, P906, DOI 10.1182/blood.V93.3.906.403k24_906_908; Dardik R, 2006, J THROMB HAEMOST, V4, P19, DOI 10.1111/j.1538-7836.2005.01473.x; de Willige SU, 2009, BLOOD, V114, P3994, DOI 10.1182/blood-2009-05-217968; Elbaz A, 2000, BLOOD, V95, P586, DOI 10.1182/blood.V95.2.586; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; Franco RF, 2000, HAEMATOLOGICA, V85, P67; Franco RF, 1999, THROMB HAEMOSTASIS, V81, P676; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Golledge J, 2006, EUR J VASC ENDOVASC, V31, P237, DOI 10.1016/j.ejvs.2005.10.032; HARTER LP, 1982, J ULTRAS MED, V1, P315; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; Houard X, 2007, J PATHOL, V212, P20, DOI 10.1002/path.2148; Ichinose A, 2012, INT J HEMATOL, V95, P362, DOI 10.1007/s12185-012-1064-3; Iwata H, 2009, J THROMB HAEMOST, V7, P1084, DOI 10.1111/j.1538-7836.2009.03443.x; Jagadesham VP, 2008, TRENDS MOL MED, V14, P522, DOI 10.1016/j.molmed.2008.09.008; Kain K, 2002, AM J EPIDEMIOL, V156, P174, DOI 10.1093/aje/kwf017; Katona E, 2014, BLOOD, V123, P1757, DOI 10.1182/blood-2013-10-533596; Kazi M, 2003, J VASC SURG, V38, P1283, DOI 10.1016/S0741-5214(03)00791-2; Kohler HP, 1998, THROMB HAEMOSTASIS, V79, P8, DOI 10.1055/s-0037-1614250; Komanasin N, 2005, J THROMB HAEMOST, V3, P2487, DOI 10.1111/j.1538-7836.2005.01624.x; Ladenvall C, 2009, J NEUROSURG, V110, P475, DOI 10.3171/2008.7.JNS08272; Lim BCB, 2003, LANCET, V361, P1424, DOI 10.1016/S0140-6736(03)13135-2; LopezCandales A, 1997, AM J PATHOL, V150, P993; Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; MIKKOLA H, 1994, BLOOD, V84, P517; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Newman AB, 2001, ANN INTERN MED, V134, P182, DOI 10.7326/0003-4819-134-3-200102060-00008; Parry DJ, 2009, BRIT J SURG, V96, P870, DOI 10.1002/bjs.6632; Parry DJ, 2010, J VASC SURG, V52, P145, DOI 10.1016/j.jvs.2010.02.279; Patel A, 2008, EUR J VASC ENDOVASC, V36, P20, DOI 10.1016/j.ejvs.2008.01.014; Rasmussen-Torvik LJ, 2007, THROMB RES, V121, P1, DOI 10.1016/j.thromres.2007.02.008; Ruigrok YM, 2010, ACTA NEUROCHIR, V152, P257, DOI 10.1007/s00701-009-0505-0; Ryan AW, 2009, EUR J HUM GENET, V17, P219, DOI 10.1038/ejhg.2008.137; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; Scott DJA, 2011, ARTERIOSCL THROM VAS, V31, P3004, DOI 10.1161/ATVBAHA.111.236786; Singh K, 2001, AM J EPIDEMIOL, V154, P236, DOI 10.1093/aje/154.3.236; Standeven KF, 2003, CIRCULATION, V107, P2326, DOI 10.1161/01.CIR.0000066690.89407.CE; Suntharalingam J, 2008, EUR RESPIR J, V31, P736, DOI 10.1183/09031936.00055107; Thompson RW, 1997, CORONARY ARTERY DIS, V8, P623, DOI 10.1097/00019501-199710000-00005; van der Bom JG, 1998, ARTERIOSCL THROM VAS, V18, P621, DOI 10.1161/01.ATV.18.4.621; Vardulaki KA, 1998, BRIT J SURG, V85, P1674; Vorp DA, 2001, J VASC SURG, V34, P291, DOI 10.1067/mva.2001.114813; Wartiovaara U, 1999, ATHEROSCLEROSIS, V142, P295, DOI 10.1016/S0021-9150(98)00241-X	51	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112407	10.1371/journal.pone.0112407	http://dx.doi.org/10.1371/journal.pone.0112407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384012	gold, Green Submitted, Green Published			2022-12-26	WOS:000344816700057
J	Russell, S; Duquette, M; Liu, J; Drapkin, R; Lawler, J; Petrik, J				Russell, Samantha; Duquette, Mark; Liu, Joyce; Drapkin, Ronny; Lawler, Jack; Petrik, Jim			Combined therapy with thrombospondin-1 type I repeats (3TSR) and chemotherapy induces regression and significantly improves survival in a preclinical model of advanced stage epithelial ovarian cancer	FASEB JOURNAL			English	Article						antiangiogenic; metronomic; vessel normalization	GROWTH-FACTOR-BETA; ENDOTHELIAL-CELLS; PHASE-1 TRIAL; TUMOR-GROWTH; MOUSE MODEL; METRONOMIC CHEMOTHERAPY; PANCREATIC-CANCER; UP-REGULATION; ABT-510; ANGIOGENESIS	Most women are diagnosed with epithelial ovarian cancer ( EOC) at advanced stage, where therapies have limited effectiveness and the long- term survival rate is low. We evaluated the effects of combined antiangiogenic and chemotherapy treatments on advanced stage EOC. Treatment of EOC cells with a recombinant version of the thrombospondin- 1 type I repeats ( 3TSR) induced more apoptotic cell death ( 36.5 6 9.6%) in vitro compared to untreated controls ( 4.1 6 1.4). In vivo, tumors were induced in an orthotopic, syngeneic mouse model of advanced stage EOC. Mice were treated with 3TSR ( 4 mg/ kg per day) alone or in combination with chemotherapy drugs delivered with maximum tolerated dose or metronomic scheduling. Pretreatment with 3TSR induced tumor regression, normalized tumor vasculature, and improved uptake of chemotherapy drugs. Combination 3TSR and metronomic chemotherapy induced the greatest tumor regression ( 6.2- fold reduction in size compared to PBS- treated controls) and highest survival when treatment was initiated at advanced stage. 3TSR binding to its receptor, CD36 ( cluster of differentiation 36), increased binding of CD36 and SHP- 1, which significantly inhibited phosphorylation of the VEGF receptor. In this study, we describe a novel treatment approach and mechanism of action with 3TSR and chemotherapy that induces regression of advanced stage EOC and significantly improves survival.-	[Russell, Samantha; Petrik, Jim] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Duquette, Mark; Lawler, Jack] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Liu, Joyce; Drapkin, Ronny] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	University of Guelph; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Petrik, J (corresponding author), Univ Guelph, 50 Stone Rd, Guelph, ON N1G 2W1, Canada.	jpetrik@uoguelph.ca	Drapkin, Ronny/E-9944-2016; Lawler, Jack/AAJ-1379-2020	Drapkin, Ronny/0000-0002-6912-6977; Russell, Samantha/0000-0002-1593-993X	NATIONAL CANCER INSTITUTE [R01CA130895] Funding Source: NIH RePORTER; Canadian Institutes of Health Research [450084] Funding Source: Medline; NCI NIH HHS [R01 CA130895, CA130895] Funding Source: Medline; NINDS NIH HHS [NS077797] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adamcic U, 2012, NEOPLASIA, V14, P612, DOI 10.1593/neo.11948; Allegrini G, 2004, CANCER CHEMOTH PHARM, V53, P261, DOI 10.1007/s00280-003-0712-y; Berkenblit A, 2005, J REPROD MED, V50, P426; Bocci G, 2012, NEOPLASIA, V14, P833, DOI 10.1593/neo.12772; Borofsky SE, 2013, ABDOM IMAGING, V38, P265, DOI 10.1007/s00261-012-9913-3; Calzada MJ, 2004, J BIOL CHEM, V279, P41734, DOI 10.1074/jbc.M406267200; Campbell N, 2011, MOL CANCER THER, V10, P1876, DOI 10.1158/1535-7163.MCT-11-0402; Campbell NE, 2010, NEOPLASIA, V12, P275, DOI 10.1593/neo.91880; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chu LY, 2013, BLOOD, V122, P1822, DOI 10.1182/blood-2013-01-482315; Clauss A, 2010, NEOPLASIA, V12, P161, DOI 10.1593/neo.91542; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Dawson DW, 1999, MOL PHARMACOL, V55, P332, DOI 10.1124/mol.55.2.332; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gately S, 2001, CANCER J, V7, P427; Gordon MS, 2008, CANCER-AM CANCER SOC, V113, P3420, DOI 10.1002/cncr.23953; Greenaway J, 2008, GYNECOL ONCOL, V108, P385, DOI 10.1016/j.ygyno.2007.10.035; Greenaway J, 2009, MOL CANCER THER, V8, P64, DOI 10.1158/1535-7163.MCT-08-0864; Harries M, 2002, LANCET ONCOL, V3, P537, DOI 10.1016/S1470-2045(02)00847-1; Harries M, 2002, LANCET ONCOL, V3, P529, DOI 10.1016/S1470-2045(02)00846-X; Horowitz A, 2012, CELL SIGNAL, V24, P1810, DOI 10.1016/j.cellsig.2012.05.007; Iruela-Arispe ML, 1999, CIRCULATION, V100, P1423, DOI 10.1161/01.CIR.100.13.1423; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kamat AA, 2007, CANCER RES, V67, P281, DOI 10.1158/0008-5472.CAN-06-3282; Kelley RK, 2013, BRIT J CANCER, V109, P1725, DOI 10.1038/bjc.2013.553; LAWLER J, 1989, BLOOD, V74, P2022; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Li L, 2004, ANTICANCER RES, V24, P1973; Longuespee R, 2012, CANCER METAST REV, V31, P713, DOI 10.1007/s10555-012-9383-7; Mayer EL, 2012, BREAST CANCER RES TR, V136, P169, DOI 10.1007/s10549-012-2256-5; Miao WM, 2001, CANCER RES, V61, P7830; PIERCE DF, 1995, P NATL ACAD SCI USA, V92, P4254, DOI 10.1073/pnas.92.10.4254; Quesada AJ, 2005, CELL DEATH DIFFER, V12, P649, DOI 10.1038/sj.cdd.4401615; Ren B, 2009, CANCER RES, V69, P3856, DOI 10.1158/0008-5472.CAN-08-2940; Sahora AI, 2012, J VET INTERN MED, V26, P1169, DOI 10.1111/j.1939-1676.2012.00966.x; Scharovsky OG, 2009, CURR ONCOL, V16, P91; Sher I, 2009, INT J CANCER, V124, P553, DOI 10.1002/ijc.23963; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Simons M, 2012, PHYSIOLOGY, V27, P213, DOI 10.1152/physiol.00016.2012; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; TOLSMA SS, 1993, J CELL BIOL, V122, P497, DOI 10.1083/jcb.122.2.497; Uronis HE, 2013, CANCER MED-US, V2, P316, DOI 10.1002/cam4.65; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Recouvreux MV, 2012, ENDOCRINOLOGY, V153, P3861, DOI 10.1210/en.2012-1007; Yap R, 2005, CLIN CANCER RES, V11, P6678, DOI 10.1158/1078-0432.CCR-05-0621; Yee KO, 2004, AM J PATHOL, V165, P541, DOI 10.1016/S0002-9440(10)63319-6; Yigit R, 2010, GYNECOL ONCOL, V117, P366, DOI 10.1016/j.ygyno.2010.01.019; Zhang J, 2014, ONCOL LETT, V7, P95, DOI 10.3892/ol.2013.1650; Zhang XF, 2005, CLIN CANCER RES, V11, P2337, DOI 10.1158/1078-0432.CCR-04-1900; Zhang XF, 2007, CLIN CANCER RES, V13, P3968, DOI 10.1158/1078-0432.CCR-07-0245; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649; Zhou MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081858	55	40	42	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2015	29	2					576	588		10.1096/fj.14-261636	http://dx.doi.org/10.1096/fj.14-261636			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CB1ET	25395453	Green Published			2022-12-26	WOS:000349370400020
J	Filios, SR; Xu, GL; Chen, JQ; Hong, K; Jing, G; Shalev, A				Filios, Stephen R.; Xu, Guanlan; Chen, Junqin; Hong, Kyunghee; Jing, Gu; Shalev, Anath			MicroRNA-200 Is Induced by Thioredoxin-interacting Protein and Regulates Zeb1 Protein Signaling and Beta Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; REPRESSORS ZEB1; FEEDBACK LOOP; CANCER-CELLS; GLUCOSE; PROLIFERATION; INVASION; TARGETS; EMT	Small noncoding microRNAs have emerged as important regulators of cellular processes, but their role in pancreatic beta cells has only started to be elucidated. Loss of pancreatic beta cells is a key factor in the pathogenesis of diabetes, and we have demonstrated that beta cell expression of thioredoxin-interacting protein (TXNIP) is increased in diabetes and causes beta cell apoptosis, whereas TXNIP deficiency is protective against diabetes. Recently, we found that TXNIP also impairs beta cell function by inducing microRNA (miR)-204. Interestingly, using INS-1 beta cells and primary islets, we have now discovered that expression of another microRNA, miR-200, is induced by TXNIP and by diabetes. Furthermore, we found that miR-200 targeted and decreased Zeb1 (zinc finger E-box-binding homeobox 1) and promoted beta cell apoptosis as measured by cleaved caspase-3 levels, Bax/Bcl2 ratio, and TUNEL. In addition, Zeb1 knockdown mimicked the miR-200 effects on beta cell apoptosis, suggesting that Zeb1 plays an important role in mediating miR-200 effects. Moreover, miR-200 increased beta cell expression of the epithelial marker E-cadherin, consistent with inhibition of epithelial-mesenchymal transition, a process thought to be involved in beta cell expansion. Thus, we have identified a novel TXNIP/miR-200/Zeb1/E-cadherin signaling pathway that, for the first time, links miR-200 to beta cell apoptosis and diabetes and also beta cell TXNIP to epithelial-mesenchymal transition. In addition, our results shed new light on the regulation and function of miR-200 in beta cells and show that TXNIP-induced microRNAs control various processes of beta cell biology.	Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shalev, A (corresponding author), Univ Alabama Birmingham, 1825 Univ Blvd,SHEL 1206, Birmingham, AL 35294 USA.	shalev@uab.edu			National Institutes of Health [R01 DK-078752]; American Diabetes Association [7-12-BS-167]; JDRF/JNJSI [40-2011-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); JDRF/JNJSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK-078752. This work was also supported by American Diabetes Association Grant 7-12-BS-167 and JDRF/JNJSI Grant 40-2011-1.	Adam L, 2009, CLIN CANCER RES, V15, P5060, DOI 10.1158/1078-0432.CCR-08-2245; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Atouf F, 2007, DIABETES, V56, P699, DOI 10.2337/db06-1446; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chen JQ, 2008, FASEB J, V22, P3581, DOI 10.1096/fj.08-111690; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chen JQ, 2010, DIABETES, V59, P440, DOI 10.2337/db09-0949; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hay ED, 1995, ACTA ANAT, V154, P8; Iliopoulos D, 2010, MOL CELL, V39, P761, DOI 10.1016/j.molcel.2010.08.013; Joglekar MV, 2010, CELL CYCLE, V9, P4077, DOI 10.4161/cc.9.20.13590; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Lim YY, 2013, J CELL SCI, V126, P2256, DOI 10.1242/jcs.122275; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Russ HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006417; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Schliekelman MJ, 2011, CANCER RES, V71, P7670, DOI 10.1158/0008-5472.CAN-11-0964; Shalev A, 2002, ENDOCRINOLOGY, V143, P3695, DOI 10.1210/en.2002-220564; Tang HL, 2013, CANCER LETT, V340, P72, DOI 10.1016/j.canlet.2013.06.027; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Wiklund ED, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027840; Wiklund ED, 2011, INT J CANCER, V128, P1327, DOI 10.1002/ijc.25461; Williams LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083991; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	39	72	75	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 26	2014	289	52					36275	36283		10.1074/jbc.M114.592360	http://dx.doi.org/10.1074/jbc.M114.592360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JA	25391656	hybrid, Green Published			2022-12-26	WOS:000346897900051
J	Goyal, R; Goyal, D; Chu, N; Van Wickle, J; Longo, LD				Goyal, Ravi; Goyal, Dipali; Chu, Nina; Van Wickle, Jonathan; Longo, Lawrence D.			Cerebral Artery Alpha-1 AR Subtypes: High Altitude Long-Term Acclimatization Responses	PLOS ONE			English	Article							ALPHA-1-ADRENERGIC RECEPTOR SUBTYPES; ALPHA(1)-ADRENERGIC RECEPTORS; INS(1,4,5)P-3 RESPONSES; BLOOD-FLOW; RHO-KINASE; FETAL; HYPOXIA; MATURATION; BRAIN; CONTRACTILITY	In response to hypoxia and other stress, the sympathetic (adrenergic) nervous system regulates arterial contractility and blood flow, partly through differential activities of the alpha1 (alpha(1))-adrenergic receptor (AR) subtypes (alpha 1A-, alpha 1B-, and alpha 1D-AR). Thus, we tested the hypothesis that with acclimatization to long-term hypoxia (LTH), contractility of middle cerebral arteries (MCA) is regulated by changes in expression and activation of the specific alpha(1)-AR subtypes. We conducted experiments in MCA from adult normoxic sheep maintained near sea level (300 m) and those exposed to LTH (110 days at 3801 m). Following acclimatization to LTH, ovine MCA showed a 20% reduction (n = 5; P<0.05) in the maximum tension achieved by 10(-5) M phenylephrine (PHE). LTH-acclimatized cerebral arteries also demonstrated a statistically significant (P<0.05) inhibition of PHE-induced contractility in the presence of specific alpha 1-AR subtype antagonists. Importantly, compared to normoxic vessels, there was significantly greater (P<0.05) alpha 1B-AR subtype mRNA and protein levels in LTH acclimatized MCA. Also, our results demonstrate that extracellular regulated kinase 1 and 2 (ERK1/2)-mediated negative feedback regulation of PHE-induced contractility is modulated by alpha 1B-AR subtype. Overall, in ovine MCA, LTH produces profound effects on alpha 1-AR subtype expression and function.	[Goyal, Ravi; Goyal, Dipali; Chu, Nina; Van Wickle, Jonathan; Longo, Lawrence D.] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA 92354 USA; [Goyal, Ravi; Goyal, Dipali; Chu, Nina; Van Wickle, Jonathan; Longo, Lawrence D.] Epigenuity LLC, Loma Linda, CA USA	Loma Linda University	Goyal, R (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA 92354 USA.	rgoyal@llu.edu			United States Public Health Service Grant [PO1 HD031226]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD003807, P01HD031226] Funding Source: NIH RePORTER	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The studies were supported by United States Public Health Service Grant PO1 HD031226 to LDL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEVAN JA, 1984, BLOOD VESSELS, V21, P110; Bishai JM, 2002, AM J PHYSIOL-REG I, V282, pR1654, DOI 10.1152/ajpregu.00475.2001; BROWN JK, 1974, DEV MED CHILD NEUROL, V16, P567; DIECKHOFF D, 1969, PFLUG ARCH EUR J PHY, V310, P75, DOI 10.1007/BF00586876; Docherty JR, 1998, EUR J PHARMACOL, V361, P1, DOI 10.1016/S0014-2999(98)00682-7; EDVINSSON L, 1982, PATHOL BIOL, V30, P261; GOETZ AS, 1995, EUR J PHARMACOL, V272, pR5, DOI 10.1016/0014-2999(94)00751-R; Goyal R, 2014, PHYSL GENOMICS; Goyal R, 2008, AM J PHYSIOL-LUNG C, V295, pL905, DOI 10.1152/ajplung.00053.2008; Goyal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082200; Goyal R, 2010, AM J PHYSIOL-REG I, V299, pR1377, DOI 10.1152/ajpregu.00344.2010; Goyal R, 2010, AM J PHYSIOL-HEART C, V298, pH1797, DOI 10.1152/ajpheart.00112.2010; Goyal R, 2009, AM J PHYSIOL-HEART C, V297, pH2242, DOI 10.1152/ajpheart.00681.2009; Graham RM, 1996, CIRC RES, V78, P737, DOI 10.1161/01.RES.78.5.737; GREENBERG B, 1993, AM J PHYSIOL, V265, pH1712, DOI 10.1152/ajpheart.1993.265.5.H1712; Guimaraes S, 2001, PHARMACOL REV, V53, P319; HEISTAD DD, 1978, J CLIN INVEST, V62, P761, DOI 10.1172/JCI109187; KAMITOMO M, 1994, AM J PHYSIOL, V266, pR1778, DOI 10.1152/ajpregu.1994.266.6.R1778; Kandabashi T, 2003, ARTERIOSCL THROM VAS, V23, P2209, DOI 10.1161/01.ATV.0000104010.87348.26; KITANAKA T, 1989, AM J PHYSIOL, V256, pR1340, DOI 10.1152/ajpregu.1989.256.6.R1340; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Long W, 2000, AM J PHYSIOL-REG I, V279, pR2004, DOI 10.1152/ajpregu.2000.279.6.R2004; Longo LD, 1997, BRIT J OBSTET GYNAEC, V104, P652, DOI 10.1111/j.1471-0528.1997.tb11974.x; LONGO LD, 1993, AM J PHYSIOL, V264, pR65, DOI 10.1152/ajpregu.1993.264.1.R65; Longo LD, 1998, COMP BIOCHEM PHYS A, V119, P683, DOI 10.1016/S1095-6433(98)01006-X; Longo LD, 1996, AM J PHYSIOL-HEART C, V270, pH915, DOI 10.1152/ajpheart.1996.270.3.H915; MCCALDEN TA, 1981, J AUTON PHARMACOL, V1, P421, DOI 10.1111/j.1474-8673.1981.tb00082.x; MINNEMAN KP, 1994, ANNU REV PHARMACOL, V34, P117; MINNEMAN KP, 1988, MOL PHARMACOL, V33, P509; MORROW AL, 1986, MOL PHARMACOL, V29, P321; MULLIGAN JC, 1980, J PEDIATR-US, V96, P903, DOI 10.1016/S0022-3476(80)80575-0; Nelson KB, 2003, NEW ENGL J MED, V349, P1765, DOI 10.1056/NEJMsb035364; Onishi J, 2003, J SOC GYNECOL INVEST, V10, P189, DOI 10.1016/S1071-5576(03)00042-X; PEETERS LLH, 1979, AM J OBSTET GYNECOL, V135, P637, DOI 10.1016/S0002-9378(16)32989-1; Purkayastha S, 2013, EXP PHYSIOL, V98, P451, DOI 10.1113/expphysiol.2012.066118; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robertson TP, 2003, AM J PHYSIOL-LUNG C, V284, pL1121, DOI 10.1152/ajplung.00422.2002; ter Laan M, 2013, BRIT J ANAESTH, V111, P361, DOI 10.1093/bja/aet122; Tsai MH, 2006, PFLUG ARCH EUR J PHY, V453, P223, DOI 10.1007/s00424-006-0133-y; Ueno N, 1997, AM J PHYSIOL-REG I, V272, pR669, DOI 10.1152/ajpregu.1997.272.2.R669; West JB, 2012, AM J RESP CRIT CARE, V186, P1229, DOI 10.1164/rccm.201207-1323CI	41	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112784	10.1371/journal.pone.0112784	http://dx.doi.org/10.1371/journal.pone.0112784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393740	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300103
J	Guidino, C; Llapapasca, MA; Silva, S; Alcorta, B; Pacheco, AS				Guidino, Chiara; Llapapasca, Miguel A.; Silva, Sebastian; Alcorta, Belen; Pacheco, Aldo S.			Patterns of Spatial and Temporal Distribution of Humpback Whales at the Southern Limit of the Southeast Pacific Breeding Area	PLOS ONE			English	Article							MEGAPTERA-NOVAEANGLIAE; MIGRATORY DESTINATIONS; REPRODUCTIVE STATUS; HAWAIIAN-ISLANDS; CENTRAL-AMERICA; CURRENT SYSTEM; HABITAT; FEMALE; WATERS; IDENTIFICATION	Understanding the patterns of spatial and temporal distribution in threshold habitats of highly migratory and endangered species is important for understanding their habitat requirements and recovery trends. Herein, we present new data about the distribution of humpback whales (Megaptera novaeangliae) in neritic waters off the northern coast of Peru: an area that constitutes a transitional path from cold, upwelling waters to warm equatorial waters where the breeding habitat is located. Data was collected during four consecutive austral winter/spring seasons from 2010 to 2013, using whale-watching boats as platforms for research. A total of 1048 whales distributed between 487 groups were sighted. The spatial distribution of humpbacks resembled the characteristic segregation of whale groups according to their size/age class and social context in breeding habitats; mother and calf pairs were present in very shallow waters close to the coast, while dyads, trios or more whales were widely distributed from shallow to moderate depths over the continental shelf break. Sea surface temperatures (range: 18.2-25.9 degrees C) in coastal waters were slightly colder than those closer to the oceanic realm, likely due to the influence of cold upwelled waters from the Humboldt Current system. Our results provide new evidence of the southward extension of the breeding region of humpback whales in the Southeast Pacific. Integrating this information with the knowledge from the rest of the breeding region and foraging grounds would enhance our current understanding of population dynamics and recovery trends of this species.	[Guidino, Chiara] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Llapapasca, Miguel A.] Inst Mar Peru, Oficina Invest Depredadores Super, Callao, Peru; [Silva, Sebastian; Alcorta, Belen] Pacifico Adventures Manejo Integral Ambiente Mari, Los Organos, Peru; [Pacheco, Aldo S.] Univ Antofagasta, Inst Ciencias Nat Alexander Von Humboldt, Antofagasta, Chile	University of Technology Sydney; Instituto del Mar del Peru; Universidad de Antofagasta	Pacheco, AS (corresponding author), Univ Antofagasta, Inst Ciencias Nat Alexander Von Humboldt, Antofagasta, Chile.	aldo.pacheco@uantof.cl	Ll., Miguel A. Llapapasca/AAC-9856-2020; Pacheco, Aldo S/L-9939-2017	Ll., Miguel A. Llapapasca/0000-0003-1332-0874; Pacheco, Aldo S/0000-0002-2767-6436; Guidino, Chiara/0000-0002-2918-7636	Pacifico Adventures crew	Pacifico Adventures crew	We deeply thank the support of the Pacifico Adventures crew and volunteers particularly, F. Sanchez-Salazar, N. Balducci, A. Petit and E. Larranaga. C. Paulino and J. Ledesma (IMARPE) who kindly provided us the sea surface temperature data. Comments by R. Cartwright, A. Zerbini, K. Van Waerebeek and an anonymous reviewer helped us to improve an early version of the manuscript. N. Burns and K. Rasmussen kindly revised the English of this manuscript. This is study was supported by the participation of hundreds of enthusiastic whale-watchers.	Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Capella JJ, 2008, REV CHIL HIST NAT, V81, P547; Cartwright R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038004; Cartwright R, 2009, BEHAVIOUR, V146, P1573, DOI 10.1163/156853909X458377; Cartwright R, 2009, MAR MAMMAL SCI, V25, P659, DOI 10.1111/j.1748-7692.2009.00286.x; Clapham P, 2001, MAR MAMMAL SCI, V17, P432, DOI 10.1111/j.1748-7692.2001.tb01289.x; Clarke R., 1962, Norsk Hvalfangsttidende Sandefjord, V51, P265; Contini Ferreira Mariana Elias, 2011, Latin American Journal of Aquatic Mammals, V9, P160; Corkeron PJ, 1999, MAR MAMMAL SCI, V15, P1228, DOI 10.1111/j.1748-7692.1999.tb00887.x; Craig AS, 2014, BEHAVIOUR, V151, P613, DOI 10.1163/1568539X-00003151; Craig AS, 2003, BEHAVIOUR, V140, P981, DOI 10.1163/156853903322589605; Craig AS, 2000, MAR ECOL PROG SER, V193, P209, DOI 10.3354/meps193209; Dawbin W. H., 1997, Memoirs of the Queensland Museum, V42, P105; Doniol-Valcroze T, 2007, MAR ECOL PROG SER, V335, P207, DOI 10.3354/meps335207; Ersts PJ, 2003, J ZOOL, V260, P337, DOI 10.1017/S0952836903003807; Faria MA, 2013, AQUAT MAMM, V39, P296, DOI 10.1578/AM.39.3.2013.296; Felix Fernando, 2005, Journal of Cetacean Research and Management, V7, P21; Felix Fernando, 2001, Revista de Biologia Marina y Oceanografia, V36, P61; Felix Fernando, 2011, Journal of Cetacean Research and Management, P301; Felix F, 2011, MAR ECOL PROG SER, V426, P277, DOI 10.3354/meps08984; FLOREZ-GONZALEZ L, 1991, Memoirs of the Queensland Museum, V30, P291; Florez-Gonzalez L, 1998, MAR MAMMAL SCI, V14, P189, DOI 10.1111/j.1748-7692.1998.tb00707.x; FLOREZGONZALEZ L, 1994, MAR MAMMAL SCI, V10, P218, DOI 10.1111/j.1748-7692.1994.tb00264.x; Garcia-Godos I, 2013, PAC SCI, V67, P523, DOI 10.2984/67.4.3; Gibbons Jorge, 2003, Journal of Cetacean Research and Management, V5, P203; Heithaus MR, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P414; Hucke-Gaete R, 2013, AQUAT CONSERV, V23, P858, DOI 10.1002/aqc.2343; Johnston D. W., 2007, Endangered Species Research, V3, P249, DOI 10.3354/esr00049; McClean SA, 1998, J WILDLIFE MANAGE, V62, P793, DOI 10.2307/3802356; Morete ME, 2007, J MAR BIOL ASSOC UK, V87, P87, DOI 10.1017/S0025315407054616; Moron A. O., 2000, B I MAR PERU, V19, P179; NEU CW, 1974, J WILDLIFE MANAGE, V38, P541, DOI 10.2307/3800887; Oviedo L, 2008, REV BIOL TROP, V56, P591; Pacheco AS, 2013, REV BIOL MAR OCEANOG, V48, P185, DOI 10.4067/S0718-19572013000100016; Pacheco Aldo S., 2009, Latin American Journal of Aquatic Mammals, V7, P33; Pacheco AS, 2011, LAT AM J AQUAT RES, V39, P189, DOI 10.3856/vol39-issue1-fulltext-20; Ramirez P, 1988, B LIMA, V56, P91; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Rasmussen K, 2012, MAR MAMMAL SCI, V28, pE267, DOI 10.1111/j.1748-7692.2011.00529.x; Santillan Luis, 2011, Journal of Marine Animals and their Ecology, V4, P29; Scheidat Meike, 2000, Journal of Cetacean Research and Management, V2, P165; Smith JN, 2012, MAR ECOL PROG SER, V447, P259, DOI 10.3354/meps09462; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; STONE GS, 1990, NATURE, V346, P705, DOI 10.1038/346705a0; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Tynan CT, 2005, DEEP-SEA RES PT II, V52, P145, DOI 10.1016/j.dsr2.2004.09.024; URBAN J, 1987, MAR MAMMAL SCI, V3, P333; Urban J, 1999, BALLENA JOROBADA MEG; Van Waerebeek K, 1996, SC48SH1 INT WHAL COM; Van Waerebeek K, 2013, AFR ZOOL, V48, P177; Zerbini Alexandre N., 2004, Journal of Cetacean Research and Management, V6, P101	51	39	40	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112627	10.1371/journal.pone.0112627	http://dx.doi.org/10.1371/journal.pone.0112627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391137	Green Published, Green Submitted, gold			2022-12-26	WOS:000349144400112
J	Hudson, LE; Fasken, MB; McDermott, CD; McBride, SM; Kuiper, EG; Guiliano, DB; Corbett, AH; Lamb, TJ				Hudson, Lauren E.; Fasken, Milo B.; McDermott, Courtney D.; McBride, Shonna M.; Kuiper, Emily G.; Guiliano, David B.; Corbett, Anita H.; Lamb, Tracey J.			Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii	PLOS ONE			English	Article							ESCHERICHIA-COLI; CEREVISIAE; STRAINS; DECARBOXYLASE; TRANSLOCATION; GENERATION; MUTANTS; HOST; ACID; GENE	Recent studies have suggested the potential of probiotic organisms to be adapted for the synthesis and delivery of oral therapeutics. The probiotic yeast Saccharomyces boulardii would be especially well suited for this purpose due to its ability, in contrast to probiotic prokaryotes, to perform eukaryotic post translational modifications. This probiotic yeast thus has the potential to express a broad array of therapeutic proteins. Currently, however, use of wild type (WT) S. boulardii relies on antibiotic resistance for the selection of transformed yeast. Here we report the creation of auxotrophic mutant strains of S. boulardii that can be selected without antibiotics and demonstrate that these yeast can express functional recombinant protein even when recovered from gastrointestinal immune tissues in mice. A UV mutagenesis approach was employed to generate three uracil auxotrophic S. boulardii mutants that show a low rate of reversion to wild type growth. These mutants can express recombinant protein and are resistant in vitro to low pH, bile acid salts, and anaerobic conditions. Critically, oral gavage experiments using C57BL/6 mice demonstrate that mutant S. boulardii survive and are taken up into gastrointestinal immune tissues on a similar level as WT S. boulardii. Mutant yeast recovered from gastrointestinal immune tissues furthermore retain expression of functional recombinant protein. These data show that auxotrophic mutant S. boulardii can safely express recombinant protein without antibiotic selection and can deliver recombinant protein to gastrointestinal immune tissues. These auxotrophic mutants of S. boulardii pave the way for future experiments to test the ability of S. boulardii to deliver therapeutics and mediate protection against gastrointestinal disorders.	[Hudson, Lauren E.; McDermott, Courtney D.; Lamb, Tracey J.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Fasken, Milo B.; Kuiper, Emily G.; Corbett, Anita H.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [McBride, Shonna M.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Guiliano, David B.] Univ E London, Sch Hlth Sport & Biosci, London E15 4LZ, England	Emory University; Emory University; Emory University; University of East London	Corbett, AH (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	acorbe2@emory.edu; tracey.j.lamb@emory.edu	Fasken, Milo/K-2177-2019; Corbett, Anita/AAH-6106-2021	Fasken, Milo/0000-0003-4317-7909; Corbett, Anita/0000-0002-0461-6895; Lamb, Tracey/0000-0003-0620-3944; McBride, Shonna/0000-0001-6221-714X	CCVI Seed Grant from Emory University; National Institutes of Health [1DP2AI112242-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI112242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367, T32GM008169] Funding Source: NIH RePORTER	CCVI Seed Grant from Emory University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided through a CCVI Seed Grant from Emory University (http://www.emory.edu) and a New Innovator Award 1DP2AI112242-01 through the National Institutes of Health (http://commonfund.nih.gov/newinnovator/index). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation in the manuscript.	Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; BERG R, 1993, J INFECT DIS, V168, P1314, DOI 10.1093/infdis/168.5.1314; BLEHAUT H, 1989, BIOPHARM DRUG DISPOS, V10, P353, DOI 10.1002/bdd.2510100403; Boddy AV, 1991, PHARM RES, V8; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Burke D., 2000, METHODS YEAST GENETI; Castagliuolo I, 1996, TOXIN A, P64; CZERUCKA D, 1994, GASTROENTEROLOGY, V106, P65, DOI 10.1016/S0016-5085(94)94403-2; Dahan S, 2003, INFECT IMMUN, V71, P766, DOI 10.1128/IAI.71.2.766-773.2003; Degtyareva NP, 2008, MOL CELL BIOL, V28, P5432, DOI 10.1128/MCB.00307-08; Demain AL, 2009, BIOTECHNOL ADV, V27, P297, DOI 10.1016/j.biotechadv.2009.01.008; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Douradinha B, 2014, BIOENGINEERED, V5, P21, DOI 10.4161/bioe.26271; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Edwards AN, 2013, JOVE-J VIS EXP, DOI 10.3791/50787; Edwards-Ingram L, 2007, APPL ENVIRON MICROB, V73, P2458, DOI 10.1128/AEM.02201-06; Edwards-Ingram LC, 2004, GENOME RES, V14, P1043, DOI 10.1101/gr.2114704; Fietto JLR, 2004, CAN J MICROBIOL, V50, P615, DOI [10.1139/w04-050, 10.1139/W04-050]; Generoso SV, 2011, EUR J NUTR, V50, P261, DOI 10.1007/s00394-010-0134-7; Hamedi Hassan, 2013, Avicenna Journal of Medical Biotechnology, V5, P29; Hashimoto S, 2005, APPL ENVIRON MICROB, V71, P312, DOI 10.1128/AEM.71.1.312-319.2005; Kuhle AVDA, 2005, INT J FOOD MICROBIOL, V101, P29, DOI 10.1016/j.ijfoodmicro.2004.10.039; Kurugol Z, 2005, ACTA PAEDIATR, V94, P44, DOI 10.1080/08035250410022521; Latorre-Garcia L, 2008, WORLD J MICROB BIOT, V24, P2957, DOI 10.1007/s11274-008-9837-9; LEHR R, 1992, STAT MED, V11, P1099, DOI 10.1002/sim.4780110811; Martins FS, 2009, ARCH MICROBIOL, V191, P623, DOI 10.1007/s00203-009-0491-x; Martins FS, 2013, MICROBES INFECT, P1; McFarland LV, 2010, WORLD J GASTROENTERO, V16, P2202, DOI 10.3748/wjg.v16.i18.2202; Michael S, 2013, INFLAMM BOWEL DIS, V19, P185, DOI 10.1002/ibd.23006; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; ROSE M, 1984, GENE, V29, P113, DOI 10.1016/0378-1119(84)90172-0; Sambrook J., 2001, MOL CLONING LAB MANU; Schulz O, 2013, TRENDS IMMUNOL, V34, P155, DOI 10.1016/j.it.2012.09.006; SIKORSKI RS, 1989, GENETICS, V122, P19; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Wang T., 2013, FORMING CONDITIONS R, P1	39	21	22	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112660	10.1371/journal.pone.0112660	http://dx.doi.org/10.1371/journal.pone.0112660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391025	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000349144400117
J	Puttkammer, N; Zeliadt, S; Balan, JG; Baseman, J; Destine, R; Domercant, JW; France, G; Hyppolite, N; Pelletier, V; Raphael, NA; Sherr, K; Yuhas, K; Barnhart, S				Puttkammer, Nancy; Zeliadt, Steven; Balan, Jean Gabriel; Baseman, Janet; Destine, Rodney; Domercant, Jean Wysler; France, Garilus; Hyppolite, Nathaelf; Pelletier, Valerie; Raphael, Nernst Atwood; Sherr, Kenneth; Yuhas, Krista; Barnhart, Scott			Development of an Electronic Medical Record Based Alert for Risk of HIV Treatment Failure in a Low-Resource Setting	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY ADHERENCE; CLINICAL DECISION-SUPPORT; PHARMACY; CARE; RECOMMENDATIONS; DEFINITIONS; OUTCOMES; SYSTEM; ADULTS	Background: The adoption of electronic medical record systems in resource-limited settings can help clinicians monitor patients' adherence to HIV antiretroviral therapy (ART) and identify patients at risk of future ART failure, allowing resources to be targeted to those most at risk. Methods: Among adult patients enrolled on ART from 2005-2013 at two large, public-sector hospitals in Haiti, ART failure was assessed after 6-12 months on treatment, based on the World Health Organization's immunologic and clinical criteria. We identified models for predicting ART failure based on ART adherence measures and other patient characteristics. We assessed performance of candidate models using area under the receiver operating curve, and validated results using a randomly-split data sample. The selected prediction model was used to generate a risk score, and its ability to differentiate ART failure risk over a 42-month follow-up period was tested using stratified Kaplan Meier survival curves. Results: Among 923 patients with CD4 results available during the period 6-12 months after ART initiation, 196 (21.2%) met ART failure criteria. The pharmacy-based proportion of days covered (PDC) measure performed best among five possible ART adherence measures at predicting ART failure. Average PDC during the first 6 months on ART was 79.0% among cases of ART failure and 88.6% among cases of non-failure (p<0.01). When additional information including sex, baseline CD4, and duration of enrollment in HIV care prior to ART initiation were added to PDC, the risk score differentiated between those who did and did not meet failure criteria over 42 months following ART initiation. Conclusions: Pharmacy data are most useful for new ART adherence alerts within iSante. Such alerts offer potential to help clinicians identify patients at high risk of ART failure so that they can be targeted with adherence support interventions, before ART failure occurs.	[Puttkammer, Nancy; Barnhart, Scott] Univ Washington, Int Training & Educ Ctr Hlth, Dept Global Hlth, Seattle, WA 98195 USA; [Puttkammer, Nancy; Zeliadt, Steven] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Balan, Jean Gabriel; Destine, Rodney; Hyppolite, Nathaelf; Raphael, Nernst Atwood] Int Training & Educ Ctr Health Haiti, Port Au Prince, Haiti; [Baseman, Janet] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Domercant, Jean Wysler; Pelletier, Valerie] Ctr Dis Control & Prevent, Div Global HIV AIDS, Port Au Prince, Haiti; [France, Garilus] Minist Publ Hlth & Populat, Populat Div, Port Au Prince, Haiti; [Sherr, Kenneth] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Yuhas, Krista] Univ Washington, Ctr AIDS Res, Dept Global Hlth, Seattle, WA 98195 USA; [Barnhart, Scott] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Puttkammer, N (corresponding author), Univ Washington, Int Training & Educ Ctr Hlth, Dept Global Hlth, Seattle, WA 98195 USA.			Raphael, Nernst-Atwood/0000-0002-6229-9584	President's Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration [U91HA0680]; United States Centers for Disease Control and Prevention [5U2GGH000549-03]; University of Washington Center for AIDS Research (CFAR); National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases) [P30AI027757]; National Institutes of Health (NIH) (National Cancer Institute) [P30AI027757]; National Institutes of Health (NIH) (National Institute of Mental Health) [P30AI027757]; National Institutes of Health (NIH) (National Institute on Drug Abuse) [P30AI027757]; National Institutes of Health (NIH) (National Institute of Child Health and Human Development) [P30AI027757]; National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute) [P30AI027757]; National Institutes of Health (NIH) (National Institute on Aging) [P30AI027757]; National Institutes of Health (NIH) (National Institute of General Medical Sciences) [P30AI027757]; National Institutes of Health (NIH) (National Institute of Diabetes and Digestive and Kidney Diseases) [P30AI027757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	President's Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration; United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of Washington Center for AIDS Research (CFAR); National Institutes of Health (NIH) (National Institute of Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH) (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH) (National Institute of Mental Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (NIH) (National Institute on Drug Abuse)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health (NIH) (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH) (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH) (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH) (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Health Resources and Services Administration, under award number U91HA0680, and the United States Centers for Disease Control and Prevention, under award number 5U2GGH000549-03, to the International Training and Education Center for Health (I-TECH) at the University of Washington. This research was also funded in part by a 2012 developmental grant from the University of Washington Center for AIDS Research (CFAR), a National Institutes of Health (NIH) funded program under award number P30AI027757 which is supported by the following NIH Institutes and Centers (National Institute of Allergy and Infectious Diseases, National Cancer Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Child Health and Human Development, National Heart, Lung, and Blood Institute, National Institute on Aging, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases). Two authors are employees of the United States Centers for Disease Control and Prevention. However, the findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Health Resources and Services Administration. The other funders for this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Amico K Rivet, 2013, J Int Assoc Provid AIDS Care, V12, P128, DOI 10.1177/1545109712459041; Balan JG, 2013, COMMUNICATION; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cayemittes M, 2013, ENQUETE MORTALITE MO; Chaiyachati K, 2011, AIDS PATIENT CARE ST, V25, P163, DOI 10.1089/apc.2010.0257; Charles M, 2008, B WORLD HEALTH ORGAN, V86, P970, DOI 10.2471/BLT.07.050120; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Chu LH., SAS MACROPROGRAM CAL; Damiani G, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-2; Fan VS, 2002, J CLIN EPIDEMIOL, V55, P371, DOI 10.1016/S0895-4356(01)00493-0; Garfield S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-149; Giordano TP, 2004, HIV CLIN TRIALS, V5, P74, DOI 10.1310/JFXH-G3X2-EYM6-D6UG; Gsponer T, 2012, AIDS, V26, P57, DOI 10.1097/QAD.0b013e32834e1b5f; Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018; Hosmer DW., 2007, APPL SURVIVAL ANAL; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Koenig SP, 2012, JAIDS-J ACQ IMM DEF, V59, pE60, DOI 10.1097/QAI.0b013e318245d3c1; Kunutsor S, 2010, JAIDS-J ACQ IMM DEF, V55, P221, DOI 10.1097/QAI.0b013e3181e255ec; Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011; Lober William B, 2008, AMIA Annu Symp Proc, P434; Matheson AI, 2012, INT J MED INFORM, V81, P244, DOI 10.1016/j.ijmedinf.2012.01.011; McMahon JH, 2013, AIDS BEHAV, V17, P2253, DOI 10.1007/s10461-013-0436-x; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; MSPP/PNLS, 2012, DECL ENG VIH SIDA RA; Oluoch T, 2012, INT J MED INFORM, V81, pE83, DOI 10.1016/j.ijmedinf.2012.07.010; Pearson SA, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-154; Pepe M. S., 2003, STAT EVALUATION MED; Pepe MS, 2009, STATA J, V9, P1; Plews I, 2010, CONSTRUCTING APPL RI; Puttkammer N, 2013, USING ELECT MED RECO; Puttkammer N, 2013, INTERNAL REPORT; Raebel MA, 2013, MED CARE, V51, pS11, DOI 10.1097/MLR.0b013e31829b1d2a; Robbins GK, 2012, ANN INTERN MED, V157, P757, DOI 10.7326/0003-4819-157-11-201212040-00003; Robbins GK, 2010, CLIN INFECT DIS, V50, P779, DOI 10.1086/650537; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; Wand H, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000005; Were MC, 2011, J AM MED INFORM ASSN, V18, P150, DOI 10.1136/jamia.2010.005520	44	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112261	10.1371/journal.pone.0112261	http://dx.doi.org/10.1371/journal.pone.0112261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390044	gold, Green Published			2022-12-26	WOS:000349144400066
J	Usta, J; Wehbeh, A; Rida, K; El-Rifai, O; Estiphan, TA; Majarian, T; Barada, K				Usta, Julnar; Wehbeh, Antonios; Rida, Khaled; El-Rifai, Omar; Estiphan, Theresa Alicia; Majarian, Tamar; Barada, Kassem			Phenotype-Genotype Correlation in Wilson Disease in a Large Lebanese Family: Association of c.2299insC with Hepatic and of p. Ala1003Thr with Neurologic Phenotype	PLOS ONE			English	Article							ATP7B GENE; MUTATION ANALYSIS; LIVER-DISEASE; SPLICE VARIANTS; INDIAN PATIENTS; DIAGNOSIS; IDENTIFICATION; SPECTRUM; HOMOZYGOSITY; METAANALYSIS	Genotype phenotype correlations in Wilson disease (WD) are best established in homozygous patients or in compound heterozygous patients carrying the same set of mutations. We determined the clinical phenotype of patients with WD carrying the c.2298_2299insC in Exon 8 (c.2299insC) or the p. Ala1003Thr missense substitution in Exon 13 mutations in the homozygous or compound heterozygous state. We investigated 76 members of a single large Lebanese family. Their genotypes were determined, and clinical assessments were carried out for affected subjects. We also performed a literature search retrieving the phenotypes of patients carrying the same mutations of our patients in the homozygous or compound heterozygous state. There were 7 consanguineous marriages in this family and the prevalence of WD was 8.9% and of carriers of ATP7B mutation 44.7%. WD was confirmed in 9 out of 76 subjects. All 9 had the c.2299insC mutation, 5 homozygous and 4-compound heterozygous with p. Ala1003Thr. Six of our patients had hepatic, 2 had neurologic and 1 had asymptomatic phenotype. Based on our data and a literature review, clear phenotypes were reported for 38 patients worldwide carrying the c.2299insC mutation. About 53% of those have hepatic and 29% have neurologic phenotype. Furthermore, there were 10 compound heterozygous patients carrying the p. Ala1003Thr mutation. Among those, 80% having c.2299insC as the second mutation had hepatic phenotype, and all others had neurologic phenotype. We hereby report an association between the c.2299insC mutation and hepatic phenotype and between the p. Ala1003Thr mutation and neurologic phenotype.	[Usta, Julnar; Rida, Khaled; El-Rifai, Omar; Majarian, Tamar] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Wehbeh, Antonios; Estiphan, Theresa Alicia] Amer Univ, Beirut Med Ctr, Fac Med, Beirut, Lebanon; [Barada, Kassem] Amer Univ, Dept Internal Med, Div Gastroenterol, Div Gastroenterol,Dept Internal Med, Beirut, Lebanon	American University of Beirut; American University of Beirut; Beirut Medical Center; American University of Beirut	Barada, K (corresponding author), Amer Univ, Dept Internal Med, Div Gastroenterol, Div Gastroenterol,Dept Internal Med, Beirut, Lebanon.	kb02@aub.edu.lb			Medical Practice Plan of AUB-MC; University Research Board of the American University of Beirut	Medical Practice Plan of AUB-MC; University Research Board of the American University of Beirut	The authors thank The Medical Practice Plan of AUB-MC and the University Research Board of the American University of Beirut for supporting the study by research grants to J. Usta. The funders had no role in study design, data collection and anlysis, decision to publish or preparation of the manuscript.	Abdelghaffar TY, 2008, J HUM GENET, V53, P681, DOI 10.1007/s10038-008-0298-7; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Barada K, 2007, CLIN GENET, V72, P264, DOI 10.1111/j.1399-0004.2007.00853.x; Barada K, 2010, J CLIN GASTROENTEROL, V44, P432, DOI 10.1097/MCG.0b013e3181ce5138; Barbour B, 2009, J BIOSOC SCI, V41, P505, DOI 10.1017/S0021932009003290; Bruha R, 2011, LIVER INT, V31, P83, DOI 10.1111/j.1478-3231.2010.02354.x; Butler P, 2001, MOL GENET METAB, V72, P223, DOI 10.1006/mgme.2000.3143; Chabik G, 2014, J INHERIT METAB DIS, V37, P131, DOI 10.1007/s10545-013-9625-z; Cheng TF, 2012, J APPL TOXICOL, V32, P643, DOI 10.1002/jat.2717; Curtis D, 1999, HUM MUTAT, V14, P304, DOI 10.1002/(SICI)1098-1004(199910)14:4<304::AID-HUMU5>3.0.CO;2-W; Dastsooz H, 2013, GENE, V514, P48, DOI 10.1016/j.gene.2012.10.085; Deguti MM, 2004, HUM MUTAT, V23, P398, DOI 10.1002/humu.9227; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2014, ANN NY ACAD SCI, V1315, P1, DOI 10.1111/nyas.12340; Ferenci P, 2012, J HEPATOL, V56, P671, DOI 10.1016/j.jhep.2011.11.007; Ghaffar TYA, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-56; Gow PJ, 2000, GUT, V46, P415, DOI 10.1136/gut.46.3.415; Gu YH, 2003, CLIN GENET, V64, P479, DOI 10.1046/j.1399-0004.2003.00179.x; Gupta A, 2005, HUM GENET, V118, P49, DOI 10.1007/s00439-005-0007-y; Harada Masaru, 2002, Medical Electron Microscopy, V35, P61, DOI 10.1007/s007950200007; Hofer H, 2012, J HUM GENET, V57, P564, DOI 10.1038/jhg.2012.65; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Kalinsky H, 1998, HUM MUTAT, V11, P145, DOI 10.1002/(SICI)1098-1004(1998)11:2<145::AID-HUMU7>3.3.CO;2-F; Keandaungjuntr Jesada, 2011, Journal of the Medical Association of Thailand, V94, P1184; Kegley KM, 2010, AM J TRANSPLANT, V10, P1325, DOI 10.1111/j.1600-6143.2010.03071.x; Kumar S, 2006, ANN HUM BIOL, V33, P177, DOI 10.1080/03014460500503275; Loudianos G, 2003, GENET TEST, V7, P107, DOI 10.1089/109065703322146786; Margarit E, 2005, CLIN GENET, V68, P61, DOI 10.1111/j.1399-0004.2005.00439.x; Mihaylova V, 2012, NEUROLOGIST, V18, P184, DOI 10.1097/NRL.0b013e31825cf3b7; Moller LB, 2011, EUR J HUM GENET, V19, P935, DOI 10.1038/ejhg.2011.80; Nicastro E, 2009, J HEPATOL, V50, P555, DOI 10.1016/j.jhep.2008.09.020; Obrador BD, 2006, EUR J GASTROEN HEPAT, V18, P57, DOI 10.1097/00042737-200601000-00010; Panagiotakaki E, 2004, AM J MED GENET A, V131A, P168, DOI 10.1002/ajmg.a.30345; Papur OS, 2013, EUR J MED GENET, V56, P175, DOI 10.1016/j.ejmg.2013.01.003; PETRUKHIN K, 1994, HUM MOL GENET, V3, P1647, DOI 10.1093/hmg/3.9.1647; Pinzani M, 2005, J HEPATOL, V42, pS22, DOI 10.1016/j.jhep.2004.12.008; Shah AB, 1997, AM J HUM GENET, V61, P317, DOI 10.1086/514864; Stapelbroek JM, 2004, J HEPATOL, V41, P758, DOI 10.1016/j.jhep.2004.07.017; STERNLIEB I, 1993, J HEPATOL, V17, P263, DOI 10.1016/S0168-8278(05)80202-8; THOMAS GR, 1995, NAT GENET, V9, P210, DOI 10.1038/ng0295-210; Usta J, 2012, JIMD REP, V4, P129, DOI 10.1007/8904_2011_91; Wan L, 2010, HEPATOLOGY, V52, P1662, DOI 10.1002/hep.23865; Wilson AME, 2009, BIOCHIMIE, V91, P1342, DOI 10.1016/j.biochi.2009.06.008; Yoo HW, 2002, GENET MED, V4, p43S, DOI 10.1097/00125817-200211001-00009	44	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e109727	10.1371/journal.pone.0109727	http://dx.doi.org/10.1371/journal.pone.0109727			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390358	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400007
J	Correia, M; Thiagarajan, V; Coutinho, I; Gajula, GP; Petersen, SB; Neves-Petersen, MT				Correia, Manuel; Thiagarajan, Viruthachalam; Coutinho, Isabel; Gajula, Gnana Prakash; Petersen, Steffen B.; Neves-Petersen, Maria Teresa			Modulating the Structure of EGFR with UV Light: New Possibilities in Cancer Therapy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EXCITED-STATE CHEMISTRY; AROMATIC-AMINO-ACIDS; RECEPTOR EXTRACELLULAR DOMAIN; VITAMIN-D; ULTRAVIOLET-IRRADIATION; SIGNAL-TRANSDUCTION; OXIDATION-PRODUCTS; CRYSTAL-STRUCTURE; DECAY KINETICS	The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor tyrosine kinases. EGFR is activated upon binding to e. g. epidermal growth factor (EGF), leading to cell survival, proliferation and migration. EGFR overactivation is associated with tumor progression. We have previously shown that low dose UVB illumination of cancer cells overexpressing EGFR prior to adding EGF halted the EGFR signaling pathway. We here show that UVB illumination of the extracellular domain of EGFR (sEGFR) induces protein conformational changes, disulphide bridge breakage and formation of tryptophan and tyrosine photoproducts such as dityrosine, N-formylkynurenine and kynurenine. Fluorescence spectroscopy, circular dichroism and thermal studies confirm the occurrence of conformational changes. An immunoassay has confirmed that UVB light induces structural changes in the EGF binding site. A monoclonal antibody which competes with EGF for binding sEGFR was used. We report clear evidence that UVB light induces structural changes in EGFR that impairs the correct binding of an EGFR specific antibody that competes with EGF for binding EGFR, confirming that the 3D structure of the EGFR binding domain suffered conformational changes upon UV illumination. The irradiance used is in the same order of magnitude as the integrated intensity in the solar UVB range. The new photonic technology disables a key receptor and is most likely applicable to the treatment of various types of cancer, alone or in combination with other therapies.	[Correia, Manuel] Aalborg Univ, Dept Phys & Nanotechnol, Aalborg, Denmark; [Thiagarajan, Viruthachalam; Coutinho, Isabel; Gajula, Gnana Prakash; Neves-Petersen, Maria Teresa] Int Iberian Nanotechnol Lab INL, Dept Nanomed, BioPhoton Grp, Braga, Portugal; [Thiagarajan, Viruthachalam] Bharathidasan Univ, Sch Chem, Tiruchirappalli, Tamil Nadu, India; [Petersen, Steffen B.] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Petersen, Steffen B.] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA	Aalborg University; International Iberian Nanotechnology Laboratory; Bharathidasan University; Aalborg University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Neves-Petersen, MT (corresponding author), Int Iberian Nanotechnol Lab INL, Dept Nanomed, BioPhoton Grp, Braga, Portugal.	nevespetersen@gmail.com	Viruthachalam, Thiagarajan/I-2503-2013; INL, Citations/K-3436-2015; Petersen, Steffen b/E-8727-2015; Coutinho, Isabel/J-4165-2016	INL, Citations/0000-0002-3745-5100; Petersen, Steffen b/0000-0002-0739-2751; Thiagarajan, Viruthachalam/0000-0003-4197-2255; Correia, Manuel/0000-0001-7619-2780	"Fundaco para a Ciencia e Tecnologia" (FCT) [SFRH/BD/61012/2009]; "Programa Operacional Potencial Humano" (POPH); European Social Fund ("Fundo Social Europeu", FSE)	"Fundaco para a Ciencia e Tecnologia" (FCT); "Programa Operacional Potencial Humano" (POPH); European Social Fund ("Fundo Social Europeu", FSE)(European Social Fund (ESF))	MC acknowledges the support from "Fundaco para a Ciencia e Tecnologia" (FCT) for the PhD grant (SFRH/BD/61012/2009) supported by "Programa Operacional Potencial Humano" (POPH) in the framework of "Quadro de Referencia Estrategica Nacional" (QREN) and co-financed by the European Social Fund ("Fundo Social Europeu", FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2011, J BIOL CHEM, V286, P26178, DOI 10.1074/jbc.M111.240630; Banwell CM, 2003, RECENT RESULTS CANC, V164, P83; BENT DV, 1975, J AM CHEM SOC, V97, P2599, DOI 10.1021/ja00843a002; BENT DV, 1975, J AM CHEM SOC, V97, P2606, DOI 10.1021/ja00843a003; BENT DV, 1975, J AM CHEM SOC, V97, P2612, DOI 10.1021/ja00843a004; Budiyanto A, 2003, J INVEST DERMATOL, V121, P1088, DOI 10.1046/j.1523-1747.2003.12529.x; Cao C, 2008, CELL SIGNAL, V20, P1830, DOI 10.1016/j.cellsig.2008.06.010; Casanova ML, 2002, CANCER RES, V62, P3402; Correia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050733; Correia M, 2012, J FLUORESC, V22, P323, DOI 10.1007/s10895-011-0963-7; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Finley EL, 1997, PHOTOCHEM PHOTOBIOL, V66, P635, DOI 10.1111/j.1751-1097.1997.tb03200.x; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; FUKUNAGA Y, 1982, J BIOCHEM-TOKYO, V92, P129, DOI 10.1093/oxfordjournals.jbchem.a133909; Garland CF, 2006, AM J PUBLIC HEALTH, V96, P252, DOI 10.2105/AJPH.2004.045260; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giulivi C, 2003, AMINO ACIDS, V25, P227, DOI 10.1007/s00726-003-0013-0; Gorham ED, 2005, J STEROID BIOCHEM, V97, P179, DOI 10.1016/j.jsbmb.2005.06.018; Grant WB, 2002, CANCER-AM CANCER SOC, V94, P1867, DOI 10.1002/cncr.10427; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; HOFFMAN MZ, 1972, J AM CHEM SOC, V94, P7950, DOI 10.1021/ja00778a002; Huang RP, 1996, J CELL BIOL, V133, P211, DOI 10.1083/jcb.133.1.211; Jacob JS, 1996, J BIOL CHEM, V271, P19950, DOI 10.1074/jbc.271.33.19950; JONES CA, 1987, RADIAT RES, V110, P244, DOI 10.2307/3576902; Kaskel P, 2001, BRIT J DERMATOL, V145, P602, DOI 10.1046/j.1365-2133.2001.04432.x; Kawaguchi J, 2012, ONCOL REP, V27, P935, DOI 10.3892/or.2011.1612; KAWAMOTO T, 1992, IN VITRO CELL DEV-AN, V28A, P782; Kerwin BA, 2007, J PHARM SCI-US, V96, P1468, DOI 10.1002/jps.20815; Kiguchi K, 1998, MOL CARCINOGEN, V22, P73, DOI 10.1002/(SICI)1098-2744(199806)22:2<73::AID-MC2>3.0.CO;2-L; Kim YN, 2002, EXP CELL RES, V280, P134, DOI 10.1006/excr.2002.5623; LI Z, 1989, BIOPHYS J, V56, P361, DOI 10.1016/S0006-3495(89)82682-7; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Macdonald J, 2006, BBA-MOL CELL RES, V1763, P870, DOI 10.1016/j.bbamcr.2006.05.002; Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z; MALENCIK DA, 1987, BIOCHEMISTRY-US, V26, P695, DOI 10.1021/bi00377a006; Moan J., 2001, RAD HOME OUTDOORS WO, P69; Neves-Petersen MT, 2009, BIOPHYS J, V97, P211, DOI 10.1016/j.bpj.2009.01.065; Neves-Petersen MT, 2006, PROTEIN SCI, V15, P343, DOI 10.1110/ps.051885306; Neves-Petersen MT, 2002, PROTEIN SCI, V11, P588, DOI 10.1110/ps.06002; Newton-Bishop JA, 2011, EUR J CANCER, V47, P732, DOI 10.1016/j.ejca.2010.10.008; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Nilsen LTN, 2011, PHOTOCH PHOTOBIO SCI, V10, P1129, DOI 10.1039/c1pp05029j; Noonberg SB, 2000, DRUGS, V59, P753, DOI 10.2165/00003495-200059040-00003; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olsen BB, 2007, INT J ONCOL, V30, P181; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; PIRIE A, 1971, BIOCHEM J, V125, P203, DOI 10.1042/bj1250203; Pukkala E, 2009, ACTA ONCOL, V48, P646, DOI 10.1080/02841860902913546; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Segrelles C, 2002, ONCOGENE, V21, P53, DOI 10.1038/sj.onc.1205032; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Suzuki S, 2005, CANCER-AM CANCER SOC, V103, P1265, DOI 10.1002/cncr.20909; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Teresa M., 2012, MOL PHOTOCHEM VAR AS, V37947, P1, DOI [10.5772/37947, DOI 10.5772/37947]; Wan YS, 2001, INT J ONCOL, V18, P461; Webb AR, 2006, PHOTOCHEM PHOTOBIOL, V82, P1697, DOI 10.1562/2006-09-01-RA-670; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhang YG, 2001, DNA CELL BIOL, V20, P769, DOI 10.1089/104454901753438589	63	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111617	10.1371/journal.pone.0111617	http://dx.doi.org/10.1371/journal.pone.0111617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386651	Green Published, Green Submitted, gold			2022-12-26	WOS:000345250400023
J	Gillis, LG; Ziegler, AD; van Oevelen, D; Cathalot, C; Herman, PMJ; Wolters, JW; Bouma, TJ				Gillis, Lucy G.; Ziegler, Alan D.; van Oevelen, Dick; Cathalot, Cecile; Herman, Peter M. J.; Wolters, Jan W.; Bouma, Tjeerd J.			Tiny Is Mighty: Seagrass Beds Have a Large Role in the Export of Organic Material in the Tropical Coastal Zone	PLOS ONE			English	Article							POSIDONIA-OCEANICA; MATTER; PARTICULATE; NUTRIENT; CARBON; NITROGEN; RETENTION; TRANSPORT; SEDIMENTS; DYNAMICS	Ecosystems in the tropical coastal zone exchange particulate organic matter (POM) with adjacent systems, but differences in this function among ecosystems remain poorly quantified. Seagrass beds are often a relatively small section of this coastal zone, but have a potentially much larger ecological influence than suggested by their surface area. Using stable isotopes as tracers of oceanic, terrestrial, mangrove and seagrass sources, we investigated the origin of particulate organic matter in nine mangrove bays around the island of Phuket (Thailand). We used a linear mixing model based on bulk organic carbon, total nitrogen and delta C-13 and delta N-15 and found that oceanic sources dominated suspended particulate organic matter samples along the mangrove-seagrass-ocean gradient. Sediment trap samples showed contributions from four sources oceanic, mangrove forest/terrestrial and seagrass beds where oceanic had the strongest contribution and seagrass beds the smallest. Based on ecosystem area, however, the contribution of suspended particulate organic matter derived from seagrass beds was disproportionally high, relative to the entire area occupied by mangrove forests, the catchment area (terrestrial) and seagrass beds. The contribution from mangrove forests was approximately equal to their surface area, whereas terrestrial contributions to suspended organic matter under contributed compared to their relative catchment area. Interestingly, mangrove forest contribution at 0 m on the transects showed a positive relationship with the exposed frontal width of the mangrove, indicating that mangrove forest exposure to hydrodynamic energy may be a controlling factor in mangrove outwelling. However we found no relationship between seagrass bed contribution and any physical factors, which we measured. Our results indicate that although seagrass beds occupy a relatively small area of the coastal zone, their role in the export of organic matter is disproportional and should be considered in coastal management especially with respect to their importance as a nutrient source for other ecosystems and organisms.	[Gillis, Lucy G.; Herman, Peter M. J.; Bouma, Tjeerd J.] Royal Netherlands Inst Sea Res NIOZ, Spatial Ecol Dept, Yerseke, Zealand, Netherlands; [Ziegler, Alan D.] Natl Univ Singapore, Dept Geog, Singapore 117548, Singapore; [van Oevelen, Dick] Royal Netherlands Inst Sea Res NIOZ, Ecosyst Studies Dept, Yerseke, Zealand, Netherlands; [Cathalot, Cecile] IFREMER, Lab Environm Profond, Polouzane, Brittany, France; [Wolters, Jan W.] Univ Antwerp, Dept Biol, B-2020 Antwerp, Flanders, Belgium	Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); National University of Singapore; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Ifremer; University of Antwerp	Gillis, LG (corresponding author), Royal Netherlands Inst Sea Res NIOZ, Spatial Ecol Dept, Yerseke, Zealand, Netherlands.	lucygwen.gillis@nioz.nl	Gillis, Lucy Gwen/I-5313-2017; Herman, Peter M.J./A-9018-2011; , dr dr/AAA-5406-2022; ZIEGLER, ALAN/A-5463-2012	Gillis, Lucy Gwen/0000-0002-3901-2258; Herman, Peter M.J./0000-0003-2188-6341; ZIEGLER, ALAN/0000-0001-5305-2136; Cathalot, Cecile/0000-0002-0868-7201; Bouma, Tjeerd/0000-0001-7824-7546	Ecoshape, Building with Nature (SDWI/Eco-Shape/Building with Nature grant) [R-303-001-020-414]	Ecoshape, Building with Nature (SDWI/Eco-Shape/Building with Nature grant)	This research was funded by Ecoshape, Building with Nature (SDWI/Eco-Shape/Building with Nature grant R-303-001-020-414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONGI DM, 1990, ESTUAR COAST SHELF S, V31, P581, DOI 10.1016/0272-7714(90)90014-I; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bouillon S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003052; Bouillon S, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000325; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; CLINE J D, 1975, Marine Chemistry, V3, P271, DOI 10.1016/0304-4203(75)90009-2; Dittmar T, 2001, ESTUAR COAST SHELF S, V52, P249, DOI 10.1006/ecss.2000.0743; Evrard V, 2005, MAR ECOL PROG SER, V295, P49, DOI 10.3354/meps295049; FONSECA MS, 1992, ESTUAR COAST SHELF S, V35, P565, DOI 10.1016/S0272-7714(05)80039-3; Forward RB, 2001, OCEANOGR MAR BIOL, V39, P305; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Gillis LG, 2014, MAR ECOL PROG SER, V498, P95, DOI 10.3354/meps10615; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Hemminga MA, 1999, AQUAT BOT, V65, P141, DOI 10.1016/S0304-3770(99)00037-6; HEMMINGA MA, 1994, MAR ECOL PROG SER, V106, P291, DOI 10.3354/meps106291; Hendriks IE, 2008, MAR ECOL PROG SER, V356, P163, DOI 10.3354/meps07316; Hunsinger GB, 2010, LIMNOL OCEANOGR, V55, P1653, DOI 10.4319/lo.2010.55.4.1653; Infantes E, 2009, BOT MAR, V52, P419, DOI 10.1515/BOT.2009.050; Kimirei IA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066320; Koch EW, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P325, DOI 10.1016/B978-044450891-1/50018-9; Krumme U, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P271, DOI 10.1007/978-90-481-2406-0_8; Krusche AV, 2002, WATER RES, V36, P2743, DOI 10.1016/S0043-1354(01)00495-X; Kuramoto T., 2001, J OCEANOGR, V57, P421, DOI DOI 10.1023/A:1021232132755; Lai S, 2013, CORAL REEFS, V32, P1061, DOI 10.1007/s00338-013-1062-9; LEE SY, 1995, HYDROBIOLOGIA, V295, P203, DOI 10.1007/BF00029127; Limpsaichol P, 1998, 1992 COMMUNITY BASED, P85; McConnachie JL, 2006, GEOMORPHOLOGY, V79, P13, DOI 10.1016/j.geomorph.2005.09.011; Meksumpun S, 2005, CONT SHELF RES, V25, P1905, DOI 10.1016/j.csr.2005.04.009; NIEUWENHUIZE J, 1994, MAR CHEM, V45, P217, DOI 10.1016/0304-4203(94)90005-1; Odum E.P., 1968, P 2 SEA GRANT C, P63; Perez M, 2007, J EXP MAR BIOL ECOL, V344, P149, DOI 10.1016/j.jembe.2006.12.020; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; R Core Team, 2012, R LANG ENV STAT COMP; Schindler Wildhaber Y, 2012, BIOGEOSCIENCES, V9, P1985, DOI 10.5194/bg-9-1985-2012; Terrados J, 2000, J EXP MAR BIOL ECOL, V243, P45, DOI 10.1016/S0022-0981(99)00110-0; Thimdee W, 2003, WETLANDS, V23, P729, DOI 10.1672/0277-5212(2003)023[0729:SAFOOM]2.0.CO;2; Todd PA, 2010, BIODIVERS CONSERV, V19, P1063, DOI 10.1007/s10531-010-9778-0; Van Engeland T, 2011, MAR ECOL PROG SER, V427, P71, DOI 10.3354/meps09054; van Oevelen D, 2010, ECOSYSTEMS, V13, P32, DOI 10.1007/s10021-009-9297-6; Vonk JA, 2008, LIMNOL OCEANOGR, V53, P542, DOI 10.4319/lo.2008.53.2.0542; Wilkie L, 2012, AQUAT BOT, V102, P15, DOI 10.1016/j.aquabot.2012.04.004; Woodroffe C, 1992, TROPICAL MANGROVE EC, P7, DOI DOI 10.1029/CE041P0007	43	18	18	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111847	10.1371/journal.pone.0111847	http://dx.doi.org/10.1371/journal.pone.0111847			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386853	Green Published, gold			2022-12-26	WOS:000345250400026
J	Yang, WZ; Qi, Y; Fu, JZ				Yang, Weizhao; Qi, Yin; Fu, Jinzhong			Exploring the Genetic Basis of Adaptation to High Elevations in Reptiles: A Comparative Transcriptome Analysis of Two Toad-Headed Agamas (Genus Phrynocephalus)	PLOS ONE			English	Article							GENOME REVEALS; SEQUENCE; LIFE; EVOLUTION; SELECTION; ALIGNMENT; HYPOXIA; EXPRESSION; INSIGHTS; PROGRAM	High elevation adaptation offers an excellent study system to understand the genetic basis of adaptive evolution. We acquired transcriptome sequences of two closely related lizards, Phrynocephalus przewalskii from low elevations and P. vlangalii from high elevations. Within a phylogenetic framework, we compared their genomic data along with green anole, chicken and Chinese softshell turtle, and identified candidate genes and functional categories that are potentially linked to adaptation to high elevation environments. More than 100 million sequence reads were generated for each species via Illumina sequencing. A de novo assembly produced 70,919 and 62,118 transcripts for P. przewalskii and P. vlangalii, respectively. Based on a well-established reptile phylogeny, we detected 143 positively selected genes (PSGs) along the P. vlangalii lineage from the 7,012 putative orthologs using a branch-site model. Furthermore, ten GO categories and one KEGG pathway that are over-represented by PSGs were recognized. In addition, 58 GO categories were revealed to have elevated evolutionary rates along the P. vlangalii lineage relative to P. przewalskii. These functional analyses further filter out PSGs that are most likely involved in the adaptation process to high elevations. Among them, ADAM17, MD, and HSP90B1 likely contributed to response to hypoxia, and POLK likely contributed to DNA repair. Many other candidate genes involved in gene expression and metabolism were also identified. Genome-wide scan for candidate genes may serve as the first step to explore the genetic basis of high elevation adaptation. Detailed comparative study and functional verification are needed to solidify any conclusions. High elevation adaptation requires coordinated changes in multiple genes that involve various physiological and biochemical pathways; we hope that our genetic studies will provide useful directions for future physiological or molecular studies in reptiles as well as other poikilothermic species.	[Yang, Weizhao; Qi, Yin; Fu, Jinzhong] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Yang, Weizhao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Fu, Jinzhong] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Guelph	Fu, JZ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.	jfu@uoguelph.ca			Key Laboratory of Mountain Ecological Restoration and Bioresource Utilization (CAS); Ecological Restoration & Biodiversity Conservation Key Laboratory of Sichuan Province; 100 Talents Programme of Sichuan Province [Y1D3011]; Chinese Academy of Sciences Knowledge Innovation Program [Y1C2021203]; NSERC Discovery Program (Canada)	Key Laboratory of Mountain Ecological Restoration and Bioresource Utilization (CAS); Ecological Restoration & Biodiversity Conservation Key Laboratory of Sichuan Province; 100 Talents Programme of Sichuan Province; Chinese Academy of Sciences Knowledge Innovation Program(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences); NSERC Discovery Program (Canada)	This work is supported by the Key Laboratory of Mountain Ecological Restoration and Bioresource Utilization (CAS), the Ecological Restoration & Biodiversity Conservation Key Laboratory of Sichuan Province, the 100 Talents Programme of Sichuan Province (Y1D3011), the Chinese Academy of Sciences Knowledge Innovation Program (grant Y1C2021203), and the NSERC Discovery Program (Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bavoux C, 2005, BIOCHIMIE, V87, P637, DOI 10.1016/j.biochi.2005.02.007; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Blumthaler M, 1997, J PHOTOCH PHOTOBIO B, V39, P130, DOI 10.1016/S1011-1344(96)00018-8; Castoe TA, 2013, P NATL ACAD SCI USA, V110, P20645, DOI 10.1073/pnas.1314475110; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheviron ZA, 2012, HEREDITY, V108, P354, DOI 10.1038/hdy.2011.85; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gruenheit N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-92; Guo XG, 2007, MOL PHYLOGENET EVOL, V45, P643, DOI 10.1016/j.ympev.2007.06.013; Habib T, 1998, J BIOL CHEM, V273, P18605, DOI 10.1074/jbc.273.29.18605; He JZ, 2013, J EXP ZOOL PART A, V319A, P117, DOI 10.1002/jez.1776; HOLM S, 1979, SCAND J STAT, V6, P65; Hua Fang-fang, 2012, Chinese Journal of Pathology, V41, P466, DOI 10.3760/cma.j.issn.0529-5807.2012.07.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huey R.B., 1982, Biology of Reptilia, V12, P25; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WH, 2005, NATURE, V437, P50, DOI 10.1038/437050a; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; McGowen MR, 2012, P ROY SOC B-BIOL SCI, V279, P3643, DOI 10.1098/rspb.2012.0869; Merx Marc W., 2001, FASEB Journal, V15, P1077; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Qu YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3071; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Rose Michael R., 2001, P17; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Srour N, 2003, FEBS LETT, V554, P275, DOI 10.1016/S0014-5793(03)01159-1; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Sun YB, 2013, GENOME BIOL EVOL, V5, P130, DOI 10.1093/gbe/evs123; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Svobodova AR, 2012, ARCH DERMATOL RES, V304, P407, DOI 10.1007/s00403-012-1212-x; Vonk FJ, 2013, P NATL ACAD SCI USA, V110, P20651, DOI 10.1073/pnas.1314702110; Wang Z, 2013, NAT GENET, V45, P701, DOI 10.1038/ng.2615; Yang WZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-588; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao E.M., 1999, FAUNA SINICA REPTILI; Zhou J, 2003, MOL BIOL CELL, V14, P2216, DOI 10.1091/mbc.E02-09-0598	59	28	33	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e112218	10.1371/journal.pone.0112218	http://dx.doi.org/10.1371/journal.pone.0112218			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386640	gold, Green Published			2022-12-26	WOS:000345250400051
J	Lee, LC; Tu, CH; Chen, LF; Shen, HD; Chao, HT; Lin, MW; Hsieh, JC				Lee, Lin-Chien; Tu, Cheng-Hao; Chen, Li-Fen; Shen, Horng-Der; Chao, Hsiang-Tai; Lin, Ming-Wei; Hsieh, Jen-Chuen			Association of Brain-Derived Neurotrophic Factor Gene Val66Met Polymorphism with Primary Dysmenorrhea	PLOS ONE			English	Article							MENSTRUAL-CYCLE; MOOD DISORDERS; NONDYSMENORRHEIC WOMEN; FIBROMYALGIA SYNDROME; OXYTOCIN RECEPTOR; YOUNG-WOMEN; PAIN; BDNF; ANXIETY; STRESS	Primary dysmenorrhea (PDM), the most prevalent menstrual cycle-related problem in women of reproductive age, is associated with negative moods. Whether the menstrual pain and negative moods have a genetic basis remains unknown. Brain-derived neurotrophic factor (BDNF) plays a key role in the production of central sensitization and contributes to chronic pain conditions. BDNF has also been implicated in stress-related mood disorders. We screened and genotyped the BDNF Val66Met polymorphism (rs6265) in 99 Taiwanese (Asian) PDMs (20-30 years old) and 101 age-matched healthy female controls. We found that there was a significantly higher frequency of the Met allele of the BDNF Val66Met polymorphism in the PDM group. Furthermore, BDNF Met/Met homozygosity had a significantly stronger association with PDM compared with Val carrier status. Subsequent behavioral/hormonal assessments of sub-groups (PDMs = 78, controls = 81; eligible for longitudinal multimodal neuroimaging battery studies) revealed that the BDNF Met/Met homozygous PDMs exhibited a higher menstrual pain score (sensory dimension) and a more anxious mood than the Val carrier PDMs during the menstrual phase. Although preliminary, our study suggests that the BDNF Val66Met polymorphism is associated with PDM in Taiwanese (Asian) people, and BDNF Met/Met homozygosity may be associated with an increased risk of PDM. Our data also suggest the BDNF Val66Met polymorphism as a possible regulator of menstrual pain and pain-related emotions in PDM. Absence of thermal hypersensitivity may connote an ethnic attribution. The presentation of our findings calls for further genetic and neuroscientific investigations of PDM.	[Lee, Lin-Chien; Tu, Cheng-Hao; Chen, Li-Fen; Hsieh, Jen-Chuen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lee, Lin-Chien] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Lee, Lin-Chien; Tu, Cheng-Hao; Chen, Li-Fen; Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Dept Med Res, Div Clin Res, Integrated Brain Res Unit, Taipei, Taiwan; [Tu, Cheng-Hao] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Shen, Horng-Der; Lin, Ming-Wei] Taipei Vet Gen Hosp, Dept Med Res, Basic Res Div, Taipei, Taiwan; [Chao, Hsiang-Tai] Taipei Vet Gen Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chao, Hsiang-Tai] Natl Yang Ming Univ, Fac Med, Sch Med, Dept Obstet & Gynecol, Taipei 112, Taiwan; [Lin, Ming-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; Cheng Hsin General Hospital; Taipei Veterans General Hospital; Taipei City Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lin, MW (corresponding author), Taipei Vet Gen Hosp, Dept Med Res, Basic Res Div, Taipei, Taiwan.	mwlin@ym.edu.tw; jchsieh@ym.edu.tw	Tu, Cheng-Hao/GOE-4336-2022	Tu, Cheng-Hao/0000-0002-7695-5570	Taipei Veterans General Hospital [V100D-001, V100D-001-1, V100D-001-2, V100E3-002, V101E3-002, V102E3002]; Cheng-Hsin General Hospital [101-33]; National Science Council [NSC 100-2314-B-010-006-MY3, NSC 100-2629-B-010-001, NSC 101-2629-B-010-001, NSC 1012911-I-009-101, NSC 102-2629-B-010-001]; Yen Tjing Ling Medical Foundation [CI-100-5]; Top University Plan of the Ministry of Education for National Yang-Ming University	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Cheng-Hsin General Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Yen Tjing Ling Medical Foundation; Top University Plan of the Ministry of Education for National Yang-Ming University	This research was supported by the Taipei Veterans General Hospital (V100D-001, V100D-001-1, V100D-001-2, V100E3-002, V101E3-002, and V102E3002),Cheng-Hsin General Hospital (101-33), National Science Council (NSC 100-2314-B-010-006-MY3, NSC 100-2629-B-010-001, NSC 101-2629-B-010-001, NSC 1012911-I-009-101, and NSC 102-2629-B-010-001), Yen Tjing Ling Medical Foundation (CI-100-5), and The Aim for the Top University Plan of the Ministry of Education for National Yang-Ming University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu JI, 2000, HUM REPROD UPDATE, V6, P200, DOI 10.1093/humupd/6.2.200; AKERLUND M, 1994, ANN NY ACAD SCI, V734, P47, DOI 10.1111/j.1749-6632.1994.tb21735.x; Akerlund M, 2006, EXPERT OPIN THER TAR, V10, P423, DOI 10.1517/14728222.10.3.423; Alonso C, 2001, HEALTH PSYCHOL, V20, P411, DOI 10.1037/0278-6133.20.6.411; AMODEI N, 1989, J BEHAV MED, V12, P373, DOI 10.1007/BF00844930; Bajaj P, 2002, CLIN J PAIN, V18, P180, DOI 10.1097/00002508-200205000-00007; Barnard K, 2003, J WOMENS HEALTH, V12, P911, DOI 10.1089/154099903770948140; Bath KG, 2012, BIOL PSYCHIAT, V72, P499, DOI 10.1016/j.biopsych.2012.03.032; Beck A., 1993, MANUAL BECK ANXIETY; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Berkley KJ, 2011, PAIN, V152, P1940, DOI 10.1016/j.pain.2011.04.013; Berkley KJ, 2013, PAIN, V1, P1; Blurton-Jones M, 2004, J COMP NEUROL, V468, P347, DOI 10.1002/cne.10989; Brinkert W, 2007, PAIN, V132, pS46, DOI 10.1016/j.pain.2006.12.011; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Choi MJ, 2006, BRAIN RES, V1118, P176, DOI 10.1016/j.brainres.2006.08.012; Davis A R, 2001, J Pediatr Adolesc Gynecol, V14, P3, DOI 10.1016/S1083-3188(00)00076-0; Di Lorenzo C, 2012, J PAIN, V13, P866, DOI 10.1016/j.jpain.2012.05.014; Dorn LD, 2009, J ADOLESCENT HEALTH, V44, P237, DOI 10.1016/j.jadohealth.2008.07.018; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duric V, 2006, J PAIN, V7, P544, DOI 10.1016/j.jpain.2006.01.458; Fedorowicz Z, 2012, COCHRANE DB SYST REV, V5; French L, 2005, AM FAM PHYSICIAN, V71, P285; Frustaci A, 2008, NEUROPSYCHOBIOLOGY, V58, P163, DOI 10.1159/000182892; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Giamberardino MA, 1997, PAIN, V71, P187, DOI 10.1016/S0304-3959(97)03362-9; Giamberardino MA, 2010, PAIN, V151, P307, DOI 10.1016/j.pain.2010.06.023; Granot M, 2001, OBSTET GYNECOL, V98, P407, DOI 10.1016/S0029-7844(01)01465-X; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Guo SW, 2013, FERTIL STERIL, V99, P231, DOI 10.1016/j.fertnstert.2012.08.038; Haas L, 2010, NEUROCHEM RES, V35, P830, DOI 10.1007/s11064-010-0129-z; HAPIDOU EG, 1988, PAIN, V34, P277, DOI 10.1016/0304-3959(88)90123-6; Hariri AR, 2006, BIOL PSYCHIAT, V59, P888, DOI 10.1016/j.biopsych.2005.11.005; HOLDEN RR, 1988, J CONSULT CLIN PSYCH, V56, P766, DOI 10.1037/0022-006X.56.5.766; Hong CJ, 2003, NEUROPSYCHOBIOLOGY, V48, P186, DOI 10.1159/000074636; Huennerkopf R, 2007, NEUROPSYCHOPHARMACOL, V32, P2552, DOI 10.1038/sj.npp.1301383; Hwang JP, 2006, NEUROBIOL AGING, V27, P1834, DOI 10.1016/j.neurobiolaging.2005.10.013; Hwang RJ, 2008, HORM BEHAV, V54, P28, DOI 10.1016/j.yhbeh.2007.11.007; Hwang RJ, 2009, HORM BEHAV, V55, P203, DOI 10.1016/j.yhbeh.2008.10.008; Ignacio ZM, 2014, NEUROSCIENCE, V275, P455, DOI 10.1016/j.neuroscience.2014.06.036; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lommatzsch M, 2005, NEUROBIOL AGING, V26, P115, DOI 10.1016/j.neurobiolaging.2004.03.002; Ma HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055200; Martinowich K, 2008, NEUROPSYCHOPHARMACOL, V33, P73, DOI 10.1038/sj.npp.1301571; Merighi A, 2008, PROG NEUROBIOL, V85, P297, DOI 10.1016/j.pneurobio.2008.04.004; Montag C, 2010, PSYCHIAT RES, V179, P86, DOI 10.1016/j.psychres.2008.08.005; Nugraha B, 2012, RHEUMATOL INT, V32, P2593, DOI 10.1007/s00296-011-2348-2; Obata K, 2006, NEUROSCI RES, V55, P1, DOI 10.1016/j.neures.2006.01.005; Petryshen TL, 2010, MOL PSYCHIATR, V15, P810, DOI 10.1038/mp.2009.24; Quartana PJ, 2009, EXPERT REV NEUROTHER, V9, P745, DOI 10.1586/ERN.09.34; Ren K, 2007, MOL NEUROBIOL, V35, P224, DOI 10.1007/s12035-007-0028-8; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Sarchielli P, 2007, J PAIN, V8, P737, DOI 10.1016/j.jpain.2007.05.002; Sherman JJ, 2006, AM J PHYSIOL-REG I, V291, pR245, DOI 10.1152/ajpregu.00920.2005; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; Spencer JL, 2010, P NATL ACAD SCI USA, V107, P4395, DOI 10.1073/pnas.0915105107; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sun RF, 2011, NEUROSCI LETT, V489, P34, DOI 10.1016/j.neulet.2010.11.061; SUNDELL G, 1990, BRIT J OBSTET GYNAEC, V97, P588, DOI 10.1111/j.1471-0528.1990.tb02545.x; Tu CH, 2013, PAIN, V154, P1718, DOI 10.1016/j.pain.2013.05.022; Tu CH, 2009, NEUROIMAGE, V47, P28, DOI 10.1016/j.neuroimage.2009.03.080; Tzafettas John, 2006, Pediatr Endocrinol Rev, V3 Suppl 1, P160; Verhagen M, 2010, MOL PSYCHIATR, V15, P260, DOI 10.1038/mp.2008.109; Vincent K, 2011, PAIN, V152, P1966, DOI 10.1016/j.pain.2011.03.029; Vossen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013641; Ware J., 1993, SF 36 HLTH SURVEY MA; Westling AM, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.020; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Yu YB, 2012, GUT, V61, P685, DOI 10.1136/gutjnl-2011-300265; Zhang HP, 2006, AM J MED GENET B, V141B, P387, DOI 10.1002/ajmg.b.30332	71	30	32	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112766	10.1371/journal.pone.0112766	http://dx.doi.org/10.1371/journal.pone.0112766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383981	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700093
J	Goodspeed, D; Seferovic, MD; Holland, W; Mcknight, RA; Summers, SA; Branch, DW; Lane, RH; Aagaard, KM				Goodspeed, Danielle; Seferovic, Maxim D.; Holland, William; Mcknight, Robert A.; Summers, Scott A.; Branch, D. Ware; Lane, Robert H.; Aagaard, Kjersti M.			Essential nutrient supplementation prevents heritable metabolic disease in multigenerational intrauterine growth-restricted rats	FASEB JOURNAL			English	Article						one-carbon pathway; epigenomics; methyl donors; IGF-1; obesity	COACTIVATOR-1 GENE-EXPRESSION; FACTOR BINDING PROTEIN-1; ONE-CARBON METABOLISM; UTEROPLACENTAL INSUFFICIENCY; DNA METHYLATION; INSULIN-RESISTANCE; FETAL-GROWTH; SKELETAL-MUSCLE; ADULT HYPERTENSION; EPIGENETIC CHANGES	Intrauterine growth restriction (IUGR) confers heritable alterations in DNA methylation, rendering risk of adult metabolic syndrome (MetS). Because CpG methylation is coupled to intake of essential nutrients along the one-carbon pathway, we reasoned that essential nutrient supplementation (ENS) may abrogate IUGR-conferred multigenerational MetS. Pregnant Sprague-Dawley rats underwent bilateral uterine artery ligation causing IUGR in F1. Among the F2 generation, IUGR lineage rats were underweight at birth (6.7 vs. 8.0 g, P < 0.0001) and obese by adulthood (p160: 613 vs. 510 g; P < 0.0001). Dual energy X-ray absorptiometry studies revealed increased central fat mass (Delta+40 g), accompanied by dyslipidemic (>30% elevated, P < 0.05) serum triglycerides (139 mg/dl), very-LDLs (27.8 mg/dl), and fatty acids (632 mu M). Hyperglycemic-euglycemic clamp studies and glucose tolerance testing revealed insulin resistance. Conversely, IUGR lineage ENS-fed rats did not manifest MetS, with significantly lower body weight (p160: 410 g), >5-fold less central fat mass, normal hepatic glucose efflux, and >70% reduced circulating triglycerides and very-LDLs compared with IUGR control-fed F2 offspring (P < 0.01). Moreover, increased methylation of the IGF-1 P2 transcriptional start site among IUGR lineage F2 offspring was reversed in ENS (P < 0.04). This is an initial demonstration that supplementation along the one-carbon pathway abrogates adult morbidity and associated epigenomic modifications of IGF-1 in a rodent model of multigenerational MetS.	[Goodspeed, Danielle; Seferovic, Maxim D.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Holland, William] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Mcknight, Robert A.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Branch, D. Ware] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA; [Summers, Scott A.] Duke Natl Univ Singapore, Grad Sch Med, Program Cardiovasc & Metab Dis, Singapore, Singapore; [Lane, Robert H.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Lane, Robert H.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA	Baylor College of Medicine; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; National University of Singapore; Medical College of Wisconsin; Children's Hospital of Wisconsin	Aagaard, KM (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, One Baylor Plaza,Jones 314, Houston, TX 77030 USA.	aagaardt@bcm.tmc.edu	/AAE-5384-2020		U.S. National Institutes of Health (NIH) [DP21DP2OD001500-01]; U.S. NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Scientist Development Program [5K12HD00849]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Scientist Development Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Xing Yu for the technical contributions made during this project. Funding for this project was provided by U.S. National Institutes of Health (NIH) Grant DP21DP2OD001500-01 ("Mapping the Fetal Primate Epigenome and Metabolome"), and the U.S. NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Reproductive Scientist Development Program Grant 5K12HD00849 ("Transgenerational Growth Restriction through Altered Placental Epigenetics") (to K.A.).	Abu Shehab M, 2009, J PROTEOME RES, V8, P5325, DOI 10.1021/pr900633x; Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1993, BRIT MED J, V307, P1524, DOI 10.1136/bmj.307.6918.1524; Baserga M, 2005, AM J PHYSIOL-REG I, V289, pR1348, DOI 10.1152/ajpregu.00211.2005; Baserga M, 2004, EARLY HUM DEV, V79, P93, DOI 10.1016/j.earlhumdev.2004.04.015; Baserga M, 2006, AM J PHYSIOL-REG I, V291, pR412, DOI 10.1152/ajpregu.00880.2005; Baserga M, 2009, EARLY HUM DEV, V85, P361, DOI 10.1016/j.earlhumdev.2008.12.015; Benyshek DC, 2006, DIABETOLOGIA, V49, P1117, DOI 10.1007/s00125-006-0196-5; Cordero P, 2013, GENES NUTR, V8, P105, DOI 10.1007/s12263-012-0300-z; Cordero P, 2013, MOL GENET METAB, V110, P388, DOI 10.1016/j.ymgme.2013.08.022; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Curhan GC, 1996, CIRCULATION, V94, P1310, DOI 10.1161/01.CIR.94.6.1310; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; ERVIN RB, 2009, NATL HLTH STAT REPOR, V13, P1; Fischer LM, 2010, AM J CLIN NUTR, V92, P1113, DOI 10.3945/ajcn.2010.30064; Fu Q, 2004, PHYSIOL GENOMICS, V20, P108, DOI 10.1152/physiolgenomics.00175.2004; Fu Q, 2006, FASEB J, V20, P2127, DOI 10.1096/fj.06-6179fje; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gallo LA, 2012, J PHYSIOL-LONDON, V590, P617, DOI 10.1113/jphysiol.2011.219147; Ganu RS, 2012, ILAR J, V53, P306, DOI 10.1093/ilar.53.3-4.306; Gong L, 2010, EPIGENETICS-US, V5, P619, DOI 10.4161/epi.5.7.12882; Grossniklaus U, 2013, NAT REV GENET, V14, P228, DOI 10.1038/nrg3435; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Haluzik M, 2003, DIABETES, V52, P2483, DOI 10.2337/diabetes.52.10.2483; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Jahangir E, 2009, VASC MED, V14, P239, DOI 10.1177/1358863X08100834; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Koklu E, 2007, ACTA PAEDIATR, V96, P1858, DOI 10.1111/j.1651-2227.2007.00531.x; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Lane RH, 2003, PEDIATR RES, V53, P994, DOI 10.1203/01.PDR.0000064583.40495.51; Lane RH, 2002, ENDOCRINOLOGY, V143, P2486, DOI 10.1210/en.143.7.2486; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Lane RH, 2001, PEDIATR RES, V50, P83, DOI 10.1203/00006450-200107000-00016; Lane RH, 1999, AM J PHYSIOL-ENDOC M, V276, pE135, DOI 10.1152/ajpendo.1999.276.1.E135; LUKASKI HC, 1993, J NUTR, V123, P438, DOI 10.1093/jn/123.suppl_2.438; MacLennan NK, 2004, PHYSIOL GENOMICS, V18, P43, DOI 10.1152/physiolgenomics.00042.2004; Maloney CA, 2011, J NUTR, V141, P95, DOI 10.3945/jn.109.119453; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Netchine I, 2009, J CLIN ENDOCR METAB, V94, P3913, DOI 10.1210/jc.2009-0452; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; OGATA ES, 1986, METABOLISM, V35, P970, DOI 10.1016/0026-0495(86)90064-8; OGATA ES, 1985, PEDIATR RES, V19, P32, DOI 10.1203/00006450-198501000-00010; Painter RC, 2008, BJOG-INT J OBSTET GY, V115, P1243, DOI 10.1111/j.1471-0528.2008.01822.x; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; Schwitzgebel VM, 2009, MOL CELL ENDOCRINOL, V304, P78, DOI 10.1016/j.mce.2009.02.019; Seferovic MD, 2009, ENDOCRINOLOGY, V150, P220, DOI 10.1210/en.2008-0657; Seki Y, 2012, ENDOCRINOLOGY, V153, P1031, DOI 10.1210/en.2011-1805; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Sjogren K, 2001, DIABETES, V50, P1539, DOI 10.2337/diabetes.50.7.1539; Skilton MR, 2005, LANCET, V365, P1484, DOI 10.1016/S0140-6736(05)66419-7; Sohi G, 2011, MOL ENDOCRINOL, V25, P785, DOI 10.1210/me.2010-0395; Suter M, 2011, FASEB J, V25, P714, DOI 10.1096/fj.10-172080; Tan Y, 2012, TOXICOL LETT, V214, P279, DOI 10.1016/j.toxlet.2012.09.007; Thamotharan M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1270, DOI 10.1152/ajpendo.00462.2006; Thompson RF, 2010, J BIOL CHEM, V285, P15111, DOI 10.1074/jbc.M109.095133; Tosh DN, 2010, AM J PHYSIOL-GASTR L, V299, pG1023, DOI 10.1152/ajpgi.00052.2010; Tran M, 2013, J ENDOCRINOL, V217, P105, DOI 10.1530/JOE-12-0560; Van den Veyver IB, 2002, ANNU REV NUTR, V22, P255, DOI 10.1146/annurev.nutr.22.010402.102932; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, HUM MOL GENET, V15, P705, DOI 10.1093/hmg/ddi484; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Waterland RA, 2007, FASEB J, V21, P3380, DOI 10.1096/fj.07-8229com; Watson CS, 2006, ENDOCRINOLOGY, V147, P1175, DOI 10.1210/en.2005-0606; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Woods KA, 2000, J CLIN ENDOCR METAB, V85, P1407, DOI 10.1210/jc.85.4.1407; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Zheng SS, 2011, EPIGENETICS-US, V6, P161, DOI 10.4161/epi.6.2.13472	81	22	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					807	819		10.1096/fj.14-259614	http://dx.doi.org/10.1096/fj.14-259614			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25395450	Green Published			2022-12-26	WOS:000350633000008
J	Brown, SC; Lester, RE; Versace, VL; Fawcett, J; Laurenson, L				Brown, Stuart C.; Lester, Rebecca E.; Versace, Vincent L.; Fawcett, Jonathon; Laurenson, Laurie			Hydrologic Landscape Regionalisation Using Deductive Classification and Random Forests	PLOS ONE			English	Article							LAND-USE CHANGE; UNITED-STATES; SPATIAL-RESOLUTION; FLOW VARIABILITY; STREAM-FLOW; FRAMEWORK; COVER; CONSEQUENCES; AGREEMENT; REGIMES	Landscape classification and hydrological regionalisation studies are being increasingly used in ecohydrology to aid in the management and research of aquatic resources. We present a methodology for classifying hydrologic landscapes based on spatial environmental variables by employing non-parametric statistics and hybrid image classification. Our approach differed from previous classifications which have required the use of an a priori spatial unit (e.g. a catchment) which necessarily results in the loss of variability that is known to exist within those units. The use of a simple statistical approach to identify an appropriate number of classes eliminated the need for large amounts of post-hoc testing with different number of groups, or the selection and justification of an arbitrary number. Using statistical clustering, we identified 23 distinct groups within our training dataset. The use of a hybrid classification employing random forests extended this statistical clustering to an area of approximately 228,000 km(2) of south-eastern Australia without the need to rely on catchments, landscape units or stream sections. This extension resulted in a highly accurate regionalisation at both 30-m and 2.5-km resolution, and a less-accurate 10-km classification that would be more appropriate for use at a continental scale. A smaller case study, of an area covering 27,000 km(2), demonstrated that the method preserved the intra-and inter-catchment variability that is known to exist in local hydrology, based on previous research. Preliminary analysis linking the regionalisation to streamflow indices is promising suggesting that the method could be used to predict streamflow behaviour in ungauged catchments. Our work therefore simplifies current classification frameworks that are becoming more popular in ecohydrology, while better retaining small-scale variability in hydrology, thus enabling future attempts to explain and visualise broad-scale hydrologic trends at the scale of catchments and continents.	[Brown, Stuart C.; Lester, Rebecca E.; Laurenson, Laurie] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Versace, Vincent L.] Flinders Univ S Australia, Dept Rural Hlth, Greater Green Triangle Univ, Warrnambool, Vic, Australia; [Versace, Vincent L.] Federat Univ Australia, Fac Sci & Technol, Ctr Environm Management, Ballarat, Vic, Australia; [Fawcett, Jonathon] Sinclair Knight Merz, Bendigo, Vic, Australia	Deakin University; Deakin University; Flinders University South Australia; Federation University Australia	Brown, SC (corresponding author), Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia.	stuart.brown@research.deakin.edu.au	Brown, Stuart/AAC-7472-2020; Versace, Vincent/AAL-6418-2021; Laurenson, Laurie J/C-8903-2009; Lester, Rebecca/H-3907-2011	Brown, Stuart/0000-0002-0669-1418; Versace, Vincent/0000-0002-8514-1763; Lester, Rebecca/0000-0003-2682-6495	Sinclair-Knight-Merz	Sinclair-Knight-Merz	The authors received no specific funding for this work. Jonathon Fawcett is employed by Sinclair-Knight-Merz. Sinclair-Knight-Merz provided support in the form of salary for author JF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; BELBIN L, 1993, J VEG SCI, V4, P341, DOI 10.2307/3235592; BELBIN L, 1987, AUST COMPUT J, V19, P32; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 1993, CLASSIFICATION REGRE; Brown S, 2012, ENVIRON MODEL ASSESS, V17, P241, DOI 10.1007/s10666-011-9289-8; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Carlisle DM, 2010, RIVER RES APPL, V26, P118, DOI 10.1002/rra.1247; Clarke K.R., 2006, PRIMER V6 USER MANUA; Clarke K. R., 2001, CHANGES MARINE COMMU; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clifford D.H.T., 1975, INTRO NUMERICAL CLAS; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CORMACK RM, 1971, J R STAT SOC SER A-G, V134, P321, DOI 10.2307/2344237; Corrick A, 1992, ASSESSMENT VICTORIAS; Department of Environment and Primary Industries, 2013, VICT RES ONL TEMP; Dixon P, 2006, ENCY ENV; ESRI, 2012, ARCGIS DESKT 10 1; Everitt B., 1980, CLUSTER ANAL; Exelis Visual Information Solutions, 2010, ENVI VERS 4 8; Fay MP, 2010, R J, V2, P53; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Gamer M, 2012, IRR VARIOUS COEFFICI; Held M, 2012, ENMAP BOX MANUAL VER; Ierodiaconou D, 2005, J ENVIRON MANAGE, V74, P305, DOI 10.1016/j.jenvman.2004.09.010; Kennard MJ, 2010, RIVER RES APPL, V26, P137, DOI 10.1002/rra.1249; Kennard MJ, 2010, FRESHWATER BIOL, V55, P171, DOI 10.1111/j.1365-2427.2009.02307.x; Kennard MJ, 2009, ECOHYDROLOGICAL REGI; Legendre P., 2012, NUMERICAL ECOLOGY; Lillesand T.M., 2015, REMOTE SENSING IMAGE, V7th; Mackey BG, 2008, J BIOGEOGR, V35, P213, DOI 10.1111/j.1365-2699.2007.01822.x; Marsh N. A., 2003, RIVER ANAL PACKAGE; McKenzie DP, 1996, J PSYCHIAT RES, V30, P483, DOI 10.1016/S0022-3956(96)00033-7; McManamay RA, 2012, RIVER RES APPL, V28, P1325, DOI 10.1002/rra.1535; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Mumby PJ, 2002, REMOTE SENS ENVIRON, V82, P248, DOI 10.1016/S0034-4257(02)00041-X; Naiman RJ, 2008, CR GEOSCI, V340, P629, DOI 10.1016/j.crte.2008.01.002; Olden JD, 2003, RIVER RES APPL, V19, P101, DOI 10.1002/rra.700; Olden JD, 2012, ECOHYDROLOGY, V5, P503, DOI 10.1002/eco.251; PATN Website. Blatant Fabrications Pty. Ltd, 2009, PATN VERS 3 1 2; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Poff NL, 1996, FRESHWATER BIOL, V36, P71, DOI 10.1046/j.1365-2427.1996.00073.x; Poff NL, 2006, RIVER RES APPL, V22, P149, DOI 10.1002/rra.902; POFF NL, 1995, ECOLOGY, V76, P606, DOI 10.2307/1941217; R Core Team, 2021, R LANGUAGE ENV STAT; Revelle William, 2020, CRAN; Rodriguez-Galiano VF, 2012, ISPRS J PHOTOGRAMM, V67, P93, DOI 10.1016/j.isprsjprs.2011.11.002; Santhi C, 2008, J HYDROL, V351, P139, DOI 10.1016/j.jhydrol.2007.12.018; Sawicz K, 2011, HYDROL EARTH SYST SC, V15, P2895, DOI 10.5194/hess-15-2895-2011; Snelder TH, 2005, RIVER RES APPL, V21, P609, DOI 10.1002/rra.826; Sprintsin M, 2007, REMOTE SENS ENVIRON, V109, P416, DOI 10.1016/j.rse.2007.01.020; Stein JL, 2009, ECOHYDROLOGICAL REGI; Versace VL, 2008, ENVIRON MONIT ASSESS, V142, P171, DOI 10.1007/s10661-007-9918-5; Versace VL, 2008, AGR ECOSYST ENVIRON, V123, P328, DOI 10.1016/j.agee.2007.07.012; Winter TC, 2001, J AM WATER RESOUR AS, V37, P335, DOI 10.1111/j.1752-1688.2001.tb00973.x; Wolock DM, 2004, ENVIRON MANAGE, V34, pS71, DOI 10.1007/s00267-003-5077-9; Yihdego Y, 2013, WATER RESOUR MANAG, V27, P4941, DOI 10.1007/s11269-013-0449-2; Yihdego Y, 2011, HYDROGEOL J, V19, P877, DOI 10.1007/s10040-011-0726-1	63	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2014	9	11							e112856	10.1371/journal.pone.0112856	http://dx.doi.org/10.1371/journal.pone.0112856			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU4DF	25396410	Green Submitted, Green Published, gold			2022-12-26	WOS:000345558500102
J	Cordina, NM; Liew, CK; Potluri, PR; Curmi, PM; Fajer, PG; Logan, TM; Mackay, JP; Brown, LJ				Cordina, Nicole M.; Liew, Chu K.; Potluri, Phani R.; Curmi, Paul M.; Fajer, Piotr G.; Logan, Timothy M.; Mackay, Joel P.; Brown, Louise J.			Ca2+-Induced PRE-NMR Changes in the Troponin Complex Reveal the Possessive Nature of the Cardiac Isoform for Its Regulatory Switch	PLOS ONE			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; INHIBITORY REGION; SKELETAL-MUSCLE; CONFORMATIONAL EXCHANGE; THIN FILAMENT; DOMAIN; DYNAMICS; CALCIUM; SITE; BINDING	The interaction between myosin and actin in cardiac muscle, modulated by the calcium (Ca2+) sensor Troponin complex (Tn), is a complex process which is yet to be fully resolved at the molecular level. Our understanding of how the binding of Ca2+ triggers conformational changes within Tn that are subsequently propagated through the contractile apparatus to initiate muscle activation is hampered by a lack of an atomic structure for the Ca2+-free state of the cardiac isoform. We have used paramagnetic relaxation enhancement (PRE)-NMR to obtain a description of the Ca2+-free state of cardiac Tn by describing the movement of key regions of the troponin I (cTnI) subunit upon the release of Ca2+ from Troponin C (cTnC). Site-directed spin-labeling was used to position paramagnetic spin labels in cTnI and the changes in the interaction between cTnI and cTnC subunits were then mapped by PRE-NMR. The functionally important regions of cTnI targeted in this study included the cTnC-binding N-region (cTnI57), the inhibitory region (cTnI143), and two sites on the regulatory switch region (cTnI151 and cTnI159). Comparison of H-1-N-15-TROSY spectra of Ca2+-bound and free states for the spin labeled cTnC-cTnI binary constructs demonstrated the release and modest movement of the cTnI switch region (similar to 10 angstrom) away from the hydrophobic N-lobe of troponin C (cTnC) upon the removal of Ca2+. Our data supports a model where the non-bound regulatory switch region of cTnI is highly flexible in the absence of Ca2+ but remains in close vicinity to cTnC. We speculate that the close proximity of TnI to TnC in the cardiac complex is favourable for increasing the frequency of collisions between the N-lobe of cTnC and the regulatory switch region, counterbalancing the reduction in collision probability that results from the incomplete opening of the N-lobe of TnC that is unique to the cardiac isoform.	[Cordina, Nicole M.; Potluri, Phani R.; Brown, Louise J.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Liew, Chu K.] Victor Chang Cardiac Res Inst, Dept Mol Cardiol & Biophys, Darlinghurst, NSW, Australia; [Curmi, Paul M.] Univ New S Wales, Sch Phys, Sydney, NSW, Australia; [Fajer, Piotr G.; Logan, Timothy M.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Mackay, Joel P.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	Macquarie University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; State University System of Florida; Florida State University; University of Sydney	Brown, LJ (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	Louise.Brown@mq.edu.au	Mackay, Joel P/D-6834-2011; Curmi, Paul/G-7185-2011	Mackay, Joel P/0000-0001-7508-8033; Curmi, Paul/0000-0001-5762-7638; Potluri, Phani Rekha/0000-0002-7488-633X; Cordina, Nicole/0000-0001-5775-7256; Brown, Louise/0000-0001-8592-2431	Australian Government; National Health and Medical Research Council of Australia [434220]	Australian Government(Australian GovernmentCGIAR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	NMC was supported by the Australian Postgraduate Award from the Australian Government (http://www.innovation.gov.au/). This work was funded by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) with funds from project grant 434220 to LJB and PMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott MB, 2000, J BIOL CHEM, V275, P20610, DOI 10.1074/jbc.M909252199; Aihara T, 2010, J BIOL CHEM, V285, P10671, DOI 10.1074/jbc.M109.082925; Baker KA, 2006, BIOCHEMISTRY-US, V45, P1663, DOI 10.1021/bi0516430; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Blumenschein TMA, 2006, BIOPHYS J, V90, P2436, DOI 10.1529/biophysj.105.076216; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Cordina NM, 2013, BIOCHEMISTRY-US, V52, P1950, DOI 10.1021/bi4000172; Cordina NM, 2012, PROTEIN SCI, V21, P1376, DOI 10.1002/pro.2124; Donaldson LW, 2001, J AM CHEM SOC, V123, P9843, DOI 10.1021/ja011241p; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6745, DOI 10.1021/bi962226d; Dong WJ, 2003, J BIOL CHEM, V278, P42394, DOI 10.1074/jbc.M304858200; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dvoretsky A, 2002, J BIOL CHEM, V277, P38565, DOI 10.1074/jbc.M205306200; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; GAGNE SM, 1995, NAT STRUCT BIOL, V2, P784, DOI 10.1038/nsb0995-784; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; Geeves MA, 2000, BIOCHEMISTRY-US, V39, P9345, DOI 10.1021/bi0002232; Goddard T. D, 2007, SPARKY 3; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d; Jayasundar JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087135; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Lindert S, 2012, BIOPHYS J, V103, P1784, DOI 10.1016/j.bpj.2012.08.058; Lindhout DA, 2003, J BIOL CHEM, V278, P27024, DOI 10.1074/jbc.M302497200; Luo Y, 1999, BIOCHEMISTRY-US, V38, P6678, DOI 10.1021/bi9824341; Madl T, 2011, ANGEW CHEM INT EDIT, V50, P3993, DOI 10.1002/anie.201007168; McKay RT, 1997, J BIOL CHEM, V272, P28494, DOI 10.1074/jbc.272.45.28494; McKay RT, 1998, BIOCHEMISTRY-US, V37, P12419, DOI 10.1021/bi9809019; Paakkonen K, 1998, J BIOL CHEM, V273, P15633, DOI 10.1074/jbc.273.25.15633; PERRY SV, 1973, COLD SPRING HARB SYM, V37, P251, DOI 10.1101/SQB.1973.037.01.035; POTTER JD, 1974, BIOCHEMISTRY-US, V13, P2697, DOI 10.1021/bi00710a007; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sheldahl C, 2003, BIOPHYS J, V84, P1057, DOI 10.1016/S0006-3495(03)74922-4; Sivakolundu SG, 2008, J MOL BIOL, V384, P240, DOI 10.1016/j.jmb.2008.09.019; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SYSKA H, 1976, BIOCHEM J, V153, P375, DOI 10.1042/bj1530375; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2798; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112976	10.1371/journal.pone.0112976	http://dx.doi.org/10.1371/journal.pone.0112976			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392916	gold, Green Published, Green Submitted			2022-12-26	WOS:000347709300130
J	Ordonez, R; Gallo-Oller, G; Martinez-Soto, S; Legarra, S; Pata-Merci, N; Guegan, J; Danglot, G; Bernheim, A; Melendez, B; Rey, JA; Castresana, JS				Ordonez, Raquel; Gallo-Oller, Gabriel; Martinez-Soto, Soledad; Legarra, Sheila; Pata-Merci, Noemie; Guegan, Justine; Danglot, Giselle; Bernheim, Alain; Melendez, Barbara; Rey, Juan A.; Castresana, Javier S.			Genome-Wide Microarray Expression and Genomic Alterations by Array-CGH Analysis in Neuroblastoma Stem-Like Cells	PLOS ONE			English	Article							TARGETING ION CHANNELS; COPY NUMBER VARIATIONS; INITIATING CELLS; TGF-BETA; SELF-RENEWAL; BRAIN-TUMORS; CANCER; OCT4; GENE; NOTCH	Neuroblastoma has a very diverse clinical behaviour: from spontaneous regression to a very aggressive malignant progression and resistance to chemotherapy. This heterogeneous clinical behaviour might be due to the existence of Cancer Stem Cells (CSC), a subpopulation within the tumor with stem-like cell properties: a significant proliferation capacity, a unique self-renewal capacity, and therefore, a higher ability to form new tumors. We enriched the CSC-like cell population content of two commercial neuroblastoma cell lines by the use of conditioned cell culture media for neurospheres, and compared genomic gains and losses and genome expression by array-CGH and microarray analysis, respectively (in CSC-like versus standard tumor cells culture). Despite the array-CGH did not show significant differences between standard and CSC-like in both analyzed cell lines, the microarray expression analysis highlighted some of the most relevant biological processes and molecular functions that might be responsible for the CSC-like phenotype. Some signalling pathways detected seem to be involved in self-renewal of normal tissues (Wnt, Notch, Hh and TGF-beta) and contribute to CSC phenotype. We focused on the aberrant activation of TGF-beta and Hh signalling pathways, confirming the inhibition of repressors of TGF-beta pathway, as SMAD6 and SMAD7 by RT-qPCR. The analysis of the Sonic Hedgehog pathway showed overexpression of PTCH1, GLI1 and SMO. We found overexpression of CD133 and CD15 in SIMA neurospheres, confirming that this cell line was particularly enriched in stem-like cells. This work shows a cross-talk among different pathways in neuroblastoma and its importance in CSC-like cells.	[Ordonez, Raquel; Gallo-Oller, Gabriel; Martinez-Soto, Soledad; Legarra, Sheila; Castresana, Javier S.] Univ Navarra, Sch Sci, Dept Biochem & Genet, E-31080 Pamplona, Spain; [Pata-Merci, Noemie; Guegan, Justine; Danglot, Giselle; Bernheim, Alain] Inst Gustave Roussy, Villejuif, France; [Melendez, Barbara] Virgen Salud Hosp, Dept Pathol, Mol Pathol Res Unit, Toledo, Spain; [Rey, Juan A.] La Paz Univ Hosp, IdiPaz Res Unit, Madrid, Spain	University of Navarra; UNICANCER; Gustave Roussy; Hospital Universitario La Paz	Castresana, JS (corresponding author), Univ Navarra, Sch Sci, Dept Biochem & Genet, E-31080 Pamplona, Spain.	jscastresana@unav.es	Castresana, Javier S/AFT-2167-2022; Melendez, Barbara/E-1216-2017; Gallo-Oller, Gabriel/D-6825-2019	Melendez, Barbara/0000-0001-5004-8895; Gallo-Oller, Gabriel/0000-0002-3864-1941; Ordonez, Raquel/0000-0002-6924-5175; Castresana, Javier S./0000-0002-2373-482X	Departamento de Educacion of Gobierno de Navarra, Pamplona; Departmento de Salud del Gobierno de Navarra; Caja Navarra [13912]; Fundacion Universitaria de Navarra, Pamplona; Fondo de Investigacion Sanitaria, Madrid [PI-081849, PI-101972]	Departamento de Educacion of Gobierno de Navarra, Pamplona; Departmento de Salud del Gobierno de Navarra; Caja Navarra; Fundacion Universitaria de Navarra, Pamplona; Fondo de Investigacion Sanitaria, Madrid	G. Gallo-Oller was supported by a fellowship from the Departamento de Educacion of Gobierno de Navarra, Pamplona. This research was supported in part by grants from the Departmento de Salud del Gobierno de Navarra, Caja Navarra (project 13912), Fundacion Universitaria de Navarra, Pamplona; and Fondo de Investigacion Sanitaria (PI-081849 to JSC and PI-101972 to JAR), Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2012, CANCER TREAT REV, V38, P589, DOI 10.1016/j.ctrv.2012.03.003; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Arcangeli A, 2010, PHARMACEUTICALS, V3, P1202, DOI 10.3390/ph3041202; Azimi I, 2014, BRIT J PHARMACOL, V171, P945, DOI 10.1111/bph.12486; Bailey JM, 2012, PANCREATIC CANC TUMO; Barone G, 2013, CLIN CANCER RES, V19, P5814, DOI 10.1158/1078-0432.CCR-13-0680; Becchetti A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00312; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Capasso M, 2010, CANCER TREAT RES, V155, P65, DOI 10.1007/978-1-4419-6033-7_4; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Coulon A, 2011, NEOPLASIA, V13, P991, DOI 10.1593/neo.11800; Cournoyer S, 2012, GENE CHROMOSOME CANC, V51, P792, DOI 10.1002/gcc.21964; Davidoff AM, 2012, SEMIN PEDIATR SURG, V21, P2, DOI 10.1053/j.sempedsurg.2011.10.009; de Resende MF, 2013, TUMOR BIOL, V34, P2665, DOI 10.1007/s13277-013-0817-9; Dear PH, 2009, TRENDS BIOTECHNOL, V27, P448, DOI 10.1016/j.tibtech.2009.05.003; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhir S, 2010, EARLY HUM DEV, V86, P601, DOI 10.1016/j.earlhumdev.2010.08.019; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Faigle R, 2013, BBA-GEN SUBJECTS, V1830, P2435, DOI 10.1016/j.bbagen.2012.09.002; Fakhr MG, 2013, GENET RES INT, V2013, DOI 10.1155/2013/317569; Fanciulli M, 2010, CLIN GENET, V77, P201, DOI 10.1111/j.1399-0004.2009.01342.x; Faunes F, 2013, DEVELOPMENT, V140, P1171, DOI 10.1242/dev.085654; George RE, 2010, PEDIATR BLOOD CANCER, V55, P629, DOI 10.1002/pbc.22607; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hoffmann EK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0109; Holland JD, 2013, CURR OPIN CELL BIOL, V25, P254, DOI 10.1016/j.ceb.2013.01.004; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang FT, 2012, INT J ONCOL, V41, P1707, DOI 10.3892/ijo.2012.1597; Jerabek S, 2013, BIOCHIM BIOPHYS ACTA, V1839, P138; Jiang YW, 2011, NEOPLASIA, V13, P492, DOI 10.1593/neo.11314; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PA, 2014, J CLIN INVEST, V124, P14, DOI 10.1172/JCI74145; Joseph JV, 2013, BIOCHEM PHARMACOL, V85, P478, DOI 10.1016/j.bcp.2012.11.005; Khaitan D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-258; Kim KI, 2012, BASIC CLIN PHARMACOL, V111, P317, DOI 10.1111/j.1742-7843.2012.00904.x; Kochert K, 2011, ONCOGENE, V30, P1831, DOI 10.1038/onc.2010.544; Kondratskyi A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00272; Kuiper RP, 2010, CURR OPIN GENET DEV, V20, P282, DOI 10.1016/j.gde.2010.03.005; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lang F, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0108; Liu Y, 2013, J CLIN ENDOCR METAB, V98, pE558, DOI 10.1210/jc.2012-3113; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YH, 2013, CANCER LETT, V340, P113, DOI 10.1016/j.canlet.2013.07.009; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Matthay KK, 2012, CLIN CANCER RES, V18, P2740, DOI 10.1158/1078-0432.CCR-11-1939; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Michaud NR, 2014, MOL CANCER THER, V13, P386, DOI 10.1158/1535-7163.MCT-13-0420; Montenegro M.F., 2014, ONCOGENE; Nejman D, 2014, CANCER RES, V74, P1475, DOI 10.1158/0008-5472.CAN-13-3042; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Ningaraj NS, 2009, CANCER BIOL THER, V8, P1924, DOI 10.4161/cbt.8.20.9490; Oeggerli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041664; Ohira M, 2010, CANCER SCI, V101, P2295, DOI 10.1111/j.1349-7006.2010.01681.x; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Park Kyung-Soon, 2011, Int J Stem Cells, V4, P18; Purow B, 2012, ADV EXP MED BIOL, V727, P305, DOI 10.1007/978-1-4614-0899-4_23; Rahman R, 2009, BBA-MOL BASIS DIS, V1792, P280, DOI 10.1016/j.bbadis.2009.01.011; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Romania P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078481; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; Schatton T, 2009, BIOESSAYS, V31, P1038, DOI 10.1002/bies.200900058; Schwab A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0102; Sethi N, 2011, BRIT J CANCER, V105, P1805, DOI 10.1038/bjc.2011.497; SHAO HW, 2012, CHAPTER 7 TARGETING, V65, P191; Shi JL, 2013, ONCOL REP, V30, P201, DOI 10.3892/or.2013.2456; Sigalotti L, 2013, PHARMACOL THERAPEUT, V142, P339; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Speleman F, 2011, SEMIN CANCER BIOL, V21, P238, DOI 10.1016/j.semcancer.2011.07.003; Stallings RL, 2010, EXPERT OPIN THER TAR, V14, P951, DOI 10.1517/14728222.2010.510136; Sumer-Turanligil NC, 2013, CHILD NERV SYST, V29, P381, DOI 10.1007/s00381-012-2014-3; Takebe N, 2014, PHARMACOL THERAPEUT, V141, P140, DOI 10.1016/j.pharmthera.2013.09.005; Tantin D, 2013, DEVELOPMENT, V140, P2857, DOI 10.1242/dev.095927; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van Amerongen R, 2010, ONCOGENE, V29, P93, DOI 10.1038/onc.2009.310; Villamon E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053740; Wainwright DA, 2012, EXPERT OPIN EMERG DR, V17, P181, DOI 10.1517/14728214.2012.679929; Wakefield LM, 2013, NAT REV CANCER, V13, P328, DOI 10.1038/nrc3500; Wan F, 2010, BRAIN PATHOL, V20, P877, DOI 10.1111/j.1750-3639.2010.00379.x; Wang L, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt96; Wang YD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.272; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Wezel F, 2013, AM J PATHOL, V183, P1128, DOI 10.1016/j.ajpath.2013.06.025; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Wu WKK, 2013, CRIT REV ONCOL HEMAT, V86, P251, DOI 10.1016/j.critrevonc.2012.11.009; Xie JW, 2013, ONCOTARGETS THER, V6, P1425, DOI 10.2147/OTT.S34678; Xin YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083373; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Yang L, 2013, ONCOL REP, V29, P2191, DOI 10.3892/or.2013.2356; Yang SB, 2012, ONCOL REP, V28, P186, DOI 10.3892/or.2012.1765; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	105	5	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113105	10.1371/journal.pone.0113105	http://dx.doi.org/10.1371/journal.pone.0113105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25392930	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300142
J	Stahlberg, A; Gustafsson, CK; Engtrom, K; Thomsen, C; Dolatabadi, S; Jonasson, E; Li, CY; Ruff, D; Chen, SM; Aman, P				Stahlberg, Anders; Gustafsson, Christina Kabjorn; Engtrom, Katarina; Thomsen, Christer; Dolatabadi, Soheila; Jonasson, Emma; Li, Chieh-Yuan; Ruff, David; Chen, Shiaw-Min; Aman, Pierre			Normal and Functional TP53 in Genetically Stable Myxoid/Round Cell Liposarcoma	PLOS ONE			English	Article							P53 GENE ALTERATIONS; FREQUENT ALTERATION; POOR-PROGNOSIS; EXPRESSION; FUSION; TLS; CHOP; EWS; TAF15; TRANSCRIPTION	Myxoid/round-cell liposarcoma (MLS/RCLS) is characterized by either the fusion gene FUS-DDIT3 or the less commonly occurring EWSR1-DDIT3 and most cases carry few or no additional cytogenetic changes. There are conflicting reports concerning the status and role of TP53 in MLS/RCLS. Here we analysed four MLS/RCLS derived cell lines for TP53 mutations, expression and function. Three SV40 transformed cell lines expressed normal TP53 proteins. Irradiation caused normal posttranslational modifications of TP53 and induced P21 expression in two of these cell lines. Transfection experiments showed that the FUS-DDIT3 fusion protein had no effects on irradiation induced TP53 responses. Ion Torrent AmpliSeq screening, using the Cancer Hotspot panel, showed no dysfunctional or disease associated alleles/mutations. In conclusion, our results suggest that most MLS/RCLS cases carry functional TP53 genes and this is consistent with the low numbers of secondary mutations observed in this tumor entity.	[Stahlberg, Anders; Gustafsson, Christina Kabjorn; Thomsen, Christer; Dolatabadi, Soheila; Jonasson, Emma; Aman, Pierre] Univ Gothenburg, Inst Biomed, Dept Pathol, Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Engtrom, Katarina] Univ Gothenburg, Inst Med Sci, Dept Oncol, Gothenburg, Sweden; [Li, Chieh-Yuan; Ruff, David; Chen, Shiaw-Min] Thermo Fisher Sci, Life Sci Grp, Genet Med & Appl Sci Div, San Francisco, CA USA	University of Gothenburg; University of Gothenburg; Thermo Fisher Scientific	Aman, P (corresponding author), Univ Gothenburg, Inst Biomed, Dept Pathol, Sahlgrenska Canc Ctr, Gothenburg, Sweden.	pierre.aman@llcr.med.gu.se		Li, Chieh-yuan/0000-0003-0907-8704; Jonasson, Emma/0000-0003-0463-9373; Li, Chieh-Yuan/0000-0003-1038-5218; Aman, Pierre/0000-0002-1482-8875; Stahlberg, Anders/0000-0003-4243-0191	ALF Vastra Gotalandsregionen; Swedish Cancer Society; Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Swedish Society for Medical Research; BioCARE National Strategic Research Program at University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council [2367]; Thermo Fisher Scientific	ALF Vastra Gotalandsregionen; Swedish Cancer Society(Swedish Cancer Society); Assar Gabrielssons Research Foundation; Johan Jansson Foundation for Cancer Research; Swedish Society for Medical Research; BioCARE National Strategic Research Program at University of Gothenburg; Wilhelm and Martina Lundgren Foundation for Scientific Research; Swedish Research Council(Swedish Research CouncilEuropean Commission); Thermo Fisher Scientific	This work was supported by grants from: ALF Vastra Gotalandsregionen, Swedish Cancer Society, Assar Gabrielssons Research Foundation, Johan Jansson Foundation for Cancer Research, Swedish Society for Medical Research, BioCARE National Strategic Research Program at University of Gothenburg, Wilhelm and Martina Lundgren Foundation for Scientific Research, and the Swedish Research Council (2367). AS has a collaborative research grant from Thermo Fisher Scientific. The funder provided support in the form of salaries for authors (CYL, DR, SMC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	Aman P, 1999, SEMIN CANCER BIOL, V9, P303, DOI 10.1006/scbi.1999.0130; AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Antonescu CR, 2001, CLIN CANCER RES, V7, P3977; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Chin PL, 1997, ONCOGENE, V15, P87, DOI 10.1038/sj.onc.1201161; CLASSON M, 1987, NATURE, V330, P272, DOI 10.1038/330272a0; Di Giandomenico S, 2013, ONCOGENE; Engstrom K, 2006, AM J PATHOL, V168, P1642, DOI 10.2353/ajpath.2006.050872; Engstrom K, 2007, ACTA ONCOL, V46, P838, DOI 10.1080/02841860601080415; Forni C, 2009, MOL CANCER THER, V8, P449, DOI 10.1158/1535-7163.MCT-08-0848; Frapolli R, 2010, CLIN CANCER RES, V16, P4958, DOI 10.1158/1078-0432.CCR-10-0317; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Goransson M, 2005, INT J CANCER, V115, P556, DOI 10.1002/ijc.20893; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Hollstein M, 2010, J PATHOL, V220, P164, DOI 10.1002/path.2637; Khoury MP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000927; Law Warren J., 2006, Briefings in Functional Genomics & Proteomics, V5, P8, DOI 10.1093/bfgp/ell015; MANDAHL N, 1994, INT J ONCOL, V4, P307; Mertens F, 2010, VIRCHOWS ARCH, V456, P129, DOI 10.1007/s00428-009-0736-8; Oda Y, 2005, J PATHOL, V207, P410, DOI 10.1002/path.1848; Panagopoulos I, 1996, ONCOGENE, V12, P489; Perrone F, 2006, J PATHOL, V209, P281, DOI 10.1002/path.1994; Pilotti S, 1998, TUMORI, V84, P571, DOI 10.1177/030089169808400512; Pipas JM, 2001, SEMIN CANCER BIOL, V11, P23, DOI 10.1006/scbi.2000.0343; Rodriguez R, 2011, STEM CELLS, V29, P179, DOI 10.1002/stem.571; Sanchez Garcia I, 1994, P NATL ACAD SCI USA, V91, P7869; SHARMA S, 1993, CELL GROWTH DIFFER, V4, P861; Technau A, 2001, INT J ONCOL, V18, P281; Thelin-Jarnum S, INT J CANC, V83, P30; Thomsen C, 2013, FASEB J, V27, P4965, DOI 10.1096/fj.13-234435; Wu L, 1997, MOL MED, V3, P441, DOI 10.1007/BF03401691; Wurl P, 1997, J CANCER RES CLIN, V123, P502, DOI 10.1007/s004320050095; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; Zinszner H, 1997, ONCOGENE, V14, P451, DOI 10.1038/sj.onc.1200854	35	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e113110	10.1371/journal.pone.0113110	http://dx.doi.org/10.1371/journal.pone.0113110			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393000	Green Submitted, Green Published, gold			2022-12-26	WOS:000347709300143
J	Schiffner, I; Wiltschko, R				Schiffner, Ingo; Wiltschko, Roswitha			Pigeon Navigation: Different Routes Lead to Frankfurt	PLOS ONE			English	Article							HOMING PIGEONS; MATHEMATICAL-ANALYSIS; ORIENTATION; PILOTAGE; LOYALTY	Background: Tracks of pigeons homing to the Frankfurt loft revealed an odd phenomenon: whereas birds returning from the North approach their loft more or less directly in a broad front, pigeons returning from the South choose, from 25 km from home onward, either of two corridors, a direct one and one with a considerable detour to the West. This implies differences in the navigational process. Methodology/Principle Findings: Pigeons released at sites at the beginning of the westerly corridor and in this corridor behave just like pigeons returning from farther south, deviating to the west before turning towards their loft. Birds released at sites within the straight corridors, in contrast, take more or less straight routes. The analysis of the short-term correlation dimension, a quantity reflecting the complexity of the system and with it, the number of factors involved in the navigational process, reveals that it is significantly larger in pigeons choosing the westerly corridor than in the birds flying straight -3.03 vs. 2.85. The difference is small, however, suggesting a different interpretation of the same factors, with some birds apparently preferring particular factors over others. Conclusions: The specific regional distribution of the factors which pigeons use to determine their home course seems to provide ambiguous information in the area 25 km south of the loft, resulting in the two corridors. Pigeons appear to navigate by deriving their routes directly from the locally available navigational factors which they interpret in an individual way. The fractal nature of the correlation dimensions indicates that the navigation process of pigeons is chaotic-deterministic; published tracks of migratory birds suggest that this may apply to avian navigation in general.	[Schiffner, Ingo; Wiltschko, Roswitha] Goethe Univ Frankfurt, FB Biowissensch, D-60054 Frankfurt, Germany; [Schiffner, Ingo] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	Goethe University Frankfurt; University of Queensland	Wiltschko, R (corresponding author), Goethe Univ Frankfurt, FB Biowissensch, Siesmayerstr 70, D-60054 Frankfurt, Germany.	Wiltschko@bio.uni-frankfurt.de	Schiffner, Ingo/M-5114-2018	Schiffner, Ingo/0000-0003-0044-1677	Deutsche Forschungsgemeinschaft (DFG) [Wi 988/6-2, Wi 988/6-3, Wi 988/7-1, Wi 988/7-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG), with grants to RW: Wi 988/6-2,3 and Wi 988/7-1,2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; Batschelet E, 1981, CIRCULAR STAT BIOL; Biro D, 2006, J NAVIGATION, V59, P43, DOI 10.1017/S0373463305003541; Biro D, 2004, P NATL ACAD SCI USA, V101, P17440, DOI 10.1073/pnas.0406984101; Biro D, 2007, P NATL ACAD SCI USA, V104, P7471, DOI 10.1073/pnas.0701575104; Blaser N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077102; Bonadonna F, 1997, BEHAV PROCESS, V39, P137, DOI 10.1016/S0376-6357(96)00054-X; Dennis TE, 2007, P ROY SOC B-BIOL SCI, V274, P1153, DOI 10.1098/rspb.2007.3768; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Gagliardo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022385; Gagliardo A, 2009, BEHAV ECOL SOCIOBIOL, V64, P289, DOI 10.1007/s00265-009-0847-x; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; GRAUE LOUIS C., 1963, THE OHIO JOUR SCI, V63, P214; GRIFFIN DR, 1952, BIOL REV, V27, P359, DOI 10.1111/j.1469-185X.1952.tb01509.x; Hagstrum JT, 2013, J EXP BIOL, V216, P687, DOI 10.1242/jeb.072934; Hagstrum JT, 2000, J EXP BIOL, V203, P1103; Jorge PE, 2010, P R SOC B, V277, P45, DOI 10.1098/rspb.2009.1521; Jorge PE, 2009, CURR BIOL, V19, P650, DOI 10.1016/j.cub.2009.02.066; Kantz H., 1997, NONLINEAR TIME SERIE; KAPLAN D, 1995, UNDERSTANDING NONLIN; KEETON WT, 1973, J COMP PHYSIOL, V86, P1, DOI 10.1007/BF00694473; LEDNOR AJ, 1984, J EXP BIOL, V111, P259; Lipp HP, 2004, CURR BIOL, V14, P1239, DOI 10.1016/j.cub.2004.07.024; Mann R, 2011, J R SOC INTERFACE, V8, P210, DOI 10.1098/rsif.2010.0301; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Michael S, 2005, APPL NONLINEAR TIME; Mora CV, 2009, P R SOC B, V276, P3295, DOI 10.1098/rspb.2009.0872; Nehmzow Ulrich, 2006, SCI METHODS MOBILE R; PAPI F, 1986, MONIT ZOOL ITAL, V20, P471; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Schiffner I, 2014, J EXP BIOL, V217, P2643, DOI 10.1242/jeb.104182; Schiffner I, 2013, ANIM BEHAV, V86, P291, DOI 10.1016/j.anbehav.2013.05.018; Schiffner I, 2011, J THEOR BIOL, V291, P42, DOI 10.1016/j.jtbi.2011.09.009; Schiffner I, 2011, J NAVIGATION, V64, P431, DOI 10.1017/S0373463311000063; SKINNER JE, 1994, BIO-TECHNOL, V12, P596, DOI 10.1038/nbt0694-596; Steiner I, 2000, PHYSIOL BEHAV, V71, P1; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; von Hunerbein K, 2000, NATURWISSENSCHAFTEN, V87, P278, DOI 10.1007/s001140050721; Walcott C, 2005, INTEGR COMP BIOL, V45, P574, DOI 10.1093/icb/45.3.574; Walcott C., 1978, ANIMAL MIGRATION NAV, P143, DOI 10.1007/978-3-662-11147-5_13; WALLRAFF HANS G., 1959, ZEITSCHR TIERPSYCHOL, V16, P513; Wallraff HG, 2004, ANIM BEHAV, V67, P189, DOI 10.1016/j.anbehav.2003.06.007; Wallraff HG, 1974, SCHRIFTENREIHE KYBER; Whitney H, 1936, ANN MATH, V37, P645, DOI 10.2307/1968482; WILTSCHKO R, 1994, BEHAV ECOL SOCIOBIOL, V35, P63, DOI 10.1007/s002650050071; Wiltschko R, 1993, ORIENTATION NAVIGATI; Wiltschko R, 2007, ANIM BEHAV, V74, P1229, DOI 10.1016/j.anbehav.2007.01.028; Wiltschko R, 2010, CURR BIOL, V20, P1534, DOI 10.1016/j.cub.2010.06.073; Wiltschko R, 2009, AUK, V126, P717, DOI 10.1525/auk.2009.11009; Wiltschko W., 1982, P239; YEAGLEY HL, 1951, J APPL PHYS, V22, P746, DOI 10.1063/1.1700043	52	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112439	10.1371/journal.pone.0112439	http://dx.doi.org/10.1371/journal.pone.0112439			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25391144	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400082
J	Berthet, N; Falguieres, M; Filippone, C; Bertolus, C; Bole-Feysot, C; Brisse, S; Gessain, A; Heard, I; Favre, M				Berthet, Nicolas; Falguieres, Michael; Filippone, Claudia; Bertolus, Chloe; Bole-Feysot, Christine; Brisse, Sylvain; Gessain, Antoine; Heard, Isabelle; Favre, Michel			Resequencing Microarray Technology for Genotyping Human Papillomavirus in Cervical Smears	PLOS ONE			English	Article							DNA MICROARRAYS; VIRUSES; CANCER; DESIGN	There are more than 40 human papillomaviruses (HPVs) belonging to the alpha genus that cause sexually transmitted infections; these infections are among the most frequent and can lead to condylomas and anogenital intra-epithelial neoplasia. At least 18 of these viruses are causative agents of anogenital carcinomas. We evaluated the performance of a resequencing microarray for the detection and genotyping of alpha HPV of clinical significance using cloned HPV DNA. To reduce the number of HPV genotypes tiled on microarray, we used reconstructed ancestral sequences (RASs) as they are more closely related to the various genotypes than the current genotypes are among themselves. The performance of this approach was tested by genotyping with a set of 40 cervical smears already genotyped using the commercial PapilloCheck kit. The results of the two tests were concordant for 70% (28/40) of the samples and compatible for 30% (12/40). Our findings indicate that RASs were able to detect and identify one or several HPV in clinical samples. Associating RASs with homonym sequences improved the genotyping of HPV present in cases of multiple infection. In conclusion, we demonstrate the diagnostic potential of resequencing technology for genotyping of HPV, and illustrate its value both for epidemiological studies and for monitoring the distribution of HPV in the post-vaccination era.	[Berthet, Nicolas; Filippone, Claudia; Gessain, Antoine] Inst Pasteur, F-75724 Paris 15, France; [Berthet, Nicolas; Filippone, Claudia; Gessain, Antoine] CNRS, UMR 3569, F-75724 Paris 15, France; [Falguieres, Michael; Heard, Isabelle; Favre, Michel] Inst Pasteur, Ctr Natl Reference Papillomavirus, F-75724 Paris 15, France; [Bertolus, Chloe] Hop La Pitie Salpetriere, AP HP, Serv Chirurg Maxillofaciale & Stomatol, F-75013 Paris, France; [Bertolus, Chloe] Univ Paris 06, CIMI Paris, UMRS CR7, INSERM U1135, F-75005 Paris, France; [Bole-Feysot, Christine] Hop Necker Enfants Malad, Inst Malad Genet Plateforme Genom, F-75743 Paris 15, France; [Brisse, Sylvain] Inst Pasteur, Plate Forme Genotypage Pathogenes & Sante Publ, F-75724 Paris 15, France; [Heard, Isabelle] Univ Paris 06, Grp Hosp Pitie Salpetriere, Paris 13, France; [Favre, Michel] Inst Pasteur, Unite Genet Papillomavirus & Canc Humain, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Berthet, N (corresponding author), CIRMF, Dept Zoonose & Malad Emergentes, BP769, Franceville, Gabon.	nicolas.berthet@ird.fr	Brisse, Sylvain/M-8723-2013; Berthet, Nicolas/J-9373-2012	Brisse, Sylvain/0000-0002-2516-2108; 	Programme Transversal de Recherche DEVA - Institut Pasteur (Paris, France) [246]; Fondation Total-Institut Pasteur; Academie Nationale de Medecine; French Institut National du Cancer [2011-1VADS 03-IP1]	Programme Transversal de Recherche DEVA - Institut Pasteur (Paris, France); Fondation Total-Institut Pasteur; Academie Nationale de Medecine; French Institut National du Cancer(Institut National du Cancer (INCA) France)	This program was supported by the Programme Transversal de Recherche DEVA No. 246 financed by the Institut Pasteur (Paris, France), sponsored by the Fondation Total-Institut Pasteur and the Elisabeth Taub award from the Academie Nationale de Medecine. This study was funded by the French Institut National du Cancer (Canceropole 2011-1VADS 03-IP1). The funders had no role in study design, data analysis or preparation of the manuscript.	Albrecht V, 2006, J VIROL METHODS, V137, P236, DOI 10.1016/j.jviromet.2006.06.023; Berthet N, 2012, J CLIN VIROL; Berthet N, 2008, MICROB BIOTECHNOL, V1, P79, DOI 10.1111/j.1751-7915.2007.00012.x; Berthet N, 2011, LANCET, V378, P1354, DOI 10.1016/S0140-6736(11)61142-2; Berthet N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015243; Berthet N, 2010, NAT BIOTECHNOL, V28, P25, DOI 10.1038/nbt0110-25; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Chen ZG, 2007, VIROLOGY, V360, P447, DOI 10.1016/j.virol.2006.10.022; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dacheux L, 2010, J VIROL, V84, P9557, DOI 10.1128/JVI.00771-10; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Filippone C, 2012, CLIN MICROBIOLOGY IN; Heard I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079372; Leclercq I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-586; Lin ZH, 2005, PATHOL INT, V55, P491, DOI 10.1111/j.1440-1827.2005.01858.x; Mendoza JA, 2006, J VIROL, V80, P12420, DOI 10.1128/JVI.02576-05; Mighty KK, 2014, RECENT RESULTS CANC, V193, P135, DOI 10.1007/978-3-642-38965-8_8; Saslow D, 2012, AM J CLIN PATHOL, V137, P516, DOI [10.1309/AJCPTGD94EVRSJCG, 10.3322/caac.21139]; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; Wang Z, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-577; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e109301	10.1371/journal.pone.0109301	http://dx.doi.org/10.1371/journal.pone.0109301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383888	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700003
J	Ganguly, A; Chakravorty, R; Sarkar, A; Mandal, DK; Haldar, P; Ramos-Elorduy, J; Moreno, JMP				Ganguly, Arijit; Chakravorty, Ranita; Sarkar, Angshuman; Mandal, Dipak K.; Haldar, Parimalendu; Ramos-Elorduy, Julieta; Pino Moreno, Jose Manuel			A Preliminary Study on Oxya fuscovittata (Marschall) as an Alternative Nutrient Supplement in the Diets of Poecillia sphenops (Valenciennes)	PLOS ONE			English	Article								Growth of the ornamental fish industry is being hindered by the scarcity of low cost feed; hence alternative protein supplements should be explored. In this context the present study aims to evaluate whether the grasshopper Oxya fuscovittata could be used as a supplement for fish meal in the diets of Poecillia sphenops, which is one of the most common ornamental fishes worldwide. The present work is divided into three phases: In the first phase proximate composition of the grasshopper is obtained and five diets are prepared where fish meal is gradually replaced by Oxya meal and named as control, D1, D2, D3 and D4. All the diets are formulated on iso-nitrogenous basis where the protein percentage is fixed at 400 g/kg. The second phase deals with feeding trial and in the third phase all the data of the feeding trial are subjected to a linear model. The feeding trial shows that the control, D1 and D2 fed fishes have almost similar results. The linear model proves that the variation in the indices are mainly due to replacement of fish meal by Oxya meal, not due to the variations of rice husk and mustard oil cake that are also used to formulate the diets of the present study. From the results two Oxya supplemented diets, i.e. D1 and D2 are proved to be almost equivalent to the control diet. Hence it is concluded that Oxya meal is able to replace 25% to 50% of fish meal from the diets of P. sphenops.	[Ganguly, Arijit; Chakravorty, Ranita; Mandal, Dipak K.; Haldar, Parimalendu] Visva Bharati Univ, Dept Zool, Santini Ketan, W Bengal, India; [Sarkar, Angshuman] Visva Bharati Univ, Dept Stat, Santini Ketan, W Bengal, India; [Ramos-Elorduy, Julieta; Pino Moreno, Jose Manuel] Univ Nacl Autonoma Mexico, Dept Zool, Mexico City 04510, DF, Mexico	Visva Bharati University; Visva Bharati University; Universidad Nacional Autonoma de Mexico	Moreno, JMP (corresponding author), Univ Nacl Autonoma Mexico, Dept Zool, Mexico City 04510, DF, Mexico.	jpino@ib.unam.mx		Mandal, Dipak Kumar/0000-0002-2492-7180				AKAND AM, 1991, ASIAN FISH SOC SPEC, V5, P93; Anand H., 2008, J ENV SOCIOBIOL, V5, P181; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; APHA, 1999, STANDARD METHODS EXA; Arockiaraj A. Jesu, 1999, Acta Zoologica Taiwanica, V10, P103; Bahnasawy M., 2009, EGYPT J AQUAT BIOL F, V13, P1; Bailey M, 2001, ULTIMATE AQUARIUM; Cowey C.B., 1979, FISH PHYSIOL, P1; De Silva SS, 1998, FISH NUTR AQUACULTUR; Fernando A.A., 1991, Asian Fisheries Science, V4, P99; Furuichi M., 1982, Bulletin of the Japanese Society of Scientific Fisheries, V48, P945; Guillaume Jean, 1997, Advances in World Aquaculture, V6, P26; Hasan MR, 1990, P 2 AS FISH FOR, P275; Hossain M. H., 2003, International Journal of Poultry Science, V2, P159; Kalita P, 2007, FOOD CHEM, V103, P204, DOI 10.1016/j.foodchem.2006.08.007; LAGLER KF, 1956, FRESHWATER FISHERY B; Lawrence C, 2007, AQUACULTURE, V269, P1, DOI 10.1016/j.aquaculture.2007.04.077; Martinez HH, 2008, CIENC PESQ, V16, P25; Mohanta KN, 2011, TECHNICAL B ICAR RES, V27; Moyle P. B., 1996, FISHES INTRO ICHTHYO; National Research Council (NRC), 1983, NUTR REQ WARM WAT FI; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Nyirenda J, 2000, NAGA ICLARM Q, V23, P13; Parker R, 2011, AQUACULTURE SCI; Shim Kim Fah, 1986, Journal of Aquariculture & Aquatic Sciences, V4, P79; Sogbesan AO, 2008, TURK J FISH AQUAT SC, V8, P149; Sogbesan OA, 2006, NIGERIAN J FISHERIES, V2, P358; Timmerman CM, 2004, J FISH BIOL, V65, P635, DOI 10.1111/j.0022-1112.2004.00474.x; Van Huis A, 2013, EDIBLE INSECTS FUTUR; Wade JW, 1992, J AQUATIC SCI, V7, P59; Xiaoming C, 2010, FOREST INSECTS FOOD, P85	31	5	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111848	10.1371/journal.pone.0111848	http://dx.doi.org/10.1371/journal.pone.0111848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25383946	gold, Green Published, Green Submitted			2022-12-26	WOS:000344816700021
J	Malentacchi, F; Pazzagli, M; Simi, L; Orlando, C; Wyrich, R; Gunther, K; Verderio, P; Pizzamiglio, S; Ciniselli, CM; Zhang, H; Korenkova, V; Rainen, L; Bar, T; Kubista, M; Gelmini, S				Malentacchi, Francesca; Pazzagli, Mario; Simi, Lisa; Orlando, Claudio; Wyrich, Ralf; Guenther, Kalle; Verderio, Paolo; Pizzamiglio, Sara; Ciniselli, Chiara Maura; Zhang, Hui; Korenkova, Vlasta; Rainen, Lynne; Bar, Tzachi; Kubista, Mikael; Gelmini, Stefania			SPIDIA-RNA: Second External Quality Assessment for the Pre-Analytical Phase of Blood Samples Used for RNA Based Analyses	PLOS ONE			English	Article							WHOLE-BLOOD; QUANTITATIVE PCR; EXPRESSION; QUANTIFICATION; DNA	One purpose of the EC funded project, SPIDIA, is to develop evidence-based quality guidelines for the pre-analytical handling of blood samples for RNA molecular testing. To this end, two pan-European External Quality Assessments (EQAs) were implemented. Here we report the results of the second SPIDIA-RNA EQA. This second study included modifications in the protocol related to the blood collection process, the shipping conditions and pre-analytical specimen handling for participants. Participating laboratories received two identical proficiency blood specimens collected in tubes with or without an RNA stabilizer. For pre-defined specimen storage times and temperatures, laboratories were asked to perform RNA extraction from whole blood according to their usual procedure and to return extracted RNA to the SPIDIA facility for further analysis. These RNA samples were evaluated for purity, yield, integrity, stability, presence of interfering substances, and gene expression levels for the validated markers of RNA stability: FOS, IL1B, IL8, GAPDH, FOSB and TNFRSF10c. Analysis of the gene expression results of FOS, IL8, FOSB, and TNFRSF10c, however, indicated that the levels of these transcripts were significantly affected by blood collection tube type and storage temperature. These results demonstrated that only blood collection tubes containing a cellular RNA stabilizer allowed reliable gene expression analysis within 48 h from blood collection for all the genes investigated. The results of these two EQAs have been proposed for use in the development of a Technical Specification by the European Committee for Standardization.	[Malentacchi, Francesca; Pazzagli, Mario; Simi, Lisa; Orlando, Claudio; Gelmini, Stefania] Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy; [Wyrich, Ralf; Guenther, Kalle] Qiagen GmbH, Hilden, Germany; [Verderio, Paolo; Pizzamiglio, Sara; Ciniselli, Chiara Maura] Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Unit Med Stat Biometry & Bioinformat, Ist Nazl Tumori, Milan, Italy; [Zhang, Hui] DiaGenic ASA, Oslo, Norway; [Korenkova, Vlasta; Kubista, Mikael] Acad Sci Czech Republic, Inst Biotechnol, Prague, Czech Republic; [Rainen, Lynne] Becton Dickinson, Franklin Lakes, NJ USA; [Bar, Tzachi] Labonnet Ltd, St Ramat Hasharon, Israel; [Kubista, Mikael] TATAA Bioctr AB, Gothenburg, Sweden	University of Florence; QIAGEN GmbH; Fondazione IRCCS Istituto Nazionale Tumori Milan; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Becton Dickinson	Malentacchi, F (corresponding author), Univ Florence, Dept Biomed Expt & Clin Sci, Florence, Italy.	francesca.malentacchi@gmail.com	Kubista, Mikael/A-5689-2008; Ciniselli, Chiara M/C-4518-2017; Korenková, Vlasta/G-6401-2014; GELMINI, STEFANIA/K-8387-2018; Pizzamiglio, Sara/C-1061-2017; Verderio, Paolo/B-5034-2017	Kubista, Mikael/0000-0002-2940-352X; Ciniselli, Chiara M/0000-0003-4488-885X; GELMINI, STEFANIA/0000-0002-4718-0833; Pizzamiglio, Sara/0000-0002-7759-0550; Verderio, Paolo/0000-0002-9231-1281; Korenkova, Vlasta/0000-0002-6289-5175; Pazzagli, Mario/0000-0003-3673-691X; Bar, Tzachi/0000-0001-7315-0710	European Union (FP7. Title "SPIDIA: Standardization and improvement of generic pre-analytical tools and procedures for in vitro diagnostic'') [222916]	European Union (FP7. Title "SPIDIA: Standardization and improvement of generic pre-analytical tools and procedures for in vitro diagnostic'')	The SPIDIA RNA study has been supported by European Union (FP7. Title "SPIDIA: Standardization and improvement of generic pre-analytical tools and procedures for in vitro diagnostic'', Grant agreement no. 222916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Gunther K, 2012, CLIN CHIM ACTA, V413, P779, DOI 10.1016/j.cca.2012.01.015; Hartel C, 2001, J IMMUNOL METHODS, V249, P63, DOI 10.1016/S0022-1759(00)00334-3; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Kim SJ, 2007, CLIN CHEM, V53, P1038, DOI 10.1373/clinchem.2006.078436; Laurell H, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1259; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madej RM, 2005, MM14A CLSI, V25, P1; Malentacchi F, 2013, CLIN CHIM ACTA, V424, P274, DOI 10.1016/j.cca.2013.05.012; McCulloch CE, 2001, GEN LINEAR MIXED MOD, P281; Nussbaumer C, 2006, FORENSIC SCI INT, V157, P181, DOI 10.1016/j.forsciint.2005.10.009; Ovstebo R, 2007, CLIN CHEM LAB MED, V45, P171, DOI 10.1515/CCLM.2007.035; Pahl A, 2002, BLOOD, V100, P1094, DOI 10.1182/blood-2002-03-0813; Pazzagli M, 2013, METHODS, V59, P20, DOI 10.1016/j.ymeth.2012.10.007; Rainen L, 2002, CLIN CHEM, V48, P1883; Tichopad A, 2010, METHODS, V50, P308, DOI 10.1016/j.ymeth.2010.01.028	19	23	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e112293	10.1371/journal.pone.0112293	http://dx.doi.org/10.1371/journal.pone.0112293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384019	Green Published, gold, Green Submitted			2022-12-26	WOS:000344816700048
J	Rosca, EV; Penet, MF; Mori, N; Koskimaki, JE; Lee, E; Pandey, NB; Bhujwalla, ZM; Popel, AS				Rosca, Elena V.; Penet, Marie-France; Mori, Noriko; Koskimaki, Jacob E.; Lee, Esak; Pandey, Niranjan B.; Bhujwalla, Zaver M.; Popel, Aleksander S.			A Biomimetic Collagen Derived Peptide Exhibits Anti-Angiogenic Activity in Triple Negative Breast Cancer	PLOS ONE			English	Article							TUMOR-GROWTH; IV COLLAGEN; BEVACIZUMAB; INTEGRIN; IDENTIFICATION; VASCULATURE; COOPERATION; MECHANISM; VEGFR2; AGENT	We investigated the application of a mimetic 20 amino acid peptide derived from type IV collagen for treatment of breast cancer. We showed that the peptide induced a decrease of proliferation, adhesion, and migration of endothelial and tumor cells in vitro. We also observed an inhibition of triple negative MDA-MB-231 xenograft growth by 75% relative to control when administered intraperitoneally for 27 days at 10 mg/kg. We monitored in vivo the changes in vascular properties throughout the treatment using MRI and found that the vascular volume and permeability surface area product decreased significantly. The treatment also resulted in an increase of caspase-3 activity and in a reduction of microvascular density. The multiple mode of action of this peptide, i.e., anti-angiogenic, and anti-tumorigenic, makes it a viable candidate as a therapeutic agent as a monotherapy or in combination with other compounds.	[Rosca, Elena V.; Koskimaki, Jacob E.; Lee, Esak; Pandey, Niranjan B.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Penet, Marie-France; Mori, Noriko; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, In Vivo Cellular & Mol Imaging Ctr Program,Div Ca, Baltimore, MD 21205 USA; [Bhujwalla, Zaver M.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Bhujwalla, Zaver M.; Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Rosca, EV (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	e.v.rosca@gmail.com	Penet, Marie-France/AGZ-6991-2022; Popel, Aleksander S/A-6724-2009; Lee, Esak/AAC-6403-2020	Lee, Esak/0000-0002-5328-6677; Popel, Aleksander/0000-0002-6706-9235	National Institutes of Health [R01CA138264, R21CA152473, R01CA136576, P50CA103175]; Safeway Foundation; NATIONAL CANCER INSTITUTE [R01CA138264, R21CA152473, R01CA136576, P50CA103175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Safeway Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants R01CA138264, R21CA152473, R01CA136576 and P50CA103175 and the Safeway Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer MV, 2012, THERANOSTICS, V2, P502, DOI 10.7150/thno.3623; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355; Braghiroli MI, 2012, EXPERT REV ANTICANC, V12, P567, DOI [10.1586/ERA.12.13, 10.1586/era.12.13]; Mena AC, 2010, ANTI-CANCER DRUG, V21, pS3, DOI 10.1097/01.cad.0000361534.44052.c5; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Glunde K, 2009, NMR BIOMED, V22, P92, DOI 10.1002/nbm.1269; Goel S, 2012, P NATL ACAD SCI USA, V109, pE1214, DOI 10.1073/pnas.1203794109; Imoukhuede PI, 2014, CANCER MED-US, V3, P225, DOI 10.1002/cam4.188; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Karagiannis ED, 2008, P NATL ACAD SCI USA, V105, P13775, DOI 10.1073/pnas.0803241105; Karagiannis ED, 2007, BIOCHEM BIOPH RES CO, V354, P434, DOI 10.1016/j.bbrc.2006.12.231; Koskimaki JE, 2009, NEOPLASIA, V11, P1285, DOI 10.1593/neo.09620; Koskimaki JE, BMC CANC, V10, P29; Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282; Manegold C, 2012, INVEST NEW DRUGS; Montenegro CF, 2012, BIOCHIMIE, V94, P1812, DOI 10.1016/j.biochi.2012.04.020; Nabors LB, 2010, ARCH NEUROL-CHICAGO, V67, P313, DOI 10.1001/archneurol.2010.16; OGAN MD, 1987, INVEST RADIOL, V22, P665, DOI 10.1097/00004424-198708000-00008; Pathak AP, 2010, ADV GENET, V69, P1, DOI 10.1016/S0065-2660(10)69010-4; Pathak AP, 2008, ANGIOGENESIS, V11, P321, DOI 10.1007/s10456-008-9119-z; Preusser M, 2012, ONCOLOGIST, V17, pE13, DOI 10.1634/theoncologist.2012-0115; Raatschen HJ, 2008, RADIOLOGY, V247, P391, DOI 10.1148/radiol.2472070363; Rivera CG, 2011, J MED CHEM, V54, P6492, DOI 10.1021/jm200114f; Rosca EV, 2012, CHEM BIOL DRUG DES, V80, P27, DOI 10.1111/j.1747-0285.2012.01376.x; Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101; Rose S, 2011, CANCER DISCOV, V1, DOI 10.1158/2159-8290.CD-ND112311OL-08; Shojaei F, 2012, CANCER LETT, V320, P130, DOI 10.1016/j.canlet.2012.03.008; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; van der Veldt AAM, 2012, NEW ENGL J MED, V366, P1637, DOI 10.1056/NEJMc1202229; West XZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031071	33	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2014	9	11							e111901	10.1371/journal.pone.0111901	http://dx.doi.org/10.1371/journal.pone.0111901			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT3DP	25384034	Green Published, Green Submitted, gold			2022-12-26	WOS:000344816700023
J	Couceiro, JR; Gallardo, R; De Smet, F; De Baets, G; Baatsen, P; Annaert, W; Roose, K; Saelens, X; Schymkowitz, J; Rousseau, F				Couceiro, Jose R.; Gallardo, Rodrigo; De Smet, Frederik; De Baets, Greet; Baatsen, Pieter; Annaert, Wim; Roose, Kenny; Saelens, Xavier; Schymkowitz, Joost; Rousseau, Frederic			Sequence-dependent Internalization of Aggregating Peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aggresome; Amyloid; Molecular Chaperone; Peptide Transport; Protein Aggregation; Internalization; Peptide; Prionoid	EXTRACELLULAR ALPHA-SYNUCLEIN; AMYLOID-BETA-PROTEIN; NEURONAL CELL-DEATH; HEAT-SHOCK PROTEINS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; INTRACELLULAR ACCUMULATION; MICROGLIAL ACTIVATION; SCAVENGER RECEPTOR; HEPARAN-SULFATE	Background: Prionoid propagation requires cell internalization of aggregated polypeptides. Results: Aggregates of different sequence are internalized through different endocytic pathways. Only phagocytosed aggregates (>1 m) elicit an HSF1-dependent proteostatic response. Conclusion: Proteostatic response upon aggregate internalization differs markedly depending on the sequence. Significance: The characterization of mechanisms of cell penetration is fundamental for the understanding of aggregate transmission in disease. Recently, a number of aggregation disease polypeptides have been shown to spread from cell to cell, thereby displaying prionoid behavior. Studying aggregate internalization, however, is often hampered by the complex kinetics of the aggregation process, resulting in the concomitant uptake of aggregates of different sizes by competing mechanisms, which makes it difficult to isolate pathway-specific responses to aggregates. We designed synthetic aggregating peptides bearing different aggregation propensities with the aim of producing modes of uptake that are sufficiently distinct to differentially analyze the cellular response to internalization. We found that small acidic aggregates (500 nm in diameter) were taken up by nonspecific endocytosis as part of the fluid phase and traveled through the endosomal compartment to lysosomes. By contrast, bigger basic aggregates (>1 m) were taken up through a mechanism dependent on cytoskeletal reorganization and membrane remodeling with the morphological hallmarks of phagocytosis. Importantly, the properties of these aggregates determined not only the mechanism of internalization but also the involvement of the proteostatic machinery (the assembly of interconnected networks that control the biogenesis, folding, trafficking, and degradation of proteins) in the process; whereas the internalization of small acidic aggregates is HSF1-independent, the uptake of larger basic aggregates was HSF1-dependent, requiring Hsp70. Our results show that the biophysical properties of aggregates determine both their mechanism of internalization and proteostatic response. It remains to be seen whether these differences in cellular response contribute to the particular role of specific aggregated proteins in disease.	[Couceiro, Jose R.; Gallardo, Rodrigo; De Smet, Frederik; De Baets, Greet; Schymkowitz, Joost; Rousseau, Frederic] VIB, SWITCH Lab, Leuven, Belgium; [Baatsen, Pieter] Katholieke Univ Leuven, Leuven Ctr Human Genet, Electron Microscopy Facil EMoNe, B-3000 Louvain, Belgium; [Annaert, Wim] VIB Ctr Biol Dis, Lab Membrane Trafficking, B-3000 Louvain, Belgium; [Annaert, Wim] VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Roose, Kenny; Saelens, Xavier] VIB Inflammat Res Ctr, B-9052 Ghent, Belgium; [Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Ghent University	Rousseau, F (corresponding author), SWITCH Lab, Dept Cellular & Mol Med, Gasthuisberg Campus O&N1,Herestr 49 Bus, B-3000 Leuven, Belgium.	frederic.rousseau@switch.vib-kuleuven.be	Rousseau, Frederic/J-9044-2016; De Smet, Frederik/Q-7808-2016; De Baets, Greet/J-1881-2014; Saelens, Xavier/N-5728-2015; Rodríguez Couceiro, Jose/F-1497-2016; Schymkowitz, Joost/AAV-3680-2021; Bustelo, Xose R./A-9526-2010; Schymkowitz, Joost/K-7764-2016	Rousseau, Frederic/0000-0002-9189-7399; De Smet, Frederik/0000-0002-6669-3335; De Baets, Greet/0000-0001-8844-800X; Rodríguez Couceiro, Jose/0000-0002-5742-1071; Bustelo, Xose R./0000-0001-9398-6072; , Xavier/0000-0002-3861-6965; Gallardo, Rodrigo/0000-0003-1584-3564; Schymkowitz, Joost/0000-0003-2020-0168	VIB, University of Leuven [GOA/11/009]; Funds for Scientific Research Flanders (FWO); Flanders Institute for Science and Technology (IWT); Federal Office for Scientific Affairs of Belgium (Belspo) Grant [IUAP P7/16]; Hercules Foundation [AKUL/09/037, AKUL/11/30]	VIB, University of Leuven; Funds for Scientific Research Flanders (FWO)(FWO); Flanders Institute for Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Federal Office for Scientific Affairs of Belgium (Belspo) Grant; Hercules Foundation	This work was supported in part by VIB, University of Leuven, Grant GOA/11/009 (to W. A.), the Funds for Scientific Research Flanders (FWO), the Flanders Institute for Science and Technology (IWT), Federal Office for Scientific Affairs of Belgium (Belspo) Grant IUAP P7/16, and Hercules Foundation Grants AKUL/09/037 and AKUL/11/30.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Avrahami D, 2008, J NEUROSCI RES, V86, P2753, DOI 10.1002/jnr.21720; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cortese K, 2013, MOL BIOL CELL, V24, P129, DOI 10.1091/mbc.E12-04-0282; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gehrmann M, 2005, CELL DEATH DIFFER, V12, P38, DOI 10.1038/sj.cdd.4401510; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Hofmann JP, 2013, P NATL ACAD SCI USA, V110, P5951, DOI 10.1073/pnas.1217321110; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kanekiyo T, 2011, J NEUROSCI, V31, P1644, DOI 10.1523/JNEUROSCI.5491-10.2011; Kfoury N, 2012, J BIOL CHEM, V287, P19440, DOI 10.1074/jbc.M112.346072; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lamark Trond, 2012, Int J Cell Biol, V2012, P736905, DOI 10.1155/2012/736905; Laramie JM, 2008, SHOCK, V29, P623, DOI 10.1097/SHK.0b013e318157f33c; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Luo K, 2010, BIOCHEM BIOPH RES CO, V394, P493, DOI 10.1016/j.bbrc.2010.02.159; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Magenau A, 2011, TRAFFIC, V12, P1730, DOI 10.1111/j.1600-0854.2011.01272.x; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nagao G, 2010, ANTICANCER RES, V30, P3167; Nakamura K, 2006, J NEUROSCI RES, V84, P874, DOI 10.1002/jnr.20992; Novoselova TV, 2005, J NEUROCHEM, V94, P597, DOI 10.1111/j.1471-4159.2005.03119.x; Omtri RS, 2012, MOL PHARMACEUT, V9, P1887, DOI 10.1021/mp200530q; Otsuka A, 2009, BIOCHEM BIOPH RES CO, V378, P478, DOI 10.1016/j.bbrc.2008.11.066; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Park JY, 2009, J NEUROCHEM, V110, P400, DOI 10.1111/j.1471-4159.2009.06150.x; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Singh TD, 2010, FEBS LETT, V584, P3936, DOI 10.1016/j.febslet.2010.08.050; Song M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-92; Soura V, 2012, BIOCHEM J, V441, P579, DOI 10.1042/BJ20110749; Sousa R, 2006, TRAFFIC, V7, P1596, DOI 10.1111/j.1600-0854.2006.00497.x; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Trevino RS, 2012, J BIOL CHEM, V287, P29722, DOI 10.1074/jbc.M112.372474; Trinklein ND, 2004, MOL BIOL CELL, V15, P1254, DOI 10.1091/mbc.E03-10-0738; Vega VL, 2008, J IMMUNOL, V180, P4299, DOI 10.4049/jimmunol.180.6.4299; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Wang RB, 2006, J SURG RES, V136, P58, DOI 10.1016/j.jss.2006.06.003; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yerbury JJ, 2010, CELL STRESS CHAPERON, V15, P115, DOI 10.1007/s12192-009-0122-0	72	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 2	2015	290	1					242	258		10.1074/jbc.M114.586636	http://dx.doi.org/10.1074/jbc.M114.586636			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX9OG	25391649	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000347231200023
J	Fuentes, E; Pereira, J; Mezzano, D; Alarcon, M; Caballero, J; Palomo, I				Fuentes, Eduardo; Pereira, Jaime; Mezzano, Diego; Alarcon, Marcelo; Caballero, Julio; Palomo, Ivan			Inhibition of Platelet Activation and Thrombus Formation by Adenosine and Inosine: Studies on Their Relative Contribution and Molecular Modeling	PLOS ONE			English	Article							P-SELECTIN EXPRESSION; CD40 LIGAND; CARDIOVASCULAR RISK; RECEPTOR; AGGREGATION; AGENTS; BLOOD; CAMP; INTERVENTION; MECHANISMS	Background: The inhibitory effect of adenosine on platelet aggregation is abrogated after the addition of adenosine-deaminase. Inosine is a naturally occurring nucleoside degraded from adenosine. Objectives: The mechanisms of antiplatelet action of adenosine and inosine in vitro and in vivo, and their differential biological effects by molecular modeling were investigated. Results: Adenosine (0.5, 1 and 2 mmol/L) inhibited phosphatidylserine exposure from 52 +/- 4% in the control group to 44 +/- 4 (p<0.05), 29 +/- 2 (p<0.01) and 20 +/- 3% (p<0.001). P-selectin expression in the presence of adenosine 0.5, 1 and 2 mmol/L was inhibited from 32 +/- 4 to 27 +/- 2 (p<0.05), 14 +/- 3 (p<0.01) and 9 +/- 3% (p<0.001), respectively. At the concentrations tested, only inosine to 4 mmol/L had effect on platelet P-selectin expression (p<0.05). Adenosine and inosine inhibited platelet aggregation and ATP release stimulated by ADP and collagen. Adenosine and inosine reduced collagen-induced platelet adhesion and aggregate formation under flow. At the same concentrations adenosine inhibited platelet aggregation, decreased the levels of sCD40L and increased intraplatelet cAMP. In addition, SQ22536 (an adenylate cyclase inhibitor) and ZM241385 (a potent adenosine receptor A(2A) antagonist) attenuated the effect of adenosine on platelet aggregation induced by ADP and intraplatelet level of cAMP. Adenosine and inosine significantly inhibited thrombosis formation in vivo (6262% occlusion at 60 min [n = 6, p<0.01] and 7261.9% occlusion at 60 min, [n = 6, p<0.05], respectively) compared with the control (9862% occlusion at 60 min, n = 6). A(2A) is the adenosine receptor present in platelets; it is known that inosine is not an A(2A) ligand. Docking of adenosine and inosine inside A(2A) showed that the main difference is the formation by adenosine of an additional hydrogen bond between the NH2 of the adenine group and the residues Asn253 in H6 and Glu169 in EL2 of the A(2A) receptor. Conclusion: Therefore, adenosine and inosine may represent novel agents lowering the risk of arterial thrombosis.	[Fuentes, Eduardo; Alarcon, Marcelo; Palomo, Ivan] Univ Talca, Dept Clin Biochem & Immunohematol, Fac Hlth Sci, Interdisciplinary Excellence Res Program Hlth Agi, Talca, Chile; [Fuentes, Eduardo; Alarcon, Marcelo; Palomo, Ivan] CONICYT Reg, CEAP, Gore Maule, Talca, Chile; [Pereira, Jaime; Mezzano, Diego] Pontificia Univ Catolica Chile, Sch Med, Dept Hematol Oncol, Santiago, Chile; [Caballero, Julio] Univ Talca, Fac Engn Bioinformat, Ctr Bioinformat & Mol Simulat, Talca, Chile	Universidad de Talca; Pontificia Universidad Catolica de Chile; Universidad de Talca	Fuentes, E (corresponding author), Univ Talca, Dept Clin Biochem & Immunohematol, Fac Hlth Sci, Interdisciplinary Excellence Res Program Hlth Agi, Talca, Chile.	edfuentes@utalca.cl; ipalomo@utalca.cl	Palomo, Iván/I-4321-2018; Caballero, Julio/G-3654-2014; Alarcon, Marcelo A/I-5016-2018	Caballero, Julio/0000-0003-0182-1444; Alarcon, Marcelo A/0000-0001-7596-5382; Fuentes Quinteros, Eduardo/0000-0003-0099-4108; Palomo, Ivan/0000-0002-9618-8778	CONICYT REGIONAL / GORE MAULE / CEAP [R09I2001]; Interdisciplinary Excellence Research Program on Healthy Aging (PIEI-ES); Fondecyt, Chile [1130216]	CONICYT REGIONAL / GORE MAULE / CEAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CEAP); Interdisciplinary Excellence Research Program on Healthy Aging (PIEI-ES); Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was funded by the CONICYT REGIONAL / GORE MAULE / CEAP / R09I2001, Interdisciplinary Excellence Research Program on Healthy Aging (PIEI-ES), and supported by grant no. 1130216 (I. P., M. G., R. M., M. A., J. C.) from Fondecyt, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTMAN R, 1985, THROMB HAEMOSTASIS, V53, P312; Anfossi G, 2002, THROMB RES, V105, P71, DOI 10.1016/S0049-3848(01)00412-1; Antczak AJ, 2010, CELL IMMUNOL, V263, P129, DOI 10.1016/j.cellimm.2010.03.009; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; Barrett NE, 2008, BRIT J PHARMACOL, V154, P918, DOI 10.1038/bjp.2008.151; Bautista LE, 2006, EUR J CARDIOV PREV R, V13, P769, DOI 10.1097/01.hjr.0000219113.40662.dd; BORN GVR, 1963, J PHYSIOL-LONDON, V168, P178, DOI 10.1113/jphysiol.1963.sp007185; Burger PC, 2003, BLOOD, V101, P2661, DOI 10.1182/blood-2002-07-2209; Chakhtoura EY, 2000, AM J CARDIOL, V86, P835, DOI 10.1016/S0002-9149(00)01102-4; Collins B, 2003, NAT REV DRUG DISCOV, V2, P11, DOI 10.1038/nrd966; Conant CG, 2009, J VIS EXP; Cristalli G, 2001, MED RES REV, V21, P105, DOI 10.1002/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO;2-U; Daniel JL, 1999, THROMB HAEMOSTASIS, V82, P1322; Dutta-Roy AK, 2001, PLATELETS, V12, P218, DOI 10.1080/09537100120058757; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; Enomoto Y, 2011, INT J MOL MED, V27, P695, DOI 10.3892/ijmm.2011.637; Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fuentes E, 2012, EVID-BASED COMPL ALT, V2012, P1; Fuentes E, 2014, THROMB HAEMOSTASIS, V111, P491, DOI 10.1160/TH13-05-0386; Fuentes E, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/147031; Fuentes E, 2013, PLATELETS, V24, P255, DOI 10.3109/09537104.2012.690113; Fukuoka T, 2012, J THROMB THROMBOLYS, V34, P193, DOI 10.1007/s11239-012-0703-0; Galliera E, 2012, J Biol Regul Homeost Agents, V26, p35S; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; Harding SA, 2004, ATHEROSCLEROSIS, V176, P321, DOI 10.1016/j.atherosclerosis.2004.05.008; Hasko G, 2004, TRENDS PHARMACOL SCI, V25, P152, DOI 10.1016/j.tips.2004.01.006; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; HOFFMEISTER HM, 1987, CARDIOVASC RES, V21, P65, DOI 10.1093/cvr/21.1.65; Hsiao G, 2005, ARTERIOSCL THROM VAS, V25, P1998, DOI 10.1161/01.ATV.0000174798.25085.d6; Inoue O, 2003, J CELL BIOL, V160, P769, DOI 10.1083/jcb.200208043; Ji XB, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-44; Johnston-Cox HA, 2011, PURINERG SIGNAL, V7, P357, DOI 10.1007/s11302-011-9220-4; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kim JH, 1996, MOL PHARMACOL, V49, P683; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; LEREA KM, 1987, J BIOL CHEM, V262, P282; LEREA KM, 1987, P NATL ACAD SCI USA, V84, P5620, DOI 10.1073/pnas.84.16.5620; Libersan D, 2003, THROMB HAEMOSTASIS, V89, P310, DOI 10.1055/s-0037-1613448; Loyau S, 2012, ARTERIOSCL THROM VAS, V32, P778, DOI 10.1161/ATVBAHA.111.241067; Minamino T, 1998, J CLIN INVEST, V101, P1643, DOI 10.1172/JCI635; Mujica V, 2010, J AM SOC HYPERTENS, V4, P148, DOI 10.1016/j.jash.2010.02.008; Munoz C, 2012, J MOL GRAPH MODEL, V32, P39, DOI 10.1016/j.jmgm.2011.10.005; Palomo Ivan, 2010, Front Biosci (Schol Ed), V2, P194; Palomo I, 2008, MOL MED REP, V1, P179; Palomo I, 2007, REV MED CHILE, V135, P904; Patrono C, 2008, CHEST, V133, p199S, DOI 10.1378/chest.08-0672; Przyklenk K, 2007, LASER MED SCI, V22, P42, DOI 10.1007/s10103-006-0410-1; Ritchie JL, 2000, CLIN LAB HAEMATOL, V22, P359, DOI 10.1046/j.1365-2257.2000.00339.x; Ruggeri ZM, 1997, THROMB HAEMOSTASIS, V78, P611; SAGEL J, 1975, ANN INTERN MED, V82, P733, DOI 10.7326/0003-4819-82-6-733; Setianto BY, 2010, HEART VESSELS, V25, P282, DOI 10.1007/s00380-009-1199-1; Storey RF, 2002, THROMB HAEMOSTASIS, V88, P488; Tantry US, 2006, FUTUR CARDIOL, V2, P343, DOI 10.2217/14796678.2.3.343; Wagner DD, 2003, ARTERIOSCL THROM VAS, V23, P2131, DOI 10.1161/01.ATV.0000095974.95122.EC; Wang J, 2008, J SEP SCI, V31, P1173, DOI 10.1002/jssc.200700507; Willoughby Scott, 2002, Eur J Cardiovasc Nurs, V1, P273; Yang D, 2010, J THROMB HAEMOST, V8, P817, DOI 10.1111/j.1538-7836.2010.03769.x; Zhao ZH, 2000, BBA-MOL BASIS DIS, V1500, P280, DOI 10.1016/S0925-4439(99)00111-8	62	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112741	10.1371/journal.pone.0112741	http://dx.doi.org/10.1371/journal.pone.0112741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393959	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300092
J	Gorokhova, E; Hajdu, S; Larsson, U				Gorokhova, Elena; Hajdu, Susanna; Larsson, Ulf			Responses of Phyto- and Zooplankton Communities to Prymnesium polylepis (Prymnesiales) Bloom in the Baltic Sea	PLOS ONE			English	Article							CHRYSOCHROMULINA-POLYLEPIS; PRYMNESIOPHYCEAE; GROWTH; TOXICITY; HAPTOPHYTA; PARVUM; PROPER; RNA; DYNAMICS; COPEPODS	A large bloom of Prymnesium polylepis occurred in the Baltic Sea during the winter 2007 - spring 2008. Based on numerous reports of strong allelopathic effects on phytoplankton exerted by P. polylepis and its toxicity to grazers, we hypothesized that during this period negative correlations will be observed between P. polylepis and (1) main phytoplankton groups contributing to the spring bloom (i.e., diatoms and dinoflagellates), and (2) zooplankton growth and abundance. To test these hypotheses, we analyzed inter-annual variability in phytoplankton and zooplankton dynamics as well as growth indices (RNA: DNA ratio) in dominant zooplankton in relation to the Prymnesium abundance and biomass. Contrary to the hypothesized relationships, no measurable negative responses to P. polylepis were observed for either the total phytoplankton stocks or the zooplankton community. The only negative response, possibly associated with P. polylepis occurrence, was significantly lower abundance of dinoflagellates both during and after the bloom in 2008. Moreover, contrary to the expected negative effects, there were significantly higher total phytoplankton abundance as well as significantly higher winter abundance and winter-spring RNA: DNA ratio in dominant zooplankton species in 2008, indicating that P. polylepis bloom coincided with favourable feeding conditions for zooplankton. Thus, primary consumers, and consequently also zooplanktivores (e.g., larval fish and mysids), may benefit from haptophyte blooms, particularly in winter, when phytoplankton is scarce.	[Gorokhova, Elena; Hajdu, Susanna; Larsson, Ulf] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Gorokhova, Elena] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University	Gorokhova, E (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	elena.gorokhova@itm.su.se	Gorokhova, Elena/E-7105-2018	Gorokhova, Elena/0000-0002-4192-6956	Swedish EPA's National Marine Monitoring Program; SYVAB's marine monitoring program in Himmerfjarden; Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management	Swedish EPA's National Marine Monitoring Program; SYVAB's marine monitoring program in Himmerfjarden; Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management	Financial support was received from The Swedish EPA's National Marine Monitoring Program (UL, EG), SYVAB's marine monitoring program in Himmerfjarden (UL), and Stockholm University's strategic marine environmental research program Baltic Ecosystem Adaptive Management (EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro A, 2005, AQUAT MICROB ECOL, V38, P259, DOI 10.3354/ame038259; CARLSSON P, 1990, TOXIC MARINE PHYTOPLANKTON, P116; Dahl E, 2005, J SEA RES, V54, P15, DOI 10.1016/j.seares.2005.02.004; Dahl E, 1989, COASTAL ESTUARINE ST, V35, P383; EDVARDSEN B, 1992, J PHYCOL, V28, P104, DOI 10.1111/j.0022-3646.1992.00104.x; EDVARDSEN B, 1990, TOXIC MARINE PHYTOPLANKTON, P284; Edvardsen B., 1998, PHYSL ECOLOGY HARMFU, P193; EDVARDSEN B, 1996, THESIS U OSLO; EDVARDSEN B., 1996, HARMFUL TOXIC ALGAL, P231; Edvardsen B, 2011, EUR J PHYCOL, V46, P202, DOI 10.1080/09670262.2011.594095; Errera RM, 2008, AQUAT MICROB ECOL, V52, P33, DOI 10.3354/ame01199; Gjosaeter J, 2000, MAR ECOL PROG SER, V207, P201, DOI 10.3354/meps207201; Gorokhova E, 2005, LIMNOL OCEANOGR-METH, V3, P143, DOI 10.4319/lom.2005.3.143; Gorokhova E, 2002, J PLANKTON RES, V24, P511, DOI 10.1093/plankt/24.5.511; Gorokhova E, 2007, MAR ECOL PROG SER, V349, P213, DOI 10.3354/meps07100; GRANELI E, 1993, DEV MAR BIO, V3, P23; Graneli E, 2012, HARMFUL ALGAE, V14, P260, DOI 10.1016/j.hal.2011.10.024; Graneli E, 2010, J AM WATER RESOUR AS, V46, P108, DOI 10.1111/j.1752-1688.2009.00395.x; GRANMO A, 1988, J EXP MAR BIOL ECOL, V124, P65, DOI 10.1016/0022-0981(88)90206-7; Hajdu S, 1996, BOT MAR, V39, P281, DOI 10.1515/botm.1996.39.1-6.281; HANSEN PJ, 1995, PHYCOLOGIA, V34, P409, DOI 10.2216/i0031-8884-34-5-409.1; HELCOM, 1988, BALT SEA ENV P D; Hernroth L., 1985, MESOZOOPLANKTON BIOM, V10; Hook TO, 2008, ESTUAR COAST SHELF S, V76, P29, DOI 10.1016/j.ecss.2007.06.012; Hogfors H, 2011, J PLANKTON RES, V33, P1460, DOI 10.1093/plankt/fbr043; Hoglander H, 2004, MAR ECOL PROG SER, V283, P15, DOI 10.3354/meps283015; Holmborn T, 2009, LIMNOL OCEANOGR-METH, V7, P785, DOI 10.4319/lom.2009.7.785; Houdan A, 2004, J PLANKTON RES, V26, P875, DOI 10.1093/plankt/fbh079; Johansson M, 2004, J PLANKTON RES, V26, P67, DOI 10.1093/plankt/fbg115; Johansson N, 1999, MAR BIOL, V135, P209, DOI 10.1007/s002270050618; John Uwe, 2002, Harmful Algae, V1, P45, DOI 10.1016/S1568-9883(02)00005-7; Jones Harriet L.J., 1994, Systematics Association Special Volume Series, V51, P247; JONES HLJ, 1995, PHYCOLOGIA, V34, P128, DOI 10.2216/i0031-8884-34-2-128.1; JONES HLJ, 1993, J MAR BIOL ASSOC UK, V73, P283, DOI 10.1017/S0025315400032859; Jorgensen L, 2014, BIOGEOCHEMISTRY, V117, P455, DOI 10.1007/s10533-013-9890-9; Kott P., 1953, AUST J MAR FRESHW RE, V4, P387; Larsson K, 2014, J SEA RES, V88, P21, DOI 10.1016/j.seares.2013.12.017; Leivestad H, 1988, 8803 BKO NORV I MAR; Lindehoff E, 2011, HARMFUL ALGAE, V12, P70, DOI 10.1016/j.hal.2011.09.001; Majaneva M, 2012, EUR J PHYCOL, V47, P310, DOI 10.1080/09670262.2012.713997; Moestrup Ojvind, 1994, Systematics Association Special Volume Series, V51, P265; Myklestad Sverre M., 1995, P633; Nejstgaard JC, 1996, SARSIA, V81, P339, DOI 10.1080/00364827.1996.10413631; NIELSEN TG, 1990, MAR ECOL PROG SER, V62, P21, DOI 10.3354/meps062021; Ning J, 2013, DEEP-SEA RES PT II, V97, P109, DOI 10.1016/j.dsr2.2013.05.019; Olenina I, 2006, HELCOM BALTIC SEA EN; Ptacnik R, 2004, LIMNOL OCEANOGR, V49, P1435, DOI 10.4319/lo.2004.49.4_part_2.1435; ROSENBERG R, 1988, AMBIO, V17, P289; Savage C, 2004, ECOL APPL, V14, P517, DOI 10.1890/02-5396; Schmidt LE, 2001, MAR ECOL PROG SER, V216, P67, DOI 10.3354/meps216067; TOBIESEN A, 1991, OPHELIA, V33, P205, DOI 10.1080/00785326.1991.10429711; Unrein F, 2014, ISME J, V8, P164, DOI 10.1038/ismej.2013.132; Vehmaa A, 2012, ICES J MAR SCI, V69, P351, DOI 10.1093/icesjms/fsr138; YASUMOTO T, 1990, TOXIC MARINE PHYTOPLANKTON, P436; [No title captured]	55	7	7	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112985	10.1371/journal.pone.0112985	http://dx.doi.org/10.1371/journal.pone.0112985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393031	Green Published, Green Submitted, gold			2022-12-26	WOS:000347709300133
J	Noulin, F; Manesia, JK; Rosanas-Urgell, A; Erhart, A; Borlon, C; Van Den Abbeele, J; d'Alessandro, U; Verfaillie, CM				Noulin, Florian; Manesia, Javed Karim; Rosanas-Urgell, Anna; Erhart, Annette; Borlon, Celine; Van Den Abbeele, Jan; d'Alessandro, Umberto; Verfaillie, Catherine M.			Hematopoietic Stem/Progenitor Cell Sources to Generate Reticulocytes for Plasmodium vivax Culture	PLOS ONE			English	Article							RED-BLOOD-CELLS; IN-VITRO CULTURE; STEM-CELLS; BONE-MARROW; CORD-BLOOD; PERIPHERAL-BLOOD; MALARIA; INFECTION; INVASION	The predilection of Plasmodium vivax (P. vivax) for reticulocytes is a major obstacle for its establishment in a long-term culture system, as this requires a continuous supply of large quantities of reticulocytes, representing only 1-2% of circulating red blood cells. We here compared the production of reticulocytes using an established in vitro culture system from three different sources of hematopoietic stem/ progenitor cells (HSPC), i.e. umbilical cord blood (UCB), bone marrow (BM) and adult peripheral blood (PB). Compared to CD34(+)-enriched populations of PB and BM, CD34(+)-enriched populations of UCB produced the highest amount of reticulocytes that could be invaded by P. vivax. In addition, when CD34(+)-enriched cells were first expanded, a further extensive increase in reticulocytes was seen for UCB, to a lesser degree BM but not PB. As invasion by P. vivax was significantly better in reticulocytes generated in vitro, we also suggest that P. vivax may have a preference for invading immature reticulocytes, which should be confirmed in future studies.	[Noulin, Florian; Rosanas-Urgell, Anna; Erhart, Annette; Borlon, Celine] Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium; [Manesia, Javed Karim; Verfaillie, Catherine M.] Stem Cell Inst, Dept Dev & regenerat, Leuven, Belgium; [Van Den Abbeele, Jan] Inst Trop Med, Unit Vet Protozool, B-2000 Antwerp, Belgium; [d'Alessandro, Umberto] MRC Unit, Fajara, Gambia	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM); University of London; London School of Hygiene & Tropical Medicine	Noulin, F (corresponding author), Inst Trop Med, Unit Malariol, B-2000 Antwerp, Belgium.	flo_noulin@hotmail.com	Rosanas-Urgell, Anna/D-3193-2015; D'Alessandro, Umberto/D-3457-2015; noulin, florian/J-3809-2013; Verfaillie, Catherine/H-5148-2013	Rosanas-Urgell, Anna/0000-0002-0432-5203; D'Alessandro, Umberto/0000-0001-6341-5009; noulin, florian/0000-0001-7430-8073; Van Den Abbeele, Jan/0000-0002-4533-4480; Verfaillie, Catherine/0000-0001-7564-4079	ITM Secondary Research Funding (SOFI-B)	ITM Secondary Research Funding (SOFI-B)	The funding was provided by ITM Secondary Research Funding (SOFI-B), http://www.itg.be/itgtool_v2/Projecten/Project.asp?PNr=755023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER JG, 1994, CLIN IMMUNOL IMMUNOP, V70, P10, DOI 10.1006/clin.1994.1003; Borlon C, 2012, INT J PARASITOL, V42, P155, DOI 10.1016/j.ijpara.2011.10.011; Douay L, 2007, TRANSFUS MED REV, V21, P91, DOI 10.1016/j.tmrv.2006.11.004; Fernandez-Becerra C, 2013, MEM I OSWALDO CRUZ, V108, P801, DOI 10.1590/0074-0276108062013019; Furuya T, 2014, PARASITOL INT, V63, P278, DOI 10.1016/j.parint.2013.11.011; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Golenda CF, 1997, P NATL ACAD SCI USA, V94, P6786, DOI 10.1073/pnas.94.13.6786; Martin-Jaular L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-434; Moreno-Perez DA, 2013, BIOL CELL, V105, P251, DOI 10.1111/boc.201200093; Noulin F, 2013, TRENDS PARASITOL, V29, P286, DOI 10.1016/j.pt.2013.03.012; Noulin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040798; PATERAKIS GS, 1993, ACTA HAEMATOL-BASEL, V90, P182; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Russell B, 2011, BLOOD, V118, pE74, DOI 10.1182/blood-2011-04-348748; Steidl U, 2002, BLOOD, V99, P2037, DOI 10.1182/blood.V99.6.2037; Tasanee P, 2007, INT J PARASITOL, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009	16	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112496	10.1371/journal.pone.0112496	http://dx.doi.org/10.1371/journal.pone.0112496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393299	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300061
J	Vidal, NM; Grazziotin, AL; Ramos, HCC; Pereira, MG; Venancio, TM				Vidal, Newton Medeiros; Grazziotin, Ana Laura; Cancela Ramos, Helaine Christine; Pereira, Messias Gonzaga; Venancio, Thiago Motta			Development of a Gene-Centered SSR Atlas as a Resource for Papaya (Carica papaya) Marker-Assisted Selection and Population Genetic Studies	PLOS ONE			English	Article							NONCODING MICROSATELLITES; CANDIDATE GENES; TANDEM REPEATS; DNA; RESISTANCE; ETHYLENE; PLANTS; AUXIN; RICE	Carica papaya (papaya) is an economically important tropical fruit. Molecular marker-assisted selection is an inexpensive and reliable tool that has been widely used to improve fruit quality traits and resistance against diseases. In the present study we report the development and validation of an atlas of papaya simple sequence repeat (SSR) markers. We integrated gene predictions and functional annotations to provide a gene-centered perspective for marker-assisted selection studies. Our atlas comprises 160,318 SSRs, from which 21,231 were located in genic regions (i.e. inside exons, exon-intron junctions or introns). A total of 116,453 (72.6%) of all identified repeats were successfully mapped to one of the nine papaya linkage groups. Primer pairs were designed for markers from 9,594 genes (34.5% of the papaya gene complement). Using papaya-tomato orthology assessments, we assembled a list of 300 genes (comprising 785 SSRs) potentially involved in fruit ripening. We validated our atlas by screening 73 SSR markers (including 25 fruit ripening genes), achieving 100% amplification rate and uncovering 26% polymorphism rate between the parental genotypes (Sekati and JS12). The SSR atlas presented here is the first comprehensive gene-centered collection of annotated and genome positioned papaya SSRs. These features combined with thousands of high-quality primer pairs make the atlas an important resource for the papaya research community.	[Vidal, Newton Medeiros; Grazziotin, Ana Laura; Venancio, Thiago Motta] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil; [Cancela Ramos, Helaine Christine; Pereira, Messias Gonzaga] Univ Estadual Norte Fluminense, Ctr Ciencias & Tecnol Agr, Lab Melhoramento Genet Vegetal, Rio De Janeiro, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Vidal, NM (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Campos Goytacazes, Bethesda, MD 20894 USA.	nwvidal@gmail.com; thiago.venancio@gmail.com	Pereira, Messias/AAS-4261-2020; Pereira, Messias G/G-4782-2015; Venancio, Thiago M/B-5003-2011	Pereira, Messias/0000-0002-3463-3768; Venancio, Thiago M/0000-0002-2215-8082; Cancela Ramos, Helaine Christine/0000-0002-0098-1027	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Instituto Nacional de Ciencia e Tecnologia - Entomologia Molecular (INCT-EM); Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ) [PENSARIO E-26/110.720/2012]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Instituto Nacional de Ciencia e Tecnologia - Entomologia Molecular (INCT-EM); Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Instituto Nacional de Ciencia e Tecnologia - Entomologia Molecular (INCT-EM), Universidade Estadual do Norte Fluminense Darcy Ribeiro (UENF), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro Carlos Chagas Filho (FAPERJ) (PENSARIO E-26/110.720/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombarely A, 2011, NUCLEIC ACIDS RES, V39, pD1149, DOI 10.1093/nar/gkq866; Carrillo E, 2014, PLANT CELL REP, V33, P1133, DOI 10.1007/s00299-014-1603-x; Coulibaly I, 2005, ANIM GENET, V36, P309, DOI 10.1111/j.1365-2052.2005.01305.x; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; Doyle JJ, 1990, FOCUS, V12, P3; Du QZ, 2013, DNA RES, V20, P31, DOI 10.1093/dnares/dss031; Eustice M, 2008, TREE GENET GENOMES, V4, P333, DOI 10.1007/s11295-007-0112-2; Evans E, 2012, OVERVIEW GLOBAL PAPA; Fabi JP, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-242; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; HUBBARD NL, 1990, PLANT PHYSIOL, V94, P201, DOI 10.1104/pp.94.1.201; Jimenez-Coello M, 2013, MOLECULES, V18, P12621, DOI 10.3390/molecules181012621; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kim MS, 2002, GENOME, V45, P503, DOI 10.1139/G02-012; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Leclercq S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-125; Li XP, 2013, PLANT PHYSIOL BIOCH, V70, P81, DOI 10.1016/j.plaphy.2013.05.020; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Lim KG, 2013, BRIEF BIOINFORM, V14, P67, DOI 10.1093/bib/bbs023; Liu SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075149; Ma H, 2004, GENETICS, V166, P419, DOI 10.1534/genetics.166.1.419; Marotta Francesco, 2012, Acta Biomed, V83, P21; Merkel A, 2008, BRIEF BIOINFORM, V9, P355, DOI 10.1093/bib/bbn028; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Parida SK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-140; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Quint M, 2006, CURR OPIN PLANT BIOL, V9, P448, DOI [10.1016/j.pbi.2006.07.006, 10.1104/pp.17.00765]; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITO K, 1978, PLANT PHYSIOL, V62, P215, DOI 10.1104/pp.62.2.215; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Shi JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059988; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; Trainotti L, 2007, J EXP BOT, V58, P3299, DOI 10.1093/jxb/erm178; Tu T, 2013, FOOD CHEM, V141, P2974, DOI 10.1016/j.foodchem.2013.05.132; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Victoria FC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-15; Wang J, 2008, TROPICAL PLANT BIOL, V14; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113603; Xiao L, 2013, THEOR APPL GENET, V126, P2279, DOI 10.1007/s00122-013-2134-5; Yilancioglu K, 2013, GENOME, V56, P295, DOI 10.1139/gen-2012-0175; Young ET, 2000, GENETICS, V154, P1053; Zhang LD, 2006, BMC GENOMICS, V7, DOI [10.1186/1471-2164-7-323, 10.1186/1471-2164-7-153]; Zhou H, 2014, THEORETICAL APPL GEN	46	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112654	10.1371/journal.pone.0112654	http://dx.doi.org/10.1371/journal.pone.0112654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	25393538	Green Published, gold, Green Submitted			2022-12-26	WOS:000347709300079
J	Arora, R; Bhushan, S; Kumar, R; Mannan, R; Kaur, P; Singh, AP; Singh, B; Vig, AP; Sharma, D; Arora, S				Arora, Rohit; Bhushan, Sakshi; Kumar, Rakesh; Mannan, Rahul; Kaur, Pardeep; Singh, Amrit Pal; Singh, Bikram; Vig, Adarsh P.; Sharma, Deepika; Arora, Saroj			Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(alpha) anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; OXIDATIVE STRESS; RAT-LIVER; DMBA; ISOTHIOCYANATES; CANCER; SULFORAPHANE; BINDING; CHEMOPREVENTION; PRODUCTS	The toxicity induced by 7, 12-dimethylbenz(alpha) anthracene (DMBA) has been widely delineated by a number of researchers. This potent chemical damages many internal organs including liver, by inducing the production of reactive oxygen species, DNA-adduct formation and affecting the activities of phase I, II, antioxidant and serum enzymes. Glucosinolate hydrolytic products like isothiocyanates (ITCs) are well known for inhibiting the DNA-adduct formation and modulating phase I, II enzymes. Sulforaphane is ITC, currently under phase trials, is readily metabolized and inter-converted into erucin upon ingestion. We isolated erucin from Eruca sativa (Mill.) Thell. evaluated its hepatoprotective role in DMBA induced toxicity in male wistar rats. The rats were subjected to hepatic damage by five day regular intraperitoneal doses of DMBA. At the end of the protocol, the rats were euthanized, their blood was collected and livers were processed. The liver homogenate was analyzed for phase I (NADPH-cytochrome P450 reductase, NADH-cytochrome b5 reductase, cytochrome P450, cytochrome P420 and cytochrome b5), phase II (DT diaphorase, glutathione-S-transferase and gamma-glutamyl transpeptidase) and antioxidant enzymes (superoxide dismutase, catalase, guaiacol peroxidise, ascorbate peroxidise, glutathione reductase and lactate dehydrogenase). The level of thiobarbituric acid reactive substances, lipid hydroperoxides, conjugated dienes and reduced glutathione in the liver homogenate was also analyzed. The serum was also analyzed for markers indicating hepatic damage (alkaline phosphatase, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, direct bilirubin and total bilirubin). Erucin provided significant protection against DMBA induced damage by modulating the phase I, II and antioxidant enzymes. The histological evaluation of liver tissue was also conducted, which showed the hepatoprotective role of erucin.	[Arora, Rohit; Bhushan, Sakshi; Kumar, Rakesh; Kaur, Pardeep; Vig, Adarsh P.; Arora, Saroj] Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India; [Mannan, Rahul] Sri Guru Ram Inst Med Sci & Res, Amritsar, Punjab, India; [Singh, Amrit Pal] Guru Nanak Dev Univ, Dept Pharmaceut Sci, Amritsar, Punjab, India; [Singh, Bikram; Sharma, Deepika] Inst Himalayan Bioresource & Technol, CSIR, Nat Plant Prod Div, Palampur, Himachal Prades, India	Guru Nanak Dev University; Guru Nanak Dev University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Arora, S (corresponding author), Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India.	sarojarora.gndu@gmail.com	Kumar, Rakesh/ABD-1065-2020; Arora, Saroj/AAV-3682-2021; Kaur, Pardeep/N-7224-2019; Arora, Rohit/AAF-8162-2020; Vig, Adarsh Pal/AAI-1312-2020; Mannan, Rahul/AAQ-2608-2021; Singh, Amrit Pal/ABI-8109-2020	Kumar, Rakesh/0000-0001-7664-0803; Arora, Saroj/0000-0002-4086-5653; Kaur, Pardeep/0000-0001-7350-7839; Vig, Adarsh Pal/0000-0003-1419-2501; Mannan, Rahul/0000-0002-6642-0468; Singh, Amrit Pal/0000-0002-7658-241X; Arora, Rohit/0000-0001-6447-5628; SHARMA, DEEPIKA/0000-0001-7627-6458	Department of Science and Technology (DST) & University Grants Commission (UGC), New Delhi; Guru Nanak Dev University, Amritsar	Department of Science and Technology (DST) & University Grants Commission (UGC), New Delhi; Guru Nanak Dev University, Amritsar	The authors thank financial support of Department of Science and Technology (DST) & University Grants Commission (UGC), New Delhi and Guru Nanak Dev University, Amritsar. Authors are thankful to UPE (under the university with potential for excellence), BSR and CPEPA programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Agca CA, 2012, PHARM BIOL, V50, P1513, DOI 10.3109/13880209.2012.688057; Ahmed HA, 2006, J EGYPT SOC TOXICOL, V35, P97; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Anzenbacherova E, 2008, PHYSIOL RES, V57, P761, DOI 10.33549/physiolres.931319; Arora R, 2014, J FOOD SCI, V79, pC1964, DOI 10.1111/1750-3841.12579; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Blazevic I, 2009, FOOD CHEM, V113, P96, DOI 10.1016/j.foodchem.2008.07.029; Boghori M, 2014, J ORAL BIOL CRANIOFA; Carlberg I, 1975, METHOD ENZYMOL, P484; Chatterjee M, 2010, CHEM-BIOL INTERACT, V188, P102, DOI 10.1016/j.cbi.2010.06.007; Cho HJ, 2013, INT J MOL SCI, V14, P20564, DOI 10.3390/ijms141020564; Choi SJ, 2003, J BIOCHEM MOL BIOL, V36, P332; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Cornblatt BS, 2007, CARCINOGENESIS, V28, P1485, DOI 10.1093/carcin/bgm049; Danson S, 2004, CANCER TREAT REV, V30, P437, DOI 10.1016/j.ctrv.2004.01.002; Devasagayam TPA, 2003, INDIAN J BIOCHEM BIO, V40, P300; Dimitrova-Shumkovska J, 2010, TOXICOL PATHOL, V38, P957, DOI 10.1177/0192623310379137; Ernster, 1967, METHOD ENZYMOL, V10, P309, DOI [DOI 10.1016/0076-6879(67)10059-1, 10.1016/0076-6879(67)10059-1]; Ganin H, 2013, MEDCHEMCOMM, V4, P175, DOI 10.1039/c2md20196h; Gao J, 2005, TOXICOL SCI, V86, P68, DOI 10.1093/toxsci/kfi176; Gnaiger E., 2010, MITO PHYSL NET, V08, P1; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hanlon N, 2009, MOL NUTR FOOD RES, V53, P836, DOI 10.1002/mnfr.200800292; Harmeet Singh, 2011, European Journal of Medicinal Plants, V1, P162; Her JL, 2013, SENSOR ACTUAT B-CHEM, V182, P396, DOI 10.1016/j.snb.2013.03.026; HUBERMAN E, 1979, P NATL ACAD SCI USA, V76, P862, DOI 10.1073/pnas.76.2.862; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Izzotti A, 1999, CANCER RES, V59, P4285; JIANG ZY, 1992, ANAL BIOCHEM, V202, P384, DOI 10.1016/0003-2697(92)90122-N; Kaur R, 2013, FREE RADICAL BIO MED, V65, P131, DOI 10.1016/j.freeradbiomed.2013.06.016; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Kumagai A, 2013, CELL, V153, P1602, DOI 10.1016/j.cell.2013.05.038; Kumar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090083; MORSE MA, 1987, CANCER LETT, V37, P25, DOI 10.1016/0304-3835(87)90142-X; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1970, J BIOCHEM-TOKYO, V67, P249, DOI 10.1093/oxfordjournals.jbchem.a129248; Putter J., 1974, METHODS ENZYMATIC AN, P685, DOI [DOI 10.1016/B978-0-12-091302-2.50033-5, 10.1016/B978-0-12-091302-2.50033-5]; Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010; Rohit Arora, 2014, International Journal of Life Sciences Biotechnology and Pharma Research, V3, P42; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; SCHWARTZ JH, 1963, P NATL ACAD SCI USA, V49, P871, DOI 10.1073/pnas.49.6.871; Strasak AM, 2008, CANCER RES, V68, P3970, DOI 10.1158/0008-5472.CAN-07-6686; Szaefer H, 2014, DRUG CHEM TOXICOL, V37, P472, DOI 10.3109/01480545.2014.893442; SZASZ G, 1976, CLIN CHEM, V22, P2051; Veyrand B, 2013, ENVIRON INT, V54, P11, DOI 10.1016/j.envint.2012.12.011; WONG LK, 1983, APPL ENVIRON MICROB, V46, P1239, DOI 10.1128/AEM.46.5.1239-1242.1983; YANG SK, 1975, P NATL ACAD SCI USA, V72, P2601, DOI 10.1073/pnas.72.7.2601; Yu H, 2005, INT J ENV RES PUB HE, V2, P114; Zhang YS, 2004, MUTAT RES-FUND MOL M, V555, P173, DOI 10.1016/j.mrfmmm.2004.04.017; Zhang YS, 2010, MOL NUTR FOOD RES, V54, P127, DOI 10.1002/mnfr.200900323	52	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112614	10.1371/journal.pone.0112614	http://dx.doi.org/10.1371/journal.pone.0112614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390337	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400109
J	Dang, SN; Yan, H; Zeng, LX; Wang, QL; Li, Q; Xiao, SB; Fan, XJ				Dang, Shaonong; Yan, Hong; Zeng, Lingxia; Wang, Quanli; Li, Qiang; Xiao, Shengbin; Fan, Xiaojing			The Status of Vitamin B12 and Folate among Chinese Women: A Population-Based Cross-Sectional Study in Northwest China	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; FOLIC-ACID; COGNITIVE IMPAIRMENT; TOTAL HOMOCYSTEINE; RISK; PREVALENCE; HEALTH; PREVENTION	Objective: To assess the status of the vitamin B12 and folate of Chinese women living in northwest China. Methods: A population-based cross-sectional study was conducted in 2008 among Chinese women aged 10-49 years living in Shaanxi province of northwest China. A stratified multistage random sampling method was adopted to obtain a sample of 1170 women. The women were interviewed for collection of their background information and their plasma vitamin B12 and folate were measured with the immunoassay method. The status of both vitamins was evaluated and the prevalence of deficiency was estimated. Results: The median value of the women was 214.5 pg/mL for vitamin B12 and 4.6 ng/mL for folate. The urban women had a significantly higher vitamin B12 (254.1 vs. 195.9 pg/mL) but lower folate (4.4 vs. 4.7 ng/mL) than rural women. Total prevalence of deficiency was 45.5% (95% CI: 42.6%similar to 48.4%) for vitamin B12 and 14.7% (95% CI: 12.6%similar to 16.8%) for folate. About 36% of women presented vitamin B12 deficiency alone, 5.2% belonged to folate deficiency alone and 9.5% was combined deficiency in both vitamins. More than 25% of the women were in marginal vitamin B12 status (200-299 pg/mL) and 60% in marginal status of folate (3-6 ng/mL). About 75.2% of rural women with folate deficiency were deficient in vitamin B12 and 46% for urban women. Quantile regression model found decreasing coefficient of folate status across 73 different quantiles of vitamin B12, which indicated that the women with folate deficiency had lower vitamin B12 significantly compared with those with no deficiency. Conclusions: The deficiency of vitamin B12 and folate is still prevalent among the Chinese women in northwest China. Vitamin B12 deficiency could be more serious and the improvement of poor vitamin B12 status should be invoked when practicing the supplementation of folate against the neural tube defects in northwest China.	[Dang, Shaonong; Yan, Hong; Zeng, Lingxia; Wang, Quanli; Li, Qiang; Xiao, Shengbin; Fan, Xiaojing] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian 710049, Shaanxi, Peoples R China.	yanhonge@mail.xjtu.edu.cn	Fan, Xiaojing/W-1806-2018; Shaonong, Dang/J-7421-2019	Fan, Xiaojing/0000-0002-6704-0678; Shaonong, Dang/0000-0002-6980-8169	National Natural Science Foundation of China [81230016]; Science and Technology Research and Development Program of Shaanxi Province, China, Beijing, China [2006K08-G10(3)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research and Development Program of Shaanxi Province, China, Beijing, China	This work was supported by the National Natural Science Foundation of China (Grant No 81230016, http://www.nsfc.gov.cn), Beijing, China, and the Science and Technology Research and Development Program of Shaanxi Province, China (Grant No. 2006K08-G10(3), http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2004, NUTR REV, V62, pS29, DOI 10.1111/j.1753-4887.2004.tb00069.x; Benson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057998; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Clarke R, 2007, AM J CLIN NUTR, V86, P1384, DOI 10.1093/ajcn/86.5.1384; De Steur H, 2010, NAT BIOTECHNOL, V28, P554, DOI 10.1038/nbt0610-554; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Ellinson M, 2004, J HUM NUTR DIET, V17, P371, DOI 10.1111/j.1365-277X.2004.00532.x; Ganji V, 2006, J NUTR, V136, P153, DOI 10.1093/jn/136.1.153; Hao L, 2003, J NUTR, V133, P3630, DOI 10.1093/jn/133.11.3630; Hao L, 2007, J NUTR, V137, P407, DOI 10.1093/jn/137.2.407; Herrmann W, 2005, CURR DRUG METAB, V6, P47, DOI 10.2174/1389200052997384; Hooshmand B, 2012, J INTERN MED, V271, P204, DOI 10.1111/j.1365-2796.2011.02484.x; Hughes CF, 2013, ANN CLIN BIOCHEM, V50, P315, DOI 10.1177/0004563212473279; Laillou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034906; Li P, 2012, CHINESE J CHILD HLTH, V20, P259; Liu Ru-ru, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P225; Liu RR, 2013, HYPERTENS RES, V36, P972, DOI 10.1038/hr.2013.71; Liu Ruru, 2012, Wei Sheng Yan Jiu, V41, P997; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; Ministry of Health of China, 2012, NAT REP PREV TREATM; Ministry of Health of China, MAN POL SUPPL FOL AC; Molloy AM, 2009, PEDIATRICS, V123, P917, DOI 10.1542/peds.2008-1173; Muthayya S, 2006, EUR J CLIN NUTR, V60, P791, DOI 10.1038/sj.ejcn.1602383; Nguyen PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089504; Quadri P, 2004, AM J CLIN NUTR, V80, P114; Ray JG, 2007, EPIDEMIOLOGY, V18, P362, DOI 10.1097/01.ede.0000257063.77411.e9; Schnyder G, 2001, NEW ENGL J MED, V345, P1593, DOI 10.1056/NEJMoa011364; Selhub J, 2008, FOOD NUTR BULL, V29, pS67, DOI 10.1177/15648265080292S110; Seshadri S, 2001, BRIT J NUTR, V85, pS87, DOI 10.1079/BJN2000299; Shaanxi Provincial Bureau of Statistics, 2012, STAT YB SHAANX 2012; Smith AD, 2012, J INTERN MED, V271, P179, DOI 10.1111/j.1365-2796.2011.02485.x; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Thompson MD, 2009, AM J CLIN NUTR, V89, p697S, DOI 10.3945/ajcn.2008.26947B; Veena SR, 2010, J NUTR, V140, P1014, DOI 10.3945/jn.109.118075; Vogiatzoglou A, 2009, CLIN CHEM, V55, P2198, DOI 10.1373/clinchem.2009.128678; WHO, 2012, NUTR MICR; Wolff T, 2009, ANN INTERN MED, V150, P632, DOI 10.7326/0003-4819-150-9-200905050-00010; Zhang BY, 2008, BIOMED ENVIRON SCI, V21, P37, DOI 10.1016/S0895-3988(08)60005-7	38	17	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112586	10.1371/journal.pone.0112586	http://dx.doi.org/10.1371/journal.pone.0112586			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390898	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400105
J	Gamble, AL; D'Rozario, AL; Bartlett, DJ; Williams, S; Bin, YS; Grunstein, RR; Marshall, NS				Gamble, Amanda L.; D'Rozario, Angela L.; Bartlett, Delwyn J.; Williams, Shaun; Bin, Yu Sun; Grunstein, Ronald R.; Marshall, Nathaniel S.			Adolescent Sleep Patterns and Night-Time Technology Use: Results of the Australian Broadcasting Corporation's Big Sleep Survey	PLOS ONE			English	Article							AMERICA-POLL; MEDIA USE; CHILDREN; TIME; DURATION; ASSOCIATION; DISORDERS; HEALTH; IMPACT; RISK	Introduction: Electronic devices in the bedroom are broadly linked with poor sleep in adolescents. This study investigated whether there is a dose-response relationship between use of electronic devices (computers, cellphones, televisions and radios) in bed prior to sleep and adolescent sleep patterns. Methods: Adolescents aged 11-17 yrs (n = 1,184; 67.6% female) completed an Australia-wide internet survey that examined sleep patterns, sleepiness, sleep disorders, the presence of electronic devices in the bedroom and frequency of use in bed at night. Results: Over 70% of adolescents reported 2 or more electronic devices in their bedroom at night. Use of devices in bed a few nights per week or more was 46.8% cellphone, 38.5% computer, 23.2% TV, and 15.8% radio. Device use had dose-dependent associations with later sleep onset on weekdays (highest-dose computer adjOR = 3.75: 99% CI = 2.17-6.46; cellphone 2.29: 1.22-4.30) and weekends (computer 3.68: 2.14-6.32; cellphone 3.24: 1.70-6.19; TV 2.32: 1.30-4.14), and later waking on weekdays (computer 2.08: 1.25-3.44; TV 2.31: 1.33-4.02) and weekends (computer 1.99: 1.21-3.26; cellphone 2.33: 1.33-4.08; TV 2.04: 1.18-3.55). Only 'almost every night' computer use (: 2.43: 1.45-4.08) was associated with short weekday sleep duration, and only 'almost every night' cellphone use (2.23: 1.26-3.94) was associated with wake lag (waking later on weekends). Conclusions: Use of computers, cell-phones and televisions at higher doses was associated with delayed sleep/wake schedules and wake lag, potentially impairing health and educational outcomes.	[Gamble, Amanda L.; D'Rozario, Angela L.; Bartlett, Delwyn J.; Williams, Shaun; Bin, Yu Sun; Grunstein, Ronald R.; Marshall, Nathaniel S.] Univ Sydney, NHMRC CIRUS, Sydney, NSW 2006, Australia; [D'Rozario, Angela L.; Bartlett, Delwyn J.; Grunstein, Ronald R.; Marshall, Nathaniel S.] Woolcock Inst Med Res, Sleep & Circadian Res Grp, Sydney, NSW, Australia; [Grunstein, Ronald R.] Royal Prince Alfred Hosp, Dept Sleep & Resp Failure, Sydney, NSW, Australia; [Marshall, Nathaniel S.] Univ Sydney, Sydney Nursing Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of Sydney	Marshall, NS (corresponding author), Univ Sydney, NHMRC CIRUS, Sydney, NSW 2006, Australia.	nathaniel.marshall@sydney.edu.au	D'Rozario, Angela Louise/J-1626-2019; Marshall, Nathaniel S/H-7375-2019; Bin, Yu Sun/A-6944-2015; bin, yu/GQZ-1362-2022	D'Rozario, Angela Louise/0000-0001-8564-796X; Marshall, Nathaniel S/0000-0002-9014-1397; Bin, Yu Sun/0000-0002-4954-2658; 	NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS) at The University of Sydney [571421]; NHMRC Practitioner Fellowship [1022730]; NHMRC Dora Lush PhD Scholarship [633172]	NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS) at The University of Sydney; NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Dora Lush PhD Scholarship(National Health and Medical Research Council (NHMRC) of Australia)	ABC National Science Week Big Sleep Survey was supported by the NHMRC Centre for Integrated Research and Understanding of Sleep (CIRUS) at The University of Sydney providing personnel and expertise (NHMRC grant # 571421 to Prof Grunstein providing salary support to Drs Gamble, Williams, Marshall and Ms Bin). The Australian Broadcasting Corporation hosts National Science Week and this survey and provided the IT support and advertising to collect these data. Prof Grunstein is supported by an NHMRC Practitioner Fellowship (1022730) and Dr D'Rozario by a NHMRC Dora Lush PhD Scholarship (# 633172). The NHMRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The ABC did have a role in design data collection but no input into analyses, decision to publish or preparation of the manuscript.	Australian Bureau of Statistics (ABS), 2006, SOC IND AR SEIFA TEC; Cain N, 2010, SLEEP MED, V11, P735, DOI 10.1016/j.sleep.2010.02.006; Calamaro CJ, 2009, PEDIATRICS, V123, pE1005, DOI 10.1542/peds.2008-3641; CARSKADON MA, 1993, SLEEP, V16, P258, DOI 10.1093/sleep/16.3.258; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; Carskadon MA, 2011, PEDIATR CLIN N AM, V58, P637, DOI 10.1016/j.pcl.2011.03.003; Carskadon MA, 2011, PROG BRAIN RES, V190, P137, DOI 10.1016/B978-0-444-53817-8.00008-6; Carter PJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2712; Chien KL, 2010, SLEEP, V33, P177, DOI 10.1093/sleep/33.2.177; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Fichter MM, 2009, SOC PSYCH PSYCH EPID, V44, P792, DOI 10.1007/s00127-009-0501-y; Fischer FM, 2008, CHRONOBIOL INT, V25, P359, DOI 10.1080/07420520802110639; Foley LS, 2013, PEDIATRICS, V131, P276, DOI 10.1542/peds.2012-1651; Gradisar M, 2013, J CLIN SLEEP MED, V9, P1291, DOI 10.5664/jcsm.3272; Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008; Higuchi S, 2005, J SLEEP RES, V14, P267, DOI 10.1111/j.1365-2869.2005.00463.x; Jenni OG, 2005, SLEEP, V28, P1446, DOI 10.1093/sleep/28.11.1446; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Mindell JA, 2009, SLEEP MED, V10, P771, DOI 10.1016/j.sleep.2008.07.016; Munezawa T, 2011, SLEEP, V34, P1013, DOI 10.5665/SLEEP.1152; Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002; Ong SH, 2006, J AFFECT DISORDERS, V96, P1, DOI 10.1016/j.jad.2006.05.025; Owens J.A., 2005, PRINCIPLES PRACTICE, P27; Punamaki RL, 2007, J ADOLESCENCE, V30, P569, DOI 10.1016/j.adolescence.2006.07.004; Sadeh A, 2003, CHILD DEV, V74, P444, DOI 10.1111/1467-8624.7402008; Short MA, 2011, SLEEP, V34, P797, DOI 10.5665/SLEEP.1052; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Tavernier R, 2014, J SLEEP RES, V23, P389, DOI 10.1111/jsr.12132; Van den Bulck J, 2004, SLEEP, V27, P101, DOI 10.1093/sleep/27.1.101; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979	32	78	80	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e111700	10.1371/journal.pone.0111700	http://dx.doi.org/10.1371/journal.pone.0111700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CP	25390034	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400030
J	Hagen, MW; Riddle, A; McClendon, E; Gong, X; Shaver, D; Srivastava, T; Dean, JM; Bai, JZ; Fowke, TM; Gunn, AJ; Jones, DF; Sherman, LS; Grafe, MR; Hohimer, AR; Back, SA				Hagen, Matthew W.; Riddle, Art; McClendon, Evelyn; Gong, Xi; Shaver, Daniel; Srivastava, Taasin; Dean, Justin M.; Bai, Ji-Zhong; Fowke, Tania M.; Gunn, Alistair J.; Jones, Daniel F.; Sherman, Larry S.; Grafe, Marjorie R.; Hohimer, A. Roger; Back, Stephen A.			Role of Recurrent Hypoxia-Ischemia in Preterm White Matter Injury Severity	PLOS ONE			English	Article							OLIGODENDROCYTE LINEAGE PROGRESSION; PERINATAL BRAIN-DAMAGE; PERIVENTRICULAR LEUKOMALACIA; DEVELOPMENTAL NEUROPATHOLOGY; SELECTIVE VULNERABILITY; MATURATION; LESIONS; SHEEP; GENE; ABNORMALITIES	Objective: Although the spectrum of white matter injury (WMI) in preterm infants is shifting from cystic necrotic lesions to milder forms, the factors that contribute to this changing spectrum are unclear. We hypothesized that recurrent hypoxiaischemia (rHI) will exacerbate the spectrum of WMI defined by markers of inflammation and molecules related to the extracellular matrix (hyaluronan (HA) and the PH20 hyaluronidase) that regulate maturation of the oligodendrocyte (OL) lineage after WMI. Methods: We employed a preterm fetal sheep model of in utero moderate hypoxemia and global severe but not complete cerebral ischemia that reproduces the spectrum of human WMI. The response to rHI was compared against corresponding early or later single episodes of HI. An ordinal rating scale of WMI was compared against an unbiased quantitative image analysis protocol that provided continuous histo-pathological outcome measures for astrogliosis and microglial activation. Late oligodendrocyte progenitors (preOLs) were quantified by stereology. Analysis of hyaluronan and the hyaluronidase PH20 defined the progressive response of the extracellular matrix to WMI. Results: rHI resulted in a more severe spectrum of WMI with a greater burden of necrosis, but an expanded population of preOLs that displayed reduced susceptibility to cell death. WMI from single episodes of HI or rHI was accompanied by elevated HA levels and increased labeling for PH20. Expression of PH20 in fetal ovine WMI was confirmed by RT-PCR and RNA-sequencing. Conclusions: rHI is associated with an increased risk for more severe WMI with necrosis, but reduced risk for preOL degeneration compared to single episodes of HI. Expansion of the preOL pool may be linked to elevated hyaluronan and PH20.	[Hagen, Matthew W.; Riddle, Art; McClendon, Evelyn; Gong, Xi; Shaver, Daniel; Srivastava, Taasin; Back, Stephen A.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Dean, Justin M.; Bai, Ji-Zhong; Fowke, Tania M.; Gunn, Alistair J.] Univ Auckland, Fac Med & Hlth Sci, Dept Physiol, Auckland 1, New Zealand; [Jones, Daniel F.] Univ Auckland, New Zealand Genom Ltd, Sch Biol Sci, Bioinformat Inst, Auckland 1, New Zealand; [Sherman, Larry S.] Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR USA; [Sherman, Larry S.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; [Grafe, Marjorie R.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Hohimer, A. Roger] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Back, Stephen A.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	Oregon Health & Science University; University of Auckland; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Back, SA (corresponding author), Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA.	backs@ohsu.edu	Dean, Justin/AAD-8576-2021	Dean, Justin/0000-0002-1377-0878; McClendon, Evelyn/0000-0003-3541-189X; Hagen, Matthew/0000-0002-9812-2262; Gunn, Alistair/0000-0003-0656-7035	National Institutes of Health (NIH): NINDS awards [1RO1NS054044, R37NS045737-06S1/06S2, 1F30NS066704]; NICHD award [P01HD03443]; American Heart Association (SAB); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS045737, R01NS054044, F30NS066704, R01NS045737] Funding Source: NIH RePORTER	National Institutes of Health (NIH): NINDS awards; NICHD award; American Heart Association (SAB); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by the National Institutes of Health (NIH): NINDS awards: 1RO1NS054044, R37NS045737-06S1/06S2 to SAB and 1F30NS066704 to AR and NICHD award P01HD03443. Supported by a Grant in Aid from the American Heart Association (SAB) and the March of Dimes Birth Defects Foundation (SAB). Supported by grants from Health Research Council of New Zealand (JD, AG), the Marsden Fund (JD, AG, TF), the Auckland Medical Research Foundation (JD, JB), the Neurological Foundation of New Zealand (TF), and the National Centre for Growth and Development, New Zealand (JD, AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiman SE, 2010, BRAIN PATHOL, V20, P803, DOI 10.1111/j.1750-3639.2010.00380.x; Andrews S., 2012, FASTQC QUALITY CONTR; [Anonymous], LANG ENV STAT COMP; Aronesty E., 2011, EA UTILS COMMAND LIN; Autheman D, 2012, PEDIATR RES, V72, P568, DOI 10.1038/pr.2012.124; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Back SA, 2005, ANN NEUROL, V58, P108, DOI 10.1002/ana.20530; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; Back SA, 2014, GLIA, V62, P1790, DOI 10.1002/glia.22658; Back SA, 2014, ANN NEUROL, V75, P469, DOI 10.1002/ana.24132; Back SA, 2014, CLIN PERINATOL, V41, P1, DOI 10.1016/j.clp.2013.11.001; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; BALDWIN BA, 1963, J ANAT, V97, P203; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386, DOI 10.1001/archneur.1962.04210050022004; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Chau V, 2012, PEDIATR RES, V71, P274, DOI 10.1038/pr.2011.40; Chau V, 2009, ANN NEUROL, V66, P155, DOI 10.1002/ana.21713; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Craig A, 2003, EXP NEUROL, V181, P231, DOI 10.1016/S0014-4886(03)00032-3; Dean JM, 2011, ANN NEUROL, V70, P846, DOI 10.1002/ana.22480; Dean JM, 2011, DEV NEUROSCI-BASEL, V33, P251, DOI 10.1159/000327242; Fan LW, 2008, DEV NEUROBIOL, V68, P365, DOI 10.1002/dneu.20591; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Fraser M, 2007, REPROD SCI, V14, P182, DOI 10.1177/1933719107299612; GIDDAY JM, 1994, NEUROSCI LETT, V168, P221, DOI 10.1016/0304-3940(94)90455-3; Glass HC, 2008, PEDIATRICS, V122, P299, DOI 10.1542/peds.2007-2184; Greisen G, 2009, SEMIN PEDIATR NEUROL, V16, P207, DOI 10.1016/j.spen.2009.09.002; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Jones NM, 2001, J CEREBR BLOOD F MET, V21, P1105, DOI 10.1097/00004647-200109000-00008; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kimura M, 2009, BIOL REPROD, V81, P939, DOI 10.1095/biolreprod.109.078816; Kinney H C, 1998, Semin Pediatr Neurol, V5, P180, DOI 10.1016/S1071-9091(98)80033-8; Kinney HC, 2012, ANN NEUROL, V71, P397, DOI 10.1002/ana.22612; Lin WY, 2009, J NEUROCHEM, V108, P847, DOI [10.1111/j.1471-4159.2008.05828.x, 10.1111/j.0022-3042.2008.05828.x]; Marin-Padilla M, 1999, J NEUROPATH EXP NEUR, V58, P407, DOI 10.1097/00005072-199905000-00001; MarinPadilla M, 1997, J NEUROPATH EXP NEUR, V56, P219, DOI 10.1097/00005072-199703000-00001; McClure MM, 2008, J CEREBR BLOOD F MET, V28, P995, DOI 10.1038/sj.jcbfm.9600597; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Preston M, 2013, ANN NEUROL, V73, P266, DOI 10.1002/ana.23788; PRIMAKOFF P, 1988, NATURE, V335, P543, DOI 10.1038/335543a0; Ran RQ, 2005, DEV NEUROSCI-BASEL, V27, P87, DOI 10.1159/000085979; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5200-05.2006; Riddle A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082940; Riddle A, 2012, STROKE, V43, P178, DOI 10.1161/STROKEAHA.111.632265; Riddle A, 2011, ANN NEUROL, V70, P493, DOI 10.1002/ana.22501; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Segovia KN, 2008, ANN NEUROL, V63, P520, DOI 10.1002/ana.21359; Shah DK, 2008, J PEDIATR-US, V153, P170, DOI 10.1016/j.jpeds.2008.02.033; Sherman L, 2008, GLYCOFORUM SCI HYALU; Sherman LS, 2008, TRENDS NEUROSCI, V31, P44, DOI 10.1016/j.tins.2007.11.001; Sloane JA, 2010, P NATL ACAD SCI USA, V107, P11555, DOI 10.1073/pnas.1006496107; Suryana E, 2014, INT J DEV NEUROSCI, V37, P69, DOI 10.1016/j.ijdevneu.2014.06.007; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vannucci RC, 2005, DEV NEUROSCI-BASEL, V27, P81, DOI 10.1159/000085978; Yudin AI, 1999, MOL REPROD DEV, V53, P350, DOI 10.1002/(SICI)1098-2795(199907)53:3<350::AID-MRD11>3.3.CO;2-0	58	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112800	10.1371/journal.pone.0112800	http://dx.doi.org/10.1371/journal.pone.0112800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390897	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400129
J	Odden, M; Athreya, V; Rattan, S; Linnell, JDC				Odden, Morten; Athreya, Vidya; Rattan, Sandeep; Linnell, John D. C.			Adaptable Neighbours: Movement Patterns of GPS-Collared Leopards in Human Dominated Landscapes in India	PLOS ONE			English	Article							BARDIA NATIONAL-PARK; LARGE CARNIVORES; PANTHERA-PARDUS; CONSERVATION; WILDLIFE	Understanding the nature of the interactions between humans and wildlife is of vital importance for conflict mitigation. We equipped five leopards with GPS-collars in Maharashtra (4) and Himachal Pradesh (1), India, to study movement patterns in human-dominated landscapes outside protected areas. An adult male and an adult female were both translocated 52 km, and exhibited extensive, and directional, post release movements (straight line movements: male = 89 km in 37 days, female = 45 km in 5 months), until they settled in home ranges of 42 km(2) (male) and 65 km(2) (female). The three other leopards, two adult females and a young male were released close to their capture sites and used small home ranges of 8 km(2) (male), 11 km 2 and 15 km(2) (females). Movement patterns were markedly nocturnal, with hourly step lengths averaging 33969.5 m (SE) during night and 60 +/- 4.1 m during day, and night locations were significantly closer to human settlements than day locations. However, more nocturnal movements were observed among those three living in the areas with high human population densities. These visited houses regularly at nighttime (20% of locations,25 m from houses), but rarely during day (<1%). One leopard living in a sparsely populated area avoided human settlements both day and night. The small home ranges of the leopards indicate that anthropogenic food resources may be plentiful although wild prey is absent. The study provides clear insights into the ability of leopards to live and move in landscapes that are extremely modified by human activity.	[Odden, Morten] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Koppang, Norway; [Athreya, Vidya] Wildlife Conservat Soc India, Bangalore, Karnataka, India; [Athreya, Vidya] Ctr Wildlife Studies, Bangalore, Karnataka, India; [Rattan, Sandeep] Himachal Pradesh Forest Dept, Wildlife Wing, Shimla, Himachal Prades, India; [Linnell, John D. C.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	Inland Norway University of Applied Sciences; Norwegian Institute Nature Research	Odden, M (corresponding author), Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Campus Evenstad, Koppang, Norway.	morten.odden@hihm.no	Linnell, John/V-4177-2019	Linnell, John/0000-0002-8370-5633	Royal Norwegian Embassy; Norwegian Research Council	Royal Norwegian Embassy; Norwegian Research Council(Research Council of NorwayEuropean Commission)	The project was funded by the Royal Norwegian Embassy and the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athreya V., 2014, ORYX IN PRESS, DOI [10.1017/S0030605314000106, DOI 10.1017/S0030605314000106]; Athreya V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057872; Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Banerjee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049457; Belsare A, 2004, CAT NEWS, V41; Boitani Luigi, 2009, P15; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; Deka K., 2012, J BOMBAY NATURAL HIS, V109, P153; Downs JA, 2008, J WILDLIFE MANAGE, V72, P1813, DOI 10.2193/2007-454; Fattebert J, 2013, S AFR J WILDL RES, V43, P61, DOI 10.3957/056.043.0108; Ghosal S, 2013, BIODIVERS CONSERV, V22, P2665, DOI 10.1007/s10531-013-0549-6; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Henschel P., 2008, IUCN RED LIST THREAT; Jackson P., 1996, BIOL CONSERVATION; JHALA YV, 1991, CONSERV BIOL, V5, P476, DOI 10.1111/j.1523-1739.1991.tb00354.x; Kolowski JM, 2006, BIOL CONSERV, V128, P529, DOI 10.1016/j.biocon.2005.10.021; Larue MA, 2012, J WILDLIFE MANAGE, V76, P1364, DOI 10.1002/jwmg.396; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Linnell John D.C., 2009, P72, DOI 10.1002/9781444312034.ch4; Marker LL, 2005, S AFR J WILDL RES, V35, P105; Martins Q, 2013, AFR J ECOL, V51, P571, DOI 10.1111/aje.12068; MOHR CO, 1947, AM MIDL NAT, V37, P223, DOI 10.2307/2421652; Muntifering JR, 2006, ANIM CONSERV, V9, P103, DOI 10.1111/j.1469-1795.2005.00008.x; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; Odden M, 2009, ACTA THERIOL, V54, P23, DOI 10.1007/BF03193134; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Powell RA, 2000, METH C CONS, P65; Rogers L.L., 1988, P76; Saberwal V., 2003, BATTLES NATURE SCI P; Simcharoen S, 2008, BIOL CONSERV, V141, P2242, DOI 10.1016/j.biocon.2008.06.015; Singh HS, 2005, CAT NEWS, V42; Stander PE, 1997, AFR J ECOL, V35, P156, DOI 10.1111/j.1365-2028.1997.068-89068.x; Stein AB, 2011, AFR J ECOL, V49, P383, DOI 10.1111/j.1365-2028.2011.01267.x; Woodroffe R., 2005, CONSERV BIOL; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	37	74	79	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112044	10.1371/journal.pone.0112044	http://dx.doi.org/10.1371/journal.pone.0112044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25390067	Green Published, gold, Green Submitted			2022-12-26	WOS:000349144400048
J	Yang, YW; Huang, L; Dong, Y; Zhang, HC; Zhou, W; Ban, JH; Wei, JJ; Liu, Y; Gao, J; Chen, JH				Yang, Yanwei; Huang, Li; Dong, Yan; Zhang, Hongchen; Zhou, Wei; Ban, Jinghao; Wei, Jingjing; Liu, Yan; Gao, Jing; Chen, Jihua			In Vitro Antibacterial Activity of a Novel Resin-Based Pulp Capping Material Containing the Quaternary Ammonium Salt MAE-DB and Portland Cement	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; CALCIUM HYDROXIDE; PROROOT MTA; ADHESIVE; BIOCOMPATIBILITY; PHOSPHATE; CARIES; NANOCOMPOSITES; COMPOSITES; MONOMER	Background: Vital pulp preservation in the treatment of deep caries is challenging due to bacterial infection. The objectives of this study were to synthesize a novel, light-cured composite material containing bioactive calcium-silicate (Portland cement, PC) and the antimicrobial quaternary ammonium salt monomer 2-methacryloxylethyl dodecyl methyl ammonium bromide (MAE-DB) and to evaluate its effects on Streptococcus mutans growth in vitro. Methods: The experimental material was prepared from a 2: 1 ratio of PC mixed with a resin of 2-hydroxyethylmethacrylate, bisphenol glycerolate dimethacrylate, and triethylene glycol dimethacrylate (4: 3: 1) containing 5 wt% MAE-DB. Cured resin containing 5% MAE-DB without PC served as the positive control material, and resin without MAE-DB or PC served as the negative control material. Mineral trioxide aggregate (MTA) and calcium hydroxide (Dycal) served as commercial controls. S. mutans biofilm formation on material surfaces and growth in the culture medium were tested according to colony-forming units (CFUs) and metabolic activity after 24 h incubation over freshly prepared samples or samples aged in water for 6 months. Biofilm formation was also assessed by Live/Dead staining and scanning electron microscopy. Results: S. mutans biofilm formation on the experimental material was significantly inhibited, with CFU counts, metabolic activity, viability staining, and morphology similar to those of biofilms on the positive control material. None of the materials affected bacterial growth in solution. Contact-inhibition of biofilm formation was retained by the aged experimental material. Significant biofilm formation was observed on MTA and Dycal. Conclusion: The synthesized material containing HEMA-BisGMA-TEGDMA resin with MAE-DB as the antimicrobial agent and PC to support mineralized tissue formation inhibited S. mutans biofilm formation even after aging in water for 6 months, but had no inhibitory effect on bacteria in solution. Therefore, this material shows promise as a pulp capping material for vital pulp preservation in the treatment of deep caries.	[Yang, Yanwei; Dong, Yan; Zhou, Wei; Ban, Jinghao; Wei, Jingjing; Liu, Yan; Gao, Jing; Chen, Jihua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Huang, Li] Fourth Mil Med Univ, Sch Stomatol, Dept Gen Dent & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China; [Zhang, Hongchen] Fourth Mil Med Univ, Sch Nursing, Dept Clin Nursing, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Huang, L (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Dept Gen Dent & Emergency, State Key Lab Mil Stomatol, Xian 710032, Peoples R China.	519huang@fmmu.edu.cn; jhchen@fmmu.edu.cn	wei, jing/GXA-1455-2022	Chen, Ji-hua/0000-0002-1151-0693	National Natural Science Foundation of China [81200816, 81130078, 81200823]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This research was financially supported by grants from the National Natural Science Foundation of China (No. 81200816, No. 81130078 and No. 81200823) and by the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT13051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorinte MDR, 2008, J ENDODONT, V34, P1, DOI 10.1016/j.joen.2007.09.012; Aguilar FG, 2012, J ENDODONT, V38, P367, DOI 10.1016/j.joen.2011.11.002; Al-Hiyasat AS, 2006, J AM DENT ASSOC, V137, P1699, DOI 10.14219/jada.archive.2006.0116; Antonucci JM, 2012, DENT MATER, V28, P219, DOI 10.1016/j.dental.2011.10.004; Asgary S, 2009, J ENDODONT, V35, P243, DOI 10.1016/j.joen.2008.10.026; Ber BS, 2007, J ENDODONT, V33, P1231, DOI 10.1016/j.joen.2007.06.012; Bergenholtz G, 2001, Adv Dent Res, V15, P84; Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003; Bjorndal L, 2001, QUINTESSENCE INT, V32, P717; Bjorndal L, 2010, EUR J ORAL SCI, V118, P290, DOI 10.1111/j.1600-0722.2010.00731.x; Borges Álvaro H, 2010, Acta odontol. latinoam., V23, P175; Camilleri J, 2005, INT ENDOD J, V38, P834, DOI 10.1111/j.1365-2591.2005.01028.x; Cheng L, 2012, DENT MATER, V28, P561, DOI 10.1016/j.dental.2012.01.005; Cheng L, 2012, DENT MATER, V28, P573, DOI 10.1016/j.dental.2012.01.006; Cox CF, 1998, AM J DENT, V11, pS55; Dammaschke T, 2010, J ENDODONT, V36, P814, DOI 10.1016/j.joen.2010.02.001; Estrela C, 2000, Braz Dent J, V11, P3; Formosa LM, 2013, DENT MATER, V29, pE11, DOI 10.1016/j.dental.2012.11.006; Gandolfi MG, 2011, DENT MATER, V27, P1055, DOI 10.1016/j.dental.2011.07.007; Gandolfi MG, 2011, DENT MATER, V27, pE134, DOI 10.1016/j.dental.2011.03.011; Hayashi M, 2011, J DENT, V39, P95, DOI 10.1016/j.jdent.2010.10.012; Huang L, 2012, J BIOMED MATER RES B, V100B, P1353, DOI 10.1002/jbm.b.32703; Huang L, 2011, ARCH ORAL BIOL, V56, P367, DOI 10.1016/j.archoralbio.2010.10.011; IMAZATO S, 1994, J DENT RES, V73, P1437, DOI 10.1177/00220345940730080701; Imazato S, 1998, J BIOMED MATER RES, V39, P511, DOI 10.1002/(SICI)1097-4636(19980315)39:4<511::AID-JBM1>3.0.CO;2-M; Kitasako Y, 1999, J DENT, V27, P257, DOI 10.1016/S0300-5712(98)00054-2; Li F, 2009, J DENT RES, V88, P372, DOI 10.1177/0022034509334499; Li F, 2014, DENT MATER, V30, P182, DOI 10.1016/j.dental.2013.11.004; Li F, 2013, DENT MATER, V29, P450, DOI 10.1016/j.dental.2013.01.012; Li F, 2009, J DENT, V37, P289, DOI 10.1016/j.jdent.2008.12.004; Min KS, 2007, J ENDODONT, V33, P163, DOI 10.1016/j.joen.2006.07.022; Miyagak Daniela Cristina, 2006, Braz. oral res., V20, P303, DOI 10.1590/S1806-83242006000400004; Momoi Y, 2012, J DENT, V40, P95, DOI 10.1016/j.jdent.2011.10.011; Namba N, 2009, DENT MATER, V25, P424, DOI 10.1016/j.dental.2008.08.012; Saidon J, 2003, ORAL SURG ORAL MED O, V95, P483, DOI 10.1067/moe.2003.20; Shayegan A, 2009, DENT TRAUMATOL, V25, P413, DOI 10.1111/j.1600-9657.2009.00799.x; Shen QY, 2010, J BIOMED MATER RES B, V94B, P141, DOI 10.1002/jbm.b.31634; Simon S R J, 2011, Adv Dent Res, V23, P340, DOI 10.1177/0022034511405327; Song JS, 2006, ORAL SURG ORAL MED O, V102, P809, DOI 10.1016/j.tripleo.2005.11.034; Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010; Tran XV, 2012, J DENT RES, V91, P1166, DOI 10.1177/0022034512460833; Tziafas D, 2007, INT ENDOD J, V40, P58, DOI 10.1111/j.1365-2591.2006.01183.x; Xiao YH, 2009, J BIOMED MATER RES B, V90B, P813, DOI 10.1002/jbm.b.31350; Xiao Yu-Hong, 2008, J Oral Sci, V50, P323, DOI 10.2334/josnusd.50.323; Yasuda Yoshiyuki, 2008, J Oral Sci, V50, P309, DOI 10.2334/josnusd.50.309	45	22	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112549	10.1371/journal.pone.0112549	http://dx.doi.org/10.1371/journal.pone.0112549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25389975	gold, Green Submitted, Green Published			2022-12-26	WOS:000349144400096
J	do Carmo, AM; Santos, FM; Ortiz-Agostinho, CL; Nishitokukado, I; Frota, CS; Gomes, FU; Leite, AZD; Pannuti, CS; Boas, LSV; Teixeira, MG; Sipahi, AM				do Carmo, Alexandre Medeiros; Santos, Fabiana Maria; Ortiz-Agostinho, Carmen Lucia; Nishitokukado, Ieda; Frota, Cintia S.; Gomes, Flavia Ubeda; de Arruda Leite, Andre Zonetti; Pannuti, Claudio Sergio; Vilas Boas, Lucy Santos; Teixeira, Magaly Gemio; Sipahi, Aytan Miranda			Cytomegalovirus Infection in Inflammatory Bowel Disease Is Not Associated with Worsening of Intestinal Inflammatory Activity	PLOS ONE			English	Article							ULCERATIVE-COLITIS PATIENTS; CROHNS-DISEASE; FECAL CALPROTECTIN; PREVALENCE; THERAPY	Background: Cytomegalovirus is highly prevalent virus and usually occurs in immunocompromised patients. The pathophysiology and treatment of inflammatory bowel disease often induce a state of immunosuppression. Because this, there are still doubts and controversies about the relationship between inflammatory bowel disease and cytomegalovirus. Aim: Evaluate the frequency of cytomegalovirus in patients with inflammatory bowel disease and identify correlations. Methods: Patients with inflammatory bowel disease underwent an interview, review of records and collection of blood and fecal samples. The search for cytomegalovirus was performed by IgG and IgM blood serology, by real-time PCR in the blood and by qualitative PCR in feces. Results were correlated with red blood cell levels, C-reactive protein levels, erythrocyte sedimentation rates and fecal calprotectin levels for each patient. Results: Among the 400 eligible patients, 249 had Crohn's disease, and 151 had ulcerative colitis. In the group of Crohn's disease, 67 of the patients had moderate or severe disease, but 126 patients presented with active disease, based on the evaluation of the fecal calprotectin. In patients with ulcerative colitis, only 21 patients had moderate disease, but 76 patients presented with active disease, based on the evaluation of the fecal calprotectin. A large majority of patients had positive CMV IgG. Overall, 10 patients had positive CMV IgM, and 9 patients had a positive qualitative detection of CMV DNA by PCR in the feces. All 400 patients returned negative results after the quantitative detection of CMV DNA in blood by real-time PCR. Analyzing the 19 patients with active infections, we only found that such an association occurred with the use of combined therapy (anti-TNF-alpha + azathioprine) Conclusion: The findings show that latent cytomegalovirus infections are frequent and active cytomegalovirus infection is rare. We did not find any association between an active infection of CMV and inflammatory bowel disease activity.	[do Carmo, Alexandre Medeiros; Santos, Fabiana Maria; Ortiz-Agostinho, Carmen Lucia; Nishitokukado, Ieda; Frota, Cintia S.; Gomes, Flavia Ubeda; de Arruda Leite, Andre Zonetti; Sipahi, Aytan Miranda] Univ Sao Paulo, Fac Med, Hosp Clin, Dept Gastroenterol, Sao Paulo, Brazil; [Pannuti, Claudio Sergio] Univ Sao Paulo, Fac Med, Inst Trop Med, Sao Paulo, Brazil; [Pannuti, Claudio Sergio] Univ Sao Paulo, Fac Med, Dept Doencas Infecciosas & Parasitarias LIM HC, Sao Paulo, Brazil; [Vilas Boas, Lucy Santos] Univ Sao Paulo, Fac Med LIM HC, Inst Trop Med, Sao Paulo, Brazil; [Vilas Boas, Lucy Santos] Univ Sao Paulo, Fac Med LIM HC, Hosp Clin, Sao Paulo, Brazil; [Teixeira, Magaly Gemio] Univ Sao Paulo, Fac Med, Hosp Clin, Serv Cirurgia Colon Reto & Anus,Dept Cirurgia, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	do Carmo, AM (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Dept Gastroenterol, LIM 07, Sao Paulo, Brazil.	amccirurgia@gmail.com	de Arruda Leite, André Zonetti/W-5660-2019; de Arruda Leite, André Z A Zonetti/G-1341-2014; Sipahi, Aytan Miranda/O-7768-2019	de Arruda Leite, André Zonetti/0000-0002-6494-8234; de Arruda Leite, André Z A Zonetti/0000-0002-6494-8234; Sipahi, Aytan Miranda/0000-0002-9686-1627; Maria dos Santos, Fabiana/0000-0003-1785-7388	FAPESP [2010/18275-8]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This project received funding from FAPESP helping to buy products to experiments (project 2010/18275-8, http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankier A T, 1991, DNA Seq, V2, P1, DOI 10.3109/10425179109008433; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Boom R, 2000, J VIROL METHODS, V84, P1, DOI 10.1016/S0166-0934(99)00127-5; CHOU SW, 1991, J INFECT DIS, V163, P1229, DOI 10.1093/infdis/163.6.1229; Criscuoli V, 2004, DIGEST LIVER DIS, V36, P818, DOI 10.1016/j.dld.2004.05.013; Criscuoli V, 2006, WORLD J GASTROENTERO, V12, P4813; Denis MA, 2007, INFLAMM BOWEL DIS, V13, P1100, DOI 10.1002/ibd.20178; Dimitroulia E, 2006, INFLAMM BOWEL DIS, V12, P879, DOI 10.1097/01.mib.0000231576.11678.57; Domenech E, 2008, INFLAMM BOWEL DIS, V14, P1373, DOI 10.1002/ibd.20498; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; GOODGAME RW, 1993, ANN INTERN MED, V119, P924, DOI 10.7326/0003-4819-119-9-199311010-00010; Helbling D, 2002, EUR J GASTROEN HEPAT, V14, P1393, DOI 10.1097/00042737-200212000-00018; Kambham N, 2004, AM J SURG PATHOL, V28, P365, DOI 10.1097/00000478-200403000-00009; Kandiel A, 2006, AM J GASTROENTEROL, V101, P2857, DOI 10.1111/j.1572-0241.2006.00869.x; Kim JJ, 2010, DIGEST DIS SCI, V55, P1059, DOI 10.1007/s10620-010-1126-4; Kishore J, 2004, J MED MICROBIOL, V53, P1155, DOI 10.1099/jmm.0.45629-0; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Lakatos PL, 2009, DIGEST DIS, V27, P215, DOI 10.1159/000228553; Lawlor G, 2010, INFLAMM BOWEL DIS; Leveque N, 2010, J MED VIROL, V82, P1694, DOI 10.1002/jmv.21877; Maconi G, 2005, DIGEST LIVER DIS, V37, P418, DOI 10.1016/j.dld.2005.01.011; Maher MM, 2009, DIGEST DIS SCI, V54, P2456, DOI 10.1007/s10620-008-0639-6; Matsuoka K, 2007, AM J GASTROENTEROL, V102, P331, DOI 10.1111/j.1572-0241.2006.00989.x; Onyeagocha C, 2009, AM J PATHOL, V175, P2034, DOI 10.2353/ajpath.2009.090471; ORVAR K, 1993, DIGEST DIS SCI, V38, P2307, DOI 10.1007/BF01299914; PANNUTI CS, 1985, REV I MED TROP, V27, P105, DOI 10.1590/S0036-46651985000200010; Papadakis KA, 2001, AM J GASTROENTEROL, V96, P2137, DOI 10.1111/j.1572-0241.2001.03949.x; Pickering O, 2009, PEDIATR INFECT DIS J, V28, P556, DOI 10.1097/INF.0b013e3181a39571; Pillet S, 2012, DIGEST LIVER DIS, V44, P541, DOI 10.1016/j.dld.2012.03.018; Rowshani AT, 2005, TRANSPLANTATION, V79, P381, DOI 10.1097/01.TP.0000148239.00384.F0; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Suassuna J H, 1995, Rev Soc Bras Med Trop, V28, P105, DOI 10.1590/S0037-86821995000200003; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Vieira Andrea, 2009, BMC Res Notes, V2, P221, DOI 10.1186/1756-0500-2-221; Vilela EG, 2012, WORLD J GASTROENTERO, V18, P872, DOI 10.3748/wjg.v18.i9.872	35	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e111574	10.1371/journal.pone.0111574	http://dx.doi.org/10.1371/journal.pone.0111574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25387236	Green Submitted, Green Published, gold			2022-12-26	WOS:000345250400022
J	Meagher, RK; Dallaire, JA; Campbell, DLM; Ross, M; Moller, SH; Hansen, SW; Diez-Leon, M; Palme, R; Mason, GJ				Meagher, Rebecca K.; Dallaire, Jamie Ahloy; Campbell, Dana L. M.; Ross, Misha; Moller, Steen H.; Hansen, Steffen W.; Diez-Leon, Maria; Palme, Rupert; Mason, Georgia J.			Benefits of a Ball and Chain: Simple Environmental Enrichments Improve Welfare and Reproductive Success in Farmed American Mink (Neovison vison)	PLOS ONE			English	Article							FERRETS MUSTELA-NIGRIPES; STEREOTYPIC BEHAVIOR; QUANTITATIVE ASSESSMENT; INDIVIDUAL-DIFFERENCES; ENRICHED ENVIRONMENTS; ACCESS; STRESS; SELECTION; PERFORMANCE; EXPERIENCE	Can simple enrichments enhance caged mink welfare? Pilot data from 756 sub-adults spanning three colour-types (strains) identified potentially practical enrichments, and suggested beneficial effects on temperament and fur-chewing. Our main experiment started with 2032 Black mink on three farms: from each of 508 families, one juvenile male-female pair was enriched (E) with two balls and a hanging plastic chain or length of hose, while a second pair was left as a non-enriched (NE) control. At 8 months, more than half the subjects were killed for pelts, and 302 new females were recruited (half enriched: 'late E'). Several signs of improved welfare or productivity emerged. Access to enrichment increased play in juveniles. E mink were calmer (less aggressive in temperament tests; quieter when handled; less fearful, if male), and less likely to fur-chew, although other stereotypic behaviours were not reduced. On one farm, E females had lower cortisol (inferred from faecal metabolites). E males tended to copulate for longer. E females also weaned more offspring: about 10% more juveniles per E female, primarily caused by reduced rates of barrenness ('late E' females also giving birth to bigger litters on one farm), effects that our data cautiously suggest were partly mediated by reduced inactivity and changes in temperament. Pelt quality seemed unaffected, but E animals had cleaner cages. In a subsidiary side-study using 368 mink of a second colour-type ('Demis'), similar temperament effects emerged, and while E did not reduce fur-chewing or improve reproductive success in this colour-type, E animals were judged to have better pelts. Overall, simple enrichments were thus beneficial. These findings should encourage welfare improvements on fur farms (which house 60-70 million mink p.a.) and in breeding centres where endangered mustelids (e.g. black-footed ferrets) often reproduce poorly. They should also stimulate future research into more effective practical enrichments.	[Meagher, Rebecca K.; Dallaire, Jamie Ahloy; Campbell, Dana L. M.; Ross, Misha; Diez-Leon, Maria; Mason, Georgia J.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Meagher, Rebecca K.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC V5Z 1M9, Canada; [Moller, Steen H.; Hansen, Steffen W.] Aarhus Univ, Dept Anim Sci, Aarhus, Denmark; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci Biochem, Vienna, Austria	University of Guelph; University of British Columbia; Aarhus University; University of Veterinary Medicine Vienna	Mason, GJ (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	gmason@uoguelph.ca	Meagher, Rebecca/G-6530-2013; Campbell, Dana/S-6777-2017; Palme, Rupert/A-3499-2008	Meagher, Rebecca/0000-0002-6576-8155; Campbell, Dana/0000-0003-4028-8347; Palme, Rupert/0000-0001-9466-3662; Diez Leon, Maria/0000-0002-0105-7039; Ahloy Dallaire, Jamie/0000-0001-6515-4009; Moller, Steen Henrik/0000-0003-3086-753X	Ontario Ministry of Agriculture, Food and Rural Affairs [200116]	Ontario Ministry of Agriculture, Food and Rural Affairs	This study was supported by the Ontario Ministry of Agriculture, Food and Rural Affairs, project 200116, grant to GJM (http://www.omafra.gov.on.ca/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anna I, 2002, LAB ANIM-UK, V36, P243, DOI 10.1258/002367702320162379; Arranz L, 2010, REJUV RES, V13, P415, DOI 10.1089/rej.2009.0989; Axelsson HMK, 2009, APPL ANIM BEHAV SCI, V121, P222, DOI 10.1016/j.applanim.2009.09.013; Baran SW, 2010, ENRICH REC, V3, P4; Boinski S, 1999, ZOO BIOL, V18, P295, DOI 10.1002/(SICI)1098-2361(1999)18:4<295::AID-ZOO4>3.3.CO;2-X; Booth S, 1998, PURELY POSITIVE TRAI; Branvold HA, 2003, ZOO BIOL, V22, P1, DOI 10.1002/zoo.10066; Bronson E, 2007, J ZOO WILDLIFE MED, V38, P169, DOI 10.1638/1042-7260(2007)038[0169:MOCBFM]2.0.CO;2; Buob M, 2013, APPL ANIM BEHAV SCI, V147, P194, DOI 10.1016/j.applanim.2013.05.004; Campbell DLM, 2013, BEHAV BRAIN RES, V239, P177, DOI 10.1016/j.bbr.2012.11.004; CARLSTEAD K, 1994, ZOO BIOL, V13, P447, DOI 10.1002/zoo.1430130507; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Cooper JJ, 2000, APPL ANIM BEHAV SCI, V66, P135, DOI 10.1016/S0168-1591(99)00069-6; Dallaire JA, 2012, APPL ANIM BEHAV SCI, V142, P98, DOI 10.1016/j.applanim.2012.09.012; Dallaire JA, 2011, BEHAV BRAIN RES, V224, P213, DOI 10.1016/j.bbr.2011.03.061; Damgaard BM, 2004, APPL ANIM BEHAV SCI, V89, P163, DOI 10.1016/j.applanim.2004.04.010; Damm BI, 2010, APPL ANIM BEHAV SCI, V126, P97, DOI 10.1016/j.applanim.2010.06.009; Dawson L, 2013, APPL ANIM BEHAV SCI, V147, P224, DOI 10.1016/j.applanim.2013.04.001; Diaz-Fleischer F, 2009, J EXP BIOL, V212, P2119, DOI 10.1242/jeb.027342; Diez-Leon M., 2014, THESIS; Diez-Leon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080494; Dukas R, 2003, ANIM BEHAV, V66, P741, DOI 10.1006/anbe.2002.2261; Duncan LM, 2012, APPL ANIM BEHAV SCI, V140, P179, DOI 10.1016/j.applanim.2012.06.003; Dunstone N., 1993, MINK; European Fur Breeders Association, 2013, WELF WELF ASS PROT M, P182; European Medicines Agency, 2011, EN ROADM 2050, P1, DOI DOI 10.2810/52708; Fernandez LT, 2008, ZOO BIOL, V27, P200, DOI 10.1002/zoo.20180; Frigerio D, 2004, GEN COMP ENDOCR, V137, P29, DOI 10.1016/j.ygcen.2004.02.013; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gaskill BN, 2013, APPL ANIM BEHAV SCI, V143, P110, DOI 10.1016/j.applanim.2012.10.009; Girard I, 2002, J APPL PHYSIOL, V92, P1553, DOI 10.1152/japplphysiol.00465.2001; Gourkow N, 2006, ANIM WELFARE, V15, P371; Grafen A., 2002, MODERN STAT LIFE SCI; Hansen SW, 2007, ANIM WELFARE, V16, P63; Hansen S.W., 1990, Scientifur, V14, P187; Hansen SW, 2006, APPL ANIM BEHAV SCI, V98, P127, DOI 10.1016/j.applanim.2005.08.017; Hansen SW, 1996, APPL ANIM BEHAV SCI, V49, P137, DOI 10.1016/0168-1591(96)01045-3; Hansen SW, 2001, ACTA AGR SCAND A-AN, V51, P93, DOI 10.1080/090647001316923144; Hansen SW, 2008, ANN REP 2007, P13; Hattori S, 2007, BEHAV BRAIN RES, V180, P69, DOI 10.1016/j.bbr.2007.02.036; Held SDE, 2011, ANIM BEHAV, V81, P891, DOI 10.1016/j.anbehav.2011.01.007; Hellstedt P, 2005, J ZOOL, V266, P37, DOI 10.1017/S0952836905006618; Honess PE, 2005, ATLA-ALTERN LAB ANIM, V33, P193, DOI 10.1177/026119290503300308; HUTSON GD, 1990, APPL ANIM BEHAV SCI, V26, P363, DOI 10.1016/0168-1591(90)90035-C; Jeppesen L. L., 2004, Scientifur, V28, P11; Jeppesen L.L., 1990, Scientifur, V14, P179; Jeppesen LL, 2004, APPL ANIM BEHAV SCI, V86, P137, DOI 10.1016/j.applanim.2003.11.011; Jeppesen LL, 2000, APPL ANIM BEHAV SCI, V68, P85, DOI 10.1016/S0168-1591(00)00099-X; Joergensen G., 1985, MINK PRODUCTION; Kiik K, 2013, ZOO BIOL, V32, P387, DOI 10.1002/zoo.21062; Leone EH, 2008, POULTRY SCI, V87, P14, DOI 10.3382/ps.2007-00154; Lumeij JT, 2008, APPL ANIM BEHAV SCI, V111, P85, DOI 10.1016/j.applanim.2007.05.015; Malmkvist J, 2011, STRESS, V14, P312, DOI 10.3109/10253890.2010.547640; Malmkvist J, 2002, ANIM BEHAV, V64, P487, DOI 10.1006/anbe.2002.3058; Malmkvist J, 2013, APPL ANIM BEHAV SCI, V149, P77, DOI 10.1016/j.applanim.2013.10.001; Marashi V, 2003, HORM BEHAV, V43, P281, DOI 10.1016/S0018-506X(03)00002-3; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Mason GJ, 2001, NATURE, V410, P35, DOI 10.1038/35065157; Mason GJ., 1991, INDIVIDUAL DIFFERENC; Meagher R, 2012, CAN J ANIM SCI, V92, P131, DOI [10.4141/CJAS2011-107, 10.4141/cjas2011-107]; Meagher RK, 2013, APPL ANIM BEHAV SCI, V144, P138, DOI 10.1016/j.applanim.2013.01.008; Meagher RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049180; Meagher RK, 2011, APPL ANIM BEHAV SCI, V133, P254, DOI 10.1016/j.applanim.2011.05.009; Mellen J.D., 1998, 2 NATURE ENV ENRICHM, P329; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mills DS., 2010, ENCY APPL ANIMAL BEH, P685; Molla MI, 2011, J APPL ANIM WELF SCI, V14, P85, DOI 10.1080/10888705.2011.551619; Mononen J, 2012, ANIM WELFARE, V21, P363, DOI 10.7120/09627286.21.3.363; Moore D.S., 1993, INTRO PRACTICE STAT; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; NFACC, 2013, CODE PRACTICE CARE H; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; PALME R, 1994, ADVANCES IN STEROID ANALYSIS '93, P111; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Quinn GP, 2002, EXPERIMENTAL DESIGN; Reading RP, 2013, ZOO BIOL, V32, P332, DOI 10.1002/zoo.21054; Rojas IG, 2002, BRAIN BEHAV IMMUN, V16, P74, DOI 10.1006/brbi.2000.0619; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; RUSHEN J, 1991, APPL ANIM BEHAV SCI, V28, P381, DOI 10.1016/0168-1591(91)90170-3; Oliveira AFS, 2010, J ETHOL, V28, P1, DOI 10.1007/s10164-009-0167-7; SCHNEIDER RR, 1993, CAN VET J, V34, P159; Scientific Committee on Animal Health and Animal Welfare, 2001, WELF AN KEPT FUR PRO; Sharp J, 2005, CONTEMP TOP LAB ANIM, V44, P32; Shepherdson D., 1994, P167; SUNDQVIST C, 1984, J REPROD FERTIL, V70, P409, DOI 10.1530/jrf.0.0700409; SUNDQVIST C, 1989, J REPROD FERTIL, V85, P413, DOI 10.1530/jrf.0.0850413; Svendsen PM, 2013, APPL ANIM BEHAV SCI, V147, P172, DOI 10.1016/j.applanim.2013.05.011; Svendsen PM, 2007, APPL ANIM BEHAV SCI, V107, P110, DOI 10.1016/j.applanim.2006.09.014; Swaisgood RR, 2005, ZOO BIOL, V24, P499, DOI 10.1002/zoo.20066; Swaisgood RR, 2001, ANIM BEHAV, V61, P447, DOI 10.1006/anbe.2000.1610; Talbot S, 2014, APPL ANIM BEHAV SCI, V151, P94, DOI 10.1016/j.applanim.2013.11.017; Tuyttens FAM, 2014, ANIM BEHAV, V90, P273, DOI 10.1016/j.anbehav.2014.02.007; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Vinke CM, 2005, ANIM WELFARE, V14, P53; Walker MD, 2011, BEHAV BRAIN RES, V224, P207, DOI 10.1016/j.bbr.2011.06.003; Ward S, 2011, WORLD MINK OUTPUT CL; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; Whitaker J, 2009, LAB ANIMAL, V38, P24, DOI 10.1038/laban0109-24; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Wolf KN, 2000, ZOO BIOL, V19, P517, DOI 10.1002/1098-2361(2000)19:6<517::AID-ZOO4>3.3.CO;2-M	102	16	16	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2014	9	11							e110589	10.1371/journal.pone.0110589	http://dx.doi.org/10.1371/journal.pone.0110589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT9MC	25386726	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000345250400011
J	Yu, J; Yu, B; He, J; Zheng, P; Mao, XB; Han, GQ; Chen, DW				Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Han, Guoquan; Chen, Daiwen			Chronic Glucocorticoid Exposure-Induced Epididymal Adiposity Is Associated with Mitochondrial Dysfunction in White Adipose Tissue of Male C57BL/6J Mice	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; GROWTH-FACTOR 21; METABOLIC SYNDROME; CUSHINGS-SYNDROME; HUMAN ADIPOCYTES; PRIMARY SITE; LIPOLYSIS; CORTICOSTERONE; BIOGENESIS; ROSIGLITAZONE	Prolonged and excessive glucocorticoids (GC) exposure resulted from Cushing's syndrome or GC therapy develops central obesity. Moreover, mitochondria are crucial in adipose energy homeostasis. Thus, we tested the hypothesis that mitochondrial dysfunction may contribute to chronic GC exposure-induced epididymal adiposity in the present study. A total of thirty-six 5-week-old male C57BL/6J mice (similar to 20 g) were administrated with 100 mu g/ml corticosterone (CORT) or vehicle through drinking water for 4 weeks. Chronic CORT exposure mildly decreased body weight without altering food and water intake in mice. The epididymal fat accumulation was increased, but adipocyte size was decreased by CORT. CORT also increased plasma CORT, insulin, leptin, and fibroblast growth factor 21 concentrations as measured by RIA or ELISA. Interestingly, CORT increased plasma levels of triacylglycerols and nonesterified fatty acids, and up-regulated the expression of both lipolytic and lipogenic genes as determined by real-time RT-PCR. Furthermore, CORT impaired mitochondrial biogenesis and oxidative function in epididymal WAT. The reactive oxygen species production was increased and the activities of anti-oxidative enzymes were reduced by CORT treatment as well. Taken together, these findings reveal that chronic CORT administration-induced epididymal adiposity is, at least in part, associated with mitochondrial dysfunction in mouse epididymal white adipose tissue.	[Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Han, Guoquan; Chen, Daiwen] Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China; [Yu, Jie; Yu, Bing; He, Jun; Zheng, Ping; Mao, Xiangbing; Chen, Daiwen] Sichuan Agr Univ, Key Lab Anim Dis Resistance Nutr, China Minist Educ, Chengdu 611130, Peoples R China; [Han, Guoquan] Sichuan Agr Univ, Coll Food Sci, Yaan 625014, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Chen, DW (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Chengdu 611130, Peoples R China.	dwchen@sicau.edu.cn		Yu, Jiaojun/0000-0001-9400-5408	Sichuan Department of Education [13ZA0261]; Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education of China [IRT0555-5]	Sichuan Department of Education; Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by Key Project (13ZA0261) from Sichuan Department of Education (JY) and Program for Changjiang Scholars and Innovative Research Team in University (IRT0555-5) from Ministry of Education of China (DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany M, 2013, NUTR RES, V33, P1, DOI 10.1016/j.nutres.2012.11.013; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; BERDANIER CD, 1989, FASEB J, V3, P2179, DOI 10.1096/fasebj.3.10.2666232; Buttgereit F, 2005, LANCET, V365, P801; Campbell JE, 2011, AM J PHYSIOL-CELL PH, V300, pC198, DOI 10.1152/ajpcell.00045.2010; Cassano AE, 2012, COMPARATIVE MED, V62, P348; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Davies NA, 2013, J ENDOCRINOL; DEMONACOS C, 1995, J STEROID BIOCHEM, V55, P43, DOI 10.1016/0960-0760(95)00159-W; DIVERTIE GD, 1991, DIABETES, V40, P1228, DOI 10.2337/diabetes.40.10.1228; Djurhuus CB, 2002, AM J PHYSIOL-ENDOC M, V283, pE172, DOI 10.1152/ajpendo.00544.2001; Galitzky J, 2013, CELL METAB, V18, P3, DOI 10.1016/j.cmet.2013.06.008; Gathercole LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026223; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hassan-Smith Z, 2014, LANCET, V383, P53; Kaaman M, 2007, DIABETOLOGIA, V50, P2526, DOI 10.1007/s00125-007-0818-6; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Lee MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE1126, DOI 10.1152/ajpendo.00228.2012; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Liu JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034835; Liu Y, 2008, PHYSIOL GENOMICS, V32, P343, DOI 10.1152/physiolgenomics.00067.2007; Lu RH, 2010, MOL BIOL REP, V37, P2173, DOI 10.1007/s11033-009-9695-z; Lundgren M, 2008, HORM METAB RES, V40, P854, DOI 10.1055/s-0028-1087168; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; MAYOSMITH W, 1989, RADIOLOGY, V170, P515, DOI 10.1148/radiology.170.2.2911678; Minami I, 2006, INTERNAL MED, V45, P1231, DOI 10.2169/internalmedicine.45.1809; Murphy MP, 2013, CELL METAB, V18, P145, DOI 10.1016/j.cmet.2013.07.006; Murray F, 2008, EUR J PHARMACOL, V583, P115, DOI 10.1016/j.ejphar.2008.01.014; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Yuji OA, 2007, EXP MOL PATHOL, V83, P73, DOI 10.1016/j.yexmp.2007.02.007; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pezaro C, 2013, BRIT J CANCER, V109, P325, DOI 10.1038/bjc.2013.340; Rees SL, 2004, HORM BEHAV, V46, P411, DOI 10.1016/j.yhbeh.2004.03.010; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Schuff KG, 2003, PRIMARY CARE, V30, P791, DOI 10.1016/S0095-4543(03)00088-5; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SLAVIN BG, 1994, J LIPID RES, V35, P1535; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Stewart PM, 2005, CLIN MED, V5, P142, DOI 10.7861/clinmedicine.5-2-142; Stewart PM, 2003, EUR J ENDOCRINOL, V149, P163, DOI 10.1530/eje.0.1490163; Tang VM, 2013, HORM METAB RES, V45, P709, DOI 10.1055/s-0033-1345119; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Tsiriyotis C, 1997, BIOCHEM BIOPH RES CO, V235, P349, DOI 10.1006/bbrc.1997.6787; Wang Minghan, 2005, Nutr Metab (Lond), V2, P3, DOI 10.1186/1743-7075-2-3; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Yu J, 2012, BRIT J NUTR, V107, P461, DOI 10.1017/S0007114511003205; Yu J, 2012, ENDOCRINOLOGY, V153, P750, DOI 10.1210/en.2011-1591	51	43	46	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2014	9	11							e112628	10.1371/journal.pone.0112628	http://dx.doi.org/10.1371/journal.pone.0112628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CP	25551379	gold, Green Published, Green Submitted			2022-12-26	WOS:000349144400113
J	Wang, GZ; Huang, XY; Ng, TB; Lin, J; Ye, XY				Wang, Guozeng; Huang, Xiaoyun; Ng, Tzi Bun; Lin, Juan; Ye, Xiu Yun			High Phylogenetic Diversity of Glycosyl Hydrolase Family 10 and 11 Xylanases in the Sediment of Lake Dabusu in China	PLOS ONE			English	Article							BACTERIAL DIVERSITY; SODA LAKE; LONAR LAKE; SP-NOV.; ALKALINE; ENDO-BETA-1,4-XYLANASE; PURIFICATION; EXPRESSION; GENETICS; PROGRAM	Soda lakes are one of the most stable naturally occurring alkaline and saline environments, which harbor abundant microorganisms with diverse functions. In this study, culture-independent molecular methods were used to explore the genetic diversity of glycoside hydrolase (GH) family 10 and GH11 xylanases in Lake Dabusu, a soda lake with a pH value of 10.2 and salinity of 10.1%. A total of 671 xylanase gene fragments were obtained, representing 78 distinct GH10 and 28 GH11 gene fragments respectively, with most of them having low homology with known sequences. Phylogenetic analysis revealed that the GH10 xylanase sequences mainly belonged to Bacteroidetes, Proteobacteria, Actinobacteria, Firmicutes and Verrucomicrobia, while the GH11 sequences mainly consisted of Actinobacteria, Firmicutes and Fungi. A full-length GH10 xylanase gene (xynAS10-66) was directly cloned and expressed in Escherichia coli, and the recombinant enzymes showed high activity at alkaline pH. These results suggest that xylanase gene diversity within Lake Dabusu is high and that most of the identified genes might be novel, indicating great potential for applications in industry and agriculture.	[Wang, Guozeng; Huang, Xiaoyun; Lin, Juan; Ye, Xiu Yun] Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350108, Peoples R China; [Wang, Guozeng; Lin, Juan; Ye, Xiu Yun] Natl Engn Lab High Efficiency Enzyme Express, Fuzhou 350002, Peoples R China; [Ng, Tzi Bun] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Shatin, Hong Kong, Peoples R China	Fuzhou University; Chinese University of Hong Kong	Lin, J (corresponding author), Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou 350108, Peoples R China.	ljuan@fzu.edu.cn; xiuyunye@fzu.edu.cn	zhang, qingqing/GXF-2381-2022	Wang, Guozeng/0000-0001-6547-0490	National Natural Science Foundation of China [31301406]; Oceanic Public Welfare Industry Special Research Project of China [201305015]; Priming Scientific Research Foundation of Fuzhou University [XRC-1326]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Oceanic Public Welfare Industry Special Research Project of China; Priming Scientific Research Foundation of Fuzhou University	This research was supported by the National Natural Science Foundation of China (31301406), the Oceanic Public Welfare Industry Special Research Project of China (201305015) and the Priming Scientific Research Foundation of Fuzhou University (XRC-1326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarba SS, 2002, INT J SYST EVOL MICR, V52, P525, DOI [10.1099/ijs.0.01658-0, 10.1099/00207713-52-2-525]; Antony CP, 2013, ISME J, V7, P468, DOI 10.1038/ismej.2012.137; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Biely P, 1997, J BIOTECHNOL, V57, P151, DOI 10.1016/S0168-1656(97)00096-5; Blanco J, 1997, APPL MICROBIOL BIOT, V48, P208, DOI 10.1007/s002530051040; Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Foti MJ, 2008, EXTREMOPHILES, V12, P133, DOI 10.1007/s00792-007-0117-7; Gessesse A, 1998, APPL ENVIRON MICROB, V64, P3533; Gessesse A, 1998, J IND MICROBIOL BIOT, V20, P210, DOI 10.1038/sj.jim.2900503; Huang H, APPL MICROBIOL BIOTE, V87, P1141; Jeffries TW, 1996, CURR OPIN BIOTECH, V7, P337, DOI 10.1016/S0958-1669(96)80041-3; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; Joshi AA, 2008, MICROB ECOL, V55, P163, DOI 10.1007/s00248-007-9264-8; Khandeparkar R, 2007, BIORESOURCE TECHNOL, V98, P897, DOI 10.1016/j.biortech.2006.02.037; Kovaleva OL, 2011, FEMS MICROBIOL ECOL, V75, P37, DOI 10.1111/j.1574-6941.2010.00996.x; Kulkarni N, 1999, FEMS MICROBIOL REV, V23, P411, DOI 10.1111/j.1574-6976.1999.tb00407.x; Lanzen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072577; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin JL, 2005, APPL ENVIRON MICROB, V71, P6458, DOI 10.1128/AEM.71.10.6458-6462.2005; Ma YH, 2004, EXTREMOPHILES, V8, P45, DOI 10.1007/s00792-003-0358-z; Mamo G, 2006, MOL BIOTECHNOL, V33, P149; Martin-Sampedro R, 2012, BIORESOURCE TECHNOL, V110, P371, DOI 10.1016/j.biortech.2012.01.111; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Pagaling E, 2009, APPL ENVIRON MICROB, V75, P5750, DOI 10.1128/AEM.00040-09; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Rees HC, 2004, EXTREMOPHILES, V8, P63, DOI 10.1007/s00792-003-0361-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Shen J, 2001, CHIN J OCEANOL LIMN, V19, P91; Simkhada JR, 2012, APPL BIOCHEM BIOTECH, V168, P2017, DOI 10.1007/s12010-012-9914-2; Solomon V, 2007, ACTA CRYSTALLOGR D, V63, P845, DOI 10.1107/S0907444907024845; Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Verma D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052459; Wang GZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043480; Wang GZ, 2010, APPL MICROBIOL BIOT, V87, P1383, DOI 10.1007/s00253-010-2564-9; White JR, 2008, BIOINFORMATICS, V24, P462, DOI 10.1093/bioinformatics/btm632; Zhao BS, 2012, INT J SYST EVOL MICR, V62, P2618, DOI 10.1099/ijs.0.038315-0	41	38	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2014	9	11							e112798	10.1371/journal.pone.0112798	http://dx.doi.org/10.1371/journal.pone.0112798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AY6YT	24603699	gold, Green Submitted, Green Published			2022-12-26	WOS:000347709300106
J	Wang, GF; Zhang, QQ; Xu, N; Xu, KF; Wang, J; He, W; Yang, T				Wang, Guofeng; Zhang, Qingqing; Xu, Ning; Xu, Kuanfeng; Wang, Jian; He, Wei; Yang, Tao			Associations between Two Polymorphisms (FokI and BsmI) of Vitamin D Receptor Gene and Type 1 Diabetes Mellitus in Asian Population: A Meta-Analysis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; SUSCEPTIBILITY; ONSET; PATTERN; APAI; TAQI	Background: Vitamin D receptor (VDR) gene polymorphisms are possibly involved in the development of type 1 diabetes mellitus (T1DM). However, the results to date have been inconclusive. We performed a meta-analysis to examine the association between 2 polymorphisms (FokI and BsmI) of the VDR gene and T1DM in the Asian population. Methods: Literature was retrieved from PubMed, Web of Science, CBM, Embase and Chinese databases. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a random or fixed effect model. Results: In total, 20 papers (BsmI: 13 studies; FokI: 13 studies) were included. In contrast to the FokI polymorphism, the BsmI polymorphism was associated with an increased risk of T1DM in the Asian population (OR = 1.47, 95% CI = 1.13-1.91, P = 0.004 for B vs. b). Upon stratification by regional geography, an increased risk of T1DM in association with the BsmI polymorphism was observed in the East Asian population (OR = 1.97, 95% CI = 1.38-2.83, P<0.001 for B vs. b), whereas the FokI polymorphism was associated with an increased risk of T1DM in the West Asian population (OR = 1.45, 95% CI = 1.12-1.88, P = 0.004 for F vs. f). Conclusions: Our meta-analysis suggests that the BsmI polymorphism may be a risk factor for susceptibility to T1DM in the East Asian population, and the FokI polymorphism is associated with an increased risk of T1DM in the West Asian population. However, because the study size was limited, further studies are essential to confirm our results.	[Wang, Guofeng; Xu, Ning] Xuzhou Med Coll, Affiliated Hosp, Lianyungang Peoples Hosp 1, Dept Endocrinol Med, Lianyungang, Peoples R China; [Zhang, Qingqing; Xu, Kuanfeng; Wang, Jian; He, Wei; Yang, Tao] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol Med, Nanjing, Jiangsu, Peoples R China	Xuzhou Medical University; Nanjing Medical University	Yang, T (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol Med, Nanjing, Jiangsu, Peoples R China.	yangt@njmu.edu.cn	zhang, qingqing/GXF-2381-2022	Wang, Guozeng/0000-0001-6547-0490				Ban Y, 2001, BMC Med Genet, V2, P7, DOI 10.1186/1471-2350-2-7; Bonakdaran S., 2012, Eastern Mediterranean Health Journal, V18, P614; Chang TJ, 2000, CLIN ENDOCRINOL, V52, P575, DOI 10.1046/j.1365-2265.2000.00985.x; Cheng J., 2010, ZHONG GUO GU ZHI SHU, V16, P9; Du T, 2008, THESIS ZHONGNAN MED, P1; Guo SW, 2006, AM J EPIDEMIOL, V164, P711, DOI 10.1093/aje/kwj278; Israni N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008023; Kocabas A, 2010, J PEDIATR ENDOCR MET, V23, P1289, DOI 10.1515/jpem.2010.203; Lee YH, 2012, MOL BIOL REP, V39, P6471, DOI 10.1007/s11033-012-1466-6; Lemos MC, 2008, HUM IMMUNOL, V69, P134, DOI 10.1016/j.humimm.2008.01.008; Liao L., 2005, THESIS CENTRAL S U, P01, DOI [10.7666/d.y813612, DOI 10.7666/D.Y813612]; Liu JL, 2003, TRADE INFORM, P1; Mohammadnejad Z, 2012, MOL BIOL REP, V39, P831, DOI 10.1007/s11033-011-0805-3; Motohashi Y, 2003, J CLIN ENDOCR METAB, V88, P3137, DOI 10.1210/jc.2002-021881; Ponsonby AL, 2008, AM J EPIDEMIOL, V168, P358, DOI 10.1093/aje/kwn142; Sahin SB, 2012, GENET TEST MOL BIOMA, V16, P1179, DOI 10.1089/gtmb.2012.0173; Shen BS., 2004, THESIS TIANJIN MED U, P01; [盛正妍 SHENG Zheng-yan], 2009, [中国糖尿病杂志, Chinese Journal of Diabetes], V17, P666; Shi YJ., 2007, CHIN J DIABETES, V15, P219; Shimada A, 2008, J AUTOIMMUN, V30, P207, DOI 10.1016/j.jaut.2007.09.002; Xiao Xin-hua, 2006, Chinese Medical Sciences Journal, V21, P95; Xie YT, 2012, THESIS ZHONGNAN MED, P1; Xu MQ, 2010, ATHEROSCLEROSIS, V213, P191, DOI 10.1016/j.atherosclerosis.2010.07.046; Yavuz DG, 2011, ACTA DIABETOL, V48, P329, DOI 10.1007/s00592-011-0284-y; Yokota I, 2002, DIABETES CARE, V25, P1244, DOI 10.2337/diacare.25.7.1244; Zhang J, 2012, MOL CELL ENDOCRINOL, V355, P135, DOI 10.1016/j.mce.2012.02.003; Zhou W, 2006, CANCER EPIDEM BIOMAR, V15, P2239, DOI 10.1158/1055-9965.EPI-06-0023	27	38	43	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2014	9	3							e89325	10.1371/journal.pone.0089325	http://dx.doi.org/10.1371/journal.pone.0089325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4ID	24603699	gold, Green Submitted, Green Published			2022-12-26	WOS:000332483600011
